PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Andersson, AK; Ma, J; Wang, JM; Chen, X; Gedman, AL; Dang, JJ; Nakitandwe, J; Holmfeldt, L; Parker, M; Easton, J; Huether, R; Kriwacki, R; Rusch, M; Wu, G; Li, YJ; Mulder, H; Raimondi, S; Pounds, S; Kang, GL; Shi, L; Becksfort, J; Gupta, P; Payne-Turner, D; Vadodaria, B; Boggs, K; Yergeau, D; Manne, J; Song, GC; Edmonson, M; Nagahawatte, P; Wei, L; Cheng, C; Pei, DQ; Sutton, R; Venn, NC; Chetcuti, A; Rush, A; Catchpoole, D; Heldrup, J; Fioretos, T; Lu, C; Ding, L; Pui, CH; Shurtleff, S; Mullighan, CG; Mardis, ER; Wilson, RK; Gruber, TA; Zhang, JH; Downing, JR				Andersson, Anna K.; Ma, Jing; Wang, Jianmin; Chen, Xiang; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Parker, Matthew; Easton, John; Huether, Robert; Kriwacki, Richard; Rusch, Michael; Wu, Gang; Li, Yongjin; Mulder, Heather; Raimondi, Susana; Pounds, Stanley; Kang, Guolian; Shi, Lei; Becksfort, Jared; Gupta, Pankaj; Payne-Turner, Debbie; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi; Song, Guangchun; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Cheng, Cheng; Pei, Deqing; Sutton, Rosemary; Venn, Nicola C.; Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel; Heldrup, Jesper; Fioretos, Thoas; Lu, Charles; Ding, Li; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Mardis, Elaine R.; Wilson, Richard K.; Gruber, Tanja A.; Zhang, Jinghui; Downing, James R.		St Jude Children's Res Hosp-Washin	The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; K-RAS MUTATIONS; CHROMOSOMAL TRANSLOCATIONS; GENETIC ALTERATIONS; CANCER; IDENTIFICATION; RESISTANCE; T(4/11); FLT3; BREAKPOINT	Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leukemia with a poor prognosis. To define its mutational landscape, we performed whole-genome, exome, RNA and targeted DNA sequencing on 65 infants (47 MLL-R and 18 non-MLL-R cases) and 20 older children (MLL-R cases) with leukemia. Our data show that infant MLL-R ALL has one of the lowest frequencies of somatic mutations of any sequenced cancer, with the predominant leukemic clone carrying a mean of 1.3 non-silent mutations. Despite this paucity of mutations, we detected activating mutations in kinase-PI3K-RAS signaling pathway components in 47% of cases. Surprisingly, these mutations were often subclonal and were frequently lost at relapse. In contrast to infant cases, MLL-R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 x 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL, was rarely mutated in infant MLL-R ALL.	[Andersson, Anna K.; Ma, Jing; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Raimondi, Susana; Payne-Turner, Debbie; Song, Guangchun; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Gruber, Tanja A.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Andersson, Anna K.; Fioretos, Thoas] Lund Univ, Dept Clin Genet, Lund, Sweden; [Wang, Jianmin; Chen, Xiang; Parker, Matthew; Huether, Robert; Rusch, Michael; Wu, Gang; Li, Yongjin; Becksfort, Jared; Gupta, Pankaj; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Easton, John; Mulder, Heather; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi] St Jude Childrens Res Hosp, Pediat Canc Genome Project Lab, Memphis, TN 38105 USA; [Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Pounds, Stanley; Kang, Guolian; Shi, Lei; Cheng, Cheng; Pei, Deqing] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Sutton, Rosemary; Venn, Nicola C.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel] Childrens Hosp Westmead, Tumor Bank, Childrens Canc Res Unit, Sydney, NSW, Australia; [Heldrup, Jesper] Skane Univ Hosp, Dept Pediat, Lund, Sweden; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO USA; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO USA; [Pui, Ching-Hon; Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Lund University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Children's Cancer Institute; University of New South Wales Sydney; University of Sydney; Lund University; Skane University Hospital; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); St Jude Children's Research Hospital	Andersson, AK (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	anna.andersson@med.lu.se; tanja.gruber@stjude.org; james.downing@stjude.org	Pui, Ching-Hon/N-8076-2018; Mardis, Elaine/W-2202-2019; Heldrup, Jesper/AAW-6836-2020; Mullighan, Charles/H-3253-2011; Rush, Amanda/ABD-3077-2020; Wu, Gang/M-8012-2014; Chen, Xiang/N-2524-2018; Gruber, Tanja/AAH-1248-2021; Downing, James R./N-8102-2018; Zhang, Jing/GWZ-7332-2022; Cheng, Cheng/N-8075-2018; Rush, Amanda/AFO-5668-2022; Rusch, Michael/AAG-1998-2019; Kriwacki, Richard/N-8154-2018; Rush, Amanda/AAZ-5391-2020; wang, jian/GVS-0711-2022; Wilson, Richard K./AAF-4139-2019; Sutton, Rosemary/J-3784-2014; Raimondi, Susana C/N-8166-2018; LI, YONGJIN/E-1688-2011; Pounds, Stanley B/N-2480-2018; Huether, Robert/E-9638-2012	Pui, Ching-Hon/0000-0003-0303-5658; Mullighan, Charles/0000-0002-1871-1850; Wu, Gang/0000-0002-1678-5864; Chen, Xiang/0000-0002-2499-8261; Rush, Amanda/0000-0002-8714-8547; Rusch, Michael/0000-0002-5363-1848; Kriwacki, Richard/0000-0002-9798-6018; Wilson, Richard K./0000-0002-1992-1358; Sutton, Rosemary/0000-0002-0188-6005; Pounds, Stanley B/0000-0002-9167-2114; Huether, Robert/0000-0001-7077-7470; Easton, John/0000-0003-4503-6608; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Parker, Matthew/0000-0003-2999-3870; Holmfeldt, Linda/0000-0003-4140-3423; Heldrup, Jesper/0000-0002-6211-1967; Fioretos, Thoas/0000-0002-3235-6154	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; US National Institutes of Health [P30 CA021765]; Swedish Childhood Cancer Society; Swedish Research Council; Swedish Cancer Society; BioCARE; Gunnar Nilsson Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA016056] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Childhood Cancer Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE; Gunnar Nilsson Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the patients and their parents from the St. Jude Children's Research Hospital (USA), the Department of Pediatrics at Lund University Hospital (Sweden) and the children's hospitals associated with the Australian and New Zealand Children's Haematology and Oncology Group. We thank B. Pappas and S. Malone for IT infrastructure. We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital. We thank E. Parganas and J. Ihle (St. Jude Children's Research Hospital) for the mouse BaF3 cells. This work was funded by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and was supported by a grant from the US National Institutes of Health (P30 CA021765). A.K.A. was supported by the Swedish Childhood Cancer Society, the Swedish Research Council, the Swedish Cancer Society, BioCARE and the Gunnar Nilsson Cancer Foundation. C.G.M. is a Pew Scholar in Biomedical Sciences and a St. Baldrick's Scholar.	Bardini M, 2015, LEUKEMIA, V29, P38, DOI 10.1038/leu.2014.154; Bardini M, 2011, LEUKEMIA, V25, P175, DOI 10.1038/leu.2010.232; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Chang VY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-55; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; De Lorenzo P, 2014, LEUKEMIA, V28, P428, DOI 10.1038/leu.2013.280; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dobbins SE, 2013, GENE CHROMOSOME CANC, V52, P954, DOI 10.1002/gcc.22090; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; DOWNING JR, 1994, BLOOD, V83, P330, DOI 10.1182/blood.V83.2.330.bloodjournal832330; Driessen EMC, 2013, HAEMATOLOGICA, V98, P937, DOI 10.3324/haematol.2012.067983; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heerema NA, 2002, CANCER-AM CANCER SOC, V94, P1102, DOI 10.1002/cncr.10325; HEEREMA NA, 1994, BLOOD, V83, P2274, DOI 10.1182/blood.V83.8.2274.bloodjournal8382274; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kim WI, 2009, BLOOD, V113, P1086, DOI 10.1182/blood-2008-01-132316; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ono R, 2009, LEUKEMIA, V23, P2197, DOI 10.1038/leu.2009.177; Opatz S, 2013, BLOOD, V122, P1761, DOI 10.1182/blood-2013-01-476473; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pounds S, 2013, BIOINFORMATICS, V29, P2088, DOI 10.1093/bioinformatics/btt372; Prelle C, 2013, LEUKEMIA, V27, P1425, DOI 10.1038/leu.2012.365; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reichel M, 1998, ONCOGENE, V17, P3035, DOI 10.1038/sj.onc.1202229; Rozen S, 2000, Methods Mol Biol, V132, P365; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; Szczepanski T, 2010, LANCET ONCOL, V11, P880, DOI 10.1016/S1470-2045(09)70369-9; Tamai H, 2011, LEUKEMIA, V25, P888, DOI 10.1038/leu.2011.15; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	67	295	303	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					330	U192		10.1038/ng.3230	http://dx.doi.org/10.1038/ng.3230			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730765	Green Accepted			2022-12-25	WOS:000351922900007
J	Lassak, J; Keilhauer, EC; Furst, M; Wuichet, K; Godeke, J; Starosta, AL; Chen, JM; Sogaard-Andersen, L; Rohr, J; Wilson, DN; Haussler, S; Mann, M; Jung, K				Lassak, Juergen; Keilhauer, Eva C.; Fuerst, Maximilian; Wuichet, Kristin; Goedeke, Julia; Starosta, Agata L.; Chen, Jhong-Min; Sogaard-Andersen, Lotte; Rohr, Juergen; Wilson, Daniel N.; Haeussler, Susanne; Mann, Matthias; Jung, Kirsten			Arginine-rhamnosylation as new strategy to activate translation elongation factor P	NATURE CHEMICAL BIOLOGY			English	Article							FACTOR EF-P; PSEUDOMONAS-AERUGINOSA; PROMOTES TRANSLATION; AMINO-ACID; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; HYPUSINE; LYSINE; VIRULENCE	Ribosome stalling at polyproline stretches is common and fundamental. In bacteria, translation elongation factor P (EF-P) rescues such stalled ribosomes, but only when it is post-translationally activated. In Escherichia coli, activation of EF-P is achieved by (R)-beta-lysinylation and hydroxylation of a conserved lysine. Here we have unveiled a markedly different modification strategy in which a conserved arginine of EF-P is rhamnosylated by a glycosyltransferase (EarP) using dTDP-L-rhamnose as a substrate. This is to our knowledge the first report of N-linked protein glycosylation on arginine in bacteria and the first example in which a glycosylated side chain of a translation elongation factor is essential for function. Arginine-rhamnosylation of EF-P also occurs in clinically relevant bacteria such as Pseudomonas aeruginosa. We demonstrate that the modification is needed to develop pathogenicity, making EarP and dTDP-L-rhamnose-biosynthesizing enzymes ideal targets for antibiotic development.	[Lassak, Juergen; Fuerst, Maximilian; Starosta, Agata L.; Wilson, Daniel N.; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Lassak, Juergen; Fuerst, Maximilian; Jung, Kirsten] Univ Munich, Microbiol, Dept Biol 1, Martinsried, Germany; [Keilhauer, Eva C.; Mann, Matthias] Max Planck Inst Biochem, Prote & Signal Transduct, D-82152 Martinsried, Germany; [Wuichet, Kristin; Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Goedeke, Julia; Haeussler, Susanne] Twincore, Ctr Clin & Expt Infect Res, Inst Mol Bacteriol, Hannover, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany; [Chen, Jhong-Min; Rohr, Juergen] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany	University of Munich; University of Munich; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich; University of Kentucky; Helmholtz Association; Helmholtz-Center for Infection Research	Lassak, J (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany.	juergen.lassak@lmu.de; jung@lmu.de	Wilson, Daniel/AAE-8504-2019; Starosta, Agata/D-9535-2017; Häussler, Susanne/I-2605-2014; Lassak, Jürgen Michael/Q-2128-2019	Wilson, Daniel/0000-0003-3816-3828; Starosta, Agata/0000-0003-3915-5723; Häussler, Susanne/0000-0001-6141-9102; Lassak, Jürgen Michael/0000-0003-3936-3389; Sogaard-Andersen, Lotte/0000-0002-0674-0013	Deutsche Forschungsgemeinschaft: Center for Integrated Protein Science Munich (CiPSM) [Exc114/2, WI3285/4-1]; Max Planck Society; AXA Research Fund Postdoctoral Fellowship; Helmholtz Association; Bundesministerium fur Bildung und Forschung; US National Institutes of Health [CA 091901]; NATIONAL CANCER INSTITUTE [R01CA091901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105977] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft: Center for Integrated Protein Science Munich (CiPSM); Max Planck Society(Max Planck SocietyFoundation CELLEX); AXA Research Fund Postdoctoral Fellowship(AXA Research Fund); Helmholtz Association(Helmholtz Association); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank I. Weitl for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft: Center for Integrated Protein Science Munich (CiPSM; Exc114/2 to K.J. and WI3285/4-1 to D.N.W.) and the Max Planck Society (to E.C.K., K.W., L.S.-A. and M.M.). A.L.S. is funded by an AXA Research Fund Postdoctoral Fellowship. The work of S.H. and J.G. was supported by the Helmholtz Association and the Bundesministerium fur Bildung und Forschung. J.-M.C. and J.R are funded by the US National Institutes of Health (CA 091901).	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Eddy Sean R, 2009, Genome Inform, V23, P205; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gentzsch J, 2011, ANTIVIR RES, V89, P136, DOI 10.1016/j.antiviral.2010.12.005; Gilreath MS, 2011, FEBS LETT, V585, P3284, DOI 10.1016/j.febslet.2011.09.008; Godeke J, 2013, ANTIMICROB AGENTS CH, V57, P1617, DOI 10.1128/AAC.02582-12; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Haid S, 2010, J VIROL, V84, P964, DOI 10.1128/JVI.01504-09; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Haneburger I, 2011, J BIOL CHEM, V286, P10681, DOI 10.1074/jbc.M110.196923; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keilberg D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002951; Kharel MK, 2011, ORG BIOMOL CHEM, V9, P1799, DOI 10.1039/c0ob00854k; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Maki M, 2004, GLYCOBIOLOGY, V14, p1R, DOI 10.1093/glycob/cwh040; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Neuhauser N, 2012, MOL CELL PROTEOMICS, V11, P1500, DOI 10.1074/mcp.M112.020271; OCHSNER UA, 1994, J BACTERIOL, V176, P2044, DOI 10.1128/jb.176.7.2044-2054.1994; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; SINGH DG, 1995, FEBS LETT, V376, P61, DOI 10.1016/0014-5793(95)01247-6; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wang GJ, 2012, ANGEW CHEM INT EDIT, V51, P10638, DOI 10.1002/anie.201205414; Wang GJ, 2011, CHEMBIOCHEM, V12, P2568, DOI 10.1002/cbic.201100540; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	58	85	89	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					266	U44		10.1038/NCHEMBIO.1751	http://dx.doi.org/10.1038/NCHEMBIO.1751			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25686373	Green Accepted			2022-12-25	WOS:000351666500008
J	Klijn, C; Durinck, S; Stawiski, EW; Haverty, PM; Jiang, ZS; Liu, HB; Degenhardt, J; Mayba, O; Gnad, F; Liu, JF; Pau, G; Reeder, J; Cao, Y; Mukhyala, K; Selvaraj, SK; Yu, MM; Zynda, GJ; Brauer, MJ; Wu, TD; Gentleman, RC; Manning, G; Yauch, RL; Bourgon, R; Stokoe, D; Modrusan, Z; Neve, RM; de Sauvage, FJ; Settleman, J; Seshagiri, S; Zhang, ZM				Klijn, Christiaan; Durinck, Steffen; Stawiski, Eric W.; Haverty, Peter M.; Jiang, Zhaoshi; Liu, Hanbin; Degenhardt, Jeremiah; Mayba, Oleg; Gnad, Florian; Liu, Jinfeng; Pau, Gregoire; Reeder, Jens; Cao, Yi; Mukhyala, Kiran; Selvaraj, Suresh K.; Yu, Mamie; Zynda, Gregory J.; Brauer, Matthew J.; Wu, Thomas D.; Gentleman, Robert C.; Manning, Gerard; Yauch, Robert L.; Bourgon, Richard; Stokoe, David; Modrusan, Zora; Neve, Richard M.; de Sauvage, Frederic J.; Settleman, Jeffrey; Seshagiri, Somasekar; Zhang, Zemin			A comprehensive transcriptional portrait of human cancer cell lines	NATURE BIOTECHNOLOGY			English	Article							TO-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; COPY-NUMBER ALTERATION; BREAST-CANCER; MOLECULAR PHARMACOLOGY; DRUG-SENSITIVITY; TYROSINE KINASE; IDENTIFICATION; INHIBITOR; GENOME	Tumor-derived cell lines have served as vital models to advance our understanding of oncogene function and therapeutic responses. Although substantial effort has been made to define the genomic constitution of cancer cell line panels, the transcriptome remains understudied. Here we describe RNA sequencing and single-nucleotide polymorphism ( SNP) array analysis of 675 human cancer cell lines. We report comprehensive analyses of transcriptome features including gene expression, mutations, gene fusions and expression of non-human sequences. Of the 2,200 gene fusions catalogued, 1,435 consist of genes not previously found in fusions, providing many leads for further investigation. We combine multiple genome and transcriptome features in a pathway-based approach to enhance prediction of response to targeted therapeutics. Our results provide a valuable resource for studies that use cancer cell lines.	[Klijn, Christiaan; Durinck, Steffen; Stawiski, Eric W.; Haverty, Peter M.; Jiang, Zhaoshi; Liu, Hanbin; Degenhardt, Jeremiah; Mayba, Oleg; Gnad, Florian; Liu, Jinfeng; Pau, Gregoire; Reeder, Jens; Cao, Yi; Mukhyala, Kiran; Zynda, Gregory J.; Brauer, Matthew J.; Wu, Thomas D.; Gentleman, Robert C.; Manning, Gerard; Bourgon, Richard; Zhang, Zemin] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Durinck, Steffen; Stawiski, Eric W.; Modrusan, Zora; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Cao, Yi; Selvaraj, Suresh K.; Yu, Mamie; Yauch, Robert L.; Stokoe, David; Neve, Richard M.; Settleman, Jeffrey] Genentech Inc, Dept Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, Dept Oncol, San Francisco, CA 94080 USA.	jeffrees@gene.com; sekar@gene.com; zemin@pku.edu.cn	de Sauvage, Frederic/ABE-8400-2020; Manning, Gerard/C-8308-2009	de Sauvage, Frederic/0000-0002-5275-2584; Bourgon, Richard/0000-0002-5890-4374; Manning, Gerard/0000-0002-5087-9151; Gnad, Florian/0000-0002-2287-2251; Klijn, Christiaan/0000-0003-0878-4121; Seshagiri, Somasekar/0000-0003-4272-6443; Liu, Jinfeng/0000-0002-0343-8222				Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Alves CP, 2013, STEM CELLS, V31, P2827, DOI 10.1002/stem.1547; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2010, NAT REV CANC, V10, P441; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; DeRisi J, 1996, NAT GENET, V14, P457; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin Z, 2012, J VIROL, V86, P2970, DOI 10.1128/JVI.06717-11; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitelman F., MITELMAN DATABASE CH; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sutherlin DP, 2011, J MED CHEM, V54, P7579, DOI 10.1021/jm2009327; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050	50	385	408	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					306	+		10.1038/nbt.3080	http://dx.doi.org/10.1038/nbt.3080			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485619				2022-12-25	WOS:000350766900029
J	Moignard, V; Woodhouse, S; Haghverdi, L; Lilly, AJ; Tanaka, Y; Wilkinson, AC; Buettner, F; Macaulay, IC; Jawaid, W; Diamanti, E; Nishikawa, SI; Piterman, N; Kouskoff, V; Theis, FJ; Fisher, J; Gottgens, B				Moignard, Victoria; Woodhouse, Steven; Haghverdi, Laleh; Lilly, Andrew J.; Tanaka, Yosuke; Wilkinson, Adam C.; Buettner, Florian; Macaulay, Iain C.; Jawaid, Wajid; Diamanti, Evangelia; Nishikawa, Shin-Ichi; Piterman, Nir; Kouskoff, Valerie; Theis, Fabian J.; Fisher, Jasmin; Goettgens, Berthold			Decoding the regulatory network of early blood development from single-cell gene expression measurements	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELL; YOLK-SAC; HEMATOPOIETIC DEVELOPMENT; DEFINITIVE HEMATOPOIESIS; RNA-SEQ; ADULT HEMATOPOIESIS; FATE DECISIONS; MOUSE EMBRYOS; LEUKEMIA; MICE	Reconstruction of the molecular pathways controlling organ development has been hampered by a lack of methods to resolve embryonic progenitor cells. Here we describe a strategy to address this problem that combines gene expression profiling of large numbers of single cells with data analysis based on diffusion maps for dimensionality reduction and network synthesis from state transition graphs. Applying the approach to hematopoietic development in the mouse embryo, we map the progression of mesoderm toward blood using single-cell gene expression analysis of 3,934 cells with blood-forming potential captured at four time points between E7.0 and E8.5. Transitions between individual cellular states are then used as input to develop a single-cell network synthesis toolkit to generate a computationally executable transcriptional regulatory network model of blood development. Several model predictions concerning the roles of Sox and Hox factors are validated experimentally. Our results demonstrate that single-cell analysis of a developing organ coupled with computational approaches can reveal the transcriptional programs that underpin organogenesis.	[Moignard, Victoria; Woodhouse, Steven; Tanaka, Yosuke; Wilkinson, Adam C.; Jawaid, Wajid; Diamanti, Evangelia; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; [Moignard, Victoria; Woodhouse, Steven; Tanaka, Yosuke; Wilkinson, Adam C.; Diamanti, Evangelia; Goettgens, Berthold] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England; [Haghverdi, Laleh; Buettner, Florian; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Haghverdi, Laleh; Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany; [Lilly, Andrew J.; Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Haematopoiesis Grp, Manchester, Lancs, England; [Tanaka, Yosuke; Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo, Japan; [Macaulay, Iain C.] Wellcome Trust Sanger Inst, EBI Single Cell Genom Ctr, Sanger Inst, Cambridge, England; [Piterman, Nir] Univ Leicester, Dept Comp Sci, Leicester, Leics, England; [Fisher, Jasmin] Microsoft Res Cambridge, Cambridge, England; [Fisher, Jasmin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; RIKEN; Wellcome Trust Sanger Institute; University of Leicester; Microsoft; University of Cambridge	Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England.	jasmin.fisher@microsoft.com; bg200@cam.ac.uk	Theis, Fabian J/ABD-5212-2021; Buettner, Florian/ABF-1230-2020; Jawaid, Wajid/L-3625-2016	Theis, Fabian J/0000-0002-2419-1943; Buettner, Florian/0000-0001-5587-6761; Jawaid, Wajid/0000-0002-4861-6694; Fisher, Jasmin/0000-0003-4477-9047; Piterman, Nir/0000-0002-8242-5357; Gottgens, Berthold/0000-0001-6302-5705; Macaulay, Iain/0000-0002-6761-757X; Haghverdi, Laleh/0000-0001-9280-9170	Medical Research Council; Biotechnology and Biological Sciences Research Council; Leukaemia and Lymphoma Research; Leukemia and Lymphoma Society; Wellcome Trust; Medical Research Council Studentship and Centenary Award; Microsoft Research PhD Scholarship; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12486, 12765] Funding Source: researchfish; Medical Research Council [MR/M008975/1, MC_PC_12009, G0900951] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0900951, MR/M008975/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Wellcome Trust(Wellcome Trust); Medical Research Council Studentship and Centenary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Microsoft Research PhD Scholarship(Microsoft); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Downing (St. Jude Children's Research Hospital, Memphis, TN, USA) for the Runx1-ires-GFP mouse. Research in the authors' laboratory is supported by the Medical Research Council, Biotechnology and Biological Sciences Research Council, Leukaemia and Lymphoma Research, the Leukemia and Lymphoma Society, Microsoft Research and core support grants by the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust - MRC Cambridge Stem Cell Institute. V.M. is supported by a Medical Research Council Studentship and Centenary Award and S.W. by a Microsoft Research PhD Scholarship.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bailey N.T.J., 1995, STAT METHODS BIOL, V1995, P255; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Ding G, 2013, DEV DYNAM, V242, P254, DOI 10.1002/dvdy.23923; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Fan R, 2012, BLOOD, V119, pE139, DOI 10.1182/blood-2011-12-396754; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Koksal AS, 2013, ACM SIGPLAN NOTICES, V48, P469, DOI 10.1145/2480359.2429125; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Moignard V, 2013, BLOOD CELL MOL DIS, V51, P239, DOI 10.1016/j.bcmd.2013.07.007; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; North T, 1999, DEVELOPMENT, V126, P2563; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wareing S, 2012, STEM CELLS, V30, P1521, DOI 10.1002/stem.1115; Wilkinson AC, 2013, BIOL OPEN, V2, P1229, DOI 10.1242/bio.20136296; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	58	227	227	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					269	+		10.1038/nbt.3154	http://dx.doi.org/10.1038/nbt.3154			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25664528	Green Accepted			2022-12-25	WOS:000350766900023
J	Carriere, Y; Crickmore, N; Tabashnik, BE				Carriere, Yves; Crickmore, Neil; Tabashnik, Bruce E.			Optimizing pyramided transgenic Bt crops for sustainable pest management	NATURE BIOTECHNOLOGY			English	Article							BACILLUS-THURINGIENSIS TOXINS; EUROPEAN CORN-BORER; HELICOVERPA-ZEA LEPIDOPTERA; FIELD-DERIVED STRAIN; INSECT RESISTANCE; TOLERANCE RESPONSE; CROSS-RESISTANCE; MULTIPLE TOXINS; FITNESS COSTS; CRY1AB TOXIN	Transgenic crop pyramids producing two Or more Bacillus thuringiensis (Bt) toxins that kill the same insect pest have been widely used to delay evolution of pest resistance. To assess the potential of pyramids to achieve this goal, we analyze data from 38 studies that report effects of ten Bt toxins used in transgenic crops against 15 insect pests. We find that compared with optimal low levels of insect survival, survival on currently used pyramids is often higher for both susceptible insects and insects resistant to one of the toxins in the pyramid. Furthermore, we find that cross-resistance and antagonism between toxins used in pyramids are common, and that these problems are associated with the similarity of the amino acid sequences of domains II and III of the toxins, respectively. This analysis should assist in future pyramid design and the development of sustainable resistance management strategies.	[Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Crickmore, Neil] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Arizona; University of Sussex	Carriere, Y (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu		Crickmore, Neil/0000-0002-8448-0763	US Department of Agriculture (USDA) Biotechnology Risk Assessment [2011-33522-30729]	US Department of Agriculture (USDA) Biotechnology Risk Assessment(United States Department of Agriculture (USDA))	We thank J. Rick for help with searching the literature for cross-resistance data and F. Huang for providing data from one of his publications. This study was supported by US Department of Agriculture (USDA) Biotechnology Risk Assessment Grant Award 2011-33522-30729.	Adamczyk JJ, 2004, FLA ENTOMOL, V87, P427, DOI 10.1653/0015-4040(2004)087[0427:LAFPOC]2.0.CO;2; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Alphey N, 2008, THEOR ECOL-NETH, V1, P103, DOI 10.1007/s12080-008-0010-8; Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; Brevault T, 2012, EVOL APPL, V5, P53, DOI 10.1111/j.1752-4571.2011.00207.x; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Caprio MA, 1998, J ECON ENTOMOL, V91, P1021, DOI 10.1093/jee/91.5.1021; Carmona D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019952; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Crespo ALB, 2011, J INVERTEBR PATHOL, V107, P185, DOI 10.1016/j.jip.2011.04.007; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Dutton A., 2004, Bulletin OILB/SROP, V27, P49; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1986, ENVIRON ENTOMOL, V15, P1, DOI 10.1093/ee/15.1.1; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; Groeters FR, 2000, J ECON ENTOMOL, V93, P1580, DOI 10.1603/0022-0493-93.6.1580; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; James C., 2013, ISAAA BRIEFS; Jurat-Fuentes JL, 2012, INSECT PATHOLOGY, 2ND EDITION, P265, DOI 10.1016/B978-0-12-384984-7.00008-7; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Matten, 2012, REGULATION AGR BIOTE, P1752267; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; National Research Council, 2010, IMP GEN ENG CROPS FA; NELSON R R, 1972, Journal of Environmental Quality, V1, P220, DOI 10.2134/jeq1972.00472425000100030004x; Nguyen HT, 2009, J AGR FOOD CHEM, V57, P9990, DOI 10.1021/jf901115m; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shi GM, 2013, NAT BIOTECHNOL, V31, P111, DOI 10.1038/nbt.2496; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 1996, APPL ENVIRON MICROB, V62, P2839, DOI 10.1128/AEM.62.8.2839-2844.1996; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; US Environmental Protection Agency, 1998, FIN REP SUBP BAC THU; US Environmental Protection Agency, 2011, CURR PREV REG SECT 3; US EPA, 2007, PEST NEWS STOR EPA A; (US EPA) U. S. Environmental Protection Agency, 1998, ENV PROT AG WHIT PAP; van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	75	208	225	2	161	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					161	168		10.1038/nbt.3099	http://dx.doi.org/10.1038/nbt.3099			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599179				2022-12-25	WOS:000349198800021
J	Rad, R; Rad, L; Wang, W; Strong, A; Ponstingl, H; Bronner, IF; Mayho, M; Steiger, K; Weber, J; Hieber, M; Veltkamp, C; Eser, S; Geumann, U; Ollinger, R; Zukowska, M; Barenboim, M; Maresch, R; Cadinanos, J; Friedrich, M; Varela, I; Constantino-Casas, F; Sarver, A; ten Hoeve, J; Prosser, H; Seidler, B; Bauer, J; Heikenwalder, M; Metzakopian, E; Krug, A; Ehmer, U; Schneider, G; Knosel, T; Ruemmele, P; Aust, D; Grutzmann, R; Pilarsky, C; Ning, ZM; Wessels, L; Schmid, RM; Quail, MA; Vassiliou, G; Esposito, I; Liu, P; Saur, D; Bradley, A				Rad, Roland; Rad, Lena; Wang, Wei; Strong, Alexander; Ponstingl, Hannes; Bronner, Iraad F.; Mayho, Matthew; Steiger, Katja; Weber, Julia; Hieber, Maren; Veltkamp, Christian; Eser, Stefan; Geumann, Ulf; Oellinger, Rupert; Zukowska, Magdalena; Barenboim, Maxim; Maresch, Roman; Cadinanos, Juan; Friedrich, Mathias; Varela, Ignacio; Constantino-Casas, Fernando; Sarver, Aaron; ten Hoeve, Jelle; Prosser, Haydn; Seidler, Barbara; Bauer, Judith; Heikenwaelder, Mathias; Metzakopian, Emmanouil; Krug, Anne; Ehmer, Ursula; Schneider, Guenter; Knoesel, Thomas; Ruemmele, Petra; Aust, Daniela; Gruetzmann, Robert; Pilarsky, Christian; Ning, Zemin; Wessels, Lodewyk; Schmid, Roland M.; Quail, Michael A.; Vassiliou, George; Esposito, Irene; Liu, Pentao; Saur, Dieter; Bradley, Allan			A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer	NATURE GENETICS			English	Article							SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; SOMATIC MUTAGENESIS; EXPRESSION; TOOL; LANDSCAPE; DISCOVERY; PROTEINS; FIDGETIN; PATHWAYS	Here we describe a conditional piggyBac transposition system in mice and report the discovery of large sets of new cancer genes through a pancreatic insertional mutagenesis screen. We identify Foxp1 as an oncogenic transcription factor that drives pancreatic cancer invasion and spread in a mouse model and correlates with lymph node metastasis in human patients with pancreatic cancer. The propensity of piggyBac for open chromatin also enabled genome-wide screening for cancer-relevant noncoding DNA, which pinpointed a Cdkn2a cis-regulatory region. Histologically, we observed different tumor subentities and discovered associated genetic events, including Fign insertions in hepatoid pancreatic cancer. Our studies demonstrate the power of genetic screening to discover cancer drivers that are difficult to identify by other approaches to cancer genome analysis, such as downstream targets of commonly mutated human cancer genes. These piggyBac resources are universally applicable in any tissue context and provide unique experimental access to the genetic complexity of cancer.	[Rad, Roland; Weber, Julia; Hieber, Maren; Veltkamp, Christian; Eser, Stefan; Geumann, Ulf; Oellinger, Rupert; Zukowska, Magdalena; Barenboim, Maxim; Maresch, Roman; Seidler, Barbara; Krug, Anne; Ehmer, Ursula; Schneider, Guenter; Schmid, Roland M.; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, D-80290 Munich, Germany; [Rad, Roland; Weber, Julia; Geumann, Ulf; Barenboim, Maxim; Maresch, Roman; Saur, Dieter] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Rad, Roland; Rad, Lena; Wang, Wei; Strong, Alexander; Ponstingl, Hannes; Bronner, Iraad F.; Mayho, Matthew; Friedrich, Mathias; Prosser, Haydn; Metzakopian, Emmanouil; Ning, Zemin; Quail, Michael A.; Vassiliou, George; Bradley, Allan] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Steiger, Katja] Tech Univ Munich, Klinikum Rechts Isar, Dept Pathol, D-80290 Munich, Germany; [Cadinanos, Juan] IMOMA, Oviedo, Spain; [Varela, Ignacio] Inst Biomed & Biotecnol Cantabria UC CSIC SODERCA, Santander, Spain; [Constantino-Casas, Fernando] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sarver, Aaron] Univ Minnesota, Biostat & Bioinformat Mason Canc Ctr, Minneapolis, MN USA; [ten Hoeve, Jelle; Wessels, Lodewyk] Netherlands Canc Inst, Amsterdam, Netherlands; [Bauer, Judith; Heikenwaelder, Mathias] Tech Univ Munich, Inst Virol, D-80290 Munich, Germany; [Knoesel, Thomas] Univ Munich, Inst Pathol, Munich, Germany; [Ruemmele, Petra] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Aust, Daniela] Tech Univ Dresden, Inst Pathol, D-01062 Dresden, Germany; [Gruetzmann, Robert; Pilarsky, Christian] Tech Univ Dresden, Dept Surg, D-01062 Dresden, Germany; [Esposito, Irene] Med Univ Insbruck, Inst Pathol, Insbruck, Austria	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Wellcome Trust Sanger Institute; Technical University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; Technical University of Munich; University of Munich; University of Regensburg; Technische Universitat Dresden; Technische Universitat Dresden	Rad, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, D-80290 Munich, Germany.	roland.rad@lrz.tum.de	Varela, Ignacio/AAA-7680-2021; Ning, Zemin/D-2411-2013; Heikenwalder, Mathias/AAA-2269-2020; Varela, Ignacio/G-1699-2016; Quail, michael/ABE-6131-2020; Saur, Dieter/O-8355-2015; Wilson, Matthew H/K-3193-2013; Barenboim, Maxim/ABE-1253-2021	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Saur, Dieter/0000-0001-5874-0210; Barenboim, Maxim/0000-0002-9821-3797; Vassiliou, George/0000-0003-4337-8022; Cadinanos, Juan/0000-0001-7561-7759; Hieber, Maren/0000-0003-0940-9972; Ollinger, Rupert/0000-0002-2292-5982; Bradley, Allan/0000-0002-2349-8839; Steiger, Katja/0000-0002-7269-5433; Pilarsky, Christian/0000-0002-7968-3283; Weber, Julia/0000-0002-0183-8994; Ning, Zemin/0000-0003-4359-776X	Wellcome Trust; German Cancer Consortium; Helmholtz Gemeinschaft; Wellcome Trust Sanger Institute Research	Wellcome Trust(Wellcome TrustEuropean Commission); German Cancer Consortium; Helmholtz Gemeinschaft(Helmholtz Association); Wellcome Trust Sanger Institute Research	We thank the Wellcome Trust Sanger Institute Research Support Facility for excellent technical assistance as well as K. Yusa and B. Gottgens for discussions and advice. The work was supported by the Wellcome Trust (to A.B.), the German Cancer Consortium (to R.R.) and the Helmholtz Gemeinschaft (PCCC Consortium; to R.R. and D.S.).	Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bessereau J.L., 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.70.1, DOI 10.1895/W0RMB00K.1.70.1]; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Klimstra DS, 2009, ARCH PATHOL LAB MED, V133, P454, DOI 10.1043/1543-2165-133.3.454; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; Metzgeroth G, 2010, ONKOLOGIE, V33, P263, DOI 10.1159/000305717; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Quail M.A., 2009, CURR PROTOC HUM GENE, V62; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Sarver AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-154; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105	55	52	54	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					47	+		10.1038/ng.3164	http://dx.doi.org/10.1038/ng.3164			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25485836				2022-12-25	WOS:000346990400011
J	Amini, S; Pushkarev, D; Christiansen, L; Kostem, E; Royce, T; Turk, C; Pignatelli, N; Adey, A; Kitzman, JO; Vijayan, K; Ronaghi, M; Shendure, J; Gunderson, KL; Steemers, FJ				Amini, Sasan; Pushkarev, Dmitry; Christiansen, Lena; Kostem, Emrah; Royce, Tom; Turk, Casey; Pignatelli, Natasha; Adey, Andrew; Kitzman, Jacob O.; Vijayan, Kandaswamy; Ronaghi, Mostafa; Shendure, Jay; Gunderson, Kevin L.; Steemers, Frank J.			Haplotype-resolved whole-genome sequencing by contiguity-preserving transposition and combinatorial indexing	NATURE GENETICS			English	Article							PHASE; ALGORITHMS; LIBRARIES; DESIGN	Haplotype-resolved genome sequencing enables the accurate interpretation of medically relevant genetic variation, deep inferences regarding population history and non-invasive prediction of fetal genomes. We describe an approach for genome-wide haplotyping based on contiguity-preserving transposition (CPT-seq) and combinatorial indexing. Tn5 transposition is used to modify DNA with adaptor and index sequences while preserving contiguity. After DNA dilution and compartmentalization, the transposase is removed, resolving the DNA into individually indexed libraries. The libraries in each compartment, enriched for neighboring genomic elements, are further indexed via PCR. Combinatorial 96-plex indexing at both the transposition and PCR stage enables the construction of phased synthetic reads from each of the nearly 10,000 'virtual compartments'. We demonstrate the feasibility of this method by assembling >95% of the heterozygous variants in a human genome into long, accurate haplotype blocks (N50 = 1.4-2.3 Mb). The rapid, scalable and cost-effective workflow could enable haplotype resolution to become routine in human genome sequencing.	[Amini, Sasan; Pushkarev, Dmitry; Christiansen, Lena; Kostem, Emrah; Royce, Tom; Turk, Casey; Pignatelli, Natasha; Vijayan, Kandaswamy; Ronaghi, Mostafa; Gunderson, Kevin L.; Steemers, Frank J.] Illumina Inc, Adv Res Grp, San Diego, CA 92122 USA; [Adey, Andrew; Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Illumina; University of Washington; University of Washington Seattle	Steemers, FJ (corresponding author), Illumina Inc, Adv Res Grp, San Diego, CA 92122 USA.	fsteemers@illumina.com	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; Kitzman, Jacob/0000-0002-6145-882X	National Human Genome Research Institute [HG006283]; National Science Foundation [DGE-0718124]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are thankful to J. Bruand, F. Zhang and A. Kia for help with the data analysis. We are also thankful to I. Goryshin, N. Caruccio and R. Vaidyanathan for discussions at different stages of the project. We also thank S. Norberg, J. Zhang, J. Bernd, T. McSherry, T. Le, P. Diep and G. Roberts for performing sequericing, helping with custom recipes and supporting data transfer. J.S. was supported by grant HG006283 from the National Human Genome Research Institute. A.A. and J.O.K. were supported by graduate research fellowship DGE-0718124 from the National Science Foundation.	Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Bansal V, 2011, NAT BIOTECHNOL, V29, P38, DOI 10.1038/nbt.1757; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Duitama J, 2010, P 1 ACM INT C BIOINF, P160, DOI DOI 10.1145/1854776.1854802; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Geraci F, 2010, BIOINFORMATICS, V26, P2217, DOI 10.1093/bioinformatics/btq411; He D, 2010, BIOINFORMATICS, V26, pi183, DOI 10.1093/bioinformatics/btq215; Hosomichi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-355; Hua ZS, 2010, ANAL CHEM, V82, P2310, DOI 10.1021/ac902510u; Kamphans T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070151; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lo C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r100; Lo C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S24; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380	34	104	178	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1343	1349		10.1038/ng.3119	http://dx.doi.org/10.1038/ng.3119			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25326703	Green Accepted			2022-12-25	WOS:000345547300017
J	Bowman, CJ; Ayer, DE; Dynlacht, BD				Bowman, Christopher John; Ayer, Donald E.; Dynlacht, Brian David			Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE ATROPHY; HISTONE DEACETYLASE INHIBITOR; DNA-DAMAGE RESPONSE; GENOME-WIDE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-SURVIVAL; COMPLEX; IDENTIFICATION; MECHANISM	Autophagy is the primary catabolic process triggered in response to starvation. Although autophagic regulation within the cytosolic compartment is well established, it is becoming clear that nuclear events also regulate the induction or repression of autophagy. Nevertheless, a thorough understanding of the mechanisms by which sequence-specific transcription factors modulate expression of genes required for autophagy is lacking. Here, we identify Foxk proteins (Foxk1 and Foxk2) as transcriptional repressors of autophagy in muscle cells and fibroblasts. Interestingly, Foxk1/2 serve to counter-balance another forkhead transcription factor, Foxo3, which induces an overlapping set of autophagic and atrophic targets in muscle. Foxk1/2 specifically recruits Sin3A-HDAC complexes to restrict acetylation of histone H4 and expression of critical autophagy genes. Remarkably, mTOR promotes the transcriptional activity of Foxk1 by facilitating nuclear entry to specifically limit basal levels of autophagy in nutrient-rich conditions. Our study highlights an ancient, conserved mechanism whereby nutritional status is interpreted by mTOR to restrict autophagy by repressing essential autophagy genes through Foxk-Sin3-mediated transcriptional control.	[Bowman, Christopher John; Dynlacht, Brian David] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA; [Ayer, Donald E.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	New York University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA.	brian.dynlacht@nyumc.org		Ayer, Donald/0000-0002-5595-3269	NIH [2R01CA077245-16, 2R01GM067132-09A1, F30AG040894]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA077245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067132, R01GM055668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W. Lane for mass spectrometric analysis; A. Heguy, E. Venturini and O. Aminova of the New York University Langone Medical Center (NYULMC) Genome Technology Center for ChIP-seq and RNA-seq library sequencing; F. Liang, C. Petzold and K. Dancel of the NYULMC OCS Microscopy Core for the preparation of samples and imaging for TEM; D. Garry (University of Minnesota, USA) for Foxk1 cDNA; Y. Zhang (Harvard Medical School, USA), D. Reinberg (New York University, USA), E. Benevolenskaya (University of Illinois at Chicago, USA) and A. Brunet (Stanford University, USA) for their generous gifts of antibodies. This work used computing resources at the High Performance Computing Facility of the NYULMC Center for Health Informatics and Bioinformatics. This work was supported by NIH grants 2R01CA077245-16 and 2R01GM067132-09A1 to B.D.D. and F30AG040894 to C.J.B.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen XF, 2012, CURR BIOL, V22, P56, DOI 10.1016/j.cub.2011.11.042; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Micsinai M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks048; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Rigbolt K. T., 2014, AUTOPHAGY, V10, P1; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Shi XZ, 2012, MOL CELL BIOCHEM, V366, P251, DOI 10.1007/s11010-012-1302-2; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang Q, 2000, BIOCHEM J, V345, P335, DOI 10.1042/0264-6021:3450335; Yoon MS, 2013, MOL BIOL CELL, V24, P3754, DOI 10.1091/mbc.E13-06-0353; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	63	85	88	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1202	U173		10.1038/ncb3062	http://dx.doi.org/10.1038/ncb3062			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25402684	Green Accepted			2022-12-25	WOS:000345777300011
J	Kling, J				Kling, Jim			Labeling for better or worse	NATURE BIOTECHNOLOGY			English	News Item																		European Commission Directorate General for Health and Consumers (DG SANCO), 2010, EV EU LEG FRAM FIELD; Handel L., 2014, WILL VERMONTS GMO LA; Leibtag E, 2008, CORN PRICES NEAR REC; Revkin A. C., 2014, NY TIMES; Ruanjan P, 2007, BIOL PLANTARUM, V51, P517, DOI 10.1007/s10535-007-0110-0; Speath B., 2011, CROPS REAPING BENEFI	6	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1180	1183		10.1038/nbt.3087	http://dx.doi.org/10.1038/nbt.3087			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489830				2022-12-25	WOS:000346156800014
J	Hillwig, ML; Liu, XY				Hillwig, Matthew L.; Liu, Xinyu			A new family of iron-dependent halogenases acts on freestanding substrates	NATURE CHEMICAL BIOLOGY			English	Article							ALIPHATIC HALOGENASE; ALPHA-KETOGLUTARATE; BIOSYNTHESIS; CHLORINATION; ALKALOIDS; SYRB2	Regio- and stereospecific incorporation of a halogen atom to an unactivated sp(3) carbon in a freestanding molecule is a challenging transformation that is currently missing in the inventory of enzyme-mediated reactions. Here we report what is to our knowledge the first example of a nonheme iron enzyme (WelO5) in the welwitindolinone biosynthetic pathway that can monochlorinate an aliphatic carbon in 12-epi-fischerindole U and 12-epi-hapalindole C, substrates that are free from peptidyl or acyl carrier protein.	[Hillwig, Matthew L.; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, XY (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	xinyuliu@pitt.edu		Hillwig, Matthew/0000-0002-1168-4191	University of Pittsburgh-Department of Chemistry startup fund	University of Pittsburgh-Department of Chemistry startup fund	This work was supported by University of Pittsburgh-Department of Chemistry startup fund.	Bernhardt P, 2011, J AM CHEM SOC, V133, P4268, DOI 10.1021/ja201088k; Bhat Vikram, 2014, Alkaloids Chem Biol, V73, P65, DOI 10.1016/B978-0-12-411565-1.00002-0; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Carter-Franklin JN, 2004, J AM CHEM SOC, V126, P15060, DOI 10.1021/ja047925p; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gribble G. W., 2010, PROG CHEM ORG NAT PR, V91, P1, DOI DOI 10.1007/978-3-211-99323-1; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; HARRIS CM, 1985, J AM CHEM SOC, V107, P6652, DOI 10.1021/ja00309a038; Hillwig ML, 2014, CHEMBIOCHEM, V15, P665, DOI 10.1002/cbic.201300794; Hillwig ML, 2014, ACS CHEM BIOL, V9, P372, DOI 10.1021/cb400681n; INSALL R, 1990, EMBO J, V9, P3323, DOI 10.1002/j.1460-2075.1990.tb07532.x; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Neumann CS, 2010, P NATL ACAD SCI USA, V107, P5798, DOI 10.1073/pnas.1001681107; PARK A, 1992, TETRAHEDRON LETT, V33, P3257, DOI 10.1016/S0040-4039(00)92061-6; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; STRATMANN K, 1994, J AM CHEM SOC, V116, P9935, DOI 10.1021/ja00101a015; Ueki M, 2006, CHEM BIOL, V13, P1183, DOI 10.1016/j.chembiol.2006.09.012; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+	25	93	95	4	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					921	923		10.1038/NCHEMBIO.1625	http://dx.doi.org/10.1038/NCHEMBIO.1625			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25218740				2022-12-25	WOS:000343621500012
J	King, RW; Finley, D				King, Randall W.; Finley, Daniel			Sculpting the proteome with small molecules	NATURE CHEMICAL BIOLOGY			English	Article							UBIQUITIN LIGASE; INHIBITOR; ENZYMES; COMPLEX	The ubiquitin-proteasome system (UPS) pervades the biology of eukaryotes. Because it depends on the activity of hundreds of different enzymes and protein-protein interactions, the UPS provides many opportunities for selective modulation of the pathway with small molecules. Here we discuss the principles that underlie the development of effective inhibitors or activators of the pathway. We emphasize insights from structural analysis and describe strategies for evaluating the selectivity of compounds.	[King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA	Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA.	randy_king@hms.harvard.edu			US National Institutes of Health [GM066492, GM095526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM095526, R01GM066492] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories is supported by US National Institutes of Health grants GM066492 (R.W.K.) and GM095526 (D.F.).	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/NCHEMBIO.1455, 10.1038/nchembio.1455]; Lill JR, 2014, TRENDS PHARMACOL SCI, V35, P187, DOI 10.1016/j.tips.2014.01.005; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]	24	7	7	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					870	874		10.1038/nchembio.1671	http://dx.doi.org/10.1038/nchembio.1671			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25325686	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000343621500002
J	Pittolo, I; Gomez-Santacana, X; Eckelt, K; Rovira, X; Dalton, J; Goudet, C; Pin, JP; Llobet, A; Giraldo, J; Llebaria, A; Gorostiza, P				Pittolo, Ilvia; Gomez-Santacana, Xavier; Eckelt, Kay; Rovira, Xavier; Dalton, James; Goudet, Cyril; Pin, Jean-Philippe; Llobet, Artur; Giraldo, Jesus; Llebaria, Amadeu; Gorostiza, Pau			An allosteric modulator to control endogenous G protein-coupled receptors with light	NATURE CHEMICAL BIOLOGY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; OPTICAL CONTROL; DRUG-DELIVERY; PHARMACOLOGY; AGONIST	Controlling drug activity with light offers the possibility of enhancing pharmacological selectivity with spatial and temporal regulation, thus enabling highly localized therapeutic effects and precise dosing patterns. Here we report on the development and characterization of what is to our knowledge the first photoswitchable allosteric modulator of a G protein-coupled receptor. Alloswitch-1 is selective for the metabotropic glutamate receptor mGlu(5) and enables the optical control of endogenous mGlu(5) receptors.	[Pittolo, Ilvia; Gomez-Santacana, Xavier; Eckelt, Kay; Gorostiza, Pau] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Gomez-Santacana, Xavier; Llebaria, Amadeu] IQAC CSIC, Inst Adv Chem Catalonia, Barcelona, Spain; [Gomez-Santacana, Xavier; Rovira, Xavier; Dalton, James; Giraldo, Jesus] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Spain; [Gomez-Santacana, Xavier; Rovira, Xavier; Dalton, James; Giraldo, Jesus] Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain; [Eckelt, Kay; Gorostiza, Pau] Network Biomed Res Ctr Bioengn Biomat & Nanomed C, Zaragoza, Spain; [Rovira, Xavier; Goudet, Cyril; Pin, Jean-Philippe] Univ Montpellier, CNRS, UMR 5203, Inst Genom Fonct, F-34059 Montpellier, France; [Rovira, Xavier; Goudet, Cyril; Pin, Jean-Philippe] INSERM, U661, F-34000 Montpellier, France; [Llobet, Artur] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Gorostiza, Pau] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Barcelona; Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Llebaria, A (corresponding author), IQAC CSIC, Inst Adv Chem Catalonia, Barcelona, Spain.	amadeu.llebaria@cid.csic.es; pau@icrea.cat	Goudet, Cyril/AAE-3415-2020; Gómez-Santacana, Xavier/GOH-3451-2022; Llebaria, Amadeu/C-4287-2015; Giraldo, Jesus/F-9881-2011; Pin, Jean-Philippe/Y-6668-2019; Llobet, Artur/D-4339-2014; Pittolo, Silvia/A-7860-2017; Algans, Xavier Rovira/M-4669-2015; Gómez-Santacana, Xavier/AAA-2690-2020; Gorostiza, Pau/Q-2544-2015; Dalton, James/L-9792-2017	Goudet, Cyril/0000-0002-8255-3535; Gómez-Santacana, Xavier/0000-0001-8830-0494; Llebaria, Amadeu/0000-0002-8200-4827; Giraldo, Jesus/0000-0001-7082-4695; Pin, Jean-Philippe/0000-0002-1423-345X; Llobet, Artur/0000-0001-5797-6782; Pittolo, Silvia/0000-0002-5673-1692; Algans, Xavier Rovira/0000-0002-9764-9927; Gómez-Santacana, Xavier/0000-0001-8830-0494; Gorostiza, Pau/0000-0002-7268-5577; Dalton, James/0000-0002-5279-4581	RecerCaixa foundation [2010ACUP00378]; Marato de TV3 Foundation [110230, 110231, 110232, 111531]; Human Frontier Science Program [CDA022/2006]; European Union's Seventh Framework Programme for research, technological development and demonstration [270483, 210355, 335011]; Federation of European Biochemical Societies; Catalan government [2010 BP-A 00194, 2012FI_B01122, 2012 CTP 00033, 2012 BE1 00597, 2014SGR-1251, 2009SGR-1072]; Spanish Government [CTQ2008-06160, SAF2010-19257, SAF2012-36375, CTQ2013-43892R]; ERANET Neuron LIGHT PAIN project; ICREA Funding Source: Custom	RecerCaixa foundation; Marato de TV3 Foundation; Human Frontier Science Program(Human Frontier Science Program); European Union's Seventh Framework Programme for research, technological development and demonstration; Federation of European Biochemical Societies; Catalan government; Spanish Government(Spanish GovernmentEuropean Commission); ERANET Neuron LIGHT PAIN project; ICREA(ICREA)	We are grateful to C. Serra, R. Perez-Gregorio and L. Munoz for synthetic and analytical support; F. Malhaire for technical support in cell-based pharmacological assays; Y. Perez for NMR support; and H. Masanas and B. Terni for animal care and natural matings. We thank the Center for Scientific and Academic Services of Catalonia (CESCA) for the use of their facilities. The Pt-Fe catalyst used in the synthesis was a kind gift of Evonik Industries AG (Germany). We are also grateful to F. Ciruela, M. Izquierdo-Serra, F. Aguado and M.J. Bleda for helpful discussions. We acknowledge financial support from the RecerCaixa foundation (2010ACUP00378 to P.G., J.G. and A. Llebaria); the Marato de TV3 Foundation (110230 to J.G., 110231 to A. Llebaria, 110232 to C.G., 111531 to A. Llobet and P.G.); the Human Frontier Science Program (CDA022/2006 to P.G.); the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreements 270483 (Focus), 210355 (Opticalbullet) and 335011 (Theralight) to P.G.; the Federation of European Biochemical Societies; the Catalan government (2010 BP-A 00194 to X.R., 2012FI_B01122 to S.P., 2012 CTP 00033 and 2012 BE1 00597 to X.G.-S., 2014SGR-1251 to P. G. and 2009SGR-1072 to A. Llebaria); the Spanish Government (CTQ2008-06160, SAF2010-19257, SAF2012-36375 and CTQ2013-43892R to P.G.); and the ERANET Neuron LIGHT PAIN project (to A. Llebaria, J.G. and J.-P.P.).	Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Banghart MR, 2009, ANGEW CHEM INT EDIT, V48, P9097, DOI 10.1002/anie.200904504; BARTELS E, 1971, P NATL ACAD SCI USA, V68, P1820, DOI 10.1073/pnas.68.8.1820; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Engers DW, 2011, J MED CHEM, V54, P1106, DOI 10.1021/jm101271s; Ghose AK, 2012, ACS CHEM NEUROSCI, V3, P50, DOI 10.1021/cn200100h; Gomeza J, 1996, MOL PHARMACOL, V50, P923; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gregory KJ, 2013, PROG MOL BIOL TRANSL, V115, P61, DOI 10.1016/B978-0-12-394587-7.00002-6; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Kramer RH, 2013, NAT NEUROSCI, V16, P816, DOI 10.1038/nn.3424; Langer R, 1998, NATURE, V392, P5; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Masseck OA, 2011, EXP PHYSIOL, V96, P51, DOI 10.1113/expphysiol.2010.055517; Mathiesen JM, 2003, BRIT J PHARMACOL, V138, P1026, DOI 10.1038/sj.bjp.0705159; Miller G, 2010, SCIENCE, V329, P502, DOI 10.1126/science.329.5991.502; MILLER S, 1995, J NEUROSCI, V15, P6103; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nevola L, 2013, ANGEW CHEM INT EDIT, V52, P7704, DOI 10.1002/anie.201303324; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Reiter A, 2013, BIOCHEMISTRY-US, V52, P8972, DOI 10.1021/bi4014402; Stein M, 2013, ANGEW CHEM INT EDIT, V52, P9845, DOI 10.1002/anie.201302530; Stein M, 2012, ANGEW CHEM INT EDIT, V51, P10500, DOI 10.1002/anie.201205475; Timko BP, 2010, ADV MATER, V22, P4925, DOI 10.1002/adma.201002072; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Wood MR, 2011, BIOCHEMISTRY-US, V50, P2403, DOI 10.1021/bi200129s	33	97	98	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					813	+		10.1038/NCHEMBIO.1612	http://dx.doi.org/10.1038/NCHEMBIO.1612			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25173999				2022-12-25	WOS:000342462100006
J	Hou, SP; Du, LP; Lei, B; Pang, CP; Zhang, MF; Zhuang, WJ; Zhang, ML; Huang, LL; Gong, B; Wang, ML; Zhang, Q; Hu, K; Zhou, QY; Qi, J; Wang, CK; Tian, Y; Ye, Z; Liang, L; Yu, HS; Li, H; Zhou, Y; Cao, QF; Liu, YJ; Bai, L; Liao, D; Kijlstra, A; Xu, JF; Yang, ZL; Yang, PZ				Hou, Shengping; Du, Liping; Lei, Bo; Pang, Chi Pui; Zhang, Meifen; Zhuang, Wenjuan; Zhang, Minglian; Huang, Lulin; Gong, Bo; Wang, Meilin; Zhang, Qi; Hu, Ke; Zhou, Qingyun; Qi, Jian; Wang, Chaokui; Tian, Yuan; Ye, Zi; Liang, Liang; Yu, Hongsong; Li, Hong; Zhou, Yan; Cao, Qingfeng; Liu, Yunjia; Bai, Lin; Liao, Dan; Kijlstra, Aize; Xu, Jianfeng; Yang, Zhenglin; Yang, Peizeng			Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3	NATURE GENETICS			English	Article							BEHCETS-DISEASE; ATOPIC-DERMATITIS; GENE; HLA; POLYMORPHISMS; IL23R-IL12RB2; PSORIASIS; IL10; VARIANTS; ANTIGENS	To identify new genetic risk factors for Vogt-Koyanagi-Harada (VKH) syndrome, we conducted a genome-wide association study of 2,208,258 SNPs in 774 cases and 2,009 controls with follow-up in a collection of 415 cases and 2,006 controls and a further collection of 349 cases and 1,588 controls from a Han Chinese population. We identified three loci associated with VKH syndrome susceptibility (IL23R-C1orf141, rs117633859, P-combined = 3.42 x 10(-21), odds ratio (OR) = 1.82; ADO-ZNF365-EGR2, rs442309, P-combined = 2.97 x 10(-11), OR = 1.37; and HLA-DRB1/DQA1, rs3021304, P-combined = 1.26 x 10(-118), OR = 2.97). The five non-HLA genes were all expressed in human iris tissue. IL23R was also expressed in the ciliary body, and EGR2 was expressed in the ciliary body and choroid. The risk G allele of rs117633859 in the promoter region of IL23R exhibited low transcriptional activation in a cell-based reporter assay and was associated with diminished IL23R mRNA expression in human peripheral blood mononuclear cells.	[Hou, Shengping; Du, Liping; Lei, Bo; Zhang, Qi; Hu, Ke; Zhou, Qingyun; Qi, Jian; Wang, Chaokui; Tian, Yuan; Ye, Zi; Liang, Liang; Yu, Hongsong; Li, Hong; Zhou, Yan; Cao, Qingfeng; Liu, Yunjia; Bai, Lin; Liao, Dan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Hou, Shengping; Du, Liping; Lei, Bo; Zhang, Qi; Hu, Ke; Zhou, Qingyun; Qi, Jian; Wang, Chaokui; Tian, Yuan; Ye, Zi; Liang, Liang; Yu, Hongsong; Li, Hong; Zhou, Yan; Cao, Qingfeng; Liu, Yunjia; Bai, Lin; Liao, Dan; Yang, Peizeng] Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Hou, Shengping; Du, Liping; Lei, Bo; Zhang, Qi; Hu, Ke; Zhou, Qingyun; Qi, Jian; Wang, Chaokui; Tian, Yuan; Ye, Zi; Liang, Liang; Yu, Hongsong; Li, Hong; Zhou, Yan; Cao, Qingfeng; Liu, Yunjia; Bai, Lin; Liao, Dan; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Meifen] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing 100730, Peoples R China; [Zhuang, Wenjuan] Peoples Hosp Ningxia Hui Autonomous Reg, Dept Ophthalmol, Yinchuan, Peoples R China; [Zhang, Minglian] Xingtai Eye Hosp, Dept Ophthalmol, Xingtai, Peoples R China; [Huang, Lulin; Gong, Bo; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Huang, Lulin; Gong, Bo; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wang, Meilin] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Canc Genom, Winston Salem, NC 27109 USA; [Tian, Yuan; Kijlstra, Aize] Univ Clin Ophthalmol Maastricht, Maastricht, Netherlands; [Xu, Jianfeng] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China	Chongqing Medical University; Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; Nanjing Medical University; Wake Forest University; Maastricht University; Fudan University; University of Electronic Science & Technology of China	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	zliny@yahoo.com; peizengycmu@126.com	Du, Liping/M-9495-2019; Yu, Hongsong/J-9106-2014; Zi, Ye/GWM-3932-2022; Cao, Qingfeng/C-2947-2017	Yu, Hongsong/0000-0002-1209-2104; Cao, Qingfeng/0000-0001-6252-5628; Lei, Bo/0000-0002-5497-0905; Tian, Yuan/0000-0002-9551-9061	Natural Science Foundation Major International (Regional) Joint Research Project [81320108009]; National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of the Natural Science Foundation [81130019]; National Natural Science Foundation Project [31370893, 81270990, 81025006]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Clinic Key Project of the Ministry of Health [20115503110002]; Basic Research program of Chongqing [cstc2013jcyjC10001]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; National Key Clinical Specialties Construction Program of China; Key Project of Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program; The Youth Outstanding-notch Talent Support Program of Chongqing	Natural Science Foundation Major International (Regional) Joint Research Project; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of the Natural Science Foundation; National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Clinic Key Project of the Ministry of Health; Basic Research program of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); National Key Clinical Specialties Construction Program of China; Key Project of Health Bureau of Chongqing; Fund for PAR-EU Scholars Program; The Youth Outstanding-notch Talent Support Program of Chongqing	This work was supported by the Natural Science Foundation Major International (Regional) Joint Research Project (81320108009) (P.Y.), the National Basic Research Program of China (973 Program) (2011CB510200) (P.Y.), the Key Project of the Natural Science Foundation (81130019) (P.Y.), the National Natural Science Foundation Project (31370893 (P.Y.), 81270990 (S.H.) and 81025006 (Z. Yang)), the Research Fund for the Doctoral Program of Higher Education of China (20115503110002) (P.Y.), the Clinic Key Project of the Ministry of Health (201002019) (P.Y.), the Basic Research program of Chongqing (cstc2013jcyjC10001) (P.Y.), the Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003) (P.Y.), the National Key Clinical Specialties Construction Program of China (P.Y.), the Key Project of Health Bureau of Chongqing (2012-1-003) (P.Y.), the Fund for PAR-EU Scholars Program (P.Y.) and The Youth Outstanding-notch Talent Support Program of Chongqing (S.H.). We thank H. Zhou (Zhongshan Ophthalmic Center, Sun Yat-sen University), X. Liu (Department of Ophthalmology, The Second Hospital of Jilin University), Y. Wang (The Eye Hospital of Wenzhou Medical University), H. Wang (Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University), L. Xing (Ophthalmology of Department, the First Affiliated Hospital, Harbin Medical University), R. Zhang (Department of Ophthalmology, Eye and ENT Hospital of Fudan University), Y. Shi (Department of Ophthalmology, Shanxi Eye Hospital) and C. Zhao (Department of Ophthalmology, Nanjing General Hospital of the Nanjing Military Region) for helping with sample collection, and we also thank the individuals, their families and friends who participated in this project. Some samples of cases and controls were collected in the Zhongshan Ophthalmic Center, Sun Yat-sen University. We thank Genergy Bio-technology Corporation (Shanghai) and CapitalBio Corporation (Beijing) for helping with the microarray experiment, and we also thank Beijing Genomics Institute for luciferase reporter analysis.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Du LP, 2008, CLIN IMMUNOL, V127, P43, DOI 10.1016/j.clim.2008.01.004; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Haritunians T, 2011, GUT, V60, P1060, DOI 10.1136/gut.2010.227256; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hou SP, 2008, MOL VIS, V14, P2597; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; ISLAM SMM, 1994, INVEST OPHTH VIS SCI, V35, P3890; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Kim MH, 2000, AM J OPHTHALMOL, V129, P173, DOI 10.1016/S0002-9394(99)00434-1; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; MCMENAMIN PG, 1994, INVEST OPHTH VIS SCI, V35, P3234; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; MURAKAMI S, 1994, JPN J OPHTHALMOL, V38, P208; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Okamura T, 2012, ANN RHEUM DIS, V71, P96, DOI 10.1136/annrheumdis-2011-200588; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; SILMAN AJ, 1990, LANCET, V335, P1078; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WEISZ JM, 1995, OPHTHALMOLOGY, V102, P1012; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Zhang CX, 2013, INVEST OPHTH VIS SCI, V54, P7734, DOI 10.1167/iovs.13-12187; ZHANG XY, 1992, AM J OPHTHALMOL, V113, P567, DOI 10.1016/S0002-9394(14)74731-2; ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368, DOI 10.1001/archopht.1991.01080030070041; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	48	67	74	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1007	+		10.1038/ng.3061	http://dx.doi.org/10.1038/ng.3061			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108386				2022-12-25	WOS:000341579400016
J	Samocha, KE; Robinson, EB; Sanders, SJ; Stevens, C; Sabo, A; McGrath, LM; Kosmicki, JA; Rehnstrom, K; Mallick, S; Kirby, A; Wall, DP; MacArthur, DG; Gabriel, SB; DePristo, M; Purcell, SM; Palotie, A; Boerwinkle, E; Buxbaum, JD; Cook, EH; Gibbs, RA; Schellenberg, GD; Sutcliffe, JS; Devlin, B; Roeder, K; Neale, BM; Daly, MJ				Samocha, Kaitlin E.; Robinson, Elise B.; Sanders, Stephan J.; Stevens, Christine; Sabo, Aniko; McGrath, Lauren M.; Kosmicki, Jack A.; Rehnstrom, Karola; Mallick, Swapan; Kirby, Andrew; Wall, Dennis P.; MacArthur, Daniel G.; Gabriel, Stacey B.; DePristo, Mark; Purcell, Shaun M.; Palotie, Aarno; Boerwinkle, Eric; Buxbaum, Joseph D.; Cook, Edwin H., Jr.; Gibbs, Richard A.; Schellenberg, Gerard D.; Sutcliffe, James S.; Devlin, Bernie; Roeder, Kathryn; Neale, Benjamin M.; Daly, Mark J.			A framework for the interpretation of de novo mutation in human disease	NATURE GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; DNA-SEQUENCING DATA; INTELLECTUAL DISABILITY; GENOME; PATTERNS; GENES; RATES	Spontaneously arising (de novo) mutations have an important role in medical genetics. For diseases with extensive locus heterogeneity, such as autism spectrum disorders (ASDs), the signal from de novo mutations is distributed across many genes, making it difficult to distinguish disease-relevant mutations from background variation. Here we provide a statistical framework for the analysis of excesses in de novo mutation per gene and gene set by calibrating a model of de novo mutation. We applied this framework to de novo mutations collected from 1,078 ASD family trios, and, whereas we affirmed a significant role for loss-of-function mutations, we found no excess of de novo loss-of-function mutations in cases with IQ above 100, suggesting that the role of de novo mutations in ASDs might reside in fundamental neurodevelopmental processes. We also used our model to identify similar to 1,000 genes that are significantly lacking in functional coding variation in non-ASD samples and are enriched for de novo loss-of-function mutations identified in ASD cases.	[Samocha, Kaitlin E.; Robinson, Elise B.; Kosmicki, Jack A.; Kirby, Andrew; MacArthur, Daniel G.; Purcell, Shaun M.; Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Samocha, Kaitlin E.; Robinson, Elise B.; Kosmicki, Jack A.; Kirby, Andrew; MacArthur, Daniel G.; Purcell, Shaun M.; Neale, Benjamin M.; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Samocha, Kaitlin E.; Robinson, Elise B.; Stevens, Christine; Kirby, Andrew; MacArthur, Daniel G.; Gabriel, Stacey B.; Purcell, Shaun M.; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Samocha, Kaitlin E.; Robinson, Elise B.; Stevens, Christine; Neale, Benjamin M.; Daly, Mark J.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Samocha, Kaitlin E.] Harvard Univ, Sch Med, Program Genet & Gen Biol & Biomed Sci, Boston, MA USA; [Sanders, Stephan J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Sanders, Stephan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Sabo, Aniko; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [McGrath, Lauren M.; Purcell, Shaun M.; Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiatr & Neurodev Genet Unit, Boston, MA 02114 USA; [McGrath, Lauren M.; Purcell, Shaun M.; Palotie, Aarno] Harvard Univ, Sch Med, Boston, MA USA; [Kosmicki, Jack A.; Wall, Dennis P.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Kosmicki, Jack A.; Wall, Dennis P.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Rehnstrom, Karola; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Rehnstrom, Karola; Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Mallick, Swapan] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [DePristo, Mark] Synapdx, Lexington, MA USA; [Purcell, Shaun M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Purcell, Shaun M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Purcell, Shaun M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA USA; [Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37235 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Roeder, Kathryn] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Yale University; Yale University; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	mjdaly@atgu.mgh.harvard.edu	Buxbaum, Joseph D/G-6001-2010; McGrath, Lauren M./AFP-3898-2022; Sanders, Stephan/S-8645-2019; Daly, Mark J/B-2453-2017; Sutcliffe, James S/C-1348-2012	McGrath, Lauren M./0000-0001-6928-9656; Daly, Mark J/0000-0002-0949-8752; Sutcliffe, James S/0000-0001-5200-6007; Stevens, Christine/0000-0002-2621-2234; Roeder, Kathryn/0000-0002-8869-6254; Sanders, Stephan/0000-0001-9112-5148; Samocha, Kaitlin/0000-0002-1704-3352; MacArthur, Daniel/0000-0002-5771-2290; Palotie, Aarno/0000-0002-2527-5874; Robinson, Elise/0000-0003-2314-2792; Buxbaum, Joseph/0000-0001-8898-8313	Autism Genetic Resource Exchange (AGRE) Consortium, a program of Autism Speaks [1U24MH081810]; Autism Speaks; Simons Foundation; Autism Consortium; US National Institutes of Health (NIH) [R01MH089208, R01MH089025, R01MH089004, R01MH089175, R01MH089482, P50HD055751, R01MH057881, R01MH061009]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010];  [U54HG003273];  [U54HG003067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, T32HG002295, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089175, R01MH089004, R01MH089025, R01MH089482, R01MH057881, U24MH081810, U24MH068457, R01MH089208, U01MH100229, R37MH057881, R01MH061009] Funding Source: NIH RePORTER	Autism Genetic Resource Exchange (AGRE) Consortium, a program of Autism Speaks; Autism Speaks; Simons Foundation; Autism Consortium; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All data from published studies are available in the respective publications. All newly generated data and computational tools used in this paper will be available online as downloadable material. We have also constructed a website to query genes that provides information on constraint and the de novo mutations found in the specified gene across published studies of de novo mutation. We would like to thank E. Daly and M. Chess for their contributions to data analysis and the construction of the website, respectively. We acknowledge the following resources and families who contributed to them: the National Institute of Mental Health (NIMH) repository (U24MH068457); the Autism Genetic Resource Exchange (AGRE) Consortium, a program of Autism Speaks (1U24MH081810 to C.M. Lajonchere); The Autism Simplex Collection (TASC) (grant from Autism Speaks); the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (grant from the Simons Foundation); and The Autism Consortium (grant from the Autism Consortium). This work was directly supported by US National Institutes of Health (NIH) grants R01MH089208 (M.J.D.), R01MH089025 (J.D.B.), R01MH089004 (G.D.S.), R01MH089175 (R.A.G.) and R01MH089482 (J.S.S.) and was supported in part by US NIH grants P50HD055751 (E.H.C.), R01MH057881 (B.D.) and R01MH061009 (J.S.S.). We acknowledge partial support from grants U54HG003273 (R.A.G.) and U54HG003067 (E. Lander). We thank T. Lehner (NIMH), A. Felsenfeld (National Human Genome Research Institute) and P. Bender (NIMH) for their support and contribution to the project. E.B., J.D.B., B.D., M.J.D., R.A.G., K. Roeder, A.S., G.D.S. and J.S.S. are lead investigators in the ARRA Autism Sequencing Collaboration (AASC). We would also like to thank the NHLBI GO Exome Sequencing Project (ESP) and its ongoing studies that produced and provided exome variant calls on the web: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Antonarakis S.E., 2006, ENCY LIFE SCI; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446	25	582	587	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					944	+		10.1038/ng.3050	http://dx.doi.org/10.1038/ng.3050			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25086666	Green Accepted, Green Submitted			2022-12-25	WOS:000341579400007
J	Fehrmann, RSN; Karjalainen, JM; Krajewska, M; Westra, HJ; Maloney, D; Simeonov, A; Pers, TH; Hirschhorn, JN; Jansen, RC; Schultes, EA; van Haagenl, HHHBM; de Vries, EGE; Meerman, GJT; Wijmenga, C; van Vugt, MATM; Franke, L				Fehrmann, Rudolf S. N.; Karjalainen, Juha M.; Krajewska, Malgorzata; Westra, Harm-Jan; Maloney, David; Simeonov, Anton; Pers, Tune H.; Hirschhorn, Joel N.; Jansen, Ritsert C.; Schultes, Erik A.; van Haagenl, Herman H. H. B. M.; de Vries, Elisabeth G. E.; Meerman, Gerard J. te; Wijmenga, Cisca; van Vugt, Marcel A. T. M.; Franke, Lude			Gene expression analysis identifies global gene dosage sensitivity in cancer	NATURE GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; HUMAN-BREAST; MUTATIONS; LANDSCAPE; REPAIR	Many cancer-associated somatic copy number alterations (SCNAs) are known. Currently, one of the challenges is to identify the molecular downstream effects of these variants. Although several SCNAs are known to change gene expression levels, it is not clear whether each individual SCNA affects gene expression. We reanalyzed 77,840 expression profiles and observed a limited set of 'transcriptional components' that describe well-known biology, explain the vast majority of variation in gene expression and enable us to predict the biological function of genes. On correcting expression profiles for these components, we observed that the residual expression levels (in 'functional genomic mRNA' profiling) correlated strongly with copy number. DNA copy number correlated positively with expression levels for 99% of all abundantly expressed human genes, indicating global gene dosage sensitivity. By applying this method to 16,172 patient-derived tumor samples, we replicated many loci with aberrant copy numbers and identified recurrently disrupted genes in genomically unstable cancers.	[Fehrmann, Rudolf S. N.; Krajewska, Malgorzata; de Vries, Elisabeth G. E.; van Vugt, Marcel A. T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Fehrmann, Rudolf S. N.; Karjalainen, Juha M.; Westra, Harm-Jan; Meerman, Gerard J. te; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Maloney, David; Simeonov, Anton] US Natl Inst Hlth, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Pers, Tune H.; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Hirschhorn, Joel N.] Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jansen, Ritsert C.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, Haren, Netherlands; [Schultes, Erik A.; van Haagenl, Herman H. H. B. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Schultes, Erik A.] Leiden Univ, Leiden Inst Adv Comp Sci, BioSemant Grp, Leiden, Netherlands	University of Groningen; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Technical University of Denmark; Harvard University; Harvard Medical School; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Fehrmann, RSN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	r.s.n.fehrmann@umcg.nl; lude@ludesign.nl	Schultes, Erik/B-6035-2012; Fehrmann, Rudolf/E-2551-2011; Krajewska, Malgorzata/AAH-1158-2021; Karjalainen, Juha/P-8624-2016; Franke, Lude/P-7036-2016; Wijmenga, Cisca/AAE-7719-2019	Schultes, Erik/0000-0001-8888-635X; Fehrmann, Rudolf/0000-0002-7516-315X; Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Pers, Tune/0000-0003-0207-4831; Krajewska, Malgorzata/0000-0002-2243-5924; de Vries, Elisabeth/0000-0002-8949-7425	Netherlands Organization for Scientific Research [916-10135, 916-76062, 917-14374]; Horizon Breakthrough grant from the Netherlands Genomics Initiative [92519031]; Van der Meer-Boerema Foundation; Dutch Cancer Society [RUG 2011-5093, RUG 2013-5960]; SIA-raakPRO subsidy for project BioCOMP; European Community's Health Seventh Framework Programme (FP7) [259867]; John Templeton Foundation; Leiden Centre for Data Sciences; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Horizon Breakthrough grant from the Netherlands Genomics Initiative; Van der Meer-Boerema Foundation; Dutch Cancer Society(KWF Kankerbestrijding); SIA-raakPRO subsidy for project BioCOMP; European Community's Health Seventh Framework Programme (FP7); John Templeton Foundation; Leiden Centre for Data Sciences; Lundbeck Foundation(Lundbeckfonden); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	We thank J.L. Senior for editing the manuscript. This work was financially supported by grants from the Netherlands Organization for Scientific Research (NWO-VENI grant 916-10135 to L.F., NWO VIDI grant 916-76062 to M.A.T.M.v.V. and NWO VIDI grant 917-14374 to L.F.), a Horizon Breakthrough grant from the Netherlands Genomics Initiative (grant 92519031 to L.F.), a grant from the Van der Meer-Boerema Foundation to M.K. and grants from the Dutch Cancer Society (RUG 2011-5093 to M.A.T.M.v.V. and RUG 2013-5960 to R.S.N.F.). In addition, this study was financed in part by the SIA-raakPRO subsidy for project BioCOMP. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement 259867. This publication was made possible through the support of a grant from the John Templeton Foundation. Additional support for E.A.S. was provided by the Leiden Centre for Data Sciences.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Hovey RM, 1998, CANCER RES, V58, P3555; Kikuchi K, 2005, MOL CELL BIOL, V25, P6948, DOI 10.1128/MCB.25.16.6948-6955.2005; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Monzon J, 1998, NEW ENGL J MED, V338, P879, DOI 10.1056/NEJM199803263381305; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sworczak K, 2002, ONCOL REP, V9, P1373; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	31	201	204	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					115	125		10.1038/ng.3173	http://dx.doi.org/10.1038/ng.3173			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25581432	Green Published			2022-12-25	WOS:000348694700006
J	Giganti, D; Albesa-Jove, D; Urresti, S; Rodrigo-Unzueta, A; Martinez, MA; Comino, N; Barilone, N; Bellinzoni, M; Chenal, A; Guerin, ME; Alzari, PM				Giganti, David; Albesa-Jove, David; Urresti, Saioa; Rodrigo-Unzueta, Ane; Martinez, Mariano A.; Comino, Natalia; Barilone, Nathalie; Bellinzoni, Marco; Chenal, Alexandre; Guerin, Marcelo E.; Alzari, Pedro M.			Secondary structure reshuffling modulates glycosyltransferase function at the membrane	NATURE CHEMICAL BIOLOGY			English	Article							MANNOSYLTRANSFERASE PIMA; MYCOBACTERIA; DOMAIN; CONSTANTS; CATALYSIS; PROTEIN	Secondary structure refolding is a key event in biology as it modulates the conformation of many proteins in the cell, generating functional or aberrant states. The crystal structures of mannosyltransferase PimA reveal an exceptional flexibility of the protein along the catalytic cycle, including beta-strand-to-alpha-helix and alpha-helix-to-beta-strand transitions. These structural changes modulate catalysis and are promoted by interactions of the protein with anionic phospholipids in the membrane.	[Giganti, David; Martinez, Mariano A.; Barilone, Nathalie; Bellinzoni, Marco; Alzari, Pedro M.] CNRS UMR 3528, Inst Pasteur, Unite Microbiol Struct, Paris, France; [Albesa-Jove, David; Urresti, Saioa; Rodrigo-Unzueta, Ane; Comino, Natalia; Guerin, Marcelo E.] Univ Basque Country, CSIC, Ctr Mixto, Euskal Herriko Unibertsitatea,Unidad Biofis, Leioa, Bizkaia, Spain; [Albesa-Jove, David; Urresti, Saioa; Rodrigo-Unzueta, Ane; Comino, Natalia; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa, Bizkaia, Spain; [Chenal, Alexandre] CNRNRS UMR 3528, Inst Pasteur, Unite Biochim Interact Macromol, Paris, France; [Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Basque Foundation for Science	Guerin, ME (corresponding author), Univ Basque Country, CSIC, Ctr Mixto, Euskal Herriko Unibertsitatea,Unidad Biofis, Leioa, Bizkaia, Spain.	mrcguerin@gmail.com; pedro.alzari@pasteur.fr	Guerin, Marcelo M/N-7245-2016; Chenal, Alexandre/C-2240-2009; Albesa-Jové, David/F-5683-2016; Albesa-Jové, David/O-3822-2019	Guerin, Marcelo M/0000-0001-9524-3184; Chenal, Alexandre/0000-0002-4959-1003; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Bellinzoni, Marco/0000-0002-8887-6917; Urresti, Saioa/0000-0002-8678-8358; Martinez, Mariano/0000-0003-4460-8045; Alzari, Pedro/0000-0002-4233-1903; Comino, Natalia/0000-0001-8924-8819; Giganti, David/0000-0001-5735-5679	European Community's Sixth and Seventh Framework Programmes [LSHP-CT-2005-018923, HEALTH-F3-2011-260872]; Institut Pasteur, the Spanish Ministry of Science and Innovation [SAF2010-19096, BIO2013-49022-C2-2-R]; IKERBASQUE; Basque Foundation for Science; Basque Government; Fundacion Biofisica Bizkaia	European Community's Sixth and Seventh Framework Programmes; Institut Pasteur, the Spanish Ministry of Science and Innovation; IKERBASQUE; Basque Foundation for Science; Basque Government(Basque Government); Fundacion Biofisica Bizkaia	We acknowledge A. Haouz and P. Weber (Institut Pasteur, France) for help with robotic crystallization; S. Lopez Fernandez and P. Arrasate (Structural Glycobiology Group, Unit of Biophysics, Spain) for technical assistance; and the European Synchrotron Radiation Facility (ESRF), the French National Synchrotron SOLEIL, the Diamond Light Source (DLS) and the Swiss Light Source (SLS) for granting access to synchrotron radiation facilities and their staff for the onsite assistance. We specially thank the BioStruct-X project to support access to structural biology facilities. Technical support provided by Universidad del Pais Vasco/Euskal Herriko Unibertsitatea and Ministerio de Ciencia e Innovacion is acknowledged. We also thank all members of the Structural Glycobiology Group for valuable scientific discussions. This work was supported by the European Community's Sixth and Seventh Framework Programmes (contracts LSHP-CT-2005-018923 and HEALTH-F3-2011-260872), the Institut Pasteur, the Spanish Ministry of Science and Innovation (contracts SAF2010-19096 and BIO2013-49022-C2-2-R), IKERBASQUE, the Basque Foundation for Science, the Basque Government and the Fundacion Biofisica Bizkaia.	Albesa-Jove D, 2014, GLYCOBIOLOGY, V24, P108, DOI 10.1093/glycob/cwt101; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiske CH, 1925, J BIOL CHEM, V66, P375; Ge CR, 2011, J BIOL CHEM, V286, P6669, DOI 10.1074/jbc.M110.138495; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Schmidt H, 2012, P NATL ACAD SCI USA, V109, P6253, DOI 10.1073/pnas.1119894109; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Varki A., 2009, ESSENTIALS GLYCOBIOL; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	29	36	38	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					16	+		10.1038/nchembio.1694	http://dx.doi.org/10.1038/nchembio.1694			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402770				2022-12-25	WOS:000346448600006
J	Kile, BT				Kile, Benjamin T.			Aging platelets stimulate TPO production	NATURE MEDICINE			English	Editorial Material							MEGAKARYOCYTES; THROMBOPOIESIS; APOPTOSIS		Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Res Fdn Chem Biol Div, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Kile, BT (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Res Fdn Chem Biol Div, Parkville, Vic 3050, Australia.	kile@wehi.edu.au	Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947				Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Grozovsky R, 2015, NAT MED, V21, P47, DOI 10.1038/nm.3770; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Karpatkin S, 1980, Trans Assoc Am Physicians, V93, P244; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kile BT, 2014, BRIT J HAEMATOL, V165, P217, DOI 10.1111/bjh.12757; Kuter DJ, 2014, BRIT J HAEMATOL, V165, P248, DOI 10.1111/bjh.12781; KUTER DJ, 1994, P NATL ACAD SCI USA, V91, P11104, DOI 10.1073/pnas.91.23.11104; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; MCCARTY JM, 1995, BLOOD, V86, P3668, DOI 10.1182/blood.V86.10.3668.bloodjournal86103668	11	4	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					11	12		10.1038/nm.3780	http://dx.doi.org/10.1038/nm.3780			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569543				2022-12-25	WOS:000348408000005
J	McDonald, RI; Guilinger, JP; Mukherji, S; Curtis, EA; Lee, WI; Liu, DR				McDonald, Richard I.; Guilinger, John P.; Mukherji, Shankar; Curtis, Edward A.; Lee, Won I.; Liu, David R.			Electrophilic activity-based RNA probes reveal a self-alkylating RNA for RNA labeling	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVITY-BASED PROTEOMICS; PROTEIN INTERACTIONS; LIVING CELLS; LINKED RNA; RIBOZYME; YEAST; TRANSCRIPTION; EXPRESSION; PREDICTION; CHEMISTRY	Probes that form covalent bonds with RNA molecules on the basis of their chemical reactivity would advance our ability to study the transcriptome. We developed a set of electrophilic activity-based RNA probes designed to react with unusually nucleophilic RNAs. We used these probes to identify reactive genome-encoded RNAs, resulting in the discovery of a 42-nt catalytic RNA from an archaebacterium that reacts with a 2,3-disubstituted epoxide at N7 of a specific guanosine. Detailed characterization of the catalytic RNA revealed the structural requirements for reactivity. We developed this catalytic RNA into a general tool to selectively conjugate a small molecule to an RNA of interest. This strategy enabled up to 500-fold enrichment of target RNA from total mammalian RNA or from cell lysate. We demonstrated the utility of this approach by selectively capturing proteins in yeast cell lysate that bind the ASH1 mRNA.	[McDonald, Richard I.; Guilinger, John P.; Curtis, Edward A.; Lee, Won I.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [McDonald, Richard I.; Guilinger, John P.; Mukherji, Shankar; Curtis, Edward A.; Lee, Won I.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Mukherji, Shankar] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@chemistry.harvard.edu	Curtis, Edward/S-7560-2019; Curtis, Edward A/G-5586-2014; Liu, David R./HCH-3132-2022		US National Institutes of Health (NIH)/National Institute of General Medical Sciences [R01 GM065865]; Howard Hughes Medical Institute; NIH National Research Service Award Postdoctoral Fellowship [F32GM099359, F32GM101751]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101751, F32GM099359, R01GM065865] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Institute of General Medical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH)/National Institute of General Medical Sciences R01 GM065865 and the Howard Hughes Medical Institute. R. I. M. and S. M. were supported by a NIH National Research Service Award Postdoctoral Fellowship (F32GM099359 and F32GM101751). We thank L. Goff for assistance with bioinformatics analysis, D. Engelke (University of Michigan, Ann Arbor) for providing the 5S rRNA plasmid and E. Weerapana (Boston College) for providing the fluoro-phosphonate probe. We are also grateful to C. Dumelin, A. Leconte, L. McGregor, D. Thompson and D. Usanov for helpful discussions.	Ameta S, 2013, CHEM SCI, V4, P957, DOI 10.1039/c2sc21588h; Armitage BA, 2011, CURR OPIN CHEM BIOL, V15, P806, DOI 10.1016/j.cbpa.2011.10.006; Baker M, 2012, NAT METHODS, V9, P787, DOI 10.1038/nmeth.2108; Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Barglow KT, 2004, CHEM BIOL, V11, P1523, DOI 10.1016/j.chembiol.2004.08.023; Baruah H, 2008, ANGEW CHEM INT EDIT, V47, P7018, DOI 10.1002/anie.200802088; Boysen G, 2009, MUTAT RES-GEN TOX EN, V678, P76, DOI 10.1016/j.mrgentox.2009.05.006; Chen YG, 2009, NAT CHEM BIOL, V5, P879, DOI 10.1038/nchembio.235; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Curtis EA, 2013, CHEM BIOL, V20, P521, DOI 10.1016/j.chembiol.2013.02.015; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Doudna JA, 2005, NAT STRUCT MOL BIOL, V12, P395, DOI 10.1038/nsmb932; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Fusz S, 2005, CHEM BIOL, V12, P941, DOI 10.1016/j.chembiol.2005.06.008; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hansen MR, 1996, ACCOUNTS CHEM RES, V29, P249, DOI 10.1021/ar950167a; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; Lee N, 2000, NAT STRUCT BIOL, V7, P28; LILLEY D. M. J., 2008, RIBOZYMES RNA CATALY; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Paul CP, 2003, MOL THER, V7, P237, DOI 10.1016/S1525-0016(02)00038-2; Ponchon L, 2007, NAT METHODS, V4, P571, DOI 10.1038/NMETH1058; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rutkowska A, 2011, ANGEW CHEM INT EDIT, V50, P12655, DOI 10.1002/anie.201106404; Sadaghiani AM, 2007, CURR OPIN CHEM BIOL, V11, P20, DOI 10.1016/j.cbpa.2006.11.030; Saran D, 2005, BIOCHEMISTRY-US, V44, P15007, DOI 10.1021/bi051086h; Sengle G, 2001, CHEM BIOL, V8, P459, DOI 10.1016/S1074-5521(01)00026-6; Sharma AK, 2014, ACS CHEM BIOL, V9, P1680, DOI 10.1021/cb5002119; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Thomas JM, 2006, J AM CHEM SOC, V128, P16540, DOI 10.1021/ja063942y; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tretyakova NY, 1997, CHEM RES TOXICOL, V10, P779, DOI 10.1021/tx970004q; Walker Scott C., 2008, V488, P23, DOI 10.1007/978-1-60327-475-3_3; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	23	24	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1049	+		10.1038/nchembio.1655	http://dx.doi.org/10.1038/nchembio.1655			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25306441	Green Accepted, Green Submitted			2022-12-25	WOS:000345122300013
J	Citorik, RJ; Mimee, M; Lu, TK				Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.			Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGE; RESISTANCE; SYSTEMS; DNA; ENTEROBACTERIACEAE; VIRULENCE; IMMUNITY; GENES	Current antibiotics tend to be broad spectrum, leading to indiscriminate killing of commensal bacteria and accelerated evolution of drug resistance. Here, we use CRISPR-Cas technology to create antimicrobials whose spectrum of activity is chosen-by design. RNA-guided nucleases (RGNs) targeting specific DNA sequences are delivered efficiently to microbial populations using bacteriophage or bacteria carrying plasmids transmissible by conjugation. The DNA targets of RGNs can be undesirable genes or polymorphisms, including antibiotic resistance and virulence determinants in carbapenem-resistant Enterobacteriaceae and enterohemorrhagic Escherichia coli. Delivery of RGNs significantly improves survival in a Galleria mellonella infection model. We also show that RGNs enable modulation of complex bacterial populations by selective knockdown of targeted strains based on genetic signatures. RGNs constitute a class of highly discriminatory, customizable antimicrobials that enact selective pressure at the DNA level to reduce the prevalence of undesired genes, minimize off-target effects and enable programmable remodeling of microbiota.	[Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.] MIT, Microbiol Program, Cambridge, MA 02139 USA; [Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Lu, Timothy K.] Harvard Univ, Harvard Biophys Program, Boston, MA 02115 USA; [Lu, Timothy K.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lu, TK (corresponding author), MIT, Microbiol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		Mimee, Mark/0000-0002-0749-8054; Citorik, Robert/0000-0002-6397-5417; /0000-0002-3083-2671	US National Institutes of Health (NIH) [1DP2OD008435]; NIH National Centers for Systems Biology [1P50GM098792]; Defense Threat Reduction Agency [HDTRA1-14-1-0007]; US Army Research Laboratory; US Army Research Office through the Institute for Soldier Nanotechnologies [W911NF13D0001]; NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program [5T32 GM008334]; Fonds de recherche Sante Quebec Master's Training Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792, T32GM008334] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Centers for Systems Biology; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office through the Institute for Soldier Nanotechnologies; NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program; Fonds de recherche Sante Quebec Master's Training Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank R. Meyer (Institute for Cell and Molecular Biology, University of Texas Austin) for R1162, D.L. Court (Center for Cancer Research, National Cancer Institute at Frederick) for pSIM9, and A.R.M. Bradbury (Los Alamos National Laboratory) for M13cp. The authors thank J. Rubens for assistance with flow cytometry experiments and H. Gancz and D. Zurawski for assistance with the Galleria infection model. T.K.L. acknowledges support from the US National Institutes of Health (NIH) New Innovator Award (1DP2OD008435), an NIH National Centers for Systems Biology grant (1P50GM098792), the Defense Threat Reduction Agency (HDTRA1-14-1-0007), the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies (W911NF13D0001) and the Henry L. and Grace Doherty Professorship in Ocean Utilization. R.J.C. is supported by funding from the NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program (5T32 GM008334), and M.M. is a Howard Hughes Medical Institute International Student Research fellow and a recipient of a Fonds de recherche Sante Quebec Master's Training Award.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; CDC, 2013, ANTIBIOTIC RESISTANC; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Desbois AP, 2012, ADV APPL MICROBIOL, V78, P25, DOI 10.1016/B978-0-12-394805-2.00002-6; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perez-Mendoza D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-71; Rasheed JK, 2013, EMERG INFECT DIS, V19, P870, DOI 10.3201/eid1906.121515; Rasheed JK, 2000, ANTIMICROB AGENTS CH, V44, P2382, DOI 10.1128/AAC.44.9.2382-2388.2000; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Sonnenburg JL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001626; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005	30	385	437	10	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1141	1145		10.1038/nbt.3011	http://dx.doi.org/10.1038/nbt.3011			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25240928	Green Published, Green Accepted			2022-12-25	WOS:000344977000019
J	Ottone, C; Krusche, B; Whitby, A; Clements, M; Quadrato, G; Pitulescu, ME; Adams, RH; Parrinello, S				Ottone, Cristina; Krusche, Benjamin; Whitby, Ariadne; Clements, Melanie; Quadrato, Giorgia; Pitulescu, Mara E.; Adams, Ralf H.; Parrinello, Simona			Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells	NATURE CELL BIOLOGY			English	Article							ADULT SUBVENTRICULAR ZONE; SELF-RENEWAL; MAMMALIAN BRAIN; NOTCH LIGANDS; LINEAGE; NEUROGENESIS; EPHRIN-B2; ROLES; DIFFERENTIATION; PROLIFERATION	The vasculature is a prominent component of the subventricular zone neural stem cell niche. Although quiescent neural stem cells physically contact blood vessels at specialized endfeet, the significance of this interaction is not understood. In contrast, it is well established that vasculature-secreted soluble factors promote lineage progression of committed progenitors. Here we specifically investigated the role of cell-cell contact-dependent signalling in the vascular niche. Unexpectedly, we find that direct cell-cell interactions with endothelial cells enforce quiescence and promote stem cell identity. Mechanistically, endothelial ephrinB2 and Jagged1 mediate these effects by suppressing cell-cycle entry downstream of mitogens and inducing stemness genes to jointly inhibit differentiation. In vivo, endothelial-specific ablation of either of the genes which encode these proteins, Efnb2 and Jag1 respectively, aberrantly activates quiescent stem cells, resulting in depletion. Thus, we identify the vasculature as a critical niche compartment for stem cell maintenance, furthering our understanding of how anchorage to the niche maintains stem cells within a pro-differentiative microenvironment.	[Ottone, Cristina; Krusche, Benjamin; Whitby, Ariadne; Clements, Melanie; Parrinello, Simona] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Interact & Canc Grp, London W12 0NN, England; [Quadrato, Giorgia] Univ Tubingen, Hertie Inst Brain Res, D-72076 Tubingen, Germany; [Pitulescu, Mara E.; Adams, Ralf H.] Univ Munster, Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Pitulescu, Mara E.; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; University of Munster; University of Munster	Parrinello, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Interact & Canc Grp, Du Cane Rd, London W12 0NN, England.	simona.parrinello@imperial.ac.uk	Quadrato, Giorgia/G-7808-2018; Adams, Ralf H/AAE-9274-2019	Quadrato, Giorgia/0000-0003-0717-4874; Pitulescu, Mara E/0000-0001-5322-8146	Medical Research Council, UK; Royal Society; Medical Research Council [MC_UP_A652_1002] Funding Source: researchfish; MRC [MC_UP_A652_1002] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK (C.O., B.K., M.C. and S.P.) and the Royal Society (S.P.). We thank A. Fisher, M. Raff, L. Aragon and M. Ungless for critical reading of the manuscript, S. Nicolis (Univerity of Milano-Bicocca, Italy), M. Herlyn (The Wistar Institute, USA) and J. Gil (MRC Clinical Sciences Centre, UK) for constructs, S. Di Giovanni (Imperial College London, UK) and V. Taylor (University of Basel, Switzerland) for Hes5-GFP neural stem to inhibit proliferation. In parallel, activation of Notch signalling by Jagged1 maintains quiescent type-B fate by modulating gene expression. (b) Type-C progenitors contact the endothelium more transiently and at smaller sites. This terminates Eph and Notch signalling, allowing the cells to activate MAPK in response to soluble cues and enter the cell cycle to progress through the lineage.	Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Chen SY, 2011, CURR OPIN GENET DEV, V21, P684, DOI 10.1016/j.gde.2011.07.008; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Davy A, 2007, DEV BIOL, V304, P182, DOI 10.1016/j.ydbio.2006.12.028; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Goldberg JS, 2009, REGEN MED, V4, P879, DOI [10.2217/rme.09.61, 10.2217/RME.09.61]; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Mathieu C, 2008, MOL CELL NEUROSCI, V38, P569, DOI 10.1016/j.mcn.2008.05.005; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Mirzadeh Z., 2010, JOVE-J VIS EXP, V39, P1938; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yoshioka N, 2012, J COMP NEUROL, V520, P1301, DOI 10.1002/cne.22788; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	53	188	190	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1045	+		10.1038/ncb3045	http://dx.doi.org/10.1038/ncb3045			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25283993	Green Accepted			2022-12-25	WOS:000344744000004
J	Castellana, M; Wilson, MZ; Xu, YF; Joshi, P; Cristea, IM; Rabinowitz, JD; Gitai, Z; Wingreen, NS				Castellana, Michele; Wilson, Maxwell Z.; Xu, Yifan; Joshi, Preeti; Cristea, Ileana M.; Rabinowitz, Joshua D.; Gitai, Zemer; Wingreen, Ned S.			Enzyme clustering accelerates processing of intermediates through metabolic channeling	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SPATIAL-ORGANIZATION; INCLUSION-BODIES; COMPLEX; INACTIVATION; MOLECULES; SCAFFOLDS; PROTEINS	We present a quantitative model to demonstrate that coclustering multiple enzymes into compact agglomerates accelerates the processing of intermediates, yielding the same efficiency benefits as direct channeling, a well-known mechanism in which enzymes are funneled between enzyme active sites through a physical tunnel. The model predicts the separation and size of coclusters that maximize metabolic efficiency, and this prediction is in agreement with previously reported spacings between coclusters in mammalian cells. For direct validation, we study a metabolic branch point in Escherichia coli and experimentally confirm the model prediction that enzyme agglomerates can accelerate the processing of a shared intermediate by one branch, and thus regulate steady-state flux division. Our studies establish a quantitative framework to understand coclustering-mediated metabolic channeling and its application to both efficiency improvement and metabolic regulation.	[Castellana, Michele; Xu, Yifan; Rabinowitz, Joshua D.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wilson, Maxwell Z.; Xu, Yifan; Joshi, Preeti; Cristea, Ileana M.; Gitai, Zemer; Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Wingreen, NS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	zgitai@princeton.edu; wingreen@princeton.edu	Gitai, Zemer/AAI-6989-2021; Rabinowitz, Joshua/GPP-4019-2022; xu, yifan/GWZ-7154-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Wilson, Maxwell/0000-0003-0768-7004	National Science Foundation [PHY-0957573, PHY-1305525, GRFP DGE-1148900]; US National Institutes of Health [NIDA DP1DA026192, NIAID R21AI102187]; Human Frontiers Science Program; NJCCR postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1305525] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NJCCR postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Benkovic for valuable conversations and T. Silhavy for E. coli strains. We also thank K. Drescher, K. Papenfort and S. van Teeffelen for critical reading of the manuscript. Research supported by National Science Foundation grants PHY-0957573, PHY-1305525 and GRFP DGE-1148900, by US National Institutes of Health grants NIDA DP1DA026192 and NIAID R21AI102187, by Human Frontiers Science Program and by the NJCCR postdoctoral fellowship.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bauler P, 2010, J PHYS CHEM LETT, V1, P1332, DOI 10.1021/jz1002007; Bernhard S.A., 1987, NATO ASI SER, V127, P143; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delebecque CJ, 2012, NAT PROTOC, V7, P1797, DOI 10.1038/nprot.2012.102; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Friedrich P., 1984, SUPRAMOLECULAR ENZYM; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Perez AI, 1999, ARCH BIOCHEM BIOPHYS, V362, P329, DOI 10.1006/abbi.1998.1051; GERHART JC, 1962, J BIOL CHEM, V237, P891; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GINSBURG A, 1970, ANNU REV BIOCHEM, V39, P429, DOI 10.1146/annurev.bi.39.070170.002241; GUILLOU F, 1992, BIOCHEMISTRY-US, V31, P1656, DOI 10.1021/bi00121a012; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HRAZDINA G, 1992, ANNU REV PLANT PHYS, V43, P241, DOI 10.1146/annurev.pp.43.060192.001325; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Johnson S. G, 2010, NLOPT NONLINEAR OPTI; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; PERHAM RN, 1975, PHILOS T ROY SOC B, V272, P123, DOI 10.1098/rstb.1975.0075; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Rodriguez-Carmona E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-71; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; SHEPHERDSON M, 1960, J BIOL CHEM, V235, P3233; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1974, ANNU REV MICROBIOL, V28, P61, DOI 10.1146/annurev.mi.28.100174.000425; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Welch G.R., 1985, ORG MULTIENZYME SYST; WELCH GR, 1977, PROG BIOPHYS MOL BIO, V32, P103; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; Zhao A., 2013, PLOS ONE, V8, P2	53	241	245	6	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1011	+		10.1038/nbt.3018	http://dx.doi.org/10.1038/nbt.3018			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25262299	Bronze, Green Accepted			2022-12-25	WOS:000343763800018
J	Gross, AM; Orosco, RK; Shen, JP; Egloff, AM; Carter, H; Hofree, M; Choueiri, M; Coffey, CS; Lippman, SM; Hayes, DN; Cohen, EE; Grandis, JR; Nguyen, QT; Ideker, T				Gross, Andrew M.; Orosco, Ryan K.; Shen, John P.; Egloff, Ann Marie; Carter, Hannah; Hofree, Matan; Choueiri, Michel; Coffey, Charles S.; Lippman, Scott M.; Hayes, D. Neil; Cohen, Ezra E.; Grandis, Jennifer R.; Nguyen, Quyen T.; Ideker, Trey			Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss	NATURE GENETICS			English	Article							SQUAMOUS-CELL CARCINOMA; SURVIVAL; LANDSCAPE; DISCOVERY; GENE	Head and neck squamous cell carcinoma (HNSCC) is characterized by aggressive behavior with a propensity for metastasis and recurrence. Here we report a comprehensive analysis of the molecular and clinical features of HNSCC that govern patient survival. We find that TP53 mutation is frequently accompanied by loss of chromosome 3p and that the combination of these events is associated with a surprising decrease in survival time (1.9 years versus >5 years for TP53 mutation alone). The TP53-3p interaction is specific to chromosome 3p and validates in HNSCC and pan-cancer cohorts. In human papillomavirus (HPV)-positive tumors, in which HPV inactivates TP53, 3p deletion is also common and is associated with poor outcomes. The TP53-3p event is modified by mir-548k expression, which decreases survival further, and is mutually exclusive with mutations affecting RAS signaling. Together, the identified markers underscore the molecular heterogeneity of HNSCC and enable a new multi-tiered classification of this disease.	[Gross, Andrew M.; Ideker, Trey] Univ Calif, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Orosco, Ryan K.; Coffey, Charles S.; Lippman, Scott M.; Nguyen, Quyen T.] Univ Calif San Diego, Div Head & Neck Surg, San Diego, CA USA; [Shen, John P.; Carter, Hannah; Choueiri, Michel; Lippman, Scott M.; Cohen, Ezra E.; Ideker, Trey] Univ Calif, Dept Med, La Jolla, CA USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Hofree, Matan; Ideker, Trey] Univ Calif, Dept Comp Sci & Engn, La Jolla, CA USA; [Lippman, Scott M.; Cohen, Ezra E.; Nguyen, Quyen T.; Ideker, Trey] Univ Calif, Moores Canc Ctr, La Jolla, CA USA; [Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Ideker, T (corresponding author), Univ Calif, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.	tideker@ucsd.edu	Orosco, Ryan K/AAR-7252-2021; Carter, Hannah/R-8425-2017	Orosco, Ryan K/0000-0002-7885-4327; Hofree, Matan/0000-0001-8368-0299; Ideker, Trey/0000-0002-1708-8454; Carter, Hannah/0000-0002-1729-2463; Coffey, Charles/0000-0002-4513-3400; Cohen, Ezra/0000-0002-9872-6242	US National Institutes of Health [P50 GM085764, U24 CA184427, P41 GM103504, T32 DC000028, P50 CA097190, K07 CA137140, DP5 OD017937-01]; US National Institutes of Health (Burroughs Welcome Fund CAMS); US National Institutes of Health (American Cancer Society); Marsha Rivkin Center for Ovarian Cancer Research; Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA158448, U24CA184427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR031228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504, P50GM085764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000028] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017937] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Burroughs Welcome Fund CAMS); US National Institutes of Health (American Cancer Society); Marsha Rivkin Center for Ovarian Cancer Research; Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The results published here are based upon data generated by the TCGA Research Network. We thank K. Messer and A. Tward for helpful discussions. We gratefully acknowledge support for this study from the US National Institutes of Health (P50 GM085764, U24 CA184427 and P41 GM103504 to T.I.; T32 DC000028 to R.K.O.; Burroughs Welcome Fund CAMS to Q.T.N.; P50 CA097190 and The American Cancer Society to J.R.G.; K07 CA137140 to A.M.E.; DP5 OD017937-01 to H.C.). J.P.S. is supported in part by grants from the Marsha Rivkin Center for Ovarian Cancer Research and a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cox D. R., 1984, ANAL SURVIVAL DATA; Farshadpour F, 2011, HEAD NECK-J SCI SPEC, V33, P817, DOI 10.1002/hed.21549; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Meredith S.D., 1995, HEAD NECK SURG, V121, P790; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mroz EA, 2013, CANCER-AM CANCER SOC, V119, P3034, DOI 10.1002/cncr.28150; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Partridge M, 1999, BRIT J CANCER, V79, P1821, DOI 10.1038/sj.bjc.6690290; Partridge M, 1996, BRIT J CANCER, V73, P366, DOI 10.1038/bjc.1996.62; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Rosin MP, 2000, CLIN CANCER RES, V6, P357; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	31	81	83	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					939	+		10.1038/ng.3051	http://dx.doi.org/10.1038/ng.3051			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25086664	Green Accepted, Green Submitted			2022-12-25	WOS:000341579400006
J	He, XL; Zhang, LG; Chen, Y; Remke, M; Shih, D; Lu, FH; Wang, HB; Deng, YQ; Yu, Y; Xia, Y; Wo, XC; Ramaswamy, V; Hu, T; Wang, F; Zhou, WH; Burns, DK; Kim, SH; Kool, M; Pfister, SM; Weinstein, LS; Pomeroy, SL; Gilbertson, RJ; Rubin, JB; Hou, YP; Wechsler-Reya, R; Taylor, MD; Lu, QR				He, Xuelian; Zhang, Liguo; Chen, Ying; Remke, Marc; Shih, David; Lu, Fanghui; Wang, Haibo; Deng, Yaqi; Yu, Yang; Xia, Yong; Wo, Xiaochong; Ramaswamy, Vijay; Hu, Tom; Wang, Fan; Zhou, Wenhao; Burns, Dennis K.; Kim, Se Hoon; Kool, Marcel; Pfister, Stefan M.; Weinstein, Lee S.; Pomeroy, Scott L.; Gilbertson, Richard J.; Rubin, Joshua B.; Hou, Yiping; Wechsler-Reya, Robert; Taylor, Michael D.; Lu, Q. Richard			The G protein alpha subunit G alpha(s) is a tumor suppressor in Sonic hedgehog-driven medulloblastoma	NATURE MEDICINE			English	Article							PRIMARY CILIUM; COUPLED RECEPTORS; KINASE-A; PATHWAY; ACTIVATION; INHIBITOR; MUTATION; BRAIN; PHOSPHODIESTERASE; LANDSCAPE	Medulloblastoma, the most common malignant childhood brain tumor, exhibits distinct molecular subtypes and cellular origins. Genetic alterations driving medulloblastoma initiation and progression remain poorly understood. Herein, we identify GNAS, encoding the G protein G alpha(s), as a potent tumor suppressor gene that, when expressed at low levels, defines a subset of aggressive Sonic hedgehog (SHH)-driven human medulloblastomas. Ablation of the single Gnas gene in anatomically distinct progenitors in mice is sufficient to induce Shh-associated medulloblastomas, which recapitulate their human counterparts. G alpha(s) is highly enriched at the primary cilium of granule neuron precursors and suppresses Shh signaling by regulating both the cAMP-dependent pathway and ciliary trafficking of Hedgehog pathway components. Elevation in levels of a G alpha(s) effector, cAMP, effectively inhibits tumor cell proliferation and progression in Gnas-ablated mice. Thus, our gain- and loss-of-function studies identify a previously unrecognized tumor suppressor function for G alpha(s) that can be found consistently across Shh-group medulloblastomas of disparate cellular and anatomical origins, highlighting G protein modulation as a potential therapeutic avenue.	[He, Xuelian; Wang, Fan; Hou, Yiping] Sichuan Univ, Sch Preclin & Forens Med, Collaborat Innovat Ctr Biotherapy, Dept Forens Med,State Key Lab Biotherapy,West Ch, Chengdu 610064, Peoples R China; [He, Xuelian; Zhang, Liguo; Lu, Fanghui; Wang, Haibo; Deng, Yaqi; Lu, Q. Richard] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Brain Tumor Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; [He, Xuelian; Zhang, Liguo; Lu, Fanghui; Wang, Haibo; Deng, Yaqi; Lu, Q. Richard] Cincinnati Childrens Hosp Med Ctr, Canc Biol Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Chen, Ying] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Remke, Marc; Shih, David; Wo, Xiaochong; Ramaswamy, Vijay; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Yu, Yang; Lu, Q. Richard] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Dept Pediat,West China Hosp 2, Chengdu 610064, Peoples R China; [Xia, Yong] Sichuan Univ, Dept Neurosurg, West China Hosp, Chengdu 610064, Peoples R China; [Hu, Tom; Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Zhou, Wenhao; Lu, Q. Richard] Fudan Univ, Key Lab Birth Defects, Childrens Hosp, Shanghai 200433, Peoples R China; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Weinstein, Lee S.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD USA; [Pomeroy, Scott L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Neurol,Childrens Hosp, Boston, MA 02115 USA; [Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wechsler-Reya, Robert] Sanford Burnham Med Res Inst, Tumor Dev Program, La Jolla, CA USA	Sichuan University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Xiamen University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sichuan University; Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Fudan University; Yonsei University; Yonsei University Health System; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; St Jude Children's Research Hospital; Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Lu, QR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Brain Tumor Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA.	richard.lu@cchmc.org	Gilbertson, Richard James/ABE-1346-2021; Shih, David J H/H-3186-2011; Pfister, Stefan M/F-6860-2013; Weinstein, Lee S/I-5575-2015; Hou, Yiping/H-9232-2018; wenhao, zhou/AAA-1505-2020; Shih, David J. H./AAE-8726-2019	Gilbertson, Richard James/0000-0001-7539-9472; Shih, David J H/0000-0002-9802-4937; Pfister, Stefan M/0000-0002-5447-5322; Hou, Yiping/0000-0003-4254-2388; Shih, David J. H./0000-0002-9802-4937; Taylor, Michael/0000-0001-7009-3466; Remke, Marc/0000-0002-9404-9993; Ramaswamy, Vijay/0000-0002-6557-895X; Kim, Se Hoon/0000-0001-7516-7372	US National Institutes of Health [R01 NS078092, R01 NS075243]; Ministry of Education of China [IRT0935]; Canadian Institutes of Health Research; Mildred-Scheel Foundation/German Cancer Aid; NATIONAL CANCER INSTITUTE [P01CA096832, R01CA109467, R01CA129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078092, R01NS075243, R01NS072427] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of China(Ministry of Education, China); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Mildred-Scheel Foundation/German Cancer Aid; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank A. Gilman, L. Lum, E. Hurlock, K. Campbell, J. Chan, H. Li, A. Hassan, D. He, E. Lu, L. He and W Ding for comments and technical support. We thank B. Fritzsch (University of Iowa) and J. Johnson (UT Southwestern) for Atoh1-Cre and Atoh1-GFP lines, respectively, C. Stiles (Harvard Medical School) for anti-Olig2, R. Rohatgi (Stanford University) for Ptch1-specific antibody and S. Scales (Genentech) for Gli2-, Gli3- and GPR161-specific antibodies. This study was funded in part by grants from the US National Institutes of Health (R01 NS078092 and R01 NS075243) to Q.R.L., the Ministry of Education of China (IRT0935) and from the Canadian Institutes of Health Research to M.D.T. and a postdoctoral fellowship by the Mildred-Scheel Foundation/German Cancer Aid (M.R.).	Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Grammel D, 2012, ACTA NEUROPATHOL, V123, P601, DOI 10.1007/s00401-012-0961-0; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Huh JY, 2014, J DERMATOL, V41, P319, DOI 10.1111/1346-8138.12284; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Machold R, 2011, GENE EXPR PATTERNS, V11, P349, DOI 10.1016/j.gep.2011.03.007; Mishra PK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002303; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; NIKAIDO T, 1989, CHEM PHARM BULL, V37, P1392, DOI 10.1248/cpb.37.1392; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pounds S, 2011, BIOINFORMATICS, V27, P2098, DOI 10.1093/bioinformatics/btr362; Regard JB, 2013, NAT MED, V19, P1505, DOI 10.1038/nm.3314; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Remke M, 2011, J CLIN ONCOL, V29, P2717, DOI 10.1200/JCO.2011.34.9373; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Ruiz I, 2007, TRENDS CELL BIOL, V17, P438, DOI DOI 10.1016/J.TCB.2007.06.007; Sasai K, 2007, CANCER RES, V67, P3871, DOI 10.1158/0008-5472.CAN-07-0493; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Sengupta R, 2011, TRENDS PHARMACOL SCI, V32, P337, DOI 10.1016/j.tips.2011.02.015; Silbereis JC, 2014, NEURON, V81, P574, DOI 10.1016/j.neuron.2013.11.024; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	55	84	85	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1035	1042		10.1038/nm.3666	http://dx.doi.org/10.1038/nm.3666			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25150496	Green Accepted, Green Submitted			2022-12-25	WOS:000341404000016
J	Sevenich, L; Bowman, RL; Mason, SD; Quail, DE; Rapaport, F; Elie, BT; Brogi, E; Brastianos, PK; Hahn, WC; Holsinger, LJ; Massague, J; Leslie, CS; Joyce, JA				Sevenich, Lisa; Bowman, Robert L.; Mason, Steven D.; Quail, Daniela E.; Rapaport, Franck; Elie, Benelita T.; Brogi, Edi; Brastianos, Priscilla K.; Hahn, William C.; Holsinger, Leslie J.; Massague, Joan; Leslie, Christina S.; Joyce, Johanna A.			Analysis of tumour-and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; PROTEOMIC IDENTIFICATION; TIGHT JUNCTION; MICROENVIRONMENT; PROTEASES; TARGETS; BARRIER; DISSEMINATION	Metastasis remains the most common cause of death in most cancers, with limited therapies for combating disseminated disease. While the primary tumour microenvironment is an important regulator of cancer progression, it is less well understood how different tissue environments influence metastasis. We analysed tumour stroma interactions that modulate organ tropism of brain, bone and lung metastasis in xenograft models. We identified a number of potential modulators of site-specific metastasis, including cathepsin S as a regulator of breast-to-brain metastasis. High cathepsin S expression at the primary site correlated with decreased brain metastasis-free survival in breast cancer patients. Both macrophages and tumour cells produce cathepsin S, and only the combined depletion significantly reduced brain metastasis in vivo. Cathepsin S specifically mediates blood brain barrier transmigration through proteolytic processing of the junctional adhesion molecule, JAM-B. Pharmacological inhibition of cathepsin S significantly reduced experimental brain metastasis, supporting its consideration as a therapeutic target for this disease.	[Sevenich, Lisa; Bowman, Robert L.; Mason, Steven D.; Quail, Daniela E.; Elie, Benelita T.; Massague, Joan; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Rapaport, Franck; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Brastianos, Priscilla K.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02214 USA; [Holsinger, Leslie J.] Virobay Inc, Menlo Pk, CA 94025 USA; [Massague, Joan; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Massague, Joan; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Metastasis Res Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	johanna@joycelab.org	Bowman, Robert/ABF-1007-2021	Massague, Joan/0000-0001-9324-8408; Brastianos, Priscilla/0000-0003-4470-8425; Rapaport, Franck/0000-0001-6553-2110; Bowman, Robert/0000-0002-8294-8748	US National Cancer Institute program grant of the Integrative Cancer Biology Program [CA148967]; US National Cancer Institute program grant of Tumour Microenvironment Network [CA126518]; Health Research Science Board of New York; Alan and Sandra Gerry Metastasis Research Initiative; Deutsche Forschungsgemeinschaft [SE2234/1-1]; US National Cancer Institute F31 fellowship [CA167863]; Gerstner Sloan Kettering graduate program; US National Cancer Institute F32 fellowship [CA130329]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA148967, U54CA126518, F31CA167863, P01CA142536, F32CA130329] Funding Source: NIH RePORTER	US National Cancer Institute program grant of the Integrative Cancer Biology Program; US National Cancer Institute program grant of Tumour Microenvironment Network; Health Research Science Board of New York; Alan and Sandra Gerry Metastasis Research Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Cancer Institute F31 fellowship; Gerstner Sloan Kettering graduate program; US National Cancer Institute F32 fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Simpson and X. Chen for excellent technical support, and members of the J.A.J. laboratory for insightful discussion. We thank L. Akkari, O. Olson and D. Yan for reading the manuscript,We are grateful to P. Bos for advice on the BBB assays and experimental brain metastasis model. We thank the MSKCC Core Facilities of Genomics, Molecular Cytology, Small Animal Imaging and Monoclonal Antibody Production for technical assistance. We thank H. Chapman (UCSF) for providing cathepsin S KO mice. This research was supported by the following: US National Cancer Institute program grants of the Integrative Cancer Biology Program (CA148967; J.A.J., C.S.L.) and Tumour Microenvironment Network (CA126518; J.A.J., J.M.), the Health Research Science Board of New York, and the Alan and Sandra Gerry Metastasis Research Initiative (J.A.J.), Deutsche Forschungsgemeinschaft (SE2234/1-1; L.S.), US National Cancer Institute F31 fellowship CA167863 and Gerstner Sloan Kettering graduate program (R.L.B.), US National Cancer Institute F32 fellowship CA130329 (S.D.M.), and Canadian Institutes of Health Research (D.F.Q.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Affara Nesrine I., 2009, V539, P1, DOI 10.1007/978-1-60327-003-8_1; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Gupta S, 2008, EXPERT OPIN THER TAR, V12, P291, DOI 10.1517/14728222.12.3.291; Jia W, 2013, ANTICANCER RES, V33, P2353; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katz AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032453; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Oliveira M, 2010, PEPTIDES, V31, P562, DOI 10.1016/j.peptides.2009.12.027; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; PAGET S, 1989, CANCER METAST REV, V8, P98; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schwartz DR, 2007, MOL CANCER RES, V5, P443, DOI 10.1158/1541-7786.MCR-06-0337; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Small DM, 2013, INT J CANCER, V133, P2102, DOI 10.1002/ijc.28238; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092	49	221	228	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					876	888		10.1038/ncb3011	http://dx.doi.org/10.1038/ncb3011			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25086747	Green Accepted			2022-12-25	WOS:000341404400008
J	Winter, GE; Radic, B; Mayor-Ruiz, C; Blomen, VA; Trefzer, C; Kandasamy, RK; Huber, KVM; Gridling, M; Chen, D; Klampfl, T; Kralovics, R; Kubicek, S; Fernandez-Capetillo, O; Brummelkamp, TR; Superti-Furga, G				Winter, Georg E.; Radic, Branka; Mayor-Ruiz, Cristina; Blomen, Vincent A.; Trefzer, Claudia; Kandasamy, Richard K.; Huber, Kilian V. M.; Gridling, Manuela; Chen, Doris; Klampfl, Thorsten; Kralovics, Robert; Kubicek, Stefan; Fernandez-Capetillo, Oscar; Brummelkamp, Thijn R.; Superti-Furga, Giulio			The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity	NATURE CHEMICAL BIOLOGY			English	Article							CELLULAR UPTAKE; HUMAN-CELLS; GENOME; TRANSPORTERS; SURVIVIN; FAMILY; DRUGS; YM155	Genotoxic chemotherapy is the most common cancer treatment strategy. However, its untargeted generic DNA-damaging nature and associated systemic cytotoxicity greatly limit its therapeutic applications. Here, we used a haploid genetic screen in human cells to discover an absolute dependency of the clinically evaluated anticancer compound YM155 on solute carrier family member 35 F2 (SLC35F2), an uncharacterized member of the solute carrier protein family that is highly expressed in a variety of human cancers. YM155 generated DNA damage through intercalation, which was contingent on the expression of SLC35F2 and its drug-importing activity. SLC35F2 expression and YM155 sensitivity correlated across a panel of cancer cell lines, and targeted genome editing verified SLC35F2 as the main determinant of YM155-mediated DNA damage toxicity in vitro and in vivo. These findings suggest a new route to targeted DNA damage by exploiting tumor and patient-specific import of YM155.	[Winter, Georg E.; Radic, Branka; Trefzer, Claudia; Kandasamy, Richard K.; Huber, Kilian V. M.; Gridling, Manuela; Chen, Doris; Klampfl, Thorsten; Kralovics, Robert; Kubicek, Stefan; Brummelkamp, Thijn R.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Mayor-Ruiz, Cristina; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain; [Blomen, Vincent A.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Centro Nacional de Investigaciones Oncologicas (CNIO); Netherlands Cancer Institute	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Huber, Kilian V. M./L-6921-2015; Jessen-Trefzer, Claudia/E-3710-2019; Fernandez-Capetillo, Oscar/H-3508-2015; Mayor-Ruiz, Cristina/AAH-5877-2020; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015; blomen, vincent/AAE-1477-2020; Kandasamy, Richard Kumaran/C-8981-2009; Kubicek, Stefan/C-2089-2017	Huber, Kilian V. M./0000-0002-1103-5300; Jessen-Trefzer, Claudia/0000-0003-4216-8189; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Mayor-Ruiz, Cristina/0000-0001-6442-5495; Superti-Furga, Giulio/0000-0002-0570-1768; Kandasamy, Richard Kumaran/0000-0002-0894-1222; Kubicek, Stefan/0000-0003-0855-8343; Klampfl, Thorsten/0000-0002-6666-9773; Winter, Georg/0000-0001-6606-1437; Chen, Doris/0000-0001-8835-0280; Radic Sarikas, Branka/0000-0002-3597-0483; Kralovics, Robert/0000-0002-6997-8539	Austrian Academy of Sciences; Gen-AU initiative of the Austrian Federal Ministry for Science, Research and Economy; European Commission [259348]; European Research Council [250179, ERC-617840]; Swiss National Science Foundation; Cancer Genomics Center; Netherlands Organisation for Scientific Research-VIDI grant [91711316]; Spanish Ministry of Economy and Competitiveness [SAF2011-23753]; Association for International Cancer Research [12-0229]; Howard Hughes Medical Institute; La Caixa Foundation; Worldwide Cancer Research [12-0229] Funding Source: researchfish	Austrian Academy of Sciences; Gen-AU initiative of the Austrian Federal Ministry for Science, Research and Economy; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Genomics Center; Netherlands Organisation for Scientific Research-VIDI grant; Spanish Ministry of Economy and Competitiveness(Spanish Government); Association for International Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); La Caixa Foundation(La Caixa Foundation); Worldwide Cancer Research	We thank all of the members of the Superti-Furga research laboratory and U. Rix (Moffitt Cancer Center) for skillful advice and discussions. The present work was, in part, financed by the Austrian Academy of Sciences (S.K., R.K.K., G.S.-F, D.C. and T.K.); the Gen-AU initiative of the Austrian Federal Ministry for Science, Research and Economy (G.E.W., PLACEBO); the European Commission (BR., K.V.M.H. and M.G., grant agreement number 259348, ASSET); the European Research Council (R.K.K., grant agreement number 250179, i-FIVE); and the Swiss National Science Foundation (C.T., Fellowship). T.R.B. is funded by the Cancer Genomics Center (http://www.cancergenomics.nl/) and the Netherlands Organisation for Scientific Research-VIDI grant 91711316. Work in the O.F.-C. laboratory was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2011-23753), the Association for International Cancer Research (12-0229), the Howard Hughes Medical Institute and the European Research Council (ERC-617840). C.M.-R. is funded by a PhD fellowship from La Caixa Foundation.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; COHEN SN, 1965, P NATL ACAD SCI USA, V54, P521, DOI 10.1073/pnas.54.2.521; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kell DB, 2011, DRUG DISCOV TODAY, V16, P704, DOI 10.1016/j.drudis.2011.05.010; Lanthaler K, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-70; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Minematsu T, 2010, DRUG METAB DISPOS, V38, P1, DOI 10.1124/dmd.109.028142; Minematsu T, 2009, DRUG METAB DISPOS, V37, P619, DOI 10.1124/dmd.108.025254; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Sappal DS, 2004, MOL CANCER THER, V3, P47; Sarangi A, 2007, P NATL ACAD SCI USA, V104, P11032, DOI 10.1073/pnas.0704182104; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965	27	120	122	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					768	773		10.1038/NCHEMBIO.1590	http://dx.doi.org/10.1038/NCHEMBIO.1590			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25064833	Green Accepted			2022-12-25	WOS:000341126800014
J	Bi, PP; Shan, TZ; Liu, WY; Yue, F; Yang, X; Liang, XR; Wang, JH; Li, J; Carlesso, N; Liu, XQ; Kuang, SH				Bi, Pengpeng; Shan, Tizhong; Liu, Weiyi; Yue, Feng; Yang, Xin; Liang, Xin-Rong; Wang, Jinghua; Li, Jie; Carlesso, Nadia; Liu, Xiaoqi; Kuang, Shihuan			Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity	NATURE MEDICINE			English	Article							STEM-CELLS; DIFFERENTIATION; EXPRESSION; PROLIFERATION; METABOLISM; ACTIVATION; ADIPOCYTES; PATHWAY; MOUSE; COLD	Beige adipocytes in white adipose tissue (WAT) are similar to classical brown adipocytes in that they can burn lipids to produce heat. Thus, an increase in beige adipocyte content in WAT browning would raise energy expenditure and reduce adiposity. Here we report that adipose-specific inactivation of Notch1 or its signaling mediator Rbpj in mice results in browning of WAT and elevated expression of uncoupling protein 1 (Ucp1), a key regulator of thermogenesis. Consequently, as compared to wild-type mice, Notch mutants exhibit elevated energy expenditure, better glucose tolerance and improved insulin sensitivity and are more resistant to high fat diet-induced obesity. By contrast, adipose-specific activation of Notch1 leads to the opposite phenotypes. At the molecular level, constitutive activation of Notch signaling inhibits, whereas Notch inhibition induces, Ppargc1a and Prdm16 transcription in white adipocytes. Notably, pharmacological inhibition of Notch signaling in obese mice ameliorates obesity, reduces blood glucose and increases Ucp1 expression in white fat. Therefore, Notch signaling may be therapeutically targeted to treat obesity and type 2 diabetes.	[Bi, Pengpeng; Shan, Tizhong; Liu, Weiyi; Yue, Feng; Yang, Xin; Liang, Xin-Rong; Wang, Jinghua; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Li, Jie; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Carlesso, Nadia] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Shan, Tizhong/G-1947-2015; Yue, Feng/S-6565-2017; Bi, Pengpeng/P-4936-2016	Bi, Pengpeng/0000-0002-9871-6773; Kuang, Shihuan/0000-0001-9180-3180	US National Institutes of Health [R01AR060652]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Honjo (Kyoto University, Japan) for providing the Rbpj<SUP>flox/flox</SUP> mice; Dow AgroScience for providing Methocel E4M reagent; K. Ajuwon for providing access to the calorimetry facility; S. Koser and S. Donkin for assistance with luciferase assays; D. Zhou for Odyssey imaging facility support; T. Wiegand and C. Bain for assistance with histology; J. Wu and S. Hobaugh for maintaining mouse colonies; and members of the Kuang laboratory for comments. This work was partially supported by a grant from the US National Institutes of Health (R01AR060652 to S.K.).	Battle M, 2014, INT J CANCER, V134, P1605, DOI 10.1002/ijc.28496; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Garces C, 1997, J BIOL CHEM, V272, P29729, DOI 10.1074/jbc.272.47.29729; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Huang Y, 2010, CELL PROLIFERAT, V43, P147, DOI 10.1111/j.1365-2184.2009.00661.x; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lai PY, 2013, BIOCHEM BIOPH RES CO, V430, P1132, DOI 10.1016/j.bbrc.2012.12.024; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Osathanon T, 2012, CELL BIOL INT, V36, P1161, DOI 10.1042/CBI20120288; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; SMITH RE, 1964, SCIENCE, V146, P1686, DOI 10.1126/science.146.3652.1686; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Urs S, 2012, ADIPOCYTE, V1, P46, DOI 10.4161/adip.19186; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vujovic S, 2007, CELL PROLIFERAT, V40, P185, DOI 10.1111/j.1365-2184.2007.00426.x; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	57	170	177	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					911	918		10.1038/nm.3615	http://dx.doi.org/10.1038/nm.3615			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25038826	Green Accepted, Green Submitted			2022-12-25	WOS:000340074600023
J	Cai, QY; Zhang, B; Sung, H; Low, SK; Kweon, SS; Lu, W; Shi, JJ; Long, JR; Wen, WQ; Choi, JY; Noh, DY; Shen, CY; Matsuo, K; Teo, SH; Kim, MK; Khoo, US; Iwasaki, M; Hartman, M; Takahashi, A; Ashikawa, K; Matsuda, K; Shin, MH; Park, MH; Zheng, Y; Xiang, YB; Ji, BT; Park, SK; Wu, PE; Hsiung, CN; Ito, H; Kasuga, YS; Kang, P; Mariapun, S; Ahn, SH; Kang, HS; Chan, KYK; Man, EPS; Iwata, H; Tsugane, SC; Miao, H; Liao, JM; Nakamura, YS; Kubo, M; Delahanty, RJ; Zhang, YF; Li, BS; Li, C; Gao, YT; Shu, XO; Kang, D; Zheng, W				Cai, Qiuyin; Zhang, Ben; Sung, Hyuna; Low, Siew-Kee; Kweon, Sun-Seog; Lu, Wei; Shi, Jiajun; Long, Jirong; Wen, Wanqing; Choi, Ji-Yeob; Noh, Dong-Young; Shen, Chen-Yang; Matsuo, Keitaro; Teo, Soo-Hwang; Kim, Mi Kyung; Khoo, Ui Soon; Iwasaki, Motoki; Hartman, Mikael; Takahashi, Atsushi; Ashikawa, Kyota; Matsuda, Koichi; Shin, Min-Ho; Park, Min Ho; Zheng, Ying; Xiang, Yong-Bing; Ji, Bu-Tian; Park, Sue K.; Wu, Pei-Ei; Hsiung, Chia-Ni; Ito, Hidemi; Kasuga, Yoshio; Kang, Peter; Mariapun, Shivaani; Ahn, Sei Hyun; Kang, Han Sung; Chan, Kelvin Y. K.; Man, Ellen P. S.; Iwata, Hiroji; Tsugane, Shoichiro; Miao, Hui; Liao, Jiemin; Nakamura, Yusuke; Kubo, Michiaki; Delahanty, Ryan J.; Zhang, Yanfeng; Li, Bingshan; Li, Chun; Gao, Yu-Tang; Shu, Xiao-Ou; Kang, Daehee; Zheng, Wei		DRIVE GAME-ON Consortium	Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1	NATURE GENETICS			English	Article							RISK VARIANT; METAANALYSIS; CYTOKINESIS; PRC1	In a three-stage genome-wide association study among East Asian women including 22,780 cases and 24,181 controls, we identified 3 genetic loci newly associated with breast cancer risk, including rs4951011 at 1q32.1 (in intron 2 of the ZC3H1 IA gene; P = 8.82 x 10(-9)), rs10474352 at 5q14.3 (near the ARRDC3 gene; P = 1.67 x 10(-9)) and rs2290203 at 15q26.1 (in intron 14 of the PRC1 gene; P= 4.25 x 10(-8)). We replicated these associations in 16,003 cases and 41,335 controls of European ancestry (P = 0.030, 0.004 and 0.010, respectively). Data from the ENCODE Project suggest that variants rs4951011 and rs10474352 might be located in an enhancer region and transcription factor binding sites, respectively. This study provides additional insights into the genetics and biology of breast cancer.	[Cai, Qiuyin; Zhang, Ben; Shi, Jiajun; Long, Jirong; Wen, Wanqing; Delahanty, Ryan J.; Zhang, Yanfeng; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr, Sch Med,Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Sung, Hyuna; Choi, Ji-Yeob; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Sung, Hyuna] NCI, Div Epidemiol & Genet, Genet Epidemiol Branch, Rockville, MD USA; [Low, Siew-Kee; Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kweon, Sun-Seog; Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun, South Korea; [Lu, Wei; Zheng, Ying] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Choi, Ji-Yeob; Noh, Dong-Young; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Shen, Chen-Yang; Wu, Pei-Ei; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang; Wu, Pei-Ei; Hsiung, Chia-Ni] Acad Sinica, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka, Japan; [Teo, Soo-Hwang; Kang, Peter; Mariapun, Shivaani] Sime Darby Med Ctr, Cancer Res Initiat Fdn, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Mariapun, Shivaani] Univ Malaya, Fac Med, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Management, Gyeonggi Do, South Korea; [Khoo, Ui Soon; Chan, Kelvin Y. K.; Man, Ellen P. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China; [Iwasaki, Motoki] Natl Canc Ctr, Epidemiol Div,Res Ctr Canc Prevent & Screen, Tokyo, Japan; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hartman, Mikael; Miao, Hui] Natl Univ Singapore, Dept Surg, Singapore, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ashikawa, Kyota] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Matsuda, Koichi] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Park, Min Ho] Chonnam Natl Univ, Sch Med, Dept Surg, Kwangju, South Korea; [Xiang, Yong-Bing; Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Ji, Bu-Tian] US Dept Hlth & Human Serv, US Natl Inst Hlth, Natl Canc Inst, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Kasuga, Yoshio] Nagano Matsushiro Gen Hosp, Dept Surg, Nagano, Japan; [Ahn, Sei Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Kang, Han Sung] Natl Canc Ctr, Ctr Breast Canc, Gyeonggi Do, South Korea; [Chan, Kelvin Y. K.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Iwata, Hiroji] Aichi Canc Ctr Cent Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo, Japan; [Liao, Jiemin] Singapore Eye Res Inst, Singapore, Singapore; [Liao, Jiemin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Liao, Jiemin] Natl Univ Hlth Syst, Singapore, Singapore; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Li, Bingshan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); RIKEN; Chonnam National University; Chonnam National University; Shanghai Center for Disease Control & Prevention; Seoul National University (SNU); Seoul National University (SNU); Academia Sinica - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; Kyushu University; Universiti Malaya; National Cancer Center - Korea (NCC); University of Hong Kong; National Cancer Center - Japan; National University of Singapore; National University of Singapore; Karolinska Institutet; Karolinska Institutet; RIKEN; University of Tokyo; Chonnam National University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Aichi Cancer Center; University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); University of Hong Kong; Aichi Cancer Center; National Cancer Center - Japan; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; University of Chicago; Vanderbilt University; Vanderbilt University	Cai, QY (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr, Sch Med,Dept Med,Div Epidemiol, Nashville, TN 37212 USA.	qiuyin.cai@vanderbilt.edu	Tsugane, Shoichiro/A-2424-2015; Matsuo, Keitaro/H-6758-2019; Lu, Wei/AAE-2921-2022; Li, Chun/R-1095-2019; Teo, Soo-hwang/H-2353-2014; Kweon, Sun-Seog/AAZ-4732-2021; Khoo, Ui Soon/C-4293-2009; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022; zhang, weihua/GXV-1334-2022; Gao, Y./GWZ-3665-2022; Khoo, Ui Soon/C-1345-2014; Chan, Kelvin/HGA-3097-2022; Zhang, Ben/GQP-3420-2022; zhang, yanfeng/E-6971-2016; Khoo, Ui Soon/K-2041-2019; Kubo, Michiaki/N-7947-2015; Zheng, Wei/O-3351-2013; Zhang, Yanfeng/AAW-3915-2020; Hartman, Mikael/B-4324-2011; Matsuda, Koichi/D-4597-2011	Tsugane, Shoichiro/0000-0003-4105-2774; Matsuo, Keitaro/0000-0003-1761-6314; Lu, Wei/0000-0002-4150-8674; Li, Chun/0000-0002-8819-2443; Kweon, Sun-Seog/0000-0003-2378-8550; Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; zhang, yanfeng/0000-0002-3859-3839; Zheng, Wei/0000-0003-1226-070X; Zhang, Yanfeng/0000-0002-3859-3839; Hartman, Mikael/0000-0001-5726-9965; SHI, JIAJUN/0000-0001-5194-0009; Long, Jirong/0000-0002-7433-9766; Low, Siew-Kee/0000-0003-2386-0698; Kang, Daehee/0000-0003-4031-5878; Matsuda, Koichi/0000-0001-7292-2686	US National Institutes of Health grants [R01CA124558, R01CA148667, R37CA070867, R01CA118229, R01CA092585, R01CA064277, R01CA122756, R01CA137013]; US Department of Defense Idea Awards [BC011118, BC050791]; Ingram Professorship and Research Reward funds; Vanderbilt-Ingram Cancer Center [P30CA068485]; BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0001564]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [1020350]; Shanghai Breast Cancer Study [R01CA064277]; Shanghai Women's Health Study [R37CA070867]; Shanghai Breast Cancer Survival Study [R01CA118229]; Shanghai Endometrial Cancer Study [R01CA092585]; Seoul Breast Cancer Study (BRL program through the National Research Foundation of Korea - Ministry of Education, Science and Technology) [2012-0000347]; BioBank Japan Project (Ministry of Education, Culture, Sports, Science and Technology of Japan); Hwasun Cancer Epidemiology Study-Breast (National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea) [1020010]; Taiwan Study (Institute of Biomedical Sciences, Academia Sinica, Taiwan and National Science Council) [DOH97-01]; Hong Kong Study (Research Grant Council, Hong Kong, China) [HKU 7520/05M, 76730M]; Korean-NCC Study (Korea National Cancer Center) [NCC-0910310]; Nagano Breast Cancer Study (Ministry of Health, Labor and Welfare of Japan, for Scientific Research on Priority Areas) [17015049]; Nagano Breast Cancer Study (Ministry of Education, Culture, Sports, Science and Technology of Japan) [221S0001]; Hospital-Based Epidemiologic Research Program at the Aichi Cancer Center (Ministry of Education, Culture, Sports, Science and Technology of Japan) [221S0001, 24590776, 17015018]; Malaysian Breast Cancer Genetic Study (Malaysian Ministry of Science, Technology and Innovation, Malaysian Ministry of Higher Education) [UM.C/H1R/MOHE/06]; Cancer Research Initiatives Foundation; Yayasan Sime Darby LPGA; Singapore Breast Cancer Study (National Medical Research Council Start-Up Grant and Centre Grant ) [NMRC/CG/NCIS/2010]; Biomedical Research Council [05/1/21/19/425]; US NIH grant [U19CA148065]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense Idea Awards(United States Department of Defense); Ingram Professorship and Research Reward funds; Vanderbilt-Ingram Cancer Center; BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Shanghai Breast Cancer Study; Shanghai Women's Health Study; Shanghai Breast Cancer Survival Study; Shanghai Endometrial Cancer Study; Seoul Breast Cancer Study (BRL program through the National Research Foundation of Korea - Ministry of Education, Science and Technology)(National Research Foundation of Korea); BioBank Japan Project (Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hwasun Cancer Epidemiology Study-Breast (National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea); Taiwan Study (Institute of Biomedical Sciences, Academia Sinica, Taiwan and National Science Council); Hong Kong Study (Research Grant Council, Hong Kong, China); Korean-NCC Study (Korea National Cancer Center); Nagano Breast Cancer Study (Ministry of Health, Labor and Welfare of Japan, for Scientific Research on Priority Areas); Nagano Breast Cancer Study (Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hospital-Based Epidemiologic Research Program at the Aichi Cancer Center (Ministry of Education, Culture, Sports, Science and Technology of Japan); Malaysian Breast Cancer Genetic Study (Malaysian Ministry of Science, Technology and Innovation, Malaysian Ministry of Higher Education); Cancer Research Initiatives Foundation; Yayasan Sime Darby LPGA; Singapore Breast Cancer Study (National Medical Research Council Start-Up Grant and Centre Grant ); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by US National Institutes of Health grants R01CA124558, R01CA148667 and R37CA070867 (to W.Z.); R01CA118229, R01CA092585 and R01CA064277 (to X.-O.S.); R01CA122756 (to Q.C.); and R01CA137013 (to J. Long), US Department of Defense Idea Awards BC011118 (to X.-O.S.) and BC050791 (to Q.C.), and Ingram Professorship and Research Reward funds (to W.Z.). Sample preparation and genotyping assays at Vanderbilt were conducted at the Survey and Biospecimen Shared Resources and the Vanderbilt Microarray Shared Resource, which are supported in part by the Vanderbilt-Ingram Cancer Center (P30CA068485). SeBCS was supported by the BRL (Basic Research Laboratory) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0001564). KOHBRA/KOGES was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (1020350).; Studies participating in the ABCC include (principal investigator, grant support) the Shanghai Breast Cancer Study (W.Z. and X.-O.S., R01CA064277), the Shanghai Women's Health Study (W.Z., R37CA070867), the Shanghai Breast Cancer Survival Study (X.-O.S., R01CA118229), the Shanghai Endometrial Cancer Study (X.-O.S., R01CA092585, controls only), the Seoul Breast Cancer Study (D.K., BRL program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0000347)), the BioBank Japan Project (S.-K.L., the Ministry of Education, Culture, Sports, Science and Technology of Japan), the Hwasun Cancer Epidemiology Study-Breast (S.-S.K., the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea, 1020010), the Taiwan Study (C.-Y.S., Institute of Biomedical Sciences, Academia Sinica, Taiwan and National Science Council, DOH97-01), the Hong Kong Study (U.S.K., Research Grant Council, Hong Kong, China, HKU 7520/05M and 76730M), the Korean-NCC Study (M.K.K., grant-in-aid from the Korea National Cancer Center, NCC-0910310), the Nagano Breast Cancer Study (S.T., Grants-in-Aid for the Third-Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, for Scientific Research on Priority Areas, 17015049 and for Scientific Research on Innovative Areas, 221S0001, from the Ministry of Education, Culture, Sports, Science and Technology of Japan), the Hospital-Based Epidemiologic Research Program at the Aichi Cancer Center (K. Tajima, Grant-in-Aid for Scientific Research (C) (24590776) and Grant-in-Aid for Scientific Research on Priority Areas of Cancer (17015018) and Scientific Research on Innovative Areas (221S0001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan), the Malaysian Breast Cancer Genetic Study (S.-H.T., the Malaysian Ministry of Science, Technology and Innovation, Malaysian Ministry of Higher Education (UM.C/H1R/MOHE/06) and the Cancer Research Initiatives Foundation; controls were recruited by the Malaysian More than a Mammo Programme, which was supported by a grant from Yayasan Sime Darby LPGA) and the Singapore Breast Cancer Study (M.H., National Medical Research Council Start-Up Grant and Centre Grant (NMRC/CG/NCIS/2010); additional controls were recruited by the Singapore Consortium of Cohort Studies Multi-Ethnic Cohort (SCCS-MEC), which was funded by the Biomedical Research Council, grant 05/1/21/19/425). The DRIVE GAME-ON Consortium is funded by US NIH grant U19CA148065 (D. Hunter). We thank I. Soong, A. Chan and T.Y. Leung for their assistance in facilitating recruitment of the breast cancer cases included in the Hong Kong Study.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li C, 2004, ONCOGENE, V23, P9336, DOI 10.1038/sj.onc.1208114; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mustacchi G, 2013, INT J MOL SCI, V14, P9686, DOI 10.3390/ijms14059686; Rafiq S, 2013, CANCER RES, V73, P1883, DOI 10.1158/0008-5472.CAN-12-3377; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	25	102	104	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					886	890		10.1038/ng.3041	http://dx.doi.org/10.1038/ng.3041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038754	Green Accepted			2022-12-25	WOS:000339704400019
J	Roberts, M; Wall, IB; Bingham, I; Icely, D; Reeve, B; Bure, K; French, A; Brindley, DA				Roberts, MacKenna; Wall, Ivan B.; Bingham, Ian; Icely, Dominic; Reeve, Brock; Bure, Kim; French, Anna; Brindley, David A.			The global intellectual property landscape of induced pluripotent stem cell technologies	NATURE BIOTECHNOLOGY			English	Editorial Material							PATENTS; LICENSES	Will freedom to research and innovate be restricted as the induced pluripotent stem cell field advances toward the clinic, or are concerns premature within a rapidly changing ecosystem?	[Roberts, MacKenna; Wall, Ivan B.; French, Anna; Brindley, David A.] Univ Oxford, Oxford Univ Coll London, Ctr Adv Sustainable Med Innovat, Oxford, England; [Wall, Ivan B.] UCL, Dept Biochem Engn, London, England; [Wall, Ivan B.] Dankook Univ, Dept Nanobiomed Sci, Global Res Ctr Regenerat Med, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, Plus NBM BK21, Global Res Ctr Regenerat Med, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, Dept Nanobiomed Sci, Biomat & Tissue Engn Lab, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, World Class Univ Res Ctr, Cheonan, South Korea; [Bingham, Ian; Icely, Dominic] IP Asset LLP, Oxford, England; [Reeve, Brock; Brindley, David A.] Harvard Stem Cell Inst, Cambridge, MA USA; [Bure, Kim] Sartorius Stedim, Gottingen, Germany; [Brindley, David A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford, England; [Brindley, David A.] UCL, UCL Sch Pharm, Ctr Behav Med, London, England	University of Oxford; University of London; University College London; Dankook University; Dankook University; Dankook University; Dankook University; Harvard University; Nuffield Orthopaedic Centre; University of Oxford; University of London; University College London; University of London School of Pharmacy	Roberts, M (corresponding author), Univ Oxford, Oxford Univ Coll London, Ctr Adv Sustainable Med Innovat, Oxford, England.	anna.french@casmi.org.uk; david.brindley@ndorms.ox.ac.uk			Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics; Cell Therapy Catapult; CIRM; Eisai; GE Healthcare; Lonza; SENS Research Foundation; Sartorius Stedim; MEDIPOST Co., Ltd.; MEDIPOST America Inc.; New York Stem Cell Foundation; US National Institutes of Health Center for Regenerative Medicine; UK Technology Strategy Board	Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); Cell Therapy Catapult; CIRM(California Institute for Regenerative Medicine); Eisai(Eisai Co Ltd); GE Healthcare(General ElectricGE Healthcare); Lonza; SENS Research Foundation; Sartorius Stedim; MEDIPOST Co., Ltd.; MEDIPOST America Inc.; New York Stem Cell Foundation; US National Institutes of Health Center for Regenerative Medicine; UK Technology Strategy Board	The authors thank B. Larner, F. Wattler and J. Evans (Thomson Reuters) for their invaluable assistance; A. Carr (University of Oxford) and J. Karp (Harvard University and Brigham and Women's Hospital) for their invaluable support and insights; and R. Barker (the Centre for the Advancement of Sustainable Medical Innovation (CASMI)) and M. Morys (CASMI) for their support of the CASMI Translational Stem Cell Consortium. The authors wish to express sincere thanks to the following organizations that have contributed to the consortium as funding and events partners: Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics; Cell Therapy Catapult; CIRM; Eisai; GE Healthcare; Lonza; SENS Research Foundation; TAP Biosystems (now Sartorius Stedim); MEDIPOST Co., Ltd.; MEDIPOST America Inc.; the New York Stem Cell Foundation and the US National Institutes of Health Center for Regenerative Medicine. Additionally, CASMI is a past recipient of funding from the UK Technology Strategy Board to support an investigation into cell therapy regulation. The content outlined herein represents the individual opinions of the authors and may not necessarily represent the viewpoints of their employers. D.B. is subject to the CFA Institute's codes, standards and guidelines and as such, must stress that this piece is provided for academic interest only and must not be construed in any way as an investment recommendation.	[Anonymous], 2010, US Patent Application Patent, Patent No. [12/703,015, 12703015]; [Anonymous], 2008, Japan Patent, Patent No. [2008-131577, 2008131577]; [Anonymous], 2013, INITIAL PUBLIC OFFER; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; BioInformant Worldwide, 2014, COMPL 2012 13 IND PL; Bubela T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003490; Cyranoski D, 2013, NAT MED, V19, P510, DOI 10.1038/nm0513-510; Feldman R., 2010, STANFORD J LAW SCI P, V3, P17; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; House of Commons Science and Technology Committee, 2013, 348 HC; Jaenisch R, 2010, Patent No. [US7682828, 7682828]; Mathews DJH, 2013, CELL STEM CELL, V12, P508, DOI 10.1016/j.stem.2013.04.015; Mathews DJH, 2011, SCIENCE, V331, P725, DOI 10.1126/science.1201382; Moran N, 2013, NAT BIOTECHNOL, V31, P376, DOI 10.1038/nbt0513-376; Rao MS, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-98, 10.1186/scrt309]; Sakurada K, 2010, Patent No. [2450603, GB2450603]; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Simon BM, 2010, NAT BIOTECHNOL, V28, P557, DOI 10.1038/nbt0610-557; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The Hinxton Group, 2010, CONS STAT POL PRACT; UK Intellectual Property Office Patent Informatics Team, 2012, STEM CELLS UKSCN PAT; Webb S, 2009, NAT BIOTECHNOL, V27, P977, DOI 10.1038/nbt1109-977; Winickoff David E, 2009, Yale J Health Policy Law Ethics, V9, P52; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	24	24	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					742	749		10.1038/nbt.2975	http://dx.doi.org/10.1038/nbt.2975			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093884				2022-12-25	WOS:000346455900013
J	Williams, SE; Ratliff, LA; Postiglione, MP; Knoblich, JA; Fuchs, E				Williams, Scott E.; Ratliff, Lyndsay A.; Postiglione, Maria Pia; Knoblich, Juergen A.; Fuchs, Elaine			Par3-mInsc and G alpha(i3) cooperate to promote oriented epidermal cell divisions through LGN	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; MITOTIC SPINDLE ORIENTATION; HETEROTRIMERIC G-PROTEINS; NEURAL STEM-CELLS; G-ALPHA; DROSOPHILA NEUROBLASTS; ASYMMETRIC DIVISIONS; DEVELOPING NEOCORTEX; PLANAR DIVISIONS; POLARITY PROTEIN	Asymmetric cell divisions allow stem cells to balance proliferation and differentiation. During embryogenesis, murine epidermis expands rapidly from a single layer of unspecified basal layer progenitors to a stratified, differentiated epithelium. Morphogenesis involves perpendicular (asymmetric) divisions and the spindle orientation protein LGN, but little is known about how the apical localization of LGN is regulated. Here, we combine conventional genetics and lentiviral-mediated in vivo RNAi to explore the functions of the LGN-interacting proteins Par3, mInsc and G alpha(i3). Whereas loss of each gene alone leads to randomized division angles, combined loss of Gnai3 and mInsc causes a phenotype of mostly planar divisions, akin to loss of LGN. These findings lend experimental support for the hitherto untested model that Par3-mInsc and G alpha(i3) act cooperatively to polarize LGN and promote perpendicular divisions. Finally, we uncover a developmental switch between delamination-driven early stratification and spindle-orientation-dependent differentiation that occurs around E15, revealing a two-step mechanism underlying epidermal maturation.	[Williams, Scott E.; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA; [Williams, Scott E.; Ratliff, Lyndsay A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Postiglione, Maria Pia; Knoblich, Juergen A.] Inst Mol Biotechnol Austrian Acad Sci IMB, A-1030 Vienna, Austria	Howard Hughes Medical Institute; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, 1230 York Ave,Box 300, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Knoblich, Juergen A/C-2974-2015; Fuchs, Elaine/G-1565-2016	Knoblich, Juergen A/0000-0002-6751-3404; Williams, Scott/0000-0001-9975-7334	American Cancer Society; National Institutes of Health [R37-27883]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank N. Stokes, D. Oristi an and A. Aldeguer (Fuchs laboratory) and T. Anthony Curtis (Williams laboratory), for their expert technical assistance. We thank K. Byrd, K. Lough, and members of the Williams and Fuchs laboratories for critical reading of the manuscript and K. Lough for valuable input into the model presented in Fig. 8. We are grateful to S. Ohno and T. Hirose (both at Yokohama City University of Medicine, Japan) for sharing the Pard3 foxed mouse line. SEW was supported by an American Cancer Society postdoctoral fellowship and E.F. is an investigator in the Howard Hughes Medical Institute. Work in the Fuchs laboratory was supported by a grant from the National Institutes of Health (E.F. R37-27883).	Beronja Slobodan, 2013, Methods Mol Biol, V961, P351, DOI 10.1007/978-1-62703-227-8_23; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Culurgioni S, 2011, P NATL ACAD SCI USA, V108, P20998, DOI 10.1073/pnas.1113077108; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; El-Hashash AH, 2011, DEV DYNAM, V240, P441, DOI 10.1002/dvdy.22551; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; Gao L, 2002, GENE, V294, P99, DOI 10.1016/S0378-1119(02)00681-9; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mauser JF, 2012, PLOS ONE, V7, P118, DOI 10.1371/journal.pone.0029611; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Pan Z, 2013, STRUCTURE, V21, P1007, DOI 10.1016/j.str.2013.04.005; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Williams SE, 2013, CURR OPIN CELL BIOL, V25, P749, DOI 10.1016/j.ceb.2013.08.003; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	64	88	88	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					758	U231		10.1038/ncb3001	http://dx.doi.org/10.1038/ncb3001			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	25016959	Green Accepted, Green Published			2022-12-25	WOS:000339904900008
J	Ernst, J; Kellis, M				Ernst, Jason; Kellis, Manolis			Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues	NATURE BIOTECHNOLOGY			English	Article							HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; METHYLATION STATUS; DNA METHYLATION; DISCOVERY; GENE; RESOLUTION; BINDING; ENCODE; IDENTIFICATION	With hundreds of epigenomic maps, the opportunity arises to exploit the correlated nature of epigenetic signals, across both marks and samples, for large-scale prediction of additional datasets. Here, we undertake epigenome imputation by leveraging such correlations through an ensemble of regression trees. We impute 4,315 high-resolution signal maps, of which 26% are also experimentally observed. Imputed signal tracks show overall similarity to observed signals and surpass experimental datasets in consistency, recovery of gene annotations and enrichment for disease-associated variants. We use the imputed data to detect low-quality experimental datasets, to find genomic sites with unexpected epigenomic signals, to define high-priority marks for new experiments and to delineate chromatin states in 127 reference epigenomes spanning diverse tissues and cell types. Our imputed datasets provide the most comprehensive human regulatory region annotation to date, and our approach and the ChromImpute software constitute a useful complement to large-scale experimental mapping of epigenomic information.	[Ernst, Jason] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Ernst, Jason] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA USA; [Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ernst, J (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.	jason.ernst@ucla.edu; manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	National Science Foundation CAREER Award [1254200]; Alfred P. Sloan Fellowship; US National Institutes of Health through National Human Genome Research Institute [RC1HG005334, R01HG004037]; Direct For Biological Sciences [1254200, 0644282] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U41HG007000, U01HG007610, RC1HG005334, U54HG004570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113708] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); US National Institutes of Health through National Human Genome Research Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Kundaje, W. Meuleman, M. Bilenky and members of the NIH Roadmap Epigenomics Data Analysis and Coordination Center for data processing. We thank P. Kheradpour for advice on the motif analysis. We thank M. Eaton for generating the chromatin state segmentation visualization. We thank T. Wang for hosting the imputed data on the WashU Epigenome Browser. We thank N. Rajagopal, B. Ren and members of the Kellis laboratory and Roadmap Epigenomics Consortium for discussions related to this work. We thank the NIH Roadmap Epigenomics and ENCODE consortia for generating the data used in this paper. Funding for this work provided by National Science Foundation CAREER Award # 1254200 and an Alfred P. Sloan Fellowship to J.E. and by US National Institutes of Health through National Human Genome Research Institute grants RC1HG005334 and R01HG004037 to M.K.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Capra JA, 2014, BIOINFORMATICS, V30, pI408, DOI 10.1093/bioinformatics/btu445; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fan SC, 2008, BIOCHEM BIOPH RES CO, V374, P559, DOI 10.1016/j.bbrc.2008.07.077; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hastie T., 2009, UNSUPERVISED LEARNIN; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lasserre J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003168; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Yuan GC, 2009, J COMPUT BIOL, V16, P341, DOI 10.1089/cmb.2008.18TT; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S13; Zhou J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003525; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	57	209	211	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					364	U74		10.1038/nbt.3157	http://dx.doi.org/10.1038/nbt.3157			16	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25690853	Green Submitted, hybrid, Green Accepted			2022-12-25	WOS:000352348500022
J	Tian, ZH; Sun, P; Yan, Y; Wu, ZH; Zheng, QF; Zhou, SX; Zhang, H; Yu, FT; Jia, XY; Chen, DD; Mandi, A; Kurtan, T; Liu, W				Tian, Zhenhua; Sun, Peng; Yan, Yan; Wu, Zhuhua; Zheng, Qingfei; Zhou, Shuaixiang; Zhang, Hua; Yu, Futao; Jia, Xinying; Chen, Dandan; Mandi, Attila; Kurtan, Tibor; Liu, Wen			An enzymatic [4+2] cyclization cascade creates the pentacyclic core of pyrroindomycins	NATURE CHEMICAL BIOLOGY			English	Article							DIELS-ALDER REACTION; POLYKETIDE SYNTHASE; GENE-CLUSTER; SPIROTETRONATE ANTIBIOTICS; BIOSYNTHESIS; INSIGHTS; STEPS; PREDICTION; LL-42D005; CATALYZE	The [4+2] cycloaddition remains one of the most intriguing transformations in synthetic and natural products chemistry. In nature, however, there are remarkably few enzymes known to have this activity. We herein report an unprecedented enzymatic [4+2] cyclization cascade that has a central role in the biosynthesis of pyrroindomycins, which are pentacyclic spirotetramate natural products. Beginning with a linear intermediate that contains two pairs of 1,3-diene and alkene groups, the dedicated cyclases PyrE3 and PyrI4 act in tandem to catalyze the formation of two cyclohexene rings in the dialkyldecalin system and the tetramate spiro-conjugate of the molecules. The two cyclizations are completely enzyme dependent and proceed in a regio- and stereoselective manner to establish the enantiomerically pure pentacyclic core. Analysis of a related spirotetronate pathway confirms that homologs are functionally exchangeable, establishing the generality of these findings and explaining how nature creates diverse active molecules with similar rigid scaffolds.	[Tian, Zhenhua; Sun, Peng; Yan, Yan; Wu, Zhuhua; Zheng, Qingfei; Zhou, Shuaixiang; Zhang, Hua; Yu, Futao; Jia, Xinying; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Sun, Peng] Second Mil Med Univ, Sch Pharm, Res Ctr Marine Drugs, Shanghai, Peoples R China; [Chen, Dandan; Liu, Wen] Huzhou Ctr Biosynthet Innovat, Huzhou, Peoples R China; [Mandi, Attila; Kurtan, Tibor] Univ Debrecen, Dept Organ Chem, Debrecen, Hungary	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Naval Medical University; University of Debrecen	Liu, W (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Zheng, Qingfei/AAD-9431-2020; Jia, Xinying/B-8949-2016; Chen, Dan/GRY-2691-2022	Zheng, Qingfei/0000-0002-8397-3507; Jia, Xinying/0000-0003-0133-8321; Chen, Dan/0000-0002-1570-9034; Kurtan, Tibor/0000-0002-8831-8499; Mandi, Attila/0000-0002-7867-7084	National Natural Science Foundation of China [91213303, 81202453, 31430005, 91413101]; STCSM [14JC1407700, 13XD1404500]; Ministry of Science and Technology of China [2012AA02A706]; National Research Foundation of Hungary [OTKA K105871]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); STCSM(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Research Foundation of Hungary	This work was supported in part by grants from the National Natural Science Foundation of China (91213303, 81202453, 31430005 and 91413101), STCSM (14JC1407700 and 13XD1404500), the Ministry of Science and Technology of China (2012AA02A706) and the National Research Foundation (OTKA K105871) of Hungary.	Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Carey FA, 2000, ORGANIC CHEM, P365; DING WD, 1994, J ANTIBIOT, V47, P1250, DOI 10.7164/antibiotics.47.1250; Fang J, 2008, J BACTERIOL, V190, P6014, DOI 10.1128/JB.00533-08; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; Gottardi EM, 2011, CHEMBIOCHEM, V12, P1401, DOI 10.1002/cbic.201100172; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Hashimoto T, 2015, J AM CHEM SOC, V137, P572, DOI 10.1021/ja510711x; He HY, 2012, CHEM BIOL, V19, P1313, DOI 10.1016/j.chembiol.2012.07.024; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kallio P, 2013, BIOCHEMISTRY-US, V52, P4507, DOI 10.1021/bi400381s; Kanchanabanca C, 2013, ANGEW CHEM INT EDIT, V52, P5785, DOI 10.1002/anie.201301680; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keiser T, 2000, PRACTICAL STREPTOMYC; Kelly WL, 2011, NATURE, V473, P35, DOI 10.1038/473035a; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Li SM, 2013, ORG LETT, V15, P1374, DOI 10.1021/ol400342e; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; Oikawa H., 1995, J CHEM SOC CHEM COMM, P1321; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Roush WR, 1998, J AM CHEM SOC, V120, P7411, DOI 10.1021/ja980611f; Roush WR, 1997, J ORG CHEM, V62, P8708, DOI 10.1021/jo970960c; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SINGH MP, 1994, J ANTIBIOT, V47, P1258, DOI 10.7164/antibiotics.47.1258; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stephens PJ, 2010, CHIRALITY, V22, P229, DOI 10.1002/chir.20733; Sun P, 2013, J AM CHEM SOC, V135, P1540, DOI 10.1021/ja311339u; Sun YH, 2010, NAT CHEM BIOL, V6, P99, DOI [10.1038/nchembio.285, 10.1038/NCHEMBIO.285]; Takahashi S, 2011, NAT CHEM BIOL, V7, P461, DOI [10.1038/NCHEMBIO.583, 10.1038/nchembio.583]; Townsend CA, 2011, CHEMBIOCHEM, V12, P2267, DOI 10.1002/cbic.201100431; Varetto U., 2009, MOLEKEL 5 4; Vieweg L, 2014, NAT PROD REP, V31, P1554, DOI 10.1039/c4np00015c; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wu JQ, 2005, J AM CHEM SOC, V127, P17393, DOI 10.1021/ja055672+; Wu QQ, 2012, J AM CHEM SOC, V134, P17342, DOI 10.1021/ja304829g; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854	47	95	100	3	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					259	U91		10.1038/NCHEMBIO.1769	http://dx.doi.org/10.1038/NCHEMBIO.1769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25730548				2022-12-25	WOS:000351666500007
J	Zhou, ZK; Jiang, Y; Wang, Z; Gou, ZH; Lyu, J; Li, WY; Yu, YJ; Shu, LP; Zhao, YJ; Ma, YM; Fang, C; Shen, YT; Liu, TF; Li, CC; Li, Q; Wu, M; Wang, M; Wu, YS; Dong, Y; Wan, WT; Wang, X; Ding, ZL; Gao, YD; Xiang, H; Zhu, BG; Lee, SH; Wang, W; Tian, ZX				Zhou, Zhengkui; Jiang, Yu; Wang, Zheng; Gou, Zhiheng; Lyu, Jun; Li, Weiyu; Yu, Yanjun; Shu, Liping; Zhao, Yingjun; Ma, Yanming; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wu, Mian; Wang, Min; Wu, Yunshuai; Dong, Yang; Wan, Wenting; Wang, Xiao; Ding, Zhaoli; Gao, Yuedong; Xiang, Hui; Zhu, Baoge; Lee, Suk-Ha; Wang, Wen; Tian, Zhixi			Resequencing 302 wild and cultivated accessions identifies genes related to domestication and improvement in soybean	NATURE BIOTECHNOLOGY			English	Article							COPY NUMBER VARIATION; FLAVONOID 3'-HYDROXYLASE GENE; MAP-BASED CLONING; LINKAGE DISEQUILIBRIUM; GENOME ASSOCIATION; LEAFLET SHAPE; DIVERSITY; TRAITS; RICE; ALIGNMENT	Understanding soybean (Glycine max) domestication and improvement at a genetic level is important to inform future efforts to further improve a crop that provides the world's main source of oilseed. We detect 230 selective sweeps and 162 selected copy number variants by analysis of 302 resequenced wild, landrace and improved soybean accessions at > 11x depth. A genomewide association study using these new sequences reveals associations between 10 selected regions and 9 domestication or improvement traits, and identifies 13 previously uncharacterized loci for agronomic traits including oil content, plant height and pubescence form. Combined with previous quantitative trait loci (QTL) information, we find that, of the 230 selected regions, 96 correlate with reported oil QTLs and 21 contain fatty acid biosynthesis genes. Moreover, we observe that some traits and loci are associated with geographical regions, which shows that soybean populations are structured geographically. This study provides resources for genomics-enabled improvements in soybean breeding.	[Zhou, Zhengkui; Wang, Zheng; Li, Weiyu; Ma, Yanming; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wu, Mian; Wang, Min; Wu, Yunshuai; Zhu, Baoge; Tian, Zhixi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Jiang, Yu; Gou, Zhiheng; Lyu, Jun; Shu, Liping; Zhao, Yingjun; Dong, Yang; Wan, Wenting; Wang, Xiao; Ding, Zhaoli; Gao, Yuedong; Xiang, Hui; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Jiang, Yu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Gou, Zhiheng; Zhao, Yingjun; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wang, Min; Wang, Xiao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yanjun] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Lee, Suk-Ha] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Lee, Suk-Ha] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Seoul National University (SNU); Seoul National University (SNU)	Tian, ZX (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	wwang@mail.kiz.ac.cn; zxtian@genetics.ac.cn	Fang, Chao/U-5365-2019; Wang, Wen/AAP-9873-2020; Ma, Yanming/ABE-8450-2020; Jiang, Yu/O-5114-2015	Jiang, Yu/0000-0003-4821-3585; Zhou, Zhengkui/0000-0002-5192-2465; Wang, Wen/0000-0002-7801-2066; Li, Qing/0000-0001-7010-7776; Fang, Chao/0000-0003-0555-8487	National Key Basic Research Program [2013CB835200]; National Natural Science Foundation of China [31222042]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA08020202]; "One-hundred talents" Startup Funds from Chinese Academy of Sciences	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); "One-hundred talents" Startup Funds from Chinese Academy of Sciences	We thank the USDA GRIN database, SoyBase, the Platform of National Crop Germplasm Resources of China, and L. Qiu for providing publicly available resources and R. Nelson at the University of Illinois for sharing some of the phenotype data. We thank X. Liu (BGI-Shenzhen) for helping to upload sequence data to NCBI. This work was supported by the National Key Basic Research Program (No. 2013CB835200), National Natural Science Foundation of China (grant no. 31222042), "Strategic Priority Research Program" of the Chinese Academy of Sciences (grant no. XDA08020202), and "One-hundred talents" Startup Funds from Chinese Academy of Sciences for Z.T.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, SOYBEANS IMPROVEMENT; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen YW, 2004, CROP SCI, V44, P671, DOI 10.2135/cropsci2004.0671; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fang C, 2013, J GENET GENOMICS, V40, P93, DOI 10.1016/j.jgg.2013.01.002; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Funatsuki H, 2009, JARQ-JPN AGR RES Q, V43, P95, DOI 10.6090/jarq.43.95; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo JA, 2010, ANN BOT-LONDON, V106, P505, DOI 10.1093/aob/mcq125; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Jeong N, 2012, PLANT CELL, V24, P4807, DOI 10.1105/tpc.112.104968; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pathan M. S., 2008, ADV SOYBEAN BREEDING; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Sayama T, 2012, PLANT CELL, V24, P2123, DOI 10.1105/tpc.111.095174; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Toda K, 2005, CROP SCI, V45, P2212, DOI 10.2135/cropsci2004.0623; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Wilson, 2008, SOYBEAN MARKET DRIVE; Xia Z., 2013, THESCIENTIFICWORLDJO, V2013, P1; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yamada T, 2011, BREEDING SCI, V61, P480, DOI 10.1270/jsbbs.61.480; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg	63	617	670	23	354	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					408	U125		10.1038/nbt.3096	http://dx.doi.org/10.1038/nbt.3096			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25643055	hybrid			2022-12-25	WOS:000352348500028
J	Steinbeck, JA; Choi, SJ; Mrejeru, A; Ganat, Y; Deisseroth, K; Sulzer, D; Mosharov, EV; Studer, L				Steinbeck, Julius A.; Choi, Se Joon; Mrejeru, Ana; Ganat, Yosif; Deisseroth, Karl; Sulzer, David; Mosharov, Eugene V.; Studer, Lorenz			Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model	NATURE BIOTECHNOLOGY			English	Article							STRIATAL SYNAPTIC PLASTICITY; DOPAMINERGIC-NEURONS; GLUTAMATE RECEPTORS; AMPA RECEPTOR; MODULATION; EXPRESSION; D1; APOMORPHINE; RECOVERY; RATS	Recent studies have shown evidence of behavioral recovery after transplantation of human pluripotent stem cell (PSC)-derived neural cells in animal models of neurological disease. However, little is known about the mechanisms underlying graft function. Here we use optogenetics to modulate in real time electrophysiological and neurochemical properties of mesencephalic dopaminergic (mesDA) neurons derived from human embryonic stem cells (hESCs). In mice that had recovered from lesion-induced Parkinsonian motor deficits, light-induced selective silencing of graft activity rapidly and reversibly re-introduced the motor deficits. The re-introduction of motor deficits was prevented by the dopamine agonist apomorphine. These results suggest that functionality depends on graft neuronal activity and dopamine release. Combining optogenetics, slice electrophysiology and pharmacological approaches, we further show that mesDA-rich grafts modulate host glutamatergic synaptic transmission onto striatal medium spiny neurons in a manner reminiscent of endogenous mesDA neurons. Thus, application of optogenetics in cell therapy can link transplantation, animal behavior and postmortem analysis to enable the identification of mechanisms that drive recovery.	[Steinbeck, Julius A.; Ganat, Yosif; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Steinbeck, Julius A.; Ganat, Yosif; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY USA; [Choi, Se Joon; Mrejeru, Ana; Sulzer, David; Mosharov, Eugene V.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sulzer, David] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA; [Sulzer, David] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Columbia University; Columbia University	Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.	em706@columbia.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	Deutsche Forschungsgemeinschaft fellowship; US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [NS052671]; NYSTEM [C028503]; NINDS/NIH [NS075222]; Parkinson's disease Foundation; Jeffry and Barbara Picower Foundation; Udall Center of Excellence; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075222, R01NS052671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R01DA007418] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft fellowship(German Research Foundation (DFG)); US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NYSTEM; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's disease Foundation; Jeffry and Barbara Picower Foundation; Udall Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Oh and K. Manova (MSKCC molecular cytology core), and M. Tomishima (SKI stem cell core) for excellent technical support. We further thank Y. Schmitz (Sulzer laboratory) for advice on the corridor test. J.A.S. was supported by a Deutsche Forschungsgemeinschaft fellowship. The work was supported in part by US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grant NS052671 and NYSTEM contract C028503 to L.S. and by the NINDS/NIH grant NS075222 to E.V.M. This work was further supported by grants from the Parkinson's disease and Jeffry and Barbara Picower Foundations and the Udall Center of Excellence to D.S.	Andre VM, 2010, EUR J NEUROSCI, V31, P14, DOI 10.1111/j.1460-9568.2009.07047.x; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Battista D, 2014, STEM CELL TRANSL MED, V3, P108, DOI 10.5966/sctm.2013-0084; CENCI MA, 1992, NEUROSCIENCE, V46, P943, DOI 10.1016/0306-4522(92)90196-9; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Chan WS, 2003, NEUROSIGNALS, V12, P302, DOI 10.1159/000075312; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dell'Anno MT, 2014, J CLIN INVEST, V124, P3215, DOI 10.1172/JCI74664; Dowd E, 2005, BRAIN RES BULL, V68, P24, DOI 10.1016/j.brainresbull.2005.08.009; DUNNETT SB, 1988, EXP BRAIN RES, V71, P411; Fujita S, 2013, SYNAPSE, V67, P363, DOI 10.1002/syn.21644; Ganat YM, 2012, J CLIN INVEST, V122, P2928, DOI 10.1172/JCI58767; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kish LJ, 1999, BRAIN RES, V833, P58, DOI 10.1016/S0006-8993(99)01496-1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Paille V, 2010, J NEUROSCI, V30, P14182, DOI 10.1523/JNEUROSCI.2149-10.2010; Pina-Crespo JC, 2012, J NEUROSCI, V32, P15837, DOI 10.1523/JNEUROSCI.3735-12.2012; Pothos E, 1996, J NEUROCHEM, V66, P629; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Rylander D, 2013, P NATL ACAD SCI USA, V110, pE4375, DOI 10.1073/pnas.1311187110; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song RS, 2013, P NATL ACAD SCI USA, V110, P15437, DOI 10.1073/pnas.1311783110; Sorensen AT, 2005, EUR J NEUROSCI, V21, P2793, DOI 10.1111/j.1460-9568.2005.04116.x; Steinbeck JA, 2012, CELL MOL LIFE SCI, V69, P461, DOI 10.1007/s00018-011-0759-6; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	42	193	201	1	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					204	209		10.1038/nbt.3124	http://dx.doi.org/10.1038/nbt.3124			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25580598	Green Accepted			2022-12-25	WOS:000349198800027
J	Blaum, BS; Hannan, JP; Herbert, AP; Kavanagh, D; Uhrin, D; Stehle, T				Blaum, Baerbel S.; Hannan, Jonathan P.; Herbert, Andrew P.; Kavanagh, David; Uhrin, Dusan; Stehle, Thilo			Structural basis for sialic acid-mediated self-recognition by complement factor H	NATURE CHEMICAL BIOLOGY			English	Article							POLYANION BINDING-SITE; ALTERNATIVE PATHWAY; NMR-SPECTROSCOPY; C3 CONVERTASE; ACTIVATION; MEMBRANE; PROTEINS; DISCRIMINATION; CELLS; HOST	The serum protein complement factor H (FH) ensures downregulation of the complement alternative pathway, a branch of innate immunity, upon interaction with specific glycans on host cell surfaces. Using ligand-based NMR, we screened a comprehensive set of sialylated glycans for binding to FH and solved the crystal structure of a ternary complex formed by the two C-terminal domains of FH, a sialylated trisaccharide and the complement C3b thioester-containing domain. Key residues in the sialic acid binding site are conserved from mice to men, and residues linked to atypical hemolytic uremic syndrome cluster within this binding site, suggesting a possible role for sialic acid as a host marker also in other mammals and a critical role in human renal complement homeostasis. Unexpectedly, the FH sialic acid binding site is structurally homologous to the binding sites of two evolutionarily unrelated proteins. The crystal structure also advances our understanding of bacterial immune evasion strategies.	[Blaum, Baerbel S.; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Hannan, Jonathan P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Herbert, Andrew P.; Uhrin, Dusan] Univ Edinburgh, Sch Chem, Edinburgh EH8 9YL, Midlothian, Scotland; [Kavanagh, David] Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Edinburgh; Newcastle University - UK; Vanderbilt University	Blaum, BS (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	baerbel.blaum@uni-tuebingen.de	Herbert, Andy P/F-6693-2010; Kavanagh, David/E-8498-2011; Herbert, Andrew P/C-4755-2008	Herbert, Andy P/0000-0002-4549-6965; Kavanagh, David/0000-0003-4718-0072; Herbert, Andrew P/0000-0002-4549-6965; Blaum, Baerbel/0000-0003-4312-8912; Hannan, Jonathan/0000-0003-3318-2341	Engineering and Physical Sciences Research Council [EP/K039717/1] Funding Source: researchfish; EPSRC [EP/K039717/1] Funding Source: UKRI; Wellcome Trust Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Clark SJ, 2010, J BIOL CHEM, V285, P30192, DOI 10.1074/jbc.M110.103986; Copelovitch L, 2008, PEDIATR NEPHROL, V23, P1951, DOI 10.1007/s00467-007-0518-y; Crespo HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00491; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEARON DT, 1978, P NATL ACAD SCI USA, V75, P1971, DOI 10.1073/pnas.75.4.1971; Ferreira VP, 2007, BLOOD, V110, P2190, DOI 10.1182/blood-2007-04-083170; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Frank M, 2007, NUCLEIC ACIDS RES, V35, pD287, DOI 10.1093/nar/gkl907; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Herbert AP, 2012, BIOCHEMISTRY-US, V51, P1874, DOI 10.1021/bi201689j; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kavanagh D, 2013, SEMIN NEPHROL, V33, P508, DOI 10.1016/j.semnephrol.2013.08.003; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; KLEIN PJ, 1977, LANCET, V2, P1024; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; MICHALEK MT, 1988, J IMMUNOL, V140, P1588; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; OKADA N, 1982, NATURE, V299, P261, DOI 10.1038/299261a0; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rademacher C, 2012, GLYCOBIOLOGY, V22, P1086, DOI 10.1093/glycob/cws073; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Renner B, 2010, J IMMUNOL, V185, P3086, DOI 10.4049/jimmunol.1000111; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; Skerka C, 2013, MOL IMMUNOL, V56, P170, DOI 10.1016/j.molimm.2013.06.001; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; VARKI A, 1980, J EXP MED, V152, P532, DOI 10.1084/jem.152.3.532; Varki A., 2009, ESSENTIALS GLYCOBIOL; Williamson MP, 2009, ANNU REP NMR SPECTRO, V65, P77, DOI 10.1016/S0066-4103(08)00203-2; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005	57	187	192	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					77	+		10.1038/NCHEMBIO.1696	http://dx.doi.org/10.1038/NCHEMBIO.1696			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402769	Green Submitted			2022-12-25	WOS:000346448600016
J	Mahalatchimy, A; Rial-Sebbag, E; Duguet, AM; Taboulet, F; Cambon-Thomsen, A				Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne			The impact of European embryonic stem cell patent decisions on research strategies	NATURE BIOTECHNOLOGY			English	Editorial Material							COURT; PATENTABILITY		[Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne] INSERM, UMR1027, Toulouse, France; [Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne] Univ Toulouse 3, F-31062 Toulouse, France; [Mahalatchimy, Aurelie] Univ Sussex, Sch Global Studies, Ctr Global Hlth Policy, Brighton, E Sussex, England; [Mahalatchimy, Aurelie] Univ Toulouse 1, IRDEIC, F-31042 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Sussex; Universite de Toulouse; Universite Toulouse 1 Capitole	Mahalatchimy, A (corresponding author), INSERM, UMR1027, Toulouse, France.	aurelie.mahalatchimy@gmail.com	Mahalatchimy, Aurelie/D-2485-2018	Mahalatchimy, Aurelie/0000-0002-4365-2143				Bonadio E, 2012, EIPR, V34, P433; Court of Justice of the European Union, 2011, GRAND CHAMB BRUSTL G; EPO, 2008, ENL BOARD APP WARF G; EPO, 2014, BOARDS APP TECHN RES; European Council, 2006, POL AGR 7 RES FRAM P; Harmon SHE, 2013, EUR LAW REV, V38, P92; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Koch NJ, 2011, CELL STEM CELL, V9, P499, DOI 10.1016/j.stem.2011.11.001; Mahalatchimy A., EUR INTELLE IN PRESS; Moran N, 2011, NAT BIOTECHNOL, V29, P1057, DOI 10.1038/nbt1211-1057; Paton M, 2011, EIPR, V33, P590; Schuster MI, 2012, IIC-INT REV INTELL P, V43, P626; Wilmut I, 2011, CELL STEM CELL, V9, P498, DOI 10.1016/j.stem.2011.11.002	13	4	5	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					41	43		10.1038/nbt.3105	http://dx.doi.org/10.1038/nbt.3105			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574634	Green Accepted			2022-12-25	WOS:000347714200022
J	Miller, AM; Schoenberger, SP				Miller, Aaron M.; Schoenberger, Stephen P.			Notch signaling maintains T cell memories	NATURE MEDICINE			English	Editorial Material							DIFFERENTIATION		[Miller, Aaron M.; Schoenberger, Stephen P.] Univ Calif San Diego, Cellular Immunol Lab, La Jolla Inst Allergy & Immunol, San Diego, CA 92103 USA; [Miller, Aaron M.; Schoenberger, Stephen P.] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, San Diego, CA 92103 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, AM (corresponding author), Univ Calif San Diego, Cellular Immunol Lab, La Jolla Inst Allergy & Immunol, San Diego, CA 92103 USA.	sps@liai.org			NIAID NIH HHS [R01 AI107010] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107010] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Backer RA, 2014, NAT IMMUNOL, V15, P1143, DOI 10.1038/ni.3027; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Devarajan P, 2013, IMMUNOL RES, V57, P12, DOI 10.1007/s12026-013-8448-1; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	13	2	2	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					16	18		10.1038/nm.3784	http://dx.doi.org/10.1038/nm.3784			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569546				2022-12-25	WOS:000348408000008
J	Zuris, JA; Thompson, DB; Shu, Y; Guilinger, JP; Bessen, JL; Hu, JH; Maeder, ML; Joung, JK; Chen, ZY; Liu, DR				Zuris, John A.; Thompson, David B.; Shu, Yilai; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Maeder, Morgan L.; Joung, J. Keith; Chen, Zheng-Yi; Liu, David R.			Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo	NATURE BIOTECHNOLOGY			English	Article							GENE; CRISPR; SIRNA; CAS9; THERAPY; THERAPEUTICS; TRAFFICKING; SPECIFICITY; EXPRESSION; PEPTIDES	Efficient intracellular delivery of proteins is needed to fully realize the potential of protein therapeutics. Current methods of protein delivery commonly suffer from low tolerance for serum, poor endosomal escape and limited in vivo efficacy. Here we report that common cationic lipid nucleic acid transfection reagents can potently deliver proteins that are fused to negatively supercharged proteins, that contain natural anionic domains or that natively bind to anionic nucleic acids. This approach mediates the potent delivery of nM concentrations of Cre recombinase, TALE- and Cas9-based transcription activators, and Cas9:sgRNA nuclease complexes into cultured human cells in media containing 10% serum. Delivery of unmodified Cas9:sgRNA complexes resulted in up to 80% genome modification with substantially higher specificity compared to DNA transfection. This approach also mediated efficient delivery of Cre recombinase and Cas9:sgRNA complexes into the mouse inner ear in vivo, achieving 90% Cre-mediated recombination and 20% Cas9-mediated genome modification in hair cells.	[Zuris, John A.; Thompson, David B.; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zuris, John A.; Thompson, David B.; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Shu, Yilai; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otol & Laryngol, Cambridge, MA 02138 USA; [Shu, Yilai; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Shu, Yilai] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China; [Shu, Yilai] Minist Hearing Med, Key Lab Hlth, Shanghai, Peoples R China; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Eye & Ear Infirmary; Fudan University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Shu, Yilai/0000-0001-8893-434X; Bessen, Jeffrey/0000-0002-0351-7393	Ruth L. Kirchstein National Research Service Award [F32 GM 106601-2]; US National Institutes of Health (NIH) [R01 GM095501, R01 DC006908]; Defense Advanced Research Projects Agency [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute (HHMI); Bertarelli Foundation; David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; National Nature Science Foundation of China [NSFC81300824]; National Science Foundation Graduate Research Fellowship Program [DGE1144152]; NIH Director's Pioneer Award [DP1 GM105378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106601, R01GM095501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	Ruth L. Kirchstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Bertarelli Foundation; David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	J.A.Z. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 106601-2) D.B.T., J.P.G. and J.L.B. were supported by US National Institutes of Health (NIH) R01 GM095501 (to D. R. L.), Defense Advanced Research Projects Agency HR0011-11-2-0003 (to D. R. L.) and N66001-12-C-4207 (to D. R. L.), and the Howard Hughes Medical Institute (HHMI). D.R.L. was supported as a HHMI Investigator. Z.-Y.C. was supported by US National Institutes of Health (R01 DC006908), the Bertarelli Foundation, and the David-Shulsky Foundation. Y.S. was supported by the Frederick and Ines Yeatts Hair Cell Regeneration grant and by The National Nature Science Foundation of China NSFC81300824. J.H.H. was supported by National Science Foundation Graduate Research Fellowship Program (DGE1144152). M.L.M. and J.K.J. were supported by an NIH Director's Pioneer Award (DP1 GM105378). We thank A. Lawson, M. Sonnett, R. Xiao, S. Wang and J. Gehrke for technical assistance. We thank A. Edge, Massachusetts Eye & Ear Infirmary, Boston, for mouse embryonic stem cell (ES) line Tau-GFP and J. Johnson, Southwestern Medical Center, University of Texas, for floxPtdTomato mice (The Jackson Laboratory).	Adrian JE, 2010, J CONTROL RELEASE, V144, P341, DOI 10.1016/j.jconrel.2010.03.003; Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Colletier Jacques-Philippe, 2002, BMC Biotechnol, V2, P9, DOI 10.1186/1472-6750-2-9; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Daniels DS, 2007, J AM CHEM SOC, V129, P14578, DOI 10.1021/ja0772445; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hartung SD, 2004, MOL THER, V9, P866, DOI 10.1016/j.ymthe.2004.03.011; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Liu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091606, 10.1371/journal.pone.0085755, 10.1371/journal.pone.0089315, 10.1371/journal.pone.0098300]; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Mullen L, 2014, EXPERT OPIN DRUG DEL, V11, P101, DOI 10.1517/17425247.2014.863872; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shete HK, 2014, J NANOSCI NANOTECHNO, V14, P460, DOI 10.1166/jnn.2014.9082; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200	46	897	1031	23	587	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					73	80		10.1038/nbt.3081	http://dx.doi.org/10.1038/nbt.3081			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25357182	Green Accepted, Green Submitted			2022-12-25	WOS:000347714200030
J	von Mentzer, A; Connor, TR; Wieler, LH; Semmler, T; Iguchi, A; Thomson, NR; Rasko, DA; Joffre, E; Corander, J; Pickard, D; Wiklund, G; Svennerholm, AM; Sjoling, A; Dougan, G				von Mentzer, Astrid; Connor, Thomas R.; Wieler, Lothar H.; Semmler, Torsten; Iguchi, Atsushi; Thomson, Nicholas R.; Rasko, David A.; Joffre, Enrique; Corander, Jukka; Pickard, Derek; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa; Dougan, Gordon			Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution	NATURE GENETICS			English	Article							COLONIZATION FACTOR; VIRULENCE FACTORS; STRAINS; DIARRHEA; TRANSMISSION; EPIDEMIOLOGY; EXPRESSION; EVOLUTION; COUNTRIES; PLASMIDS	Enterotoxigenic Escherichia coli (ETEC), a major cause of infectious diarrhea, produce heat-stable and/or heat-labile enterotoxins and at least 25 different colonization factors that target the intestinal mucosa. The genes encoding the enterotoxins and most of the colonization factors are located on plasmids found across diverse E. coli serogroups. Whole-genome sequencing of a representative collection of ETEC isolated between 1980 and 2011 identified globally distributed lineages characterized by distinct colonization factor and enterotoxin profiles. Contrary to current notions, these relatively recently emerged lineages might harbor chromosome and plasmid combinations that optimize fitness and transmissibility. These data have implications for understanding, tracking and possibly preventing ETEC disease.	[von Mentzer, Astrid; Joffre, Enrique; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [von Mentzer, Astrid; Connor, Thomas R.; Thomson, Nicholas R.; Pickard, Derek; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Wieler, Lothar H.; Semmler, Torsten] Free Univ Berlin, Ctr Infect Med, Inst Microbiol & Epizoot, Berlin, Germany; [Iguchi, Atsushi] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Gothenburg; Wellcome Trust Sanger Institute; Cardiff University; Free University of Berlin; University of Miyazaki; University System of Maryland; University of Maryland Baltimore; University of Helsinki; Karolinska Institutet	von Mentzer, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden.	astrid.von.mentzer@gu.se; ann-mari.svennerholm@microbio.gu.se; asa.sjoling@ki.se; gdl@sanger.ac.uk	Joffré, Enrique/AAW-7546-2021; Connor, Thomas/ABD-6533-2021; Semmler, Torsten/O-9540-2019; Connor, Thomas/ABE-5989-2020; Thomson, Nicholas R/P-5988-2014; Joffre, Enrique/AHA-2603-2022; Semmler, Torsten/Q-7716-2018; von Mentzer, Astrid/I-5449-2018	Joffré, Enrique/0000-0003-0328-518X; Semmler, Torsten/0000-0002-2225-7267; Connor, Thomas/0000-0003-2394-6504; Thomson, Nicholas R/0000-0002-4432-8505; Joffre, Enrique/0000-0003-0328-518X; Semmler, Torsten/0000-0002-2225-7267; von Mentzer, Astrid/0000-0002-2167-1394; Sjoling, Asa/0000-0003-1529-1720; David, Rasko/0000-0002-7337-7154; Wieler, Lothar H./0000-0003-4365-3717; , Atsushi/0000-0003-3826-7520	Wellcome Trust [098051]; Swedish Research Council [2012-3464, 2011-3435]; Swedish Strategic Foundation [SB12-0072]; European Research Council [239784]; Medical Research Council [MR/L015080/1] Funding Source: researchfish; MRC [MR/L015080/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Foundation; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant 098051), the Swedish Research Council (grants 2012-3464 and 2011-3435), the Swedish Strategic Foundation (grant SB12-0072) and the European Research Council (grant 239784).	Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Grossman L.C, 2010, J BACTERIOL, V192, P5822; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Regua-Mangia AH, 2004, FEMS IMMUNOL MED MIC, V40, P155, DOI 10.1016/S0928-8244(03)00308-0; Rodrigues J, 1996, INFECT IMMUN, V64, P2680, DOI 10.1128/IAI.64.7.2680-2686.1996; Sabui S, 2010, J MED MICROBIOL, V59, P770, DOI 10.1099/jmm.0.017582-0; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; SMITH HW, 1973, P ROY SOC MED, V66, P272, DOI 10.1177/003591577306600335; Steinsland H, 2004, J CLIN MICROBIOL, V42, P3100, DOI 10.1128/JCM.42.7.3100-3107.2004; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Svennerholm AM, 2012, EXPERT REV VACCINES, V11, P495, DOI [10.1586/erv.12.12, 10.1586/ERV.12.12]; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Valvatne H, 2002, APMIS, V110, P665, DOI 10.1034/j.1600-0463.2002.1100911.x; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; WHO, 2009, DIARRH DIS; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	32	127	128	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1321	1326		10.1038/ng.3145	http://dx.doi.org/10.1038/ng.3145			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383970				2022-12-25	WOS:000345547300013
J	Kariolis, MS; Miao, YR; Ii, DSJ; Kapur, S; Mathews, II; Giaccia, AJ; Cochran, JR				Kariolis, Mihalis S.; Miao, Yu Rebecca; Ii, Douglas S. Jones; Kapur, Shiven; Mathews, Irimpan I.; Giaccia, Amato J.; Cochran, Jennifer R.			An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis	NATURE CHEMICAL BIOLOGY			English	Article							ARREST-SPECIFIC GENE-6; THERAPEUTIC TARGET; BREAST-CANCER; MONOCLONAL-ANTIBODY; PROLONGS SURVIVAL; TAM RECEPTORS; TUMOR-GROWTH; PROTEIN-S; KINASE; METASTASIS	Aberrant signaling through the Axl receptor tyrosine kinase has been associated with a myriad of human diseases, most notably metastatic cancer, identifying Axl and its ligand Gas6 as important therapeutic targets. Using rational and combinatorial approaches, we engineered an Axl 'decoy receptor' that binds Gas6 with high affinity and inhibits its function, offering an alternative approach from drug discovery efforts that directly target Axl. Four mutations within this high-affinity Axl variant caused structural alterations in side chains across the Gas6-Axl binding interface, stabilizing a conformational change on Gas6. When reformatted as an Fc fusion, the engineered decoy receptor bound Gas6 with femtomolar affinity, an 80-fold improvement compared to binding of the wild-type Axl receptor, allowing effective sequestration of Gas6 and specific abrogation of Axl signaling. Moreover, increased Gas6 binding affinity was critical and correlative with the ability of decoy receptors to potently inhibit metastasis and disease progression in vivo.	[Kariolis, Mihalis S.; Ii, Douglas S. Jones; Kapur, Shiven; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Miao, Yu Rebecca; Giaccia, Amato J.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Mathews, Irimpan I.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Stanford, CA USA; [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	Giaccia, AJ (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA.	giaccia@stanford.edu; jennifer.cochran@stanford.edu		Jones, Douglas/0000-0002-8456-6073	Wallace H. Coulter Translational Research Grant Program; Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H) Institute; Stanford Bio-X fellowship; US National Institutes of Health (NIH) [CA-088480, CA-67166]; NIH National Institute of General Medical Sciences Training Grant [T32 GM008412]; Siebel Graduate Fellowship; ARCS Graduate Fellowship; NATIONAL CANCER INSTITUTE [P01CA067166, R01CA088480, P30CA124435, R37CA088480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	Wallace H. Coulter Translational Research Grant Program; Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H) Institute; Stanford Bio-X fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of General Medical Sciences Training Grant; Siebel Graduate Fellowship; ARCS Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank E. Hohenester (Imperial College London) for his generous gift of the Gas6 plasmid and helpful discussions regarding protein production, L.L. Zheng for technical assistance with protein production and purification and the Stanford FACS Core Facility for assistance with the flow cytometric sorting. All in vivo and ex vivo imaging was conducted in the Stanford Small Animal Imaging Facility Portions of this research were performed at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the US Department of Energy Office of Basic Energy Sciences. This work was supported by the Wallace H. Coulter Translational Research Grant Program (J.R.C. and A.J.G.), the Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H) Institute (J.R.C. and I.I.M.), Stanford Bio-X and ARCS Graduate Fellowships (M.S.K.), US National Institutes of Health (NIH) grants CA-088480 and CA-67166 (A.J.G. and Y.R.M.), NIH National Institute of General Medical Sciences Training Grant T32 GM008412 and the Siebel Graduate Fellowship (D.S.J.).	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cerchia L, 2012, MOL THER, V20, P2291, DOI 10.1038/mt.2012.163; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Chen PX, 2013, ANN DIAGN PATHOL, V17, P425, DOI 10.1016/j.anndiagpath.2013.01.005; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fisher PW, 2005, BIOCHEM J, V387, P727, DOI 10.1042/BJ20040859; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong J, 2013, CANCER RES, V73, P331, DOI 10.1158/0008-5472.CAN-12-3151; Kariolis MS, 2013, CURR OPIN BIOTECH, V24, P1072, DOI 10.1016/j.copbio.2013.03.017; Leconet W, 2014, ONCOGENE, V33, P5405, DOI 10.1038/onc.2013.487; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Marshall SA, 2003, DRUG DISCOV TODAY, V8, P212, DOI 10.1016/S1359-6446(03)02610-2; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Yan SB, 2013, INVEST NEW DRUG, V31, P833, DOI 10.1007/s10637-012-9912-9; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	37	92	98	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					977	983		10.1038/NCHEMBIO.1636	http://dx.doi.org/10.1038/NCHEMBIO.1636			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25242553	Green Submitted, Green Accepted			2022-12-25	WOS:000343621500022
J	Prasain, N; Lee, MR; Vemula, S; Meador, JL; Yoshimoto, M; Ferkowicz, MJ; Fett, A; Gupta, M; Rapp, BM; Saadatzadeh, MR; Ginsberg, M; Elemento, O; Lee, Y; Voytik-Harbin, SL; Chung, HM; Hong, KS; Reid, E; O'Neill, CL; Medina, RJ; Stitt, AW; Murphy, MP; Rafii, S; Broxmeyer, HE; Yoder, MC				Prasain, Nutan; Lee, Man Ryul; Vemula, Sasidhar; Meador, Jonathan Luke; Yoshimoto, Momoko; Ferkowicz, Michael J.; Fett, Alexa; Gupta, Manav; Rapp, Brian M.; Saadatzadeh, Mohammad Reza; Ginsberg, Michael; Elemento, Olivier; Lee, Younghee; Voytik-Harbin, Sherry L.; Chung, Hyung Min; Hong, Ki Sung; Reid, Emma; O'Neill, Christina L.; Medina, Reinhold J.; Stitt, Alan W.; Murphy, Michael P.; Rafii, Shahin; Broxmeyer, Hal E.; Yoder, Mervin C.			Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells	NATURE BIOTECHNOLOGY			English	Article							PROGENITOR CELLS; NEUROPILIN-1; TRANSPLANTATION; COMMITMENT; HIERARCHY; EXPANSION; OUTGROWTH; VEGF	The ability to differentiate human pluripotent stem cells into endothelial cells with properties of cord-blood endothelial colony forming cells (CB-ECFCs) may enable the derivation of clinically relevant numbers of highly proliferative blood vessel forming cells to restore endothelial function in patients with vascular disease. We describe a protocol to convert human induced pluripotent stem cells (hiPSCs) or embryonic stem cells (hESCs) into cells similar to CB-ECFCs at an efficiency of >10(8) ECFCs produced from each starting pluripotent stem cell. The CB-ECFC-like cells display a stable endothelial phenotype with high clonal proliferative potential and the capacity to form human vessels in mice and to repair the ischemic mouse retina and limb, and they lack teratoma formation potential. We identify Neuropilin-1 (NRP-1)-mediated activation of KDR signaling through VEGF(165) as a critical mechanism for the emergence and maintenance of CB-ECFC-like cells.	[Prasain, Nutan; Vemula, Sasidhar; Meador, Jonathan Luke; Yoshimoto, Momoko; Ferkowicz, Michael J.; Fett, Alexa; Gupta, Manav; Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Lee, Man Ryul; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Rapp, Brian M.; Saadatzadeh, Mohammad Reza; Murphy, Michael P.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Ginsberg, Michael; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY USA; [Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Lee, Younghee] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Voytik-Harbin, Sherry L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Chung, Hyung Min] Konkuk Univ, Sch Med, Seoul, South Korea; [Hong, Ki Sung] CHA Univ, Stem Cell Res Lab, Seoul, South Korea; [O'Neill, Christina L.; Medina, Reinhold J.; Stitt, Alan W.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cornell University; Howard Hughes Medical Institute; Cornell University; University of Chicago; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Konkuk University; Konkuk University Medical Center; Pochon Cha University; Queens University Belfast	Yoder, MC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	myoder@iu.edu	Medina, Reinhold J/A-7949-2015; Stitt, Alan/A-9842-2009	Medina, Reinhold J/0000-0003-4351-7010; Stitt, Alan/0000-0002-8647-9918; Gupta, Manav/0000-0001-5163-2911; Reid, Emma/0000-0002-2555-438X; Yoder, Mervin/0000-0003-4354-7631	Riley Children's Foundation; AHA postdoctoral fellowship; Public Health Service [R01 HL109602, RO1 HL056416, RO1 HL067384, PO1 DK090948]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); South Korean government (MEST) [2011-0019487]; MRC [G0801962] Funding Source: UKRI; Medical Research Council [G0801962] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [10JTA] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112669, R01HL056416, R01HL067384, R01HL109602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049218, P30DK090948, U54DK106846] Funding Source: NIH RePORTER	Riley Children's Foundation; AHA postdoctoral fellowship(American Heart Association); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); South Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by funds provided by the Riley Children's Foundation (M.C.Y.), by an AHA postdoctoral fellowship (N.P.), and Public Health Service Grants R01 HL109602 (M.C.Y. and S.L.V.-H.), RO1 HL056416 (H.E.B.), RO1 HL067384 (H.E.B.), PO1 DK090948 (H.E.B. and M.C.Y.), and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), which is funded by the South Korean government (MEST; No. 2011-0019487). The authors thank H.P. Poudel (Indiana University Purdue University Indianapolis) for critical input in biostatistical analysis. The authors also thank H.J. Lee (CHA Stem Cell Institute, CHA University, South Korea) for HLI experiments.	Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Cimato T, 2009, CIRCULATION, V119, P2170, DOI 10.1161/CIRCULATIONAHA.109.849596; Critser PJ, 2010, MICROVASC RES, V80, P23, DOI 10.1016/j.mvr.2010.03.001; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kang KT, 2013, ANGIOGENESIS, V16, P773, DOI 10.1007/s10456-013-9354-9; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uniewicz KA, 2011, J BIOL CHEM, V286, P12, DOI 10.1074/jbc.M110.190801; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	29	158	165	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1151	1157		10.1038/nbt.3048	http://dx.doi.org/10.1038/nbt.3048			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25306246	Green Accepted, Green Published			2022-12-25	WOS:000344977000021
J	Schonhuber, N; Seidler, B; Schuck, K; Veltkamp, C; Schachtler, C; Zukowska, M; Eser, S; Feyerabend, TB; Paul, MC; Eser, P; Klein, S; Lowy, AM; Banerjee, R; Yang, F; Lee, CL; Moding, EJ; Kirsch, DG; Scheideler, A; Alessi, DR; Varela, I; Bradley, A; Kind, A; Schnieke, AE; Rodewald, HR; Rad, R; Schmid, RM; Schneider', G; Saur, D				Schoenhuber, Nina; Seidler, Barbara; Schuck, Kathleen; Veltkamp, Christian; Schachtler, Christina; Zukowska, Magdalena; Eser, Stefan; Feyerabend, Thorsten B.; Paul, Mariel C.; Eser, Philipp; Klein, Sabine; Lowy, Andrew M.; Banerjee, Ruby; Yang, Fangtang; Lee, Chang-Lung; Moding, Everett J.; Kirsch, David G.; Scheideler, Angelika; Alessi, Dario R.; Varela, Ignacio; Bradley, Allan; Kind, Alexander; Schnieke, Angelika E.; Rodewald, Hans-Reimer; Rad, Roland; Schmid, Roland M.; Schneider', Gunter; Saur, Dieter			A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer	NATURE MEDICINE			English	Article							DUCTAL ADENOCARCINOMA; MAST-CELLS; ONCOGENIC KRAS; INTRAEPITHELIAL NEOPLASIA; MOUSE MODEL; IN-VIVO; RAS ONCOGENES; GENOME-WIDE; ADULT MICE; K-RAS	Genetically engineered mouse models (GEMMs) have dramatically improved our understanding of tumor evolution and therapeutic resistance. However, sequential genetic manipulation of gene expression and targeting of the host is almost impossible using conventional Cre-loxP-based models. We have developed an inducible dual-recombinase system by combining flippase-FRT(Flp-FR7) and Cre-loxP recombination technologies to improve GEMMs of pancreatic cancer. This enables investigation of multistep carcinogenesis, genetic manipulation of tumor subpopulations (such as cancer stem cells), selective targeting of the tumor microenvironment and genetic validation of therapeutic targets in autochthonous tumors on a genome-wide scale. As a proof of concept, we performed tumor cell-autonomous and nonautonomous targeting, recapitulated hallmarks of human multistep carcinogenesis, validated genetic therapy by 3-phosphoinositide-dependent protein kinase inactivation as well as cancer cell depletion and show that mast cells in the tumor microenvironment, which had been thought to be key oncogenic players, are dispensable for tumor formation.	[Schoenhuber, Nina; Seidler, Barbara; Schuck, Kathleen; Veltkamp, Christian; Schachtler, Christina; Zukowska, Magdalena; Eser, Stefan; Paul, Mariel C.; Klein, Sabine; Rad, Roland; Schmid, Roland M.; Schneider', Gunter; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany; [Eser, Philipp] Univ Munich, Ctr Integrated Prot Sci CIPSM, Gene Ctr, Munich, Germany; [Lowy, Andrew M.] Univ Munich, Ctr Integrated Prot Sci CIPSM, Dept Biochem, Munich, Germany; [Banerjee, Ruby; Yang, Fangtang; Bradley, Allan; Rad, Roland] Univ Calif San Diego, Div Surg Oncol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Lee, Chang-Lung; Kirsch, David G.] Wellcome Trust Sanger Inst, Cambridge, England; [Moding, Everett J.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Scheideler, Angelika] Helmholtz Zentrum Munchen, Res Unit Comparat Med, Neuherberg, Germany; [Alessi, Dario R.] Univ Dundee, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria CSIC UC Soderca, E-39005 Santander, Spain; [Kind, Alexander; Schnieke, Angelika E.] Tech Univ Munich, Freising Weihenstephan, Germany; [Schmid, Roland M.; Schneider', Gunter; Saur, Dieter] German Canc Consortium DKTK, Heidelberg, Germany; [Rad, Roland; Schmid, Roland M.; Saur, Dieter] German Canc Res Ctr, Heidelberg, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Munich; University of California System; University of California San Diego; Wellcome Trust Sanger Institute; Duke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Saur, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany.	dieter.saur@lrz.tum.de	Yang, Fan/GYU-4249-2022; Schuck, Kathleen/AAQ-4664-2021; Saur, Dieter/O-8355-2015; Varela, Ignacio/AAA-7680-2021; Scheideler, Angelika/B-8944-2015; Varela, Ignacio/G-1699-2016	Saur, Dieter/0000-0001-5874-0210; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Yang, Fengtang/0000-0002-3573-2354; Alessi, Dario/0000-0002-2140-9185; Bradley, Allan/0000-0002-2349-8839; Schnieke, Angelika/0000-0002-5761-9635; Lee (He/Him/His), Chang-Lung/0000-0002-0673-633X	Deutsche Forschungsgemeinschaft [DFG SA 1374/4-1, SFB824, TP C9]; Helmholtz Alliance Preclinical Comprehensive Cancer Center; German Cancer Consortium; Wilhelm-Sander Foundation [2012.084.1]; Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal; European Union (ERC) [233074]; National Cancer Institute USA [R01 CA138265, CA155620]; Medical Research Council [MC_EX_G0802532, MC_UU_12016/2] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA138265, R01CA155620, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER; MRC [MC_UU_12016/2, MC_EX_G0802532] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance Preclinical Comprehensive Cancer Center; German Cancer Consortium; Wilhelm-Sander Foundation; Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal; European Union (ERC)(European Research Council (ERC)European Commission); National Cancer Institute USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Berns (Netherlands Cancer Institute), S. Dymecki (Harvard Medical School), T. Jacks (Massachusetts Institute of Technology), L. Luo (Stanford University), J. Martinez-Barbera (University College London) and D. Tuveson (Cold Spring Harbor Laboratory) for providing transgenic animals, C. Wright (Vanderbilt University) for the mouse Pdx1 promoter construct, P. Soriano (Mount Sinai School of Medicine) for the Flp-o expression vector and the R26 targeting vector, T. Schmidt and M. Bewerunge-Hudler (DKFZ Microarray Core Facility) for mRNA analyses, and J. Gotzfried, U. Gotz and S. Jaeckel for technical assistance. This work was supported by funding from Deutsche Forschungsgemeinschaft (DFG SA 1374/4-1 to D.S. and SFB824, TP C9 to G.S. and D.S.), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (to H.-R.R., R.R., R.M.S. and D.S.), the German Cancer Consortium (DKTK) (to R.R., R.M.S. and D.S.), the Wilhelm-Sander Foundation (2012.084.1 to G.S.), the Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal (I.V.), the European Union (ERC Advanced Grant No.233074 to H.-R.R.), and the National Cancer Institute USA (R01 CA138265 to D.G.K. and CA155620 to A.M.L.).	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Chang DZ, 2011, CLIN CANCER RES, V17, P7015, DOI 10.1158/1078-0432.CCR-11-0607; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mazur PK, 2012, GUT, V61, P1488, DOI 10.1136/gutjnl-2011-300756; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Nielsen HJ, 1999, J PATHOL, V189, P487, DOI 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rajput AB, 2008, BREAST CANCER RES TR, V107, P249, DOI 10.1007/s10549-007-9546-3; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Theoharides TC, 2008, NEW ENGL J MED, V358, P1860, DOI 10.1056/NEJMcibr0801519; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563	35	149	150	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1340	1347		10.1038/nm.3646	http://dx.doi.org/10.1038/nm.3646			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326799	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000344724300025
J	Tichauer, KM; Samkoe, KS; Gunn, JR; Kanick, SC; Hoopes, PJ; Barth, RJ; Kaufman, PA; Hasan, T; Pogue, BW				Tichauer, Kenneth M.; Samkoe, Kimberley S.; Gunn, Jason R.; Kanick, Stephen C.; Hoopes, P. Jack; Barth, Richard J.; Kaufman, Peter A.; Hasan, Tayyaba; Pogue, Brian W.			Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; HER3 EXPRESSION; CANCER; EGFR; METASTASES; TISSUES	Lymph node biopsy is employed in many cancer surgeries to identify metastatic disease and to determine cancer stage, yet morbidity and diagnostic delays associated with lymph node biopsy could be avoided if noninvasive imaging of nodal involvement were reliable. Molecular imaging has potential in this regard; however, variable delivery and nonspecific uptake of imaging tracers have made conventional approaches ineffective clinically. Here we present a method of correcting for nonspecific uptake with injection of a second untargeted tracer that allows for quantification of tumor burden in lymph nodes. We confirmed the approach in an athymic mouse model of metastatic human breast cancer by targeting epidermal growth factor receptor, a cell surface receptor overexpressed by many cancers. We observed a significant correlation between in vivo (dual-tracer) and ex vivo measures of tumor burden (r = 0.97, P < 0.01), with an ultimate sensitivity of approximately 200 cells (potentially more sensitive than conventional lymph node biopsy).	[Tichauer, Kenneth M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Samkoe, Kimberley S.; Hoopes, P. Jack; Barth, Richard J.; Pogue, Brian W.] Geisel Sch Med, Dept Surg, Hanover, NH USA; [Gunn, Jason R.; Kanick, Stephen C.; Hoopes, P. Jack; Pogue, Brian W.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Kaufman, Peter A.] Geisel Sch Med, Dept Med, Lebanon, NH USA; [Hasan, Tayyaba; Pogue, Brian W.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA	Illinois Institute of Technology; Dartmouth College; Dartmouth College; Dartmouth College; Harvard University; Massachusetts General Hospital	Tichauer, KM (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	ktichaue@iit.edu; brian.w.pogue@dartmouth.edu	Pogue, Brian/AAD-8114-2020	Hasan, Tayyaba/0000-0003-0871-6057; Pogue, Brian/0000-0002-9887-670X; Kanick, Stephen/0000-0002-2046-8298	US National Institutes of Health [R01 CA109558, R01 CA156177, U54 CA151662]; Canadian Institutes of Health Research postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA023108, U54CA151662, R01CA109558, R01CA156177] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was sponsored by US National Institutes of Health research grants R01 CA109558, R01 CA156177, and U54 CA151662 as well as a the Canadian Institutes of Health Research postdoctoral fellowship for K.M.T.	Baeten J, 2009, NEOPLASIA, V11, P220, DOI 10.1593/neo.08648; Brader P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004789; Bue P, 1998, INT J CANCER, V76, P189, DOI 10.1002/(SICI)1097-0215(19980413)76:2<189::AID-IJC4>3.0.CO;2-T; Carlsson J, 2013, ONCOL LETT, V5, P208, DOI 10.3892/ol.2012.996; Chen SL, 2006, CA-CANCER J CLIN, V56, P292, DOI 10.3322/canjclin.56.5.292; Davis SC, 2013, P NATL ACAD SCI USA, V110, P9025, DOI 10.1073/pnas.1213490110; Flynn BP, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046008; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hettiarachchi K, 2012, MICROFLUID NANOFLUID, V13, P967, DOI 10.1007/s10404-012-1016-5; Italiano A, 2005, ANN ONCOL, V16, P1503, DOI 10.1093/annonc/mdi282; Kern KA, 1999, J AM COLL SURGEONS, V189, P539, DOI 10.1016/S1072-7515(99)00200-8; KORAL KF, 1990, J NUCL MED, V31, P90; Liebert A, 2004, APPL OPTICS, V43, P3037, DOI 10.1364/AO.43.003037; Liu JTC, 2009, BIOPHYS J, V96, P2405, DOI 10.1016/j.bpj.2008.12.3908; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Pogue BW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3449109; Porter CJH, 2000, J PHARM SCI-US, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P; REAL FX, 1986, CANCER RES, V46, P4726; REILLY RM, 1995, CLIN PHARMACOKINET, V28, P126, DOI 10.2165/00003088-199528020-00004; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sampath L, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2953498; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K; Sexton K, 2013, OPT LETT, V38, P3249, DOI 10.1364/OL.38.003249; Shen L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-232; Tafreshi NK, 2012, CLIN CANCER RES, V18, P207, DOI 10.1158/1078-0432.CCR-11-0238; Tafreshi NK, 2011, CANCER RES, V71, P1050, DOI 10.1158/0008-5472.CAN-10-3091; Tichauer KM, 2012, MOL IMAGING BIOL, V14, P584, DOI 10.1007/s11307-011-0534-y; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; VanAgthoven T, 1995, INT J CANCER, V63, P790, DOI 10.1002/ijc.2910630607; Weaver DL, 2010, MODERN PATHOL, V23, pS26, DOI 10.1038/modpathol.2010.36; Wei QC, 2008, ANN SURG ONCOL, V15, P1193, DOI 10.1245/s10434-007-9771-3; Wei QC, 2007, INT J ONCOL, V31, P493; Zhu Q, 2005, RADIOLOGY, V237, P57, DOI 10.1148/radiol.2371041236	34	80	81	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1348	1353		10.1038/nm.3732	http://dx.doi.org/10.1038/nm.3732			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25344739	Green Accepted			2022-12-25	WOS:000344724300026
J	Weinreb, I; Piscuoglio, S; Martelotto, LG; Waggott, D; Ng, CKY; Perez-Ordonez, B; Harding, NJ; Alfaro, J; Chu, KC; Viale, A; Fusco, N; Paula, AD; Marchio, C; Sakr, RA; Lim, R; Thompson, LDR; Chiosea, SI; Seethala, RR; Skalova, A; Stelow, EB; Fonseca, I; Assaad, A; How, C; Wang, JX; de Borja, R; Chan-Seng-Yue, M; Howlett, CJ; Nichols, AC; Wen, YH; Katabi, N; Buchner, N; Mullen, L; Kislinger, T; Wouters, BG; Liu, FF; Norton, L; McPherson, JD; Rubin, BP; Clarke, BA; Weigelt, B; Boutros, PC; Reis, JS				Weinreb, Ilan; Piscuoglio, Salvatore; Martelotto, Luciano G.; Waggott, Daryl; Ng, Charlotte K. Y.; Perez-Ordonez, Bayardo; Harding, Nicholas J.; Alfaro, Javier; Chu, Kenneth C.; Viale, Agnes; Fusco, Nicola; Paula, Arnaud da Cruz; Marchio, Caterina; Sakr, Rita A.; Lim, Raymond; Thompson, Lester D. R.; Chiosea, Simion I.; Seethala, Raja R.; Skalova, Alena; Stelow, Edward B.; Fonseca, Isabel; Assaad, Adel; How, Christine; Wang, Jianxin; de Borja, Richard; Chan-Seng-Yue, Michelle; Howlett, Christopher J.; Nichols, Anthony C.; Wen, Y. Hannah; Katabi, Nora; Buchner, Nicholas; Mullen, Laura; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei; Norton, Larry; McPherson, John D.; Rubin, Brian P.; Clarke, Blaise A.; Weigelt, Britta; Boutros, Paul C.; Reis-Filho, Jorge S.			Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adeno carcinomas of the salivary glands	NATURE GENETICS			English	Article							CANCER; ADENOCARCINOMA; CULTURES; PROTEIN; BREAST	Polymorphous low-grade adenocarcinoma (PLGA) is the second most frequent type of malignant tumor of the minor salivary glands. We identified PRKD1 hotspot mutations encoding p.Glu710Asp in 72.9% of PLGAs but not in other salivary gland tumors. Functional studies demonstrated that this kinase-activating alteration likely constitutes a driver of PLGA.	[Weinreb, Ilan; Perez-Ordonez, Bayardo; Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Piscuoglio, Salvatore; Martelotto, Luciano G.; Ng, Charlotte K. Y.; Fusco, Nicola; Paula, Arnaud da Cruz; Marchio, Caterina; Lim, Raymond; Wen, Y. Hannah; Katabi, Nora; Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Waggott, Daryl; Harding, Nicholas J.; Alfaro, Javier; Chu, Kenneth C.; Wang, Jianxin; de Borja, Richard; Chan-Seng-Yue, Michelle; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Waggott, Daryl; Alfaro, Javier; How, Christine; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Waggott, Daryl; How, Christine; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei] Univ Hlth Network, Campbell Family Inst Canc Res, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Alfaro, Javier; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei; McPherson, John D.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10021 USA; [Fusco, Nicola] Univ Milan, Sch Pathol, Milan, Italy; [Paula, Arnaud da Cruz] Inst Portugues Oncol Francisco Gentil, Oporto, Portugal; [Sakr, Rita A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Thompson, Lester D. R.] Kaiser Permanente, Woodland Hills Med Ctr, Dept Pathol, Woodland Hills, CA USA; [Chiosea, Simion I.; Seethala, Raja R.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; [Skalova, Alena] Charles Univ Prague, Dept Pathol & Lab Med, Plzen, Czech Republic; [Stelow, Edward B.] Univ Virginia, Med Ctr, Dept Pathol, Charlottesville, VA USA; [Fonseca, Isabel] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Fonseca, Isabel] Fac Med Lisbon, Lisbon, Portugal; [Assaad, Adel; McPherson, John D.] Virginia Mason Hosp, Dept Pathol, Seattle, WA USA; [Assaad, Adel; McPherson, John D.] Seattle Med Ctr, Seattle, WA USA; [Howlett, Christopher J.; Nichols, Anthony C.] Univ Western Ontario, London, ON, Canada; [Buchner, Nicholas; Mullen, Laura] Ontario Inst Canc Res, Canc Genom Platform, Toronto, ON, Canada; [Liu, Fei-Fei] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada; [Liu, Fei-Fei] Univ Toronto, Toronto, ON, Canada; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rubin, Brian P.] Lerner Res Inst, Dept Mol Genet, Cleveland, OH USA; [Rubin, Brian P.] Cleveland Clin, Taussig Canc Ctr, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Memorial Sloan Kettering Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Memorial Sloan Kettering Cancer Center; University of Milan; Portuguese Institute of Oncology; Memorial Sloan Kettering Cancer Center; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Charles University Prague; University of Virginia; Portuguese Institute of Oncology; Universidade de Lisboa; Virginia Mason Medical Center; Western University (University of Western Ontario); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Toronto	Reis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	reisfilj@mskcc.org	Ng, Charlotte K Y/AAA-1670-2020; Ng, Charlotte K Y/AAY-3178-2021; Fonseca, Isabel/A-7396-2008; McPherson, John D/D-2633-2017; Nichols, Anthony Charles/H-9595-2019; Alfaro, Javier/ABA-5639-2020; Thompson, Lester D. R./J-8404-2016; Wouters, Bradly/T-1525-2017; Kislinger, Thomas/A-5934-2008; Marchio, Caterina/J-9152-2016; Martelotto, Luciano/D-1946-2015; Fusco, Nicola/D-6264-2016; Piscuoglio, Salvatore/AAB-4959-2022	Ng, Charlotte K Y/0000-0002-6100-0026; Fonseca, Isabel/0000-0002-1359-6494; McPherson, John D/0000-0001-8049-9347; Nichols, Anthony Charles/0000-0002-0760-980X; Thompson, Lester D. R./0000-0003-3714-1432; Wouters, Bradly/0000-0002-8187-592X; Marchio, Caterina/0000-0003-2024-6131; Martelotto, Luciano/0000-0002-9625-1183; Fusco, Nicola/0000-0002-9101-9131; Piscuoglio, Salvatore/0000-0003-2686-2939; Da Cruz Paula, Arnaud/0000-0001-7694-8760; Harding, Nicholas/0000-0001-5907-0773; Norton, Larry/0000-0003-3701-9250; Kislinger, Thomas/0000-0003-3525-5540; Clarke, Blaise/0000-0002-2585-8391; Boutros, Paul/0000-0003-0553-7520; Spence, Tara/0000-0001-7098-4103; Perez-Ordonez, Bayardo/0000-0003-1222-8208; Liu, Fei-Fei/0000-0003-4344-6486; Chiosea, Simion/0000-0002-5766-8779; Alfaro, Javier/0000-0002-5553-6991; Lim, Raymond/0000-0001-8772-3882	IDEAS grant from Princess Margaret Hospital; Head and Neck Translational Research Program; Ontario Institute for Cancer Research; government of Ontario; Terry Fox Research Institute; Wharton family, Joe's Team, Gordon Tozer; Campbell Family Institute for Cancer Research; Ministry of Health and Long-Term Planning, Canada	IDEAS grant from Princess Margaret Hospital; Head and Neck Translational Research Program; Ontario Institute for Cancer Research; government of Ontario; Terry Fox Research Institute; Wharton family, Joe's Team, Gordon Tozer; Campbell Family Institute for Cancer Research; Ministry of Health and Long-Term Planning, Canada	This work was supported in part by an IDEAS grant from Princess Margaret Hospital, the Head and Neck Translational Research Program (I.W, B.A.C., P.C.B. and J.D.M.), the Ontario Institute for Cancer Research and the government of Ontario (P.C.B. and J.D.M.) and by a Terry Fox Research Institute New Investigator Award (P.C.B.). C.H. and F.-F.L. acknowledge support from the Wharton family, Joe's Team, Gordon Tozer, the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-Term Planning, Canada.	Barnes L, 2005, WORLD HEALTH ORGANIZ; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Evans HL, 2000, AM J SURG PATHOL, V24, P1319, DOI 10.1097/00000478-200010000-00001; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foschini MP, 2009, PATHOLOGY, V41, P48, DOI 10.1080/00313020802563528; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Perez-Ordonez B, 1998, HISTOPATHOLOGY, V32, P521, DOI 10.1046/j.1365-2559.1998.t01-2-00410.x; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Weinreb I, 2013, ADV ANAT PATHOL, V20, P367, DOI 10.1097/PAP.0b013e3182a92cc3	12	131	133	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1166	1169		10.1038/ng.3096	http://dx.doi.org/10.1038/ng.3096			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240283	Green Submitted			2022-12-25	WOS:000344131900006
J	Cole, F; Baudat, F; Grey, C; Keeney, S; de Massy, B; Jasin, M				Cole, Francesca; Baudat, Frederic; Grey, Corinne; Keeney, Scott; de Massy, Bernard; Jasin, Maria			Mouse tetrad analysis provides insights into recombination mechanisms and hotspot evolutionary dynamics	NATURE GENETICS			English	Article							DOUBLE-STRAND-BREAK; MEIOTIC RECOMBINATION; GENE CONVERSION; CROSSING-OVER; HOT-SPOT; CROSSOVER; PRDM9; NONCROSSOVER; INITIATION; REPAIR	The ability to examine all chromatids from a single meiosis in yeast tetrads has been indispensable for defining the mechanisms of homologous recombination initiated by DNA double-strand breaks (DSBs). Using a broadly applicable strategy for the analysis of chromatids from a single meiosis at two recombination hotspots in mouse oocytes and spermatocytes, we demonstrate here the unidirectional transfer of information-gene conversion-in both crossovers and noncrossovers. Whereas gene conversion in crossovers is associated with reciprocal exchange, the unbroken chromatid is not altered in noncrossover gene conversion events, providing strong evidence that noncrossovers arise from a distinct pathway. Gene conversion frequently spares the binding site of the hotspot-specifying protein PRDM9, with the result that erosion of the hotspot is slowed. Thus, mouse tetrad analysis demonstrates how unique aspects of mammalian recombination mechanisms shape hotspot evolutionary dynamics.	[Cole, Francesca; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Cole, Francesca] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Baudat, Frederic; Grey, Corinne; de Massy, Bernard] CNRS, Inst Genet Humaine, Unite Propre Rech 1142, Montpellier, France; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.	s-keeney@ski.mskcc.org; bernard.de-massy@igh.cnrs.fr; m-jasin@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Cole, Francesca/0000-0001-6391-2363; Keeney, Scott/0000-0002-1283-6417; Baudat, Frederic/0000-0003-2415-8366	R.L. Kirschstein National Research Service Award [F32HD51392]; Cancer Prevention and Research Institute of Texas award [R1213]; Centre National de Is Recherche Scientifique; Agence Nationale pour la Recherche [ANR-09-BLAN-0269-01]; Association pour la Recherche contre le Cancer; US National Institutes of Health [R01GM105421, R01HD53855]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051392] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105421] Funding Source: NIH RePORTER	R.L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas award; Centre National de Is Recherche Scientifique; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Jasin, Keeney and de Massy laboratories, especially J. Lange, E. de Boer, S. Tischfield, S. Yamada and S. Peterson. We also thank P. Hunt (Washington State University) for encouraging the oocyte experiments, A. Gabow (Memorial Sloan Kettering Cancer Center) and Y. Lu (University of Texas MD Anderson Cancer Center) for fixation calculations, and the Reseau des Animaleries de Montpellier (RAM) and D. Haddou for management of mice. This work was supported by R.L. Kirschstein National Research Service Award F32HD51392 (F.C.) and Cancer Prevention and Research Institute of Texas award R1213 (F.C.), the Centre National de Is Recherche Scientifique (F.B., C.G. and B.d.M.), the Agence Nationale pour la Recherche (program ANR-09-BLAN-0269-01 to B.d.M.), the Association pour la Recherche contre le Cancer (B.d.M.) and US National Institutes of Health grants R01GM105421 (M.J. and S.K.) and R01HD53855 (S.K. and M.J.). This paper is dedicated to the memory of our colleague Jerome Buard.	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1999, GENETICS, V151, P1569; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Billings T, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r35; Bois PRJ, 2007, MOL CELL BIOL, V27, P7053, DOI 10.1128/MCB.00874-07; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Calabrese P, 2007, P NATL ACAD SCI USA, V104, P4748, DOI 10.1073/pnas.0610195104; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Cole F, 2011, METHODS MOL BIOL, V745, P251, DOI 10.1007/978-1-61779-129-1_15; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Guillon H, 2002, NAT GENET, V32, P296, DOI 10.1038/ng990; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2007, MOL GENETICS RECOMBI, P381; HURST DD, 1972, P NATL ACAD SCI USA, V69, P101, DOI 10.1073/pnas.69.1.101; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ng SH, 2008, GENOMICS, V92, P204, DOI 10.1016/j.ygeno.2008.06.008; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; Radford SJ, 2007, GENETICS, V176, P53, DOI 10.1534/genetics.107.070367; Sarbajna S, 2012, HUM MOL GENET, V21, P2029, DOI 10.1093/hmg/dds019; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; WINGE O., 1937, Comptes rendus des Travaux du Laboratoire Carlsberg, V22, P99; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	59	68	68	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1072	1080		10.1038/ng.3068	http://dx.doi.org/10.1038/ng.3068			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151354	Green Accepted			2022-12-25	WOS:000342554100009
J	Hysi, PG; Cheng, CY; Springelkamp, H; Macgregor, S; Bailey, JNC; Wojciechowski, R; Vitart, V; Nag, A; Hewitt, AW; Hohn, R; Venturini, C; Mirshahi, A; Ramdas, WD; Thorleifsson, G; Vithana, E; Khor, CC; Stefansson, AB; Liao, JM; Haines, JL; Amin, N; Wang, YX; Wild, PS; Ozel, AB; Li, JZ; Fleck, BW; Zeller, T; Staffieri, SE; Teo, YY; Cuellar-Partida, G; Luo, XY; Allingham, RR; Richards, JE; Senft, A; Karssen, LC; Zheng, YF; Bellenguez, C; Xu, L; Iglesias, AI; Wilson, JF; Kang, JH; van Leeuwen, EM; Jonsson, V; Thorsteinsdottir, U; Despriet, DDG; Ennis, S; Moroi, SE; Martin, NG; Jansonius, NM; Yazar, S; Tai, ES; Amouyel, P; Kirwan, J; van Koolwijk, LME; Hauser, MA; Jonasson, F; Leo, P; Loomis, SJ; Fogarty, R; Rivadeneira, F; Kearns, L; Lackner, KJ; de Jong, PTVM; Simpson, CL; Pennell, CE; Oostra, BA; Uitterlinden, AG; Saw, SM; Lotery, AJ; Bailey-Wilson, JE; Hofman, A; Vingerling, JR; Maubaret, C; Pfeiffer, N; Wolfs, RCW; Lemij, HG; Young, TL; Pasquale, LR; Delcourt, C; Spector, TD; Klaver, CCW; Small, KS; Burdon, KP; Stefansson, K; Wong, TY; Viswanathan, A; Mackey, DA; Craig, JE; Wiggs, JL; van Duijn, CM; Hammond, CJ; Aung, T				Hysi, Pirro G.; Cheng, Ching-Yu; Springelkamp, Henriet; Macgregor, Stuart; Bailey, Jessica N. Cooke; Wojciechowski, Robert; Vitart, Veronique; Nag, Abhishek; Hewitt, Alex W.; Hohn, Rene; Venturini, Cristina; Mirshahi, Alireza; Ramdas, Wishal D.; Thorleifsson, Gudmar; Vithana, Eranga; Khor, Chiea-Chuen; Stefansson, Arni B.; Liao, Jiemin; Haines, Jonathan L.; Amin, Najaf; Wang, Ya Xing; Wild, Philipp S.; Ozel, Ayse B.; Li, Jun Z.; Fleck, Brian W.; Zeller, Tanja; Staffieri, Sandra E.; Teo, Yik-Ying; Cuellar-Partida, Gabriel; Luo, Xiaoyan; Allingham, R. Rand; Richards, Julia E.; Senft, Andrea; Karssen, Lennart C.; Zheng, Yingfeng; Bellenguez, Celine; Xu, Liang; Iglesias, Adriana I.; Wilson, James F.; Kang, Jae H.; van Leeuwen, Elisabeth M.; Jonsson, Vesteinn; Thorsteinsdottir, Unnur; Despriet, Dominiek D. G.; Ennis, Sarah; Moroi, Sayoko E.; Martin, Nicholas G.; Jansonius, Nomdo M.; Yazar, Seyhan; Tai, E-Shyong; Amouyel, Philippe; Kirwan, James; van Koolwijk, Leonieke M. E.; Hauser, Michael A.; Jonasson, Fridbert; Leo, Paul; Loomis, Stephanie J.; Fogarty, Rhys; Rivadeneira, Fernando; Kearns, Lisa; Lackner, Karl J.; de Jong, Paulus T. V. M.; Simpson, Claire L.; Pennell, Craig E.; Oostra, Ben A.; Uitterlinden, Andre G.; Saw, Seang-Mei; Lotery, Andrew J.; Bailey-Wilson, Joan E.; Hofman, Albert; Vingerling, Johannes R.; Maubaret, Cecilia; Pfeiffer, Norbert; Wolfs, Roger C. W.; Lemij, Hans G.; Young, Terri L.; Pasquale, Louis R.; Delcourt, Cecile; Spector, Timothy D.; Klaver, Caroline C. W.; Small, Kerrin S.; Burdon, Kathryn P.; Stefansson, Kari; Wong, Tien-Yin; Viswanathan, Ananth; Mackey, David A.; Craig, Jamie E.; Wiggs, Janey L.; van Duijn, Cornelia M.; Hammond, Christopher J.; Aung, Tin		BMES GWAS Grp; NEIGHBORHOOD Consortium; Wellcome Trust Case Control Conso	Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma	NATURE GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; COMMON VARIANTS; ASSOCIATION; METAANALYSIS; POPULATION; EXPRESSION; REDUCTION; TRIAL; RISK	Elevated intraocular pressure (IOP) is an important risk factor in developing glaucoma, and variability in IOP might herald glaucomatous development or progression. We report the results of a genome-wide association study meta-analysis of 18 population cohorts from the International Glaucoma Genetics Consortium (IGGC), comprising 35,296 multi-ancestry participants for IOP. We confirm genetic association of known loci for IOP and primary open-angle glaucoma (POAG) and identify four new IOP-associated loci located on chromosome 3q25.31 within the FNDC3B gene (P = 4.19 x 10(-8) for rs6445055), two on chromosome 9 (P = 2.80 x 10(-11) for rs2472493 near ABCA1 and P = 6.39 x 10(-11) for rs8176693 within ABO) and one on chromosome 11p11.2 (best P = 1.04 x 10(-11) for rs747782). Separate meta-analyses of 4 independent POAG cohorts, totaling 4,284 cases and 95,560 controls, showed that 3 of these loci for IOP were also associated with POAG.	[Hysi, Pirro G.; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Cheng, Ching-Yu; Nag, Abhishek; Vithana, Eranga; Liao, Jiemin; Zheng, Yingfeng; Saw, Seang-Mei; Wong, Tien-Yin; Aung, Tin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu; Vithana, Eranga; Khor, Chiea-Chuen; Liao, Jiemin; Wong, Tien-Yin; Aung, Tin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Cheng, Ching-Yu; Vithana, Eranga; Khor, Chiea-Chuen; Liao, Jiemin; Teo, Yik-Ying; Zheng, Yingfeng; Tai, E-Shyong; Saw, Seang-Mei; Wong, Tien-Yin; Aung, Tin] Natl Univ Hlth Syst, Singapore, Singapore; [Cheng, Ching-Yu; Teo, Yik-Ying; Zheng, Yingfeng; Tai, E-Shyong; Saw, Seang-Mei; Wong, Tien-Yin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cheng, Ching-Yu; Vithana, Eranga; Tai, E-Shyong; Saw, Seang-Mei] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Springelkamp, Henriet; Ramdas, Wishal D.; Richards, Julia E.; Despriet, Dominiek D. G.; Vingerling, Johannes R.; Wolfs, Roger C. W.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Springelkamp, Henriet; Ramdas, Wishal D.; Amin, Najaf; Karssen, Lennart C.; Iglesias, Adriana I.; van Leeuwen, Elisabeth M.; van Koolwijk, Leonieke M. E.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Albert; Vingerling, Johannes R.; Klaver, Caroline C. W.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Macgregor, Stuart; Cuellar-Partida, Gabriel; Martin, Nicholas G.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Bailey, Jessica N. Cooke; Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Wojciechowski, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wojciechowski, Robert; Simpson, Claire L.; Bailey-Wilson, Joan E.] Natl Human Genome Res Inst, US Natl Inst Hlth, Baltimore, MD USA; [Vitart, Veronique] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Hewitt, Alex W.; Staffieri, Sandra E.; Kearns, Lisa; Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Hohn, Rene; Mirshahi, Alireza; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Venturini, Cristina] UCL, Inst Ophthalmol, London, England; [Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Amgen, Reykjavik, Iceland; [Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Stefansson, Arni B.] Eye Clin, Reykjavik, Iceland; [Wang, Ya Xing; Xu, Liang] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wild, Philipp S.] Univ Med Ctr Mainz, Dept Internal Med 2, Mainz, Germany; [Ozel, Ayse B.; Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fleck, Brian W.] Natl Hlth Serv NHS Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Zeller, Tanja] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Luo, Xiaoyan; Young, Terri L.] Duke Univ, Duke Eye Ctr, Durham, NC USA; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Senft, Andrea] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; [Bellenguez, Celine; Amouyel, Philippe] INSERM, UMR 774, F-59045 Lille, France; [Bellenguez, Celine; Amouyel, Philippe] Univ Lille 2, Lille, France; [Bellenguez, Celine; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Wilson, James F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kang, Jae H.; Pasquale, Louis R.] Harvard Univ, Sch Med, Channing Div Network Med, Boston, MA USA; [Jonsson, Vesteinn] Landspitali Natl Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Ennis, Sarah] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Moroi, Sayoko E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Yazar, Seyhan; Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Tai, E-Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France; [Kirwan, James] Portsmouth Hosp NHS Trust, Dept Ophthalmol, Portsmouth, Hants, England; [Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Jonasson, Fridbert] Univ Iceland, Fac Med, Reykjavik, Iceland; [Leo, Paul] Univ Queensland, Diamantina Inst, Woollongabba, Qld, Australia; [Loomis, Stephanie J.; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Loomis, Stephanie J.; Pasquale, Louis R.; Wiggs, Janey L.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Fogarty, Rhys; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Albert] Netherlands Consortium Healthy Ageing, Netherlands Genom Initiat, The Hague, Netherlands; [Lackner, Karl J.] Inst Clin Chem, Mainz, Germany; [Lackner, Karl J.] Lab Med, Mainz, Germany; [de Jong, Paulus T. V. M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [de Jong, Paulus T. V. M.] Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Lotery, Andrew J.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Maubaret, Cecilia; Delcourt, Cecile] Univ Bordeaux, ISPED, Bordeaux, France; [Maubaret, Cecilia; Delcourt, Cecile] INSERM, Ctr INSERM Epidemiol Biostat Bordeaux U897, Bordeaux, France; [Lemij, Hans G.] Rotterdam Eye Hosp, Glaucoma Serv, Rotterdam, Netherlands; [Viswanathan, Ananth] Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England	University of London; King's College London; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Edinburgh; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Johannes Gutenberg University of Mainz; University of London; University College London; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Capital Medical University; Johannes Gutenberg University of Mainz; University of Michigan System; University of Michigan; University of Hamburg; University Medical Center Hamburg-Eppendorf; National University of Singapore; Duke University; Duke University; University of Kiel; Schleswig Holstein University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Edinburgh; Harvard University; Harvard Medical School; Landspitali National University Hospital; University of Southampton; University of Michigan System; University of Michigan; University of Groningen; Lions Eye Institute; University of Western Australia; National University of Singapore; Universite de Lille - ISITE; CHU Lille; Portsmouth Hospitals NHS Trust; Duke University; University of Iceland; University of Queensland; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Flinders University South Australia; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Western Australia; Erasmus University Rotterdam; Erasmus MC; University of Southampton; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Rotterdam Eye Hospital; University of London; King's College London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Aung, T (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	chris.hammond@kcl.ac.uk; aung_tin@yahoo.co.uk	Klaver, Caroline C.W./A-2013-2016; Staffieri, Sandra/R-1216-2019; Bellenguez, Céline/X-4004-2019; Hewitt, Alex W/D-1936-2013; Fingert, John/AAX-4750-2021; Zhang, Kang/Y-2740-2019; Fingert, John/F-8787-2012; Zheng, Yingfeng/AAE-2983-2022; Jonasson, Fridbert/ABA-9889-2021; Pennell, Craig/ABD-6902-2020; Bramon, Elvira/HHC-3809-2022; Martin, Nicholas/R-9235-2019; Partida, Gabriel Cuellar/C-6686-2017; Rivadeneira, Fernando/O-5385-2015; Wojciechowski, Robert/L-4970-2017; Wild, Philipp S./M-2106-2019; Belllenguez, Céline/Y-3183-2018; W, Robert/AAE-4192-2019; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Pfeiffer, Norbert/AAO-7586-2020; Wilson, James F/A-5704-2009; Wong, Tien Yin/AAC-9724-2020; Mackey, David A/H-5340-2014; Haines, Jonathan/C-3374-2012; Burdon, Kathryn/AAD-2334-2022; Bailey, Jessica Cooke/Q-5062-2019; wang, YA XING/K-9671-2016; Yazar, Seyhan/U-4032-2018; Ramdas, Wishal D/H-5062-2018; Delcourt, Cecile/I-2627-2013; Stefansson, Kari/AAE-7187-2019; Zheng, Yingfeng/CAE-9225-2022; Leo, Paul/R-4464-2019; Burdon, Kathryn/A-5026-2009; van Leeuwen, Elisabeth/G-3382-2017; Macgregor, Stuart/C-6442-2009; Cheng, Ching-Yu/Y-2229-2019; Scott, Rodney/B-2827-2013; Wood, Nicholas/C-2505-2009; Schuman, Joel/K-7304-2012	Staffieri, Sandra/0000-0003-3131-9359; Bellenguez, Céline/0000-0002-1240-7874; Hewitt, Alex W/0000-0002-5123-5999; Fingert, John/0000-0002-0377-0479; Zhang, Kang/0000-0002-4549-1697; Fingert, John/0000-0002-0377-0479; Pennell, Craig/0000-0002-0937-6165; Bramon, Elvira/0000-0003-1369-5983; Martin, Nicholas/0000-0003-4069-8020; Partida, Gabriel Cuellar/0000-0001-7648-4097; Rivadeneira, Fernando/0000-0001-9435-9441; Wojciechowski, Robert/0000-0002-9593-4652; Belllenguez, Céline/0000-0002-1240-7874; W, Robert/0000-0002-9593-4652; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Wilson, James F/0000-0001-5751-9178; Wong, Tien Yin/0000-0002-8448-1264; Mackey, David A/0000-0001-7914-4709; Haines, Jonathan/0000-0002-4351-4728; Burdon, Kathryn/0000-0001-8217-1249; Bailey, Jessica Cooke/0000-0002-4001-8702; wang, YA XING/0000-0003-2749-7793; Yazar, Seyhan/0000-0003-0994-6196; Ramdas, Wishal D/0000-0002-1780-5281; Delcourt, Cecile/0000-0002-2099-0481; Zheng, Yingfeng/0000-0002-0914-7864; Burdon, Kathryn/0000-0001-8217-1249; Macgregor, Stuart/0000-0001-6731-8142; Cheng, Ching-Yu/0000-0003-0655-885X; Karssen, Lennart C./0000-0002-1959-342X; Bailey-Wilson, Joan/0000-0002-9153-2920; Amin, Najaf/0000-0002-8944-1771; Baird, Paul/0000-0002-1305-3502; Scott, Rodney/0000-0001-7724-3404; Wood, Nicholas/0000-0002-9500-3348; Amouyel, Philippe/0000-0001-9088-234X; Wild, Philipp/0000-0003-4413-9752; Kraft, Peter/0000-0002-4472-8103; Van Duijn, Cornelia/0000-0002-2374-9204; Giannoulatou, Eleni/0000-0002-7084-6736; Moroi, Sayoko E/0000-0002-0418-0657; Hammond, Christopher/0000-0002-3227-2620; Sim, Xueling/0000-0002-1233-7642; Tai, E Shyong/0000-0003-2929-8966; Hysi, Pirro/0000-0001-5752-2510; Klaver, Caroline/0000-0002-2355-5258; Craig, Jamie/0000-0001-9955-9696; Lotery, Andrew/0000-0001-5541-4305; Kearns, Lisa/0000-0001-9432-4054; Small, Kerrin/0000-0003-4566-0005; Hohn, Rene/0000-0003-2870-1469; Schuman, Joel/0000-0002-8885-3766; Khor, Chiea Chuen/0000-0002-1128-4729; Zeller, Tanja/0000-0003-3379-2641; Simpson, Claire/0000-0003-2244-7690; Venturini, Cristina/0000-0002-4769-7912; Ozel, Ayse Bilge/0000-0002-1112-4258; Lichter, Paul/0000-0001-8394-4813; Jansonius, Nomdo/0000-0002-6495-6568; Scott, William/0000-0001-9336-6404; Walters, James/0000-0002-6980-4053	MRC [MC_PC_U127561128] Funding Source: UKRI; Medical Research Council [MC_PC_U127561128] Funding Source: Medline; NEI NIH HHS [P30 EY014104, R01 EY022305, K08 EY022943, R01 EY023512, R01 EY022124, R01 EY015473] Funding Source: Medline; NHGRI NIH HHS [U01 HG004728] Funding Source: Medline; Department of Health [SRF/01/010] Funding Source: Medline; Chief Scientist Office [CZB/4/438, CZB/4/710] Funding Source: Medline; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; Fight for Sight [1329/30, 1895/96] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY022305, R01EY015473, R01EY023512, R01EY022124, P30EY014104, K08EY022943] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327, U01HG004728] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Health; Chief Scientist Office; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carbonaro F, 2010, EYE, V24, P1165, DOI 10.1038/eye.2010.11; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Denis M, 2003, MOL GENET METAB, V78, P265, DOI 10.1016/S1096-7192(03)00020-9; Denomme G A, 2010, Immunohematology, V26, P47; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Janssen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044973; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khan MI, 2009, CAN J OPHTHALMOL, V44, P582, DOI 10.3129/i09-104; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Yeghiazaryan K, 2005, AMINO ACIDS, V28, P207, DOI 10.1007/s00726-005-0170-4	28	163	169	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1126	1130		10.1038/ng.3087	http://dx.doi.org/10.1038/ng.3087			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25173106	Green Submitted, Green Accepted			2022-12-25	WOS:000342554100017
J	Stanley, DA; Honko, AN; Asiedu, C; Trefry, JC; Lau-Kilby, AW; Johnson, JC; Hensley, L; Ammendola, V; Abbate, A; Grazioli, F; Foulds, KE; Cheng, C; Wang, LS; Donaldson, MM; Colloca, S; Folgori, A; Roederer, M; Nabel, GJ; Mascola, J; Nicosia, A; Cortese, R; Koup, RA; Sullivan, NJ				Stanley, Daphne A.; Honko, Anna N.; Asiedu, Clement; Trefry, John C.; Lau-Kilby, Annie W.; Johnson, Joshua C.; Hensley, Lisa; Ammendola, Virginia; Abbate, Adele; Grazioli, Fabiana; Foulds, Kathryn E.; Cheng, Cheng; Wang, Lingshu; Donaldson, Mitzi M.; Colloca, Stefano; Folgori, Antonella; Roederer, Mario; Nabel, Gary J.; Mascola, John; Nicosia, Alfredo; Cortese, Riccardo; Koup, Richard A.; Sullivan, Nancy J.			Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge	NATURE MEDICINE			English	Article							NONHUMAN-PRIMATES; VIRUS INFECTION; VECTOR; IMMUNOGENICITY; QUALITY	Ebolavirus disease causes high mortality, and the current outbreak has spread unabated through West Africa. Human adenovirus type 5 vectors (rAd5) encoding ebolavirus glycoprotein (GP) generate protective immunity against acute lethal Zaire ebolavirus (EBOV) challenge in macaques, but fail to protect animals immune to Ad5, suggesting natural Ad5 exposure may limit vaccine efficacy in humans. Here we show that a chimpanzee-derived replication-defective adenovirus (ChAd) vaccine also rapidly induced uniform protection against acute lethal EBOV challenge in macaques. Because protection waned over several months, we boosted ChAd3 With modified vaccinia Ankara (MVA) and generated, for the first time, durable protection against lethal EBOV Challenge.	[Stanley, Daphne A.; Asiedu, Clement; Lau-Kilby, Annie W.; Foulds, Kathryn E.; Cheng, Cheng; Wang, Lingshu; Donaldson, Mitzi M.; Roederer, Mario; Nabel, Gary J.; Mascola, John; Koup, Richard A.; Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Honko, Anna N.; Trefry, John C.; Johnson, Joshua C.; Hensley, Lisa] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA; [Ammendola, Virginia; Abbate, Adele; Grazioli, Fabiana; Colloca, Stefano; Folgori, Antonella; Nicosia, Alfredo] Okairos, Rome, Italy; [Nicosia, Alfredo] Ctr Ingn Genet CEINGE, Naples, Italy; [Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Cortese, Riccardo] Keires AG, Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of Naples Federico II	Sullivan, NJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	njsull@mail.nih.gov	Cheng, Cheng/AAE-8255-2019; Honko, Anna/H-9539-2019; Roederer, Mario/G-1887-2011; Mascola, John/AAI-7193-2021	Honko, Anna/0000-0001-9165-148X; Lau-Kilby, Annie/0000-0002-2666-1347; Johnson, Joshua/0000-0002-5677-3841; Hensley, Lisa/0000-0003-1188-4342	US NIH NIAID Vaccine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005073, ZICAI005103, ZICAI005123] Funding Source: NIH RePORTER	US NIH NIAID Vaccine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Cichanowski for graphics, A. Tislerics and B. Hartman for assistance with the manuscript and R. Seder for review and helpful suggestions. S. Perfetto and S. Norris and D. Follmann for technical discussions, and the Vaccine Research Center's Nonhuman Primate Immunogenicity Core for NHP sample processing. We thank the Vaccine Research Center Laboratory Animal Medicine, S. Rao, A. Taylor, J.P. Todd and H. Bao for protocol support and the NIH Division of Veterinary Resources for animal care. We also thank H. Esham for technical assistance and data management and D. Alves for pathology assistance. TPG shuttle vector was provided by A. Siccardi (Istituto San Raffaele). This work was supported by the Intramural Research Program of the US NIH NIAID Vaccine Research Center. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army or the US Department of Defense.	Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Brown SA, 2010, VIRUSES-BASEL, V2, P435, DOI 10.3390/v2020435; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Mire CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094355; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108	22	246	263	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1126	1129		10.1038/nm.3702	http://dx.doi.org/10.1038/nm.3702			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25194571				2022-12-25	WOS:000343194100022
J	Krutauz, D; Reis, N; Nakasone, MA; Siman, P; Zhang, DN; Kirkpatrick, DS; Gygi, SP; Brik, A; Fushman, D; Glickman, MH				Krutauz, Daria; Reis, Noa; Nakasone, Mark A.; Siman, Peter; Zhang, Daoning; Kirkpatrick, Donald S.; Gygi, Steven P.; Brik, Ashraf; Fushman, David; Glickman, Michael H.			Extended ubiquitin species are protein-based DUB inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; PROTEASOMAL DEGRADATION; STRUCTURAL BASIS; 26S PROTEASOME; NEURODEGENERATIVE DISORDERS; POLYUBIQUITIN CHAINS; REGULATORY PARTICLE; ALZHEIMERS-DISEASE; SUBSTRATE; ACCUMULATION	A frameshift mutation in the transcript of the ubiquitin-B gene leads to a C-terminally extended ubiquitin (Ub), UBB+1. UBB+1 has been considered to inhibit proteasomes and as such to be the underlying cause for toxic protein buildup correlated with certain neuropathological conditions. We demonstrate that expression of extended Ub variants leads to accumulation of heterogeneously linked polyubiquitin conjugates, indicating a pervasive effect on Ub-dependent turnover. 20S proteasomes selectively proteolyzed Ub extensions, yet no evidence for inhibition of 26S holoenzymes was found. However, among susceptible targets for inhibition was Ubp6, the primary enzyme responsible for disassembly of Lys48 linkages at 26S proteasomes. Processing of Lys48 and Lys63 linkages by other deubiquitinating enzymes (DUBs) was also inhibited. Disruption of Ub-dependent degradation by extended Ub variants may therefore be attributed to their inhibitory effect on select DUBs, thus shifting research efforts related to protein accumulation in neurodegenerative processes from proteasomes to DUBs.	[Krutauz, Daria; Reis, Noa; Nakasone, Mark A.; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Nakasone, Mark A.; Zhang, Daoning; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; [Siman, Peter; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel; [Kirkpatrick, Donald S.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Technion Israel Institute of Technology; University System of Maryland; University of Maryland College Park; Ben Gurion University; Harvard University; Harvard Medical School	Glickman, MH (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	glickman@techunix.technion.ac.il	Nakasone, Mark A./ABD-2173-2021	Nakasone, Mark A./0000-0002-1362-191X; Glickman, Michael/0000-0002-1222-8104; Kirkpatrick, Donald/0000-0003-3091-2804	US National Institutes of Health [GM095755]; USA-Israel Binational Science Foundation [2009487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095755] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by US National Institutes of Health grant GM095755 to D. F. and M. H. G. and a USA-Israel Binational Science Foundation grant (2009487) to D. F. and M. H. G.	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glickman MH, 2001, CURR PROTOC PROTEIN; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Ko S, 2010, J BIOL CHEM, V285, P36070, DOI 10.1074/jbc.M110.145219; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; NEWMAN AJ, 1994, CURR OPIN GENET DEV, V4, P298, DOI 10.1016/S0959-437X(05)80057-7; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Shabek N, 2007, BIOCHEM BIOPH RES CO, V363, P425, DOI 10.1016/j.bbrc.2007.08.185; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; van Tijn P, 2012, NEUROCHEM INT, V61, P739, DOI 10.1016/j.neuint.2012.07.007; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Wu SS, 2002, PEDIATR DEVEL PATHOL, V5, P293, DOI 10.1007/s10024-001-0202-3; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	57	26	26	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					664	U212		10.1038/NCHEMBIO.1574	http://dx.doi.org/10.1038/NCHEMBIO.1574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24997605	Green Submitted, Green Accepted			2022-12-25	WOS:000339380100013
J	Jeffery, E; Church, CD; Holtrup, B; Colman, L; Rodeheffer, MS				Jeffery, Elise; Church, Christopher D.; Holtrup, Brandon; Colman, Laura; Rodeheffer, Matthew S.			Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; LIPID-ACCUMULATION; INSULIN-RESISTANCE; SUBCUTANEOUS FAT; MICE LACKING; GROWTH; DIET; CELLULARITY; NUMBER; AKT2	Excessive accumulation of white adipose tissue (WAT) is the defining characteristic of obesity. WAT mass is composed primarily of mature adipocytes, which are generated through the proliferation and differentiation of adipocyte precursors (APs). Although the production of new adipocytes contributes to WAT growth in obesity, little is known about the cellular and molecular mechanisms underlying adipogenesis in vivo. Here, we show that high-fat diet feeding in mice rapidly and transiently induces proliferation of APs within WAT to produce new adipocytes. Importantly, the activation of adipogenesis is specific to the perigonadal visceral depot in male mice, consistent with the patterns of obesogenic WAT growth observed in humans. Furthermore, we find that in multiple models of obesity, the activation of APs is dependent on the phosphoinositide 3-kinase (PI3K)-AKT2 pathway; however, the development of WAT does not require AKT2. These data indicate that developmental and obesogenic adipogenesis are regulated through distinct molecular mechanisms.	[Jeffery, Elise] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Church, Christopher D.; Colman, Laura; Rodeheffer, Matthew S.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Holtrup, Brandon; Rodeheffer, Matthew S.] Yale Univ, Sch Med, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; [Rodeheffer, Matthew S.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Rodeheffer, MS (corresponding author), Yale Univ, Sch Med, Sect Comparat Med, 375 Congress Ave, New Haven, CT 06520 USA.	matthew.rodeheffer@yale.edu			American Diabetes Association Award [7-12-JF-46]; DERC pilot protect grant [DK045735]; NIDDK [DK090489]; Lo Graduate Fellowship for Excellence in Stem Cell Research Rom the Yale Stem Cell Center; EMBO long-term fellowship ALTF [132-2011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090489, R01DK090489, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	American Diabetes Association Award(American Diabetes Association); DERC pilot protect grant; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lo Graduate Fellowship for Excellence in Stem Cell Research Rom the Yale Stem Cell Center; EMBO long-term fellowship ALTF; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Award 7-12-JF-46, DERC pilot protect grant DK045735 and NIDDK grant DK090489 to M.S.R., Lo Graduate Fellowship for Excellence in Stem Cell Research Rom the Yale Stem Cell Center to E.J., and EMBO long-term fellowship ALTF 132-2011 to C.D.C.	Arner P, 2013, J CLIN ENDOCR METAB, V98, pE897, DOI 10.1210/jc.2012-4106; Berry R, 2014, METHOD ENZYMOL, V537, P47, DOI 10.1016/B978-0-12-411619-1.00004-5; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Bjorntorp P, 2000, DIABETES METAB, V26, P10; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; CLEARY MP, 1979, AM J PHYSIOL, V236, pE508, DOI 10.1152/ajpendo.1979.236.5.E508; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; ENESCO M, 1962, J EMBRYOL EXP MORPH, V10, P530; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hudak CS, 2014, CELL REP, V8, P678, DOI 10.1016/j.celrep.2014.06.060; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PECKHAM SC, 1962, J NUTR, V77, P187, DOI 10.1093/jn/77.2.187; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Pollack A., 2013, NY TIMES; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STEINBERG MD, 1962, J PEDIATR-US, V61, P299, DOI 10.1016/S0022-3476(62)80282-0; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512	53	248	251	1	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					376	+		10.1038/ncb3122	http://dx.doi.org/10.1038/ncb3122			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25730471	Green Accepted			2022-12-25	WOS:000351920500008
J	Lin, LP; Sabnis, AJ; Chan, E; Olivas, V; Cade, L; Pazarentzos, E; Asthana, S; Neel, D; Yan, JJ; Lu, XY; Pham, L; Wang, MXM; Karachaliou, N; Cao, MG; Manzano, JL; Ramirez, JL; Torres, JMS; Buttitta, F; Rudin, CM; Collisson, EA; Algazi, A; Robinson, E; Osman, I; Munoz-Couselo, E; Cortes, J; Frederick, DT; Cooper, ZA; McMahon, M; Marchetti, A; Rosell, R; Flaherty, KT; Wargo, JA; Bivona, TG				Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Karachaliou, Niki; Gonzalez Cao, Maria; Luis Manzano, Jose; Luis Ramirez, Jose; Sanchez Torres, Jose Miguel; Buttitta, Fiamma; Rudin, Charles M.; Collisson, Eric A.; Algazi, Alain; Robinson, Eric; Osman, Iman; Munoz-Couselo, Eva; Cortes, Javier; Frederick, Dennie T.; Cooper, Zachary A.; McMahon, Martin; Marchetti, Antonio; Rosell, Rafael; Flaherty, Keith T.; Wargo, Jennifer A.; Bivona, Trever G.			The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies	NATURE GENETICS			English	Article							SIGNALING PATHWAY; COLON-CANCER; INHIBITION; BRAF; KRAS; LUNG; MELANOMA; TRANSCRIPTION; ACTIVATION; SURVIVAL	Resistance to RAF-and MEK-targeted therapy is a major clinical challenge(1-4). RAF and MEK inhibitors are initially but only transiently effective in some but not all patients with BRAF gene mutation and are largely ineffective in those with RAS gene mutation because of resistance(5-14). Through a genetic screen in BRAF-mutant tumor cells, we show that the Hippo pathway effector YAP (encoded by YAP1) acts as a parallel survival input to promote resistance to RAF and MEK inhibitor therapy. Combined YAP and RAF or MEK inhibition was synthetically lethal not only in several BRAF-mutant tumor types but also in RAS-mutant tumors. Increased YAP in tumors harboring BRAF V600E was a biomarker of worse initial response to RAF and MEK inhibition in patients, establishing the clinical relevance of our findings. Our data identify YAP as a new mechanism of resistance to RAF-and MEK-targeted therapy. The findings unveil the synthetic lethality of combined suppression of YAP and RAF or MEK as a promising strategy to enhance treatment response and patient survival.	[Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Collisson, Eric A.; Algazi, Alain; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Collisson, Eric A.; Algazi, Alain; McMahon, Martin; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Sabnis, Amit J.] Univ Calif San Francisco, Dept Pediat, Div Pediat Hematol & Oncol, San Francisco, CA USA; [Karachaliou, Niki; Gonzalez Cao, Maria; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Canc Biol & Precis Med Program, Badalona, Spain; [Luis Manzano, Jose] Hosp Badalona Germans Trias & Pujol, Calalan Inst Oncol, Med Oncol Serv, Badalona, Spain; [Luis Ramirez, Jose] Hosp Badalona Germans Trias & Pujol, Fundacio Inst Recerca Germans Trias & Pujol IGTP, Translat Oncol Lab, Catalan Inst Oncol, Barcelona, Spain; [Sanchez Torres, Jose Miguel] Hosp Univ La Princess, Med Oncol Serv, Madrid, Spain; [Buttitta, Fiamma] Univ Fdn, Ctr Predict Mol Med, Chieti, Italy; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Chem & Pharmacol Program, New York, NY 10021 USA; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, New York, NY 10021 USA; [Robinson, Eric; Osman, Iman] NYU, Inst Canc, Ronald O Perelman Dept Dermatol Med & Urol, New York, NY USA; [Munoz-Couselo, Eva; Cortes, Javier] Vall dHebron Inst Oncol, Barcelona, Spain; [Frederick, Dennie T.; Flaherty, Keith T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Frederick, Dennie T.; Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Comprehens Canc, Boston, MA 02114 USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Catalan Institute of Oncology; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	tbivona@medicine.ucsf.edu	Rudin, Charles/R-2530-2019; Ramirez, Jose Luis/E-5161-2018	Rudin, Charles/0000-0001-5204-3465; Ramirez, Jose Luis/0000-0003-1447-2941; Pham, Luu/0000-0002-2437-5590; Sabnis, Amit/0000-0002-2061-5139; Cooper, Zachary/0000-0003-1059-0940; Pazarentzos, Evangelos/0000-0002-5453-1646	US National Institutes of Health (NIH) Director's New Innovator Award [DP2CA174497]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; American Lung Association; National Lung Cancer Partnership; Addario Foundation; Van Auken Private Foundation; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; La Caixa Foundation; US NIH [R01CA131261]; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA016672, R01CA131261, DP2CA174497, P01CA163222] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Lung Association; National Lung Cancer Partnership; Addario Foundation; Van Auken Private Foundation; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; La Caixa Foundation(La Caixa Foundation); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Bollag and P. Lin (Plexxikon) for providing PLX4720. We thank J. Weissman and members of the Bivona laboratory for critical review of the manuscript. The authors acknowledge funding support (to T.G.B.) from the following sources: US National Institutes of Health (NIH) Director's New Innovator Award (DP2CA174497), the Howard Hughes Medical Institute (Collaborative Innovation Award), the Doris Duke Charitable Foundation, the American Lung Association, the National Lung Cancer Partnership, the Addario and Van Auken Private Foundations, the Sidney Kimmel Foundation for Cancer Research and the Searle Scholars Program. The authors also acknowledge funding from La Caixa Foundation (to R.R.) and from US NIH grant R01CA131261 (to M.M.).	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fordyce SL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-116; Frederick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101286; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Riely GJ, 2012, J CLIN ONCOL, V30; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rudin CM, 2013, J THORAC ONCOL, V8, pE41, DOI 10.1097/JTO.0b013e31828bb1b3; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	36	327	334	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					250	+		10.1038/ng.3218	http://dx.doi.org/10.1038/ng.3218			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665005	Green Accepted, Green Submitted			2022-12-25	WOS:000350327900016
J	Liu, YQ; Wu, H; Chen, H; Liu, YL; He, J; Kang, HY; Sun, ZG; Pan, G; Wang, Q; Hu, JL; Zhou, F; Zhou, KN; Zheng, XM; Ren, YL; Chen, LM; Wang, YH; Zhao, ZG; Lin, QB; Wu, FQ; Zhang, X; Guo, XP; Cheng, XI; Jiang, L; Wu, CY; Wang, HY; Wan, JM				Liu, Yuqiang; Wu, Han; Chen, Hong; Liu, Yanling; He, Jun; Kang, Haiyan; Sun, Zhiguang; Pan, Gen; Wang, Qi; Hu, Jinlong; Zhou, Feng; Zhou, Kunneng; Zheng, Xiaoming; Ren, Yulong; Chen, Liangming; Wang, Yihua; Zhao, Zhigang; Lin, Qibing; Wu, Fuqing; Zhang, Xin; Guo, Xiuping; Cheng, Xianian; Jiang, Ling; Wu, Chuanyin; Wang, Haiyang; Wan, Jianmin			A gene cluster encoding lectin receptor kinases confers broad-spectrum and durable insect resistance in rice	NATURE BIOTECHNOLOGY			English	Article							NILAPARVATA-LUGENS HOMOPTERA; ORYZA-SATIVA L.; BROWN PLANTHOPPER; ARABIDOPSIS; IDENTIFICATION; DELPHACIDAE; RESPONSES; SEQUENCE; PROTEIN; BAC	The brown planthopper (BPH) is the most destructive pest of rice (Oryza sativa) and a substantial threat to rice production, causing losses of billions of dollars annually(1,2). Breeding of resistant cultivars is currently hampered by the rapid breakdown of BPH resistance(2). Thus, there is an urgent need to identify more effective BPH-resistance genes. Here, we report molecular cloning and characterization of Bph3, a locus in rice identified more than 30 years ago that confers resistance to BPH. We show that Bph3 is a cluster of three genes encoding plasma membrane-localized lectin receptor kinases (OsLecRK1-OsLecRK3). Introgression of Bph3 into susceptible rice varieties by transgenic or marker-assisted selection strategies significantly enhanced resistance to both the BPH and the white back planthopper. Our results suggest that these lectin receptor kinase genes function together to confer broad-spectrum and durable insect resistance and provide a resource for molecular breeding of insect-resistant rice cultivars.	[Liu, Yuqiang; Wu, Han; Chen, Hong; Liu, Yanling; He, Jun; Kang, Haiyan; Sun, Zhiguang; Pan, Gen; Wang, Qi; Hu, Jinlong; Zhou, Feng; Zhou, Kunneng; Ren, Yulong; Chen, Liangming; Wang, Yihua; Zhao, Zhigang; Cheng, Xianian; Jiang, Ling; Wan, Jianmin] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiaoming; Lin, Qibing; Wu, Fuqing; Zhang, Xin; Guo, Xiuping; Wu, Chuanyin; Wang, Haiyang; Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wan, JM (corresponding author), Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	wanjm@njau.edu.cn	Ren, Yulong/HHC-8217-2022; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Lin, Qibing/AAG-3882-2021	chen, hong/0000-0002-7376-172X; Wang, Qi/0000-0002-2379-4814	333 Program [BRA2012126]; NSFC [31471470]; 863 Program of China [2012AA101101, 2011AA10A101, 2011BAD35B02-02]; National Science and Technology Supporting Program [2011BAD35B02-02]; National Key Transformation Program [2014ZX08001-001]; Jiangsu Science and Technology Development Program [BE2012303, BK2010016]; Jiangsu PAPD program	333 Program; NSFC(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China); National Science and Technology Supporting Program; National Key Transformation Program; Jiangsu Science and Technology Development Program; Jiangsu PAPD program	This work was supported by Jiangsu 333 Program (BRA2012126), NSFC (31471470), 863 Program of China (2012AA101101, 2011AA10A101 and 2011BAD35B02-02), National Science and Technology Supporting Program (2011BAD35B02-02), National Key Transformation Program (2014ZX08001-001), Jiangsu Science and Technology Development Program (BE2012303, BK2010016), and the Jiangsu PAPD program. We thank R. Guan (Nanjing Agricultural University) and J. Wang (Chinese Academy of Agricultural Sciences) for statistical analysis, and J. Zhou (Chinese Academy of Sciences), W. Terzaghi (Wilkes University) and C. Lin (UC-LA) for proofreading the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bharathi M, 2002, RICE GENETICS, P255; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen Yan, 2013, Yingyong Shengtai Xuebao, V24, P190; Cheng XY, 2013, PLANT J, V76, P687, DOI 10.1111/tpj.12328; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Gallagher S.R., 1992, GUS PROTOCOLS USING, P47; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; Gilardoni PA, 2011, PLANT CELL, V23, P3512, DOI 10.1105/tpc.111.088229; Gouhier-Darimont C, 2013, J EXP BOT, V64, P665, DOI 10.1093/jxb/ers362; Heinrichs E. A., 1985, GENETIC EVALUATION I; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JUNGTSUNG W, 1986, ENVIRON ENTOMOL, V15, P648, DOI 10.1093/ee/15.3.648; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; LAKSHMINARAYANA A, 1977, CROP SCI, V17, P96, DOI 10.2135/cropsci1977.0011183X001700010028x; Li Qing, 1997, Acta Entomologica Sinica, V40, P139; Lv WT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-674; Madurangi S.A.P, 2010, P 15 INT FOR ENV S, P172; Nagata T., 1984, Chinese Journal of Entomology, V4, P117; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; PATHAK PK, 1982, ENVIRON ENTOMOL, V11, P85, DOI 10.1093/ee/11.1.85; PATHAK PK, 1982, J ECON ENTOMOL, V75, P194, DOI 10.1093/jee/75.2.194; Cruz AP, 2011, ENTOMOL EXP APPL, V141, P245, DOI 10.1111/j.1570-7458.2011.01193.x; Piper R., 2011, PESTS GUIDE WORLDS M; Shen JunHui, 2003, Rice Science, V11, P57; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Singh P, 2012, PLANT CELL, V24, P1256, DOI 10.1105/tpc.112.095778; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun LH, 2005, BREEDING SCI, V55, P391, DOI 10.1270/jsbbs.55.391; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05872; Vaid N, 2012, PLANT MOL BIOL, V80, P365, DOI 10.1007/s11103-012-9952-8; Wang G.-L., 2009, ADV GENETICS GENOMIC; Wu H, 2014, MOL BREEDING, V33, P909, DOI 10.1007/s11032-013-0005-z; Xiong ZY, 2004, CHINESE SCI BULL, V49, P591, DOI 10.1360/03wc0533; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	46	200	258	10	195	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					301	+		10.1038/nbt.3069	http://dx.doi.org/10.1038/nbt.3069			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485617				2022-12-25	WOS:000350766900028
J	Fukazawa, Y; Lum, R; Okoye, AA; Park, H; Matsuda, K; Bae, JY; Hagen, SI; Shoemaker, R; Deleage, C; Lucero, C; Morcock, D; Swanson, T; Legasse, AW; Axthelm, MK; Hesselgesser, J; Geleziunas, R; Hirsch, VM; Edlefsen, PT; Piatak, M; Estes, JD; Lifson, JD; Picker, LJ				Fukazawa, Yoshinori; Lum, Richard; Okoye, Afam A.; Park, Haesun; Matsuda, Kenta; Bae, Jin Young; Hagen, Shoko I.; Shoemaker, Rebecca; Deleage, Claire; Lucero, Carissa; Morcock, David; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Hesselgesser, Joseph; Geleziunas, Romas; Hirsch, Vanessa M.; Edlefsen, Paul T.; Piatak, Michael, Jr.; Estes, Jacob D.; Lifson, Jeffrey D.; Picker, Louis J.			B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers	NATURE MEDICINE			English	Article							LOW-LEVEL VIREMIA; CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; DURABLE CONTROL; HELPER-CELLS; HIV-1; REPLICATION; MECHANISMS; RESPONSES; ABSENCE	Chronic-phase HIV and simian immunodeficiency virus (SIV) replication is reduced by as much as 10,000-fold in elite controllers (ECs) compared with typical progressors (TPs), but sufficient viral replication persists in EC tissues to allow viral sequence evolution and induce excess immune activation. Here we show that productive SIV infection in rhesus monkey ECs, but not TPs, is markedly restricted to CD4(+) follicular helper T (T-FH) cells, suggesting that these EC monkeys' highly effective SIV-specific CD8(+) T cells can effectively clear productive SIV infection from extrafollicular sites, but their relative exclusion from B cell follicles prevents their elimination of productively infected T-FH cells. CD8(+) lymphocyte depletion in EC monkeys resulted in a dramatic re-distribution of productive SIV infection to non-T-FH cells, with restriction of productive infection to T-FH cells resuming upon CD8(+) T cell recovery. Thus, B cell follicles constitute 'sanctuaries' for persistent SIV replication in the presence of potent anti-viral CD8(+) T cell responses, potentially complicating efforts to cure HIV infection with therapeutic vaccination or T cell immunotherapy.	[Fukazawa, Yoshinori; Lum, Richard; Okoye, Afam A.; Park, Haesun; Bae, Jin Young; Hagen, Shoko I.; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Fukazawa, Yoshinori; Lum, Richard; Okoye, Afam A.; Park, Haesun; Bae, Jin Young; Hagen, Shoko I.; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Matsuda, Kenta] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Shoemaker, Rebecca; Deleage, Claire; Lucero, Carissa; Morcock, David; Piatak, Michael, Jr.; Estes, Jacob D.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Hesselgesser, Joseph; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gilead Sciences; Fred Hutchinson Cancer Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	pickerl@ohsu.edu			US National Institutes of Health [5R37A1054292, 5U19AI096109, 8P51OD01109255, HHSN261200800001E]; Intramural Program of the US National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation [41185]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000686, R37AI054292, ZIAAI000370, U19AI096109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010426, P51OD011092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Program of the US National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors dedicate this paper to the memory of Michael Piatak, Jr., in recognition of his key enabling contributions to this study and so many others. This work was supported by the US National Institutes of Health; grants 5R37A1054292 (L.J.P.), 5U19AI096109 (L.J.P. and A.A.O.), and 8P51OD01109255, contract HHSN261200800001E (R.S., M.P., J.D.E. and J.D.L.) and Intramural Program of the US National Institute of Allergy and Infectious Diseases, and the Bill and Melinda Gates Foundation (grant no. 41185; L.J.P.). The authors thank R. Wiseman and D. Watkins for MHC typing; Dr. K. Reimann and the US National Institutes of Health Nonhuman Primate Reagent Resource Program for provision of the CD8 alpha-specific monoclonal antibody M-T807R1; D. Hazuda (Merck Research Labs) for providing cART drugs for cohort 1; Cytheris SA (Issy Les Moulineaux, France) for recombinant rhesus IL-7; S. Hansen for animal study management; A. Sylwester, L. Koo, J. Clock, A. Konfe, H.W. Kim, M. Rohankhedkar, M. Reyes, N. Coombes, B. Assaf, K. Oswald, R. Fast, Y. Li, C. Trubey, J. Turner, S. Planer and L. Boshears for technical or administrative assistance.	Anolik JH, 2005, BEST PRACT RES CL RH, V19, P859, DOI 10.1016/j.berh.2005.05.006; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; Leone A, 2010, J IMMUNOL, V185, P1650, DOI 10.4049/jimmunol.0902626; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Mendoza D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003195; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Mudd PA, 2011, J VIROL, V85, P7454, DOI 10.1128/JVI.00738-11; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C., 2014, 20 INT AIDS C MELB A; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Robinson HL, 2012, NAT MED, V18, P1614, DOI 10.1038/nm.2986; Saez-Cirion A, 2013, IMMUNOL REV, V254, P281, DOI 10.1111/imr.12076; Sasikala-Appukuttan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081623; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Skinner PJ, 2014, J HUM VIROL RETROVIR, V1; TENNERRACZ K, 1987, AIDS, V1, P95; TENNERRACZ K, 1993, AM J PATHOL, V142, P1750; Tjernlund A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-12; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; WOOD GS, 1985, BLOOD, V66, P1092	45	361	367	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					132	139		10.1038/nm.3781	http://dx.doi.org/10.1038/nm.3781			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25599132	Green Accepted			2022-12-25	WOS:000348974800015
J	Swiech, L; Heidenreich, M; Banerjee, A; Habib, N; Li, YQ; Trombetta, J; Sur, M; Zhang, F				Swiech, Lukasz; Heidenreich, Matthias; Banerjee, Abhishek; Habib, Naomi; Li, Yinqing; Trombetta, John; Sur, Mriganka; Zhang, Feng			In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; DUAL-RNA; TRANSCRIPTION; MECP2; CAS9; EXPRESSION; REPRESSION; NEURONS; MODEL	Probing gene function in the mammalian brain can be greatly assisted with methods to manipulate the genome of neurons in vivo. The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas) 9 from Streptococcus pyogenes (SpCas9) 1 can be used to edit single or multiple genes in replicating eukaryotic cells, resulting in frame-shifting insertion/deletion (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and guide RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as well as multiple genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in vivo. We characterized the effects of genome modifications in postmitotic neurons using biochemical, genetic, electrophysiological and behavioral readouts. Our results demonstrate that AAV-mediated SpCas9 genome editing can enable reverse genetic studies of gene function in the brain.	[Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Li, Yinqing; Trombetta, John; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Li, Yinqing; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Banerjee, Abhishek; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Li, Yinqing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Habib, Naomi/AAA-8937-2020; Core, Vector/CAF-4832-2022	Li, Yinqing/0000-0002-9096-8482	Human Frontiers Scientific Program; NATIONAL EYE INSTITUTE [R01EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085802, DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	Human Frontiers Scientific Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Trevino and C. Le for technical assistance and the entire Zhang lab for technical support and critical discussions; we thank R. Platt (Broad Institute) and H. Worman (Columbia University) for sharing plasmids, R. Rikhye for providing a template for electrophysiology analysis; and X. Yu for statistical discussions. L. S. is a European Molecular Biology Organization (EMBO) Fellow and is supported by the Foundation for Polish Science. M. H. is supported by the Human Frontiers Scientific Program. A. B. holds a postdoctoral fellowship from the Simons Center for the Social Brain. N. H. is an EMBO Fellow and Y. L. is supported by Friends of the McGovern Institute Fellowship. M. S. is supported by grants from the US National Institutes of Health (NIH) (R01EY007023 and R01MH085802) and the Simons Foundation. F. Z. is supported by the National Institute of Mental Health (NIMH) through NIH Director's Pioneer Award (5DP1-MH100706), the NINDS through a NIH Transformative R01 grant (5R01-NS073124), the Keck, Merkin, Vallee, Damon Runyon, Searle Scholars, Klarman Family Foundation, Klingenstein, Poitras and Simons Foundations, and Bob Metcalfe. The authors plan on making the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab website (http://www. genome-engineering.org/).	Banerjee Abhishek, 2012, Front Psychiatry, V3, P34, DOI 10.3389/fpsyt.2012.00034; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SHOLL DA, 1953, J ANAT, V87, P387; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	42	504	612	7	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					102	U286		10.1038/nbt.3055	http://dx.doi.org/10.1038/nbt.3055			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25326897	Green Accepted, Green Submitted			2022-12-25	WOS:000347714200034
J	Byrareddy, SN; Kallam, B; Arthos, J; Cicala, C; Nawaz, F; Hiatt, J; Kersh, EN; McNicholl, JM; Hanson, D; Reimann, KA; Brameier, M; Walter, L; Rogers, K; Mayne, AE; Dunbar, P; Villinger, T; Little, D; Parslow, TG; Santangelo, PJ; Villinger, F; Fauci, AS; Ansari, AA				Byrareddy, Siddappa N.; Kallam, Brianne; Arthos, James; Cicala, Claudia; Nawaz, Fatima; Hiatt, Joseph; Kersh, Ellen N.; McNicholl, Janet M.; Hanson, Debra; Reimann, Keith A.; Brameier, Markus; Walter, Lutz; Rogers, Kenneth; Mayne, Ann E.; Dunbar, Paul; Villinger, Tara; Little, Dawn; Parslow, Tristram G.; Santangelo, Philip J.; Villinger, Francois; Fauci, Anthony S.; Ansari, Aftab A.			Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection	NATURE MEDICINE			English	Article							T-CELL SUBSET; MAINTENANCE THERAPY; IMMUNE ACTIVATION; ALPHA-4-BETA-7; VEDOLIZUMAB; INDUCTION; DEPLETION; RECEPTOR; TRACT; CD4	alpha(4)beta(7) integrin expressing CD4(+) T cells preferentially traffic to gut-associated lymphoid tissue (GALT) and have a key role in HIV and simian immunodeficiency virus (SIV) pathogenesis. We show here that the administration of an anti-alpha(4)beta(7) monoclonal antibody just prior to and during acute infection protects rhesus macaques from transmission following repeated low-dose intravaginal challenges with SIVmac251. In treated animals that became infected, the GALT was significantly protected from infection and CD4(+) T cell numbers were maintained in both the blood and the GALT. Thus, targeting alpha(4)beta(7) reduces mucosal transmission of Sly in macaques.	[Byrareddy, Siddappa N.; Kallam, Brianne; Mayne, Ann E.; Dunbar, Paul; Villinger, Tara; Little, Dawn; Parslow, Tristram G.; Villinger, Francois; Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Arthos, James; Cicala, Claudia; Nawaz, Fatima; Hiatt, Joseph; Fauci, Anthony S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Kersh, Ellen N.; McNicholl, Janet M.; Hanson, Debra] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Reimann, Keith A.] Univ Massachusetts, Sch Med, Mass Biol, Boston, MA 02125 USA; [Brameier, Markus; Walter, Lutz] German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany; [Rogers, Kenneth; Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA; [Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA	Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; University of Massachusetts System; University of Massachusetts Boston; Deutsches Primatenzentrum (DPZ); Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Ansari, AA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pathaaa@emory.edu	Walter, Lutz/I-2606-2017	Walter, Lutz/0000-0001-9408-3131; Hiatt, Joseph/0000-0002-8015-9614	NIH-NIAID [AI-098628-01]; NIAID NIH Intramural Research Program; Nonhuman Primate Reagent Resource (NIAID, NIH) [HHSN272200900037C];  [OD 51POD1113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683, ZIAAI000887, ZIAAI000883, R01AI098628, R21AI095129] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010947, P51OD011132] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH Intramural Research Program; Nonhuman Primate Reagent Resource (NIAID, NIH); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH-NIAID AI-098628-01 (to A.A.A.), the NIAID NIH Intramural Research Program and OD 51POD1113 to the Yerkes National Primate Research Center. We are grateful to F. Connor-Stroud for help with the cytobrush studies and to the veterinary staff and animal caretakers of the Yerkes National Primate Center of Emory University, specially S. Ehnert and her team. The authors also acknowledge the assistance of M. Piatak for performing the ultrasensitive PCR analysis and R. Kaul and L.R. McKinnon for sharing with us their finding on cervical brush analyses in Africa and advising us on how to proceed in adapting their human findings to our nonhuman primates. Recombinant mAbs were produced by the Nonhuman Primate Reagent Resource (NIAID, NIH contract # HHSN272200900037C). The virus stock of SIV<INF>mac251</INF> was obtained courtesy of N. Miller (NIAID, NIH). We apologize to all the authors whose publications we failed to cite. The findings in this report are those of the authors and do not necessarily reflect the views of the US Centers for Disease Control and Prevention.	Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Danese S, 2014, ANN INTERN MED, V160, P704, DOI 10.7326/M13-2403; ERLE DJ, 1994, J IMMUNOL, V153, P517; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Jovani M, 2013, CURR DRUG TARGETS, V14, P1433, DOI 10.2174/13894501113146660206; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Kwa S, 2011, BLOOD, V118, P2763, DOI 10.1182/blood-2011-02-339515; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Pereira LE, 2009, CELL IMMUNOL, V259, P165, DOI 10.1016/j.cellimm.2009.06.012; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427	20	108	114	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1397	1400		10.1038/nm.3715	http://dx.doi.org/10.1038/nm.3715			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25419708	Green Accepted			2022-12-25	WOS:000345817900014
J	Cameron, DE; Collins, JJ				Cameron, D. Ewen; Collins, James J.			Tunable protein degradation in bacteria	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; ALLELE REPLACEMENT; GENETIC CIRCUITS; TIGHT REGULATION; EXPRESSION; DESIGN; SYSTEM; SWITCH; RIBOREGULATORS	Tunable control of protein degradation in bacteria would provide a powerful research tool. Here we use components of the Mesoplasma florum transfer-messenger RNA system to create a synthetic degradation system that provides both independent control of steady-state protein level and inducible degradation of targeted proteins in Escherichia coli. We demonstrate application of this system in synthetic circuit development and control of core bacterial processes and antibacterial targets, and we transfer the system to Lactococcus lactis to establish its broad functionality in bacteria. We create a 238-member library of tagged essential proteins in E. coli that can serve as both a research tool to study essential gene function and an applied system for antibiotic discovery. Our synthetic protein degradation system is modular, does not require disruption of host systems and can be transferred to diverse bacteria with minimal modification.	[Cameron, D. Ewen; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu			Office of Naval Research (ONR); Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to C. Bashor, M. Lobritz, M. Khalil and D. Dwyer for helpful discussions and critical reviews of the manuscript. This work was supported by funding from the Office of Naval Research (ONR) MURI Program, Defense Threat Reduction Agency grant HDTRA1-14-1-0006 and the Howard Hughes Medical Institute.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JH, 2011, ACS CHEM BIOL, V6, P1205, DOI 10.1021/cb2001389; DeVito JA, 2002, NAT BIOTECHNOL, V20, P478, DOI 10.1038/nbt0502-478; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ge ZY, 2009, MOL MICROBIOL, V74, P1083, DOI 10.1111/j.1365-2958.2009.06923.x; Gur E, 2008, P NATL ACAD SCI USA, V105, P16113, DOI 10.1073/pnas.0808802105; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holo H, 1995, Methods Mol Biol, V47, P195; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Huang D, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-9; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Litcofsky KD, 2012, NAT METHODS, V9, P1077, DOI [10.1038/NMETH.2205, 10.1038/nmeth.2205]; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; MULLERHILL B, 1968, P NATL ACAD SCI USA, V59, P1259, DOI 10.1073/pnas.59.4.1259; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Peterson EJR, 2012, ASSAY DRUG DEV TECHN, V10, P260, DOI 10.1089/adt.2011.0409; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; VANDEGUCHTE M, 1992, FEMS MICROBIOL LETT, V88, P73, DOI 10.1016/0378-1097(92)90685-H; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhu W, 2013, P NATL ACAD SCI USA, V110, P123, DOI 10.1073/pnas.1219899110	41	124	132	3	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1276	U149		10.1038/nbt.3053	http://dx.doi.org/10.1038/nbt.3053			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402616	Green Accepted, Green Submitted			2022-12-25	WOS:000346156800031
J	Berod, L; Friedrich, C; Nandan, A; Freitag, J; Hagemann, S; Harmrolfs, K; Sandouk, A; Hesse, C; Castro, CN; Bahres, H; Tschirner, SK; Gorinski, N; Gohmert, M; Mayer, CT; Huehn, J; Ponimaskin, E; Abraham, WR; Muller, R; Lochner, M; Sparwasser, T				Berod, Luciana; Friedrich, Christin; Nandan, Amrita; Freitag, Jenny; Hagemann, Stefanie; Harmrolfs, Kirsten; Sandouk, Aline; Hesse, Christina; Castro, Carla N.; Baehres, Heike; Tschirner, Sarah K.; Gorinski, Nataliya; Gohmert, Melanie; Mayer, Christian T.; Huehn, Jochen; Ponimaskin, Evgeni; Abraham, Wolf-Rainer; Mueller, Rolf; Lochner, Matthias; Sparwasser, Tim			De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells	NATURE MEDICINE			English	Article							ACETYL-COA CARBOXYLASE-1; ROR-GAMMA-T; DIFFERENTIATION; METABOLISM; EFFECTOR; INHIBITION; COENZYME; T(H)17; MTOR	Interleukin-17 (IL-17)-secreting T cells of the T helper 17 (T(H)17) lineage play a pathogenic role in multiple inflammatory and autoimmune conditions and thus represent a highly attractive target for therapeutic intervention. We report that inhibition of acetyl-CoA carboxylase 1 (ACC1) restrains the formation of human and mouse T(H)17 cells and promotes the development of anti-inflammatory Foxp(3+) regulatory T (T-reg) cells. We show that T(H)17 cells, but not Treg cells, depend on ACC1-mediated de novo fatty acid synthesis and the underlying glycolytic-lipogenic metabolic pathway for their development. Although T(H)17 cells use this pathway to produce phospholipids for cellular membranes, Treg cells readily take up exogenous fatty acids for this purpose. Notably, pharmacologic inhibition or T cell-specific deletion of ACC1 not only blocks de novo fatty acid synthesis but also interferes with the metabolic flux of glucose-derived carbon via glycolysis and the tricarboxylic acid cycle. In vivo, treatment with the ACC-specific inhibitor soraphen A or T cell-specific deletion of ACC1 in mice attenuates T(H)17 cell-mediated autoimmune disease. Our results indicate fundamental differences between T(H)17 cells and Treg cells regarding their dependency on ACC1-mediated de novo fatty acid synthesis, which might be exploited as a new strategy for metabolic immune modulation of T(H)17 cell-mediated inflammatory diseases.	[Berod, Luciana; Friedrich, Christin; Nandan, Amrita; Freitag, Jenny; Hagemann, Stefanie; Sandouk, Aline; Hesse, Christina; Castro, Carla N.; Gohmert, Melanie; Mayer, Christian T.; Lochner, Matthias; Sparwasser, Tim] TWINCORE, Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany; [Harmrolfs, Kirsten; Mueller, Rolf] Univ Saarland, Helmholtz Inst Pharmaceut Res, Helmholtz Ctr Infect Res, D-66123 Saarbrucken, Germany; [Harmrolfs, Kirsten; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Baehres, Heike; Tschirner, Sarah K.] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Baehres, Heike] Hannover Med Sch, Res Core Unit Metabol, Hannover, Germany; [Gorinski, Nataliya] Hannover Med Sch, Inst Cellular Neurophysiol, Hannover, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Abraham, Wolf-Rainer] Helmholtz Ctr Infect Res, Dept Chem Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Lochner, M (corresponding author), TWINCORE, Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany.	matthias.lochner@twincore.de; sparwasser.office@mh-hannover.de	Abraham, Wolf-Rainer/I-2179-2019; Müller, Rolf/B-1559-2008; Lochner, Matthias/L-6963-2015; Berod, Luciana/AAG-8095-2019; Sparwasser, Tim/AAF-7085-2019; Sparwasser, Tim D/AAA-4306-2022	Abraham, Wolf-Rainer/0000-0002-2850-2649; Müller, Rolf/0000-0002-1042-5665; Lochner, Matthias/0000-0002-7979-5613; Berod, Luciana/0000-0002-9677-3483; Sparwasser, Tim/0000-0001-5645-902X; Castro, Carla Noemi/0000-0002-2689-9072; Harmrolfs, Kirsten/0000-0001-5648-0750; Ponimaskin, evgeni/0000-0002-4570-5130	Deutsche Forschungsgemeinschaft [LO1415/2-1, KFO250, SFB900, PO732]; Novartis Research Foundation; German academic exchange service; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novartis Research Foundation; German academic exchange service(Deutscher Akademischer Austausch Dienst (DAAD)); German National Academic Foundation	We thank S.J. Wakil (Baylor College of Medicine) for providing ACC1<SUP>lox</SUP> and ACC2-knockout mice, M. Swallow for critical reading of the manuscript and all members of the Institute of Infection Immunology at TWINCORE for discussion and support. We would like to acknowledge the assistance of the Cell Sorting Core Facility of the Hannover Medical School supported in part by the Braukmann-Wittenberg-Herz-Stiftung and the Deutsche Forschungsgemeinschaft. We thank E. Surges for excellent technical help, B. Beckmann for support using the Seahorse XF Analyzer, F. Sasse (Helmholtz Centre for Infection Research) for providing SorA and M. Haidulciewicz (Hannover Medical School) for providing human cord blood. This work was supported by grants from the Deutsche Forschungsgemeinschaft (LO1415/2-1, KFO250 and SFB900 to T.S. and M.L. and PO732 to E.P.) and the Novartis Research Foundation to M.L.; A.N. was supported by the German academic exchange service and C.T.M. by the German National Academic Foundation.	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Barbi J, 2013, IMMUNOL REV, V252, P52, DOI 10.1111/imr.12029; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; GERTH K, 1994, J ANTIBIOT, V47, P23, DOI 10.7164/antibiotics.47.23; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shriver LP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00079; Ueda A, 2012, J IMMUNOL, V188, P5247, DOI 10.4049/jimmunol.1102241; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	29	498	518	7	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1327	1333		10.1038/nm.3704	http://dx.doi.org/10.1038/nm.3704			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25282359				2022-12-25	WOS:000344724300023
J	Leslie, DC; Waterhouse, A; Berthet, JB; Valentin, TM; Watters, AL; Jain, A; Kim, P; Hatton, BD; Nedder, A; Donovan, K; Super, EH; Howell, C; Johnson, CP; Vu, TL; Bolgen, DE; Rifai, S; Hansen, AR; Aizenberg, M; Super, M; Aizenberg, J; Ingber, DE				Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Kim, Philseok; Hatton, Benjamin D.; Nedder, Arthur; Donovan, Kathryn; Super, Elana H.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Bolgen, Dana E.; Rifai, Sami; Hansen, Anne R.; Aizenberg, Michael; Super, Michael; Aizenberg, Joanna; Ingber, Donald E.			A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling	NATURE BIOTECHNOLOGY			English	Article							CARDIOPULMONARY BYPASS CIRCUITS; HEPARIN; BIOCOMPATIBILITY; ANTICOAGULATION; HEMODIALYSIS; PERFORMANCE; OXYGEN; PMEA	Thrombosis and biofouling of extracorporeal circuits and indwelling medical devices cause significant morbidity and mortality worldwide. We apply a bioinspired, omniphobic coating to tubing and catheters and show that it completely repels blood and suppresses biofilm formation. The coating is a covalently tethered, flexible molecular layer of perfluorocarbon, which holds a thin liquid film of medical-grade perfluorocarbon on the surface. This coating prevents fibrin attachment, reduces platelet adhesion and activation, suppresses biofilm formation and is stable under blood flow in vitro. Surface-coated medical-grade tubing and catheters, assembled into arteriovenous shunts and implanted in pigs, remain patent for at least 8 h without anticoagulation. This surface-coating technology could reduce the use of anticoagulants in patients and help to prevent thrombotic occlusion and biofouling of medical devices.	[Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Kim, Philseok; Hatton, Benjamin D.; Super, Elana H.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Bolgen, Dana E.; Rifai, Sami; Aizenberg, Michael; Super, Michael; Aizenberg, Joanna; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Leslie, Daniel C.; Kim, Philseok; Hatton, Benjamin D.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Aizenberg, Joanna; Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Hansen, Anne R.; Super, Michael; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Leslie, Daniel C.; Jain, Abhishek; Super, Michael; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Waterhouse, Anna; Berthet, Julia B.; Hansen, Anne R.] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Nedder, Arthur; Donovan, Kathryn] Boston Childrens Hosp, Boston, MA USA; [Aizenberg, Joanna] Harvard Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Waterhouse, Anna/E-2464-2011; Waterhouse, Anna/M-1681-2018; Leslie, Dan/AAX-9698-2020; Howell, Caitlin/E-4274-2016; Super, Michael/AAW-7952-2021; Jain, Abhishek/M-6851-2019; Leslie, Daniel/O-1680-2014	Waterhouse, Anna/0000-0003-1498-9393; Howell, Caitlin/0000-0002-9345-6642; Jain, Abhishek/0000-0003-2235-5139; Hicks-Berthet, Julia/0000-0002-6549-8116; Aizenberg, Michael/0000-0002-2901-7012; Leslie, Daniel/0000-0003-0606-792X	Defense Advanced Research Projects Agency [N66001-11-1-4180, HR0011-13-C-0025]; Wyss Institute for Biologically Inspired Engineering at Harvard University; National Science Foundation [ECS-0335765]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Science Foundation(National Science Foundation (NSF))	This work was supported by Defense Advanced Research Projects Agency grant N66001-11-1-4180 and contract HR0011-13-C-0025, and the Wyss Institute for Biologically Inspired Engineering at Harvard University. We thank D. Super, R. Cooper, E. Murray and J. Lee for phlebotomy, T. Ferrante for assistance with fluorescence microscopy, H. Kozakewich for assistance with histology evaluation and O. Ahanotu for assistance in preparing surfaces. Scanning electron microscopy and X-ray photoelectron spectroscopy were conducted at the Center for Nanoscale Systems at Harvard University, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (ECS-0335765).	Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008; Bannan S, 1997, ANN THORAC SURG, V63, P663, DOI 10.1016/S0003-4975(96)01054-5; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Canaud B, 2005, J AM SOC NEPHROL, V16, P1819, DOI 10.1681/ASN.2004050361; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; CLARK LC, 1973, SCIENCE, V181, P680, DOI 10.1126/science.181.4100.680; Conn G, 2006, EXPERT REV MED DEVIC, V3, P245, DOI 10.1586/17434440.3.2.245; Cronin RE, 2010, SEMIN DIALYSIS, V23, P510, DOI 10.1111/j.1525-139X.2010.00770.x; Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; GOULD SA, 1986, NEW ENGL J MED, V314, P1653, DOI 10.1056/NEJM198606263142601; HARTMANN RC, 1952, J CLIN INVEST, V31, P685, DOI 10.1172/JCI102650; Kim P, 2013, NANO LETT, V13, P1793, DOI 10.1021/nl4003969; Kutay V, 2006, J CARDIAC SURG, V21, P572, DOI 10.1111/j.1540-8191.2006.00298.x; LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804; Liu F., 2011, COMPREHENSIVE BIOMAT; Lobato RL, 2010, J THORAC CARDIOV SUR, V139, P1665, DOI 10.1016/j.jtcvs.2010.02.038; McCarthy PM, 2002, SCIENCE, V295, P998, DOI 10.1126/science.1068555; Nilsson J, 2012, INTERACT CARDIOV TH, V15, P834, DOI 10.1093/icvts/ivs345; NILSSON L, 1990, ARTIF ORGANS, V14, P46; Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A; Reser D, 2012, PERFUSION-UK, V27, P530, DOI 10.1177/0267659112454558; Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y; Shen JI, 2013, NEPHROL DIAL TRANSPL, V28, P1589, DOI 10.1093/ndt/gft067; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120; Stark AY, 2013, P NATL ACAD SCI USA, V110, P6340, DOI 10.1073/pnas.1219317110; Strobel M, 1994, PLASMA SURFACE MODIF; Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3; Tevaearai HT, 1999, INT J ARTIF ORGANS, V22, P629, DOI 10.1177/039139889902200907; Thiara AS, 2010, PERFUSION-UK, V25, P9, DOI 10.1177/0267659110362822; Toes GJ, 2002, BIOMATERIALS, V23, P255, DOI 10.1016/S0142-9612(01)00103-X; Vogel N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3176; VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391; Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Zhang Z, 2013, LAB CHIP, V13, P1963, DOI 10.1039/c3lc50302j	40	451	468	47	648	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1134	1140		10.1038/nbt.3020	http://dx.doi.org/10.1038/nbt.3020			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25306244	Green Submitted			2022-12-25	WOS:000344977000018
J	Moverare-Skrtic, S; Henning, P; Liu, XW; Nagano, K; Saito, H; Borjesson, AE; Sjogren, K; Windahl, SH; Farman, H; Kindlund, B; Engdahl, C; Koskela, A; Zhang, FP; Eriksson, EE; Zaman, F; Hammarstedt, A; Isaksson, H; Bally, M; Kassem, A; Lindholm, C; Sandberg, O; Aspenberg, P; Savendahl, L; Feng, JQ; Tuckermann, J; Tuukkanen, J; Poutanen, M; Baron, R; Lerner, UH; Gori, F; Ohlsson, C				Moverare-Skrtic, Sofia; Henning, Petra; Liu, Xianwen; Nagano, Kenichi; Saito, Hiroaki; Borjesson, Anna E.; Sjogren, Klara; Windahl, Sara H.; Farman, Helen; Kindlund, Bert; Engdahl, Cecilia; Koskela, Antti; Zhang, Fu-Ping; Eriksson, Emma E.; Zaman, Farasat; Hammarstedt, Ann; Isaksson, Hanna; Bally, Marta; Kassem, Ali; Lindholm, Catharina; Sandberg, Olof; Aspenberg, Per; Savendahl, Lars; Feng, Jian Q.; Tuckermann, Jan; Tuukkanen, Juha; Poutanen, Matti; Baron, Roland; Lerner, Ulf H.; Gori, Francesca; Ohlsson, Claes			Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures	NATURE MEDICINE			English	Article							MINERAL DENSITY; BETA-CATENIN; GENOME-WIDE; SOST GENE; DIFFERENTIATION; MASS; HOMODIMERIZATION; PROLIFERATION; METAANALYSIS; ACTIVATION	The WNT16 locus is a major determinant of cortical bone thickness and nonvertebral fracture risk in humans. The disability, mortality and costs caused by osteoporosis-induced nonvertebral fractures are enormous. We demonstrate here that Wnt16-deficient mice develop spontaneous fractures as a result of low cortical thickness and high cortical porosity. In contrast, trabecular bone volume is not altered in these mice. Mechanistic studies revealed that WNT16 is osteoblast derived and inhibits human and mouse osteoclastogenesis both directly by acting on osteoclast progenitors and indirectly by increasing expression of osteoprotegerin (Opg) in osteoblasts. The signaling pathway activated by WNT16 in osteoclast progenitors is noncanonical, whereas the pathway activated in osteoblasts is both canonical and noncanonical. Conditional Wnt16 inactivation revealed that osteoblast-lineage cells are the principal source of WNT16, and its targeted deletion in osteoblasts increases fracture susceptibility. Thus, osteoblast-derived WNT16 is a previously unreported key regulator of osteoclastogenesis and fracture susceptibility. These findings open new avenues for the specific prevention or treatment of nonvertebral fractures, a substantial unmet medical need.	[Moverare-Skrtic, Sofia; Henning, Petra; Borjesson, Anna E.; Sjogren, Klara; Windahl, Sara H.; Farman, Helen; Kindlund, Bert; Engdahl, Cecilia; Lindholm, Catharina; Poutanen, Matti; Lerner, Ulf H.; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med, Gothenburg, Sweden; [Liu, Xianwen; Nagano, Kenichi; Saito, Hiroaki; Baron, Roland; Gori, Francesca] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Liu, Xianwen] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Sichuan, Peoples R China; [Liu, Xianwen] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Sichuan, Peoples R China; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Med Res Ctr, Dept Anat & Cell Biol, Oulu, Finland; [Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Inst Biomed, Dept Physiol, Turku Ctr Dis Modeling, Turku, Finland; [Eriksson, Emma E.; Zaman, Farasat; Savendahl, Lars] Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Zaman, Farasat] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Hammarstedt, Ann] Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Isaksson, Hanna] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Isaksson, Hanna] Lund Univ, Dept Orthoped, Lund, Sweden; [Bally, Marta] Chalmers Univ Technol, Dept Appl Phys, Div Biol Phys, S-41296 Gothenburg, Sweden; [Kassem, Ali] Umea Univ, Umea, Sweden; [Sandberg, Olof; Aspenberg, Per] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Tuckermann, Jan] Univ Ulm, Inst Gen Zool & Endocrinol, D-89069 Ulm, Germany; [Baron, Roland; Gori, Francesca] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA	University of Gothenburg; Harvard University; Harvard School of Dental Medicine; Sichuan University; Sichuan University; University of Oulu; University of Turku; Karolinska Institutet; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Gothenburg; Lund University; Lund University; Chalmers University of Technology; Umea University; Linkoping University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Ulm University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ohlsson, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med, Gothenburg, Sweden.	roland_baron@hsdm.harvard.edu; ulf.lerner@odont.umu.se; francesca_gori@hsdm.harvard.edu; claes.ohlsson@medic.gu.se	Skrtic, Sofia/AAQ-1585-2020; Bally, Marta/G-8744-2011; Isaksson, Hanna/L-1340-2015; Zaman, Farasat/AAE-1144-2020; Nagano, Kenichi/AAH-3246-2019; Gori, Francesca/S-9422-2019; Poutanen, Matti/I-1700-2018; Ohlsson, Claes/AGP-3544-2022; Tuukkanen, Juha/R-3728-2018	Isaksson, Hanna/0000-0002-9690-8907; Nagano, Kenichi/0000-0003-3145-4841; Poutanen, Matti/0000-0002-8953-1734; Ohlsson, Claes/0000-0002-9633-2805; Tuukkanen, Juha/0000-0002-1723-6461; Henning, Petra/0000-0002-9330-6265; Lerner, Ulf/0000-0002-3579-1960; Tornqvist, Anna/0000-0003-2621-9038; Kassem, Ali/0000-0002-1820-8518; Savendahl, Lars/0000-0003-1067-4976; Engdahl, Cecilia/0000-0002-8914-0178; Bally, Marta/0000-0002-5865-8302; Saito, Hiroaki/0000-0002-8130-0624; Koskela, Antti/0000-0001-7371-2488; Sjogren, Klara/0000-0001-5776-7278; Windahl, Sara/0000-0002-6611-6001	Swedish Research Council; Swedish Foundation for Strategic Research, COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet (ALF/LUA) research grant in Gothenburg, Linkoping University, Swedish National Graduate School in Odontological Sciences; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V; Novo Nordisk Foundation; German Research Foundation [SPP 1468 Tu220/6]; University of Turku and Biocenter Finland; US National Institutes of Health [R01AR064724]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064724] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research, COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet (ALF/LUA) research grant in Gothenburg, Linkoping University, Swedish National Graduate School in Odontological Sciences; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); German Research Foundation(German Research Foundation (DFG)); University of Turku and Biocenter Finland; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We are grateful to C. Uggla, M. Petersson, A. Hansevi, A. Lie, I. Lundgren, B. Aleksic and the staff at the Turku Center for Disease Modeling (TCDM) for technical assistance. We thank M. Johansson at Bergman Labora for help with photographing the embryos. We thank R. Brommage (Lexicon Pharmaceuticals Inc.) for providing the Wnt164<SUP>-/-,exon</SUP> <SUP>1-3</SUP> mice. This study was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, COMBINE, the Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet (ALF/LUA) research grant in Gothenburg, Linkoping University, Swedish National Graduate School in Odontological Sciences, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Swedish Rheumatism Association, the Royal 80 Year Fund of King Gustav V, the Novo Nordisk Foundation and the German Research Foundation (SPP 1468 Tu220/6, Immunobone). The work at TCDM was supported by funding provided by University of Turku and Biocenter Finland. This work was supported in part by a grant to R.B. from the US National Institutes of Health (R01AR064724). The HSDM micro-CT core facility performed the micro-CT analyses of the Wnt16<SUP>-/-,exon</SUP> <SUP>1-3</SUP> mice.	Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brommage R, 2007, BONE, V40, pS187; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garcia-Ibarbia C, 2013, OSTEOPOROSIS INT, V24, P2449, DOI 10.1007/s00198-013-2302-0; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Green JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058395; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hendrickx G, 2014, BONE, V59, P57, DOI 10.1016/j.bone.2013.10.022; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Jiang Z, 2014, J CELL PHYSIOL, V229, P384, DOI 10.1002/jcp.24460; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Koller DL, 2013, J BONE MINER RES, V28, P547, DOI 10.1002/jbmr.1796; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Miclea R.L., 2009, BMC DEV BIOL, V9, P26; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Santiago F, 2012, BIOCHEM BIOPH RES CO, V417, P223, DOI 10.1016/j.bbrc.2011.11.089; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wermelin K, 2008, BONE, V42, P365, DOI 10.1016/j.bone.2007.10.013; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	48	223	230	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1279	1288		10.1038/nm.3654	http://dx.doi.org/10.1038/nm.3654			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25306233	Green Accepted			2022-12-25	WOS:000344724300017
J	Gibbons, D; Fleming, P; Virasami, A; Michel, ML; Sebire, NJ; Costeloe, K; Carr, R; Klein, N; Hayday, A				Gibbons, Deena; Fleming, Paul; Virasami, Alex; Michel, Marie-Laure; Sebire, Neil J.; Costeloe, Kate; Carr, Robert; Klein, Nigel; Hayday, Adrian			Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants	NATURE MEDICINE			English	Article							PRETERM INFANTS; INFLAMMATION; EXPRESSION; SECRETION; INFECTION; SUBSETS; FETAL	In spite of their precipitous encounter with the environment, newborn infants cannot readily mount T helper type 1 (T(H)1) cell antibacterial and antiviral responses. Instead, they show skewing toward T(H)2 responses, which, together with immunoregulatory functions, are thought to limit the potential for inflammatory damage, while simultaneously permitting intestinal colonization by commensals(1-3). However, these collective capabilities account for relatively few T cells. Here we demonstrate that a major T cell effector function in human newborns is interleukin-8 (CXCL8) production, which has the potential to activate antimicrobial neutrophils and gamma delta T cells. CXCL8 production was provoked by antigen receptor engagement of T cells that are distinct from those few cells. producing T(H)1, T(H)2 and T(H)17 cytokines, was co-stimulated by Toll-like receptor signaling, and was readily apparent in preterm babies, particularly those experiencing neonatal infections and severe pathology. By contrast, CXCL8-producing T cells were rare in adults, and no equivalent function was evident in neonatal mice. CXCL8 production counters the widely held view that T lymphocytes in very early life are intrinsically anti-inflammatory, with implications for immune monitoring, immune interventions (including vaccination) and immunopathologies. It also emphasizes qualitative distinctions between infants' and adults' immune systems.	[Gibbons, Deena; Michel, Marie-Laure; Hayday, Adrian] Kings Coll London, Peter Gorer Dept lmmunobiol, London WC2R 2LS, England; [Gibbons, Deena; Michel, Marie-Laure; Hayday, Adrian] Canc Res UK, London Res Inst, London, England; [Fleming, Paul; Costeloe, Kate] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Fleming, Paul; Costeloe, Kate] Homerton Univ Hosp, Dept Neonatol, London, England; [Virasami, Alex; Sebire, Neil J.; Klein, Nigel] Great Ormond St Hosp Sick Children, London, England; [Carr, Robert] Kings Coll London, Dept Haematol, London WC2R 2LS, England; [Klein, Nigel] UCL, Inst Child Hlth, London, England	University of London; King's College London; Cancer Research UK; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University of London; University College London	Gibbons, D (corresponding author), Kings Coll London, Peter Gorer Dept lmmunobiol, London WC2R 2LS, England.	deena.gibbons@kcl.ac.uk; adrian.hayday@kcl.ac.uk		Gibbons, Deena/0000-0002-7953-3576; HAYDAY, ADRIAN/0000-0002-9495-5793; Klein, Nigel/0000-0003-3925-9258; Michel, Marie-Laure/0000-0003-2657-4662; Sebire, Neil/0000-0001-5348-9063	Barts; London Charity; UK National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC); GOSH Children's charity; Guy's and St. Thomas', charity; NIHR Biomedical Research Centre at Guy's; St. Thomas', Hospital and King's College; Wellcome Trust Programme Grant; Great Ormond Street Hospital Childrens Charity [V1303] Funding Source: researchfish	Barts; London Charity; UK National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC); GOSH Children's charity; Guy's and St. Thomas', charity; NIHR Biomedical Research Centre at Guy's(National Institute for Health Research (NIHR)); St. Thomas', Hospital and King's College; Wellcome Trust Programme Grant(Wellcome Trust); Great Ormond Street Hospital Childrens Charity	We thank P. Hunter for helpful discussions, T. Hayday for flow cytometry, K. Rouault-Pierre (London Research Institute, Cancer Research UK) for cord blood, Pierre Vantourout (London Research Institute, Cancer Research UK) for gamma delta T cell lines, M. Greaves for advice on T-ALL, P. Chakravarty for microarray analysis and M. Leite-de-Moraes for support of mouse studies. P.F. was funded by a strategic research grant from the Barts and the London Charity, A.V. and N.J.S. by the UK National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC), N.J.S. partly by GOSH Children's charity, and D.G., R.C. and A.H. by the Guy's and St. Thomas', charity, the NIHR Biomedical Research Centre at Guy's and St. Thomas', Hospital and King's College, and by a Wellcome Trust Programme Grant to A.H.	Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; Carr R, 2013, ARCH DIS CHILD-FETAL, V98, pF192, DOI 10.1136/archdischild-2011-301269; Carr R, 2009, LANCET, V373, P226, DOI 10.1016/S0140-6736(09)60071-4; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Dagna L, 2002, EUR J IMMUNOL, V32, P2934, DOI 10.1002/1521-4141(2002010)32:10<2934::AID-IMMU2934>3.0.CO;2-6; De Rosa SC, 2004, J IMMUNOL, V172, P1637, DOI 10.4049/jimmunol.172.3.1637; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hebel K, 2014, J IMMUNOL, V192, P5160, DOI 10.4049/jimmunol.1302539; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Himmel ME, 2011, EUR J IMMUNOL, V41, P306, DOI 10.1002/eji.201040459; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Khalaf Hazem, 2013, Int J Biochem Mol Biol, V4, P150; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kyriakakis E, 2010, EUR J IMMUNOL, V40, P3268, DOI 10.1002/eji.201040619; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Levy E, 2009, PEDIATR RES, V66, P179, DOI 10.1203/PDR.0b013e3181a9f41b; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Panero A, 1997, PEDIATR INFECT DIS J, V16, P370, DOI 10.1097/00006454-199704000-00007; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Schaerli P, 2004, J IMMUNOL, V173, P2151, DOI 10.4049/jimmunol.173.3.2151; SCHRODER JM, 1988, J IMMUNOL, V140, P3534; Sharma N, 2013, J LEUKOCYTE BIOL, V93, P521, DOI 10.1189/jlb.0712328; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Thornton NL, 2012, NEONATOLOGY, V101, P140, DOI 10.1159/000330567; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	33	122	123	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1206	1210		10.1038/nm.3670	http://dx.doi.org/10.1038/nm.3670			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25242415				2022-12-25	WOS:000343194100033
J	Selvadurai, K; Wang, P; Seimetz, J; Huang, RH				Selvadurai, Kiruthika; Wang, Pei; Seimetz, Joseph; Huang, Raven H.			Archaeal Elp3 catalyzes tRNA wobble uridine modification at C5 via a radical mechanism	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE ACETYLTRANSFERASE; ELONGATOR; PROTEIN; HOLOENZYME; EXPRESSION; DOMAIN; SAM	Approximately 25% of cytoplasmic tRNAs in eukaryotic organisms have the wobble uridine (U34) modified at C5 through a process that, according to genetic studies, is carried out by the eukaryotic Elongator complex. Here we show that a single archaeal protein, the homolog of the third subunit of the eukaryotic Elongator complex (Elp3), is able to catalyze the same reaction. The mechanism of action by Elp3 described here represents unprecedented chemistry performed on acetyl-CoA.	[Selvadurai, Kiruthika; Wang, Pei; Seimetz, Joseph; Huang, Raven H.] Univ Illinois, Dept Biochem, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Huang, RH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61820 USA.	huang@illinois.edu			US National Institute of Health [GM107533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107533] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by US National Institute of Health (GM107533 to R.H.H.). We thank Y. Fu and C. He (University of Chicago) for providing us with the synthetic cm<SUP>5</SUP>U, F. Sun for assistance with ESI-LC/MS, J. Li and E. Oldfield for assistance with EPR and J. Imlay for the initial use of an anaerobic chamber.	Bauer F, 2012, CELL REPORTS, V1, P424, DOI 10.1016/j.celrep.2012.04.001; Broussard TC, 2013, BIOCHEMISTRY-US, V52, P3346, DOI 10.1021/bi4000707; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Fichtner L, 2002, MOL MICROBIOL, V45, P817, DOI 10.1046/j.1365-2958.2002.03055.x; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Ragab AE, 2011, J AM CHEM SOC, V133, P15288, DOI 10.1021/ja206163j; Singh N, 2010, J NEUROCHEM, V115, P493, DOI 10.1111/j.1471-4159.2010.06892.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X	23	73	75	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					810	+		10.1038/NCHEMBIO.1610	http://dx.doi.org/10.1038/NCHEMBIO.1610			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25151136	Green Accepted			2022-12-25	WOS:000342462100005
J	Keener, AB				Keener, Amanda B.			Oldie but goodie: Repurposing penicillin for tuberculosis	NATURE MEDICINE			English	News Item							MEROPENEM-CLAVULANATE; AMOXICILLIN; COMBINATION; ACID											Center for Healthcare Research & Transformation, 2011, ANT PRESCR US; Chambers HF, 1998, CLIN INFECT DIS, V26, P874, DOI 10.1086/513945; CYNAMON MH, 1983, ANTIMICROB AGENTS CH, V24, P429, DOI 10.1128/AAC.24.3.429; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; De Lorenzo S, 2013, EUR RESPIR J, V41, P1386, DOI 10.1183/09031936.00124312; Doctors Without Borders, 2013, DOCT BORD DR TB DRUG; Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954; Hazra S, 2014, BIOCHEMISTRY-US, V53, P3671, DOI 10.1021/bi500339j; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Iwanaga T, 1997, Kekkaku, V72, P9; NADLER JP, 1991, CHEST, V99, P1025, DOI 10.1378/chest.99.4.1025; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Payen MC, 2012, INT J TUBERC LUNG D, V16, P558, DOI 10.5588/ijtld.11.0414; Zeliadt N, 2014, NAT MED, V20, P692, DOI 10.1038/nm0714-692	14	20	20	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					976	978		10.1038/nm0914-976	http://dx.doi.org/10.1038/nm0914-976			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25198041	Bronze			2022-12-25	WOS:000341404000005
J	Wang, YP; Cheng, X; Shan, QW; Zhang, Y; Liu, JX; Gao, CX; Qiu, JL				Wang, Yanpeng; Cheng, Xi; Shan, Qiwei; Zhang, Yi; Liu, Jinxing; Gao, Caixia; Qiu, Jin-Long			Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; TARGETED MUTAGENESIS; PLANTS; GENE; ARABIDOPSIS; SYSTEM; SPECIFICITY; EFFECTORS; TALEN; RICE	Sequence-specific nucleases have been applied to engineer targeted modifications in polyploid genomes(1), but simultaneous modification of multiple homoeoalleles has not been reported. Here we use transcription activator like effector nuclease (TALEN)(2,3) and clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 (refs. 4,5) technologies in hexaploid bread wheat to introduce targeted mutations in the three homoeoalleles that encode MILDEW-RESISTANCE LOCUS (MLO) proteins(6). Genetic redundancy has prevented evaluation of whether mutation of all three MLO alleles in bread wheat might confer resistance to powdery mildew, a trait not found in natural populations(7). We show that TALEN-induced mutation of all three TaMLO homoeologs in the same plant confers heritable broad-spectrum resistance to powdery mildew. We further use CRISPR-Cas9 technology to generate transgenic wheat plants that carry mutations in the TaMLO-A1 allele. We also demonstrate the feasibility of engineering targeted DNA insertion in bread wheat through nonhomologous end joining of the double-strand breaks caused by TALENs. Our findings provide a methodological framework to improve polyploid crops.	[Wang, Yanpeng; Shan, Qiwei; Zhang, Yi; Liu, Jinxing; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Cheng, Xi; Qiu, Jin-Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, CX (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	cxgao@genetics.ac.cn; qiujl@im.ac.cn	Gao, Caixia/AAG-8577-2019; Wang, Yanpeng/ABE-8732-2020	Gao, Caixia/0000-0003-3169-8248; Qiu, Jin-Long/0000-0001-8054-2552; Zhang, Yi/0000-0002-0745-3497	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030500]; National Basic Research Program of China (973 Program) [2011CB100702]; National Natural Science Foundation of China [31271795]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank D. Wang for critical reading of the manuscript and providing the E22 and B13 strains, Q. Shen for providing E09 strain, and T. Li for technical support in flow cytometry (all three are at the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences). This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB11030500) and the National Basic Research Program of China (973 Program, 2011CB100702) to J.-L.Q. and a grant to C.G. from the National Natural Science Foundation of China (31271795).	Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dvorak J, 2009, PLANT GENET GENOMICS, V7, P685, DOI 10.1007/978-0-387-77489-3_23; Elliott C, 2002, MOL PLANT MICROBE IN, V15, P1069, DOI 10.1094/MPMI.2002.15.10.1069; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Varallyay E, 2012, ARCH VIROL, V157, P1345, DOI 10.1007/s00705-012-1286-y; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107	27	1017	1175	42	793	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					947	951		10.1038/nbt.2969	http://dx.doi.org/10.1038/nbt.2969			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25038773				2022-12-25	WOS:000342600300035
J	Duellberg, C; Trokter, M; Jha, R; Sen, I; Steinmetz, MO; Surrey, T				Duellberg, Christian; Trokter, Martina; Jha, Rupam; Sen, Indrani; Steinmetz, Michel O.; Surrey, Thomas			Reconstitution of a hierarchical plus TIP interaction network controlling microtubule end tracking of dynein	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC LINKER PROTEIN-170; LOCALIZATION SIGNAL; STRUCTURAL BASIS; MAMMALIAN-CELLS; IN-VITRO; DYNACTIN; CLIP-170; P150(GLUED); EB1; TRANSPORT	Growing microtubule end regions recruit a variety of proteins collectively termed +TIPs, which confer local functions to the microtubule cytoskeleton. +TIPs form dynamic interaction networks whose behaviour depends on a number of potentially competitive and hierarchical interaction modes. The rules that determine which of the various +TIPs are recruited to the limited number of available binding sites at microtubule ends remain poorly understood. Here we examined how the human dynein complex, the main minus-end-directed motor and an important +TIP (refs 2-4), is targeted to growing microtubule ends in the presence of different +TIP competitors. Using a total internal reflection fluorescence microscopy-based reconstitution assay, we found that a hierarchical recruitment mode targets the large dynactin subunit p150Glued to growing microtubule ends via EB1 and CLIP-170 in the presence of competing SxIP-motif-containing peptides. We further show that the human dynein complex is targeted to growing microtubule ends through an interaction of the tail domain of dynein with p150Glued. Our results highlight how the connectivity and hierarchy within dynamic +TIP networks are orchestrated.	[Duellberg, Christian; Trokter, Martina; Jha, Rupam; Surrey, Thomas] Canc Res UK London Res Inst, London WC2A 3LY, England; [Duellberg, Christian; Trokter, Martina; Surrey, Thomas] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Sen, Indrani; Steinmetz, Michel O.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland	Cancer Research UK; European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Surrey, T (corresponding author), Canc Res UK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	thomas.surrey@cancer.org.uk	Steinmetz, Michel O/AAA-3349-2022; Surrey, Thomas/AAC-4608-2021	Steinmetz, Michel O/0000-0001-6157-3687; Surrey, Thomas/0000-0001-9082-1870; Jha, Rupam/0000-0003-0332-2542	European Research Council (ERC) [323042]; German Research Foundation [DFG SU 175/7-1]; Swiss National Science Foundation [310030B_138659]; Cancer Research UK [14256] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	We thank R. M. Buey for cloning of the p150-GCN4 construct, I. Luke for help with insect cell culture and protein expressions, the Peptide Chemistry facility LRI for peptide synthesis, J. Roostalu for Atto488-labelled tubulin, N. Cade for microscopy support and critical reading of the manuscript, and H. Walden for useful advice on protein purification. C.D. and T.S. acknowledge financial support from the European Research Council (ERC project ID 323042) and the German Research Foundation (DFG SU 175/7-1). M.O.S. is supported by a grant from the Swiss National Science Foundation (310030B_138659).	Ahmed S, 2010, BIOCHEMISTRY-US, V49, P5083, DOI 10.1021/bi100235z; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Buey RM, 2012, J BIOL CHEM, V287, P28227, DOI 10.1074/jbc.M112.373928; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007827; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Lesniewska K, 2014, MOL BIOL CELL, V25, P1025, DOI 10.1091/mbc.E13-08-0504; Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Moore JK, 2009, CELL MOTIL CYTOSKEL, V66, P546, DOI 10.1002/cm.20364; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Weng JH, 2013, NAT CHEM BIOL, V9, P636, DOI [10.1038/NCHEMBIO.1321, 10.1038/nchembio.1321]; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zhapparova ON, 2009, TRAFFIC, V10, P1635, DOI 10.1111/j.1600-0854.2009.00976.x	45	69	70	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					804	U314		10.1038/ncb2999	http://dx.doi.org/10.1038/ncb2999			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	24997520				2022-12-25	WOS:000339904900012
J	Cooper, CS; Eeles, R; Wedge, DC; Van Loo, P; Gundem, G; Alexandrov, LB; Kremeyer, B; Butler, A; Lynch, AG; Camacho, N; Massie, CE; Kay, J; Luxton, HJ; Edwards, S; Kote-Jarai, Z; Dennis, N; Merson, S; Leongamornlert, D; Zamora, J; Corbishley, C; Thomas, S; Nik-Zainal, S; O'Meara, S; Matthews, L; Clark, J; Hurst, R; Mithen, R; Bristow, RG; Boutros, PC; Fraser, M; Cooke, S; Raine, K; Jones, D; Menzies, A; Stebbings, L; Hinton, J; Teague, J; McLaren, S; Mudie, L; Hardy, C; Anderson, E; Joseph, O; Goody, V; Robinson, B; Maddison, M; Gamble, S; Greenman, C; Berney, D; Hazell, S; Livni, N; Fisher, C; Ogden, C; Kumar, P; Thompson, A; Woodhouse, C; Nicol, D; Mayer, E; Dudderidge, T; Shah, NC; Gnanapragasam, V; Voet, T; Campbell, P; Futreal, A; Easton, D; Warren, AY; Foster, CS; Stratton, MR; Whitaker, HC; McDermott, U; Brewer, DS; Neal, DE				Cooper, Colin S.; Eeles, Rosalind; Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Lynch, Andrew G.; Camacho, Niedzica; Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Edwards, Sandra; Kote-Jarai, Zsofia; Dennis, Nening; Merson, Sue; Leongamornlert, Daniel; Zamora, Jorge; Corbishley, Cathy; Thomas, Sarah; Nik-Zainal, Serena; O'Meara, Sarah; Matthews, Lucy; Clark, Jeremy; Hurst, Rachel; Mithen, Richard; Bristow, Robert G.; Boutros, Paul C.; Fraser, Michael; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Greenman, Christopher; Berney, Dan; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim; Shah, Nimish C.; Gnanapragasam, Vincent; Voet, Thierry; Campbell, Peter; Futreal, Andrew; Easton, Douglas; Warren, Anne Y.; Foster, Christopher S.; Stratton, Michael R.; Whitaker, Hayley C.; McDermott, Ultan; Brewer, Daniel S.; Neal, David E.		ICGC Prostate Grp	Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue	NATURE GENETICS			English	Article							COPY-NUMBER ANALYSIS; 21 BREAST CANCERS; MUTATIONAL PROCESSES; RADICAL PROSTATECTOMY; LANDSCAPE; GENOMES; HETEROGENEITY; ALGORITHMS; SIGNATURES; EVOLUTION	Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men. Mutations were present at high levels in morphologically normal tissue distant from the cancer, reflecting clonal expansions, and the underlying mutational processes at work in morphologically normal tissue were also at work in cancer. Our observations demonstrate the existence of ongoing abnormal mutational processes, consistent with field effects, underlying carcinogenesis. This mechanism gives rise to extensive branching evolution and cancer clone mixing, as exemplified by the coexistence of multiple cancer lineages harboring distinct ERG fusions within a single cancer nodule. Subsets of mutations were shared either by morphologically normal and malignant tissues or between different ERG lineages, indicating earlier or separate clonal cell expansions. Our observations inform on the origin of multifocal disease and have implications for prostate cancer therapy in individual cases.	[Cooper, Colin S.; Eeles, Rosalind; Camacho, Niedzica; Edwards, Sandra; Kote-Jarai, Zsofia; Merson, Sue; Leongamornlert, Daniel; Matthews, Lucy; Brewer, Daniel S.] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Cooper, Colin S.] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin S.; Clark, Jeremy; Hurst, Rachel; Brewer, Daniel S.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, London, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Zamora, Jorge; Nik-Zainal, Serena; O'Meara, Sarah; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Campbell, Peter; Futreal, Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Leuven, Belgium; [Van Loo, Peter] Canc Res UK London Res Inst, London WC2A 3PX, England; [Lynch, Andrew G.] Canc Res UK Cambridge Res Inst, Stat & Computat Biol Lab, Cambridge, England; [Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Shah, Nimish C.; Gnanapragasam, Vincent; Whitaker, Hayley C.; Neal, David E.] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge, England; [Corbishley, Cathy] St George Hosp, Dept Histopathol, London, England; [Mithen, Richard] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Greenman, Christopher] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Berney, Dan] Barts & London Queen Marys Sch Med & Dent, Barts Canc Ctr, Dept Mol Oncol, London, England; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Leuven, Belgium; [Easton, Douglas] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Warren, Anne Y.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Foster, Christopher S.] Univ Liverpool, Dept Histopathol, Liverpool L69 3BX, Merseyside, England; [Foster, Christopher S.] HCA Pathol Labs, London, England; [Brewer, Daniel S.] Genome Anal Ctr, Norwich, Norfolk, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 2QQ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of East Anglia; University of East Anglia; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; Cancer Research UK; Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute; St Georges University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of East Anglia; University of London; Queen Mary University London; KU Leuven; University of Cambridge; University of Cambridge; University of Liverpool; The Genome Analysis Centre (TGAC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cooper, CS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England.	colin.cooper@icr.ac.uk; ros.eeles@icr.ac.uk; den22@medschl.cam.ac.uk	Luxton, Hayley/AAT-2450-2020; Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Dudderidge, Tim/AAO-1430-2020; Alexandrov, Ludmil/AAS-1454-2021; Nicol, David L/M-6809-2016; Brewer, Daniel S/D-6201-2018; Voet, Thierry/E-8877-2017; Mayer, Erik K/A-6207-2013; Kay, Jonathan/HGE-1248-2022; Gamble, Stephen/D-1417-2011	Luxton, Hayley/0000-0003-1431-3844; Alexandrov, Ludmil/0000-0003-3596-4515; Nicol, David L/0000-0002-5623-7467; Brewer, Daniel S/0000-0003-4753-9794; Voet, Thierry/0000-0003-1204-9963; Mayer, Erik K/0000-0002-5509-4580; Gamble, Stephen/0000-0002-0867-3723; Berney, Daniel/0000-0001-5474-8696; Bristow, Robert/0000-0002-8553-9544; Dudderidge, Tim/0000-0001-6373-3613; McDermott, Ultan/0000-0001-9032-4700; Mithen, Richard/0000-0001-7307-4324; Raine, Keiran/0000-0002-5634-1539; Eeles, Rosalind/0000-0002-3698-6241; Nicol, David/0000-0003-0107-6990; Bova, George/0000-0003-1639-3104; Lynch, Andy/0000-0002-7876-7338; Massie, Charlie/0000-0003-2314-4843; Wedge, David/0000-0002-7572-3196; Boutros, Paul/0000-0003-0553-7520; Nik-Zainal, Serena/0000-0001-5054-1727; Van Loo, Peter/0000-0003-0292-1949; Leongamornlert, Daniel/0000-0002-3486-3168; Hurst, Rachel/0000-0001-8066-324X	Cancer Research UK [C5047/A14835]; Dallaglio Foundation; Wellcome Trust; Bob Champion Cancer Trust; Orchid Cancer Appeal; RoseTrees Trust; North West Cancer Research Fund; Big C; King family; Grand Charity of Freemasons; Research Foundation Flanders (FWO); Biomedical Research Centre at the Institute of Cancer Research - National Institute for Health Research; Royal Marsden NHS Foundation Trust - National Institute for Health Research; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042686, BBS/E/T/000PR5885, BBS/E/T/000PR6193, BBS/E/F/00044431] Funding Source: researchfish; Cancer Research UK [14835, 15007, 17528] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; BBSRC [BBS/E/F/00042686, BBS/E/F/00044431, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Dallaglio Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Bob Champion Cancer Trust; Orchid Cancer Appeal; RoseTrees Trust(Rosetrees Trust); North West Cancer Research Fund; Big C; King family; Grand Charity of Freemasons; Research Foundation Flanders (FWO)(FWO); Biomedical Research Centre at the Institute of Cancer Research - National Institute for Health Research; Royal Marsden NHS Foundation Trust - National Institute for Health Research; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Cancer Research UK (grant C5047/A14835), the Dallaglio Foundation and the Wellcome Trust. We also acknowledge support from the Bob Champion Cancer Trust, the Orchid Cancer Appeal, the RoseTrees Trust, the North West Cancer Research Fund, Big C, the King family, the Grand Charity of Freemasons, and the Research Foundation Flanders (FWO). We thank D. Holland from the Infrastructure Management Team and P. Clapham from the Informatics Systems Group at the Wellcome Trust Sanger Institute. We acknowledge the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, supported by the National Institute for Health Research. We acknowledge support from the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant G0500966/75466). We thank the National Institute for Health Research, Hutchison Whampoa Limited and the Human Research Tissue Bank (Addenbrooke's Hospital), the Cancer Research UK Cambridge Research Institute Histopathology, the In-situ Hybridisation Core Facility, the Genomics Core Facility Cambridge and the Cambridge University Hospitals Media Studio.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Karavitakis M, 2011, NAT REV CLIN ONCOL, V8, P48, DOI 10.1038/nrclinonc.2010.190; Kobayashi M, 2008, PROSTATE, V68, P1715, DOI 10.1002/pros.20832; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Mucci NR, 2000, J NATL CANCER I, V92, P1941, DOI 10.1093/jnci/92.23.1941; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Svensson MA, 2011, LAB INVEST, V91, P404, DOI 10.1038/labinvest.2010.179; Tareen Basir, 2009, Rev Urol, V11, P203; Tsai MF, 2007, NUCLEIC ACIDS RES, V35, pW63, DOI 10.1093/nar/gkm383; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Warren AY, 2013, PROSTATE, V73, P194, DOI 10.1002/pros.22556; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	281	283	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					367	U118		10.1038/ng.3221	http://dx.doi.org/10.1038/ng.3221			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730763	Green Accepted, Green Submitted			2022-12-25	WOS:000351922900012
J	Schwarz, EM; Hu, Y; Antoshechkin, I; Miller, MM; Sternberg, PW; Aroian, RV				Schwarz, Erich M.; Hu, Yan; Antoshechkin, Igor; Miller, Melanie M.; Sternberg, Paul W.; Aroian, Raffi V.			The genome and transcriptome of the zoonotic hookworm Ancylostoma ceylanicum identify infection-specific gene families	NATURE GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; C-TYPE LECTIN; HAMSTERS MESOCRICETUS-AURATUS; RNA-SEQ; HELIGMOSOMOIDES-POLYGYRUS; HAEMONCHUS-CONTORTUS; HELMINTH INFECTIONS; FILARIAL PARASITE; HOST; CAENORHABDITIS	Hookworms infect over 400 million people, stunting and impoverishing them(1-3). Sequencing hookworm genomes and finding which genes they express during infection should help in devising new drugs or vaccines against hookworms(4,5). Unlike other hookworms, Ancylostoma ceylanicum infects both humans and other mammals, providing a laboratory model for hookworm disease(6,7). We determined an A. ceylanicum genome sequence of 313 Mb, with transcriptomic data throughout infection showing expression of 30,738 genes. Approximately 900 genes were upregulated during early infection in vivo, including ASPRs, a cryptic subfamily of activation-associated secreted proteins (ASPs) (8). Genes downregulated during early infection included ion channels and G protein-coupled receptors; this downregulation was observed in both parasitic and free-living nematodes. Later, at the onset of heavy blood feeding, C-lectin genes were upregulated along with genes for secreted clade V proteins (SCVPs), encoding a previously undescribed protein family. These findings provide new drug and vaccine targets and should help elucidate hookworm pathogenesis.	[Schwarz, Erich M.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Hu, Yan; Aroian, Raffi V.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Hu, Yan; Miller, Melanie M.; Aroian, Raffi V.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Antoshechkin, Igor; Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Cornell University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Schwarz, EM (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ems394@cornell.edu		Sternberg, Paul/0000-0002-7699-0173; Schwarz, Erich/0000-0003-3151-4381	US Department of Agriculture [2010-65205-20361]; National Institute of Food and Agriculture [IOS-0923812]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084389] Funding Source: NIH RePORTER	US Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.T. Brown, P.K. Korhonen, S. Kumar and J.E. Stajich for advice on bioinformatics, T.A. Aydin, J. Liu and A.H.K. Roeder for comments on the manuscript, L. Schaeffer and V. Kumar for genome and RNA sequencing, and C.T. Brown for use of the Michigan State University High-Performance Computing Center (supported by grant 2010-65205-20361 from the US Department of Agriculture and grant IOS-0923812 from the National Institute of Food and Agriculture and the National Science Foundation).	Abubucker S, 2008, MOL BIOCHEM PARASIT, V157, P187, DOI 10.1016/j.molbiopara.2007.11.001; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashrafian H, 2007, CARDIOVASC DRUG REV, V25, P76, DOI 10.1111/j.1527-3466.2007.00006.x; BANSEMIR AD, 1994, J PARASITOL, V80, P24, DOI 10.2307/3283340; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Borloo J, 2013, J PROTEOME RES, V12, P3900, DOI 10.1021/pr400114y; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; Brown C.T., 2012, SINGLE PASS APPROACH; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Capella-Gutierrez S., 2009, BIOINFORMATICS, V25, P1972; Chilton NB, 2006, MOL PHYLOGENET EVOL, V40, P118, DOI 10.1016/j.ympev.2006.01.003; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Crowther GJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002628; Danchin EGJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00027; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; DURETTEDESSET MC, 1994, INT J PARASITOL, V24, P1139, DOI 10.1016/0020-7519(94)90188-0; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farelli JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004245; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Fyfe PK, 2010, ACTA CRYSTALLOGR D, V66, P881, DOI 10.1107/S0907444910020081; GARSIDE P, 1989, PARASITOLOGY, V98, P283, DOI 10.1017/S003118200006220X; Gems D, 2000, BIOGERONTOLOGY, V1, P289, DOI 10.1023/A:1026546719091; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilleard JS, 2013, PARASITOLOGY, V140, P1506, DOI 10.1017/S0031182013001145; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; He HL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-97; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hu Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001900; Huang SF, 2012, GENOME RES, V22, P1581, DOI 10.1101/gr.133652.111; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Jian X, 2003, EXP PARASITOL, V105, P192, DOI 10.1016/j.exppara.2003.12.016; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim DH, 2013, NAT GENET, V45, P1337, DOI 10.1038/ng.2763; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Knox D., 2012, PARASITIC HELMINTHS, P399; Laha T, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000035; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loukas A, 2000, PARASITOLOGY, V121, P545, DOI 10.1017/S0031182099006721; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; McDowall J, 2011, METHODS MOL BIOL, V694, P37, DOI 10.1007/978-1-60761-977-2_3; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; MENON S, 1985, J HELMINTHOL, V59, P143, DOI 10.1017/S0022149X00025724; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Osman A, 2012, BIOTECHNOL ADV, V30, P652, DOI 10.1016/j.biotechadv.2011.11.002; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Ranjit N, 2009, J INFECT DIS, V199, P904, DOI 10.1086/597048; RAY DK, 1972, J HELMINTHOL, V46, P357, DOI 10.1017/S0022149X00023361; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schneider B, 2011, HUM VACCINES, V7, P1234, DOI 10.4161/hv.7.11.18443; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Sivendran S, 2010, BIOORGAN MED CHEM, V18, P896, DOI 10.1016/j.bmc.2009.11.033; Somvanshi VS, 2014, MOL BIOCHEM PARASIT, V193, P1, DOI 10.1016/j.molbiopara.2013.12.002; Srinivasan J, 2013, GENETICS, V193, P1279, DOI 10.1534/genetics.112.148809; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tang YT, 2014, NAT GENET, V46, P261, DOI 10.1038/ng.2875; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003505; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wu B, 2013, P NATL ACAD SCI USA, V110, P7748, DOI 10.1073/pnas.1304049110; Yeates GW, 2006, NEMATOLOGY, V8, P111, DOI 10.1163/156854106776179881; Yoshida A, 2012, PARASITOL RES, V110, P1583, DOI 10.1007/s00436-011-2677-9; Zarowiecki M, 2015, PARASITOLOGY, V142, pS85, DOI 10.1017/S0031182014001449; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	103	65	68	0	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					416	U186		10.1038/ng.3237	http://dx.doi.org/10.1038/ng.3237			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730766	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000351922900022
J	Loh, PR; Tucker, G; Bulik-Sullivan, BK; Vilhjalmsson, BJ; Finucane, HK; Salem, RM; Chasman, DI; Ridker, PM; Neale, BM; Berger, B; Patterson, N; Price, AL				Loh, Po-Ru; Tucker, George; Bulik-Sullivan, Brendan K.; Vilhjalmsson, Bjarni J.; Finucane, Hilary K.; Salem, Rany M.; Chasman, Daniel I.; Ridker, Paul M.; Neale, Benjamin M.; Berger, Bonnie; Patterson, Nick; Price, Alkes L.			Efficient Bayesian mixed-model analysis increases association power in large cohorts	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; STRUCTURED POPULATIONS; GENETIC ASSOCIATION; COMMON SNPS; PREDICTION; STRATIFICATION; REGRESSION; ALGORITHM; INFERENCE	Linear mixed models are a powerful statistical tool for identifying genetic associations and avoiding confounding. However, existing methods are computationally intractable in large cohorts and may not optimize power. All existing methods require time cost O(MN2) (where N is the number of samples and M is the number of SNPs) and implicitly assume an infinitesimal genetic architecture in which effect sizes are normally distributed, which can limit power. Here we present a far more efficient mixed-model association method, BOLT-LMM, which requires only a small number of O(MN) time iterations and increases power by modeling more realistic, non-infinitesimal genetic architectures via a Bayesian mixture prior on marker effect sizes. We applied BOLT-LMM to 9 quantitative traits in 23,294 samples from the Women's Genome Health Study (WGHS) and observed significant increases in power, consistent with simulations. Theory and simulations show that the boost in power increases with cohort size, making BOLT-LMM appealing for genome-wide association studies in large cohorts.	[Loh, Po-Ru; Tucker, George; Vilhjalmsson, Bjarni J.; Price, Alkes L.] Harvard IH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Loh, Po-Ru; Bulik-Sullivan, Brendan K.; Vilhjalmsson, Bjarni J.; Salem, Rany M.; Neale, Benjamin M.; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Progrram Med & Populat Genet, Cambridge, MA USA; [Tucker, George; Finucane, Hilary K.; Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Tucker, George; Berger, Bonnie] Comp Sci & Artificial Intelligence Lab, Cambridge, MA USA; [Bulik-Sullivan, Brendan K.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Salem, Rany M.] Childrens Hosp Boston, Dept Endocrinol, Boston, MA USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Loh, PR (corresponding author), Harvard IH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	loh@hsph.harvard.edu; aprice@hsph.harvard.edu	Vilhjálmsson, Bjarni/ABC-1369-2020; Vilhjalmsson, Bjarni/K-3971-2014	Vilhjálmsson, Bjarni/0000-0003-2277-9249; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Salem, Rany/0000-0001-8816-6862	US National Institutes of Health [R01 HG006399]; US National Institutes of Health fellowship [F32 HG007805]; Fannie and John Hertz Foundation; National Heart, Lung, and Blood Institute [HL043851, HL080467]; National Cancer Institute [CA047988]; Donald W. Reynolds Foundation; Fondation Leducq; Amgen; NATIONAL CANCER INSTITUTE [R01CA047988, UM1CA182913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122515, R01HL043851, R01HL080467] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, F32HG007805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); Amgen(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Lipson, S. Simmons, A. Gusev, K. Galinsky, J. Yang, P. Visscher, Z. Zhu and D. Gudbjartsson for helpful discussions. This research was supported by US National Institutes of Health grant R01 HG006399 and US National Institutes of Health fellowship F32 HG007805. H.K.F. was supported by the Fannie and John Hertz Foundation. The WGHS is supported by HL043851 and grants HL080467 from the National Heart, Lung, and Blood Institute and grant CA047988 from the National Cancer Institute, by the Donald W. Reynolds Foundation and by the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen.	Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Boyd S., 2004, CONVEX OPTIMIZATION; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; GARCIACORTES LA, 1992, J ANIM BREED GENET, V109, P358, DOI 10.1111/j.1439-0388.1992.tb00415.x; Hayeck T., 2014, BIORXIV, DOI [10.1101/008755, DOI 10.1101/008755]; Jakobsdottir J, 2013, AM J HUM GENET, V92, P652, DOI 10.1016/j.ajhg.2013.03.014; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Legarra A, 2008, J DAIRY SCI, V91, P360, DOI 10.3168/jds.2007-0403; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01815; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Logsdon BA, 2012, BIOINFORMATICS, V28, P1738, DOI 10.1093/bioinformatics/bts261; Logsdon BA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-58; Matilainen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080821; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rakitsch B, 2013, BIOINFORMATICS, V29, P206, DOI 10.1093/bioinformatics/bts669; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tucker G, 2014, GENETICS, V197, P1045, DOI 10.1534/genetics.114.164285; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	48	647	661	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					284	+		10.1038/ng.3190	http://dx.doi.org/10.1038/ng.3190			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25642633	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000350327900022
J	Tullman-Ercek, D				Tullman-Ercek, Danielle			METABOLISM 'Channeling' Hans Krebs	NATURE CHEMICAL BIOLOGY			English	Editorial Material								The physical arrangement of enzymes within native metabolic pathways is emerging as an important but underexplored area of molecular biology. Recent advances in mass spectrometry enabled confirmation of the proposal that the Krebs cycle enzymes form a complex and suggest that substrate channeling is the most likely benefit to this structural arrangement.	Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Tullman-Ercek, D (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	dtercek@berkeley.edu	Tullman-Ercek, Danielle/L-2792-2016					Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Hu YL, 2013, BBA-BIOENERGETICS, V1827, P1112, DOI 10.1016/j.bbabio.2012.12.001; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Khosla C, 2014, BIOCHEMISTRY-US, V53, P2875, DOI 10.1021/bi500290t; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Moehlenbrock MJ, 2010, J AM CHEM SOC, V132, P6288, DOI 10.1021/ja101326b; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Walter H., 1999, INT REV CYTOL, V192, P255; Wu F, 2015, ANGEW CHEM INT EDIT, V54, P1851, DOI 10.1002/anie.201409336	10	6	6	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					180	181		10.1038/nchembio.1758	http://dx.doi.org/10.1038/nchembio.1758			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25689335				2022-12-25	WOS:000349840500004
J	Elliott, H; Fischer, RS; Myers, KA; Desai, RA; Gao, L; Chen, CS; Adelstein, RS; Waterman, CM; Danuser, G				Elliott, Hunter; Fischer, Robert S.; Myers, Kenneth A.; Desai, Ravi A.; Gao, Lin; Chen, Christopher S.; Adelstein, Robert S.; Waterman, Clare M.; Danuser, Gaudenz			Myosin II controls cellular branching morphogenesis and migration in three dimensions by minimizing cell-surface curvature	NATURE CELL BIOLOGY			English	Article							PHOSPHORYLATION; MUTATIONS; MATRICES; KINASE	In many cases, cell function is intimately linked to cell shape control. We used endothelial cell branching morphogenesis as a model to understand the role of myosin II in shape control of invasive cells migrating in 3D collagen gels. We applied principles of differential geometry and mathematical morphology to 3D image sets to parameterize cell branch structure and local cell-surface curvature. We find that Rho/ROCK-stimulated myosin II contractility minimizes cell-scale branching by recognizing and minimizing local cell-surface curvature. Using microfabrication to constrain cell shape identifies a positive feedback mechanism in which low curvature stabilizes myosin II cortical association, where it acts to maintain minimal curvature. The feedback between regulation of myosin II by curvature and control of curvature by myosin II drives cycles of localized cortical myosin II assembly and disassembly. These cycles in turn mediate alternating phases of directionally biased branch initiation and retraction to guide 3D cell migration.	[Elliott, Hunter; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Fischer, Robert S.; Myers, Kenneth A.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Myers, Kenneth A.] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [Desai, Ravi A.; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Gao, Lin; Chen, Christopher S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Gao, Lin; Chen, Christopher S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Adelstein, Robert S.] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Boston University; Harvard University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fischer, RS (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	fischerr2@nhlbi.nih.gov; watermancm@nhlbi.nih.gov; gaudenz.danuser@utsouthwestern.edu	Chen, Christopher S./ABD-8499-2021	Chen, Christopher S./0000-0003-2445-8449; Desai, Ravi/0000-0002-4217-3351; Waterman, Clare/0000-0001-6142-6775; Fischer, Robert/0000-0003-0650-2696; Danuser, Gaudenz/0000-0001-8583-2014; Adelstein, Robert/0000-0002-8683-2144	NIH [R01 GM090317]; NHLBI Division of Intramural Research; NATIONAL CANCER INSTITUTE [R21CA124990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004228, ZIAHL005106, K22HL113069, ZIGHL006020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was initiated as a collaborative effort between R.S.E. and G.D. (NII I R2 1 CA124990). H.E. and G.D. are supported by NIH R01 GM090317. R.S.F, R.S.A., K.A.M. and C.M.W. are supported by the NHLBI Division of Intramural Research.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; Cornea ND, 2007, IEEE T VIS COMPUT GR, V13, P530, DOI 10.1109/TVCG.2007.1002; Dasanayake NL, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/036006; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Klein C, 2010, MICROSCOPY SCI TECHN, P772; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kubow KE, 2013, CURR BIOL, V23, P1607, DOI 10.1016/j.cub.2013.06.053; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palagyi K, 1999, GRAPH MODEL IM PROC, V61, P199, DOI 10.1006/gmip.1999.0498; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Surcel A, 2010, SEMIN CELL DEV BIOL, V21, P866, DOI 10.1016/j.semcdb.2010.08.003; Terasaki M, 2013, CELL, V154, P285, DOI 10.1016/j.cell.2013.06.031; Terry SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050188; Theisel H, 2004, 12TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, PROCEEDINGS, P288, DOI 10.1109/PCCGA.2004.1348359; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	31	78	78	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					137	+		10.1038/ncb3092	http://dx.doi.org/10.1038/ncb3092			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25621949	Green Submitted, Green Accepted			2022-12-25	WOS:000349152400005
J	Fox, JL				Fox, Jeffrey L.			Agricultural probiotics enter spotlight	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P211	1	10	10	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					122	122		10.1038/nbt0215-122	http://dx.doi.org/10.1038/nbt0215-122			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658267	Bronze			2022-12-25	WOS:000349198800007
J	Jin, L; Zhang, HN; Lu, YH; Yang, YH; Wu, KM; Tabashnik, BE; Wu, YD				Jin, Lin; Zhang, Haonan; Lu, Yanhui; Yang, Yihua; Wu, Kongming; Tabashnik, Bruce E.; Wu, Yidong			Large-scale test of the natural refuge strategy for delaying insect resistance to transgenic Bt crops	NATURE BIOTECHNOLOGY			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS; COTTON BOLLWORM; PEST RESISTANCE; CRY1AC COTTON; TOXIN; NOCTUIDAE; MAIZE; POPULATIONS	The 'natural refuge strategy' for delaying insect resistance to transgenic cotton that produces insecticidal proteins from Bacillus thuringiensis (Bt) relies on refuges of host plants other than cotton that do not make Bt toxins. We tested this widely adopted strategy by comparing predictions from modeling with data from a four-year field study of cotton bollworm (Helicoverpa armigera) resistance to transgenic cotton producing Bt toxin Cry1Ac in six provinces of northern China. Bioassay data revealed that the percentage of resistant insects increased from 0.93% in 2010 to 5.5% in 2013. Modeling predicted that the percentage of resistant insects would exceed 98% in 2013 without natural refuges, but would increase to only 1.1% if natural refuges were as effective as non-Bt cotton refuges. Therefore, the results imply that natural refuges delayed resistance, but were not as effective as an equivalent area of non-Bt cotton refuges. The percentage of resistant insects with nonrecessive inheritance of resistance increased from 37% in 2010 to 84% in 2013. Switching to Bt cotton producing two or more toxins and integrating other control tactics could slow further increases in resistance.	[Jin, Lin; Zhang, Haonan; Yang, Yihua; Wu, Yidong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Lu, Yanhui; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona	Wu, YD (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	wyd@njau.edu.cn	Jin, Lin/N-1361-2018; ZHANG, HAONAN/N-6395-2018; Wu, Yidong/E-9720-2012; Zhang, Haonan/J-2245-2019	Jin, Lin/0000-0002-5114-7139; ZHANG, HAONAN/0000-0003-1196-2750; Wu, Yidong/0000-0003-3456-3373; Zhang, Haonan/0000-0003-1196-2750; Lu, Yanhui/0000-0002-6552-0248	Ministry of Agriculture of China [2014ZX08012-004]; National Natural Science Foundation of China [31071983, 31321004]; 111 program of China [B07030]; US Department of Agriculture Biotechnology Risk Assessment Grants program [2011-33522-30729]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 program of China(Ministry of Education, China - 111 Project); US Department of Agriculture Biotechnology Risk Assessment Grants program	We thank M. Sisterson and three anonymous reviewers for their comments that improved the manuscript. This work was funded by grants from the Ministry of Agriculture of China (2014ZX08012-004), the National Natural Science Foundation of China (31071983 and 31321004), the 111 program of China (B07030) and the US Department of Agriculture Biotechnology Risk Assessment Grants program (2011-33522-30729). We thank M.P. Carey (Case Western Reserve University, USA) for providing activated Cry1Ac toxin.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Brevault T, 2012, EVOL APPL, V5, P53, DOI 10.1111/j.1752-4571.2011.00207.x; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gilbert N, 2013, NATURE, V497, P24, DOI 10.1038/497024a; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Gustafson DI, 2006, J ECON ENTOMOL, V99, P2116, DOI 10.1603/0022-0493-99.6.2116; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; James C., 2013, ISAAA BRIEFS; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Li GP, 2010, ENVIRON ENTOMOL, V39, P1698, DOI 10.1603/EN10077; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Ravi KC, 2005, ENVIRON ENTOMOL, V34, P59, DOI 10.1603/0046-225X-34.1.59; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; US Environmental Protection Agency, 2007, PEST NEWS STOR EPA A; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	50	129	157	5	181	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					169	174		10.1038/nbt.3100	http://dx.doi.org/10.1038/nbt.3100			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25503384				2022-12-25	WOS:000349198800022
J	Morrison, C				Morrison, Chris			Merck splashes on Cubist, antibiotics prospects brighten	NATURE BIOTECHNOLOGY			English	News Item																		2012, NAT BIOTECHNOL, V30, P735	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					120	121		10.1038/nbt0215-120	http://dx.doi.org/10.1038/nbt0215-120			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658265				2022-12-25	WOS:000349198800006
J	Kang, HM; Ahn, SH; Choi, P; Ko, YA; Han, SH; Chinga, F; Park, ASD; Tao, JL; Sharma, K; Pullman, J; Bottinger, EP; Goldberg, IJ; Susztak, K				Kang, Hyun Mi; Ahn, Seon Ho; Choi, Peter; Ko, Yi-An; Han, Seung Hyeok; Chinga, Frank; Park, Ae Seo Deok; Tao, Jian Ling; Sharma, Kumar; Pullman, James; Bottinger, Erwin P.; Goldberg, Ira J.; Susztak, Katalin			Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development	NATURE MEDICINE			English	Article							TO-MESENCHYMAL TRANSITION; LIPID-METABOLISM; DIABETIC-NEPHROPATHY; DISEASE; INJURY; MICE; INFLAMMATION; APOPTOSIS; ACCUMULATION; PROGRESSION	Renal fibrosis is the histological manifestation of a progressive, usually irreversible process causing chronic and end-stage kidney disease. We performed genome-wide transcriptome studies of a large cohort (n = 95) of normal and fibrotic human kidney tubule samples followed by systems and network analyses and identified inflammation and metabolism as the top dysregulated pathways in the diseased kidneys. In particular, we found that humans and mouse models with tubulointerstitial fibrosis had lower expression of key enzymes and regulators of fatty acid oxidation (FAO) and higher intracellular lipid deposition compared to controls. In vitro experiments indicated that inhibition of FAO in tubule epithelial cells caused ATP depletion, cell death, dedifferentiation and intracellular lipid deposition, phenotypes observed in fibrosis. In contrast, restoring fatty acid metabolism by genetic or pharmacological methods protected mice from tubulointerstitial fibrosis. Our results raise the possibility that correcting the metabolic defect in FAO may be useful for preventing and treating chronic kidney disease.	[Kang, Hyun Mi; Ahn, Seon Ho; Choi, Peter; Ko, Yi-An; Han, Seung Hyeok; Chinga, Frank; Park, Ae Seo Deok; Tao, Jian Ling; Susztak, Katalin] Univ Penn, Perelman Sch Med, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA; [Sharma, Kumar] Univ Calif San Diego, Dept Med, Vet Adm San Diego HealthCare Syst, Div Nephrol, San Diego, CA 92103 USA; [Pullman, James] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Bottinger, Erwin P.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Goldberg, Ira J.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center	Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA.	ksusztak@mail.med.upenn.edu	Han, Seung Hyeok/K-4559-2018; Susztak, Katalin/ABE-7474-2021; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Susztak, Katalin/0000-0002-1005-3726; Han, Seung Hyeok/0000-0001-7923-5635	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087635, R01DK076077]; Diabetic Complications Consortium (DiaComp) [DK076169]; US National Institutes of Health [HL45095, HL73029, DP3 DK 094352]; Juvenile Diabetes Research Foundation [3-2013-182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076077, R01DK087635] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetic Complications Consortium (DiaComp); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for this work was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK087635 and R01DK076077 to K. Susztak) and the Diabetic Complications Consortium (DiaComp, http://www.diacomp.org; grant DK076169 to K. Susztak and E.P.B.). I.J.G. is supported by US National Institutes of Health grants HL45095 and HL73029. K. Sharma is supported by US National Institutes of Health grant DP3 DK 094352. H.M.K. is supported by a post-doctoral fellowship from the Juvenile Diabetes Research Foundation (3-2013-182). We thank D. Melton (Harvard Medical School) for providing TRE-ICNotchl animals. We thank the Einstein (P60-DK020541) and Penn Diabetes Research Centers (P30-DK19525) for GC-FID and Seahorse measurements, respectively, and the Einstein Analytical imaging facility for the electron microscopy studies. Part of this work was presented at the Annual Nephrology Society Meetings in 2011 and 2013.	[Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jun M, 2012, J AM COLL CARDIOL, V60, P2061, DOI 10.1016/j.jacc.2012.07.049; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Khan S, 2014, J CLIN INVEST, V124, P1057, DOI 10.1172/JCI71863; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Kovesdy CP, 2007, J AM SOC NEPHROL, V18, P304, DOI 10.1681/ASN.2006060674; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li SY, 2009, KIDNEY INT, V76, P1049, DOI 10.1038/ki.2009.330; Meyer C, 1997, AM J PHYSIOL-ENDOC M, V273, pE650, DOI 10.1152/ajpendo.1997.273.3.E650; NATH KA, 1992, KIDNEY INT, V42, pS109; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; Portilla D, 2006, KIDNEY INT, V69, P2194, DOI 10.1038/sj.ki.5000433; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wanner C, 2007, J RENAL NUTR, V17, P75, DOI 10.1053/j.jrn.2006.10.012; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	40	684	706	13	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					37	46		10.1038/nm.3762	http://dx.doi.org/10.1038/nm.3762			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25419705	Green Accepted			2022-12-25	WOS:000348408000011
J	Schirner, K; Eun, YJ; Dion, M; Luo, Y; Helmann, JD; Garner, EC; Walker, S				Schirner, Kathrin; Eun, Ye-Jin; Dion, Mike; Luo, Yun; Helmann, John D.; Garner, Ethan C.; Walker, Suzanne			Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB	NATURE CHEMICAL BIOLOGY			English	Article							BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; STRESS RESPONSES; ACID; PEPTIDOGLYCAN; LOCALIZATION; MORPHOGENESIS; BIOSYNTHESIS; PROTEINS	The bacterial actin homolog MreB, which is crucial for rod shape determination, forms filaments that rotate around the cell width on the inner surface of the cytoplasmic membrane. What determines filament association with the membranes or with other cell wall elongation proteins is not known. Using specific chemical and genetic perturbations while following MreB filament motion, we find that MreB membrane association is an actively regulated process that depends on the presence of lipid-linked peptidoglycan precursors. When precursors are depleted, MreB filaments disassemble into the cytoplasm, and peptidoglycan synthesis becomes disorganized. In cells that lack wall teichoic acids but continue to make peptidoglycan, dynamic MreB filaments are observed, although their presence is not sufficient to establish a rod shape. We propose that the cell regulates MreB filament association with the membrane, allowing rapid and reversible inactivation of cell wall enzyme complexes in response to the inhibition of cell wall synthesis.	[Schirner, Kathrin; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Eun, Ye-Jin; Dion, Mike; Garner, Ethan C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Luo, Yun; Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Harvard University; Harvard Medical School; Harvard University; Cornell University	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	egarner@fas.harvard.edu; suzanne_walker@hms.harvard.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555; Dion, Michael/0000-0002-0434-4236; Eun, Ye Jin/0000-0002-4787-515X	US National Institutes of Health (NIH) [P01AI083214]; NIH [GM-047446, GM073831]; Smith Family Award; Searle Scholar Fellowship; DFG; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI117923, P01AI083214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, R01GM076710, R01GM047446] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Award; Searle Scholar Fellowship; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Meeske and D. Rudner (Harvard Medical School) for strains bEG275 and bKM424, K. Asai (Saitama University) for strain BSU2007, and P. Stoddard (Harvard University) for strain bPS01. We also thank S. Ringgaard and T. Bernhardt for critical reading of the manuscript. We are also grateful to Y. Brun for the fluorescent D-amino acids, and to T. Bottcher (Harvard Medical School) and H. Elliott (Harvard Image and Data Analysis Core) for the temporal variance algorithm. This work was funded by US National Institutes of Health (NIH) grant P01AI083214 (to S.W.), NIH grant GM-047446 (to J.D.H.), NIH grant GM073831 (to D. Rudner for initial support of E.C.G.). E.C.G. was also supported by the Smith Family Award and a Searle Scholar Fellowship. K.S. gratefully acknowledges the DFG for a Research Fellowship.	ANDERSON JS, 1967, J BIOL CHEM, V242, P3180; Asai K, 2008, J BACTERIOL, V190, P2633, DOI 10.1128/JB.01859-07; Bach JN, 2013, MOL MICROBIOL, V88, P1205, DOI 10.1111/mmi.12252; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Cao M, 2002, J BACTERIOL, V184, P6123, DOI 10.1128/JB.184.22.6123-6129.2002; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Ganchev DN, 2006, BIOCHEMISTRY-US, V45, P6195, DOI 10.1021/bi051913e; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Inoue H, 2013, BIOCHEM BIOPH RES CO, V436, P6, DOI 10.1016/j.bbrc.2013.04.064; Janas Teresa, 1994, Acta Biochimica Polonica, V41, P351; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lages MCA, 2013, ENVIRON MICROBIOL, V15, P3272, DOI 10.1111/1462-2920.12206; Lara B, 2005, FEMS MICROBIOL LETT, V250, P195, DOI 10.1016/j.femsle.2005.07.005; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Lee K, 2010, BIOORG MED CHEM LETT, V20, P1767, DOI 10.1016/j.bmcl.2010.01.036; Lee YH, 2013, ANTIMICROB AGENTS CH, V57, P4267, DOI 10.1128/AAC.00794-13; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Reimold C, 2013, MOL BIOL CELL, V24, P2340, DOI 10.1091/mbc.E12-10-0728; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schirner K, 2011, ACS CHEM BIOL, V6, P407, DOI 10.1021/cb100390w; Schirner K, 2009, J BACTERIOL, V191, P1404, DOI 10.1128/JB.01497-08; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Strahl H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4442; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Thackray PD, 2003, J BACTERIOL, V185, P3491, DOI 10.1128/JB.185.12.3491-3498.2003; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TIPPER DJ, 1968, J BIOL CHEM, V243, P3169; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; WACHI M, 1989, J BACTERIOL, V171, P3123, DOI 10.1128/jb.171.6.3123-3127.1989	52	52	52	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					38	+		10.1038/nchembio.1689	http://dx.doi.org/10.1038/nchembio.1689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402772	Green Accepted, Green Submitted			2022-12-25	WOS:000346448600010
J	Barisic, M; Aguiar, P; Geley, S; Maiato, H				Barisic, Marin; Aguiar, Paulo; Geley, Stephan; Maiato, Helder			Kinetochore motors drive congression of peripheral polar chromosomes by overcoming random arm-ejection forces	NATURE CELL BIOLOGY			English	Article							CENP-E; MICROTUBULE ATTACHMENT; SPINDLE CHECKPOINT; MITOTIC SPINDLE; IN-VITRO; CENTROSOME SEPARATION; MAMMALIAN-CELLS; METAPHASE PLATE; MITOSIS; CHROMOKINESIN	Accurate chromosome segregation during cell division in metazoans relies on proper chromosome congression at the equator. Chromosome congression is achieved after bi-orientation to both spindle poles shortly after nuclear envelope breakdown, or by the coordinated action of motor proteins that slide misaligned chromosomes along pre-existing spindle microtubules(1). These proteins include the minus-end-directed kinetochore motor dynein(2-5), and the plus-end-directed motors CENP-E at kinetochores(6,7) and chromokinesins on chromosome arms(8-11). However, how these opposite and spatially distinct activities are coordinated to drive chromosome congression remains unknown. Here we used RNAi, chemical inhibition, kinetochore tracking and laser microsurgery to uncover the functional hierarchy between kinetochore and arm-associated motors, exclusively required for congression of peripheral polar chromosomes in human cells. We show that dynein poleward force counteracts chromokinesins to prevent stabilization of immature/incorrect end-on kinetochore microtubule attachments and random ejection of polar chromosomes. At the poles, CENP-E becomes dominant over dynein and chromokinesins to bias chromosome ejection towards the equator. Thus, dynein and CENP-E at kinetochores drive congression of peripheral polar chromosomes by preventing arm-ejection forces mediated by chromokinesins from working in the wrong direction.	[Barisic, Marin; Maiato, Helder] Univ Porto, Inst Mol & Cell Biol, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Dept Biomed Engn, P-4150180 Oporto, Portugal; [Geley, Stephan] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Medical University of Innsbruck; Universidade do Porto	Maiato, H (corresponding author), Univ Porto, Inst Mol & Cell Biol, Chromosome Instabil & Dynam Lab, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	maiato@ibmc.up.pt	Aguiar, Paulo/AAD-2462-2020; Maiato, Helder/J-9466-2013; Barisic, Marin/K-2301-2013	Aguiar, Paulo/0000-0003-4164-5713; Maiato, Helder/0000-0002-6200-9997; Barisic, Marin/0000-0001-7587-3867	FEDER through the Operational Competitiveness Programme-COMPETE; National Funds through FCT-Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-015941, PTDC/SAUONC/112917/2009]; Human Frontier Science Program; 7th framework program grant PRECISE from the European Research Council;  [FWF DK W 1101]	FEDER through the Operational Competitiveness Programme-COMPETE; National Funds through FCT-Fundacao para a Ciencia e a Tecnologia; Human Frontier Science Program(Human Frontier Science Program); 7th framework program grant PRECISE from the European Research Council; 	We thank A. Pereira for the development of image analysis tools, M. Barisic for exceptional technical help and R. Gassmann for the critical reading of this manuscript S.G. is supported by FWF DK W 1101 'MCBO'. H.M. is financially supported by FEDER through the Operational Competitiveness Programme-COMPETE and by National Funds through FCT-Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-015941 (PTDC/SAUONC/112917/2009), the Human Frontier Science Program and the 7th framework program grant PRECISE from the European Research Council.	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bakhoum S. F., 2014, CANC DISCOV; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Brouhard GJ, 2005, P NATL ACAD SCI USA, V102, P13903, DOI 10.1073/pnas.0506017102; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Cane S, 2013, J CELL BIOL, V200, P203, DOI 10.1083/jcb.201211119; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Harborth J, 2001, J CELL SCI, V114, P4557; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kaseda K, 2012, BIOL OPEN, V1, P12, DOI 10.1242/bio.2011012; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Maffini S, 2009, CURR BIOL, V19, P1566, DOI 10.1016/j.cub.2009.07.059; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Pereira AJ, 2010, METHODS, V51, P214, DOI 10.1016/j.ymeth.2010.01.016; Pereira AJ, 2009, METHODS MOL BIOL, V545, P145, DOI 10.1007/978-1-60327-993-2_9; Poirier CC, 2010, BIOPHYS J, V99, P3182, DOI 10.1016/j.bpj.2010.09.053; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shrestha RL, 2013, CURR BIOL, V23, P1514, DOI 10.1016/j.cub.2013.06.040; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Stumpff J, 2012, DEV CELL, V22, P1017, DOI 10.1016/j.devcel.2012.02.013; Takagi J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02808; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wandke C, 2006, HYBRIDOMA, V25, P41, DOI 10.1089/hyb.2006.25.41; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150	48	91	91	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1249	U259		10.1038/ncb3060	http://dx.doi.org/10.1038/ncb3060			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25383660				2022-12-25	WOS:000345777300015
J	Guo, B; Liang, QQ; Li, L; Hu, Z; Wu, F; Zhang, PP; Ma, YF; Zhao, B; Kovacs, AL; Zhang, ZY; Feng, D; Chen, S; Zhang, H				Guo, Bin; Liang, Qianqian; Li, Lin; Hu, Zhe; Wu, Fan; Zhang, Peipei; Ma, Yongfen; Zhao, Bin; Kovacs, Attila L.; Zhang, Zhiyuan; Feng, Du; Chen, She; Zhang, Hong			O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation	NATURE CELL BIOLOGY			English	Article							C. ELEGANS; SIGNALING PATHWAYS; SACCHAROMYCES-CEREVISIAE; NUTRIENT STRESS; PROTEIN; SNARE; COMPLEX; GOLGI; ENDOSOMES; DISEASE	The mechanism by which nutrient status regulates the fusion of autophagosomes with endosomes/lysosomes is poorly understood. Here, we report that O-linked fi-N-acetylglucosamine (O-GlcNAc) transferase (OGT) mediates O-GlcNAcylation of the SNARE protein SNAP-29 and regulates autophagy in a nutrient-dependent manner. In mammalian cells, OGT knockdown, or mutating the O-GlcNAc sites in SNAP-29, promotes the formation of a SNAP-29-containing SNARE complex, increases fusion between autophagosomes and endosomes/lysosomes, and promotes autophagic flux. In Caenorhabditis elegans, depletion of ogt-1 has a similar effect on autophagy; moreover, expression of an O-GlcNAc-defective SNAP-29 mutant facilitates autophagic degradation of protein aggregates. O-GlcNAcylated SNAP-29 levels are reduced during starvation in mammalian cells and in C. elegans. Our study reveals a mechanism by which O-GlcNAc-modification integrates nutrient status with autophagosome maturation.	[Guo, Bin; Liang, Qianqian; Wu, Fan; Zhang, Peipei; Zhang, Hong] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China; [Li, Lin; Ma, Yongfen; Zhang, Zhiyuan; Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hu, Zhe; Zhao, Bin; Feng, Du] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Key Lab Age Associated Cardiac Cerebral Vasc Dis, Zhanjiang 524001, Peoples R China; [Kovacs, Attila L.] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, H-1117 Budapest, Hungary	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Guangdong Medical University; Eotvos Lorand University	Zhang, H (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China.	hongzhang@sun5.ibp.ac.cn	zhang, zhiyuan/GRS-2141-2022; Zhang, Peipei/N-6997-2018; Zhang, Peipei/AAL-4181-2021	Zhang, Peipei/0000-0003-1742-1680; Feng, Du/0000-0002-2489-4702; liang, qianqian/0000-0001-8172-7292	National Institutes of Health [P40 OD010440]; National Basic Research Program of China [2013CB910100, 2011CB910100]; National Natural Science Foundation of China [31225018]; International Early Career Scientist grant from the Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Hanson for editing services and F. Shao (NIBS) for OGA proteins. Some strains were obtained from CGC, which is funded by the National Institutes of Health (P40 OD010440). This work was supported by the National Basic Research Program of China (2013CB910100, 2011CB910100) and also a grant from the National Natural Science Foundation of China (31225018) to H.Z. The research of H.Z. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Guo B, 2014, EMBO REP, V15, P705, DOI 10.1002/embr.201338310; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kang J, 2011, DEV BIOL, V355, P77, DOI 10.1016/j.ydbio.2011.04.013; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lu Q, 2013, BIOCHEM J, V452, P381, DOI 10.1042/BJ20121721; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091471; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao HY, 2013, J CELL BIOL, V200, P731, DOI 10.1083/jcb.201211014	54	177	181	5	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1215	U202		10.1038/ncb3066	http://dx.doi.org/10.1038/ncb3066			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25419848				2022-12-25	WOS:000345777300012
J	Lim, A; Shin, K; Zhao, C; Kawano, S; Beachy, PA				Lim, Agnes; Shin, Kunyoo; Zhao, Chen; Kawano, Sally; Beachy, Philip A.			Spatially restricted Hedgehog signalling regulates HGF-induced branching of the adult prostate	NATURE CELL BIOLOGY			English	Article							HEPATOCYTE GROWTH-FACTOR; SONIC-HEDGEHOG; STEM-CELLS; MOUSE PROSTATE; TARGET PREDICTION; STROMAL CELLS; BENIGN; MORPHOGENESIS; HYPERPLASIA; REGENERATION	Branching morphogenesis is thought to be governed by epithelial-stromal interactions, but the mechanisms underlying specification of branch location remain largely unknown. Prompted by the striking absence of Hedgehog (Hh) response at the sites of nascent buds in regenerating tubules of the adult prostate, we investigated the role of Hh signalling in adult prostate branching morphogenesis. We find that pathway activity is localized to stromal cells, and that its attenuation by genetic or pharmacologic manipulation leads to increased branching. Decreased pathway activity correlates with increased stromal production of hepatocyte growth factor (Hgf), and we show that Hgf induces epithelial tubule branching. Regulation of Hgf expression by Hh signalling is indirect, mediated by Hh-induced expression of the microRNAs miR-26a and miR-26b, which in turn downregulate expression of Hgf. Prostate tubule branching thus may be initiated from regions of low Hh pathway activity, with implications for the prostatic hyperplasia commonly observed in late adulthood.	[Lim, Agnes; Shin, Kunyoo; Zhao, Chen; Kawano, Sally; Beachy, Philip A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Lim, Agnes; Beachy, Philip A.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Lim, Agnes; Shin, Kunyoo; Zhao, Chen; Kawano, Sally; Beachy, Philip A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Shin, Kunyoo; Zhao, Chen; Beachy, Philip A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Shin, K (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell Dev & Canc Biol, Dept Urol, Portland, OR 97239 USA.	shink@ohsu.edu; pbeachy@stanford.edu		Shin, Kunyoo/0000-0002-1519-9839; Lim, Agnes/0000-0002-6618-2500	National Institutes of Health; Pathway to Independence Award [K99/R00]; NATIONAL CANCER INSTITUTE [R01CA157877, R00CA166232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by grants from the National Institutes of Health to P.A.B. and a Pathway to Independence Award (K99/R00) to K.S. P.A.B. is an investigator of the Howard Hughes Medical Institute. We acknowledge the Stanford Neuroscience Imaging Facility for use of the two-photon microscope. We thank O. Witte for advice on subrenal prostate regeneration experiments.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Doles J, 2006, DEV BIOL, V295, P13, DOI 10.1016/j.ydbio.2005.12.002; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lee KL, 2004, J UROLOGY, V172, P1784, DOI 10.1097/01.ju.0000133655.71782.14; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu LB, 2008, J MED CHEM, V51, P3688, DOI 10.1021/jm800401t; Long FX, 2001, DEVELOPMENT, V128, P5099; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; MCNEAL J, 1990, UROL CLIN N AM, V17, P477; MCNEAL JE, 1978, INVEST UROL, V15, P340; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashiro K, 2000, AM J PATHOL, V157, P795, DOI 10.1016/S0002-9440(10)64593-2; NIRANJAN B, 1995, DEVELOPMENT, V121, P2897; Ohmichi H, 1998, DEVELOPMENT, V125, P1315; Paolone DR, 2010, CLIN GERIATR MED, V26, P223, DOI 10.1016/j.cger.2010.02.010; Peng YC, 2013, P NATL ACAD SCI USA, V110, P20611, DOI 10.1073/pnas.1315729110; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; PRICE H, 1990, HUM PATHOL, V21, P578, DOI 10.1016/S0046-8177(96)90002-7; Pu YB, 2004, DEV BIOL, V273, P257, DOI 10.1016/j.ydbio.2004.06.002; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; SANTOS OFP, 1994, DEV BIOL, V163, P525, DOI 10.1006/dbio.1994.1169; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; SORIANO JV, 1995, J CELL SCI, V108, P413; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exger.2004.12.008; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Yu M, 2013, DEV BIOL, V380, P87, DOI 10.1016/j.ydbio.2013.04.032	50	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1135	U33		10.1038/ncb3057	http://dx.doi.org/10.1038/ncb3057			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25362352	Green Accepted			2022-12-25	WOS:000345777300005
J	Mueller, MM; Castells-Roca, L; Babu, V; Ermolaeva, MA; Muller, RU; Frommolt, P; Williams, AB; Greiss, S; Schneider, JI; Benzing, T; Schermer, B; Schumacher, B				Mueller, Michael M.; Castells-Roca, Laia; Babu, Vipin; Ermolaeva, Maria A.; Mueller, Roman-Ulrich; Frommolt, Peter; Williams, Ashley B.; Greiss, Sebastian; Schneider, Jennifer I.; Benzing, Thomas; Schermer, Bernhard; Schumacher, Bjoern			DAF-16/FOXO and EGL-27/GATA promote developmental growth in response to persistent somatic DNA damage	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; INDUCED APOPTOSIS; TRANSCRIPTION; PROTEIN; GENES; LONGEVITY; STRESS; NEMATODE	Genome maintenance defects cause complex disease phenotypes characterized by developmental failure, cancer susceptibility and premature ageing. It remains poorly understood how DNA damage responses function during organismal development and maintain tissue functionality when DNA damage accumulates with ageing. Here we show that the FOXO transcription factor DAF-16 is activated in response to DNA damage during development, whereas the DNA damage responsiveness of DAF-16 declines with ageing. We find that in contrast to its established role in mediating starvation arrest, DAF-16 alleviates DNA-damage-induced developmental arrest and even in the absence of DNA repair promotes developmental growth and enhances somatic tissue functionality. We demonstrate that the GATA transcription factor EGL-27 co-regulates DAF-16 target genes in response to DNA damage and together with DAF-16 promotes developmental growth. We propose that EGL-27/GATA activity specifies DAF-16-mediated DNA damage responses to enable developmental progression and to prolong tissue functioning when DNA damage persists.	[Mueller, Michael M.; Castells-Roca, Laia; Babu, Vipin; Ermolaeva, Maria A.; Williams, Ashley B.; Schneider, Jennifer I.; Schumacher, Bjoern] Univ Cologne, Fac Med, Inst Genome Stabil Ageing & Dis, D-50931 Cologne, Germany; [Mueller, Michael M.; Castells-Roca, Laia; Babu, Vipin; Ermolaeva, Maria A.; Mueller, Roman-Ulrich; Frommolt, Peter; Williams, Ashley B.; Greiss, Sebastian; Schneider, Jennifer I.; Benzing, Thomas; Schermer, Bernhard; Schumacher, Bjoern] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Mueller, Michael M.; Castells-Roca, Laia; Babu, Vipin; Ermolaeva, Maria A.; Mueller, Roman-Ulrich; Frommolt, Peter; Williams, Ashley B.; Greiss, Sebastian; Schneider, Jennifer I.; Benzing, Thomas; Schermer, Bernhard; Schumacher, Bjoern] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Mueller, Roman-Ulrich; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Mueller, Roman-Ulrich; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Frommolt, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schumacher, B (corresponding author), Univ Cologne, Fac Med, Inst Genome Stabil Ageing & Dis, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	bjoern.schumacher@uni-koeln.de	Schermer, Bernhard/E-9972-2014; Frommolt, Peter/L-9656-2016; Benzing, Thomas/X-5476-2019; Greiss, Sebastian/B-2395-2015; Castells-Roca, Laia/I-1227-2015; Müller, Roman-Ulrich/AAK-3493-2021; Schumacher, Björn/I-4829-2013	Schermer, Bernhard/0000-0002-5194-9000; Frommolt, Peter/0000-0002-1966-8014; Castells-Roca, Laia/0000-0002-4604-9999; Müller, Roman-Ulrich/0000-0001-6910-0745; Schumacher, Björn/0000-0001-6097-5238; Williams, Ashley/0000-0002-7558-9599; Greiss, Sebastian/0000-0001-9130-0831; Babu, Vipin/0000-0002-0001-8783	NIH Office of Research Infrastructure Programs [P40OD010440]; EMBO long-term fellowship; Deutsche Forschungsgemeinschaft [SFB832, SCHE 1562/2]; Deutsche Forschungsgemeinschaft (CECAD) [SFB 829, SFB 670, KFO 286]; European Research Council (ERC Starting grant) [260383]; Marie Curie (FP7 ITN) [316354, 316390, 316964, 239330]; German-Israeli Foundation (GIF) [2213-1935.13/2008, 1104-68.11/2010]; Deutsche Krebshilfe [109453]; Bundesministerium fur Forschung und Bildung [FKZ0315893A-B]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CECAD)(German Research Foundation (DFG)); European Research Council (ERC Starting grant)(European Research Council (ERC)); Marie Curie (FP7 ITN); German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Forschung und Bildung(Federal Ministry of Education & Research (BMBF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Keller and K. Riehl for excellent technical assistance, D. Magner and A. Steckelberg for contributions earlier in the project, C. Jungst and A. Schauss of the CECAD Imaging Facility, and J. Altmuller, I. Bassmann and C. Becker of the CCG. Some strains were kindly provided by the MITANI Lab through the National Bio-Resource Project of the MEXT, Japan and CGC (funded by the NIH Office of Research Infrastructure Programs (P40OD010440)). V.B. received an IGSDHD, and M.A.E. an EMBO long-term fellowship. B. Schermer was supported by the Deutsche Forschungsgemeinschaft (SFB832 and SCHE 1562/2). B. Schumacher acknowledges financial support from the Deutsche Forschungsgemeinschaft (CECAD, SFB 829, SFB 670 and KFO 286), the European Research Council (ERC Starting grant 260383), Marie Curie (FP7 ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964 and ERG 239330), the German-Israeli Foundation (GIF, 2213-1935.13/2008 and 1104-68.11/2010), the Deutsche Krebshilfe (109453) and the Bundesministerium fur Forschung und Bildung (Sybacol FKZ0315893A-B).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boyd WA, 2010, MUTAT RES-FUND MOL M, V683, P57, DOI 10.1016/j.mrfmmm.2009.10.008; BRENNER S, 1974, GENETICS, V77, P71; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GOTTLIEB S, 1994, GENETICS, V137, P107; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hader DP, 2006, NATO SCI S SS IV EAR, V57, P95; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herman MA, 1999, DEVELOPMENT, V126, P1055; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Li DQ, 2010, J BIOL CHEM, V285, P19802, DOI 10.1074/jbc.M109.085258; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; Solari F, 1999, DEVELOPMENT, V126, P2483; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Wolters Stefanie, 2013, Frontiers in Genetics, V4, P19, DOI 10.3389/fgene.2013.00019; Xu X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003108; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013	59	66	66	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1168	U97		10.1038/ncb3071	http://dx.doi.org/10.1038/ncb3071			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25419847	Green Accepted			2022-12-25	WOS:000345777300008
J	Scheeren, FA; Kuo, AH; van Weele, LJ; Cai, S; Glykofridis, I; Sikandar, SS; Zabala, M; Qian, DL; Lam, JS; Johnston, D; Volkmer, JP; Sahoo, D; van de Rijn, M; Dirbas, FM; Somlo, G; Kalisky, T; Rothenberg, ME; Quake, SR; Clarke, MF				Scheeren, Ferenc A.; Kuo, Angera H.; van Weele, Linda J.; Cai, Shang; Glykofridis, Iris; Sikandar, Shaheen S.; Zabala, Maider; Qian, Dalong; Lam, Jessica S.; Johnston, Darius; Volkmer, Jens P.; Sahoo, Debashis; van de Rijn, Matt; Dirbas, Frederick M.; Somlo, George; Kalisky, Tomer; Rothenberg, Michael E.; Quake, Stephen R.; Clarke, Michael F.			A cell-intrinsic role for TLR2 MYD88 in intestinal and breast epithelia and oncogenesis	NATURE CELL BIOLOGY			English	Article							FUNCTIONAL MAMMARY-GLAND; TOLL-LIKE RECEPTOR-2; LGR5(+) STEM-CELLS; CANCER; PROTEIN; IDENTIFICATION; INFLAMMATION; RECOGNITION; MORPHOGENESIS; TUMORIGENESIS	It has been postulated that there is a link between inflammation and cancer. Here we describe a role for cell-intrinsic toll-like receptor-2 (TLR2; which is involved in inflammatory response) signalling in normal intestinal and mammary epithelial cells and oncogenesis. The downstream effectors of TLR2 are expressed by normal intestinal and mammary epithelia, including the stem/progenitor cells. Deletion of MYD88 or TLR2 in the intestinal epithelium markedly reduces DSS-induced colitis regeneration and spontaneous tumour development in mice. Limiting dilution transplantations of breast epithelial cells devoid of TLR2 or MYD88 revealed a significant decrease in mammary repopulating unit frequency compared with the control. Inhibition of TLR2, its co-receptor CD 14, or its downstream targets MYD88 and IRAK1 inhibits growth of human breast cancers in vitro and in vivo. These results suggest that inhibitors of the TLR2 pathway merit investigation as possible therapeutic and chemoprevention agents.	[Scheeren, Ferenc A.; Kuo, Angera H.; van Weele, Linda J.; Cai, Shang; Sikandar, Shaheen S.; Zabala, Maider; Qian, Dalong; Lam, Jessica S.; Johnston, Darius; Volkmer, Jens P.; Sahoo, Debashis; Rothenberg, Michael E.; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Scheeren, Ferenc A.; Glykofridis, Iris] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [van de Rijn, Matt] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Dirbas, Frederick M.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Somlo, George] City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol, Duarte, CA 91010 USA; [Somlo, George] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Clarke, Michael F.] Stanford Univ, Div Oncol, Dept Med, Stanford, CA 94305 USA	Stanford University; Netherlands Cancer Institute; Stanford University; Stanford University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Clarke, MF (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Cai, Shang/0000-0003-0630-7719; Glykofridis, Iris/0000-0003-1829-2403; Scheeren, Ferenc/0000-0002-8304-9023; van de Rijn, Matt/0000-0002-1909-9739	National Institutes of Health (NCI); Breast Cancer Research Foundation; Ludwig Institute; California Institute for Regenerative Medicine; Department of Defense (DOD); NWO-Rubicon grant; Dutch Cancer Society; NIH Shared Instrumentation Grant funds [S10, 1S 10RR02933801]	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Ludwig Institute; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Department of Defense (DOD)(United States Department of Defense); NWO-Rubicon grant; Dutch Cancer Society(KWF Kankerbestrijding); NIH Shared Instrumentation Grant funds	This study was supported by the National Institutes of Health (NCI), the Breast Cancer Research Foundation, the Ludwig Institute, The California Institute for Regenerative Medicine and the Department of Defense (DOD). F.A.S. was supported by NWO-Rubicon grant, a fellowship from the Dutch Cancer Society and by a seed grant of the organization My Blue Dots. We thank T.N. Schumacher and M.A. Child for scientific input, S. Sim for her assistance with single-cell PCR assays, P. Lovelace for her assistance with flow cytometry and K. Montgomery for IHC. Some research was performed on a FACS Aria that was purchased using NIH S10 Shared Instrumentation Grant (1S 10RR02933801) funds.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; HALL PA, 1994, J CELL SCI, V107, P3569; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x	65	81	87	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1238	U245		10.1038/ncb3058	http://dx.doi.org/10.1038/ncb3058			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25362351				2022-12-25	WOS:000345777300014
J	Wang, GX; Zhao, XY; Meng, ZX; Kern, M; Dietrich, A; Chen, ZM; Cozacov, Z; Zhou, DQ; Okunade, AL; Su, X; Li, SM; Bluher, M; Lin, JDD				Wang, Guo-Xiao; Zhao, Xu-Yun; Meng, Zhuo-Xian; Kern, Matthias; Dietrich, Arne; Chen, Zhimin; Cozacov, Zoharit; Zhou, Dequan; Okunade, Adewole L.; Su, Xiong; Li, Siming; Blueher, Matthias; Lin, Jiandie D.			The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis	NATURE MEDICINE			English	Article							FIBROBLAST GROWTH-FACTORS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; SIGNALING NETWORKS; GENE-EXPRESSION; TRANSGENIC MICE; OBESITY; ACTIVATION; RECEPTORS; SREBP-1C	Brown fat activates uncoupled respiration in response to cold temperature and contributes to systemic metabolic homeostasis. To date, the metabolic action of brown fat has been primarily attributed to its role in fuel oxidation and uncoupling protein 1 (UCP1)-mediated thermogenesis. Whether brown fat engages other tissues through secreted factors remains largely unexplored. Here we show that neuregulin 4 (Nrg4), a member of the epidermal growth factor (EGF) family of extracellular ligands, is highly expressed in adipose tissues, enriched in brown fat and markedly increased during brown adipocyte differentiation. Adipose tissue Nrg4 expression was reduced in rodent and human obesity. Gain- and loss-of-function studies in mice demonstrated that Nrg4 protects against diet-induced insulin resistance and hepatic steatosis through attenuating hepatic lipogenic signaling. Mechanistically, Nrg4 activates ErbB3 and ErbB4 signaling in hepatocytes and negatively regulates de novo lipogenesis mediated by LXR and SREBP1c in a cell-autonomous manner. These results establish Nrg4 as a brown fat-enriched endocrine factor with therapeutic potential for the treatment of obesity-associated disorders, including type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).	[Wang, Guo-Xiao; Zhao, Xu-Yun; Meng, Zhuo-Xian; Chen, Zhimin; Cozacov, Zoharit; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; [Wang, Guo-Xiao; Zhao, Xu-Yun; Meng, Zhuo-Xian; Chen, Zhimin; Cozacov, Zoharit; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04109 Leipzig, Germany; [Zhou, Dequan; Okunade, Adewole L.; Su, Xiong] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Su, Xiong] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Leipzig University; Leipzig University; Washington University (WUSTL); Soochow University - China	Lin, JDD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA.	jdlin@umich.edu		Chen, Zhimin/0000-0003-4241-7122	Michigan Diabetes Research and Training Center [DK020572]; Nutrition Obesity Research Center [DK089503]; US National Institutes of Health [DK077086, DK095151, DK097608]; Novo Nordisk; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK095151, R01DK077086, P30DK089503, P60DK020572, P30DK056341, R01DK097608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center; Nutrition Obesity Research Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Dempsey (University of Colorado) for ErbB4-Min6 cells, Y. Yarden (Weizmann Institute of Science) for ErbB expression plasmids, D. Leahy (Johns Hopkins University) for expression constructs for ErbB3 and ErbB4 extracellular domains, D. Threadgill (Texas A&M University) for Erbb3<SUP>flox/flox</SUP> mice and A. Saltiel for discussions. We are grateful to Q. Yu and L. Wang for technical support, the lab members for discussion, and the staff at the University of Michigan Transgenic Animal Model Core and the metabolic phenotyping core supported by Michigan Diabetes Research and Training Center (DK020572) and Nutrition Obesity Research Center (DK089503). This work was supported by the US National Institutes of Health (DK077086 and DK095151, J.D.L.; DK097608, X.S.) and a grant from Novo Nordisk. S.L. and G.-X.W. were supported by Scientist Development Grant and Predoctoral Fellowship, respectively, from the American Heart Association.	Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carver RS, 2002, GASTROENTEROLOGY, V123, P2017, DOI 10.1053/gast.2002.37060; Chen Y, 2005, NUCLEIC ACIDS RES, V33, pD169; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hayes NVL, 2008, ONCOGENE, V27, P715, DOI 10.1038/sj.onc.1210689; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Kohjima M, 2008, INT J MOL MED, V21, P507; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Muller H, 1998, J HISTOCHEM CYTOCHEM, V46, P737, DOI 10.1177/002215549804600606; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	54	257	278	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1436	1443		10.1038/nm.3713	http://dx.doi.org/10.1038/nm.3713			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25401691	Green Accepted			2022-12-25	WOS:000345817900019
J	Xie, T; Lim, SM; Westover, KD; Dodge, ME; Ercan, D; Ficarro, SB; Udayakumar, D; Gurbani, D; Tae, HS; Riddle, SM; Sim, T; Marto, JA; Janne, PA; Crews, CM; Gray, NS				Xie, Ting; Lim, Sang Min; Westover, Kenneth D.; Dodge, Michael E.; Ercan, Dalia; Ficarro, Scott B.; Udayakumar, Durga; Gurbani, Deepak; Tae, Hyun Seop; Riddle, Steven M.; Sim, Taebo; Marto, Jarrod A.; Jaenne, Pasi A.; Crews, Craig M.; Gray, Nathanael S.			Pharmacological targeting of the pseudokinase Her3	NATURE CHEMICAL BIOLOGY			English	Article							HER2-POSITIVE BREAST-CANCER; TYROSINE KINASE; LUNG-CANCER; EXTENDED 5-SUBSTITUENT; ADJUVANT CHEMOTHERAPY; SELECTIVE INHIBITORS; MET AMPLIFICATION; OVARIAN-CANCER; PROTEIN; DOMAIN	Her3 (also known as ErbB3) belongs to the epidermal growth factor receptor tyrosine kinases and is well credentialed as an anti-cancer target but is thought to be 'undruggable' using ATP-competitive small molecules because it lacks appreciable kinase activity. Here we report what is to our knowledge the first selective Her3 ligand, TX1-85-1, that forms a covalent bond with Cys721 located in the ATP-binding site of Her3. We demonstrate that covalent modification of Her3 inhibits Her3 signaling but not proliferation in some Her3-dependent cancer cell lines. Subsequent derivatization with a hydrophobic adamantane moiety demonstrates that the resultant bivalent ligand (TX2-121-1) enhances inhibition of Her3-dependent signaling. Treatment of cells with TX2-121-1 results in partial degradation of Her3 and serendipitously interferes with productive heterodimerization between Her3 with either Her2 or c-Met. These results suggest that small molecules will be capable of perturbing the biological function of Her3 and -60 other pseudokinases found in human cells.	[Xie, Ting; Lim, Sang Min; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Xie, Ting; Lim, Sang Min; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xie, Ting; Lim, Sang Min] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Westover, Kenneth D.; Udayakumar, Durga; Gurbani, Deepak] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Westover, Kenneth D.; Udayakumar, Durga; Gurbani, Deepak] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Dodge, Michael E.; Ercan, Dalia; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Tae, Hyun Seop; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Riddle, Steven M.] Life Technol Corp, Primary & Stem Cell Syst, Madison, WI USA; [Sim, Taebo] Korea Inst Sci & Technol, Chem Kin Res Ctr, Seoul, South Korea; [Sim, Taebo] KU KIST Grad Sch Converging Sci & Technol, Seoul, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Yale University; Thermo Fisher Scientific; Korea Institute of Science & Technology (KIST); Korea University	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA.	pjanne@partners.org; craig.crews@yale.edu; nathanael_gray@dfci.harvard.edu	Westover, Ken/AAZ-1795-2020; Crews, Craig M./ABH-9346-2020	Westover, Ken/0000-0003-3653-5923; Crews, Craig M./0000-0002-8456-2005; GURBANI, DEEPAK/0000-0002-0982-7173	Dana Farber Cancer Institute Lander Fellowship; Claudia Adams Barr Program Award; US National Institutes of Health (NIH) [AI 084140-03]; Cancer Prevention Research Institute of Texas [R1207]; National Research Foundation of Korea [NRF-2011-0028676]; NIH [P01 CA154303]; NATIONAL CANCER INSTITUTE [P01CA154303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084140] Funding Source: NIH RePORTER	Dana Farber Cancer Institute Lander Fellowship; Claudia Adams Barr Program Award; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank staff at The Institute of Chemistry and Cell Biology for the guidance of screening equipment and assay development discussion. We thank J. Minna and M. Peyton of UT Southwestern Medical Center for providing the HCC2935 cell line. This work is supported by the Dana Farber Cancer Institute Lander Fellowship (T.X.), Claudia Adams Barr Program Award (N.S.G.), US National Institutes of Health (NIH) grant AI 084140-03 (C.M.C.), Cancer Prevention Research Institute of Texas grant R1207 (K.D.W.), creative/challenging research program of National Research Foundation of Korea NRF-2011-0028676 (T.S.) and NIH grant P01 CA154303 (P.A.J. and N.S.G.).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Arnold LD, 2000, BIOORG MED CHEM LETT, V10, P2167, DOI 10.1016/S0960-894X(00)00441-8; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Berlin J, 2011, J CLIN ONCOL S, V29; Boschelli D.H., J MED CHEM, V44, P3965; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Burchat A, 2006, BIOORG MED CHEM LETT, V16, P118, DOI 10.1016/j.bmcl.2005.09.039; Burchat AF, 2000, BIOORG MED CHEM LETT, V10, P2171, DOI 10.1016/S0960-894X(00)00442-X; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Das J., J MED CHEM, V49, P6819; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Long MJC, 2012, CHEM BIOL, V19, P629, DOI 10.1016/j.chembiol.2012.04.008; Neklesa TK, 2012, NATURE, V487, P308, DOI 10.1038/487308a; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Tae HS, 2012, CHEMBIOCHEM, V13, P538, DOI 10.1002/cbic.201100793; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	50	125	128	8	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1006	+		10.1038/nchembio.1658	http://dx.doi.org/10.1038/nchembio.1658			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25326665	Green Accepted, Green Submitted			2022-12-25	WOS:000345122300007
J	Zhang, YX; van Dijk, ADJ; Scaffidi, A; Flematti, GR; Hofmann, M; Charnikhova, T; Verstappen, F; Hepworth, J; van der Krol, S; Leyser, O; Smith, SM; Zwanenburg, B; Al-Babili, S; Ruyter-Spira, C; Bouwmeester, HJ				Zhang, Yanxia; van Dijk, Aalt D. J.; Scaffidi, Adrian; Flematti, Gavin R.; Hofmann, Manuel; Charnikhova, Tatsiana; Verstappen, Francel; Hepworth, Jo; van der Krol, Sander; Leyser, Ottoline; Smith, Steven M.; Zwanenburg, Binne; Al-Babili, Salim; Ruyter-Spira, Carolien; Bouwmeester, Harro J.			Rice cytochrome P450 MAX1 homologs catalyze distinct steps in strigolactone biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL REQUIREMENTS; GERMINATION STIMULANTS; CRYSTAL-STRUCTURES; PROTEIN; INHIBITION; EXPRESSION; CARLACTONE; STRIGA; TRANSFORMATION; MOLECULES	Strigolactones (SLs) are a class of phytohormones and rhizosphere signaling compounds with high structural diversity. Three enzymes, carotenoid isomerase DWARF27 and carotenoid cleavage dioxygenases CCD7 and CCD8, were previously shown to convert all-trans-beta-carotene to carlactone (CL), the SL precursor. However, how CL is metabolized to SLs has remained elusive. Here, by reconstituting the SL biosynthetic pathway in Nicotiana benthamiana, we show that a rice homolog of Arabidopsis MORE AXILLARY GROWTH 1 (MAX1), encodes a cytochrome P450 CYP711 subfamily member that acts as a CL oxidase to stereoselectively convert CL into ent-2'-epi-5-deoxystrigol (B-C lactone ring formation), the presumed precursor of rice SLs. A protein encoded by a second rice MAX1 homolog then catalyzes the conversion of ent-2'-epi-5-deoxystrigol to orobanchol. We therefore report that two members of CYP711 enzymes can catalyze two distinct steps in SL biosynthesis, identifying the first enzymes involved in B-C ring closure and a subsequent structural diversification step of SLs.	[Zhang, Yanxia; Charnikhova, Tatsiana; Verstappen, Francel; van der Krol, Sander; Ruyter-Spira, Carolien; Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [van Dijk, Aalt D. J.] Plant Res Int, Appl Bioinformat, Wageningen, Netherlands; [Scaffidi, Adrian; Flematti, Gavin R.; Smith, Steven M.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Hofmann, Manuel; Al-Babili, Salim] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Hepworth, Jo; Leyser, Ottoline] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Leyser, Ottoline] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Zwanenburg, Binne] Radboud Univ Nijmegen, Inst Mol & Mat, Cluster Organ Chem, NL-6525 ED Nijmegen, Netherlands; [Al-Babili, Salim] King Abdullah Univ Sci & Technol, BESE Div, Ctr Desert Agr, Thuwal, Saudi Arabia; [Ruyter-Spira, Carolien] Plant Res Int, Bioscience, Wageningen, Netherlands; [Bouwmeester, Harro J.] Ctr Biosyst Genom, Wageningen, Netherlands	Wageningen University & Research; University of Western Australia; University of Freiburg; University of York - UK; University of Cambridge; Radboud University Nijmegen; King Abdullah University of Science & Technology; Centre for BioSystems Genomics	Bouwmeester, HJ (corresponding author), Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands.	harro.bouwmeester@wur.nl	Leyser, Ottoline/AAC-5577-2019; Smith, Steven M/G-7183-2015; Zhang, Yanxia/AAM-7135-2021; Zhang, Yanxia/AGD-9959-2022; Bouwmeester, Harro J/C-1414-2008; van der Krol, Alexander/C-5720-2015; Flematti, Gavin R/J-2018-2012; Smith, Steven/HDM-9496-2022	Smith, Steven M/0000-0001-5661-9994; Zhang, Yanxia/0000-0002-0577-5142; Zhang, Yanxia/0000-0002-0577-5142; van der Krol, Alexander/0000-0001-6585-7572; Leyser, Ottoline/0000-0003-2161-3829; Al-Babili, Salim/0000-0003-4823-2882; Flematti, Gavin/0000-0003-2545-6939; Hepworth, Jo/0000-0002-4621-8414; van Dijk, Aalt-Jan/0000-0002-8872-5123; Bouwmeester, Harro/0000-0003-0907-2732	Netherlands Organization for Scientific Research (VICI) [865.06.002, 834.08.001]; Australian Research Council [LP0882775, FT110100304]; UK Biotechnology and Biological Sciences Research Council; King Abdullah University of Science and Technology; Centre for BioSystems Genomics; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research (VICI)(Netherlands Organization for Scientific Research (NWO)); Australian Research Council(Australian Research Council); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Centre for BioSystems Genomics; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank Y. Wang from the Institute of Genetics and Developmental Biology at the Chinese Academy of Science for the p35s:OsD27:PJTK13 plasmid and K. Yoneyama (Weed Science Center, Utsunomiya University, Utsunomiya, Japan) and T. Asami (Department of Applied Biological Chemistry, The University of Tokyo, Japan) for supplying SL standards. We thank J. Beekwilder and K. Cankar (Plant Research International, Wageningen, the Netherlands) for technical advice on the yeast assays and B. Ramakers (Nijmegen University) for technical support with the CD spectra measurement of CL. We thank A. Reeder from the Centre for Microscopy, Characterisation and Analysis (University of Western Australia (UWA)) and M. Clarke from the Centre for Metabolomics (UWA) for technical assistance and instrument access. We acknowledge funding by the Netherlands Organization for Scientific Research (VICI grant 865.06.002 and equipment grant 834.08.001 to H.J.B.), the Australian Research Council (LP0882775 for A.S. and FT110100304 for G.R.F.) and the UK Biotechnology and Biological Sciences Research Council (for J.H. and O.L.). Research reported in this publication was supported by the King Abdullah University of Science and Technology and was cofinanced by the Centre for BioSystems Genomics, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Alder A, 2008, BIOCHEM J, V416, P289, DOI 10.1042/BJ20080568; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Batard Y, 2000, ARCH BIOCHEM BIOPHYS, V379, P161, DOI 10.1006/abbi.2000.1867; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno M, 2014, FEBS LETT, V588, P1802, DOI 10.1016/j.febslet.2014.03.041; Cankar K, 2011, FEBS LETT, V585, P178, DOI 10.1016/j.febslet.2010.11.040; Cardoso C, 2014, P NATL ACAD SCI USA, V111, P2379, DOI 10.1073/pnas.1317360111; Challis RJ, 2013, PLANT PHYSIOL, V161, P1885, DOI 10.1104/pp.112.211383; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; de Vetten N, 1999, P NATL ACAD SCI USA, V96, P778, DOI 10.1073/pnas.96.2.778; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldwasser Y, 2008, PLANT GROWTH REGUL, V55, P21, DOI 10.1007/s10725-008-9253-z; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Li LO, 2008, P NATL ACAD SCI USA, V105, P13883, DOI 10.1073/pnas.0804099105; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nomura S, 2013, PLANT CELL REP, V32, P829, DOI 10.1007/s00299-013-1429-y; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Rani K, 2008, PLANT PHYSIOL BIOCH, V46, P617, DOI 10.1016/j.plaphy.2008.04.012; Reizelman A, 2000, SYNTHESIS-STUTTGART, P1944; Reizelman A, 2000, SYNTHESIS-STUTTGART, P1952; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Ting HM, 2013, NEW PHYTOL, V199, P352, DOI 10.1111/nph.12274; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yoneyama K., 2013, INDUCTION GERMINATIO; Yoneyama K, 2009, PEST MANAG SCI, V65, P467, DOI 10.1002/ps.1726; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141	51	218	236	10	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1028	+		10.1038/nchembio.1660	http://dx.doi.org/10.1038/nchembio.1660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25344813				2022-12-25	WOS:000345122300010
J	Doroghazi, JR; Albright, JC; Goering, AW; Ju, KS; Haines, RR; Tchalukov, KA; Labeda, DP; Kelleher, NL; Metcalf, WW				Doroghazi, James R.; Albright, Jessica C.; Goering, Anthony W.; Ju, Kou-San; Haines, Robert R.; Tchalukov, Konstantin A.; Labeda, David P.; Kelleher, Neil L.; Metcalf, William W.			A roadmap for natural product discovery based on large-scale genomics and metabolomics	NATURE CHEMICAL BIOLOGY			English	Article							GENE-CLUSTER; DATABASE; POLYKETIDE; IDENTIFICATION; BIOSYNTHESIS; ANTIBIOTICS; FAMILIES; DOMAINS	Actinobacteria encode a wealth of natural product biosynthetic gene clusters, whose systematic study is complicated by numerous repetitive motifs. By combining several metrics, we developed a method for the global classification of these gene clusters into families (GCFs) and analyzed the biosynthetic capacity of Actinobacteria in 830 genome sequences, including 344 obtained for this project. The GCF network, comprising 11,422 gene clusters grouped into 4,122 GCFs, was validated in hundreds of strains by correlating confident mass spectrometric detection of known small molecules with the presence or absence of their established biosynthetic gene clusters. The method also linked previously unassigned GCFs to known natural products, an approach that will enable de novo, bioassay-free discovery of new natural products using large data sets. Extrapolation from the 830-genome data set reveals that Actinobacteria encode hundreds of thousands of future drug leads, and the strong correlation between phylogeny and GCFs frames a roadmap to efficiently access them.	[Doroghazi, James R.; Ju, Kou-San; Metcalf, William W.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Albright, Jessica C.; Goering, Anthony W.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Albright, Jessica C.; Goering, Anthony W.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Albright, Jessica C.; Goering, Anthony W.; Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Haines, Robert R.; Tchalukov, Konstantin A.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [Labeda, David P.] USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Kelleher, NL (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	n-kelleher@northwestern.edu; metcalf@illinois.edu		Ju, Kou-San/0000-0003-0438-6740; Metcalf, William/0000-0002-0182-0671	Institute for Genomic Biology fellowship; US National Institutes of Health [GM PO1 GM077596, GM 067725]; Institute for Genomic Biology Proof of Concept grant; ARS National Program [301]; ARS [ARS-0424489] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, R01GM067725] Funding Source: NIH RePORTER	Institute for Genomic Biology fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Genomic Biology Proof of Concept grant; ARS National Program; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.R.D. was funded through an Institute for Genomic Biology fellowship. This work was supported in part by US National Institutes of Health grants GM PO1 GM077596 and GM 067725 (N.L.K.) and an Institute for Genomic Biology Proof of Concept grant. D.P.L. and the Agricultural Research Service (ARS) Culture Collection Current Research Information System project is funded through ARS National Program 301.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; Bunge J, 2014, ANNU REV STAT APPL, V1, P427, DOI 10.1146/annurev-statistics-022513-115654; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Charlop-Powers Z, 2014, P NATL ACAD SCI USA, V111, P3757, DOI 10.1073/pnas.1318021111; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Conway KR, 2013, NUCLEIC ACIDS RES, V41, pD402, DOI 10.1093/nar/gks993; Diminic J, 2013, J IND MICROBIOL BIOT, V40, P653, DOI 10.1007/s10295-013-1252-z; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Doroghazi JR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-611; Dunbar KL, 2012, NAT CHEM BIOL, V8, P569, DOI [10.1038/NCHEMBIO.944, 10.1038/nchembio.944]; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Ichikawa N, 2013, NUCLEIC ACIDS RES, V41, pD408, DOI 10.1093/nar/gks1177; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Kim J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-169; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Raghupathy N, 2009, MOL BIOL EVOL, V26, P957, DOI 10.1093/molbev/msp002; Tae H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-327; Wang XL, 2013, MOL BIOSYST, V9, P1286, DOI 10.1039/c3mb70081j; Yadav G, 2003, NUCLEIC ACIDS RES, V31, P3654, DOI 10.1093/nar/gkg607; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	24	306	317	10	207	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					963	968		10.1038/NCHEMBIO.1659	http://dx.doi.org/10.1038/NCHEMBIO.1659			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25262415	Green Accepted			2022-12-25	WOS:000343621500020
J	Suzuki, T; Tanaka, K; Wakabayashi, C; Saita, E; Yoshida, M				Suzuki, Toshiharu; Tanaka, Kazumi; Wakabayashi, Chiaki; Saita, Ei-ichiro; Yoshida, Masasuke			Chemomechanical coupling of human mitochondrial F-1-ATPase motor	NATURE CHEMICAL BIOLOGY			English	Article							BOVINE F-1-ATPASE; ATP SYNTHASE; ESCHERICHIA-COLI; INHIBITOR PROTEIN; GAMMA-SUBUNIT; F-1 MOTOR; ROTATION; MECHANISM; ACTIVATION; RESOLUTION	The rotary motor enzyme F-1-ATPase (F-1) is a catalytic subcomplex of F0F1-ATP synthase that produces most of the ATP in respiring cells. Chemomechanical coupling has been studied extensively for bacterial F-1 but very little for mitochondrial F-1. Here we report ATP-driven rotation of human mitochondrial F-1. A rotor-shaft gamma-subunit in the stator alpha(3)beta(3) ring rotates 1200 per ATP with three catalytic steps: ATP binding to one beta-subunit at 0 degrees, inorganic phosphate (P-i) release from another beta-subunit at 65 degrees and ATP hydrolysis on the third beta-subunit at 90 degrees. Rotation is often interrupted at 900 by persistent ADP binding and is stalled at 65 degrees by a specific inhibitor azide. A mitochondrial endogenous inhibitor for F0F1-ATP synthase, IF1, blocks rotation at 90 degrees. These features differ from those of bacterial F-1, in which both ATP hydrolysis and P-i release occur at around 80 degrees, demonstrating that chemomechanical coupling angles of the gamma-subunit are tuned during evolution.	[Suzuki, Toshiharu; Yoshida, Masasuke] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Tanaka, Kazumi; Wakabayashi, Chiaki; Saita, Ei-ichiro; Yoshida, Masasuke] Japan Sci & Technol Corp JST, Int Res Project ICORP, ATP Synth Regulat Project, Miraikan,Koto Ku, Tokyo, Japan; [Suzuki, Toshiharu] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Tanaka, Kazumi; Saita, Ei-ichiro; Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 603, Japan	Waseda University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Kyoto Sangyo University	Suzuki, T (corresponding author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan.	toshisuz@aoni.waseda.jp; masasuke.yoshida@cc.kyoto-su.ac.jp			Japan Society for the Promotion of Science [24570149, 23227006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank our colleagues B. Feniouk, N. Taniguchi and K. Sugawara (Japan Science and Technology Agency), S. Furuike (Osaka Medical college), K. Kinosita Jr., N. Soga and K. Adachi (Waseda University) and T. Hisabori (Tokyo Institute of Technology) for their valuable discussions. S. Furuike helped T.S. in setting up the center-shielded dark-field microscopic system. We thank K. Adachi (Waseda University) for the kind gift of the software program Center-5. The cDNA library from human lung cells was a kind gift from F. Ishikawa of Kyoto University and M. Fujikawa of the Japan Science and Technology Agency. This work was supported in part by grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (grant numbers 24570149 (T.S.) and 23227006 (M.Y.)).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	41	60	61	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					930	936		10.1038/NCHEMBIO.1635	http://dx.doi.org/10.1038/NCHEMBIO.1635			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25242551				2022-12-25	WOS:000343621500015
J	Watson, CL; Mahe, MM; Munera, J; Howell, JC; Sundaram, N; Poling, HM; Schweitzer, JI; Vallance, JE; Mayhew, CN; Sun, Y; Grabowski, G; Finkbeiner, SR; Spence, JR; Shroyer, NF; Wells, JM; Helmrath, MA				Watson, Carey L.; Mahe, Maxime M.; Munera, Jorge; Howell, Jonathan C.; Sundaram, Nambirajan; Poling, Holly M.; Schweitzer, Jamie I.; Vallance, Jefferson E.; Mayhew, Christopher N.; Sun, Ying; Grabowski, Gregory; Finkbeiner, Stacy R.; Spence, Jason R.; Shroyer, Noah F.; Wells, James M.; Helmrath, Michael A.			An in vivo model of human small intestine using pluripotent stem cells	NATURE MEDICINE			English	Article							SMALL-BOWEL; TRANSPLANTATION; RESECTION; VITRO; PROLIFERATION; EPITHELIUM; EXPANSION; COLON; DIFFERENTIATION; ORGANOIDS	Differentiation of human pluripotent stem cells (hPSCs) into organ-specific subtypes offers an exciting avenue for the study of embryonic development and disease processes, for pharmacologic studies and as a potential resource for therapeutic transplant(1,2). To date, limited in vivo models exist for human intestine, all of which are dependent upon primary epithelial cultures or digested tissue from surgical biopsies that include mesenchymal cells transplanted on biodegradable scaffolds(3,4). Here, we generated human intestinal organoids (HIOs) produced in vitro from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs)(5,6) that can engraft in vivo. These HIOs form mature human intestinal epithelium with intestinal stem cells contributing to the cryptvillus architecture and a laminated human mesenchyme, both supported by mouse vasculature ingrowth. In vivo transplantation resulted in marked expansion and maturation of the epithelium and mesenchyme, as demonstrated by differentiated intestinal cell lineages (enterocytes, goblet cells, Paneth cells, tuft cells and enteroendocrine cells), presence of functional brush-border enzymes (lactase, sucrase-isomaltase and dipeptidyl peptidase 4) and visible subepithelial and smooth muscle layers when compared with HIOs in vitro. Transplanted intestinal tissues demonstrated digestive functions as shown by permeability and peptide uptake studies. Furthermore, transplanted HIO-derived tissue was responsive to systemic signals from the host mouse following ileocecal resection, suggesting a role for circulating factors in the intestinal adaptive response(7-9). This model of the human small intestine may pave the way for studies of intestinal physiology, disease and translational studies.	[Watson, Carey L.; Mahe, Maxime M.; Sundaram, Nambirajan; Poling, Holly M.; Helmrath, Michael A.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Watson, Carey L.; Helmrath, Michael A.] Univ Cincinnati, Dept Gen Surg, Cincinnati, OH USA; [Munera, Jorge; Schweitzer, Jamie I.; Mayhew, Christopher N.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Howell, Jonathan C.] Cincinnati Childrens Hosp Med Ctr, Dept Endocrinol, Cincinnati, OH 45229 USA; [Vallance, Jefferson E.; Shroyer, Noah F.] Cincinnati Childrens Hosp Med Ctr, Dept Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory] Cincinnati Childrens Hosp Med Ctr, Dept Human Genet, Cincinnati, OH 45229 USA; [Grabowski, Gregory] Synageva Corp, Lexington, MA USA; [Finkbeiner, Stacy R.; Spence, Jason R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Shroyer, Noah F.] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; Baylor College of Medicine	Helmrath, MA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA.	michael.helmrath@cchmc.org	Mahe, Maxime M/G-5552-2017; Mayhew, Christopher N/AGB-4929-2022	Mahe, Maxime M/0000-0003-2560-193X; poling, holly/0000-0002-3595-1944; Vallance, Jefferson/0000-0001-6473-3623; Mayhew, Chris/0000-0002-7408-1726	US National Institutes of Health (NIH) [NIH-DK092456, NIH-U18NS080815, R01DK098350, NIH-DK092306, NIH-CA142826, N1H-R01DK083325, NIH P30 DK078392, NIH UL1RR026314, NIH-DK36729, NIH-K01DK091415, NIH-P30DK034933, NIH-DK094775]; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092306, R01DK092456, R01DK083325, P30DK034933, R01DK098350, K01DK091415, T32DK094775, U01DK103117, R01DK036729, P30DK078392] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported in part by US National Institutes of Health (NIH) grants NIH-DK092456 (J.M.W. and N.F.S.), NIH-U18NS080815 and R01DK098350 (J.M.W.), NIH-DK092306 and NIH-CA142826 (N.E.S.), N1H-R01DK083325 (M.A.H.), NIH P30 DK078392 (Digestive Health Center, Cincinnati Children Hospital Medical Center), NIH UL1RR026314 (Clinical and Translational Science Awards (CTSA), University of Cincinnati), NIH-DK36729 (G.G.), NIH-K01DK091415 (J.R.S.), NIH-P30DK034933 (University of Michigan) and NIH-DK094775 (S.R.F.).	Agopian VG, 2009, J GASTROINTEST SURG, V13, P971, DOI 10.1007/s11605-009-0806-x; Avansino JR, 2006, SURGERY, V140, P423, DOI 10.1016/j.surg.2006.03.012; CAMPBELL FC, 1993, GUT, V34, P1153, DOI 10.1136/gut.34.9.1153; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Dekaney CM, 2007, AM J PHYSIOL-GASTR L, V293, pG1013, DOI 10.1152/ajpgi.00218.2007; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Juno RJ, 2003, J PEDIATR SURG, V38, P868, DOI 10.1016/S0022-3468(03)00113-1; Juno RJ, 2002, SURGERY, V132, P377, DOI 10.1067/msy.2002.125724; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kovalenko PL, 2013, JAMA SURG, V148, P1013, DOI 10.1001/jamasurg.2013.3572; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Levin DE, 2013, J PEDIATR SURG, V48, P129, DOI 10.1016/j.jpedsurg.2012.10.029; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; TAIT IS, 1994, DIFFERENTIATION, V56, P91, DOI 10.1046/j.1432-0436.1994.56120091.x; TAIT IS, 1994, AM J SURG, V167, P67, DOI 10.1016/0002-9610(94)90055-8; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; WILLIAMSON RCN, 1978, GASTROENTEROLOGY, V75, P249; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	26	343	363	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1310	1314		10.1038/nm.3737	http://dx.doi.org/10.1038/nm.3737			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326803	Green Accepted			2022-12-25	WOS:000344724300020
J	Zhang, M; Wang, YX; Jones, S; Sausen, M; McMahon, K; Sharma, R; Wang, Q; Belzberg, AJ; Chaichana, K; Gallia, GL; Gokaslan, ZL; Riggins, GJ; Wolinksy, JP; Wood, LD; Montgomery, EA; Hruban, RH; Kinzler, KW; Papadopoulos, N; Vogelstein, B; Bettegowda, C				Zhang, Ming; Wang, Yuxuan; Jones, Sian; Sausen, Mark; McMahon, Kevin; Sharma, Rajni; Wang, Qing; Belzberg, Allan J.; Chaichana, Kaisorn; Gallia, Gary L.; Gokaslan, Ziya L.; Riggins, Greg J.; Wolinksy, Jean-Paul; Wood, Laura D.; Montgomery, Elizabeth A.; Hruban, Ralph H.; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Vogelstein, Bert; Bettegowda, Chetan			Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NEUROFIBROMATOSIS TYPE-1; CELL-PROLIFERATION; NF1 MICRODELETIONS; CANCER CELLS; PHENOTYPE; GENOTYPE; GENES	Neurofibromatosis 1 is a hereditary syndrome characterized by the development of numerous benign neurofibromas, a small subset of which progress to malignant peripheral nerve sheath tumors (MPNSTs). To better understand the genetic basis for MPNSTs, we performed genome-wide or targeted sequencing on 50 cases. Sixteen MPNSTs but none of the neurofibromas tested were found to have somatic mutations in SUZ12, implicating it as having a central role in malignant transformation.	[Zhang, Ming; Wang, Yuxuan; McMahon, Kevin; Wang, Qing; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Vogelstein, Bert; Bettegowda, Chetan] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA; [Zhang, Ming; Wang, Yuxuan; McMahon, Kevin; Wang, Qing; Kinzler, Kenneth W.; Papadopoulos, Nickolas; Vogelstein, Bert; Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Sausen, Mark] Personalized Genome Diagnost, Baltimore, MD USA; [Sharma, Rajni; Wood, Laura D.; Montgomery, Elizabeth A.; Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Belzberg, Allan J.; Chaichana, Kaisorn; Gallia, Gary L.; Gokaslan, Ziya L.; Riggins, Greg J.; Wolinksy, Jean-Paul; Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA.	vogelbe@jhmi.edu; cbetteg1@jhmi.edu	Wood, Laura/ABF-1531-2020	Sharma, Rajni/0000-0003-0393-0943; Sausen, Mark/0000-0002-2916-5269	Virginia and D.K. Ludwig Fund for Cancer Research; Burroughs Wellcome Career Award for Medical Scientists; Johns Hopkins Clinical Scientist Award; Doris Duke Charitable Foundation [2014107]; NATIONAL CANCER INSTITUTE [P30CA006973, R37CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Virginia and D.K. Ludwig Fund for Cancer Research; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Johns Hopkins Clinical Scientist Award; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our patients for their courage and generosity. We also thank J. Ptak, N. Silliman, L. Dobbyn, J. Schaeffer and M. Papoli for expert technical assistance. The work was supported by the Virginia and D.K. Ludwig Fund for Cancer Research, a Burroughs Wellcome Career Award for Medical Scientists, a Johns Hopkins Clinical Scientist Award and grant 2014107 from the Doris Duke Charitable Foundation.	Benoit YD, 2013, J CELL PHYSIOL, V228, P764, DOI 10.1002/jcp.24224; Brecqueville M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.31; CAREY JC, 1986, ANN NY ACAD SCI, V486, P45, DOI DOI 10.1111/J.1749-6632.1986.TB48061.X; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Cui YJ, 2013, CELL PHYSIOL BIOCHEM, V31, P778, DOI 10.1159/000350095; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Liu CH, 2014, TUMOR BIOL, V35, P6073, DOI 10.1007/s13277-014-1804-5; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Pasmant E, 2012, J MED GENET, V49, P483, DOI 10.1136/jmedgenet-2012-100978; Pasmant E, 2010, HUM MUTAT, V31, pE1506, DOI 10.1002/humu.21271; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Yuen BTK, 2013, CANCER CELL, V24, P567, DOI 10.1016/j.ccr.2013.09.015; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zou CY, 2009, ANN SURG, V249, P1014, DOI 10.1097/SLA.0b013e3181a77e9a	19	170	171	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1170	1172		10.1038/ng.3116	http://dx.doi.org/10.1038/ng.3116			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25305755	Green Accepted			2022-12-25	WOS:000344131900007
J	Caboche, S				Caboche, Segolene			BIOSYNTHESIS Bioinformatics bolster a renaissance	NATURE CHEMICAL BIOLOGY			English	News Item							INSIGHTS		[Caboche, Segolene] Univ Lille Nord France, CNRS, FRE Mol & Cellular Medecine 3642, Transcript & Appl Genom CIIL Inst Pasteur Lille, Lille, France; [Caboche, Segolene] Univ Lille Nord France, Lille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Caboche, S (corresponding author), Univ Lille Nord France, CNRS, FRE Mol & Cellular Medecine 3642, Transcript & Appl Genom CIIL Inst Pasteur Lille, Lille, France.	segolene.caboche@pasteur-lille.fr		Caboche, Segolene/0000-0002-3658-3477				Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Letzel AC, 2013, NAT PROD REP, V30, P392, DOI 10.1039/c2np20103h; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084028; Weber T, 2014, INT J MED MICROBIOL, V304, P230, DOI 10.1016/j.ijmm.2014.02.001; Wilson MC, 2013, CHEM BIOL, V20, P636, DOI 10.1016/j.chembiol.2013.04.011; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111	9	7	8	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					798	800		10.1038/nchembio.1634	http://dx.doi.org/10.1038/nchembio.1634			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25229448				2022-12-25	WOS:000342462100003
J	Wallberg, A; Han, F; Wellhagen, G; Dahle, B; Kawata, M; Haddad, N; Simoes, ZLP; Allsopp, MH; Kandemir, I; De la Rua, P; Pirk, CW; Webster, MT				Wallberg, Andreas; Han, Fan; Wellhagen, Gustaf; Dahle, Bjorn; Kawata, Masakado; Haddad, Nizar; Paulino Simoes, Zila Luz; Allsopp, Mike H.; Kandemir, Irfan; De la Rua, Pilar; Pirk, Christian W.; Webster, Matthew T.			A worldwide survey of genome sequence variation provides insight into the evolutionary history of the honeybee Apis mellifera	NATURE GENETICS			English	Article							MATING FREQUENCY; GENE-EXPRESSION; DNA METHYLATION; BEE; AFRICAN; WORKER; VITELLOGENIN; CONSERVATION; POPULATIONS; COLONIES	The honeybee Apis mellifera has major ecological and economic importance. We analyze patterns of genetic variation at 8.3 million SNPs, identified by sequencing 140 honeybee genomes from a worldwide sample of 14 populations at a combined total depth of 634x. These data provide insight into the evolutionary history and genetic basis of local adaptation in this species. We find evidence that population sizes have fluctuated greatly, mirroring historical fluctuations in climate, although contemporary populations have high genetic diversity, indicating the absence of domestication bottlenecks. Levels of genetic variation are strongly shaped by natural selection and are highly correlated with patterns of gene expression and DNA methylation. We identify genomic signatures of local adaptation, which are enriched in genes expressed in workers and in immune system and sperm motility related genes that might underlie geographic variation in reproduction, dispersal and disease resistance. This study provides a framework for future investigations into responses to pathogens and climate change in honeybees.	[Wallberg, Andreas; Han, Fan; Wellhagen, Gustaf; Webster, Matthew T.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Dahle, Bjorn] Norwegian Beekeepers Assoc, Klofta, Norway; [Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan; [Haddad, Nizar] Natl Ctr Agr Res & Extens, Bee Res Dept, Amman, Jordan; [Paulino Simoes, Zila Luz] Univ Sao Paulo, Dept Biol, Sao Paulo, Brazil; [Allsopp, Mike H.] Agr Res Council, Plant Protect Res Inst, Stellenbosch, South Africa; [Kandemir, Irfan] Ankara Univ, Dept Biol, TR-06100 Ankara, Turkey; [De la Rua, Pilar] Univ Murcia, Dept Zool & Phys Anthropol, Murcia, Spain; [Pirk, Christian W.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	Uppsala University; Tohoku University; Universidade de Sao Paulo; Agricultural Research Council of South Africa; Ankara University; University of Murcia; University of Pretoria	Wallberg, A (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	andreas.wallberg@imbim.uu.se; matthew.webster@imbim.uu.se	De la Rúa, Pilar/A-4578-2009; kandemir, irfan/L-3944-2019; Haddad, Nizar/H-9421-2015; Kawata, Masakado/E-3962-2012; Pirk, Christian/E-4180-2010	De la Rúa, Pilar/0000-0002-0058-1402; Haddad, Nizar/0000-0003-0250-5291; Pirk, Christian/0000-0001-6821-7044; Webster, Matthew/0000-0003-1141-2863; kandemir, irfan/0000-0002-2888-1044; Kawata, Masakado/0000-0001-8716-5438; Dahle, Bjorn/0000-0002-5131-2405; Wallberg, Andreas/0000-0002-9081-9663; Simoes, Zila Luz Paulino/0000-0003-2363-6178; Wellhagen, Gustaf/0000-0002-7228-0422	Swedish Research Council Formas [2010-1295]; Grants-in-Aid for Scientific Research [26650153] Funding Source: KAKEN	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank I. Fries, J. Evans, M. Lodesani, M. Spivak, I. Arvidsson, A. Yusuf and P. Rosenkranz for providing samples. We also thank I. Jonasson, C. Tellgren-Roth, L. Nyberg and the Uppsala Genome Centre for performing the sequencing and mapping. Bioinformatic analyses were performed using resources at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). We thank I. Fries, D. Hultmark, A. Eyre-Walker, M. Jakobsson, L. Andersson and K. Lindblad-Toh for helpful discussions and comments on the manuscript. This study was funded by the Swedish Research Council Formas (grant 2010-1295).	Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Baudry E, 1998, P ROY SOC B-BIOL SCI, V265, P2009, DOI 10.1098/rspb.1998.0533; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; DeGrandi-Hoffman G, 2003, APIDOLOGIE, V34, P111, DOI 10.1051/apido:2003007; Dietemann V, 2009, APIDOLOGIE, V40, P285, DOI 10.1051/apido/2009013; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Fazier M, 2010, APIDOLOGIE, V41, P463, DOI 10.1051/apido/2009073; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Franck P, 2000, INSECT SOC, V47, P364, DOI 10.1007/PL00001732; Fries I, 2003, J ECON ENTOMOL, V96, P1641, DOI 10.1603/0022-0493-96.6.1641; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Han F, 2012, ECOL EVOL, V2, P1949, DOI 10.1002/ece3.312; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Hepburn H.R., 1998, HONEYBEES AFRICA; Hernandez-Garcia R, 2009, J APICULT RES, V48, P121, DOI 10.3896/IBRA.1.48.2.06; Jaffe R, 2009, MOL ECOL, V18, P1511, DOI 10.1111/j.1365-294X.2009.04143.x; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Martin SJ, 2004, TRENDS PARASITOL, V20, P112, DOI 10.1016/j.pt.2004.01.001; Moritz RFA, 2007, J INSECT CONSERV, V11, P391, DOI 10.1007/s10841-006-9054-5; Nakayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022984; Nanty L, 2011, GENOME RES, V21, P1841, DOI 10.1101/gr.121640.111; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Sarda S, 2012, MOL BIOL EVOL, V29, P1907, DOI 10.1093/molbev/mss062; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Wakeley J., 2009, COALESCENT THEORY; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Zayed A, 2012, GENES BRAIN BEHAV, V11, P253, DOI 10.1111/j.1601-183X.2011.00750.x	44	202	211	7	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1081	1088		10.1038/ng.3077	http://dx.doi.org/10.1038/ng.3077			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151355	Green Published			2022-12-25	WOS:000342554100010
J	Li, S; Tighe, SW; Nicolet, CM; Grove, D; Levy, S; Farmerie, W; Viale, A; Wright, C; Schweitzer, PA; Gao, Y; Kim, D; Boland, J; Hicks, B; Kim, R; Chhangawala, S; Jafari, N; Raghavachari, N; Gandara, J; Garcia-Reyero, N; Hendrickson, C; Roberson, D; Rosenfeldr, J; Smith, T; Underwood, JG; Wang, M; Zumbo, P; Baldwin, DA; Grills, GS; Mason, CE				Li, Sheng; Tighe, Scull W.; Nicolet, Charles M.; Grove, Deborah; Levy, Shawn; Farmerie, William; Viale, Agnes; Wright, Chris; Schweitzer, Peter A.; Gao, Yuan; Kim, Dewey; Boland, Joe; Hicks, Belynda; Kim, Ryan; Chhangawala, Sagar; Jafari, Nadereh; Raghavachari, Nalini; Gandara, Jorge; Garcia-Reyero, Natalia; Hendrickson, Cynthia; Roberson, David; Rosenfeldr, Jeffrey; Smith, Todd; Underwood, Jason G.; Wang, May; Zumbo, Paul; Baldwin, Don A.; Grills, George S.; Mason, Christopher E.			Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; REPRODUCIBILITY; TECHNOLOGIES; GENOMES	High-throughput RNA sequencing (RNA-seq) greatly expands the potential for genomics discoveries, but the wide variety of platforms, protocols and performance capabilitites has created the need for comprehensive reference data. Here we describe the Association of Biomolecular Resource Facilities next-generation sequencing (ABRF-NGS) study on RNA-seq. We carried out replicate experiments across 15 laboratory sites using reference RNA standards to test four protocols (poly-A-selected, ribo-depleted, size-selected and degraded) on five sequencing platforms (Illumina HiSeq, Life Technologies PGM and Proton, Pacific Biosciences RS and Roche 454). The results show high intraplatform (Spearman rank R > 0.86) and inter-platform (R > 0.83) concordance for expression measures across the deep-count platforms, but highly variable efficiency and cost for splice junction and variant detection between all platforms. For intact RNA, gene expression profiles from rRNA-depletion and poly-A enrichment are similar. In addition, rRNA depletion enables effective analysis of degraded RNA samples. This study provides a broad foundation for cross-platform standardization, evaluation and improvement of RNA-seq.	[Li, Sheng; Chhangawala, Sagar; Gandara, Jorge; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Li, Sheng; Chhangawala, Sagar; Gandara, Jorge; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Tighe, Scull W.] Univ Vermont, Vermont Canc Ctr, Burlington, VT USA; [Nicolet, Charles M.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Grove, Deborah] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Farmerie, William] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Wright, Chris] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Schweitzer, Peter A.; Grills, George S.] Cornell Univ, Inst Biotechnol, Biotechnol Resource Ctr, Ithaca, NY USA; [Gao, Yuan; Kim, Dewey] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Boland, Joe; Hicks, Belynda; Roberson, David] NIH NCI SAIC Frederick, Gaithersburg, MD USA; [Kim, Ryan] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Raghavachari, Nalini] NHLBI, NIH, Bethesda, MD 20892 USA; [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA; [Rosenfeldr, Jeffrey] Univ Med & Dent New Jersey, Div High Performance & Res Comp, Newark, NJ 07103 USA; [Smith, Todd] PerkinElmer Inc, Seattle, WA USA; [Underwood, Jason G.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wang, May] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Wang, May] Emory Univ, Atlanta, GA 30322 USA; [Baldwin, Don A.] Pathonomics LLC, Philadelphia, PA 19104 USA; [Mason, Christopher E.] Fell Family Brain & Mind Res Inst, New York, NY USA	Cornell University; Cornell University; University of Vermont; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; HudsonAlpha Institute for Biotechnology; State University System of Florida; University of Florida; Memorial Sloan Kettering Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California Davis; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mississippi State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology; Emory University	Baldwin, DA (corresponding author), Pathonomics LLC, Philadelphia, PA 19104 USA.	pathonomics@gmail.com; gsg34@cornell.edu; chm2042@med.cornell.edu	Wang, May Dongmei/AAF-2065-2021; Mason, Christopher/HCH-3977-2022	Wang, May Dongmei/0000-0003-3961-3608; Chhangawala, Sagar/0000-0001-9626-1034; Levy, Shawn/0000-0002-1369-5740	National Institutes of Health (NIH) [R01HG006798, R01NS076465, R24RR032341]; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium [I7-A765]; Illumina; Life Technologies; Pacific Biosciences; Roche Life Sciences; Association of Biomolecular Resource Facilities (ABRF); NATIONAL CANCER INSTITUTE [U10CA180827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032341] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011172] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium; Illumina; Life Technologies; Pacific Biosciences; Roche Life Sciences; Association of Biomolecular Resource Facilities (ABRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We greatly appreciate the contribution and distribution of reference sample RNA from L. Shi (FDA) and his valuable interactions to assist in the planning of this study. This work was supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, R24RR032341, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765).; We would also like to thank the platform vendors, Illumina, Life Technologies, Pacific Biosciences and Roche Life Sciences, for their support of this study, and their distinguished scientists for providing technical expertise and assistance in study designs, protocols, new methods development and significant contributions of reagents and sequencing kits. In particular, alphabetically by vendor: G. Schroth (Illumina); M. Gallad, J. Smith, T. Bittick, R. Setterquist and G. Scott (Life Technologies); J. Korlach, S. Turner and E. Tseng (Pacific Biosciences); and K. Fredrickson and C. Telling (Roche Life Sciences).; We are sincerely appreciative of the Association of Biomolecular Resource Facilities (ABRF) for supporting this study and the contributing ABRF Research Groups. Special thanks to our ABRF executive board liaison A. Perera (Stowers Institute for Medical Research).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angeletti RH, 1999, FASEB J, V13, P595; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moelans CB, 2011, J CLIN PATHOL, V64, P960, DOI 10.1136/jclinpath-2011-200152; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U., 2010, CURR PROTOC MOL BIOL, V89; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	48	141	142	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					915	925		10.1038/nbt.2972	http://dx.doi.org/10.1038/nbt.2972			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150835	Green Accepted			2022-12-25	WOS:000342600300031
J	Molyneux, SD; Waterhouse, PD; Shelton, D; Shao, YW; Watling, CM; Tang, QL; Harris, IS; Dickson, BC; Tharmapalan, P; Sandve, GK; Zhang, XY; Bailey, SD; Berman, H; Wunder, JS; Iszvak, Z; Lupien, M; Mak, TW; Khokha, R				Molyneux, Sam D.; Waterhouse, Paul D.; Shelton, Dawne; Shao, Yang W.; Watling, Christopher M.; Tang, Qing-Lian; Harris, Isaac S.; Dickson, Brendan C.; Tharmapalan, Pirashaanthy; Sandve, Geir K.; Zhang, Xiaoyang; Bailey, Swneke D.; Berman, Hal; Wunder, Jay S.; Iszvak, Zsuzsanna; Lupien, Mathieu; Mak, Tak W.; Khokha, Rama			Human somatic cell mutagenesis creates genetically tractable sarcomas	NATURE GENETICS			English	Article							CANCER GENE DISCOVERY; SLEEPING-BEAUTY; INSERTIONAL MUTAGENESIS; CHROMOSOMAL-ABERRATIONS; TRANSPOSON; MOUSE; HETEROCHROMATIN; SCREEN; RNA; IDENTIFICATION	Creating spontaneous yet genetically tractable human tumors from normal cells presents a fundamental challenge. Here we combined retroviral and transposon insertional mutagenesis to enable cancer gene discovery starting with human primary cells. We used lentiviruses to seed gain- and loss-of-function gene disruption elements, which were further deployed by Sleeping Beauty transposons throughout the genome of human bone explant mesenchymal cells. De novo tumors generated rapidly in this context were high-grade myxofibrosarcomas. Tumor insertion sites were enriched in recurrent somatic copy-number aberration regions from multiple cancer types and could be used to pinpoint new driver genes that sustain somatic alterations in patients. We identified HDLBP, which encodes the RNA-binding protein vigilin, as a candidate tumor suppressor deleted at 2q37.3 in greater than one out of ten tumors across multiple tissues of origin. Hybrid viral-transposon systems may accelerate the functional annotation of cancer genomes by enabling insertional mutagenesis screens in higher eukaryotes that are not amenable to germline transgenesis.	[Molyneux, Sam D.; Waterhouse, Paul D.; Shao, Yang W.; Watling, Christopher M.; Tang, Qing-Lian; Harris, Isaac S.; Tharmapalan, Pirashaanthy; Zhang, Xiaoyang; Bailey, Swneke D.; Berman, Hal; Lupien, Mathieu; Mak, Tak W.; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Shelton, Dawne] Digital Biol Ctr, Biorad Labs, Pleasanton, CA USA; [Dickson, Brendan C.; Wunder, Jay S.] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Dickson, Brendan C.; Wunder, Jay S.] Mt Sinai Hosp, Div Orthopaed Surg, Toronto, ON M5G 1X5, Canada; [Sandve, Geir K.] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Iszvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Oslo; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, Dept Med Biophys, 500 Sherbourne St, Toronto, ON M5S 1A1, Canada.	rkhokha@uhnres.utoronto.ca	Dickson, Brendan C/J-2347-2016	Dickson, Brendan C/0000-0003-2269-6216; Khokha, Rama/0000-0002-6028-1524; Sandve, Geir Kjetil/0000-0002-4959-1409; Izsvak, Zsuzsanna/0000-0002-2053-2384; Waterhouse, Paul/0000-0001-8745-5224; Lupien, Mathieu/0000-0003-0929-9478; Harris, Isaac/0000-0002-6855-2763	Canadian Institutes of Health Research (CIHR) Banting and Best Doctoral Research Award; Ontario Institute for Cancer Research (OICR) [09NOV-328]; Canadian Cancer Society Research Institute (CCSRI) [2012 701468]	Canadian Institutes of Health Research (CIHR) Banting and Best Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research (OICR); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS))	S.D.M. was supported by the Canadian Institutes of Health Research (CIHR) Banting and Best Doctoral Research Award. This project was supported by Ontario Institute for Cancer Research (OICR; grant 09NOV-328) and Canadian Cancer Society Research Institute (CCSRI; grant 2012 701468) grants to R.K. We thank D. Largaespada (University of Minnesota) and Z. Izsvak (Max Delbruck Center) for providing materials related to the Sleeping Beauty transposon, J. Moffat (Donnelly Center) for providing lentiviral vectors, C. Miskey (Max Delbruck Center) for discussions related to LAM-PCR and K. Munger (Harvard Medical School) for providing the UBR4 knockdown vector. We also thank all core facility services involved in this work, especially L. Lau at The Centre for Applied Genomics, J. Pittman for electron microscopy and G. Kuruzar for immunohistochemistry. We also thank M. Di Grappa for facilitating artwork.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berquam-Vrieze KE, 2011, BLOOD, V118, P4646, DOI 10.1182/blood-2011-03-343947; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Fernandez HR, 2005, CURR BIOL, V15, pR132, DOI 10.1016/j.cub.2005.02.012; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mentzel T., 2002, PATHOLOGY GENETICS T, P102; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Woo HH, 2011, MOL CELL BIOL, V31, P215, DOI 10.1128/MCB.01031-10; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yen CC, 2009, INT J ONCOL, V35, P775, DOI 10.3892/ijo_00000390; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Zhou J, 2008, RNA, V14, P1773, DOI 10.1261/rna.1036308	47	26	26	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					964	+		10.1038/ng.3065	http://dx.doi.org/10.1038/ng.3065			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129143				2022-12-25	WOS:000341579400010
J	Quinn, JJ; Ilik, IA; Qu, K; Georgiev, P; Chu, C; Alchtar, A; Chang, HY				Quinn, Jeffrey J.; Ilik, Ibrahim A.; Qu, Kun; Georgiev, Plamen; Chu, Ci; Alchtar, Asifa; Chang, Howard Y.			Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification	NATURE BIOTECHNOLOGY			English	Article							DROSOPHILA X-CHROMOSOME; DOSAGE COMPENSATION; GENE-EXPRESSION; MSL COMPLEX; TRANSCRIPTION; BINDING; SITES; PRINCIPLES; PROTEIN; INACTIVATION	Little is known about the functional domain architecture of long noncoding RNAs (lncRNAs) because of a relative paucity of suitable methods to analyze RNA function at a domain level. Here we describe domain-specific chromatin isolation by RNA purification (dChIRP), a scalable technique to dissect pairwise RNA-RNA, RNA-protein and RNA-chromatin interactions at the level of individual RNA domains in living cells. dChIRP of roX1, a lncRNA essential for Drosophila melanogaster X-chromosome dosage compensation, reveals a 'three-fingered hand' ribonucleoprotein topology. Each RNA finger binds chromatin and the male-specific lethal (MSL) protein complex and can individually rescue male lethality in roX-null flies, thus defining a minimal RNA domain for chromosome-wide dosage compensation. dChIRP improves the RNA genomic localization signal by >20-fold relative to previous techniques, and these binding sites are correlated with chromosome conformation data, indicating that most roX-bound loci cluster in a nuclear territory. These results suggest dChIRP can reveal lncRNA architecture and function with high precision and sensitivity.	[Quinn, Jeffrey J.; Qu, Kun; Chu, Ci; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Quinn, Jeffrey J.; Qu, Kun; Chu, Ci; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Quinn, Jeffrey J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Quinn, Jeffrey J.] Stanford Univ, Sch Engn, Stanford, CA 94305 USA; [Ilik, Ibrahim A.; Georgiev, Plamen; Alchtar, Asifa] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Max Planck Society	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu	Qu, Kun/G-3359-2012	Ilik, Ibrahim Avsar/0000-0003-0966-9504	US National Institutes of Health [R01-CA118750, R01-ES023168]; Max Planck Society; Bio-X Fellowship; DFG [SFB992, SFB746]; EU; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); Bio-X Fellowship; DFG(German Research Foundation (DFG)); EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank members of the Chang and Akhtar labs, P. Sharp and X. Wu (Massachusetts Institute of Technology) for meaningful discussion and E. Larschan (Brown University) for CLAMP antibody. Supported by US National Institutes of Health R01-CA118750 and R01-ES023168 (H.Y.C.), Max Planck Society (A.A.) and Bio-X Fellowship (J.J.Q.). This work was supported by DFG-funded SFB992 and SFB746 and EU-funded EpiGeneSys awarded to A.A. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute; A.A. is part of the BIOSS excellence initiative.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Grimaud C, 2009, GENE DEV, V23, P2490, DOI 10.1101/gad.539509; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Kelley RL, 2008, MECH DEVELOP, V125, P1009, DOI 10.1016/j.mod.2008.08.003; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Park SW, 2007, GENETICS, V177, P1429, DOI 10.1534/genetics.107.071001; Rossetto CC, 2013, J VIROL, V87, P5540, DOI 10.1128/JVI.03111-12; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Stuckenholz C, 2003, GENETICS, V164, P1003; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	119	127	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					933	940		10.1038/nbt.2943	http://dx.doi.org/10.1038/nbt.2943			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	24997788	Green Accepted			2022-12-25	WOS:000342600300033
J	Wang, MH; Yu, Y; Haberer, G; Marri, PR; Fan, CZ; Goicoechea, JL; Zuccolo, A; Song, X; Kudrna, D; Ammiraju, JSS; Cossu, RM; Maldonado, C; Chen, J; Lee, S; Sisneros, N; de Baynast, K; Golser, W; Wissotski, M; Kim, W; Sanchez, P; Ndjiondjop, MN; Sanni, K; Long, MY; Carney, J; Panaud, O; Wicker, T; Machado, CA; Chen, MS; Mayer, KFX; Rounsley, S; Wing, RA				Wang, Muhua; Yu, Yeisoo; Haberer, Georg; Marri, Pradeep Reddy; Fan, Chuanzhu; Goicoechea, Jose Luis; Zuccolo, Andrea; Song, Xiang; Kudrna, Dave; Ammiraju, Jetty S. S.; Cossu, Rosa Maria; Maldonado, Carlos; Chen, Jinfeng; Lee, Seunghee; Sisneros, Nick; de Baynast, Kristi; Golser, Wolfgang; Wissotski, Marina; Kim, Woojin; Sanchez, Paul; Ndjiondjop, Marie-Noelle; Sanni, Kayode; Long, Manyuan; Carney, Judith; Panaud, Olivier; Wicker, Thomas; Machado, Carlos A.; Chen, Mingsheng; Mayer, Klaus F. X.; Rounsley, Steve; Wing, Rod A.			The genome sequence of African rice (Oryza glaberrima) and evidence for independent domestication	NATURE GENETICS			English	Article							SELECTIVE SWEEPS; GENE; ALIGNMENT; SATIVA; EVOLUTION; ENCODES; PROTEIN; ORIGIN; TOOL; RETROTRANSPOSONS	The cultivation of rice in Africa dates back more than 3,000 years. Interestingly, African rice is not of the same origin as Asian rice (Oryza sativa L.) but rather is an entirely different species (i.e., Oryza glaberrima Steud.). Here we present a high-quality assembly and annotation of the O. glaberrima genome and detailed analyses of its evolutionary history of domestication and selection. Population genomics analyses of 20 O. glaberrima and 94 Oryza barthii accessions support the hypothesis that O. glaberrima was domesticated in a single region along the Niger river as opposed to noncentric domestication events across Africa. We detected evidence for artificial selection at a genome-wide scale, as well as with a set of O. glaberrima genes orthologous to O. sativa genes that are known to be associated with domestication, thus indicating convergent yet independent selection of a common set of genes during two geographically and culturally distinct domestication processes.	[Wang, Muhua; Yu, Yeisoo; Fan, Chuanzhu; Goicoechea, Jose Luis; Song, Xiang; Kudrna, Dave; Ammiraju, Jetty S. S.; Maldonado, Carlos; Lee, Seunghee; Sisneros, Nick; de Baynast, Kristi; Golser, Wolfgang; Wissotski, Marina; Kim, Woojin; Sanchez, Paul; Wing, Rod A.] Univ Arizona, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; [Haberer, Georg; Mayer, Klaus F. X.] Helmholtz Ctr Munich, Neuherberg, Germany; [Marri, Pradeep Reddy] Dow AgroSci, Indianapolis, IN USA; [Fan, Chuanzhu] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Ammiraju, Jetty S. S.] DuPont Pioneer, Johnston, IA USA; [Cossu, Rosa Maria] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Chen, Jinfeng; Chen, Mingsheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Sanchez, Paul] US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Ndjiondjop, Marie-Noelle; Sanni, Kayode] Africa Rice Ctr, Cotonou, Benin; [Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Carney, Judith] Univ Calif Los Angeles, Inst Environm & Sustainabil, Dept Geog, Los Angeles, CA USA; [Panaud, Olivier] Univ Perpignan, UMR CNRS Inst Rech Devel, Lab Genome & Dev Plantes, F-66025 Perpignan, France; [Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Machado, Carlos A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University of Arizona; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Dow Chemical Company; Wayne State University; Scuola Superiore Sant'Anna; DuPont; Pioneer Hi-Bred International, Inc.; University of Pisa; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; CGIAR; Africa Rice Center; University of Chicago; University of California System; University of California Los Angeles; Universite Perpignan Via Domitia; University of Zurich; University System of Maryland; University of Maryland College Park	Wing, RA (corresponding author), Univ Arizona, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA.	mschen@genetics.ac.cn; rwing@mail.arizona.edu	Wicker, Thomas/Z-1978-2019; Mayer, Klaus FX/M-7941-2015; Wing, Rod A/Z-2885-2019; Chen, Jinfeng/K-4024-2015; Zuccolo, Andrea/H-5636-2019; Machado, Carlos A/B-8855-2009; Chen, Jinfeng/ABE-4816-2020	Mayer, Klaus FX/0000-0001-6484-1077; Wing, Rod A/0000-0001-6633-6226; Zuccolo, Andrea/0000-0001-7574-0714; Machado, Carlos A/0000-0003-1546-7415; Chen, Jinfeng/0000-0002-5628-6322; Wang, Muhua/0000-0002-5604-6417; , Thomas/0000-0002-6777-7135; Haberer, Georg/0000-0002-6612-6939; Yu, Yeisoo/0000-0002-8410-0310	US National Science Foundation [0321678, 0638541, 0822284, 1026200]; Bud Antle Endowed Chair of Excellence in Agriculture and Life Sciences	US National Science Foundation(National Science Foundation (NSF)); Bud Antle Endowed Chair of Excellence in Agriculture and Life Sciences	This material is based on work supported by the US National Science Foundation under grants #0321678, #0638541, #0822284 and #1026200 to Y.Y., C.A.M., S.R. and R.A.W. and the Bud Antle Endowed Chair of Excellence in Agriculture and Life Sciences to R.A.W. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US National Science Foundation. We thank coauthor J. Carney, author of Black Rice, for her inspiration and encouragement in our attempt to convey the deep-rooted and far-reaching history of African rice farming through the O. glaberrima genome sequence. We thank Z. Lu from Arizona Statistical Consulting Laboratory for statistical advice and J. Ross-Ibarra for comments.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Carney J.A., 2001, BLACK RICE AFRICAN O; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Garrigan D, 2013, EVOL BIOINFORM, V9, P343, DOI 10.4137/EBO.S12751; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Geneva A.J., 2014, NEW METHOD SCAN GENO; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Gross BL, 2010, J EVOLUTION BIOL, V23, P2747, DOI 10.1111/j.1420-9101.2010.02125.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harlan J. R., 1976, ORIGINS AFRICAN PLAN, P3; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kim H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r45; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Littlefield Daniel C., 1991, RICE SLAVES ETHNICIT; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Piao R, 2009, THEOR APPL GENET, V119, P1497, DOI 10.1007/s00122-009-1151-x; PORTERES R, 1962, J AFR HIST, V3, P195, DOI 10.1017/S0021853700003030; Porteres R., 1976, ORIGINS AFRICAN PLAN, P409, DOI DOI 10.1515/9783110806373.409; Porteres R, 1970, PAPERS AFRICAN PREHI, P43; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rounsley S, 2009, RICE, V2, P35, DOI 10.1007/s12284-009-9025-z; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sanchez P.L., 2013, GENETICS GENOMICS RI, P616, DOI DOI 10.1007/978-1-4614-7903-1_2; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Sanyal A, 2010, MOL BIOL EVOL, V27, P2487, DOI 10.1093/molbev/msq133; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Vitte C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-218; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yona G, 2000, NUCLEIC ACIDS RES, V28, P49, DOI 10.1093/nar/28.1.49; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhu KM, 2010, GENETICS, V184, P343, DOI 10.1534/genetics.109.112045	84	246	254	6	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					982	+		10.1038/ng.3044	http://dx.doi.org/10.1038/ng.3044			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25064006	hybrid, Green Published			2022-12-25	WOS:000341579400012
J	Zhu, LJ; Li, TY; Luo, CX; Jiang, N; Chang, L; Lin, YH; Zhou, HH; Chen, C; Zhang, Y; Lu, W; Gao, LY; Ma, Y; Zhou, QG; Hu, Q; Hu, XL; Zhang, J; Wu, HY; Zhu, DY				Zhu, Li-Juan; Li, Ting-You; Luo, Chun-Xia; Jiang, Nan; Chang, Lei; Lin, Yu-Hui; Zhou, Hai-Hui; Chen, Chen; Zhang, Yu; Lu, Wei; Gao, Li-Yan; Ma, Yu; Zhou, Qi-Gang; Hu, Qin; Hu, Xiao-Ling; Zhang, Jing; Wu, Hai-Yin; Zhu, Dong-Ya			CAPON-nNOS coupling can serve as a target for developing new anxiolytics	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; PREFRONTAL CORTEX; PROTEIN; DEPRESSION; ANXIETY; BEHAVIORS; SYNAPSIN; RECEPTOR; NOS1AP; MOUSE	Anxiety disorders are highly prevalent psychiatric diseases(1,2). There is need for a deeper understanding of anxiety control mechanisms in the mammalian brain and for development of new anxiolytic agents. Here we report that the coupling between neuronal nitric oxide synthase (nNOS) and its carboxy-terminal PDZ ligand (CAPON) can serve as a target for developing new anxiolytic agents. Augmenting nNOS-CAPON interaction in the hippocampus of mice by overexpressing full-length CAPON gave rise to anxiogenic-like behaviors, whereas dissociating CAPON from nNOS by overexpressing CAPON-125C or CAPON-20C (the C-terminal 125 or 20 amino acids of CAPON) or delivering Tat-CAPON-12C (a peptide comprising Tat and the 12 C-terminal amino acids of CAPON) in the hippocampus of mice produced anxiolytic-like effects. Mice subjected to chronic mild stress (CMS) displayed a substantial increase in nNOS-CAPON coupling in the hippocampus and a consequent anxiogenic-like phenotype. Disrupting nNOS-CAPON coupling reversed the CMS-induced anxiogenic-like behaviors. Moreover, small-molecule blockers of nNOS-CAPON binding rapidly produced anxiolytic-like effects. Dexamethasone-induced ras protein 1 (Dexras1)-extracellular signal-regulated kinase (ERK) signaling was involved in the behavioral effects of nNOS-CAPON association. Thus, nNOS-CAPON association contributes to the modulation of anxiety-related behaviors via regulating Dexras1-ERK signaling and can serve as a target for developing potential anxiolytics.	[Zhu, Li-Juan; Luo, Chun-Xia; Chang, Lei; Lin, Yu-Hui; Zhou, Hai-Hui; Chen, Chen; Gao, Li-Yan; Wu, Hai-Yin; Zhu, Dong-Ya] Nanjing Med Univ, Lab Cerebrovasc Dis, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Zhu, Li-Juan; Luo, Chun-Xia; Lin, Yu-Hui; Zhou, Hai-Hui; Chen, Chen; Zhang, Yu; Gao, Li-Yan; Zhou, Qi-Gang; Zhang, Jing; Wu, Hai-Yin; Zhu, Dong-Ya] Nanjing Med Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Li, Ting-You; Jiang, Nan; Chang, Lei; Ma, Yu] Nanjing Med Univ, Dept Med Chem, Nanjing, Jiangsu, Peoples R China; [Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China; [Hu, Qin] Nanjing Med Univ, Dept Chem, Nanjing, Jiangsu, Peoples R China; [Hu, Xiao-Ling] Jiangsu Simcere Pharmaceut, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, DY (corresponding author), Nanjing Med Univ, Lab Cerebrovasc Dis, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	chunxialuo@njmu.edu.cn; dyzhu@njmu.edu.cn	JIANG, NAN/AHB-1945-2022	/0000-0002-1673-4362; Lin, Yu-Hui/0000-0003-2244-0587	National Natural Science Foundation of China [91232304, 81222016, 81030023, 21303086]; National Basic Research Program of China (973 Program) [2011CB504404]; Natural Science Foundation of Jiangsu Province [BK2011029, BK20130040]; Collaborative Innovation Center For Cardiovascular Disease Translational Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Collaborative Innovation Center For Cardiovascular Disease Translational Medicine	This work was supported by grants from the National Natural Science Foundation of China (91232304, 81222016, 81030023 and 21303086), the National Basic Research Program of China (973 Program) (2011CB504404) and the Natural Science Foundation of Jiangsu Province-Special Program grant BK2011029 and Distinguished Young Scientist Fund BK20130040, and by the Collaborative Innovation Center For Cardiovascular Disease Translational Medicine. We thank X.D. Qian, H.Y. Ni, F.Y. Zhang, Y. Hu, Y. Tang and Z. Zhu for technical assistance.	Brzustowicz Linda M, 2008, Curr Psychiatry Rep, V10, P158, DOI 10.1007/s11920-008-0027-0; Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Cheng HYM, 2006, J NEUROSCI, V26, P12984, DOI 10.1523/JNEUROSCI.4253-06.2006; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Feyder M, 2010, AM J PSYCHIAT, V167, P1508, DOI 10.1176/appi.ajp.2010.10040484; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Hu Y, 2012, P NATL ACAD SCI USA, V109, P14224, DOI 10.1073/pnas.1207461109; Jaffrey SR, 2002, P NATL ACAD SCI USA, V99, P3199, DOI 10.1073/pnas.261705799; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lawford BR, 2013, J AFFECT DISORDERS, V147, P87, DOI 10.1016/j.jad.2012.10.013; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mogha A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.58; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Richier L, 2010, J NEUROSCI, V30, P4796, DOI 10.1523/JNEUROSCI.3726-09.2010; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Soetanto A, 2010, ARCH GEN PSYCHIAT, V67, P448, DOI 10.1001/archgenpsychiatry.2010.48; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Xu B, 2005, PLOS MED, V2, P999, DOI 10.1371/journal.pmed.0020263; Xu JY, 2005, BRAIN RES, V1062, P134, DOI 10.1016/j.brainres.2005.09.008; Zhang J, 2010, J NEUROSCI, V30, P2433, DOI 10.1523/JNEUROSCI.5880-09.2010; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zhou QG, 2011, J NEUROSCI, V31, P7579, DOI 10.1523/JNEUROSCI.0004-11.2011	35	58	63	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1050	1054		10.1038/nm.3644	http://dx.doi.org/10.1038/nm.3644			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25129479				2022-12-25	WOS:000341404000018
J	Rimmer, A; Phan, H; Mathieson, I; Iqbal, Z; Twigg, SRF; Wilkie, AOM; McVean, G; Lunter, G				Rimmer, Andy; Phan, Hang; Mathieson, Iain; Iqbal, Zamin; Twigg, Stephen R. F.; Wilkie, Andrew O. M.; McVean, Gil; Lunter, Gerton		WGS500 Consortium	Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications	NATURE GENETICS			English	Article							HIGH-RESOLUTION HLA; DE-NOVO MUTATIONS; GENOME; GENERATION; EXOME; FRAMEWORK; ASSOCIATION; ALGORITHMS; DISCOVERY; ALIGNMENT	High-throughput DNA sequencing technology has transformed genetic research and is starting to make an impact on clinical practice. However, analyzing high-throughput sequencing data remains challenging, particularly in clinical settings where accuracy and turnaround times are critical. We present a new approach to this problem, implemented in a software package called Platypus. Platypus achieves high sensitivity and specificity for SNPs, indels and complex polymorphisms by using local de novo assembly to generate candidate variants, followed by local realignment and probabilistic haplotype estimation. It is an order of magnitude faster than existing tools and generates calls from raw aligned read data without preprocessing. We demonstrate the performance of Platypus in clinically relevant experimental designs by comparing with SAMtools and GATK on whole-genome and exome-capture data, by identifying de novo variation in 15 parent-offspring trios with high sensitivity and specificity, and by estimating human leukocyte antigen genotypes directly from variant calls.	[Rimmer, Andy; Phan, Hang; Mathieson, Iain; Iqbal, Zamin; McVean, Gil; Lunter, Gerton] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Lunter, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, S Parks Rd, Oxford, England.	gerton.lunter@well.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; Knight, Julian Charles/W-2399-2019; Twigg, Stephen/AAU-1135-2021; Humburg, Peter/A-4191-2009; Lunter, Gerton/H-4939-2016	Wilkie, Andrew/0000-0002-2972-5481; Knight, Julian Charles/0000-0002-0377-5536; Twigg, Stephen/0000-0001-5024-049X; Humburg, Peter/0000-0002-3331-6496; Phan, Hang T.T./0000-0001-9586-081X; Iqbal, Zamin/0000-0001-8466-7547; Lunter, Gerton/0000-0002-3798-2058	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I02593X/1]; Wellcome Trust [102731/Z/13/Z, 089250/Z/09/Z, 090532/Z/09/Z]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; BBSRC [BB/I02593X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02593X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/I02593X/1 (G.L., G.M., A.R. and H.P.), by Wellcome Trust grants 102731/Z/13/Z (A.O.M.W. and S.R.F.T.), 089250/Z/09/Z (I.M.) and 090532/Z/09/Z (G.M., G.L. and A.R.), and by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), NIHR or the UK Department of Health.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Chen JM, 2012, MUTAT RES-REV MUTAT, V750, P52, DOI 10.1016/j.mrrev.2011.10.002; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donmez N, 2011, LECT N BIOINFORMAT, V6577, P38, DOI 10.1007/978-3-642-20036-6_5; Garrison A., 2012, HAPLOTYPE BASED VARI; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Ku CS, 2013, J MED GENET, V50, P203, DOI 10.1136/jmedgenet-2013-101519; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	602	609	4	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					912	918		10.1038/ng.3036	http://dx.doi.org/10.1038/ng.3036			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25017105	Green Accepted			2022-12-25	WOS:000339704400024
J	Worley, KC; Warren, WC; Rogers, J; Locke, D; Muzny, DM; Mardis, ER; Weinstock, GM; Tardif, SD; Aagaard, KM; Archidiacono, N; Rayan, NA; Batzer, MA; Beal, K; Brejova, B; Capozzi, O; Capuano, SB; Casola, C; Chandrabose, MM; Cree, A; Dao, MD; de Jong, PJ; del Rosario, RCH; Delehaunty, KD; Dinh, HH; Eichler, EE; Fitzgerald, S; Flicek, P; Fontenot, CC; Fowler, RG; Fronick, C; Fulton, LA; Fulton, RS; Gabisi, RA; Gerlach, D; Graves, TA; Gunaratne, PH; Hahn, MW; Haig, D; Han, Y; Harris, RA; Herrero, J; Hillier, LW; Hubley, R; Hughes, JF; Hume, J; Jhangiani, SN; Jorde, LB; Joshi, V; Karakor, E; Konkel, MK; Kosiol, C; Kovar, CL; Kriventseva, EV; Lee, SL; Lewis, LR; Liu, YS; Lopez, J; Lopez-Otin, C; Lorente-Galdos, B; Mansfield, KG; Marques-Bonet, T; Minx, P; Misceo, D; Moncrieff, JS; Morgan, MB; Nazareth, LV; Newsham, I; Nguyen, NB; Okwuonu, G; Prabhakar, S; Perales, L; Pu, LL; Puente, XS; Quesada, V; Ranck, MC; Raney, BJ; Raveendran, M; Deiros, DR; Rocchi, M; Rodriguez, D; Ross, C; Ruffier, M; Ruiz, SJ; Sajjadian, S; Santibanez, J; Schrider, DR; Searle, S; Skaletsky, H; Soibam, B; Smit, AFA; Tennakoon, JB; Tomaska, L; Ullmer, B; Vejnar, CE; Ventura, M; Vilella, AJ; Vinar, T; Vogel, JH; Walker, JA; Wang, Q; Warner, CM; Wildman, DE; Witherspoon, DJ; Wright, RA; Wu, YQ; Xiao, WM; Xing, JC; Zdobnov, EM; Zhu, BL; Gibbs, RA; Wilson, RK				Worley, Kim C.; Warren, Wesley C.; Rogers, Jeffrey; Locke, Devin; Muzny, Donna M.; Mardis, Elaine R.; Weinstock, George M.; Tardif, Suzette D.; Aagaard, Kjersti M.; Archidiacono, Nicoletta; Rayan, Nirmala Arul; Batzer, Mark A.; Beal, Kathryn; Brejova, Brona; Capozzi, Oronzo; Capuano, Saverio B.; Casola, Claudio; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; de Jong, Pieter J.; del Rosario, Ricardo Cruz-Herrera; Delehaunty, Kim D.; Dinh, Huyen H.; Eichler, Evan E.; Fitzgerald, Stephen; Flicek, Paul; Fontenot, Catherine C.; Fowler, R. Gerald; Fronick, Catrina; Fulton, Lucinda A.; Fulton, Robert S.; Gabisi, Ramatu Ayiesha; Gerlach, Daniel; Graves, Tina A.; Gunaratne, Preethi H.; Hahn, Matthew W.; Haig, David; Han, Yi; Harris, R. Alan; Herrero, Javier; Hillier, LaDeana W.; Hubley, Robert; Hughes, Jennifer F.; Hume, Jennifer; Jhangiani, Shalini N.; Jorde, Lynn B.; Joshi, Vandita; Karakor, Emre; Konkel, Miriam K.; Kosiol, Carolin; Kovar, Christie L.; Kriventseva, Evgenia V.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Lopez-Otin, Carlos; Lorente-Galdos, Belen; Mansfield, Keith G.; Marques-Bonet, Tomas; Minx, Patrick; Misceo, Doriana; Moncrieff, J. Scott; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Prabhakar, Shyam; Perales, Lora; Pu, Ling-Ling; Puente, Xose S.; Quesada, Victor; Ranck, Megan C.; Raney, Brian J.; Raveendran, Muthuswamy; Deiros, David Rio; Rocchi, Mariano; Rodriguez, David; Ross, Corinna; Ruffier, Magali; Ruiz, San Juana; Sajjadian, Saba; Santibanez, Jireh; Schrider, Daniel R.; Searle, Steve; Skaletsky, Helen; Soibam, Benjamin; Smit, Arian F. A.; Tennakoon, Jayantha B.; Tomaska, Lubomir; Ullmer, Brygg; Vejnar, Charles E.; Ventura, Mario; Vilella, Albert J.; Vinar, Tomas; Vogel, Jan-Hinnerk; Walker, Jerilyn A.; Wang, Qing; Warner, Crystal M.; Wildman, Derek E.; Witherspoon, David J.; Wright, Rita A.; Wu, Yuanqing; Xiao, Weimin; Xing, Jinchuan; Zdobnov, Evgeny M.; Zhu, Baoli; Gibbs, Richard A.; Wilson, Richard K.		Marmoset Genome Sequencing Anal Co	The common marmoset genome provides insight into primate biology and evolution	NATURE GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; INCREASED OVULATION RATE; SEGMENTAL DUPLICATIONS; GENE; GROWTH; MUTATIONS; VARIANTS; VERTEBRATES; CHIMPANZEE; CHIMERISM	We report the whole-genome sequence of the common marmoset (Callithrix jacchus). The 2.26-Gb genome of a female marmoset was assembled using Sanger read data (6x) and a whole-genome shotgun strategy. A first analysis has permitted comparison with the genomes of apes and Old World monkeys and the identification of specific features that might contribute to the unique biology of this diminutive primate, including genetic changes that may influence body size, frequent twinning and chimerism. We observed positive selection in growth hormone/insulin-like growth factor genes (growth pathways), respiratory complex I genes (metabolic pathways), and genes encoding immunobiological factors and proteases (reproductive and immunity pathways). In addition, both protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution. This genome sequence for a New World monkey enables increased power for comparative analyses among available primate genomes and facilitates biomedical research application.	[Worley, Kim C.; Rogers, Jeffrey; Muzny, Donna M.; Weinstock, George M.; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; Dinh, Huyen H.; Fowler, R. Gerald; Gabisi, Ramatu Ayiesha; Gunaratne, Preethi H.; Han, Yi; Harris, R. Alan; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Perales, Lora; Pu, Ling-Ling; Raveendran, Muthuswamy; Deiros, David Rio; Ruiz, San Juana; Santibanez, Jireh; Warner, Crystal M.; Wright, Rita A.; Wu, Yuanqing; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Worley, Kim C.; Rogers, Jeffrey; Muzny, Donna M.; Weinstock, George M.; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; Dinh, Huyen H.; Fowler, R. Gerald; Gabisi, Ramatu Ayiesha; Gunaratne, Preethi H.; Han, Yi; Harris, R. Alan; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Perales, Lora; Pu, Ling-Ling; Raveendran, Muthuswamy; Deiros, David Rio; Ruiz, San Juana; Santibanez, Jireh; Warner, Crystal M.; Wright, Rita A.; Wu, Yuanqing; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Warren, Wesley C.; Locke, Devin; Mardis, Elaine R.; Weinstock, George M.; Delehaunty, Kim D.; Fronick, Catrina; Fulton, Lucinda A.; Fulton, Robert S.; Graves, Tina A.; Hillier, LaDeana W.; Minx, Patrick; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Tardif, Suzette D.; Ross, Corinna] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Aagaard, Kjersti M.; Harris, R. Alan] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Archidiacono, Nicoletta; Capozzi, Oronzo; Misceo, Doriana; Rocchi, Mariano] Univ Bari, Dept Biol, Bari, Italy; [Rayan, Nirmala Arul; del Rosario, Ricardo Cruz-Herrera; Prabhakar, Shyam] Genome Inst Singapore, Singapore, Singapore; [Batzer, Mark A.; Fontenot, Catherine C.; Ranck, Megan C.; Walker, Jerilyn A.; Wang, Qing] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Beal, Kathryn; Fitzgerald, Stephen; Flicek, Paul; Herrero, Javier; Ruffier, Magali; Vilella, Albert J.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, Cambs, England; [Brejova, Brona; Vinar, Tomas] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Capuano, Saverio B.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Casola, Claudio; Hahn, Matthew W.; Schrider, Daniel R.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Casola, Claudio; Hahn, Matthew W.; Schrider, Daniel R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [de Jong, Pieter J.; Misceo, Doriana; Zhu, Baoli] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Eichler, Evan E.; Karakor, Emre; Sajjadian, Saba; Ventura, Mario] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Flicek, Paul; Kriventseva, Evgenia V.; Ruffier, Magali; Searle, Steve; Vogel, Jan-Hinnerk] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Gerlach, Daniel; Moncrieff, J. Scott; Vejnar, Charles E.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gunaratne, Preethi H.; Konkel, Miriam K.; Soibam, Benjamin; Tennakoon, Jayantha B.; Xiao, Weimin] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hubley, Robert; Smit, Arian F. A.] Inst Syst Biol, Seattle, WA USA; [Hughes, Jennifer F.; Skaletsky, Helen] Whitehead Inst, Cambridge, MA 02142 USA; [Jorde, Lynn B.; Witherspoon, David J.; Xing, Jinchuan] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Kosiol, Carolin] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Lopez-Otin, Carlos; Puente, Xose S.; Quesada, Victor; Rodriguez, David] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain; [Lorente-Galdos, Belen] Spanish Natl Bioinformat Inst INB, Barcelona, Spain; [Lorente-Galdos, Belen; Marques-Bonet, Tomas] Univ Pompeu Fabra, Inst Biol Evolut, Consejo Super Invest Cient, Inst Catalana Recerca & Estudis Avangats, Barcelona, Spain; [Mansfield, Keith G.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Comparat Pathol, Southborough, MA 01772 USA; [Marques-Bonet, Tomas] CNAG, Barcelona, Spain; [Raney, Brian J.] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Skaletsky, Helen] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Tomaska, Lubomir] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava, Slovakia; [Ullmer, Brygg] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Ullmer, Brygg] Louisiana State Univ, Dept Comp Sci, Baton Rouge, LA 70803 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Zdobnov, Evgeny M.] Swiss Inst Bioinformat, Geneva, Switzerland; [Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Universita degli Studi di Bari Aldo Moro; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Louisiana State University System; Louisiana State University; European Molecular Biology Laboratory (EMBL); Comenius University Bratislava; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; University of Geneva; University of Houston System; University of Houston; Baylor College of Medicine; Harvard University; Institute for Systems Biology (ISB); Massachusetts Institute of Technology (MIT); Whitehead Institute; Utah System of Higher Education; University of Utah; University of Veterinary Medicine Vienna; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA; Pompeu Fabra University; Harvard University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Comenius University Bratislava; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Wayne State University; Swiss Institute of Bioinformatics; Imperial College London	Worley, KC (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	kworley@bcm.edu	Vinar, Tomas/I-3695-2014; Vogel, Jan-Hinnerk/C-4582-2013; Wilson, Richard K./AAF-4139-2019; Zdobnov, Evgeny M/K-1133-2012; Marques-Bonet, Tomas/ABF-3734-2020; Misceo, Doriana/AAR-9085-2020; Harris, R. Alan/AAI-2784-2020; Weinstock, George M/C-6314-2013; Nguyen, Ngoc/HHZ-0886-2022; Rodríguez, David/K-3872-2017; Tomaska, Lubomir/I-3071-2014; Herrero, Javier/H-6971-2019; Puente, Xosé S./ADB-0672-2022; Zdobnov, Evgeny/AAB-2745-2022; Quesada, Víctor/B-6557-2014; López-Otín, Carlos/AAB-2106-2020; Mardis, Elaine/W-2202-2019; Brejova, Brona/I-3718-2014; Raney, Brian/ABE-6267-2020; Ventura, Mario/E-6420-2011	Vinar, Tomas/0000-0003-3898-3447; Wilson, Richard K./0000-0002-1992-1358; Marques-Bonet, Tomas/0000-0002-5597-3075; Misceo, Doriana/0000-0002-6594-5801; Harris, R. Alan/0000-0002-7333-4752; Weinstock, George M/0000-0002-2997-4592; Rodríguez, David/0000-0002-7530-2770; Tomaska, Lubomir/0000-0003-4886-1910; Herrero, Javier/0000-0001-7313-717X; Puente, Xosé S./0000-0001-9525-1483; Zdobnov, Evgeny/0000-0002-5178-1498; Quesada, Víctor/0000-0002-8398-3457; López-Otín, Carlos/0000-0001-6964-1904; Brejova, Brona/0000-0002-9483-1766; Ventura, Mario/0000-0001-7762-8777; Lorente-Galdos, Belen/0000-0001-5390-2452; Worley, Kim/0000-0002-0282-1000; Locke, Devin/0000-0002-2527-0475; Wildman, Derek/0000-0002-6374-5136; Flicek, Paul/0000-0002-3897-7955; CAPOZZI, Oronzo/0000-0002-7443-6777; del Rosario, Ricardo/0000-0002-7038-9598; Casola, Claudio/0000-0003-4853-1866; Rocchi, Mariano/0000-0002-9451-5616; Ruffier, Magali/0000-0002-8386-1580; archidiacono, nicoletta/0000-0002-1439-9521; Vilella, Albert/0000-0002-2005-2516; Gerlach, Daniel/0000-0001-9338-3765; Hahn, Matthew/0000-0002-5731-8808	National Human Genome Research Institute (NHGRI) [U54 HG003273, U54 HG003079]; US National Institutes of Health (NIH) [R01 DK077639, R01 GM59290, HG002385, P51-OD011133]; National Science Foundation [NSF BCS-0751508]; VEGA grant agency [1/0719/14, 1/1085/12]; Howard Hughes Medical Institute grant; NHGRI [K99 HG005846]; Cullen Foundation; European Research Council Starting Grant [260372]; MICINN (Spain) [BFU2011-28549]; Spanish National Institute of Bioinformatics; Austrian Science Fund (FWF) [P 24551] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG005846, U41HG002371, U54HG003079, U54HG003273, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER; Direct For Biological Sciences [0845494] Funding Source: National Science Foundation; ICREA Funding Source: Custom	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); VEGA grant agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cullen Foundation; European Research Council Starting Grant(European Research Council (ERC)); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ICREA(ICREA)	The authors acknowledge the contributions of the sequence production staff of the Human Genome Sequencing Center: K. Abraham, C. Adams, C. Allen, U. Anosike, T. Attaway, D. Bandaranaike, A. Bell, S.N. Bell, B. Beltran, C. Bickham, J. Chacko, A. Chavez, H.-S. Chu, M. Coyle, M.L. Davila, L. Davy-Carroll, S. Denson, Y. Ding, S. Dugan, V. Ebong, S. Fernandez, P. Fernando, A. Ferrer, J. Ganer, R. Garcia III, T. Garrett, E. Hawkins, S. Hines, M. Holder, B. Hollins, H. Jiang, B. Johnson, H. Kisamo, L. Lago, M. Lago, C.-Y. Lai, T.-K. Le, F. Legal III, S. Lemon, R. Madu, E. Martinez, I. Mercado, C. Mercado, M. Munidasa, D. Ngo, P. Nguyen, O. Nwaokelemeh, M. Obregon, C. Onwere, A. Parra, H. Paul, A. Perez, Y. Perez, E. Primus, J. Quiroz, B. Schneider, I. Sisson, X.-Z. Song, A. Svatek, T. Taylor, R. Thelus, N. Thomas, R. Thornton, Z. Trejos, K. Usmani, S. Vattathil, D. Villasana, D. Walker, K. Wang, S. Wang, C. White, A. Williams, J. Williams, J. Woodworth and L. Zhang. The Washington University Genome Sequencing Center acknowledges the many people who contributed to the sequencing and analysis in this project who are not named here individually. We thank J. Steitz for mRNA data used to annotate the 3' UTRs of genes. The miRNA analysis group acknowledges the contributions of D. Rajapakshe, C. Athulathmudali, H. Jiang and A. Moehring. We gratefully acknowledge the assistance of D. Opheim with the figures. The marmoset genome project was funded by the National Human Genome Research Institute (NHGRI), including from grants U54 HG003273 (R.A. Gibbs) and U54 HG003079 (R.K.W.), with additional support from the US National Institutes of Health (NIH), including from grants R01 DK077639 (S.D.T.), R01 GM59290 (L.B.J. and M.A.B.), HG002385 (E.E.E.) and P51-OD011133 (Southwest NPRC), and support from the National Science Foundation (NSF BCS-0751508 to DEW.) and the VEGA grant agency: 1/0719/14 (TV.) and 1/1085/12 (B.B.). C.C.F. and M.C.R. were supported in part by a Howard Hughes Medical Institute grant to Louisiana State University through the Undergraduate Biological Sciences Education program. J.X. was supported by NHGRI grant K99 HG005846. P.H.G. was supported by the Cullen Foundation. T.M.-B. was supported by European Research Council Starting Grant (260372) and MICINN (Spain) grant BFU2011-28549. B.L.-G. was supported by the Spanish National Institute of Bioinformatics (see URLs). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Cheung VG, 2010, SCIENCE, V327, P791, DOI 10.1126/science.1187155; Choi JH, 2011, J CLIN ENDOCR METAB, V96, pE130, DOI 10.1210/jc.2010-1789; del Rosario R. C. H., GENOME RES; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Falush D, 2003, GENETICS, V164, P1567; Fang P, 2012, J CLIN ENDOCR METAB, V97, pE243, DOI 10.1210/jc.2011-2142; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GENGOZIAN N, 1964, CYTOGENETICS, V3, P384, DOI 10.1159/000129828; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; GOLDIZEN AW, 1988, TRENDS ECOL EVOL, V3, P36, DOI 10.1016/0169-5347(88)90045-6; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Kingsley CB, 2011, METHODS MOL BIOL, V700, P37, DOI 10.1007/978-1-61737-954-3_3; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEUTENEGGER W, 1973, FOLIA PRIMATOL, V20, P280, DOI 10.1159/000155580; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Marroig G, 2010, EVOLUTION, V64, P1470, DOI 10.1111/j.1558-5646.2009.00920.x; McNerney ME, 2005, BLOOD, V106, P1337, DOI 10.1182/blood-2005-01-0357; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Palmer JS, 2006, J CLIN ENDOCR METAB, V91, P4713, DOI 10.1210/jc.2006-0970; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Pritchard JK, 2000, GENETICS, V155, P945; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sharma N, 2008, MOL REPROD DEV, V75, P1136, DOI 10.1002/mrd.20855; TARDIF SD, 1994, ANN NY ACAD SCI, V709, P214, DOI 10.1111/j.1749-6632.1994.tb30405.x; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wang QF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r68; Wang QF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r1; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	50	147	155	0	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					850	857		10.1038/ng.3042	http://dx.doi.org/10.1038/ng.3042			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038751	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000339704400013
J	Landeta, C; Blazyk, JL; Hatahet, F; Meehan, BM; Eser, M; Myrick, A; Bronstain, L; Minami, S; Arnold, H; Ke, N; Rubin, EJ; Furie, BC; Furie, B; Beckwith, J; Dutton, R; Boyd, D				Landeta, Cristina; Blazyk, Jessica L.; Hatahet, Feras; Meehan, Brian M.; Eser, Markus; Myrick, Alissa; Bronstain, Ludmila; Minami, Shoko; Arnold, Holly; Ke, Na; Rubin, Eric J.; Furie, Barbara C.; Furie, Bruce; Beckwith, Jon; Dutton, Rachel; Boyd, Dana			Compounds targeting disulfide bond forming enzyme DsbB of Gram-negative bacteria	NATURE CHEMICAL BIOLOGY			English	Article							SIGNAL RECOGNITION PARTICLE; PSEUDOMONAS-AERUGINOSA; YIELDS MUTATIONS; MEMBRANE-PROTEIN; DRUG DISCOVERY; IDENTIFICATION; VIRULENCE; GENE; MECHANISMS; DIVERSITY	In bacteria, disulfide bonds confer stability on many proteins exported to the cell envelope or beyond. These proteins include numerous bacterial virulence factors, and thus bacterial enzymes that promote disulfide bond formation represent targets for compounds inhibiting bacterial virulence. Here, we describe a new target-and cell-based screening methodology for identifying compounds that inhibit the disulfide bond-forming enzymes Escherichia coli DsbB (EcDsbB) or Mycobacterium tuberculosis VKOR (MtbVKOR), which can replace EcDsbB, although the two are not homologs. Initial screening of 51,487 compounds yielded six specifically inhibiting EcDsbB. These compounds share a structural motif and do not inhibit MtbVKOR. A medicinal chemistry approach led us to select related compounds, some of which are much more effective DsbB inhibitors than those found in the screen. These compounds inhibit purified DsbB and prevent anaerobic growth of E. coli. Furthermore, these compounds inhibit all but one of the DsbBs of nine other Gram-negative pathogenic bacteria tested.	[Landeta, Cristina; Blazyk, Jessica L.; Hatahet, Feras; Meehan, Brian M.; Eser, Markus; Arnold, Holly; Ke, Na; Beckwith, Jon; Dutton, Rachel; Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02138 USA; [Myrick, Alissa; Minami, Shoko; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Bronstain, Ludmila; Furie, Barbara C.; Furie, Bruce] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Bronstain, Ludmila; Furie, Barbara C.; Furie, Bruce] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02138 USA.	Jon_Beckwith@hms.harvard.edu	Landeta, Cristina/AAQ-4320-2020	Landeta, Cristina/0000-0003-4065-9646	US National Institute of General Medical Sciences [GMO41883]; Harvard Catalyst Pilot Grant Harvard [149734]; US National Institutes of Health (NIH) [5-UL1RR02568-01]; Blavatnik Biomedical Accelerator at Harvard University; NIH [3P01-A1AI074805-04S1 Subaward R01638, PO1-HL087203, RO1-HL092125]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE-BEID) [U54-AI057159]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award; New England BioLabs Grant; Harvard School of Public Health Yerby postdoctoral fellowship;  [T32-HL07917]	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard Catalyst Pilot Grant Harvard; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blavatnik Biomedical Accelerator at Harvard University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE-BEID); Consejo Nacional de Ciencia y Tecnologia (CONACYT) postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England BioLabs Grant; Harvard School of Public Health Yerby postdoctoral fellowship; 	We thank the ICCB-Longwood screening facility for access to their compound libraries, equipment and, screening supplies, and the staff, including S. Chiang, K. Lee, S. Rudnicki and D. Flood, for helpful advice and data handling. We thank R. Goldman of the US National Institute of Allergy and Infectious disease for the collection of M. tuberculosis growth inhibitors. We thank R. Tomaino of the Taplin Mass Spectrometry Core Facility at Harvard Medical School for his assistance in sample analysis. This work was supported by US National Institute of General Medical Sciences grants GMO41883 (to J.B. and D.B.), Harvard Catalyst Pilot Grant Harvard #149734 (to J.B.), US National Institutes of Health (NIH) Grant 5-UL1RR02568-01 (to J.B.), Blavatnik Biomedical Accelerator at Harvard University (to J.B.), NIH Grant 3P01-A1AI074805-04S1 Subaward R01638 (to E.J.R.), NIH Grant PO1-HL087203 (to B.F.), NIH Grant RO1-HL092125 (to B.C.F.) and New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE-BEID) Grant U54-AI057159. C.L. was partially supported by a Consejo Nacional de Ciencia y Tecnologia (CONACYT) postdoctoral fellowship. J.L.B. was supported by T32-HL07917 Grant (to B.F.). B.M.M. was supported by a Ruth L. Kirschstein National Research Service Award. M.E. was supported by a New England BioLabs Grant. A.M. was supported by a Harvard School of Public Health Yerby postdoctoral fellowship. J.B. is an American Cancer Society Professor.	Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Chng SS, 2012, MOL MICROBIOL, V85, P996, DOI 10.1111/j.1365-2958.2012.08157.x; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; Fruh V, 2010, CHEM BIOL, V17, P881, DOI 10.1016/j.chembiol.2010.06.011; Goldman RC, 2009, TUBERCULOSIS, V89, P331, DOI 10.1016/j.tube.2009.07.007; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hatahet F, 2014, BBA-PROTEINS PROTEOM, V1844, P1402, DOI 10.1016/j.bbapap.2014.02.014; Hatahet F, 2013, J MOL BIOL, V425, P3268, DOI 10.1016/j.jmb.2013.04.034; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kolpen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084353; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Lin DX, 2009, MICROBIOL-SGM, V155, P4014, DOI 10.1099/mic.0.032904-0; Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Tian HP, 2002, J BACTERIOL, V184, P111, DOI 10.1128/JB.184.1.111-118.2002; Wang XY, 2011, ANTIOXID REDOX SIGN, V14, P1413, DOI 10.1089/ars.2010.3558; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971	42	33	35	5	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					292	U81		10.1038/NCHEMBIO.1752	http://dx.doi.org/10.1038/NCHEMBIO.1752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25686372	Green Accepted, Green Submitted			2022-12-25	WOS:000351666500013
J	Ai, HS; Fang, XD; Yang, B; Huang, ZY; Chen, H; Mao, LK; Zhang, F; Zhang, L; Cui, LL; He, WM; Yang, J; Yao, XM; Zhou, LS; Han, LJ; Li, J; Sun, SL; Xie, XH; Lai, BX; Su, Y; Lu, Y; Yang, H; Huang, T; Deng, WJ; Nielsen, R; Ren, J; Huang, LS				Ai, Huashui; Fang, Xiaodong; Yang, Bin; Huang, Zhiyong; Chen, Hao; Mao, Likai; Zhang, Feng; Zhang, Lu; Cui, Leilei; He, Weiming; Yang, Jie; Yao, Xiaoming; Zhou, Lisheng; Han, Lijuan; Li, Jing; Sun, Silong; Xie, Xianhua; Lai, Boxian; Su, Ying; Lu, Yao; Yang, Hui; Huang, Tao; Deng, Wenjiang; Nielsen, Rasmus; Ren, Jun; Huang, Lusheng			Adaptation and possible ancient interspecies introgression in pigs identified by whole-genome sequencing	NATURE GENETICS			English	Article							RECOMBINATION MAP; REVEALS LOCI; SELECTION; SIGNATURES; EVOLUTION; DOMESTICATION; CHROMOSOMES; PATTERNS; HISTORY; LINKAGE	Domestic pigs have evolved genetic adaptations to their local environmental conditions, such as cold and hot climates. We sequenced the genomes of 69 pigs from 15 geographically divergent locations in China and detected 41 million variants, of which 21 million were absent from the dbSNP database. In a genome-wide scan, we identified a set of loci that likely have a role in regional adaptations to high-and low-latitude environments within China. Intriguingly, we found an exceptionally large (14-Mb) region with a low recombination rate on the X chromosome that appears to have two distinct haplotypes in the high-and low-latitude populations, possibly underlying their adaptation to cold and hot environments, respectively. Surprisingly, the adaptive sweep in the high-latitude regions has acted on DNA that might have been introgressed from an extinct Sus species. Our findings provide new insights into the evolutionary history of pigs and the role of introgression in adaptation.	[Ai, Huashui; Yang, Bin; Chen, Hao; Zhang, Feng; Cui, Leilei; Yang, Jie; Zhou, Lisheng; Li, Jing; Xie, Xianhua; Su, Ying; Yang, Hui; Huang, Tao; Deng, Wenjiang; Ren, Jun; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Ai, Huashui; Yang, Bin; Chen, Hao; Zhang, Feng; Cui, Leilei; Yang, Jie; Zhou, Lisheng; Li, Jing; Xie, Xianhua; Su, Ying; Yang, Hui; Huang, Tao; Deng, Wenjiang; Ren, Jun; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Fang, Xiaodong; Huang, Zhiyong; Mao, Likai; Zhang, Lu; He, Weiming; Yao, Xiaoming; Han, Lijuan; Sun, Silong; Lai, Boxian; Lu, Yao; Nielsen, Rasmus] BGI Shenzhen, BGI Tech, Shenzhen, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); University of California System; University of California Berkeley	Ren, J (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	renjunjxau@hotmail.com; lushenghuang@hotmail.com	chen, hao/HGA-8980-2022; Ren, Jun/H-9793-2019; Zhang, Lu/AAV-2606-2020; zhou, lisheng/AGY-5728-2022; Nielsen, Rasmus/D-4405-2009; Fang, Xiaodong/K-6743-2018; Deng, Wenjiang/CAF-1431-2022; Zhang, Feng/O-2571-2017	chen, hao/0000-0002-5210-8924; Nielsen, Rasmus/0000-0003-0513-6591; Fang, Xiaodong/0000-0001-7061-3337; Zhang, Lu/0000-0002-2794-7371	National Key Research Project of China [2013ZX08006-5]; Natural Science Foundation of China [31230069]; Changjiang Scholars and Innovative Research Team in University [IRT1136]	National Key Research Project of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	We thank L. Andersson for critical discussions and reading of the manuscript. This study is supported by the National Key Research Project of China (2013ZX08006-5), the Natural Science Foundation of China (31230069) and the Changjiang Scholars and Innovative Research Team in University (IRT1136).	ADOLPH EF, 1946, AM J PHYSIOL, V146, P507, DOI 10.1152/ajplegacy.1946.146.4.507; Ai HS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-834; Alazami AM, 2008, AM J HUM GENET, V83, P684, DOI 10.1016/j.ajhg.2008.10.018; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; BOULANT JA, 1986, ANNU REV PHYSIOL, V48, P639, DOI 10.1146/annurev.ph.48.030186.003231; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; CHAFFEE RRJ, 1969, FED PROC, V28, P1029; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062534; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; JANSKY L, 1968, CAN J PHYSIOL PHARM, V46, P653, DOI 10.1139/y68-096; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Ma JW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-159; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schmidt EM, 2013, FASEB J, V27, P2799, DOI 10.1096/fj.13-229286; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Shriver Mark D, 2004, Hum Genomics, V1, P274; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang L., 2011, ANIMAL GENETIC RESOU, P2	49	198	225	9	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					217	+		10.1038/ng.3199	http://dx.doi.org/10.1038/ng.3199			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25621459	Green Published			2022-12-25	WOS:000350327900011
J	Coll, RC; Robertson, AAB; Chae, JJ; Higgins, SC; Munoz-Planillo, R; Inserra, MC; Vetter, I; Dungan, LS; Monks, BG; Stutz, A; Croker, DE; Butler, MS; Haneklaus, M; Sutton, CE; Nunez, G; Latz, E; Kastner, DL; Mills, KHG; Masters, SL; Schroder, K; Cooper, MA; O'Neill, LAJ				Coll, Rebecca C.; Robertson, Avril A. B.; Chae, Jae Jin; Higgins, Sarah C.; Munoz-Planillo, Raul; Inserra, Marco C.; Vetter, Irina; Dungan, Lara S.; Monks, Brian G.; Stutz, Andrea; Croker, Daniel E.; Butler, Mark S.; Haneklaus, Moritz; Sutton, Caroline E.; Nunez, Gabriel; Latz, Eicke; Kastner, Daniel L.; Mills, Kingston H. G.; Masters, Seth L.; Schroder, Kate; Cooper, Matthew A.; O'Neill, Luke A. J.			A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases	NATURE MEDICINE			English	Article							DIFFERENTIAL REQUIREMENT; NALP3 INFLAMMASOME; AUTOIMMUNE ENCEPHALOMYELITIS; CYTOPLASMIC DNA; CELL-DEATH; T-CELLS; ACTIVATION; IL-1-BETA; INTERLEUKIN-1; MECHANISMS	The NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inflammasome is a component of the inflammatory process, and its aberrant activation is pathogenic in inherited disorders such as cryopyrin-associated periodic syndrome (CAPS) and complex diseases such as multiple sclerosis, type 2 diabetes, Alzheimer's disease and atherosclerosis. We describe the development of MCC950, a potent, selective, small-molecule inhibitor of NLRP3. MCC950 blocked canonical and noncanonical NLRP3 activation at nanomolar concentrations. MCC950 specifically inhibited activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes. MCC950 reduced interleukin-1 beta (IL-1 beta) production in vivo and attenuated the severity of experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis. Furthermore, MCC950 treatment rescued neonatal lethality in a mouse model of CAPS and was active in ex vivo samples from individuals with Muckle-Wells syndrome. MCC950 is thus a potential therapeutic for NLRP3-associated syndromes, including autoinflammatory and autoimmune diseases, and a tool for further study of the NLRP3 inflammasome in human health and disease.	[Coll, Rebecca C.; Higgins, Sarah C.; Dungan, Lara S.; Haneklaus, Moritz; Sutton, Caroline E.; Mills, Kingston H. G.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Coll, Rebecca C.; Robertson, Avril A. B.; Inserra, Marco C.; Vetter, Irina; Croker, Daniel E.; Butler, Mark S.; Schroder, Kate; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chae, Jae Jin; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Munoz-Planillo, Raul; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Munoz-Planillo, Raul; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Inserra, Marco C.; Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Monks, Brian G.; Stutz, Andrea; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Masters, Seth L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Trinity College Dublin; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Queensland; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Royal Melbourne Hospital; Walter & Eliza Hall Institute	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	m.cooper@imb.uq.edu.au; laoneill@tcd.ie	Coll, Rebecca/J-2124-2014; Latz, Eicke/H-3951-2014; Schroder, Kate/C-6132-2008; Butler, Mark S./D-9973-2011; Cooper, Matthew A./C-7988-2009; Haneklaus, Moritz/AAE-4728-2020; Robertson, Avril/A-4043-2012; Nuñez, Gabriel/A-7160-2014; Mills, Kingston H/F-5684-2013; Vetter, Irina/A-6035-2010; Masters, Seth L/N-2886-2013; Croker, Daniel/N-7134-2013	Coll, Rebecca/0000-0002-7359-6023; Latz, Eicke/0000-0003-1488-5666; Schroder, Kate/0000-0001-9261-3805; Butler, Mark S./0000-0001-6689-4236; Cooper, Matthew A./0000-0003-3147-3460; Robertson, Avril/0000-0002-9652-8357; Mills, Kingston H/0000-0003-3646-8222; Vetter, Irina/0000-0002-3594-9588; Masters, Seth L/0000-0003-4763-576X; Croker, Daniel/0000-0001-9533-4019; Chae, Jae Jin/0000-0003-0719-4349; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland [G20598, 11/PI/1036, 07/SRC/B1144]; Intramural Research Program of the National Human Genome Research Institute, US National Institutes of Health; Australian Research Council [FT130101215, FT130100361]; US National Institutes of Health [DK091191, DK095782]; German Research Foundation [SFB645, SFB670, SFB704, TRR57]; European Research Council (ERC, InflammAct); Excellence Cluster ImmunoSensation; VESKI innovation fellowship; National Health and Medical Research Council of Australia [1032065, 1057815]; Queensland Smart Futures Fund; ERC Advanced Grant [E12435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK095782] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Intramural Research Program of the National Human Genome Research Institute, US National Institutes of Health; Australian Research Council(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); European Research Council (ERC, InflammAct); Excellence Cluster ImmunoSensation; VESKI innovation fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart Futures Fund; ERC Advanced Grant(European Research Council (ERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Kitanovic (German Center for Neurodegenerative Diseases) for image analysis (Fig. 3c), S. Corr (Trinity College Dublin) for providing S. typhimurium UK-1 strain and H.M. Hoffman (University of California, San Diego) for providing Nlrp3 (A350VneoR) mice. This work was supported by the following funding bodies, grants and fellowships. L.A.J.O'N. and R.C.C.: Science Foundation Ireland (G20598). D.L.K. and J.J.C.: Intramural Research Program of the National Human Genome Research Institute, US National Institutes of Health. S.C.H., C.E.S. and K.H.G.M.: Science Foundation Ireland (11/PI/1036) and (07/SRC/B1144). I.V.: Australian Research Council (FT130101215). G.N.: US National Institutes of Health (DK091191) and (DK095782). E.L.: German Research Foundation (SFB645, SFB670, SFB704, TRR57), European Research Council (ERC, InflammAct) and Excellence Cluster ImmunoSensation. S.L.M.: VESKI innovation fellowship and National Health and Medical Research Council of Australia (1032065) and (1057815). K.S.: Queensland Smart Futures Fund and Australian Research Council (FT130100361). L.A.J.O'N.: ERC Advanced Grant (E12435).	Ahn H, 2014, IMMUNOBIOLOGY, V219, P315, DOI 10.1016/j.imbio.2013.11.003; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Croker DE, 2014, IMMUNOL CELL BIOL, V92, P631, DOI 10.1038/icb.2014.32; De Nardo D, 2014, AM J PATHOL, V184, P42, DOI 10.1016/j.ajpath.2013.09.007; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Fautrel B, 2012, RHEUMATOLOGY, V51, piv21, DOI 10.1093/rheumatology/kes088; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; He Y, 2014, J BIOL CHEM, V289, P1142, DOI 10.1074/jbc.M113.515080; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hett EC, 2013, NAT CHEM BIOL, V9, P398, DOI [10.1038/nchembio.1236, 10.1038/NCHEMBIO.1236]; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horng T, 2014, TRENDS IMMUNOL, V35, P253, DOI 10.1016/j.it.2014.02.007; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lopez-Castejon G, 2012, EXPERT OPIN INV DRUG, V21, P995, DOI 10.1517/13543784.2012.690032; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Perregaux DG, 2001, J PHARMACOL EXP THER, V299, P187; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Urban FJ, 2003, SYNTHETIC COMMUN, V33, P2029, DOI 10.1081/SCC-120021029; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	59	1433	1505	30	443	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					248	+		10.1038/nm.3806	http://dx.doi.org/10.1038/nm.3806			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25686105	Green Accepted			2022-12-25	WOS:000350362000017
J	Keener, AB				Keener, Amanda B.			A sense of immunity: Scientists are detailing the immune system as never before	NATURE MEDICINE			English	News Item							T-CELL REPERTOIRE; TRANSPLANTATION											Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Meyer EH, 2013, BLOOD, V121, P4955, DOI 10.1182/blood-2013-03-489757; Muraro PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656	18	0	0	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					3	5		10.1038/nm0115-3	http://dx.doi.org/10.1038/nm0115-3			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569540	Bronze			2022-12-25	WOS:000348408000003
J	Maier, FC; Wehrl, HF; Schmid, AM; Mannheim, JG; Wiehr, S; Lerdkrai, C; Calaminus, C; Stahlschmidt, A; Ye, L; Burnet, M; Stiller, D; Sabri, O; Reischl, G; Staufenbiel, M; Garaschuk, O; Jucker, M; Pichler, BJ				Maier, Florian C.; Wehrl, Hans F.; Schmid, Andreas M.; Mannheim, Julia G.; Wiehr, Stefan; Lerdkrai, Chommanad; Calaminus, Carsten; Stahlschmidt, Anke; Ye, Lan; Burnet, Michael; Stiller, Detlef; Sabri, Osama; Reischl, Gerald; Staufenbiel, Mathias; Garaschuk, Olga; Jucker, Mathias; Pichler, Bernd J.			Longitudinal PET-MRI reveals beta-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion	NATURE MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; HYPOTHETICAL MODEL; A-BETA; MICE; BRAIN; PLAQUES; GROWTH; IMPAIRMENT	The dynamics of beta-amyloid deposition and related second-order physiological effects, such as regional cerebral blood flow (rCBF), are key factors for a deeper understanding of Alzheimer's disease (AD). We present longitudinal in vivo data on the dynamics of p-amyloid deposition and the decline of rCBF in two different amyloid precursor protein (APP) transgenic mouse models of AD. Using a multiparametric positron emission tomography and magnetic resonance imaging approach, we demonstrate that in the presence of cerebral beta-amyloid angiopathy (CAA), beta-amyloid deposition is accompanied by a decline of rCBF. Loss of perfusion correlates with the growth of beta-amyloid plaque burden but is not related to the number of CAA-induced microhemorrhages. However, in a mouse model of parenchymal beta-amyloidosis and negligible CAA, rCBF is unchanged. Because synaptically driven spontaneous network activity is similar in both transgenic mouse strains, we conclude that the disease-related decline of rCBF is caused by CAA.	[Maier, Florian C.; Wehrl, Hans F.; Schmid, Andreas M.; Mannheim, Julia G.; Wiehr, Stefan; Calaminus, Carsten; Stahlschmidt, Anke; Reischl, Gerald; Pichler, Bernd J.] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany; [Lerdkrai, Chommanad; Garaschuk, Olga] Univ Tubingen, Inst Physiol 2, Tubingen, Germany; [Ye, Lan; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Ye, Lan; Jucker, Mathias] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Burnet, Michael] Synovo GmbH, Tubingen, Germany; [Stiller, Detlef] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res, Ingelheim, Germany; [Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Staufenbiel, Mathias] Novartis Inst BioMed Res, Basel, Switzerland	Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Synovo GmbH; Boehringer Ingelheim; Leipzig University; Novartis	Pichler, BJ (corresponding author), Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany.	bernd.pichler@med.uni-tuebingen.de	Mannheim, Julia G./AAF-8425-2021; Schmid, Andreas M/M-8163-2014; Pichler, Bernd J/B-4483-2012; Garaschuk, Olga/G-5633-2015; Burnet, Michael/AAB-2958-2019	Schmid, Andreas M/0000-0001-6483-8759; Lerdkrai, Chommanad/0000-0002-0527-9405; Sabri, Osama/0000-0002-6425-3504	German Federal Ministry of Education and Research (BMBF) [01 Gi 0705]; German Research Foundation (DFG) [PI 771/1-1]; Interdisciplinary Center for Clinical Research (IZKF) junior research group program (Functional and Metabolic Brain Imaging) [2209-0-0]; Werner Siemens Foundation	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) junior research group program (Functional and Metabolic Brain Imaging); Werner Siemens Foundation	This work was funded by the German Federal Ministry of Education and Research (BMBF) grant 01 Gi 0705, the German Research Foundation (DFG) (PI 771/1-1), the Interdisciplinary Center for Clinical Research (IZKF) junior research group program (Functional and Metabolic Brain Imaging, fortune number 2209-0-0) and the Werner Siemens Foundation. We acknowledge support from P. Martirosian, J. van den Hoff and M. Kneilling. We thank D. Bukala, F. Cay, M. Harant and M. Lehnhoff for their excellent technical assistance during all experiments. We thank J. Odenthal (Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tubingen) for providing APPPS1 mice. We thank S.C. Vega for confirmative data evaluation. We thank M. Eichner for statistical expert advice.	Bacskai BJ, 2007, ARCH NEUROL-CHICAGO, V64, P431, DOI 10.1001/archneur.64.3.431; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beckmann N, 2011, J NEUROSCI, V31, P1023, DOI 10.1523/JNEUROSCI.4936-10.2011; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Christie RH, 2001, J NEUROSCI, V21, P858, DOI 10.1523/JNEUROSCI.21-03-00858.2001; Eichhoff G, 2010, NEUROMETHODS, V43, P205, DOI 10.1007/978-1-60761-476-0_11; Fenchel M, 2006, RADIOLOGY, V238, P1013, DOI 10.1148/radiol.2382041623; Hefendehl JK, 2011, J NEUROSCI, V31, P624, DOI 10.1523/JNEUROSCI.5147-10.2011; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Kuntner C, 2009, MOL IMAGING BIOL, V11, P236, DOI 10.1007/s11307-009-0198-z; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Manook A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031310; PHELPS ME, 1975, J NUCL MED, V16, P649; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Raichle M E, 1984, Int J Neurol, V18, P75; Rojas S, 2013, NEUROBIOL AGING, V34, P1790, DOI 10.1016/j.neurobiolaging.2012.12.027; Rosen RF, 2010, ACTA NEUROPATHOL, V119, P221, DOI 10.1007/s00401-009-0583-3; Sabri O, 2012, J NUCL MED, V53; Snellman A, 2013, J NUCL MED, V54, P1434, DOI 10.2967/jnumed.112.110163; Snellman A, 2012, EUR J NUCL MED MOL I, V39, P1784, DOI 10.1007/s00259-012-2178-9; Toyama H, 2005, EUR J NUCL MED MOL I, V32, P593, DOI 10.1007/s00259-005-1780-5; Villain N, 2012, BRAIN, V135, P2126, DOI 10.1093/brain/aws125; von Reutern B, 2013, MOL IMAGING BIOL, V15, P576, DOI 10.1007/s11307-013-0625-z; Wadghiri YZ, 2003, MAGN RESON MED, V50, P293, DOI 10.1002/mrm.10529; Wegenast-Braun BM, 2009, AM J PATHOL, V175, P271, DOI 10.2353/ajpath.2009.090044; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yang J, 2011, NEUROIMAGE, V55, P1600, DOI 10.1016/j.neuroimage.2011.01.023	36	86	87	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1485	1492		10.1038/nm.3734	http://dx.doi.org/10.1038/nm.3734			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25384087				2022-12-25	WOS:000345817900026
J	Meade, BR; Gogoi, K; Hamil, AS; Palm-Apergi, C; van den Berg, A; Hagopian, JC; Springer, AD; Eguchi, A; Kacsinta, AD; Dowdy, CF; Presente, A; Lonn, P; Kaulich, M; Yoshioka, N; Gros, E; Cui, XS; Dowdy, SF				Meade, Bryan R.; Gogoi, Khirud; Hamil, Alexander S.; Palm-Apergi, Caroline; van den Berg, Arjen; Hagopian, Jonathan C.; Springer, Aaron D.; Eguchi, Akiko; Kacsinta, Apollo D.; Dowdy, Connor F.; Presente, Asaf; Loenn, Peter; Kaulich, Manuel; Yoshioka, Naohisa; Gros, Edwige; Cui, Xian-Shu; Dowdy, Steven F.			Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications	NATURE BIOTECHNOLOGY			English	Article							SOLID-PHASE SYNTHESIS; CHEMICAL-MODIFICATION; SIRNA DELIVERY; INTERFERENCE; DESIGN; SATE; PHOSPHODIESTER; PHOSPHONATE; PROGRESS; DNA	RNA interference (RNAi) has great potential to treat human disease(1-3). However, in vivo delivery of short interfering RNAs (siRNAs), which are negatively charged double-stranded RNA macromolecules, remains a major hurdle(4-9). Current siRNA delivery has begun to move away from large lipid and synthetic nanoparticles to more defined molecular conjugates(9). Here we address this issue by synthesis of short interfering ribonucleic neutrals (siRNNs) whose phosphate backbone contains neutral phosphotriester groups, allowing for delivery into cells. Once inside cells, siRNNs are converted by cytoplasmic thioesterases into native, charged phosphodiester-backbone siRNAs, which induce robust RNAi responses. siRNNs have favorable drug-like properties, including high synthetic yields, serum stability and absence of innate immune responses. Unlike siRNAs, siRNNs avidly bind serum albumin to positively influence pharmacokinetic properties. Systemic delivery of siRNNs conjugated to a hepatocyte-specific targeting domain induced extended dose-dependent in vivo RNAi responses in mice. We believe that siRNNs represent a technology that will open new avenues for development of RNAi therapeutics.	[Meade, Bryan R.; Gogoi, Khirud; Hamil, Alexander S.; Palm-Apergi, Caroline; van den Berg, Arjen; Hagopian, Jonathan C.; Springer, Aaron D.; Eguchi, Akiko; Kacsinta, Apollo D.; Dowdy, Connor F.; Presente, Asaf; Loenn, Peter; Kaulich, Manuel; Yoshioka, Naohisa; Gros, Edwige; Cui, Xian-Shu; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Presente, Asaf] Univ Calif San Diego, Sch Med, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	Eguchi, Akiko/E-3086-2010; Kaulich, Manuel/U-4523-2017	Kaulich, Manuel/0000-0002-9528-8822; Palm Apergi, Caroline/0000-0003-2236-2099	Cancer Biology Training grant (NCI); San Diego Foundation; C.I.R.M. Fellowship; Knut and Alice Wallenberg Foundation; Sweden-America Foundation; CT2 training grant (N.C.I.); Swedish Research Council grant; IRACDA Training grant (N.I.H.); W.M. Keck Foundation; Department of Defense; Leukemia & Lymphoma Society; Pardee Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA121938, T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	Cancer Biology Training grant (NCI); San Diego Foundation; C.I.R.M. Fellowship; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sweden-America Foundation; CT2 training grant (N.C.I.); Swedish Research Council grant(Swedish Research Council); IRACDA Training grant (N.I.H.); W.M. Keck Foundation(W.M. Keck Foundation); Department of Defense(United States Department of Defense); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Pardee Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tor (UCSD) for critical input, Y. Su (UCSD) for help with mass spectrometry, and Z. Rudolph and L.D.F. Vasconcelos for technical assistance. B.R.M., A.S.H. and A.D.S. were supported by a T32 Cancer Biology Training grant (NCI); A.S.H. was also supported by a Blasker Award from The San Diego Foundation; A. P. was supported by a C.I.R.M. Fellowship; C.P.-A. was supported by fellowships from Knut and Alice Wallenberg Foundation and Sweden-America Foundation; J.C.H. was supported by the CT2 training grant (N.C.I.); P.L. was supported by a Swedish Research Council grant; A.D.K. was supported by a IRACDA Training grant (N.I.H.). This work was supported by the W.M. Keck Foundation (S.F.D.), the Department of Defense (S.F.D.), SCOR grant from the Leukemia & Lymphoma Society (S.F.D.), the Pardee Foundation (S.F.D.), a grant from an anonymous donor (S.F.D.) and the Howard Hughes Medical Institute (S.F.D.).	Beaucage SL, 2008, CURR OPIN DRUG DISC, V11, P203; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bologna JC, 1999, EUR J ORG CHEM, V1999, P2353; Bramsen JB, 2011, METHODS MOL BIOL, V721, P77, DOI 10.1007/978-1-61779-037-9_5; BRESLOW R, 1993, P NATL ACAD SCI USA, V90, P1201, DOI 10.1073/pnas.90.4.1201; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Dellinger DJ, 2003, J AM CHEM SOC, V125, P940, DOI 10.1021/ja027983f; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; Faraj A, 1999, NUCLEOS NUCLEOT, V18, P987, DOI 10.1080/15257779908041623; Gao S, 2009, MOL THER, V17, P1225, DOI 10.1038/mt.2009.91; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Grajkowski A, 2001, ORG LETT, V3, P1287, DOI 10.1021/ol0156852; Guzaev A, 1999, NUCLEOS NUCLEOT, V18, P1391, DOI 10.1080/07328319908044727; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Krishna H, 2012, J AM CHEM SOC, V134, P11618, DOI 10.1021/ja3026714; KUIJPERS WHA, 1990, NUCLEIC ACIDS RES, V18, P5197, DOI 10.1093/nar/18.17.5197; LEFEBVRE I, 1995, J MED CHEM, V38, P3941, DOI 10.1021/jm00020a007; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Meade Bryan R, 2009, Discov Med, V8, P253; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; PERIGAUD C, 1993, BIOORG MED CHEM LETT, V3, P2521, DOI 10.1016/S0960-894X(01)80709-5; Petersen S, 2014, USPTO, Patent No. [8,691,971, 8691971]; Peyrottes S, 2004, MINI-REV MED CHEM, V4, P395; Pon RT, 1997, NUCLEIC ACIDS RES, V25, P3629, DOI 10.1093/nar/25.18.3629; Reese CB, 2005, ORG BIOMOL CHEM, V3, P3851, DOI 10.1039/b510458k; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Sliedregt LAJM, 1999, J MED CHEM, V42, P609, DOI 10.1021/jm981078h; Tanabe K, 2011, TETRAHEDRON LETT, V52, P7135, DOI 10.1016/j.tetlet.2011.10.109; Tosquellas G, 1998, NUCLEIC ACIDS RES, V26, P2069, DOI 10.1093/nar/26.9.2069; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Whitehead KA, 2011, ANNU REV CHEM BIOMOL, V2, P77, DOI 10.1146/annurev-chembioeng-061010-114133; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085	38	144	168	6	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1256	U122		10.1038/nbt.3078	http://dx.doi.org/10.1038/nbt.3078			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402614	Green Accepted			2022-12-25	WOS:000346156800028
J	Ono, N; Ono, W; Nagasawa, T; Kronenberg, HM				Ono, Noriaki; Ono, Wanida; Nagasawa, Takashi; Kronenberg, Henry M.			A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones	NATURE CELL BIOLOGY			English	Article							OSTEO-CHONDROPROGENITOR CELLS; STEM-CELLS; CRE ACTIVITY; MARROW; DIFFERENTIATION; EXPRESSION; GENE; MICE; VASCULATURE; OSTEOBLASTS	The hallmark of endochondral bone development is the presence of cartilaginous templates, in which osteoblasts and stromal cells are generated to form mineralized matrix and support bone marrow haematopoiesis. However, the ultimate source of these mesenchymal cells and the relationship between bone progenitors in fetal life and those in later life are unknown. Fate-mapping studies revealed that cells expressing cre-recombinases driven by the collagen II (Col2) promoter/enhancer and their descendants contributed to, in addition to chondrocytes, early perichondrial precursors before Runx2 expression and, subsequently, to a majority of osteoblasts, Cxcl12 (chemokine (C-X-C motif) ligand 12)-abundant stromal cells and bone marrow stromal/mesenchymal progenitor cells in postnatal life. Lineage-tracing experiments using a tamoxifen-inducible creER system further revealed that early postnatal cells marked by Col2-creER, as well as Sox9-creER and aggrecan (Acan)-creER, progressively contributed to multiple mesenchymal lineages and continued to provide descendants for over a year. These cells are distinct from adult mesenchymal progenitors and thus provide opportunities for regulating the explosive growth that occurs uniquely in growing mammals.	[Ono, Noriaki; Ono, Wanida; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Ono, Noriaki; Ono, Wanida; Kronenberg, Henry M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ono, Noriaki; Ono, Wanida] Univ Michigan, Dept Orthodont & Pediat Dent, Sch Dent, Ann Arbor, MI 48109 USA; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Kyoto University; Japan Science & Technology Agency (JST)	Kronenberg, HM (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	hkronenberg@mgh.harvard.edu		Nagasawa, Takashi/0000-0002-1085-0960; Ono, Wanida/0000-0002-0358-1897	National Institutes of Health [DE022564, DK056246]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE022564, K99DE022564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank D. Rowe (University of Connecticut, USA) for Col2.3-GFP and Oc-GFP mice and S. Mackem (National Cancer Institute, USA) for Col2a1-creER<SUP>T2</SUP> mice, H. Akiyama (Kyoto University, Japan) and B. de Crombrugghe (MD Anderson Cancer Center, USA) for Sox9-creER<SUP>T2</SUP> and Acan-creER<SUP>T2</SUP> mice, and L. Prickett, K. Folz-Donahue and M. Weglarz of Harvard Stem Cell Institute/Massachusetts General Hospital flow cytometry core and T. Diefenbach of Ragon Institute imaging core for their expert assistance. This work was supported by National Institutes of Health Grants DE022564 to N.O. and DK056246 to H.M.K.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	31	263	268	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1157	U73		10.1038/ncb3067	http://dx.doi.org/10.1038/ncb3067			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25419849	Green Accepted, Green Submitted			2022-12-25	WOS:000345777300007
J	Ronan, B; Flamand, O; Vescovi, L; Dureuil, C; Durand, L; Fassy, F; Bachelot, MF; Lamberton, A; Mathieu, M; Bertrand, T; Marquette, JP; El-Ahmad, Y; Filoche-Romme, B; Schio, L; Garcia-Echeverria, C; Goulaouic, H; Pasquier, B				Ronan, Baptiste; Flamand, Odile; Vescovi, Lionel; Dureuil, Christine; Durand, Laurence; Fassy, Florence; Bachelot, Marie-France; Lamberton, Annabelle; Mathieu, Magali; Bertrand, Thomas; Marquette, Jean-Pierre; El-Ahmad, Youssef; Filoche-Romme, Bruno; Schio, Laurent; Garcia-Echeverria, Carlos; Goulaouic, Helene; Pasquier, Benoit			A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy	NATURE CHEMICAL BIOLOGY			English	Article							T-CELL HOMEOSTASIS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; KINASE VPS34; MAMMALIAN-CELLS; LIPID KINASE; DISEASE; MTOR; MECHANISMS; REVEALS; OPTIMIZATION	Vps34 is a phosphoinositide 3-kinase (PI3K) class III isoform that has attracted major attention over the recent years because of its role in autophagy. Herein we describe the biological characterization of SAR405, which is a low-molecular-mass kinase inhibitor of Vps34 (K-D 1.5 nM). This compound has an exquisite protein and lipid kinase selectivity profile that is explained by its unique binding mode and molecular interactions within the ATP binding cleft of human Vps34. To the best of our knowledge, this is the first potent and specific Vps34 inhibitor described so far. Our results demonstrate that inhibition of Vps34 kinase activity by SAR405 affects both late endosome-lysosome compartments and prevents autophagy. Moreover, we show that the concomitant inhibition of Vps34 and mTOR, with SAR405 and the US Food and Drug Administration-approved mTOR inhibitor everolimus, results in synergistic antiproliferative activity in renal tumor cell lines, indicating a potential clinical application in cancer.	[Ronan, Baptiste; Flamand, Odile; Vescovi, Lionel; Dureuil, Christine; Durand, Laurence; Fassy, Florence; Bachelot, Marie-France; Lamberton, Annabelle; El-Ahmad, Youssef; Filoche-Romme, Bruno; Schio, Laurent; Garcia-Echeverria, Carlos; Goulaouic, Helene; Pasquier, Benoit] Sanofi, Oncol Drug Discovery, Vitry Sur Seine, France; [Mathieu, Magali; Bertrand, Thomas; Marquette, Jean-Pierre] Sanofi, Struct Design & Informat, Vitry Sur Seine, France	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Pasquier, B (corresponding author), Sanofi, Oncol Drug Discovery, Vitry Sur Seine, France.	benoit.pasquier@sanofi.com		Fassy, Florence/0000-0001-8337-9674				Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Certal V, 2012, J MED CHEM, V55, P4788, DOI 10.1021/jm300241b; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kutateladze TG, 2007, PROG LIPID RES, V46, P315, DOI 10.1016/j.plipres.2007.06.001; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Peppard J V, 2014, Curr Chem Genom Transl Med, V8, P3, DOI 10.2174/2213988501408010003; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Stauffer F, 2008, BIOORG MED CHEM LETT, V18, P1027, DOI 10.1016/j.bmcl.2007.12.018; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; STUFFERS S, 2010, HEALTH TECHNOL ASSES, V14, P1025; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wiczer BM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003019; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	53	289	304	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1013	+		10.1038/nchembio.1681	http://dx.doi.org/10.1038/nchembio.1681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25326666				2022-12-25	WOS:000345122300008
J	Xie, H; Cui, Z; Wang, L; Xia, ZY; Hu, Y; Xian, LL; Li, CJ; Xie, L; Crane, J; Wan, M; Zhen, GH; Bian, Q; Yu, B; Chang, WZ; Qiu, T; Pickarski, M; Duong, LT; Windle, JJ; Luo, XH; Liao, EY; Cao, X				Xie, Hui; Cui, Zhuang; Wang, Long; Xia, Zhuying; Hu, Yin; Xian, Lingling; Li, Changjun; Xie, Liang; Crane, Janet; Wan, Mei; Zhen, Gehua; Bian, Qin; Yu, Bin; Chang, Weizhong; Qiu, Tao; Pickarski, Maureen; Le Thi Duong; Windle, Jolene J.; Luo, Xianghang; Liao, Eryuan; Cao, Xu			PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; CATHEPSIN-K; CORTICAL BONE; OSTEOCLASTS; MECHANISMS; MIGRATION; RESORPTION; MICE; DIFFERENTIATION	Osteogenesis during bone modeling and remodeling is coupled with angiogenesis. A recent study showed that a specific vessel subtype, strongly positive for CD31 and endomucin (CD31(hi)Emcn(hi)), couples angiogenesis and osteogenesis. Here, we found that platelet-derived growth factor-BB (PDGF-BB) secreted by preosteoclasts induces CD31(hi)Emcn(hi) vessel formation during bone modeling and remodeling. Mice with depletion of PDGF-BB in the tartrate-resistant acid phosphatase-positive cell lineage show significantly lower trabecular and cortical bone mass, serum and bone marrow PDGF-BB concentrations, and fewer CD31(hi)Emcn(hi) vessels compared to wild-type mice. In the ovariectomy (OVX)-induced osteoporotic mouse model, serum and bone marrow levels of PDGF-BB and numbers of CD31(hi)Emcn(hi) vessels are significantly lower compared to sham-operated controls. Treatment with exogenous PDGF-BB or inhibition of cathepsin K to increase the number of preosteoclasts, and thus the endogenous levels of PDGF-BB, increases CD31(hi)Emcn(hi) vessel number and stimulates bone formation in OVX mice. Thus, pharmacotherapies that increase PDGF-BB secretion from preosteoclasts offer a new therapeutic target for treating osteoporosis by promoting angiogenesis and thus bone formation.	[Xie, Hui; Cui, Zhuang; Wang, Long; Xia, Zhuying; Hu, Yin; Xian, Lingling; Li, Changjun; Xie, Liang; Crane, Janet; Wan, Mei; Zhen, Gehua; Bian, Qin; Chang, Weizhong; Qiu, Tao; Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Xie, Hui; Xia, Zhuying; Hu, Yin; Luo, Xianghang; Liao, Eryuan] Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, Changsha, Hunan, Peoples R China; [Cui, Zhuang; Yu, Bin] Southern Med Univ, Nan Fang Hosp, Dept Orthoped & Trauma, Guangzhou, Cuangdong, Peoples R China; [Wang, Long] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Pickarski, Maureen; Le Thi Duong] Merck Res Labs, West Point, PA USA; [Windle, Jolene J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Johns Hopkins University; Central South University; Southern Medical University - China; Central South University; Merck & Company; Virginia Commonwealth University	Cao, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	xianghangluo@hotmail.com; eyliao@21cn.com; xcao11@jhmi.edu	Bian, Qin/C-8831-2014; Xie, Hui/AAF-8152-2020; Xie, Liang/AAR-7725-2021	Windle, Jolene/0000-0001-6690-385X; Bian, Qin/0000-0003-4190-0913; Crane, Janet/0000-0001-7713-0936	US National Institutes of Health [DK 057501, AR 063943]; China National Funds for Distinguished Young Scientists [81125006]; Merck Investigator-Initiated Studies Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR064833, R01AR063943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057501, P30DK079637] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Merck Investigator-Initiated Studies Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grants DK 057501 and AR 063943 (to X.C.), China National Funds for Distinguished Young Scientists grant 81125006 (to X.L.) and the Merck Investigator-Initiated Studies Program.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Baroukh B, 2000, BONE, V27, P627, DOI 10.1016/S8756-3282(00)00372-0; Boonen S, 2012, CURR OSTEOPOROS REP, V10, P73, DOI 10.1007/s11914-011-0085-9; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Brixen K, 2013, J CLIN ENDOCR METAB, V98, P571, DOI 10.1210/jc.2012-2972; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen WCW, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/983059; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Choi IH, 2002, J KOREAN MED SCI, V17, P435, DOI 10.3346/jkms.2002.17.4.435; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Cusick T, 2012, J BONE MINER RES, V27, P524, DOI 10.1002/jbmr.1477; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Del Fattore Andrea, 2012, Front Biosci (Elite Ed), V4, P2302; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Friedlaender GE, 2013, CURR PHARM DESIGN, V19, P3384, DOI 10.2174/1381612811319190005; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7; Henriksen K, 2012, BONE, V51, P353, DOI 10.1016/j.bone.2012.06.007; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Kreja L, 2010, J CELL BIOCHEM, V109, P347, DOI 10.1002/jcb.22406; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Nassiri SM, 2014, STEM CELLS DEV, V23, P319, DOI 10.1089/scd.2013.0419; Ochareon P, 2011, J ANAT, V218, P285, DOI 10.1111/j.1469-7580.2010.01336.x; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0; Pazzaglia UE, 2010, ANAT HISTOL EMBRYOL, V39, P17, DOI 10.1111/j.1439-0264.2009.00973.x; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Roche B, 2014, J BONE MINER RES, V29, P1608, DOI 10.1002/jbmr.2191; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Sakagami N, 2005, MICRON, V36, P688, DOI 10.1016/j.micron.2005.06.008; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; Seeman E, 2009, CRIT REV EUKAR GENE, V19, P219, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.40; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shih TTF, 2004, RADIOLOGY, V233, P121, DOI 10.1148/radiol.2331031509; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiang A, 2007, BONE, V40, P1231, DOI 10.1016/j.bone.2007.01.010; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhao Q, 2012, BONE, V50, P763, DOI 10.1016/j.bone.2011.12.003; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	60	453	499	34	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1270	1278		10.1038/nm.3668	http://dx.doi.org/10.1038/nm.3668			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25282358	Green Accepted			2022-12-25	WOS:000344724300016
J	Thodey, K; Galanie, S; Smolke, CD				Thodey, Kate; Galanie, Stephanie; Smolke, Christina D.			A microbial biomanufacturing platform for natural and semisynthetic opioids	NATURE CHEMICAL BIOLOGY			English	Article							PSEUDOMONAS-PUTIDA M10; BENZYLISOQUINOLINE ALKALOID METABOLISM; OPIUM POPPY; SACCHAROMYCES-CEREVISIAE; MORPHINE BIOSYNTHESIS; CODEINONE REDUCTASE; PAPAVER-SOMNIFERUM; DIOXYGENASES CATALYZE; ENDOPLASMIC-RETICULUM; YEAST MITOCHONDRIA	Opiates and related molecules are medically essential, but their production via field cultivation of opium poppy Papaver somniferum leads to supply inefficiencies and insecurity. As an alternative production strategy, we developed baker's yeast Saccharomyces cerevisiae as a microbial host for the transformation of opiates. Yeast strains engineered to express heterologous genes from P. somniferum and bacterium Pseudomonas putida M10 convert thebaine to codeine, morphine, hydromorphone, hydrocodone and oxycodone. We discovered a new biosynthetic branch to neopine and neomorphine, which diverted pathway flux from morphine and other target products. We optimized strain titer and specificity by titrating gene copy number, enhancing cosubstrate supply, applying a spatial engineering strategy and performing high-density fermentation, which resulted in total opioid titers up to 131 mg/l. This work is an important step toward total biosynthesis of valuable benzylisoquinoline alkaloid drug molecules and demonstrates the potential for developing a sustainable and secure yeast biomanufacturing platform for opioids.	[Thodey, Kate; Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Galanie, Stephanie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	csmolke@stanford.edu	Galanie, Stephanie/T-1373-2019	Galanie, Stephanie/0000-0001-5712-2568	NIH [1S10RR02557401]; US National Institutes of Health [DP1OD009329]; National Science Foundation [CBET-1066100]; Bill and Melinda Gates Foundation [OPP1058690]; New Zealand Foundation for Research, Science and Technology [SFRD0901]; Stanford University; National Center for Complementary & Integrative Health [DP1AT007886] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Stanford University(Stanford University); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank F.J. Lu for contributions to strain construction and testing; Noramco for the gift of standards codeinone, dihydrocodeine, oripavine, morphinone and 14-hydroxycodeine; members of the Stanford Cell Sciences Imaging Facility for providng fluorescence microscopy access (Leica SP5 NIH grant SIG number: 1S10RR02557401) and training; members of the Stanford Chemistry NMR Facility and S. Lynch for instrument access and training; J. Li for helpful discussions and sharing equipment for compound isolation; D. Endy, M. McKeague, I. Trenchard, A.L. Chang and Y.-H. Wang for valuable feedback in the preparation of the manuscript. This work was supported by US National Institutes of Health (grant to C.D.S., DP1OD009329), the National Science Foundation (grant to C.D.S., CBET-1066100; fellowship to S.G.), the Bill and Melinda Gates Foundation (grant to C.D.S., OPP1058690), the New Zealand Foundation for Research, Science and Technology (fellowship to K.T., SFRD0901) and Stanford University (fellowship to S.G.).	Al-Amri AM, 2005, ANAL BIOANAL CHEM, V382, P830, DOI 10.1007/s00216-005-3168-6; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alcantara J, 2005, PLANT PHYSIOL, V138, P173, DOI 10.1104/pp.105.059287; Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; [Anonymous], 2012, PDR NETW PHYS DESK R; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Becker JVW, 2003, FEMS YEAST RES, V4, P79, DOI 10.1016/S1567-1356(03)00157-0; BERNATH J, 1998, POPPY GENUS PAPAVER; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bird DA, 2001, PLANTA, V213, P888, DOI 10.1007/s004250100582; BRUCE NC, 1991, BIOCHEM J, V274, P875, DOI 10.1042/bj2740875; BRUCE NC, 1990, ARCH MICROBIOL, V154, P465, DOI 10.1007/BF00245229; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dumas B, 1996, EUR J BIOCHEM, V238, P495, DOI 10.1111/j.1432-1033.1996.0495z.x; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; FRENCH CE, 1995, BIO-TECHNOL, V13, P674, DOI 10.1038/nbt0795-674; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; GOLLWITZER J, 1993, TETRAHEDRON LETT, V34, P5703, DOI 10.1016/S0040-4039(00)73838-X; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; HOMEYER AH, 1947, J ORG CHEM, V12, P356, DOI 10.1021/jo01166a022; International Narcotics Control Board, 2012, NARC DRUGS EST WORLD; Kim JS, 2013, BIOSCI BIOTECH BIOCH, V77, P2166, DOI 10.1271/bbb.130552; Larkin PJ, 2007, PLANT BIOTECHNOL J, V5, P26, DOI 10.1111/j.1467-7652.2006.00212.x; LENZ R, 1995, EUR J BIOCHEM, V233, P132, DOI 10.1111/j.1432-1033.1995.132_1.x; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Lister DL, 1999, FEMS MICROBIOL LETT, V181, P137; MEUZELAAR GJ, 1993, RECL TRAV CHIM PAY B, V112, P573; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Nakagawa A, 2012, BIOENGINEERED, V3, P49, DOI [10.4161/bbug.3.1.18446, 10.1038/ncomms1327]; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; NIELSEN B, 1983, PLANTA MED, V48, P205, DOI 10.1055/s-2007-969921; Onoyovwe A, 2013, PLANT CELL, V25, P4110, DOI 10.1105/tpc.113.115113; PARKER HI, 1972, J AM CHEM SOC, V94, P1276, DOI 10.1021/ja00759a039; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Raith K, 2003, J AM SOC MASS SPECTR, V14, P1262, DOI 10.1016/S1044-0305(03)00539-7; Rinner U, 2012, TOP CURR CHEM, V309, P33, DOI 10.1007/128_2011_133; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Zhang QB, 2005, J AM CHEM SOC, V127, P7286, DOI 10.1021/ja051682z	50	174	192	7	209	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					837	+		10.1038/NCHEMBIO.1613	http://dx.doi.org/10.1038/NCHEMBIO.1613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25151135	Green Accepted			2022-12-25	WOS:000342462100010
J	Jin, DQ; Ni, TT; Sun, JJ; Wan, HY; Amack, JD; Yu, GJ; Fleming, J; Chiang, C; Li, WY; Papierniak, A; Cheepala, S; Conseil, G; Cole, SPC; Zhou, B; Drummond, IA; Schuetz, JD; Malicki, J; Zhong, TP				Jin, Daqing; Ni, Terri T.; Sun, Jianjian; Wan, Haiyan; Amack, Jeffrey D.; Yu, Guangju; Fleming, Jonathan; Chiang, Chin; Li, Wenyan; Papierniak, Anna; Cheepala, Satish; Conseil, Gwenaelle; Cole, Susan P. C.; Zhou, Bin; Drummond, Iain A.; Schuetz, John D.; Malicki, Jarema; Zhong, Tao P.			Prostaglandin signalling regulates ciliogenesis by modulating intraflagellar transport	NATURE CELL BIOLOGY			English	Article							LEFT-RIGHT ASYMMETRY; KUPFFERS VESICLE; EFFLUX TRANSPORTER; SENSORY NEURONS; LENGTH CONTROL; PRIMARY CILIUM; GTPASE RAB8; ZEBRAFISH; RESISTANCE; MULTIDRUG	Cilia are microtubule-based organelles that mediate signal transduction in a variety of tissues. Despite their importance, the signalling cascades that regulate cilium formation remain incompletely understood. Here we report that prostaglandin signalling affects ciliogenesis by regulating anterograde intraflagellar transport (IFT). Zebrafish leakytail (Ikt) mutants show ciliogenesis defects, and the Ikt locus encodes an ATP-binding cassette transporter (ABCC4). We show that Lkt/ABCC4 localizes to the cell membrane and exports prostaglandin E2 (PGE2), a function that is abrogated by the Lkt/ABCC4T8 4m mutant. PGE2 synthesis enzyme cyclooxygenase-1 and its receptor, EP4, which localizes to the cilium and activates the cyclic-AMP-mediated signalling cascade, are required for cilium formation and elongation. Importantly, PGE2 signalling increases anterograde but not retrograde velocity of IFT and promotes ciliogenesis in mammalian cells. These findings lead us to propose that Lkt/ABCC4-mediated PGE2 signalling acts through a ciliary G-protein-coupled receptor, EP4, to upregulate cAMP synthesis and increase anterograde IFT, thereby promoting ciliogenesis.	[Jin, Daqing; Sun, Jianjian; Yu, Guangju; Li, Wenyan; Zhong, Tao P.] Fudan Univ, Sch Life Sci, Dept Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ni, Terri T.; Wan, Haiyan; Zhong, Tao P.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Amack, Jeffrey D.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, New York, NY 13210 USA; [Fleming, Jonathan; Chiang, Chin] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Papierniak, Anna; Malicki, Jarema] Univ Sheffield, ARC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; [Cheepala, Satish; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Conseil, Gwenaelle; Cole, Susan P. C.] Queens Univ, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Zhou, Bin] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Drummond, Iain A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Cambridge, MA 02148 USA	Fudan University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Vanderbilt University; University of Sheffield; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Queens University - Canada; Chinese Academy of Sciences; Harvard University; Massachusetts General Hospital	Zhong, TP (corresponding author), Fudan Univ, Sch Life Sci, Dept Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	taozhong@fudan.edu.cn	Cole, Susan P.C./I-6389-2017; malicki, jarema/G-8611-2014; Schuetz, John D/N-2692-2018	Cole, Susan P.C./0000-0001-6571-6884; malicki, jarema/0000-0002-5947-8805; Papierniak-Wygladala, Anna/0000-0001-9814-2899; Amack, Jeffrey/0000-0002-5465-9754; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [CMST2013CB945301, CMST2012CB944501]; National Natural Science Foundation of China [NSFC31172173]; Shanghai Pujiang Program [11PJ1401600]; National Institute of Health of America; Canadian Institutes of Health Research [MOP106513]; NATIONAL CANCER INSTITUTE [T32CA119925, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053093] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Institute of Health of America; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge P. Yuanyuan and J. Guan for assistance in fish care, X. Zhu for hRPE1 cells, J. Shah for IFT88-EYFP cells, C. Yi for cAMP assays, Q. Li for diagram drawing and L. Cai and G. Zhu for spin-disk confocal microscopy analysis. We are grateful to H. Ma, B. Appel, Z. Sun, J. Gamse and members of our laboratories for comments on the manuscript and helpful discussions. This research was supported in part by grants from the National Basic Research Program of China (CMST2013CB945301, CMST2012CB944501; T.P.Z.), National Natural Science Foundation of China (NSFC31172173; T.P.Z.) and Shanghai Pujiang Program (11PJ1401600; T.P.Z.) as well as the National Institute of Health of America (T.P.Z., J.D.S., J.M., I.A.D.) and Canadian Institutes of Health Research (MOP106513, S.P.C.C.).	Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fukuda Y, 2013, MOL PHARMACOL, V84, P361, DOI 10.1124/mol.113.086967; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; Haxel BR, 2001, EUR ARCH OTO-RHINO-L, V258, P230, DOI 10.1007/s004050100339; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lord AM, 2007, CELL CYCLE, V6, P3054, DOI 10.4161/cc.6.24.5129; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sarmah B, 2007, P NATL ACAD SCI USA, V104, P19843, DOI 10.1073/pnas.0706934104; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Schuldiner S, 2006, NATURE, V443, P156, DOI 10.1038/443156b; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; St-Jacques B, 2013, PAIN, V154, P313, DOI 10.1016/j.pain.2012.11.005; Starner RJ, 2010, EXP DERMATOL, V19, P682, DOI 10.1111/j.1600-0625.2010.01074.x; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	50	56	60	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					841	851		10.1038/ncb3029	http://dx.doi.org/10.1038/ncb3029			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25173977	Green Accepted, Green Submitted			2022-12-25	WOS:000341404400005
J	Villar, EA; Beglov, D; Chennamadhavuni, S; Porco, JA; Kozakov, D; Vajda, S; Whitty, A				Villar, Elizabeth A.; Beglov, Dmitri; Chennamadhavuni, Spandan; Porco, John A., Jr.; Kozakov, Dima; Vajda, Sandor; Whitty, Adrian			How proteins bind macrocycles	NATURE CHEMICAL BIOLOGY			English	Article							DRUGGABLE HOT-SPOTS; FRAGMENT-BASED APPROACH; HIGH-HANGING FRUIT; DRUG DISCOVERY; NATURAL-PRODUCTS; CYCLIC-PEPTIDES; IDENTIFICATION; INTERFACES; LESSONS; SITES	The potential utility of synthetic macrocycles (MCs) as drugs, particularly against low-druggability targets such as protein-protein interactions, has been widely discussed. There is little information, however, to guide the design of MCs for good target protein-binding activity or bioavailability. To address this knowledge gap, we analyze the binding modes of a representative set of MC-protein complexes. The results, combined with consideration of the physicochemical properties of approved macrocyclic drugs, allow us to propose specific guidelines for the design of synthetic MC libraries with structural and physicochemical features likely to favor strong binding to protein targets as well as good bioavailability. We additionally provide evidence that large, natural product-derived MCs can bind targets that are not druggable by conventional, drug-like compounds, supporting the notion that natural product-inspired synthetic MCs can expand the number of proteins that are druggable by synthetic small molecules.	[Villar, Elizabeth A.; Chennamadhavuni, Spandan; Porco, John A., Jr.; Vajda, Sandor; Whitty, Adrian] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Beglov, Dmitri; Kozakov, Dima; Vajda, Sandor] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Villar, EA (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	midas@bu.edu; vajda@bu.edu; whitty@bu.edu	madhavuni, Spandan Chenna/D-3208-2017	madhavuni, Spandan Chenna/0000-0002-1026-9527; Kozakov, Dima/0000-0003-0464-4500	US National Institutes of Health [GM094551, GM064700]; NIH [GM094551-01S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064700, R01GM094551] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by US National Institutes of Health grants GM094551 to A.W., S.V. and J.A.P. and GM064700 to S.V. and NIH diversity supplement GM094551-01S1 to E.A.V.	Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Bockus AT, 2013, CURR TOP MED CHEM, V13, P821, DOI 10.2174/1568026611313070005; Brandt W, 2010, CURR TOP MED CHEM, V10, P1361, DOI 10.2174/156802610792232060; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Buchwald P, 2010, IUBMB LIFE, V62, P724, DOI 10.1002/iub.383; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Chuang GY, 2009, BIOPHYS J, V97, P2846, DOI 10.1016/j.bpj.2009.09.004; Ciulli A, 2006, J MED CHEM, V49, P4992, DOI 10.1021/jm060490r; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Giordanetto F, 2014, J MED CHEM, V57, P278, DOI 10.1021/jm400887j; Golden MS, 2013, J AM CHEM SOC, V135, P6242, DOI 10.1021/ja400914z; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hall DH, 2011, J AM CHEM SOC, V133, P20668, DOI 10.1021/ja207914y; Hall DR, 2012, J CHEM INF MODEL, V52, P199, DOI 10.1021/ci200468p; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mallinson J, 2012, FUTURE MED CHEM, V4, P1409, DOI [10.4155/FMC.12.93, 10.4155/fmc.12.93]; Marsault E, 2011, J MED CHEM, V54, P1961, DOI 10.1021/jm1012374; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Raj M, 2013, BIOORGAN MED CHEM, V21, P4051, DOI 10.1016/j.bmc.2012.11.023; Rand AC, 2012, MEDCHEMCOMM, V3, P1282, DOI 10.1039/c2md20203d; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vieth M, 2004, J MED CHEM, V47, P224, DOI 10.1021/jm030267j; Vistoli G, 2008, DRUG DISCOV TODAY, V13, P285, DOI 10.1016/j.drudis.2007.11.007; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wessjohann LA, 2005, MOL DIVERS, V9, P171, DOI 10.1007/s11030-005-1314-x; White TR, 2011, NAT CHEM BIOL, V7, P810, DOI 10.1038/nchembio.664; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Wu CY, 2005, PHARM RES-DORDR, V22, P11, DOI 10.1007/s11095-004-9004-4; Yu XF, 2013, MOLECULES, V18, P6230, DOI 10.3390/molecules18066230; Zerbe BS, 2012, J CHEM INF MODEL, V52, P2236, DOI [10.1021/ci300175u, 10.1021/cI300175u]	49	267	270	6	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					723	731		10.1038/NCHEMBIO.1584	http://dx.doi.org/10.1038/NCHEMBIO.1584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038790	Green Accepted			2022-12-25	WOS:000341126800008
J	Zhang, P; Wei, Y; Wang, L; Debeb, BG; Yuan, Y; Zhang, JS; Yuan, JS; Wang, M; Chen, DH; Sun, YT; Woodward, WA; Liu, YQ; Dean, DC; Liang, H; Hu, Y; Ang, KK; Hung, MC; Chen, JJ; Ma, L				Zhang, Peijing; Wei, Yongkun; Wang, Li; Debeb, Bisrat G.; Yuan, Yuan; Zhang, Jinsong; Yuan, Jingsong; Wang, Min; Chen, Dahu; Sun, Yutong; Woodward, Wendy A.; Liu, Yongqing; Dean, Douglas C.; Liang, Han; Hu, Ye; Ang, K. Klan; Hung, Mien-Chie; Chen, Junjie; Ma, Li			ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CH K1	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE H2AX PHOSPHORYLATION; BREAST-CANCER; HOMOLOGOUS RECOMBINATION; STRAND BREAKS; STEM-CELLS; CHECKPOINT; REPAIR; P53; TRANSCRIPTION	Epithelial-mesenchymal transition (EMT) is associated with characteristics of breast cancer stem cells, including chemoresistance and radioresistance. However, it is unclear whether EMT itself or specific EMT regulators play causal roles in these properties. Here we identify an EMT-inducing transcription factor, zinc finger E-box binding homeobox 1 (ZEB1), as a regulator of radiosensitivity and DNA damage response. Radioresistant subpopulations of breast cancer cells derived from ionizing radiation exhibit hyperactivation of the kinase ATM and upregulation of ZEB1, and the latter promotes tumour cell radioresistance in vitro and in vivo. Mechanistically, ATM phosphorylates and stabilizes ZEB1 in response to DNA damage, ZEB1 in turn directly interacts with USP7 and enhances its ability to deubiquitylate and stabilize CHK1, thereby promoting homologous recombination-dependent DNA repair and resistance to radiation. These findings identify ZEB1 as an ATM substrate linking ATM to CHK1 and the mechanism underlying the association between EMT and radioresistance.	[Zhang, Peijing; Wang, Li; Zhang, Jinsong; Yuan, Jingsong; Wang, Min; Chen, Dahu; Chen, Junjie; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wei, Yongkun; Sun, Yutong; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Debeb, Bisrat G.; Woodward, Wendy A.; Ang, K. Klan] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Yuan, Yuan; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Yongqing; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Hu, Ye] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 402, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 402, Taiwan; [Hung, Mien-Chie; Chen, Junjie; Ma, Li] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Louisville; The Methodist Hospital System; The Methodist Hospital - Houston; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; University of Texas Health Science Center Houston	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	lma4@mdanderson.org	Woodward, Wendy/AAX-6593-2020; Chen, Dahu/AAX-6349-2021; Hung, Mien-Chie/ABD-5911-2021; Ma, Li/GQR-1313-2022; Yuan, Yuan/H-4007-2013	Hung, Mien-Chie/0000-0003-4317-4740; Ma, Li/0000-0001-9965-989X; Yuan, Yuan/0000-0003-4706-7897; Hu, Tony/0000-0001-7255-5409; Zhang, Peijing/0000-0003-1586-8710; Sun, Yutong/0000-0002-9368-2957; Woodward, Wendy/0000-0002-7935-739X	NIH [R00CA138572, R01CA166051, R01CA181029, U54CA151668]; CPRIT Scholar Award [R1004]; Komen Foundation [KG101478]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA166051, R00CA138572, U54CA151668, R01CA181029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT Scholar Award; Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the shRNA and ORFeome Core at MD Anderson Cancer Center and Z. Gong, A. Lin, J. Wang, W Wang, G. Wan and X. Lu for reagents and technical assistance. We thank A. Postigo, H-L. Plan and J. Kim for discussion. This work is supported by the NIH grants R00CA138572, R01CA166051 and R01CA181029 (to L.M.) and a CPRIT Scholar Award R1004 (to L.M.). L.M. is an R. Lee Clark Fellow of The University of Texas MD Anderson Cancer Center. B.G.D. and W.A.W. are supported by a Komen Foundation Grant KG101478. Y.H. is supported in part by NIH U54CA151668. We wish to dedicate this work to the memory of K. Kian Ang.	Ahn JY, 2000, CANCER RES, V60, P5934; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bauer E, 1998, MUTAT RES-FUND MOL M, V398, P101, DOI 10.1016/S0027-5107(97)00246-7; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BEDFORD JS, 1991, INT J RADIAT ONCOL, V21, P1457, DOI 10.1016/0360-3016(91)90320-4; Brabletz T, 2013, NAT MED, V19, P1104, DOI 10.1038/nm.3327; Buchholz TA, 2009, NEW ENGL J MED, V360, P63, DOI 10.1056/NEJMct0803525; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; FRANKENBERGSCHWAGER M, 1981, RADIAT RES, V87, P710, DOI 10.2307/3575532; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Graham TR, 2010, BREAST CANCER RES TR, V123, P139, DOI 10.1007/s10549-009-0623-7; Horsman MR, 2006, INT J RADIAT ONCOL, V64, P551, DOI 10.1016/j.ijrobp.2005.09.032; Jameel JKA, 2004, BREAST, V13, P452, DOI 10.1016/j.breast.2004.08.004; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Kenney PA, 2011, BJU INT, V107, P656, DOI 10.1111/j.1464-410X.2010.09489.x; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lukas C, 2001, CANCER RES, V61, P4990; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	61	292	307	5	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					864	875		10.1038/ncb3013	http://dx.doi.org/10.1038/ncb3013			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25086746	Green Accepted			2022-12-25	WOS:000341404400007
J	Lecland, N; Luders, J				Lecland, Nicolas; Lueders, Jens			The dynamics of microtubule minus ends in the human mitotic spindle	NATURE CELL BIOLOGY			English	Article							GAMMA-TUBULIN; CENTROSOME; RECRUITMENT; NUCLEATION; AUGMIN; COMPLEX; MITOSIS; AMPLIFICATION; ORGANIZATION; MECHANISMS	During mitotic spindle assembly, gamma-tubulin ring complexes (gamma TuRCs) nucleate microtubules at centrosomes, around chromosomes, and, by interaction with augmin, from pre-existing microtubules. How different populations of microtubules are organized to form a bipolar spindle is poorly understood, in part because we lack information on the dynamics of microtubule minus ends. Here we show that gamma TuRC is associated with minus ends of non-centrosomal spindle microtubules. Recruitment of gamma TuRC to spindles occurs preferentially at pole-distal regions, requires nucleation and/or interaction with minus ends, and is followed by sorting of minus-end-bound gamma TuRC towards the poles. Poleward movement of gamma TuRC exceeds k-fibre flux, involves the motors dynein, HSET (also known as KIFC1; a kinesin-14 family member) and Eg5 (also known as KIF11; a kinesin-5 family member), and slows down in pole-proximal regions, resulting in the accumulation of minus ends. Thus, in addition to nucleation, gamma TuRC actively contributes to spindle architecture by organizing microtubule minus ends.	[Lecland, Nicolas; Lueders, Jens] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Luders, J (corresponding author), Inst Res Biomed IRB Barcelona, C Baldiri Reixac 10, Barcelona 08028, Spain.	jens.luders@irbbarcelona.org	Lüders, Jens/H-2812-2015	Lüders, Jens/0000-0002-9018-7977; Lecland, Nicolas/0000-0002-0629-5263	MINECO, Spain [BFU2009-08522, BFU2012-33960]; Marie Curie International Reintegration Grant [FP7-PEOPLE-2007-4-3-IRG, 224835]; IRB Barcelona intramural funds; Ramon y Cajal Programme (MINECO, Spain); La Caixa PhD fellowship ('la Caixa' Foundation, Spain)	MINECO, Spain; Marie Curie International Reintegration Grant(European Commission); IRB Barcelona intramural funds; Ramon y Cajal Programme (MINECO, Spain); La Caixa PhD fellowship ('la Caixa' Foundation, Spain)	We thank C. Lacasa for technical support, P. Draber (Institute of Molecular Genetics of the ASCR, Prague, Czech Republic) for the TUBG1 shRNA plasmid, I. Vernos (CRG, Barcelona, Spain) for anti-TPX2 antibodies, and J. Colombelli and the staff of the Advanced Digital Microscopy facility of the IRB Barcelona for their excellent support. We are particularly grateful to S. Tosi for providing custom macros for image analysis. This study was supported by grants BFU2009-08522 and BFU2012-33960 to J. L. (MINECO, Spain), a Marie Curie International Reintegration Grant (FP7-PEOPLE-2007-4-3-IRG, project #224835) to J. L., and IRB Barcelona intramural funds. J. L. acknowledges additional support from the Ramon y Cajal Programme (MINECO, Spain). N.L. was supported by a La Caixa PhD fellowship ('la Caixa' Foundation, Spain).	Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Cai S, 2010, CURR BIOL, V20, P880, DOI 10.1016/j.cub.2010.03.067; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hallen MA, 2008, BIOPHYS J, V95, P3048, DOI 10.1529/biophysj.108.134593; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hayward D, 2014, DEV CELL, V28, P81, DOI 10.1016/j.devcel.2013.12.001; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Inclan YF, 2001, J CELL SCI, V114, P413; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kamasaki T, 2013, J CELL BIOL, V202, P25, DOI 10.1083/jcb.201304031; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kleylein-Sohn J, 2012, J CELL SCI, V125, P5391, DOI 10.1242/jcs.107474; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Maffini S, 2009, CURR BIOL, V19, P1566, DOI 10.1016/j.cub.2009.07.059; Manning JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009618; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919; Wang HF, 2013, J CELL BIOL, V203, P35, DOI 10.1083/jcb.201306001; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	49	59	61	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					770	U248		10.1038/ncb2996	http://dx.doi.org/10.1038/ncb2996			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	24976384				2022-12-25	WOS:000339904900009
J	Mei, F; Fancy, SPJ; Shen, YAA; Niu, JQ; Zhao, C; Presley, B; Miao, E; Lee, S; Mayoral, SR; Redmond, SA; Etxeberria, A; Xiao, L; Franklin, RJM; Green, A; Hauser, SL; Chan, JR				Mei, Feng; Fancy, Stephen P. J.; Shen, Yun-An A.; Niu, Jianqin; Zhao, Chao; Presley, Bryan; Miao, Edna; Lee, Seonok; Mayoral, Sonia R.; Redmond, Stephanie A.; Etxeberria, Ainhoa; Xiao, Lan; Franklin, Robin J. M.; Green, Ari; Hauser, Stephen L.; Chan, Jonah R.			Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis	NATURE MEDICINE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; ADULT SPINAL-CORD; ENGINEERED NANOFIBERS; CNS DEMYELINATION; PROGENITOR CELLS; SCHWANN-CELLS; MYELINATION; REMYELINATION; LESIONS; DIFFERENTIATION	Functional screening for compounds that promote remyelination represents a major hurdle in the development of rational therapeutics for multiple sclerosis. Screening for remyelination is problematic, as myelination requires the presence of axons. Standard methods do not resolve cell-autonomous effects and are not suited for high-throughput formats. Here we describe a binary indicant for myelination using micropillar arrays (BIMA). Engineered with conical dimensions, micropillars permit resolution of the extent and length of membrane wrapping from a single two-dimensional image. Confocal imaging acquired from the base to the tip of the pillars allows for detection of concentric wrapping observed as 'rings' of myelin. The platform is formatted in 96-well plates, amenable to semiautomated random acquisition and automated detection and quantification. Upon screening 1,000 bioactive molecules, we identified a cluster of antimuscarinic compounds that enhance oligodendrocyte differentiation and remyelination. Our findings demonstrate a new high-throughput screening platform for potential regenerative therapeutics in multiple sclerosis.	[Mei, Feng; Fancy, Stephen P. J.; Shen, Yun-An A.; Miao, Edna; Lee, Seonok; Mayoral, Sonia R.; Redmond, Stephanie A.; Etxeberria, Ainhoa; Green, Ari; Hauser, Stephen L.; Chan, Jonah R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mei, Feng; Fancy, Stephen P. J.; Shen, Yun-An A.; Miao, Edna; Lee, Seonok; Mayoral, Sonia R.; Redmond, Stephanie A.; Etxeberria, Ainhoa; Green, Ari; Hauser, Stephen L.; Chan, Jonah R.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Niu, Jianqin; Xiao, Lan] Third Mil Med Univ, Dept Histol & Embryol, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England; [Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Presley, Bryan] Trianja Technol, Allen, TX USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Army Medical University; University of Cambridge; University of Cambridge	Chan, JR (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	jonah.chan@ucsf.edu	Hauser, Stephen L/J-2978-2016	Redmond, Stephanie/0000-0002-5580-6269; Franklin, Robin/0000-0001-6522-2104	Multiple Sclerosis Research Group at the University of California, San Francisco (UCSF); US National Multiple Sclerosis Society Harry Weaver Neuroscience Scholar Award [JF 2142-A2/T]; UCSF CTSI Catalyst Award for Innovation; Joint Research Fund for Overseas Chinese Young Scholars (NSCF) [31228011]; Rosetrees Trust [M144] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081905] Funding Source: NIH RePORTER	Multiple Sclerosis Research Group at the University of California, San Francisco (UCSF); US National Multiple Sclerosis Society Harry Weaver Neuroscience Scholar Award; UCSF CTSI Catalyst Award for Innovation; Joint Research Fund for Overseas Chinese Young Scholars (NSCF); Rosetrees Trust(Rosetrees Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Multiple Sclerosis Research Group at the University of California, San Francisco (UCSF) for support, advice and insightful discussions. This work was supported by the US National Multiple Sclerosis Society Harry Weaver Neuroscience Scholar Award (JF 2142-A2/T), UCSF CTSI Catalyst Award for Innovation, gifts from friends of the Multiple Sclerosis Research Group at UCSF and the Joint Research Fund for Overseas Chinese Young Scholars (NSCF, 31228011). The rabbit monoclonal antibody to PDGFR alpha was a gift from W.B. Stallcup (Sanford Burnham Medical Research Institute).	Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Buckley CE, 2008, DIS MODEL MECH, V1, P221, DOI 10.1242/dmm.001248; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Colello RJ, 1997, MOL NEUROBIOL, V15, P83, DOI 10.1007/BF02740617; De Angelis F, 2012, DEV NEUROBIOL, V72, P713, DOI 10.1002/dneu.20976; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; FRIEDE RL, 1972, J COMP NEUROL, V144, P233, DOI 10.1002/cne.901440207; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi JY, 1998, J NEUROSCI, V18, P4627; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	27	335	346	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					954	960		10.1038/nm.3618	http://dx.doi.org/10.1038/nm.3618			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	24997607	Green Accepted			2022-12-25	WOS:000340074600029
J	Monte, I; Hamberg, M; Chini, A; Gimenez-Ibanez, S; Garcia-Casado, G; Porzel, A; Pazos, F; Boter, M; Solano, R				Monte, Isabel; Hamberg, Mats; Chini, Andrea; Gimenez-Ibanez, Selena; Garcia-Casado, Gloria; Porzel, Andrea; Pazos, Florencio; Boter, Marta; Solano, Roberto			Rational design of a ligand-based antagonist of jasmonate perception	NATURE CHEMICAL BIOLOGY			English	Article							BHLH TRANSCRIPTION FACTORS; DOMAIN PROTEINS INTERACT; PLANT STRESS-RESPONSE; SIGNAL-TRANSDUCTION; REGULATED DEFENSE; AUXIN PERCEPTION; JAZ REPRESSORS; ARABIDOPSIS; BIOSYNTHESIS; PATHOGEN	(+)-7-iso-Jasmonoyl-L-isoleucine (JA-Ile) regulates developmental and stress responses in plants. Its perception involves the formation of a ternary complex with the F-box COI1 and a member of the JAZ family of co-repressors and leads to JAZ degradation. Coronatine (COR) is a bacterial phytotoxin that functionally mimics JA-Ile and interacts with the COI1-JAZ co-receptor with higher affinity than JA-Ile. On the basis of the co-receptor structure, we designed ligand derivatives that spatially impede the interaction of the co-receptor proteins and, therefore, should act as competitive antagonists. One derivative, coronatine-O-methyloxime (COR-MO), has strong activity in preventing the COI1-JAZ interaction, JAZ degradation and the effects of JA-Ile or COR on several JA-mediated responses in Arabidopsis thaliana. Moreover, it potentiates plant resistance, preventing the effect of bacterially produced COR during Pseudomonas syringae infections in different plant species. In addition to the utility of COR-MO for plant biology research, our results underscore its biotechnological potential for safer and sustainable agriculture.	[Monte, Isabel; Chini, Andrea; Gimenez-Ibanez, Selena; Boter, Marta; Solano, Roberto] CSIC, Plant Mol Genet Dept, Natl Ctr Biotechnol CNB, Madrid, Spain; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Garcia-Casado, Gloria] CSIC, Natl Biotechnol Ctr, Genom Unit, Madrid, Spain; [Porzel, Andrea] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany; [Pazos, Florencio] CSIC, Dept Syst Biol, CNB, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Karolinska Institutet; Consejo Superior de Investigaciones Cientificas (CSIC); Leibniz Institut fur Pflanzenbiochemie; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Solano, R (corresponding author), CSIC, Plant Mol Genet Dept, Natl Ctr Biotechnol CNB, Campus Univ Autonoma, Madrid, Spain.	rsolano@cnb.csic.es	Porzel, Andrea/B-1423-2014; Monte, Isabel/AAC-7062-2020; Boter, Marta/AAB-7614-2022; Boter, Marta/AAS-4916-2021; Solano, Roberto/O-5908-2017; Chini, Andrea/D-1336-2009; Gimenez-Ibanez, Selena/B-1172-2017	Porzel, Andrea/0000-0002-8148-6895; Monte, Isabel/0000-0002-7058-8343; Boter, Marta/0000-0001-7489-2791; Solano, Roberto/0000-0001-5459-2417; Gimenez-Ibanez, Selena/0000-0002-5453-8565; Chini, Andrea/0000-0001-5841-0254; Hamberg, Mats/0000-0002-8910-7810	Spanish Ministerio de Ciencia e Innovacion [BIO2010-21739, CSD2007-00057, EUI2008-03666, 2010-05680, JCI-2010-07532]; Ministerio de Educacion, Spain [AP2010-1410]; CSIC [2010-01411]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion, Spain(Spanish Government); CSIC	We thank K.-i. Hayashi (Okayama University) for important suggestions for the design of the antagonists. J. Browse (Washington State University) kindly provided the 35S: JAZ1-GUS seeds. M. Estelle (University of California-San Diego) kindly provided DR5: GUS and Dexp: TIR1-myc/tir1-1 seeds and the IAA7-GST clone. We obtained the fungal pathogen B. cinerea from E. Monte (Instituto Hispano-Luso de Investigaciones Agrarias (CIALE)). We also thank J. Paz-Ares (CNB-CSIC) and members of the lab for critical reading of the manuscript and suggestions. This work was financed by grants to R. S. (BIO2010-21739, CSD2007-00057 and EUI2008-03666) from the Spanish Ministerio de Ciencia e Innovacion. I. M. was supported by a predoctoral fellowship from the Ministerio de Educacion, Spain (grant AP2010-1410). A. C. and S. G.-I. were supported by postdoctoral fellowships from the Spanish Ministerio de Ciencia e Innovacion ('Ramon y Cajal' 2010-05680 and 'Juan de la Cierva' JCI-2010-07532, respectively). M. B. was supported by a JAE-Doc fellowship (2010-01411) from CSIC.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Browse J, 2009, PHYTOCHEMISTRY, V70, P1539, DOI 10.1016/j.phytochem.2009.08.004; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Enserink M, 2013, SCIENCE, V341, P729, DOI 10.1126/science.341.6147.728; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086182; Fonseca Sandra, 2013, Methods Mol Biol, V1011, P159, DOI 10.1007/978-1-62703-414-2_13; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gimenez-Ibanez S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001792; Gimenez-Ibanez S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00072; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Lamberth C, 2013, SCIENCE, V341, P742, DOI 10.1126/science.1237227; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Nakata M, 2013, PLANT CELL, V25, P1641, DOI 10.1105/tpc.113.111112; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Nonaka H, 2010, ORG BIOMOL CHEM, V8, P5212, DOI 10.1039/c0ob00218f; Okada M, 2009, ORG BIOMOL CHEM, V7, P3065, DOI 10.1039/b905159g; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Song SS, 2011, PLANT CELL, V23, P1000, DOI 10.1105/tpc.111.083089; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	57	60	62	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					671	U108		10.1038/NCHEMBIO.1575	http://dx.doi.org/10.1038/NCHEMBIO.1575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24997606				2022-12-25	WOS:000339380100014
J	Mullard, A				Mullard, Asher			EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appeal	NATURE BIOTECHNOLOGY			English	News Item																		2013, NAT BIOTECHNOL, V31, P771; 2014, LANCET RESPIR MED, V2, P539	2	12	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					706	706		10.1038/nbt0814-706	http://dx.doi.org/10.1038/nbt0814-706			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101726	Bronze			2022-12-25	WOS:000346455900032
J	Gulko, B; Hubisz, MJ; Gronau, I; Siepel, A				Gulko, Brad; Hubisz, Melissa J.; Gronau, Ilan; Siepel, Adam			A method for calculating probabilities of fitness consequences for point mutations across the human genome	NATURE GENETICS			English	Article							FUNCTIONAL VARIATION; MAMMALIAN GENOMES; NATURAL-SELECTION; ENCODE PROJECT; NONCODING DNA; MOUSE GENOME; JUNK DNA; SEQUENCE; ANNOTATION; ELEMENTS	We describe a new computational method for estimating the probability that a point mutation at each position in a genome will influence fitness. These 'fitness consequence' (fitCons) scores serve as evolution-based measures of potential genomic function. Our approach is to cluster genomic positions into groups exhibiting distinct 'fingerprints' on the basis of high-throughput functional genomic data, then to estimate a probability of fitness consequences for each group from associated patterns of genetic polymorphism and divergence. We have generated fitCons scores for three human cell types on the basis of public data from ENCODE. In comparison with conventional conservation scores, fitCons scores show considerably improved prediction power for cis regulatory elements. In addition, fitCons scores indicate that 4.2-7.5% of nucleotides in the human genome have influenced fitness since the human-chimpanzee divergence, and they suggest that recent evolutionary turnover has had limited impact on the functional content of the genome.	[Gulko, Brad; Siepel, Adam] Cornell Univ, Grad Field Comp Sci, Ithaca, NY USA; [Hubisz, Melissa J.; Gronau, Ilan; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Cornell University	Siepel, A (corresponding author), Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, POB 100, Cold Spring Harbor, NY 11724 USA.	ilan.gronau@idc.ac.il; asiepel@cshl.edu		Hubisz, Melissa/0000-0002-9561-6830; Siepel, Adam/0000-0002-3557-7219	US National Institutes of Health [GM102192]; David and Lucile Packard Fellowship for Science and Engineering; Cornell Center for Comparative and Population Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); Cornell Center for Comparative and Population Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Arbiza for helpful discussions and assistance with early analyses and G. Cooper for constructive criticism of our validation experiments and comparisons with CADD. This research was supported by US National Institutes of Health grant GM102192, a David and Lucile Packard Fellowship for Science and Engineering (to A.S.) and a postdoctoral fellowship from the Cornell Center for Comparative and Population Genomics (to I.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2013, CURR BIOL, V23, pR259, DOI 10.1016/j.cub.2013.03.023; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fay JC, 2001, GENETICS, V158, P1227; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Gronau I, 2013, MOL BIOL EVOL, V30, P1159, DOI 10.1093/molbev/mst019; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Niu DK, 2013, BIOCHEM BIOPH RES CO, V430, P1340, DOI 10.1016/j.bbrc.2012.12.074; Ovcharenko I, 2004, GENOME RES, V14, P1191, DOI 10.1101/gr.1773104; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Ponting CP, 2011, ANNU REV GENOM HUM G, V12, P275, DOI 10.1146/annurev-genom-090810-183115; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith NGC, 2004, GENOMICS, V84, P806, DOI 10.1016/j.ygeno.2004.07.012; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilson DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002395; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157	54	151	155	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					276	+		10.1038/ng.3196	http://dx.doi.org/10.1038/ng.3196			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25599402	Green Submitted, Green Accepted			2022-12-25	WOS:000350327900021
J	Li, YQ; Jiang, Y; Chen, H; Liao, WX; Li, ZH; Weiss, R; Xie, Z				Li, Yinqing; Jiang, Yun; Chen, He; Liao, Weixi; Li, Zhihua; Weiss, Ron; Xie, Zhen			Modular construction of mammalian gene circuits using TALE transcriptional repressors	NATURE CHEMICAL BIOLOGY			English	Article							LOGIC INTEGRATION; ESCHERICHIA-COLI; CELLS; EXPRESSION; RNAI; COMPUTATION; EFFECTORS; NETWORKS; PROTEIN; DESIGN	An important goal of synthetic biology is the rational design and predictable implementation of synthetic gene circuits using standardized and interchangeable parts. However, engineering of complex circuits in mammalian cells is currently limited by the availability of well-characterized and orthogonal transcriptional repressors. Here, we introduce a library of 26 reversible transcription activator-like effector repressors (TALERs) that bind newly designed hybrid promoters and exert transcriptional repression through steric hindrance of key transcriptional initiation elements. We demonstrate that using the input-output transfer curves of our TALERs enables accurate prediction of the behavior of modularly assembled TALER cascade and switch circuits. We also show that TALER switches using feedback regulation exhibit improved accuracy for microRNA-based HeLa cancer cell classification versus HEK293 cells. Our TALER library is a valuable toolkit for modular engineering of synthetic circuits, enabling programmable manipulation of mammalian cells and helping elucidate design principles of coupled transcriptional and microRNA-mediated post-transcriptional regulation.	[Li, Yinqing; Weiss, Ron] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Jiang, Yun; Chen, He; Liao, Weixi; Xie, Zhen] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Bioinformat Div, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China; [Liao, Weixi; Xie, Zhen] Tsinghua Univ, Dept Automat, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Li, Zhihua] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Li, Zhihua] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Massachusetts Institute of Technology (MIT)	Li, YQ (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rweiss@mit.edu; zhenxie@tsinghua.edu.cn	Xie, Zhen/GPW-5925-2022	Chen, He/0000-0001-9644-8202; Li, Yinqing/0000-0002-9096-8482	Beijing Natural Science Foundation [5152013]; National Key Basic Research Program of China [2014CB745200]; Junior '1,000 Plan' Program; Cross-strait Tsinghua University Joint Grant [2012THZ0]; US National Institutes of Health [5R01CA155320-04, P50GM098792, 1R01CA173712-01]; NATIONAL CANCER INSTITUTE [R01CA155320, R01CA173712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key Basic Research Program of China(National Basic Research Program of China); Junior '1,000 Plan' Program; Cross-strait Tsinghua University Joint Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Xie lab and the Weiss lab for helpful discussions. We thank H. Huang and T. Wang for technical support. We thank C. Le and F. Zhang (both at Department of Biological Engineering, Massachusetts Institute of Technology) for providing TALE1 and TALE2 as gifts. We thank J. Beal and M. Q. Zhang for insightful discussions. The research is supported by Beijing Natural Science Foundation (5152013 to Z.X.), National Key Basic Research Program of China (2014CB745200 to Z.X.), Junior '1,000 Plan' Program (to Z.X.), Cross-strait Tsinghua University Joint Grant (2012THZ0 to Z.X.) and US National Institutes of Health Grants (5R01CA155320-04, P50GM098792 and 1R01CA173712-01 to R.W.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bacchus W, 2012, NAT BIOTECHNOL, V30, P991, DOI 10.1038/nbt.2351; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Beisel CL, 2011, NUCLEIC ACIDS RES, V39, P2981, DOI 10.1093/nar/gkq954; Beisel CL, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.62; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaber R, 2014, NAT CHEM BIOL, V10, P203, DOI [10.1038/nchembio.1433, 10.1038/NCHEMBIO.1433]; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kashida S, 2012, NUCLEIC ACIDS RES, V40, P9369, DOI 10.1093/nar/gks668; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Li Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00897; Liang J, 2014, ACS SYNTH BIOL, V3, P67, DOI 10.1021/sb400109p; Lienert F, 2013, NUCLEIC ACIDS RES, V41, P9967, DOI 10.1093/nar/gkt758; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wang G., 2013, QUANT BIOL, V1, P32, DOI DOI 10.1007/S40484-013-0007-1; Wei P, 2012, NATURE, V488, P384, DOI 10.1038/nature11259; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xie Z, 2010, NUCLEIC ACIDS RES, V38, P2692, DOI 10.1093/nar/gkq117; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	50	58	67	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					207	U156		10.1038/nchembio.1736	http://dx.doi.org/10.1038/nchembio.1736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25643171	Green Accepted, Green Submitted			2022-12-25	WOS:000349840500012
J	Youm, YH; Nguyen, KY; Grant, RW; Goldberg, EL; Bodogai, M; Kim, D; D'Agostino, D; Planavsky, N; Lupfer, C; Kanneganti, TD; Kang, S; Horvath, TL; Fahmy, TM; Crawford, PA; Biragyn, A; Alnemri, E; Dixit, VD				Youm, Yun-Hee; Nguyen, Kim Y.; Grant, Ryan W.; Goldberg, Emily L.; Bodogai, Monica; Kim, Dongin; D'Agostino, Dominic; Planavsky, Noah; Lupfer, Christopher; Kanneganti, Thirumala D.; Kang, Seokwon; Horvath, Tamas L.; Fahmy, Tarek M.; Crawford, Peter A.; Biragyn, Arya; Alnemri, Emad; Dixit, Vishwa Deep			The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease	NATURE MEDICINE			English	Article							CALORIE RESTRICTION; OXIDATIVE STRESS; INNATE IMMUNITY; ACTIVATION; RECEPTOR; BODY; MECHANISMS; CRYSTALS; BODIES	The ketone bodies beta-hydroxybutyrate (BHB) and acetoacetate (AcAc) support mammalian survival during states of energy deficit by serving as alternative sources of ATP(1). BHB levels are elevated by starvation, caloric restriction, high-intensity exercise, or the low-carbohydrate ketogenic diet(2). Prolonged fasting reduces inflammation; however, the impact that ketones and other alternative metabolic fuels produced during energy deficits have on the innate immune response is unknown(2-6). We report that BHB, but neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses activation of the NLRP3 inflammasome in response to urate crystals, ATP and lipotoxic fatty acids. BHB did not inhibit caspase-1 activation in response to pathogens that activate the NLR family, CARD domain containing 4 (NLRC4) or absent in melanoma 2 (AIM2) inflammasome and did not affect non-canonical caspase-11, inflammasome activation. Mechanistically, BHB inhibits the NLRP3 inflammasome by preventing K+ efflux and reducing ASC oligomerization and speck formation. The inhibitory effects of BHB on NLRP3 are not dependent on chirality or starvation-regulated mechanisms like AMP-activated protein kinase (AMPK), reactive oxygen species (ROS), autophagy or glycolytic inhibition. BHB blocks the NLRP3 inflammasome without undergoing oxidation in the TCA cycle, and independently of uncoupling protein-2 (UCP2), sirtuin-2 (SIRT2), the G protein-coupled receptor GPR109A or hydrocaboxylic acid receptor 2 (HCAR2). BHB reduces NLRP3 inflammasome-mediated interleukin (IL)-1 beta and IL-18 production in human monocytes. In vivo, BHB or a ketogenic diet attenuates caspase-1 activation and IL-1 beta secretion in mouse models of NLRP3-mediated diseases such as Muckle-Wells syndrome, familial cold autoinflammatory syndrome and urate crystal-induced peritonitis. Our findings suggest that the anti-inflammatory effects of caloric restriction or ketogenic diets may be linked to BHB-mediated inhibition of the NLRP3 inflammasome.	[Youm, Yun-Hee; Nguyen, Kim Y.; Goldberg, Emily L.; Horvath, Tamas L.; Dixit, Vishwa Deep] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Youm, Yun-Hee; Nguyen, Kim Y.; Goldberg, Emily L.; Horvath, Tamas L.; Dixit, Vishwa Deep] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT USA; [Grant, Ryan W.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Bodogai, Monica] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Kim, Dongin; Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [D'Agostino, Dominic] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Planavsky, Noah] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Lupfer, Christopher; Kanneganti, Thirumala D.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN USA; [Kang, Seokwon; Alnemri, Emad] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Crawford, Peter A.] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL USA; [Dixit, Vishwa Deep] Yale Univ, Sch Med, Dept Immunol, New Haven, CT USA	Yale University; Yale University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University; State University System of Florida; University of South Florida; Yale University; St Jude Children's Research Hospital; Jefferson University; Sanford Burnham Prebys Medical Discovery Institute; Yale University	Dixit, VD (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA.	vishwa.dixit@yale.edu	Kanneganti, Thirumala-Devi/Y-2503-2019; D'Agostino, Dominic/I-6194-2012; Kanneganti, Thirumala-Devi/M-9435-2018; D'Agostino, Dominic/GPJ-9744-2022	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Crawford, Peter/0000-0001-8597-4426; Goldberg, Emily/0000-0002-3848-6590; Youm, Yun-Hee/0000-0002-8098-8527; Kim, Dongin/0000-0003-2078-6138; Grant, Ryan/0000-0002-8940-4196; Bodogai, Monica/0000-0002-8174-9608	National Institute on Aging-Intramural Research Program; Office of Naval Research (ONR) [N000141310062]; National Institutes of Health [AG043608, AG31797, DK090556, AI105097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105097, R01AI105097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043608, R01AG031797, R01AG045712] Funding Source: NIH RePORTER	National Institute on Aging-Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Naval Research (ONR)(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Koch, Y. Kui, P. Chang and D. Albarado for technical assistance, and V.M. Dixit (Genentech) and R. Medzhitov (Yale School of Medicine) for helpful discussions and for providing knockout mice. Salmonella typhimurium and Francisella tularensis (U112) were provided by D. Monack (Stanford University School of Medicine) and J. Teale (University of Texas at San Antonio). M.B. and A.B. were supported by the National Institute on Aging-Intramural Research Program. D.D'A. was supported by the Office of Naval Research (ONR) Grant N000141310062. V.D.D. was supported in part by the grants from National Institutes of Health (AG043608, AG31797, DK090556 and AI105097).	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Cotter DG, 2013, J BIOL CHEM, V288, P19739, DOI 10.1074/jbc.M113.454868; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Demento SL, 2011, TRENDS BIOTECHNOL, V29, P294, DOI 10.1016/j.tibtech.2011.02.004; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Laeger T, 2012, J ENDOCRINOL, V213, P193, DOI 10.1530/JOE-11-0457; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; Mercken EM, 2013, AGING CELL, V12, P645, DOI 10.1111/acel.12088; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; SHIDO O, 1989, J APPL PHYSIOL, V67, P963, DOI 10.1152/jappl.1989.67.3.963; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	35	960	1002	22	302	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					263	+		10.1038/nm.3804	http://dx.doi.org/10.1038/nm.3804			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25686106	Green Submitted, Green Accepted			2022-12-25	WOS:000350362000019
J	Chen, XP; Zhao, CY; Li, XL; Wang, T; Li, YZ; Cao, C; Ding, YH; Dong, MQ; Finci, L; Wang, JH; Li, XY; Liu, L				Chen, Xinping; Zhao, Chunyue; Li, Xiaolong; Wang, Tao; Li, Yizhou; Cao, Cheng; Ding, Yuehe; Dong, Mengqiu; Finci, Lorenzo; Wang, Jia-huai; Li, Xiaoyu; Liu, Lei			Terazosin activates Pgk1 and Hsp90 to promote stress resistance	NATURE CHEMICAL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; PHOSPHOGLYCERATE KINASE; CECAL LIGATION; SEPTIC SHOCK; SEPSIS; APOPTOSIS; GENE; INHIBITORS; MICE; MACROPHAGES	Drugs that can protect against organ damage are urgently needed, especially for diseases such as sepsis and brain stroke. We discovered that terazosin (TZ), a widely marketed. 1-adrenergic receptor antagonist, alleviated organ damage and improved survival in rodent models of stroke and sepsis. Through combined studies of enzymology and X-ray crystallography, we discovered that TZ binds a new target, phosphoglycerate kinase 1 (Pgk1), and activates its enzymatic activity, probably through 2,4-diamino-6,7-dimethoxyisoquinoline's ability to promote ATP release from Pgk1. Mechanistically, the ATP generated from Pgk1 may enhance the chaperone activity of Hsp90, an ATPase known to associate with Pgk1. Upon activation, Hsp90 promotes multistress resistance. Our studies demonstrate that TZ has a new protein target, Pgk1, and reveal its corresponding biological effect. As a clinical drug, TZ may be quickly translated into treatments for diseases including stroke and sepsis.	[Chen, Xinping; Zhao, Chunyue; Wang, Tao] Peking Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Chen, Xinping; Zhao, Chunyue; Wang, Tao; Liu, Lei] Capital Med Univ, Beijing Inst Brain Disorder, Beijing, Peoples R China; [Chen, Xinping; Zhao, Chunyue; Wang, Tao; Liu, Lei] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China; [Li, Xiaolong; Wang, Jia-huai] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Li, Xiaolong; Finci, Lorenzo; Wang, Jia-huai] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Li, Yizhou; Cao, Cheng; Li, Xiaoyu] Peking Univ, Coll Chem & Mol Engn, Key Lab Bioorgan Chem & Mol Engn, Beijing 100871, Peoples R China; [Ding, Yuehe; Dong, Mengqiu] Natl Inst Biol Sci, Beijing, Peoples R China; [Wang, Jia-huai] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Li, Xiaoyu] Peking Univ, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China	Peking University; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Peking University; Peking University; National Institute of Biological Sciences, Beijing; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Peking University; University Town of Shenzhen	Wang, JH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	jwang@red.dfci.harvard.edu; xiaoyuli@pku.edu.cn; lei_liu_2005@yahoo.com	Li, Xiaolong/AAG-7297-2019; Chen, Xinping/C-7877-2018; Wang, Tao/K-3518-2016; ding, yuehe/AAZ-6994-2021	Li, Xiaolong/0000-0001-6549-4089; Liu, Lei/0000-0002-6387-7745; Chen, Xinping/0000-0002-7490-9036; Li, Yizhou/0000-0003-1650-3780	Chinese Ministry of Science and Technology [2013CB530700]; National Natural Science Foundation of China [NSFC31171324]; Beijing Institute for Brain Disorder and Beijing Tiantan Hospital, Capital Medical University, China; Ministry of Education of China; US National Institutes of Health [HL48675]; Peking-Tsinghua Center for Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Institute for Brain Disorder and Beijing Tiantan Hospital, Capital Medical University, China; Ministry of Education of China(Ministry of Education, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peking-Tsinghua Center for Life Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Chinese Ministry of Science and Technology (2013CB530700), the National Natural Science Foundation of China (NSFC31171324) and the Beijing Institute for Brain Disorder and Beijing Tiantan Hospital, Capital Medical University, China to L.L. and by the Ministry of Education of China and US National Institutes of Health grant HL48675 and funds from the Peking-Tsinghua Center for Life Sciences to J.W. We also acknowledge the Ministry of Science and Technology Basic Research Program (2011CB809100), the National Natural Science Foundation of China (21272016) and the Doctoral Fund of Ministry of Education of China (20120001110083) to Xiaoyu Li. We thank. L. Lai (Peking University) for her generous support in the ITC experiments. We thank the staff members at the Shanghai Synchrotron Radiation Facility and KEK-PF for generous support.	Ai JZ, 2011, CELL PHYSIOL BIOCHEM, V27, P207, DOI 10.1159/000327946; Akduman B, 2001, UROLOGY, V58, P49, DOI 10.1016/S0090-4295(01)01302-4; ALBINA JE, 1993, J IMMUNOL, V150, P5080; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; BORDNER J, 1988, J MED CHEM, V31, P1036, DOI 10.1021/jm00400a026; Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Duan Z, 2002, ANTICANCER RES, V22, P1933; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Flachner B, 2005, BIOCHEMISTRY-US, V44, P16853, DOI 10.1021/bi051726g; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Geerlof A, 1997, BIOCHEMISTRY-US, V36, P5538, DOI 10.1021/bi962842+; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jana S, 2007, CURR MED CHEM, V14, P2369, DOI 10.2174/092986707781745569; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kumar A, 2011, CRIT CARE NURS CLIN, V23, P79, DOI 10.1016/j.ccell.2010.12.005; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lang JD, 2009, CRIT CARE, V13, DOI 10.1186/cc7144; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Lee DL, 2004, AM J PHYSIOL-REG I, V287, pR1394, DOI 10.1152/ajpregu.00306.2004; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li XP, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-8; Maciel Alexandre Toledo, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P252; Mazzoni C, 2009, YEAST, V26, P31, DOI 10.1002/yea.1647; Miksa M, 2005, FRONT BIOSCI-LANDMRK, V10, P2217, DOI 10.2741/1691; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ndubaku C, 2009, FUTURE MED CHEM, V1, P1509, DOI 10.4155/FMC.09.116; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sawyer GM, 2008, PROTEINS, V71, P1134, DOI 10.1002/prot.21801; Shirakawa K, 2006, NEUROLOGY, V66, P925, DOI 10.1212/01.wnl.0000203500.63884.39; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813; Zhao C, 2004, CELL SIGNAL, V16, P313, DOI 10.1016/j.cellsig.2003.08.005; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	48	51	53	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					19	+		10.1038/nchembio.1657	http://dx.doi.org/10.1038/nchembio.1657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25383758	Green Accepted			2022-12-25	WOS:000346448600007
J	Cianfanelli, V; Fuoco, C; Lorente, M; Salazar, M; Quondamatteo, F; Gherardini, PF; De Zio, D; Nazio, F; Antonioli, M; D'Orazio, M; Skobo, T; Bordi, M; Rohde, M; Dalla Valle, L; Helmer-Citterich, M; Gretzmeier, C; Dengjel, J; Fimia, GM; Piacentini, M; Di Bartolomeo, S; Velasco, G; Cecconi, F				Cianfanelli, Valentina; Fuoco, Claudia; Lorente, Mar; Salazar, Maria; Quondamatteo, Fabio; Gherardini, Pier Federico; De Zio, Daniela; Nazio, Francesca; Antonioli, Manuela; D'Orazio, Melania; Skobo, Tatjana; Bordi, Matteo; Rohde, Mikkel; Dalla Valle, Luisa; Helmer-Citterich, Manuela; Gretzmeier, Christine; Dengjel, Joern; Fimia, Gian Maria; Piacentini, Mauro; Di Bartolomeo, Sabrina; Velasco, Guillermo; Cecconi, Francesco			AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATES AUTOPHAGY; INHIBITS AUTOPHAGY; GROWTH; PP2A; MTOR; ASSOCIATION; COMPLEX; DEFICIENT; DEFECTS	Inhibition of a main regulator of cell metabolism, the protein kinase mTOR, induces autophagy and inhibits cell proliferation. However, the molecular pathways involved in the cross-talk between these two mTOR-dependent cell processes are largely unknown. Here we show that the scaffold protein AMBRA1, a member of the autophagy signalling network and a downstream target of mTOR, regulates cell proliferation by facilitating the dephosphorylation and degradation of the proto-oncogene c-Myc. We found that AMBRA1 favours the interaction between c-Myc and its phosphatase PP2A and that, when mTOR is inhibited, it enhances PP2A activity on this specific target, thereby reducing the cell division rate. As expected, such a de-regulation of c-Myc correlates with increased tumorigenesis in AMBRA1-defective systems, thus supporting a role for AMBRA1 as a haploinsufficient tumour suppressor gene.	[Cianfanelli, Valentina; De Zio, Daniela; Cecconi, Francesco] Danish Canc Soc, Res Ctr, Unit Cell Stress & Survival, DK-2100 Copenhagen, Denmark; [Cianfanelli, Valentina; Nazio, Francesca; Bordi, Matteo; Cecconi, Francesco] IRCCS Fdn Santa Lucia, Lab Mol Neuroembryol, I-00143 Rome, Italy; [Fuoco, Claudia; Gherardini, Pier Federico; Antonioli, Manuela; D'Orazio, Melania; Helmer-Citterich, Manuela; Piacentini, Mauro; Di Bartolomeo, Sabrina; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Lorente, Mar; Salazar, Maria; Velasco, Guillermo] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Lorente, Mar; Salazar, Maria; Velasco, Guillermo] Inst Invest Sanitarias San Carlos IdISSC, Madrid 28040, Spain; [Quondamatteo, Fabio] Anat NUI Galway, Skin & Extracellular Matrix Res Grp, Galway, Ireland; [Antonioli, Manuela; Fimia, Gian Maria; Piacentini, Mauro] Natl Inst Infect Dis IRCCS L Spallanzani, I-00149 Rome, Italy; [Skobo, Tatjana; Dalla Valle, Luisa] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Rohde, Mikkel] Danish Canc Soc, Res Ctr, Unit Cell Death & Metab, DK-2100 Copenhagen, Denmark; [Gretzmeier, Christine; Dengjel, Joern] Univ Freiburg, Med Ctr, Dept Dermatol, D-79104 Freiburg, Germany; [Gretzmeier, Christine; Dengjel, Joern] Univ Freiburg, ZBSA Ctr Biol Syst Anal, D-79104 Freiburg, Germany; [Fimia, Gian Maria] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy	Danish Cancer Society; IRCCS Santa Lucia; University of Rome Tor Vergata; Complutense University of Madrid; Ollscoil na Gaillimhe-University of Galway; IRCCS Lazzaro Spallanzani; University of Padua; Danish Cancer Society; University of Freiburg; University of Freiburg; University of Salento	Cecconi, F (corresponding author), Danish Canc Soc, Res Ctr, Unit Cell Stress & Survival, DK-2100 Copenhagen, Denmark.	cecconi@cancer.dk	Di+Bartolomeo, Sabrina/AAB-9791-2019; Cecconi, Francesco/K-3969-2016; antonioli, manuela/F-5898-2015; Dengjel, Joern/AAI-3682-2020; Velasco, Guillermo/AAU-9189-2020; Lorente, Mar/K-2401-2014; Piacentini, Mauro/I-2411-2016; antonioli, manuela/L-6681-2019; Velasco, Guillermo/H-5260-2012; Nazio, Francesca/K-5272-2014; Fimia, Gian Maria/K-3232-2016; Lorente, Mar/O-5106-2017; Cianfanelli, Valentina/AAA-2682-2020; Dalla Valle, Luisa/G-6721-2011; Fuoco, Claudia/AAB-2268-2019; Roa, Maria Salazar/I-1168-2015	Cecconi, Francesco/0000-0002-5614-4359; antonioli, manuela/0000-0002-7568-4713; Velasco, Guillermo/0000-0002-1994-2386; Piacentini, Mauro/0000-0003-2919-1296; antonioli, manuela/0000-0002-7568-4713; Velasco, Guillermo/0000-0002-1994-2386; Nazio, Francesca/0000-0002-3039-4448; Fimia, Gian Maria/0000-0003-4438-3325; Lorente, Mar/0000-0003-0982-0956; Cianfanelli, Valentina/0000-0002-3857-9463; Dalla Valle, Luisa/0000-0001-8097-6369; Roa, Maria Salazar/0000-0001-6784-9541; Dengjel, Joern/0000-0002-9453-4614; Fuoco, Claudia/0000-0001-8372-305X; Skobo, Tatjana/0000-0002-4868-5606; Helmer-Citterich, Manuela/0000-0001-9530-7504; DI BARTOLOMEO, Sabrina/0000-0002-5748-1541; Bordi, Matteo/0000-0001-8207-8546; De Zio, Daniela/0000-0002-9454-402X	KBVU [R72-A4408]; Lundbeck Foundation [R167-2013-16100, R165-2013-15982]; Novo Nordisk Foundation [7559]; Bjarne Saxhof Foundation, AIRC [IG2010, IG2012]; FISM; Telethon Foundation [GGP10225]; Italian Ministry of University and Research; Italian Ministry of Health [RF 2009]; Spanish Ministry of Economy and Competitiveness (MINECO) [PS09/01401, PI12/02248, FR2009-0052, IT2009-0053]; Fundacion Mutua Madrilena [AP101042012]; Novo Nordisk Fonden [NNF13OC0007559] Funding Source: researchfish; The Danish Cancer Society [R72-A4408] Funding Source: researchfish	KBVU; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bjarne Saxhof Foundation, AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Spanish Ministry of Economy and Competitiveness (MINECO); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	We wish to thank M. Canney, V. Unterkircher, R. Laricchia and M. Salome for excellent technical assistance, and M. Acuna Villa and M. W. Bennett for editorial and secretarial work. We also thank S. Campello for critical reading of the manuscript. We are indebted to R. Sears (Portland, Oregon, USA), A. C. Gingras (Toronto, Canada) and A. Teleman and K. Dimitriadis (Heidelberg, Germany) for providing us with V5-Flag-c-Myc and Flag-PR65A constructs and Tsc2 MEFs, respectively, and to S. Cannata (Rome) for his advice on histopathology. This work was supported by grants from KBVU (R72-A4408), Lundbeck Foundation (R167-2013-16100), Novo Nordisk Foundation (7559), The Bjarne Saxhof Foundation, AIRC (IG2010 and IG2012 to both F.C. and M.P.), and in part from FISM (2009), the Telethon Foundation (GGP10225), the Italian Ministry of University and Research (PRIN 2009 and FIRB Accordi di Programma 2011) and the Italian Ministry of Health (RF 2009). V.C. is supported by the Lundbeck Foundation (R165-2013-15982). Also, we are grateful to the Spanish Ministry of Economy and Competitiveness (MINECO) (PS09/01401; PI12/02248, FR2009-0052 and IT2009-0053) and to Fundacion Mutua Madrilena (AP101042012) for funding the laboratory of G.V.	Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; AYERS MM, 1988, EUR RESPIR J, V1, P58; Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; Benato F, 2013, AUTOPHAGY, V9, P476, DOI 10.4161/auto.23278; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Evan BJ, 2008, BIOCHEM BIOPH RES CO, V377, P1067, DOI 10.1016/j.bbrc.2008.10.108; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Helgason GV, 2013, ESSAYS BIOCHEM, V55, P133, DOI [10.1042/BSE0550133, 10.1042/bse0550133]; Holzinger A, 1996, HYBRIDOMA, V15, P49, DOI 10.1089/hyb.1996.15.49; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jayadeva G, 2010, J BIOL CHEM, V285, P29863, DOI 10.1074/jbc.M110.162354; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; Kolupaeva V, 2013, FEBS J, V280, P627, DOI 10.1111/j.1742-4658.2012.08511.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; N_usslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Puustinen P, 2014, J CELL BIOL, V204, P713, DOI 10.1083/jcb.201304012; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Szabo E, 2001, J NATL CANCER I, V93, P1042, DOI 10.1093/jnci/93.14.1042; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	55	159	165	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					20	+		10.1038/ncb3072	http://dx.doi.org/10.1038/ncb3072			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25438055	Green Accepted, Green Submitted			2022-12-25	WOS:000346823900005
J	DeKosky, BJ; Kojima, T; Rodin, A; Charab, W; Ippolito, GC; Ellington, AD; Georgiou, G				DeKosky, Brandon J.; Kojima, Takaaki; Rodin, Alexa; Charab, Wissam; Ippolito, Gregory C.; Ellington, Andrew D.; Georgiou, George			In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire	NATURE MEDICINE			English	Article							B-CELLS; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN HEAVY; ALLELIC INCLUSION; RECEPTOR; REARRANGEMENTS; MICROSPHERES; SIGNATURES; MODEL; GENE	High-throughput immune repertoire sequencing has emerged as a critical step in the understanding of adaptive responses following infection or vaccination or in autoimmunity. However, determination of native antibody variable heavy-light pairs (VH-VL pairs) remains a major challenge, and no technologies exist to adequately interrogate the >1 x 10(6) B cells in typical specimens. We developed a low-cost, single-cell, emulsion-based technology for sequencing antibody VH-VL repertoires from >2 x 10(6) B cells per experiment with demonstrated pairing precision >97%. A simple flow-focusing apparatus was used to sequester single B cells into emulsion droplets containing lysis buffer and magnetic beads for mRNA capture; subsequent emulsion RT-PCR generated VH-VL amplicons for next-generation sequencing. Massive VH-VL repertoire analyses of three human donors provided new immunological insights including (i) the identity, frequency and pairing propensity of shared, or 'public', VL genes, (ii) the detection of allelic inclusion (an implicated autoimmune mechanism) in healthy individuals and (iii) the occurrence of antibodies with features, in terms of gene usage and CDR3 length, associated with broadly neutralizing antibodies to rapidly evolving viruses such as HIV-1 and influenza.	[DeKosky, Brandon J.; Kojima, Takaaki; Rodin, Alexa; Charab, Wissam; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Kojima, Takaaki] Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Nagoya, Aichi 4648601, Japan; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Nagoya University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Ippolito, Gregory C./AAR-2930-2021; Kojima, Takaaki/H-6802-2017	Ippolito, Gregory C./0000-0002-7565-7002; 	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation; US Defense Threat Reduction Agency (DTRA) [HDTRA1-12-C-0105]; US National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0169]; DTRA [HDTRA1-12-C-0007]; Welch Foundation [F-1654]	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation(National Science Foundation (NSF)); US Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); US National Security Science and Engineering Faculty Fellowship; DTRA(United States Department of DefenseDefense Threat Reduction Agency); Welch Foundation(The Welch Foundation)	We thank C. Berkland, M. Singh and N. Dormer for critical help and advice. We thank B. Iverson and D. Derryberry for insightful feedback, M. Ronalter, C. Das, M. Wirth and Y. Wine for help with experiments, J. Lavinder for reviewing the manuscript, O. Lungu for help with data analysis, B. Briney for sharing an unpublished primer sequence, L. Morris (National Institute for Communicable Diseases of the National Health Laboratory Service, South Africa) and P. Kwong (Vaccine Research Center, NIAID, USA) for sharing CAP256 samples, C. McHenry for PacBio sequencing, and J. Wheeler and S. Hunicke-Smith for Illumina MiSeq sequencing. This work was funded by fellowships to B.J.D. from the Hertz Foundation, the University of Texas Donald D. Harrington Foundation and the National Science Foundation, and by the US Defense Threat Reduction Agency (DTRA) HDTRA1-12-C-0105 (G.G.). A.D.E. would like to acknowledge funding from US National Security Science and Engineering Faculty Fellowship (FA9550-10-1-0169) and grants from the DTRA (HDTRA1-12-C-0007) and the Welch Foundation (F-1654). The content is solely the responsibility of the authors and do not necessarily represent the official Views of the sponsors.	Andrews SF, 2013, J EXP MED, V210, P125, DOI 10.1084/jem.20120525; Berkland C, 2004, J CONTROL RELEASE, V96, P101, DOI 10.1016/j.jconrel.2004.01.018; Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9; Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Casellas R, 2007, J EXP MED, V204, P153, DOI 10.1084/jem.20061918; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Finco O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00012; Finn JA, 2013, CURR OPIN IMMUNOL, V25, P613, DOI 10.1016/j.coi.2013.09.010; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Furutani S, 2012, ANALYST, V137, P2951, DOI 10.1039/c2an15866c; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; GIACHINO C, 1995, J EXP MED, V181, P1245, DOI 10.1084/jem.181.3.1245; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Hoi KH, 2013, GENES IMMUN, V14, P271, DOI 10.1038/gene.2013.10; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Jackson KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00263; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Liu S, 2005, J IMMUNOL, V175, P5067, DOI 10.4049/jimmunol.175.8.5067; Logan AC, 2011, P NATL ACAD SCI USA, V108, P21194, DOI 10.1073/pnas.1118357109; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Pelanda R, 2014, CURR OPIN IMMUNOL, V27, P53, DOI 10.1016/j.coi.2014.01.012; Rezanka LJ, 2005, CELL IMMUNOL, V238, P38, DOI 10.1016/j.cellimm.2005.12.004; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Turchaninova MA, 2013, EUR J IMMUNOL, V43, P2507, DOI 10.1002/eji.201343453; Warren EH, 2013, BLOOD, V122, P19, DOI 10.1182/blood-2013-03-453142; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012	40	242	254	2	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					86	91		10.1038/nm.3743	http://dx.doi.org/10.1038/nm.3743			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25501908	Bronze			2022-12-25	WOS:000348408000018
J	Savai, R; Al-Tamari, HM; Sedding, D; Kojonazarov, B; Muecke, C; Teske, R; Capecchi, MR; Weissmann, N; Grimminger, F; Seeger, W; Schermuly, RT; Pullamsetti, SS				Savai, Rajkumar; Al-Tamari, Hamza M.; Sedding, Daniel; Kojonazarov, Baktybek; Muecke, Christian; Teske, Rebecca; Capecchi, Mario R.; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai			Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension	NATURE MEDICINE			English	Article							ARTERIAL-HYPERTENSION; MOLECULAR PATHOGENESIS; GROWTH-FACTOR; SURVIVAL; METABOLISM; MECHANISMS; INHIBITORS; PACLITAXEL; THERAPY; LUNG	Pulmonary hypertension (PH) is characterized by increased proliferation and apoptosis resistance of pulmonary artery smooth muscle cells (PASMCs). Forkhead box O (FoxO) transcription factors are key regulators of cellular proliferation. Here we show that in pulmonary vessels and PASMCs of human and experimental PH lungs, FoxO1 expression is downregulated and FoxO1 is inactivated via phosphorylation and nuclear exclusion. These findings could be reproduced using ex vivo exposure of PASMCs to growth factors and inflammatory cytokines. Pharmacological inhibition and genetic ablation of FoxO1 in smooth muscle cells reproduced PH features in vitro and in vivo. Either pharmacological reconstitution of FoxO1 activity using intravenous or inhaled paclitaxel, or reconstitution of the transcriptional activity of FoxO1 by gene therapy, restored the physiologically quiescent PASMC phenotype in vitro, linked to changes in cell cycle control and bone morphogenic protein receptor type 2 (BMPR2) signaling, and reversed vascular remodeling and right-heart hypertrophy in vivo. Thus, PASMC FoxO1 is a critical integrator of multiple signaling pathways driving PH, and reconstitution of FoxO1 activity offers a potential therapeutic option for PH.	[Savai, Rajkumar; Al-Tamari, Hamza M.; Muecke, Christian; Seeger, Werner; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Savai, Rajkumar; Kojonazarov, Baktybek; Weissmann, Norbert; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai] Univ Giessen & Marburg Lung Ctr UGMLC, Dept Internal Med, Giessen, Germany; [Sedding, Daniel; Teske, Rebecca] Univ Clin Giessen & Marburg, Dept Mol Cardiol, Giessen, Germany; [Sedding, Daniel] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Capecchi, Mario R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Max Planck Society; University Hospital of Giessen & Marburg; Hannover Medical School; Utah System of Higher Education; University of Utah	Pullamsetti, SS (corresponding author), Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany.	soni.pullamsetti@mpi-bn.mpg.de		Seeger, Werner/0000-0003-1946-0894; Schermuly, Ralph/0000-0002-5167-6970; Pullamsetti, Soni Savai/0000-0003-0440-8831; Mamdouh Al-Tamari, Hamza/0000-0003-3253-1423; Savai, Rajkumar/0000-0003-1538-2091; Grimminger, Friedrich/0000-0001-8725-6276; Weissmann, Norbert/0000-0003-2675-3871	Max Planck Society; Scientific and Economic Excellence in Hesse (LOEWE) Programm; German Research Foundation through Excellence Cluster 147 Cardio-Pulmonary System (ECCPS), Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Scientific and Economic Excellence in Hesse (LOEWE) Programm; German Research Foundation through Excellence Cluster 147 Cardio-Pulmonary System (ECCPS), Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)(German Research Foundation (DFG))	We thank J. Clardy and R. Kalb from Harvard Medical School for kindly providing Sam A. We thank M. Rabinovitch (Stanford University School of Medicine) for providing the mouse PASMC isolation protocol. We also acknowledge the excellent technical assistance of K. Leib in performing cell culture experiments, U. Eule, C. Vroom and A. Hecker in intact animal experiments and M. Schmoranzer, M. Hoeck and V. Golchert in histological studies. We thank K. Quanz for performing isolated lung experiments. We acknowledge M. Potente for providing genotyping protocol and siRNAs. This work was supported by the Max Planck Society, the Scientific and Economic Excellence in Hesse (LOEWE) Programm and the German Research Foundation through Excellence Cluster 147 Cardio-Pulmonary System (ECCPS), Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Frid MG, 2009, AM J PHYSIOL-LUNG C, V297, pL1059, DOI 10.1152/ajplung.90611.2008; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Goto T, 2008, BRIT J CANCER, V98, P1068, DOI 10.1038/sj.bjc.6604279; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kherbeck N, 2013, CLIN REV ALLERG IMMU, V44, P31, DOI 10.1007/s12016-011-8265-z; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; Mahajan SG, 2012, THROMB HAEMOSTASIS, V108, P148, DOI 10.1160/TH11-11-0756; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Milas L, 1996, RADIOTHER ONCOL, V40, P163, DOI 10.1016/0167-8140(96)01778-1; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Pullamsetti SS, 2012, ARTERIOSCL THROM VAS, V32, P1354, DOI 10.1161/ATVBAHA.112.248500; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2829, DOI 10.1200/JCO.2011.41.4987; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schroeder FC, 2005, J NAT PROD, V68, P574, DOI 10.1021/np049624z; Seeger W, 2013, PULM CIRC, V3, P128, DOI 10.4103/2045-8932.109951; Stabile E, 2012, J AM COLL CARDIOL, V60, P1739, DOI 10.1016/j.jacc.2012.07.033; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Toba M, 2014, AM J PHYSIOL-HEART C, V306, pH243, DOI 10.1152/ajpheart.00728.2013; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Voelkel NF, 2002, CRIT CARE MED, V30, pS251, DOI 10.1097/00003246-200205001-00013; Yang J, 2013, AM J PHYSIOL-LUNG C, V305, pL312, DOI 10.1152/ajplung.00054.2013; Yeager ME, 2012, CHEST, V141, P944, DOI 10.1378/chest.11-0205; Yin YJ, 2013, PHARM RES-DORDR, V30, P2050, DOI 10.1007/s11095-013-1058-8; Zhang XC, 1997, ANTI-CANCER DRUG, V8, P696, DOI 10.1097/00001813-199708000-00008; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	58	181	192	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1289	1300		10.1038/nm.3695	http://dx.doi.org/10.1038/nm.3695			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25344740				2022-12-25	WOS:000344724300018
J	Zhang, ZT; Song, MK; Liu, X; Kang, SS; Kwon, TS; Duong, DM; Seyfried, NT; Hu, WT; Liu, ZX; Wang, JZ; Cheng, LM; Sun, YE; Yu, SP; Levey, AI; Ye, KQ				Zhang, Zhentao; Song, Mingke; Liu, Xia; Kang, Seong Su; Kwon, Ti-Sun; Duong, Duc M.; Seyfried, Nicholas T.; Hu, William T.; Liu, Zhixue; Wang, Jian-Zhi; Cheng, Liming; Sun, Yi E.; Yu, Shan Ping; Levey, Allan I.; Ye, Keqiang			Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease	NATURE MEDICINE			English	Article							CASPASE-CLEAVAGE; CEREBROSPINAL-FLUID; EARLY EVENT; IN-VIVO; TANGLES; PROTEIN; BRAIN; DEGENERATION; ACTIVATION; FILAMENTS	Neurofibrillary tangles (NFTs), composed of truncated and hyperphosphorylated tau, are a common feature of numerous aging-related neurodegenerative diseases, including Alzheimer's disease (AD). However, the molecular mechanisms mediating tau truncation and aggregation during aging remain elusive. Here we show that asparagine endopeptidase (AEP), a lysosomal cysteine proteinase, is activated during aging and proteolytically degrades tau, abolishes its microtubule assembly function, induces tau aggregation and triggers neurodegeneration. AEP is upregulated and active during aging and is activated in human AD brain and tau P301S-transgenic mice with synaptic pathology and behavioral impairments, leading to tau truncation in NFTs. Tau P301S-transgenic mice with deletion of the gene encoding AEP show substantially reduced tau hyperphosphorylation, less synapse loss and rescue of impaired hippocampal synaptic function and cognitive deficits. Mice infected with adeno-associated virus encoding an uncleavable tau mutant showed attenuated pathological and behavioral defects compared to mice injected with adeno-associated virus encoding tau P301S. Together, these observations indicate that AEP acts as a crucial mediator of tau-related clinical and neuropathological changes. Inhibition of AEP may be therapeutically useful for treating tau-mediated neurodegenerative diseases.	[Zhang, Zhentao; Liu, Xia; Kang, Seong Su; Kwon, Ti-Sun; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430072, Peoples R China; [Song, Mingke; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Duong, Duc M.; Seyfried, Nicholas T.; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Hu, William T.; Levey, Allan I.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Liu, Zhixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China; [Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Dept Pathophysiol, Key Lab Minist Educ Neurol Dis, Tongji Med Coll, Wuhan 430074, Peoples R China; [Cheng, Liming; Sun, Yi E.] Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Dept Regenerat Med,Sch Med, Shanghai 200092, Peoples R China	Emory University; Wuhan University; Emory University; Emory University; Emory University; Emory University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Tongji University	Cheng, LM (corresponding author), Tongji Univ, Translat Ctr Stem Cell Res, Tongji Hosp, Dept Regenerat Med,Sch Med, Shanghai 200092, Peoples R China.	limingcheng@tongji.edu.cn; kye@emory.edu	Song, Mingke/N-5971-2014; Levey, Allan/F-2104-2011; Xiao, Hu/GMX-0258-2022; cheng, liming/GMX-4116-2022	Levey, Allan/0000-0002-3153-502X; Zhang, Zhentao/0000-0001-6708-1472; Duong, Duc/0000-0001-5880-1888; Hu, William/0000-0003-4862-6777	RO1 from the US National Institutes of Health [NS045627, NS060680]; US National Institutes of Health/National Institute on Aging Alzheimer's Disease Research Centers [P50AG025688]; National Natural Science Foundation of China [81100958, 91132305]; National Key Basic Research Program of China [2010CB945202]; National Science Foundation of China [81330030]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014449, R01AG043375, P50AG025688, K23AG042856] Funding Source: NIH RePORTER	RO1 from the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health/National Institute on Aging Alzheimer's Disease Research Centers; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by RO1 grants (NS045627 and NS060680) from the US National Institutes of Health to K.Y., the US National Institutes of Health/National Institute on Aging Alzheimer's Disease Research Centers (P50AG025688) grant to AIL., a grant from the National Natural Science Foundation of China (no. 81100958) to Z.Z., a grant from the National Natural Science Foundation of China (no. 91132305) to J.Z.W, a National Key Basic Research Program of China grant (2010CB945202) to YES. and a National Science Foundation of China grant (81330030) to L.C. and Y.E.S. We thank D. Weinshenker (Emory University) for tau P301S-transgenic mice, M. Asano (Kanazawa University) for Lgmn knockout mice, S. Kuegler (Max Planck Institute of Psychiatry) for pAAV vectors carrying tau GFP and C. Hales (Emory University) for technical support.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arai T, 2005, J BIOL CHEM, V280, P5145, DOI 10.1074/jbc.M409234200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Herskowitz JH, 2012, PROTEOMICS, V12, P2455, DOI 10.1002/pmic.201200006; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kenessey A, 1997, J NEUROCHEM, V69, P2026; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Portelius E, 2008, J PROTEOME RES, V7, P2114, DOI 10.1021/pr7008669; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	37	269	276	12	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1254	1262		10.1038/nm.3700	http://dx.doi.org/10.1038/nm.3700			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326800	Green Accepted			2022-12-25	WOS:000344724300014
J	Sae-Ueng, U; Li, D; Zuo, XB; Huffman, JB; Homa, FL; Rau, D; Evilevitch, A				Sae-Ueng, Udom; Li, Dong; Zuo, Xiaobing; Huffman, Jamie B.; Homa, Fred L.; Rau, Donald; Evilevitch, Alex			Solid-to-fluid DNA transition inside HSV-1 capsid close to the temperature of infection	NATURE CHEMICAL BIOLOGY			English	Article							SIMPLEX-VIRUS TYPE-1; EJECTION; DYNAMICS; GENOME; FORCES; BACTERIOPHAGE-T5; SPERMIDINE; ELEMENTS; VIRIONS; PACKING	DNA in the human Herpes simplex virus type 1 (HSV-1) capsid is packaged to a tight density. This leads to tens of atmospheres of internal pressure responsible for the delivery of the herpes genome into the cell nucleus. In this study we show that, despite its liquid crystalline state inside the capsid, the DNA is fluid-like, which facilitates its ejection into the cell nucleus during infection. We found that the sliding friction between closely packaged DNA strands, caused by interstrand repulsive interactions, is reduced by the ionic environment of epithelial cells and neurons susceptible to herpes infection. However, variations in the ionic conditions corresponding to neuronal activity can restrict DNA mobility in the capsid, making it more solid-like. This can inhibit intranuclear DNA release and interfere with viral replication. In addition, the temperature of the human host (37 degrees C) induces a disordering transition of the encapsidated herpes genome, which reduces interstrand interactions and provides genome mobility required for infection.	[Sae-Ueng, Udom; Li, Dong; Evilevitch, Alex] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Zuo, Xiaobing] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Huffman, Jamie B.; Homa, Fred L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Rau, Donald] NIH, Lab Phys & Struct Biol, Program Phys Biol, Bethesda, MD USA; [Evilevitch, Alex] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Carnegie Mellon University; United States Department of Energy (DOE); Argonne National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; Lund University	Evilevitch, A (corresponding author), Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA.	alexe@cmu.edu	Li, Dong/D-9221-2015; Evilevitch, Alex/P-3103-2014	Li, Dong/0000-0002-5282-6918; Evilevitch, Alex/0000-0002-0245-9574	Swedish Research Council, VR grant [622-2008-726]; US National Science Foundation grant [CHE-1152770]; Public Health Service Grant from the US National Institutes of Health (NIH) [AI060836]; McWilliams Fellowship in the Mellon College of Science; Intramural Research Program of the National Institutes of Child Health and Human Development-NIH; US Department of Energy [DE-AC02-06CH11357]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060836, R01AI060836] Funding Source: NIH RePORTER	Swedish Research Council, VR grant; US National Science Foundation grant(National Science Foundation (NSF)); Public Health Service Grant from the US National Institutes of Health (NIH); McWilliams Fellowship in the Mellon College of Science; Intramural Research Program of the National Institutes of Child Health and Human Development-NIH; US Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge T. Liu and I. Shefer for their substantial help with the manuscript preparation. We also thank B. Jonsson for discussions that have been inspiring for this work. We are grateful to G. Berry, M. Widom, P. LeDuc, M. Deserno and L. Walker for providing critically important feedback on data analysis. We acknowledge J. Shaw, B. Pittenger and M. Thompson from Bruker Nano Surfaces Division for outstanding support with AFM measurements. We thank A. Templeton for help with proofreading. The SAXS experiments were performed at beamline 12ID-B of the Advanced Photon Source at Argonne National Laboratory. We acknowledge the Advanced Photon Source, which is an Office of Science User Facility operated by Argonne National Laboratory for the US Department of Energy under contract no. DE-AC02-06CH11357. This work was supported by the Swedish Research Council, VR grant 622-2008-726 (A.E.) and US National Science Foundation grant CHE-1152770 (A.E.). Support was also provided by the Public Health Service Grant AI060836 from the US National Institutes of Health (NIH) (F.L.H.) and by the McWilliams Fellowship in the Mellon College of Science (to U.S.). This work was partially supported by the Intramural Research Program of the National Institutes of Child Health and Human Development-NIH (to D.R.).	Bauer DW, 2013, J AM CHEM SOC, V135, P11216, DOI 10.1021/ja404008r; Berndsen ZT, 2014, P NATL ACAD SCI USA, V111, P8345, DOI 10.1073/pnas.1405109111; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; CAMERON IL, 1979, J CELL PHYSIOL, V101, P493, DOI 10.1002/jcp.1041010315; CAMERON IL, 1980, CANCER RES, V40, P1493; Coen D. M., 2006, Alpha herpesviruses: molecular and cellular biology, P361; DAVIS RH, 1992, MICROBIOL REV, V56, P280, DOI 10.1128/MMBR.56.2.280-290.1992; de Frutos M, 2005, BIOPHYS J, V88, P1364, DOI 10.1529/biophysj.104.048785; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; EARNSHAW WC, 1977, NATURE, V268, P598, DOI 10.1038/268598a0; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Evilevitch A, 2008, BIOPHYS J, V94, P1110, DOI 10.1529/biophysj.107.115345; Evilevitch A, 2011, J MOL BIOL, V405, P18, DOI 10.1016/j.jmb.2010.10.039; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; GABASHVILI IS, 1992, J BIOMOL STRUCT DYN, V9, P911, DOI 10.1080/07391102.1992.10507966; Geggier S, 2011, NUCLEIC ACIDS RES, V39, P1419, DOI 10.1093/nar/gkq932; GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Hanhijarvi KJ, 2013, BIOPHYS J, V104, P2264, DOI 10.1016/j.bpj.2013.03.061; Hendrix R. W., 1983, LAMBDA 2, VII; Homa FL, 1997, REV MED VIROL, V7, P107, DOI 10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Ivanovska I, 2007, P NATL ACAD SCI USA, V104, P9603, DOI 10.1073/pnas.0703166104; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kornyshev AA, 2007, REV MOD PHYS, V79, P943, DOI 10.1103/RevModPhys.79.943; Lander GC, 2013, NUCLEIC ACIDS RES, V41, P4518, DOI 10.1093/nar/gkt137; Leforestier A, 2008, J MOL BIOL, V384, P730, DOI 10.1016/j.jmb.2008.09.035; LIVOLANT F, 1991, PHYSICA A, V176, P117, DOI 10.1016/0378-4371(91)90436-G; Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0; Odijk T, 2004, PHILOS T R SOC A, V362, P1497, DOI 10.1098/rsta.2004.1385; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Purves D, 2012, NEUROSCIENCE; Qiu XY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028102; RAU DC, 1992, BIOPHYS J, V61, P260, DOI 10.1016/S0006-3495(92)81832-5; RIEMER SC, 1978, BIOPOLYMERS, V17, P785, DOI 10.1002/bip.1978.360170317; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; Sao-Jose C, 2007, J MOL BIOL, V374, P346, DOI 10.1016/j.jmb.2007.09.045; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Todd BA, 2008, NUCLEIC ACIDS RES, V36, P501, DOI 10.1093/nar/gkm1038; Tzlil S, 2003, BIOPHYS J, V84, P1616, DOI 10.1016/S0006-3495(03)74971-6; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Zhang CX, 2005, J NEUROVIROL, V11, P256, DOI 10.1080/13550280590952781; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; ZSNAGY I, 1981, J CELL BIOL, V90, P769, DOI 10.1083/jcb.90.3.769	54	25	27	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					861	+		10.1038/NCHEMBIO.1628	http://dx.doi.org/10.1038/NCHEMBIO.1628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25195012	Green Accepted			2022-12-25	WOS:000342462100013
J	Ren, AM; Patel, DJ				Ren, Aiming; Patel, Dinshaw J.			c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIC GMP-AMP; SENSING RIBOSWITCH; EUBACTERIA SENSE; STRUCTURAL BASIS; GENE-EXPRESSION; LIGAND-BINDING; 2ND-MESSENGER; RECOGNITION; RNA; DINUCLEOTIDE	The ydaO riboswitch, involved in sporulation, osmotic stress responses and cell wall metabolism, targets the second messenger cyclic-di-AMP with subnanomolar affinity. We have solved the structure of c-di-AMP bound to the Thermoanaerobacter tengcongensis ydaO riboswitch, thereby identifying a five-helical scaffold containing a zippered-up bubble, a pseudoknot and long-range tertiary base pairs. Highlights include the identification of two c-di-AMP binding pockets on the same face of the riboswitch, related by pseudo-two-fold symmetry, with potential for Cross-talk between sites mediated by adjacently positioned base-stacking alignments connecting pockets. The adenine rings of bound c-di-AMP molecules are wedged between bases and stabilized by stacking, base-sugar and sugar-sugar intermolecular hydrogen bonding interactions. The structural studies are complemented by isothermal titration calorimetry-based binding studies of mutants mediating key tertiary intermolecular contacts. The T. tengcongensis ydaO riboswitch, like its Bacillus subtilis counterpart, most likely functions through a transcription termination mechanism, with the c-di-AMP bound state representing an 'off' switch.	[Ren, Aiming; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ren, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org			US National Institutes of Health [1 U19 CA179564]; NATIONAL CANCER INSTITUTE [U19CA179564, P30CA008748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge assistance by staff at the X-29 beamline at the Brookhaven National Laboratory and NE-CAT beamlines at the Advanced Photon Source. We thank B. Gaffney and R. Jones of Rutgers University for samples of chemically synthesized cGAMP linkage isomers. The research was supported by US National Institutes of Health grant 1 U19 CA179564 to D.J.P.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Smith KD, 2011, P NATL ACAD SCI USA, V108, P7757, DOI 10.1073/pnas.1018857108; Smith KD, 2011, BIOCHEM SOC T, V39, P647, DOI 10.1042/BST0390647; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Witte G., 2010, SCIENCE, V329, P845; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	31	72	74	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					780	786		10.1038/NCHEMBIO.1606	http://dx.doi.org/10.1038/NCHEMBIO.1606			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25086509	Green Accepted			2022-12-25	WOS:000341126800016
J	Yang, SK; Hong, M; Baek, J; Choi, H; Zhao, WT; Jung, YS; Haritunians, T; Ye, BD; Kim, KJ; Park, SH; Park, SK; Yang, DH; Dubinsky, M; Lee, I; McGovern, DPB; Liu, JJ; Song, K				Yang, Suk-Kyun; Hong, Myunghee; Baek, Jiwon; Choi, Hyunchul; Zhao, Wanting; Jung, Yusun; Haritunians, Talin; Ye, Byong Duk; Kim, Kyung-Jo; Park, Sang Hyoung; Park, Soo-Kyung; Yang, Dong-Hoon; Dubinsky, Marla; Lee, Inchul; McGovern, Dermot P. B.; Liu, Jianjun; Song, Kyuyoung			A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE; AZATHIOPRINE; MYELOSUPPRESSION; MANAGEMENT; FREQUENCY; TOXICITY; GENOTYPE; JAPANESE; GENE	Thiopurine therapy, commonly used in autoimmune conditions, can be complicated by life-threatening leukopenia. This leukopenia is associated with genetic variation in TPMT (encoding thiopurine S-methyltransferase). Despite a lower frequency of TPMT mutations in Asians, the incidence of thiopurine-induced leukopenia is higher in Asians than in individuals of European descent. Here we performed an Immunochip-based 2-stage association study in 978 Korean subjects with Crohn's disease treated with thiopurines. We identified a nonsynonymous SNP in NUDT15 (encoding p.Arg139Cys) that was strongly associated with thiopurine-induced early leukopenia (odds ratio (OR) = 35.6; P-combined = 4.88 x 10(-94)). In Koreans, this variant demonstrated sensitivity and specificity of 89.4% and 93.2%, respectively, for thiopurine-induced early leukopenia (in comparison to 12.1% and 97.6% for TPMT variants). Although rare, this SNP was also strongly associated with thiopurine-induced leukopenia in subjects with inflammatory bowel disease of European descent (OR = 9.50; P = 4.64 x 10(-4)). Thus, NUDT15 is a pharmacogenetic determinant for thiopurine-induced leukopenia in diverse populations.	[Yang, Suk-Kyun; Ye, Byong Duk; Kim, Kyung-Jo; Park, Sang Hyoung; Park, Soo-Kyung; Yang, Dong-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Hong, Myunghee; Baek, Jiwon; Choi, Hyunchul; Jung, Yusun; Song, Kyuyoung] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Zhao, Wanting; Liu, Jianjun] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Haritunians, Talin; McGovern, Dermot P. B.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Dubinsky, Marla] Cedars Sinai Med Ctr, Pediat Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA; [Lee, Inchul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Ulsan; Asan Medical Center	Song, K (corresponding author), Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	kysong@amc.seoul.kr	Park, Sang Hyoung/CAH-4735-2022; Ye, Byong Duk/AAF-4955-2020; Liu, Jianjun/AAK-4989-2020; Yang, Dong-Hoon/B-3437-2015	Ye, Byong Duk/0000-0001-6647-6325; Liu, Jianjun/0000-0002-3255-3019; Yang, Dong-Hoon/0000-0001-7756-2704; McGovern, Dermot/0000-0001-5621-759X	Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC) Singapore [SPF2014/001]; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P01DK046763, U01DK062413, U01AI067068, R01HS021747]; European Union (IBD-BIOM) [305479]; Leona M. and Harry B. Helmsley Charitable Trust [2011PG-MED004, 2014PG-IBD014]; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; NRF (National Research Foundation of Korea) - Ministry of Science, Information and Communication Technology (ICT) and Future Planning [2010-0015648, 2014R1A2A1A09005824]; Korean Health Technology R&D Project from the Ministry of Health and Welfare, the Republic of Korea [A120176]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062413, P01DK046763] Funding Source: NIH RePORTER	Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC) Singapore; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Union (IBD-BIOM); Leona M. and Harry B. Helmsley Charitable Trust; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; NRF (National Research Foundation of Korea) - Ministry of Science, Information and Communication Technology (ICT) and Future Planning; Korean Health Technology R&D Project from the Ministry of Health and Welfare, the Republic of Korea; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank all participants who provided the DNA and clinical information necessary for this study. J.L. and W.Z. are supported by the Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC SPF2014/001), Singapore. D.P.B.M., T.H. and M.D. are supported by the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, U01DK062413, U01AI067068, R01HS021747), the European Union (IBD-BIOM 305479), the Leona M. and Harry B. Helmsley Charitable Trust (2011PG-MED004, 2014PG-IBD014) and internal funding from the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute. This work was supported by a Mid-Career Researcher Program grant through NRF (National Research Foundation of Korea) to K.S. (2010-0015648, 2014R1A2A1A09005824) funded by the Ministry of Science, Information and Communication Technology (ICT) and Future Planning and by a Korean Health Technology R&D Project grant to S.-K.Y. (A120176) from the Ministry of Health and Welfare, the Republic of Korea.	Booth RA, 2011, ANN INTERN MED, V154, P814, DOI 10.7326/0003-4819-154-12-201106210-00009; Cao Q, 2009, DIGESTION, V79, P58, DOI 10.1159/000205268; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; Dewit O, 2011, CLIN BIOCHEM, V44, P1062, DOI 10.1016/j.clinbiochem.2011.06.079; Fraser AG, 2002, GUT, V50, P485, DOI 10.1136/gut.50.4.485; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; Lee HJ, 2009, INTEST RES, V7, P22; Lewis JD, 2009, CLIN GASTROENTEROL H, V7, P1195, DOI 10.1016/j.cgh.2009.07.019; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3; Zhang FB, 2012, THER DRUG MONIT, V34, P695, DOI 10.1097/FTD.0b013e3182731925	19	319	339	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1017	+		10.1038/ng.3060	http://dx.doi.org/10.1038/ng.3060			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108385	Green Accepted			2022-12-25	WOS:000341579400018
J	Gaugler, T; Klei, L; Sanders, SJ; Bodea, CA; Goldberg, AP; Lee, AB; Mahajan, ML; Manaa, D; Pawitan, YD; Reichert, J; Ripke, S; Sandin, S; Sklar, P; Svantesson, O; Reichenberg, A; Hultman, CM; Devlin, B; Roeder, K; Buxbaum, JD				Gaugler, Trent; Klei, Lambertus; Sanders, Stephan J.; Bodea, Corneliu A.; Goldberg, Arthur P.; Lee, Ann B.; Mahajan, Milind; Manaa, Dina; Pawitan, Yudi; Reichert, Jennifer; Ripke, Stephan; Sandin, Sven; Sklar, Pamela; Svantesson, Oscar; Reichenberg, Abraham; Hultman, Christina M.; Devlin, Bernie; Roeder, Kathryn; Buxbaum, Joseph D.			Most genetic risk for autism resides with common variation	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; HERITABILITY; VARIANTS; REVEALS; LOCI	A key component of genetic architecture is the allelic spectrum influencing trait variability. For autism spectrum disorder (herein termed autism), the nature of the allelic spectrum is uncertain. Individual risk-associated genes have been identified from rare variation, especially de novo mutations(1-8). From this evidence, one might conclude that rare variation dominates the allelic spectrum in autism, yet recent studies show that common variation, individually of small effect, has substantial impact en masse(9,10). At issue is how much of an impact relative to rare variation this common variation has. Using a unique epidemiological sample from Sweden, new methods that distinguish total narrow-sense heritability from that due to common variation and synthesis of results from other studies, we reach several conclusions about autism's genetic architecture: its narrow-sense heritability is similar to 52.4%, with most due to common variation, and rare de novo mutations contribute substantially to individual liability, yet their contribution to variance in liability, 2.6%, is modest compared to that for heritable variation.	[Gaugler, Trent; Bodea, Corneliu A.; Lee, Ann B.; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Sanders, Stephan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Goldberg, Arthur P.; Reichert, Jennifer; Reichenberg, Abraham; Buxbaum, Joseph D.] Seaver Autism Ctr Res & Treatment, Icahn Sch Med Mt Sinai, New York, NY USA; [Goldberg, Arthur P.; Reichert, Jennifer; Sklar, Pamela; Reichenberg, Abraham; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Goldberg, Arthur P.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY USA; [Mahajan, Milind; Manaa, Dina; Sklar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Pawitan, Yudi; Sandin, Sven; Svantesson, Oscar; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ripke, Stephan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA; [Sklar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Div Psychiat Gen, New York, NY USA; [Reichenberg, Abraham] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA; [Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Roeder, K (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	roeder@stat.cmu.edu; joseph.buxbaum@mssm.edu	Sanders, Stephan/S-8645-2019; Ripke, Stephan/AAK-5486-2021; Buxbaum, Joseph D/G-6001-2010; Sandin, Sven/ABE-2959-2021; Sandin, Sven/L-5357-2015; Reichenberg, Abraham/GQB-1227-2022	Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884; Sanders, Stephan/0000-0001-9112-5148; ripke, stephan/0000-0003-3622-835X; Roeder, Kathryn/0000-0002-8869-6254; Buxbaum, Joseph/0000-0001-8898-8313; Gaugler, Trent/0000-0002-8006-9184	National Institute of Mental Health (NIMH) [MH057881, MH097849]; NIMH [MH095034, MH077139]; US NIH [HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NSO42165, NSO49261]; Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris, France; Autism Speaks, UK; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft, Germany [Po 255/17-4]; European Community's Sixth Framework Programme AUTISM MOLGEN; Fundacao Calouste Gulbenkian, Portugal; Fondation de France; Fondation FondaMental, France; Fondation Orange, France; Fondation pour la Recherche Medicale, France; Fundacao pars a Ciencia e Tecnologia, Portugal; Hospital for Sick Children Foundation; University of Toronto, Canada; INSERM, France; Institut Pasteur, France; Italian Ministry of Health [181]; John P. Hussman Foundation, USA; McLaughlin Centre, Canada; Netherlands Organization for Scientific Research [Rubicon 825.06.031]; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Ontario Ministry of Research and Innovation, Canada; Seaver Foundation, USA; Swedish Science Council; Centre for Applied Genomics, Canada; Utah Autism Foundation, USA; Wellcome Trust, UK [075491/Z/04]; Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R10MH055284, U54MH066673, R37MH057881, R01MH081754, R01MH077139, R01MH095034, R01MH061009, R56MH097849, R01MH052708, R01MH097849, U10MH066766, R01MH055284, R01MH057881, R01MH080647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS042165, R01NS049261] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique-Hopitaux de Paris, France; Autism Speaks, UK; Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); European Community's Sixth Framework Programme AUTISM MOLGEN; Fundacao Calouste Gulbenkian, Portugal; Fondation de France(Fondation de France); Fondation FondaMental, France; Fondation Orange, France; Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); Fundacao pars a Ciencia e Tecnologia, Portugal; Hospital for Sick Children Foundation; University of Toronto, Canada(University of Toronto); INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur, France; Italian Ministry of Health(Ministry of Health, Italy); John P. Hussman Foundation, USA; McLaughlin Centre, Canada; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences; Ontario Ministry of Research and Innovation, Canada(Ministry of Research and Innovation, Ontario); Seaver Foundation, USA; Swedish Science Council; Centre for Applied Genomics, Canada; Utah Autism Foundation, USA; Wellcome Trust, UK(Wellcome Trust); Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Mental Health (NIMH) grants MH057881 and MH097849 and also in part through the computational resources and staff expertise provided by the Scientific Computing Facility at the Icahn School of Medicine at Mount Sinai. We thank the Mount Sinai Genomics Core Facility for carrying out Illumina bead array genotyping. We thank D. Cutler, M. Daly and S. Purcell for comments on the manuscript and M. Daly and P. Sullivan for facilitating access to control samples, collected and genotyped by M. Daly, C.M.H., P.S. and P. Sullivan with support from NIMH grants MH095034 and MH077139. We also thank the nurses, A.-K. Sundberg and A.-B. Holmgren, for their hard work in collecting the samples. AGP: We used data from the Autism Genome Project (AGP) Consortium Whole-Genome Association and Copy Number Variation Study of over 2,600 parent-offspring trios (database of Genotypes and Phenotypes (dbGaP) study phs000267.v4.p2). Funding for AGP was provided from the US NIH (HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NSO42165 and NSO49261); the Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris, France; Autism Speaks, UK; the Canada Foundation for Innovation/Ontario Innovation Trust; grant Po 255/17-4 from Deutsche Forschungsgemeinschaft, Germany; the European Community's Sixth Framework Programme AUTISM MOLGEN; Fundacao Calouste Gulbenkian, Portugal; Fondation de France; Fondation FondaMental, France; Fondation Orange, France; Fondation pour la Recherche Medicale, France; Fundacao pars a Ciencia e Tecnologia, Portugal; The Hospital for Sick Children Foundation and the University of Toronto, Canada; INSERM, France; Institut Pasteur, France; Convention 181 of 19.10.2001 from the Italian Ministry of Health; the John P. Hussman Foundation, USA; the McLaughlin Centre, Canada; Rubicon 825.06.031 from the Netherlands Organization for Scientific Research; TMF/DA/5801 from the Royal Netherlands Academy of Arts and Sciences; the Ontario Ministry of Research and Innovation, Canada; the Seaver Foundation, USA; the Swedish Science Council; the Centre for Applied Genomics, Canada; the Utah Autism Foundation, USA; and Core award 075491/Z/04 from the Wellcome Trust, UK. Genotype and phenotype data were obtained from dbGaP, as provided by AGP study investigators. HealthABC: These controls were obtained from dbGaP. Funding support for the CIDR Visceral Adiposity Study (dbGaP study phs000169.v1.p1) was provided through the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging. The CIDR Visceral Adiposity Study includes a GWAS funded as part of the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Health ABC study investigators. This manuscript reflects the views of the authors and does not necessarily reflect the opinions or views of the US NIH.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Crossett A, 2013, ANN APPL STAT, V7, P669, DOI 10.1214/12-AOAS598; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lundstrom S, 2012, ARCH GEN PSYCHIAT, V69, P46, DOI 10.1001/archgenpsychiatry.2011.144; Lynch M., 1998, GENETICS ANAL QUANTI; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Orozco G, 2010, HUM MOL GENET, V19, pR137, DOI 10.1093/hmg/ddq368; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S., 2014, J AM MED AS IN PRESS; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	32	674	685	6	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					881	885		10.1038/ng.3039	http://dx.doi.org/10.1038/ng.3039			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038753	Green Accepted, Green Submitted			2022-12-25	WOS:000339704400018
J	Ndong, JD; Makowski, AJ; Uppuganti, S; Vignaux, G; Ono, K; Perrien, DS; Joubert, S; Baglio, SR; Granchi, D; Stevenson, DA; Rios, JJ; Nyman, JS; Elefteriou, F				Ndong, Jean de la Croix; Makowski, Alexander J.; Uppuganti, Sasidhar; Vignaux, Guillaume; Ono, Koichiro; Perrien, Daniel S.; Joubert, Simon; Baglio, Serena R.; Granchi, Donatella; Stevenson, David A.; Rios, Jonathan J.; Nyman, Jeffry S.; Elefteriou, Florent			Asfotase-alpha improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1	NATURE MEDICINE			English	Article							SUPPRESSES OSTEOBLAST DIFFERENTIATION; CONGENITAL PSEUDOARTHROSIS; MORPHOGENETIC PROTEIN-7; INORGANIC PYROPHOSPHATE; ENZYME-REPLACEMENT; TIBIAL PSEUDOARTHROSIS; DISTINCT ROLES; NF1; OSTEOPONTIN; EXPRESSION	Individuals with neurofibromatosis type-1 (NF1) can manifest focal skeletal dysplasias that remain extremely difficult to treat. NF1 is caused by mutations in the NF1 gene, which encodes the RAS GTPase-activating protein neurofibromin. We report here that ablation of Nf1 in bone-forming cells leads to supraphysiologic accumulation of pyrophosphate (PPi), a strong inhibitor of hydroxyapatite formation, and that a chronic extracellular signal-regulated kinase (ERK)-dependent increase in expression of genes promoting PPi synthesis and extracellular transport, namely Enpp1 and Ank, causes this phenotype. Nf1 ablation also prevents bone morphogenic protein-2 induced osteoprogenitor differentiation and, consequently, expression of alkaline phosphatase and PPi breakdown, further contributing to PPi accumulation. The short stature and impaired bone mineralization and strength in mice lacking Nf1 in osteochondroprogenitors or osteoblasts can be corrected by asfotase-alpha enzyme therapy aimed at reducing PPi concentration. These results establish neurofibromin as an essential regulator of bone mineralization. They also suggest that altered PPi homeostasis contributes to the skeletal dysplasias associated with NF1 and that some of the NF1 skeletal conditions could be prevented pharmacologically.	[Ndong, Jean de la Croix; Makowski, Alexander J.; Uppuganti, Sasidhar; Vignaux, Guillaume; Ono, Koichiro; Perrien, Daniel S.; Nyman, Jeffry S.; Elefteriou, Florent] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, Nashville, TN 37235 USA; [Ndong, Jean de la Croix; Vignaux, Guillaume; Ono, Koichiro; Elefteriou, Florent] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Makowski, Alexander J.; Nyman, Jeffry S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Makowski, Alexander J.; Uppuganti, Sasidhar; Perrien, Daniel S.; Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Nashville, TN USA; [Makowski, Alexander J.; Perrien, Daniel S.; Nyman, Jeffry S.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA; [Ono, Koichiro] Nohon Koukan Hosp, Dept Orthopaed, Kawasaki, Kanagawa, Japan; [Perrien, Daniel S.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Joubert, Simon] Alex Pharmaceut, Cheshire, CT USA; [Baglio, Serena R.; Granchi, Donatella] Ist Ortoped Rizzoli, Lab Orthoped Pathophysiol & Regenerat Med, Bologna, Italy; [Stevenson, David A.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Rios, Jonathan J.] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Rios, Jonathan J.] UT SW Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Rios, Jonathan J.] UT SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Rios, Jonathan J.] UT SW Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX USA; [Elefteriou, Florent] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Elefteriou, Florent] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; IRCCS Istituto Ortopedico Rizzoli; Utah System of Higher Education; University of Utah; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University	Elefteriou, F (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, Nashville, TN 37235 USA.	florent.elefteriou@vanderbilt.edu	Granchi, Donatella/J-3647-2016; Elefteriou, Florent/GMW-8429-2022; Perrien, Daniel S/AAH-3889-2020; Elefteriou, Florent/P-2586-2017; Granchi, Donatella/ABD-5402-2021	Granchi, Donatella/0000-0001-7225-0023; Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Perrien, Daniel/0000-0002-5488-3932; Baglio, Serena Rubina/0000-0003-0503-8908; Nyman, Jeffry/0000-0001-7403-7605	Children's Tumor Foundation [2012-01-028]; US National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Research Resources of the US National Institutes of Health [5R01 AR055966, S10 RR027631]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]; Pediatric Orthopaedic Society of North America; Texas Scottish Rite Hospital for Children; US Army Medical Research Acquisition Activity [W81XWH-11-1-0250]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055966] Funding Source: NIH RePORTER	Children's Tumor Foundation; US National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pediatric Orthopaedic Society of North America; Texas Scottish Rite Hospital for Children; US Army Medical Research Acquisition Activity; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Bianchi and F. Cailotto for their help in establishing the PP<INF>1</INF> measurement protocol and K.S. Campbell for editorial assistance. This work was supported by a Young Investigator Award (2012-01-028) from the Children's Tumor Foundation (J.d.l.C.N.), the US National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Center for Research Resources, part of the US National Institutes of Health, under award numbers 5R01 AR055966 (F.E.) and S10 RR027631 (D.S.P.), the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001105 (J.J.R.), the Pediatric Orthopaedic Society of North America and Texas Scottish Rite Hospital for Children (J.J.R.) and the US Army Medical Research Acquisition Activity under award W81XWH-11-1-0250 (D.A.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health or US government.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Alves RDAM, 2013, MOL CELL PROTEOMICS, V12, P2890, DOI 10.1074/mcp.M112.024927; Anticevic D, 2006, J PEDIATR ORTHOP B, V15, P220, DOI 10.1097/01.bpb.0000194439.75378.ac; Cailotto F, 2010, J BIOL CHEM, V285, P10572, DOI 10.1074/jbc.M109.050534; Duman O, 2008, BRAIN DEV-JPN, V30, P584, DOI 10.1016/j.braindev.2008.02.002; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Fabeck L, 2006, J BONE JOINT SURG BR, V88B, P116, DOI 10.1302/0301-620X.88B1.16619; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hatch NE, 2005, CONNECT TISSUE RES, V46, P184, DOI 10.1080/03008200500237203; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; Ippolito E, 2000, J PEDIATR ORTHOP B, V9, P3, DOI 10.1097/01202412-200001000-00002; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Kuhnisch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086115; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Larizza L, 2009, CURR MOL MED, V9, P634, DOI 10.2174/156652409788488801; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; Lee DY, 2011, CLIN ORTHOP SURG, V3, P230, DOI 10.4055/cios.2011.3.3.230; Lee FYI, 2006, J BONE JOINT SURG AM, V88A, P627, DOI 10.2106/JBJS.D.02201; Leskela HV, 2009, BONE, V44, P243, DOI 10.1016/j.bone.2008.10.050; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Neitzschman H R, 2001, J La State Med Soc, V153, P119; Ono K, 2013, HUM MOL GENET, V22, P3048, DOI 10.1093/hmg/ddt162; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schindeler A, 2011, J BONE JOINT SURG BR, V93B, P1134, DOI 10.1302/0301-620X.93B8.25940; Schindeler A, 2008, J ORTHOP RES, V26, P65, DOI 10.1002/jor.20481; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; Sohn P, 2002, OSTEOARTHR CARTILAGE, V10, P482, DOI 10.1053/joca.2002.0810; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Stevenson DA, 1999, AM J MED GENET, V84, P413, DOI 10.1002/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1; Stevenson DA, 2007, J PEDIATR-US, V150, P83, DOI 10.1016/j.jpeds.2006.10.048; Stevenson DA, 2013, J PEDIATR ORTHOPED, V33, P269, DOI 10.1097/BPO.0b013e31828121b8; Sullivan K, 2011, BONE, V49, P1311, DOI 10.1016/j.bone.2011.09.043; Terkeltaub RA, 1998, J BONE MINER RES, V13, P931, DOI 10.1359/jbmr.1998.13.6.931; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Vitale MG, 2002, CLIN ORTHOP RELAT R, P107, DOI 10.1097/01.blo.0000022199.37246.c9; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Wang WX, 2010, J BONE MINER RES, V25, P1658, DOI 10.1002/jbmr.42; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yadav MC, 2011, BONE, V49, P250, DOI 10.1016/j.bone.2011.03.770; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	53	41	51	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					904	910		10.1038/nm.3583	http://dx.doi.org/10.1038/nm.3583			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	24997609	Green Accepted			2022-12-25	WOS:000340074600022
J	Oh, DY; Walenta, E; Akiyama, TE; Lagakos, WS; Lackey, D; Pessentheiner, AR; Sasik, R; Hah, N; Chi, TJ; Cox, JM; Powels, MA; Di Salvo, J; Sinz, C; Watkins, SM; Armando, AM; Chung, H; Evans, RM; Quehenberger, O; McNeils, J; Bogner-Strauss, JG; Olefsky, JM				Oh, Da Young; Walenta, Evelyn; Akiyama, Taro E.; Lagakos, William S.; Lackey, Denise; Pessentheiner, Ariane R.; Sasik, Roman; Hah, Nasun; Chi, Tyler J.; Cox, Jason M.; Powels, Mary Ann; Di Salvo, Jerry; Sinz, Christopher; Watkins, Steven M.; Armando, Aaron M.; Chung, Heekyung; Evans, Ronald M.; Quehenberger, Oswald; McNeils, Joanne; Bogner-Strauss, Juliane G.; Olefsky, Jerrold M.			A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice	NATURE MEDICINE			English	Article							N-3 FATTY-ACIDS; GPR120; CELLS; SECRETION; POTENT; RECEPTORS	It is well known that the omega-3 fatty acids (omega-3-FAs; also known as n-3 fatty acids) can exert potent anti-inflammatory effects(1-4). Commonly consumed as fish products, dietary supplements and pharmaceuticals, omega-3-FAs have a number of health benefits ascribed to them, including reduced plasma triglyceride levels, amelioration of atherosclerosis and increased insulin sensitivity(5-7). We reported that Gpr120 is the functional receptor for these fatty acids and that omega-3-FAs produce robust anti-inflammatory, insulin-sensitizing effects, both in vivo and in vitro, in a Gpr120-dependent manner(8). Indeed, genetic variants that predispose to obesity and diabetes have been described in the gene encoding GPR120 in humans (FFAR4)(9). However, the amount of fish oils that would have to be consumed to sustain chronic agonism of Gpr120 is too high to be practical, and, thus, a high-affinity small-molecule Gpr120 agonist would be of potential clinical benefit. Accordingly, Gpr120 is a widely studied drug discovery target within the pharmaceutical industry. Gpr40 is another lipid-sensing G protein-coupled receptor(10), and it has been difficult to identify compounds with a high degree of selectivity for Gpr120 over Gpr40 (ref. 11). Here we report that a selective high-affinity, orally available, small-molecule Gpr120 agonist (cpdA) exerts potent anti-inflammatory effects on macrophages in vitro and in obese mice in vivo. Gpr120 agonist treatment of high-fat diet-fed obese mice causes improved glucose tolerance, decreased hyperinsulinemia, increased insulin sensitivity and decreased hepatic steatosis. This suggests that Gpr120 agonists could become new insulin-sensitizing drugs for the treatment of type 2 diabetes and other human insulinresistant states in the future.	[Oh, Da Young; Walenta, Evelyn; Lagakos, William S.; Lackey, Denise; Pessentheiner, Ariane R.; Sasik, Roman; Chi, Tyler J.; Chung, Heekyung; Quehenberger, Oswald; McNeils, Joanne; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Akiyama, Taro E.; Cox, Jason M.; Powels, Mary Ann; Di Salvo, Jerry; Sinz, Christopher] Merck Res Labs, Kenilworth, NJ USA; [Pessentheiner, Ariane R.; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Hah, Nasun; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Watkins, Steven M.] Lipomics Technol, West Sacramento, CA USA; [Armando, Aaron M.; Quehenberger, Oswald] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Merck & Company; Graz University of Technology; Salk Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	Oh, DY (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	dayoungoh@ucsd.edu; jolefsky@ucsd.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Hah, Nasun/0000-0003-1509-2799; Pessentheiner, Ariane/0000-0002-5010-9528; Bogner-Strauss, Juliane/0000-0003-2459-0124; Atkins, Annette/0000-0003-2558-7058	Merck, Inc.; Austrian science fund (FWF Doktoratskolleg) [DK-MCD W1226]; Austrian science fund (FWF) [P24143]; Marshall Plan Scholarship; UCSD [P30 NS047101];  [DK033651];  [DK074868];  [DK063491];  [DK09062];  [P30 DK063491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, P01DK074868, R37DK057978, R01DK033651, F32DK009062, P30DK063491, P01DK054441] Funding Source: NIH RePORTER	Merck, Inc.(Merck & Company); Austrian science fund (FWF Doktoratskolleg)(Austrian Science Fund (FWF)); Austrian science fund (FWF)(Austrian Science Fund (FWF)); Marshall Plan Scholarship; UCSD; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by grants to J.M.O. (DK033651, DK074868, DK063491 and DK09062) and D.Y.O. (P30 DK063491), a grant from Merck, Inc. to J.M.O. and D.Y.O., Austrian science fund (FWF Doktoratskolleg DK-MCD W1226 and the FWF project P24143) to J.G.B.-S., and a Marshall Plan Scholarship to A.R.P. We thank A. Tyler for editorial assistance and N. Sekiya for assistance with FACS analysis at the Veterans Affairs San Diego hospital, the University of California, San Diego (UCSD) Histology Core lab for technical help with processing liver specimens, and the UCSD Microscope Resource for microscopy analysis, which is funded by UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101.	Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paulsen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088227; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Proudman SM, 2008, RHEUM DIS CLIN N AM, V34, P469, DOI 10.1016/j.rdc.2008.03.003; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sijben JWC, 2007, P NUTR SOC, V66, P237, DOI 10.1017/S0029665107005472; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	21	252	262	1	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					942	947		10.1038/nm.3614	http://dx.doi.org/10.1038/nm.3614			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	24997608	Green Submitted, Green Accepted			2022-12-25	WOS:000340074600027
J	Aung, T; Ozaki, M; Mizoguchi, T; Allingham, RR; Li, Z; Haripriya, A; Nakano, S; Uebe, S; Harder, JM; Chan, ASY; Lee, MC; Burdon, KP; Astakhov, YS; Abu-Amero, KK; Zenteno, JC; Nilgun, Y; Zarnowski, T; Pakravan, M; Abu Safieh, L; Jia, LY; Wang, YX; Williams, S; Paoli, D; Schlottmann, PG; Huang, LL; Sim, KS; Foo, JN; Nakano, M; Ikeda, Y; Kumar, RS; Ueno, M; Manabe, SI; Hayashi, K; Kazama, S; Ideta, R; Mori, Y; Miyata, K; Sugiyama, K; Higashide, T; Chihara, E; Inoue, K; Ishiko, S; Yoshida, A; Yanagi, M; Kiuchi, Y; Aihara, M; Ohashi, T; Sakurai, T; Sugimoto, T; Chuman, H; Matsuda, F; Yamashiro, K; Gotoh, N; Miyake, M; Astakhov, SY; Osman, EA; Al-Obeidan, SA; Owaidhah, O; Al-Jasim, L; Al Shahwan, S; Fogarty, RA; Leo, P; Yetkin, Y; Oguz, C; Kanavi, MR; Beni, AN; Yazdani, S; Akopov, EL; Toh, KY; Howell, GR; Orr, AC; Goh, Y; Meah, WY; Peh, SQ; Kosior-Jarecka, E; Lukasik, U; Krumbiegel, M; Vithana, EN; Wong, TY; Liu, YT; Koch, AEA; Challa, P; Rautenbach, RM; Mackey, DA; Hewitt, AW; Mitchell, P; Wang, JJ; Ziskind, A; Carmichael, T; Ramakrishnan, R; Narendran, K; Venkatesh, R; Vijayan, S; Zhao, PQ; Chen, XY; Guadarrama-Vallejo, D; Cheng, CY; Perera, SA; Husain, R; Ho, SL; Welge-Luessen, UC; Mardin, C; Schloetzer-Schrehardt, U; Hillmer, AM; Herms, S; Moebus, S; Nothen, MM; Weisschuh, N; Shetty, R; Ghosh, A; Teo, YY; Brown, MA; Lischinsky, I; Crowston, JG; Coote, M; Zhao, BW; Sang, JH; Zhang, NH; You, QS; Vysochinskaya, V; Founti, P; Chatzikyriakidou, A; Lambropoulos, A; Anastasopoulos, E; Coleman, AL; Wilson, MR; Rhee, DJ; Kang, JH; May-Bolchakova, I; Heegaard, S; Mori, K; Alward, WLM; Jonas, JB; Xu, L; Liebmann, JM; Chowbay, B; Schaeffeler, E; Schwab, M; Lerner, F; Wang, NL; Yang, ZL; Frezzotti, P; Kinoshita, S; Fingert, JH; Inatani, M; Tashiro, K; Reis, A; Edward, DP; Pasquale, LR; Kubota, T; Wiggs, JL; Pasutto, F; Topouzis, F; Dubina, M; Craig, JE; Yoshimura, N; Sundaresan, P; John, SWM; Ritch, R; Hauser, MA; Khor, CC				Aung, Tin; Ozaki, Mineo; Mizoguchi, Takanori; Allingham, R. Rand; Li, Zheng; Haripriya, Aravind; Nakano, Satoko; Uebe, Steffen; Harder, Jeffrey M.; Chan, Anita S. Y.; Lee, Mei Chin; Burdon, Kathryn P.; Astakhov, Yury S.; Abu-Amero, Khaled K.; Zenteno, Juan C.; Nilguen, Yildirim; Zarnowski, Tomasz; Pakravan, Mohammad; Abu Safieh, Leen; Jia, Liyun; Wang, Ya Xing; Williams, Susan; Paoli, Daniela; Schlottmann, Patricio G.; Huang, Lulin; Sim, Kar Seng; Foo, Jia Nee; Nakano, Masakazu; Ikeda, Yoko; Kumar, Rajesh S.; Ueno, Morio; Manabe, Shin-Ichi; Hayashi, Ken; Kazama, Shigeyasu; Ideta, Ryuichi; Mori, Yosai; Miyata, Kazunori; Sugiyama, Kazuhisa; Higashide, Tomomi; Chihara, Etsuo; Inoue, Kenji; Ishiko, Satoshi; Yoshida, Akitoshi; Yanagi, Masahide; Kiuchi, Yoshiaki; Aihara, Makoto; Ohashi, Tsutomu; Sakurai, Toshiya; Sugimoto, Takako; Chuman, Hideki; Matsuda, Fumihiko; Yamashiro, Kenji; Gotoh, Norimoto; Miyake, Masahiro; Astakhov, Sergei Y.; Osman, Essam A.; Al-Obeidan, Saleh A.; Owaidhah, Ohoud; Al-Jasim, Leyla; Al Shahwan, Sami; Fogarty, Rhys A.; Leo, Paul; Yetkin, Yaz; Oguz, Cilingir; Kanavi, Mozhgan Rezaei; Beni, Afsaneh Nederi; Yazdani, Shahin; Akopov, Evgeny L.; Toh, Kai-Yee; Howell, Gareth R.; Orr, Andrew C.; Goh, Yufen; Meah, Wee Yang; Peh, Su Qin; Kosior-Jarecka, Ewa; Lukasik, Urszula; Krumbiegel, Mandy; Vithana, Eranga N.; Wong, Tien Yin; Liu, Yutao; Koch, Allison E. Ashley; Challa, Pratap; Rautenbach, Robyn M.; Mackey, David A.; Hewitt, Alex W.; Mitchell, Paul; Wang, Jie Jin; Ziskind, Ari; Carmichael, Trevor; Ramakrishnan, Rangappa; Narendran, Kalpana; Venkatesh, Rangaraj; Vijayan, Saravanan; Zhao, Peiquan; Chen, Xueyi; Guadarrama-Vallejo, Dalia; Cheng, Ching Yu; Perera, Shamira A.; Husain, Rahat; Ho, Su-Ling; Welge-Luessen, Ulrich-Christoph; Mardin, Christian; Schloetzer-Schrehardt, Ursula; Hillmer, Axel M.; Herms, Stefan; Moebus, Susanne; Noethen, Markus M.; Weisschuh, Nicole; Shetty, Rohit; Ghosh, Arkasubhra; Teo, Yik Ying; Brown, Matthew A.; Lischinsky, Ignacio; Crowston, Jonathan G.; Coote, Michael; Zhao, Bowen; Sang, Jinghong; Zhang, Nihong; You, Qisheng; Vysochinskaya, Vera; Founti, Panayiota; Chatzikyriakidou, Anthoula; Lambropoulos, Alexandros; Anastasopoulos, Eleftherios; Coleman, Anne L.; Wilson, M. Roy; Rhee, Douglas J.; Kang, Jae Hee; May-Bolchakova, Inna; Heegaard, Steffen; Mori, Kazuhiko; Alward, Wallace L. M.; Jonas, Jost B.; Xu, Liang; Liebmann, Jeffrey M.; Chowbay, Balram; Schaeffeler, Elke; Schwab, Matthias; Lerner, Fabian; Wang, Ningli; Yang, Zhenglin; Frezzotti, Paolo; Kinoshita, Shigeru; Fingert, John H.; Inatani, Masaru; Tashiro, Kei; Reis, Andre; Edward, Deepak P.; Pasquale, Louis R.; Kubota, Toshiaki; Wiggs, Janey L.; Pasutto, Francesca; Topouzis, Fotis; Dubina, Michael; Craig, Jamie E.; Yoshimura, Nagahisa; Sundaresan, Periasamy; John, Simon W. M.; Ritch, Robert; Hauser, Michael A.; Khor, Chiea-Chuen		Blue Mountains Eye Study GWAS Team; Wellcome Trust Case Control Consor	A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome	NATURE GENETICS			English	Article							LOXL1 GENE POLYMORPHISMS; PSEUDOEXFOLIATION SYNDROME; SEQUENCE VARIANTS; JAPANESE POPULATION; UNITED-STATES; GLAUCOMA; DISEASE; GERMAN	Exfoliation syndrome (XFS) is the most common recognizable cause of open-angle glaucoma worldwide. To better understand the etiology of XFS, we conducted a genome-wide association study (GWAS) of 1,484 cases and 1,188 controls from Japan and followed up the most significant findings in a further 6,901 cases and 20,727 controls from 17 countries across 6 continents. We discovered a genome-wide significant association between a new locus (CACNA1A rs4926244) and increased susceptibility to XFS (odds ratio (OR) = 1.16, P = 3.36 x 10(-11)). Although we also confirmed overwhelming association at the LOXL1 locus, the key SNP marker (LOXL1 rs4886776) demonstrated allelic reversal depending on the ancestry group (Japanese: ORA allele = 9.87, P = 2.13 x 10(-217); non-Japanese: ORA allele = 0.49, P = 2.35 x 10(-31)). Our findings represent the first genetic locus outside of LOXL1 surpassing genome-wide significance for XFS and provide insight into the biology and pathogenesis of the disease.	[Aung, Tin; Chan, Anita S. Y.; Lee, Mei Chin; Vithana, Eranga N.; Wong, Tien Yin; Cheng, Ching Yu; Perera, Shamira A.; Husain, Rahat; Ghosh, Arkasubhra; Khor, Chiea-Chuen] Singapore Eye Res Inst, Singapore, Singapore; [Aung, Tin; Chan, Anita S. Y.; Wong, Tien Yin; Perera, Shamira A.; Husain, Rahat] Singapore Natl Eye Ctr, Singapore, Singapore; [Aung, Tin; Wong, Tien Yin; Cheng, Ching Yu; Khor, Chiea-Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Aung, Tin; Li, Zheng; Sim, Kar Seng; Foo, Jia Nee; Toh, Kai-Yee; Goh, Yufen; Meah, Wee Yang; Peh, Su Qin; Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Aung, Tin] Natl Univ Singapore, Duke Univ, Grad Sch Med, Singapore 117548, Singapore; [Ozaki, Mineo] Ozaki Eye Hosp, Hyuga, Japan; [Ozaki, Mineo; Manabe, Shin-Ichi; Hayashi, Ken] Hayashi Eye Hosp, Fukuoka, Japan; [Mizoguchi, Takanori] Mizoguchi Eye Hosp, Sasebo, Japan; [Allingham, R. Rand; Challa, Pratap; Teo, Yik Ying; Hauser, Michael A.] Duke Univ, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA; [Haripriya, Aravind; Ramakrishnan, Rangappa; Narendran, Kalpana; Venkatesh, Rangaraj] Aravind Eye Hosp, Intraocular Lens & Cataract Clin, Madurai, Tamil Nadu, India; [Nakano, Satoko; Kubota, Toshiaki] Oita Univ, Fac Med, Dept Ophthalmol, Oita 87011, Japan; [Uebe, Steffen; Krumbiegel, Mandy; Reis, Andre; Pasutto, Francesca] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Harder, Jeffrey M.; Howell, Gareth R.; John, Simon W. M.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Burdon, Kathryn P.; Fogarty, Rhys A.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Burdon, Kathryn P.; Hewitt, Alex W.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Astakhov, Yury S.; Astakhov, Sergei Y.; Akopov, Evgeny L.; Dubina, Michael] First Pavlov State Med Univ St Petersburg, Dept Ophthalmol, St Petersburg, Russia; [Abu-Amero, Khaled K.; Osman, Essam A.; Al-Obeidan, Saleh A.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Abu-Amero, Khaled K.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Zenteno, Juan C.; Guadarrama-Vallejo, Dalia] Inst Ophthalmol Conde de Valenciana, Dept Genet, Mexico City, DF, Mexico; [Zenteno, Juan C.; Guadarrama-Vallejo, Dalia] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; [Nilguen, Yildirim; Yetkin, Yaz; Oguz, Cilingir] Eskisehir Osmangazi Univ, Dept Ophthalmol, Meselik, Turkey; [Zarnowski, Tomasz; Kosior-Jarecka, Ewa; Lukasik, Urszula] Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland; [Pakravan, Mohammad; Owaidhah, Ohoud; Al-Jasim, Leyla; Al Shahwan, Sami; Kanavi, Mozhgan Rezaei; Beni, Afsaneh Nederi; Yazdani, Shahin] Shahid Beheshti Univ Med Sci, Labbafinejad Med Ctr, Ophthalm Res Ctr, Dept Ophthalmol, Tehran, Iran; [Abu Safieh, Leen; Zhao, Bowen; Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Jia, Liyun; Sang, Jinghong; Zhang, Nihong; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wang, Ya Xing; You, Qisheng; Xu, Liang] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Williams, Susan; Carmichael, Trevor] Univ Witwatersrand, Dept Neurosci, Div Ophthalmol, Johannesburg, South Africa; [Paoli, Daniela] Monfalcone Hosp, Dept Ophthalmol, Gorizia, Italy; [Schlottmann, Patricio G.] Org Med Invest, Buenos Aires, DF, Argentina; [Huang, Lulin; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Nakano, Masakazu; Mori, Kazuhiko; Tashiro, Kei] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan; [Ikeda, Yoko; Ueno, Morio; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kumar, Rajesh S.; Shetty, Rohit] Narayana Nethralaya Eye Hosp, Glaucoma Serv, Bangalore, Karnataka, India; [Kazama, Shigeyasu] Shinjo Eye Clin, Miyazaki, Japan; [Ideta, Ryuichi] Ideta Eye Hosp, Kumamoto, Japan; [Mori, Yosai; Miyata, Kazunori] Miyata Eye Hosp, Miyazaki, Japan; [Miyata, Kazunori; Sugimoto, Takako; Chuman, Hideki] Miyazaki Univ, Fac Med, Dept Ophthalmol, Miyazaki, Japan; [Sugiyama, Kazuhisa; Higashide, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan; [Chihara, Etsuo] Sensho Kai Eye Inst, Kyoto, Japan; [Inoue, Kenji] Inouye Eye Hosp, Tokyo, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Dept Med, Asahikawa, Hokkaido, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Engn Combined Res Inst, Asahikawa, Hokkaido, Japan; [Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan; [Yanagi, Masahide; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Aihara, Makoto] Yotsuya Shirato Eye Clin, Tokyo, Japan; [Ohashi, Tsutomu] Ohashi Eye Ctr, Sapporo, Hokkaido, Japan; [Sakurai, Toshiya] Tane Mem Eye Hosp, Osaka, Japan; [Matsuda, Fumihiko; Miyake, Masahiro] Kyoto Univ, Grad Sch Med, INSERM, Ctr Genom Med,U852, Kyoto, Japan; [Yamashiro, Kenji; Gotoh, Norimoto; Miyake, Masahiro; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Leo, Paul] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld, Australia; [Orr, Andrew C.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Liu, Yutao; Koch, Allison E. Ashley; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liu, Yutao] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Rautenbach, Robyn M.; Ziskind, Ari] Univ Stellenbosch, Fac Med & Hlth Sci, Div Ophthalmol, Cape Town, South Africa; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Hewitt, Alex W.; Crowston, Jonathan G.; Coote, Michael] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Vijayan, Saravanan; Sundaresan, Periasamy] Aravind Med Res Fdn, Dept Genet, Madurai, Tamil Nadu, India; [Zhao, Peiquan] Shanghai Jiao Tong Univ, Dept Ophthalmol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Chen, Xueyi; Brown, Matthew A.] Xinjiang Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Urumqi, Xinjiang Uygur, Peoples R China; [Ho, Su-Ling] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore; [Welge-Luessen, Ulrich-Christoph; Mardin, Christian; Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Hillmer, Axel M.] Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore, Singapore; [Herms, Stefan; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Herms, Stefan; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Herms, Stefan] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Herms, Stefan] Univ Basel, Dept Biomed, Human Genet Res Grp, Basel, Switzerland; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Weisschuh, Nicole] Dept Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Ghosh, Arkasubhra] Narayana Nethralaya Fdn, Genes Repair & Regenerat Ophthalm Workstat Res La, Bangalore, Karnataka, India; [Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Lischinsky, Ignacio] Ctr Oftalmol Lischinsky, San Miguel De Tucuman, Argentina; [Crowston, Jonathan G.; Coote, Michael] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; [Vysochinskaya, Vera; Dubina, Michael] St Petersburg Acad Univ, St Petersburg, Russia; [Founti, Panayiota; Anastasopoulos, Eleftherios; Topouzis, Fotis] Aristotle Univ Thessaloniki, Fac Med, Dept Ophthalmol, Amer Hellen Educ Progress Assoc Hosp, GR-54006 Thessaloniki, Greece; [Chatzikyriakidou, Anthoula; Lambropoulos, Alexandros] Aristotle Univ Thessaloniki, Fac Med, Dept Biol & Genet, GR-54006 Thessaloniki, Greece; [Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Ctr Commun Outreach & Policy, Los Angeles, CA 90095 USA; [Wilson, M. Roy] Wayne State Univ, Detroit, MI USA; [Rhee, Douglas J.; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Kang, Jae Hee; Pasquale, Louis R.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [May-Bolchakova, Inna] Mil Hosp Begin, Dept Ophthalmol, Paris, France; [Heegaard, Steffen] Univ Copenhagen, Dept Neurosci & Pharmacol, Eye Pathol Inst, Copenhagen, Denmark; [Heegaard, Steffen] Glostrup Univ Hosp, Dept Ophthalmol, Glostrup, Denmark; [Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Liebmann, Jeffrey M.] NYU, Sch Med, Manhattan Eye Ear & Throat Hosp, New York, NY USA; [Chowbay, Balram] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Schaeffeler, Elke; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Schwab, Matthias] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Lerner, Fabian] Fdn Estudio Glaucoma, Buenos Aires, DF, Argentina; [Frezzotti, Paolo] Univ Siena, Dept Surg, Sect Ophthalmol, I-53100 Siena, Italy; [Inatani, Masaru] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Fukui 910, Japan; [Edward, Deepak P.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY USA	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Duke University; Oita University; University of Erlangen Nuremberg; Howard Hughes Medical Institute; Jackson Laboratory; Flinders University South Australia; University of Tasmania; Menzies Institute for Medical Research; Pavlov First Saint Petersburg State Medical University; King Saud University; State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico; Eskisehir Osmangazi University; Medical University of Lublin; Shahid Beheshti University Medical Sciences; King Khaled Eye Specialist Hospital; Capital Medical University; Capital Medical University; University of Witwatersrand; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; University of Miyazaki; Kanazawa University; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Hiroshima University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Kyoto University; University of Queensland; Dalhousie University; Duke University; University System of Georgia; Augusta University; Stellenbosch University; Lions Eye Institute; University of Western Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Shanghai Jiao Tong University; Xinjiang Medical University; Tan Tock Seng Hospital; University of Erlangen Nuremberg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Bonn; University of Bonn; University of Basel; University of Basel; University of Duisburg Essen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National University of Singapore; University of Melbourne; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Wayne State University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; University of Copenhagen; University of Copenhagen; University of Iowa; University of Iowa; Ruprecht Karls University Heidelberg; Manhattan Eye Ear & Throat Hospital; New York University; National Cancer Centre Singapore (NCCS); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Siena; University of Fukui; Johns Hopkins University; Johns Hopkins Medicine; New York Eye & Ear Infirmary of Mount Sinai	Aung, T (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	aung_tin@yahoo.co.uk; khorcc@gis.a-star.edu.sg	Kubota, Toshiaki/AAN-4334-2021; Astakhov, Sergei/ABF-8566-2020; Alward, Wallace/AAY-4149-2020; Fingert, John/AAX-4750-2021; Al Obeidan, Saleh/AAX-5361-2021; You, Qisheng/AAG-7153-2020; Mitchell, Paul/P-1498-2014; Akopov, Evgeny/AAM-4563-2021; Chatzikyriakidou, Anthoula/GMX-3038-2022; Blackwell, Jenefer M/H-3015-2015; wang, YA XING/K-9671-2016; Burdon, Kathryn/A-5026-2009; Zarnowski, Tomasz/AAM-6460-2020; Jankowski, Janusz/H-2706-2012; Leo, Paul/R-4464-2019; Brown, Matthew A/E-5749-2010; Reis, André/D-2309-2009; Akopov, Evgeny L/D-5474-2016; Kumar, Rajesh S/L-2018-2019; Bellenguez, Céline/X-4004-2019; Foo, Jia Nee/D-6069-2014; Schwab, Matthias/ABH-7449-2020; Williams, Susan Eileen Isabella/L-6725-2019; Palmer, Colin NA/C-7053-2008; Belllenguez, Céline/Y-3183-2018; Cheng, Ching-Yu/Y-2229-2019; Wong, Tien Yin/AAC-9724-2020; Wang, Jie Jin/P-1499-2014; Miyake, Masahiro/V-1261-2019; Yazdani, Shahin/AAW-5387-2020; Hewitt, Alex W/D-1936-2013; Deloukas, Panos/B-2922-2013; Yildirim, Nilgun/ABA-6534-2021; Hillmer, Axel M/N-2927-2014; wang, jie/GRS-0942-2022; Herms, Stefan/J-1949-2014; Burdon, Kathryn/AAD-2334-2022; Kanavi, Mozhgan Rezaei/AAX-9617-2020; Mackey, David A/H-5340-2014; .P, Sundaresan/AAR-8426-2021; Dubina, Michael/E-1888-2014; Fingert, John/F-8787-2012; Naderi Beni, Afsaneh/F-9350-2018	Astakhov, Sergei/0000-0003-0777-4861; Fingert, John/0000-0002-0377-0479; Al Obeidan, Saleh/0000-0002-0573-4017; You, Qisheng/0000-0003-0743-7320; Akopov, Evgeny/0000-0002-7827-1180; wang, YA XING/0000-0003-2749-7793; Burdon, Kathryn/0000-0001-8217-1249; Jankowski, Janusz/0000-0003-2130-9181; Brown, Matthew A/0000-0003-0538-8211; Reis, André/0000-0002-6301-6363; Bellenguez, Céline/0000-0002-1240-7874; Foo, Jia Nee/0000-0001-9899-2308; Williams, Susan Eileen Isabella/0000-0002-4479-8638; Palmer, Colin NA/0000-0002-6415-6560; Belllenguez, Céline/0000-0002-1240-7874; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Miyake, Masahiro/0000-0001-7410-3764; Hewitt, Alex W/0000-0002-5123-5999; Deloukas, Panos/0000-0001-9251-070X; Hillmer, Axel M/0000-0002-3381-7266; Herms, Stefan/0000-0002-2786-8200; Burdon, Kathryn/0000-0001-8217-1249; Kanavi, Mozhgan Rezaei/0000-0002-1497-2260; Mackey, David A/0000-0001-7914-4709; Dubina, Michael/0000-0002-6606-3309; Fingert, John/0000-0002-0377-0479; Nothen, Markus/0000-0002-8770-2464; Plomin, Robert/0000-0002-0756-3629; Moebus, Susanne/0000-0002-0072-5410; Toh, Kai Yee/0000-0001-9763-1762; Husain, Rahat/0000-0002-5234-9621; Alward, Wallace/0000-0001-6368-9018; Orr, Andrew/0000-0002-9388-9034; Lerner, Simon Fabian/0000-0002-4657-286X; Yazdani, Shahin/0000-0002-9583-1434; Perera, Shamira/0000-0002-1404-5096; Zarnowski, Tomasz/0000-0002-6978-7417; Ghosh, Arkasubhra/0000-0002-6570-5891; Lee, Mei Chin/0000-0001-7689-6446; Nakano, Satoko/0000-0003-4016-7676; Topouzis, Fotis/0000-0002-8966-537X; Naderi Beni, Afsaneh/0000-0003-2958-7805; Edkins, Sarah/0000-0003-0717-1972; Yamashiro, Kenji/0000-0001-9354-8558; Li, Zheng/0000-0002-7060-2213; Yaz, Yetkin/0000-0002-6425-7767; Yildirim, Nilgun/0000-0001-6266-4951; Schlottmann, Patricio/0000-0003-0196-0452; Khor, Chiea Chuen/0000-0002-1128-4729; Craig, Jamie/0000-0001-9955-9696; Sim, Kar Seng/0000-0002-3822-7759	Biomedical Research Council; Agency for Science, Technology and Research, Singapore; US National Institutes of Health/National Eye Institute grants [NIH/NEI R01 EY020928, NIH/NEI P30 EY014104]; US National Institutes of Health/National Eye Institute [EY11721, EY023512, EY018825]; Harvard Medical School Distinguished Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; National Natural Science Foundation of China [81025006, 81170883]; Department of Science and Technology of Sichuan Province, China [2012SZ0219, 2011jtd0020]; Robert Bosch Stiftung (Stuttgart, Germany); German Cancer Consortium (DKTK), Germany; Ophthalmic Research Institute of Australia; National Health and Medical Research Council (NHMRC) [535044]; European Union (European Social Fund); Greek national funds under act 'Aristia' of the operational program 'Education and Lifelong Learning'; Australian NHMRC Canberra, Australia; NHMRC project [512423, 475604, 529912]; Wellcome Trust, UK, Wellcome Trust Case Control Consortium 2;  [085475/B/08/Z];  [085475/08/Z]; NATIONAL EYE INSTITUTE [R29EY011721, R01EY013882, R01EY018825, P30EY014104, R01EY020928, R01EY011721, R01EY023512] Funding Source: NIH RePORTER	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health/National Eye Institute grants; US National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Harvard Medical School Distinguished Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province, China; Robert Bosch Stiftung (Stuttgart, Germany); German Cancer Consortium (DKTK), Germany; Ophthalmic Research Institute of Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds under act 'Aristia' of the operational program 'Education and Lifelong Learning'; Australian NHMRC Canberra, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK, Wellcome Trust Case Control Consortium 2; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank the staff and participants of all studies for their important contributions. We thank K.-K. Heng, X.-Y. Chen, H.-M. Soo, S.-Q. Mok, A. Jamuth, N. Foxworth and M. Elbl for technical assistance. This research was funded by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore. J.L.W. acknowledges support from US National Institutes of Health/National Eye Institute grants (NIH/NEI R01 EY020928 and NIH/NEI P30 EY014104). S.W.M.J. acknowledges support from grant EY11721 from the US National Institutes of Health/National Eye Institute and is an investigator of the Howard Hughes Medical Institute. L.R.P. acknowledges support from a Harvard Medical School Distinguished Ophthalmology Scholar Award and the Harvard Glaucoma Center of Excellence. J.H.F. acknowledges support from US National Institutes of Health/National Eye Institute grants (EY023512 and EY018825). Z.Y. acknowledges support from the National Natural Science Foundation of China (81025006 and 81170883), as well as from the Department of Science and Technology of Sichuan Province, China (2012SZ0219 and 2011jtd0020). M.S. acknowledges support from Robert Bosch Stiftung (Stuttgart, Germany) and the German Cancer Consortium (DKTK), Germany. The Australian case cohort was funded by grants from the Ophthalmic Research Institute of Australia and National Health and Medical Research Council (NHMRC) project 535044. The Thessaloniki Eye Study was cofunded by the European Union (European Social Fund) and Greek national funds under act 'Aristia' of the operational program 'Education and Lifelong Learning' (Supplementary Note). Blue Mountains Eye Study (BMES) GWAS and genotyping costs were supported by the Australian NHMRC Canberra, Australia; NHMRC project grants 512423, 475604 and 529912) and the Wellcome Trust, UK, as part of the Wellcome Trust Case Control Consortium 2 (A. Viswanathan, P. McGuffin, P. Mitchell, F. Topouzis, P. Foster; grants 085475/B/08/Z and 085475/08/Z). K.P.B. is an NHMRC Senior Research Fellow, and J.E.C. is an NHMRC Practitioner Fellow. M.A.B. is an NHMRC Principal Research Fellow. A.W.H. is an NHMRC Peter Doherty Fellow.	Aragon-Martin JA, 2008, MOL VIS, V14, P533; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Challa P, 2008, MOL VIS, V14, P146; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; Chen L, 2009, MOL VIS, V15, P2349; Fan BJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-5; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P2372, DOI 10.1167/iovs.10-6268; Fingert JH, 2007, AM J OPHTHALMOL, V144, P974, DOI 10.1016/j.ajo.2007.09.034; Hayashi H, 2008, AM J OPHTHALMOL, V145, P582, DOI 10.1016/j.ajo.2007.10.023; Hewitt AW, 2008, HUM MOL GENET, V17, P710, DOI 10.1093/hmg/ddm342; Krumbiegel M, 2011, EUR J HUM GENET, V19, P186, DOI 10.1038/ejhg.2010.144; Lee MC, 2014, INVEST OPHTH VIS SCI, V55, P3833, DOI 10.1167/iovs.14-14145; Lemmela S, 2009, J HUM GENET, V54, P289, DOI 10.1038/jhg.2009.28; Mori K, 2008, MOL VIS, V14, P1037; Mossbock G, 2008, MOL VIS, V14, P857; Nakano M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05340; Ozaki M, 2008, INVEST OPHTH VIS SCI, V49, P3976, DOI 10.1167/iovs.08-1805; Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P1459, DOI 10.1167/iovs.07-1449; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ramprasad VL, 2008, MOL VIS, V14, P318; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Schlotzer-Schrehardt U, 2001, CURR EYE RES, V22, P154, DOI 10.1076/ceyr.22.2.154.5522; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tsou WL, 2011, NEUROBIOL DIS, V43, P533, DOI 10.1016/j.nbd.2011.04.016; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams SEI, 2010, MOL VIS, V16, P705; Wolf C, 2010, J GLAUCOMA, V19, P136, DOI 10.1097/IJG.0b013e31819f9330; Yang X, 2008, CELL CYCLE, V7, P521, DOI 10.4161/cc.7.4.5388	34	64	69	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					387	U145		10.1038/ng.3226	http://dx.doi.org/10.1038/ng.3226			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25706626	Green Accepted, Green Submitted			2022-12-25	WOS:000351922900015
J	Bellot, M; Galandrin, S; Boularan, C; Matthies, HJ; Despas, F; Denis, C; Javitch, J; Mazeres, S; Sanni, SJ; Pons, V; Seguelas, MH; Hansen, JL; Pathak, A; Galli, A; Senard, JM; Gales, C				Bellot, Morgane; Galandrin, Segolene; Boularan, Cedric; Matthies, Heinrich J.; Despas, Fabien; Denis, Colette; Javitch, Jonathan; Mazeres, Serge; Sanni, Samra Joke; Pons, Veronique; Seguelas, Marie-Helene; Hansen, Jakob L.; Pathak, Atul; Galli, Aurelio; Senard, Jean-Michel; Gales, Celine			Dual agonist occupancy of AT(1)-R-alpha(2C)-AR heterodimers results in atypical G(s)-PKA signaling	NATURE CHEMICAL BIOLOGY			English	Article							SYMPATHETIC-NERVE ACTIVITY; ANGIOTENSIN-II; NORADRENALINE RELEASE; RECEPTOR DIMERS; IN-VIVO; PROTEIN; ACTIVATION; REVEALS; HETEROMERIZATION; MODULATION	Hypersecretion of norepinephrine (NE) and angiotensin II (AngII) is a hallmark of major prevalent cardiovascular diseases that contribute to cardiac pathophysiology and morbidity. Herein, we explore whether heterodimerization of presynaptic AngII AT(1) receptor (AT1-R) and NE alpha(2C)-adrenergic receptor (alpha(2C)-AR) could underlie their functional cross-talk to control NE secretion. Multiple bioluminescence resonance energy transfer and protein complementation assays allowed us to accurately probe the structures and functions of the alpha(2C)-AR-AT1-R dimer promoted by ligand binding to individual protomers. We found that dual agonist occupancy resulted in a conformation of the heterodimer different from that induced by active individual protomers and triggered atypical G(s)-cAMP-PKA signaling. This specific pharmacological signaling unit was identified in vivo to promote not only NE hypersecretion in sympathetic neurons but also sympathetic hyperactivity in mice. Thus, we uncovered a new process by which GPCR heterodimerization creates an original functional pharmacological entity and that could constitute a promising new target in cardiovascular therapeutics.	[Bellot, Morgane; Galandrin, Segolene; Boularan, Cedric; Despas, Fabien; Denis, Colette; Pons, Veronique; Seguelas, Marie-Helene; Pathak, Atul; Senard, Jean-Michel; Gales, Celine] Univ Toulouse 3, INSERM, U1048, Inst Malad Metab & Cardiovasc, F-31062 Toulouse, France; [Matthies, Heinrich J.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Matthies, Heinrich J.; Galli, Aurelio] Vanderbilt Univ, Sch Med, Neurosci Program Subst Abuse, Nashville, TN 37212 USA; [Despas, Fabien; Pathak, Atul; Senard, Jean-Michel] Ctr Hosp Univ Toulouse, Fac Med, Serv Pharmacol Clin, Toulouse, France; [Javitch, Jonathan] Columbia Univ, Ctr Mol Recognit, New York, NY USA; [Javitch, Jonathan] Columbia Univ, Dept Psychiat, New York, NY USA; [Javitch, Jonathan] Columbia Univ, Dept Pharmacol, New York, NY USA; [Javitch, Jonathan] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Javitch, Jonathan] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Mazeres, Serge] Univ Toulouse 3, CNRS, UMR 508, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Sanni, Samra Joke] Glostrup Cty Hosp, Dept Clin Biochem, Glostrup, Denmark; [Sanni, Samra Joke; Hansen, Jakob L.] Novo Nordisk, Diabet Biol & Metab, Malov, Denmark; [Galli, Aurelio] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Galli, Aurelio] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Vanderbilt University; Vanderbilt University; CHU de Toulouse; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Novo Nordisk; Vanderbilt University; Vanderbilt University	Gales, C (corresponding author), Univ Toulouse 3, INSERM, U1048, Inst Malad Metab & Cardiovasc, F-31062 Toulouse, France.	celine.gales@inserm.fr	Denis, Colette/U-5267-2017; Pathak, Atul/ABC-5223-2020; Matthies, Heinrich/B-7284-2017; Matthies, Heinrich/AAD-2375-2019; Denis, Colette/K-1571-2019; soler, martha maricel m gomez/L-6025-2014	Pathak, Atul/0000-0001-6151-0096; Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Denis, Colette/0000-0002-8376-8351; soler, martha maricel m gomez/0000-0002-4412-8108; PONS, Veronique/0000-0001-5821-8481; MAZERES, Serge/0000-0002-0263-634X; Senard, Jean-Michel/0000-0001-7679-1281; Javitch, Jonathan/0000-0001-7395-2967; GALES, Celine/0000-0002-4938-1583; Sanni, Samra/0000-0002-9708-5674	Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; La Societe Francaise d'Hypertension Arterielle; Fondation Bettencourt Schueller; US National Institutes of Health grant [DA038058-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R01DA038058] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Societe Francaise d'Hypertension Arterielle; Fondation Bettencourt Schueller; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	M. B. was supported by a doctoral fellow fellowship from the Fondation pour la Recherche Medicale. J.- M. S. and C. G. are supported by the Institut National de la Sante et de la Recherche Medicale and by grants from La Societe Francaise d'Hypertension Arterielle and the Fondation Bettencourt Schueller. H.J.M. was supported by a US National Institutes of Health grant (grant number DA038058-01).	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; COSTA M, 1988, BRIT J PHARMACOL, V95, P993, DOI 10.1111/j.1476-5381.1988.tb11730.x; Cox SL, 2000, BRIT J PHARMACOL, V129, P1095, DOI 10.1038/sj.bjp.0703167; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Esler M, 2003, ACTA PHYSIOL SCAND, V177, P275, DOI 10.1046/j.1365-201X.2003.01089.x; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kubista H, 2006, PHARMACOL THERAPEUT, V112, P213, DOI 10.1016/j.pharmthera.2006.04.005; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Ma XY, 2001, J HYPERTENS, V19, P609, DOI 10.1097/00004872-200103001-00014; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Paulis L, 2010, NAT REV CARDIOL, V7, P431, DOI 10.1038/nrcardio.2010.85; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; RUMP LC, 1995, HYPERTENSION, V26, P445, DOI 10.1161/01.HYP.26.3.445; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; SENARD JM, 1989, EUR J PHARMACOL, V162, P225, DOI 10.1016/0014-2999(89)90285-9; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Talaia C, 2006, NEUROCHEM INT, V49, P698, DOI 10.1016/j.neuint.2006.07.002; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	49	75	78	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					271	U56		10.1038/NCHEMBIO.1766	http://dx.doi.org/10.1038/NCHEMBIO.1766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25706338	Green Accepted			2022-12-25	WOS:000351666500010
J	Dow, LE; Fisher, J; O'Rourke, KP; Muley, A; Kastenhuber, ER; Livshits, G; Tschaharganeh, DF; Socci, ND; Lowe, SW				Dow, Lukas E.; Fisher, Jonathan; O'Rourke, Kevin P.; Muley, Ashlesha; Kastenhuber, Edward R.; Livshits, Geulah; Tschaharganeh, Darjus F.; Socci, Nicholas D.; Lowe, Scott W.			Inducible in vivo genome editing with CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; MICE; GENE; SYSTEM; CANCER; MOUSE; CELLS; CAS9; DIFFERENTIATION; TRANSCRIPTION	CRISPR-Cas9-based genome editing enables the rapid genetic manipulation of any genomic locus without the need for gene targeting by homologous recombination. Here we describe a conditional transgenic approach that allows temporal control of CRISPR-Cas9 activity for inducible genome editing in adult mice. We show that doxycycline-regulated Cas9 induction enables widespread gene disruption in multiple tissues and that limiting the duration of Cas9 expression or using a Cas9(D10A) (Cas9n) variant can regulate the frequency and size of target gene modifications, respectively. Further, we show that this inducible CRISPR (iCRISPR) system can be used effectively to create biallelic mutation in multiple target loci and, thus, provides a flexible and fast platform to study loss-of-function phenotypes in vivo.	[Dow, Lukas E.; Fisher, Jonathan; O'Rourke, Kevin P.; Kastenhuber, Edward R.; Livshits, Geulah; Tschaharganeh, Darjus F.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Dow, Lukas E.; Muley, Ashlesha] Weill Cornell Med Coll, Dept Med, Hematol Med Oncol Div, New York, NY USA; [O'Rourke, Kevin P.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Kastenhuber, Edward R.] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Facil, New York, NY 10021 USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Dow, LE (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	lud2005@med.cornell.edu; lowes@mskcc.org		Kastenhuber, Edward/0000-0002-1872-212X; Dow, Lukas/0000-0001-7048-1418	National Cancer Institute (NCI) [CA-013106]; NCI/ National Institutes of Health (NIH) [1K22CA181280-01]; National Institute of General Medical Sciences of the NIH [T32GM07739]; American Cancer Society postdoctoral fellowship [PF-13-037-01]; NIH F32 grant [1F32CA177072-01]; NATIONAL CANCER INSTITUTE [F31CA192835, R01CA195787, P01CA013106, F32CA177072, P30CA008748, P01CA087497, K22CA181280, P01CA129243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI/ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society postdoctoral fellowship(American Cancer Society); NIH F32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Simon for technical assistance with animal colonies, and other members of the Lowe laboratory for advice and discussions. We thank the MSKCC transgenic core facility for production of transgenic animals by blastocyst injection and the MSKCC Genomics core facility for library preparation and Illumina sequencing. This work was supported by a program project grant number CA-013106 from the National Cancer Institute (NCI). L.E.D. was supported by a K22 Career Development Award from the NCI/ National Institutes of Health (NIH) under award number 1K22CA181280-01. K.P.O'R. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. G.L. was supported by an American Cancer Society postdoctoral fellowship PF-13-037-01 and NIH F32 grant 1F32CA177072-01. S.W.L. is an investigator of the Howard Hughes Medical Institute and the Geoffrey Beene Chair for Cancer Biology.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	25	330	359	5	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					390	U98		10.1038/nbt.3155	http://dx.doi.org/10.1038/nbt.3155			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25690852	Green Accepted			2022-12-25	WOS:000352348500025
J	Kourtis, N; Moubarak, RS; Aranda-Orgilles, B; Lui, K; Aydin, IT; Trimarchi, T; Darvishian, F; Salvaggio, C; Zhong, J; Bhatt, K; Chen, EI; Celebi, JT; Lazaris, C; Tsirigos, A; Osman, I; Hernando, E; Aifantis, I				Kourtis, Nikos; Moubarak, Rana S.; Aranda-Orgilles, Beatriz; Lui, Kevin; Aydin, Iraz T.; Trimarchi, Thomas; Darvishian, Farbod; Salvaggio, Christine; Zhong, Judy; Bhatt, Kamala; Chen, Emily I.; Celebi, Julide T.; Lazaris, Charalampos; Tsirigos, Aristotelis; Osman, Iman; Hernando, Eva; Aifantis, Iannis			FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification	NATURE CELL BIOLOGY			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; SYNTHASE KINASE 3-BETA; NON-ONCOGENE ADDICTION; F-BOX PROTEINS; TUMOR-SUPPRESSOR; BREAST-CANCER; MOLECULAR CHAPERONES; GENE-EXPRESSION; POOR-PROGNOSIS	Heat-shock factor 1 (HSF1) orchestrates the heat-shock response in eukaryotes. Although this pathway has evolved to help cells adapt in the presence of challenging conditions, it is co-opted in cancer to support malignancy. However, the mechanisms that regulate HSF1 and thus cellular stress response are poorly understood. Here we show that the ubiquitin ligase FBXW7 alpha interacts with HSF1 through a conserved motif phosphorylated by GSK3 beta and ERK1. FBXW7 alpha ubiquitylates HSF1 and loss of FBXW7 alpha results in impaired degradation of nuclear HSF1 and defective heat-shock response attenuation. FBXW7 alpha is either mutated or transcriptionally downregulated in melanoma and HSF1 nuclear stabilization correlates with increased metastatic potential and disease progression. FBXW7 alpha deficiency and subsequent HSF1 accumulation activates an invasion-supportive transcriptional program and enhances the metastatic potential of human melanoma cells. These findings identify a post-translational mechanism of regulation of the HSF1 transcriptional program both in the presence of exogenous stress and in cancer.	[Kourtis, Nikos; Aranda-Orgilles, Beatriz; Trimarchi, Thomas; Bhatt, Kamala; Lazaris, Charalampos; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Kourtis, Nikos; Aranda-Orgilles, Beatriz; Trimarchi, Thomas; Bhatt, Kamala; Lazaris, Charalampos; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Kourtis, Nikos; Aranda-Orgilles, Beatriz; Trimarchi, Thomas; Bhatt, Kamala; Lazaris, Charalampos; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Kourtis, Nikos; Aranda-Orgilles, Beatriz; Trimarchi, Thomas; Bhatt, Kamala; Lazaris, Charalampos; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Moubarak, Rana S.; Darvishian, Farbod; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Moubarak, Rana S.; Lui, Kevin; Darvishian, Farbod; Salvaggio, Christine; Zhong, Judy; Osman, Iman; Hernando, Eva] NYU, Inst Canc, Interdisciplinary Melanoma Cooperat Grp, New York, NY 10016 USA; [Lui, Kevin; Salvaggio, Christine; Osman, Iman] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Aydin, Iraz T.; Celebi, Julide T.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Aydin, Iraz T.; Celebi, Julide T.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Zhong, Judy] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Zhong, Judy] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Chen, Emily I.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pharmacol, New York, NY 10032 USA; [Lazaris, Charalampos; Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; New York University; Columbia University; New York University	Osman, I (corresponding author), NYU, Inst Canc, Interdisciplinary Melanoma Cooperat Grp, New York, NY 10016 USA.	Iman.Osman@nyumc.org; Eva.Hernando-Monge@nyumc.org; Iannis.aifantis@nyumc.org	Lazaris, Charalampos/J-9230-2015; zhong, Judy/ABE-8314-2020	Lazaris, Charalampos/0000-0002-7345-8288; Zhong, Judy/0000-0002-2163-8447; Hernando, Eva/0000-0003-1023-0312; Aydin, Iraz Toprak/0000-0001-9608-8577; Moubarak, Rana/0000-0003-2096-1258; Tsirigos, Aristotelis/0000-0002-7512-8477	National Institutes of Health [1R01CA169784-02, 1R01CA133379-06, 1R01CA105129-08, 1R01CA149655-04, 5R01CA173636-03, 1R24OD018339-01]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; NYSTEM grant [CO28130]; NIH/NCI [1R01CA155234, 1R01CA163891-01A1]; Department of Defense (DOD) Collaborative Award [CA093471]; Deutsche Jose Carreras Leukaemie Stiftung; European Molecular Biology Organization (EMBO) Long Term Fellowship; Human Frontiers Science Program (HFSP) Long Term Fellowship; NATIONAL CANCER INSTITUTE [R01CA149655, R01CA133379, R01CA173636, R01CA155234, P30CA016087, R01CA169784, R01CA105129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM110450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; NYSTEM grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense (DOD) Collaborative Award; Deutsche Jose Carreras Leukaemie Stiftung; European Molecular Biology Organization (EMBO) Long Term Fellowship; Human Frontiers Science Program (HFSP) Long Term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the members of the Aifantis laboratory for helpful discussions, B. Vogelstein (Johns Hopkins University, USA) for the HCT116 cell lines and M. Pagano (New York University School of Medicine, USA) and L. Busino (University of Pennsylvania, USA) for helpful discussions and for plasmids. The Aifantis laboratory is supported by the National Institutes of Health (1R01CA169784-02, 1R01CA133379-06, 1R01CA105129-08, 1R01CA149655-04, 5R01CA173636-03, 1R24OD018339-01), the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society (TRP no. 6340-11, LLS no. 6373-13), The Chemotherapy Foundation, The V Foundation for Cancer Research, Alex's Lemonade Stand Foundation for Childhood Cancer and St. Baldrick's Cancer Research Foundation. FBXW7 work has also been supported by a NYSTEM grant (CO28130). The Hernando Laboratory is supported by the NIH/NCI (1R01CA155234, 1R01CA163891-01A1) and the Department of Defense (DOD) Collaborative Award (CA093471). B.A-O. is supported by Deutsche Jose Carreras Leukaemie Stiftung. N.K. is supported by a European Molecular Biology Organization (EMBO) Long Term Fellowship and a Human Frontiers Science Program (HFSP) Long Term Fellowship. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Cheng YB, 2013, J INVEST DERMATOL, V133, P1794, DOI 10.1038/jid.2013.58; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2012, J CLIN INVEST, V122, P3742, DOI 10.1172/JCI62727; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Hagedorn M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-9; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu YZ, 2011, J BIOL CHEM, V286, P31397, DOI 10.1074/jbc.M111.255851; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tsirigos A, 2012, BIOINFORMATICS, V28, P282, DOI 10.1093/bioinformatics/btr646; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang LX, 2014, ONCOTARGET, V5, P2000, DOI 10.18632/oncotarget.1859; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang YL, 2013, BIOCHEM BIOPH RES CO, V434, P352, DOI 10.1016/j.bbrc.2013.03.077; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	67	80	82	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					322	+		10.1038/ncb3121	http://dx.doi.org/10.1038/ncb3121			50	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25720964	Green Accepted			2022-12-25	WOS:000350770200016
J	Medina, DL; Di Paola, S; Peluso, I; Armani, A; De Stefani, D; Venditti, R; Montefusco, S; Scotto-Rosato, A; Prezioso, C; Forrester, A; Settembre, C; Wang, WY; Gao, Q; Xu, HX; Sandri, M; Rizzuto, R; De Matteis, MA; Ballabio, A				Medina, Diego L.; Di Paola, Simone; Peluso, Ivana; Armani, Andrea; De Stefani, Diego; Venditti, Rossella; Montefusco, Sandro; Scotto-Rosato, Anna; Prezioso, Carolina; Forrester, Alison; Settembre, Carmine; Wang, Wuyang; Gao, Qiong; Xu, Haoxing; Sandri, Marco; Rizzuto, Rosario; De Matteis, Maria Antonietta; Ballabio, Andrea			Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB	NATURE CELL BIOLOGY			English	Article							MUCOLIPIDOSIS TYPE-IV; CELLULAR CLEARANCE; SKELETAL-MUSCLE; MENDELIAN-INHERITANCE; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; ACIDIC ORGANELLES; GENE-EXPRESSION; AMINO-ACIDS; TRP CHANNEL	The view of the lysosome as the terminal end of cellular catabolic pathways has been challenged by recent studies showing a central role of this organelle in the control of cell function. Here we show that a lysosomal Ca2+ signalling mechanism controls the activities of the phosphatase calcineurin and of its substrate TFEB, a master transcriptional regulator of lysosomal biogenesis and autophagy. Lysosomal Ca2+ release through mucolipin 1 (MCOLN1) activates calcineurin, which binds and dephosphorylates TFEB, thus promoting its nuclear translocation. Genetic and pharmacological inhibition of calcineurin suppressed TFEB activity during starvation and physical exercise, while calcineurin overexpression and constitutive activation had the opposite effect. Induction of autophagy and lysosomal biogenesis through TFEB required MCOLN1-mediated calcineurin activation. These data link lysosomal calcium signalling to both calcineurin regulation and autophagy induction and identify the lysosome as a hub for the signalling pathways that regulate cellular homeostasis.	[Medina, Diego L.; Di Paola, Simone; Peluso, Ivana; Venditti, Rossella; Montefusco, Sandro; Scotto-Rosato, Anna; Prezioso, Carolina; Forrester, Alison; Settembre, Carmine; Sandri, Marco; De Matteis, Maria Antonietta; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, I-80078 Naples, Italy; [Armani, Andrea; De Stefani, Diego; Sandri, Marco; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [De Stefani, Diego; Rizzuto, Rosario] CNR, Inst Neurosci, I-35121 Padua, Italy; [Settembre, Carmine] Dulbecco Telethon Inst TIGEM, I-80078 Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Univ Naples Federico II, Dept Translat Med, Med Genet, I-80131 Naples, Italy; [Wang, Wuyang; Gao, Qiong; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ballabio, Andrea] Texas Children Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Michigan System; University of Michigan; Baylor College of Medicine	Medina, DL (corresponding author), Telethon Inst Genet & Med TIGEM, Via Campi Flegrei 34, I-80078 Naples, Italy.	medina@tigem.it; ballabio@tigem.it	Forrester, Alison Ruth/ABC-2636-2021; De Matteis, Maria Antonietta/AHE-5161-2022; Rosato, Anna Scotto/AAC-5919-2020; Medina, Diego/AAC-9622-2020; De Stefani, Diego/I-7715-2015; Venditti, Rossella/AAT-4281-2020; Di Paola, Simone/GYU-0514-2022; BALLABIO, Andrea/AAL-2672-2020; xu, hao/GWQ-7394-2022; Settembre, Carmine/AIA-9170-2022	Forrester, Alison Ruth/0000-0003-3352-9173; De Matteis, Maria Antonietta/0000-0003-0053-3061; Medina, Diego/0000-0002-7347-2645; De Stefani, Diego/0000-0003-3796-8907; Venditti, Rossella/0000-0002-1884-6501; Di Paola, Simone/0000-0003-3753-5722; BALLABIO, Andrea/0000-0003-1381-4604; SETTEMBRE, Carmine/0000-0002-5829-8589; Armani, Andrea/0000-0002-4765-9748; Wang, Wuyang/0000-0003-1875-5463; Scotto Rosato, Anna/0000-0002-1358-299X; Rizzuto, Rosario/0000-0001-7044-5097; Gao, Qiong/0000-0002-5281-7392	Italian Telethon Foundation [TGM11CB6]; Beyond Batten Disease Foundation; European Research Council Advanced Investigator grant [250154 (CLEAR)]; US National Institutes of Health [R01-NS078072]; Telethon-Italy [TCP04009]; European Research Council Consolidator grant [282310-(MyoPHAGY)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078072] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); Beyond Batten Disease Foundation; European Research Council Advanced Investigator grant(European Research Council (ERC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon-Italy(Fondazione Telethon); European Research Council Consolidator grant(European Research Council (ERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Meldolesi, T. Pozzan, D. Rubinsztein and R. Polishchuk for helpful suggestions and critical review of the manuscript. We thank G. Diez-Roux and A. Burton for their support in manuscript preparation. We are also grateful to R. De Cegli and D. Carrella for their support in the statistical analysis of the results. The TIGEM Bioinformatic and High Content Screening Facilities are gratefully acknowledged for their technological contributions to the project. We also thank J. D. Molkentin for the CanB KO MEFs, B. A. Rothermel for the HA Delta CnA, and P. Aza-Blanc for suggestions on the reverse transfection protocol. We acknowledge the support of the Italian Telethon Foundation grant numbers TGM11CB6 (A.B.); the Beyond Batten Disease Foundation (A. B.); European Research Council Advanced Investigator grant no. 250154 (CLEAR) (A.B.); US National Institutes of Health (R01-NS078072) (A.B.); Telethon-Italy (TCP04009) (M.S.), European Research Council Consolidator grant no. 282310-(MyoPHAGY) (M.S.).	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Granatiero Veronica, 2014, Cold Spring Harb Protoc, V2014, P9, DOI 10.1101/pdb.top066118; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heineke J, 2012, J MOL CELL CARDIOL, V52, P62, DOI 10.1016/j.yjmcc.2011.10.018; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martina JA, 2013, AUTOPHAGY, V9, P928, DOI 10.4161/auto.24371; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pattni K, 2001, CURR BIOL, V11, P1636, DOI 10.1016/S0960-9822(01)00486-9; Plyte S, 2001, J BIOL CHEM, V276, P14350, DOI 10.1074/jbc.M007854200; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	64	732	755	12	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					288	+		10.1038/ncb3114	http://dx.doi.org/10.1038/ncb3114			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25720963	Green Accepted			2022-12-25	WOS:000350770200013
J	Shlien, A; Campbell, BB; de Borja, R; Alexandrov, LB; Merico, D; Wedge, D; Van Loo, P; Tarpey, PS; Coupland, P; Behjati, S; Pollett, A; Lipman, T; Heidari, A; Deshmukh, S; Avitzur, N; Meier, B; Gerstung, M; Hong, Y; Merino, DM; Ramakrishna, M; Remke, M; Arnold, R; Panigrahi, GB; Thakkar, NP; Hodel, KP; Henninger, EE; Goksenin, AY; Bakry, D; Charames, GS; Druker, H; Lerner-Ellis, J; Mistry, M; Dvir, R; Grant, R; Elhasid, R; Farah, R; Taylor, GP; Nathan, PC; Alexander, S; Ben-Shachar, S; Ling, SC; Gallinger, S; Constantini, S; Dirks, P; Huang, A; Scherer, SW; Grundy, RG; Durno, C; Aronson, M; Gartner, A; Meyn, MS; Taylor, MD; Pursell, ZF; Pearson, CE; Malkin, D; Futreal, PA; Stratton, MR; Bouffet, E; Hawkins, C; Campbell, PJ; Tabori, U				Shlien, Adam; Campbell, Brittany B.; de Borja, Richard; Alexandrov, Ludmil B.; Merico, Daniele; Wedge, David; Van Loo, Peter; Tarpey, Patrick S.; Coupland, Paul; Behjati, Sam; Pollett, Aaron; Lipman, Tatiana; Heidari, Abolfazl; Deshmukh, Shriya; Avitzur, Na'ama; Meier, Bettina; Gerstung, Moritz; Hong, Ye; Merino, Diana M.; Ramakrishna, Manasa; Remke, Marc; Arnold, Roland; Panigrahi, Gagan B.; Thakkar, Neha P.; Hodel, Karl P.; Henninger, Erin E.; Goeksenin, A. Yasemin; Bakry, Doua; Charames, George S.; Druker, Harriet; Lerner-Ellis, Jordan; Mistry, Matthew; Dvir, Rina; Grant, Ronald; Elhasid, Ronit; Farah, Roula; Taylor, Glenn P.; Nathan, Paul C.; Alexander, Sarah; Ben-Shachar, Shay; Ling, Simon C.; Gallinger, Steven; Constantini, Shlomi; Dirks, Peter; Huang, Annie; Scherer, Stephen W.; Grundy, Richard G.; Durno, Carol; Aronson, Melyssa; Gartner, Anton; Meyn, M. Stephen; Taylor, Michael D.; Pursell, Zachary F.; Pearson, Christopher E.; Malkin, David; Futreal, P. Andrew; Stratton, Michael R.; Bouffet, Eric; Hawkins, Cynthia; Campbell, Peter J.; Tabori, Uri		Biallelic Mismatch Repair	Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers	NATURE GENETICS			English	Article							DNA-POLYMERASE EPSILON; SEQUENCING DATA; ACTIVE-SITE; HUMAN COLON; FIDELITY; INSTABILITY; ALIGNMENT; TISSUES; FORK	DNA replication-associated mutations are repaired by two components: polymerase proofreading and mismatch repair. The mutation consequences of disruption to both repair components in humans are not well studied. We sequenced cancer genomes from children with inherited biallelic mismatch repair deficiency (bMMRD). High-grade bMMRD brain tumors exhibited massive numbers of substitution mutations (>250/Mb), which was greater than all childhood and most cancers (>7,000 analyzed). All ultra-hypermutated bMMRD cancers acquired early somatic driver mutations in DNA polymerase epsilon or delta. The ensuing mutation signatures and numbers are unique and diagnostic of childhood germ-line bMMRD (P < 10(-13)). Sequential tumor biopsy analysis revealed that bMMRD/polymerase-mutant cancers rapidly amass an excess of simultaneous mutations (similar to 600 mutations/cell division), reaching but not exceeding similar to 20,000 exonic mutations in <6 months. This implies a threshold compatible with cancer-cell survival. We suggest a new mechanism of cancer progression in which mutations develop in a rapid burst after ablation of replication repair.	[Shlien, Adam; Campbell, Brittany B.; de Borja, Richard; Merico, Daniele; Lipman, Tatiana; Heidari, Abolfazl; Deshmukh, Shriya; Avitzur, Na'ama; Merino, Diana M.; Arnold, Roland; Panigrahi, Gagan B.; Thakkar, Neha P.; Mistry, Matthew; Scherer, Stephen W.; Meyn, M. Stephen; Pearson, Christopher E.; Malkin, David; Tabori, Uri] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Shlien, Adam] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Shlien, Adam; Charames, George S.; Lerner-Ellis, Jordan; Hawkins, Cynthia] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Campbell, Brittany B.; Lipman, Tatiana; Heidari, Abolfazl; Deshmukh, Shriya; Avitzur, Na'ama; Remke, Marc; Mistry, Matthew; Dirks, Peter; Huang, Annie; Taylor, Michael D.; Bouffet, Eric; Hawkins, Cynthia; Tabori, Uri] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Campbell, Brittany B.; Mistry, Matthew] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Alexandrov, Ludmil B.; Wedge, David; Van Loo, Peter; Tarpey, Patrick S.; Behjati, Sam; Gerstung, Moritz; Ramakrishna, Manasa; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Merico, Daniele; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Van Loo, Peter] Univ Leuven, Dept Human Genet, Leuven, Belgium; [Coupland, Paul] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Pollett, Aaron; Charames, George S.; Lerner-Ellis, Jordan] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Meier, Bettina; Hong, Ye; Gartner, Anton] Univ Dundee, Ctr Gene Regulat & Express, Dundee, Scotland; [Thakkar, Neha P.; Druker, Harriet; Scherer, Stephen W.; Meyn, M. Stephen; Pearson, Christopher E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hodel, Karl P.; Henninger, Erin E.; Goeksenin, A. Yasemin; Pursell, Zachary F.] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Bakry, Doua; Druker, Harriet; Grant, Ronald; Nathan, Paul C.; Alexander, Sarah; Huang, Annie; Malkin, David; Bouffet, Eric; Tabori, Uri] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Bakry, Doua; Grant, Ronald; Nathan, Paul C.; Alexander, Sarah; Ling, Simon C.; Huang, Annie; Meyn, M. Stephen; Malkin, David; Bouffet, Eric; Tabori, Uri] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Lerner-Ellis, Jordan] Ontario Inst Canc Res, Toronto, ON, Canada; [Dvir, Rina; Elhasid, Ronit] Tel Aviv Med Ctr & Sch Med, Dept Pediat Hematooncol, Tel Aviv, Israel; [Farah, Roula] St George Hosp Univ Med Ctr, Beirut, Lebanon; [Taylor, Glenn P.; Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Ben-Shachar, Shay] Tel Aviv Med Ctr & Sch Med, Gilbert Israeli Neurofibromatosis Ctr, Tel Aviv, Israel; [Ling, Simon C.; Durno, Carol] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Gallinger, Steven; Durno, Carol; Aronson, Melyssa] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Familial Gastrointestinal Canc Registry, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada; [Constantini, Shlomi] Tel Aviv Med Ctr & Sch Med, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-64239 Tel Aviv, Israel; [Dirks, Peter; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Grundy, Richard G.] Univ Nottingham, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Meyn, M. Stephen] Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); KU Leuven; Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Dundee; University of Toronto; Tulane University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Tel Aviv University; Sackler Faculty of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Tel Aviv University; Sackler Faculty of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Nottingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge	Shlien, A (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	adam.shlien@sickkids.ca; pc8@sanger.ac.uk; uri.tabori@sickkids.ca	Alexandrov, Ludmil/AAS-1454-2021; Charames, George/J-2328-2016; Bouffet, Eric/AAB-8999-2020; Pollett, Aaron/AAQ-2540-2021; Wedge, David/AAC-4977-2021; Arnold, Roland/AAC-5256-2022; Hawkins, Cynthia/M-2571-2019; Gallinger, Steven/E-4575-2013; Malkin, David/AAW-8715-2021; Lerner-Ellis, Jordan/J-5559-2016; Nathan, Paul/GRR-2377-2022; Pollett, Aaron/J-2308-2016; Scherer, Stephen W./B-3785-2013; FARAH, Roula/AAL-8893-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Charames, George/0000-0002-5937-9276; Pollett, Aaron/0000-0001-5121-8788; Arnold, Roland/0000-0002-7496-7578; Pollett, Aaron/0000-0001-5121-8788; Scherer, Stephen W./0000-0002-8326-1999; FARAH, Roula/0000-0002-6392-1590; Merico, Daniele/0000-0002-3728-4401; Meyn, M Stephen/0000-0001-6444-2607; Coupland, Paul/0000-0002-2871-3374; Van Loo, Peter/0000-0003-0292-1949; Nathan, Paul/0000-0003-0334-0871; Ling, Simon/0000-0002-4223-4601; Wedge, David/0000-0002-7572-3196; Pursell, Zachary/0000-0001-5871-7192; Pearson, Christopher/0000-0001-9545-4205; Goksenin, Alexandra Yasemin/0000-0002-1120-1356; Meier, Bettina/0000-0002-9227-6519; Gartner, Anton/0000-0003-4639-9902; Taylor, Michael/0000-0001-7009-3466; Remke, Marc/0000-0002-9404-9993; Gerstung, Moritz/0000-0001-6709-963X	BRAINchild Canada; Canadian Institute of Health Research [MOP123268, FRN131596]; Wellcome Trust Senior Clinical and Basic Research Fellowships; Wellcome Trust Research Training Fellowship; SickKids Restracomp award; Cancer Research UK [21145] Funding Source: researchfish	BRAINchild Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust Senior Clinical and Basic Research Fellowships; Wellcome Trust Research Training Fellowship(Wellcome Trust); SickKids Restracomp award; Cancer Research UK(Cancer Research UK)	U.T. received funding from BRAINchild Canada and the Canadian Institute of Health Research (operating grant MOP123268). C.E.P. received funding from the Canadian Institute of Health Research (operating grant FRN131596). P.J.C. and A.G. are personally funded through Wellcome Trust Senior Clinical and Basic Research Fellowships and are members of the Wellcome-funded COMSIG consortium. S.B. is funded through a Wellcome Trust Research Training Fellowship for Clinicians. B.B.C., M.M. and R.A. are supported by a SickKids Restracomp award. We acknowledge J. Costello for his contribution to the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bakry D, 2014, EUR J CANCER, V50, P987, DOI 10.1016/j.ejca.2013.12.005; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Durno CA, 2012, PEDIATR BLOOD CANCER, V59, P652, DOI 10.1002/pbc.24019; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghodgaonkar MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5990; Henninger EE, 2014, IUBMB LIFE, V66, P339, DOI 10.1002/iub.1276; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Korona DA, 2011, NUCLEIC ACIDS RES, V39, P1763, DOI 10.1093/nar/gkq1034; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Lujan SA, 2014, GENOME RES, V24, P1751, DOI 10.1101/gr.178335.114; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikolaev SI, 2012, CANCER RES, V72, P6279, DOI 10.1158/0008-5472.CAN-12-3869; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Schmitt MW, 2010, J BIOL CHEM, V285, P32264, DOI 10.1074/jbc.M110.147017; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tome S, 2013, DNA REPAIR, V12, P46, DOI 10.1016/j.dnarep.2012.10.006; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938	29	229	232	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					257	+		10.1038/ng.3202	http://dx.doi.org/10.1038/ng.3202			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25642631				2022-12-25	WOS:000350327900017
J	Zuo, WL; Chao, Q; Zhang, N; Ye, JR; Tan, GQ; Li, BL; Xing, YX; Zhang, BQ; Liu, HJ; Fengler, KA; Zhao, J; Zhao, XR; Chen, YS; Lai, JS; Yan, JB; Xu, ML				Zuo, Weiliang; Chao, Qing; Zhang, Nan; Ye, Jianrong; Tan, Guoqing; Li, Bailin; Xing, Yuexian; Zhang, Boqi; Liu, Haijun; Fengler, Kevin A.; Zhao, Jing; Zhao, Xianrong; Chen, Yongsheng; Lai, Jinsheng; Yan, Jianbing; Xu, Mingliang			A maize wall-associated kinase confers quantitative resistance to head smut	NATURE GENETICS			English	Article							DISEASE-RESISTANCE; RECEPTOR KINASE; GENETIC ARCHITECTURE; TRAIT LOCI; EXPRESSION; FUNGAL; QTL; INFECTION; PATHOGENS; BACTERIAL	Head smut is a systemic disease in maize caused by the soil-borne fungus Sporisorium reilianum that poses a grave threat to maize production worldwide. A major head smut quantitative resistance locus, qHSR1, has been detected on maize chromosome bin2.09. Here we report the map-based cloning of qHSR1 and the molecular mechanism of qHSR1-mediated resistance. Sequential fine mapping and transgenic complementation demonstrated that ZmWAK is the gene within qHSR1 conferring quantitative resistance to maize head smut. ZmWAK spans the plasma membrane, potentially serving as a receptor-like kinase to perceive and transduce extracellular signals. ZmWAK was highly expressed in the mesocotyl of seedlings where it arrested biotrophic growth of the endophytic S. reilianum. Impaired expression in the mesocotyl compromised ZmWAK-mediated resistance. Deletion of the ZmWAK locus appears to have occurred after domestication and spread among maize germplasm, and the ZmWAK kinase domain underwent functional constraints during maize evolution.	[Zuo, Weiliang; Chao, Qing; Zhang, Nan; Ye, Jianrong; Zhao, Jing; Zhao, Xianrong; Chen, Yongsheng; Lai, Jinsheng; Xu, Mingliang] China Agr Univ, Natl Maize Improvement Ctr China, Beijing, Peoples R China; [Tan, Guoqing; Xing, Yuexian] Jilin Acad Agr Sci, Maize Res Inst, Gongzhuling, Peoples R China; [Li, Bailin; Fengler, Kevin A.] DuPont Agr Biotechnol, Wilmington, DC USA; [Liu, Haijun; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	China Agricultural University; Jilin Academy of Agricultural Sciences; DuPont; Huazhong Agricultural University	Xu, ML (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing, Peoples R China.	mxu@cau.edu.cn	Liu, Haijun/AFN-0017-2022; Chen, Yongsheng/D-3256-2011; li, bz/GVR-7133-2022	Liu, Haijun/0000-0001-7717-893X; Chen, Yongsheng/0000-0003-1448-8177; Zuo, Weiliang/0000-0001-5241-1440	National High-Tech Research and Development Program of China [2012AA10A306, 2012AA101104]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	We thank J. Schirawski (RWTH Aachen University) for providing the mating-compatible S. reilianum isolates SRZ1 and SRZ2 and X. Yang (China Agricultural University) for providing the DNA for 522 maize inbred lines and 184 teosinte accessions. We also thank N. Dengler for her help in the identification of microscopy structures. This work was supported by the National High-Tech Research and Development Program of China (grant numbers 2012AA10A306 and 2012AA101104).	Balint-Kurti Peter J., 2009, P229, DOI 10.1007/978-0-387-79418-1_12; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Broglie K.E., 2011, US patent, Patent No. [8,062,847, 8062847]; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Chen YS, 2008, THEOR APPL GENET, V117, P1241, DOI 10.1007/s00122-008-0858-4; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Fischer G. W., 1957, BIOL CONTROL SMUT FU; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Ghareeb H, 2011, PLANT PHYSIOL, V156, P2037, DOI 10.1104/pp.111.179499; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Kohorn BD, 2009, PLANT J, V60, P974, DOI 10.1111/j.1365-313X.2009.04016.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu Y, 2006, FUNCT PLANT BIOL, V33, P811, DOI 10.1071/FP06041; Martinez C, 2000, PROTOPLASMA, V213, P83, DOI 10.1007/BF01280508; Miedaner T, 2006, THEOR APPL GENET, V112, P562, DOI 10.1007/s00122-005-0163-4; Parlevliet JE, 2002, EUPHYTICA, V124, P147, DOI 10.1023/A:1015601731446; Remington DL, 2001, GENET RES, V78, P213, DOI 10.1017/S0016672301005456; Richardson KL, 2006, THEOR APPL GENET, V113, P485, DOI 10.1007/s00122-006-0314-2; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Sivaguru M, 2003, PLANT PHYSIOL, V132, P2256, DOI 10.1104/pp.103.022129; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Wang ZhenHua, 2002, Journal of Maize Sciences, V10, P61; Weng JF, 2012, PHYTOPATHOLOGY, V102, P692, DOI 10.1094/PHYTO-12-11-0330; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao XR, 2012, MOL BREEDING, V30, P1077, DOI 10.1007/s11032-011-9694-3	44	212	232	17	237	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					151	157		10.1038/ng.3170	http://dx.doi.org/10.1038/ng.3170			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25531751				2022-12-25	WOS:000348694700010
J	Fry, CS; Lee, JD; Mula, J; Kirby, TJ; Jackson, JR; Liu, FJ; Yang, L; Mendias, CL; Dupont-Versteegden, EE; McCarthy, JJ; Peterson, CA				Fry, Christopher S.; Lee, Jonah D.; Mula, Jyothi; Kirby, Tyler J.; Jackson, Janna R.; Liu, Fujun; Yang, Lin; Mendias, Christopher L.; Dupont-Versteegden, Esther E.; McCarthy, John J.; Peterson, Charlotte A.			Inducible depletion of satellite cells in adult, sedentary mice impairs muscle regenerative capacity without affecting sarcopenia	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; STEM-CELLS; BETA-CELLS; AGE; HYPERTROPHY; FRAILTY; MICROENVIRONMENT; DYSREGULATION; REJUVENATION; DYSFUNCTION	A key determinant of geriatric frailty is sarcopenia, the age-associated loss of skeletal muscle mass and strength(1,2). Although the etiology of sarcopenia is unknown, the correlation during aging between the loss of activity of satellite cells, which are endogenous muscle stem cells, and impaired muscle regenerative capacity has led to the hypothesis that the loss of satellite cell activity is also a cause of sarcopenia(3,4). We tested this hypothesis in male sedentary mice by experimentally depleting satellite cells in young adult animals to a degree sufficient to impair regeneration throughout the rest of their lives. A detailed analysis of multiple muscles harvested at various time points during aging in different cohorts of these mice showed that the muscles were of normal size, despite low regenerative capacity, but did have increased fibrosis. These results suggest that lifelong reduction of satellite cells neither accelerated nor exacerbated sarcopenia and that satellite cells did not contribute to the maintenance of muscle size or fiber type composition during aging, but that their loss may contribute to age-related muscle fibrosis.	[Fry, Christopher S.; Lee, Jonah D.; Mula, Jyothi; Jackson, Janna R.; Dupont-Versteegden, Esther E.; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Rehabil Sci, Lexington, KY 40506 USA; [Fry, Christopher S.; Lee, Jonah D.; Mula, Jyothi; Kirby, Tyler J.; Jackson, Janna R.; Liu, Fujun; Yang, Lin; Dupont-Versteegden, Esther E.; McCarthy, John J.; Peterson, Charlotte A.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Kirby, Tyler J.; McCarthy, John J.; Peterson, Charlotte A.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Liu, Fujun; Yang, Lin] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA; [Mendias, Christopher L.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Michigan System; University of Michigan	Peterson, CA (corresponding author), Univ Kentucky, Coll Hlth Sci, Dept Rehabil Sci, Lexington, KY 40506 USA.	cpete4@uky.edu	Mendias, Christopher/C-5557-2018; Fry, Christopher/U-2216-2019	Mendias, Christopher/0000-0002-2384-0171; Kirby, Tyler/0000-0002-0210-3826	Jeane B. Kempner Postdoctoral Scholar Award; US National Institutes of Health (NIH) [AR065337]; Ellison Medical Foundation/American Federation of Aging Research (AFAR) Fellowship [EPD 12102]; NIH [AG34453, AG043721, AR60701]; NIH National Center for Advancing Translational Sciences Award [ULITR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR065337, R01AR060701, R01AR065479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K12DE023574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034453, R21AG043721] Funding Source: NIH RePORTER	Jeane B. Kempner Postdoctoral Scholar Award; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation/American Federation of Aging Research (AFAR) Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Advancing Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank B. Lawson and K. Campbell (University of Kentucky Center for Muscle Biology) and S. Roche (University of Michigan) for technical assistance on single-fiber functional analyses; H. Bush and C. Starnes for biostatistics expertise; T. Chaillou for assistance with muscle regeneration experiments; A. Confides for assistance with grip-strength testing; and M. Ubele, R. Erfani, J. Beggs, M. Campbell, T. Kmiec, J. Werker, R. Anglin and Z. Hardyniec for image acquisition and quantification. Research was supported by the Jeane B. Kempner Postdoctoral Scholar Award and US National Institutes of Health (NIH) grant AR065337 to C.S.F.; Ellison Medical Foundation/American Federation of Aging Research (AFAR) Fellowship EPD 12102 to J.D.L.; NIH grants AG34453 to C.A.R, AG043721 to E.E.D.-V. and AR60701 to C.A.P. and LW.; and the NIH National Center for Advancing Translational Sciences Award ULITR000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or AFAR.	Bareja A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-2; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Jones DA, 1998, ARCH FAM MED, V7, P285; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Law P K, 1992, Cell Transplant, V1, P235; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McKay BR, 2013, AM J PHYSIOL-CELL PH, V304, pC717, DOI 10.1152/ajpcell.00305.2012; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Morrison J, 2000, LAB INVEST, V80, P881, DOI 10.1038/labinvest.3780092; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Shephard R J, 1991, Br J Sports Med, V25, P204; Sinaki M, 2001, AM J PHYS MED REHAB, V80, P330, DOI 10.1097/00002060-200105000-00002; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Yu F, 2007, ACTA PHYSIOL, V190, P229, DOI 10.1111/j.1748-1716.2007.01699.x	39	257	267	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					76	80		10.1038/nm.3710	http://dx.doi.org/10.1038/nm.3710			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25501907	Green Accepted, Green Submitted			2022-12-25	WOS:000348408000016
J	Pott, S; Lieb, JD				Pott, Sebastian; Lieb, Jason D.			What are super-enhancers?	NATURE GENETICS			English	Editorial Material							BROMODOMAIN PROTEIN BRD4; HEAVY-CHAIN LOCUS; BETA-GLOBIN GENE; C-MYC GENE; TRANSCRIPTION FACTORS; HUMAN GENOME; REGULATORY ELEMENTS; OPEN CHROMATIN; CELL IDENTITY; IN-VIVO	The term 'super-enhancer' has been used to describe groups of putative enhancers in close genomic proximity with unusually high levels of Mediator binding, as measured by chromatin immunoprecipitation and sequencing (ChIP-seq). Here we review the identification and composition of super-enhancers, describe links between super-enhancers, gene regulation and disease, and discuss the functional significance of enhancer clustering. We also provide our perspective regarding the proposition that super-enhancers are a regulatory entity conceptually distinct from what was known before the introduction of the term. Our opinion is that there is not yet strong evidence that super-enhancers are a novel paradigm in gene regulation and that use of the term in this context is not currently justified. However, the term likely identifies strong enhancers that exhibit behaviors consistent with previous models and concepts of transcriptional regulation. In this respect, the super-enhancer definition is useful in identifying regulatory elements likely to control genes important for cell type specification.	[Pott, Sebastian; Lieb, Jason D.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Lieb, JD (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jdlieb@uchicago.edu		Lieb, Jason/0000-0001-7601-8061				Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Walker BA, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.13; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	69	397	413	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					8	12		10.1038/ng.3167	http://dx.doi.org/10.1038/ng.3167			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25547603				2022-12-25	WOS:000346990400005
J	Jarchum, I				Jarchum, Irene			What's in a stomach?	NATURE BIOTECHNOLOGY			English	Editorial Material																		McCracken K. W., 2014, NATURE          1029, DOI [10.1038/nature13863, DOI 10.1038/NATURE13863]	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1201	1201		10.1038/nbt.3092	http://dx.doi.org/10.1038/nbt.3092			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489838	Bronze			2022-12-25	WOS:000346156800021
J	De Smet, F; Christopoulos, A; Carmeliet, P				De Smet, Frederik; Christopoulos, Arthur; Carmeliet, Peter			Allosteric targeting of receptor tyrosine kinases	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; SMALL-MOLECULE; EGF RECEPTOR; BCR-ABL; LIGAND-BINDING; IN-VIVO; INHIBITORS; ACTIVATION; GROWTH	The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.	[De Smet, Frederik] Univ Leuven, Dept Cellular & Mol Med, SWITCH Lab, Leuven, Belgium; [De Smet, Frederik] Flanders Inst Biotechnol VIB, SWITCH Lab, Leuven, Belgium; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Clayton, Vic 3800, Australia; [Carmeliet, Peter] Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium; [Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Monash University; Monash University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Carmeliet, P (corresponding author), Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium.	peter.carmeliet@vib-kuleuven.be	Christopoulos, Arthur/B-6207-2013; De Smet, Frederik/Q-7808-2016; Carmeliet, Peter/AAQ-5140-2020	Christopoulos, Arthur/0000-0003-4442-3294; De Smet, Frederik/0000-0002-6669-3335; Carmeliet, Peter/0000-0001-7961-1821	Fund for Scientific Research (FWO), Flanders; FWO, Belgium [G.0789.11, G.00764.10]; Belgian Science Policy (IAP) [P7/03]; Leducq Network of Excellence; Flemish Government	Fund for Scientific Research (FWO), Flanders(FWO); FWO, Belgium(FWO); Belgian Science Policy (IAP)(Belgian Federal Science Policy Office); Leducq Network of Excellence; Flemish Government(European Commission)	F.D.S. is supported by the Fund for Scientific Research (FWO), Flanders. A.C. is a principal research fellow of the National Health and Medical Research Council of Australia. This work is supported by grant #G.0789.11 and #G.00764.10 from the FWO, Belgium; the Belgian Science Policy (IAP #P7/03); Leducq Network of Excellence; and long-term structural Methusalem funding by the Flemish Government to P.C.	Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bono F, 2013, CANCER CELL, V23, P477, DOI 10.1016/j.ccr.2013.02.019; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cazorla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009777; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Corbin JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088684; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; He KY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003900; Herbert C, 2013, CANCER CELL, V23, P489, DOI 10.1016/j.ccr.2013.02.018; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hyde CAC, 2012, MOL CELL BIOL, V32, P3802, DOI 10.1128/MCB.06787-11; Jaffe EK, 2013, CURR TOP MED CHEM, V13, P55; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Landgraf KE, 2010, J BIOL CHEM, V285, P40362, DOI 10.1074/jbc.M110.179721; Leahy DJ, 2008, CANCER CELL, V13, P291, DOI 10.1016/j.ccr.2008.03.010; Lebakken CS, 2012, J BIOMOL SCREEN, V17, P813, DOI 10.1177/1087057112439889; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Melancon BJ, 2012, J MED CHEM, V55, P1445, DOI 10.1021/jm201139r; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Perron MD, 2014, MOL PHARMACOL, V85, P553, DOI 10.1124/mol.113.089847; Shah DR, 2013, DRUG SAFETY, V36, P413, DOI 10.1007/s40264-013-0050-x; Suarez RM, 2013, EUR J MED CHEM, V61, P2, DOI 10.1016/j.ejmech.2012.06.005; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; Weisheit S, 2012, CELL SIGNAL, V24, P422, DOI 10.1016/j.cellsig.2011.09.010; Weisheit S, 2011, CELL SIGNAL, V23, P436, DOI 10.1016/j.cellsig.2010.10.018; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	60	57	58	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1113	1120		10.1038/nbt.3028	http://dx.doi.org/10.1038/nbt.3028			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380447				2022-12-25	WOS:000344977000016
J	Weinhold, N; Jacobsen, A; Schultz, N; Sander, C; Lee, W				Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William			Genome-wide analysis of noncoding regulatory mutations in cancer	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; LUNG-CANCER; DNA; GENES; ADENOCARCINOMA; PARAGANGLIOMA; DISCOVERY; PROTEINS; MELANOMA; TUMORS	Cancer primarily develops because of somatic alterations in the genome. Advances in sequencing have enabled large-scale sequencing studies across many tumor types, emphasizing the discovery of alterations in protein-coding genes. However, the protein-coding exome comprises less than 2% of the human genome. Here we analyze the complete genome sequences of 863 human tumors from The Cancer Genome Atlas and other sources to systematically identify noncoding regions that are recurrently mutated in cancer. We use new frequency- and sequence-based approaches to comprehensively scan the genome for noncoding mutations with potential regulatory impact. These methods identify recurrent mutations in regulatory elements upstream of PLEKHS1, WDR74 and SDHD, as well as previously identified mutations in the TERT promoter. SDHD promoter mutations are frequent in melanoma and are associated with reduced gene expression and poor prognosis. The non-protein-coding cancer genome remains widely unexplored, and our findings represent a step toward targeting the entire genome for clinical purposes.	[Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Jacobsen, Anders] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, Copenhagen, Denmark; [Lee, William] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Copenhagen; Memorial Sloan Kettering Cancer Center	Lee, W (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	leew1@mskcc.org	Skanderup, Anders Jacobsen/K-1081-2013; Schultz, Nikolaus/ABE-6347-2020	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Schultz, Nikolaus/0000-0002-0131-4904	TCGA GDAC grant from the US National Institutes of Health [NCI U24-CA143840]; Danish Research Council; Carlsberg Foundation; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	TCGA GDAC grant from the US National Institutes of Health; Danish Research Council(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank TCGA as well as numerous other groups who have made their data available for public analysis. The authors additionally thank the CGHub team, members of the Memorial Sloan Kettering Cancer Center Bioinformatics Core, G. Ratsch and J. Chodera for the setup and administration of high-performance computing resources. This work was supported in part by a TCGA GDAC grant from the US National Institutes of Health for N.W., N.S., CS. and W.L. (NCI U24-CA143840) and grants from the Danish Research Council and the Carlsberg Foundation for A.J.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lehmann KV, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks800; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Schneider C, 2011, SEMIN DIAGN PATHOL, V28, P167, DOI 10.1053/j.semdp.2011.04.001; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670	34	336	338	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1160	1165		10.1038/ng.3101	http://dx.doi.org/10.1038/ng.3101			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25261935	Green Accepted			2022-12-25	WOS:000344131900005
J	Chaikuad, A; Tacconi, EMC; Zimmer, J; Liang, YK; Gray, NS; Tarsounas, M; Knapp, S				Chaikuad, Apirat; Tacconi, Eliana M. C.; Zimmer, Jutta; Liang, Yanke; Gray, Nathanael S.; Tarsounas, Madalena; Knapp, Stefan			A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics	NATURE CHEMICAL BIOLOGY			English	Article							MAP KINASE ERK2; ACQUIRED-RESISTANCE; MEK INHIBITION; DNA-DAMAGE; BRAF; RAF; CONFORMATION; DETERMINANTS; DEFICIENCY; ACTIVATION	Activation of the ERK pathway is a hallmark of cancer, and targeting of upstream signaling partners led to the development of approved drugs. Recently, SCH772984 has been shown to be a selective and potent ERK1/2 inhibitor. Here we report the structural mechanism for its remarkable selectivity. In ERK1/2, SCH772984 induces a so-far-unknown binding pocket that accommodates the piperazine-phenyl-pyrimidine decoration. This new binding pocket was created by an inactive conformation of the phosphate-binding loop and an outward tilt of helix alpha C. In contrast, structure determination of SCH772984 with the off-target haspin and JNK1 revealed two canonical but distinct type I binding modes. Notably, the new binding mode with ERK1/2 was associated with slow binding kinetics in vitro as well as in cell-based assay systems. The described binding mode of SCH772984 with ERK1/2 enables the design of a new type of specific kinase inhibitors with prolonged on-target activity.	[Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford, England; [Tacconi, Eliana M. C.; Zimmer, Jutta; Tarsounas, Madalena] Canc Res UK, Telomere & Genome Stabil Grp, Oxford, England; [Tacconi, Eliana M. C.; Zimmer, Jutta; Tarsounas, Madalena] Oxford Inst Radiat Oncol, MRC, Oxford, England; [Liang, Yanke; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol,Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Knapp, Stefan] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA; [Knapp, Stefan] Univ Oxford, Target Discovery Inst, Oxford, England	University of Oxford; Cancer Research UK; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; George Washington University; University of Oxford	Knapp, S (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus,Res Bldg, Oxford, England.	madalena.tarsounas@oncology.ox.ac.uk; stefan.knapp@ndm.ox.ac.uk	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Tacconi, Eliana/0000-0002-4118-4286; Chaikuad, Apirat/0000-0003-1120-2209	Structural Genomics Consortium; AbbVie [1097737]; Bayer; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; European Union FP7 Grant [278568]; Cancer Research UK; EMBO Young Investigator Program; Royal Society; Medical Research Council PhD Studentship; Cancer Research UK [17201] Funding Source: researchfish	Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome Trust); European Union FP7 Grant; Cancer Research UK(Cancer Research UK); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Royal Society(Royal Society of London); Medical Research Council PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	S.K. is supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). A.C. is supported by the European Union FP7 Grant No. 278568 'PRIMES' (Protein interaction machines in oncogenic EGF receptor signalling). Work in M.T.'s laboratory is supported by Cancer Research UK, the EMBO Young Investigator Program and The Royal Society, and E.T. is funded by a Medical Research Council PhD Studentship. We thank the staff at Diamond Light Source for assistance during data collection at the synchrotron and H. Lee (Seoul National University) for providing the sheep anti-BRCA2 antibody.	Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Chaikuad A, 2014, BIOCHEM J, V459, P59, DOI 10.1042/BJ20131399; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Gruenbaum LM, 2009, BIOCHEM PHARMACOL, V77, P422, DOI 10.1016/j.bcp.2008.10.032; Guimaraes CRW, 2011, J CHEM INF MODEL, V51, P1199, DOI 10.1021/ci200153c; Hari SB, 2013, ACS CHEM BIOL, V8, P2734, DOI 10.1021/cb400663k; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keates T, 2012, NEW BIOTECHNOL, V29, P515, DOI 10.1016/j.nbt.2011.10.007; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V377, P1123, DOI 10.1016/j.bbrc.2008.10.127; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schmidtke P, 2011, J AM CHEM SOC, V133, P18903, DOI 10.1021/ja207494u; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Swinney DC, 2009, CURR OPIN DRUG DISC, V12, P31; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	58	142	144	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					853	+		10.1038/NCHEMBIO.1629	http://dx.doi.org/10.1038/NCHEMBIO.1629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25195011	Green Submitted, Green Accepted			2022-12-25	WOS:000342462100012
J	Bock, FJ; Chang, P				Bock, Florian J.; Chang, Paul			STRESS RESPONSE PARP1 911	NATURE CHEMICAL BIOLOGY			English	Editorial Material							ACTIVATION; SIRT1	Although resveratrol is thought to provide many beneficial health effects, its cellular targets and mechanism of function are still under investigation. A new study found that resveratrol binds to tyrosyl transfer-RNA synthetase, resulting in the activation of the stress response effector PARP1.	[Bock, Florian J.; Chang, Paul] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chang, Paul] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bock, FJ (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pchang2@mit.edu		Bock, Florian/0000-0002-1133-1767	NIGMS NIH HHS [R01 GM087465] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657	10	5	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					179	180		10.1038/nchembio.1756	http://dx.doi.org/10.1038/nchembio.1756			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25689334				2022-12-25	WOS:000349840500003
J	Jackson, HW; Waterhouse, P; Sinha, A; Kislinger, T; Berman, HK; Khokha, R				Jackson, Hartland W.; Waterhouse, Paul; Sinha, Ankit; Kislinger, Thomas; Berman, Hal K.; Khokha, Rama			Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE ORIENTATION; BREAST-CANCER; FATE; DIFFERENTIATION; RECEPTOR; METALLOPROTEINASES; ACTIVATION; EXPRESSION; INTEGRINS; PATTERNS	Age is the primary risk factor for breast cancer in women. Bipotent basal stem cells actively maintain the adult mammary ductal tree, but with age tissues atrophy. We show that cell-extrinsic factors maintain the adult stem cell pool during ageing and dictate tissue stoichiometry. Mammary stem cells spontaneously expand more than 11-fold in virgin adult female mice lacking specific genes for TIMPs, the natural metalloproteinase inhibitors. Compound Timp1/Timp3 null glands exhibit Notch activation and accelerated gestational differentiation. Proteomics of mutant basal cells uncover altered cytoskeletal and extracellular protein repertoires, and we identify aberrant mitotic spindle orientation in these glands, a process that instructs asymmetric cell division and fate. We find that progenitor activity normally declines with age, but enriched stem/progenitor pools prevent tissue regression in Timp mutant mammary glands without affecting carcinogen-induced cancer susceptibility. Thus, improved stem cell content can extend mouse mammary tissue lifespan without altering cancer risk in this mouse model.	[Jackson, Hartland W.; Sinha, Ankit; Kislinger, Thomas; Khokha, Rama] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Jackson, Hartland W.; Waterhouse, Paul; Sinha, Ankit; Kislinger, Thomas; Berman, Hal K.; Khokha, Rama] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Berman, Hal K.; Khokha, Rama] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Khokha, R (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Jackson, Hartland/AAL-7751-2020; Kislinger, Thomas/A-5934-2008	Jackson, Hartland/0000-0001-6423-2415; Kislinger, Thomas/0000-0003-3525-5540; Sinha, Ankit/0000-0002-9113-2599; Waterhouse, Paul/0000-0001-8745-5224; Khokha, Rama/0000-0002-6028-1524	Canadian Breast Cancer Foundation; Canadian Cancer Society Research Institute	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The authors thank Marco A. Di Grappa S. R. Narala and H. Fang for technical assistance, Cedric Blanpain (Brussel, Belgium) for providing the wholemount immunofluoresence protocol and P. Joshi for critical mview of the manuscript. H.W.J was awarded a Canadian Breast Cancer Foundation doctoral fellowship, and this research was supported by funding from the Canadian Breast Cancer Foundation and the Canadian Cancer Society Research Institute to RK.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Geigl JB, 2004, CANCER RES, V64, P8550, DOI 10.1158/0008-5472.CAN-04-2151; Ghosh K, 2010, J CLIN ONCOL, V28, P2207, DOI 10.1200/JCO.2009.23.4120; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Glukhova MA, 2013, CURR OPIN CELL BIOL, V25, P633, DOI 10.1016/j.ceb.2013.06.010; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Joseph H, 1999, MOL BIOL CELL, V10, P1221, DOI 10.1091/mbc.10.4.1221; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khokha Rama, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004333; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; LEE JAH, 1976, J NATL CANCER I, V57, P753, DOI 10.1093/jnci/57.4.753; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Raafat A, 2011, J CELL PHYSIOL, V226, P1940, DOI 10.1002/jcp.22526; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Regan JL, 2013, CELL REP, V4, P110, DOI 10.1016/j.celrep.2013.05.044; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rosenmeyer PA, 1997, RAMUS, V26, P29, DOI 10.1017/S0048671X00002058; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Shoker BS, 1999, J PATHOL, V188, P237; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sinha A, 2014, BIOCHEM BIOPH RES CO, V445, P694, DOI 10.1016/j.bbrc.2013.12.070; Sprenger CC, 2010, INT J CANCER, V127, P2739, DOI 10.1002/ijc.25615; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793	56	23	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					217	+		10.1038/ncb3118	http://dx.doi.org/10.1038/ncb3118			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25706237				2022-12-25	WOS:000350770200007
J	Jeffares, DC; Rallis, C; Rieux, A; Speed, D; Prevorovsky, M; Mourier, T; Marsellach, FX; Iqbal, Z; Lau, W; Cheng, TMK; Pracana, R; Mulleder, M; Lawson, JLD; Chessel, A; Bala, S; Hellenthal, G; O'Fallon, B; Keane, T; Simpson, JT; Bischof, L; Tomiczek, B; Bitton, DA; Sideri, T; Codlin, S; Hellberg, JEEU; van Trigt, L; Jeffery, L; Li, JJ; Atkinson, S; Thodberg, M; Febrer, M; McLay, K; Drou, N; Brown, W; Hayles, J; Salas, REC; Ralser, M; Maniatis, N; Balding, DJ; Balloux, F; Durbin, R; Bahler, J				Jeffares, Daniel C.; Rallis, Charalampos; Rieux, Adrien; Speed, Doug; Prevorovsky, Martin; Mourier, Tobias; Marsellach, Francesc X.; Iqbal, Zamin; Lau, Winston; Cheng, Tammy M. K.; Pracana, Rodrigo; Muelleder, Michael; Lawson, Jonathan L. D.; Chessel, Anatole; Bala, Sendu; Hellenthal, Garrett; O'Fallon, Brendan; Keane, Thomas; Simpson, Jared T.; Bischof, Leanne; Tomiczek, Bartlomiej; Bitton, Danny A.; Sideri, Theodora; Codlin, Sandra; Hellberg, Josephine E. E. U.; van Trigt, Laurent; Jeffery, Linda; Li, Juan-Juan; Atkinson, Sophie; Thodberg, Malte; Febrer, Melanie; McLay, Kirsten; Drou, Nizar; Brown, William; Hayles, Jacqueline; Salas, Rafael E. Carazo; Ralser, Markus; Maniatis, Nikolas; Balding, David J.; Balloux, Francois; Durbin, Richard; Baehler, Juerg			The genomic and phenotypic diversity of Schizosaccharomyces pombe	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; SEQUENCE; DNA; MODEL; INTEGRATION; GENERATION; DISCOVERY; SELECTION; YEAST; MAPS	Natural variation within species reveals aspects of genome evolution and function. The fission yeast Schizosaccharomyces pombe is an important model for eukaryotic biology, but researchers typically use one standard laboratory strain. To extend the usefulness of this model, we surveyed the genomic and phenotypic variation in 161 natural isolates. We sequenced the genomes of all strains, finding moderate genetic diversity (pi = 3 x 10(-3) substitutions/site) and weak global population structure. We estimate that dispersal of S. pombe began during human antiquity (similar to 340 BCE), and ancestors of these strains reached the Americas at similar to 1623 CE. We quantified 74 traits, finding substantial heritable phenotypic diversity. We conducted 223 genomewide association studies, with 89 traits showing at least one association. The most significant variant for each trait explained 22% of the phenotypic variance on average, with indels having larger effects than SNPs. This analysis represents a rich resource to examine genotype-phenotype relationships in a tractable model.	[Jeffares, Daniel C.; Rallis, Charalampos; Rieux, Adrien; Speed, Doug; Marsellach, Francesc X.; Lau, Winston; Pracana, Rodrigo; Hellenthal, Garrett; Tomiczek, Bartlomiej; Bitton, Danny A.; Sideri, Theodora; Codlin, Sandra; Hellberg, Josephine E. E. U.; van Trigt, Laurent; Atkinson, Sophie; Maniatis, Nikolas; Balding, David J.; Balloux, Francois; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London, England; [Rieux, Adrien; Speed, Doug; Hellenthal, Garrett; Balding, David J.; Balloux, Francois; Baehler, Juerg] UCL, Genet Inst, London, England; [Prevorovsky, Martin] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Mourier, Tobias; Thodberg, Malte] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Iqbal, Zamin] Wellcome Trust Ctr Human Genet, Oxford, England; [Cheng, Tammy M. K.; Jeffery, Linda; Li, Juan-Juan; Hayles, Jacqueline] Canc Res UK London Res Inst, Cell Cycle Lab, London, England; [Muelleder, Michael; Chessel, Anatole; Ralser, Markus] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Lawson, Jonathan L. D.; Salas, Rafael E. Carazo] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Lawson, Jonathan L. D.; Salas, Rafael E. Carazo] Univ Cambridge, Gurdon Inst, Cambridge CB2 3EH, England; [Bala, Sendu; Keane, Thomas; Simpson, Jared T.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge, England; [O'Fallon, Brendan] Univ Utah, Associated Reg & Univ Pathologists Inc, Salt Lake City, UT USA; [Bischof, Leanne] CSIRO Math Informat & Stat, N Ryde, NSW, Australia; [Febrer, Melanie; McLay, Kirsten; Drou, Nizar] Genome Anal Ctr, Norwich, Norfolk, England; [Brown, William] Univ Nottingham, Ctr Genet & Gen, Nottingham NG7 2RD, England; [Ralser, Markus] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Ralser, Markus] Natl Inst Med Res, MRC, Div Physiol & Metab, London NW7 1AA, England	University of London; University College London; University of London; University College London; Charles University Prague; University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; Cancer Research UK; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Utah System of Higher Education; University of Utah; Commonwealth Scientific & Industrial Research Organisation (CSIRO); The Genome Analysis Centre (TGAC); University of Nottingham; University of Cambridge; MRC National Institute for Medical Research	Jeffares, DC (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	d.jeffares@ucl.ac.uk; j.bahler@ucl.ac.uk	Bahler, Jurg/B-4572-2009; Durbin, Richard/AAE-7178-2019; Chessel, Anatole/O-8902-2019; Mourier, Tobias/C-1164-2015; Jeffares, Daniel/N-2632-2018; Převorovský, Martin/R-5191-2016; Thodberg, Malte/AAT-4791-2021; Speed, Doug/AAM-1032-2021; Marsellach, Xavi/P-7835-2017; Balloux, Francois/D-4783-2009; Balding, David/G-9898-2011; Balloux, Francois/X-7856-2019	Bahler, Jurg/0000-0003-4036-1532; Durbin, Richard/0000-0002-9130-1006; Chessel, Anatole/0000-0002-1326-6305; Mourier, Tobias/0000-0003-2727-1903; Jeffares, Daniel/0000-0001-7320-0706; Převorovský, Martin/0000-0003-0277-8361; Thodberg, Malte/0000-0001-6244-3841; Marsellach, Xavi/0000-0002-2435-6904; Balloux, Francois/0000-0003-1978-7715; Balding, David/0000-0002-1480-6115; Balloux, Francois/0000-0003-1978-7715; Nurse, Paul/0000-0002-9244-7787; Carazo-Salas, Rafael E/0000-0002-5943-3981; Ralser, Markus/0000-0001-9535-7413; Speed, Doug/0000-0002-0096-9765; Mulleder, Michael/0000-0001-9792-3861; Sideri, Theodora/0000-0002-5674-0804; Lau, Winston/0000-0001-5501-4619; Rallis, Charalampos/0000-0002-4390-0266; Tomiczek, Bartlomiej/0000-0001-9295-663X; Bala, Senduran/0000-0003-4509-8307; Iqbal, Zamin/0000-0001-8466-7547; Maniatis, Nikolas/0000-0002-6567-5936; Li, Juanjuan/0000-0003-2164-094X; Pracana, Rodrigo/0000-0003-2492-4067; Brown, William RA/0000-0001-5340-3645; Hellberg, Josephine/0000-0002-4822-1588	Wellcome Trust Senior Investigator Award [095598/Z/11/Z]; Welcome Trust [RG 0937351Z/10/Z]; European Research Council (ERC) [BB/H005854/1, 260809]; Biotechnology and Biological Sciences Research Council; UK Medical Research Council [G0901388]; Cancer Research UK Postdoctoral Fellowship; ERC Starting Grant (SYSGRO); Czech Science Foundation [P305/12/P040]; Charles University [UNCE 204013]; Cancer Research UK; Biotechnology and Biological Sciences Research Council [BB/H008802/1, BB/I012451/1, BB/H005854/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193, BB/K006320/1] Funding Source: researchfish; Cancer Research UK [15699] Funding Source: researchfish; Medical Research Council [MR/L012561/1, G0901388] Funding Source: researchfish; Wellcome Trust [095598/Z/11/Z] Funding Source: researchfish; The Francis Crick Institute [10134] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BB/I012451/1, BB/H005854/1, BB/K006320/1, BBS/E/T/000PR6193, BB/H008802/1] Funding Source: UKRI; MRC [MR/L012561/1, G0901388] Funding Source: UKRI	Wellcome Trust Senior Investigator Award(Wellcome Trust); Welcome Trust(Wellcome Trust); European Research Council (ERC)(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Postdoctoral Fellowship(Cancer Research UK); ERC Starting Grant (SYSGRO); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Clissold, H. Musk, D. Baker and R Davey for their contributions to sequencing, H. Levin for discussions about transposons, and J. Mao and S. Marguerat for comments on the manuscript. This work Was supported by a Wellcome Trust Senior Investigator Award to TB. (grant 095598/Z/11/Z), by the Welcome Trust to S.B., T.K., J.T.S. and RD., by grant 260801-BIG-IDEA from the European Research Council (ERC) and grant BB/H005854/1 from the Biotechnology and Biological Sciences Research Council (PBS RC) to A.R. and FR, by UK Medical Research Council grant G0901388 to HS, and by a Cancer Research UK Postdoctoral Fellowship to T.M.K.C., by an ERC Starting Grant (SYSGRO) to R.E.C.S., a Welcome Trust PhD studentship to J.L.D.L. and NSW" grant 1;14/K006320/1 to R.E.C.S. and A.C., by a Welcome Trust grant (RG 0937351Z/10/Z) and ERC Starting Grant 260809 to M.R. (MR. is a Welcome Trust Research Career Development and Welk ome-Beit Prize Fellow), by Czech Science Foundation grant P305/12/P040 and Charles University grant UNCE 204013 to M.P. and by Cancer Research UK to L.J. and J.H.	al Basatena NKS, 2013, GENETICS, V193, P243, DOI 10.1534/genetics.112.145599; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Avelar AT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3235; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Clement-Ziza M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145123; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2013, G3-GENES GENOM GENET, V3, P2163, DOI 10.1534/g3.113.007492; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fawcett JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104241; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Feng G, 2013, NUCLEIC ACIDS RES, V41, P775, DOI 10.1093/nar/gks1185; FLORENZANO G, 1977, VITIS, V16, P38; Fowler KR, 2013, MOL CELL, V49, P983, DOI 10.1016/j.molcel.2013.01.008; Gomes FCO, 2002, CAN J MICROBIOL, V48, P399, DOI [10.1139/w02-032, 10.1139/W02-032]; Graml V, 2014, DEV CELL, V31, P227, DOI 10.1016/j.devcel.2014.09.005; Guo YB, 2013, GENETICS, V195, P599, DOI 10.1534/genetics.113.152744; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Hornsey I., 2003, HIST BEER BREWING; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kahm M, 2010, J STAT SOFTW, V33, P1; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kwon EJG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003104; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lau W, 2007, BIOINFORMATICS, V23, P517, DOI 10.1093/bioinformatics/btl615; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Mourier T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-167; O'Fallon BD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-40; Osterwalder A, 1924, MITT GEBIETE LEBENSM, V15, P5, DOI DOI 10.1111/J.1567-1364.2010.00657.X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANG ENV STAT COMP; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; SAZER S, 1990, J CELL SCI, V97, P509; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Teoh AL, 2004, INT J FOOD MICROBIOL, V95, P119, DOI 10.1016/j.ijfoodmicro.2003.12.020; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanders SE, 2014, ELIFE, V3, DOI 10.7554/eLife.02630; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	63	106	109	1	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					235	+		10.1038/ng.3215	http://dx.doi.org/10.1038/ng.3215			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665008	Green Submitted, Green Accepted			2022-12-25	WOS:000350327900013
J	Frock, RL; Hu, JZ; Meyers, RM; Ho, YJ; Kii, E; Alt, FW				Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.			Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases	NATURE BIOTECHNOLOGY			English	Article							RECURRENT CHROMOSOMAL TRANSLOCATIONS; SEQUENCING REVEALS; B-LYMPHOCYTES; CAS SYSTEMS; SPECIFICITY; INSTABILITY; MECHANISMS; CLEAVAGE; TALENS; CELLS	Although great progress has been made in the characterization of the off-target effects of engineered nucleases, sensitive and unbiased genome-wide methods for the detection of off-target cleavage events and potential collateral damage are still lacking. Here we describe a linear amplification-mediated modification of a previously published high-throughput, genome-wide, translocation sequencing (HTGTS) method that robustly detects DNA double-stranded breaks (DSBs) generated by engineered nucleases across the human genome based on their translocation to other endogenous or ectopic DSBs. HTGTS with different Cas9:sgRNA or TALEN nucleases revealed off-target hotspot numbers for given nucleases that ranged from a few or none to dozens or more, and extended the number of known off-targets for certain previously characterized nucleases more than tenfold. We also identified translocations between bona fide nuclease targets on homologous chromosomes, an undesired collateral effect that has not been described previously. Finally, HTGTS confirmed that the, Cas9D10A paired nickase approach suppresses off-target cleavage genome-wide.	[Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Alt, FW (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Wilson, Matthew H/K-3193-2013; Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Meyers, Robin/0000-0002-1802-7231; Ho, Yu-jui/0000-0002-7540-024X; Hu, Jiazhi/0000-0002-6345-0039	National Institutes of Health [P01CA109901, P01AI076210, NRSA T32CA070083]; National Health Institutes of Health [NRSA T32AI007512]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE [P01CA109901, T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, P01AI076210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Institutes of Health; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health Grants P01CA109901 and P01AI076210. R.L.F. was supported by the National Institutes of Health NRSA T32CA070083 and is supported by the National Health Institutes of Health NRSA T32AI007512. J.H. is supported by Robertson Foundation/Cancer Research Institute Irvington Fellowship. F.W.A. is an investigator of the Howard Hughes Medical Institute. A549 cells were provided by David Weinstock (Dana-Farber Cancer Institute).	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JZ, 2014, P NATL ACAD SCI USA, V111, P10269, DOI 10.1073/pnas.1410112111; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	43	444	482	3	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					179	186		10.1038/nbt.3101	http://dx.doi.org/10.1038/nbt.3101			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25503383	Green Accepted, Green Submitted			2022-12-25	WOS:000349198800024
J	Leiserson, MDM; Vandin, F; Wu, HT; Dobson, JR; Eldridge, JV; Thomas, JL; Papoutsaki, A; Kim, Y; Niu, BF; McLellan, M; Lawrence, MS; Gonzalez-Perez, A; Tamborero, D; Cheng, YW; Ryslik, GA; Lopez-Bigas, N; Getz, G; Ding, L; Raphael, BJ				Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta; Dobson, Jason R.; Eldridge, Jonathan V.; Thomas, Jacob L.; Papoutsaki, Alexandra; Kim, Younhun; Niu, Beifang; McLellan, Michael; Lawrence, Michael S.; Gonzalez-Perez, Abel; Tamborero, David; Cheng, Yuwei; Ryslik, Gregory A.; Lopez-Bigas, Nuria; Getz, Gad; Ding, Li; Raphael, Benjamin J.			Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes	NATURE GENETICS			English	Article							LANDSCAPE; COHESIN; COMPONENTS; DISCOVERY; PATTERNS	Cancers exhibit extensive mutational heterogeneity, and the resulting long-tail phenomenon complicates the discovery of genes and pathways that are significantly mutated in cancer. We perform a pan-cancer analysis of mutated networks in 3,281 samples from 12 cancer types from The Cancer Genome Atlas (TCGA) using HotNet2, a new algorithm to find mutated subnetworks that overcomes the limitations of existing single-gene, pathway and network approaches. We identify 16 significantly mutated subnetworks that comprise well-known cancer signaling pathways as well as subnetworks with less characterized roles in cancer, including cohesin, condensin and others. Many of these subnetworks exhibit co-occurring mutations across samples. These subnetworks contain dozens of genes with rare somatic mutations across multiple cancers; many of these genes have additional evidence supporting a role in cancer. By illuminating these rare combinations of mutations, pan-cancer network analyses provide a roadmap to investigate new diagnostic and therapeutic opportunities across cancer types.	[Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta; Dobson, Jason R.; Eldridge, Jonathan V.; Thomas, Jacob L.; Papoutsaki, Alexandra; Kim, Younhun; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta; Dobson, Jason R.; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Dobson, Jason R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Niu, Beifang; Ding, Li] Washington Univ, Genome Inst, St Louis, MO USA; [Lawrence, Michael S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gonzalez-Perez, Abel; Tamborero, David; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Cheng, Yuwei] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Ryslik, Gregory A.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ding, Li] Washington Univ, Dept Med, St Louis, MO USA; [Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO USA	Brown University; Brown University; Brown University; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pompeu Fabra University; Yale University; Yale University; ICREA; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Raphael, BJ (corresponding author), Brown Univ, Dept Comp Sci, Providence, RI 02912 USA.	braphael@brown.edu	Lawrence, Michael/AAC-8202-2020; Gasull, Martina/J-4076-2019; Cheng, Yuwei/G-8402-2018; tamborero, david/M-5283-2015; Lopez-Bigas, Nuria/F-6193-2011	tamborero, david/0000-0002-7218-2806; Lopez-Bigas, Nuria/0000-0003-4925-8988; Gonzalez-Perez, Abel/0000-0002-8582-4660; Papoutsaki, Alexandra/0000-0003-1041-4760; Dobson, Jason/0000-0002-2306-2250; MCLELLAN, MICHAEL/0000-0002-2703-8784	US National Science Foundation (NSF) [IIS-1016648]; US National Institutes of Health (NIH) [R01HG005690, R01HG007069, R01CA180776]; National Human Genome Research Institute (NHGRI) grant [U01HG006517]; Career Award at the Scientific Interface from the Burroughs Wellcome Fund; Alfred P. Sloan Research Fellowship; NSF CAREER Award [CCF-1053753]; NSF fellowship GRFP [DGE 0228243]; NHGRI of the US NIH; Ellison Foundation; Dana-Farber Cancer Institute Strategic Initiative; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA180776, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517, R01HG007069, R01HG005690] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI) grant; Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF fellowship GRFP; NHGRI of the US NIH; Ellison Foundation(Lawrence Ellison Foundation); Dana-Farber Cancer Institute Strategic Initiative; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank F. Roth for his assistance in constructing the HINT+HI2012 interaction network. We gratefully acknowledge the contributions of the TCGA Research Network and its TCGA Pan-Cancer Analysis Working Group. This work is supported by US National Science Foundation (NSF) grant IIS-1016648 and US National Institutes of Health (NIH) grants R01HG005690, R01HG007069 and R01CA180776 to B.J.R. and by National Human Genome Research Institute (NHGRI) grant U01HG006517 to L.D. B.J.R. is supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, an Alfred P. Sloan Research Fellowship and an NSF CAREER Award (CCF-1053753). M.D.M.L. is supported by NSF fellowship GRFP DGE 0228243. The hinders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Data for HI2012, created by the Center for Cancer Systems Biology (CCSB) at the Dana-Farber Cancer Institute, are supported by the NHGRI of the US NIH, the Ellison Foundation and the Dana-Farber Cancer Institute Strategic Initiative.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greife A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-628; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Lapointe J, 2008, AM J SURG PATHOL, V32, P205, DOI 10.1097/PAS.0b013e318124a865; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Ryslik GA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-190; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tamborero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055489; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xu HL, 2011, NAT REV CANCER, V11, P199, DOI 10.1038/nrc3018; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Ye JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-11; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	57	514	522	5	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					106	114		10.1038/ng.3168	http://dx.doi.org/10.1038/ng.3168			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25501392	Green Accepted, Green Submitted			2022-12-25	WOS:000348694700005
J	Tang, C; Ahmed, K; Gille, A; Lu, S; Grone, HJ; Tunaru, S; Offermanns, S				Tang, Cong; Ahmed, Kashan; Gille, Andreas; Lu, Shun; Groene, Hermann-Josef; Tunaru, Sorin; Offermanns, Stefan			Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes	NATURE MEDICINE			English	Article							CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; PANCREATIC BETA-CELL; PLASMA ACETATE; GUT MICROBIOTA; GPR41; MICE; PHARMACOLOGY; ROLES; LIVER	Type 2 diabetes is a major health problem worldwide, and one of its key features is the inability of elevated glucose to stimulate the release of sufficient amounts of insulin from pancreatic beta cells to maintain normal blood glucose levels(1,2). New therapeutic strategies to improve beta cell function are therefore believed to be beneficial(3,4). Here we demonstrate that the short-chain fatty acid receptors FFA2 (encoded by FFAR2) and FFA3 (encoded by FFAR3) are expressed in mouse and human pancreatic beta cells and mediate an inhibition of insulin secretion by coupling to G(i)-type G proteins. We also provide evidence that mice with dietary-induced obesity and type 2 diabetes, as compared to non-obese control mice, have increased local formation by pancreatic islets of acetate, an endogenous agonist of FFA2 and FFA3, as well as increased systemic levels. This elevation may contribute to the insufficient capacity of beta cells to respond to hyperglycemia in obese states. Indeed, we found that genetic deletion of both receptors, either on the whole-body level or specifically in pancreatic beta cells, leads to greater insulin secretion and a profound improvement of glucose tolerance when mice are on a high-fat diet compared to controls. On the other hand, deletion of Ffar2 and Ffar3 in intestinal cells did not alter glucose tolerance in diabetic animals, suggesting these receptors act in a cell-autonomous manner in beta cells to regulate insulin secretion. In summary, under diabetic conditions elevated acetate acts on FFA2 and FFA3 to inhibit proper glucose-stimulated insulin secretion, and we expect antagonists of FFA2 and FFA3 to improve insulin secretion in type 2 diabetes.	[Tang, Cong; Ahmed, Kashan; Lu, Shun; Tunaru, Sorin; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Gille, Andreas] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Offermanns, Stefan] Goethe Univ Frankfurt, Fac Med, D-60054 Frankfurt, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt	Offermanns, S (corresponding author), Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany.	stefan.offermanns@mpi-bn.mpg.de	Tunaru, Sorin/G-8516-2011; Gille, Andreas/E-1531-2011; Offermanns, Stefan/L-3313-2017	Tunaru, Sorin/0000-0002-6005-1737; Gille, Andreas/0000-0001-5235-8897; Lu, Shun/0000-0003-4501-2008; Offermanns, Stefan/0000-0001-8676-6805; Tang, Cong/0000-0002-5228-3052	German Research Foundation [1039]; Max Planck Society	German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The authors wish to thank S. Hummer and S. Meaney-Gardian for secretarial help and K. Adolph and S. Kreutzer for technical support. H. Pijl (Leiden University Medical Centre) helped set up the hyperinsulinemic-euglycemic clamp, and P. Ravassard and R. Scharfmann (INSERM, Paris) provided EndoC-beta H1 cells. This work was supported by funds through the Collaborative Research Center 1039 of the German Research Foundation and by the Max Planck Society.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; de Azua IR, 2011, TRENDS ENDOCRIN MET, V22, P74, DOI 10.1016/j.tem.2010.10.004; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Layden BT, 2012, DIABET METAB SYND OB, V5, P49, DOI 10.2147/DMSO.S29244; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pouteau E, 2003, P NUTR SOC, V62, P87, DOI 10.1079/PNS2003208; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sakakibara I, 2009, CELL METAB, V9, P191, DOI 10.1016/j.cmet.2008.12.008; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; SMITH RF, 1986, ANN CLIN BIOCHEM, V23, P285, DOI 10.1177/000456328602300307; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; TIENGO A, 1981, DIABETES, V30, P705, DOI 10.2337/diabetes.30.9.705; TODESCO T, 1993, AM J GASTROENTEROL, V88, P751; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X; Yamashita H, 2001, BBA-MOL CELL BIOL L, V1532, P79, DOI 10.1016/S1388-1981(01)00117-2; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	40	196	202	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					173	177		10.1038/nm.3779	http://dx.doi.org/10.1038/nm.3779			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25581519				2022-12-25	WOS:000348974800020
J	Tsai, SQ; Zheng, Z; Nguyen, NT; Liebers, M; Topkar, VV; Thapar, V; Wyvekens, N; Khayter, C; Iafrate, AJ; Le, LP; Aryee, MJ; Joung, JK				Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith			GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; DUAL-RNA; SPECIFICITY; DNA; SYSTEMS; REVEALS; ENDONUCLEASE; IDENTIFICATION; NICKASES; SITES	CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but methods to delineate their genome-wide, off-target cleavage activities have been lacking. Here we describe an approach for global detection of DNA double-stranded breaks (DSBs) introduced by RGNs and potentially other nucleases. This method, called genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), relies on capture of double-stranded oligodeoxynucleotides into DSBs. Application of GUIDE-seq to 13 RGNs in two human cell lines revealed wide variability in RGN off-target activities and unappreciated characteristics of off-target sequences. The majority of identified sites were not detected by existing computational methods or chromatin immunoprecipitation sequencing (ChIP-seq). GUIDE-seq also identified RGN-independent genomic breakpoint 'hotspots'. Finally, GUIDE-seq revealed that truncated guide RNAs exhibit substantially reduced RGN-induced, off-target DSBs. Our experiments define the most rigorous framework for genome-wide identification of RGN off-target effects to date and provide a method for evaluating the safety of these nucleases before clinical use.	[Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Tsai, Shengdar Q.; Zheng, Zongli; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tsai, Shengdar Q.; Zheng, Zongli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	stsai4@mgh.harvard.edu; jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012; zheng, zongli/C-7309-2008; Aryee, Martin/AAC-8113-2020; Zheng, Zongli/B-2917-2011	Tsai, Shengdar Q./0000-0001-9161-3993; Zheng, Zongli/0000-0003-4849-4903	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM088040, R01 AR063070, F32 GM105189]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory; US Army Research Office [W911NF-11-2-0056]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378, F32GM105189] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Angstman, B. Kleinstiver, Y. Fu, J. Gehrke and R. Coltman for helpful comments on the manuscript and M. Maeder and J. Foden for technical assistance. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH R01 AR063070, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. S.Q.T. was supported by NIH F32 GM105189. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under grant number W911NF-11-2-0056. Links to software and resources for analyzing GUIDE-seq data will be made available at: http://www.jounglab.org/guideseq.	Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Marx V, 2014, NAT METHODS, V11, P1021, DOI 10.1038/nmeth.3108; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	35	1206	1350	18	277	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					187	197		10.1038/nbt.3117	http://dx.doi.org/10.1038/nbt.3117			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25513782	Green Accepted, Green Submitted			2022-12-25	WOS:000349198800025
J	Okada, T; Sinha, S; Esposito, I; Schiavon, G; Lopez-Lago, MA; Su, WJ; Pratilas, CA; Abele, C; Hernandez, JM; Ohara, M; Okada, M; Viale, A; Heguy, A; Socci, ND; Sapino, A; Seshan, VE; Long, S; Inghirami, G; Rosen, N; Giancotti, FG				Okada, Tomoyo; Sinha, Surajit; Esposito, Ilaria; Schiavon, Gaia; Lopez-Lago, Miguel A.; Su, Wenjing; Pratilas, Christine A.; Abele, Cristina; Hernandez, Jonathan M.; Ohara, Masahiro; Okada, Morihito; Viale, Agnes; Heguy, Adriana; Socci, Nicholas D.; Sapino, Anna; Seshan, Venkatraman E.; Long, Stephen; Inghirami, Giorgio; Rosen, Neal; Giancotti, Filippo G.			The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling	NATURE CELL BIOLOGY			English	Article							HUMAN BREAST-CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; RECEPTOR TYROSINE KINASE; GENE-EXPRESSION ANALYSIS; ACTIVATING PROTEIN; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; B-RAF; INDUCED SENESCENCE; EFFECTOR DOMAIN	We identified the Rho GTPase Rnd1 as a candidate metastasis suppressor in basal-like and triple-negative breast cancer through bioinformatics analysis. Depletion of Rnd1 disrupted epithelial adhesion and polarity, induced epithelial-to-mesenchymal transition, and cooperated with deregulated expression of c-Myc or loss of p53 to cause neoplastic conversion. Mechanistic studies revealed that Rnd1 suppresses Ras signalling by activating the GAP domain of Plexin B1, which inhibits Rap1. Rap1 inhibition in turn led to derepression of p120 Ras-GAP, which was able to inhibit Ras. Inactivation of Rnd1 in mammary epithelial cells induced highly undifferentiated and invasive tumours in mice. Conversely, Rnd1 expression inhibited spontaneous and experimental lung colonization in mouse models of metastasis. Genomic studies indicated that gene deletion in combination with epigenetic silencing or, more rarely, point mutation inactivates RND1 in human breast cancer. These results reveal a previously unappreciated mechanism through which Rnd1 restrains activation of Ras-MAPK signalling and breast tumour initiation and progression.	[Okada, Tomoyo; Sinha, Surajit; Esposito, Ilaria; Schiavon, Gaia; Lopez-Lago, Miguel A.; Su, Wenjing; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY 10065 USA; [Pratilas, Christine A.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Pratilas, Christine A.] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Pediat, New York, NY 10065 USA; [Abele, Cristina; Inghirami, Giorgio] Univ Turin, Dept Biomed Sci & Human Oncol, Ctr Expt Med & Res, I-10126 Turin, Italy; [Hernandez, Jonathan M.] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Surg, New York, NY 10065 USA; [Ohara, Masahiro; Okada, Morihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Grad Sch Biomed Sci, Dept Surg Oncol, Hiroshima 7348551, Japan; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Facil, New York, NY 10065 USA; [Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Geoffrey Beene Translat Oncol Core Facil, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Facil, New York, NY 10065 USA; [Sapino, Anna] Univ Turin, Ctr Expt Med & Res, Dept Med Sci, I-10126 Turin, Italy; [Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Mem Hosp, New York, NY 10065 USA; [Long, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Struct Biol Program, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Turin; Memorial Sloan Kettering Cancer Center; Hiroshima University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Turin; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	SINHA, SURAJIT/AAE-9200-2020; Rosen, Neal/ABF-2677-2020; Heguy, Adriana/GPP-3907-2022; Ohara, Mashiro/AAQ-3488-2020; Okada, Morihito/H-1495-2019; su, wenjing/V-4772-2018; Sapino, Anna/AGY-9901-2022; Sapino, Anna/J-4113-2018	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571	National Institutes of Health [P01 CA094060, P30 CA08748]; Geoffrey Beene Cancer Center at MSKCC; NATIONAL CANCER INSTITUTE [T32CA009501, R01CA078901, P30CA008748, R01CA113996, P01CA094060, R01CA058976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Center at MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank X. Zhang for advice, reagents, and for sharing the structure of the Plexin-GAP-Rap1 complex before its publication, R. A. Weinberg, J. S. Brugge, M. Overholtzer, A. Ridley, B. Park, L. Tamagnome, M. Resh, H. Djaballah, T. Kataoka, M. Negishi and D. Medina for reagents, K.Manova for assistance with confocal microscopy, R. Khanin and G. P. Gupta for help with multivariate analysis, M. Buck for comments on the manuscript, and members of the Giancotti laboratory for discussions. We thank the Geoffrey Beene Translational Oncology Core, the Genomic Core, and the HTG Core of MSKCC for technical assistance. This work was supported by grants from the National Institutes of Health (P01 CA094060 Project 4 to F.G.G. and P30 CA08748 to MSKCC) and the Geoffrey Beene Cancer Center at MSKCC.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Argast GM, 2009, ONCOGENE, V28, P2697, DOI 10.1038/onc.2009.133; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HATA Y, 1990, J BIOL CHEM, V265, P7104; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Rutherford S, 2005, LAB INVEST, V85, P1076, DOI 10.1038/labinvest.3700314; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	74	81	82	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					81	+		10.1038/ncb3082	http://dx.doi.org/10.1038/ncb3082			44	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25531777	Green Submitted, Green Accepted			2022-12-25	WOS:000346823900010
J	Li, LY; Yin, Q; Kuss, P; Maliga, Z; Millan, JL; Wu, H; Mitchison, TJ				Li, Lingyin; Yin, Qian; Kuss, Pia; Maliga, Zoltan; Millan, Jose L.; Wu, Hao; Mitchison, Timothy J.			Hydrolysis of 2 ' 3 '-cGAMP by ENPP1 and design of nonhydrolyzable analogs	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIC GMP-AMP; MEMBRANE GLYCOPROTEIN PC-1; CYTOSOLIC DNA; NUCLEOTIDE PHOSPHODIESTERASES; ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; BONE MINERALIZATION; SIGNALING PATHWAY; RESISTANCE; SENSOR	Agonists of mouse STING (TMEM173) shrink and even cure solid tumors by activating innate immunity; human STING (hSTING) agonists are needed to test this therapeutic hypothesis in humans. The endogenous STING agonist is 2'3'-cGAMP, a second messenger that signals the presence of cytosolic double-stranded DNA. We report activity-guided partial purification and identification of ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) to be the dominant 2'3'-cGAMP hydrolyzing activity in cultured cells. The hydrolysis activity of ENPP1 was confirmed using recombinant protein and was depleted in tissue extracts and plasma from Enpp1-/- mice. We synthesized a hydrolysis-resistant bisphosphothioate analog of 2'3'-cGAMP (2'3'-cGsAsMP) that has similar affinity for hSTING in vitro and is ten times more potent at inducing IFN-beta secretion from human THP1 monocytes. Studies in mouse Enpp1-/- lung fibroblasts indicate that resistance to hydrolysis contributes substantially to its higher potency. 2'3'-cGsAsMP is therefore improved over natural 2'3'-cGAMP as a model agonist and has potential as a vaccine adjuvant and cancer therapeutic.	[Li, Lingyin; Maliga, Zoltan; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA; [Yin, Qian; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Kuss, Pia; Millan, Jose L.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Sanford Burnham Prebys Medical Discovery Institute	Li, LY (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA.	lingyin_li@hms.harvard.edu		Yin, Qian/0000-0002-8481-150X	National Cancer Institute [CA139980, AR53102, AI050872, 1K99AI108793-01]; NATIONAL CANCER INSTITUTE [R00CA190896, P01CA139980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI108793, R01AI050872, R37AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Koch, P. Choi, K. Krukenberg, A. Groen, M. Loose, S. Kim and S. Gruver for helpful discussions. We thank R. Jiang for help with data analysis. We thank K. Chu for providing mouse livers. We thank S. Walker for sharing the MicroBeta plate reader and C. Fan for technical assistance. We thank J.J. Mekalanos for providing the DncV expression plasmid and T. Bernhard (both from Harvard Medical School) for providing the pTB146 plasmid. We thank G. Heffron and C. Sheahan for assistance with the NMR data collection and analysis. We thank R. Ward for help with manuscript preparation. This research was supported by the National Cancer Institute (CA139980, AR53102, AI050872 and 1K99AI108793-01). L. Li thanks the Jane Coffin Childs Fund for her postdoctoral fellowship.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BISCHOFF E, 1975, EUR J BIOCHEM, V51, P353, DOI 10.1111/j.1432-1033.1975.tb03935.x; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chin CN, 2009, EUR J PHARMACOL, V606, P17, DOI 10.1016/j.ejphar.2009.01.016; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Goding JW, 1998, IMMUNOL REV, V161, P11, DOI 10.1111/j.1600-065X.1998.tb01568.x; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kim S, 2013, ACS CHEM BIOL, V8, P1396, DOI 10.1021/cb400264n; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kubota K., J BIOL CHEM, V279, P37832; Lau WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066752; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Poulsen JB, 2011, NUCLEIC ACIDS RES, V39, P3754, DOI 10.1093/nar/gkq1282; Rey D, 2012, MOL BIOL REP, V39, P7687, DOI 10.1007/s11033-012-1604-1; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Umar A, 2009, MOL CELL PROTEOMICS, V8, P1278, DOI 10.1074/mcp.M800493-MCP200; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	43	226	258	4	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1043	+		10.1038/NChemBio.1661	http://dx.doi.org/10.1038/NChemBio.1661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25344812	Green Submitted, Green Accepted			2022-12-25	WOS:000345122300012
J	Park, SJ; Jiang, K; Tal, L; Yichie, Y; Gar, O; Zamir, D; Eshed, Y; Lippman, ZB				Park, Soon Ju; Jiang, Ke; Tal, Lior; Yichie, Yoav; Gar, Oron; Zamir, Dani; Eshed, Yuval; Lippman, Zachary B.			Optimization of crop productivity in tomato using induced mutations in the florigen pathway	NATURE GENETICS			English	Article							GROWTH HABIT; DETERMINATE GROWTH; FLOWERING TIME; GENE; ARABIDOPSIS; FT; TFL1; DOMESTICATION; ARCHITECTURE; EVOLUTION	Naturally occurring genetic variation in the universal florigen flowering pathway has produced major advancements in crop domestication(1-10). However, variants that can maximize crop yields may not exist in natural populations. Here we show that tomato productivity can be fine-tuned and optimized by exploiting combinations of selected mutations in multiple florigen pathway components. By screening for chemically induced mutations that suppress the bushy, determinate growth habit of field tomatoes, we isolated a new weak allele of the florigen gene SINGLE FLOWER TRUSS (SFT) and two mutations affecting a bZIP transcription factor component of the 'florigen activation complex' (ref. 11). By combining heterozygous mutations, we pinpointed an optimal balance of flowering signals, resulting in a new partially determinate architecture that translated to maximum yields. We propose that harnessing mutations in the florigen pathway to customize plant architecture and flower production offers a broad toolkit to boost crop productivity.	[Park, Soon Ju; Jiang, Ke; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tal, Lior; Eshed, Yuval] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Yichie, Yoav; Gar, Oron; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel	Cold Spring Harbor Laboratory; Weizmann Institute of Science; Hebrew University of Jerusalem	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu		Lippman, Zachary/0000-0001-7668-9025; Tal, Lior/0000-0002-1119-3392; Eshed, Yuval/0000-0001-8290-0018	European Research Council (ERC)-Advanced grant entitled YIELD; Israel Science Foundation (ISF) [1294-10]; Binational Agricultural Research and Development Fund (BARD) [IS4536-12C]; National Science Foundation (NSF) Plant Genome Research Program [1237880]	European Research Council (ERC)-Advanced grant entitled YIELD; Israel Science Foundation (ISF)(Israel Science Foundation); Binational Agricultural Research and Development Fund (BARD); National Science Foundation (NSF) Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank members of the Lippman laboratory for discussions, C. Brooks for technical assistance, T. Mulligan and P. Hanlon for plant care, and staff from Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York, and the Western Galilee Experimental Station in Akko, Israel, for assistance with the yield trials. We also thank M. Lodha and D. Jackson (Cold Spring Harbor Laboratory) for providing vectors, F. Yang and Y.K. Lee for guidance on in situ hybridization and Agrobacterium infiltration in tobacco, and S. Hearn for assistance with confocal microscopy. This research was supported by a European Research Council (ERC)-Advanced grant entitled YIELD to D.Z., by Israel Science Foundation (ISF; 1294-10) and Binational Agricultural Research and Development Fund (BARD; IS4536-12C) grants to YE. and by a grant from the National Science Foundation (NSF) Plant Genome Research Program (1237880) to Z.B.L.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Fernandez L, 2010, PLANT J, V61, P545, DOI 10.1111/j.1365-313X.2009.04090.x; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Guo Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00282; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00465; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; RICK CM, 1978, SCI AM, V239, P77; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869	34	121	125	13	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1337	1342		10.1038/ng.3131	http://dx.doi.org/10.1038/ng.3131			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362485				2022-12-25	WOS:000345547300016
J	Dowdle, WE; Nyfeler, B; Nagel, J; Elling, RA; Liu, SM; Triantafellow, E; Menon, S; Wang, ZC; Honda, A; Pardee, G; Cantwell, J; Luu, C; Cornella-Taracido, I; Harrington, E; Fekkes, P; Lei, H; Fang, Q; Digan, ME; Burdick, D; Powers, AF; Helliwell, SB; D'Aquin, S; Bastien, J; Wang, H; Wiederschain, D; Kuerth, J; Bergman, P; Schwalb, D; Thomas, J; Ugwonali, S; Harbinski, F; Tallarico, J; Wilson, CJ; Myer, VE; Porter, JA; Bussiere, DE; Finan, PM; Labow, MA; Mao, XH; Hamann, LG; Manning, BD; Valdez, RA; Nicholson, T; Schirle, M; Knapp, MS; Keaney, EP; Murphy, LO				Dowdle, William E.; Nyfeler, Beat; Nagel, Jane; Elling, Robert A.; Liu, Shanming; Triantafellow, Ellen; Menon, Suchithra; Wang, Zuncai; Honda, Ayako; Pardee, Gwynn; Cantwell, John; Luu, Catherine; Cornella-Taracido, Ivan; Harrington, Edmund; Fekkes, Peter; Lei, Hong; Fang, Qing; Digan, Mary Ellen; Burdick, Debra; Powers, Andrew F.; Helliwell, Stephen B.; D'Aquin, Simon; Bastien, Julie; Wang, Henry; Wiederschain, Dmitri; Kuerth, Jenny; Bergman, Philip; Schwalb, David; Thomas, Jason; Ugwonali, Savuth; Harbinski, Fred; Tallarico, John; Wilson, Christopher J.; Myer, Vic E.; Porter, Jeffery A.; Bussiere, Dirksen E.; Finan, Peter M.; Labow, Mark A.; Mao, Xiaohong; Hamann, Lawrence G.; Manning, Brendan D.; Valdez, Reginald A.; Nicholson, Thomas; Schirle, Markus; Knapp, Mark S.; Keaney, Erin P.; Murphy, Leon O.			Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo	NATURE CELL BIOLOGY			English	Article							GENOME-WIDE ASSOCIATION; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CROHN-DISEASE; IDENTIFICATION; UBIQUITIN; LYSOSOMES; DELETION; RECEPTOR; SYSTEM; KINASE	Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis. In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates. PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3) K alpha. PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates. By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes. NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative molecular mass of 450,000 to autolysosomes following starvation or iron depletion. Interestingly, Ncoa4(-/-) mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells. Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.	[Dowdle, William E.; Nagel, Jane; Liu, Shanming; Triantafellow, Ellen; Menon, Suchithra; Wang, Zuncai; Honda, Ayako; Cornella-Taracido, Ivan; Harrington, Edmund; Fekkes, Peter; Lei, Hong; Fang, Qing; Digan, Mary Ellen; Burdick, Debra; Powers, Andrew F.; Wang, Henry; Wiederschain, Dmitri; Kuerth, Jenny; Bergman, Philip; Schwalb, David; Thomas, Jason; Ugwonali, Savuth; Harbinski, Fred; Tallarico, John; Wilson, Christopher J.; Myer, Vic E.; Porter, Jeffery A.; Finan, Peter M.; Labow, Mark A.; Mao, Xiaohong; Hamann, Lawrence G.; Valdez, Reginald A.; Nicholson, Thomas; Schirle, Markus; Keaney, Erin P.; Murphy, Leon O.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Nyfeler, Beat; Helliwell, Stephen B.; D'Aquin, Simon; Bastien, Julie] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Elling, Robert A.; Pardee, Gwynn; Cantwell, John; Luu, Catherine; Bussiere, Dirksen E.; Knapp, Mark S.] Novartis Inst BioMed Res, Emeryville, CA 94608 USA; [Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Novartis; Novartis; Novartis; Harvard University; Harvard T.H. Chan School of Public Health	Murphy, LO (corresponding author), Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	leon.murphy@novartis.com	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Cornella-Taracido, Ivan/0000-0002-9433-5041; Wilson, Christopher/0000-0002-9146-522X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDREWS SC, 1987, BIOCHEM J, V245, P439, DOI 10.1042/bj2450439; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Begun J, 2013, CURR OPIN GASTROEN, V29, P588, DOI 10.1097/MOG.0b013e328365d34d; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boada-Romero E, 2013, EMBO J, V32, P566, DOI 10.1038/emboj.2013.8; BRIDGES KR, 1987, J BIOL CHEM, V262, P14773; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; COFFEY JW, 1968, J BIOL CHEM, V243, P3255; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; ERICSSON JL, 1969, EXP CELL RES, V55, P95, DOI 10.1016/0014-4827(69)90462-5; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levi S, 2005, BEST PRACT RES CL HA, V18, P265, DOI 10.1016/j.beha.2004.08.021; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger S, 2010, HUM GENET, V128, P453, DOI 10.1007/s00439-010-0873-9; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Newman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050672; Nyfeler B, 2012, METHODS MOL BIOL, V821, P239, DOI 10.1007/978-1-61779-430-8_14; Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Ohzono C, 2010, BIOL PHARM BULL, V33, P951, DOI 10.1248/bpb.33.951; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	72	384	397	10	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1069	+		10.1038/ncb3053	http://dx.doi.org/10.1038/ncb3053			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25327288				2022-12-25	WOS:000344744000006
J	Minami, SS; Min, SW; Krabbe, G; Wang, C; Zhou, YG; Asgarov, R; Li, YQ; Martens, LH; Elia, LP; Ward, ME; Mucke, L; Farese, RV; Gan, L				Minami, S. Sakura; Min, Sang-Won; Krabbe, Grietje; Wang, Chao; Zhou, Yungui; Asgarov, Rustam; Li, Yaqiao; Martens, Lauren H.; Elia, Lisa P.; Ward, Michael E.; Mucke, Lennart; Farese, Robert V., Jr.; Gan, Li			Progranulin protects against amyloid beta deposition and toxicity in Alzheimer's disease mouse models	NATURE MEDICINE			English	Article							NEURON LOSS; MICROGLIAL PHAGOCYTOSIS; TRANSGENIC MICE; INFLAMMATION; EXPRESSION; MUTATIONS; BRAIN; NEUROINFLAMMATION; ACCUMULATION; DYSFUNCTION	Haploinsufficiency of the progranulin (PGRN) gene (GRN) causes familial frontotemporal lobar degeneration (FTLD) and modulates an innate immune response in humans and in mouse models. GRN polymorphism may be linked to late-onset Alzheimer's disease (AD). However, the role of PGRN in AD pathogenesis is unknown. Here we show that PGRN inhibits amyloid beta (A beta) deposition. Selectively reducing microglial expression of PGRN in AD mouse models impaired phagocytosis, increased plaque load threefold and exacerbated cognitive deficits. Lentivirus-mediated PGRN overexpression lowered plaque load in AD mice with aggressive amyloid plaque pathology. A beta plaque load correlated negatively with levels of hippocampal PGRN, showing the dose-dependent inhibitory effects of PGRN on plaque deposition. PGRN also protected against A beta toxicity. Lentivirus-mediated PGRN overexpression prevented spatial memory deficits and hippocampal neuronal loss in AD mice. The protective effects of PGRN against A beta deposition and toxicity have important therapeutic implications. We propose enhancing PGRN as a potential treatment for PGRN-deficient FTLD and AD.	[Minami, S. Sakura; Min, Sang-Won; Krabbe, Grietje; Wang, Chao; Zhou, Yungui; Li, Yaqiao; Elia, Lisa P.; Ward, Michael E.; Mucke, Lennart; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Minami, S. Sakura; Min, Sang-Won; Krabbe, Grietje; Wang, Chao; Ward, Michael E.; Mucke, Lennart; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Asgarov, Rustam] Stockholm Univ, Grad Program Neurochem Mol Neurobiol, S-10691 Stockholm, Sweden; [Martens, Lauren H.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Stockholm University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gan, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Ward, Michael Emmerson/ABG-5892-2021; Asgarov, Rustam/ABC-5833-2021; Asgarov, Rustam/ABC-5272-2021; Asgarov, Rustam/ABB-3116-2021; Wang, Chao/A-4626-2016	Ward, Michael Emmerson/0000-0002-5296-8051; Asgarov, Rustam/0000-0001-6739-6394; Asgarov, Rustam/0000-0001-6739-6394; Asgarov, Rustam/0000-0001-6739-6394; Wang, Chao/0000-0003-0357-4096	Consortium for Frontotemporal Dementia Research; US National Institutes of Health [1R01AG036884, R0IAG030207, F32NS076239, F31AG034793, P30NS065780]; Stephen D. Bechtel Jr. Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076239, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030207, R01AG036884, P50AG023501, F31AG034793] Funding Source: NIH RePORTER	Consortium for Frontotemporal Dementia Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stephen D. Bechtel Jr. Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Finucane for statistical analyses, J. Lau and W. Weiss for technical advice, B. Miller and L. Mitic for discussions, G. Howard and A. Lucido for editorial review, J. Carroll and T. Roberts for graphics assistance, V. Shen and R. Chen for technical assistance, E.H. Koo (University of California San Diego) and P. Davies (Albert Einstein College of Medicine) for CT-15 and PHF-1 antibodies, respectively, and L. Goss for administrative assistance. This work was supported in part by the Consortium for Frontotemporal Dementia Research (L.G. and R.V.F.), the US National Institutes of Health (1R01AG036884 and R0IAG030207 to L.G.) and the Stephen D. Bechtel Jr. Foundation. S.S.M. is supported by US National Institutes of Health fellowship F32NS076239, and L.H.M. is supported by US National Institutes of Health fellowship F31AG034793. Behavioral data were obtained with the help of the Gladstone Institutes' Neurobehavioral Core (supported by US National Institutes of Health grant P30NS065780).	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cortini F, 2008, EUR J NEUROL, V15, P1111, DOI 10.1111/j.1468-1331.2008.02266.x; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gliebus G, 2009, AM J ALZHEIMERS DIS, V24, P456, DOI 10.1177/1533317509346209; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ottis P, 2012, PROTEOMICS, V12, P2445, DOI 10.1002/pmic.201100668; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Perry DC, 2013, JAMA NEUROL, V70, P774, DOI 10.1001/2013.jamaneurol.393; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Viswanathan J, 2009, AM J MED GENET B, V150B, P747, DOI 10.1002/ajmg.b.30889; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	52	157	163	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1157	1164		10.1038/nm.3672	http://dx.doi.org/10.1038/nm.3672			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25261995	Green Accepted, Green Submitted			2022-12-25	WOS:000343194100026
J	Hare, P				Hare, Peter			New plant species through grafting	NATURE BIOTECHNOLOGY			English	Editorial Material																		Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291	1	2	2	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					887	887		10.1038/nbt.3010	http://dx.doi.org/10.1038/nbt.3010			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203040				2022-12-25	WOS:000342600300027
J	Peng, WK; Kong, TF; Ng, CS; Chen, L; Huang, YX; Bhagat, AAS; Nguyen, NT; Preiser, PR; Han, J				Peng, Weng Kung; Kong, Tian Fook; Ng, Chee Sheng; Chen, Lan; Huang, Yongxue; Bhagat, Ali Asgar S.; Nam-Trung Nguyen; Preiser, Peter Rainer; Han, Jongyoon			Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis	NATURE MEDICINE			English	Article							ERYTHROCYTIC STAGES; BLOOD; CELLS; PARASITES	We report a new technique for sensitive, quantitative and rapid detection of Plasmodium spp.-infected red blood cells (RBCs) by means of magnetic resonance relaxometry (MRR). During the intraerythrocytic cycle, malaria parasites metabolize large amounts of cellular hemoglobin and convert it into hemozoin crystallites. We exploit the relatively large paramagnetic susceptibility of these hemozoin particles, which induce substantial changes in the transverse relaxation rate of proton nuclear magnetic resonance of RBCs, to infer the 'parasite load' in blood. Using an inexpensive benchtop 0.5-Tesla MRR system, we show that with minimal sample preparatory steps and without any chemical or immunolabeling, a parasitemia level of fewer than ten parasites per microliter in a volume below 10 mu l of whole blood is detected in a few minutes. We demonstrate this method both for cultured Plasmodium falciparum parasites and in vivo with Plasmodium berghei-infected mice.	[Peng, Weng Kung; Kong, Tian Fook; Chen, Lan; Huang, Yongxue; Bhagat, Ali Asgar S.; Nam-Trung Nguyen; Han, Jongyoon] Singapore MIT Alliance Res & Technol SMART Ctr, Biosyst & Micromech Interdisciplinary Res Grp IRG, Singapore, Singapore; [Kong, Tian Fook; Nam-Trung Nguyen] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Ng, Chee Sheng; Preiser, Peter Rainer] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Ng, Chee Sheng; Preiser, Peter Rainer] SMART Ctr, Infect Dis IRG, Singapore, Singapore; [Han, Jongyoon] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Han, Jongyoon] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Singapore-MIT Alliance for Research & Technology Centre (SMART); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Han, J (corresponding author), Singapore MIT Alliance Res & Technol SMART Ctr, Biosyst & Micromech Interdisciplinary Res Grp IRG, Singapore, Singapore.	wengkung@smart.mit.edu; ppreiser@ntu.edu.sg; jyhan@mit.edu	Nguyen, Nam-Trung/A-4180-2008; Peng, Weng Kung/AAE-3045-2022; Preiser, Peter R/A-2201-2011	Nguyen, Nam-Trung/0000-0003-3626-5361; Peng, Weng Kung/0000-0002-7984-9319; Bhagat, Ali Asgar/0000-0002-4695-8762; , Peter/0000-0003-4331-7000	National Research Foundation Singapore under its SMART Centre, BioSystems and Micromechanics IRG and Infectious Disease IRG; SMART Postdoctoral Research Fellows Programme; SMART Ignition Grant [ING 11025-BIO(IGN)]; Singapore-MIT Alliance (SMA) Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Research Foundation Singapore under its SMART Centre, BioSystems and Micromechanics IRG and Infectious Disease IRG; SMART Postdoctoral Research Fellows Programme; SMART Ignition Grant; Singapore-MIT Alliance (SMA) Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by the National Research Foundation Singapore under its SMART Centre, BioSystems and Micromechanics IRG and Infectious Disease IRG. W.K.P. acknowledges support from the SMART Postdoctoral Research Fellows Programme and SMART Ignition Grant (ING 11025-BIO(IGN)) and K.R. Roy for culturing and preparing the sample parasites. T.F.K. and C.S.N. acknowledge financial support from the Singapore-MIT Alliance (SMA) Graduate Fellowship.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bradley D., 2003, OXFORD TXB MED, P835; CARAMELLO P, 1993, DIAGN MICR INFEC DIS, V17, P293, DOI 10.1016/0732-8893(93)90038-9; Eccles C., 2010, ENCY SPECTROSCOPY SP; Goodman AL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01706; Hackett S, 2009, BBA-MOL BASIS DIS, V1792, P93, DOI 10.1016/j.bbadis.2008.11.001; Jr Sullivan D., 2005, BIOPOLYM        0115, DOI [10.1002/3527600035.bpol9007, DOI 10.1002/3527600035.BPOL9007]; Karl S, 2011, AM J TROP MED HYG, V85, P815, DOI 10.4269/ajtmh.2011.11-0299; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lee H, 2009, P NATL ACAD SCI USA, V106, P12459, DOI 10.1073/pnas.0902365106; MAKLER MT, 1991, AM J TROP MED HYG, V44, P11, DOI 10.4269/ajtmh.1991.44.11; MEYER ME, 1995, MAGNET RESON MED, V34, P234, DOI 10.1002/mrm.1910340215; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Peng W.K., 2012, WO Patent, Patent No. [WO2012118442, 2012118442]; Peng WK, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4754296; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Takeda K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712940; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Vo N.N., 2014, IFMBE P, V43, P558; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; Webb G.A, 1997, PROG NUCL MAGN RESON, V31, P1; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yanez DM, 1996, J IMMUNOL, V157, P1620	26	76	77	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1069	1073		10.1038/nm.3622	http://dx.doi.org/10.1038/nm.3622			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25173428	Green Published			2022-12-25	WOS:000341404000021
J	Xu, M; Nagati, JS; Xie, J; Li, JW; Walters, H; Moon, YA; Gerard, RD; Huang, CL; Comerford, SA; Hammer, RE; Horton, JD; Chen, R; Garcia, JA				Xu, Min; Nagati, Jason S.; Xie, Jian; Li, Jiwen; Walters, Holly; Moon, Young-Ah; Gerard, Robert D.; Huang, Chou-Long; Comerford, Sarah A.; Hammer, Robert E.; Horton, Jay D.; Chen, Rui; Garcia, Joseph A.			An acetate switch regulates stress erythropoiesis	NATURE MEDICINE			English	Article							INDUCIBLE FACTOR (HIF)-1-ALPHA; ACETYL-COA SYNTHETASE; ATP-CITRATE LYASE; TRANSCRIPTION FACTOR; FACTOR-I; HYPOXIA; OXYGEN; METABOLISM; ADAPTATION; EXPRESSION	The hormone erythropoietin (EPO), which is synthesized in the kidney or liver of adult mammals, controls erythrocyte production and is regulated by the stress-responsive transcription factor hypoxia-inducible factor-2 (HIF-2). We previously reported that the lysine acetyltransferase CREB-binding protein (CBP) is required for HIF-2 alpha acetylation and efficient HIF-2-dependent EPO induction during hypoxia. We now show that these processes require acetate-dependent acetyl CoA synthetase 2 (ACSS2). In human Hep3B hepatoma cells and in EPO-generating organs of hypoxic or acutely anemic mice, acetate levels rise and ACSS2 is required for HIF-2 alpha acetylation, CBP-HIF-2 alpha complex formation, CBP-HIF-2 alpha recruitment to the EPO enhancer and efficient induction of EPO gene expression. In acutely anemic mice, acetate supplementation augments stress erythropoiesis in an ACSS2-dependent manner. Moreover, in acquired and inherited chronic anemia mouse models, acetate supplementation increases EPO expression and the resting hematocrit. Thus, a mammalian stress-responsive acetate switch controls HIF-2 signaling and EPO induction during pathophysiological states marked by tissue hypoxia.	[Xu, Min; Nagati, Jason S.; Xie, Jian; Li, Jiwen; Huang, Chou-Long; Chen, Rui; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Walters, Holly; Moon, Young-Ah; Comerford, Sarah A.; Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia, Joseph A.] VA North Texas Hlth Care Syst, Dept Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Chen, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	rui.chen@utsouthwestern.edu; joseph.garcia@utsouthwestern.edu		Comerford, Sarah Ann/0000-0002-7452-7759; Hammer, Robert E./0000-0001-5487-7551; Nagati, Jason/0000-0002-4507-6581; Garcia, Joseph/0000-0002-5621-7538; Xie, Jian/0000-0001-9454-1358	US Department of Veterans Affairs [I01BX000446]; US National Institutes of Health [HL108104, HL20948, DK79328]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R01HL108104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Hogg, A. Das, J. Colunga, S. Nystrom and E. Ballard for technical assistance. We thank D. Trono, Ecole Polytechnique Federale de Lausanne, for making the lentiviral packaging and envelope plasmids available to us through Addgene. These studies were supported by funds provided by the US Department of Veterans Affairs (I01BX000446 to J.A.G.) and the US National Institutes of Health (HL108104 to JAG.; HL20948 to J.D.H.; and DK79328 to C.-L.H.).	Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; Ball AM, 2008, PHARMACOTHERAPY, V28, P1383, DOI 10.1592/phco.28.11.1383; BARTH C, 1971, BIOCHIM BIOPHYS ACTA, V248, P24, DOI 10.1016/0005-2760(71)90071-3; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Brox AG, 1996, KIDNEY INT, V50, P937, DOI 10.1038/ki.1996.394; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Cao YH, 2013, TRENDS ENDOCRIN MET, V24, P190, DOI 10.1016/j.tem.2012.10.007; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; CRABTREE B, 1987, BIOCHEM J, V243, P821, DOI 10.1042/bj2430821; CRABTREE B, 1978, EUR J BIOCHEM, V89, P19, DOI 10.1111/j.1432-1033.1978.tb20891.x; CRABTREE B, 1990, BIOCHEM J, V270, P219, DOI 10.1042/bj2700219; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; GORDON MJ, 1992, INT J BIOCHEM, V24, P1029, DOI 10.1016/0020-711X(92)90369-C; Grover A, 2014, J EXP MED, V211, P181, DOI 10.1084/jem.20131189; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; KABAYA K, 1995, LIFE SCI, V57, P1067, DOI 10.1016/0024-3205(95)02052-K; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Koury MJ, 2005, EXP HEMATOL, V33, P1263, DOI 10.1016/j.exphem.2005.06.031; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Loikkanen D, 2002, MECH DEVELOP, V115, P139, DOI 10.1016/S0925-4773(02)00097-7; LORD BI, 1973, BLOOD, V42, P89, DOI 10.1182/blood.V42.1.89.89; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; MANSELL MA, 1983, BRIT MED J, V287, P308, DOI 10.1136/bmj.287.6388.308; Masuda A, 2012, NEPHRON EXTRA, V2, P256, DOI 10.1159/000342258; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; O'Connor PM, 2006, CLIN EXP PHARMACOL P, V33, P961, DOI 10.1111/j.1440-1681.2006.04475.x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RABKIN M, 1985, BIOCHEM J, V225, P761, DOI 10.1042/bj2250761; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Richalet JP, 1997, COMP BIOCHEM PHYS A, V118, P9, DOI 10.1016/S0300-9629(96)00370-2; RUSSELL ES, 1949, GENETICS, V34, P708; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; SUZUKI M, 1994, CONTRIB NEPHROL, V108, P114; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tonia T, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD003407.PUB5; VEECH RL, 1988, ADV ENZYME REGUL, V27, P313, DOI 10.1016/0065-2571(88)90024-6; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011303; Yamashita H, 2001, BBA-MOL CELL BIOL L, V1532, P79, DOI 10.1016/S1388-1981(01)00117-2; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zhou B, 2014, J CLIN INVEST, V124, P553, DOI 10.1172/JCI69804	60	43	44	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1018	1026		10.1038/nm.3587	http://dx.doi.org/10.1038/nm.3587			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25108527	Green Accepted			2022-12-25	WOS:000341404000014
J	Bachovchin, DA; Koblan, LW; Wu, WG; Liu, YX; Li, YH; Zhao, P; Woznica, I; Shu, Y; Lai, JH; Poplawski, SE; Kiritsy, CP; Healey, SE; DiMare, M; Sanford, DG; Munford, RS; Bachovchin, WW; Golub, TR				Bachovchin, Daniel A.; Koblan, Luke W.; Wu, Wengen; Liu, Yuxin; Li, Youhua; Zhao, Peng; Woznica, Iwona; Shu, Ying; Lai, Jack H.; Poplawski, Sarah E.; Kiritsy, Christopher P.; Healey, Sarah E.; DiMare, Matthew; Sanford, David G.; Munford, Robert S.; Bachovchin, William W.; Golub, Todd R.			A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity	NATURE CHEMICAL BIOLOGY			English	Article							RETINOBLASTOMA-BINDING PROTEIN; KINASE INHIBITOR SELECTIVITY; DIPEPTIDYL PEPTIDASE-IV; A-LIKE ENZYME; SERINE HYDROLASES; IN-VIVO; PANCREATIC ELASTASE; COVALENT INHIBITORS; PROTEASOME; PROLYLCARBOXYPEPTIDASE	The selectivity of an enzyme inhibitor is a key determinant of its usefulness as a tool compound or its safety as a drug. Yet selectivity is never assessed comprehensively in the early stages of the drug discovery process, and only rarely in the later stages, because technical limitations prohibit doing otherwise. Here, we report EnPlex, an efficient, high-throughput method for simultaneously assessing inhibitor potency and specificity, and pilot its application to 96 serine hydrolases. EnPlex analysis of widely used serine hydrolase inhibitors revealed numerous previously unrecognized off-target interactions, some of which may help to explain previously confounding adverse effects. In addition, EnPlex screening of a hydrolase-directed library of boronic acid-and nitrile-containing compounds provided structure-activity relationships in both potency and selectivity dimensions from which lead candidates could be more effectively prioritized. Follow-up of a series of dipeptidyl peptidase 4 inhibitors showed that EnPlex indeed predicted efficacy and safety in animal models. These results demonstrate the feasibility and value of high-throughput, superfamily-wide selectivity profiling and suggest that such profiling can be incorporated into the earliest stages of drug discovery.	[Bachovchin, Daniel A.; Koblan, Luke W.; Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Wu, Wengen; Liu, Yuxin; Li, Youhua; Zhao, Peng; Woznica, Iwona; Shu, Ying; Lai, Jack H.; Poplawski, Sarah E.; Healey, Sarah E.; DiMare, Matthew; Sanford, David G.; Bachovchin, William W.] Tufts Univ, Dept Biochem, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Kiritsy, Christopher P.; Bachovchin, William W.] Arisaph Pharmaceut, Boston, MA USA; [Munford, Robert S.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Golub, TR (corresponding author), Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	golub@broadinstitute.org	liu, yuxin/GRY-3592-2022; william.bachovchin@tufts.edu/AAA-3538-2022	Koblan, Luke/0000-0003-2814-4412	National Cancer Institute [U54CA112962]; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [R01 CA163930]; Arisaph Pharmaceuticals; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL CANCER INSTITUTE [U54CA112962, R01CA163930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001138] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arisaph Pharmaceuticals; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Cravatt (The Scripps Research Institute) for the FP serine hydrolase probe; B. Martin (University of Michigan), J. Long (Dana-Farber Cancer Institute), A. Lone and A. Saghatelian (both at Harvard University) for constructs; J. Davis and D. Peck (both at The Broad Institute) for technical assistance; and D. Gray and C. Yu (both at The Broad Institute) for helpful discussions. This work was supported by the National Cancer Institute (grant no. U54CA112962 to T. R. G.), Howard Hughes Medical Institute (T. R. G.), the US National Institutes of Health (NIH; grant R01 CA163930 to W. W. B.), Arisaph Pharmaceuticals (W. W. B.) and in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH (R. S. M.).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bachovchin DA, 2010, BIOORG MED CHEM LETT, V20, P2254, DOI 10.1016/j.bmcl.2010.02.011; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Choy Mary, 2007, Cardiol Rev, V15, P264, DOI 10.1097/CRD.0b013e318123f771; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Connolly BA, 2008, J MED CHEM, V51, P6005, DOI 10.1021/jm800390n; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FLENTKE GR, 1991, P NATL ACAD SCI USA, V88, P1556, DOI 10.1073/pnas.88.4.1556; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2010, J MED CHEM, V53, P1830, DOI 10.1021/jm9016976; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; Mallela J, 2009, INT J BIOCHEM CELL B, V41, P477, DOI 10.1016/j.biocel.2008.02.022; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Munford R, 2009, ADV IMMUNOL, V103, P29, DOI 10.1016/S0065-2776(09)03002-8; MUNFORD RS, 1992, METHOD ENZYMOL, V209, P485; MUNFORD RS, 1989, J BIOL CHEM, V264, P15613; Ostrowska H, 1997, BIOCHEM BIOPH RES CO, V234, P729, DOI 10.1006/bbrc.1997.6434; Ostrowska H, 2000, INT J BIOCHEM CELL B, V32, P747, DOI 10.1016/S1357-2725(00)00021-2; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Roujeau JC, 2013, JAMA DERMATOL, V149, P152, DOI 10.1001/jamadermatol.2013.938; SAWYER L, 1978, J MOL BIOL, V118, P137, DOI 10.1016/0022-2836(78)90412-6; Schlutter J, 2011, NATURE, V474, pS5, DOI 10.1038/474S5a; Shields DJ, 2010, P NATL ACAD SCI USA, V107, P2189, DOI 10.1073/pnas.0911646107; Soisson SM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-16; Talas U, 2000, J INVEST DERMATOL, V114, P165, DOI 10.1046/j.1523-1747.2000.00825.x; TANI T, 1988, J BIOL CHEM, V263, P1231; Thareja S, 2010, MINI-REV MED CHEM, V10, P759, DOI 10.2174/138955710791572424; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Woitach JT, 1998, NAT GENET, V19, P371, DOI 10.1038/1258; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhou CY, 2010, J MED CHEM, V53, P7251, DOI 10.1021/jm101013m	53	47	52	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					656	U203		10.1038/NCHEMBIO.1578	http://dx.doi.org/10.1038/NCHEMBIO.1578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24997602	Green Accepted, Green Submitted			2022-12-25	WOS:000339380100012
J	Lu, Q; Insinna, C; Ott, C; Stauffer, J; Pintado, PA; Rahajeng, J; Baxa, U; Walia, V; Cuenca, A; Hwang, YS; Daar, IO; Lopes, S; Lippincott-Schwartz, J; Jackson, PK; Caplan, S; Westlake, CJ				Lu, Quanlong; Insinna, Christine; Ott, Carolyn; Stauffer, Jimmy; Pintado, Petra A.; Rahajeng, Juliati; Baxa, Ulrich; Walia, Vijay; Cuenca, Adrian; Hwang, Yoo-Seok; Daar, Ira O.; Lopes, Susana; Lippincott-Schwartz, Jennifer; Jackson, Peter K.; Caplan, Steve; Westlake, Christopher J.			Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation	NATURE CELL BIOLOGY			English	Article							MOTHER CENTRIOLE; PRIMARY CILIOGENESIS; DISTINCT ROLES; EHD PROTEINS; GTPASE RAB8; MEMBRANE; TRANSPORT; DOCKING; COMPLEX; BIOGENESIS	Membrane association with mother centriole (M-centriole) distal appendages is critical for ciliogenesis initiation. How the Rab GTPase Rab11-Rab8 cascade functions in early ciliary membrane assembly is unknown. Here, we show that the membrane shaping proteins EHD1 and EHD3, in association with the Rab11-Rab8 cascade, function in early ciliogenesis. EHD1 and EHD3 localize to preciliary membranes and the ciliary pocket. EHD-dependent membrane tubulation is essential for ciliary vesicle formation from smaller distal appendage vesicles (DAVs). Importantly, this step functions in M-centriole to basal body transformation and recruitment of transition zone proteins and IFT20. SNAP29, a SNARE membrane fusion regulator and EHD1-binding protein, is also required for DAV-mediated ciliary vesicle assembly. Interestingly, only after ciliary vesicle assembly is Rab8 activated for ciliary growth. Our studies uncover molecular mechanisms informing a previously uncharacterized ciliogenesis step, whereby EHD1 and EHD3 reorganize the M-centriole and associated DAVs before coordinated ciliary membrane and axoneme growth.	[Lu, Quanlong; Insinna, Christine; Stauffer, Jimmy; Walia, Vijay; Cuenca, Adrian; Hwang, Yoo-Seok; Daar, Ira O.; Westlake, Christopher J.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA; [Ott, Carolyn; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Pintado, Petra A.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1169056 Lisbon, Portugal; [Rahajeng, Juliati; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Rahajeng, Juliati; Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Baxa, Ulrich; Lopes, Susana] NCI, ATRF, Frederick Natl Lab, Frederick, MD 21701 USA; [Jackson, Peter K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidade Nova de Lisboa; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Westlake, CJ (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	chris.westlake@nih.gov	Lu, Quanlong/M-4436-2015; Westlake, Christopher/AAG-1150-2019; Lopes, Susana/AAB-3820-2019	Lu, Quanlong/0000-0002-4261-5121; Westlake, Christopher/0000-0001-7476-2014; Baxa, Ulrich/0000-0002-7263-5078; Jackson, Peter/0000-0002-1742-2539; Daar, Ira/0000-0003-2657-526X; Lopes, Susana/0000-0002-6733-6356	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010958, P30CA036727, ZIABC011398] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frederick National Laboratory for Cancer Research, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Nagashima and A. Kamata for help with IEM and EM, C. Lamont for data analysis, S. Lockett for help with SIM imaging, S. Specht for help with cell culture, A. Peden for SNAP29 antibodies, J. Goldenring for Rab11 antibodies, Z. Sun for the transgenic line and S. Burgess for assistance raising zebrafish embryos. We are grateful to J. Donaldson for critical reading of thismanuscript. This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. This project has also been funded in partwith federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E.	Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fuchs-Telem D, 2011, BRIT J DERMATOL, V164, P610, DOI 10.1111/j.1365-2133.2010.10133.x; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Hehnly H, 2012, CURR BIOL, V22, P1944, DOI 10.1016/j.cub.2012.08.022; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Klinger M, 2014, MOL BIOL CELL, V25, P495, DOI 10.1091/mbc.E13-09-0526; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kobayashi T, 2014, J CELL BIOL, V204, P215, DOI 10.1083/jcb.201304153; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lu QL, 2012, CELL RES, V22, P1562, DOI 10.1038/cr.2012.113; Malicki J, 2011, METHOD CELL BIOL, V101, P39, DOI 10.1016/B978-0-12-387036-0.00003-7; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; SOROKIN SP, 1968, J CELL SCI, V3, P207; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang J, 2012, BIOSCIENCE REP, V32, P17, DOI 10.1042/BSR20110009	58	137	146	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					228	+		10.1038/ncb3109	http://dx.doi.org/10.1038/ncb3109			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25686250	Green Accepted			2022-12-25	WOS:000350770200008
J	Fong, MY; Zhou, WY; Liu, L; Alontaga, AY; Chandra, M; Ashby, J; Chow, A; O'Connor, STF; Li, SS; Chin, AR; Somlo, G; Palomares, M; Li, Z; Tremblay, JR; Tsuyada, A; Sun, GQ; Reid, MA; Wu, XW; Swiderski, P; Ren, XB; Shi, YH; Kong, M; Zhong, WW; Chen, Y; Wang, SE				Fong, Miranda Y.; Zhou, Weiying; Liu, Liang; Alontaga, Aileen Y.; Chandra, Manasa; Ashby, Jonathan; Chow, Amy; O'Connor, Sean Timothy Francis; Li, Shasha; Chin, Andrew R.; Somlo, George; Palomares, Melanie; Li, Zhuo; Tremblay, Jacob R.; Tsuyada, Akihiro; Sun, Guoqiang; Reid, Michael A.; Wu, Xiwei; Swiderski, Piotr; Ren, Xiubao; Shi, Yanhong; Kong, Mei; Zhong, Wenwan; Chen, Yuan; Wang, Shizhen Emily			Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis	NATURE CELL BIOLOGY			English	Article							PYRUVATE-KINASE M2; CIRCULATING MICRORNAS; MESSENGER-RNAS; GENE-TRANSCRIPTION; UP-REGULATION; IN-SITU; CELLS; FIBROBLASTS; TRANSPORT; EXOSOMES	Reprogrammed glucose metabolism as a result of increased glycolysis and glucose uptake is a hallmark of cancer. Here we show that cancer cells can suppress glucose uptake by non-tumour cells in the premetastatic niche, by secreting vesicles that carry high levels of the miR-122 microRNA. High miR-122 levels in the circulation have been associated with metastasis in breast cancer patients, and we show that cancer-cell-secreted miR-122 facilitates metastasis by increasing nutrient availability in the premetastatic niche. Mechanistically, cancer-cell-derived miR-122 suppresses glucose uptake by niche cells in vitro and in vivo by downregulating the glycolytic enzyme pyruvate kinase. In vivo inhibition of miR-122 restores glucose uptake in distant organs, including brain and lungs, and decreases the incidence of metastasis. These results demonstrate that, by modifying glucose utilization by recipient premetastatic niche cells, cancer-derived extracellular miR-122 is able to reprogram systemic energy metabolism to facilitate disease progression.	[Fong, Miranda Y.; Zhou, Weiying; Liu, Liang; Chandra, Manasa; Chow, Amy; O'Connor, Sean Timothy Francis; Li, Shasha; Chin, Andrew R.; Tremblay, Jacob R.; Tsuyada, Akihiro; Reid, Michael A.; Kong, Mei; Wang, Shizhen Emily] City Hope Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Liu, Liang; Ren, Xiubao; Wang, Shizhen Emily] Tianjin Med Univ Canc Inst & Hosp, Dept Biotherapy, Tianjin 300060, Peoples R China; [Liu, Liang; Ren, Xiubao; Wang, Shizhen Emily] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Immunol, Tianjin 300060, Peoples R China; [Alontaga, Aileen Y.; Chen, Yuan] City Hope Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Chandra, Manasa; Chin, Andrew R.; Tremblay, Jacob R.] City Hope Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Ashby, Jonathan; Zhong, Wenwan] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Somlo, George; Palomares, Melanie] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA 91010 USA; [Palomares, Melanie] City Hope Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Li, Zhuo] City Hope Comprehens Canc Ctr, Core Electron Microscopy, Duarte, CA 91010 USA; [Sun, Guoqiang; Shi, Yanhong] City Hope Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Comprehens Canc Ctr, Core Integrat Genom, Duarte, CA 91010 USA; [Swiderski, Piotr] City Hope Comprehens Canc Ctr, Core Synthet & Biopolymer Chem, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; Tianjin Medical University; Tianjin Medical University; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Riverside; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope	Wang, SE (corresponding author), City Hope Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	ewang@coh.org	LI, SHASHA/AAT-6809-2021	LI, SHASHA/0000-0002-3523-6801; Wang, Shizhen Emily/0000-0002-5036-8175; Zhou, Weiying/0000-0001-8057-8379; Shi, Yanhong/0000-0002-3938-5839; Reid, Michael/0000-0001-6222-9538; Ashby, Jonathan/0000-0002-9379-4377	United States Army Research and Material Command [W81-14-1-0029]; National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01CA166020, R01CA163586]; California Breast Cancer Research Program [20IB-0118]; Breast Cancer Research Foundation-AACR [12-60-26-WANG]; City of Hope Women's Cancer Program; NIH/NCI [P30CA33572]; NATIONAL CANCER INSTITUTE [R01CA163586, R01CA166020, R01CA183989, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102538, R01GM086171] Funding Source: NIH RePORTER	United States Army Research and Material Command; National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program; Breast Cancer Research Foundation-AACR; City of Hope Women's Cancer Program; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States Army Research and Material Command grant W81-14-1-0029 (M.Y.E), National Institutes of Health (NIH)/National Cancer Institute (NCI) grants R01CA166020 (S.E.W.) and R01CA163586 (S.E.W.), California Breast Cancer Research Program grant 20IB-0118 (S.E.W.), Breast Cancer Research Foundation-AACR grant 12-60-26-WANG (S.E.W.) and the City of Hope Women's Cancer Program. Research reported here includes work carried out in Core Facilities supported by the NIH/NCI under grant number P30CA33572. We thank A. Riggs, E. Roberts, L. Malkas, S. Kane, S. Chen, J. Mortimer and P. Sarnow for valuable comments, as well as the Core Facilities at City ot Hope for services.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Ashby J, 2014, ANAL CHEM, V86, P9343, DOI 10.1021/ac5028929; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cano KE, 2010, J PROTEOME RES, V9, P5382, DOI 10.1021/pr100614a; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Clayton A., 2006, CURR PROTOC CELL BIO; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; EDWARDS RJ, 1981, CLIN CHEM, V27, P906; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Itoh Y, 2004, J CEREBR BLOOD F MET, V24, P993, DOI 10.1097/01.WCB.0000127661.07591.DE; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kang SS, 2002, JPN J CANCER RES, V93, P1123, DOI 10.1111/j.1349-7006.2002.tb01214.x; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lloyd PG, 1999, PHYSIOL RES, V48, P401; Loaiza A, 2003, J NEUROSCI, V23, P7337; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; ORourke JF, 1996, EUR J BIOCHEM, V241, P403, DOI 10.1111/j.1432-1033.1996.00403.x; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Redis RS, 2012, PHARMACOL THERAPEUT, V136, P169, DOI 10.1016/j.pharmthera.2012.08.003; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Spoden GA, 2009, J CELL BIOCHEM, V107, P293, DOI 10.1002/jcb.22125; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wu XW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-42; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yu Y, 2010, MOL CANCER RES, V8, P1633, DOI 10.1158/1541-7786.MCR-10-0362; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	69	690	726	7	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					183	+		10.1038/ncb3094	http://dx.doi.org/10.1038/ncb3094			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25621950	Green Accepted, Green Published			2022-12-25	WOS:000349152400009
J	Kamat, SS; Camara, K; Parsons, WH; Chen, DH; Dix, MM; Bird, TD; Howell, AR; Cravatt, BF				Kamat, Siddhesh S.; Camara, Kaddy; Parsons, William H.; Chen, Dong-Hui; Dix, Melissa M.; Bird, Thomas D.; Howell, Amy R.; Cravatt, Benjamin F.			Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay	NATURE CHEMICAL BIOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SERINE HYDROLASES; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; PHOSPHOLIPASE A(1); HISTAMINE-RELEASE; GRAVES-DISEASE; X-CHROMOSOME; MAST-CELLS; BRAIN; PHOSPHATIDYLSERINE	Lysophosphatidylserines (lyso-PSs) are a class of signaling lipids that regulate immunological and neurological processes. The metabolism of lyso-PSs remains poorly understood in vivo. Recently, we determined that ABHD12 is a major brain lyso-PS lipase, implicating lyso-PSs in the neurological disease polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and cataract (PHARC), which is caused by null mutations in the ABHD12 gene. Here, we couple activity-based profiling with pharmacological and genetic methods to annotate the poorly characterized enzyme ABHD16A as a phosphatidylserine (PS) lipase that generates lyso-PS in mammalian systems. We describe a small-molecule inhibitor of ABHD16A that depletes lyso-PSs from cells, including lymphoblasts derived from subjects with PHARC. In mouse macrophages, disruption of ABHD12 and ABHD16A respectively increases and decreases both lyso-PSs and lipopolysaccharide-induced cytokine production. Finally, Abhd16a(-/-) mice have decreased brain lyso-PSs, which runs counter to the elevation in lyso-PS in Abhd12(-/-) mice. Our findings illuminate an ABHD16A-ABHD12 axis that dynamically regulates lyso-PS metabolism in vivo, designating these enzymes as potential targets for treating neuroimmunological disorders.	[Kamat, Siddhesh S.; Parsons, William H.; Dix, Melissa M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Kamat, Siddhesh S.; Parsons, William H.; Dix, Melissa M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Camara, Kaddy; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT USA; [Chen, Dong-Hui; Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bird, Thomas D.] Univ Washington, Dept Med, Seattle, WA USA; [Bird, Thomas D.] VA Puget Sound Hlth Care Syst, Seattle, WA USA	Scripps Research Institute; Scripps Research Institute; University of Connecticut; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	cravatt@scripps.edu		Kamat, Siddhesh/0000-0001-6132-7574; Parsons, William/0000-0001-6065-2340; Howell, Amy/0000-0003-1958-6411; Camara, Kaddy/0000-0002-2618-8385	US National Institutes of Health [DA033760]; American Chemical Society; Hewitt Foundation for Medical Research fellowship; Department of Veterans Affairs Research Funds; US National Science Foundation [CHE-0809753, CHE-1048717]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033760] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001006] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Hewitt Foundation for Medical Research fellowship; Department of Veterans Affairs Research Funds(US Department of Veterans Affairs); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to K. Masuda, A. Viader and K.-L. Hsu for their helpful discussions, guidance and technical expertise in harvesting tissues; G. Simon and J. Blankman for helpful discussions; M. Niphakis for advice on the SAR studies on the beta-lactone scaffolds; O. Ulanovskaya for advice on generating the shRNA knockdown cell lines; B. Correia for the guidance on using CIMAGE; C. Joslyn and T. Takei for technical assistance; and M. Lau for contributions to initial synthetic studies. This work was supported by the US National Institutes of Health (DA033760) and the ninth Irving S. Sigal postdoctoral fellowship from the American Chemical Society (to S.S.K.), a Hewitt Foundation for Medical Research fellowship (to W.H.P.), the Department of Veterans Affairs Research Funds (to T.D.B.) and the US National Science Foundation (CHE-0809753 and CHE-1048717 to A.R.H.).	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Baggelaar MP, 2013, ANGEW CHEM INT EDIT, V52, P12081, DOI 10.1002/anie.201306295; Billich Andreas, 2008, V49, P487, DOI 10.1007/978-1-4020-8831-5_19; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; Camara K, 2015, BIOORG MED CHEM LETT, V25, P317, DOI 10.1016/j.bmcl.2014.11.038; Chen DH, 2013, HUM MUTAT, V34, P1672, DOI 10.1002/humu.22437; Chu X, 2013, J MED GENET, V50, P479, DOI 10.1136/jmedgenet-2013-101595; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Frasch SC, 2013, J BIOL CHEM, V288, P4583, DOI 10.1074/jbc.M112.438507; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; KELLEHER JA, 1985, NEUROCHEM INT, V7, P825, DOI 10.1016/0197-0186(85)90038-5; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Lee SY, 2008, BIOCHEM BIOPH RES CO, V374, P147, DOI 10.1016/j.bbrc.2008.06.117; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; LLORET S, 1995, J CELL PHYSIOL, V165, P89, DOI 10.1002/jcp.1041650112; Lynch KR, 2008, BBA-MOL CELL BIOL L, V1781, P508, DOI 10.1016/j.bbalip.2008.06.006; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Ngai MH, 2010, CHEM COMMUN, V46, P8335, DOI 10.1039/c0cc01276a; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Park KS, 2005, BIOCHEM BIOPH RES CO, V333, P353, DOI 10.1016/j.bbrc.2005.05.109; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; SPIES T, 1989, P NATL ACAD SCI USA, V86, P8955, DOI 10.1073/pnas.86.22.8955; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Sugita K, 2013, BIOCHEM BIOPH RES CO, V430, P190, DOI 10.1016/j.bbrc.2012.11.046; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Szymanski K, 2014, TISSUE ANTIGENS, V83, P41, DOI 10.1111/tan.12259; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031	49	87	89	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					164	U116		10.1038/NCHEMBIO.1721	http://dx.doi.org/10.1038/NCHEMBIO.1721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25580854	Green Accepted			2022-12-25	WOS:000348358800015
J	Korf-Klingebiel, M; Reboll, MR; Klede, S; Brod, T; Pich, A; Polten, F; Napp, LC; Bauersachs, J; Ganser, A; Brinkmann, E; Reimann, I; Kempf, T; Niessen, HW; Mizrahi, J; Schonfeld, HJ; Iglesias, A; Bobadilla, M; Wang, Y; Wollert, KC				Korf-Klingebiel, Mortimer; Reboll, Marc R.; Klede, Stefanie; Brod, Torben; Pich, Andreas; Polten, Felix; Napp, L. Christian; Bauersachs, Johann; Ganser, Arnold; Brinkmann, Eva; Reimann, Ines; Kempf, Tibor; Niessen, Hans W.; Mizrahi, Jacques; Schoenfeld, Hans-Joachim; Iglesias, Antonio; Bobadilla, Maria; Wang, Yong; Wollert, Kai C.			Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction	NATURE MEDICINE			English	Article							CELL THERAPY; MONONUCLEAR-CELLS; HEART-DISEASE; PROTEIN; IDENTIFICATION; ACTIVATION; MONOCYTES; SECRETOME; EFFICACY; IMPAIRS	Paracrine-acting proteins are emerging as a central mechanism by which bone marrow cell based therapies improve tissue repair and heart function after myocardial infarction (MI). We carried out a bioinformatic secretome analysis in bone marrow cells from patients with acute MI to identify novel secreted proteins with therapeutic potential. Functional screens revealed a secreted protein encoded by an open reading frame on chromosome 19 (C19orf10) that promotes cardiac myocyte survival and angiogenesis. We show that bone marrow derived monocytes and macrophages produce this protein endogenously to protect and repair the heart after MI, and we named it myeloid-derived growth factor (MYDGF). Whereas Mydgf-deficient mice develop larger infarct scars and more severe contractile dysfunction compared to wild-type mice, treatment with recombinant Mydgf reduces scar size and contractile dysfunction after MI. This study is the first to assign a biological function to MYDGF, and it may serve as a prototypical example for the development of protein-based therapies for ischemic tissue repair.	[Korf-Klingebiel, Mortimer; Reboll, Marc R.; Klede, Stefanie; Brod, Torben; Brinkmann, Eva; Reimann, Ines; Kempf, Tibor; Wang, Yong; Wollert, Kai C.] Hannover Med Sch, Div Mol & Translat Cardiol, Hannover, Germany; [Korf-Klingebiel, Mortimer; Reboll, Marc R.; Klede, Stefanie; Brod, Torben; Napp, L. Christian; Bauersachs, Johann; Brinkmann, Eva; Reimann, Ines; Kempf, Tibor; Wang, Yong; Wollert, Kai C.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Pich, Andreas; Polten, Felix] Hannover Med Sch, Inst Toxicol, Core Unit Mass Spectrometry & Prote, Hannover, Germany; [Ganser, Arnold] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Niessen, Hans W.] Vrije Univ Amsterdam, Univ Med Ctr, Inst Cardiovasc Res, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands; [Mizrahi, Jacques; Schoenfeld, Hans-Joachim; Iglesias, Antonio; Bobadilla, Maria] F Hoffmann La Roche, Pharma Res & Early Dev, Basel, Switzerland	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Vrije Universiteit Amsterdam; Roche Holding	Korf-Klingebiel, M (corresponding author), Hannover Med Sch, Div Mol & Translat Cardiol, Hannover, Germany.	wollert.kai@mh-hannover.de	Kempf, Tibor/ABA-3167-2021; Napp, L. Christian/AAD-2498-2020	Kempf, Tibor/0000-0001-6901-8442; Niessen, Hans/0000-0001-9404-9822; Napp, L. Christian/0000-0001-9945-0842	German Research Foundation (Programm Klinische Studien); Alfried Krupp von Bohlen und Halbach-Stiftung; German Research Foundation [WO 552/9-1, WO 552/10-1]	German Research Foundation (Programm Klinische Studien); Alfried Krupp von Bohlen und Halbach-Stiftung; German Research Foundation(German Research Foundation (DFG))	We thank the late H. Drexler for his advice during the early stages of this project. We acknowledge L. Arseniev and his team at the Cellular Therapy Center at Hannover Medical School for preparing nucleated bone marrow cells, O. Kustikova from the Institute of Experimental Hematology at Hannover Medical School for helping with the bone marrow transplantations, M. Ballmaier from the FACS core facility and C. Falk from the Institute of Transplant Immunology at Hannover Medical School for supporting us with cell sorting, R. Geffers from the Helmholtz Center for Infection Research (Braunschweig, Germany) for performing the microarray analyses and R. Patten from Tufts New England Medical Center (Boston, MA) for providing Aka adenoviruses. We are indebted to our colleagues who recruited patients into the BOOST-2 trial: G. Meyer, J. Pirr and B. Ritter, Hannover Medical School; C. Tschope and H. Schultheiss, Charite Berlin; J. Muller-Ehmsen and E. Erdmann, University of Cologne; K. Empen and S. Felix, University of Greifswald; A. May and M. Gawaz, University of Tubingen (all in Germany). The BOOST-2 trial was supported by the German Research Foundation (Programm Klinische Studien) and by the Alfried Krupp von Bohlen und Halbach-Stiftung. K.C.W. was supported by the German Research Foundation (WO 552/9-1, WO 552/10-1, Excellence Cluster REBIRTH-2).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Assmus B, 2010, J AM COLL CARDIOL, V55, P1385, DOI 10.1016/j.jacc.2009.10.059; Bailey MJ, 2011, IMMUNOL CELL BIOL, V89, P283, DOI 10.1038/icb.2010.92; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Jay SM, 2013, CIRC RES, V113, P933, DOI 10.1161/CIRCRESAHA.113.300215; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kelle S, 2009, J AM COLL CARDIOL, V54, P1770, DOI 10.1016/j.jacc.2009.07.027; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Roubille F, 2011, CIRCULATION, V124, P1330, DOI 10.1161/CIRCULATIONAHA.111.031864; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688; Shantsila E, 2013, THROMB HAEMOSTASIS, V109, P255, DOI 10.1160/TH12-06-0395; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tulin EE, 2003, J IMMUNOL, V170, P1593, DOI 10.4049/jimmunol.170.3.1593; Urbich C, 2011, J MOL CELL CARDIOL, V50, P333, DOI 10.1016/j.yjmcc.2010.11.022; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Wang X., 2011, SCI TRANSL MED, V3; Weiler T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2145; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	49	127	140	1	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					140	149		10.1038/nm.3778	http://dx.doi.org/10.1038/nm.3778			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25581518				2022-12-25	WOS:000348974800016
J	Sheridan, C				Sheridan, Cormac			Pivotal trials for beta-secretase inhibitors in Alzheimer's	NATURE BIOTECHNOLOGY			English	News Item							TARGET											2014, ACTA NEUROPATHOL, V128, P609; 2014, ACTA NEUROPATHOL, V127, P803; 2014, CELL, V159, P721	3	8	9	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					115	116		10.1038/nbt0215-115	http://dx.doi.org/10.1038/nbt0215-115			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658256				2022-12-25	WOS:000349198800003
J	Feenstra, B; Pasternak, B; Geller, F; Carstensen, L; Wang, TF; Huang, F; Eitson, JL; Hollegaard, MV; Svanstrom, H; Vestergaard, M; Hougaard, DM; Schoggins, JW; Jan, LY; Melbye, M; Hviid, A				Feenstra, Bjarke; Pasternak, Bjorn; Geller, Frank; Carstensen, Lisbeth; Wang, Tongfei; Huang, Fen; Eitson, Jennifer L.; Hollegaard, Mads V.; Svanstrom, Henrik; Vestergaard, Mogens; Hougaard, David M.; Schoggins, John W.; Jan, Lily Yeh; Melbye, Mads; Hviid, Anders			Common variants associated with general and MMR vaccine-related febrile seizures	NATURE GENETICS			English	Article							MAGNESIUM-DEFICIENCY; CELLULAR RECEPTOR; MEASLES; CD46; POLYMORPHISMS; MUTATIONS; EPILEPSY; ACTIVATION; EXPRESSION; RESPONSES	Febrile seizures represent a serious adverse event following measles, mumps and rubella (MMR) vaccination. We conducted a series of genome-wide association scans comparing children with MMR-related febrile seizures, children with febrile seizures unrelated to vaccination and controls with no history of febrile seizures. Two loci were distinctly associated with MMR-related febrile seizures, harboring the interferon-stimulated gene IFI44L (rs273259: P = 5.9 x 10(-12) versus controls, P = 1.2 x 10(-9) versus MMR-unrelated febrile seizures) and the measles virus receptor CD46 (rs1318653: P = 9.6 x 10(-11) versus controls, P = 1.6 x 10(-9) versus MMR-unrelated febrile seizures). Furthermore, four loci were associated with febrile seizures in general, implicating the sodium channel genes SCN1A (rs6432860: P = 2.2 x 10(-16)) and SCN2A (rs3769955: P = 3.1 x 10(-10)), a TMEM16 family gene (ANO3; rs114444506: P = 3.7 x 10(-20)) and a region associated with magnesium levels (12q21.33; rs11105468: P = 3.4 x 10(-11)). Finally, we show the functional relevance of ANO3 (TMEM16C) with electrophysiological experiments in wild-type and knockout rats.	[Feenstra, Bjarke; Pasternak, Bjorn; Geller, Frank; Carstensen, Lisbeth; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Wang, Tongfei; Huang, Fen; Jan, Lily Yeh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Wang, Tongfei; Huang, Fen; Jan, Lily Yeh] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Wang, Tongfei; Huang, Fen; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Eitson, Jennifer L.; Schoggins, John W.] Univ Texas Southwestern Med Sch, Dept Microbiol, Dallas, TX USA; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit, Dept Publ Hlth, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Sect Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA USA	Statens Serum Institut; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Statens Serum Institut; Aarhus University; Aarhus University; University of Copenhagen; Stanford University	Feenstra, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	fee@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hougaard, David/AAD-6368-2019; Hviid, Anders/AAH-4319-2020; Vestergaard, Mogens/M-9333-2014; Wang, Tongfei/C-1394-2015	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; Vestergaard, Mogens/0000-0001-8830-2174; Jan, Lily/0000-0003-3938-8498; melbye, mads/0000-0001-8264-6785; Wang, Tongfei/0000-0002-6306-7371; Feenstra, Bjarke/0000-0003-1478-649X; Geller, Frank/0000-0002-9238-3269	Danish Medical Research Council [0602-01818B]; US National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [R01A1093697]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [K01DK095031]; NIH/National Institute of Neurological Disorders and Stroke [R0I NS069229]; Novo Nordisk Foundation; Danish Medical Research Council; Lundbeck Foundation; Oak Foundation fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Oak Foundation fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was partially supported by a grant from the Danish Medical Research Council (0602-01818B). Research reported in this publication was supported by US National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases grant R01A1093697 (A.H.), by NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant K01DK095031 (J.W.S.) and by NIH/National Institute of Neurological Disorders and Stroke grant R0I NS069229 (L.Y.J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The Danish National Biobank was established with the support of major grants from the Novo Nordisk Foundation, the Danish Medical Research Council and the Lundbeck Foundation. L.Y.J. is an investigator of the Howard Hughes Medical Institute. B.F. is supported by an Oak Foundation fellowship.	Abdelmalik PA, 2012, CAN J NEUROL SCI, V39, P323, DOI 10.1017/S0317167100013457; ANDERSON WW, 1986, BRAIN RES, V398, P215, DOI 10.1016/0006-8993(86)91274-6; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Clifford HD, 2012, CLIN VACCINE IMMUNOL, V19, P704, DOI 10.1128/CVI.05652-11; Dhiman N, 2007, J ALLERGY CLIN IMMUN, V120, P666, DOI 10.1016/j.jaci.2007.04.036; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Eckhaus J, 2013, EPILEPSY RES, V105, P103, DOI 10.1016/j.eplepsyres.2013.02.011; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; HANNA S, 1960, LANCET, V2, P172; HAUSER WA, 1985, NEUROLOGY, V35, P1268, DOI 10.1212/WNL.35.9.1268; Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Heron SE, 2002, LANCET, V360, P851, DOI 10.1016/S0140-6736(02)09968-3; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Kasperaviciute D, 2013, BRAIN, V136, P3140, DOI 10.1093/brain/awt233; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kennedy RB, 2012, VACCINE, V30, P2159, DOI 10.1016/j.vaccine.2012.01.025; Kjeldsen MJ, 2002, EPILEPSY RES, V51, P167, DOI 10.1016/S0920-1211(02)00121-3; Kruse HD, 1932, J BIOL CHEM, V96, P519; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Millichap JG, 2006, PEDIATR NEUROL, V35, P165, DOI 10.1016/j.pediatrneurol.2006.06.004; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Sadlier LG, 2007, BMJ-BRIT MED J, V334, P307, DOI 10.1136/bmj.39087.691817.AE; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shinnar, 2002, FEBRILE SEIZURES, P1; Sugiura Y, 2012, EPILEPSIA, V53, pe111, DOI 10.1111/j.1528-1167.2012.03467.x; Thomas EA, 2009, ANN NEUROL, V66, P219, DOI 10.1002/ana.21712; TSUBOI T, 1984, NEUROLOGY, V34, P175, DOI 10.1212/WNL.34.2.175; TURNER TL, 1977, LANCET, V1, P283; Vestergaard M, 2004, JAMA-J AM MED ASSOC, V292, P351, DOI 10.1001/jama.292.3.351; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yuen AWC, 2012, EPILEPSY RES, V100, P152, DOI 10.1016/j.eplepsyres.2012.02.004; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	49	97	102	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1274	1282		10.1038/ng.3129	http://dx.doi.org/10.1038/ng.3129			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25344690	Green Submitted, Green Accepted			2022-12-25	WOS:000345547300008
J	Totoki, Y; Tatsuno, K; Covington, KR; Ueda, H; Creighton, CJ; Kato, M; Tsuji, S; Donehower, LA; Slagle, BL; Nakamura, H; Yamamoto, S; Shinbrot, E; Hama, N; Lehmkuhl, M; Hosoda, F; Arai, Y; Walker, K; Dahdouli, M; Gotoh, K; Nagae, G; Gingras, MC; Muzny, DM; Ojima, H; Shimada, K; Midorikawa, Y; Goss, JA; Cotton, R; Hayashi, A; Shibahara, J; Ishikawa, S; Guiteau, J; Tanaka, M; Urushidate, T; Ohashi, S; Okada, N; Doddapaneni, H; Wang, M; Zhu, YM; Dinh, H; Okusaka, T; Kokudo, N; Kosuge, T; Takayama, T; Fukayama, M; Gibbs, RA; Wheeler, DA; Aburatani, H; Shibata, T				Totoki, Yasushi; Tatsuno, Kenji; Covington, Kyle R.; Ueda, Hiroki; Creighton, Chad J.; Kato, Mamoru; Tsuji, Shingo; Donehower, Lawrence A.; Slagle, Betty L.; Nakamura, Hiromi; Yamamoto, Shogo; Shinbrot, Eve; Hama, Natsuko; Lehmkuhl, Megan; Hosoda, Fumie; Arai, Yasuhito; Walker, Kim; Dahdouli, Mahmoud; Gotoh, Kengo; Nagae, Genta; Gingras, Marie-Claude; Muzny, Donna M.; Ojima, Hidenori; Shimada, Kazuaki; Midorikawa, Yutaka; Goss, John A.; Cotton, Ronald; Hayashi, Akimasa; Shibahara, Junji; Ishikawa, Shumpei; Guiteau, Jacfranz; Tanaka, Mariko; Urushidate, Tomoko; Ohashi, Shoko; Okada, Naoko; Doddapaneni, Harsha; Wang, Min; Zhu, Yiming; Huyen Dinh; Okusaka, Takuji; Kokudo, Norihiro; Kosuge, Tomoo; Takayama, Tadatoshi; Fukayama, Masashi; Gibbs, Richard A.; Wheeler, David A.; Aburatani, Hiroyuki; Shibata, Tatsuhiro			Trans-ancestry mutational landscape of hepatocellular carcinoma genomes	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; SUSCEPTIBILITY LOCUS; RECURRENT MUTATIONS; ACTIVATOR PROTEIN; WIDE ASSOCIATION; CANCER; TELOMERASE; SIGNATURES; SRCAP; RECEPTOR	Diverse epidemiological factors are associated with hepatocellular carcinoma (HCC) prevalence in different populations. However, the global landscape of the genetic changes in HCC genomes underpinning different epidemiological and ancestral backgrounds still remains uncharted. Here a collection of data from 503 liver cancer genomes from different populations uncovered 30 candidate driver genes and 11 core pathway modules. Furthermore, a collaboration of two large-scale cancer genome projects comparatively analyzed the trans-ancestry substitution signatures in 608 liver cancer cases and identified unique mutational signatures that predominantly contribute to Asian cases. This work elucidates previously unexplored ancestry-associated mutational processes in HCC development. A combination of hotspot TERT promoter mutation, TERT focal amplification and viral genome integration occurs in more than 68% of cases, implicating TERT as a central and ancestry-independent node of hepatocarcinogenesis. Newly identified alterations in genes encoding metabolic enzymes, chromatin remodelers and a high proportion of mTOR pathway activations offer potential therapeutic and diagnostic opportunities.	[Totoki, Yasushi; Kato, Mamoru; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Urushidate, Tomoko; Ohashi, Shoko; Okada, Naoko; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo 104, Japan; [Tatsuno, Kenji; Ueda, Hiroki; Tsuji, Shingo; Yamamoto, Shogo; Gotoh, Kengo; Nagae, Genta; Hayashi, Akimasa; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo 113, Japan; [Covington, Kyle R.; Creighton, Chad J.; Shinbrot, Eve; Lehmkuhl, Megan; Walker, Kim; Dahdouli, Mahmoud; Gingras, Marie-Claude; Muzny, Donna M.; Doddapaneni, Harsha; Wang, Min; Zhu, Yiming; Huyen Dinh; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Donehower, Lawrence A.; Slagle, Betty L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Ojima, Hidenori] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Midorikawa, Yutaka; Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; [Goss, John A.; Cotton, Ronald; Guiteau, Jacfranz] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Hayashi, Akimasa; Shibahara, Junji; Ishikawa, Shumpei; Tanaka, Mariko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	National Cancer Center - Japan; University of Tokyo; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Cancer Center - Japan; National Cancer Center - Japan; Nihon University; Baylor College of Medicine; University of Tokyo; National Cancer Center - Japan; University of Tokyo; University of Tokyo	Wheeler, DA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	wheeler@bcm.edu; haburata-tky@umin.ac.jp; tashibat@ncc.go.jp	Wheeler, David A/M-9740-2018; Shibata, Tatsuhiro/ABA-8234-2020; Shinbrot, Eve/V-2784-2019; Nagae, Genta/H-6579-2019; Tatsuno, Kenji/B-1765-2008; Shibata, Tatsuhiro/AAO-1278-2021; Nagae, Genta/AAN-1167-2021	Wheeler, David A/0000-0002-9056-6299; Shinbrot, Eve/0000-0002-8879-3150; Nagae, Genta/0000-0002-2929-7990; doddapaneni, harshavardhan/0000-0002-2433-633X; Arai, Yasuhito/0000-0001-6306-9409	Ministry of Health, Labour and Welfare of Japan; US National Human Genome Research Institute (NHGRI) [5U541-IG003273]; National Cancer Institute (NCI) [HHSN261201000053C, P30 CA125123]; National Institute of Biomedical Innovation (NIBIO, Japan); National Cancer Center Research and Development Funds (Japan) [23-A-8]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Innovation (NIBIO, Japan)(National Institute of Biomedical Innovation); National Cancer Center Research and Development Funds (Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan for the third-term Comprehensive 10-Year Strategy for Cancer Control, grants from the US National Human Genome Research Institute (NHGRI; 5U541-IG003273) and National Cancer Institute (NCI; HHSN261201000053C and P30 CA125123), the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO, Japan) and the National Cancer Center Research and Development Funds (23-A-8, Japan). The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The supercomputing resource SHIROKANE was provided by the Human Genome Center at the University of Tokyo (http://sc.hgc.jp/shirokane.html).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Augustine MM, 2014, SURG ONCOL CLIN N AM, V23, P171, DOI 10.1016/j.soc.2013.10.001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Keng VW, 2013, HEPATOLOGY, V57, P120, DOI 10.1002/hep.26004; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Monroy MA, 2003, MOL ENDOCRINOL, V17, P2519, DOI 10.1210/me.2003-0208; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nelson RA, 2009, AM J MED GENET A, V149A, P2265, DOI 10.1002/ajmg.a.33014; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poon SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006086; Song LN, 2008, J BIOL CHEM, V283, P25988, DOI 10.1074/jbc.M800325200; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tanaka K, 2000, CANCER RES, V60, P5106; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	39	492	503	3	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1267	1273		10.1038/ng.3126	http://dx.doi.org/10.1038/ng.3126			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362482				2022-12-25	WOS:000345547300007
J	Chetaille, P; Preuss, C; Burkhard, S; Cote, JM; Houde, C; Castilloux, J; Piche, J; Gosset, N; Leclerc, S; Wunnemann, F; Thibeault, M; Gagnon, C; Galli, A; Tuck, E; Hickson, GR; El Amine, N; Boufaied, I; Lemyre, E; Barbara, PDS; Faure, S; Jonzon, A; Cameron, M; Dietz, HC; Gallo-McFarlane, E; Benson, DW; Moreau, C; Labuda, D; Zhan, SH; Shen, YQ; Jomphe, M; Jones, SJM; Bakkers, J; Andelfinger, G				Chetaille, Philippe; Preuss, Christoph; Burkhard, Silja; Cote, Jean-Marc; Houde, Christine; Castilloux, Julie; Piche, Jessica; Gosset, Natacha; Leclerc, Severine; Wuennemann, Florian; Thibeault, Maryse; Gagnon, Carmen; Galli, Antonella; Tuck, Elizabeth; Hickson, Gilles R.; El Amine, Nour; Boufaied, Ines; Lemyre, Emmanuelle; Barbara, Pascal de Santa; Faure, Sandrine; Jonzon, Anders; Cameron, Michel; Dietz, Harry C.; Gallo-McFarlane, Elena; Benson, D. Woodrow; Moreau, Claudia; Labuda, Damian; Zhan, Shing H.; Shen, Yaoqing; Jomphe, Michele; Jones, Steven J. M.; Bakkers, Jeroen; Andelfinger, Gregor		FORGE Canada Consortium	Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm	NATURE GENETICS			English	Article							DE-LANGE-SYNDROME; IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION; SICK SINUS SYNDROME; CARDIAC-ARRHYTHMIA	The pacemaking activity of specialized tissues in the heart and gut results in lifelong rhythmic contractions. Here we describe a new syndrome characterized by Chronic Atrial and Intestinal Dysrhythmia, termed CAID syndrome, in 16 French Canadians and 1 Swede. We show that a single shared homozygous founder mutation in SGOL1, a component of the cohesin complex, causes CAID syndrome. Cultured dermal fibroblasts from affected individuals showed accelerated cell cycle progression, a higher rate of senescence and enhanced activation of TGF-beta signaling. Karyotypes showed the typical railroad appearance of a centromeric cohesion defect. Tissues derived from affected individuals displayed pathological changes in both the enteric nervous system and smooth muscle. Morpholino-induced knockdown of sgol1 in zebrafish recapitulated the abnormalities seen in humans with CAID syndrome. Our findings identify CAID syndrome as a novel generalized dysrhythmia, suggesting a new role for SGOL1 and the cohesin complex in mediating the integrity of human cardiac and gut rhythm.	[Chetaille, Philippe; Cote, Jean-Marc; Houde, Christine; Castilloux, Julie] Ctr Hosp Univ CHU Quebec, Ctr Mere Enfants Soleil, Dept Pediat, Quebec City, PQ, Canada; [Preuss, Christoph; Piche, Jessica; Gosset, Natacha; Leclerc, Severine; Wuennemann, Florian; Thibeault, Maryse; Gagnon, Carmen; Cameron, Michel; Andelfinger, Gregor] Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Burkhard, Silja] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Burkhard, Silja] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Galli, Antonella; Tuck, Elizabeth] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Hickson, Gilles R.; El Amine, Nour; Boufaied, Ines; Lemyre, Emmanuelle; Moreau, Claudia; Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Barbara, Pascal de Santa; Faure, Sandrine] INSERM U1046, Montpellier, France; [Jonzon, Anders] Uppsala Univ, Astrid Lindgrens Childrens Hosp, Sect Pediat, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Dietz, Harry C.; Gallo-McFarlane, Elena] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Benson, D. Woodrow] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Zhan, Shing H.; Shen, Yaoqing; Jones, Steven J. M.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Jomphe, Michele] Univ Quebec Chicoutimi, Projet BALSAC, Chicoutimi, PQ, Canada; [Andelfinger, Gregor] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Uppsala University; Howard Hughes Medical Institute; Johns Hopkins University; Medical College of Wisconsin; British Columbia Cancer Agency; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal	Andelfinger, G (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada.	gregor.andelfinger@recherche-ste-justine.qc.ca	Scherer, Stephen W./B-3785-2013; Jones, Steven J/C-3621-2009; de Santa Barbara, Pascal/AAO-5969-2021; Bakkers, Jeroen/H-5551-2011; FAURE, Sandrine/N-6506-2018; Wünnemann, Florian/K-9613-2019; de Santa Barbara, Pascal/N-6426-2015	Scherer, Stephen W./0000-0002-8326-1999; Jones, Steven J/0000-0003-3394-2208; de Santa Barbara, Pascal/0000-0001-9040-2481; Bakkers, Jeroen/0000-0002-9418-0422; FAURE, Sandrine/0000-0002-8902-8274; de Santa Barbara, Pascal/0000-0001-9040-2481; Zhan, Shing/0000-0002-6351-8873; Hickson, Gilles/0000-0001-7670-9815	Canadian government through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; Foundation Nussia; Andre Aisenstadt; La Fondation du Grand defi Pierre Lavoie; Fondation CHU Sainte-Justine; Fondation Leducq; Association des Pseudo Obstructions Intestinales Chroniques (France); Netherlands Organization for Scientific Research (NWO); ZonMw [91212086]; Fonds de Recherche du Quebec-Sante	Canadian government through Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; Foundation Nussia; Andre Aisenstadt; La Fondation du Grand defi Pierre Lavoie; Fondation CHU Sainte-Justine; Fondation Leducq(Leducq Foundation); Association des Pseudo Obstructions Intestinales Chroniques (France); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMw(Netherlands Organization for Health Research and Development); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	We are deeply indebted to all participating families and patients. We thank L. Gosselin, L. fEcuyer, M.-F. Boudreault, C. Faure, F. LeDeist, L. D'Aoust and the McGill Genome Quebec Innovation Centre (D. Vincent) for expert assistance. We gratefully acknowledge the contribution of all referring physicians and supporting staff to this project. We would like to thank J. Marcadier (clinical coordinator) and C. Beaulieu (project manager) for their contributions to the infrastructure of the FORGE Canada Consortium. The FORGE (Finding of Rare Disease Genes) Consortium Steering Committee includes Kym Boycott (University of Ottawa), Jan Friedman (University of British Columbia), Jacques Michaud (Universite de Montreal), Francois Bernier (University of Calgary), Michael Brudno (University of Toronto), Bridget Fernandez (Memorial University), Bartha Knoppers (McGill University) and Steve Scherer (University of Toronto). FORGE Canada was funded by the Canadian government through Genome Canada, the Canadian Institutes of Health Research and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec, Genome British Columbia, Foundation Nussia and Andre Aisenstadt, La Fondation du Grand defi Pierre Lavoie, Fondation CHU Sainte-Justine, Fondation Leducq, Association des Pseudo Obstructions Intestinales Chroniques (France), the Netherlands Organization for Scientific Research (NWO) and ZonMw (91212086). G.A. holds a Senior Scholarship from the Fonds de Recherche du Quebec-Sante and holds the Banque Nationale Research Chair in Cardiovascular Genetics. We thank G. Rouleau for sharing whole-exome data for control purposes and M. Samuels for critical reading of the manuscript.	Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bouchard G, 1989, Hist Mes, V4, P39, DOI 10.3406/hism.1989.874; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Deglincerti A, 2007, EUR J HUM GENET, V15, P889, DOI 10.1038/sj.ejhg.5201844; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Gargiulo A, 2007, AM J HUM GENET, V80, P751, DOI 10.1086/513321; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Heijman J, 2013, J MOL CELL CARDIOL, V64, P90, DOI 10.1016/j.yjmcc.2013.09.006; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kline AD, 2007, AM J MED GENET A, V143A, P1287, DOI 10.1002/ajmg.a.31757; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RODRIGUEZ RD, 1990, GERIATRICS, V45, P26; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Thompson EA, 2013, GENETICS, V194, P301, DOI 10.1534/genetics.112.148825; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	30	74	73	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1245	1249		10.1038/ng.3113	http://dx.doi.org/10.1038/ng.3113			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25282101	Green Published			2022-12-25	WOS:000344131900017
J	Meesters, C; Monig, T; Oeljeklaus, J; Krahn, D; Westfall, CS; Hause, B; Jez, JM; Kaiser, M; Kombrink, E				Meesters, Christian; Moenig, Timon; Oeljeklaus, Julian; Krahn, Daniel; Westfall, Corey S.; Hause, Bettina; Jez, Joseph M.; Kaiser, Markus; Kombrink, Erich			A chemical inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thaliana	NATURE CHEMICAL BIOLOGY			English	Article							AUX/IAA PROTEINS; SMALL MOLECULES; ACID SYNTHASE; GH3 FAMILY; AUXIN; IDENTIFICATION; ISOLEUCINE; GROWTH; GENES; BIOSYNTHESIS	Jasmonates are lipid-derived plant hormones that regulate plant defenses and numerous developmental processes. Although the biosynthesis and molecular function of the most active form of the hormone, (+)-7-iso-jasmonoyl-l-isoleucine (JA-Ile), have been unraveled, it remains poorly understood how the diversity of bioactive jasmonates regulates such a multitude of plant responses. Bioactive analogs have been used as chemical tools to interrogate the diverse and dynamic processes of jasmonate action. By contrast, small molecules impairing jasmonate functions are currently unknown. Here, we report on jarin-1 as what is to our knowledge the first small-molecule inhibitor of jasmonate responses that was identified in a chemical screen using Arabidopsis thaliana. Jarin-1 impairs the activity of JA-Ile synthetase, thereby preventing the synthesis of the active hormone, JA-Ile, whereas closely related enzymes are not affected. Thus, jarin-1 may serve as a useful chemical tool in search for missing regulatory components and further dissection of the complex jasmonate signaling networks.	[Meesters, Christian; Kombrink, Erich] Max Planck Inst Plant Breeding Res, Biol Chem Lab, Cologne, Germany; [Meesters, Christian; Moenig, Timon; Oeljeklaus, Julian; Krahn, Daniel; Kaiser, Markus] Univ Duisburg Essen, Fac Biol, Dept Biol Chem, Ctr Med Biotechnol, Essen, Germany; [Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Hause, Bettina] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany	Max Planck Society; University of Duisburg Essen; Washington University (WUSTL); Leibniz Institut fur Pflanzenbiochemie	Kombrink, E (corresponding author), Max Planck Inst Plant Breeding Res, Biol Chem Lab, Cologne, Germany.	markus.kaiser@uni-due.de; kombrink@mpipz.mpg.de			Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [Ko1192/6-1/2/3]; European Research Council [258413]; International Max Planck Research School doctoral fellowship (Max Planck Institute for Plant Breeding Research, Koln); National Science Foundation [MCB-1157771]; United States Department of Agriculture-National Institute of Food and Agriculture Predoctoral Fellowship Program [MOW-2010-05240]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); International Max Planck Research School doctoral fellowship (Max Planck Institute for Plant Breeding Research, Koln); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-National Institute of Food and Agriculture Predoctoral Fellowship Program	We thank I. Somssich, C. Wasternack and members of our labs for critical reading of the manuscript and stimulating discussions. We also thank R. Solano (Universidad Autonoma, Madrid, Spain) for kindly providing seeds of the transgenic plant expressing CaMV35S :: JAZ1-GUS and J. Mundy (University of Copenhagen, Denmark) for seeds of plants harboring the dual reporter system LOX2p :: LUC/LOX2p :: GUS. This work was supported by the Max Planck Society (to E.K.), the Deutsche Forschungsgemeinschaft (DFG, Ko1192/6-1/2/3 to E.K.) and a European Research Council Starting grant (grant no. 258413 to M.K.). C.M. was the recipient of an International Max Planck Research School doctoral fellowship (Max Planck Institute for Plant Breeding Research, Koln). Additional support was provided by the National Science Foundation (MCB-1157771 to J.M.J.) and the United States Department of Agriculture-National Institute of Food and Agriculture Predoctoral Fellowship Program (MOW-2010-05240 to C.S.W.).	Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Balcke GU, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-47; Bartsch M, 2010, J BIOL CHEM, V285, P25654, DOI 10.1074/jbc.M109.092569; Browse J, 2009, PHYTOCHEMISTRY, V70, P1539, DOI 10.1016/j.phytochem.2009.08.004; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Darrouzet E, 1998, FEBS LETT, V431, P34, DOI 10.1016/S0014-5793(98)00719-4; De Rybel B, 2012, NAT CHEM BIOL, V8, P798, DOI [10.1038/NCHEMBIO.1044, 10.1038/nchembio.1044]; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hicks GR, 2012, ANNU REV PLANT BIOL, V63, P261, DOI 10.1146/annurev-arplant-042811-105456; Jensen AB, 2002, PLANT J, V29, P595, DOI 10.1046/j.0960-7412.2001.01241.x; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kienow L, 2008, J EXP BOT, V59, P403, DOI 10.1093/jxb/erm325; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Lin LC, 2010, J BIOL CHEM, V285, P33445, DOI 10.1074/jbc.M110.132498; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; McCourt P, 2010, NEW PHYTOL, V185, P15, DOI 10.1111/j.1469-8137.2009.03045.x; Meesters C, 2014, METHODS MOL BIOL, V1056, P19, DOI 10.1007/978-1-62703-592-7_3; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noutoshi Y, 2012, PLANT CELL, V24, P3795, DOI 10.1105/tpc.112.098343; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Serrano M, 2007, J BIOL CHEM, V282, P6803, DOI 10.1074/jbc.M608792200; Serrano M, 2010, PLANTA, V231, P1013, DOI 10.1007/s00425-010-1105-1; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549; Walsh TA, 2007, PLANT PHYSIOL, V144, P1292, DOI 10.1104/pp.107.099705; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Widemann Emilie, 2013, J Biol Chem, V288, P31701, DOI 10.1074/jbc.M113.499228; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zheng WG, 2006, PLANT PHYSIOL, V141, P1400, DOI 10.1104/pp.106.080390	60	59	60	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					830	+		10.1038/NCHEMBIO.1591	http://dx.doi.org/10.1038/NCHEMBIO.1591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25129030				2022-12-25	WOS:000342462100009
J	Bolger, A; Scossa, F; Bolger, ME; Lanz, C; Maumus, F; Tohge, T; Quesneville, H; Alseekh, S; Sorensen, I; Lichtenstein, G; Fich, EA; Conte, M; Keller, H; Schneeberger, K; Schwacke, R; Ofner, I; Vrebalov, J; Xu, YM; Osorio, S; Aflitos, SA; Schijlen, E; Jimenez-Gomez, JM; Ryngajllo, M; Kimura, S; Kumar, R; Koenig, D; Headland, LR; Maloof, JN; Sinha, N; van Ham, RCHJ; Lankhorst, RK; Mao, LY; Vogel, A; Arsova, B; Panstruga, R; Fei, ZJ; Rose, JKC; Zamir, D; Carrari, F; Giovannoni, JJ; Weigel, D; Usadel, B; Fernie, AR				Bolger, Anthony; Scossa, Federico; Bolger, Marie E.; Lanz, Christa; Maumus, Florian; Tohge, Takayuki; Quesneville, Hadi; Alseekh, Saleh; Sorensen, Iben; Lichtenstein, Gabriel; Fich, Eric A.; Conte, Mariana; Keller, Heike; Schneeberger, Korbinian; Schwacke, Rainer; Ofner, Itai; Vrebalov, Julia; Xu, Yimin; Osorio, Sonia; Aflitos, Saulo Alves; Schijlen, Elio; Jimenez-Gomez, Jose M.; Ryngajllo, Malgorzata; Kimura, Seisuke; Kumar, Ravi; Koenig, Daniel; Headland, Lauren R.; Maloof, Julin N.; Sinha, Neelima; van Ham, Roeland C. H. J.; Lankhorst, Rene Klein; Mao, Linyong; Vogel, Alexander; Arsova, Borjana; Panstruga, Ralph; Fei, Zhangjun; Rose, Jocelyn K. C.; Zamir, Dani; Carrari, Fernando F; Giovannoni, James J.; Weigel, Detlef; Usadel, Bjoern; Fernie, Alisdair R.			The genome of the stress-tolerant wild tomato species Solanum pennellii	NATURE GENETICS			English	Article							INTROGRESSION LINES; GENE-EXPRESSION; FRUIT; QTL; ACCUMULATION; EVOLUTION; TRICHOMES; RESPONSES; PLANTS; TRAITS	Solanum pennellii is a wild tomato species endemic to Andean regions in South America, where it has evolved to thrive in arid habitats. Because of its extreme stress tolerance and unusual morphology, it is an important donor of germplasm for the cultivated tomato Solanum lycopersicum(1). Introgression lines (ILs) in which large genomic regions of S. lycopersicum are replaced with the corresponding segments from S. pennellii can show remarkably superior agronomic performance(2). Here we describe a high-quality genome assembly of the parents of the IL population. By anchoring the S. pennellii genome to the genetic map, we define candidate genes for stress tolerance and provide evidence that transposable elements had a role in the evolution of these traits. Our work paves a path toward further tomato improvement and for deciphering the mechanisms underlying the myriad other agronomic traits that can be improved with S. pennellii germplasm.	[Bolger, Anthony; Bolger, Marie E.; Schwacke, Rainer; Ryngajllo, Malgorzata; Usadel, Bjoern] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Potsdam Golm, Germany; [Bolger, Anthony; Vogel, Alexander; Usadel, Bjoern] Rhein Westfal TH Aachen, IBMG, Inst Biol 1, Aachen, Germany; [Scossa, Federico; Tohge, Takayuki; Alseekh, Saleh; Osorio, Sonia; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam Golm, Germany; [Scossa, Federico] Ctr Ric Orticoltura, Consiglio Ric Sperimentaz Agr, Pontecagnano, Italy; [Bolger, Marie E.; Schwacke, Rainer; Usadel, Bjoern] Forschungszentrum Julich, IBG 2, D-52425 Julich, Germany; [Lanz, Christa; Keller, Heike; Schneeberger, Korbinian; Koenig, Daniel; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Maumus, Florian; Quesneville, Hadi] INRA Versailles Grignon, French Natl Inst Agr Res INRA, Res Unit Genom Info URGI UR1164, Versailles, France; [Sorensen, Iben; Fich, Eric A.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Lichtenstein, Gabriel; Conte, Mariana; Carrari, Fernando F] INTA, CICVyA, Inst Biotecnol, Castelar, Argentina; [Lichtenstein, Gabriel; Conte, Mariana; Carrari, Fernando F] Consejo Nacl Invest Cient & Tecn, Castelar, Argentina; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Ofner, Itai; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel; [Vrebalov, Julia; Xu, Yimin; Mao, Linyong; Fei, Zhangjun; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Osorio, Sonia] Univ Malaga, Inst Hortofruticultura Subtrop & Mediterrane La M, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Aflitos, Saulo Alves; Schijlen, Elio; van Ham, Roeland C. H. J.; Lankhorst, Rene Klein] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Jimenez-Gomez, Jose M.] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Jimenez-Gomez, Jose M.] INRA, Inst Jean Pierre Bourgin, UMR 1318, F-78026 Versailles, France; [Kimura, Seisuke; Kumar, Ravi; Koenig, Daniel; Headland, Lauren R.; Maloof, Julin N.; Sinha, Neelima] Univ Calif Davis, Dept Plant Biol, Davis, CA USA; [Arsova, Borjana] Univ Dusseldorf, Dusseldorf, Germany; [Panstruga, Ralph] Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany; [Fei, Zhangjun; Giovannoni, James J.] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Max Planck Society; RWTH Aachen University; Max Planck Society; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Helmholtz Association; Research Center Julich; Max Planck Society; INRAE; Cornell University; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Hebrew University of Jerusalem; Cornell University; Boyce Thompson Institute for Plant Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Wageningen University & Research; Max Planck Society; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis; Heinrich Heine University Dusseldorf; RWTH Aachen University; United States Department of Agriculture (USDA)	Usadel, B (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Potsdam Golm, Germany.	usadel@bio1.rwth-aachen.de	Tohge, Takayuki/G-7924-2017; Arsova, Borjana/AAA-5594-2020; Aflitos, Saulo/J-8930-2014; Ryngajłło, Małgorzata/M-2959-2018; Klein Lankhorst, René/HGD-0360-2022; Weigel, Detlef/AAR-3312-2021; Schneeberger, Korbinian/U-6329-2019; Maumus, Florian/O-5426-2016; Panstruga, Ralph/F-3340-2011; Weigel, Detlef/C-1418-2008; Quesneville, Hadi/AAG-1048-2020; Osorio, Sonia/M-2258-2014; Arsova, Borjana/F-4252-2017; Scossa, Federico/ABI-5343-2020; Fei, Zhangjun/H-5152-2012; Weigel, Detlef/GSJ-0799-2022; Usadel, Björn/E-1932-2011	Tohge, Takayuki/0000-0001-5555-5650; Aflitos, Saulo/0000-0002-9179-5309; Ryngajłło, Małgorzata/0000-0002-0430-0102; Schneeberger, Korbinian/0000-0002-5512-0443; Maumus, Florian/0000-0001-7325-0527; Panstruga, Ralph/0000-0002-3756-8957; Weigel, Detlef/0000-0002-2114-7963; Quesneville, Hadi/0000-0003-3001-4908; Osorio, Sonia/0000-0002-0159-6091; Arsova, Borjana/0000-0002-0566-2009; Scossa, Federico/0000-0002-6233-1679; Weigel, Detlef/0000-0002-2114-7963; Usadel, Björn/0000-0003-0921-8041; LICHTENSTEIN, GABRIEL/0000-0002-2974-6717; Fich, Eric/0000-0002-8948-7112; Bolger, Marie/0000-0001-6335-1578; Fei, Zhangjun/0000-0001-9684-1450; Sorensen, Iben/0000-0002-9768-620X; Headland, Lauren/0000-0002-3242-0806; Maloof, Julin/0000-0002-9623-2599; Kimura, Seisuke/0000-0002-6796-3675; Jimenez-Gomez, Jose M/0000-0002-5033-7192	Max Planck Society; Deutsche Israeli Project [FE 552/12-1]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 0315961]; Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG) [1525]; CRA Young Investigator Program; INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grant; NSF grant [IOS-0820854]; US National Science Foundation [DBI-0606595, DBI-1313887]; Agriculture and Food Research Initiative competitive grant ,USDA National Institute of Food and Agriculture [2011-04197]; US National Science Foundation Plant Genome Program [DBI-0820612, IOS-0923312]; Direct For Biological Sciences [0820854] Funding Source: National Science Foundation	Max Planck Society(Max Planck Society); Deutsche Israeli Project; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG); CRA Young Investigator Program; INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grant; NSF grant(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative competitive grant ,USDA National Institute of Food and Agriculture; US National Science Foundation Plant Genome Program(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We gratefully acknowledge the support of the Max Planck Society in the form of an exceptional grant to cover the costs of sequencing the tomato species. In addition, work in the laboratories of D.Z. and A.R.F. was funded in the framework of Deutsche Israeli Project FE 552/12-1, which is administered by the Deutsche Forschungsgemeinschaft. B.U. and M.E.B. acknowledge the support of the Bundesministerium fur Bildung und Forschung (BMBF)-funded primary database FKZ 0315961. B.A. thanks the Deutsche Forschungsgemeinschaft International Research Training Groups (IRTG) 1525. F.S. acknowledges the support of the CRA Young Investigator Program. Work in the laboratory of F.C. was funded by INTA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYPT) grants. Work in the laboratories of N.S. and J.N.M. was funded by NSF grant IOS-0820854. J.R. was supported by the US National Science Foundation (Plant Genome Program; DBI-0606595 and DBI-1313887) and by Agriculture and Food Research Initiative competitive grant 2011-04197 from the USDA National Institute of Food and Agriculture. Work in the laboratories of J.G. and Z.F. was additionally supported by US National Science Foundation Plant Genome Program grants DBI-0820612 and IOS-0923312. A.B. would like to thank Y. Brotman for preparing the Pseudomonas syringae-infected S. pennellii samples.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Bui Q.T., 2012, PLANT TRANSPOSABLE E, P273, DOI 10.1007/978-3-642-31842-9_14; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Eshed Y, 1992, THEOR APPL GENET, V83, P1027, DOI 10.1007/BF00232968; Filippis I, 2013, PLANT J, V75, P1039, DOI 10.1111/tpj.12250; Frary A, 2011, BIOL PLANTARUM, V55, P461, DOI 10.1007/s10535-011-0111-x; Frary A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-58; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; GRUMET R, 1981, PLANT PHYSIOL, V68, P1428, DOI 10.1104/pp.68.6.1428; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Gur A, 2011, THEOR APPL GENET, V122, P405, DOI 10.1007/s00122-010-1456-9; Iijima Y, 2013, PHYTOCHEMISTRY, V95, P145, DOI 10.1016/j.phytochem.2013.07.016; Asins MJ, 2013, PLANT CELL ENVIRON, V36, P1171, DOI 10.1111/pce.12051; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Klee HJ, 2013, CURR BIOL, V23, pR520, DOI 10.1016/j.cub.2013.05.010; Kochevenko A, 2011, J EXP BOT, V62, P3895, DOI 10.1093/jxb/err091; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Mageroy MH, 2012, PLANT J, V69, P1043, DOI 10.1111/j.1365-313X.2011.04854.x; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Nguyen CV, 2014, PLANT CELL, V26, P585, DOI 10.1105/tpc.113.118794; Parsons EP, 2012, PHYSIOL PLANTARUM, V146, P15, DOI 10.1111/j.1399-3054.2012.01592.x; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Quadrana L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5027; RICK CM, 1981, PLANT SYST EVOL, V139, P11, DOI 10.1007/BF00983920; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schauer N, 2008, PLANT CELL, V20, P509, DOI 10.1105/tpc.107.056523; Schilmiller AL, 2012, P NATL ACAD SCI USA, V109, P16377, DOI 10.1073/pnas.1207906109; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Tieman D, 2010, PLANT J, V62, P113, DOI 10.1111/j.1365-313X.2010.04128.x; Uozumi A, 2012, SCI HORTIC-AMSTERDAM, V138, P1, DOI 10.1016/j.scienta.2012.01.036; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Yeats TH, 2012, PLANT J, V69, P655, DOI 10.1111/j.1365-313X.2011.04820.x; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	45	254	265	7	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1034	+		10.1038/ng.3046	http://dx.doi.org/10.1038/ng.3046			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25064008	Green Published, hybrid			2022-12-25	WOS:000341579400021
J	Gavenonis, J; Sheneman, BA; Siegert, TR; Eshelman, MR; Kritzer, JA				Gavenonis, Jason; Sheneman, Bradley A.; Siegert, Timothy R.; Eshelman, Matthew R.; Kritzer, Joshua A.			Comprehensive analysis of loops at protein-protein interfaces for macrocycle design	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITORS; HOT-SPOTS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING-ENERGY; RECEPTOR; COMPLEX; IDENTIFICATION; DETERMINANTS; DATABASE	Inhibiting protein-protein interactions (PPIs) with synthetic molecules remains a frontier of chemical biology. Many PPIs have been successfully targeted by mimicking alpha-helices at interfaces, but most PPIs are mediated by nonhelical, nonstrand peptide loops. We sought to comprehensively identify and analyze these loop-mediated PPIs by writing and implementing Loop Finder, a customizable program that can identify loop-mediated PPIs within all of the protein-protein complexes in the Protein Data Bank. Comprehensive analysis of the entire set of 25,005 interface loops revealed common structural motifs and unique features that distinguish loop-mediated PPIs from other PPIs. 'Hot loops', named in analogy to protein hot spots, were identified as loops with favorable properties for mimicry using synthetic molecules. The hot loops and their binding partners represent new and promising PPIs for the development of macrocycle and constrained peptide inhibitors.	[Gavenonis, Jason; Sheneman, Bradley A.; Siegert, Timothy R.; Eshelman, Matthew R.; Kritzer, Joshua A.] Tufts Univ, Dept Chem, Medford, MA 02155 USA	Tufts University	Gavenonis, J (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	joshua.kritzer@tufts.edu		, Matthew/0000-0002-0328-9212; Gavenonis, Jason/0000-0002-6351-0134	US National Institutes of Health (NIH)/NIGMS Institutional Research and Academic Career Development Awards [K12GM074869]; Department of Education Graduate Assistance in Areas of National Need [P200A090303]; NIH [DP2-OD007303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM074869] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007303] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/NIGMS Institutional Research and Academic Career Development Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education Graduate Assistance in Areas of National Need(US Department of Education); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.G. was supported in part by US National Institutes of Health (NIH)/NIGMS Institutional Research and Academic Career Development Awards grant K12GM074869. T.R.S. was supported in part by Department of Education Graduate Assistance in Areas of National Need grant P200A090303. This work was supported in part by NIH DP2-OD007303 to J.A.K. The authors thank the Tufts Technology Services for research cluster access and R. Scheck for helpful conversations.	Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Bergey CM, 2013, BIOINFORMATICS, V29, P2806, DOI 10.1093/bioinformatics/btt483; Bock JE, 2013, ACS CHEM BIOL, V8, P488, DOI 10.1021/cb300515u; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Chen Y, 2011, CHEM BIOL DRUG DES, V78, P1014, DOI 10.1111/j.1747-0285.2011.01240.x; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DeLano W.L., 2006, PYMOL MOL GRAPHIC SY; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; Hancock R, 2013, ORG BIOMOL CHEM, V11, P3553, DOI 10.1039/c3ob40249e; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Horer S, 2013, ACTA CRYSTALLOGR F, V69, P592, DOI 10.1107/S174430911301124X; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Huang J, 2012, CELL RES, V22, P1078, DOI 10.1038/cr.2012.72; Huang KS, 2005, METHOD ENZYMOL, V399, P717, DOI 10.1016/S0076-6879(05)99047-2; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jochim AL, 2010, ACS CHEM BIOL, V5, P919, DOI 10.1021/cb1001747; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Koes D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032839; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Marsault E, 2011, J MED CHEM, V54, P1961, DOI 10.1021/jm1012374; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nowick JS, 2008, ACCOUNTS CHEM RES, V41, P1319, DOI 10.1021/ar800064f; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Ungermannova D, 2013, J BIOMOL SCREEN, V18, P910, DOI 10.1177/1087057113485789; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015	43	129	130	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					716	722		10.1038/NCHEMBIO.1580	http://dx.doi.org/10.1038/NCHEMBIO.1580			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038791	Green Accepted			2022-12-25	WOS:000341126800007
J	Geller, F; Feenstra, B; Carstensen, L; Pers, TH; van Rooij, IALM; Korberg, IB; Choudhry, S; Karjalainen, JM; Schnack, TH; Hollegaard, MV; Feitz, WFJ; Roeleveld, N; Hougaard, DM; Hirschhorn, JN; Franke, L; Baskin, LS; Nordenskjold, A; van der Zanden, LFMD; Melbye, M				Geller, Frank; Feenstra, Bjarke; Carstensen, Lisbeth; Pers, Tune H.; van Rooij, Iris A. L. M.; Korberg, Izabella Baranowska; Choudhry, Shweta; Karjalainen, Juha M.; Schnack, Tine H.; Hollegaard, Mads V.; Feitz, Wout F. J.; Roeleveld, Nel; Hougaard, David M.; Hirschhorn, Joel N.; Franke, Lude; Baskin, Laurence S.; Nordenskjold, Agneta; van der Zanden, Loes F. M.; Melbye, Mads			Genome-wide association analyses identify variants in developmental genes associated with hypospadias	NATURE GENETICS			English	Article							LOCI; METAANALYSIS; DISEASE; EXPRESSION; IDENTIFICATION; PRESSURE; ETIOLOGY; REVEALS; NETWORK; BMP7	Hypospadias is a common congenital condition in boys in which the urethra opens on the underside of the penis. We performed a genome-wide association study on 1,006 surgery-confirmed hypospadias cases and 5,486 controls from Denmark. After replication genotyping of an additional 1,972 cases and 1,812 controls from Denmark, the Netherlands and Sweden, 18 genomic regions showed independent association with P < 5 x 10(-8). Together, these loci explain 9% of the liability to developing this condition. Several of the identified regions harbor genes with key roles in embryonic development (including HOXA4, IRX5, IRX6 and EYA1). Subsequent pathway analysis with GRAIL and DEPICT provided additional insight into possible genetic mechanisms causing hypospadias.	[Geller, Frank; Feenstra, Bjarke; Carstensen, Lisbeth; Schnack, Tine H.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Pers, Tune H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [van Rooij, Iris A. L. M.; Roeleveld, Nel] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Korberg, Izabella Baranowska; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Korberg, Izabella Baranowska; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Choudhry, Shweta; Baskin, Laurence S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Karjalainen, Juha M.; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Feitz, Wout F. J.] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Roeleveld, Nel] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA	Statens Serum Institut; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Technical University of Denmark; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; University of California System; University of California San Francisco; University of Groningen; Statens Serum Institut; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Stanford University	Geller, F (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	fge@ssi.dk	Hougaard, David/AAD-6368-2019; Karjalainen, Juha/P-8624-2016; Iris ALM Rooij, van/A-5705-2014; van der Zanden, Loes/M-4795-2015; Roeleveld, Nel/B-4242-2008; Feitz, W.F.J./H-8028-2014; Franke, Lude/P-7036-2016	Iris ALM Rooij, van/0000-0002-9519-966X; van der Zanden, Loes/0000-0003-3914-7491; Roeleveld, Nel/0000-0002-3390-4466; Franke, Lude/0000-0002-5159-8802; melbye, mads/0000-0001-8264-6785; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Geller, Frank/0000-0002-9238-3269; Feenstra, Bjarke/0000-0003-1478-649X; Nordenskjold, Agneta/0000-0001-6638-4631; Pers, Tune/0000-0003-0207-4831	Radboud University Medical Center; Oak Foundation fellowship; Danish Council for Independent Research Medical Sciences (FSS); Alfred Benzon Foundation; FSS grant [0602-01455B]; Novo Nordisk Foundation; Lundbeck Foundation [421/06]; Swedish Research Council; Foundation Frimurare Barnhuset Stockholm; Stockholm City Council; Swedish Society for Medical Research and Karolinska Institutet; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5K12DK083021]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083021] Funding Source: NIH RePORTER	Radboud University Medical Center; Oak Foundation fellowship; Danish Council for Independent Research Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Alfred Benzon Foundation; FSS grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation Frimurare Barnhuset Stockholm; Stockholm City Council; Swedish Society for Medical Research and Karolinska Institutet; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all study participants (as well as their parents) in Denmark, the Netherlands, Sweden and the United States for their cooperation in this study. We would also like to thank everyone involved in data collection and biological material handling in the four study groups (C.H.W. Wijers, S. van der Velde-Visser, K. Kwak, J. Knoll, R. de Gier, B. Kortmann, A. Paauwen, H.G. Kho, J. Driessen and the anesthesiologists of OR 18 for the Dutch group; data collection in the Netherlands was performed as part of a PhD project supported by the Radboud University Medical Center).; B.F. is supported by an Oak Foundation fellowship. T.H.P. is supported by the Danish Council for Independent Research Medical Sciences (FSS) and the Alfred Benzon Foundation. The study was supported by an FSS grant (0602-01455B), the Novo Nordisk Foundation, the Lundbeck Foundation (421/06), the Swedish Research Council, Foundation Frimurare Barnhuset Stockholm, the Stockholm City Council, the Swedish Society for Medical Research and Karolinska Institutet. Funding support for expression analysis performed at the University of California, San Francisco came from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-sponsored K12 Urologic Research (KURe) program (5K12DK083021). The funders had no role in study design, execution or analysis or in manuscript writing.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bult CJ, 2013, NUCLEIC ACIDS RES, V41, pD885, DOI 10.1093/nar/gks1115; Carmichael SL, 2013, J UROLOGY, V189, P305, DOI 10.1016/j.juro.2012.09.002; Chen TJ, 2007, EUR J HUM GENET, V15, P23, DOI 10.1038/sj.ejhg.5201722; Chiu HS, 2010, DEV BIOL, V344, P1071, DOI 10.1016/j.ydbio.2010.05.495; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Geller F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002275; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalfa N, 2009, INT J ANDROL, V32, P187, DOI 10.1111/j.1365-2605.2008.00899.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang C, 2011, DEV BIOL, V360, P186, DOI 10.1016/j.ydbio.2011.09.020; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	56	73	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					957	+		10.1038/ng.3063	http://dx.doi.org/10.1038/ng.3063			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108383				2022-12-25	WOS:000341579400009
J	Kohler, A; Kuo, A; Nagy, LG; Morin, E; Barry, KW; Buscot, F; Canback, B; Choi, C; Cichocki, N; Clum, A; Colpaert, J; Copeland, A; Costa, MD; Dore, J; Floudas, D; Gay, G; Girlanda, M; Henrissat, B; Herrmann, S; Hess, J; Hogberg, N; Johansson, T; Khouja, HR; LaButti, K; Lahrmann, U; Levasseur, A; Lindquist, EA; Lipzen, A; Marmeisse, R; Martino, E; Murat, C; Ngan, CY; Nehls, U; Plett, JM; Pringle, A; Ohm, RA; Perotto, S; Peter, M; Riley, R; Rineau, F; Ruytinx, J; Salamov, A; Shah, F; Sun, H; Tarkka, M; Tritt, A; Veneault-Fourrey, C; Zuccaro, A; Tunlid, A; Grigoriev, IV; Hibbett, DS; Martin, F				Kohler, Annegret; Kuo, Alan; Nagy, Laszlo G.; Morin, Emmanuelle; Barry, Kerrie W.; Buscot, Francois; Canback, Bjorn; Choi, Cindy; Cichocki, Nicolas; Clum, Alicia; Colpaert, Jan; Copeland, Alex; Costa, Mauricio D.; Dore, Jeanne; Floudas, Dimitrios; Gay, Gilles; Girlanda, Mariangela; Henrissat, Bernard; Herrmann, Sylvie; Hess, Jaqueline; Hogberg, Nils; Johansson, Tomas; Khouja, Hassine-Radhouane; LaButti, Kurt; Lahrmann, Urs; Levasseur, Anthony; Lindquist, Erika A.; Lipzen, Anna; Marmeisse, Roland; Martino, Elena; Murat, Claude; Ngan, Chew Y.; Nehls, Uwe; Plett, Jonathan M.; Pringle, Anne; Ohm, Robin A.; Perotto, Silvia; Peter, Martina; Riley, Robert; Rineau, Francois; Ruytinx, Joske; Salamov, Asaf; Shah, Firoz; Sun, Hui; Tarkka, Mika; Tritt, Andrew; Veneault-Fourrey, Claire; Zuccaro, Alga; Tunlid, Anders; Grigoriev, Igor V.; Hibbett, David S.; Martin, Francis		Mycorrhizal Genomics Initiative Co	Convergent losses of decay mechanisms and rapid turnover of symbiosis genes in mycorrhizal mutualists	NATURE GENETICS			English	Article							LACCARIA-BICOLOR; CARBON; GENOME; PROTEIN; INSIGHTS; ORIGINS; LITTER; ROOTS; FUNGI	To elucidate the genetic bases of mycorrhizal lifestyle evolution, we sequenced new fungal genomes, including 13 ectomycorrhizal (ECM), orchid (ORM) and ericoid (ERM) species, and five saprotrophs, which we analyzed along with other fungal genomes. Ectomycorrhizal fungi have a reduced complement of genes encoding plant cell wall-degrading enzymes (PCWDEs), as compared to their ancestral wood decayers. Nevertheless, they have retained a unique array of PCWDEs, thus suggesting that they possess diverse abilities to decompose lignocellulose. Similar functional categories of nonorthologous genes are induced in symbiosis. Of induced genes, 7-38% are orphan genes, including genes that encode secreted effector-like proteins. Convergent evolution of the mycorrhizal habit in fungi occurred via the repeated evolution of a 'symbiosis toolkit', with reduced numbers of PCWDEs and lineage-specific suites of mycorrhiza-induced genes.	[Kohler, Annegret; Morin, Emmanuelle; Cichocki, Nicolas; Martino, Elena; Murat, Claude; Plett, Jonathan M.; Veneault-Fourrey, Claire; Martin, Francis] INRA, Lab Excellence Adv Res Biol Tree & Forest Ecosyst, UMR 1136, Champenoux, France; [Kohler, Annegret; Kuo, Alan; Morin, Emmanuelle; Cichocki, Nicolas; Murat, Claude; Plett, Jonathan M.; Veneault-Fourrey, Claire; Martin, Francis] Univ Lorraine, Lab Excellence ARBRE, UMR 1136, Champenoux, France; [Kuo, Alan; Barry, Kerrie W.; Choi, Cindy; Clum, Alicia; Copeland, Alex; LaButti, Kurt; Lindquist, Erika A.; Lipzen, Anna; Ngan, Chew Y.; Ohm, Robin A.; Riley, Robert; Salamov, Asaf; Sun, Hui; Tritt, Andrew; Grigoriev, Igor V.] US DOE, JGI, Walnut Creek, CA USA; [Nagy, Laszlo G.; Floudas, Dimitrios; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Nagy, Laszlo G.] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, H-6701 Szeged, Hungary; [Buscot, Francois; Herrmann, Sylvie; Tarkka, Mika] Helmholtz Zentrum Umweltforsch, Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Buscot, Francois; Herrmann, Sylvie; Tarkka, Mika] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Canback, Bjorn; Shah, Firoz; Tunlid, Anders] Lund Univ, Microbial Ecol Grp, Dept Biol, Lund, Sweden; [Colpaert, Jan; Johansson, Tomas; Rineau, Francois; Ruytinx, Joske] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Costa, Mauricio D.] Univ Fed Vicosa, Bolsista Conselho Nacl Desenvolvimento Cient & Te, Dept Microbiol, Vicosa, MG, Brazil; [Dore, Jeanne; Gay, Gilles; Marmeisse, Roland] Univ Lyon 1, Univ Lyon, Unite Contrat INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France; [Girlanda, Mariangela; Khouja, Hassine-Radhouane; Martino, Elena; Perotto, Silvia] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy; [Henrissat, Bernard; Levasseur, Anthony] Aix Marseille Univ, CNRS, UMR 7257, Marseille, France; [Henrissat, Bernard] Aix Marseille Univ, Architecture Fonct Macromol Biol, UMR 7257, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Hess, Jaqueline] Univ Oslo, Dept Biosci, Oslo, Norway; [Hogberg, Nils] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, Uppsala, Sweden; [Lahrmann, Urs; Zuccaro, Alga] Max Planck Inst Terr Microbiol, Dept Organism Interact, D-35043 Marburg, Germany; [Nehls, Uwe] Univ Bremen, Dept Ecol Biol Chem Bot, D-28359 Bremen, Germany; [Pringle, Anne] Harvard Univ, Harvard Forest, Petersham, MA USA; [Peter, Martina] Swiss Fed Inst Forest Snow & Landscape Res, Forest Dynam, WSL, CH-8903 Birmensdorf, Switzerland; [Zuccaro, Alga] Univ Cologne, Inst Bot, Cluster Excellence Plant Sci CEPLAS, D-50931 Cologne, Germany	INRAE; Universite de Lorraine; Universite de Lorraine; United States Department of Energy (DOE); Joint Genome Institute - JGI; Clark University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Lund University; Hasselt University; Universidade Federal de Vicosa; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of Turin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; University of Oslo; Swedish University of Agricultural Sciences; Max Planck Society; University of Bremen; Harvard University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Cologne	Martin, F (corresponding author), INRA, Lab Excellence Adv Res Biol Tree & Forest Ecosyst, UMR 1136, Champenoux, France.	DHibbett@clarku.edu; fmartin@nancy.inra.fr	Riley, Robert/AAA-4531-2020; Peter, Martina/G-2284-2018; Tarkka, Mika T/G-4374-2013; Ruytinx, Joske/K-9176-2017; Zuccaro, Alga/Q-2450-2015; Costa, Maurício/AAV-1267-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; morin, emmanuelle/AAA-1246-2019; Kohler, Annegret/AAD-1876-2019; Shah, Firoz/AAO-7771-2020; Buscot, Francois/A-4125-2016; Murat, Claude/AAA-5226-2020; Ohm, Robin A/I-6689-2016; Henrissat, Bernard/J-2475-2012; Shah, Firoz/D-4534-2018	Riley, Robert/0000-0003-0224-0975; Peter, Martina/0000-0002-6365-6889; Tarkka, Mika T/0000-0003-4630-351X; Ruytinx, Joske/0000-0001-5835-3704; Zuccaro, Alga/0000-0002-8026-0114; Barry, Kerrie Whitelaw/0000-0002-8999-6785; morin, emmanuelle/0000-0002-7268-972X; Shah, Firoz/0000-0001-7833-7832; Buscot, Francois/0000-0002-2364-0006; Murat, Claude/0000-0003-0685-7307; Henrissat, Bernard/0000-0002-3434-8588; Shah, Firoz/0000-0001-7833-7832; Lipzen, Anna/0000-0003-2293-9329; Colpaert, Jan V/0000-0003-1610-1861; Rineau, Francois/0000-0002-5135-6184; Veneault-Fourrey, Claire/0000-0001-9778-2659; PEROTTO, Silvia/0000-0003-0121-1806; Levasseur, Anthony/0000-0003-2989-7539; Hess, Jaqueline/0000-0003-3281-5434; ngan, chew yee/0000-0001-6055-1072; Plett, Jonathan/0000-0003-0514-8146; Martino, Elena/0000-0003-3446-2994; Nehls, Uwe/0000-0003-4421-6455; Grigoriev, Igor/0000-0002-3136-8903; Ohm, Robin A./0000-0003-2548-0074; Marmeisse, Roland/0000-0003-1653-3517; Costa, Mauricio/0000-0002-0828-4437	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231]; Laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]; Genomic Science Program (Plant-Microbe Interactions project) - US Department of Energy, Office of Science, Biological and Environmental Research [DE-AC05-00OR22725]; Lorraine Region Council; US National Science Foundation [DEB-1208719, DEB-0933081, DEB-1021606]; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig [DFG FTZ 118]; German Science Foundation (DFG) [BU941/20-1]; Swedish Research Council; Laboratory of Excellence TULIP [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); Laboratory of Excellence ARBRE; Genomic Science Program (Plant-Microbe Interactions project) - US Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); Lorraine Region Council(Region Grand-Est); US National Science Foundation(National Science Foundation (NSF)); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; German Science Foundation (DFG)(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Laboratory of Excellence TULIP	This material is based on work conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported under contract no. DE-AC02-05CH11231. This work was also supported by the Laboratory of Excellence ARBRE (ANR-11-LABX-0002-01), the Genomic Science Program (Plant-Microbe Interactions project) funded by the US Department of Energy, Office of Science, Biological and Environmental Research (contract DE-AC05-00OR22725), the Lorraine Region Council (to F.M.), US National Science Foundation grants DEB-1208719 and DEB-0933081 (both to D.S.H. and DEB-1021606 (to A.P.)), the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (DFG FTZ 118) and the German Science Foundation (DFG, grant BU941/20-1) (to F.B.) and the Swedish Research Council (to A. Tunlid). This work was partly supported by the Laboratory of Excellence TULIP (ANR-10-LABX-41 and ANR-11-IDEX-0002-02). F.M. would like to acknowledge M.A. Selosse and B. Lindahl for helpful discussions.	Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Bodeker ITM, 2014, NEW PHYTOL, V203, P245, DOI 10.1111/nph.12791; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; DEARNALEY JDW, 2012, FUNGAL ASS, V9, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hogberg MN, 2002, NEW PHYTOL, V154, P791, DOI 10.1046/j.1469-8137.2002.00417.x; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Plett JM, 2014, P NATL ACAD SCI USA, V111, P8299, DOI 10.1073/pnas.1322671111; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Read DJ, 2004, CAN J BOT, V82, P1243, DOI [10.1139/B04-123, 10.1139/b04-123]; Rice AV, 2006, MICROBIAL ROOT ENDOP, P227; Rineau F, 2013, ISME J, V7, P2010, DOI 10.1038/ismej.2013.91; Ryberg M, 2012, P ROY SOC B-BIOL SCI, V279, P2003, DOI 10.1098/rspb.2011.2428; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Treseder KK, 2006, SOIL BIOL BIOCHEM, V38, P1077, DOI 10.1016/j.soilbio.2005.09.006; Veneault-Fourrey C, 2014, FUNGAL GENET BIOL, V72, P168, DOI 10.1016/j.fgb.2014.08.007	24	596	624	15	360	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					410	U176		10.1038/ng.3223	http://dx.doi.org/10.1038/ng.3223			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25706625	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000351922900020
J	Grozovsky, R; Begonja, AJ; Liu, K; Visner, G; Hartwig, JH; Falai, H; Hoffmeister, KM				Grozovsky, Renata; Begonja, Antonija Jurak; Liu, Kaifeng; Visner, Gary; Hartwig, John H.; Falai, Herve; Hoffmeister, Karin M.			The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling	NATURE MEDICINE			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; PLATELET LIFE-SPAN; MESSENGER-RNA; C-MPL; ASIALOGLYCOPROTEIN RECEPTOR; ESSENTIAL THROMBOCYTHEMIA; SERUM-LEVELS; BONE-MARROW; EXPRESSION; MEGAKARYOCYTES	The hepatic Ashwell-Morell receptor (AMR) can bind and remove desialylated platelets. Here we demonstrate that platelets become desialylated as they circulate and age in blood. Binding of desialylated platelets to the AMR induces hepatic expression of thrombopoietin (TPO) mRNA and protein, thereby regulating platelet production. Endocytic AMR controls TPO expression through Janus kinase 2 (JAK2) and the acute phase response signal transducer and activator of transcription 3 (STAT3) in vivo and in vitro. Recognition of this newly identified physiological feedback mechanism illuminates the pathophysiology of platelet diseases, such as essential thrombocythemia and immune thrombocytopenia, and contributes to an understanding of the mechanisms of thrombocytopenia observed with JAK1/2 inhibition.	[Grozovsky, Renata; Begonja, Antonija Jurak; Hartwig, John H.; Falai, Herve; Hoffmeister, Karin M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; [Liu, Kaifeng; Visner, Gary] Harvard Univ, Boston Childrens Hosp, Sch Med, Div Resp Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Hoffmeister, KM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA.	hfalet@rics.bwh.harvard.edu; khoffmeister@rics.bwh.harvard.edu	Begonja, Antonija Jurak/S-6225-2018; Begonja, Antonija Jurak/AAU-3540-2020	Begonja, Antonija Jurak/0000-0001-5798-0888; Begonja, Antonija Jurak/0000-0001-5798-0888; Falet, Herve/0000-0003-0788-9204	US National Institutes of Health [R01 HL089224, P01 HL059561]; Program of Excellence in Glycosciences [P01 HL107146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089224, P01HL107146] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Excellence in Glycosciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Adelman, S. Yang and R. Abdu for technical assistance. We are grateful to M. Sola-Visner and T. Stossel (Harvard Medical School) for helpful discussions and to W Tong (University of Pennsylvania), for the anti-Mpl antibody. This work was supported by US National Institutes of Health grants R01 HL089224, P01 HL059561 and the Program of Excellence in Glycosciences (P01 HL107146). We thank F. Maigen for statistical guidance and expertise. We dedicate this work to the memory of Gilbert Ashwell (1916-2014) and Anatol Morell (1913-2009).	Cohen-Solal K, 1999, BLOOD, V93, P2859; CohenSolal K, 1996, BLOOD, V88, P2578, DOI 10.1182/blood.V88.7.2578.bloodjournal8872578; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; Debrincat MA, 2012, BLOOD, V119, P5850, DOI 10.1182/blood-2011-12-398834; Engel C, 1999, BRIT J HAEMATOL, V105, P832, DOI 10.1046/j.1365-2141.1999.01459.x; Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010; FALLON RJ, 1994, J BIOL CHEM, V269, P26626; Fielder PJ, 1996, BLOOD, V87, P2154, DOI 10.1182/blood.V87.6.2154.bloodjournal8762154; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Grewal PK, 2013, P NATL ACAD SCI USA, V110, P20218, DOI 10.1073/pnas.1313905110; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Griesshammer M, 1998, ANN HEMATOL, V77, P211, DOI 10.1007/s002770050445; Grisouard J, 2014, HAEMATOLOGICA, V99, pE52, DOI 10.3324/haematol.2013.100016; Hiyoyama K, 1997, BLOOD COAGUL FIBRIN, V8, P345, DOI 10.1097/00001721-199709000-00004; Hoffmeister KM, 2011, J THROMB HAEMOST, V9, P35, DOI 10.1111/j.1538-7836.2011.04276.x; Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031; Ichikawa N, 1996, THROMB HAEMOSTASIS, V76, P156; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Karpatkin S, 1980, Trans Assoc Am Physicians, V93, P244; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Kuter DJ, 2009, ANNU REV MED, V60, P193, DOI 10.1146/annurev.med.60.042307.181154; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; MCCARTY JM, 1995, BLOOD, V86, P3668, DOI 10.1182/blood.V86.10.3668.bloodjournal86103668; McIntosh B, 2008, EXP HEMATOL, V36, P799, DOI 10.1016/j.exphem.2008.02.012; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Mouthon MA, 1999, RADIAT RES, V152, P390, DOI 10.2307/3580223; Ng AP, 2014, P NATL ACAD SCI USA, V111, P5884, DOI 10.1073/pnas.1404354111; Park SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059675; Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Rumjantseva V, 2010, TRANSFUS APHER SCI, V42, P63, DOI 10.1016/j.transci.2009.10.008; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Shinjo K, 1998, LEUKEMIA, V12, P295, DOI 10.1038/sj.leu.2400946; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101; Wang JC, 1998, AM J MED, V104, P451, DOI 10.1016/S0002-9343(98)00090-4; Wolber EM, 2000, J INTERF CYTOK RES, V20, P499, DOI 10.1089/10799900050023915; Wolber EM, 2001, THROMB HAEMOSTASIS, V86, P1421; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	47	182	186	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					47	54		10.1038/nm.3770	http://dx.doi.org/10.1038/nm.3770			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25485912	Green Accepted			2022-12-25	WOS:000348408000012
J	Sobotta, MC; Liou, W; Stocker, S; Talwar, D; Oehler, M; Ruppert, T; Scharf, AND; Dick, TP				Sobotta, Mirko C.; Liou, Willy; Stoecker, Sarah; Talwar, Deepti; Oehler, Michael; Ruppert, Thomas; Scharf, Annette N. D.; Dick, Tobias P.			Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; GENE-EXPRESSION; SPECIFICITY; ACTIVATION; CHEMISTRY; PROTEINS; YAP1	Hydrogen peroxide (H2O2) acts as a signaling messenger by oxidatively modifying distinct cysteinyl thiols in distinct target proteins. However, it remains unclear how redox-regulated proteins, which often have low intrinsic reactivity towards H2O2 (k(app) similar to 1-10 M-1 s(-1)), can be specifically and efficiently oxidized by H2O2. Moreover, cellular thiol peroxidases, which are highly abundant and efficient H2O2 scavengers, should effectively eliminate virtually all of the H2O2 produced in the cell. Here, we show that the thiol peroxidase peroxiredoxin-2 (Prx2), one of the most H2O2-reactive proteins in the cell (k(app) similar to 107-108 M-1 s(-1)), acts as a H2O2 signal receptor and transmitter in transcription factor redox regulation. Prx2 forms a redox relay with the transcription factor STAT3 in which oxidative equivalents flow from Prx2 to STAT3. The redox relay generates disulfide-linked STAT3 oligomers with attenuated transcriptional activity. Cytokine-induced STAT3 signaling is accompanied by Prx2 and STAT3 oxidation and is modulated by Prx2 expression levels.	[Sobotta, Mirko C.; Liou, Willy; Stoecker, Sarah; Talwar, Deepti; Oehler, Michael; Dick, Tobias P.] DKFZ ZMBH Alliance, Div Redox Regulat, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Ruppert, Thomas; Scharf, Annette N. D.] Univ Heidelberg ZMBH, Core Facil Mass Spectrometry & Prote, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), DKFZ ZMBH Alliance, Div Redox Regulat, German Canc Res Ctr DKFZ, Heidelberg, Germany.	t.dick@dkfz.de	Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266	Deutsche Forschungsgemeinschaft [SFB 1036, SFB 938, SPP 1710]; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	T.P.D. is supported by the Deutsche Forschungsgemeinschaft (SFB 1036, SFB 938 and SPP 1710). M.C.S. was supported by a PhD fellowship from the Boehringer Ingelheim Fonds. We thank B. Morgan and R. Jarvis for critical and helpful comments on the manuscript.	Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Calvo IA, 2013, CELL REP, V5, P1413, DOI 10.1016/j.celrep.2013.11.027; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Mamoon NM, 2007, BIOCHEMISTRY-US, V46, P14810, DOI 10.1021/bi701118u; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei PC, 2012, MOL CELL, V48, P747, DOI 10.1016/j.molcel.2012.10.007; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	35	401	408	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					64	+		10.1038/nchembio.1695	http://dx.doi.org/10.1038/nchembio.1695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402766				2022-12-25	WOS:000346448600014
J	Moncunill, V; Gonzalez, S; Bea, S; Andrieux, LO; Salaverria, I; Royo, C; Martinez, L; Puiggros, M; Segura-Wang, M; Stutz, AM; Navarro, A; Royo, R; Gelpi, JL; Gut, IG; Lopez-Otin, C; Orozco, M; Korbel, J; Campo, E; Puente, XS; Torrents, D				Moncunill, Valenti; Gonzalez, Santi; Bea, Silvia; Andrieux, Lise O.; Salaverria, Itziar; Royo, Cristina; Martinez, Laura; Puiggros, Montserrat; Segura-Wang, Maia; Stuetz, Adrian M.; Navarro, Alba; Royo, Romina; Gelpi, Josep L.; Gut, Ivo G.; Lopez-Otin, Carlos; Orozco, Modesto; Korbel, Jan; Campo, Elias; Puente, Xose S.; Torrents, David			Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads	NATURE BIOTECHNOLOGY			English	Article							PAIRED-END; MUTATIONS; REARRANGEMENTS; RESOLUTION; LANDSCAPE; EVOLUTION; LYMPHOMA	The development of high-throughput sequencing technologies has advanced our understanding of cancer. However, characterizing somatic structural variants in tumor genomes is still challenging because current strategies depend on the initial alignment of reads to a reference genome. Here, we describe SMUFIN (somatic mutation finder), a single program that directly compares sequence reads from normal and tumor genomes to accurately identify and characterize a range of somatic sequence variation, from single-nucleotide variants (SNV) to large structural variants at base pair resolution. Performance tests on modeled tumor genomes showed average sensitivity of 92% and 74% for SNVs and structural variants, with specificities of 95% and 91%, respectively. Analyses of aggressive forms of solid and hematological tumors revealed that SMUFIN identifies breakpoints associated with chromothripsis and chromoplexy with high specificity. SMUFIN provides an integrated solution for the accurate, fast and comprehensive characterization of somatic sequence variation in cancer.	[Moncunill, Valenti; Gonzalez, Santi; Andrieux, Lise O.; Martinez, Laura; Puiggros, Montserrat; Royo, Romina; Gelpi, Josep L.; Orozco, Modesto; Torrents, David] Barcelona Supercomp Ctr, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Bea, Silvia; Salaverria, Itziar; Royo, Cristina; Navarro, Alba; Campo, Elias] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Pathol,Hematopathol Unit, Barcelona, Spain; [Puiggros, Montserrat; Royo, Romina; Gelpi, Josep L.] Natl Inst Bioinformat, Barcelona, Spain; [Stuetz, Adrian M.; Korbel, Jan] European Mol Biol Lab, Genome Biol Res Unit, D-69012 Heidelberg, Germany; [Gelpi, Josep L.; Orozco, Modesto] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Gut, Ivo G.] CNAG, Barcelona, Spain; [Lopez-Otin, Carlos; Puente, Xose S.] Univ Oviedo, IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Orozco, Modesto] IRB Barcelona, Barcelona, Spain; [Campo, Elias; Torrents, David] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; European Molecular Biology Laboratory (EMBL); University of Barcelona; University of Oviedo; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Torrents, D (corresponding author), Barcelona Supercomp Ctr, Joint IRB BSC Program Computat Biol, Barcelona, Spain.	david.torrents@bsc.es	López-Otín, Carlos/AAB-2106-2020; Gut, Ivo/ABF-3188-2020; Campo, Elias/AAC-5593-2019; Puente, Xosé S./ADB-0672-2022; SALAVERRIA, ITZIAR/L-2246-2015; SALAVERRIA, ITZIAR/AAW-9019-2021; Royo, Cristina/H-3193-2015; bea, silvia/K-7699-2014; Gelpí, Josep Ll./M-6401-2013; Navarro, Alba/H-2611-2015; Campo, elias/O-7192-2016; Torrents, David/G-5785-2015	López-Otín, Carlos/0000-0001-6964-1904; Gut, Ivo/0000-0001-7219-632X; Campo, Elias/0000-0001-9850-9793; Puente, Xosé S./0000-0001-9525-1483; SALAVERRIA, ITZIAR/0000-0002-2427-9822; Royo, Cristina/0000-0002-1214-4656; bea, silvia/0000-0001-7192-2385; Gelpí, Josep Ll./0000-0002-0566-7723; Navarro, Alba/0000-0002-4041-0974; Campo, elias/0000-0001-9850-9793; Torrents, David/0000-0002-6086-9037; Stuetz, Adrian/0000-0001-7650-3470; Royo, Romina/0000-0003-3493-0874; Puiggros, Montserrat/0000-0001-5034-7924; Gonzalez Rosado, Santiago/0000-0001-5685-4580; Segura-Wang, Maia/0000-0003-2424-618X	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII [RD12/0036/0036]; National Institute of Bioinformatics (INB); Ministerio de Economia y Competitividad; Secretaria De Estado De Investigacion; Desarrollo e Innovacion PLAN NACIONAL de I+D+i; Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; Plan Nacional [SAF12/38432]; Generalitat de Catalunya AGAUR [2009-SGR-992]; Fondo de Investigaciones Sanitarias [PI11/01177]; Association for International Cancer Research [12-0142]; European Commission [Health-F2-2010-260791]; ICREA Funding Source: Custom; Worldwide Cancer Research [12-0142] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; National Institute of Bioinformatics (INB); Ministerio de Economia y Competitividad(Spanish Government); Secretaria De Estado De Investigacion; Desarrollo e Innovacion PLAN NACIONAL de I+D+i; Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; Plan Nacional; Generalitat de Catalunya AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Association for International Cancer Research; European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA); Worldwide Cancer Research	The ICGC-CLL Genome Consortium is funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII), Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII (RD12/0036/0036) and National Institute of Bioinformatics (INB). This study was also supported by Ministerio de Economia y Competitividad, Secretaria De Estado De Investigacion, Desarrollo e Innovacion PLAN NACIONAL de I+D+i 2008-2011, Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; and Plan Nacional SAF12/38432; Generalitat de Catalunya AGAUR 2009-SGR-992; Fondo de Investigaciones Sanitarias (PI11/01177); Association for International Cancer Research (12-0142). J.O.K. and M.S.W. were supported by the European Commission (Health-F2-2010-260791). C.L.-O. is an investigator of the Botin Foundation. E.C. and M.O. are ICREA Academia Researchers. We also thank S. Guijarro and C. Gomez for their excellent technical assistance.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Shen MM, 2013, CANCER CELL, V23, P567, DOI 10.1016/j.ccr.2013.04.025; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	19	59	61	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1106	1112		10.1038/nbt.3027	http://dx.doi.org/10.1038/nbt.3027			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25344728	Bronze			2022-12-25	WOS:000344977000015
J	Torisawa, T; Ichikawa, M; Furuta, A; Saito, K; Oiwa, K; Kojima, H; Toyoshima, YY; Furuta, K				Torisawa, Takayuki; Ichikawa, Muneyoshi; Furuta, Akane; Saito, Kei; Oiwa, Kazuhiro; Kojima, Hiroaki; Toyoshima, Yoko Y.; Furuta, Ken'ya			Autoinhibition and cooperative activation mechanisms of cytoplasmic dynein	NATURE CELL BIOLOGY			English	Article							IN-VITRO; CRYSTAL-STRUCTURE; KINESIN MOTORS; PROCESSIVITY; DYNACTIN; DOMAIN; LIS1; MICROTUBULES; COMPLEXES; DIFFUSION	Cytoplasmic dynein is a two-headed microtubule-based motor responsible for diverse intracellular movements, including minus-end-directed transport of organelles(1-3). The motility of cargo transporters is regulated according to the presence or absence of cargo(4-6); however, it remains unclear how cytoplasmic dynein achieves such regulation. Here, using a recombinant and native dynein complex in vitro, we show that lone, single dynein molecules are in an autoinhibited state, in which the two motor heads are stacked together. In this state, dynein moves diffusively along a microtubule with only a small bias towards the minus end of the microtubule. When the two heads were physically separated by a rigid rod, the movement of dynein molecules became directed and processive. Furthermore, assembly of multiple dynein molecules on a single cargo enabled them to move unidirectionally and generate force cooperatively. We thus propose a mechanism of autonomous on-off switching of cargo transport, in which single dynein molecules in the cell are autoinhibited through intramolecular head-head stacking and become active when they assemble as a team on a cargo.	[Torisawa, Takayuki; Ichikawa, Muneyoshi; Saito, Kei; Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Torisawa, Takayuki; Furuta, Akane; Oiwa, Kazuhiro; Kojima, Hiroaki; Furuta, Ken'ya] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Torisawa, Takayuki; Oiwa, Kazuhiro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Oiwa, Kazuhiro] Univ Hyogo, Grad Sch Life Sci, Harima, Hyogo 6781297, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan; Japan Science & Technology Agency (JST); University of Hyogo	Toyoshima, YY (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp; furutak@nict.go.jp	Oiwa, Kazuhiro/D-7721-2011; Ichikawa, Muneyoshi/AAR-5530-2021	Oiwa, Kazuhiro/0000-0002-1281-113X; Ichikawa, Muneyoshi/0000-0002-5921-7699	JSPS; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [25113504] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. H. Bui, T. Ishikawa and H. Sakakibara for technical instruction in electron microscopy, K. Sutoh for critical comments on the manuscript, K. Kawaguchi for helpful discussion, K. Yamamoto for early work on DNA nanotubes, M. Amino and Y. Watari for technical assistance, K. Shibata for constructing the monomeric yeast dynein construct and Y. Utsumi for the chicken alpha-actinin plasmid. This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) fellowship from JSPS, a JSPS Grant-in-Aid for Scientific Research (B), a JSPS Grant-in-Aid for Scientific Research (C) and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; AMOS LA, 1989, J CELL SCI, V93, P19; Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; [Anonymous], TE; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Ichikawa M, 2011, FEBS LETT, V585, P2419, DOI 10.1016/j.febslet.2011.06.026; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Shibata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042990; SHIMIZU T, 1995, BIOCHEMISTRY-US, V34, P1575, DOI 10.1021/bi00005a013; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373	44	103	103	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1118	+		10.1038/ncb3048	http://dx.doi.org/10.1038/ncb3048			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25266423				2022-12-25	WOS:000344744000010
J	Dunbar, KL; Chekan, JR; Cox, CL; Burkhart, BJ; Nair, SK; Mitchell, DA				Dunbar, Kyle L.; Chekan, Jonathan R.; Cox, Courtney L.; Burkhart, Brandon J.; Nair, Satish K.; Mitchell, Douglas A.			Discovery of a new ATP-binding motif involved in peptidic azoline biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCTS; GENE-CLUSTER; SEQUENCE; CONSERVATION; GENERATION; RESISTANCE; COMPLEX; OXAZOLE	Despite intensive research, the cyclodehydratase responsible for azoline biogenesis in thiazole/oxazole-modified microcin (TOMM) natural products remains enigmatic. The collaboration of two proteins, C and D, is required for cyclodehydration. The C protein is homologous to E1 ubiquitin-activating enzymes, whereas the D protein is within the YcaO superfamily. Recent studies have demonstrated that TOMM YcaOs phosphorylate amide carbonyl oxygens to facilitate azoline formation. Here we report the X-ray crystal structure of an uncharacterized YcaO from Escherichia coli (Ec-YcaO). Ec-YcaO harbors an unprecedented fold and ATP-binding motif. This motif is conserved among TOMM YcaOs and is required for cyclodehydration. Furthermore, we demonstrate that the C protein regulates substrate binding and catalysis and that the proline-rich C terminus of the D protein is involved in C protein recognition and catalysis. This study identifies the YcaO active site and paves the way for the characterization of the numerous YcaO domains not associated with TOMM biosynthesis.	[Dunbar, Kyle L.; Burkhart, Brandon J.; Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Dunbar, Kyle L.; Cox, Courtney L.; Burkhart, Brandon J.; Nair, Satish K.; Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61820 USA; [Chekan, Jonathan R.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Cox, Courtney L.; Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61820 USA.	snair@uiuc.edu; douglasm@illinois.edu	Chekan, Jonathan/AAN-8499-2020; Nair, Satish/AAY-2510-2021; Mitchell, Douglas/C-4400-2011	Mitchell, Douglas/0000-0002-9564-0953; Chekan, Jonathan/0000-0003-4651-0594; Dunbar, Kyle L./0000-0002-7410-5169	US National Institutes of Health (NIH) [1R01 GM097142, 1R01 GM102602, 2T32 GM070421]; Harold R. Snyder Fellowship (University of Illinois at Urbana-Champaign (UIUC) Department of Chemistry); Robert C. and Carolyn J. Springborn Endowment (UIUC Department of Chemistry); National Science Foundation Graduate Research Fellowship [DGE-1144245]; University of Illinois Distinguished Fellowship (UIUC Graduate College); NIH National Center for Research Resources [S10 RR027109 A]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102602, R01GM097142, T32GM070421] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold R. Snyder Fellowship (University of Illinois at Urbana-Champaign (UIUC) Department of Chemistry); Robert C. and Carolyn J. Springborn Endowment (UIUC Department of Chemistry); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Illinois Distinguished Fellowship (UIUC Graduate College); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Deane and K. Taylor for the generation of select BalhD mutants and J. Melby for assistance with collecting MS/MS data. This work was supported by the US National Institutes of Health (NIH) (1R01 GM097142 to D.A.M., 1R01 GM102602 to S.K.N. and 2T32 GM070421 to K.L.D., B.J.B. and J.R.C.). Additional support was from the Harold R. Snyder Fellowship (University of Illinois at Urbana-Champaign (UIUC) Department of Chemistry to K.L.D.), the Robert C. and Carolyn J. Springborn Endowment (UIUC Department of Chemistry to B.J.B.), the National Science Foundation Graduate Research Fellowship (DGE-1144245 to B.J.B.) and the University of Illinois Distinguished Fellowship (UIUC Graduate College to J.R.C.) The Bruker UltrafleXtreme MALDI TOF/TOF mass spectrometer was purchased in part with a grant from the NIH National Center for Research Resources (S10 RR027109 A).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bhatnagar RS, 1999, BBA-MOL CELL BIOL L, V1441, P162, DOI 10.1016/S1388-1981(99)00155-9; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Breil BT, 1996, J BACTERIOL, V178, P4150, DOI 10.1128/jb.178.14.4150-4156.1996; BREIL BT, 1993, J BACTERIOL, V175, P3693, DOI 10.1128/JB.175.12.3693-3702.1993; Chen WJ, 2011, P NATL ACAD SCI USA, V108, P9804, DOI 10.1073/pnas.1105379108; CLIMIE SC, 1992, BIOCHEMISTRY-US, V31, P6032, DOI 10.1021/bi00141a011; Crone WJK, 2012, CHEM SCI, V3, P3516, DOI 10.1039/c2sc21190d; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Denessiouk KA, 2000, PROTEINS, V38, P310, DOI 10.1002/(SICI)1097-0134(20000215)38:3<310::AID-PROT7>3.0.CO;2-T; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Dunbar KL, 2013, J AM CHEM SOC, V135, P8692, DOI 10.1021/ja4029507; Dunbar KL, 2012, NAT CHEM BIOL, V8, P569, DOI [10.1038/NCHEMBIO.944, 10.1038/nchembio.944]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gomez-Escribano JP, 2012, CHEM SCI, V3, P3522, DOI 10.1039/c2sc21183a; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou YP, 2012, ORG LETT, V14, P5050, DOI 10.1021/ol3022758; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huo LJ, 2012, CHEM BIOL, V19, P1278, DOI 10.1016/j.chembiol.2012.08.013; Izawa M, 2013, APPL ENVIRON MICROB, V79, P7110, DOI 10.1128/AEM.01978-13; Koehnke J, 2013, ANGEW CHEM INT EDIT, V52, P13991, DOI 10.1002/anie.201306302; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Melby JO, 2012, J AM CHEM SOC, V134, P5309, DOI 10.1021/ja211675n; Melby JO, 2011, CURR OPIN CHEM BIOL, V15, P369, DOI 10.1016/j.cbpa.2011.02.027; Milne J.C., BIOCHEMISTRY, V38, P4768; Milne JC, 1998, BIOCHEMISTRY-US, V37, P13250, DOI 10.1021/bi980996e; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Rakus JF, 2007, BIOCHEMISTRY-US, V46, P12896, DOI 10.1021/bi701703w; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strader MB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005199; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenorio E, 2003, FEMS MICROBIOL LETT, V225, P107, DOI 10.1016/S0378-1097(03)00507-X; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	53	60	61	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					823	+		10.1038/NCHEMBIO.1608	http://dx.doi.org/10.1038/NCHEMBIO.1608			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25129028	Green Accepted			2022-12-25	WOS:000342462100008
J	Ma'ayan, A; Duan, QN				Ma'ayan, Avi; Duan, Qiaonan			A blueprint of cell identity	NATURE BIOTECHNOLOGY			English	Editorial Material							CONVERSION; NETWORK; BIOLOGY		[Ma'ayan, Avi; Duan, Qiaonan] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ma'ayan, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	avi.maayan@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	NCI NIH HHS [U54 CA189201] Funding Source: Medline; NHLBI NIH HHS [U54 HL127624] Funding Source: Medline; NIGMS NIH HHS [R01 GM098316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA189201] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ma'ayan A, 2014, TRENDS PHARMACOL SCI, V35, P450, DOI 10.1016/j.tips.2014.07.001; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Waddington C. H., 2014, STRATEGY GENES; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Xu HL, 2010, WIRES SYST BIOL MED, V2, P708, DOI 10.1002/wsbm.93	10	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1007	1008		10.1038/nbt.3035	http://dx.doi.org/10.1038/nbt.3035			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299921	Green Accepted			2022-12-25	WOS:000343763800016
J	Ollis, AA; Zhang, S; Fisher, AC; DeLisa, MP				Ollis, Anne A.; Zhang, Sheng; Fisher, Adam C.; DeLisa, Matthew P.			Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity	NATURE CHEMICAL BIOLOGY			English	Article							N-LINKED GLYCOSYLATION; PROTEIN GLYCOSYLATION; ESCHERICHIA-COLI; CAMPYLOBACTER-JEJUNI; OLIGOSACCHARIDES; INSIGHTS; PATHWAY; ROLES	The Campylobacter jejuni protein glycosylation locus (pgl) encodes machinery for asparagine-linked (N-linked) glycosylation and serves as the archetype for bacterial N-linked glycosylation. This machinery has been functionally transferred into Escherichia coli, enabling convenient mechanistic dissection of the N-linked glycosylation process in this genetically tractable host. Here we sought to identify sequence determinants in the oligosaccharyltransferase PglB that restrict its specificity to only those glycan acceptor sites containing a negatively charged residue at the -2 position relative to asparagine. This involved creation of a genetic assay, glycosylation of secreted N-linked acceptor proteins (glycoSNAP), that facilitates high-throughput screening of glycophenotypes in E. coli. Using this assay, we isolated several C. jejuni PglB variants that could glycosylate an array of noncanonical acceptor sequences, including one in a eukaryotic N-glycoprotein. These results underscore the utility of glycoSNAP for shedding light on poorly understood aspects of N-linked glycosylation and for engineering designer N-linked glycosylation biocatalysts.	[Ollis, Anne A.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA; [Zhang, Sheng] Cornell Univ, Prote & Mass Spectrometry Core Facil, Ithaca, NY USA; [Fisher, Adam C.] Glycobia Inc, Ithaca, NY USA	Cornell University; Cornell University	DeLisa, MP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	US National Science Foundation [CBET 1159581]; National Institutes of Health (NIH) [R44 GM088905-01]; NIH Shared Instrumentation Grant [1S10RR025449-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM088905, R44GM088905, R44GM093483] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Guarino (Cornell University) for plasmid pSF-ClPglB and pBS-scFv13-R4<SUP>DQNAT</SUP>, J. Merritt (Glycobia, Inc.) for plasmid pMW07-pgl Delta B, B. Clemons (California Institute of Technology) for plasmid pET33b-ClStt3, M. Aebi (ETH Zuch) for antiserum used in this work, and R. Sherwood for his technical assistance acquiring the LC-MS/MS raw data files. This material is based on work supported by the US National Science Foundation grant CBET 1159581 (to M.P.D.) and National Institutes of Health (NIH) grant R44 GM088905-01 (to A.C.F. and M.P.D.) and NIH Shared Instrumentation Grant grant 1S10RR025449-01 (to S.Z.).	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Celik E, 2010, PROTEIN SCI, V19, P2006, DOI 10.1002/pro.472; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Durr C, 2010, GLYCOBIOLOGY, V20, P1366, DOI 10.1093/glycob/cwq102; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Haitjema CH, 2014, ACS SYNTH BIOL, V3, P74, DOI 10.1021/sb400142b; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Ihssen J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-67; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mally M, 2013, MOL MICROBIOL, V87, P112, DOI 10.1111/mmi.12086; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Pandhal J, 2013, BIOTECHNOL BIOENG, V110, P2482, DOI 10.1002/bit.24920; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Zhang GJ, 2006, NAT BIOTECHNOL, V24, P100, DOI 10.1038/nbt1174; Zhang S, 2012, PROTEOMICS, V12, P1269, DOI 10.1002/pmic.201100474; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	37	45	47	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					816	+		10.1038/NCHEMBIO.1609	http://dx.doi.org/10.1038/NCHEMBIO.1609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25129029	Green Accepted			2022-12-25	WOS:000342462100007
J	Lovly, CM; McDonald, NT; Chen, HD; Ortiz-Cuaran, S; Heukamp, LC; Yan, YJ; Florin, A; Ozretic, L; Lim, D; Wang, L; Chen, Z; Chen, X; Lu, PC; Paik, PK; Shen, RL; Jin, HL; Buettner, R; Ansen, S; Perner, S; Brockmann, M; Bos, M; Wolf, J; Gardizi, M; Wright, GM; Solomon, B; Russell, PA; Rogers, TM; Suehara, Y; Red-Brewer, M; Tieu, R; de Stanchina, E; Wang, QG; Zhao, ZM; Johnson, DH; Horn, L; Wong, KK; Thomas, RK; Ladanyi, M; Pao, W				Lovly, Christine M.; McDonald, Nerina T.; Chen, Heidi; Ortiz-Cuaran, Sandra; Heukamp, Lukas C.; Yan, Yingjun; Florin, Alexandra; Ozretic, Luka; Lim, Diana; Wang, Lu; Chen, Zhao; Chen, Xi; Lu, Pengcheng; Paik, Paul K.; Shen, Ronglai; Jin, Hailing; Buettner, Reinhard; Ansen, Sascha; Perner, Sven; Brockmann, Michael; Bos, Marc; Wolf, Juergen; Gardizi, Masyar; Wright, Gavin M.; Solomon, Benjamin; Russell, Prudence A.; Rogers, Toni-Maree; Suehara, Yoshiyuki; Red-Brewer, Monica; Tieu, Rudy; de Stanchina, Elisa; Wang, Qingguo; Zhao, Zhongming; Johnson, David H.; Horn, Leora; Wong, Kwok-Kin; Thomas, Roman K.; Ladanyi, Marc; Pao, William			Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer	NATURE MEDICINE			English	Article							TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; RECEPTOR; IDENTIFICATION; CRIZOTINIB; MECHANISM; POTENT; CELLS	Crizotinib, a selective tyrosine kinase inhibitor (TKI), shows marked activity in patients whose lung cancers harbor fusions in the gene encoding anaplastic lymphoma receptor tyrosine kinase (ALK), but its efficacy is limited by variable primary responses and acquired resistance. In work arising from the clinical observation of a patient with ALKfusion-positive lung cancer who had an exceptional response to an insulin-like growth factor 1 receptor (IGF-1R)-specific antibody, we define a therapeutic synergism between ALK and IGF-1R inhibitors. Similar to IGF-1R, ALK fusion proteins bind to the adaptor insulin receptor substrate 1 (IRS-1), and IRS-1 knockdown enhances the antitumor effects of ALK inhibitors. In models of ALK TKI resistance, the IGF-1R pathway is activated, and combined ALK and IGF-1R inhibition improves therapeutic efficacy. Consistent with this finding, the levels of IGF-1R and IRS-1 are increased in biopsy samples from patients progressing on crizotinib monotherapy. Collectively these data support a role for the IGF-1R-IRS-1 pathway in both ALK TKI-sensitive and ALK TKI-resistant states and provide a biological rationale for further clinical development of dual ALK and IGF-1R inhibitors.	[Lovly, Christine M.; McDonald, Nerina T.; Yan, Yingjun; Jin, Hailing; Red-Brewer, Monica; Horn, Leora; Pao, William] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Chen, Heidi; Chen, Xi; Lu, Pengcheng] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Ortiz-Cuaran, Sandra; Bos, Marc; Thomas, Roman K.] Univ Hosp Cologne, Dept Translat Genom, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Heukamp, Lukas C.; Florin, Alexandra; Ozretic, Luka; Buettner, Reinhard; Thomas, Roman K.] Univ Hosp Cologne, Dept Pathol, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Heukamp, Lukas C.] New Oncol, Cologne, Germany; [Lim, Diana; Wang, Lu; Suehara, Yoshiyuki; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Chen, Zhao; Wong, Kwok-Kin] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA; [Paik, Paul K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Ansen, Sascha; Bos, Marc; Wolf, Juergen; Gardizi, Masyar] Univ Hosp Cologne, Dept Internal Med, Ctr Integrated Oncol Koln Bonn, Dept 1, Cologne, Germany; [Perner, Sven] Univ Hosp Bonn, Inst Pathol, Ctr Integrated Oncol Koln Bonn, Dept Prostate Canc Res, Bonn, Germany; [Brockmann, Michael] Hosp Merheim, Dept Pathol, Cologne, Germany; [Wright, Gavin M.] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic, Australia; [Solomon, Benjamin] Peter MacCallum Canc Ctr, Div Hematol & Med Oncol, Melbourne, Vic, Australia; [Russell, Prudence A.] St Vincents Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Rogers, Toni-Maree] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Tieu, Rudy; de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core Facil, New York, NY 10021 USA; [Wang, Qingguo; Zhao, Zhongming] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Johnson, David H.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	Vanderbilt University; Vanderbilt University; University of Cologne; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Cologne; University of Bonn; University of Cologne; University of Cologne; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; Peter Maccallum Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lovly, CM (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	christine.lovly@vanderbilt.edu	Wang, Lu/N-8128-2018; Johnson, David/AHI-8369-2022; Ladanyi, Marc/AAG-8585-2019; Heukamp, Lukas/G-9967-2012	Wang, Lu/0000-0002-0073-0666; Yan, Yingjun/0000-0001-6963-7112; Heukamp, Lukas/0000-0002-3388-3482; Solomon, Benjamin/0000-0003-3059-5730; Ortiz-Cuaran, Sandra/0000-0003-1152-5681; wong, kwok kin/0000-0001-6323-235X; Wang, Qingguo/0000-0002-5125-3724; Lovly, Christine/0000-0002-3641-6361; Wright, Gavin/0000-0002-7000-9305	Vanderbilt-Ingram Cancer Center Core grant [P30-CA68485]; Vanderbilt Specialized Program of Research Excellence in Lung Cancer grant [CA90949]; US National Cancer Institute [R01CA121210, P01CA129243]; Joyce Family Foundation; US National Institutes of Health (NIH) [K12 CA9060625]; American Society of Clinical Oncology Young Investigator Award; Uniting Against Lung Cancer grant; Damon Runyon Clinical Investigator Award; Deutsche Forschungsgemeinschaft [SFB 832, TH1386/3-1, SFB832 (TP6)]; German Cancer Aid (Center for Integrated Oncology (CIO) Koln-Bonn); European Regional Development Fund [FKZ:005-111-0027]; Victorian Cancer Agency grant [TS10_01]; NIH [CA122794, CA140594, CA163896, CA166480, CA154303, R01LM011177]; EU-Framework Programme CURELUNG [HEALTH-F2-2010-258677]; German Ministry of Science and Education (BMBF) as part of the NGFNplus program [01GS08100]; Deutsche Krebshilfe as part of the Oncology Centers of Excellence funding program; Rudolph Becker Foundation; German Cancer Aid (CIO Koln-Bonn); Federal Ministry of Education and Research (NGFNplus); Ministry of Economy, Energy, Industry and Craft of North Rhine-Westfalia (NRW) in the PerMed NRW framework program; Grants-in-Aid for Scientific Research [25861342] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA163896, R01CA122794, R01CA121210, P50CA090949, P01CA129243, K12CA090625, R01CA166480, P30CA068485, R01CA140594, P01CA154303] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center Core grant; Vanderbilt Specialized Program of Research Excellence in Lung Cancer grant; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joyce Family Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology Young Investigator Award; Uniting Against Lung Cancer grant; Damon Runyon Clinical Investigator Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid (Center for Integrated Oncology (CIO) Koln-Bonn); European Regional Development Fund(European Commission); Victorian Cancer Agency grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU-Framework Programme CURELUNG; German Ministry of Science and Education (BMBF) as part of the NGFNplus program(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe as part of the Oncology Centers of Excellence funding program; Rudolph Becker Foundation; German Cancer Aid (CIO Koln-Bonn); Federal Ministry of Education and Research (NGFNplus); Ministry of Economy, Energy, Industry and Craft of North Rhine-Westfalia (NRW) in the PerMed NRW framework program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Vanderbilt-Ingram Cancer Center Core grant (P30-CA68485), a career development award from the Vanderbilt Specialized Program of Research Excellence in Lung Cancer grant (CA90949), US National Cancer Institute grants R01CA121210 and P01CA129243 and the Joyce Family Foundation. C.M.L. was additionally supported by a US National Institutes of Health (NIH) K12 training grant (K12 CA9060625), an American Society of Clinical Oncology Young Investigator Award, a Uniting Against Lung Cancer grant and a Damon Runyon Clinical Investigator Award. C.M.L. was the Carol and Jim O'Hare chief fellow from 7/1/2011 through 6/30/2012. L.C.H. and R.B. were supported by the Deutsche Forschungsgemeinschaft (SFB 832, Tumormicromilieu) and the German Cancer Aid (Center for Integrated Oncology (CIO) Koln-Bonn). M. Bos was supported by the European Regional Development Fund grant number FKZ:005-111-0027. G.M.W. was supported by the Victorian Cancer Agency grant TS10_01. K.-K.W. is supported by the NIH CA122794, CA140594, CA163896, CA166480 and CA154303 grants. P.K.P. was supported by a Uniting Against Lung Cancer grant. R.K.T. is supported by the EU-Framework Programme CURELUNG (HEALTH-F2-2010-258677), the Deutsche Forschungsgemeinschaft through TH1386/3-1 and SFB832 (TP6), the German Ministry of Science and Education (BMBF) as part of the NGFNplus program (grant 01GS08100) and the Deutsche Krebshilfe as part of the Oncology Centers of Excellence funding program. S.P. was supported by a grant from the Rudolph Becker Foundation. J.W. was supported by the German Cancer Aid (CIO Koln-Bonn), the Federal Ministry of Education and Research (NGFNplus) and the Ministry of Economy, Energy, Industry and Craft of North Rhine-Westfalia (NRW) in the PerMed NRW framework program. Z.Z. was supported by NIH R01LM011177. We thank J. Sosman and C. Arteaga for their critical review of this manuscript, C. Liang (Xcovery) for providing X-376 and A. Nashabi for administrative assistance. Australian specimens were processed by the Victorian Cancer Biobank. The human anaplastic lymphoma cell line, SUDHL-1, was a generous gift from S. Morris of St. Jude Children's Research Hospital.	Boik JC, 2008, STAT MED, V27, P1040, DOI 10.1002/sim.3005; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Grande E, 2011, MOL CANCER THER, V10, P569, DOI 10.1158/1535-7163.MCT-10-0615; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Lovly CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003728; Lovly CM, 2011, CANCER RES, V71, P4920, DOI 10.1158/0008-5472.CAN-10-3879; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Suehara Y, 2012, CLIN CANCER RES, V18, P6599, DOI 10.1158/1078-0432.CCR-12-0838; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Vazquez-Martin A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02560; Yang XM, 2011, CANCER RES, V71, P5965, DOI 10.1158/0008-5472.CAN-11-0445	25	200	208	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1027	1034		10.1038/nm.3667	http://dx.doi.org/10.1038/nm.3667			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25173427	Green Accepted			2022-12-25	WOS:000341404000015
J	Viana, D; Comos, M; McAdam, PR; Ward, MJ; Selva, L; Guinane, CM; Gonzalez-Munoz, BM; Tristan, A; Foster, SJ; Fitzgerald, JR; Penades, JR				Viana, David; Comos, Maria; McAdam, Paul R.; Ward, Melissa J.; Selva, Laura; Guinane, Caitriona M.; Gonzalez-Munoz, Beatriz M.; Tristan, Anne; Foster, Simon J.; Fitzgerald, J. Ross; Penades, Jose R.			A single natural nucleotide mutation alters bacterial pathogen host tropism	NATURE GENETICS			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; LISTERIA-MONOCYTOGENES; AMINO-ACID; ADAPTATION; PROTEIN; VIRUS; GENOMICS; ORIGIN; RANGE; TRANSMISSION	The capacity of microbial pathogens to alter their host tropism leading to epidemics in distinct host species populations is a global public and veterinary health concern. To investigate the molecular basis of a bacterial host-switching event in a tractable host species, we traced the evolutionary trajectory of the common rabbit clone of Staphylococcus aureus. We report that it evolved through a likely human-to-rabbit host jump over 40 years ago and that only a single naturally occurring nucleotide mutation was required and sufficient to convert a human-specific S. aureus strain into one that could infect rabbits. Related mutations were identified at the same locus in other rabbit strains of distinct clonal origin, consistent with convergent evolution. This first report of a single mutation that was sufficient to alter the host tropism of a microorganism during its evolution highlights the capacity of some pathogens to readily expand into new host species populations.	[Viana, David; Selva, Laura] Univ CEU Cardenal Herrera, Biomed Res Inst, Valencia, Spain; [Comos, Maria] Inst Valenciano Invest Agr, Ctr Invest & Tecnol Anim, Segorbe, Spain; [McAdam, Paul R.; Guinane, Caitriona M.; Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Ward, Melissa J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Gonzalez-Munoz, Beatriz M.; Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Tristan, Anne] Univ Lyon, Ctr Natl Reference Staphylocoques, Lyon, France; [Penades, Jose R.] CSIC, Inst Biomed Valencia, Valencia, Spain; [Penades, Jose R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Universidad CEU Cardenal Herrera; Instituto Valenciano de Investigaciones Agrarias (IVIA); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Glasgow	Penades, JR (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	ross.fitzgerald@ed.ac.uk; joser.penades@glasgow.ac.uk	Viana, David/L-3701-2014; Martínez, Laura Selva/E-7018-2017; Penadés, José R/W-9685-2019; Tristan, Anne/L-9464-2014; TRISTAN, Anne/GSN-8306-2022	Viana, David/0000-0002-5813-0356; Penadés, José R/0000-0002-6439-5262; TRISTAN, Anne/0000-0001-9471-2655; Guinane, Caitriona/0000-0001-8215-1387; Selva Martinez, Laura/0000-0002-7920-1918; McAdam, Paul/0000-0001-6465-9910; Fitzgerald, Ross/0000-0002-9233-8468	Ministerio de Ciencia e Innovacion (Spain) [BIO2011-30503-C02-01, PIM2010EPA-00606, CSD2009-00006]; University of Glasgow; Biotechnology and Biological Sciences Research Council (UK) [BB/I013873/1]; Medical Research Council (UK); Ministerio de Ciencia e Innovacion, Spain [AGL2011-30170-CO2-02]; Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana [GV2013-077]; BBSRC [BBS/E/D/20231761, BBS/E/D/20310000, BB/I013873/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I013873/1, BBS/E/D/20310000, BBS/E/D/20231761] Funding Source: researchfish; Medical Research Council [G0900740, MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Glasgow; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Etienne for helpful advice, O. Schneewind, M. Woolhouse and I. Lasa for comments on the manuscript, C. Cervera and E. Blas for their support with the in vivo experiments, and R. Cartwright for excellent technical assistance. We are grateful to Edinburgh Genomics (Roslin Institute) for sequencing services. This work was supported by grants BIO2011-30503-C02-01, Eranetpathogenomics PIM2010EPA-00606 and Consolider-Ingenio CSD2009-00006 from Ministerio de Ciencia e Innovacion (Spain) and strategic grant funding from the University of Glasgow to J.R.P.; by a project grant (BB/I013873/1) and institute strategic grant funding from the Biotechnology and Biological Sciences Research Council (UK) to J.R.F., in addition to a doctoral training grant from the Medical Research Council (UK) to J.R.F.; and by grants AGL2011-30170-CO2-02 (Ministerio de Ciencia e Innovacion, Spain) and GV2013-077 (Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana) to D.V.	Tormo-Mas MA, 2013, MOL CELL, V49, P947, DOI 10.1016/j.molcel.2012.12.013; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Etienne L, 2013, CELL HOST MICROBE, V14, P85, DOI 10.1016/j.chom.2013.06.002; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Iqbal Z, 2013, BIOINFORMATICS, V29, P275, DOI 10.1093/bioinformatics/bts673; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Marano N, 2007, EMERG INFECT DIS, V13, P1807, DOI 10.3201/eid1312.071276; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Ubeda C, 2003, MOL MICROBIOL, V49, P193, DOI 10.1046/j.1365-2958.2003.03577.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vancraeynest D, 2006, J VET MED B, V53, P418, DOI 10.1111/j.1439-0450.2006.00977.x; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	42	77	78	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					361	U195		10.1038/ng.3219	http://dx.doi.org/10.1038/ng.3219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25685890	Green Accepted, Green Submitted			2022-12-25	WOS:000351922900011
J	Zhang, XL; Joehanes, R; Chen, BH; Huan, TX; Ying, SX; Munson, PJ; Johnson, AD; Levy, D; O'Donnell, CJ				Zhang, Xiaoling; Joehanes, Roby; Chen, Brian H.; Huan, Tianxiao; Ying, Saixia; Munson, Peter J.; Johnson, Andrew D.; Levy, Daniel; O'Donnell, Christopher J.			Identification of common genetic variants controlling transcript isoform variation in human whole blood	NATURE GENETICS			English	Article							SYNONYMOUS SNPS; DISEASE; EXPRESSION; DESIGN; HEART; GWAS	An understanding of the genetic variation underlying transcript splicing is essential to dissect the molecular mechanisms of common disease. The available evidence from splicing quantitative trait locus (sQTL) studies has been limited to small samples. We performed genome-wide screening to identify SNPs that might control mRNA splicing in whole blood collected from 5,257 Framingham Heart Study participants. We identified 572,333 cis sQTLs involving 2,650 unique genes. Many sQTL-associated genes (40%) undergo alternative splicing. Using the National Human Genome Research Institute (NHGRI) genome-wide association study (GWAS) catalog, we determined that 528 unique sQTLs were significantly enriched for 8,845 SNPs associated with traits in previous GWAS. In particular, we found 395 (4.5%) GWAS SNPs with evidence of cis sQTLs but not gene-level cis expression quantitative trait loci (eQTLs), suggesting that sQTL analysis could provide additional insights into the functional mechanism underlying GWAS results. Our findings provide an informative sQTL resource for further characterizing the potential functional roles of SNPs that control transcript isoforms relevant to common diseases.	[Zhang, Xiaoling; Joehanes, Roby; Chen, Brian H.; Huan, Tianxiao; Johnson, Andrew D.; Levy, Daniel; O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Zhang, Xiaoling; Joehanes, Roby; Chen, Brian H.; Huan, Tianxiao; Johnson, Andrew D.; Levy, Daniel; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Joehanes, Roby; Ying, Saixia; Munson, Peter J.] US NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	O'Donnell, CJ (corresponding author), NHLBI, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA.	odonnellc@nhlbi.nih.gov	Huan, Tianxiao/AAF-3577-2021; Levy, Daniel/ABB-2752-2021; Johnson, Andrew D/G-6520-2013; Levy, Daniel/ABF-6873-2021	Johnson, Andrew D/0000-0001-6369-5178; Levy, Daniel/0000-0003-1843-8724; Chen, Brian/0000-0001-9065-3301	US NIH [N01-HC-25195]; NHLBI, Division of Intramural Research; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006175, ZIAHL006173, ZIAHL006002, ZIAHL006170, ZIAHL006001] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The FHS is funded by US NIH contract N01-HC-25195; this work was also supported by the NHLBI, Division of Intramural Research.	1000 Genomes Project Consortium, 2010, NATURE, V467, P1061; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bondar' T N, 2012, Tsitol Genet, V46, P66; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Coulombe-Huntington J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000766; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jayaseelan S, 2011, METHODS MOL BIOL, V714, P407, DOI 10.1007/978-1-61779-005-8_25; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lange K., 2002, MATH STAT METHODS GE; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Licis N, 2011, THROMB RES, V127, P600, DOI 10.1016/j.thromres.2010.12.019; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nissim-Rafinia M, 2005, TRENDS GENET, V21, P480, DOI 10.1016/j.tig.2005.07.005; Ramasamy A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt069; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Taggart AJ, 2012, NAT STRUCT MOL BIOL, V19, P719, DOI 10.1038/nsmb.2327; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461; Zhernakova DV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003594	45	70	72	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					345	U92		10.1038/ng.3220	http://dx.doi.org/10.1038/ng.3220			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25685889	Green Accepted			2022-12-25	WOS:000351922900009
J	Iosefson, O; Nager, AR; Baker, TA; Sauer, RT				Iosefson, Ohad; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.			Coordinated gripping of substrate by subunits of a AAA plus proteolytic machine	NATURE CHEMICAL BIOLOGY			English	Article							ATP-FUELED MACHINES; CLPXP PROTEASE; DEGRADATION MACHINE; PORE LOOPS; TRANSLOCATION; PEPTIDASE; ATPASES; RECOGNITION; ENGAGEMENT; MUTATIONS	Hexameric ATP-dependent proteases and protein remodeling machines use conserved loops that line the axial pore to apply force to substrates during the mechanical processes of protein unfolding and translocation. Whether loops from multiple subunits act independently or coordinately in these processes is a critical aspect of the mechanism but is currently unknown for any AAA+ machine. By studying covalently linked hexamers of the Escherichia coli ClpX unfoldase bearing different numbers and configurations of wild-type and mutant pore loops, we show that loops function synergistically and that the number of wild-type loops required for efficient degradation is dependent on the stability of the protein substrate. Our results support a mechanism in which a power stroke initiated in one subunit of the ClpX hexamer results in the concurrent movement of all six pore loops, which coordinately grip and apply force to the substrate.	[Iosefson, Ohad; Nager, Andrew R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Iosefson, O (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	US National Institutes of Health [GM-101988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant GM-101988 (R. T. S.). T. A. B. is an employee of the Howard Hughes Medical Institute. We thank K. Schmitz and E. Gur for helpful discussions.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Graef M, 2006, J STRUCT BIOL, V156, P101, DOI 10.1016/j.jsb.2006.01.009; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003; Olivares AO, 2014, NAT STRUCT MOL BIOL, V21, P871, DOI 10.1038/nsmb.2885; Rothballer A, 2007, FEBS LETT, V581, P1197, DOI 10.1016/j.febslet.2007.02.031; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	36	46	46	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					201	U145		10.1038/nchembio.1732	http://dx.doi.org/10.1038/nchembio.1732			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25599533	Green Accepted, Green Submitted			2022-12-25	WOS:000349840500010
J	Polstein, LR; Gersbach, CA				Polstein, Lauren R.; Gersbach, Charles A.			A light-inducible CRISPR-Cas9 system for control of endogenous gene activation	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTION FACTORS; SPATIOTEMPORAL CONTROL; PROTEIN INTERACTIONS; EXPRESSION; INDUCTION; CELLS	Optogenetic systems enable precise spatial and temporal control of cell behavior. We engineered a light-activated CRISPR-Cas9 effector (LACE) system that induces transcription of endogenous genes in the presence of blue light. This was accomplished by fusing the light-inducible heterodimerizing proteins CRY2 and CIB1 to a transactivation domain and the catalytically inactive dCas9, respectively. The versatile LACE system can be easily directed to new DNA sequences for the dynamic regulation of endogenous genes.	[Polstein, Lauren R.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Polstein, Lauren R.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Polstein, Lauren R.; Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Duke University; Duke University	Polstein, LR (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	charles.gersbach@duke.edu	Gersbach, Charles/Y-3412-2019		US National Institutes of Health (NIH) [DP2OD008586]; National Science Foundation [CBET-1151035]; NIH [R01DA036865, R03AR061042, P30AR066527]; American Heart Association Scientist Development Grant [10SDG3060033]; American Heart Association Predoctoral Fellowship; NIH Biotechnology Training Grant [T32GM008555]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061042, P30AR066527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008586] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Predoctoral Fellowship(American Heart Association); NIH Biotechnology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C. Tucker (University of Colorado-Denver) provided CRY2 and CIBN plasmids. P. Vosburgh designed and fabricated the three-dimensional photomasks. This work was supported by a US National Institutes of Health (NIH) Director's New Innovator Award (DP2OD008586), US National Science Foundation Faculty Early Career Development Award (CBET-1151035), NIH R01DA036865, NIH R03AR061042, NIH P30AR066527, and an American Heart Association Scientist Development Grant (10SDG3060033 to C. A. G.). L. R. P. was supported by an American Heart Association Predoctoral Fellowship and NIH Biotechnology Training Grant (T32GM008555).	Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gautier A, 2014, NAT CHEM BIOL, V10, P533, DOI [10.1038/nchembio.1534, 10.1038/NCHEMBIO.1534]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Olson EJ, 2014, NAT CHEM BIOL, V10, P502, DOI [10.1038/NCHEMBIO.1559, 10.1038/nchembio.1559]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Polstein LR, 2014, METHODS MOL BIOL, V1148, P89, DOI 10.1007/978-1-4939-0470-9_7; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	26	416	456	10	313	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					198	U179		10.1038/nchembio.1753	http://dx.doi.org/10.1038/nchembio.1753			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25664691	Green Accepted			2022-12-25	WOS:000349840500009
J	Hyun, H; Park, MH; Owens, EA; Wada, H; Henary, M; Handgraaf, HJM; Vahrmeijer, AL; Frangioni, JV; Choi, HS				Hyun, Hoon; Park, Min Ho; Owens, Eric A.; Wada, Hideyuki; Henary, Maged; Handgraaf, Henricus J. M.; Vahrmeijer, Alexander L.; Frangioni, John V.; Choi, Hak Soo			Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging	NATURE MEDICINE			English	Article							SURGICAL ANATOMY; SURGERY	The typical method for creating targeted contrast agents requires covalent conjugation of separate targeting and fluorophore domains. In this study, we demonstrate that it is possible to create near-infrared (NIR) fluorophores with different tissue specificities driven by their inherent chemical structures. Thus, a single compact molecule performs both targeting and imaging. We use this strategy to solve a major problem in head and neck surgery: the identification and preservation of parathyroid and thyroid glands. We synthesized 700-nm and 800-nm halogenated fluorophores that show high uptake into these glands after a single intravenous (IV) injection of 0.06 mg kg(-1) in a pig. By using a dual-channel NIR imaging system, we observed-in real time and with high sensitivity-the unambiguous distinction of parathyroid and thyroid glands simultaneously in the context of blood and surrounding soft tissue. This novel technology lays a foundation for performing head and neck surgery with increased precision and efficiency along with potentially lower morbidity, and it provides a general strategy for developing targeted NIR fluorophores.	[Hyun, Hoon; Park, Min Ho; Wada, Hideyuki; Frangioni, John V.; Choi, Hak Soo] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA; [Hyun, Hoon; Park, Min Ho; Wada, Hideyuki; Frangioni, John V.; Choi, Hak Soo] Harvard Univ, Sch Med, Boston, MA USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Park, Min Ho] Chonnam Natl Univ, Sch Med, Dept Surg, Kwangju, South Korea; [Owens, Eric A.; Henary, Maged] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Owens, Eric A.; Henary, Maged] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Handgraaf, Henricus J. M.; Vahrmeijer, Alexander L.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Frangioni, John V.] Curadel LLC, Worcester, MA USA; [Choi, Hak Soo] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Chonnam National University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pusan National University	Choi, HS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA.	hchoi@bidmc.harvard.edu	Vahrmeijer, Alexander/AFK-4657-2022; Choi, Hak Soo/C-9954-2011; Vahrmeijer, Alexander/AAG-3329-2022; Handgraaf, Henricus/P-3059-2014	Vahrmeijer, Alexander/0000-0001-9370-0011; Vahrmeijer, Alexander/0000-0001-9370-0011; Choi, Hak Soo/0000-0002-7982-6483; Handgraaf, Henricus/0000-0002-5114-3584	National Institutes of Health: NCI BRP grant [R01-CA-115296]; NIBIB grant [R01-EB-010022, R01-EB-011523]; Dana Foundation in brain and immuno-imaging; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010022, R01EB011523] Funding Source: NIH RePORTER	National Institutes of Health: NCI BRP grant; NIBIB grant; Dana Foundation in brain and immuno-imaging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank D. Burrington, Jr. for editing and E. Trabucchi for administrative assistance. This study was supported by the following grants from the National Institutes of Health: NCI BRP grant no. R01-CA-115296 (J.V.F.), NIBIB grant nos. R01-EB-010022 (J.V.F.) and R01-EB-011523 (H.S.C.), and a grant from the Dana Foundation in brain and immuno-imaging (H.S.C.). The contents of this paper are solely the responsibility of the authors and do not necessarily reflect the official views of the National Institutes of Health	Achilefu S, 2010, ANGEW CHEM INT EDIT, V49, P9816, DOI 10.1002/anie.201005684; Bliss RD, 2000, WORLD J SURG, V24, P891, DOI 10.1007/s002680010173; Choi HS, 2013, NAT BIOTECHNOL, V31, P148, DOI 10.1038/nbt.2468; Fancy T, 2010, OTOLARYNG CLIN N AM, V43, P221, DOI 10.1016/j.otc.2010.01.001; Frilling A., 2007, COMPLICATIONS THYROI; Gao JH, 2010, SMALL, V6, P256, DOI 10.1002/smll.200901672; Gibbs SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073493; Gibbs-Strauss SL, 2011, MOL IMAGING, V10, P91, DOI 10.2310/7290.2010.00026; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Lee JH, 2012, QUANT IMAGING MED SU, V2, P266, DOI 10.3978/j.issn.2223-4292.2012.12.04; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Lin DT, 2002, LARYNGOSCOPE, V112, P608, DOI 10.1097/00005537-200204000-00003; McWade MA, 2013, SURGERY, V154, P1371, DOI 10.1016/j.surg.2013.06.046; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Paras C, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3583571; Pogue BW, 2010, AM J ROENTGENOL, V195, P321, DOI 10.2214/AJR.10.5002; Pollack G, 2009, LARYNGOSCOPE, V119, P1941, DOI 10.1002/lary.20581; Soshin T, 2010, J TOXICOL SCI, V35, P235, DOI 10.2131/jts.35.235; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; van der Vorst JR, 2014, HEAD NECK-J SCI SPEC, V36, P853, DOI 10.1002/hed.23384; Wang TS, 2011, AM J SURG, V202, P369, DOI 10.1016/j.amjsurg.2011.06.004	23	125	129	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					192	197		10.1038/nm.3728	http://dx.doi.org/10.1038/nm.3728			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25559343	Green Accepted, Green Submitted			2022-12-25	WOS:000348974800023
J	Zhu, XJ; Liu, J; Zhang, WJ				Zhu, Xuejun; Liu, Joyce; Zhang, Wenjun			De novo biosynthesis of terminal alkyne-labeled natural products	NATURE CHEMICAL BIOLOGY			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; CARRIER-PROTEIN DESATURASE; FATTY-ACID SYNTHESIS; ANTIMYCIN BIOSYNTHESIS; ESCHERICHIA-COLI; CHEMISTRY; DIVERSIFICATION; POLYKETIDES; FERREDOXIN; DIVERSITY	The terminal alkyne is a functionality widely used in organic synthesis, pharmaceutical science, material science and bioorthogonal chemistry. This functionality is also found in acetylenic natural products, but the underlying biosynthetic pathways for its formation are not well understood. Here we report the characterization of what is to our knowledge the first carrier protein-dependent terminal alkyne biosynthetic machinery in microbes. We further demonstrate that this enzymatic machinery can be exploited for the in situ generation and incorporation of terminal alkynes into two natural product scaffolds in Escherichia coli. These results highlight the prospect for tagging major classes of natural products, including polyketides and polyketide/nonribosomal peptide hybrids, using biosynthetic pathway engineering.	[Zhu, Xuejun; Zhang, Wenjun] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Zhu, Xuejun; Liu, Joyce; Zhang, Wenjun] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Liu, Joyce] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Zhang, Wenjun] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, WJ (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	wjzhang@berkeley.edu	kandula, sivakumar/D-4090-2015	Zhu, Xuejun/0000-0002-9839-2924	Pew Scholars Program; University of California	Pew Scholars Program; University of California(University of California System)	This research was financially supported by the Pew Scholars Program and University of California Cancer Research Coordinating Committee funds. We thank I. Abe (University of Tokyo) for providing hspks1, S. Bauer (University of California-Berkeley) for assisting with LC/HRMS analysis, J. Pelton (University of California-Berkeley) for helping with NMR spectroscopic analysis, J. Chung (University of California-Berkeley) for helping with compound purification and L. Zhang (University of California-Berkeley) for providing scACP.	Bindman NA, 2013, J AM CHEM SOC, V135, P10362, DOI 10.1021/ja4010706; Blacklock BJ, 2010, J BIOL CHEM, V285, P28442, DOI 10.1074/jbc.M110.151498; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P1537, DOI 10.1021/bi052333k; Dupuis SN, 2012, CHEM SCI, V3, P1640, DOI 10.1039/c2sc00663d; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Fritsche K, 2014, ENVIRON MICROBIOL, V16, P1334, DOI 10.1111/1462-2920.12440; Gagne SJ, 2009, BIOCHEMISTRY-US, V48, P12298, DOI 10.1021/bi901605d; Grammel M, 2013, NAT CHEM BIOL, V9, P475, DOI 10.1038/nchembio.1296; Haritos VS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2147; Harvey CJB, 2012, J AM CHEM SOC, V134, P12259, DOI 10.1021/ja304682q; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Liu J., 2014, ACS SYNTH BIOL, DOI [10.1021/sb5003136, DOI 10.1021/SB5003136]; Martin JF, 2005, CURR OPIN MICROBIOL, V8, P282, DOI 10.1016/j.mib.2005.04.009; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Neef AB, 2011, P NATL ACAD SCI USA, V108, P20404, DOI 10.1073/pnas.1101126108; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Ross C, 2014, ANGEW CHEM INT EDIT, V53, P7794, DOI 10.1002/anie.201403344; Sandy M, 2013, ORG LETT, V15, P3396, DOI 10.1021/ol4014365; Sandy M, 2012, ACS CHEM BIOL, V7, P1956, DOI 10.1021/cb300416w; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Shieh P, 2014, P NATL ACAD SCI USA, V111, P5456, DOI 10.1073/pnas.1322727111; Shieh P, 2012, J AM CHEM SOC, V134, P17428, DOI 10.1021/ja308203h; SHIMO T, 1994, J HETEROCYCLIC CHEM, V31, P387, DOI 10.3109/02770909409061318; Sin N, 1998, BIOORGAN MED CHEM, V6, P1209, DOI 10.1016/S0968-0896(98)00089-3; Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f; THOMPSON GA, 1991, P NATL ACAD SCI USA, V88, P2578, DOI 10.1073/pnas.88.6.2578; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; WADA H, 1993, J BACTERIOL, V175, P544, DOI 10.1128/JB.175.2.544-547.1993; WADA H, 1993, J BACTERIOL, V175, P6056, DOI 10.1128/JB.175.18.6056-6058.1993; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Yamaguchi M, 1995, J MED CHEM, V38, P5015, DOI 10.1021/jm00026a008; Yan Y, 2013, ANGEW CHEM INT EDIT, V52, P12308, DOI 10.1002/anie.201305569; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhang WJ, 2010, J AM CHEM SOC, V132, P6402, DOI 10.1021/ja1002845; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P20683, DOI 10.1073/pnas.0809084105	42	80	82	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					115	U51		10.1038/NCHEMBIO.1718	http://dx.doi.org/10.1038/NCHEMBIO.1718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25531891	Green Submitted			2022-12-25	WOS:000348358800008
J	Leibiger, IB; Berggren, PO				Leibiger, Ingo B.; Berggren, Per-Olof			Regulation of glucose homeostasis using radiogenetics and magnetogenetics in mice	NATURE MEDICINE			English	Editorial Material							NANOPARTICLES; FREQUENCY		[Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Berggren, Per-Olof] Nanyang Technol Univ, Imperial Coll London, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Karolinska Institutet; Karolinska University Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Leibiger, IB (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden.	per-olof.berggren@ki.se		Berggren, Per-Olof/0000-0001-8991-413X				Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Gilles C, 2002, J MAGN MAGN MATER, V241, P430, DOI 10.1016/S0304-8853(01)00461-9; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Li LS, 2014, DIABETES, V63, P4100, DOI 10.2337/db13-1855; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753	11	13	15	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					14	16		10.1038/nm.3782	http://dx.doi.org/10.1038/nm.3782			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569545	Green Accepted			2022-12-25	WOS:000348408000007
J	Pagan, JK; Marzio, A; Jones, MJK; Saraf, A; Jallepalli, PV; Florens, L; Washburn, MP; Pagano, M				Pagan, Julia K.; Marzio, Antonio; Jones, Mathew J. K.; Saraf, Anita; Jallepalli, Prasad V.; Florens, Laurence; Washburn, Michael P.; Pagano, Michele			Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing	NATURE CELL BIOLOGY			English	Article							CENTROSOMAL PROTEIN C-NAP1; GAMMA-TUBULIN COMPLEXES; CELL-CYCLE; SPINDLE ORGANIZATION; BETA-TRCP; KINASE; PHOSPHORYLATION; PERICENTRIN; CDK5RAP2; DUPLICATION	An intercentrosomal linker keeps a cell's two centrosomes joined together until it is dissolved at the onset of mitosis. A second connection keeps daughter centrioles engaged to their mothers until they lose their orthogonal arrangement at the end of mitosis. Centriole disengagement is required to license centrioles for duplication. We show that the intercentrosomal linker protein Cep68 is degraded in prometaphase through the SCF beta TrCP (Skp1-Cul1-F-box protein) ubiquitin ligase complex. Cep68 degradation is initiated by PLK1 phosphorylation of Cep68 on Ser 332, allowing recognition by beta TrCP. We also found that Cep68 forms a complex with Cep215 (also known as Cdk5Rap2) and PCNT (also known as pericentrin), two PCM (pericentriolar material) proteins involved in centriole engagement. Cep68 and PCNT bind to different pools of Cep215. We propose that Cep68 degradation allows Cep215 removal from the peripheral PCM preventing centriole separation following disengagement, whereas PCNT cleavage mediates Cep215 removal from the core of the PCM to inhibit centriole disengagement and duplication.	[Pagan, Julia K.; Marzio, Antonio; Pagano, Michele] NYU, Sch Med, Dept Pathol, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10065 USA; [Jones, Mathew J. K.; Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Memorial Sloan Kettering Cancer Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10065 USA.	michele.pagano@nyumc.org	Pagan, Julia/O-1929-2016	Pagan, Julia/0000-0002-7079-6388; Florens, Laurence/0000-0002-9310-6650; Jones, Mathew/0000-0003-2714-8411; pagano, michele/0000-0003-3210-2442; Washburn, Michael/0000-0001-7568-2585	National Center for Research Resources [S10RR031855]; National Institutes of Health [R01-GM057587, R37-CA076584]; New York State Health Department [NYSTEM-N11G-255]; National Health and Medical Research Council of Australia; Lymphoma Research Foundation; Stowers Institute for Medical Research; NIH [R01-GM094972]; Mathers Foundation; NATIONAL CANCER INSTITUTE [R37CA076584, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094972, R01GM057587] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Health Department; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lymphoma Research Foundation; Stowers Institute for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank B. D. Dynlacht, J. R. Skaar and M. F. B. Tsou for critical reading of the manuscript; K. Lee and S. Kim for helpful advice; Y. Deng at the NYU SOM Microscopy core for image processing assistance; A. North (Rockefeller University) for use of the DeltaVision OMX V4/Blaze system, supported by award S10RR031855 from the National Center for Research Resources; K. Rhee for the PCNT constructs, and I. Hoffmann for the FLAG CPAP construct. M.P. is grateful to T.M. Thor for continuous support. This work was funded by grants from the National Institutes of Health (R01-GM057587 and R37-CA076584) and New York State Health Department (NYSTEM-N11G-255) to M. P. and fellowships from the National Health and Medical Research Council of Australia and the Lymphoma Research Foundation to J.K.P. A.S., L.F. and M.P.W. are supported by the Stowers Institute for Medical Research. P.V.J. and M.J.K.J. were supported by NIH grant R01-GM094972 and an award from the Mathers Foundation. M.P. is an Investigor with the Howard Hughes Medical Institute.	Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Conduit PT, 2014, DEV CELL, V28, P659, DOI 10.1016/j.devcel.2014.02.013; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; D'Angiolella V, 2013, TRENDS CELL BIOL, V23, P135, DOI 10.1016/j.tcb.2012.10.011; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fang GL, 2014, J CELL SCI, V127, P1631, DOI 10.1242/jcs.139451; Florens Laurence, 2006, V328, P159; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; He RS, 2013, CELL REP, V4, P1100, DOI 10.1016/j.celrep.2013.08.005; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Jeong YT, 2013, J CELL BIOL, V200, P141, DOI 10.1083/jcb.201209002; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087016; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Matsuo K, 2010, BIOCHEM BIOPH RES CO, V398, P217, DOI 10.1016/j.bbrc.2010.06.063; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Mayor T, 2002, J CELL SCI, V115, P3275; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Mennella V., 2013, TRENDS CELL BIOL; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oliveira RA, 2013, CURR BIOL, V23, pR601, DOI 10.1016/j.cub.2013.04.003; Pagan J, 2011, NAT CELL BIOL, V13, P888, DOI 10.1038/ncb2312; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; ROOF DM, 1991, COLD SPRING HARB SYM, V56, P693; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Skaar J. R., 2013, NAT REV MOL CELL BIO; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Zhang Y, 2011, ANAL CHEM, V83, P9344, DOI 10.1021/ac201867h; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	69	55	63	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					31	+		10.1038/ncb3076	http://dx.doi.org/10.1038/ncb3076			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25503564	Green Accepted			2022-12-25	WOS:000346823900006
J	Fredriksson, NJ; Ny, L; Nilsson, JA; Larsson, E				Fredriksson, Nils J.; Ny, Lars; Nilsson, Jonas A.; Larsson, Erik			Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; REVERSE-TRANSCRIPTASE PROMOTER; CANCER RISK LOCI; BLADDER-CANCER; TERT-CLPTM1L LOCUS; GENOMIC LANDSCAPE; OVARIAN-CANCER; RARE VARIANTS; BREAST-CANCER; TELOMERASE	Somatic mutations in noncoding sequences are poorly explored in cancer, a rare exception being the recent identification of activating mutations in TERT regulatory DNA. Although this finding is suggestive of a general mechanism for oncogene activation, this hypothesis remains untested. Here we map somatic mutations in 505 tumor genomes across 14 cancer types and systematically screen for associations between mutations in regulatory regions and RNA-level changes. We identify recurrent promoter mutations in several genes but find that TERT mutations are exceptional in showing a strong and genome-wide significant association with increased expression. Detailed analysis of TERT across cancers shows that the strength of this association is highly variable and is strongest in copy number stable cancers such as thyroid carcinoma. We additionally propose that TERT promoter mutations control expression of the nearby gene CLPTM1L. Our analysis provides a detailed pan-cancer view of TERT transcriptional activation but finds no clear evidence for frequent oncogenic promoter mutations beyond TERT.	[Fredriksson, Nils J.; Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochemisty & Cell Biol, Gothenburg, Sweden; [Ny, Lars] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Inst Clin Sci, Gothenburg, Sweden; [Nilsson, Jonas A.] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Inst Clin Sci,Dept Surg, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Larsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochemisty & Cell Biol, Gothenburg, Sweden.	erik.larsson@gu.se	Fredriksson, Nils Johan/AAC-8083-2020; Larsson Lekholm, Erik/HDM-8032-2022; Larsson Lekholm, Erik/AHE-0932-2022; Ny, Lars/AAI-5906-2020	Fredriksson, Nils Johan/0000-0002-5763-6777; Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; Ny, Lars/0000-0003-3864-5958; Nilsson, Jonas/0000-0003-0346-6837	Swedish Foundation for Strategic Research; Swedish Medical Research Council; Swedish Cancer Society; Magnus Bergvall Foundation; Ake Wiberg foundation; Lars Hierta Memorial Foundation; Region Vastra Gotaland; BioCARE; Sahlgrenska Academy	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvall Foundation; Ake Wiberg foundation; Lars Hierta Memorial Foundation; Region Vastra Gotaland; BioCARE; Sahlgrenska Academy	The results published here are based in whole or in part on data generated by the TCGA pilot project established by the National Cancer Institute and National Human Genome Research Institute. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/. This work was supported by grants from the Swedish Foundation for Strategic Research (E.L. and N.J.F.); the Swedish Medical Research Council (E.L. and JAN.); the Swedish Cancer Society (E.L. and JAN.); the Magnus Bergvall Foundation (E.L.); the Ake Wiberg foundation (E.L.); the Lars Hierta Memorial Foundation (E.L.); Region Vastra Gotaland (JAN.); BioCARE (JAN.); and the Sahlgrenska Academy (JAN.). The computations were performed in part on resources provided by the Swedish National Infrastructure on Computing through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project 62012108. We thank the patients and their families; B. Einarsdottir and L. Nilsson for processing patient samples; R. Olofsson, U. Stierner and J. Mattsson for patient discussions; and members of our laboratory for valuable comments.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruening W, 1999, CANCER RES, V59, P4973; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Heidenreich B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4401; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; Jia JP, 2014, CANCER RES, V74, P2785, DOI 10.1158/0008-5472.CAN-13-3176; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kong FD, 2011, MOL CELL BIOCHEM, V354, P199, DOI 10.1007/s11010-011-0819-0; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liang M, 2008, GENE CHROMOSOME CANC, V47, P315, DOI 10.1002/gcc.20535; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Nobukuni Y, 2005, J BIOL CHEM, V280, P10572, DOI 10.1074/jbc.M413017200; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang K, 2014, ONCOTARGET, V5, P1829, DOI 10.18632/oncotarget.1829; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049988; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Wu S, 2014, EUR UROL, V65, P274, DOI 10.1016/j.eururo.2013.10.038; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	47	191	194	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1258	1263		10.1038/ng.3141	http://dx.doi.org/10.1038/ng.3141			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383969				2022-12-25	WOS:000345547300005
J	Herschhorn, A; Gu, C; Espy, N; Richard, J; Finzi, A; Sodroski, JG				Herschhorn, Alon; Gu, Christopher; Espy, Nicole; Richard, Jonathan; Finzi, Andres; Sodroski, Joseph G.			A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry	NATURE CHEMICAL BIOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY PG9; HUMAN MONOCLONAL-ANTIBODY; CD4-BOUND CONFORMATION; RECEPTOR-BINDING; VARIABLE LOOPS; GP120; IDENTIFICATION; INFECTION; CD4	Binding to the primary receptor, CD4, triggers conformational changes in the metastable HIV-1 envelope glycoprotein (Env) trimer ((gp120-gp41)(3)) that are important for virus entry into host cells. These changes include an 'opening' of the trimer, creation of a binding site for the CCR5 co-receptor and formation and/or exposure of a gp41 coiled coil. Here we identify a new compound, 18A (1), that specifically inhibits the entry of a wide range of HIV-1 isolates. 18A does not interfere with CD4 or CCR5 binding, but it inhibits the CD4-induced disruption of quaternary structures at the trimer apex and the exposure of the gp41 HR1 coiled coil. Analysis of HIV-1 variants with increased or reduced sensitivity to 18A suggests that the inhibitor can distinguish distinct conformational states of gp120 in the unliganded Env trimer. The broad-range activity and observed hypersensitivity of resistant mutants to antibody neutralization support further investigation of 18A.	[Herschhorn, Alon; Gu, Christopher; Espy, Nicole; Sodroski, Joseph G.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Herschhorn, Alon; Espy, Nicole; Sodroski, Joseph G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Richard, Jonathan; Finzi, Andres] Univ Montreal, Ctr Rech, Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Richard, Jonathan; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Sodroski, Joseph G.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Universite de Montreal; Universite de Montreal; McGill University; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, JG (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu	Richard, Jonathan/AAB-5185-2022	Finzi, Andres/0000-0002-4992-5288	amfAR; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108501-53-RKNT]; Canadian Institutes of Health Research operating grant [119334]; Fonds de la recherche en sante du Quebec Chercheur Boursier Junior fellowship [24639]; Canada Research Chair on Retroviral Entry; NIH [AI24755, GM56550]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024755, R01AI024755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	amfAR; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec Chercheur Boursier Junior fellowship; Canada Research Chair on Retroviral Entry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. McLaughlin and E. Carpelan for manuscript preparation; the AIDS Research and the Reference Reagent Program, Division of AIDS, US National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH) for providing reference panels for subtype B and C HIV-1 envelope clones, CFR01_AE.269 HIV-1 envelope clone, psPAX2 plasmid, T20, maraviroc and CEM cells. We also thank B. Keele, G. M. Shaw and the Center for HIV-AIDS Vaccine Immunology Consortium for providing transmitted/founder HIV-1 envelope clones; H.-X. Liao and B.F. Haynes (Duke University Medical Center) for providing the CRF01_AE.CM244 HIV-1 envelope clone; D. Burton (The Scripps Research Institute), J. Robinson (Tulane University) and P.D. Kwong (Vaccine Research Center, NIH) for providing the anti-gp120 monoclonal antibodies; D. Flood, J. Smith and C. Shamu (Institute of Chemistry and Cell Biology, Harvard Medical School) for assistance in the high-throughput screening campaign; and E. Pery, E. Cassol, V. Misra, N. Madani, H. Haim and A.M. Princiotto from Dana-Farber Cancer Institute for helpful discussions and for providing reagents. A.H. was supported by amfAR and is the recipient of an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108501-53-RKNT). A.F. was supported by Canadian Institutes of Health Research operating grant number 119334 and is the recipient of a Fonds de la recherche en sante du Quebec Chercheur Boursier Junior fellowship number 24639 and a Canada Research Chair on Retroviral Entry. Support for this work was also provided by grants from the NIH to J.G.S. (grant numbers AI24755 and GM56550).	BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta R.A., NAT STRUCT BIOL, V5, P276; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Herschhorn A, 2008, J MED CHEM, V51, P5702, DOI 10.1021/jm800473d; Herschhorn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026731; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; LaLonde JM, 2012, J MED CHEM, V55, P4382, DOI 10.1021/jm300265j; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; McGee K, 2014, J VIROL, V88, P21, DOI 10.1128/JVI.01558-13; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Regueiro-Ren A, 2013, J MED CHEM, V56, P1656, DOI 10.1021/jm3016377; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Schader SM, 2012, ANTIMICROB AGENTS CH, V56, P4257, DOI 10.1128/AAC.00639-12; SCOTT CF, 1990, P NATL ACAD SCI USA, V87, P8597, DOI 10.1073/pnas.87.21.8597; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	40	51	53	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2014	10	10					845	+		10.1038/NCHEMBIO.1623	http://dx.doi.org/10.1038/NCHEMBIO.1623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ0GV	25174000	Green Accepted			2022-12-25	WOS:000342462100011
J	Nishi, R; Wijnhoven, P; le Sage, C; Tjeertes, J; Galanty, Y; Forment, JV; Clague, MJ; Urbe, S; Jackson, SP				Nishi, Ryotaro; Wijnhoven, Paul; le Sage, Carlos; Tjeertes, Jorrit; Galanty, Yaron; Forment, Josep V.; Clague, Michael J.; Urbe, Sylvie; Jackson, Stephen P.			Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity	NATURE CELL BIOLOGY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; CHROMATIN-REMODELING COMPLEX; UCH37 DEUBIQUITINATING ENZYME; FANCONI-ANEMIA PATHWAY; HOMOLOGOUS RECOMBINATION; DEPENDENT UBIQUITINATION; PROTEASOME; STABILITY; RNF8	DNA double-strand breaks (DSBs) are perhaps the most toxic of all DNA lesions, with defects in the DNA-damage response to DSBs being associated with various human diseases. Although it is known that DSB repair pathways are tightly regulated by ubiquitylation, we do not yet have a comprehensive understanding of how deubiquitylating enzymes (DUBs) function in DSB responses. Here, by carrying out a multidimensional screening strategy for human DUBs, we identify several with hitherto unknown links to DSB repair, the G2/M DNA-damage checkpoint and genome-integrity maintenance. Phylogenetic analyses reveal functional clustering within certain DUB subgroups, suggesting evolutionally conserved functions and/or related modes of action. Furthermore, we establish that the DUB UCHL5 regulates DSB resection and repair by homologous recombination through protecting its interactor, NFRKB, from degradation. Collectively, our findings extend the list of DUBs promoting the maintenance of genome integrity, and highlight their potential as therapeutic targets for cancer.	[Nishi, Ryotaro; Wijnhoven, Paul; le Sage, Carlos; Tjeertes, Jorrit; Galanty, Yaron; Forment, Josep V.; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Nishi, Ryotaro; Wijnhoven, Paul; le Sage, Carlos; Tjeertes, Jorrit; Galanty, Yaron; Forment, Josep V.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Clague, Michael J.; Urbe, Sylvie] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	University of Cambridge; University of Cambridge; University of Liverpool; Wellcome Trust Sanger Institute	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Clague, Michael J/A-7199-2008; Urbe, Sylvie/S-1433-2018; Forment, Josep/J-3678-2015; Nishi, Ryotaro/AAA-3372-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Clague, Michael J/0000-0003-3355-9479; Urbe, Sylvie/0000-0003-4735-9814; Forment, Josep/0000-0002-7797-2583; Galanty, Yaron/0000-0001-7167-9004; Nishi, Ryotaro/0000-0001-8179-5818	Cancer Research UK [C6/A11224, C6946/A14492, C6/A14831]; European Research Council; European Community [HEALTH-F2-2010-259893]; Wellcome Trust [WT092096]; University of Cambridge; Daiichi Sankyo Foundation of Life Science; European Molecular Biology Organization [ALTF 1165-2010]; Ataxia Telangiectasia Society; Cancer Research UK [11224, 14831] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Daiichi Sankyo Foundation of Life Science; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Ataxia Telangiectasia Society; Cancer Research UK(Cancer Research UK)	We thank all members of the S.P.J. laboratory for helpful discussions. We are grateful to A. Blackford, D. Larrieu and K. Dry for commenting on the manuscript, N. Lawrence and A. Sossick for help with microscopy, and C. Green for scientific advice. Research in the S.P.J. laboratory is funded by Cancer Research UK Program Grant C6/A11224, the European Research Council and the European Community Seventh Framework Program grant agreement no. HEALTH-F2-2010-259893 (DDResponse). Core infrastructure funding was provided by Cancer Research UK Grant C6946/A14492 and Wellcome Trust Grant WT092096. S.P.J. receives a salary from the University of Cambridge, supplemented by Cancer Research UK. R.N. was funded by a Daiichi Sankyo Foundation of Life Science fellowship and Cancer Research UK Project Grant C6/A14831; C.l.S. was funded by European Molecular Biology Organization Grant ALTF 1165-2010. J.V.F. was supported by Cancer Research UK Program Grant C6/A11224 and the Ataxia Telangiectasia Society.	Aressy B, 2010, CELL CYCLE, V9, P3815, DOI 10.4161/cc.9.18.13133; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Gospodinov A, 2009, INT J BIOCHEM CELL B, V41, P925, DOI 10.1016/j.biocel.2008.09.004; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kato K, 2014, MOL CELL, V53, P617, DOI 10.1016/j.molcel.2014.01.030; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yoshida A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01054; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110	46	102	103	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					1016	1026		10.1038/ncb3028	http://dx.doi.org/10.1038/ncb3028			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25194926	Green Accepted			2022-12-25	WOS:000342712200011
J	Xing, LZ; Dai, ZP; Jabbari, A; Cerise, JE; Higgins, CA; Gong, WJ; de Jong, A; Harel, S; DeStefano, GM; Rothman, L; Singh, P; Petukhova, L; Mackay-Wiggan, J; Christiano, AM; Clynes, R				Xing, Luzhou; Dai, Zhenpeng; Jabbari, Ali; Cerise, Jane E.; Higgins, Claire A.; Gong, Weijuan; de Jong, Annemieke; Harel, Sivan; DeStefano, Gina M.; Rothman, Lisa; Singh, Pallavi; Petukhova, Lynn; Mackay-Wiggan, Julian; Christiano, Angela M.; Clynes, Raphael			Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition	NATURE MEDICINE			English	Article							HAIR LOSS; INTERFERON-GAMMA; C3H/HEJ MICE; INTERLEUKIN-15; EXPRESSION; CELLS; INCB018424; INDUCTION; THERAPY; BIOLOGY	Alopecia areata (AA) is a common autoimmune disease resulting from damage of the hair follicle by T cells. The immune pathways required for autoreactive T cell activation in AA are not defined limiting clinical development of rational targeted therapies'. Genome-wide association studies (GWAS)(2) implicated ligands for the NKG2D receptor (product of the KLRK1 gene) in disease pathogenesis. Here, we show that cytotoxic CD8(+)NKG2D(+) T cells are both necessary and sufficient for the induction of AA in mouse models of disease. Global transcriptional profiling of mouse and human AA skin revealed gene expression signatures indicative of cytotoxic T cell infiltration, an interferon-gamma (IFN-gamma) response and upregulation of several gamma-chain (gamma(c)) cytokines known to promote the activation and survival of IFN-gamma-producing CD8(+)NKG2D(+) effector T cells. Therapeutically, antibody-mediated blockade of IFN-gamma, interleukin-2 (IL-2) or interleukin-15 receptor beta (IL-15R beta) prevented disease development, reducing the accumulation of CD8(+)NKG2D(+) T cells in the skin and the dermal IFN response in a mouse model of AA. Systemically administered pharmacological inhibitors of Janus kinase (JAK) family protein tyrosine kinases, downstream effectors of the IFN-gamma and gamma(c) cytokine receptors, eliminated the IFN signature and prevented the development of AA, while topical administration promoted hair regrowth and reversed established disease. Notably, three patients treated with oral ruxolitinib, an inhibitor of JAK1 and JAK2, achieved near-complete hair regrowth within 5 months of treatment, suggesting the potential clinical utility of JAK inhibition in human AA.	[Xing, Luzhou; Clynes, Raphael] Columbia Univ, Dept Pathol, New York, NY USA; [Dai, Zhenpeng; Jabbari, Ali; Cerise, Jane E.; Higgins, Claire A.; Gong, Weijuan; de Jong, Annemieke; Harel, Sivan; DeStefano, Gina M.; Rothman, Lisa; Singh, Pallavi; Petukhova, Lynn; Mackay-Wiggan, Julian; Christiano, Angela M.; Clynes, Raphael] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Cerise, Jane E.] Columbia Univ, Dept Psychiat, New York, NY USA; [DeStefano, Gina M.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Clynes, Raphael] Columbia Univ, Dept Med, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10027 USA.	amc65@columbia.edu; rc645@columbia.edu	Petukhova, Lynn/W-6858-2019	de Jong, Annemieke/0000-0001-6707-6585; Higgins, Claire/0000-0002-9742-5149; Jabbari, Ali/0000-0002-8559-7314	US Public Health Service National Institutes of Health NIAMS [R01AR056016, R21AR061881]; Shared Instrumentation Grant for the LSR II Flow Cytometer [S10RR027050]; Columbia University Skin Disease Research Center [P30AR044535]; Locks of Love Foundation; Alopecia Areata Initiative; Medical Genetics Training Grant [T32GM082271]; Dermatology Foundation; Louis V. Gerstner Jr Scholars Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056016, P30AR044535, R21AR061881, U01AR067173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088, T32GM082771] Funding Source: NIH RePORTER	US Public Health Service National Institutes of Health NIAMS; Shared Instrumentation Grant for the LSR II Flow Cytometer; Columbia University Skin Disease Research Center; Locks of Love Foundation; Alopecia Areata Initiative; Medical Genetics Training Grant; Dermatology Foundation; Louis V. Gerstner Jr Scholars Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Alopecia Areata Registry, as well as M. Duvic, V. Price, M. Hordinsky and D. Norris, and the National Alopecia Areata Foundation. We thank J. Sundberg, T. Behrens, D. Bickers, J. O'Shea, T. Waldmann, B. Jabri, D. Raulet, L. Lanier, T. Spies, M. Hayden, R. Paus, P. Green, B. Lebwohl, D. Accili and C. Jahoda for stimulating discussions. We are grateful for clinical support from M. Furniss, C. Clark and G. Ulerio and expert technical assistance from M. Zhang, E. Chang, H. Lam and J. Huang. This work was supported in part by US Public Health Service National Institutes of Health NIAMS grants R01AR056016 (to A.M.C.) and R21AR061881 (to A.M.C and R.C.), a Shared Instrumentation Grant for the LSR II Flow Cytometer (S10RR027050) to R.C. and the Columbia University Skin Disease Research Center (P30AR044535), as well as the Locks of Love Foundation and the Alopecia Areata Initiative. J.E.C. is supported by the T32GM082271 Medical Genetics Training Grant (issued to A.M.C.). A.J., C.A.H., S.H. and A.d.J. are recipients of Career Development Awards from the Dermatology Foundation, and A.J. is also supported by the Louis V. Gerstner Jr Scholars Program.	Bertolini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094260; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Brajac Ines, 2004, Acta Dermatovenerol Croat, V12, P154; Dolgin E, 2011, NAT REV DRUG DISCOV, V10, P717, DOI 10.1038/nrd3571; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Freyschmidt-Paul P, 2006, BRIT J DERMATOL, V155, P515, DOI 10.1111/j.1365-2133.2006.07377.x; Freyschmidt-Paul P, 2005, J INVEST DERMATOL, V125, P945, DOI 10.1111/j.0022-202X.2005.23888.x; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gilhar A, 2005, J INVEST DERMATOL, V124, P288, DOI 10.1111/j.0022-202X.2004.23580.x; Gilhar A, 1998, J CLIN INVEST, V101, P62, DOI 10.1172/JCI551; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; McElwee KJ, 2005, J INVEST DERMATOL, V124, P947, DOI 10.1111/j.0022-202X.2005.23692.x; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Punwani N, 2012, J AM ACAD DERMATOL, V67, P658, DOI 10.1016/j.jaad.2011.12.018; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; SUNDBERG JP, 1994, J INVEST DERMATOL, V102, P847, DOI 10.1111/1523-1747.ep12382416; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Ye WG, 1996, CELL IMMUNOL, V174, P54, DOI 10.1006/cimm.1996.0293	29	463	523	13	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1043	1049		10.1038/nm.3645	http://dx.doi.org/10.1038/nm.3645			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25129481	Green Accepted			2022-12-25	WOS:000341404000017
J	Zhou, K; Qiao, KJ; Edgar, S; Stephanopoulos, G				Zhou, Kang; Qiao, Kangjian; Edgar, Steven; Stephanopoulos, Gregory			Distributing a metabolic pathway among a microbial consortium enhances production of natural products	NATURE BIOTECHNOLOGY			English	Article							1ST OXYGENATION STEP; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TAXOL BIOSYNTHESIS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; SYNTHETASE GENE; MIXED CULTURE; ACETATE; OPTIMIZATION	Metabolic engineering of microorganisms such as Escherichia coli and Saccharomyces cerevisiae to produce high-value natural metabolites is often done through functional reconstitution of long metabolic pathways. Problems arise when parts of pathways require specialized environments or compartments for optimal function. Here we solve this problem through co-culture of engineered organisms, each of which contains the part of the pathway that it is best suited to hosting. In one example, we divided the synthetic pathway for the acetylated diol paclitaxel precursor into two modules, expressed in either S. cerevisiae or E. coli, neither of which can produce the paclitaxel precursor on their own. Stable co-culture in the same bioreactor was achieved by designing a mutualistic relationship between the two species in which a metabolic intermediate produced by E. coli was used and functionalized by yeast. This synthetic consortium produced 33 mg/L oxygenated taxanes, including a monoacetylated dioxygenated taxane. The same method was also used to produce tanshinone precursors and functionalized sesquiterpenes.	[Zhou, Kang; Qiao, Kangjian; Edgar, Steven; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Zhou, Kang/AAQ-5730-2021; Zhou, Kang/AAI-9969-2021	Zhou, Kang/0000-0003-0606-7030; 	National Institutes of Health [1-R01-GM085323-01A1]; Singapore MIT Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge useful discussions and input from A. Ghaderi, F. Lam, H. Zhang, J. Avalos and W. Wang. This work was supported by National Institutes of Health grant 1-R01-GM085323-01A1 and the Singapore MIT Alliance.	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Artsatbanov VY, 2012, BIOCHEMISTRY-MOSCOW+, V77, P362, DOI 10.1134/S0006297912040074; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Causey TB, 2003, P NATL ACAD SCI USA, V100, P825, DOI 10.1073/pnas.0337684100; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Craft DL, 2003, APPL ENVIRON MICROB, V69, P5983, DOI 10.1128/AEM.69.10.5983-5991.2003; DAVISON BH, 1986, BIOTECHNOL BIOENG, V28, P1127, DOI 10.1002/bit.260280802; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409; Guerra-Bubb J, 2012, NAT PROD REP, V29, P683, DOI 10.1039/c2np20021j; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hefferon K, 2013, BIOTECHNOL J, V8, P1193, DOI 10.1002/biot.201300162; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; Leber C, 2014, BIOTECHNOL BIOENG, V111, P347, DOI 10.1002/bit.25021; Melnik S, 2013, CURR MED CHEM, V20, P1038; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pillai VC, 2011, CLIN EXP PHARMACOL P, V38, P846, DOI 10.1111/j.1440-1681.2011.05622.x; Reed James R, 2011, Drug Metab Lett, V5, P6; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; Santos CNS, 2012, P NATL ACAD SCI USA, V109, P13538, DOI 10.1073/pnas.1206346109; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; Smid EJ, 2013, CURR OPIN BIOTECH, V24, P148, DOI 10.1016/j.copbio.2012.11.007; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Walker K, 2000, ARCH BIOCHEM BIOPHYS, V374, P371, DOI 10.1006/abbi.1999.1609; Wheeler AL, 2001, ARCH BIOCHEM BIOPHYS, V390, P265, DOI 10.1006/abbi.2001.2377; Xia T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-77; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Zhou K, 2013, BIOTECHNOL BIOENG, V110, P2556, DOI 10.1002/bit.24900; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486; Zou RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079557	45	365	404	37	546	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					377	U157		10.1038/nbt.3095	http://dx.doi.org/10.1038/nbt.3095			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25558867	Green Submitted, Green Accepted			2022-12-25	WOS:000352348500023
J	Baker, EG; Bartlett, GJ; Crump, MP; Sessions, RB; Linden, N; Faul, CFJ; Woolfson, DN				Baker, Emily G.; Bartlett, Gail J.; Crump, Matthew P.; Sessions, Richard B.; Linden, Noah; Faul, Charl F. J.; Woolfson, Derek N.			Local and macroscopic electrostatic interactions in single alpha-helices	NATURE CHEMICAL BIOLOGY			English	Article							20 AMINO-ACIDS; GCN4 LEUCINE-ZIPPER; SALT BRIDGES; COIL TRANSITION; PROTEINS; PEPTIDE; STABILITY; STABILIZATION; CHARGES; RESIDUE	The noncovalent forces that stabilize protein structures are not fully understood. One way to address this is to study equilibria between unfolded states and alpha-helices in peptides. Electrostatic forces-which include interactions between side chains, the backbone and side chains, and side chains and the helix macrodipole-are believed to contribute to these equilibria. Here we probe these interactions experimentally using designed peptides. We find that both terminal backbone-side chain and certain side chain-side chain interactions (which include both local effects between proximal charges and interatomic contacts) contribute much more to helix stability than side chain-helix macrodipole electrostatics, which are believed to operate at larger distances. This has implications for current descriptions of helix stability, the understanding of protein folding and the refinement of force fields for biomolecular modeling and simulations. In addition, this study sheds light on the stability of rod-like structures formed by single alpha-helices, which are common in natural proteins such as non-muscle myosins.	[Baker, Emily G.; Bartlett, Gail J.; Crump, Matthew P.; Faul, Charl F. J.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Sessions, Richard B.; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Linden, Noah] Univ Bristol, Sch Math, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Baker, EG (corresponding author), Univ Bristol, Sch Chem, Bristol, Avon, England.	D.N.Woolfson@bristol.ac.uk	Faul, Charl FJ/D-7859-2016; Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015	Faul, Charl FJ/0000-0001-6224-3073; Baker, Emily Grace/0000-0002-1593-5525; Sessions, Richard/0000-0003-0320-0895; Woolfson, Derek/0000-0002-0394-3202; Crump, Matthew/0000-0002-7868-5818	Engineering and Physical Sciences Research Council (EPSRC) of the UK; EPSRC/National Science Foundation [EP/J001430]; Royal Society Wolfson Research Merit Award; Wellcome Trust; EPSRC [EP/J001430/1, EP/K03927X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J001430/1, EP/K03927X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) of the UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC/National Science Foundation(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	D.N.W. would like to dedicate this paper to the memory of Prof. Dudley H. William FRS, an inspirational scientist, mentor and person. We are grateful to the Engineering and Physical Sciences Research Council (EPSRC) of the UK for a studentship to E.G.B. and the EPSRC/National Science Foundation (EP/J001430) for a grant to D.N.W. that funded G.J.B. D.N.W. holds a Royal Society Wolfson Research Merit Award. We thank C. Wood for a script to align helical axes; M. Peckham and A. Mulholland, and members of the Woolfson and Faul groups, for helpful discussions; and S. Whittaker and the Henry Wellcome Building NMR facility at the University of Birmingham for access to the Wellcome Trust-funded 900 MHz spectrometer.	AQVIST J, 1991, P NATL ACAD SCI USA, V88, P2026, DOI 10.1073/pnas.88.5.2026; ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Bartlett GJ, 2013, J AM CHEM SOC, V135, P18682, DOI 10.1021/ja4106122; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIERZYNSKI A, 1982, P NATL ACAD SCI-BIOL, V79, P2470, DOI 10.1073/pnas.79.8.2470; CHAKRABARTI P, 1994, PROTEIN ENG, V7, P471, DOI 10.1093/protein/7.4.471; Cochran DAE, 2001, PROTEIN SCI, V10, P1305, DOI 10.1110/ps.50701; Cochran DAE, 2001, PROTEIN SCI, V10, P463, DOI 10.1110/ps.31001; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; de Sousa MM, 2011, J THEOR BIOL, V271, P136, DOI 10.1016/j.jtbi.2010.11.028; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Fernandez-Recio J, 1998, FEBS LETT, V429, P99, DOI 10.1016/S0014-5793(98)00569-9; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Gorbet G, 2014, BIOPHYS J, V106, P1741, DOI 10.1016/j.bpj.2014.02.022; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Iqbalsyah TM, 2005, BIOCHEMISTRY-US, V44, P10449, DOI 10.1021/bi0508690; Iqbalsyah TM, 2004, PROTEIN SCI, V13, P32, DOI 10.1110/ps.03341804; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KIM PS, 1984, NATURE, V307, P329, DOI 10.1038/307329a0; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136; LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Mayne L, 1998, J AM CHEM SOC, V120, P10643, DOI 10.1021/ja981592c; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Penel S, 1999, J MOL BIOL, V287, P127, DOI 10.1006/jmbi.1998.2549; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SCHOLTZ JM, 1993, BIOCHEMISTRY-US, V32, P9668, DOI 10.1021/bi00088a019; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Thomas A, 2004, PROTEINS, V56, P102, DOI 10.1002/prot.20093; Wada A, 1976, Adv Biophys, P1; WALTER S, 1995, J MOL BIOL, V252, P133, DOI 10.1006/jmbi.1995.0480; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	57	57	57	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					221	U92		10.1038/nchembio.1739	http://dx.doi.org/10.1038/nchembio.1739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25664692	Green Accepted, Green Submitted			2022-12-25	WOS:000349840500014
J	Bitler, BG; Aird, KM; Garipov, A; Li, H; Amatangelo, M; Kossenkov, AV; Schultz, DC; Liu, Q; Shih, IM; Conejo-Garcia, JR; Speicher, DW; Zhang, RG				Bitler, Benjamin G.; Aird, Katherine M.; Garipov, Azat; Li, Hua; Amatangelo, Michael; Kossenkov, Andrew V.; Schultz, David C.; Liu, Qin; Shih, Ie-Ming; Conejo-Garcia, Jose R.; Speicher, David W.; Zhang, Rugang			Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers	NATURE MEDICINE			English	Article							EPITHELIAL OVARIAN-CANCER; CLEAR-CELL CARCINOMA; ARID1A MUTATIONS; TUMOR-SUPPRESSOR; CHROMATIN; SWI/SNF; METHYLATION; INHIBITION; SENESCENCE; POLYCOMB	The gene encoding ARID1A, a chromatin remodeler, shows one of the highest mutation rates across many cancer types. Notably, ARID1A is mutated in over 50% of ovarian clear cell carcinomas, which currently have no effective therapy. To date, clinically applicable targeted cancer therapy based on ARID1A mutational status has not been described. Here we show that inhibition of the EZH2 methyltransferase acts in a synthetic lethal manner in ARID1A-mutated ovarian cancer cells and that ARID1A mutational status correlated with response to the EZH2 inhibitor. We identified PIK3IP1 as a direct target of ARID1A and EZH2 that is upregulated by EZH2 inhibition and contributed to the observed synthetic lethality by inhibiting PI3K-AKT signaling. Importantly, EZH2 inhibition caused regression of ARID1A-mutated ovarian tumors in vivo. To our knowledge, this is the first data set to demonstrate a synthetic lethality between ARID1A mutation and EZH2 inhibition. Our data indicate that pharmacological inhibition of EZH2 represents a novel treatment strategy for cancers involving ARID1A mutations.	[Bitler, Benjamin G.; Aird, Katherine M.; Garipov, Azat; Li, Hua; Amatangelo, Michael; Zhang, Rugang] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Schultz, David C.] Wistar Inst Anat & Biol, Ctr Chem Biol & Translat Med, Philadelphia, PA 19104 USA; [Liu, Qin; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Pathol Oncol & Gynecol & Obstet, Baltimore, MD 21205 USA; [Conejo-Garcia, Jose R.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; Johns Hopkins University; Johns Hopkins Medicine; The Wistar Institute	Zhang, RG (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	rzhang@wistar.org	Aird, Katherine/AAY-3300-2020; sdsd, shihieih/ABE-6190-2020; Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; Bitler, Benjamin/0000-0002-5809-5271	US National Institutes of Health/National Cancer Institute [R01CA160331, R01CA163377, T32CA9171-35]; US Department of Defense Ovarian Cancer Academy award [OC093420]; Ovarian Cancer Research Fund Program project; Ovarian Cancer Research Fund Liz Tilberis Scholar; American Cancer Society postdoctoral fellowship [PF-13-058-01-TBE]; Cancer Center [CA010815]; NATIONAL CANCER INSTITUTE [R01CA160331, R01CA163377, T32CA009171, P30CA010815, R01CA124515, R01CA202919, R01CA178687] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense Ovarian Cancer Academy award; Ovarian Cancer Research Fund Program project; Ovarian Cancer Research Fund Liz Tilberis Scholar; American Cancer Society postdoctoral fellowship(American Cancer Society); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Altieri, M. Murphy and R. Shiekhattar for critical comments and X. Hua and Y. Park for technical assistance. This work was supported by grants from the US National Institutes of Health/National Cancer Institute (R01CA160331 and R01CA163377 to R.Z.), a US Department of Defense Ovarian Cancer Academy award (OC093420 to R.Z.) and an Ovarian Cancer Research Fund Program project (to R.Z.). R.Z. is an Ovarian Cancer Research Fund Liz Tilberis Scholar. B.G.B. is supported by an American Cancer Society postdoctoral fellowship (PF-13-058-01-TBE). K.M.A. is supported by a training grant from the US National Institutes of Health/National Cancer Institute (T32CA9171-35). Support of Core Facilities was provided by Cancer Center Support grant CA010815 to the Wistar Institute.	Anglesio M.S, 2013, PLOS ONE, V8; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chandler RL, 2013, MOL CELL BIOL, V33, P265, DOI 10.1128/MCB.01008-12; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li H, 2012, MOL CANCER RES, V10, P1462, DOI 10.1158/1541-7786.MCR-12-0335; Li H, 2012, CANCER PREV RES, V5, P484, DOI 10.1158/1940-6207.CAPR-11-0414; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Samartzis EP, 2013, INT J MOL SCI, V14, P18824, DOI 10.3390/ijms140918824; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	39	411	425	11	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					231	+		10.1038/nm.3799	http://dx.doi.org/10.1038/nm.3799			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25686104	Green Accepted			2022-12-25	WOS:000350362000015
J	Chappell, J; Takahashi, MK; Lucks, JB				Chappell, James; Takahashi, Melissa K.; Lucks, Julius B.			Creating small transcription activating RNAs	NATURE CHEMICAL BIOLOGY			English	Article							SYNTHETIC GENE NETWORKS; ENVIRONMENTAL SIGNAL; SECONDARY STRUCTURE; AUTOMATED DESIGN; IN-VITRO; REGULATORS; CIRCUITS; CRISPR; RIBOSWITCH; REPRESSION	We expanded the mechanistic capability of small RNAs by creating an entirely synthetic mode of regulation: small transcription activating RNAs (STARs). Using two strategies, we engineered synthetic STAR regulators to disrupt the formation of an intrinsic transcription terminator placed upstream of a gene in Escherichia coli. This resulted in a group of four highly orthogonal STARs that had up to 94-fold activation. By systematically modifying sequence features of this group, we derived design principles for STAR function, which we then used to forward engineer a STAR that targets a terminator found in the Escherichia coli genome. Finally, we showed that STARs could be combined in tandem to create previously unattainable RNA-only transcriptional logic gates. STARs provide a new mechanism of regulation that will expand our ability to use small RNAs to construct synthetic gene networks that precisely control gene expression.	[Chappell, James; Takahashi, Melissa K.; Lucks, Julius B.] Cornell Univ, Sch Chem & Biomol Engn, New York, NY 10021 USA	Cornell University	Chappell, J (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, New York, NY 10021 USA.	jblucks@cornell.edu	Lucks, Julius/L-2801-2016	Chappell, James/0000-0001-7367-1524	National Science Foundation [DGE-1144153]; Defense Advanced Research Projects Agency Young Faculty Award (DARPA YFA) [N66001-12-1-4254]; Office of Naval Research Young Investigators Program Award (ONR YIP) [N00014-13-1-0531]	National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Young Faculty Award (DARPA YFA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research Young Investigators Program Award (ONR YIP)(Office of Naval Research)	The authors acknowledge J. Roberts, E. Strobel, A. Stroock and the Lucks Lab members for helpful discussions. We would also like to thank C. Trapnell for help with RNA-seq experimental design and analysis. We also thank J. Peters (Department of Microbiology, Cornell University) for providing E. coli strain K12 MG1655. Finally, we would like to thank D. Tapias-Rojas for preliminary work on targeting naturally occurring intrinsic terminators. This material is based on work supported by the National Science Foundation Graduate Research Fellowship Program (grant no. DGE-1144153 to M.K.T.), the Defense Advanced Research Projects Agency Young Faculty Award (DARPA YFA; no. N66001-12-1-4254 to J.B.L.) and an Office of Naval Research Young Investigators Program Award (ONR YIP; no. N00014-13-1-0531 to J.B.L.). J.B.L. is an Alfred P. Sloan Research Fellow.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Ceres P, 2013, NUCLEIC ACIDS RES, V41, P10449, DOI 10.1093/nar/gkt787; Ceres P, 2013, ACS SYNTH BIOL, V2, P463, DOI 10.1021/sb4000096; Chappell J, 2013, BIOTECHNOL J, V8, P1379, DOI 10.1002/biot.201300018; Chappell J, 2013, NUCLEIC ACIDS RES, V41, P3471, DOI 10.1093/nar/gkt052; Dawid A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025007; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Goff L, 2012, CUMMERBUND ANAL EXPL; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/nmeth.2969, 10.1038/NMETH.2969]; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; KUMAR CC, 1985, P NATL ACAD SCI USA, V82, P638, DOI 10.1073/pnas.82.3.638; Liu CC, 2012, NAT METHODS, V9, P1088, DOI [10.1038/NMETH.2184, 10.1038/nmeth.2184]; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Qi L, 2012, NUCLEIC ACIDS RES, V40, P5775, DOI 10.1093/nar/gks168; Qi LS, 2014, NAT REV MICROBIOL, V12, P341, DOI 10.1038/nrmicro3244; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Sakai Y, 2014, ACS SYNTH BIOL, V3, P152, DOI 10.1021/sb4000959; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sharma V, 2012, ACS SYNTH BIOL, V1, P6, DOI 10.1021/sb200001q; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; Sun ZZ, 2013, JOVE-J VIS EXP, DOI 10.3791/50762; Takahashi MK, 2015, ACS SYNTH BIOL, V4, P503, DOI 10.1021/sb400206c; Takahashi MK, 2013, NUCLEIC ACIDS RES, V41, P7577, DOI 10.1093/nar/gkt452; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wachsmuth M, 2013, NUCLEIC ACIDS RES, V41, P2541, DOI 10.1093/nar/gks1330; Xayaphoummine A, 2007, NUCLEIC ACIDS RES, V35, P614, DOI 10.1093/nar/gkl1036	47	149	153	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					214	U165		10.1038/nchembio.1737	http://dx.doi.org/10.1038/nchembio.1737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25643173				2022-12-25	WOS:000349840500013
J	Foote, AD; Liu, Y; Thomas, GWC; Vinar, T; Alfoldi, J; Deng, JX; Dugan, S; van Elk, CE; Hunter, ME; Joshi, V; Khan, Z; Kovar, C; Lee, SL; Lindblad-Toh, K; Mancia, A; Nielsen, R; Qin, X; Qu, JX; Raney, BJ; Vijay, N; Wolf, JBW; Hahn, MW; Muzny, DM; Worley, KC; Gilbert, MTP; Gibbs, RA				Foote, Andrew D.; Liu, Yue; Thomas, Gregg W. C.; Vinar, Tomas; Alfoeldi, Jessica; Deng, Jixin; Dugan, Shannon; van Elk, Cornelis E.; Hunter, Margaret E.; Joshi, Vandita; Khan, Ziad; Kovar, Christie; Lee, Sandra L.; Lindblad-Toh, Kerstin; Mancia, Annalaura; Nielsen, Rasmus; Qin, Xiang; Qu, Jiaxin; Raney, Brian J.; Vijay, Nagarjun; Wolf, Jochen B. W.; Hahn, Matthew W.; Muzny, Donna M.; Worley, Kim C.; Gilbert, M. Thomas P.; Gibbs, Richard A.			Convergent evolution of the genomes of marine mammals	NATURE GENETICS			English	Article							SEQUENCES; PROTEINS; LIKELIHOOD; MUTATIONS; DATABASE	Marine mammals from different mammalian orders share several phenotypic traits adapted to the aquatic environment and therefore represent a classic example of convergent evolution. To investigate convergent evolution at the genomic level, we sequenced and performed de novo assembly of the genomes of three species of marine mammals (the killer whale, walrus and manatee) from three mammalian orders that share independently evolved phenotypic adaptations to a marine existence. Our comparative genomic analyses found that convergent amino acid substitutions were widespread throughout the genome and that a subset of these substitutions were in genes evolving under positive selection and putatively associated with a marine phenotype. However, we found higher levels of convergent amino acid substitutions in a control set of terrestrial sister taxa to the marine mammals. Our results suggest that, whereas convergent molecular evolution is relatively common, adaptive molecular convergence linked to phenotypic convergence is comparatively rare.	[Foote, Andrew D.; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museurn Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Foote, Andrew D.; Vijay, Nagarjun; Wolf, Jochen B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Liu, Yue; Deng, Jixin; Dugan, Shannon; Joshi, Vandita; Khan, Ziad; Kovar, Christie; Lee, Sandra L.; Qin, Xiang; Qu, Jiaxin; Muzny, Donna M.; Worley, Kim C.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Thomas, Gregg W. C.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Vinar, Tomas] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Alfoeldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA USA; [van Elk, Cornelis E.] Dolfinarium Harderwijk, Harderwijk, Netherlands; [Hunter, Margaret E.] US Geol Survey, Sirenia Project, Southeast Ecol Sci Ctr, Gainesville, FL USA; [Lindblad-Toh, Kerstin; Wolf, Jochen B. W.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Mancia, Annalaura] Med Univ S Carolina, Marine Biomed & Environm Sci Ctr, Charleston, SC 29425 USA; [Mancia, Annalaura] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Nielsen, Rasmus] Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA; [Raney, Brian J.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6845, Australia	University of Copenhagen; Uppsala University; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Comenius University Bratislava; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of the Interior; United States Geological Survey; Uppsala University; Medical University of South Carolina; University of Ferrara; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; Curtin University	Foote, AD (corresponding author), Univ Copenhagen, Nat Hist Museurn Denmark, Ctr GeoGenet, Copenhagen, Denmark.	footead@gmail.com; kworley@bcm.edu	Vijay, Nagarjun/AAM-7687-2021; Gilbert, Marcus TP/A-8936-2013; Nielsen, Rasmus/D-4405-2009; Vinar, Tomas/I-3695-2014; Wolf, Jochen/U-2243-2017; Vijay, Nagarjun/AAI-9433-2020; Raney, Brian/ABE-6267-2020; Mancia, Annalaura/F-9706-2013	Vijay, Nagarjun/0000-0002-8703-6991; Gilbert, Marcus TP/0000-0002-5805-7195; Nielsen, Rasmus/0000-0003-0513-6591; Vinar, Tomas/0000-0003-3898-3447; Wolf, Jochen/0000-0002-2958-5183; Worley, Kim/0000-0002-0282-1000; Mancia, Annalaura/0000-0001-8680-3530; Hahn, Matthew/0000-0002-5731-8808; Foote, Andrew/0000-0001-7384-1634	National Human Genome Research Institute (NHGRI) [U54 HG003273, HG003067-08]; European Union Intra-European Fellowhip (IEF) [KWAF10]; Marie Curie IEF; Lawski Foundation fellowship; VEGA grant agency (grant agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic) [1/0719/14, 1/1085/12]; NHGRI; UPPMAX next-generation sequencing cluster and storage facility (UPPNEX); Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing;  [DNRF94]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003067, U41HG002371] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Union Intra-European Fellowhip (IEF); Marie Curie IEF(European Commission); Lawski Foundation fellowship; VEGA grant agency (grant agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); UPPMAX next-generation sequencing cluster and storage facility (UPPNEX); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Marine Mammals Genome Project was funded by the National Human Genome Research Institute (NHGRI), including grant U54 HG003273 (R.A.G.) for the dolphin, walrus and killer whale and grant U54 HG003067-08 for the manatee (K.L.-T. and J.A.), with additional funding from grant DNRF94 for the walrus and killer whale (M.T.P.G.) and European Union Intra-European Fellowhip (IEF) grant KWAF10 (A.D.F.). A.D.F. was supported by a Marie Curie IEF 'KWAF10' and a Lawski Foundation fellowship, and T.V. was supported by grants 1/0719/14 and 1/1085/12 from the VEGA grant agency (grant agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic). We thank the Baylor College of Medicine Human Genome Sequencing Center production teams, including those who worked on the Sanger sequencing data production teams for the dolphin (K. Abraham, S. Ali, U. Anosike, T. Attaway, D. Bandaranaike, S. Bell, B. Beltran, C. Bickham, V. Cardenas, K. Carter, I. Cavazos, M. Chandrabose, A. Chavez, J. Chu, R. Cockrell, A. Cree, M. Dao, M.L. Davila, L. Davy-Carroll, S. Denson, H. Dinh, V. Ebong, S. Fernandez, P. Fernando, N. Flagg, L. Forbes, G. Fowler, R. Gabisi, R. Garcia, T. Garner, T. Garrett, E. Hawkins, K. Hirani, M. Hogues, B. Hollins, S. Jhangiani, B. Johnson, J. Kalu, H. Kisamo, L. Lago, Y. Lai, F. Lara, T. Le, S. Lee, F. LeGall, S. Lemon, L. Lewis, L. Liu, P. London, J. Lopez, E. Martinez, C. Mercadao, M. Morgan, M. Munidasa, L. Nazareth, N. Nguyen, P. Nguyen, T. Nguyen, O. Nwaokelemeh, M. Obregon, G. Okwuonu, C. Onwere, A. Parra, S. Patil, A. Perez, Y. Perez, C. Pham, E. Primus, L.-L. Pu, M. Puazo, J. Quiroz, S. Richards, M. Ruiz, S. J. Ruiz, J. Santibanez, S. Scherer, B. Schneider, D. Simmons, I. Sisson, Z. Trejos, S. Vattathil, D. Walker, C. White, A. Williams, K. Wilson, I. Woghiren, J. Woodworth and R. Wright), the Illumina library and production teams for the walrus and killer whale (Y. Liu, S. L. Lee, S. Dugan, S. Jhangiani, D. Bandaranaike, M. Batterton, M. Bellair, C. Bess, K. Blankenburg, H. Chao, S. Denson, H. Dinh, S. Elkadiri, Q. Fu, B. Hernandez, M. Javaid, J. C. Jayaseelan, S. Lee, M. Li, X. Liu, T. Matskevitch, M. Munidasa, R. Najjar, L. Nguyen, F. Ongeri, N. Osuji, L. Perales, L.-L. Pu, M. Puazo, S. Qi, J. Quiroz, R. Raj, J. Shafer, H. Shen, N. Tabassum, L.-Y. Tang, A. Taylor, G. Weissenberger, Y.-Q. Wu, Y. Xin, Y. Zhang, Y. Zhu and X. Zou) and the submissions team (K. Wilczek-Boney, M. Batterton and D. Kalra). Large-scale computational effort was made possible by the computing cluster administered by the Center for Biomolecular Science and Engineering (CBSE) at the University of California, Santa Cruz (UCSC), funded primarily by the NHGRI, and the UPPMAX next-generation sequencing cluster and storage facility (UPPNEX), funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing. Any use of trade, product or firm names is for descriptive purposes only and does not imply endorsement by the US government.	Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTA A, 2006, MARINE MAMMALS EVOLU; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Desjardins PR, 2002, MOL BIOL EVOL, V19, P375, DOI 10.1093/oxfordjournals.molbev.a004093; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Foote AD, 2014, J MAR BIOL ASSOC UK, V94, P1245, DOI 10.1017/S0025315414000800; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; HOLM S, 1979, SCAND J STAT, V6, P65; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keightley PD, 2005, GENOME RES, V15, P1373, DOI 10.1101/gr.3942005; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; McGowen MR, 2014, TRENDS ECOL EVOL, V29, P336, DOI 10.1016/j.tree.2014.04.001; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; MOUREY L, 1990, BIOCHIMIE, V72, P599, DOI 10.1016/0300-9084(90)90123-X; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Orr HA, 2005, EVOLUTION, V59, P216; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wierer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050350; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	37	250	260	9	241	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					272	+		10.1038/ng.3198	http://dx.doi.org/10.1038/ng.3198			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25621460	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000350327900020
J	Levy, M; Thaiss, CA; Elinav, E				Levy, Maayan; Thaiss, Christoph A.; Elinav, Eran			Taming the inflammasome	NATURE MEDICINE			English	Editorial Material									[Levy, Maayan; Thaiss, Christoph A.; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Levy, M (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Jain N, 2015, NAT REV GASTRO HEPAT, V12, P14, DOI 10.1038/nrgastro.2014.153; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Perregaux DG, 2001, J PHARMACOL EXP THER, V299, P187; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804	13	35	37	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					213	215		10.1038/nm.3808	http://dx.doi.org/10.1038/nm.3808			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25742454				2022-12-25	WOS:000350362000010
J	Buettner, F; Natarajan, KN; Casale, FP; Proserpio, V; Scialdone, A; Theis, FJ; Teichmann, SA; Marioni, JC; Stegie, O				Buettner, Florian; Natarajan, Kedar N.; Casale, F. Paolo; Proserpio, Valentina; Scialdone, Antonio; Theis, Fabian J.; Teichmann, Sarah A.; Marioni, John C.; Stegie, Oliver			Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; FATE DECISIONS; SEQ ANALYSIS; MODELS; NOISE; TRANSCRIPTOMICS; MECHANISMS; LANDSCAPE; CYCLE	Recent technical developments have enabled the transcriptomes of hundreds of cells to be assayed in an unbiased manner, opening up the possibility that new subpopulations of cells can be found. However, the effects of potential confounding factors, such as the cell cycle, on the heterogeneity of gene expression and therefore on the ability to robustly identify subpopulations remain unclear. We present and validate a computational approach that uses latent variable models to account for such hidden factors. We show that our single-cell latent variable model (scLVM) allows the identification of otherwise undetectable subpopulations of cells that correspond to different stages during the differentiation of naive T cells into T helper 2 cells. Our approach can be used not only to identify cellular subpopulations but also to tease apart different sources of gene expression heterogeneity in single-cell transcriptomes.	[Buettner, Florian; Theis, Fabian J.] Inst Computat Biol, Munchen German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Buettner, Florian; Natarajan, Kedar N.; Casale, F. Paolo; Proserpio, Valentina; Scialdone, Antonio; Teichmann, Sarah A.; Marioni, John C.; Stegie, Oliver] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Natarajan, Kedar N.; Proserpio, Valentina; Scialdone, Antonio; Teichmann, Sarah A.; Marioni, John C.] Wellcome Trust Sanger Inst, Hinxton, England; [Theis, Fabian J.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Technical University of Munich	Marioni, JC (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	marioni@ebi.ac.uk; stegle@ebLac.uk	Buettner, Florian/ABF-1230-2020; Stegle, Oliver/AAU-9177-2020; Theis, Fabian J/ABD-5212-2021; Proserpio, Valentina/AAB-3630-2019	Buettner, Florian/0000-0001-5587-6761; Stegle, Oliver/0000-0002-8818-7193; Theis, Fabian J/0000-0002-2419-1943; Proserpio, Valentina/0000-0003-2071-4206; Marioni, John/0000-0001-9092-0852; Natarajan, Kedar Nath/0000-0002-9264-1280; Scialdone, Antonio/0000-0002-4956-2843; Teichmann, Sarah/0000-0002-6294-6366	European Research Council [260507 thSWITCH, 253524]; Sanger-EBI Single Cell Centre; European Molecular Biology Organization	European Research Council(European Research Council (ERC)European Commission); Sanger-EBI Single Cell Centre; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank S. Anders and A. Baud for helpful discussions. We also thank the Sanger-EBI Single Cell Centre for technical support. We acknowledge support of the European Research Council (Starting grant no. 260507 thSWITCH to S.A.T., Starting Grant LatentCauses to F.J.T., Marie Curie FP7 fellowship 253524 to O.S.), the Sanger-EBI Single Cell Centre (K.N.N. & A.S.) and the European Molecular Biology Organization (short-term fellowship to F.B.).	Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Gold D, 2008, J COMPUT BIOL, V15, P611, DOI 10.1089/cmb.2007.0220; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Lawrence ND, 2004, ADV NEUR IN, V16, P329; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sahoo A, 2011, J IMMUNOL, V186, P4098, DOI 10.4049/jimmunol.1002620; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Stegle O., NAT REV GEN IN PRESS; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson CB, 2002, J INFECT DIS, V185, pS37, DOI 10.1086/338001; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	46	667	675	10	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					155	160		10.1038/nbt.3102	http://dx.doi.org/10.1038/nbt.3102			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599176	Bronze			2022-12-25	WOS:000349198800020
J	Cunningham, CN; Baughman, JM; Phu, L; Tea, JS; Yu, C; Coons, M; Kirkpatrick, DS; Bingol, B; Corn, JE				Cunningham, Christian N.; Baughman, Joshua M.; Phu, Lilian; Tea, Joy S.; Yu, Christine; Coons, Mary; Kirkpatrick, Donald S.; Bingol, Bans; Corn, Jacob E.			USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria	NATURE CELL BIOLOGY			English	Article							POLYUBIQUITIN CHAINS; PROTEASOMAL DEGRADATION; SELECTIVE AUTOPHAGY; MITOPHAGY; LIGASE; PROTEINS; REVEALS; PINK1; PHOSPHORYLATION; DEUBIQUITINASES	Multiple lines of evidence indicate that mitochondrial dysfunction is central to Parkinson's disease. Here we investigate the mechanism by which parkin, an E3 ubiquitin ligase, and USP30, a mitochondrion-localized deubiquitylase, regulate mitophagy. We find that mitochondrial damage stimulates parkin to assemble Lys 6, Lys 11 and Lys 63 chains on mitochondria, and that USP30 is a ubiquitin-specific deubiquitylase with a strong preference for cleaving Lys 6-and Lys 11-linked multimers. Using mass spectrometry, we show that recombinant USP30 preferentially removes these linkage types from intact ubiquitylated mitochondria and counteracts parkin-mediated ubiquitin chain formation in cells. These results, combined with a series of chimaera and localization studies, afford insights into the mechanism by which a balance of ubiquitylation and deubiquitylation regulates mitochondrial homeostasis, and suggest a general mechanism for organelle autophagy.	[Cunningham, Christian N.; Corn, Jacob E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Baughman, Joshua M.; Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Tea, Joy S.; Bingol, Bans] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Yu, Christine; Coons, Mary] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirkpatrick, DS (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way, San Francisco, CA 94080 USA.	kirkpatrick.donald@gene.com; bingol.baris@gene.com; jcorn@berkeley.edu		Tea, Joy/0000-0002-3395-149X; Corn, Jacob/0000-0002-7798-5309; Kirkpatrick, Donald/0000-0003-3091-2804				Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bozza WP, 2012, BIOCHEMISTRY-US, V51, P10075, DOI 10.1021/bi3009104; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Durcan TM, 2014, EMBO J; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Narendra D., 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ordureau A., 2014, MOL CELL; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Pinheiro J., 2011, NLME LINEAR NONLINEA; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zhang WF, 2011, BIOCHEMISTRY-US, V50, P4775, DOI 10.1021/bi101958h	60	194	215	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					160	+		10.1038/ncb3097	http://dx.doi.org/10.1038/ncb3097			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25621951				2022-12-25	WOS:000349152400007
J	Hu, X; Wang, YH; Hao, LY; Liu, XK; Lesch, CA; Sanchez, BM; Wendling, JM; Morgan, RW; Aicher, TD; Carter, LL; Toogood, PL; Glick, GD				Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Wendling, Jay M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.			Sterol metabolism controls T(H)17 differentiation by generating endogenous ROR gamma agonists	NATURE CHEMICAL BIOLOGY			English	Article							MACROPHAGE LIPID-METABOLISM; T-CELLS; OXIDIZED CHOLESTEROL; REGULATORY NETWORK; IN-VIVO; LIGANDS; ATHEROSCLEROSIS; OXYSTEROLS; EXPRESSION; PROTEIN	Retinoic acid receptor-related orphan receptor gamma (ROR gamma t) controls the differentiation of naive CD4(+) T cells into the T(H)17 lineage, which are critical cells in the pathogenesis of autoimmune diseases. Here we report that during T(H)17 differentiation, cholesterol biosynthesis and uptake programs are induced, whereas their metabolism and efflux programs are suppressed. These changes result in the accumulation of the cholesterol precursor, desmosterol, which functions as a potent endogenous ROR gamma agonist. Generation of cholesterol precursors is essential for T(H)17 differentiation as blocking cholesterol synthesis with chemical inhibitors at steps before the formation of active precursors reduces differentiation. Upon activation, metabolic changes also lead to production of specific sterol-sulfate conjugates that favor activation of ROR gamma over the T(H)17-inhibiting sterol receptor LXR. Thus, T(H)17 differentiation is orchestrated by coordinated sterol synthesis, mobilization and metabolism to selectively activate ROR gamma.	[Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.] Lycera Corp, Ann Arbor, MI USA; [Wendling, Jay M.] Seventh Wave Labs, Chesterfield, MO USA; [Glick, Gary D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hu, X (corresponding author), Lycera Corp, Ann Arbor, MI USA.	hu@lycera.com			US National Institutes of Health [AI-47450]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047450, R21AI047450] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Lu and D. Bousley for help on maintaining cells and mice and C. Van Huis for help on extraction with organic solvents. This work was supported in part by US National Institutes of Health grant AI-47450 to G.D.G.	Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cheng HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063746; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Ekins S, 2007, DRUG METAB DISPOS, V35, P493, DOI 10.1124/dmd.106.013888; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Hakamada-Taguchi R, 2003, CIRC RES, V93, P948, DOI 10.1161/01.RES.0000101298.76864.14; Hanyu O, 2012, BIOCHEM BIOPH RES CO, V428, P99, DOI 10.1016/j.bbrc.2012.10.013; Hirayama S, 2013, ATHEROSCLEROSIS, V230, P48, DOI 10.1016/j.atherosclerosis.2013.06.016; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jiang SP, 2013, IMMUNOL REV, V252, P5, DOI 10.1111/imr.12041; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Jones Sarah A, 2012, Nat Immunol, V13, P1022, DOI 10.1038/ni.2450; Kagami S, 2009, INT IMMUNOL, V21, P679, DOI 10.1093/intimm/dxp037; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Solt LA, 2012, ACS CHEM BIOL, V7, P1515, DOI 10.1021/cb3002649; Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu SW, 2014, ARTHRITIS RHEUMATOL, V66, P304, DOI 10.1002/art.38227; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988; Zhu MY, 2013, CLIN RHEUMATOL, V32, P1045, DOI 10.1007/s10067-013-2237-z; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	50	140	148	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					141	U84		10.1038/NCHEMBIO.1714	http://dx.doi.org/10.1038/NCHEMBIO.1714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25558972				2022-12-25	WOS:000348358800012
J	Golczak, M; Sears, AE; Kiser, PD; Palczewski, K				Golczak, Marcin; Sears, Avery E.; Kiser, Philip D.; Palczewski, Krzysztof			LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3	NATURE CHEMICAL BIOLOGY			English	Article							LECITHIN-RETINOL ACYLTRANSFERASE; VISUAL CYCLE; EVOLUTION; PHOSPHOLIPASE; PURIFICATION; PROTEINS; RPE65; PROMISCUITY; HYDROLYSIS; DEFICIENCY	Cellular uptake of vitamin A, production of visual chromophore and triglyceride homeostasis in adipocytes depend on two representatives of the vertebrate N1pC/P60 protein family, lecithin: retinol acyltransferase (LRAT) and HRAS-like tumor suppressor 3 (HRASLS3). Both proteins function as lipid-metabolizing enzymes but differ in their substrate preferences and dominant catalytic activity. The mechanism of this catalytic diversity is not understood. Here, by using a gain-of-function approach, we identified a specific sequence responsible for the substrate specificity of N1pC/P60 proteins. A 2.2-angstrom crystal structure of the HRASLS3-LRAT chimeric enzyme in a thioester catalytic intermediate state revealed a major structural rearrangement accompanied by three-dimensional domain swapping dimerization not observed in native HRASLS proteins. Structural changes affecting the active site environment contributed to slower hydrolysis of the catalytic intermediate, supporting efficient acyl transfer. These findings reveal structural adaptation that facilitates selective catalysis and mechanism responsible for diverse substrate specificity within the LRAT-like enzyme family.	[Golczak, Marcin; Sears, Avery E.; Kiser, Philip D.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Golczak, M (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA.	mxg149@case.edu; kxp65@case.edu			National Eye Institute of the National Institutes of Health (NIH) [EY023948, EY009339]; Medical Scientist Training Program from the National Institutes of Health (NIH) [T32 GM007250]; Nutrition and Obesity Research Center at CWRU; US Department of Energy [DE-AC02-06CH11357]; Office of Biological and Environmental Research; Office of Basic Energy Sciences of the United States Department of Energy; NIH from the US National Center for Research Resources [P41RR012408]; US National Institute of General Medical Sciences [P41GM103473]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023948, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, T32GM007250] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health (NIH); Medical Scientist Training Program from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition and Obesity Research Center at CWRU; US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NIH from the US National Center for Research Resources; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Tu and B.M. Kevany for initial X-ray diffraction data collection of HRASLS3-LRAT crystals and L.T. Webster, Jr. for help in preparation of this manuscript. This work was supported by grants EY023948 (M.G.) and EY009339 (K.P.) from the National Eye Institute of the National Institutes of Health (NIH), the Medical Scientist Training Program grant T32 GM007250 (A.E.S.) from the National Institutes of Health (NIH) as well as the Nutrition and Obesity Research Center at CWRU (M.G.). We thank the Northeastern Collaborative Access Team staff for assistance with diffraction data collection. Use of the Advanced Photon Source, an Office of the Science User Facility operated for the US Department of Energy Office of Science by the Argonne National Laboratory, was supported by the US Department of Energy under contract DE-AC02-06CH11357. Preliminary data for this study were obtained at beamline X29 of the National Synchrotron Light Source. Its financial support is derived principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and by NIH Grant P41RR012408 from the US National Center for Research Resources and P41GM103473 from the US National Institute of General Medical Sciences. K.P. is John H. Hord Professor of Pharmacology.	Albalat R, 2012, MOL BIOL EVOL, V29, P1461, DOI 10.1093/molbev/msr313; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; Bolen AL, 2011, J LIPID RES, V52, P958, DOI 10.1194/jlr.M013326; Borman AD, 2012, INVEST OPHTH VIS SCI, V53, P3927, DOI 10.1167/iovs.12-9548; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Bussieres S, 2012, LANGMUIR, V28, P3516, DOI 10.1021/la203896n; CANADA FJ, 1990, BIOCHEMISTRY-US, V29, P9690, DOI 10.1021/bi00493a026; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEREWENDA ZS, 1994, ADV PROTEIN CHEM, V45, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; Fournand D, 2001, J APPL MICROBIOL, V91, P381, DOI 10.1046/j.1365-2672.2001.01378.x; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jahng WJ, 2002, BIOCHEMISTRY-US, V41, P6311, DOI 10.1021/bi015710b; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kusakabe TG, 2009, PHILOS T R SOC B, V364, P2897, DOI 10.1098/rstb.2009.0043; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; LIU M, 1994, P NATL ACAD SCI USA, V91, P6035, DOI 10.1073/pnas.91.13.6035; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pakhomova S, 2001, NAT STRUCT BIOL, V8, P447, DOI 10.1038/87617; Pang XY, 2012, J BIOL CHEM, V287, P35260, DOI 10.1074/jbc.M112.398859; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Rahman IAS, 2014, PHARMACOL RES, V86, P1, DOI 10.1016/j.phrs.2014.04.001; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf G, 2009, NUTR REV, V67, P551, DOI 10.1111/j.1753-4887.2009.00227.x; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	54	34	36	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					26	+		10.1038/nchembio.1687	http://dx.doi.org/10.1038/nchembio.1687			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25383759	Green Submitted, Green Accepted			2022-12-25	WOS:000346448600008
J	Yoda, A; Adelmant, G; Tamburini, J; Chapuy, B; Shindoh, N; Yoda, Y; Weigert, O; Kopp, N; Wu, SC; Kim, SS; Liu, H; Tivey, T; Christie, AL; Elpek, KG; Card, J; Gritsman, K; Gotlib, J; Deininger, MW; Makishima, H; Turley, SJ; Javidi-Sharifi, N; Maciejewski, JP; Jaiswal, S; Ebert, BL; Rodig, SJ; Tyner, JW; Marto, JA; Weinstock, DM; Lane, AA				Yoda, Akinori; Adelmant, Guillaume; Tamburini, Jerome; Chapuy, Bjoern; Shindoh, Nobuaki; Yoda, Yuka; Weigert, Oliver; Kopp, Nadja; Wu, Shuo-Chieh; Kim, Sunhee S.; Liu, Huiyun; Tivey, Trevor; Christie, Amanda L.; Elpek, Kutlu G.; Card, Joseph; Gritsman, Kira; Gotlib, Jason; Deininger, Michael W.; Makishima, Hideki; Turley, Shannon J.; Javidi-Sharifi, Nathalie; Maciejewski, Jaroslaw P.; Jaiswal, Siddhartha; Ebert, Benjamin L.; Rodig, Scott J.; Tyner, Jeffrey W.; Marto, Jarrod A.; Weinstock, David M.; Lane, Andrew A.			Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance	NATURE MEDICINE			English	Article							ACTIVATION; MELANOMA; GENES	Activating mutations in genes encoding G protein alpha (G alpha) subunits occur in 4-5% of all human cancers(1), but oncogenic alterations in G beta subunits have not been defined. Here we demonstrate that recurrent mutations in the G beta proteins GNB1 and GNB2 confer cytokine-independent growth and activate canonical G protein signaling. Multiple mutations in GNB1 affect the protein interface that binds G alpha subunits as well as downstream effectors and disrupt G alpha interactions with the dimer G beta gamma Different mutations in G beta proteins clustered partly on the basis of lineage; for example, all 11 GNB1 K57 mutations were in myeloid neoplasms, and seven of eight GNB1 180 mutations were in B cell neoplasms. Expression of patient-derived GNB1 variants in Cdkn2a-deficient mouse bone marrow followed by transplantation resulted in either myeloid or B cell malignancies. In vivo treatment with the dual PI3K-mTOR inhibitor BEZ235 suppressed GNB1-induced signaling and markedly increased survival. In several human tumors, mutations in the gene encoding GNB1 co-occurred with oncogenic kinase alterations, including the BCR-ABL fusion protein, the V617F substitution in JAK2 and the V600K substitution in BRAF. Coexpression of patient-derived GNB1 variants with these mutant kinases resulted in inhibitor resistance in each context. Thus, GNB1 and GNB2 alterations confer transformed and resistance phenotypes across a range of human tumors and may be targetable with inhibitors of G protein signaling.	[Yoda, Akinori; Tamburini, Jerome; Chapuy, Bjoern; Shindoh, Nobuaki; Yoda, Yuka; Kopp, Nadja; Wu, Shuo-Chieh; Kim, Sunhee S.; Liu, Huiyun; Tivey, Trevor; Christie, Amanda L.; Gritsman, Kira; Weinstock, David M.; Lane, Andrew A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Adelmant, Guillaume; Card, Joseph; Marto, Jarrod A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Adelmant, Guillaume; Marto, Jarrod A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Shindoh, Nobuaki] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Weigert, Oliver] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan; [Weigert, Oliver] Univ Munich, Dept Med 3, Munich, Germany; [Elpek, Kutlu G.; Turley, Shannon J.] Helmholtz Ctr, Munich, Germany; [Elpek, Kutlu G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Gotlib, Jason] Jounce Therapeut Inc, Cambridge, MA USA; [Deininger, Michael W.] Stanford Univ, Sch Med, Stanford Canc Inst, Dept Hematol, Stanford, CA USA; [Makishima, Hideki] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA; [Javidi-Sharifi, Nathalie; Tyner, Jeffrey W.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Jaiswal, Siddhartha; Rodig, Scott J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Jaiswal, Siddhartha; Ebert, Benjamin L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ebert, Benjamin L.; Weinstock, David M.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Broad Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Astellas Pharmaceuticals; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Stanford Cancer Institute; Stanford University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; Oregon Health & Science University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Weinstock, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	dweinstock@partners.org; andrew_lane@dfci.harvard.edu	tamburini, jerome/AAT-9506-2020; Gritsman, Kira/J-8644-2019; Rodig, Scott/Y-3889-2019	Gritsman, Kira/0000-0002-1367-1167; Lane, Andrew/0000-0001-7380-0226; Tivey, Trevor/0000-0003-2124-5528; Tamburini, Jerome/0000-0002-0167-5996	Aplastic Anemia and MDS International Foundation; Edwards P. Evans Foundation; Max-Eder Program of the Deutsche Krebshilfe [110659]; Leukemia and Lymphoma Society; US National Institutes of Health NCI [1R01CA183947, 5R00CA151457]; V Foundation for Cancer Research; Gabrielle's Angel Foundation; Claudia Adams Barr Fund; American Cancer Society Research Scholar Grant; Stand Up To Cancer Innovative Research Grant; American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE [K08CA181340, F30CA186477, R01CA178397, R00CA151457, R01CA183974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Aplastic Anemia and MDS International Foundation; Edwards P. Evans Foundation; Max-Eder Program of the Deutsche Krebshilfe(Deutsche Krebshilfe); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health NCI; V Foundation for Cancer Research; Gabrielle's Angel Foundation; Claudia Adams Barr Fund; American Cancer Society Research Scholar Grant(American Cancer Society); Stand Up To Cancer Innovative Research Grant; American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Radimersld, T. Haferlach, L. Garraway, M. Walter and N. Wagle for contributing to the manuscript. We thank A. Hawkins and the Brigham and Women's Hospital Cytogenomics Core Facility for karyotyping. This research was supported by the Aplastic Anemia and MDS International Foundation (AT.), the Edwards P. Evans Foundation (A.Y.), the Max-Eder Program of the Deutsche Krebshilfe (#110659 to O.W), the Leukemia and Lymphoma Society (J.W.T.), US National Institutes of Health NCI (1R01CA183947 and 5R00CA151457 to J.W.T.), the V Foundation for Cancer Research (J.W.T.), Gabrielle's Angel Foundation for Cancer Research (J.W.T.), the Claudia Adams Barr Fund (A.Y. and D.M.W.), an American Cancer Society Research Scholar Grant (D.M.W.), a Stand Up To Cancer Innovative Research Grant (D.M.W.), and an American Society of Hematology Scholar Award (A.A.L.).	Adelmant G, 2012, MOL CELL PROTEOMICS, V11, P411, DOI 10.1074/mcp.M111.013581; Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P213, DOI 10.3324/haematol.13024; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lucioni M, 2011, BLOOD, V118, P4591, DOI 10.1182/blood-2011-03-337501; Menezes J, 2014, LEUKEMIA, V28, P823, DOI 10.1038/leu.2013.283; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Shindoh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049201; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Willardson Barry M, 2012, Subcell Biochem, V63, P131, DOI 10.1007/978-94-007-4765-4_8; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107	30	55	62	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					71	75		10.1038/nm.3751	http://dx.doi.org/10.1038/nm.3751			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25485910	Green Accepted, Green Submitted			2022-12-25	WOS:000348408000015
J	Gascon, E; Lynch, K; Ruan, HY; Almeida, S; Verheyden, JM; Seeley, WW; Dickson, DW; Petrucelli, L; Sun, DQ; Jiao, J; Zhou, HR; Jakovcevski, M; Akbarian, S; Yao, WD; Gao, FB				Gascon, Eduardo; Lynch, Kelleen; Ruan, Hongyu; Almeida, Sandra; Verheyden, Jamie M.; Seeley, William W.; Dickson, Dennis W.; Petrucelli, Leonard; Sun, Danqiong; Jiao, Jian; Zhou, Hongru; Jakovcevski, Mira; Akbarian, Schahram; Yao, Wei-Dong; Gao, Fen-Biao			Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemp oral dementia	NATURE MEDICINE			English	Article							SMALL RNAS; ESCRT-III; CELL LOSS; CHMP2B; MUTATIONS; SCLEROSIS; GENE; MISREGULATION; DYSFUNCTION; MECHANISMS	Neurodegenerative diseases, such as frontotemporal dementia (FTD), are often associated with behavioral deficits, but the underlying anatomical and molecular causes remain poorly understood. Here we show that forebrain-specific expression of FTD-associated mutant CHMP2B in mice causes several age-dependent neurodegenerative phenotypes, including social behavioral impairments. The social deficits were accompanied by a change in AMPA receptor (AMPAR) composition, leading to an imbalance between Ca2+-permeable and Ca2+-impermeable AMPARs. Expression of most AMPAR subunits was regulated by the brain-enriched microRNA miR-124, whose abundance was markedly decreased in the superficial layers of the cerebral cortex of mice expressing the mutant CHMP2B. We found similar changes in miR-124 and AMPAR levels in the frontal cortex and induced pluripotent stem cell derived neurons from subjects with behavioral variant FTD. Moreover, ectopic miR-124 expression in the medial prefrontal cortex of mutant mice decreased AMPAR levels and partially rescued behavioral deficits. Knockdown of the AMPAR subunit Gria2 also alleviated social impairments. Our results identify a previously undescribed mechanism involving miR-124 and AMPARs in regulating social behavior in FTD and suggest a potential therapeutic avenue.	[Gascon, Eduardo; Lynch, Kelleen; Almeida, Sandra; Zhou, Hongru; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01610 USA; [Ruan, Hongyu; Yao, Wei-Dong] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Neurosci, Southborough, MA 01772 USA; [Verheyden, Jamie M.; Sun, Danqiong; Jiao, Jian] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Seeley, William W.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Jakovcevski, Mira; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Mayo Clinic; University of Massachusetts System; University of Massachusetts Worcester	Gao, FB (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01610 USA.	fen-biao.gao@umassmed.edu	Jakovcevski, Mira/M-1930-2018; Jakovcevski, Mira/N-2430-2019	Jakovcevski, Mira/0000-0003-2262-823X; Jakovcevski, Mira/0000-0003-2262-823X; Gascon, Eduardo/0000-0002-2625-5509	UMMS startup fund; Consortium for Frontotemporal Dementia Research; US National Institutes of Health [NS057553, NS066586, NS079725, DA032283, MH086509, AG023501, AG19724, AGO 16574]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066586, R01NS079725, R01NS073947, R01NS057553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032283] Funding Source: NIH RePORTER	UMMS startup fund; Consortium for Frontotemporal Dementia Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Ordway and Gao lab members for comments, Y. Li and A. Philbrook for help with some experiments, A. Tapper for sharing behavioral test equipment, the Digital Light Microscopy Core at the University of Massachusetts Medical School (UMMS) for assistance with Golgi staining, the UMMS Viral Vector core for help with AAV vectors, and the University of California-San Francisco Neurodegenerative Disease Brain Bank for some human brain tissues. We also thank R. Rademakers for genotyping some human samples in a previous work<SUP>51</SUP> that we used in the current study and A. Chen-Plotkin for sharing published array data<SUP>38,40</SUP>. This work was supported by a UMMS startup fund (F.-B.G.), The Consortium for Frontotemporal Dementia Research (W.W.S.) and the US National Institutes of Health (NS057553, NS066586 and NS079725 to F.-B.G.; DA032283 to W-D.Y.; MH086509 to S.A.; AG023501 and AG19724 to W.W.S.; and AGO 16574 to D.W.D. and L.P.).	Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; Adamczyk A, 2012, BEHAV BRAIN RES, V229, P265, DOI 10.1016/j.bbr.2012.01.007; Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bezprozvanny I, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-23; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Dutta R, 2013, ANN NEUROL, V73, P637, DOI 10.1002/ana.23860; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gascon E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00048; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Ghazi-Noori S, 2012, BRAIN, V135, P819, DOI 10.1093/brain/aws006; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; NAMBA T, 1994, BRAIN RES, V638, P36, DOI 10.1016/0006-8993(94)90630-0; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Prudencio M, 2012, P NATL ACAD SCI USA, V109, P21510, DOI 10.1073/pnas.1211577110; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rozov A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00022; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	51	138	142	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1444	1451		10.1038/nm.3717	http://dx.doi.org/10.1038/nm.3717			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25401692	Green Accepted, Green Submitted			2022-12-25	WOS:000345817900020
J	Gershenson, A; Gierasch, LM; Pastore, A; Radford, SE				Gershenson, Anne; Gierasch, Lila M.; Pastore, Annalisa; Radford, Sheena E.			Energy landscapes of functional proteins are inherently risky	NATURE CHEMICAL BIOLOGY			English	Article							ACID-BINDING PROTEIN; MAJOR-HISTOCOMPATIBILITY-COMPLEX; FATTY-ACID; JOSEPHIN DOMAIN; RETINOIC ACID; STRUCTURAL BASIS; ALPHA(1)-PROTEINASE INHIBITOR; PHYSIOLOGICAL CONDITIONS; CRYSTAL-STRUCTURE; AMYLOID FORMATION	Evolutionary pressure for protein function leads to unavoidable sampling of conformational states that are at risk of misfolding and aggregation. The resulting tension between functional requirements and the risk of misfolding and/or aggregation in the evolution of proteins is becoming more and more apparent. One outcome of this tension is sensitivity to mutation, in which only subtle changes in sequence that may be functionally advantageous can tip the delicate balance toward protein aggregation. Similarly, increasing the concentration of aggregation-prone species by reducing the ability to control protein levels or compromising protein folding capacity engenders increased risk of aggregation and disease. In this Perspective, we describe examples that epitomize the tension between protein functional energy landscapes and aggregation risk. Each case illustrates how the energy landscapes for the at-risk proteins are sculpted to enable them to perform their functions and how the risks of aggregation are minimized under cellular conditions using a variety of compensatory mechanisms.	[Gershenson, Anne; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Pastore, Annalisa] Kings Coll London, Dept Clin Neurosci, London WC2R 2LS, England; [Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of London; King's College London; University of Leeds	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu		Radford, Sheena/0000-0002-3079-8039; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [GM027616, GM094848, GM101644, GM060418]; Medical Research Council [U117584256]; European Research Council [322408]; Wellcome Trust [WT092896MA]; MRC [MC_U117584256, MC_PC_13054] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_PC_13054] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, R01GM094848, R01GM060418, R01GM101644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our many collaborators and co-authors whose experiments and ideas have contributed to our work. We also recognize that all relevant examples and references cannot be included in a short perspective such as this, and we apologize to those whose contributions we have omitted. We acknowledge, with thanks, funding from the National Institutes of Health (grants GM027616 and GM101644 to L.M.G., GM094848 to L.M.G. and A.G. and GM060418 to A.G.); the Medical Research Council (grant U117584256 to A.P.) and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013; 322408) and the Wellcome Trust (WT092896MA to S.E.R.).	Almeida B, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00076; Baek JH, 2009, MOL CELL PROTEOMICS, V8, P1072, DOI 10.1074/mcp.M800365-MCP200; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budyak IL, 2013, STRUCTURE, V21, P476, DOI 10.1016/j.str.2013.01.013; Cai J, 2012, BIOPHYS J, V102, P2585, DOI 10.1016/j.bpj.2012.04.039; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Clark PL, 1996, PROTEIN SCI, V5, P1108; Clark PL, 1997, NAT STRUCT BIOL, V4, P883, DOI 10.1038/nsb1197-883; Clark PL, 1998, FOLD DES, V3, P401, DOI 10.1016/S1359-0278(98)00053-4; Corlin Dorthe B, 2012, Subcell Biochem, V65, P517, DOI 10.1007/978-94-007-5416-4_19; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; de Chiara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076456; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dolmer K, 2012, J BIOL CHEM, V287, P12425, DOI 10.1074/jbc.M111.315465; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eberini I, 2008, PROTEINS, V71, P1889, DOI 10.1002/prot.21875; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Eyles SJ, 2000, J MOL BIOL, V301, P737, DOI 10.1006/jmbi.2000.4002; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Feige MJ, 2014, BBA-PROTEINS PROTEOM, V1844, P2024, DOI 10.1016/j.bbapap.2014.06.004; Ferrolino MC, 2013, BIOCHEMISTRY-US, V52, P8843, DOI 10.1021/bi4013462; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gunasekaran K, 2004, PROTEINS, V54, P179, DOI 10.1002/prot.10520; Hagen MC, 2011, BRAIN PATHOL, V21, P575, DOI 10.1111/j.1750-3639.2011.00481.x; Halabelian L, 2014, J BIOL CHEM, V289, P3318, DOI 10.1074/jbc.M113.524157; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; Kalodimos CG, 2012, ANN NY ACAD SCI, V1260, P81, DOI 10.1111/j.1749-6632.2011.06319.x; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krishnan VV, 2000, BIOCHEMISTRY-US, V39, P9119, DOI 10.1021/bi000296l; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lucke C, 1996, STRUCTURE, V4, P785, DOI 10.1016/S0969-2126(96)00086-X; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Marszal E, 2006, ARCH BIOCHEM BIOPHYS, V453, P123, DOI 10.1016/j.abb.2006.03.006; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; Matos CA, 2011, PROG NEUROBIOL, V95, P26, DOI 10.1016/j.pneurobio.2011.06.007; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Paulson Henry, 2012, Handb Clin Neurol, V103, P437, DOI 10.1016/B978-0-444-51892-7.00027-9; Pelassa I, 2014, HUM MOL GENET, V23, P3402, DOI 10.1093/hmg/ddu049; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Qi XQ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2747; Raimondi S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-159; Ricagno S, 2009, BIOCHEM BIOPH RES CO, V380, P543, DOI 10.1016/j.bbrc.2009.01.116; Schipanski A, 2014, NEUROBIOL AGING, V35, P2394, DOI 10.1016/j.neurobiolaging.2014.04.002; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Su YC, 2014, J AM CHEM SOC, V136, P6313, DOI 10.1021/ja4126092; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; Trelle MB, 2014, ANGEW CHEM INT EDIT, V53, P9751, DOI 10.1002/anie.201402796; TYSOECALNON VA, 1991, BIOCHEM J, V277, P359, DOI 10.1042/bj2770359; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zheng WH, 2013, P NATL ACAD SCI USA, V110, P1680, DOI 10.1073/pnas.1222130110; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	108	72	72	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					884	891		10.1038/nchembio.1670	http://dx.doi.org/10.1038/nchembio.1670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25325699	Green Accepted			2022-12-25	WOS:000343621500008
J	Hockendorf, B; Lavis, LD; Keller, PJ				Hoeckendorf, Burkhard; Lavis, Luke D.; Keller, Philipp J.			Making biology transparent	NATURE BIOTECHNOLOGY			English	Editorial Material							RECONSTRUCTION; TISSUE; BRAIN		[Hoeckendorf, Burkhard; Lavis, Luke D.; Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Hockendorf, B (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	hoeckendorfb@janelia.hhmi.org; lavisl@janelia.hhmi.org; kellerp@janelia.hhmi.org		Lavis, Luke/0000-0002-0789-6343; Keller, Philipp/0000-0003-2896-4920				Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2012, CURR OPIN NEUROBIOL, V22, P138, DOI 10.1016/j.conb.2011.08.003; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Wang J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061209; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	12	4	4	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1104	1105		10.1038/nbt.3061	http://dx.doi.org/10.1038/nbt.3061			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380446				2022-12-25	WOS:000344977000014
J	Chen, YH; Lin, Y; Vithana, EN; Jia, LY; Zuo, XB; Wong, TY; Chen, LJ; Zhu, XJ; Tam, POS; Gong, B; Qian, SH; Li, Z; Liu, XQ; Mani, B; Luo, Q; Guzman, C; Leung, CKS; Li, XB; Cao, WJ; Yang, QY; Tham, CCY; Cheng, YL; Zhang, XJ; Wang, NL; Aung, T; Khor, CC; Pang, CP; Sun, XH; Yang, ZL				Chen, Yuhong; Lin, Ying; Vithana, Eranga N.; Jia, Liyun; Zuo, Xianbo; Wong, Tien Yin; Chen, Li Jia; Zhu, Xianjun; Tam, Pancy O. S.; Gong, Bo; Qian, Shaohong; Li, Zheng; Liu, Xiaoqi; Mani, Baskaran; Luo, Qian; Guzman, Celeste; Leung, Christopher K. S.; Li, Xiaobo; Cao, Wenjun; Yang, Quanyao; Tham, Clement C. Y.; Cheng, Yilian; Zhang, Xuejun; Wang, Ningli; Aung, Tin; Khor, Chiea Chuen; Pang, Chi Pui; Sun, Xinghuai; Yang, Zhenglin			Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES SUSCEPTIBILITY LOCI; DENSITY-LIPOPROTEIN DEFICIENCY; CORONARY-ARTERY-DISEASE; TANGIER-DISEASE; MUTATIONS; GENE; CHOLESTEROL; TRANSPORTER; POPULATION	We performed a genome-wide association study for primary open-angle glaucoma (POAG) in 1,007 cases with high-pressure glaucoma (HPG) and 1,009 controls from southern China. We observed genome-wide significant association at multiple SNPs near ABCA1 at 9q31.1 (rs2487032; P = 1.66 x 10(-8)) and suggestive evidence of association in PMM2 at 16p13.2 (rs3785176; P= 3.18 x 10(-6)). We replicated these findings in a set of 525 HPG cases and 912 controls from Singapore and a further set of 1,374 POAG cases and 4,053 controls from China. We observed genome-wide significant association with more than one SNP at the two loci (P = 2.79 x 10(-19) for rs2487032 representing ABCA1 and P = 5.77 x 10(-10) for rs3785176 representing PMM2). Both ABCA1 and PMM2 are expressed in the trabecular meshwork, optic nerve and other ocular tissues. In addition, ABCA1 is highly expressed in the ganglion cell layer of the retina, a finding consistent with it having a role in the development of glaucoma.	[Chen, Yuhong; Qian, Shaohong; Cao, Wenjun; Sun, Xinghuai] Fudan Univ, Eye & Ear Nose Throat ENT Hosp, Shanghai Med Sch, Dept Ophthalmol & Visual Sci, Shanghai 200433, Peoples R China; [Lin, Ying; Zhu, Xianjun; Gong, Bo; Liu, Xiaoqi; Li, Xiaobo; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Lin, Ying; Zhu, Xianjun; Gong, Bo; Liu, Xiaoqi; Li, Xiaobo; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu 610054, Peoples R China; [Lin, Ying; Zhu, Xianjun; Gong, Bo; Liu, Xiaoqi; Li, Xiaobo; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China; [Vithana, Eranga N.; Wong, Tien Yin; Li, Zheng; Mani, Baskaran; Guzman, Celeste; Aung, Tin; Khor, Chiea Chuen] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Vithana, Eranga N.; Wong, Tien Yin; Li, Zheng; Mani, Baskaran; Guzman, Celeste; Aung, Tin; Khor, Chiea Chuen] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Vithana, Eranga N.; Wong, Tien Yin; Li, Zheng; Mani, Baskaran; Guzman, Celeste; Aung, Tin; Khor, Chiea Chuen] Natl Univ Singapore, Singapore 117548, Singapore; [Jia, Liyun; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Zuo, Xianbo; Zhang, Xuejun] Anhui Med Univ, China Key Lab Dermatol, Minist Educ, Hefei, Peoples R China; [Chen, Li Jia; Tam, Pancy O. S.; Leung, Christopher K. S.; Tham, Clement C. Y.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Luo, Qian; Cheng, Yilian] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu, Peoples R China; [Luo, Qian; Cheng, Yilian] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Yang, Quanyao] West High Sch, Salt Lake City, UT USA; [Khor, Chiea Chuen] Human Genet Genome Inst Singapore, Singapore, Singapore; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Minist Hlth China, Myopia Key Lab, Shanghai, Peoples R China; [Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China	Fudan University; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Capital Medical University; Anhui Medical University; Chinese University of Hong Kong; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Fudan University; Chinese Academy of Sciences	Yang, ZL (corresponding author), Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China.	xhsun@shmu.edu.cn; zliny@yahoo.com	Leung, Chris/N-8015-2019; Tham, Chee Yung Clement/AAD-6528-2020; Chen, Li Jia/I-5078-2014; Wong, Tien Yin/AAC-9724-2020	Leung, Chris/0000-0003-4862-777X; Tham, Chee Yung Clement/0000-0003-4407-6907; Chen, Li Jia/0000-0003-3500-5840; Wong, Tien Yin/0000-0002-8448-1264; Li, Zheng/0000-0002-7060-2213; Khor, Chiea Chuen/0000-0002-1128-4729; Cao, Wenjun/0000-0001-6383-9012; Zhu, Xianjun/0000-0002-2531-7552	National Natural Science Foundation of China [81025006, 81170883, 81430008, 81200723, 81271007, 81271005]; National Basic Research Program of China (973 Program) [2011CB504604]; Department of Science and Technology of Sichuan Province, China [2014SZ0169, 2012SZ0219, 2011jtd0020]; Special Scientific Research Project of Health Professions [201302015]; General Research Fund, Hong Kong [467708, 468810]; National Medical Research Council, Singapore [NMRC/TCR/002-SERI/2008 (R626/47/2008TCR), CSA R613/34/2008, NMRC 0796/2003, STaR/0003/2008]; National Research Foundation of Singapore, Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550, 10/1/35/19/675]; Genome Institute of Singapore [GIS/12-AR2105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Department of Science and Technology of Sichuan Province, China; Special Scientific Research Project of Health Professions; General Research Fund, Hong Kong; National Medical Research Council, Singapore(National Medical Research Council, Singapore); National Research Foundation of Singapore, Biomedical Research Council, Singapore(National Research Foundation, Singapore); Genome Institute of Singapore	We thank all the individuals with POAG and their families for participating in this study. The samples from Fudan University used for the analyses described in this manuscript were obtained from the EENT Hospital Biobank. We also thank B. Zhao and J. Sang of Beijing Tongren Hospital for sample collection. This research project was supported by the National Natural Science Foundation of China (81025006 (Z.Y.), 81170883 (Z.Y.), 81430008 (Z.Y.), 81200723 (Y. Chen), 81271007 (X. Zhu) and 81271005 (NW)); the National Basic Research Program of China (973 Program, 2011CB504604 to Z.Y.); the Department of Science and Technology of Sichuan Province, China (2014SZ0169 (Z.Y.), 2012SZ0219 (Z.Y.) and 2011jtd0020 (Z.Y.)); the Special Scientific Research Project of Health Professions (201302015 (X.S.)); research grants 467708 (C.P.P. and C.C.Y.T.) and 468810 (C.P.P. and C.K.S.L.) from the General Research Fund, Hong Kong; the National Medical Research Council, Singapore (NMRC/TCR/002-SERI/2008 (R626/47/2008TCR(T.A.)), CSA R613/34/2008 (T.A.), NMRC 0796/2003 (T.Y.W.) and STaR/0003/2008 (T.Y.W.)); the National Research Foundation of Singapore, Biomedical Research Council, Singapore (BMRC 09/1/35/19/616 (T.Y.W.), 08/1/35/19/550 (T.A.) and 10/1/35/19/675 (E.N.V. and C.C.K.)); and the Genome Institute of Singapore (GIS/12-AR2105 (C.C.K.)).	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; CHEUNG MC, 1993, J CLIN INVEST, V91, P522, DOI 10.1172/JCI116231; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Footz TK, 2009, HUM MOL GENET, V18, P1276, DOI 10.1093/hmg/ddp027; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Jensen Hanne, 2003, Ophthalmic Genet, V24, P81, DOI 10.1076/opge.24.2.81.13994; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kielar D, 2001, CLIN CHEM, V47, P2089; Lettre G., 2011, PLOS GENET, V7; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Oram JF, 2001, J LIPID RES, V42, P1173; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; PRESSLY TA, 1987, AM J MED, V83, P991, DOI 10.1016/0002-9343(87)90667-X; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thompson DA, 2012, ARCH OPHTHALMOL-CHIC, V130, P712, DOI 10.1001/archophthalmol.2012.130; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yeghiazaryan K, 2005, AMINO ACIDS, V28, P207, DOI 10.1007/s00726-005-0170-4	37	120	129	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1115	1119		10.1038/ng.3078	http://dx.doi.org/10.1038/ng.3078			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25173107				2022-12-25	WOS:000342554100015
J	Boztug, K; Jarvinen, PM; Salzer, E; Racek, T; Monch, S; Garncarz, W; Gertz, EM; Schaffer, AA; Antonopoulos, A; Haslam, SM; Schieck, L; Puchalka, J; Diestelhorst, J; Appaswamy, G; Lescoeur, B; Giambruno, R; Bigenzahn, JW; Elling, U; Pfeifer, D; Conde, CD; Albert, MH; Welte, K; Brandes, G; Sherkat, R; ten Bosch, JV; Rezaei, N; Etzioni, A; Bellanne-Chantelot, C; Superti-Furga, G; Penninger, JM; Bennett, KL; von Blume, J; Dell, A; Donadieu, J; Klein, C				Boztug, Kaan; Jaervinen, Paeivi M.; Salzer, Elisabeth; Racek, Tomas; Moench, Sebastian; Garncarz, Wojciech; Gertz, E. Michael; Schaeffer, Alejandro A.; Antonopoulos, Aristotelis; Haslam, Stuart M.; Schieck, Lena; Puchalka, Jacek; Diestelhorst, Jana; Appaswamy, Giridharan; Lescoeur, Brigitte; Giambruno, Roberto; Bigenzahn, Johannes W.; Elling, Ulrich; Pfeifer, Dietmar; Conde, Cecilia Dominguez; Albert, Michael H.; Welte, Karl; Brandes, Gudrun; Sherkat, Roya; ten Bosch, Jutte van der Werff; Rezaei, Nima; Etzioni, Amos; Bellanne-Chantelot, Christine; Superti-Furga, Giulio; Penninger, Josef M.; Bennett, Keiryn L.; von Blume, Julia; Dell, Anne; Donadieu, Jean; Klein, Christoph			JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia	NATURE GENETICS			English	Article							STIMULATING FACTOR-RECEPTOR; UNFOLDED PROTEIN RESPONSE; HERMANSKY-PUDLAK-SYNDROME; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; ELANE MUTATIONS; SEQUENCING DATA; COHEN-SYNDROME; GENE; ELASTASE	The analysis of individuals with severe congenital neutropenia (SCN) may shed light on the delicate balance of factors controlling the differentiation, maintenance and decay of neutrophils. We identify 9 distinct homozygous mutations in the JAGN1 gene encoding Jagunal homolog 1 in 14 individuals with SCN. JAGN1-mutant granulocytes are characterized by ultrastructural defects, a paucity of granules, aberrant N-glycosylation of multiple proteins and increased incidence of apoptosis. JAGN1 participates in the secretory pathway and is required for granulocyte colony-stimulating factor receptor-mediated signaling. JAGN1 emerges as a factor that is necessary in the differentiation and survival of neutrophils.	[Boztug, Kaan; Salzer, Elisabeth; Garncarz, Wojciech; Giambruno, Roberto; Bigenzahn, Johannes W.; Conde, Cecilia Dominguez; Superti-Furga, Giulio; Bennett, Keiryn L.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Jaervinen, Paeivi M.; Racek, Tomas; Moench, Sebastian; Puchalka, Jacek; Diestelhorst, Jana; Albert, Michael H.; Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Gertz, E. Michael; Schaeffer, Alejandro A.] US Natl Inst Hlth, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD USA; [Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Schieck, Lena; Diestelhorst, Jana; Appaswamy, Giridharan; Welte, Karl] Hannover Med Sch, Dept Pediat Hematol Oncol, Hannover, Germany; [Lescoeur, Brigitte] Hosp R Debre, Dept Hematol, Paris, France; [Elling, Ulrich] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Brandes, Gudrun] Hannover Med Sch, Dept Cell Biol, Hannover, Germany; [Sherkat, Roya] Isfahan Univ Med Sci, Acquired Immunodeficiency Res Ctr, Esfahan, Iran; [Conde, Cecilia Dominguez] Hosp Free Univ Brussels, Dept Pediat, Brussels, Belgium; [Rezaei, Nima] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran, Iran; [Etzioni, Amos] Technion Israel Inst Technol, Rappaport Sch Med, Div Pediat & Immunol, Haifa, Israel; [Bellanne-Chantelot, Christine] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [von Blume, Julia] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Donadieu, Jean] Armand Trousseau Childrens Hosp, AP HP, Reference Ctr Hereditary Immunodeficiencies, Neutropenia Registry, Paris, France	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Munich; National Institutes of Health (NIH) - USA; Imperial College London; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Freiburg; Hannover Medical School; Isfahan University Medical Science; Tehran University of Medical Sciences; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Klein, C (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany.	christoph.klein@med.uni-muenchen.de	Superti-Furga, Giulio/F-4755-2015; Boztug, Kaan/AAM-4161-2021; Rezaei, Nima/B-4245-2008; Penninger, Josef M/I-6860-2013; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Superti-Furga, Giulio/AAE-5681-2019; Giambruno, Roberto/W-4868-2017; von Blume, Julia/H-2120-2013; Giambruno, Roberto/AAI-6717-2021; Salzer, Elisabeth/G-8066-2017; Dominguez Conde, Cecilia/U-4890-2017	Superti-Furga, Giulio/0000-0002-0570-1768; Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Penninger, Josef M/0000-0002-8194-3777; Giambruno, Roberto/0000-0002-4566-261X; von Blume, Julia/0000-0001-6665-1592; Giambruno, Roberto/0000-0002-4566-261X; sherkat, Roya/0000-0001-6745-8161; Bennett, Keiryn L./0000-0001-9356-7708; Salzer, Elisabeth/0000-0002-8118-4934; Dominguez Conde, Cecilia/0000-0002-8684-4655; Dell, Anne/0000-0003-1380-2347; Bigenzahn, Johannes/0000-0002-5214-4570	CeMM; FWF (Austrian Science Fund) START Programme; European Research Council; European Program on Rare Diseases (E-RARE Neutro-Net); German Research Foundation (Gottfried-Wilhelm-Leibniz Program) [SFB914]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F0083091, BB/K016164/1]; Amgen; Chugai; Fondation Maladies Rares; Institut de Veille Sanitaire; INSERM; Association Sportive de Saint Quentin Fallavier; CEREDIH (Reference Center for Hereditary Immunodeficiencies); Societe d'Hemato-Immunologie Pediatrique; US National Institutes of Health; National Library of Medicine; DZIF (German Center for Infection Research); Care-for-Rare Foundation; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 595] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI	CeMM; FWF (Austrian Science Fund) START Programme(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); European Program on Rare Diseases (E-RARE Neutro-Net); German Research Foundation (Gottfried-Wilhelm-Leibniz Program)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Amgen(Amgen); Chugai; Fondation Maladies Rares; Institut de Veille Sanitaire; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Sportive de Saint Quentin Fallavier; CEREDIH (Reference Center for Hereditary Immunodeficiencies); Societe d'Hemato-Immunologie Pediatrique; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); DZIF (German Center for Infection Research); Care-for-Rare Foundation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the patients and their families for their participation in this study. The help of all contributing medical, technical and administrative staff is greatly appreciated. The authors thank J. Colinge for bioinformatics analysis of the mass spectrometry data. The authors thank G. Leverger, H. Ducou Lepointe, J. Levin, the association IRIS (Immunodeficience Primitive, Recherche, Information, Soutien) and V. Grosjean for their support. This study was supported by CeMM intramural funds and the FWF (Austrian Science Fund) START Programme (to K.B.) and by grants from the European Research Council (Advanced Grants to C.K. and J.P.; Starting Grant to K.B.), the European Program on Rare Diseases (E-RARE Neutro-Net) and the German Research Foundation (SFB914 and Gottfried-Wilhelm-Leibniz Program). The work at Imperial College was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; grants BB/F0083091 and BB/K016164/1). The French SCN registry is supported by grants from Amgen, Chugai, Fondation Maladies Rares, the Institut de Veille Sanitaire, INSERM, the Association Sportive de Saint Quentin Fallavier, CEREDIH (Reference Center for Hereditary Immunodeficiencies) and the Societe d'Hemato-Immunologie Pediatrique. This research is supported in part by the Intramural Research Program of the US National Institutes of Health, the National Library of Medicine, the DZIF (German Center for Infection Research) and the Care-for-Rare Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Boztug K, 2012, J PEDIATR-US, V160, P679, DOI 10.1016/j.jpeds.2011.09.019; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Bryant NJ, 2003, J CELL BIOL, V161, P691, DOI 10.1083/jcb.200212078; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DALE DC, 1993, BLOOD, V81, P2496; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Girish V, 2004, Indian J Cancer, V41, P47; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Horwitz MS, 2013, HEMATOL ONCOL CLIN N, V27, P19, DOI 10.1016/j.hoc.2012.10.004; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jun HS, 2010, BLOOD, V116, P2783, DOI 10.1182/blood-2009-12-258491; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LI JM, 1994, BIOCHEM BIOPH RES CO, V205, P238, DOI 10.1006/bbrc.1994.2655; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Pfeifer D, 2007, IMMUNOGENETICS, V59, P913, DOI 10.1007/s00251-007-0257-z; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Rudashevskaya EL, 2013, NAT PROTOC, V8, P75, DOI 10.1038/nprot.2012.133; Salzer E, 2013, HAEMATOLOGICA, V98, P473, DOI 10.3324/haematol.2012.068791; Seifert W, 2011, J BIOL CHEM, V286, P37665, DOI 10.1074/jbc.M111.267971; Stepensky P, 2013, BLOOD, V121, P5078, DOI 10.1182/blood-2012-12-475566; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070	51	79	83	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1021	+		10.1038/ng.3069	http://dx.doi.org/10.1038/ng.3069			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129144	Green Accepted			2022-12-25	WOS:000341579400019
J	Oh, P; Testa, JE; Borgstrom, P; Witkiewiczla, H; Li, Y; Schnitzer, JE				Oh, Phil; Testa, Jacqueline E.; Borgstrom, Per; Witkiewiczla, Halina; Li, Yan; Schnitzer, Jan E.			In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors	NATURE MEDICINE			English	Article							ENDOTHELIUM; GENE; EXPRESSION; MEMBRANES; FISSION; SURFACE; GROWTH; LUNG; DRUG	Technologies are needed to map and image biological barriers in vivo that limit solid tumor delivery and, ultimately, the effectiveness of imaging and therapeutic agents. Here we integrate proteomic and imaging analyses of caveolae at the blood-tumor interface to discover an active transendothelial portal to infiltrate tumors. A post-translationally modified form of annexin A1 (AnnA1) is selectively concentrated in human and rodent tumor caveolae. To follow trafficking, we generated a specific AnnA1 antibody that targets caveolae in the tumor endothelium. Intravital microscopy of caveolae-immunotargeted fluorophores even at low intravenous doses showed rapid and robust pumping across the endothelium to enter mammary, prostate and lung tumors. Within 1 h, the fluorescence signal concentrated throughout tumors to exceed the peak levels in blood. This transvascular pumping required the expression of caveolin 1 and annexin A1. Tumor uptake with other antibodies were >100-fold less. This proteomic imaging strategy reveals a unique target, antibody and caveolae pumping system for solid tumor penetration.	[Oh, Phil; Testa, Jacqueline E.; Witkiewiczla, Halina; Li, Yan; Schnitzer, Jan E.] Proteogen Res Inst Syst Med, San Diego, CA USA; [Oh, Phil; Testa, Jacqueline E.; Borgstrom, Per; Witkiewiczla, Halina; Li, Yan; Schnitzer, Jan E.] Sidney Kimmel Canc Ctr, San Diego, CA USA		Schnitzer, JE (corresponding author), Proteogen Res Inst Syst Med, San Diego, CA USA.	jschnitzer@prism-sd.org			Komen Foundation; US Department of Defense [W81XWH-11-1-0693]; state of California [18XT0196, 16IB-0104]; US National Institutes of Health [R01CA115215, P01CA104898, R01CA119378, R01CA83989]; NATIONAL CANCER INSTITUTE [P01CA104898, R01CA119378, R01CA115215, R01CA083989] Funding Source: NIH RePORTER	Komen Foundation(Susan G. Komen Breast Cancer Foundation); US Department of Defense(United States Department of Defense); state of California; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R.D. Winger for performing small animal surgeries and R. Baldwin for assistance with gold labeling experiments. We also thank R.J. Flower (Queen Mary University of London), M. Huflejt (New York University), J. Lustgarten (Mayo Clinic), D. Sanger (Beth Israel Deaconess Medical Center) and R. Tsien (University of California San Diego) for their kind gifts. This research was supported in part by the Komen Foundation, the US Department of Defense (Prostate Cancer Research Program Award number W81XWH-11-1-0693), the state of California (Tobacco-Related Disease Research Program grant 18XT0196 and California Breast Cancer Research Program grant 16IB-0104) and the US National Institutes of Health (R01CA115215, P01CA104898, R01CA119378 and R01CA83989).	ABELL RG, 1946, AM J PHYSIOL, V147, P237, DOI 10.1152/ajplegacy.1946.147.2.237; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Borgstrom Per, 2013, F1000Res, V2, P129, DOI 10.12688/f1000research.2-129.v2; Carver L.A., 2007, ENDOTHELIAL BIOMEDIC, p[664, 881]; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77; DVORAK HF, 1988, AM J PATHOL, V133, P95; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; HAIGLER HT, 1987, J BIOL CHEM, V262, P6921; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; Huber LA, 2003, NAT REV MOL CELL BIO, V4, P74, DOI 10.1038/nrm1007; Jain RK, 1998, NAT MED, V4, P655, DOI 10.1038/nm0698-655; Li Y, 2009, MOL CELL PROTEOMICS, V8, P1219, DOI 10.1074/mcp.M800215-MCP200; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; Nie SM, 2007, ANNU REV BIOMED ENG, V9, P257, DOI 10.1146/annurev.bioeng.9.060906.152025; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P., 2006, CELL BIOL LAB HDB, P11; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Schnitzer JE, 1998, NEW ENGL J MED, V339, P472, DOI 10.1056/NEJM199808133390711; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; SCHNITZER JE, 1988, AM J PHYSIOL, V254, pH425, DOI 10.1152/ajpheart.1988.254.3.H425; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Testa JE, 2009, AM J PHYSIOL-LUNG C, V297, pL251, DOI 10.1152/ajplung.90565.2008; Valadon P, 2010, J BIOL CHEM, V285, P713, DOI 10.1074/jbc.M109.061838; WANG W, 1994, BIOCHEMISTRY-US, V33, P275, DOI 10.1021/bi00167a036; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106	40	59	59	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1062	1068		10.1038/nm.3623	http://dx.doi.org/10.1038/nm.3623			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25129480				2022-12-25	WOS:000341404000020
J	Sendoel, A; Maida, S; Zheng, X; Teo, Y; Stergiou, L; Rossi, CA; Subasic, D; Pinto, SM; Kinchen, JM; Shi, M; Boettcher, S; Meyer, JN; Manz, MG; Bano, D; Hengartner, MO				Sendoel, Ataman; Maida, Simona; Zheng, Xue; Teo, Youjin; Stergiou, Lilli; Rossi, Carlo-Alberto; Subasic, Deni; Pinto, Sergio M.; Kinchen, Jason M.; Shi, Moyin; Boettcher, Steffen; Meyer, Joel N.; Manz, Markus G.; Bano, Daniele; Hengartner, Michael O.			DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; N-TERMINAL KINASE; DEP DOMAINS; ELEGANS; LET-99; POLARITY; UBIQUITYLATION; LOCALIZATION; VINCRISTINE; ASYMMETRY	Microtubule-targeting chemotherapeutics induce apoptosis in cancer cells by promoting the phosphorylation and degradation of the anti-apoptotic BCL-2 family member MCL1. The signalling cascade linking microtubule disruption to MCL1 degradation remains however to be defined. Here, we establish an in vivo screening strategy in Caenorhabditis elegans to uncover genes involved in chemotherapy-induced apoptosis. Using an RNAi-based screen, we identify three genes required for vincristine-induced apoptosis. We show that the DEP domain protein LET-99 acts upstream of the heterotrimeric G protein alpha subunit GPA-11 to control activation of the stress kinase JNK-1. The human homologue of LET-99, DEPDC1, similarly regulates vincristine-induced cell death by promoting JNK-dependent degradation of the BCL-2 family protein MCL1. Collectively, these data uncover an evolutionarily conserved mediator of anti-tubulin drug-induced apoptosis and suggest that DEPDC1 levels could be an additional determinant for therapy response upstream of MCL1.	[Sendoel, Ataman; Zheng, Xue; Teo, Youjin; Stergiou, Lilli; Subasic, Deni; Pinto, Sergio M.; Shi, Moyin; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Sendoel, Ataman; Boettcher, Steffen; Manz, Markus G.] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Maida, Simona; Rossi, Carlo-Alberto; Bano, Daniele] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Kinchen, Jason M.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Sendoel, Ataman; Stergiou, Lilli] Redbiotec, CH-8952 Schlieren, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Virginia; Duke University	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Bano, Daniele/AAZ-9371-2020; Kinchen, Jason/ABC-5663-2021; Meyer, Joel/G-9836-2017	Boettcher, Steffen/0000-0001-9937-0957; Sendoel, Ataman/0000-0002-0381-9965; Kinchen, Jason/0000-0001-8430-2265; Hengartner, Michael/0000-0002-7584-596X; Manz, Markus/0000-0002-4676-7931; Meyer, Joel/0000-0003-1219-0983	Swiss National Science Foundation, the Kanton of Zurich; Josef-Steiner Foundation; NIH National Center for Research Resources (NCRR)	Swiss National Science Foundation, the Kanton of Zurich(Swiss National Science Foundation (SNSF)); Josef-Steiner Foundation; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Hengartner and Bano laboratory members for help and discussions. We thank L. Rose for the LET-99 antibody. We are grateful to L. Rose and M. Gotta for critical reading of the manuscript. This work was supported by the Swiss National Science Foundation, the Kanton of Zurich and the Josef-Steiner Foundation. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Consonni SV, 2014, NAT REV MOL CELL BIO, V15, P357, DOI 10.1038/nrm3791; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Horvitz HR, 1999, CANCER RES, V59, p1701S; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1992, J CELL SCI, V102, P401; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krueger LE, 2010, J CELL BIOL, V189, P481, DOI 10.1083/jcb.201001115; Lant B, 2013, METHODS, V61, P174, DOI 10.1016/j.ymeth.2013.04.022; Pazdernik N, 2013, ADV EXP MED BIOL, V757, P1, DOI 10.1007/978-1-4614-4015-4_1; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Praitis V, 2001, GENETICS, V157, P1217; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rocheleau CE, 2008, GENETICS, V178, P1431, DOI 10.1534/genetics.107.084608; Rose LS, 1998, DEVELOPMENT, V125, P1337; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; Vilpo JA, 2000, EUR J HAEMATOL, V65, P370, DOI 10.1034/j.1600-0609.2000.065006370.x; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wu JC, 2007, MOL BIOL CELL, V18, P4470, DOI 10.1091/mbc.E07-02-0105; Zhu BK, 2008, ANTI-CANCER DRUG, V19, P189, DOI 10.1097/CAD.0b013e3282f3138a	39	35	36	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					812	U331		10.1038/ncb3010	http://dx.doi.org/10.1038/ncb3010			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	25064737				2022-12-25	WOS:000339904900013
J	Dey, B; Dey, RJ; Cheung, LS; Pokkali, S; Guo, HD; Lee, JH; Bishai, WR				Dey, Bappaditya; Dey, Ruchi Jain; Cheung, Laurene S.; Pokkali, Supriya; Guo, Haidan; Lee, Jong-Hee; Bishai, William R.			A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis	NATURE MEDICINE			English	Article							C-DI-AMP; I INTERFERON RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; HOST-CELL; DNA; AUTOPHAGY; GMP; MACROPHAGES; INFECTION	Detection of cyclic-di-adenosine monophosphate (c-di-AMP), a bacterial second messenger, by the host cytoplasmic surveillance pathway (CSP) is known to elicit type I interferon (IFN) responses, which are crucial to antimicrobial defense(1-3). However, the mechanisms and role of c-di-AMP signaling in Mycobacterium tuberculosis virulence remain unclear. Here we show that resistance to tuberculosis requires CSP-mediated detection of c-di-AMP produced by M. tuberculosis and that levels of c-di-AMP modulate the fate of infection. We found that a di-adenylate cyclase (disA or dacA)(4)-overexpressing M. tuberculosis strain that secretes excess c-di-AMP activates the interferon regulatory factor (IRF) pathway with enhanced levels of IFN-beta, elicits increased macrophage autophagy, and exhibits substantial virulence attenuation in mice. We show that c-di-AMP-mediated IFN-beta induction during M. tuberculosis infection requires stimulator of interferon genes (STING) 5-signaling. We observed that c-di-AMP induction of IFN-beta is independent of the cytosolic nucleic acid receptor cyclic GMP-AMP (cGAMP) synthase (cGAS)(6,7), but cGAS nevertheless contributes substantially to the overall IFN-b response to M. tuberculosis infection. In sum, our results reveal c-di-AMP to be a key mycobacterial pathogen-associated molecular pattern (PAMP) driving host type I IFN responses and autophagy. These findings suggest that modulating the levels of this small molecule may lead to novel immunotherapeutic strategies against tuberculosis.	[Dey, Bappaditya; Dey, Ruchi Jain; Cheung, Laurene S.; Pokkali, Supriya; Guo, Haidan; Lee, Jong-Hee; Bishai, William R.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD 21205 USA; [Dey, Bappaditya; Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Pokkali, Supriya] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Bishai, WR (corresponding author), Johns Hopkins Univ, Ctr TB Res, Baltimore, MD 21205 USA.	wbishai@jhmi.edu	Dey, Bappaditya/H-1831-2018; Pokkali, Supriya/T-2825-2017; Lee, JongHee/AAH-4129-2019	Dey, Bappaditya/0000-0003-2728-4683; Pokkali, Supriya/0000-0002-6209-1679; Lee, JongHee/0000-0001-9938-1306	US National Institute of Allergy and Infectious Diseases [AI037856, AI097138, AI036973]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036973, R01AI037856, R01AI097138, R01AI036973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The support of grants AI037856, AI097138 and AI036973 from the US National Institute of Allergy and Infectious Diseases and the Howard Hughes Medical Institute to W.R.B. is gratefully acknowledged. We thank MicFac facility members at Johns Hopkins Medical Institutions (JHMI) for helping with the fluorescence and confocal microscopy. We thank H.W. Virgin IV and D. MacDuff (Washington University School of Medicine in St. Louis), for generously providing bone marrow cells from cGAS-KO mice. We thank L.H. Moulton (Bloomberg School of Public Health, Johns Hopkins University) for generous assistance with the statistical analysis. We thank A. Tyagi (University of Delhi South Campus, New Delhi) and W. Jacobs, Jr. (Albert Einstein College of Medicine, New York) for mycobacterial cloning vectors.	Abdul-Sater AA, 2012, MICROBES INFECT, V14, P188, DOI 10.1016/j.micinf.2011.09.002; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bai Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Kuchtey J, 2005, J IMMUNOL, V175, P2244, DOI 10.4049/jimmunol.175.4.2244; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schwartz KT, 2012, INFECT IMMUN, V80, P1537, DOI 10.1128/IAI.06286-11; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095728; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thornley TB, 2007, J IMMUNOL, V179, P6620, DOI 10.4049/jimmunol.179.10.6620; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	168	174	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2015	21	4					401	+		10.1038/nm.3813	http://dx.doi.org/10.1038/nm.3813			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CF4BO	25730264	Green Accepted			2022-12-25	WOS:000352493600023
J	Isella, C; Terrasi, A; Bellomo, SE; Petti, C; Galatola, G; Muratore, A; Mellano, A; Senetta, R; Cassenti, A; Sonetto, C; Inghirami, G; Trusolino, L; Fekete, Z; De Ridder, M; Cassoni, P; Storme, G; Bertotti, A; Medico, E				Isella, Claudio; Terrasi, Andrea; Bellomo, Sara Erika; Petti, Consalvo; Galatola, Giovanni; Muratore, Andrea; Mellano, Alfredo; Senetta, Rebecca; Cassenti, Adele; Sonetto, Cristina; Inghirami, Giorgio; Trusolino, Livio; Fekete, Zsolt; De Ridder, Mark; Cassoni, Paola; Storme, Guy; Bertotti, Andrea; Medico, Enzo			Stromal contribution to the colorectal cancer transcriptome	NATURE GENETICS			English	Article							FIBROBLAST ACTIVATION PROTEIN; GENE-EXPRESSION; TUMOR XENOGRAFTS; POOR-PROGNOSIS; RECTAL-CANCER; HUMAN COLON; STEM-CELLS; RESISTANCE; HETEROGENEITY; RECURRENCE	Recent studies identified a poor-prognosis stem/serrated/mesenchymal (SSM) transcriptional subtype of colorectal cancer (CRC). We noted that genes upregulated in this subtype are also prominently expressed by stromal cells, suggesting that SSM transcripts could derive from stromal rather than epithelial cancer cells. To test this hypothesis, we analyzed CRC expression data from patient-derived xenografts, where mouse stroma supports human cancer cells. Species-specific expression analysis showed that the mRNA levels of SSM genes were mostly due to stromal expression. Transcriptional signatures built to specifically report the abundance of cancer-associated fibroblasts (CAFs), leukocytes or endothelial cells all had significantly higher expression in human CRC samples of the SSM subtype. High expression of the CAF signature was associated with poor prognosis in untreated CRC, and joint high expression of the stromal signatures predicted resistance to radiotherapy in rectal cancer. These data show that the distinctive transcriptional and clinical features of the SSM subtype can be ascribed to its particularly abundant stromal component.	[Isella, Claudio; Bellomo, Sara Erika; Petti, Consalvo; Galatola, Giovanni; Muratore, Andrea; Mellano, Alfredo; Trusolino, Livio; Bertotti, Andrea; Medico, Enzo] Fdn Piemontese Oncol, Ist Ricovero & Cura Carattere Sci FRO IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Isella, Claudio; Terrasi, Andrea; Bellomo, Sara Erika; Trusolino, Livio; Bertotti, Andrea; Medico, Enzo] Univ Turin, Dept Oncol, Candiolo, Italy; [Senetta, Rebecca; Cassenti, Adele] Univ Turin, Dept Med Sci, Turin, Italy; [Sonetto, Cristina] Univ Turin, Dept Oncol, Orbassano, Italy; [Inghirami, Giorgio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Expt Res & Med Studies, Turin, Italy; [Fekete, Zsolt] Inst Oncol Prof Dr Ion Chiricuta, Cluj Napoca, Romania; [De Ridder, Mark; Storme, Guy] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Radiotherapy, Brussels, Belgium	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Turin; University of Turin; Oncology Institute Prof. Dr. Ion Chiricuta; University Hospital Brussels; Vrije Universiteit Brussel	Medico, E (corresponding author), Fdn Piemontese Oncol, Ist Ricovero & Cura Carattere Sci FRO IRCCS, Candiolo Canc Inst, Candiolo, Italy.	claudio.isella@ircc.it; enzo.medico@ircc.it	Fekete, Zsolt/F-2489-2015; Cassoni, Paola/I-8544-2018; Isella, Claudio/F-7327-2012; bellomo, sara erika/AAC-1862-2022; Medico, Enzo/AAC-3185-2021; Terrasi, Andrea/J-1102-2018; De Ridder, Mark/F-4794-2013; Petti, Consalvo/K-9367-2016	Fekete, Zsolt/0000-0003-3386-8263; Isella, Claudio/0000-0003-0679-4756; bellomo, sara erika/0000-0001-5738-2351; Medico, Enzo/0000-0002-3917-2438; Terrasi, Andrea/0000-0003-4955-3346; De Ridder, Mark/0000-0003-4433-8807; Petti, Consalvo/0000-0002-3509-3142; Mellano, Alfredo/0000-0002-9090-5123; Trusolino, Livio/0000-0002-6379-3365	Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5x1000) [IG12944, IG14205, 9970-2010]; Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute); Compagnia di San Paolo/Ateneo (project 'Rethe')	Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5x1000)(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute); Compagnia di San Paolo/Ateneo (project 'Rethe')(Compagnia di San Paolo)	We thank E. Trisolini, R. Porporato, D. Cantarella, B. Martinoglio, F. Sassi and S. Destefanis for technical assistance. E.M., A.B. and L.T. are members of the EurOPDX Consortium. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (IG12944 and IG14205; 9970-2010 Special Program Molecular Clinical Oncology 5x1000), Fondazione Piemontese per la Ricerca sul Cancro (5x1000 Ministero della Salute 2010 and 2011) and Compagnia di San Paolo/Ateneo (project 'Rethe').	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chargari C, 2013, DRUG RESIST UPDATE, V16, P10, DOI 10.1016/j.drup.2013.01.001; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079874; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutman DA, 2013, J AM MED INFORM ASSN, V20, P1091, DOI 10.1136/amiajnl-2012-001469; Hollingshead MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-393; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isella C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-382; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martelli ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-254; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Oh SC, 2012, GUT, V61, P1291, DOI 10.1136/gutjnl-2011-300812; Pai RK, 2011, AM J SURG PATHOL, V35, P1373, DOI 10.1097/PAS.0b013e318224d9df; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Saigusa S, 2011, INT J ONCOL, V38, P655, DOI 10.3892/ijo.2011.906; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Schneider S, 2006, PHARMACOGENET GENOM, V16, P555, DOI 10.1097/01.fpc.0000220563.44724.6d; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Suarez J, 2008, COLORECTAL DIS, V10, P563, DOI 10.1111/j.1463-1318.2007.01424.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	57	403	420	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					312	U49		10.1038/ng.3224	http://dx.doi.org/10.1038/ng.3224			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25706627	Green Submitted			2022-12-25	WOS:000351922900005
J	Staleva, H; Komenda, J; Shukla, MK; Slouf, V; Kana, R; Polivka, T; Sobotka, R				Staleva, Hristina; Komenda, Josef; Shukla, Mahendra K.; Slouf, Vclav; Kana, Radek; Polivka, Tomas; Sobotka, Roman			Mechanism of photoprotection in the cyanobacterial ancestor of plant antenna proteins	NATURE CHEMICAL BIOLOGY			English	Article							LIGHT-HARVESTING COMPLEX; CAB-LIKE PROTEINS; SYNECHOCYSTIS-SP PCC-6803; PHOTOSYSTEM-II; ENERGY-DISSIPATION; CATION FORMATION; CHLOROPHYLL; CAROTENOIDS; BIOSYNTHESIS; FLUORESCENCE	Plants collect light for photosynthesis using light-harvesting complexes (LHCs)-an array of chlorophyll proteins that are able to reversibly switch from harvesting to energy-dissipation mode to prevent damage of the photosynthetic apparatus. LHC antennae as well as other members of the LHC superfamily evolved from cyanobacterial ancestors called high light-inducible proteins (Hlips). Here, we characterized a purified Hlip family member HliD isolated from the cyanobacterium Synechocystis sp. PCC 6803. We found that the HliD binds chlorophyll-a (Chl-a) and beta-carotene and exhibits an energy-dissipative conformation. Using femtosecond spectroscopy, we demonstrated that the energy dissipation is achieved via direct energy transfer from a Chl-a Q(y) state to the beta-carotene S-1 state. We did not detect any cation of beta-carotene that would accompany Chl-a quenching. These results provide proof of principle that this quenching mechanism operates in the LHC superfamily and also shed light on the photoprotective role of Hlips and the evolution of LHC antennae.	[Staleva, Hristina; Komenda, Josef; Shukla, Mahendra K.; Slouf, Vclav; Kana, Radek; Polivka, Tomas; Sobotka, Roman] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Komenda, Josef; Shukla, Mahendra K.; Kana, Radek; Sobotka, Roman] Acad Sci Czech Republic, Inst Microbiol, Trebon, Czech Republic; [Polivka, Tomas] Acad Sci Czech Republic, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Sobotka, R (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	sobotka@alga.cz	Sobotka, Roman/J-3077-2014; Shukla, Mahendra Kumar/J-5994-2014; Komenda, Josef/H-4083-2014; Kaňa, Radek/A-6434-2009; Polivka, Tomas/G-9564-2014	Sobotka, Roman/0000-0001-5909-3879; Shukla, Mahendra Kumar/0000-0002-6858-1441; Komenda, Josef/0000-0003-4588-0382; Kaňa, Radek/0000-0001-5768-6902; Polivka, Tomas/0000-0002-6176-0420	Czech Science Foundation [P501/12/G055, 14-13967S]; project Algatech;  [CZ.1.07/2.3.00/30.0049]	Czech Science Foundation(Grant Agency of the Czech Republic); project Algatech; 	The authors thank M. Durchan and J. Tichy for their help with fluorescence measurements. J.K., T.P., V.S.. and R.S. were supported by the project P501/12/G055 from the Czech Science Foundation and by project Algatech. M.K.S. was supported by the project 14-13967S from the Czech Science Foundation and H.S. by the project CZ.1.07/2.3.00/30.0049.	Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Berera R, 2010, CHEM PHYS, V373, P65, DOI 10.1016/j.chemphys.2010.01.011; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Boehm M, 2011, J BIOL CHEM, V286, P14812, DOI 10.1074/jbc.M110.207944; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Eijckelhoff C, 1997, PHOTOSYNTH RES, V52, P69, DOI 10.1023/A:1005834006985; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Fuciman M, 2012, J PHYS CHEM B, V116, P3834, DOI 10.1021/jp210042z; Gradinaru CC, 2001, P NATL ACAD SCI USA, V98, P2364, DOI 10.1073/pnas.051501298; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Jeevarajan JA, 1996, J PHYS CHEM-US, V100, P5637, DOI 10.1021/jp9530663; Kana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029700; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Kosumi D, 2010, CHEM PHYS, V373, P33, DOI 10.1016/j.chemphys.2009.12.013; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kruger TPJ, 2011, P NATL ACAD SCI USA, V108, P13516, DOI 10.1073/pnas.1105411108; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Vavilin D, 2007, J BIOL CHEM, V282, P37660, DOI 10.1074/jbc.M707133200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200	38	140	140	5	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					287	U96		10.1038/NCHEMBIO.1755	http://dx.doi.org/10.1038/NCHEMBIO.1755			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25706339				2022-12-25	WOS:000351666500012
J	Handsaker, RE; Van Doren, V; Berman, JR; Genovese, G; Kashin, S; Boettger, LM; McCarroll, SA				Handsaker, Robert E.; Van Doren, Vanessa; Berman, Jennifer R.; Genovese, Giulio; Kashin, Seva; Boettger, Linda M.; McCarroll, Steven A.			Large multiallelic copy number variations in humans	NATURE GENETICS			English	Article							RARE CHROMOSOMAL DELETIONS; SEQUENCING DATA; SEGMENTAL DUPLICATION; POPULATION-SCALE; KIDNEY-DISEASE; APOL1 VARIANTS; GENOME; ASSOCIATION; DISCOVERY; POLYMORPHISM	Thousands of genomic segments appear to be present in widely varying copy numbers in different human genomes. We developed ways to use increasingly abundant whole-genome sequence data to identify the copy numbers, alleles and haplotypes present at most large multiallelic CNVs (mCNVs). We analyzed 849 genomes sequenced by the 1000 Genomes Project to identify most large (>5-kb) mCNVs, including 3,878 duplications, of which 1,356 appear to have 3 or more segregating alleles. We find that mCNVs give rise to most human variation in gene dosage-seven times the combined contribution of deletions and biallelic duplications-and that this variation in gene dosage generates abundant variation in gene expression. We describe ` runaway duplication haplotypes' in which genes, including HPR and ORM1, have mutated to high copy number on specific haplotypes. We also describe partially successful initial strategies for analyzing mCNVs via imputation and provide an initial data resource to support such analyses.	[Handsaker, Robert E.; Van Doren, Vanessa; Genovese, Giulio; Kashin, Seva; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Handsaker, Robert E.; Van Doren, Vanessa; Genovese, Giulio; Kashin, Seva; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Handsaker, Robert E.; Van Doren, Vanessa; Genovese, Giulio; Kashin, Seva; Boettger, Linda M.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Berman, Jennifer R.] Biorad Labs Inc, Digital Biol Ctr, Pleasanton, CA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; McCarroll, Steven/0000-0002-6954-8184; Van Doren, Vanessa/0000-0003-4165-6025	National Human Genome Research Institute (NHGRI) [R01 HG006855]; NHGRI [U01 HG006510]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006510, R01HG006855] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Skvortsov, M. Thornton, N. Klitgord and B. Zhang for contributions to ddPCR assay design and validation. We also thank members of the 1000 Genomes Project for helpful conversations about analysis methods. This work was supported by a grant from the National Human Genome Research Institute (NHGRI; R01 HG006855). An additional grant from NHGRI (U01 HG006510) is supporting follow-on work to develop these methods into production-ready software that can be used by any research laboratory.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; Bellos E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r120; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarroll SA, 2009, NAT GENET, V41, P1341, DOI 10.1038/ng.490; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Su SY, 2010, BIOINFORMATICS, V26, P1437, DOI 10.1093/bioinformatics/btq157; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zanda M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004367	53	215	221	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					296	+		10.1038/ng.3200	http://dx.doi.org/10.1038/ng.3200			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25621458	Green Accepted, Green Submitted			2022-12-25	WOS:000350327900024
J	Liu, H; Irwanto, A; Fu, X; Yu, GQ; Yu, YX; Sun, YH; Wang, C; Wang, ZZ; Okada, Y; Low, HQ; Li, Y; Liany, H; Chen, MF; Bao, FF; Li, JH; You, JB; Zhang, QL; Liu, J; Chu, TS; Andiappan, AK; Wang, N; Niu, GY; Liu, DC; Yu, XL; Zhang, L; Tian, HQ; Zhou, GZ; Rotzschke, O; Chen, SM; Zhang, XJ; Liu, JJ; Zhang, FR				Liu, Hong; Irwanto, Astrid; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Okada, Yukinori; Low, Huiqi; Li, Yi; Liany, Herty; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Zhang, Qilin; Liu, Jian; Chu, Tongsheng; Andiappan, Anand Kumar; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Tian, Hongqing; Zhou, Guizhi; Rotzschke, Olaf; Chen, Shumin; Zhang, Xuejun; Liu, Jianjun; Zhang, Furen			Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; HIGH-RESOLUTION; POPULATION; HLA; IDENTIFICATION; IMPUTATION; VISUALIZATION; METAANALYSIS; INFERENCE	Genome-wide association studies (GWAS) have led to the discovery of several susceptibility loci for leprosy with robust evidence, providing biological insight into the role of host genetic factors in mycobacterial infection. However, the identified loci only partially explain disease heritability, and additional genetic risk factors remain to be discovered. We performed a 3-stage GWAS of leprosy in the Chinese population using 8,313 cases and 16,017 controls. Besides confirming all previously published loci, we discovered six new susceptibility loci, and further gene prioritization analysis of these loci implicated BATF3, CCDC88B and CIITA-SOCS1 as new susceptibility genes for leprosy. A systematic evaluation of pleiotropic effects demonstrated a high tendency for leprosy susceptibility loci to show association with autoimmunity and inflammatory diseases. Further analysis suggests that molecular sensing of infection might have a similar pathogenic role across these diseases, whereas immune responses have discordant roles in infectious and inflammatory diseases.	[Liu, Hong; Tian, Hongqing] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan 250100, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Liu, Jian; Chu, Tongsheng; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Zhou, Guizhi; Chen, Shumin; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Liu, Hong; Zhang, Qilin; Zhang, Furen] Shandong Univ, Sch Med, Jinan 250100, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Liu, Jian; Chu, Tongsheng; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Zhou, Guizhi; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Peoples R China; [Irwanto, Astrid; Low, Huiqi; Li, Yi; Liany, Herty; Liu, Jianjun] Agcy Sci Technol & Res Singapore, Genome Inst Singapore, Human Genet, Singapore, Singapore; [Irwanto, Astrid; Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Okada, Yukinori] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Andiappan, Anand Kumar; Rotzschke, Olaf] Singapore Immunol Network, Singapore, Singapore; [Tian, Hongqing; Zhang, Furen] Natl Clin Key Project Dermatol & Venereol, Jinan, Peoples R China; [Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Zhang, Xuejun] Minist Educ & Anhui Prov, Key Lab Gene Resource Utilizat Severe Dis, Hefei, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Anhui Medical University	Zhang, FR (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com	zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Roetzschke, Olaf/GXH-0012-2022; zhang, xuan/GQO-8953-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xuan/AAN-9914-2020; Liu, Jianjun/AAK-4989-2020; zhang, xu/GYE-3558-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; Liu, Jianjun/0000-0002-3255-3019; Andiappan, Anand Kumar/0000-0002-8442-1544; Sun, Yonghu/0000-0003-4553-2871	National Natural Science Foundation of China [81371721, 81271746, 31200933, 81101187]; National 863 Program of China [2014AA020505]; Shandong Provincial Advanced Taishan Scholar Construction Project; Agency for Science, Technology and Research of Singapore; Singapore International Graduate Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Shandong Provincial Advanced Taishan Scholar Construction Project; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore International Graduate Award	We thank the individuals who participated in this project. This work was funded by grants from the National Natural Science Foundation of China (81371721, 81271746, 31200933 and 81101187), the National 863 Program of China (2014AA020505), the Shandong Provincial Advanced Taishan Scholar Construction Project and the Agency for Science, Technology and Research of Singapore. A.I. was supported by the Singapore International Graduate Award.	Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P365; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Coulombe F, 2009, LANCET, V374, P769, DOI 10.1016/S0140-6736(09)61576-2; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fischer A, 2012, AM J RESP CRIT CARE, V186, P877, DOI 10.1164/rccm.201204-0708OC; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Liu H, 2013, HUM MOL GENET, V22, P4430, DOI 10.1093/hmg/ddt286; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; RANI R, 1993, TISSUE ANTIGENS, V42, P133, DOI 10.1111/j.1399-0039.1993.tb02179.x; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; SCHAUF V, 1985, TISSUE ANTIGENS, V26, P243; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TODD JR, 1990, REV INFECT DIS, V12, P63; Vanderborght PR, 2007, GENES IMMUN, V8, P320, DOI 10.1038/sj.gene.6364390; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	50	81	84	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					267	+		10.1038/ng.3212	http://dx.doi.org/10.1038/ng.3212			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25642632				2022-12-25	WOS:000350327900019
J	Hu, Z; Zhu, D; Wang, W; Li, WY; Jia, WL; Zeng, X; Ding, WC; Yu, L; Wang, XL; Wang, LM; Shen, H; Zhang, CL; Liu, HJ; Liu, X; Zhao, Y; Fang, XD; Li, SC; Chen, W; Tang, T; Fu, AS; Wang, Z; Chen, G; Gao, QL; Li, S; Xi, L; Wang, CY; Liao, SJ; Ma, XY; Wu, P; Li, K; Wang, SX; Zhou, JF; Wang, J; Xu, X; Wang, H; Ma, D				Hu, Zheng; Zhu, Da; Wang, Wei; Li, Weiyang; Jia, Wenlong; Zeng, Xi; Ding, Wencheng; Yu, Lan; Wang, Xiaoli; Wang, Liming; Shen, Hui; Zhang, Changlin; Liu, Hongjie; Liu, Xiao; Zhao, Yi; Fang, Xiaodong; Li, Shuaicheng; Chen, Wei; Tang, Tang; Fu, Aisi; Wang, Zou; Chen, Gang; Gao, Qinglei; Li, Shuang; Xi, Ling; Wang, Changyu; Liao, Shujie; Ma, Xiangyi; Wu, Peng; Li, Kezhen; Wang, Shixuan; Zhou, Jianfeng; Wang, Jun; Xu, Xun; Wang, Hui; Ma, Ding			Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism	NATURE GENETICS			English	Article							HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; PHYSICAL STATE; MYC LOCUS; DNA; REARRANGEMENTS; SEQUENCES; SITES	Human papillomavirus (HPV) integration is a key genetic event in cervical carcinogenesis(1). By conducting whole-genome sequencing and high-throughput viral integration detection, we identified 3,667 HPV integration breakpoints in 26 cervical intraepithelial neoplasias, 104 cervical carcinomas and five cell lines. Beyond recalculating frequencies for the previously reported frequent integration sites POU5F1B (9.7%), FHIT (8.7%), KLF12 (7.8%), KLF5 (6.8%), LRP1B (5.8%) and LEPREL1 (4.9%), we discovered new hot spots HMGA2 (7.8%), DLG2 (4.9%) and SEMA3D (4.9%). Protein expression from FHIT and LRP1B was downregulated when HPV integrated in their introns. Protein expression from MYC and HMGA2 was elevated when HPV integrated into flanking regions. Moreover, microhomologous sequence between the human and HPV genomes was significantly enriched near integration breakpoints, indicating that fusion between viral and human DNA may have occurred by microhomology-mediated DNA repair pathways(2). Our data provide insights into HPV integration-driven cervical carcinogenesis.	[Hu, Zheng; Zhu, Da; Ding, Wencheng; Yu, Lan; Wang, Xiaoli; Wang, Liming; Shen, Hui; Zhang, Changlin; Chen, Gang; Gao, Qinglei; Li, Shuang; Xi, Ling; Wang, Changyu; Liao, Shujie; Ma, Xiangyi; Wu, Peng; Li, Kezhen; Wang, Shixuan; Wang, Hui; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Wang, Wei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Li, Weiyang; Jia, Wenlong; Zeng, Xi; Liu, Hongjie; Liu, Xiao; Zhao, Yi; Fang, Xiaodong; Chen, Wei] BGI, Shenzhen, Peoples R China; [Li, Weiyang; Wang, Jun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Jia, Wenlong; Li, Shuaicheng] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Tang, Tang] WuHan Frasergen Bioinformat Co Ltd, Wuhan, Peoples R China; [Fu, Aisi; Wang, Zou] Wuhan Inst Biotechnol, Wuhan, Peoples R China; [Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Hubei, Peoples R China; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Ctr Excellence Res Hereditary Di, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Aarhus Univ, Ctr ISequencing, Aarhus, Denmark	Huazhong University of Science & Technology; Southern Medical University - China; Beijing Genomics Institute (BGI); South China University of Technology; City University of Hong Kong; Huazhong University of Science & Technology; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	xuxun@genomics.cn; huit71@sohu.com; dingma424@yahoo.com	Xu, Xun/AAI-6763-2020; wu, peng/M-1812-2019; Gao, Qinglei/B-1141-2019; Li, Weiyang/GRO-0563-2022; Liu, Xiao/P-2732-2015; Zhang, Changlin/ABI-4611-2020; Jia, Justin/AAV-4349-2021; Fang, Xiaodong/K-6743-2018; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Xu, Xun/0000-0002-5338-5173; wu, peng/0000-0002-4016-6641; Liu, Xiao/0000-0002-8073-0534; Jia, Justin/0000-0002-7136-9919; Fang, Xiaodong/0000-0001-7061-3337; Wang, Jun/0000-0002-2113-5874; gao, qinglei/0000-0002-9448-3423; Wang, Wei/0000-0002-3422-0402; LI, Shuaicheng/0000-0001-6246-6349; Wang, Jun/0000-0002-8540-8931; Hu, Zheng/0000-0001-9306-9442; Wu, Peng/0000-0003-4498-7663	National Development Program (973) for the Key Basic Research of China [2015CB553903, 2013CB911304]; National Natural Science Funding of China [81230038, 81372805, 81172466, 81272859, 81372801, 81372804, 81402158, 81372806, 81370469, 81172468, 81101964, 81230052, 81302266]; Chinese 863 Program [2012AA02A507, 2012AA02A201]; Guangdong Enterprise Key Laboratory of Human Disease Genomics; ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic; China National GeneBank-Shenzhen	National Development Program (973) for the Key Basic Research of China; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Chinese 863 Program(National High Technology Research and Development Program of China); Guangdong Enterprise Key Laboratory of Human Disease Genomics; ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic; China National GeneBank-Shenzhen	This work was supported by funds from the National Development Program (973) for the Key Basic Research of China (2015CB553903 and 2013CB911304) and the National Natural Science Funding of China (81230038, 81372805, 81172466, 81272859, 81372801, 81372804, 81402158, 81370469, 81372806, 81370469, 81172468, 81101964, 81230052 and 81302266). The study is also sponsored by the Chinese 863 Program (2012AA02A507, 2012AA02A201), Guangdong Enterprise Key Laboratory of Human Disease Genomics, ShenZhen Engineering Laboratory for Clinical Molecular Diagnostic and China National GeneBank-Shenzhen. We thank all participants recruited for this study. We thank our colleagues from BGI, H. Huang, L. Huang, X. Zhuang, L. Lin, H. Cao, X. Fang, X. Zhang, Y. Shuang and H. Yang for sequencing and analysis.	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Boulet GAV, 2009, CANCER EPIDEM BIOMAR, V18, P2992, DOI 10.1158/1055-9965.EPI-09-0025; Campitelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043393; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Das P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041012; ELAWADY MK, 1987, VIROLOGY, V159, P389, DOI 10.1016/0042-6822(87)90478-8; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Oliveira AG, 2013, CLIN MICROBIOL INFEC, V19, pE447, DOI 10.1111/1469-0691.12233; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Klaes R, 1999, CANCER RES, V59, P6132; Lawson ARJ, 2011, GENOME RES, V21, P505, DOI 10.1101/gr.115782.110; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Thorland EC, 2000, CANCER RES, V60, P5916; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	30	273	295	6	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					158	163		10.1038/ng.3178	http://dx.doi.org/10.1038/ng.3178			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25581428				2022-12-25	WOS:000348694700011
J	Liddiard, K; Taylor, PR				Liddiard, Kate; Taylor, Philip R.			Understanding Local Macrophage Phenotypes In Disease: Shape-shifting macrophages	NATURE MEDICINE			English	Editorial Material							POLARIZATION; MONOCYTES	Macrophages are responsive to local tissue signals and alter their phenotypes accordingly. In disease tissues this means that macrophage phenotypes may change with disease progression, exacerbating or facilitating the resolution of the pathology.	[Liddiard, Kate] Cardiff Univ, Sch Med, Inst Canc & Genet, Cardiff CF10 3AX, S Glam, Wales; [Taylor, Philip R.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Liddiard, K (corresponding author), Cardiff Univ, Sch Med, Inst Canc & Genet, Cardiff CF10 3AX, S Glam, Wales.	TaylorPR@cardiff.ac.uk		Taylor, Philip/0000-0003-0163-1421	Medical Research Council [G0601617, MR/J002151/1] Funding Source: Medline; MRC [MR/J002151/1, G0601617] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chittezhath M, 2014, IMMUNITY, V41, P815, DOI 10.1016/j.immuni.2014.09.014; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269	16	34	35	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					119	120		10.1038/nm.3798	http://dx.doi.org/10.1038/nm.3798			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25654602				2022-12-25	WOS:000348974800013
J	Imajo, M; Ebisuya, M; Nishida, E				Imajo, Masamichi; Ebisuya, Miki; Nishida, Eisuke			Dual role of YAP and TAZ in renewal of the intestinal epithelium	NATURE CELL BIOLOGY			English	Article							HIPPO SIGNALING PATHWAY; ORGAN SIZE CONTROL; CELL SELF-RENEWAL; LARGE GENE LISTS; STEM-CELLS; PROMOTES APOPTOSIS; WNT/BETA-CATENIN; TUMOR-SUPPRESSOR; GROWTH-CONTROL; CANCER CELLS	The rapidly self-renewing intestinal epithelium represents an exquisite model for stem cell biology. So far, genetic studies in mice have uncovered crucial roles for several signalling pathways in the tissue. Here we show, by using intestine-specific gene transfer (iGT), that Hippo signalling effectors, YAP and TAZ, promote both the proliferation of intestinal stem/progenitor cells and their differentiation into goblet cells. These functions of YAP/TAZ are regulated by the upstream Hippo pathway kinases MST1/2 and LATS1/2. Moreover, we identify TEADs and Klf4 as partner transcription factors of YAP/TAZ in the proliferation and differentiation processes, respectively. These results indicate that Hippo signalling plays a dual role in renewal of the intestinal epithelium through the regulation of two different processes, stem/progenitor cell proliferation and differentiation into goblet cells, using two different types of transcription factor. Moreover, iGT should provide a robust platform to elucidate molecular mechanisms of intestinal epithelium self-renewal.	[Imajo, Masamichi; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Imajo, Masamichi; Nishida, Eisuke] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Imajo, Masamichi] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] Kyoto Univ, Career Path Promot Unit Young Life Scientist, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] RIKEN, Ctr Dev Biol, Lab Reconstitut Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; RIKEN	Imajo, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	mimajo@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp	Ebisuya, Miki/N-5388-2015; Imajo, Masamichi/O-2140-2018	Ebisuya, Miki/0000-0003-1854-7496; Imajo, Masamichi/0000-0003-0115-5840	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Grants-in-Aid for Scientific Research [25111712, 25870363, 26114004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of our laboratory for thoughtful discussion and helpful comments on the manuscript. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology (to E.N. and M.I.).	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fre S, 2008, ADV CANCER RES, V100, P85, DOI 10.1016/S0065-230X(08)00003-1; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Imajo M., 2014, PROTOC EXCH; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Katz JP, 2002, DEVELOPMENT, V129, P2619; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	70	126	130	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					7	+		10.1038/ncb3084	http://dx.doi.org/10.1038/ncb3084			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25531778				2022-12-25	WOS:000346823900004
J	Kuffner, R; Zach, N; Norel, R; Hawe, J; Schoenfeld, D; Wang, LX; Li, G; Fang, L; Mackey, L; Hardiman, O; Cudkowicz, M; Sherman, A; Ertaylan, G; Grosse-Wentrup, M; Hothorn, T; van Ligtenberg, J; Macke, JH; Meyer, T; Scholkopf, B; Tran, L; Vaughan, R; Stolovitzky, G; Leitner, ML				Kueffner, Robert; Zach, Neta; Norel, Raquel; Hawe, Johann; Schoenfeld, David; Wang, Liuxia; Li, Guang; Fang, Lilly; Mackey, Lester; Hardiman, Orla; Cudkowicz, Merit; Sherman, Alexander; Ertaylan, Gokhan; Grosse-Wentrup, Moritz; Hothorn, Torsten; van Ligtenberg, Jules; Macke, Jakob H.; Meyer, Timm; Schoelkopf, Bernhard; Tran, Linh; Vaughan, Rubio; Stolovitzky, Gustavo; Leitner, Melanie L.			Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression	NATURE BIOTECHNOLOGY			English	Article							URIC-ACID LEVELS; BODY-MASS INDEX; FUNCTIONAL RATING-SCALE; ALSFRS-R SCORE; DISEASE PROGRESSION; PROGNOSTIC-FACTORS; BLOOD-PRESSURE; SURVIVAL; CREATININE; ALZHEIMERS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with substantial heterogeneity in its clinical presentation. This makes diagnosis and effective treatment difficult, so better tools for estimating disease progression are needed. Here, we report results from the DREAM-Phil Bowen ALS Prediction Prize4Life challenge. In this crowdsourcing competition, competitors developed algorithms for the prediction of disease progression of 1,822 ALS patients from standardized, anonymized phase 2/3 clinical trials. The two best algorithms outperformed a method designed by the challenge organizers as well as predictions by ALS clinicians. We estimate that using both winning algorithms in future trial designs could reduce the required number of patients by at least 20%. The DREAM-Phil Bowen ALS Prediction Prize4Life challenge also identified several potential nonstandard predictors of disease progression including uric acid, creatinine and surprisingly, blood pressure, shedding light on ALS pathobiology. This analysis reveals the potential of a crowdsourcing competition that uses clinical trial data for accelerating ALS research and development.	[Kueffner, Robert] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Munich, Germany; [Kueffner, Robert; Hawe, Johann] Univ Munich, Dept Informat, Munich, Germany; [Zach, Neta; Leitner, Melanie L.] Prize4Life, Tel Aviv, Israel; [Zach, Neta; Leitner, Melanie L.] Prize4Life, Cambridge, MA USA; [Norel, Raquel] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Schoenfeld, David] Massachusetts Gen Hosp, MGH Biostat Ctr, Boston, MA 02114 USA; [Schoenfeld, David] Harvard Univ, Sch Med, Charlestown, MA USA; [Wang, Liuxia; Li, Guang] Sentrana Inc, Washington, DC USA; [Fang, Lilly] Latham&Watkins LLP, Silicon Valley, CA USA; [Mackey, Lester] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Hardiman, Orla] Beaumont Hosp, Dept Neurosci, Dublin 9, Ireland; [Hardiman, Orla] Trinity Coll Dublin, Dublin, Ireland; [Cudkowicz, Merit; Sherman, Alexander] Massachusetts Gen Hosp, Neurol Clin Res Inst, Charlestown, MA USA; [Ertaylan, Gokhan] Univ Luxembourg, Esch Alzette, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Grosse-Wentrup, Moritz; Meyer, Timm; Schoelkopf, Bernhard] Max Planck Inst Intelligent Syst, Tubingen, Germany; [Hothorn, Torsten] Univ Zurich, Inst Social & Prevent Med, Zurich, Switzerland; [van Ligtenberg, Jules; Vaughan, Rubio] Orca XL Problem Solvers, Amsterdam, Netherlands; [Macke, Jakob H.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Macke, Jakob H.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Tran, Linh] Univ Calif Berkeley, Berkeley Sch Publ Hlth, Berkeley, CA USA; [Leitner, Melanie L.] Biogen Idec Inc, ALS Innovat Hub, Cambridge, MA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; International Business Machines (IBM); Harvard University; Massachusetts General Hospital; Harvard University; Stanford University; Trinity College Dublin; Harvard University; Massachusetts General Hospital; ArcelorMittal; University of Luxembourg; Max Planck Society; University of Zurich; Max Planck Society; University of California System; University of California Berkeley; Biogen	Kuffner, R (corresponding author), German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Munich, Germany.	robert.kueffner@helmholtz-muenchen.de; nzach@prize4life.org	Schölkopf, Bernhard/A-7570-2013; CUDKOWICZ, MERIT/GWM-6585-2022; Hardiman, Orla/Y-3441-2019; Norel, Raquel/ABB-3422-2021; wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	Schölkopf, Bernhard/0000-0002-8177-0925; CUDKOWICZ, MERIT/0000-0002-7075-1681; Hardiman, Orla/0000-0003-2610-1291; Norel, Raquel/0000-0001-7737-4172; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Hawe, Johann/0000-0003-3890-303X; Mackey, Lester/0000-0002-1102-0387; Ertaylan, Gokhan/0000-0001-5602-6435				Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Atassi N, 2014, NEUROLOGY, V83, P1719, DOI 10.1212/WNL.0000000000000951; Auinger P, 2010, MOVEMENT DISORD, V25, P224, DOI 10.1002/mds.22907; Baltadzhieva R, 2005, CURR OPIN NEUROL, V18, P487, DOI 10.1097/01.wco.0000183114.76056.0e; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310; Chen XP, 2014, NEUROL SCI, V35, P1591, DOI 10.1007/s10072-014-1807-4; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; Costello JC, 2013, CLIN PHARMACOL THER, V93, P396, DOI 10.1038/clpt.2013.36; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Czaplinski A, 2006, MUSCLE NERVE, V34, P702, DOI 10.1002/mus.20658; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Drigo D, 2013, NEUROEPIDEMIOLOGY, V41, P54, DOI 10.1159/000350015; Euser SM, 2009, BRAIN, V132, P377, DOI 10.1093/brain/awn316; Fujimura-Kiyono C, 2011, J NEUROL NEUROSUR PS, V82, P1244, DOI 10.1136/jnnp-2011-300141; Gomeni R, 2014, AMYOTROPH LAT SCL FR, V15, P119, DOI 10.3109/21678421.2013.838970; Grossman I, 2010, EPMA J, V1, P293, DOI 10.1007/s13167-010-0024-3; Hothorn T, 2014, AMYOTROPH LAT SCL FR, V15, P444, DOI 10.3109/21678421.2014.893361; Ikeda K, 2012, INTERNAL MED, V51, P1501, DOI 10.2169/internalmedicine.51.7465; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kandinov B, 2012, AMYOTROPH LATERAL SC, V13, P509, DOI 10.3109/17482968.2012.662986; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; Lakhani KR, 2013, NAT BIOTECHNOL, V31, P108, DOI 10.1038/nbt.2495; Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Miller RG, 2011, NEUROLOGY, V77, P973, DOI 10.1212/WNL.0b013e31822dc7a5; Murata Y, 1997, ACTA NEUROL SCAND, V96, P118; Ontaneda D, 2012, MULT SCLER J, V18, P1074, DOI 10.1177/1352458512451512; Paganoni S, 2012, J NEUROL, V259, P1923, DOI 10.1007/s00415-012-6440-7; Paganoni S, 2012, MUSCLE NERVE, V45, P612, DOI 10.1002/mus.22338; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pastula DM, 2009, AMYOTROPH LATERAL SC, V10, P332, DOI 10.3109/17482960802320545; Pavlovic S, 2010, AMYOTROPH LATERAL SC, V11, P272, DOI 10.3109/17482960903390855; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Qureshi M, 2008, AMYOTROPH LATERAL SC, V9, P369, DOI 10.1080/17482960802163614; R Core Team, 2021, R LANG ENV STAT COMP; Rafiq M., 2013, J NEUROL NEUROSUR PS, V84, pe2; Reich-Slotky R, 2013, AMYOTROPH LAT SCL FR, V14, P212, DOI 10.3109/21678421.2013.770028; Rogers JA, 2012, J PHARMACOKINET PHAR, V39, P479, DOI 10.1007/s10928-012-9263-3; Romero K, 2009, CLIN PHARMACOL THER, V86, P365, DOI 10.1038/clpt.2009.165; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Traynor BJ, 2004, NEUROLOGY, V63, P1933, DOI 10.1212/01.WNL.0000144345.49510.4E; Turner MR, 2010, AMYOTROPH LATERAL SC, V11, P369, DOI 10.3109/17482960903420140; Vender RL, 2007, AMYOTROPH LATERAL SC, V8, P36, DOI 10.1080/17482960600863951; Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018	49	128	131	2	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					51	U292		10.1038/nbt.3051	http://dx.doi.org/10.1038/nbt.3051			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25362243	Bronze, Green Published			2022-12-25	WOS:000347714200027
J	Yokoi, N; Fukata, Y; Kase, D; Miyazaki, T; Jaegle, M; Ohkawa, T; Takahashi, N; Iwanari, H; Mochizuki, Y; Hamakubo, T; Imoto, K; Meijer, D; Watanabe, M; Fukata, M				Yokoi, Norihiko; Fukata, Yuko; Kase, Daisuke; Miyazaki, Taisuke; Jaegle, Martine; Ohkawa, Toshika; Takahashi, Naoki; Iwanari, Hiroko; Mochizuki, Yasuhiro; Hamakubo, Takao; Imoto, Keiji; Meijer, Dies; Watanabe, Masahiko; Fukata, Masaki			Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; DOMINANT PARTIAL EPILEPSY; AUTOSOMAL-DOMINANT; CYSTIC-FIBROSIS; LGI1 MUTATIONS; SYNAPTIC-TRANSMISSION; LIMBIC ENCEPHALITIS; AUDITORY FEATURES; LEUCINE-RICH; ER STRESS	Epilepsy is one of the most common and intractable brain disorders. Mutations in the human gene LGI1, encoding a neuronal secreted protein, cause autosomal dominant lateral temporal lobe epilepsy (ADLTE). However, the pathogenic mechanisms of LGI1 mutations remain unclear. We classified 22 reported LGI1 missense mutations as either secretion defective or secretion competent, and we generated and analyzed two mouse models of ADLTE encoding mutant proteins representative of the two groups. The secretion-defective LGI1(E383A) protein was recognized by the ER quality-control machinery and prematurely degraded, whereas the secretable LGI1(S473L) protein abnormally dimerized and was selectively defective in binding to one of its receptors, ADAM22. Both mutations caused a loss of function, compromising intracellular trafficking or ligand activity of LGI1 and converging on reduced synaptic LGI1-ADAM22 interaction. A chemical corrector, 4-phenylbutyrate (4PBA), restored LGI1(E383A) folding and binding to ADAM22 and ameliorated the increased seizure susceptibility of the LGI 1(E383A) model mice. This study establishes LGI1-related epilepsy as a conformational disease and suggests new therapeutic options for human epilepsy.	[Yokoi, Norihiko; Fukata, Yuko; Ohkawa, Toshika; Takahashi, Naoki; Fukata, Masaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448585, Japan; [Yokoi, Norihiko; Fukata, Yuko; Ohkawa, Toshika; Imoto, Keiji; Fukata, Masaki] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi, Japan; [Kase, Daisuke; Imoto, Keiji] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Informat Physiol, Div Neural Signaling, Okazaki, Aichi 4448585, Japan; [Miyazaki, Taisuke; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Jaegle, Martine; Meijer, Dies] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Iwanari, Hiroko; Mochizuki, Yasuhiro; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Mochizuki, Yasuhiro] PeptiDream Incorporation, Komaba Open Lab, Tokyo, Japan; [Meijer, Dies] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Watanabe, Masahiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hokkaido University; Erasmus University Rotterdam; Erasmus MC; University of Tokyo; University of Edinburgh; Japan Science & Technology Agency (JST)	Fukata, Y (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	yfukata@nips.ac.jp; mfukata@nips.ac.jp	Meijer, Dies/C-7786-2012; Fukata, Masaki/AAZ-2476-2021; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	Meijer, Dies/0000-0002-8461-6341; Fukata, Masaki/0000-0001-5200-9806; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Fukata, Yuko/0000-0001-7724-8643; Kase, Daisuke/0000-0001-6787-5862; Imoto, Keiji/0000-0002-2861-5985	Japan Society for the Promotion of Science [22-2876]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25890021]; MEXT [25110733]; Ministry of Health, Labour and Welfare (MHLW) [24-12]; Grants-in-Aid for Scientific Research [25890021] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J.L. Noebels and Y. Takahashi for helpful discussion. We thank A. Maas for kind assistance with Adam22 and Adam23 KO mice, S. Okamoto for technical guidance, M. Ohashi for sharing laboratory equipment, and Y. Kawabe and the members of the Fukata laboratory for their technical assistance. We also thank D. Monard (Friedrich Miescher Institute for Biomedical Research, Switzerland) for the kind gift of a Thyl expression cassette. N.Y. was supported by the Japan Society for the Promotion of Science (22-2876) and Ministry of Education, Culture, Sports, Science and Technology (MEXT) (25890021). Y.F. is supported by grants from MEXT (25110733) and Ministry of Health, Labour and Welfare (MHLW) (Intramural Research Grant (24-12) for Neurological and Psychiatric Disorder of Japan National Center of Neurology and Psychiatry). D.M. and M.J. are supported by grants from the Dutch government to the Netherlands Institute for Regenerative Medicine (FES0908), the VICI (918.66.616) and the European Union (NeuronGlia Interactions in Nerve Development and Disease, FP7 HEALTH-F2-2008-201535). M.W is supported by a grant from MEXT (Comprehensive Brain Science Network). M.F. was supported by a grant from the Funding Program for Next Generation World-Leading Researchers (LS123).	Chabrol E, 2010, BRAIN, V133, P2749, DOI 10.1093/brain/awq171; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gu WL, 2002, ANN NEUROL, V52, P364, DOI 10.1002/ana.10280; Ho YY, 2012, NEUROLOGY, V78, P563, DOI 10.1212/WNL.0b013e318247ccbf; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kegel L, 2014, DEVELOPMENT, V141, P1749, DOI 10.1242/dev.107995; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohkawa T, 2013, J NEUROSCI, V33, P18161, DOI 10.1523/JNEUROSCI.3506-13.2013; Okiyoneda T, 2012, J CELL BIOL, V199, P199, DOI 10.1083/jcb.201208083; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Rosanoff MJ, 2008, NEUROLOGY, V71, P567, DOI 10.1212/01.wnl.0000323926.77565.ee; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Sirerol-Piquer MS, 2006, HUM MOL GENET, V15, P3436, DOI 10.1093/hmg/ddl421; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Striano P, 2011, NEUROLOGY, V76, P1173, DOI 10.1212/WNL.0b013e318212ab2e; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yang CZ, 2013, CELL REP, V3, P52, DOI 10.1016/j.celrep.2012.12.007; Yu YE, 2010, HUM MOL GENET, V19, P1702, DOI 10.1093/hmg/ddq047; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	38	48	50	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					19	26		10.1038/nm.3759	http://dx.doi.org/10.1038/nm.3759			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25485908				2022-12-25	WOS:000348408000009
J	Antonacci, F; Dennis, MY; Huddleston, J; Sudmant, PH; Steinberg, KM; Rosenfeld, JA; Miroballo, M; Graves, TA; Vives, L; Malig, M; Denman, L; Raja, A; Stuart, A; Tang, J; Munson, B; Shaffer, LG; Amemiya, CT; Wilson, RK; Eichler, EE				Antonacci, Francesca; Dennis, Megan Y.; Huddleston, John; Sudmant, Peter H.; Steinberg, Karyn Meltz; Rosenfeld, Jill A.; Miroballo, Mattia; Graves, Tina A.; Vives, Laura; Malig, Maika; Denman, Laura; Raja, Archana; Stuart, Andrew; Tang, Joyce; Munson, Brenton; Shaffer, Lisa G.; Amemiya, Chris T.; Wilson, Richard K.; Eichler, Evan E.			Palindromic GOLGA8 core duplicons promote chromosome 15q13.3 microdeletion and evolutionary instability	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; RECENT SEGMENTAL DUPLICATIONS; HUMAN GENOME; INVERTED REPEATS; RECURRENT MICRODELETIONS; DNA PALINDROMES; INCREASE RISK; SEQUENCE; REARRANGEMENTS; DISORDERS	Recurrent deletions of chromosome 15q13.3 associate with intellectual disability, schizophrenia, autism and epilepsy. To gain insight into the instability of this region, we sequenced it in affected individuals, normal individuals and nonhuman primates. We discovered five structural configurations of the human chromosome 15q13.3 region ranging in size from 2 to 3 Mb. These configurations arose recently (similar to 0.5-0.9 million years ago) as a result of human-specific expansions of segmental duplications and two independent inversion events. All inversion breakpoints map near GOLGA8 core duplicons a similar to 14-kb primate-specific chromosome 15 repeat that became organized into larger palindromic structures. GOLGA8-flanked palindromes also demarcate the breakpoints of recurrent 15q13.3 microdeletions, the expansion of chromosome 15 segmental duplications in the human lineage and independent structural changes in apes. The significant clustering (P = 0.002) of breakpoints provides mechanistic evidence for the role of this core duplicon and its palindromic architecture in promoting the evolutionary and disease-related instability of chromosome 15.	[Antonacci, Francesca; Miroballo, Mattia] Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy; [Dennis, Megan Y.; Huddleston, John; Sudmant, Peter H.; Vives, Laura; Malig, Maika; Denman, Laura; Raja, Archana; Munson, Brenton; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Huddleston, John; Vives, Laura; Raja, Archana; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Steinberg, Karyn Meltz; Graves, Tina A.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] Signature Genom Labs LLC, Spokane, WA USA; [Stuart, Andrew; Tang, Joyce; Amemiya, Chris T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Shaffer, Lisa G.] Genet Vet Sci Inc, Paw Print Genet, Spokane, WA USA	Universita degli Studi di Bari Aldo Moro; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Benaroya Research Institute; Virginia Mason Medical Center	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Antonacci, Francesca/F-5457-2013; Miroballo, Mattia/AAC-2188-2020; Wilson, Richard K./AAF-4139-2019	Antonacci, Francesca/0000-0002-5833-6186; Miroballo, Mattia/0000-0002-7006-9105; Wilson, Richard K./0000-0002-1992-1358; Rosenfeld, Jill/0000-0001-5664-7987; Sudmant, Peter/0000-0002-9573-8248; Meltz Steinberg, Karyn/0000-0002-8676-3337	US National Institutes of Health [HG002385, HG004120]; National Institute of Neurological Disorder and Stroke of the US National Institutes of Health [K99NS083627]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385, P01HG004120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS083627] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorder and Stroke of the US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ventura, C. Campbell and H.C. Mefford for useful discussions and T. Brown for critical review of the manuscript. We also thank S. Diede, W Tanaka, B. Brewer, C. Payen, L. Harshman and K. Penewit for experimental advice and support for the palindromic snapback assay. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We appreciate obtaining access to phenotypic data on SFARI Base. This work was supported, in part, by US National Institutes of Health grants HG002385 and HG004120 to E.E.E. M.Y.D. is supported by the National Institute of Neurological Disorder and Stroke of the US National Institutes of Health (award K99NS083627). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bengesser K, 2010, HUM MUTAT, V31, P742, DOI 10.1002/humu.21254; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Giannuzzi G, 2013, GENOME RES, V23, P1763, DOI 10.1101/gr.156240.113; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Inagaki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2595; Itsara A, 2012, AM J HUM GENET, V90, P599, DOI 10.1016/j.ajhg.2012.02.013; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mefford HC, 2012, J MED GENET, V49, P110, DOI 10.1136/jmedgenet-2011-100499; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; RUSKIN B, 1993, GENETICS, V134, P43; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Wat MJ, 2010, J MED GENET, V47, P777, DOI 10.1136/jmg.2009.075903; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	55	69	69	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1293	1302		10.1038/ng.3120	http://dx.doi.org/10.1038/ng.3120			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25326701	Green Accepted, Green Submitted			2022-12-25	WOS:000345547300010
J	Sanchez-Buso, L; Comas, I; Jorques, G; Gonzalez-Candelas, F				Sanchez-Buso, Leonor; Comas, Inaki; Jorques, Guillermo; Gonzalez-Candelas, Fernando			Recombination drives genome evolution in outbreak-related Legionella pneumophila isolates	NATURE GENETICS			English	Article							SEQUENCE-BASED SCHEME; LEGIONNAIRES-DISEASE; POPULATION-STRUCTURE; CLOSTRIDIUM-DIFFICILE; ANTIBIOTIC-RESISTANCE; BACTERIA; HYPERMUTATION; EPIDEMIC; HISTORY; ORIGIN	Legionella pneumophila is a strictly environmental pathogen and the etiological agent of legionellosis. It is known that non-vertical processes have a major role in the short-term evolution of pathogens, but little is known about the relevance of these and other processes in environmental bacteria. We report the whole-genome sequencing of 69 L. pneumophila strains linked to recurrent outbreaks in a single location (Alcoy, Spain) over 11 years. We found some examples where the genome sequences of isolates of the same sequence type and outbreak did not cluster together and were more closely related to sequences from different outbreaks. Our analyses identify 16 recombination events responsible for almost 98% of the SNPs detected in the core genome and an apparent acceleration in the evolutionary rate. These results have profound implications for the understanding of microbial populations and for public health interventions in Legionella outbreak investigations.	[Sanchez-Buso, Leonor; Comas, Inaki; Gonzalez-Candelas, Fernando] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Infect & Publ Hlth Joint Unit, FISABIO Fdn Fomento Invest Biomed & Sanitaria Com, Valencia, Spain; [Sanchez-Buso, Leonor; Comas, Inaki; Gonzalez-Candelas, Fernando] CIBER Ctr Invest Biomed Red Epidemiol & Publ Hlth, Valencia, Spain; [Jorques, Guillermo] Publ Hlth Ctr, Alcoy, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gonzalez-Candelas, F (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Infect & Publ Hlth Joint Unit, FISABIO Fdn Fomento Invest Biomed & Sanitaria Com, Valencia, Spain.	fernando.gonzalez@uv.es	Candelas, Fernando Gonzalez/G-5681-2010; Sánchez-Busó, Leonor/E-1023-2013; Comas, Iñaki/AAA-1155-2019; Comas, Iñaki/F-1185-2011	Candelas, Fernando Gonzalez/0000-0002-0879-5798; Sánchez-Busó, Leonor/0000-0002-4162-0228; Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408	Ministerio de Economia y Competitividad (MINECO) of the Spanish government [BFU2011-24112]; Formacion de Profesorado Universitario (FPU) predoctoral fellowship from the Ministerio de Educacion of the Spanish government; Infra-European Fellowship (IEF) from Framework Programme 7 [272086]; Ramon y Cajal from the Spanish government [RYC-2012-10627]	Ministerio de Economia y Competitividad (MINECO) of the Spanish government; Formacion de Profesorado Universitario (FPU) predoctoral fellowship from the Ministerio de Educacion of the Spanish government(German Research Foundation (DFG)); Infra-European Fellowship (IEF) from Framework Programme 7; Ramon y Cajal from the Spanish government	The authors acknowledge the Direccion General de Salud Publica (DGSP; Conselleria de Sanidad, Generalitat Valenciana) and the Centro de Salud Publica de Alcoy for sharing information and comments on the Legionella outbreaks in Alcoy and facilitating access to epidemiological data. We also thank the Microbiology Service at the Hospital Virgen de los Lirios (Alcoy) and the Laboratorio de Salud Publica for sharing the Legionella samples used in this study, as well as the Genomics section of the Serveis Centrals de Support a I'Investigacio Experimental (SCSIE; University of Valencia) for their technical help in the deep sequencing of the strains. We would also like to thank J. Parkhill and S. Harris (Wellcome Trust Sanger Institute) for their comments as well as facilitating their computational resources during the revision of the manuscript. The work has been funded by project BFU2011-24112 from the Ministerio de Economia y Competitividad (MINECO) of the Spanish government. L.S.-B. is the recipient of a Formacion de Profesorado Universitario (FPU) predoctoral fellowship from the Ministerio de Educacion of the Spanish government. I.C. was supported by an Infra-European Fellowship (IEF; 272086) from Framework Programme 7 and Ramon y Cajal from the Spanish government (RYC-2012-10627).	Baquero F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00015; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Coetzee N, 2012, EUROSURVEILLANCE, V17, P6; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Coscolla M, 2011, MOL BIOL EVOL, V28, P985, DOI 10.1093/molbev/msq278; Coscolla M, 2010, EMERG INFECT DIS, V16, P1381, DOI 10.3201/eid1609.100248; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Fernandez JA, 2002, EUR J CLIN MICROBIOL, V21, P729, DOI 10.1007/s10096-002-0819-9; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gomez-Valero L, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009993; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Keramarou M, 2010, EUROSURVEILLANCE, V15, P2; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Lawrence Jeffrey G., 2009, V532, P29, DOI 10.1007/978-1-60327-853-9_3; Levin BR, 2000, P NATL ACAD SCI USA, V97, P6981, DOI 10.1073/pnas.97.13.6981; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; McCormick D, 2012, EUROSURVEILLANCE, V17, P6; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mentasti M., 2014, CLIN MICROBIOL INFEC, V20; Miller J, 2010, NY TIMES BK REV, P6; Nicolas P, 2008, APPL ENVIRON MICROB, V74, P3702, DOI 10.1128/AEM.00244-08; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Rota MC, 2011, EUROSURVEILLANCE, V16, P9; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Townsend JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00027; Underwood AP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-302; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Weigand MR, 2012, P NATL ACAD SCI USA, V109, P13680, DOI 10.1073/pnas.1205357109; Yiallouros PK, 2013, CLIN INFECT DIS, V57, P48, DOI 10.1093/cid/cit176	50	54	54	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1205	1211		10.1038/ng.3114	http://dx.doi.org/10.1038/ng.3114			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25282102				2022-12-25	WOS:000344131900011
J	Walsh, G				Walsh, Gary			Biopharmaceutical benchmarks 2014	NATURE BIOTECHNOLOGY			English	Article							ANTIBODIES		[Walsh, Gary] Univ Limerick, Dept Chem & Environm Sci, Ind Biochem Program, Limerick, Ireland; [Walsh, Gary] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	University of Limerick; University of Limerick	Walsh, G (corresponding author), Univ Limerick, Dept Chem & Environm Sci, Ind Biochem Program, Limerick, Ireland.	gary.walsh@ul.ie	Walsh, Gary/X-1951-2019	Walsh, Gary/0000-0002-1300-8314				[Anonymous], 2013, MEIRE BIOL, V6, P3; Beck A, 2013, MABS-AUSTIN, V5, P621, DOI 10.4161/mabs.25864; Blackstone E., 2014, AM HLTH DRUG BE 0702; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Broz A., 2013, GEN GENET ENG BIOTEC, V33, P32, DOI DOI 10.1089/gen.33.4.15; Dalgaard K, 2013, BIOSIMILARS 7 YEARS; Emerton D.A., 2013, BIOPROCESS INT, V11, P6; Goede V., 2013, 55 ASH ANN M EXP NEW; Kling J, 2014, NAT BIOTECHNOL, V32, P851, DOI 10.1038/nbt0914-851a; Kwon KC, 2013, ADV DRUG DELIVER REV, V65, P782, DOI 10.1016/j.addr.2012.10.005; Nielsen LS, 2010, MOL BIOTECHNOL, V45, P257, DOI 10.1007/s12033-010-9270-9; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; PhRMA, 2013, MED DEV BIOL; Qui X., 2014, NATURE          0829, DOI [10.1038/nature13777, DOI 10.1038/NATURE13777]; Rickwood S., 2013, SEARCHING TERRA FIRM; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917	18	676	726	2	249	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					992	1000		10.1038/nbt.3040	http://dx.doi.org/10.1038/nbt.3040			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299917				2022-12-25	WOS:000343763800013
J	Hsia, KC; Wilson-Kubalek, EM; Dottore, A; Hao, Q; Tsai, KL; Forth, S; Shimamoto, Y; Milligan, RA; Kapoor, TM				Hsia, Kuo-Chiang; Wilson-Kubalek, Elizabeth M.; Dottore, Alejandro; Hao, Qi; Tsai, Kuang-Lei; Forth, Scott; Shimamoto, Yuta; Milligan, Ronald A.; Kapoor, Tarun M.			Reconstitution of the augmin complex provides insights into its architecture and function	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; MICROTUBULE NUCLEATION; MITOTIC SPINDLE; HUMAN-CELLS; PROTEIN; GENERATION; MECHANISMS; MITOSIS	Proper microtubule nucleation during cell division requires augmin, a microtubule-associated hetero-octameric protein complex. In current models, augmin recruits y-tubulin, through the carboxyl terminus of its hDgt6 subunit to nucleate microtubules within spindles. However, augmin's biochemical complexity has restricted analysis of its structural organization and function. Here, we reconstitute human augmin and show that it is a Y-shaped complex that can adopt multiple conformations. Further, we find that a dimeric sub-complex retains in vitro microtubule-binding properties of octameric complexes, but not proper metaphase spindle localization. Addition of octameric augmin complexes to Xenopus egg extracts promotes microtubule aster formation, an activity enhanced by Ran-GTP. This activity requires microtubule binding, but not the characterized hDgt6 y-tubulin-recruitment domain. Tetrameric sub-complexes induce asters, but activity and microtubule bundling within asters are reduced compared with octameric complexes. Together, our findings shed light on augmin's structural organization and microtubule-binding properties, and define subunits required for its function in organizing microtubule-based structures.	[Hsia, Kuo-Chiang; Dottore, Alejandro; Hao, Qi; Forth, Scott; Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Wilson-Kubalek, Elizabeth M.; Tsai, Kuang-Lei; Milligan, Ronald A.] Scripps Res Inst, Dept Integrated Struct & Computat Biol, La Jolla, CA 92037 USA	Rockefeller University; Scripps Research Institute	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	kapoor@rockefeller.edu	Hsia, Kuo-Chiang/AAS-8056-2021; Shimamoto, Yuta/AAH-3281-2019	Hsia, Kuo-Chiang/0000-0002-4409-6732; Shimamoto, Yuta/0000-0003-0935-2793; Forth, Scott/0000-0002-2630-8017	National Institutes of Health (NIH) [1S10RR023748-01]; National Institute of General Medical Sciences [9 P41 GM103310]; Kimberly Lawrence-Netter Cancer Research Discovery Fund at The Rockefeller University; Special Fellow Award from The Leukemia and Lymphoma Society; NIH National Research Service Award Fellowship [F32GM099380]; NIH [GM-052468, GM-65933]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, F32GM099380, R01GM052468, R37GM052468, R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kimberly Lawrence-Netter Cancer Research Discovery Fund at The Rockefeller University; Special Fellow Award from The Leukemia and Lymphoma Society; NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Goshima (Nagoya University, Japan) for the gift of UCHL5IP antibody; and L. Pelletier (University of Toronto, Canada) for the antibodies against C14orf94 and Cep27. The SEC-LS/UV/RI instrumentation used for light-scattering analysis was supported by a National Institutes of Health (NIH) award (1S10RR023748-01). TEM studies were conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institute of General Medical Sciences (9 P41 GM103310). K-C.H. was supported by the Kimberly Lawrence-Netter Cancer Research Discovery Fund at The Rockefeller University and is supported by a Special Fellow Award from The Leukemia and Lymphoma Society. S.F. acknowledges postdoctoral support from an NIH National Research Service Award Fellowship (F32GM099380). R.A.M. acknowledges support from the NIH (GM-052468). T.M.K. acknowledges support from the NIH (GM-65933).	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Colombie N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003562; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont J, 2012, TRENDS CELL BIOL, V22, P241, DOI 10.1016/j.tcb.2012.02.007; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hayward D, 2014, DEV CELL, V28, P81, DOI 10.1016/j.devcel.2013.12.001; Kamasaki T, 2013, J CELL BIOL, V202, P25, DOI 10.1083/jcb.201304031; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07	24	48	49	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					852	863		10.1038/ncb3030	http://dx.doi.org/10.1038/ncb3030			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25173975	Green Accepted			2022-12-25	WOS:000341404400006
J	Yan, JQ; Zhang, H; Yin, Y; Li, JX; Tang, YZ; Purkayastha, S; Li, LX; Cai, DS				Yan, Jingqi; Zhang, Hai; Yin, Ye; Li, Juxue; Tang, Yizhe; Purkayastha, Sudarshana; Li, Lianxi; Cai, Dongsheng			Obesity- and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response	NATURE MEDICINE			English	Article							NEURAL STEM-CELLS; NF-KAPPA-B; TGF-BETA; HYPOTHALAMIC INFLAMMATION; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; FATTY-ACIDS; IKK-BETA; DIET; EXPRESSION	The brain, in particular the hypothalamus, plays a role in regulating glucose homeostasis; however, it remains unclear whether this organ is causally and etiologically involved in the development of diabetes. Here, we found that hypothalamic transforming growth factor-beta (TGF-beta) production is excessive under conditions of not only obesity but also aging, which are two general etiological factors of type 2 diabetes. Pharmacological and genetic approaches revealed that central TGF-beta excess caused hyperglycemia and glucose intolerance independent of a change in body weight. Further, using cell-specific genetic analyses in vivo, we found that astrocytes and proopiomelanocortin neurons are responsible for the production and prodiabetic effect of central TGF-beta, respectively. Mechanistically, TGF-beta excess induced a hypothalamic RNA stress response, resulting in accelerated mRNA decay of I kappa B alpha, an inhibitor of proinflammatory nuclear factor-kappa B. These results reveal an atypical, mRNA metabolism-driven hypothalamic nuclear factor-kappa B activation, a mechanism that links obesity as well as aging to hypothalamic inflammation and ultimately to type 2 diabetes.	[Yan, Jingqi; Zhang, Hai; Yin, Ye; Li, Juxue; Tang, Yizhe; Purkayastha, Sudarshana; Li, Lianxi; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Yan, Jingqi; Zhang, Hai; Yin, Ye; Li, Juxue; Tang, Yizhe; Purkayastha, Sudarshana; Li, Lianxi; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Yan, Jingqi; Zhang, Hai; Yin, Ye; Li, Juxue; Tang, Yizhe; Purkayastha, Sudarshana; Li, Lianxi; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	dongsheng.cai@einstein.yu.edu	Tang, Yizhe/A-8682-2014	Tang, Yizhe/0000-0001-5354-478X; yan, Jingqi/0000-0002-7024-6423	US National Institutes of Health [R01 DK078750, R01 AG031774, R01 HL113180, R01 DK 099136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank members of the Cai laboratory for providing technical assistance. This study was supported by US National Institutes of Health grants R01 DK078750, R01 AG031774, R01 HL113180 and R01 DK 099136 (all to D.C.).	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Beynon AL, 2009, NEUROIMMUNOMODULAT, V16, P392, DOI 10.1159/000228914; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; Bouret S, 2001, ENDOCRINOLOGY, V142, P4055, DOI 10.1210/en.142.9.4055; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dai Y, 2014, CNS NEUROL DISORD-DR, V13, P271, DOI 10.2174/18715273113126660134; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gao Y, 2014, GLIA, V62, P17, DOI 10.1002/glia.22580; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Ilzecka J, 2002, CYTOKINE, V20, P239, DOI 10.1006/cyto.2002.2005; Ito Y, 2013, J NEUROSCI, V 33, P17166, DOI 10.1523/JNEUROSCI.0897-13.2013; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Li JX, 2014, MOL METAB, V3, P313, DOI 10.1016/j.molmet.2014.01.012; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scherf W, 2005, EUR J IMMUNOL, V35, P198, DOI 10.1002/eji.200425209; Tang YZ, 2013, CELL CYCLE, V12, P2711, DOI 10.4161/cc.26054; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; WyssCoray T, 1997, J NEUROIMMUNOL, V77, P45, DOI 10.1016/S0165-5728(97)00049-0; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	60	93	94	4	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1001	1008		10.1038/nm.3616	http://dx.doi.org/10.1038/nm.3616			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25086906	Green Accepted			2022-12-25	WOS:000341404000012
J	Schachter, B				Schachter, Beth			Therapies of the state	NATURE BIOTECHNOLOGY			English	Article								What can governmental agencies do to lower the risk of cell therapies and the enterprises commercializing them?										Alliance for Regenerative Medicine, 2014, 2014 REG MED ANN IND; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798	2	14	14	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					736	741		10.1038/nbt.2984	http://dx.doi.org/10.1038/nbt.2984			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093881				2022-12-25	WOS:000346455900012
J	Thauvin-Robinet, C; Lee, JS; Lopez, E; Herranz-Perez, V; Shida, T; Franco, B; Jego, L; Ye, F; Pasquier, L; Loget, P; Gigot, N; Aral, B; Lopes, CAM; St-Onge, J; Bruel, AL; Thevenon, J; Gonzalez-Granero, S; Alby, C; Munnich, A; Vekemans, M; Huet, F; Fry, AM; Saunier, S; Riviere, JB; Attie-Bitach, T; Garcia-Verdugo, JM; Faivre, L; Megarbane, A; Nachury, MV				Thauvin-Robinet, Christel; Lee, Jaclyn S.; Lopez, Estelle; Herranz-Perez, Vicente; Shida, Toshinobu; Franco, Brunella; Jego, Laurence; Ye, Fan; Pasquier, Laurent; Loget, Philippe; Gigot, Nadege; Aral, Bernard; Lopes, Carla A. M.; St-Onge, Judith; Bruel, Ange-Line; Thevenon, Julien; Gonzalez-Granero, Susana; Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Huet, Frederic; Fry, Andrew M.; Saunier, Sophie; Riviere, Jean-Baptiste; Attie-Bitach, Tania; Garcia-Verdugo, Jose Manuel; Faivre, Laurence; Megarbane, Andre; Nachury, Maxence V.			The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator of centriole elongation	NATURE GENETICS			English	Article							HUMAN-CELLS; BIOGENESIS; PROTEIN; COMPLEX; LENGTH; CILIA; CYCLE; CPAP; ORGANIZATION; DUPLICATION	Centrioles are microtubule-based, barrel-shaped structures that initiate the assembly of centrosomes and cilia(1,2). How centriole length is precisely set remains elusive. The microcephaly protein CPAP (also known as MCPH6) promotes procentriole growth(3-5), whereas the oral-facial-digital (OFD) syndrome protein OFD1 represses centriole elongation(6,7). Here we uncover a new subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two affected families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2CD3 colocalizes with OFD1 at the distal end of centrioles, and C2CD3 physically associates with OFD1. However, whereas OFD1 deletion leads to centriole hyperelongation, loss of C2CD3 results in short centrioles without subdistal and distal appendages. Because C2CD3 overexpression triggers centriole hyperelongation and OFD1 antagonizes this activity, we propose that C2CD3 directly promotes centriole elongation and that OFD1 acts as a negative regulator of C2CD3. Our results identify regulation of centriole length as an emerging pathogenic mechanism in ciliopathies.	[Thauvin-Robinet, Christel; Lopez, Estelle; Jego, Laurence; Gigot, Nadege; Aral, Bernard; St-Onge, Judith; Bruel, Ange-Line; Thevenon, Julien; Huet, Frederic; Riviere, Jean-Baptiste; Faivre, Laurence] Univ Bourgogne, Fed Hosp Univ, Equipe Accueil Genet Anomalies Dev 4271, Dijon, France; [Thauvin-Robinet, Christel; Thevenon, Julien; Huet, Frederic; Faivre, Laurence] Ctr Hosp Univ Dijon, Reference Malad Rares Anomalies Dev & Syndromes, Dijon, France; [Lee, Jaclyn S.; Shida, Toshinobu; Ye, Fan; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cell Physiol, Stanford, CA 94305 USA; [Herranz-Perez, Vicente; Gonzalez-Granero, Susana; Garcia-Verdugo, Jose Manuel] Univ Valencia, Inst Cavanilles, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Lab Neurobiol Comparada, Valencia, Spain; [Herranz-Perez, Vicente; Gonzalez-Granero, Susana; Garcia-Verdugo, Jose Manuel] Univ Valencia, Inst Invest Sanitaria Hosp Fe, Unidad Mixta Esclerosis Multiple Neurorregen, Valencia, Spain; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Franco, Brunella] Univ Naples Federico II, Dept Med Translat Sci, Div Pediat, Naples, Italy; [Pasquier, Laurent] Ctr Hosp Univ Rennes, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Unite Fonctionnelle Genet Medicale, Rennes, France; [Loget, Philippe] Ctr Hosp Univ Rennes, Lab Anat Pathol, Rennes, France; [Gigot, Nadege; Aral, Bernard; St-Onge, Judith; Riviere, Jean-Baptiste] Ctr Hosp Univ Dijon, Lab Genet Mol Plateau Tech Biol, Dijon, France; [Lopes, Carla A. M.; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, Inst IMAGINE, INSERM U781, Paris, France; [Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Saunier, Sophie; Attie-Bitach, Tania] Paris Descartes Sorbonne Paris Cite Univ, Inst IMAGINE, Paris, France; [Munnich, Arnold; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Saunier, Sophie] INSERM, Lab Inherited Kidney Dis, UMRS 1163, Paris, France; [Megarbane, Andre] St Josephs Univ, Fac Med, Unite Genet Med, Beirut, Lebanon	Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Stanford University; CIBERNED; University of Valencia; University of Valencia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Dijon Bourgogne; University of Leicester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cell Physiol, Stanford, CA 94305 USA.	nachury@stanford.edu	Herranz-Pérez, Vicente/AAE-9196-2021; García-Verdugo, José Manuel/L-8421-2017; ATTIE-BITACH, Tania/K-1453-2017; Nachury, Maxence/A-8759-2008; Megarbane, Andre/ABD-5574-2021; Ye, Fan/K-1620-2015; Nachury, Maxence/H-3695-2019; González-Granero, Susana/Q-3861-2018; Pasquier, Laurent/AAN-4081-2020; Saunier, Sophie/G-6044-2015; Herranz-Pérez, Vicente/A-4605-2012; FRANCO, Brunella/S-2882-2018	Herranz-Pérez, Vicente/0000-0002-1969-1214; García-Verdugo, José Manuel/0000-0001-9872-6499; ATTIE-BITACH, Tania/0000-0002-1155-3626; Nachury, Maxence/0000-0003-4918-1562; Ye, Fan/0000-0002-5777-001X; Nachury, Maxence/0000-0003-4918-1562; González-Granero, Susana/0000-0003-1531-550X; Pasquier, Laurent/0000-0003-3985-1286; Saunier, Sophie/0000-0002-1069-0047; Herranz-Pérez, Vicente/0000-0002-1969-1214; Lopes, Carla A. M./0000-0003-3182-8305; FRANCO, Brunella/0000-0001-5588-4569; Frederic, HUET/0000-0002-4510-7093; Faivre, Laurence/0000-0001-9770-444X	NIGMS [GM089933]; GIS-Institut des Maladies Rares (HTS); French Ministry of Health [PHRC national 2010-A01014-35]; Regional Council of Burgundy; Wellcome Trust; Kidney Research UK; Fondazione Telethon [TGM11CB3]; European Community's Seventh Framework Programme (FP7) [241955]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (Will) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Kidney Research UK [RP2/2013] Funding Source: researchfish; Worldwide Cancer Research [13-0042] Funding Source: researchfish	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); GIS-Institut des Maladies Rares (HTS); French Ministry of Health; Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Wellcome Trust(Wellcome TrustEuropean Commission); Kidney Research UK(Kidney Research UK (KRUK)); Fondazione Telethon(Fondazione TelethonEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); Lung GO Sequencing Project; Women's Health Initiative (Will) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Kidney Research UK(Kidney Research UK (KRUK)); Worldwide Cancer Research	We thank L. Pelletier (Lunenfeld Institute, University of Toronto), M. Bornens (Institut Curie, Paris), C. Janke (Institut Curie, Orsay), T. Stearns (Stanford University) and A. Merdes (CNRS, Universite de Toulouse) for antibodies against SASS6, ninein, glutamylated tubulin, CEP164 and PCM-1, respectively, A. Liu for the C2cd3-mutant MEFs and C2cd3 cDNA, J. Reiter for Ofd1 cDNA, S. Munro for pRFP-PACT, V. Meyer (Genoscope, Centre National de Genotypage), T. Hardy (University of Leicester) and N. Elkhartoufi (Necker, Paris) for technical support, F. Collman (Stanford University) for help with serial alignment, members of the Nachury laboratory for helpful discussions, and the patients and their families for their participation. This work was supported by grants from NIGMS (GM089933 to M.V.N.), the GIS-Institut des Maladies Rares (HTS), the French Ministry of Health (PHRC national 2010-A01014-35), the Regional Council of Burgundy (to C.T.-R.), the Wellcome Trust and Kidney Research UK (to A.M.F.), and the Fondazione Telethon (TGM11CB3) and the European Community's Seventh Framework Programme (FP7/2007-2013; 241955) (to ER). We also thank the National Heart, Lung, and Blood Institute (NHLBI) Grand Opportunity (GO) Exome Sequencing Project (see URLs) and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (Will) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Lopez E, 2014, HUM GENET, V133, P367, DOI 10.1007/s00439-013-1385-1; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Poretti A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-4; Reddick LE, 2012, JOVE-J VIS EXP, DOI 10.3791/3650; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Zhang DP, 2012, CELL CYCLE, V11, P3861, DOI 10.4161/cc.22068; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	34	80	85	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					905	911		10.1038/ng.3031	http://dx.doi.org/10.1038/ng.3031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24997988	Green Accepted			2022-12-25	WOS:000339704400023
J	Calon, A; Lonardo, E; Berenguer-Llergo, A; Espinet, E; Hernando-Momblona, X; Iglesias, M; Sevillano, M; Palomo-Ponce, S; Tauriello, DVF; Byrom, D; Cortina, C; Morral, C; Barcelo, C; Tosi, S; Riera, A; Attolini, CSO; Rossell, D; Sancho, E; Batlle, E				Calon, Alexandre; Lonardo, Enza; Berenguer-Llergo, Antonio; Espinet, Elisa; Hernando-Momblona, Xavier; Iglesias, Mar; Sevillano, Marta; Palomo-Ponce, Sergio; Tauriello, Daniele V. F.; Byrom, Daniel; Cortina, Carme; Morral, Clara; Barcelo, Carles; Tosi, Sebastien; Riera, Antoni; Attolini, Camille Stephan-Otto; Rossell, David; Sancho, Elena; Batlle, Eduard			Stromal gene expression defines poor-prognosis subtypes in colorectal cancer	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; HUMAN-COLON; TGF-BETA; STEM-CELL; MOLECULAR SUBTYPES; TUMOR-GROWTH; GENOME; RECEPTOR; TUMORIGENESIS; METASTASIS	Recent molecular classifications of colorectal cancer (CRC) based on global gene expression profiles have defined subtypes displaying resistance to therapy and poor prognosis. Upon evaluation of these classification systems, we discovered that their predictive power arises from genes expressed by stromal cells rather than epithelial tumor cells. Bioinformatic and immunohistochemical analyses identify stromal markers that associate robustly with disease relapse across the various classifications. Functional studies indicate that cancer-associated fibroblasts (CAFs) increase the frequency of tumor-initiating cells, an effect that is dramatically enhanced by transforming growth factor (TGF)-beta signaling. Likewise, we find that all poor-prognosis CRC subtypes share a gene program induced by TGF-beta in tumor stromal cells. Using patient-derived tumor organoids and xenografts, we show that the use of TGF-beta signaling inhibitors to block the cross-talk between cancer cells and the microenvironment halts disease progression.	[Calon, Alexandre; Lonardo, Enza; Berenguer-Llergo, Antonio; Espinet, Elisa; Hernando-Momblona, Xavier; Sevillano, Marta; Palomo-Ponce, Sergio; Tauriello, Daniele V. F.; Byrom, Daniel; Cortina, Carme; Morral, Clara; Barcelo, Carles; Tosi, Sebastien; Riera, Antoni; Attolini, Camille Stephan-Otto; Rossell, David; Sancho, Elena; Batlle, Eduard] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Iglesias, Mar] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Iglesias, Mar] Hosp del Mar, Res Inst IMIM, Canc Res Program, Barcelona, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; ICREA	Batlle, E (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	eduard.batlle@irbbarcelona.org	Espinet, Elisa/ABI-5385-2020; Sancho, Elena/ABH-4867-2020; Hernando-Momblona, Xavier/ABH-4881-2020; Calon, Alexandre/GPK-2061-2022; Cortina Duran, Carme/K-7203-2017; Tauriello, Daniele/H-4644-2018; Rossell, David/AAM-4292-2021; lonardo, enza/AAI-5726-2020; Palomo-Ponce, Sergio/L-2749-2017; Batlle, Eduard/K-8080-2014; Riera, Antoni/C-4385-2008	Espinet, Elisa/0000-0002-0690-9878; Sancho, Elena/0000-0002-8182-513X; Cortina Duran, Carme/0000-0003-3477-4322; Tauriello, Daniele/0000-0003-1522-3496; Rossell, David/0000-0002-7104-5789; Palomo-Ponce, Sergio/0000-0002-3371-6457; Batlle, Eduard/0000-0003-2422-0326; Riera, Antoni/0000-0001-7142-7675; Lonardo, Enza/0000-0001-6654-1043; Hernando-Momblona, Xavier/0000-0003-0755-333X; Tosi, Sebastien/0000-0001-8348-2778; SEVILLANO, MARTA/0000-0001-5761-0879; Berenguer-LLergo, Antoni/0000-0002-3742-8161; Stephan-Otto Attolini, Camille/0000-0001-8045-320X	Spanish Ministry of Economy and Competitiveness; Fundacion Olga Torres; Doctor Josef Steiner Foundation; AECC; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III [RTICC:RD12/0036/0024]; Xarxa de Bancs de Tumors - Pla Director d'Oncologia de Catalunya (XBTC); Asociacion Espanola contra el Cancer (AECC);  [SAF2011-27068]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Olga Torres; Doctor Josef Steiner Foundation; AECC; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xarxa de Bancs de Tumors - Pla Director d'Oncologia de Catalunya (XBTC); Asociacion Espanola contra el Cancer (AECC); ; ICREA(ICREA)	We thank G. Stassi (University of Palermo) for providing PDO7 and PDO8, L. Wakefield (US National Cancer Institute) for providing the plasmid encoding DNR, I. Joval for assistance in mounting the figures, M. Virtudes Cespedes and R. Mangues (IIB Sant Pau) for logistic support with CRC samples, and all members of the Batlle laboratory for support and discussions We are grateful for the excellent assistance of the IRB Barcelona core facilities for Histology, Functional Genomics and Advanced Digital Micropscopy. D.V.F.T. holds a Juan de la Cierva postdoctoral fellowship, from the Spanish Ministry of Economy and Competitiveness, and E.L. holds a fellowship from Fundacion Olga Torres and Asociacion Espanola contra el Cancer (AECC). This work has been supported by grants from the Doctor Josef Steiner Foundation, AECC, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III (RTICC:RD12/0036/0024) and grant SAF2011-27068, the latter two from the Spanish Ministry of Economy and Competitiveness, and by 'Xarxa de Bancs de Tumors' sponsored by Pla Director d'Oncologia de Catalunya (XBTC).	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berdiel-Acer M, 2014, ONCOTARGET, V5, P6437, DOI 10.18632/oncotarget.2237; Bottinger EP, 1997, CANCER RES, V57, P5564; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; MORIKAWA K, 1988, CANCER RES, V48, P1943; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; O'Shannessy DJ, 2014, ONCOTARGET, V5, P3983, DOI 10.18632/oncotarget.2108; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pathmanathan S, 2011, BIOCHEM SOC T, V39, P694, DOI 10.1042/BST0390694; R Core Team, 2014, R LANG ENV STAT COMP; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Witten IH, 1999, P ICONIP ANZIIS ANNE, V99, P192; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	54	667	683	4	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					320	U62		10.1038/ng.3225	http://dx.doi.org/10.1038/ng.3225			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25706628	Green Accepted			2022-12-25	WOS:000351922900006
J	Ashton, PM; Nair, S; Dallman, T; Rubino, S; Rabsch, W; Mwaigwisya, S; Wain, J; O'Grady, J				Ashton, Philip M.; Nair, Satheesh; Dallman, Tim; Rubino, Salvatore; Rabsch, Wolfgang; Mwaigwisya, Solomon; Wain, John; O'Grady, Justin			MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island	NATURE BIOTECHNOLOGY			English	Article							TYPHI	Short-read, high-throughput sequencing technology cannot identify the chromosomal position of repetitive insertion sequences that typically flank horizontally acquired genes such as bacterial virulence genes and antibiotic resistance genes. The MinION nanopore sequencer can produce long sequencing reads on a device similar in size to a USB memory stick. Here we apply a MinION sequencer to resolve the structure and chromosomal insertion site of a composite antibiotic resistance island in Salmonella Typhi Haplotype 58. Nanopore sequencing data from a single 18-h run was used to create a scaffold for an assembly generated from short-read Illumina data. Our results demonstrate the potential of the MinION device in clinical laboratories to fully characterize the epidemic spread of bacterial pathogens.	[Ashton, Philip M.; Nair, Satheesh; Dallman, Tim] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Rubino, Salvatore] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Rabsch, Wolfgang] Robert Koch Inst, Natl Reference Ctr Salmonellae & Other Enter, Wernigerode, Germany; [Mwaigwisya, Solomon; Wain, John; O'Grady, Justin] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; University of Sassari; King Faisal Specialist Hospital & Research Center; Robert Koch Institute; University of East Anglia	O'Grady, J (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	tim.dallman@phe.gov.uk; justin.ogrady@uea.ac.uk	Rubino, Salvatore/AAC-5848-2022; Barac, Aleksandra/W-9785-2019; O'Grady, Justin/I-2982-2012; Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	O'Grady, Justin/0000-0001-5412-7152; Nair, Satheesh/0000-0002-7297-1485; Wain, John Richard/0000-0002-1257-1148	University of East Anglia; Oxford Nanopore Technologies Ltd.	University of East Anglia; Oxford Nanopore Technologies Ltd.	M. Day (Salmonella Reference Unit, Public Health England) for antibiotic susceptibility tests. J.O'G. and J.W. were funded by the University of East Anglia. We would like to thank Oxford Nanopore Technologies Ltd. for including us in the MinION Access Programme. We would also like to thank L. Nederbragt for a thorough review and contributions toward the presentation of Figure 1.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; CALLOW B R, 1959, J Hyg (Lond), V57, P346; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Grimont P., 2007, WHO COLLABORATING CT, Vninth; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kim K.E., 2014, PREPRINT; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Livermore DM, 2013, INFECT CHEMOTHER, V45, P1, DOI 10.3947/ic.2013.45.1.1; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Underwood AP, 2013, J CLIN MICROBIOL, V51, P232, DOI 10.1128/JCM.01696-12; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Wain J, 2013, EXPERT REV MOL DIAGN, V13, P225, DOI [10.1586/erm.13.8, 10.1586/ERM.13.8]; Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590	31	267	284	7	214	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					296	+		10.1038/nbt.3103	http://dx.doi.org/10.1038/nbt.3103			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485618	Green Accepted			2022-12-25	WOS:000350766900027
J	Bronte, V; Murray, PJ				Bronte, Vincenzo; Murray, Peter J.			Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer	NATURE MEDICINE			English	Editorial Material							TUMOR-ASSOCIATED MACROPHAGES; DIFFERENTIATION; POLARIZATION; RESPONSES; REVEALS	Recent studies have suggested that manipulating the tumor-associated macrophage phenotype is a valid therapeutic approach in cancer. In turn, these studies have given some insight into the factors that polarize macrophages, thereby suggesting alternative therapeutic avenues.	[Bronte, Vincenzo] Univ Verona, Verona Univ Hosp, I-37100 Verona, Italy; [Bronte, Vincenzo] Univ Verona, Dept Pathol, Immunol Sect, I-37100 Verona, Italy; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Bronte, V (corresponding author), Univ Verona, Verona Univ Hosp, I-37100 Verona, Italy.	vincenzo.bronte@univr.it; peter.murray@stjude.org	Bronte, Vincenzo/K-7902-2016; Murray, Peter J/K-4725-2018	Bronte, Vincenzo/0000-0002-3741-5141; Murray, Peter J/0000-0001-6329-9802				Cassier PA, 2012, CANCER-AM CANCER SOC, V118, P1649, DOI 10.1002/cncr.26409; Cavnar MJ, 2013, J EXP MED, V210, P2873, DOI 10.1084/jem.20130875; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sauter KA, 2014, J LEUKOCYTE BIOL, V96, P265, DOI 10.1189/jlb.2A0114-006R; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006	17	100	102	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					117	119		10.1038/nm.3794	http://dx.doi.org/10.1038/nm.3794			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25654601				2022-12-25	WOS:000348974800012
J	Dolgin, E				Dolgin, Elie			Antidotes progress for new oral clotbusters	NATURE BIOTECHNOLOGY			English	News Item																		2014, N ENGL J MED, V371, P2141; 2014, NATURE REV DRUG DISC, V13, P571	2	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					117	118		10.1038/nbt0215-117	http://dx.doi.org/10.1038/nbt0215-117			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658260				2022-12-25	WOS:000349198800004
J	Durao, P; Aigner, H; Nagy, P; Mueller-Cajar, O; Hartl, FU; Hayer-Hartl, M				Durao, Paulo; Aigner, Harald; Nagy, Peter; Mueller-Cajar, Oliver; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Opposing effects of folding and assembly chaperones on evolvability of Rubisco	NATURE CHEMICAL BIOLOGY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; ESCHERICHIA-COLI; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; HEXADECAMERIC RUBISCO; DIRECTED EVOLUTION; PROTEIN EVOLUTION; SEQUENCE SPACE; ENZYME; OXYGENASE; SELECTION	Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) catalyzes the fixation of CO2 in photosynthesis. Despite its pivotal role, Rubisco is an inefficient enzyme and thus is a key target for directed evolution. Rubisco biogenesis depends on auxiliary factors, including the GroEL/ES-type chaperonin for folding and the chaperone RbcX for assembly. Here we performed directed evolution of cyanobacterial form I Rubisco using a Rubisco-dependent Escherichia coli strain. Overexpression of GroEL/ES enhanced Rubisco solubility and tended to expand the range of permissible mutations. In contrast, the specific assembly chaperone RbcX had a negative effect on evolvability by preventing a subset of mutants from forming holoenzyme. Mutation F140I in the large Rubisco subunit, isolated in the absence of RbcX, increased carboxylation efficiency approximately threefold without reducing CO2 specificity. The F140I mutant resulted in a similar to 55% improved photosynthesis rate in Synechocystis PCC6803. The requirement of specific biogenesis factors downstream of chaperonin may have retarded the natural evolution of Rubisco.	[Durao, Paulo; Aigner, Harald; Nagy, Peter; Mueller-Cajar, Oliver; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Durao, Paulo/I-3973-2014; Mueller-Cajar, Oliver/A-7237-2018; Durao, Paulo/AAI-5350-2020; Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Durao, Paulo/0000-0002-4411-2958; Mueller-Cajar, Oliver/0000-0003-2866-5963; Durao, Paulo/0000-0002-4411-2958; Hayer-Hartl, Manajit/0000-0001-8213-6742				AMICHAY D, 1993, PLANT MOL BIOL, V23, P465, DOI 10.1007/BF00019295; Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Bogumil D, 2012, GENOME BIOL EVOL, V4, P618, DOI 10.1093/gbe/evs025; Bogumil D, 2010, GENOME BIOL EVOL, V2, P602, DOI 10.1093/gbe/evq044; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cai Z, 2014, PROTEIN CELL, V5, P552, DOI 10.1007/s13238-014-0072-x; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; CHEN ZX, 1993, PLANT PHYSIOL, V101, P1189, DOI 10.1104/pp.101.4.1189; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; DELIEU TJ, 1983, PLANT PHYSIOL, V73, P534, DOI 10.1104/pp.73.3.534; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; HUDSON GS, 1992, AUST J PLANT PHYSIOL, V19, P213, DOI 10.1071/PP9920213; KANE HJ, 1994, AUST J PLANT PHYSIOL, V21, P449, DOI 10.1071/PP9940449; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Marcus Y, 2005, J BACTERIOL, V187, P4222, DOI 10.1128/JB.187.12.4222-4228.2005; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Parikh MR, 2006, PROTEIN ENG DES SEL, V19, P113, DOI 10.1093/protein/gzj010; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; SPREITZER RJ, 1993, ANNU REV PLANT PHYS, V44, P411, DOI 10.1146/annurev.pp.44.060193.002211; Tabita FR, 2007, CELL, V129, P1039, DOI 10.1016/j.cell.2007.06.002; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tcherkez G, 2005, FUNCT PLANT BIOL, V32, P277, DOI 10.1071/FP04211; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Toth-Petroczy A, 2011, P NATL ACAD SCI USA, V108, P11151, DOI 10.1073/pnas.1015994108; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	55	61	63	7	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					148	U94		10.1038/NCHEMBIO.1715	http://dx.doi.org/10.1038/NCHEMBIO.1715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25558973				2022-12-25	WOS:000348358800013
J	Wang, XL; Wang, YB; Wu, XW; Wang, JH; Wang, YJ; Qiu, ZJ; Chang, T; Huang, H; Lin, RJ; Yee, HK				Wang, Xiaoling; Wang, Yebo; Wu, Xiwei; Wang, Jinhui; Wang, Yingjia; Qiu, Zhaojun; Chang, Tammy; Huang, He; Lin, Ren-Jang; Yee, Jiing-Kuan			Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; NUCLEASE SPECIFICITY; CAS9; CRISPR/CAS; DNA; DELETIONS; NICKASES; SYSTEMS	The utility of CRISPR-Cas9 and TALENs for genome editing may be compromised by their off-target activity. We show that integrase-defective lentiviral vectors (IDLVs) can detect such off-target cleavage with a frequency as low as 1%. In the case of Cas9, we find frequent off-target sites with a one-base bulge or up to 13 mismatches between the single guide RNA (sgRNA) and its genomic target; which refines sgRNA design.	[Wang, Xiaoling; Wang, Yebo; Wang, Yingjia; Chang, Tammy; Yee, Jiing-Kuan] Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA; [Wang, Yebo; Wang, Yingjia; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xiwei; Wang, Jinhui; Qiu, Zhaojun; Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Yee, HK (corresponding author), Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA.	jyee@coh.org	; Lin, Ren-Jang/G-2052-2014	huang, he/0000-0002-2723-1621; Lin, Ren-Jang/0000-0002-2738-2438	California Institute of Regenerative Medicine [RB3-02161]; Nesvig Foundation; Beckman Research Institute Excellence Award; China Scholarship Council; National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China; Zhejiang Provincial Major Science and Technology Project	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Nesvig Foundation; Beckman Research Institute Excellence Award; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Major Science and Technology Project	This work is supported by a grant RB3-02161 from California Institute of Regenerative Medicine (J.-K.Y.), grants from Nesvig Foundation and Beckman Research Institute Excellence Award (R.-J.L.). Y.B.W. is support by a grant from China Scholarship Council and Y.J.W. was supported by grants from National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Major Science and Technology Project and China Scholarship Council.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	15	305	331	5	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					175	178		10.1038/nbt.3127	http://dx.doi.org/10.1038/nbt.3127			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599175				2022-12-25	WOS:000349198800023
J	Tripathy, SK; Weil, SJ; Chen, C; Anand, P; Vallee, RB; Gross, SP				Tripathy, Suvranta K.; Weil, Sarah J.; Chen, Chen; Anand, Preetha; Vallee, Richard B.; Gross, Steven P.			Autoregulatory mechanism for dynactin control of processive and diffusive dynein transport	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC DYNEIN; MICROTUBULE-BINDING; IN-VITRO; P150(GLUED); COMPLEX; DYNAMICS; REVEALS; MOTION; DOMAIN; FORCE	Dynactin is the longest known cytoplasmic dynein regulator, with roles in dynein recruitment to subcellular cargo and in stimulating processive dynein movement. The latter function was thought to involve the N-terminal microtubule-binding region of the major dynactin polypeptide p150(Glued), although recent results disputed this. To understand how dynactin regulates dynein we generated recombinant fragments of the N-terminal half of p150(Glued). We find that the dynein-binding coiled-coil alpha-helical domain CC1B is sufficient to stimulate dynein processivity, which it accomplishes by increasing average dynein step size and forward-step frequency, while decreasing lateral stepping and microtubule detachment. In contrast, the immediate upstream coiled-coil domain, CC1A, activates a surprising diffusive dynein state. CC1A interacts physically with CC1B and interferes with its effect on dynein processivity. We also identify a role for the N-terminal portion of p150(Glued) in coordinating these activities. Our results reveal an unexpected form of long-range allosteric control of dynein motor function by internal p150(Glued) sequences, and evidence for p150(Glued) autoregulation.	[Tripathy, Suvranta K.; Anand, Preetha; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Weil, Sarah J.; Chen, Chen; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Weil, Sarah J.; Chen, Chen] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of California System; University of California Irvine; Columbia University; Columbia University	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu; sgross@uci.edu	Tripathy, Suvranta/ABB-5152-2020	Tripathy, Suvranta/0000-0002-6658-1691	 [GM102347];  [GM070676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R01GM102347, R01GM070676] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. McKenney for help in initiating this project and A. Baffet for helpful comments on the manuscript. Support by GM102347 to R.B.V. and GM070676 to S.P.G	Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Bohm KJ, 2000, CELL BIOL INT, V24, P335, DOI 10.1006/cbir.1999.0515; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; PASCHAL BM, 1993, J BIOL CHEM, V268, P15318; PASCHAL BM, 1991, METHOD ENZYMOL, V196, P181; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rao L, 2013, MOL BIOL CELL, V24, P2362, DOI 10.1091/mbc.E13-03-0166; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Scherer J, 2014, J CELL BIOL, V205, P163, DOI 10.1083/jcb.201307116; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Sigua R, 2012, JOVE-J VIS EXP, DOI 10.3791/3501; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tang XY, 2012, J CELL BIOL, V196, P743, DOI 10.1083/jcb.201112017; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076	57	46	47	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1192	U147		10.1038/ncb3063	http://dx.doi.org/10.1038/ncb3063			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25419851	Green Accepted			2022-12-25	WOS:000345777300010
J	Anderson, RJ; Tang, CW; Daniels, NJ; Compton, BJ; Hayman, CM; Johnston, KA; Knight, DA; Gasser, O; Poyntz, HC; Ferguson, PM; Larsen, DS; Ronchese, F; Painter, GF; Hermans, IF				Anderson, Regan J.; Tang, Ching-wen; Daniels, Naomi J.; Compton, Benjamin J.; Hayman, Colin M.; Johnston, Karen A.; Knight, Deborah A.; Gasser, Olivier; Poyntz, Hazel C.; Ferguson, Peter M.; Larsen, David S.; Ronchese, Franca; Painter, Gavin F.; Hermans, Ian F.			A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-GALACTOSYLCERAMIDE; DENDRITIC CELLS; NKT CELLS; IN-VIVO; AIRWAY INFLAMMATION; TLR7 AGONIST; ANTIGEN; LIGAND; HELP; ACTIVATION	Epitope-based peptide vaccines encompass minimal immunogenic regions of protein antigens to allow stimulation of precisely targeted adaptive immune responses. However, because efficacy is largely determined by the functional status of antigen-presenting cells (APCs) that acquire and present peptides to cells of the adaptive immune system, adjuvant compounds are needed to enhance immunogenicity. We present here a vaccine consisting of an allergen-derived peptide conjugated to a pro-drug of the natural killer-like T (NKT) cell agonist a-galactosylceramide, which is highly effective in reducing inflammation in a mouse model of allergic airway inflammation. Unlike other peptide-adjuvant conjugates that directly activate APCs through pattern recognition pathways, this vaccine encourages third-party interactions with NKT cells to enhance APC function. Therapeutic efficacy was correlated with marked increases in the number and functional activity of allergen-specific cytotoxic T lymphocytes (CTLs), leading to suppression of immune infiltration into the lungs after allergen challenge in sensitized hosts.	[Anderson, Regan J.; Compton, Benjamin J.; Hayman, Colin M.; Johnston, Karen A.; Painter, Gavin F.] Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand; [Tang, Ching-wen; Daniels, Naomi J.; Knight, Deborah A.; Gasser, Olivier; Poyntz, Hazel C.; Ronchese, Franca; Hermans, Ian F.] Malaghan Inst Med Res, Wellington, New Zealand; [Daniels, Naomi J.] Wellington Sch Med & Hlth Sci, Dept Pathol & Mol Med, Wellington, New Zealand; [Ferguson, Peter M.] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Larsen, David S.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington; Malaghan Institute; Victoria University Wellington; University of Otago; University of Otago; Victoria University Wellington	Anderson, RJ (corresponding author), Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand.	gavin.painter@vuw.ac.nz; ihermans@malaghan.org.nz	Ronchese, Franca/M-9618-2019; Hermans, Ian/I-3961-2013; Larsen, David S/A-6367-2014	Ronchese, Franca/0000-0001-5835-8230; Larsen, David S/0000-0002-3563-1086; Ferguson, Peter M./0000-0002-8335-0406; Gasser, Olivier/0000-0002-8235-2274; Compton, Benjamin/0000-0002-5245-9767; Hermans, Ian/0000-0002-7584-887X; Anderson, Regan/0000-0003-3467-9202	New Zealand Ministry of Science and Innovation [C08X0808]; research grant from the New Zealand Health Research Council; Rotary Club of Wellington; University of Otago; US National Institutes of Health Tetramer Core Facility [HHSN272201300006C]	New Zealand Ministry of Science and Innovation; research grant from the New Zealand Health Research Council; Rotary Club of Wellington; University of Otago; US National Institutes of Health Tetramer Core Facility	We thank the personnel of the Biomedical Research Unit of the Malaghan Institute of Medical Research for animal husbandry, K. Price for flow cytometry support, and the US National Institutes of Health Tetramer Core Facility (contract HHSN272201300006C) for provision of CD1d monomers. This research was supported by the New Zealand Ministry of Science and Innovation (C08X0808) and a research grant from the New Zealand Health Research Council to ER. N.J.D. was supported by the Rotary Club of Wellington and the University of Otago.	Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; ALEXANDER J, 1988, J MED CHEM, V31, P318, DOI 10.1021/jm00397a008; ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Enomoto N, 2012, J IMMUNOL, V188, P1734, DOI 10.4049/jimmunol.1102699; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Flechtner JB, 2006, J IMMUNOL, V177, P1017, DOI 10.4049/jimmunol.177.2.1017; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hunn MK, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23789; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kim JO, 2004, J ALLERGY CLIN IMMUN, V114, P1332, DOI 10.1016/j.jaci.2004.09.004; Kitamura H, 2000, CELL IMMUNOL, V199, P37, DOI 10.1006/cimm.1999.1602; Lang GA, 2006, IMMUNOLOGY, V119, P116, DOI 10.1111/j.1365-2567.2006.02413.x; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Morishima Y, 2005, EUR J IMMUNOL, V35, P2803, DOI 10.1002/eji.200525994; Mustapa MFM, 2009, BIOCONJUGATE CHEM, V20, P518, DOI 10.1021/bc800450r; Oh JZ, 2010, J IMMUNOL, V185, P4602, DOI 10.4049/jimmunol.1001892; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stober D, 2003, J IMMUNOL, V170, P2540, DOI 10.4049/jimmunol.170.5.2540; Tighe H, 2000, EUR J IMMUNOL, V30, P1939, DOI 10.1002/1521-4141(200007)30:7<1939::AID-IMMU1939>3.0.CO;2-#; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vecchi S, 2014, EUR J PHARM BIOPHARM, V87, P310, DOI 10.1016/j.ejpb.2014.01.002; Wells JW, 2007, J ALLERGY CLIN IMMUN, V119, P226, DOI 10.1016/j.jaci.2006.09.004; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	46	56	59	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					943	949		10.1038/NCHEMBIO.1640	http://dx.doi.org/10.1038/NCHEMBIO.1640			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25282504				2022-12-25	WOS:000343621500017
J	Bruns, I; Lucas, D; Pinho, S; Ahmed, J; Lambert, MP; Kunisaki, Y; Scheiermann, C; Schiff, L; Poncz, M; Bergman, A; Frenette, PS				Bruns, Ingmar; Lucas, Daniel; Pinho, Sandra; Ahmed, Jalal; Lambert, Michele P.; Kunisaki, Yuya; Scheiermann, Christoph; Schiff, Lauren; Poncz, Mortimer; Bergman, Aviv; Frenette, Paul S.			Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion	NATURE MEDICINE			English	Article							PLATELET FACTOR-IV; BONE-MARROW; TRANSGENIC MICE; NICHE; PROLIFERATION; CHEMOKINES; CYTOKINES; PLATELET-FACTOR-4; INHIBITION; ALPHA	In the bone marrow, hematopoietic stem cells (HSCs) lodge in specialized microenvironments that tightly control the proliferative state of HSCs to adapt to the varying needs for replenishment of blood cells while also preventing HSC exhaustion(1). All putative niche cells suggested thus far have a nonhematopoietic origin(2-8). Thus, it remains unclear how feedback from mature cells is conveyed to HSCs to adjust their proliferation. Here we show that megakaryocytes (MKs) can directly regulate HSC pool size in mice. Three-dimensional whole-mount imaging revealed that endogenous HSCs are frequently located adjacent to MKs in a nonrandom fashion. Selective in vivo depletion of MKs resulted in specific loss of HSC quiescence and led to a marked expansion of functional HSCs. Gene expression analyses revealed that MKs are the source of chemokine C-X-C motif ligand 4 (CXCL4, also named platelet factor 4 or PF4) in the bone marrow, and we found that CXCL4 regulates HSC cell cycle activity. CXCL4 injection into mice resulted in a reduced number of HSCs because of their increased quiescence. By contrast, Cxcl(4-/-) mice exhibited an increased number of HSCs and increased HSC proliferation. Combined use of whole-mount imaging and computational modeling was highly suggestive of a megakaryocytic niche capable of independently influencing HSC maintenance by regulating quiescence. These results indicate that a terminally differentiated cell type derived from HSCs contributes to the HSC niche, directly regulating HSC behavior.	[Bruns, Ingmar; Lucas, Daniel; Pinho, Sandra; Ahmed, Jalal; Kunisaki, Yuya; Scheiermann, Christoph; Schiff, Lauren; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Bruns, Ingmar] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Bruns, Ingmar; Lucas, Daniel; Pinho, Sandra; Ahmed, Jalal; Kunisaki, Yuya; Scheiermann, Christoph; Schiff, Lauren; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Ahmed, Jalal; Frenette, Paul S.] Mt Sinai Sch Med, New York, NY USA; [Poncz, Mortimer] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Heinrich Heine University Dusseldorf; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA.	paul.frenette@einstein.yu.edu	Scheiermann, Christoph/B-8261-2014; Pinho, Sandra/GWC-8029-2022; Frenette, Paul S/J-8272-2012; Lucas, Daniel/ABB-6893-2021; Lambert, Michele P./AAB-9225-2021	Scheiermann, Christoph/0000-0002-9212-0995; Frenette, Paul S/0000-0003-0862-9922; Lucas, Daniel/0000-0002-0147-5425; Lambert, Michele P./0000-0003-0439-402X; Pinho, Sandra/0000-0002-5241-7364; Bruns, Ingmar/0000-0001-6316-8378; Schiff, Lauren/0000-0003-2438-2456	American Society of Hematology-European Hematology Association (ASH-EHA); University of Dusseldorf; New York Stem Cell Foundation-Druckenmiller Fellow; Integrated Training in Pharmacological Science program [NIGMS T32 063754]; New York Stem Cell Foundation; New York State Department of Health (NYSTEM Program); US National Institutes of Health (NIH) [R01 DK056638, HL069438, CA164468, DA033788, P01 HL110860, U01 HL099656]; NATIONAL CANCER INSTITUTE [R01CA164468, P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099656, P01HL110860, U01HL099993, P01HL064190, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033788] Funding Source: NIH RePORTER	American Society of Hematology-European Hematology Association (ASH-EHA); University of Dusseldorf; New York Stem Cell Foundation-Druckenmiller Fellow; Integrated Training in Pharmacological Science program; New York Stem Cell Foundation; New York State Department of Health (NYSTEM Program); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Prophete and P. Ciero for mouse husbandry and L. Tesfa, O. Uche and J. Zhang for technical assistance with sorting. I.B. was supported by the American Society of Hematology-European Hematology Association (ASH-EHA) research exchange award and the University of Dusseldorf. S.P. is a New York Stem Cell Foundation-Druckenmiller Fellow. J.A. was supported by the Integrated Training in Pharmacological Science program, NIGMS T32 063754. This work was supported by the New York Stem Cell Foundation and the New York State Department of Health (NYSTEM Program) and by grants from the US National Institutes of Health (NIH; R01 grants DK056638 and HL069438 to P.S.E, CA164468 and DA033788 to A.B. and P01 HL110860 and U01 HL099656 to M.P.).	Aivado M, 2007, P NATL ACAD SCI USA, V104, P1307, DOI 10.1073/pnas.0610330104; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Broxmeyer HE, 2006, EXP HEMATOL, V34, P1069, DOI 10.1016/j.exphem.2006.04.007; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Eslin DE, 2004, BLOOD, V104, P3173, DOI 10.1182/blood-2003-11-3994; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; FASANO G, 1987, MON NOT R ASTRON SOC, V225, P155, DOI 10.1093/mnras/225.1.155; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Han ZC, 1997, BLOOD, V89, P2328, DOI 10.1182/blood.V89.7.2328; HAN ZC, 1990, BLOOD, V75, P1234; Heazlewood SY, 2013, STEM CELL RES, V11, P782, DOI 10.1016/j.scr.2013.05.007; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; LU L, 1993, EXP HEMATOL, V21, P1442; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PEACOCK JA, 1983, MON NOT R ASTRON SOC, V202, P615, DOI 10.1093/mnras/202.3.615; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Press W. H., 1992, ART SCI COMPUTING; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; STENBERG PE, 1991, J CELL PHYSIOL, V147, P7, DOI 10.1002/jcp.1041470103; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	40	376	385	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1315	1320		10.1038/nm.3707	http://dx.doi.org/10.1038/nm.3707			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326802	Green Accepted			2022-12-25	WOS:000344724300021
J	Chalcrabarti, R; Wei, Y; Hwang, J; Hang, X; Blanco, MA; Choudhury, A; Tiede, B; Romano, RA; DeCoste, C; Mercatali, L; Ibrahim, T; Amadori, D; Kannan, N; Eaves, CJ; Sinha, S; Kang, YB				Chalcrabarti, Rumela; Wei, Yong; Hwang, Julie; Hang, Xiang; Blanco, Mario Andres; Choudhury, Abrar; Tiede, Benjamin; Romano, Rose-Anne; DeCoste, Christina; Mercatali, Laura; Ibrahim, Toni; Amadori, Dino; Kannan, Nagarajan; Eaves, Connie J.; Sinha, Satrajit; Kang, Yibin			Delta Np63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling	NATURE CELL BIOLOGY			English	Article							P63; METASTASIS; ACTIVATION; MOUSE; GENE; PROLIFERATION; SURVIVAL; TARGET; MODELS; GROWTH	Emerging evidence suggests that cancer is populated and maintained by tumour-initiating cells (TICs) with stem-like properties similar to those of adult tissue stem cells. Despite recent advances, the molecular regulatory mechanisms that may be shared between normal and malignant stem cells remain poorly understood. Here we show that the Delta Np63 isoform of the Trp63 transcription factor promotes normal mammary stem cell (MaSC) activity by increasing the expression of the Wnt receptor Fzd7, thereby enhancing Wnt signalling. Importantly, Fzd7-dependent enhancement of Wnt signalling by Delta Np63 also governs tumour-initiating activity of the basal subtype of breast cancer. These findings establish Delta Np63 as a key regulator of stem cells in both normal and malignant mammary tissues and provide direct evidence that breast cancer TICs and normal MaSCs share common regulatory mechanisms.	[Chalcrabarti, Rumela; Wei, Yong; Hwang, Julie; Hang, Xiang; Blanco, Mario Andres; Choudhury, Abrar; Tiede, Benjamin; DeCoste, Christina; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Blanco, Mario Andres] Harvard Univ, Boston Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Romano, Rose-Anne; Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA; [Mercatali, Laura; Ibrahim, Toni; Amadori, Dino] IRCCS, Osteoncol & Rare Tumors Ctr, Ist Sci Romagnolo Studio & Cura Turmoil IRST, I-47014 Meldola, Italy; [Kannan, Nagarajan; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Kang, Yibin] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Princeton University; Harvard University; Boston Children's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; British Columbia Cancer Agency; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu	Mercatali, Laura/J-9154-2016	Mercatali, Laura/0000-0003-2162-8238; Kannan, Nagarajan/0000-0002-8825-2178; Ibrahim, Toni/0000-0003-0259-4167; Choudhury, Abrar/0000-0001-8312-2457; Kang, Yibin/0000-0002-1626-6730; Eaves, Connie/0000-0002-3452-1926; Blanco, M. Andres/0000-0003-4404-2301	Brewster Foundation; Department of Defense [BC123187]; National Institutes of Health [R01CA134519, R01CA141062]; Canadian Cancer Society Research Institute; Department of Defense; MITACS; Transgenic/Knockout, Tissue Analytic Service and Flow Cytometry Shared Resources of the Cancer Institute of New Jersey [P30CA072720]	Brewster Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Department of Defense(United States Department of Defense); MITACS; Transgenic/Knockout, Tissue Analytic Service and Flow Cytometry Shared Resources of the Cancer Institute of New Jersey	We thank our laboratory members for helpful discussions, R. A. Weinberg and Karantza for iMMEC and HMLE cell lines, and A. L. Welm and M. T. Lewis for PDX lines, respectively. This research was supported by grants from the Brewster Foundation, the Department of Defense (BC123187) and the National Institutes of Health (R01CA134519 and R01CA141062) to Y.K. and from the Canadian Cancer Society Research Institute to C.J.E. R.C. and N.K. are recipients of postdoctoral fellowships from the Department of Defense and MITACS, respectively. This research was also supported by the Transgenic/Knockout, Tissue Analytic Service and Flow Cytometry Shared Resources of the Cancer Institute of New Jersey (P30CA072720).	Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Barton CE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.49; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; DiRenzo J, 2002, CANCER RES, V62, P89; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Maddox J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003048; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Makarem M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001630; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Molyneux G, 2011, J MAMMARY GLAND BIOL, V16, P51, DOI 10.1007/s10911-011-9202-8; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	63	132	137	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					1004	1015		10.1038/ncb3040	http://dx.doi.org/10.1038/ncb3040			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25241036	Green Accepted			2022-12-25	WOS:000342712200010
J	Feng, YH; De Franceschi, G; Kahraman, A; Soste, M; Melnik, A; Boersema, PJ; de Laureto, PP; Nikolaev, Y; Oliveira, AP; Picotti, P				Feng, Yuehan; De Franceschi, Giorgia; Kahraman, Abdullah; Soste, Martin; Melnik, Andre; Boersema, Paul J.; de laureto, Patrizia Polverino; Nikolaev, Yaroslav; Oliveira, Ana Paula; Picotti, Paola			Global analysis of protein structural changes in complex proteomes	NATURE BIOTECHNOLOGY			English	Article							CONFORMATIONAL-CHANGES; LIMITED PROTEOLYSIS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TARGETED PROTEOMICS; SECONDARY STRUCTURE; MOLTEN GLOBULE; YEAST; SCALE; PHOSPHORYLATION	Changes in protein conformation can affect protein function, but methods to probe these structural changes on a global scale in cells have been lacking. To enable large-scale analyses of protein conformational changes directly in their biological matrices, we present a method that couples limited proteolysis with a targeted proteomics workflow. Using our method, we assessed the structural features of more than 1,000 yeast proteins simultaneously and detected altered conformations for similar to 300 proteins upon a change of nutrients. We find that some branches of carbon metabolism are transcriptionally regulated whereas others are regulated by enzyme conformational changes. We detect structural changes in aggregation-prone proteins and show the functional relevance of one of these proteins to the metabolic switch. This approach enables probing of both subtle and pronounced structural changes of proteins on a large scale.	[Feng, Yuehan; De Franceschi, Giorgia; Kahraman, Abdullah; Soste, Martin; Melnik, Andre; Boersema, Paul J.; Picotti, Paola] ETH, Inst Biochem, Dept Biol, Zurich, Switzerland; [De Franceschi, Giorgia; de laureto, Patrizia Polverino] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Nikolaev, Yaroslav] ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland; [Oliveira, Ana Paula] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Padua; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Picotti, P (corresponding author), ETH, Inst Biochem, Dept Biol, Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch	Oliveira, Ana Paula/B-8366-2009; Nikolaev, Yaroslav/I-1976-2013	Oliveira, Ana Paula/0000-0003-3787-9138; Nikolaev, Yaroslav/0000-0002-1479-7474; Kahraman, Abdullah/0000-0003-3523-4467				ACETO A, 1995, INT J BIOCHEM CELL B, V27, P1033, DOI 10.1016/1357-2725(95)00081-Y; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Costenoble R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.122; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dieckmann R, 1999, J MOL BIOL, V288, P129, DOI 10.1006/jmbi.1999.2671; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Flikweert MT, 1996, YEAST, V12, P247, DOI 10.1002/(SICI)1097-0061(19960315)12:3<247::AID-YEA911>3.0.CO;2-I; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Heintz D, 2012, J PROTEOME RES, V11, P1228, DOI 10.1021/pr201127u; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Ilari Andrea, 2008, V452, P63, DOI 10.1007/978-1-60327-159-2_3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; KIRTLEY ME, 1977, MOL CELL BIOCHEM, V18, P141, DOI 10.1007/BF00280279; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lozza J., 2010, THESIS ETH ZURICH; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Oliveira AP, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.55; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; PENG ZY, 1994, BIOCHEMISTRY-US, V33, P2136, DOI 10.1021/bi00174a021; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Xie XL, 2010, ELECTROPHORESIS, V31, P1842, DOI 10.1002/elps.200900752; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	69	193	198	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1036	+		10.1038/nbt.2999	http://dx.doi.org/10.1038/nbt.2999			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25218519				2022-12-25	WOS:000343763800021
J	Joyal, JS; Nim, S; Zhu, T; Sitaras, N; Rivera, JC; Shao, Z; Sapieha, P; Hamel, D; Sanchez, M; Zaniolo, K; St-Louis, M; Ouellette, J; Montoya-Zavala, M; Zabeida, A; Picard, E; Hardy, P; Bhosle, V; Varma, DR; Gobeil, F; Beausejour, C; Boileau, C; Klein, W; Hollenberg, M; Ribeiro-da-Silva, A; Andelfinger, G; Chemtob, S				Joyal, Jean-Sebastien; Nim, Satra; Zhu, Tang; Sitaras, Nicholas; Rivera, Jose Carlos; Shao, Zhuo; Sapieha, Przemyslaw; Hamel, David; Sanchez, Melanie; Zaniolo, Karine; St-Louis, Manon; Ouellette, Johanne; Montoya-Zavala, Martin; Zabeida, Alexandra; Picard, Emilie; Hardy, Pierre; Bhosle, Vikrant; Varma, Daya R.; Gobeil, Fernand, Jr.; Beausejour, Christian; Boileau, Christelle; Klein, William; Hollenberg, Morley; Ribeiro-da-Silva, Alfredo; Andelfinger, Gregor; Chemtob, Sylvain			Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis	NATURE MEDICINE			English	Article							PROTEASE-ACTIVATED RECEPTORS; INNER NUCLEAR-MEMBRANE; VASCULAR MORPHOGENESIS; TISSUE FACTOR; GENE; TRANSPORT; PROTEINS; IMPORT; ROLES; PROTEASE-ACTIVATED-RECEPTOR-1	Neurons have an important role in retinal vascular development. Here we show that the G protein-coupled receptor (GPCR) coagulation factor 11 receptor-like 1 (F2rl1, previously known as Par2) is abundant in retinal ganglion cells and is associated with new blood vessel formation during retinal development and in ischemic retinopathy. After stimulation, F2rl1 in retinal ganglion cells translocates from the plasma membrane to the cell nucleus using a microtubule-dependent shuttle that requires sorting nexin 11 (Snx11). At the nucleus, F2rl1 facilitates recruitment of the transcription factor Sp1 to trigger Vegfa expression and, in turn, neovascularization. In contrast, classical plasma membrane activation of F2rl1 leads to the expression of distinct genes, including Ang1, that are involved in vessel maturation. Mutant versions of F2rl1 that prevent nuclear relocalization but not plasma membrane activation interfere with Vegfa but not Ang1 expression. Complementary angiogenic factors are therefore regulated by the subcellular localization of a receptor (F2rl1) that governs angiogenesis. These findings may have implications for the selectivity of drug actions based on the subcellular distribution of their targets.	[Joyal, Jean-Sebastien; Zhu, Tang; Rivera, Jose Carlos; Zaniolo, Karine; Zabeida, Alexandra; Picard, Emilie; Hardy, Pierre; Chemtob, Sylvain] Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Joyal, Jean-Sebastien; Sitaras, Nicholas; Rivera, Jose Carlos; Sapieha, Przemyslaw; Chemtob, Sylvain] Univ Montreal, Hop Maisonneuve Rosemont Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada; [Joyal, Jean-Sebastien; Sitaras, Nicholas; Hamel, David; Beausejour, Christian; Boileau, Christelle; Chemtob, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Joyal, Jean-Sebastien; Nim, Satra; Shao, Zhuo; Sanchez, Melanie; St-Louis, Manon; Ouellette, Johanne; Bhosle, Vikrant; Varma, Daya R.; Ribeiro-da-Silva, Alfredo; Chemtob, Sylvain] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Montoya-Zavala, Martin] Harvard Univ, Wyss Inst, Boston, MA 02115 USA; [Gobeil, Fernand, Jr.] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Klein, William] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hollenberg, Morley] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Andelfinger, Gregor] Univ Montreal, Dept Cardiol, CHU St Justine Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; McGill University; Harvard University; University of Sherbrooke; University of Texas System; UTMD Anderson Cancer Center; University of Calgary; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Chemtob, S (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada.	js.joyal@umontreal.ca; gregor.andelfinger@recherche-ste-justine.qc.ca; sylvain.chemtob@umontreal.ca	Bhosle, Vikrant K./ABF-6691-2020; picard, Emilie/A-6919-2013; Ribeiro-da-Silva, Alfredo/K-4783-2012; Hollenberg, Morley/AFV-6966-2022	picard, Emilie/0000-0002-2689-0510; Ribeiro-da-Silva, Alfredo/0000-0002-4125-0255; Bhosle, Vikrant/0000-0002-2103-6454	Canadian Institutes of Health Research (CIHR); March of Dimes Birth Defects Foundation; Foundation Fighting Blindness; Fonds de la Recherche en Sante du Quebec; Le Reseau de Recherche en Sante de la Vision; National Eye Institute; Robert Welch Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; Canadian Child Health Clinician Scientist Program (CIHR); CIHR Clinician-Scientist Scholarship; Leopoldine Wolfe Chair in translational research in age-related macular degeneration	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); March of Dimes Birth Defects Foundation(March of Dimes); Foundation Fighting Blindness(European Commission); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Le Reseau de Recherche en Sante de la Vision; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Robert Welch Foundation(The Welch Foundation); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Canadian Child Health Clinician Scientist Program (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Clinician-Scientist Scholarship(Canadian Institutes of Health Research (CIHR)); Leopoldine Wolfe Chair in translational research in age-related macular degeneration	This study was supported by grants from the Canadian Institutes of Health Research (CIHR; P.S., F.G. Jr., C. Beausejour, M.H., A.R.-d.-S., G.A. and S.C.), the March of Dimes Birth Defects Foundation (S.C.), the Foundation Fighting Blindness (J.-S.J. and P.S.), Fonds de la Recherche en Sante du Quebec (J.-S.J., P.S., G.A. and S.C.), Le Reseau de Recherche en Sante de la Vision (P.S. and S.C.), the National Eye Institute (W.K.) and the Robert Welch Foundation (W.K.). J.-S.J. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and the Canadian Child Health Clinician Scientist Program (CIHR). G.A. is a recipient of a CIHR Clinician-Scientist Scholarship. P.S. and S.C. hold Canada Research Chairs. S.C. holds the Leopoldine Wolfe Chair in translational research in age-related macular degeneration. We thank G. Bourque and L. Letourneau (Genome Quebec Innovation Center, McGill University) for advice on ChIP-Seq analysis, C. Brown (Life Sciences Imaging Facility, McGill University) for live imaging advice, D. Barbaz (Department of Pharmacology, Sherbrooke University) for support with scanning EM and M. Chai-An (Department of Biochemistry and Molecular Biology University of Texas MD Anderson Cancer Center) for breeding Pou4f2<SUP>LacZ-DTA/+</SUP> mice. We thank N. Agarwal (National Eye Institute, US National Institutes of Health) for providing RGC-5 cells and N. Bunnett (Department of Physiology, University of California) for providing F2RL1-GFP and Flag-F2RL1-HA plasmids.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Cho JH, 2009, EXP EYE RES, V88, P542, DOI 10.1016/j.exer.2008.11.021; Cringle SJ, 2006, INVEST OPHTH VIS SCI, V47, P4072, DOI 10.1167/iovs.05-1638; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Gobeil F, 2006, J BIOL CHEM, V281, P16058, DOI 10.1074/jbc.M602219200; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Linde N, 2010, NUCLEUS-PHILA, V1, P343, DOI 10.4161/nucl.1.4.12352; Luo WB, 2005, BRAIN RES, V1047, P159, DOI 10.1016/j.brainres.2005.04.040; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; MARALDI NM, 1992, ADV ENZYME REGUL, V32, P73; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Milia AF, 2002, CIRC RES, V91, P346, DOI 10.1161/01.RES.0000031958.92781.9E; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Osborne KD, 2009, ASN NEURO, V1, DOI 10.1042/AN20090040; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Saito T, 2005, NEUROMOL MED, V7, P79, DOI 10.1385/NMM:7:1-2:079; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; THYBERG J, 1985, EXP CELL RES, V159, P1, DOI 10.1016/S0014-4827(85)80032-X; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4; Zhu T, 2011, AM J PHYSIOL-REG I, V300, pR577, DOI 10.1152/ajpregu.00137.2010; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	60	50	52	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1165	1173		10.1038/nm.3669	http://dx.doi.org/10.1038/nm.3669			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25216639				2022-12-25	WOS:000343194100027
J	Mayers, JR; Wu, C; Clish, CB; Kraft, P; Torrence, ME; Fiske, BP; Yuan, C; Bao, Y; Townsend, MK; Tworoger, SS; Davidson, SM; Papagiannakopoulos, T; Yang, A; Dayton, TL; Ogino, S; Stampfer, MJ; Giovannucci, EL; Qian, ZR; Rubinson, DA; Ma, J; Sesso, HD; Gaziano, JM; Cochrane, BB; Liu, SM; Wactawski-Wende, J; Manson, JE; Pollak, MN; Kimmelman, AC; Souza, A; Pierce, K; Wang, TJ; Gerszten, RE; Fuchs, CS; Vander Heiden, MG; Wolpin, BM				Mayers, Jared R.; Wu, Chen; Clish, Clary B.; Kraft, Peter; Torrence, Margaret E.; Fiske, Brian P.; Yuan, Chen; Bao, Ying; Townsend, Mary K.; Tworoger, Shelley S.; Davidson, Shawn M.; Papagiannakopoulos, Thales; Yang, Annan; Dayton, Talya L.; Ogino, Shuji; Stampfer, Meir J.; Giovannucci, Edward L.; Qian, Zhi Rong; Rubinson, Douglas A.; Ma, Jing; Sesso, Howard D.; Gaziano, John M.; Cochrane, Barbara B.; Liu, Simin; Wactawski-Wende, Jean; Manson, Joann E.; Pollak, Michael N.; Kimmelman, Alec C.; Souza, Amanda; Pierce, Kerry; Wang, Thomas J.; Gerszten, Robert E.; Fuchs, Charles S.; Vander Heiden, Matthew G.; Wolpin, Brian M.			Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development	NATURE MEDICINE			English	Article							CANCER CACHEXIA; INSULIN-RESISTANCE; POOLED ANALYSIS; WEIGHT-LOSS; RISK; METABOLOMICS; TRANSPORT; PROFILES; AREA	Most patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed with advanced disease and survive less than 12 months(1). PDAC has been linked with obesity and glucose intolerance(2-4), but whether changes in circulating metabolites are associated with early cancer progression is unknown. To better understand metabolic derangements associated with early disease, we profiled metabolites in prediagnostic plasma from individuals with pancreatic cancer (cases) and matched controls from four prospective cohort studies. We find that elevated plasma levels of branched-chain amino acids (BCAAs) are associated with a greater than twofold increased risk of future pancreatic cancer diagnosis. This elevated risk was independent of known predisposing factors, with the strongest association observed among subjects with samples collected 2 to 5 years before diagnosis, when occult disease is probably present. We show that plasma BCAAs are also elevated in mice with early-stage pancreatic cancers driven by mutant Kras expression but not in mice with Kras-driven tumors in other tissues, and that breakdown of tissue protein accounts for the increase in plasma BCAAs that accompanies early-stage disease. Together, these findings suggest that increased whole-body protein breakdown is an early event in development of PDAC.	[Mayers, Jared R.; Torrence, Margaret E.; Fiske, Brian P.; Davidson, Shawn M.; Papagiannakopoulos, Thales; Dayton, Talya L.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mayers, Jared R.; Torrence, Margaret E.; Fiske, Brian P.; Davidson, Shawn M.; Papagiannakopoulos, Thales; Dayton, Talya L.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wu, Chen] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Wu, Chen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Chen; Yuan, Chen; Ogino, Shuji; Qian, Zhi Rong; Rubinson, Douglas A.; Fuchs, Charles S.; Vander Heiden, Matthew G.; Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Chen; Yuan, Chen; Bao, Ying; Townsend, Mary K.; Tworoger, Shelley S.; Ogino, Shuji; Stampfer, Meir J.; Giovannucci, Edward L.; Qian, Zhi Rong; Rubinson, Douglas A.; Ma, Jing; Sesso, Howard D.; Gaziano, John M.; Manson, Joann E.; Gerszten, Robert E.; Fuchs, Charles S.; Vander Heiden, Matthew G.; Wolpin, Brian M.] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Chen; Kraft, Peter; Tworoger, Shelley S.; Ogino, Shuji; Stampfer, Meir J.; Giovannucci, Edward L.; Ma, Jing; Sesso, Howard D.; Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Clish, Clary B.; Souza, Amanda; Pierce, Kerry; Gerszten, Robert E.; Vander Heiden, Matthew G.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Bao, Ying; Townsend, Mary K.; Tworoger, Shelley S.; Stampfer, Meir J.; Giovannucci, Edward L.; Ma, Jing; Manson, Joann E.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Yang, Annan; Kimmelman, Alec C.] Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Stampfer, Meir J.; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sesso, Howard D.; Gaziano, John M.; Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Gaziano, John M.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Cochrane, Barbara B.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Liu, Simin] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Liu, Simin] Brown Univ, Dept Med, Providence, RI 02912 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Pollak, Michael N.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Pollak, Michael N.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Wang, Thomas J.] Vanderbilt Univ, Div Cardiovasc Med, Nashville, TN 37235 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Wolpin, Brian M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Washington; University of Washington Seattle; Brown University; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McGill University; McGill University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu; bwolpin@partners.org	Liu, Simin/GSN-4159-2022; Wactawski-Wende, Jean/AGH-5457-2022; Clish, Clary/AAB-7124-2019; yuan, chen/N-7118-2019; Liu, Simin/I-3689-2014; King, Mary/H-7967-2018; Clish, Clary B/ABB-9374-2021; Rubinson, Douglas/G-3502-2019	Wactawski-Wende, Jean/0000-0003-3096-9595; Liu, Simin/0000-0003-2098-3844; King, Mary/0000-0003-0242-3069; Clish, Clary B/0000-0001-8259-9245; Rubinson, Douglas/0000-0002-5337-5231; Yuan, Chen/0000-0002-0708-9648; Mayers, Jared/0000-0002-8607-1787; Wang, Thomas/0000-0003-4063-6508; Dayton, Talya/0000-0002-7994-7963; Pollak, Michael/0000-0003-3047-0604; Wu, Chen/0000-0003-4954-1011; Tworoger, Shelley/0000-0002-6986-7046; Ogino, Shuji/0000-0002-3909-2323; Fiske, Brian/0000-0001-5891-4268	US National Institutes of Health (NIH) [P01 CA87969, P01 CA55075, P50 CA127003, R01 CA124908, R01 CA49449, 1UM1 CA167552]; NIH [CA 97193, CA 34944, CA 40360, HL 26490, HL 34595, HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; Nestle Research Center award; Robert T. and Judith B. Hale Fund for Pancreatic Cancer, Perry S. Levy Fund for Gastrointestinal Cancer Research and Pappas Family Research Fund for Pancreatic Cancer; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Smith Family; Stern Family; NIH/NCI [K07 CA140790]; American Society of Clinical Oncology Conquer Cancer Foundation; Howard Hughes Medical Institute and Promises for Purple; Howard Hughes Medical Institute; Lustgarten Foundation;  [F30 CA183474];  [R01 DK081572];  [P30-CA14051];  [P01-CA117969]; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA087969, P50CA127003, R01CA124908, P01CA117969, R01CA040360, UM1CA186107, R01CA168653, R01CA049449, UM1CA167552, F30CA183474, R01CA097193, K07CA140790, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL034595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nestle Research Center award(Nestle SA); Robert T. and Judith B. Hale Fund for Pancreatic Cancer, Perry S. Levy Fund for Gastrointestinal Cancer Research and Pappas Family Research Fund for Pancreatic Cancer; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Smith Family; Stern Family; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Clinical Oncology Conquer Cancer Foundation; Howard Hughes Medical Institute and Promises for Purple; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Lustgarten Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge A. Deik and K. Bullock of the Broad Institute for assistance with LC-MS sample analyses and the Tang Histology facility in the Koch Institute Swanson Biotechnology Center for assistance processing mouse tissues. Cambridge Isotope Laboratories supplied <SUP>13</SUP>C-BCAA diets for mouse labeling studies. We would like to thank C. Newgard and A. Goldberg for their thoughtful discussions regarding this manuscript. We would also like to thank the participants and staff of the Health Professionals Follow-Up Study (HPFS), Nurses' Health Study (NHS), Physicians' Health Study I (PHS) and Women's Health Initiative-Observational Study (WHI-OS) for their contributions as well as the cancer registries of the following states for their help: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Indiana, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Nebraska, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington and Wyoming. NHS and HPFS are supported by US National Institutes of Health (NIH) grants P01 CA87969, P01 CA55075, P50 CA127003, R01 CA124908, R01 CA49449 and 1UM1 CA167552. PHS is supported by NIH grants CA 97193, CA 34944, CA 40360, HL 26490 and HL 34595. The WHI program is funded by the NIH through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C. We acknowledge additional support from grant F30 CA183474 to J.R.M.; from a Nestle Research Center award to the Broad Institute; from R01 DK081572 grant to T.J.W. and R.E.G.; from the Robert T. and Judith B. Hale Fund for Pancreatic Cancer, Perry S. Levy Fund for Gastrointestinal Cancer Research and Pappas Family Research Fund for Pancreatic Cancer to C.S.F.; from the Burroughs Wellcome Fund, Damon Runyon Cancer Research Foundation, the Smith Family and the Stern Family to M.G.V.H.; and from NIH/NCI grant K07 CA140790, the American Society of Clinical Oncology Conquer Cancer Foundation, the Howard Hughes Medical Institute and Promises for Purple to B.M.W. M.G.V.H. additionally acknowledges support from P30-CA14051 and P01-CA117969, and major support for this project was provided by the Howard Hughes Medical Institute to B.M.W. and the Lustgarten Foundation to C.S.F., M.G.V.H. and B.M.W.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Claudino WM, 2012, CRIT REV ONCOL HEMAT, V84, P1, DOI 10.1016/j.critrevonc.2012.02.009; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HEYMSFIELD SB, 1985, CANCER, V55, P238, DOI 10.1002/1097-0142(19850101)55:1+<238::AID-CNCR2820551306>3.0.CO;2-S; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LUNDHOLM K, 1976, EUR J CANCER, V12, P465, DOI 10.1016/0014-2964(76)90036-0; Lynch SM, 2009, AM J EPIDEMIOL, V170, P403, DOI 10.1093/aje/kwp134; MATTHEWS DE, 1993, AM J PHYSIOL, V264, pE109, DOI 10.1152/ajpendo.1993.264.1.E109; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tsoli M, 2013, TRENDS ENDOCRIN MET, V24, P174, DOI 10.1016/j.tem.2012.10.006; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wigmore SJ, 1997, BRIT J CANCER, V75, P106, DOI 10.1038/bjc.1997.17; Wolpin BM, 2013, JNCI-J NATL CANCER I, V105, P1027, DOI 10.1093/jnci/djt123; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	42	392	405	2	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1193	1198		10.1038/nm.3686	http://dx.doi.org/10.1038/nm.3686			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25261994	Green Accepted, Green Submitted			2022-12-25	WOS:000343194100031
J	Lescroart, F; Chabab, S; Lin, XH; Rulands, S; Paulissen, C; Rodolosse, A; Auer, H; Achouri, Y; Dubois, C; Bondue, A; Simons, BD; Blanpain, C				Lescroart, Fabienne; Chabab, Samira; Lin, Xionghui; Rulands, Steffen; Paulissen, Catherine; Rodolosse, Annie; Auer, Herbert; Achouri, Younes; Dubois, Christine; Bondue, Antoine; Simons, Benjamin D.; Blanpain, Cedric			Early lineage restriction in temporally distinct populations of Mespl progenitors during mammalian heart development	NATURE CELL BIOLOGY			English	Article							SMOOTH-MUSCLE; TRANSCRIPTION FACTORS; MESODERMAL CELLS; FATE DIVERSITY; MOUSE; DIFFERENTIATION; EXPRESSION; FIELD; GENE; MORPHOGENESIS	Cardiac development arises from two sources of mesoderm progenitors, the first heart field (FHF) and the second (SHF). Mespl has been proposed to mark the most primitive multipotent cardiac progenitors common for both heart fields. Here, using clonal analysis of the earliest prospective cardiovascular progenitors in a temporally controlled manner during early gastrulation, we found that Mespl progenitors consist of two temporally distinct pools of progenitors restricted to either the FHF or the SHE FHF progenitors were unipotent, whereas SHF progenitors were either unipotent or bipotent. Microarray and single-cell PCR with reverse transcription analysis of Mespl progenitors revealed the existence of molecularly distinct populations of Mespl progenitors, consistent with their lineage and regional contribution. Together, these results provide evidence that heart development arises from distinct populations of unipotent and bipotent cardiac progenitors that independently express Mespl at different time points during their specification, revealing that the regional segregation and lineage restriction of cardiac progenitors occur very early during gastrulation.	[Lescroart, Fabienne; Chabab, Samira; Lin, Xionghui; Paulissen, Catherine; Dubois, Christine; Bondue, Antoine; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rulands, Steffen; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Rulands, Steffen; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Rodolosse, Annie; Auer, Herbert] Inst Biomed Res, Funct Genom Core, Barcelona 08028, Spain; [Achouri, Younes] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Bondue, Antoine] Hop Erasme, Dept Cardiol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; University of Cambridge; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universite Catholique Louvain; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Auer, Herbert/AAV-2332-2020; lescroart, fabienne/AAE-4486-2022; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Lin, Xionghui/0000-0001-7488-1435; Rulands, Steffen/0000-0001-6398-1553; ACHOURI, Younes/0000-0001-7409-1441; Lescroart, Fabienne/0000-0003-4942-7921	FNRS; EMBO long-term fellowship; FRS/FRIA; FRS/FNRS; Wellcome Trust [0983571Z/12/Z]; ULB foundation; Fondation contre le Cancer; European Research Council (ERC); foundation Bettencourt Schueller	FNRS(Fonds de la Recherche Scientifique - FNRS); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); FRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome TrustEuropean Commission); ULB foundation; Fondation contre le Cancer; European Research Council (ERC)(European Research Council (ERC)European Commission); foundation Bettencourt Schueller	We thank F. Bollet-Quivogne and J-M. Vanderwinden for their help with confocal imaging and M. Tarabichi for his help with gene set enrichment analysis. We thank M. Buckingham and A. Joyner for kindly providing the probes for in situ hybridization. We also thank the Genomic core facility of the EMBL, Heidelberg for their help with the ChIP-Seq. F.L. has been sequentially supported by the FNRS and the EMBO long-term fellowship. S.C. is supported by a fellowship of the FRS/FRIA. X.L. is supported by the FNRS. A.B. is supported by the FRS/FNRS. S.R. and B.D.S. are supported by the Wellcome Trust (grant number 0983571Z/12/Z). C.B. is an investigator of WELBIO. This work was supported by the FNRS, the ULB foundation, the Fondation contre le Cancer, the European Research Council (ERC), and the foundation Bettencourt Schueller (C.B. and F.L.).	Acampora D, 2003, GENE EXPR PATTERNS, V3, P497, DOI 10.1016/S1567-133X(03)00056-5; Bertrand N, 2011, DEV BIOL, V353, P266, DOI 10.1016/j.ydbio.2011.02.029; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; CohenGould L, 1996, DEV BIOL, V177, P265, DOI 10.1006/dbio.1996.0161; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; DUSH MK, 1992, DEV BIOL, V151, P273, DOI 10.1016/0012-1606(92)90232-6; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Haraguchi S, 2001, MECH DEVELOP, V108, P59, DOI 10.1016/S0925-4773(01)00478-6; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Harris IS, 2010, PEDIATR CARDIOL, V31, P391, DOI 10.1007/s00246-010-9642-8; Hart AH, 2002, DEVELOPMENT, V129, P3597; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kitajima S, 2006, DEV DYNAM, V235, P395, DOI 10.1002/dvdy.20640; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lescroart F, 2012, CIRC RES, V111, P1313, DOI 10.1161/CIRCRESAHA.112.271064; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nakamura H, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-9; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nomura-Kitabayashi A, 2002, DEVELOPMENT, V129, P2473; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Stanley EG, 2002, INT J DEV BIOL, V46, P431; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tsang TE, 2000, DEV BIOL, V223, P77, DOI 10.1006/dbio.2000.9733; van den Ameele J, 2012, EMBO REP, V13, P355, DOI 10.1038/embor.2012.23; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wei Y, 2000, DEV DYNAM, V219, P505, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1076>3.0.CO;2-6; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	59	168	170	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					829	840		10.1038/ncb3024	http://dx.doi.org/10.1038/ncb3024			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25150979	Green Accepted			2022-12-25	WOS:000341404400004
J	Zakrzewski, JL; van den Brink, MRM; Hubbell, JA				Zakrzewski, Johannes L.; van den Brink, Marcel R. M.; Hubbell, Jeffrey A.			Overcoming immunological barriers in regenerative medicine	NATURE BIOTECHNOLOGY			English	Article							VERSUS-HOST-DISEASE; MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-SPECIFIC TOLERANCE; DONOR-SPECIFIC TOLERANCE; REFRACTORY ACUTE GVHD; DENDRITIC CELLS; INTRATHYMIC INJECTION; MYCOPHENOLATE-MOFETIL	Regenerative therapies that use allogeneic cells are likely to encounter immunological barriers similar to those that occur with transplantation of solid organs and allogeneic hematopoietic stem cells (HSCs). Decades of experience in clinical transplantation hold valuable lessons for regenerative medicine, offering approaches for developing tolerance-induction treatments relevant to cell therapies. Outside the field of solid-organ and allogeneic HSC transplantation, new strategies are emerging for controlling the immune response, such as methods based on biomaterials or mimicry of antigen-specific peripheral tolerance. Novel biomaterials can alter the behavior of cells in tissue-engineered constructs and can blunt host immune responses to cells and biomaterial scaffolds. Approaches to suppress autoreactive immune cells may also be useful in regenerative medicine. The most innovative solutions will be developed through closer collaboration among stem cell biologists, transplantation immunologists and materials scientists.	[Zakrzewski, Johannes L.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Chicago	Zakrzewski, JL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	zakrzewj@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022		NCI NIH HHS [P30 CA008748, K08 CA160659, P30 CA072720] Funding Source: Medline; NHLBI NIH HHS [R01 HL069929] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA160659, P30CA008748, P30CA072720] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adkins D, 2009, TRANSPLANTATION, V88, P198, DOI 10.1097/TP.0b013e3181abfbf7; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Asberg A, 2006, TRANSPLANTATION, V82, P62, DOI 10.1097/01.tp.0000225803.04995.2b; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; CALNE RY, 1978, LANCET, V2, P1323; Chen WJ, 1998, J IMMUNOL, V160, P1504; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Christopeit M, 2009, BLOOD, V113, P3130, DOI 10.1182/blood-2009-01-200527; Chung B, 2007, BLOOD, V110, P2803, DOI 10.1182/blood-2006-11-055673; Cicciarelli J.C., 2012, IMMUNOLOGICAL BARRIE, P147; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Cober SR, 1999, J SURG RES, V85, P204, DOI 10.1006/jsre.1999.5688; Crop MJ, 2009, TRANSPLANTATION, V87, P896, DOI 10.1097/TP.0b013e31819b3d72; Cui H, 2009, TRANSPLANTATION, V88, P160, DOI 10.1097/TP.0b013e3181abbfc1; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Djamali A, 2004, TRANSPL INT, V17, P301, DOI 10.1111/j.1432-2277.2004.tb00447.x; Drobyski WR, 2011, BIOL BLOOD MARROW TR, V17, P1862, DOI 10.1016/j.bbmt.2011.07.001; Eggenhofer E, 2011, TRANSPL IMMUNOL, V24, P157, DOI 10.1016/j.trim.2010.12.002; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Ezzelarab MB, 2013, AM J TRANSPLANT, V13, P1989, DOI 10.1111/ajt.12310; Fan HM, 2011, SEMIN IMMUNOL, V23, P453, DOI 10.1016/j.smim.2011.08.012; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Garcia-Cadenas I, 2013, BIOL BLOOD MARROW TR, V19, P435, DOI 10.1016/j.bbmt.2012.11.012; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Ghobadi A., 2013, 55 AM SOC HEM ANN M; Gill RG, 2010, CURR OPIN IMMUNOL, V22, P649, DOI 10.1016/j.coi.2010.09.005; Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Hoda D, 2010, BONE MARROW TRANSPL, V45, P1347, DOI 10.1038/bmt.2009.343; Jacobson P, 1998, BONE MARROW TRANSPL, V22, P217, DOI 10.1038/sj.bmt.1701331; Jang MS, 2008, TRANSPLANTATION, V85, P1051, DOI 10.1097/TP.0b013e31816846f6; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009; Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Koreth J, 2009, BLOOD, V114, P3956, DOI 10.1182/blood-2009-07-231092; Lakkis FG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014993; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Leveson-Gower DB, 2011, BLOOD, V117, P3220, DOI 10.1182/blood-2010-08-303008; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Li J, 2011, BIOL BLOOD MARROW TR, V17, P962, DOI 10.1016/j.bbmt.2011.01.018; Li N, 2010, CELL MOL IMMUNOL, V7, P133, DOI 10.1038/cmi.2009.120; Li S, 2006, J SURG RES, V136, P238, DOI 10.1016/j.jss.2006.05.032; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Logan AC, 2012, CURR OPIN IMMUNOL, V24, P640, DOI 10.1016/j.coi.2012.08.002; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750; Mai HL, 2014, J CLIN INVEST, V124, P1723, DOI 10.1172/JCI66287; Maltzman JS, 2012, AM J TRANSPLANT, V12, P2269, DOI 10.1111/j.1600-6143.2012.04185.x; Mapara MY, 2001, BIOL BLOOD MARROW TR, V7, P646, DOI 10.1053/bbmt.2001.v7.pm11787527; Marodon G, 2006, BLOOD, V108, P2972, DOI 10.1182/blood-2006-03-010900; Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mukherjee G, 2013, INT IMMUNOL, V25, P651, DOI 10.1093/intimm/dxt031; Muraoka N, 2014, ANNU REV PHYSIOL, V76, P21, DOI 10.1146/annurev-physiol-021113-170301; Neufeld T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070150; Page A, 2012, AM J TRANSPLANT, V12, P115, DOI 10.1111/j.1600-6143.2011.03737.x; Penack O, 2010, JNCI-J NATL CANCER I, V102, P894, DOI 10.1093/jnci/djq172; Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729, DOI 10.1038/77288; Pruett TL, 2009, TRANSPL P, V41, P3655, DOI 10.1016/j.transproceed.2009.06.226; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Rossi Robert J, 2012, Methods Mol Biol, V900, P471, DOI 10.1007/978-1-60761-720-4_23; Sachs DH, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015529; Sagoo P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00184; Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1; Schneidawind D, 2013, BLOOD, V122, P3116, DOI 10.1182/blood-2013-08-453126; Schub N, 2011, BONE MARROW TRANSPL, V46, P143, DOI 10.1038/bmt.2010.68; Seach N, 2010, TISSUE ENG PART C-ME, V16, P543, DOI [10.1089/ten.tec.2009.0135, 10.1089/ten.TEC.2009.0135]; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Shimabukuro-Vornhagen A, 2008, BLOOD, V112, P1544, DOI 10.1182/blood-2008-04-149609; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shono Y, 2014, CANCER DISCOV, V4, P578, DOI 10.1158/2159-8290.CD-13-0585; Shtrichman R, 2013, CURR MOL MED, V13, P792, DOI 10.2174/1566524011313050010; Stenger EO, 2012, BLOOD, V119, P5088, DOI 10.1182/blood-2011-11-364091; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Strioga MM, 2013, CRIT REV IMMUNOL, V33, P489; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Chad, 2013, Methods Mol Biol, V1029, P17, DOI 10.1007/978-1-62703-478-4_2; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Tuckett AZ, 2014, BLOOD, V123, P2797, DOI 10.1182/blood-2013-10-535401; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Vodanovic-Jankovic S, 2006, BLOOD, V107, P827, DOI 10.1182/blood-2005-05-1820; Wabbijn Marike, 2004, Exp Clin Transplant, V2, P201; WALLACE PM, 1994, TRANSPLANTATION, V58, P602, DOI 10.1097/00007890-199409150-00013; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012; Yap WT, 2013, TISSUE ENG PT A, V19, P2361, DOI [10.1089/ten.tea.2013.0033, 10.1089/ten.TEA.2013.0033]; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	123	91	91	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					786	794		10.1038/nbt.2960	http://dx.doi.org/10.1038/nbt.2960			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093888	Green Accepted			2022-12-25	WOS:000346455900019
J	Xu, H; Robinson, GW; Huang, J; Lim, JYS; Zhang, H; Bass, JK; Broniscer, A; Chintagumpala, M; Bartels, U; Gururangan, S; Hassall, T; Fisher, M; Cohn, R; Yamashita, T; Teitz, T; Zuo, J; Onar-Thomas, A; Gajjar, A; Stewart, CF; Yang, JJ				Xu, Heng; Robinson, Giles W.; Huang, Jie; Lim, Joshua Yew-Suang; Zhang, Hui; Bass, Johnnie K.; Broniscer, Alberto; Chintagumpala, Murali; Bartels, Ute; Gururangan, Sri; Hassall, Tim; Fisher, Michael; Cohn, Richard; Yamashita, Tetsuji; Teitz, Tal; Zuo, Jian; Onar-Thomas, Arzu; Gajjar, Amar; Stewart, Clinton F.; Yang, Jun J.			Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss	NATURE GENETICS			English	Article							PLATINUM-INDUCED OTOTOXICITY; GENETIC-VARIANTS; INTERNATIONAL SOCIETY; RISK MEDULLOBLASTOMA; GRADING SCALES; AVERAGE-RISK; HAIR-CELLS; CHILDREN; CANCER; NEUROBLASTOMA	Taking a genome-wide association study approach, we identified inherited genetic variations in ACYP2 associated with cisplatin-related ototoxicity (rs1872328: P = 3.9 x 10(-8), hazard ratio = 4.5) in 238 children with newly diagnosed brain tumors, with independent replication in 68 similarly treated children. The ACYP2 risk variant strongly predisposed these patients to precipitous hearing loss and was related to ototoxicity severity. These results point to new biology underlying the ototoxic effects of platinum agents.	[Xu, Heng; Lim, Joshua Yew-Suang; Zhang, Hui; Stewart, Clinton F.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Xu, Heng] Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Collaborat Innovat Ctr,Dept Lab Med, Chengdu 610064, Peoples R China; [Xu, Heng] Sichuan Univ, West China Hosp, Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China; [Robinson, Giles W.; Broniscer, Alberto; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Huang, Jie; Onar-Thomas, Arzu] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Lim, Joshua Yew-Suang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Bass, Johnnie K.] St Jude Childrens Res Hosp, Rehabil Serv, Memphis, TN 38105 USA; [Chintagumpala, Murali] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Bartels, Ute] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Gururangan, Sri] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hassall, Tim] Royal Childrens Hosp, Dept Oncol, Parkville, Vic 3052, Australia; [Fisher, Michael] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Cohn, Richard] Univ New S Wales, Sch Womens & Childrens Hlth, Kensington, NSW 2033, Australia; [Yamashita, Tetsuji; Teitz, Tal; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Sichuan University; Sichuan University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National University of Singapore; St Jude Children's Research Hospital; Baylor College of Medicine; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Duke University; Royal Children's Hospital Melbourne; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New South Wales Sydney; St Jude Children's Research Hospital	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	clinton.stewart@stjude.org; jun.yang@stjude.org	Robinson, Giles W/N-8095-2018; Xu, Heng/AAS-3465-2021; Yang, Jun J./ABG-5646-2020; Onar-Thomas, Arzu/M-9356-2018; Stewart, Clinton/N-3822-2018; Gajjar, Amar/N-8059-2018	Robinson, Giles W/0000-0001-7441-9486; Xu, Heng/0000-0002-7748-2621; Yang, Jun J./0000-0002-0770-9659; Stewart, Clinton/0000-0002-1546-9720; Cohn, Richard/0000-0002-2400-1353; Zhang, Hui/0000-0001-6825-5649; Hassall, Timothy/0000-0002-7883-3710; Bass, Johnnie/0000-0001-7432-3863	US National Institutes of Health [P30 CA21765-34, U01GM92666]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA154619, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC013879] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Throm for coordinating patient samples, S. Hughes for curating the ototoxicity data, all patients and their parents who participated in the St. Jude protocols included in this study, G. Koh (National University of Singapore) for her assistance in genome-wide genotyping, and L. Robison and K. Ness (St. Jude Children's Research Hospital) for insightful discussions. This work was supported by the US National Institutes of Health (P30 CA21765-34 and U01GM92666) and the American Lebanese Syrian Associated Charities (ALSAC).	Bass JK, 2014, PEDIATR BLOOD CANCER, V61, P601, DOI 10.1002/pbc.24830; Boddy AV, 2013, CLIN PHARMACOL THER, V94, P198, DOI 10.1038/clpt.2013.116; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Chang KW, 2010, J CLIN ONCOL, V28, P1788, DOI 10.1200/JCO.2009.24.4228; Chen WC, 2006, CANCER-AM CANCER SOC, V106, P820, DOI 10.1002/cncr.21683; CHEUNG NKV, 1991, J CLIN ONCOL, V9, P1050, DOI 10.1200/JCO.1991.9.6.1050; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Dean JB, 2008, J PEDIAT HEMATOL ONC, V30, P130, DOI 10.1097/MPH.0b013e31815d1d83; Degl'Innocenti D, 1999, BIOCHIMIE, V81, P1031, DOI 10.1016/S0300-9084(99)00333-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fouladi M, 2008, J CLIN ONCOL, V26, P3749, DOI 10.1200/JCO.2007.14.3974; Fuchs PA, 2014, J PHYSIOL-LONDON, V592, P3393, DOI 10.1113/jphysiol.2013.267914; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gurney JG, 2014, NEURO-ONCOLOGY, V16, P848, DOI 10.1093/neuonc/not241; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Kushner BH, 2006, CANCER-AM CANCER SOC, V107, P417, DOI 10.1002/cncr.22004; Landier W, 2014, J CLIN ONCOL, V32, P527, DOI 10.1200/JCO.2013.51.2038; Langer T, 2013, TRENDS PHARMACOL SCI, V34, P458, DOI 10.1016/j.tips.2013.05.006; Lanvers-Kaminsky C, 2014, CLIN PHARMACOL THER, V96, P156, DOI 10.1038/clpt.2014.67; Li Y, 2004, EUR J CANCER, V40, P2445, DOI 10.1016/j.ejca.2003.08.009; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Mukherjea D, 2011, PHARMACOGENOMICS, V12, P1039, DOI [10.2217/PGS.11.48, 10.2217/pgs.11.48]; Oguri T, 2013, INT J CLIN PHARM TH, V51, P475, DOI 10.5414/CP201851; Oldenburg J, 2007, J CLIN ONCOL, V25, P708, DOI 10.1200/JCO.2006.08.9599; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perilongo G, 2009, NEW ENGL J MED, V361, P1662, DOI 10.1056/NEJMoa0810613; Potter DM, 2005, STAT MED, V24, P693, DOI 10.1002/sim.1931; Pussegoda K, 2013, CLIN PHARMACOL THER, V94, P243, DOI 10.1038/clpt.2013.80; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; Ratain MJ, 2013, CLIN PHARMACOL THER, V94, P631, DOI 10.1038/clpt.2013.178; Ross CJD, 2009, NAT GENET, V41, P1345, DOI 10.1038/ng.478; Thomas AJ, 2013, J NEUROSCI, V33, P4405, DOI 10.1523/JNEUROSCI.3940-12.2013; Travis LB, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju044; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614; Yang JJ, 2013, CLIN PHARMACOL THER, V94, P252, DOI 10.1038/clpt.2013.121	36	77	80	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					263	+		10.1038/ng.3217	http://dx.doi.org/10.1038/ng.3217			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665007	Green Accepted			2022-12-25	WOS:000350327900018
J	Hamamoto, H; Urai, M; Ishii, K; Yasukawa, J; Paudel, A; Murai, M; Kaji, T; Kuranaga, T; Hamase, K; Katsu, T; Su, J; Adachi, T; Uchida, R; Tomoda, H; Yamada, M; Souma, M; Kurihara, H; Inoue, M; Sekimizu, K				Hamamoto, Hiroshi; Urai, Makoto; Ishii, Kenichi; Yasukawa, Jyunichiro; Paudel, Atmika; Murai, Motoki; Kaji, Takuya; Kuranaga, Takefumi; Hamase, Kenji; Katsu, Takashi; Su, Jie; Adachi, Tatsuo; Uchida, Ryuji; Tomoda, Hiroshi; Yamada, Maki; Souma, Manabu; Kurihara, Hiroki; Inoue, Masayuki; Sekimizu, Kazuhisa			Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane	NATURE CHEMICAL BIOLOGY			English	Article							SMALL COLONY VARIANTS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; INFECTION MODEL; MUTANTS; IDENTIFICATION; SILKWORM; RESISTANT; BIOSYNTHESIS; REPLICATION	To obtain therapeutically effective new antibiotics, we first searched for bacterial culture supernatants with antimicrobial activity in vitro and then performed a secondary screening using the silkworm infection model. Through further purification of the in vivo activity, we obtained a compound with a previously uncharacterized structure and named it 'lysocin E'. Lysocin E interacted with menaquinone in the bacterial membrane to achieve its potent bactericidal activity, a mode of action distinct from that of any other known antibiotic, indicating that lysocin E comprises a new class of antibiotic. This is to our knowledge the first report of a direct interaction between a small chemical compound and menaquinone that leads to bacterial killing. Furthermore, lysocin E decreased the mortality of infected mice. To our knowledge, lysocin E is the first compound identified and purified by quantitative measurement of therapeutic effects in an invertebrate infection model that exhibits robust in vivo effects in mammals.	[Hamamoto, Hiroshi; Urai, Makoto; Ishii, Kenichi; Yasukawa, Jyunichiro; Paudel, Atmika; Su, Jie; Adachi, Tatsuo; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan; [Murai, Motoki; Kaji, Takuya; Kuranaga, Takefumi; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Synthet Med Chem, Tokyo, Japan; [Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Drug Discovery & Evolut, Fukuoka 812, Japan; [Katsu, Takashi] Yasuda Womens Univ, Grad Sch Pharm, Dept Pharm, Hiroshima, Japan; [Uchida, Ryuji; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Microbial Chem, Tokyo, Japan; [Yamada, Maki; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo, Japan; [Yamada, Maki; Kurihara, Hiroki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Souma, Manabu] MASIS Inc, Aomori, Japan	University of Tokyo; University of Tokyo; Kyushu University; Kitasato University; University of Tokyo; Japan Science & Technology Agency (JST)	Sekimizu, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Yamada, Maki/U-5251-2019; Ishii, Kenichi/H-5469-2019; Paudel, Atmika/S-4394-2019; Hamamoto, Hiroshi/G-6397-2019; Su, Jie/AAH-3964-2021; Yamada, Maki/A-1573-2015	Paudel, Atmika/0000-0003-3478-9452; Hamamoto, Hiroshi/0000-0001-9315-7442; Su, Jie/0000-0002-3380-9274; Kaji, Takuya/0000-0001-9633-5208; Yamada, Maki/0000-0002-1956-6069; Kurihara, Hiroki/0000-0002-6476-5593	Genome Pharmaceuticals Institute Co., Ltd.; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Japan Society for the Promotion of Science (JSPS) [24689008, 25460036]; MEXT [24102510, 26102714]; JSPS [24-11042]; Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [13F03093, 26102714] Funding Source: KAKEN	Genome Pharmaceuticals Institute Co., Ltd.; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from Genome Pharmaceuticals Institute Co., Ltd. for K.S., the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) for K.S., a Grant-in-Aid for Young Scientists (A; 24689008) for H.H., a Grant-in-Aid for Scientific Research (25460036) for T. Katsu from Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas-Chemical Biology of Natural Products to K.S. (24102510) and to H.H. (26102714) from MEXT, and it was supported in part by a Grant-in-Aid for JSPS Fellows (24-11042) for K.I. from JSPS and the Japan Science and Technology Agency (JST) A-STEP (High-Risk Challenging Type). We thank A. Noguchi, F. Aihara and S. Nishida (Genome Pharmaceutical Institute, Co., Ltd.) for screening and production of lysocin E. We thank K. Sakamoto (Hirosaki University) for advice regarding the menaquinone analysis. We thank M. Hyodo (Okayama University), K. Kyogoku (University of Tokyo) and Y. Matsuzawa (Genome Pharmaceutical Institute, Co., Ltd.) for technical assistance. We thank Shiseido Co. Ltd. for their technical support in 2D-HPLC analyses.	Barry A.L., 1999, METHODS DETERMINING, V19; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Breeuwer P., 2004, ASSESSMENT MEMBRANE; CANEPARI P, 1987, J BACTERIOL, V169, P2432, DOI 10.1128/jb.169.6.2432-2439.1987; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Clinical and Laboratory Standards Institute, 1997, M27A CLSI; CLSI, 2018, METHODS DILUTION ANT; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hamase K, 2010, J CHROMATOGR A, V1217, P1056, DOI 10.1016/j.chroma.2009.09.002; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Ishibashi M, 2007, FEMS MICROBIOL LETT, V274, P204, DOI 10.1111/j.1574-6968.2007.00829.x; Ishigo S, 2015, CHROMATOGRAPHY, V36, P45, DOI 10.15583/jpchrom.2015.017; JUKES T H, 1969, P21; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1111/j.1574-6968.2002.tb11175.x; KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5; KAWAI M, 1976, MOL GEN GENET, V143, P233, DOI 10.1007/BF00269399; Komagoe K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1181, DOI 10.1039/c0pp00376j; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; Kurokawa K, 2009, ANTIMICROB AGENTS CH, V53, P4025, DOI 10.1128/AAC.00200-09; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Maki H, 2001, ANTIMICROB AGENTS CH, V45, P1823, DOI 10.1128/AAC.45.6.1823-1827.2001; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; Murai N, 2006, FEMS MICROBIOL LETT, V254, P19, DOI 10.1111/j.1574-6968.2005.00012.x; Nishida S, 2006, J BIOL CHEM, V281, P1714, DOI 10.1074/jbc.M509277200; Paudel A, 2012, J ANTIBIOT, V65, P53, DOI 10.1038/ja.2011.110; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2001, INT J SYST EVOL MICR, V51, P2119, DOI 10.1099/00207713-51-6-2119; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchida R, 2010, J ANTIBIOT, V63, P151, DOI 10.1038/ja.2010.9; Wakeman CA, 2012, MOL MICROBIOL, V86, P1376, DOI 10.1111/mmi.12063; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	44	146	156	6	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					127	U68		10.1038/NCHEMBIO.1710	http://dx.doi.org/10.1038/NCHEMBIO.1710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25485686				2022-12-25	WOS:000348358800010
J	Hammer, SC; Marjanovic, A; Dominicus, JM; Nestl, BM; Hauer, B				Hammer, Stephan C.; Marjanovic, Antonija; Dominicus, Joerg M.; Nestl, Bettina M.; Hauer, Bernhard			Squalene hopene cyclases are protonases for stereoselective Bronsted acid catalysis	NATURE CHEMICAL BIOLOGY			English	Article							ENZYME MECHANISMS; CYCLIZATION; CITRONELLAL; GENERATION; TERPENOIDS; GERANIOL; BONDS; KEY	For many important reactions catalyzed in chemical laboratories, the corresponding enzymes are missing, representing a restriction in biocatalysis. Although nature provides highly developed machineries appropriate to catalyze such reactions, their potential is often ignored. This also applies to Bronsted acid catalysis, a powerful method to promote a myriad of chemical transformations. Here, we report on the unique protonation machinery of a squalene hopene cyclase (SHC). Active site engineering of this highly evolvable enzyme yielded a platform for enzymatic Bronsted acid catalysis in water. This is illustrated by activation of different functional groups (alkenes, epoxides and carbonyls), enabling the highly stereoselective syntheses of various cyclohexanoids while uncoupling SHC from polycyclization chemistry. This work highlights the potential of systematic investigation on nature's catalytic machineries to generate unique catalysts.	[Hammer, Stephan C.; Marjanovic, Antonija; Dominicus, Joerg M.; Nestl, Bettina M.; Hauer, Bernhard] Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany	University of Stuttgart	Hauer, B (corresponding author), Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany.	bernhard.hauer@itb.uni-stuttgart.de	Hammer, Stephan/V-9465-2018; Hammer, Stephan Christian/AAO-9971-2020	Hammer, Stephan/0000-0002-3620-9362; Hammer, Stephan Christian/0000-0002-3620-9362; Marjanovic, Antonija/0000-0003-1865-5673; Nestl, Bettina/0000-0003-1282-195X	European Union [289646]; Kekule scholarship; Fonds der Chemischen Industrie [K 187/01]	European Union(European Commission); Kekule scholarship; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We gratefully acknowledge funding by the European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 289646 as well as a Kekule scholarship by the Fonds der Chemischen Industrie (to SCH, grant number K 187/01). We thank P.-O. Syren (KTH Royal Institute of Technology, Stockholm) for stimulating discussions, M. Breuer (BASF SE, Ludwigshafen) for the AacSHC gene, C. Geinitz (University of Stuttgart) for providing the mutants at position F365 and E. Kervio (University of Stuttgart) for help with measuring specific rotations of the products.	Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Beszant S, 2002, TETRAHEDRON-ASYMMETR, V13, P1245, DOI 10.1016/S0957-4166(02)00335-X; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Breslow R, 2009, J BIOL CHEM, V284, P1337, DOI 10.1074/jbc.X800011200; Breuer M., 2010, [No title captured], Patent No. [2010/139719 A2, 2010139719, 2010/139719]; Brunoldi E, 2006, CURR ORG CHEM, V10, P2259, DOI 10.2174/138527206778742614; Cheon CH, 2011, CHEM COMMUN, V47, P3043, DOI 10.1039/c0cc04867d; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Hammer SC, 2013, CURR OPIN CHEM BIOL, V17, P293, DOI 10.1016/j.cbpa.2013.01.016; Hammer SC, 2012, TETRAHEDRON, V68, P7624, DOI 10.1016/j.tet.2012.06.041; Hoshino T, 2004, ORG BIOMOL CHEM, V2, P2650, DOI 10.1039/b407001a; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Jung ST, 2011, CURR OPIN BIOTECH, V22, P809, DOI 10.1016/j.copbio.2011.02.008; Kampen D, 2009, TOP CURR CHEM, V291, P395, DOI 10.1007/128_2009_1; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Lenardao EJ, 2007, TETRAHEDRON, V63, P6671, DOI 10.1016/j.tet.2007.03.159; Maki-Arvela P, 2004, J CATAL, V225, P155, DOI 10.1016/j.jcat.2004.03.043; McIntosh JA, 2013, ANGEW CHEM INT EDIT, V52, P9309, DOI 10.1002/anie.201304401; Merlini V, 2011, NAT PROD COMMUN, V6, P465; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Nestl BM, 2014, ANGEW CHEM INT EDIT, V53, P3070, DOI 10.1002/anie.201302195; NEUMANN S, 1986, BIOL CHEM H-S, V367, P723, DOI 10.1515/bchm3.1986.367.2.723; Racolta S, 2012, PROTEINS, V80, P2009, DOI 10.1002/prot.24089; Reinert DJ, 2004, CHEM BIOL, V11, P121, DOI 10.1016/j.chembiol.2003.12.013; Rueping M, 2011, ANGEW CHEM INT EDIT, V50, P6706, DOI 10.1002/anie.201100169; Rueping M, 2010, CHEM SCI, V1, P473, DOI 10.1039/c0sc00206b; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Seitz M, 2013, CHEMBIOCHEM, V14, P436, DOI 10.1002/cbic.201300018; Seitz M, 2012, J MOL CATAL B-ENZYM, V84, P72, DOI 10.1016/j.molcatb.2012.02.007; Siedenburg G, 2013, APPL MICROBIOL BIOT, V97, P1571, DOI 10.1007/s00253-012-4008-1; Siedenburg G, 2012, APPL ENVIRON MICROB, V78, P1055, DOI 10.1128/AEM.07059-11; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stecher H, 2009, ANGEW CHEM INT EDIT, V48, P9546, DOI 10.1002/anie.200905095; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Surendra K, 2008, J AM CHEM SOC, V130, P8865, DOI 10.1021/ja802730a; Syren PO, 2014, ANGEW CHEM INT EDIT, V53, P4845, DOI 10.1002/anie.201402087; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tsangarakis C, 2008, ADV SYNTH CATAL, V350, P1587, DOI 10.1002/adsc.200800180; Turner NJ, 2013, NAT CHEM BIOL, V9, P285, DOI 10.1038/nchembio.1235; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wang ZJ, 2014, CHEM SCI, V5, P598, DOI 10.1039/c3sc52535j; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Yonemura Y, 2012, ORG BIOMOL CHEM, V10, P440, DOI 10.1039/c1ob06419c	54	63	64	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					121	U59		10.1038/NCHEMBIO.1719	http://dx.doi.org/10.1038/NCHEMBIO.1719			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25503928				2022-12-25	WOS:000348358800009
J	Ramanathan, SP; Helenius, J; Stewart, MP; Catlin, CJ; Hyman, AA; Muller, DJ				Ramanathan, Subramanian P.; Helenius, Jonne; Stewart, Martin P.; Catlin, Cedric J.; Hyman, Anthony A.; Muller, Daniel J.			Cdk1-dependent mitotic enrichment of cortical myosin II promotes cell rounding against confinement	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; REGULATORY LIGHT-CHAIN; P21-ACTIVATED KINASE; F-ACTIN; SERINE PHOSPHORYLATION; SPINDLE ORIENTATION; SPATIAL CONTROL; ARP2/3 COMPLEX; PROTEIN-KINASE; SMALL GTPASE	Actomyosin-dependent mitotic rounding occurs in both cell culture and tissue, where it is involved in cell positioning and epithelial organization. How actomyosin is regulated to mediate mitotic rounding is not well understood. Here we characterize the mechanics of single mitotic cells while imaging actomyosin recruitment to the cell cortex. At mitotic onset, the assembly of a uniform DIAPH1-dependent F-actin cortex coincides with initial rounding. Thereafter, cortical enrichment of F-actin remains stable while myosin II progressively accumulates at the cortex, and the amount of myosin at the cortex correlates with intracellular pressure. Whereas F-actin provides only short-term (< 10 s) resistance to mechanical deformation, myosin sustains intracellular pressure for a longer duration (> 60 s). Our data suggest that progressive accumulation of myosin II to the mitotic cell cortex probably requires the Cdk1 activation of both p21-activated kinases, which inhibit myosin recruitment, and of Rho kinase, which stimulates myosin recruitment to the cortex.	[Ramanathan, Subramanian P.; Helenius, Jonne; Stewart, Martin P.; Catlin, Cedric J.; Muller, Daniel J.] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Stewart, Martin P.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Stewart, Martin P.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; daniel.mueller@bsse.ethz.ch	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Ramanathan, Subramanian/AAE-9817-2020; Müller, Daniel J./A-5967-2010; Stewart, Martin Philip/E-8059-2011	Hyman, Anthony A/0000-0003-3664-154X; Müller, Daniel J./0000-0003-3075-0665; Stewart, Martin Philip/0000-0003-4112-6622; Ramanathan, Subu/0000-0002-2876-0322	Eidgenossische Technische Hochschule Zurich (ETH) [ETH-05 11-2]; Swiss National Science Foundation [31003A_138063]; National Center of Competence in Research Nano	Eidgenossische Technische Hochschule Zurich (ETH)(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research Nano	We thank S. Weiser, Y. Toyoda, S. Raghuraman, R. Newton and B. Sorce for input, S. Hayashi, T. Kondo, M. Piel, C. Cabernard and O. Pertz for critical reading of the manuscript, the E. Paluch and F. Buchholz laboratories for contributing HeLa cell lines, J. Mercer for providing the mutant Rho GTPase plasmids as well as Cdc42 inhibitor, pirl1, and T. Horn and A. Ponti for help with the experiments on fluorescence recovery after photobleaching. This work was supported by the Eidgenossische Technische Hochschule Zurich (ETH research grant ETH-05 11-2), Swiss National Science Foundation (advanced mobility fellowship to M.P.S. and grant 31003A_138063 to D.J.M.) and National Center of Competence in Research Nano.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Clark AG, 2011, RESULTS PROBL CELL D, V53, P31, DOI 10.1007/978-3-642-19065-0_3; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Fischer-Friedrich E, 2014, SCI REP-UK, V4, DOI 10.1038/srep06213; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Ideses Y, 2013, SOFT MATTER, V9, P7127, DOI 10.1039/c3sm50309g; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Li Y, 2008, CELL MOTIL CYTOSKEL, V65, P393, DOI 10.1002/cm.20268; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Stewart MP, 2013, METHODS, V60, P186, DOI 10.1016/j.ymeth.2013.02.015; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strangeways TSP, 1922, P R SOC LOND B-CONTA, V94, P137, DOI 10.1098/rspb.1922.0050; Surviladze Z., 2010, PROBE REPORTS NIH MO; Szczepanowska J, 2006, CELL MOTIL CYTOSKEL, V63, P356, DOI 10.1002/cm.20125; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Tse HTK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038986; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Yamaguchi R, 1997, ONCOGENE, V15, P1753, DOI 10.1038/sj.onc.1201345; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yamakita Y, 1999, J CELL BIOL, V144, P315, DOI 10.1083/jcb.144.2.315; Zeng Q, 2000, J CELL SCI, V113, P471	68	97	101	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					148	+		10.1038/ncb3098	http://dx.doi.org/10.1038/ncb3098			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25621953				2022-12-25	WOS:000349152400006
J	Takeda, H; Wei, ZB; Koso, H; Rust, AG; Yew, CCK; Mann, MB; Ward, JM; Adams, DJ; Copeland, NG; Jenkins, NA				Takeda, Haruna; Wei, Zhubo; Koso, Hideto; Rust, Alistair G.; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Adams, David J.; Copeland, Neal G.; Jenkins, Nancy A.			Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression	NATURE GENETICS			English	Article							NEGATIVE REGULATOR; COLORECTAL-CANCER; STEM-CELLS; P53; SUPPRESSOR; WNT; MUTATIONS; SCREEN; LRIG1; TRANSCRIPTION	To provide a more comprehensive understanding of the genes and evolutionary forces driving colorectal cancer (CRC) progression, we performed Sleeping Beauty (SB) transposon mutagenesis screens in mice carrying sensitizing mutations in genes that act at different stages of tumor progression. This approach allowed us to identify a set of genes that appear to be highly relevant for CRC and to provide a better understanding of the evolutionary forces and systems properties of CRC. We also identified six genes driving malignant tumor progression and a new human CRC tumor-suppressor gene, ZNF292, that might also function in other types of cancer. Our comprehensive CRC data set provides a resource with which to develop new therapies for treating CRC.	[Takeda, Haruna; Koso, Hideto; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Copeland, Neal G.; Jenkins, Nancy A.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore; [Takeda, Haruna] Kanazawa Med Univ, Sch Med, Dept Oncol Pathol, Kanazawa, Ishikawa, Japan; [Wei, Zhubo; Mann, Michael B.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX USA; [Koso, Hideto] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, Cambs, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Kanazawa Medical University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Tokyo; Wellcome Trust Sanger Institute	Jenkins, NA (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore.	njenkins2@houstonmethodist.org	Mann, Michael Bruce/M-4674-2019	Mann, Michael Bruce/0000-0002-7515-6515; KOSO, HIDETO/0000-0002-8986-7617; Adams, David/0000-0001-9490-0306; Rust, Alistair/0000-0001-7287-192X	Biomedical Research Council; Agency for Science, Technology and Research (A-STAR), Singapore; Cancer Prevention Research Institute of Texas (CPRIT); Cancer Research UK; Wellcome Trust; Cancer Research UK [13031] Funding Source: researchfish	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Prevention Research Institute of Texas (CPRIT); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	We thank K. Rogers, S. Rogers and the Institute of Molecular and Cell Biology histopathology core for performing the histopathological analysis; M.M. Taketo (Kyoto University) for supplying Smad4<SUP>KO</SUP> mice and S. Robin (Institute Curie) for supplying Vil1-creER<SUP>T2</SUP> mice; Y. Ito for helpful discussions and encouragement; and, P. Goh, P. Cheok, N. Lim,.D. Chen and C. Wee for monitoring mice and animal technical assistance. The Biomedical Research Council, Agency for Science, Technology and Research (A-STAR), Singapore, and the Cancer Prevention Research Institute of Texas (CPRIT) supported this research. N.G.C. and N.A.J. are both CPRIT Scholars in Cancer Research. D.J.A. and A.G.R. are supported by Cancer Research UK and the Wellcome Trust.	Ahn J, 2011, ONCOGENE, V30, P445, DOI 10.1038/onc.2010.424; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BOS JL, 1989, CANCER RES, V49, P4682; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Das TK, 2013, ONCOGENE, V32, P3184, DOI 10.1038/onc.2012.326; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meek DW, 2011, MOL CELL BIOCHEM, V356, P133, DOI 10.1007/s11010-011-0966-3; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Pinto D, 2005, BIOL CELL, V97, P185; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Singh H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.16; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Yoshio T, 2010, CARCINOGENESIS, V31, P1185, DOI 10.1093/carcin/bgq065; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	55	84	85	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					142	150		10.1038/ng.3175	http://dx.doi.org/10.1038/ng.3175			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25559195				2022-12-25	WOS:000348694700009
J	Henry, BD; Neill, DR; Becker, KA; Gore, S; Bricio-Moreno, L; Ziobro, R; Edwards, MJ; Muhlemann, K; Steinmann, J; Kleuser, B; Japtok, L; Luginbuhl, M; Wolfmeier, H; Scherag, A; Gulbins, E; Kadioglu, A; Draeger, A; Babiychuk, EB				Henry, Brian D.; Neill, Daniel R.; Becker, Katrin Anne; Gore, Suzanna; Bricio-Moreno, Laura; Ziobro, Regan; Edwards, Michael J.; Muehlemann, Kathrin; Steinmann, Joerg; Kleuser, Burkhard; Japtok, Lukasz; Luginbuehl, Miriam; Wolfmeier, Heidi; Scherag, Andre; Gulbins, Erich; Kadioglu, Aras; Draeger, Annette; Babiychuk, Eduard B.			Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice	NATURE BIOTECHNOLOGY			English	Article							PORE-FORMING TOXINS; ANTIBIOTIC-RESISTANCE; CHOLESTEROL; VIRULENCE; PNEUMOLYSIN; SPHINGOLIPIDS; DYNAMICS; SEPSIS; FAMILY; RAFTS	Gram-positive bacterial pathogens that secrete cytotoxic pore-forming toxins, such as Staphylococcus aureus and Streptococcus pneumoniae, cause a substantial burden of disease. Inspired by the principles that govern natural toxin-host interactions, we have engineered artificial liposomes that are tailored to effectively compete with host cells for toxin binding. Liposome-bound toxins are unable to lyse mammalian cells in vitro. We use these artificial liposomes as decoy targets to sequester bacterial toxins that are produced during active infection in vivo. Administration of artificial liposomes within 10 h after infection rescues mice from septicemia caused by S. aureus and S. pneumoniae, whereas untreated mice die within 24-33 h. Furthermore, liposomes protect mice against invasive pneumococcal pneumonia. Composed exclusively of naturally occurring lipids, tailored liposomes are not bactericidal and could be used therapeutically either alone or in conjunction with antibiotics to combat bacterial infections and to minimize toxin-induced tissue damage that occurs during bacterial clearance. npg (C) 2015 Nature America, Inc. All rights reserved.	[Henry, Brian D.; Becker, Katrin Anne; Ziobro, Regan; Gulbins, Erich] Univ Duisburg Essen, Inst Mol Biol, Essen, Germany; [Henry, Brian D.; Ziobro, Regan; Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Neill, Daniel R.; Gore, Suzanna; Bricio-Moreno, Laura; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Steinmann, Joerg] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Kleuser, Burkhard; Japtok, Lukasz] Univ Potsdam, Inst Nutr Sci, Dept Toxicol, Potsdam, Germany; [Luginbuehl, Miriam; Wolfmeier, Heidi; Draeger, Annette; Babiychuk, Eduard B.] Univ Bern, Inst Anat, Bern, Switzerland; [Scherag, Andre] Jena Univ Hosp, CSCC, Clin Epidemiol Integrated Res & Treatment Ctr, Jena, Germany	University of Duisburg Essen; University System of Ohio; University of Cincinnati; University of Liverpool; University of Bern; University of Duisburg Essen; University of Potsdam; University of Bern; Friedrich Schiller University of Jena	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	edik@ana.unibe.ch	Bricio-Moreno, Laura/AAD-2781-2019; Neill, Daniel/Q-6290-2019; Babiychuk, Eduard/AAV-7223-2021	Neill, Daniel/0000-0002-7911-8153; Bricio Moreno, Laura/0000-0002-4956-7142; Scherag, Andre/0000-0002-9406-4704; Wolfmeier, Heidi/0000-0003-2474-3717; Babiychuk, Eduard/0000-0003-1786-0085; kadioglu, aras/0000-0003-1137-6321; Lim, Suzanna/0000-0002-1753-1954; Kleuser, Burkhard/0000-0002-1888-9595	University of Bern, Commission for Technology and Innovation (CTI) [16001.1 PFLS-LS]; Deutsche Forschungsgemeinschaft (DFG) [GU 335/16-2, SFB 1112]; Federal Ministry of Education and Research (BMBF) (FKZ) [01EO1002]; Institute of Infection & Global Health, University of Liverpool; MRC [MC_PC_13068] Funding Source: UKRI; Medical Research Council [MC_PC_13068] Funding Source: researchfish	University of Bern, Commission for Technology and Innovation (CTI); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF) (FKZ); Institute of Infection & Global Health, University of Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge the financial support of the University of Bern, Commission for Technology and Innovation (CTI) (16001.1 PFLS-LS to A.D. and E.B.B.), Deutsche Forschungsgemeinschaft (DFG GU 335/16-2 to E.G. and SFB 1112 to B.K.), Federal Ministry of Education and Research (BMBF) (FKZ: 01EO1002 to A.S.) and the Institute of Infection & Global Health, University of Liverpool to A.K.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bakker-Woudenberg IAJM, 2001, ANTIMICROB AGENTS CH, V45, P1487, DOI 10.1128/AAC.45.5.1487-1492.2001; BRISSEAU GF, 1994, ANTIMICROB AGENTS CH, V38, P2671, DOI 10.1128/AAC.38.11.2671; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Drulis-Kawa Z, 2010, INT J PHARMACEUT, V387, P187, DOI 10.1016/j.ijpharm.2009.11.033; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Huttunen R, 2011, J INFECTION, V63, P407, DOI 10.1016/j.jinf.2011.08.004; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Moore CL, 2011, ANTIMICROB AGENTS CH, V55, P4581, DOI 10.1128/AAC.00115-11; MORTON DB, 1985, NATURE, V317, P106, DOI 10.1038/317106a0; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHAH H, 2011, NATL J PHYSL PHARM P, V1, P35, DOI DOI 10.4103/0976; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Spreer A, 2003, ANTIMICROB AGENTS CH, V47, P2649, DOI 10.1128/AAC.47.8.2649-2654.2003; Stefani S, 2010, INT J INFECT DIS, V14, pS19, DOI 10.1016/j.ijid.2010.05.009; Stringaris AK, 2002, NEUROBIOL DIS, V11, P355, DOI 10.1006/nbdi.2002.0561; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Wall EC, 2012, CLIN INFECT DIS, V54, P701, DOI 10.1093/cid/cir926; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405	38	139	142	3	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					81	U295		10.1038/nbt.3037	http://dx.doi.org/10.1038/nbt.3037			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25362245				2022-12-25	WOS:000347714200031
J	Maekawa, Y; Ishifune, C; Tsukumo, SI; Hozumi, K; Yagita, H; Yasutomo, K				Maekawa, Yoichi; Ishifune, Chieko; Tsukumo, Shin-ichi; Hozumi, Katsuto; Yagita, Hideo; Yasutomo, Koji			Notch controls the survival of memory CD4(+) T cells by regulating glucose uptake	NATURE MEDICINE			English	Article							IMMUNE-SYSTEM; DIFFERENTIATION; METABOLISM; EXPRESSION; EFFECTOR; LYMPHOCYTES; SIGNALS	CD4(+) T cells differentiate into memory T cells that protect the host from subsequent infection. In contrast, autoreactive memory CD4(+) T cells harm the body by persisting in the tissues. The underlying pathways controlling the maintenance of memory CD4(+) T cells remain undefined. We show here that memory CD4(+) T cell survival is impaired in the absence of the Notch signaling protein known as recombination signal binding protein for immunoglobulin K J region (Rbpj). Treatment of mice with a Notch inhibitor reduced memory CD4(+) T cell numbers and prevented the recurrent induction of experimental autoimmune encephalomyelitis. Rbpj-deficient CD4(+) memory T cells exhibit reduced glucose uptake due to impaired AKT phosphorylation, resulting in low Glutl expression. Treating mice with pyruvic acid, which bypasses glucose uptake and supplies the metabolite downstream of glucose uptake, inhibited the decrease of autoimmune memory CD4(+) T cells in the absence of Notch signaling, suggesting memory CD4(+) T cell survival relies on glucose metabolism. Together, these data define a central role for Notch signaling in maintaining memory CD4(+) T cells through the regulation of glucose uptake.	[Maekawa, Yoichi; Ishifune, Chieko; Tsukumo, Shin-ichi; Yasutomo, Koji] Univ Tokushima, Grad Sch Med, Dept Immunol & Parasitol, Tokushima 770, Japan; [Hozumi, Katsuto] Tokai Univ, Sch Med, Dept Immunol, Kanagawa 2591100, Japan; [Hozumi, Katsuto] Tokai Univ, Sch Med, Ctr Embryogenesis & Organogenesis, Kanagawa 2591100, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Tokushima University; Tokai University; Tokai University; Juntendo University	Yasutomo, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Immunol & Parasitol, Tokushima 770, Japan.	yasutomo@tokushima-u.ac.jp		Yasutomo, Koji/0000-0003-0411-2037; Maekawa, Yoichi/0000-0002-3879-5713	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Chiba (University of Tsukuba), K. Tanigaki (Shiga Medical Center Research Institute), T. Honjo (Kyoto University), M. Kubo (Tokyo University of Science), M. Farrar (University of Minnesota) and Y. Itoh (Shiga Medical University) for providing mice; T. Azuma (Tokyo Science University) for antibodies; and C. Kinouchi and C. Tomari for technical and editorial assistance. This work was supported by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science and by a Grant-in-Aid for Scientific Research on Innovative Areas (Tying Codes') from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Reiner SL, 2009, NAT REV IMMUNOL, V9, P81, DOI 10.1038/nri2490; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Sandy AR, 2013, J IMMUNOL, V190, P5818, DOI 10.4049/jimmunol.1203452; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tremblay F, 2003, FRONT BIOSCI-LANDMRK, V8, pD1072, DOI 10.2741/1137; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Youngblood B, 2010, INT IMMUNOL, V22, P797, DOI 10.1093/intimm/dxq437; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	92	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					55	61		10.1038/nm.3758	http://dx.doi.org/10.1038/nm.3758			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25501905				2022-12-25	WOS:000348408000013
J	Stephan, SB; Taber, AM; Jileaeva, I; Pegues, EP; Sentman, CL; Stephan, MT				Stephan, Sirkka B.; Taber, Alexandria M.; Jileaeva, Ilona; Pegues, Ericka P.; Sentman, Charles L.; Stephan, Matthias T.			Biopolymer implants enhance the efficacy of adoptive T-cell therapy	NATURE BIOTECHNOLOGY			English	Article							PHASE-I; IMMUNOTHERAPY; VIVO; SUPERAGONIST; RECEPTOR; PATIENT; IL-15	Although adoptive T-cell therapy holds promise for the treatment of many cancers, its clinical utility has been limited by problems in delivering targeted lymphocytes to tumor sites, and the cells' inefficient expansion in the immunosuppressive tumor microenvironment. Here we describe a bioactive polymer implant capable of delivering, expanding and dispersing tumor-reactive T cells. The approach can be used to treat inoperable or incompletely removed tumors by situating implants near them or at resection sites. Using a mouse breast cancer resection model, we show that the implants effectively support tumor-targeting T cells throughout resection beds and associated lymph nodes, and reduce tumor relapse compared to conventional delivery modalities. In a multifocal ovarian cancer model, we demonstrate that polymer-delivered T cells trigger regression, whereas injected tumor-reactive lymphocytes have little curative effect. Scaffold-based T-cell delivery may provide a viable treatment option for inoperable tumors and reduce the rate of metastatic relapse after surgery. npg (C) 2015 Nature America, Inc. All rights reserved.	[Stephan, Sirkka B.; Taber, Alexandria M.; Stephan, Matthias T.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jileaeva, Ilona; Pegues, Ericka P.; Stephan, Matthias T.] Fred Hutchinson Canc Res Ctr, Technol Access Fdn TAF Acad, Seattle, WA 98104 USA; [Sentman, Charles L.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Stephan, Matthias T.] Univ Washington, Dept Bioengn & Mol Engn, Seattle, WA 98195 USA; [Stephan, Matthias T.] Univ Washington, Inst Sci, Seattle, WA 98195 USA; [Stephan, Matthias T.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Dartmouth College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stephan, MT (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mstephan@fhcrc.org		Stephan, Matthias/0000-0001-8310-0100; Taber, Alexandria/0000-0002-9510-3517	Bezos Family Foundation; NATIONAL CANCER INSTITUTE [P50CA138293, P50CA083636, R01CA181413] Funding Source: NIH RePORTER	Bezos Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Ehlert (cognitionstudio. com) for the design of the illustration in Figure 1. This work was supported in part by the Fred Hutchinson Cancer Research Center's Immunotherapy Initiative with funds provided by the Bezos Family Foundation, the National Cancer Institute (NCI; RO1 CA181413), the George and Margaret McLane Foundation, the Breast Cancer Development Research Program funded by the Safeway Foundation and the Seattle Cancer Consortium Breast SPORE (NCI P50 CA138293, PI: Peggy Porter) and the Pacific Ovarian Cancer Research Consortium (NCI P50 CA83636, PI: Nicole Urban). We thank K. Roby (University of Kansas Medical Center, Kansas City, KS, USA) for giving us the murine ovarian cancer cell line ID8. SFG-CBR-luc (expressing click beetle red luciferase), SFG-F-luc (expressing firefly luciferase), and SFG-B7.1 and SFG-4-1BBL (encoding the costimulatory ligands B7.1 and 4-1BBL) vectors were kindly provided by M. Sadelain (Memorial Sloan-Kettering Cancer Center, New York).	Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Erskine CL, 2012, JOVE-J VIS EXP, DOI 10.3791/3683; Hinrichs CS, 2014, AM J CLIN ONCOL-CANC, V32, P3008, DOI DOI 10.1200/JCO.2014.32.18_SUPPL.LBA3008; Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033; Janat-Amsbury MM, 2006, ANTICANCER RES, V26, P2785; Kandalaft LE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-157; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Krebs S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00322; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Peres E, 2008, NEUROPEDIATRICS, V39, P151, DOI 10.1055/s-0028-1093333; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Sentman CL, 2014, CANCER J, V20, P156, DOI 10.1097/PPO.0000000000000029; Stone JD, 2012, BIOTECHNOL PROGR, V28, P1588, DOI 10.1002/btpr.1631; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2010, J IMMUNOTHER, V33, P759, DOI 10.1097/CJI.0b013e3181f1d644; Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278	30	244	264	9	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					97	U277		10.1038/nbt.3104	http://dx.doi.org/10.1038/nbt.3104			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25503382	Green Accepted			2022-12-25	WOS:000347714200033
J	Vittal, V; Shi, L; Wenzel, DM; Scaglione, KM; Duncan, ED; Basrur, V; Elenitoba-Johnson, KSJ; Baker, D; Paulson, HL; Brzovic, PS; Klevit, RE				Vittal, Vinayak; Shi, Lei; Wenzel, Dawn M.; Scaglione, K. Matthew; Duncan, Emily D.; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.; Baker, David; Paulson, Henry L.; Brzovic, Peter S.; Klevit, Rachel E.			Intrinsic disorder drives N-terminal ubiquitination by Ube2w	NATURE CHEMICAL BIOLOGY			English	Article							POLYGLUTAMINE DISEASE PROTEIN; STRUCTURE PREDICTION; E3 LIGASE; E2; REVEALS; BRCA1; UBIQUITYLATION; DEGRADATION; MECHANISM; DYNAMICS	Ubiquitination of the alpha N-terminus of protein substrates has been reported sporadically since the early 1980s. However, the identity of an enzyme responsible for this unique ubiquitin (Ub) modification has only recently been elucidated. We show the Ub-conjugating enzyme (E2) Ube2w uses a unique mechanism to facilitate the specific ubiquitination of the alpha-amino group of its substrates that involves recognition of backbone atoms of intrinsically disordered N termini. We present the NMR-based solution ensemble of full-length Ube2w that reveals a structural architecture unlike that of any other E2 in which its C terminus is partly disordered and flexible to accommodate variable substrate N termini. Flexibility of the substrate is critical for recognition by Ube2w, and either point mutations in or the removal of the flexible C terminus of Ube2w inhibits substrate binding and modification. Mechanistic insights reported here provide guiding principles for future efforts to define the N-terminal ubiquitome in cells.	[Vittal, Vinayak; Shi, Lei; Wenzel, Dawn M.; Duncan, Emily D.; Baker, David; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Shi, Lei; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Scaglione, K. Matthew; Paulson, Henry L.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Medical College of Wisconsin; Medical College of Wisconsin; University of Michigan System; University of Michigan	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	klevit@u.washington.edu	Baker, David/K-8941-2012; Klevit, Rachel/AAI-7038-2021	Baker, David/0000-0001-7896-6217; Klevit, Rachel/0000-0002-3476-969X; Scaglione, Kenneth/0000-0002-3858-9418; Duncan, Emily/0000-0003-2062-2942; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institute of General Medical Sciences [R01 GM088055, R01 GM098503, K99 NS073936, R01 AG034228]; University of Washington Hurd Fellowship Fund; Public Health Service National Research Service Award [2T32 GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098503, R01GM088055, T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS073936, R00NS073936] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Washington Hurd Fellowship Fund; Public Health Service National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge D. Christensen and C. Eakin for their initial observations on Ube2w and J. N. Pruneda for collecting SAXS data on Ube2w. This work was supported by National Institute of General Medical Sciences grants R01 GM088055 (REK), R01 GM098503 (P.S.B.), K99 NS073936 (K.M.S.) and R01 AG034228 (H.L.P.) and the University of Washington Hurd Fellowship Fund and Public Health Service National Research Service Award 2T32 GM007270 (to V.V.).	Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Barghorn Stefan, 2004, V299, P35; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dormeyer W, 2007, J PROTEOME RES, V6, P4634, DOI 10.1021/pr070375k; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; McDowell GS, 2010, BIOCHEM BIOPH RES CO, V400, P655, DOI 10.1016/j.bbrc.2010.08.122; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Thompson JM, 2012, P NATL ACAD SCI USA, V109, P9875, DOI 10.1073/pnas.1202485109; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Vittal V, 2013, CELL BIOCHEM BIOPHYS, V67, P103, DOI 10.1007/s12013-013-9633-5; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Wand AJ, 1996, BIOCHEMISTRY-US, V35, P6116, DOI 10.1021/bi9530144; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wu PY, 2007, EMBO J, V26, P4051, DOI 10.1038/sj.emboj.7601829; Wu PY, 2004, EMBO J, V23, P4876, DOI 10.1038/sj.emboj.7600513; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Wu WW, 2007, CANCER RES, V67, P951, DOI 10.1158/0008-5472.CAN-06-3187; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Yin G, 2006, FRONT BIOSCI-LANDMRK, V11, P1500, DOI 10.2741/1899; Zhang YY, 2011, MOL CELLS, V31, P113, DOI 10.1007/s10059-011-0015-9	53	45	45	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					83	+		10.1038/NCHEMBIO.1700	http://dx.doi.org/10.1038/NCHEMBIO.1700			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25436519	Green Accepted			2022-12-25	WOS:000346448600017
J	Baumann, U; Fernandez-Saiz, V; Rudelius, M; Lemeer, S; Rad, R; Knorn, AM; Slawska, J; Engel, K; Jeremias, I; Li, ZL; Tomiatti, V; Illert, AL; Targosz, BS; Braun, M; Perner, S; Leitges, M; Klapper, W; Dreyling, M; Miething, C; Lenz, G; Rosenwald, A; Peschel, C; Keller, U; Kuster, B; Bassermann, F				Baumann, Ursula; Fernandez-Saiz, Vanesa; Rudelius, Martina; Lemeer, Simone; Rad, Roland; Knorn, Anna-Maria; Slawska, Jolanta; Engel, Katharina; Jeremias, Irmela; Li, Zhoulei; Tomiatti, Viktoriya; Illert, Anna-Lena; Targosz, Bianca-Sabrina; Braun, Martin; Perner, Sven; Leitges, Michael; Klapper, Wolfram; Dreyling, Martin; Miething, Cornelius; Lenz, Georg; Rosenwald, Andreas; Peschel, Christian; Keller, Ulrich; Kuster, Bernhard; Bassermann, Florian			Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis	NATURE MEDICINE			English	Article							MANTLE-CELL LYMPHOMA; PROTEIN-KINASE-C; COMPARATIVE GENOMIC HYBRIDIZATION; DNA-DAMAGE-RESPONSE; HOMOZYGOUS DELETIONS; GENE-EXPRESSION; B-CELLS; HAX-1; DELTA; MYC	We searched for genetic alterations in human B cell lymphoma that affect the ubiquitin-proteasome system. This approach identified FBXO25 within a minimal common region of frequent deletion in mantle cell lymphoma (MCL). FBXO25 encodes an BX orphan F-box protein that determines the substrate specificity of the SCF (SKP1-CUL1-F-box)(FBXO25) ubiquitin ligase complex. An unbiased screen uncovered the prosurvival protein HCLS1-associated protein X-1 (HAX-1) as the bona fide substrate of FBXO25 that is targeted after apoptotic stresses. Protein kinase C delta (PRKCD) initiates this process by phosphorylating FBXO25 and HAX-1, thereby spatially directing nuclear FBXO25 to mitochondria! HAX-1. Our analyses in primary human MCL identify monoallelic loss of FBXO25 and stabilizing HAX1 phosphodegron mutations. Accordingly, FBXO25 re-expression in FBXO25-deleted MCL cells promotes cell death, whereas expression of the HAX-1 phosphodegron mutant inhibits apoptosis. In addition, knockdown of FBXO25 significantly accelerated lymphoma development in E mu-Myc mice and in a human MCL xenotransplant model. Together we identify a PRKCD-dependent proapoptotic mechanism controlling HAX-1 stability, and we propose that FBXO25 functions as a haploinsufficient tumor suppressor and that HAX1 is a proto-oncogene in MCL.	[Baumann, Ursula; Fernandez-Saiz, Vanesa; Knorn, Anna-Maria; Engel, Katharina; Tomiatti, Viktoriya; Targosz, Bianca-Sabrina; Peschel, Christian; Keller, Ulrich; Bassermann, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-80290 Munich, Germany; [Rudelius, Martina; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Rudelius, Martina; Rosenwald, Andreas] Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Dept Prote & Bioanalyt, Freising Weihenstephan, Germany; [Rad, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-80290 Munich, Germany; [Rad, Roland; Peschel, Christian; Keller, Ulrich; Kuster, Bernhard; Bassermann, Florian] German Canc Consortium DKTK, Heidelberg, Germany; [Rad, Roland; Peschel, Christian; Keller, Ulrich; Kuster, Bernhard; Bassermann, Florian] German Canc Res Ctr, Heidelberg, Germany; [Slawska, Jolanta; Li, Zhoulei] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-80290 Munich, Germany; [Jeremias, Irmela] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany; [Jeremias, Irmela] Univ Munich, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany; [Illert, Anna-Lena; Miething, Cornelius] Univ Med Ctr Freiburg, Dept Hematol Oncol, Freiburg, Germany; [Braun, Martin; Perner, Sven] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany; [Leitges, Michael] Biotechnol Ctr Oslo, Oslo, Norway; [Klapper, Wolfram] Univ Klinikum Schleswig Holstein, Inst Pathol, Hematopathol Sect, Kiel, Germany; [Klapper, Wolfram] Univ Klinikum Schleswig Holstein, Lymph Node Registry, Kiel, Germany; [Dreyling, Martin] Univ Hosp Munchen, Dept Med 3, Munich, Germany; [Lenz, Georg] Univ Klinikum Munster, Dept Med A, Munster, Germany; [Kuster, Bernhard] CIPSM, Freising Weihenstephan, Germany	Technical University of Munich; University of Wurzburg; University of Wurzburg; Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Freiburg; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Munich; University of Munster	Bassermann, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-80290 Munich, Germany.	florian.bassermann@lrz.tum.de	Jeremias, Irmela/C-6090-2015; Miething, Cornelius/F-9498-2014; Kuster, Bernhard/Q-6031-2016; Jeremias, Irmela/Q-5934-2019; Illert, Anna L/G-8127-2019; Fernandez, Vanesa/ABD-6688-2021; Lemeer, Simone/I-4363-2016; Leitges, Michael/AAN-1953-2021; Lenz, Georg/I-6844-2012; Klapper, Wolfram/S-6314-2016; Keller, Ulrich/L-1763-2016	Miething, Cornelius/0000-0003-4699-3805; Kuster, Bernhard/0000-0002-9094-1677; Jeremias, Irmela/0000-0003-1773-7677; Clemm von Hohenberg, Katharina/0000-0002-2853-208X; Leitges, Michael/0000-0003-4203-6995; Fernandez-Saiz, Vanesa/0000-0002-7139-8680; Keller, Ulrich/0000-0002-8485-1958	German Research Foundation [KE 222/-1, SFB824, BA 2851/4-1, BA 2851/3-1]; German Cancer Aid [109543]	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe)	We thank J. Ihle (St. Jude Children's Research Hospital), V. Kalscheuer (Max Planck Institute for Molecular Genetics), M. Pagano (New York University School of Medicine) and A. Villunger (Medical University of Innsbruck) for reagents and cell lines; J. Martinez-Climent, M. Schraders, H. Tagawa, H. Kohlhammer and E. Flordal Thelander for sending the raw data of aCGH studies; G. Keller and K. Malinowski for suggestions; K.-F. Becker and C. Schott for help with extract preparation from MCL tissue samples; and R. Oellinger for help with the MCL tissue culture models. This work was supported by grants from the German Research Foundation (KE 222/-1 and SFB824 to U.K.; and BA 2851/4-1 and Emmy Noether Program grant BA 2851/3-1 to F.B.) and the German Cancer Aid (#109543 to F.B.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dreyling M, 2011, LEUKEMIA LYMPHOMA, V52, P2226, DOI 10.3109/10428194.2011.600488; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fernandez-Saiz V, 2013, NAT CELL BIOL, V15, P72, DOI 10.1038/ncb2651; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hagens O, 2006, BBA-GEN SUBJECTS, V1760, P110, DOI 10.1016/j.bbagen.2005.09.018; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kwiecinska A, 2011, LEUKEMIA, V25, P868, DOI 10.1038/leu.2010.321; Li B, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-20; Li M, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-47; Martinez-Climent JA, 2001, BLOOD, V98, P3479, DOI 10.1182/blood.V98.12.3479; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Peckl-Schmid D, 2010, EUR J IMMUNOL, V40, P3161, DOI 10.1002/eji.200940221; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Puebla-Osorio N, 2008, IMMUNOL RES, V41, P103, DOI 10.1007/s12026-008-8015-3; Rubio-Moscardo F, 2005, BLOOD, V105, P4445, DOI 10.1182/blood-2004-10-3907; Salaverria I, 2007, J CLIN ONCOL, V25, P1216, DOI 10.1200/JCO.2006.08.4251; Schraders M, 2005, BLOOD, V105, P1686, DOI 10.1182/blood-2004-07-2730; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Thelander EF, 2007, LEUKEMIA RES, V31, P1219, DOI 10.1016/j.leukres.2006.10.022; Toujani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007089; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wei XJ, 2014, TUMOR BIOL, V35, P1411, DOI 10.1007/s13277-013-1194-0; Yap SV, 2011, J CELL PHYSIOL, V226, P2752, DOI 10.1002/jcp.22638; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027	40	40	40	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1401	1409		10.1038/nm.3740	http://dx.doi.org/10.1038/nm.3740			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25419709				2022-12-25	WOS:000345817900015
J	Fang, NN; Chan, GT; Zhu, M; Comyn, SA; Persaud, A; Deshaies, RJ; Rotin, D; Gsponer, J; Mayor, T				Fang, Nancy N.; Chan, Gerard T.; Zhu, Mang; Comyn, Sophie A.; Persaud, Avinash; Deshaies, Raymond J.; Rotin, Daniela; Gsponer, Joerg; Mayor, Thibault			Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins following heat stress	NATURE CELL BIOLOGY			English	Article							DEPENDENT DEGRADATION; SOLVENT ACCESSIBILITY; GLOBAL ANALYSIS; DOWN-REGULATION; NUCLEAR EXPORT; MESSENGER-RNA; RSP5; PREDICTION; SUBSTRATE; UBIQUITYLATION	The heat-shock response is a complex cellular program that induces major changes in protein translation, folding and degradation to alleviate toxicity caused by protein misfolding. Although heat shock has been widely used to study proteostasis, it remained unclear how misfolded proteins are targeted for proteolysis in these conditions. We found that Rsp5 and its mammalian homologue Nedd4 are important E3 ligases responsible for the increased ubiquitylation induced by heat stress. We determined that Rsp5 ubiquitylates mainly cytosolic misfolded proteins upon heat shock for proteasome degradation. We found that ubiquitylation of heat-induced substrates requires the Hsp40 co-chaperone Ydj1 that is further associated with Rsp5 upon heat shock. In addition, ubiquitylation is also promoted by PY Rsp5-binding motifs found primarily in the structured regions of stress-induced substrates, which can act as heat-induced degrons. Our results support a bipartite recognition mechanism combining direct and chaperone-dependent ubiquitylation of misfolded cytosolic proteins by Rsp5.	[Fang, Nancy N.; Chan, Gerard T.; Zhu, Mang; Comyn, Sophie A.; Gsponer, Joerg; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Persaud, Avinash; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Persaud, Avinash; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; California Institute of Technology; Howard Hughes Medical Institute	Mayor, T (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Ctr High Throughput Biol, 2125 East Mall, Vancouver, BC V6T 1Z4, Canada.	mayor@mail.ubc.ca	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	We thank N. Stoynov for his support for the mass spectrometry analyses, all colleagues cited in Methods who provided reagents and a previous anonymous reviewer who suggested investigating Rsp5. This work was supported by a CIHR grant. R.J.D. is an HHMI investigator and T.M. is a CIHR and MSFHR new investigator.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Comyn SA, 2014, J PROTEOMICS, V100, P92, DOI 10.1016/j.jprot.2013.08.005; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Gajewska B, 2001, GENETICS, V157, P91; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Haitani Y, 2008, GENES CELLS, V13, P105, DOI 10.1111/j.1365-2443.2007.01154.x; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Ng AHM, 2013, MOL CELL PROTEOMICS, V12, P2456, DOI 10.1074/mcp.M112.023416; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Shahsavarani H, 2012, BIOTECHNOL ADV, V30, P1289, DOI 10.1016/j.biotechadv.2011.09.002; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Wagner S. A., 2011, IN VIVO, V10; Wang GL, 1999, MOL CELL BIOL, V19, P342; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	66	122	122	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1227	U225		10.1038/ncb3054	http://dx.doi.org/10.1038/ncb3054			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25344756	Green Accepted, Green Submitted			2022-12-25	WOS:000345777300013
J	Li, J; Jia, S; Chen, PR				Li, Jie; Jia, Shang; Chen, Peng R.			Diels-Alder reaction-triggered bioorthogonal protein decaging in living cells	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; SMALL MOLECULES; GENETIC-CODE; CHEMISTRY; ENZYME; CLICK	Small molecules that specifically activate an intracellular protein of interest are highly desirable. A generally applicable strategy, however, remains elusive. Herein we describe a small molecule-triggered bioorthogonal protein decaging technique that relies on the inverse electron-demand Diels-Alder reaction for eliminating a chemically caged protein side chain within living cells. This method permits the efficient activation of a given protein (for example, an enzyme) in its native cellular context within minutes.	[Li, Jie; Jia, Shang; Chen, Peng R.] Peking Univ, Coll Chem & Mol Engn, Minist Educ,Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci,Key Lab Bioorgan Chem &, Beijing 100871, Peoples R China; [Chen, Peng R.] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Peking University	Chen, PR (corresponding author), Peking Univ, Coll Chem & Mol Engn, Minist Educ,Synthet & Funct Biomol Ctr, Beijing Natl Lab Mol Sci,Key Lab Bioorgan Chem &, Beijing 100871, Peoples R China.	pengchen@pku.edu.cn	贾, 上/P-7344-2019	贾, 上/0000-0001-6285-8959; Li, Jie/0000-0002-8065-5749	R. Meng and the Proteomic Mass Spectrometry Core of the National Facilities for Protein Sciences; National Basic Research Program of China [2010CB912300, 2012CB917301]; National Natural Science Foundation of China [21225206, 91313301]; Peking University Principal Foundation	R. Meng and the Proteomic Mass Spectrometry Core of the National Facilities for Protein Sciences; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University Principal Foundation	We acknowledge support from R. Meng and the Proteomic Mass Spectrometry Core of the National Facilities for Protein Sciences (the Phoenix Project) at Peking University. This work was supported by the National Basic Research Program of China (2010CB912300 and 2012CB917301) and the National Natural Science Foundation of China (21225206 and 91313301). J.L. acknowledges support from the Peking University Principal Foundation. S.F. Reichard edited the manuscript.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bielski R, 2013, CHEM REV, V113, P2205, DOI 10.1021/cr200338q; Chan J, 2012, NAT CHEM, V4, P973, DOI [10.1038/nchem.1500, 10.1038/NCHEM.1500]; Chatgilialoglu C, 2005, ACCOUNTS CHEM RES, V38, P441, DOI 10.1021/ar0400847; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Knall AC, 2013, CHEM SOC REV, V42, P5131, DOI 10.1039/c3cs60049a; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Li J, 2014, NAT CHEM, V6, P352, DOI [10.1038/NCHEM.1887, 10.1038/nchem.1887]; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4276; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Nikic I, 2014, ANGEW CHEM INT EDIT, V53, P2245, DOI 10.1002/anie.201309847; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Royzen M, 2008, J AM CHEM SOC, V130, P3760, DOI 10.1021/ja8001919; Sasmal PK, 2013, CHEM COMMUN, V49, P1581, DOI 10.1039/c2cc37832a; Sauer J, 1998, EUR J ORG CHEM, V1998, P2885; Selvaraj R, 2013, CURR OPIN CHEM BIOL, V17, P753, DOI 10.1016/j.cbpa.2013.07.031; Versteegen RM, 2013, ANGEW CHEM INT EDIT, V52, P14112, DOI 10.1002/anie.201305969; Wan W, 2014, BBA-PROTEINS PROTEOM, V1844, P1059, DOI 10.1016/j.bbapap.2014.03.002; Wei P, 2012, NATURE, V488, P384, DOI 10.1038/nature11259; Yanagisawa T, 2012, MOL BIOSYST, V8, P1131, DOI 10.1039/c2mb05321g; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Zhao JY, 2013, J AM CHEM SOC, V135, P7410, DOI 10.1021/ja4013535; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	25	167	173	18	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1003	+		10.1038/nchembio.1656	http://dx.doi.org/10.1038/nchembio.1656			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25362360				2022-12-25	WOS:000345122300006
J	Coe, BP; Witherspoon, K; Rosenfeld, JA; van Bon, BWM; Vulto-van Silfhout, AT; Bosco, P; Friend, KL; Baker, C; Buono, S; Vissers, LELM; Schuurs-Hoeijmakers, JH; Hoischen, A; Pfundt, R; Krumm, N; Carvill, GL; Li, D; Amaral, D; Brown, N; Lockhart, PJ; Scheffer, IE; Alberti, A; Shaw, M; Pettinato, R; Tervo, R; de Leeuw, N; Reijnders, MRF; Torchia, BS; Peeters, H; O'Roak, BJ; Fichera, M; Hehir-Kwa, JY; Shendure, J; Mefford, HC; Haan, E; Gecz, J; de Vries, BBA; Romano, C; Eichler, EE				Coe, Bradley P.; Witherspoon, Kali; Rosenfeld, Jill A.; van Bon, Bregje W. M.; Vulto-van Silfhout, Anneke T.; Bosco, Paolo; Friend, Kathryn L.; Baker, Carl; Buono, Serafino; Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H.; Hoischen, Alex; Pfundt, Rolph; Krumm, Nik; Carvill, Gemma L.; Li, Deana; Amaral, David; Brown, Natasha; Lockhart, Paul J.; Scheffer, Ingrid E.; Alberti, Antonino; Shaw, Marie; Pettinato, Rosa; Tervo, Raymond; de Leeuw, Nicole; Reijnders, Margot R. F.; Torchia, Beth S.; Peeters, Hilde; O'Roak, Brian J.; Fichera, Marco; Hehir-Kwa, Jayne Y.; Shendure, Jay; Mefford, Heather C.; Haan, Eric; Gecz, Jozef; de Vries, Bert B. A.; Romano, Corrado; Eichler, Evan E.			Refining analyses of copy number variation identifies specific genes associated with developmental delay	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDER; SCHINZEL-GIEDION SYNDROME; INTELLECTUAL DISABILITY; MICRODELETION SYNDROME; MENTAL-RETARDATION; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; CLINICAL-SIGNIFICANCE; DELETIONS	Copy number variants (CNVs) are associated with many neurocognitive disorders; however, these events are typically large, and the underlying causative genes are unclear. We created an expanded CNV morbidity map from 29,085 children with developmental delay in comparison to 19,584 healthy controls, identifying 70 significant CNVs. We resequenced 26 candidate genes in 4,716 additional cases with developmental delay or autism and 2,193 controls. An integrated analysis of CNV and single-nucleotide variant (SNV) data pinpointed 10 genes enriched for putative loss of function. Follow-up of a subset of affected individuals identified new clinical subtypes of pediatric disease and the genes responsible for disease-associated CNVs. These genetic changes include haploinsufficiency of SETBP1 associated with intellectual disability and loss of expressive language and truncations of ZMYND11 in individuals with autism, aggression and complex neuropsychiatric features. This combined CNV and SNV approach facilitates the rapid discovery of new syndromes and genes involved in neuropsychiatric disease despite extensive genetic heterogeneity.	[Coe, Bradley P.; Witherspoon, Kali; Baker, Carl; Krumm, Nik; O'Roak, Brian J.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Torchia, Beth S.] PerkinElmer Inc, Signature Genom Labs LLC, Spokane, WA USA; [van Bon, Bregje W. M.; Vulto-van Silfhout, Anneke T.; Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H.; Hoischen, Alex; Pfundt, Rolph; de Leeuw, Nicole; Reijnders, Margot R. F.; Hehir-Kwa, Jayne Y.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van Bon, Bregje W. M.; Friend, Kathryn L.; Shaw, Marie; Haan, Eric; Gecz, Jozef] SA Pathol, Adelaide, SA, Australia; [Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Pettinato, Rosa; Fichera, Marco; Romano, Corrado] Associaz Oasi Maria Santissima, IRCCS, Troina, Italy; [Carvill, Gemma L.; Mefford, Heather C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Li, Deana; Amaral, David] Univ Calif Davis, MIND Inst, Autism Phenome Project, Sacramento, CA 95616 USA; [Brown, Natasha; Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Brown, Natasha] Barwon Hlth, Barwon Child Hlth Unit, Geelong, Vic, Australia; [Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Florey Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Tervo, Raymond] Mayo Clin, Div Dev & Behav Pediat, Rochester, MN USA; [Peeters, Hilde] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Peeters, Hilde] Leuven Autism Res LAuRes, Leuven, Belgium; [Haan, Eric] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Gecz, Jozef] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Radboud University Nijmegen; SA Pathology; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; Mayo Clinic; KU Leuven; University Hospital Leuven; University of Adelaide; Robinson Research Institute; University of Adelaide; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Pettinato, Rosa/D-3358-2017; Pfundt, Rolph/L-4576-2015; Hehir, g. J.Y./L-4358-2015; Peeters, Hilde/AAA-7338-2020; AT, Vulto-van Silfhout/H-4199-2015; Brown, Natasha Jane/AAP-6872-2020; Coe, Bradley/A-2878-2009; van Bon, Bregje/Q-2445-2015; Scheffer, Ingrid E/G-1668-2013; Shendure, Jay/AAU-3684-2021; Lockhart, Paul J/E-7753-2011; Romano, Corrado/B-9695-2008; Gecz, Jozef/X-3469-2019; Vissers, Lisenka ELM/A-2598-2015; de Leeuw, N./L-4480-2015; Hoischen, Alexander/AGF-7293-2022; Alberti, Antonino/D-5653-2017; Hoischen, Alexander/D-1282-2013; Buono, Serafino/D-8568-2017; Fichera, Marco/K-9220-2016	Pettinato, Rosa/0000-0002-2120-3152; Brown, Natasha Jane/0000-0002-1822-9191; van Bon, Bregje/0000-0003-2234-0105; Scheffer, Ingrid E/0000-0002-2311-2174; Lockhart, Paul J/0000-0003-2531-8413; Romano, Corrado/0000-0003-1049-0683; Gecz, Jozef/0000-0002-7884-6861; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Alberti, Antonino/0000-0001-6742-7429; Hoischen, Alexander/0000-0002-8072-4476; Buono, Serafino/0000-0002-3786-3323; Fichera, Marco/0000-0002-8225-6880; Coe, Bradley/0000-0001-8471-4016; O'Roak, Brian/0000-0002-4141-0095; Hehir-Kwa, Jayne/0000-0003-0837-304X; Peeters, Hilde/0000-0002-7295-3375; Rosenfeld, Jill/0000-0001-5664-7987; Shendure, Jay/0000-0002-1516-1865	Canadian Institutes of Health Research; US National Institute of Mental Health [MH101221]; Paul G. Allen Family Foundation Award [11631]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS089858] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Paul G. Allen Family Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E Hormozdiari, M. Dennis and T. Brown for useful discussions and for editing the manuscript. B.P.C. is supported by a fellowship from the Canadian Institutes of Health Research. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/. JAR. and B.S.T. are employees of Signature Genomics Laboratories, LLC, a subsidiary of PerkinElmer, Inc. This work was supported by US National Institute of Mental Health grant MH101221 and Paul G. Allen Family Foundation Award 11631 to E.E.E. E.E.E. is an Allen Distinguished Investigator and an investigator of the Howard Hughes Medical Institute.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Alliman S, 2010, CLIN GENET, V78, P162, DOI 10.1111/j.1399-0004.2010.01373.x; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Burkardt DD, 2011, AM J MED GENET A, V155A, P1336, DOI 10.1002/ajmg.a.34049; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dabell MP, 2013, AM J MED GENET A, V161A, P717, DOI 10.1002/ajmg.a.35780; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeScipio C, 2012, AM J MED GENET A, V158A, P2152, DOI 10.1002/ajmg.a.35574; Docker D, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.280; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Filges I, 2011, J MED GENET, V48, P117, DOI 10.1136/jmg.2010.084582; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gimelli S, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-52; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Madrigal I, 2012, AM J MED GENET A, V158A, P1071, DOI 10.1002/ajmg.a.35287; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Marseglia G, 2012, EUR J MED GENET, V55, P216, DOI 10.1016/j.ejmg.2012.01.005; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Paciorkowski AR, 2013, NEUROGENETICS, V14, P99, DOI 10.1007/s10048-013-0356-y; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shuvarikov A, 2013, HUM MUTAT, V34, P1415, DOI 10.1002/humu.22384; Stankiewicz P, 2012, HUM MUTAT, V33, P165, DOI 10.1002/humu.21614; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Thorsson T, 2015, CONGENIT HEART DIS, V10, P193, DOI 10.1111/chd.12179; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; van Bon BWM, 2011, EUR J HUM GENET, V19, P400, DOI 10.1038/ejhg.2010.211; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yu B, 2009, EXP CELL RES, V315, P3543, DOI 10.1016/j.yexcr.2009.09.011; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	56	371	386	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1063	1071		10.1038/ng.3092	http://dx.doi.org/10.1038/ng.3092			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217958	Green Accepted			2022-12-25	WOS:000342554100008
J	Evans, LM; Slavov, GT; Rodgers-Melnick, E; Martin, J; Ranjan, P; Muchero, W; Brunner, AM; Schackwitz, W; Gunter, L; Chen, JG; Tuskan, GA; DiFazio, SP				Evans, Luke M.; Slavov, Gancho T.; Rodgers-Melnick, Eli; Martin, Joel; Ranjan, Priya; Muchero, Wellington; Brunner, Amy M.; Schackwitz, Wendy; Gunter, Lee; Chen, Jin-Gui; Tuskan, Gerald A.; DiFazio, Stephen P.			Population genomics of Populus trichocarpa identifies signatures of selection and adaptive trait associations	NATURE GENETICS			English	Article							FLOWERING-LOCUS-T; WIDE ASSOCIATION; WHOLE-GENOME; LATITUDINAL GRADIENT; BLACK COTTONWOOD; LOCAL ADAPTATION; GROWTH CESSATION; GENE; ARABIDOPSIS; MODEL	Forest trees are dominant components of terrestrial ecosystems that have global ecological and economic importance. Despite distributions that span wide environmental gradients, many tree populations are locally adapted, and mechanisms underlying this adaptation are poorly understood. Here we use a combination of whole-genome selection scans and association analyses of 544 Populus trichocarpa trees to reveal genomic bases of adaptive variation across a wide latitudinal range. Three hundred ninety-seven genomic regions showed evidence of recent positive and/or divergent selection and enrichment for associations with adaptive traits that also displayed patterns consistent with natural selection. These regions also provide unexpected insights into the evolutionary dynamics of duplicated genes and their roles in adaptive trait variation.	[Evans, Luke M.; Rodgers-Melnick, Eli; DiFazio, Stephen P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Slavov, Gancho T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Martin, Joel; Schackwitz, Wendy; Tuskan, Gerald A.] Joint Genome Inst, Walnut Creek, CA USA; [Ranjan, Priya; Muchero, Wellington; Gunter, Lee; Chen, Jin-Gui; Tuskan, Gerald A.] Oak Ridge Natl Lab, Plant Syst Biol Grp, BioSci Div, Oak Ridge, TN USA; [Brunner, Amy M.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA	West Virginia University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Oak Ridge National Laboratory; Virginia Polytechnic Institute & State University	DiFazio, SP (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	spdifazio@mail.wvu.edu	Tuskan, Gerald/A-6225-2011; Chen, Jin-Gui/A-4773-2011; Schackwitz, Wendy/GXH-9536-2022; Gunter, Lee E/L-3480-2016; Chen, Jin-Gui/AFV-6337-2022	Tuskan, Gerald/0000-0003-0106-1289; Chen, Jin-Gui/0000-0002-1752-4201; Gunter, Lee E/0000-0003-1211-7532; Chen, Jin-Gui/0000-0002-1752-4201; Schackwitz, Wendy/0000-0002-3013-9180; DiFazio, Stephen/0000-0003-4077-1590; Ranjan, Priya/0000-0002-0357-1939; muchero, wellington/0000-0002-0200-9856; Martin, Joel/0000-0001-9511-6441	BioEnergy Science Center; Office of Biological and Environmental Research in the DOE Office of Science; Virginia Agricultural Experiment Station; McIntire Stennis Program of the National Institute of Food and Agriculture, US Department of Agriculture; BBSRC [BB/K01711X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K01711X/1] Funding Source: researchfish	BioEnergy Science Center; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Virginia Agricultural Experiment Station; McIntire Stennis Program of the National Institute of Food and Agriculture, US Department of Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the members of BioEnergy Science Center for their varied contributions to this work, and especially those involved in the collection, propagation and maintenance of the common gardens, including G. Howe, A. Groover, R. Stettler, J. Johnson and the staff at Mt. Jefferson Farms and Greenwood Resources. We thank the West Virginia University High Performance Computing facility, in particular N. Gregg and M. Carlise. P. balsamifera transcriptomes were provided by M. Olson (Texas Tech University). This work was supported by funding from the BioEnergy Science Center, a US Department of Energy (DOE) Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. A.M.B. acknowledges support from the Virginia Agricultural Experiment Station and the McIntire Stennis Program of the National Institute of Food and Agriculture, US Department of Agriculture.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Ingvarsson PK, 2006, GENETICS, V172, P1845, DOI 10.1534/genetics.105.047522; Inigo S, 2012, PLANT J, V69, P601, DOI 10.1111/j.1365-313X.2011.04815.x; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; LANGLET O, 1971, Taxon, V20, P653, DOI 10.2307/1218596; Lynch M, 2000, GENETICS, V154, P459; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Mohamed R, 2010, PLANT J, V62, P674, DOI 10.1111/j.1365-313X.2010.04185.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PAULEY S. S., 1954, Journal of the Arnold Arboretum, V35, P167; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rodgers-Melnick E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-608; Rodgers-Melnick E, 2012, GENOME RES, V22, P95, DOI 10.1101/gr.125146.111; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; SPITZE K, 1993, GENETICS, V135, P367; Sun J, 2013, GENES GENOM, V35, P597, DOI 10.1007/s13258-013-0108-2; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vanholme B, 2013, NEW PHYTOL, V198, P765, DOI 10.1111/nph.12179; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Werner AK, 2013, PLANT PHYSIOL, V163, P672, DOI 10.1104/pp.113.224261; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Xie B, 2011, PLANT J, V65, P1, DOI 10.1111/j.1365-313X.2010.04399.x; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]	60	232	238	13	205	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1089	1096		10.1038/ng.3075	http://dx.doi.org/10.1038/ng.3075			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151358	Green Submitted			2022-12-25	WOS:000342554100011
J	Pefani, DE; Latusek, R; Pires, I; Grawenda, AM; Yee, KS; Hamilton, G; van der Weyden, L; Esashi, F; Hammond, EM; O'Neill, E				Pefani, Dafni-Eleftheria; Latusek, Robert; Pires, Isabel; Grawenda, Anna M.; Yee, Karen S.; Hamilton, Garth; van der Weyden, Louise; Esashi, Fumiko; Hammond, Ester M.; O'Neill, Eric			RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2	NATURE CELL BIOLOGY			English	Article							LATS TUMOR-SUPPRESSOR; PROMOTER HYPERMETHYLATION; HOMOLOGOUS RECOMBINATION; MST2 PATHWAY; SIZE-CONTROL; LUNG-CANCER; ORGAN SIZE; ACTIVATION; POLYMORPHISM; APOPTOSIS	Genomic instability is a key hallmark of cancer leading to tumour heterogeneity and therapeutic resistance. BRCA2 has a fundamental role in error-free DNA repair but also sustains genome integrity by promoting RAD51 nucleofilament formation at stalled replication forks. CDK2 phosphorylates BRCA2 (pS3291-BRCA2) to limit stabilizing contacts with polymerized RAD51; however, how replication stress modulates CDK2 activity and whether loss of pS3291-BRCA2 regulation results in genomic instability of tumours are not known. Here we demonstrate that the Hippo pathway kinase LATS1 interacts with CDK2 in response to genotoxic stress to constrain pS3291-BRCA2 and support RAD51 nucleofilaments, thereby maintaining genomic fidelity during replication stalling. We also show that LATS1 forms part of an AIR-mediated response to replication stress that requires the tumour suppressor RASSF1A. Importantly, perturbation of the ATR-RASSF1A-LATS1 signalling axis leads to genomic defects associated with loss of BRCA2 function and contributes to genomic instability and 'BRCA-ness' in lung cancers.	[Pefani, Dafni-Eleftheria; Latusek, Robert; Pires, Isabel; Grawenda, Anna M.; Yee, Karen S.; Hamilton, Garth; Hammond, Ester M.; O'Neill, Eric] Univ Oxford, CRUK MRC Oxford Inst, Dept Oncol, Oxford OX3 7DQ, England; [van der Weyden, Louise] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Esashi, Fumiko] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; Wellcome Trust Sanger Institute; University of Oxford	O'Neill, E (corresponding author), Univ Oxford, CRUK MRC Oxford Inst, Dept Oncol, Oxford OX3 7DQ, England.	eric.oneill@oncology.ox.ac.uk	van der Weyden, Louise/AAV-5711-2021	van der Weyden, Louise/0000-0002-0645-1879; Esashi, Fumiko/0000-0003-0902-2364; Pires, Isabel/0000-0002-0417-2710; Hammond, Ester/0000-0002-2335-3146	Cancer Research UK [A19277]; Vertex; Medical Research Council (MRC); Cancer Research UK [19277, 13031, 19276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Vertex(Vertex Pharmaceuticals); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	The authors would like to acknowledge T. Helleday for helpful discussions, M. Woodcock for fluorescence-activated cell sorting analysis and A. G. Abraham for useful comments on the manuscript. Lats1<SUP>-/-</SUP> MEFs were provided by T. Xu and myc-LATS1 constructs by H. Sillje. This work was funded by Cancer Research UK A19277, Vertex and the Medical Research Council (MRC).	Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bergqvist J, 2010, FAM CANCER, V9, P263, DOI 10.1007/s10689-010-9335-8; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; de Fraipont F, 2012, CLIN CANCER RES, V18, P2976, DOI 10.1158/1078-0432.CCR-11-2797; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Endoh H, 2003, INT J CANCER, V106, P45, DOI 10.1002/ijc.11184; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Feng ZH, 2012, NUCLEIC ACIDS RES, V40, P726, DOI 10.1093/nar/gkr748; Gao BN, 2008, CANCER RES, V68, P22, DOI 10.1158/0008-5472.CAN-07-5183; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hashimoto Y, 2012, NAT STRUCT MOL BIOL, V19, P17, DOI 10.1038/nsmb.2177; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Kanzaki H, 2006, CANCER LETT, V238, P128, DOI 10.1016/j.canlet.2005.07.006; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Olcina MM, 2013, MOL CELL, V52, P758, DOI 10.1016/j.molcel.2013.10.019; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Romano D, 2014, NAT CELL BIOL, V16, P673, DOI 10.1038/ncb2986; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Siaud N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002409; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; van der Weyden L, 2012, CANCER RES, V72, P3817, DOI 10.1158/0008-5472.CAN-11-3343; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Wang J, 2004, CLIN CANCER RES, V10, P6119, DOI 10.1158/1078-0432.CCR-04-0652; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Yabuta N, 2013, J CELL SCI, V126, P508, DOI 10.1242/jcs.113431; Yee KS, 2012, CANCER RES, V72, P2206, DOI 10.1158/0008-5472.CAN-11-2906; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	55	62	65	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					962	971		10.1038/ncb3035	http://dx.doi.org/10.1038/ncb3035			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25218637	Green Accepted			2022-12-25	WOS:000342712200006
J	Wirnsberger, G; Zwolanek, F; Stadlmann, J; Tortola, L; Liu, SW; Perlot, T; Jarvinen, P; Dunberger, G; Kozieradzki, I; Sarao, R; De Martino, A; Boztug, K; Mechtler, K; Kuchler, K; Klein, C; Elling, U; Penninger, JM				Wirnsberger, Gerald; Zwolanek, Florian; Stadlmann, Johannes; Tortola, Luigi; Liu, Shang Wan; Perlot, Thomas; Jaervinen, Paeivi; Duenberger, Gerhard; Kozieradzki, Ivona; Sarao, Renu; De Martino, Alba; Boztug, Kaan; Mechtler, Karl; Kuchler, Karl; Klein, Christoph; Elling, Ulrich; Penninger, Josef M.			Jagunal homolog 1 is a critical regulator of neutrophil function in fungal host defense	NATURE GENETICS			English	Article							CANDIDA-ALBICANS; MICE; ADHESION; MYELOPEROXIDASE; GLYCOSYLATION; DEFICIENCY; GRANULES; INSIGHTS; IMMUNITY; RECEPTOR	Neutrophils are key innate immune effector cells that are essential to fighting bacterial and fungal pathogens. Here we report that mice carrying a hematopoietic lineage-specific deletion of Jagn1 (encoding Jagunal homolog 1) cannot mount an efficient neutrophil-dependent immune response to the human fungal pathogen Candida albicans. Global glycobiome analysis identified marked alterations in the glycosylation of proteins involved in cell adhesion and cytotoxicity in Jagn1-deficient neutrophils. Functional analysis confirmed marked defects in neutrophil migration in response to Candida albicans infection and impaired formation of cytotoxic granules, as well as defective myeloperoxidase release and killing of Candida albicans. Treatment with granulocyte/macrophage colony-stimulating factor (GM-CSF) protected mutant mice from increased weight loss and accelerated mortality after Candida albicans challenge. Notably, GM-CSF also restored the defective fungicidal activity of bone marrow cells from humans with JAGN1 mutations. These data directly identify Jagn1 (JAGN1 in humans) as a new regulator of neutrophil function in microbial pathogenesis and uncover a potential treatment option for humans.	[Wirnsberger, Gerald; Stadlmann, Johannes; Tortola, Luigi; Liu, Shang Wan; Perlot, Thomas; Duenberger, Gerhard; Kozieradzki, Ivona; Sarao, Renu; Mechtler, Karl; Elling, Ulrich; Penninger, Josef M.] Austrian Acad Sci IMBA Vienna, Inst Mol Biotechnol, Vienna, Austria; [Zwolanek, Florian; Kuchler, Karl] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Stadlmann, Johannes; Duenberger, Gerhard; Mechtler, Karl] IMP, Vienna, Austria; [Jaervinen, Paeivi; Klein, Christoph] Univ Munich, Dr Von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [De Martino, Alba] Campus Sci Support Facil CSF, Vienna, Austria; [Boztug, Kaan] Austrian Acad Sci CeMM, Res Ctr Mol Med, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Munich; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Penninger, JM (corresponding author), Austrian Acad Sci IMBA Vienna, Inst Mol Biotechnol, Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Mechtler, Karl/AAF-2717-2019; kuchler, karl/AAL-6937-2020; Boztug, Kaan/AAM-4161-2021; Penninger, Josef M/I-6860-2013; Stadlmann, Johannes/AAC-3157-2021	Mechtler, Karl/0000-0002-3392-9946; kuchler, karl/0000-0003-2719-5955; Boztug, Kaan/0000-0001-8387-9185; Penninger, Josef M/0000-0002-8194-3777; Stadlmann, Johannes/0000-0001-5693-6690; Tortola, Luigi/0000-0002-8480-2080; De Martino Rodriguez, Alba/0000-0002-2436-9852	European Community [262067]; MeioSys [222883-2]; Austrian Science Fund [SFB F3402, P24685-B24, TRP 308-N15]; Medical University of Vienna; Austrian Science Fund (FWF) [FWF-P-25333-B08]; European Research Council; EU ERARE program (NEUTRO-NET); German Research Foundation (DFG) Gottfried-Wilhelm-Leibniz program; Migration of Immune Cells [DFG-SFB914]; DZIF (German Center for Infection Research); IMBA; Austrian National Foundation; Austrian Academy of Sciences; NEUTRO-NET; European Union European Research Council Advanced Grant; Austrian Science Fund (FWF) [TRP 308, P 25333] Funding Source: researchfish	European Community(European Commission); MeioSys; Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); EU ERARE program (NEUTRO-NET); German Research Foundation (DFG) Gottfried-Wilhelm-Leibniz program(German Research Foundation (DFG)); Migration of Immune Cells; DZIF (German Center for Infection Research); IMBA; Austrian National Foundation; Austrian Academy of Sciences; NEUTRO-NET; European Union European Research Council Advanced Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank all members of the Penninger laboratory for helpful discussions and technical support. We thank all members of the IMP-IMBA Biooptics service facility for assistance in cell sorting and image quantification. K.M. is supported by the European Community's Seventh Framework Programme PRIME-XS (262067) and MeioSys (222883-2) projects and by the Austrian Science Fund (SFB F3402, P24685-B24 and TRP 308-N15). K.K. was supported by a grant from the Medical University of Vienna and in part by a grant from the Austrian Science Fund (FWF) (FWF-P-25333-B08). C.K. is supported by the European Research Council, an EU ERARE program (NEUTRO-NET), the German Research Foundation (DFG) Gottfried-Wilhelm-Leibniz program, DFG-SFB914 (Migration of Immune Cells) and the DZIF (German Center for Infection Research). J.M.P. is supported by grants from IMBA, the Austrian National Foundation, the Austrian Academy of Sciences, NEUTRO-NET and a European Union European Research Council Advanced Grant.	ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Antonopoulos A, 2011, BIOCHEM SOC T, V39, P1334, DOI 10.1042/BST0391334; Aratani Y, 2002, J INFECT DIS, V185, P1833, DOI 10.1086/340635; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; Borjesson DL, 2003, BLOOD, V101, P3257, DOI 10.1182/blood-2002-04-1019; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bourgeois Christelle, 2009, V470, P125, DOI 10.1007/978-1-59745-204-5_11; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Fulurija A, 1996, MICROBIOL-SGM, V142, P3487, DOI 10.1099/13500872-142-12-3487; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Hentzen ER, 2000, BLOOD, V95, P911, DOI 10.1182/blood.V95.3.911.003k36_911_920; Homme M, 2013, INFLAMM RES, V62, P981, DOI 10.1007/s00011-013-0656-6; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kullberg BJ, 2004, CLIN INFECT DIS, V39, pS218, DOI 10.1086/421960; Lionakis MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003079; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Nielsen ML, 2005, MOL CELL PROTEOMICS, V4, P835, DOI 10.1074/mcp.T400022-MCP200; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van Veen HA, 2004, EUR J BIOCHEM, V271, P678, DOI 10.1111/j.1432-1033.2003.03965.x; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vonk AG, 2003, ANTIMICROB AGENTS CH, V47, P3688, DOI 10.1128/AAC.47.12.3688-3693.2003; Vonk Alieke G, 2012, Methods Mol Biol, V845, P277, DOI 10.1007/978-1-61779-539-8_18; Wang L, 2013, EUR J HAEMATOL, V90, P436, DOI 10.1111/ejh.12095; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004	37	41	44	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1028	+		10.1038/ng.3070	http://dx.doi.org/10.1038/ng.3070			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129145	Green Accepted			2022-12-25	WOS:000341579400020
J	Flanagan, SE; Haapaniemi, E; Russell, MA; Caswell, R; Allen, HL; De Francol, E; McDonald, TJ; Rajala, H; Ramelius, A; Barton, J; Heiskanen, K; Heiskanen-Kosmal, T; Kajosaari, M; Murphyli, NP; Milenkovic, T; Seppanen, M; Lemmark, A; Mustjoki, S; Otonkoski, T; Kere, J; Morgan, NG; Ellard, S; Hattersley, AT				Flanagan, Sarah E.; Haapaniemi, Emma; Russell, Mark A.; Caswell, Richard; Allen, Hana Lango; De Francol, Elisa; McDonald, Timothy J.; Rajala, Hanna; Ramelius, Anita; Barton, John; Heiskanen, Kaarina; Heiskanen-Kosmal, Tarja; Kajosaari, Merja; Murphyli, Nuala P.; Milenkovic, Tatjana; Seppanen, Mikko; Lemmark, Ake; Mustjoki, Satu; Otonkoski, Timo; Kere, Juha; Morgan, Noel G.; Ellard, Sian; Hattersley, Andrew T.			Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HYPER IGE SYNDROME; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; TH17 CELLS; VARIANTS; RISK	Monogenic causes of autoimmunity provide key insights into the complex regulation of the immune system. We report a new monogenic cause of autoimmunity resulting from de novo germline activating STAT3 mutations in five individuals with a spectrum of early-onset autoimmune disease, including type 1 diabetes. These findings emphasize the critical role of STAT3 in autoimmune disease and contrast with the germline inactivating STAT3 mutations that result in hyper IgE syndrome.	[Flanagan, Sarah E.; Russell, Mark A.; Caswell, Richard; Allen, Hana Lango; De Francol, Elisa; McDonald, Timothy J.; Morgan, Noel G.; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Haapaniemi, Emma; Ellard, Sian] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Haapaniemi, Emma; Heiskanen, Kaarina; Otonkoski, Timo] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Rajala, Hanna] Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland; [Rajala, Hanna; Mustjoki, Satu] Univ Helsinki, Cent Hosp, Ctr Canc, Helsinki, Finland; [Ramelius, Anita; Lemmark, Ake] Lund Univ, Dept Clin Sci, Lund, Sweden; [Ramelius, Anita; Lemmark, Ake] Skane Univ Hosp, Clin Res Ctr, Malmo, Sweden; [Barton, John] Bristol Royal Hosp Children, Bristol, Avon, England; [Heiskanen, Kaarina; Kere, Juha] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Heiskanen-Kosmal, Tarja] Kuopio Univ Hosp, Dept Pediat, Helsinki, Finland; [Murphyli, Nuala P.] Childrens Univ Hosp, Dept Endocrinol & Diabet, Dublin, Ireland; [Milenkovic, Tatjana] Inst Mother & Child Hlth Care Serbia Dr Vukan Cup, Dept Endocrinol, Belgrade, Serbia; [Seppanen, Mikko] Univ Helsinki, Cent Hosp, Div Infect Dis, Immunodeficiency Unit, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kere, Juha] Karolinska Inst, Ctr Innovat Med, Huddinge, Sweden	University of Exeter; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University; Lund University; Skane University Hospital; Bristol Royal Hospital For Children; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Childrens University Hospital - Temple Street; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet	Hattersley, AT (corresponding author), Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.	juha.kere@ki.se; n.g.morgan@exeterac.uk; a.hattersley@exeterac.uk	Kere, Juha/AAX-9117-2021; Lernmark, Åke/F-8140-2015; Kere, Juha/A-9179-2008; Mustjoki, Satu/AAD-9974-2020	Kere, Juha/0000-0003-1974-0271; Lernmark, Åke/0000-0003-1735-0499; Kere, Juha/0000-0003-1974-0271; Mustjoki, Satu/0000-0002-0816-8241; Rajala, Hanna/0000-0003-2675-2385; Haapaniemi, Emma/0000-0002-6693-8208; McDonald, Timothy James/0000-0003-3559-6660; Flanagan, Sarah/0000-0002-8670-6340; Caswell, Richard/0000-0003-0713-4602; Lango Allen, Hana/0000-0002-7803-8688; Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526; Seppanen, Mikko/0000-0001-9733-3650; Russell, Mark/0000-0003-3706-7383; Morgan, Noel/0000-0003-1537-8113	UK National Institute for Health Research (NIHR); Wellcome Trust; Diabetes UK; Finnish Medical Foundation; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005565, NNF14OC0010719] Funding Source: researchfish; Cancer Foundation Finland sr [130127, 120107] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); Finnish Medical Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); Cancer Foundation Finland sr	We thank J. Chilton, A. Damhuis, R. Raman and B. Yang for technical assistance. This work was supported by the UK National Institute for Health Research (NIHR) Exeter Clinical Research Facility through funding for S.E. and A.T.H. A.T.H. is an NIHR Senior Investigator. S.E. and A.T.H. are supported by Wellcome Trust Senior Investigator awards. Further funding was provided by Diabetes UK and the Finnish Medical Foundation.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heimall J, 2011, CLIN IMMUNOL, V139, P75, DOI 10.1016/j.clim.2011.01.001; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Rubio-Cabezas O, 2009, DIABETES CARE, V32, P111, DOI 10.2337/dc08-1188; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; Shao SY, 2012, CELL IMMUNOL, V280, P16, DOI 10.1016/j.cellimm.2012.11.001; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	21	321	334	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					812	814		10.1038/ng.3040	http://dx.doi.org/10.1038/ng.3040			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038750	Green Submitted, Green Accepted			2022-12-25	WOS:000339704400007
J	Hare, P				Hare, Peter			Genomics separates the sheep from the goats	NATURE BIOTECHNOLOGY			English	Editorial Material																		Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806	1	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					754	754		10.1038/nbt.2985	http://dx.doi.org/10.1038/nbt.2985			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101747	Bronze			2022-12-25	WOS:000346455900040
J	Ratner, M				Ratner, Mark			Next-generation AMD drugs to wed blockbusters	NATURE BIOTECHNOLOGY			English	News Item																		2011, NAT BIOTECHNOL, V29, P560	1	10	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					701	702		10.1038/nbt0814-701	http://dx.doi.org/10.1038/nbt0814-701			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101720				2022-12-25	WOS:000346455900029
J	Fage, CD; Isiorho, EA; Liu, YN; Wagner, DT; Liu, HW; Keatinge-Clay, AT				Fage, Christopher D.; Isiorho, Eta A.; Liu, Yungnan; Wagner, Drew T.; Liu, Hung-wen; Keatinge-Clay, Adrian T.			The structure of SpnF, a standalone enzyme that catalyzes [4+2] cycloaddition	NATURE CHEMICAL BIOLOGY			English	Article							MACROPHOMATE SYNTHASE; DIELS-ALDER; BIOSYNTHESIS; CYCLIZATION; EVOLUTION; SPINOSYNS; INSIGHT; CLUSTER	In the biosynthetic pathway of the spinosyn insecticides, the tailoring enzyme SpnF performs a [4 + 2] cycloaddition on a 22-membered macrolactone to forge an embedded cyclohexene ring. To learn more about this reaction, which could potentially proceed through a Diels-Alder mechanism, we determined the 1.50-angstrom-resolution crystal structure of SpnF bound to S-adenosylhomocysteine. This sets the stage for advanced experimental and computational studies to determine the precise mechanism of SpnF-mediated cyclization.	[Fage, Christopher D.; Isiorho, Eta A.; Wagner, Drew T.; Keatinge-Clay, Adrian T.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Liu, Yungnan; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Liu, Hung-wen; Keatinge-Clay, Adrian T.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu; adriankc@utexas.edu		Wagner, Drew/0000-0002-9043-5731; Fage, Christopher Dane/0000-0001-5015-644X	National Institutes of Health [GM106112, GM035906, GM040541]; Welch Foundation [F-1712, F-1511]; College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106112, R01GM035906, R37GM035906, R01GM040541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ruszczycky for helpful discussions. We thank K. Diederichs for assistance in processing diffraction data. We thank the National Institutes of Health (GM106112 to A.T.K.-C. and GM035906 and GM040541 to H.L.) and the Welch Foundation (F-1712 to A.T.K.-C. and F-1511 to H.L.) for financial support. Instrumentation and technical assistance for this work were provided by the Macromolecular Crystallography Facility, with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost and the Institute for Cellular and Molecular Biology at the University of Texas at Austin. Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Diels O, 1929, BER DTSCH CHEM GES, V62, P2081, DOI 10.1002/cber.19290620829; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; Hahn DR, 2006, J IND MICROBIOL BIOT, V33, P94, DOI 10.1007/s10295-005-0016-9; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hess BA, 2012, ORG BIOMOL CHEM, V10, P7503, DOI 10.1039/c2ob25827g; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim HJ, 2014, ANGEW CHEM INT EDIT, V53, P13553, DOI 10.1002/anie.201407806; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Preiswerk N, 2014, P NATL ACAD SCI USA, V111, P8013, DOI 10.1073/pnas.1401073111; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Waldron C, 2000, ANTON LEEUW INT J G, V78, P385, DOI 10.1023/A:1010289901631; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang GT, 2014, ANGEW CHEM INT EDIT, V53, P4840, DOI 10.1002/anie.201402078	35	86	86	5	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2015	11	4					256	+		10.1038/NCHEMBIO.1768	http://dx.doi.org/10.1038/NCHEMBIO.1768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2SG	25730549	Green Submitted, Green Accepted			2022-12-25	WOS:000351666500006
J	Cociancich, S; Pesic, A; Petras, D; Uhlmann, S; Kretz, J; Schubert, V; Vieweg, L; Duplan, S; Marguerettaz, M; Noell, J; Pieretti, I; Hugelland, M; Kemper, S; Mainz, A; Rott, P; Royer, M; Sussmuth, RD				Cociancich, Stephane; Pesic, Alexander; Petras, Daniel; Uhlmann, Stefanie; Kretz, Julian; Schubert, Vivien; Vieweg, Laura; Duplan, Sandrine; Marguerettaz, Melanie; Noell, Julie; Pieretti, Isabelle; Hugelland, Manuela; Kemper, Sebastian; Mainz, Andi; Rott, Philippe; Royer, Monique; Suessmuth, Roderich D.			The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; LEAF SCALD DISEASE; XANTHOMONAS-ALBILINEANS; GENE-CLUSTER; DNA GYRASE; TOPOISOMERASES; BIOSYNTHESIS; POLYKETIDE; PREDICTION; CHLOROSIS	Albicidin is a potent DNA gyrase inhibitor produced by the sugarcane pathogenic bacterium Xanthomonas albilineans. Here we report the elucidation of the hitherto unknown structure of albicidin, revealing a unique polyaromatic oligopeptide mainly composed of p-aminobenzoic acids. In vitro studies provide further insights into the biosynthetic machinery of albicidin. These findings will enable structural investigations on the inhibition mechanism of albicidin and its assessment as a highly effective antibacterial drug.	[Cociancich, Stephane; Duplan, Sandrine; Marguerettaz, Melanie; Noell, Julie; Pieretti, Isabelle; Rott, Philippe; Royer, Monique] Cirad, UMR Biol & Genet Interact Plante Parasite, Montpellier, France; [Pesic, Alexander; Petras, Daniel; Uhlmann, Stefanie; Kretz, Julian; Schubert, Vivien; Vieweg, Laura; Hugelland, Manuela; Kemper, Sebastian; Mainz, Andi; Suessmuth, Roderich D.] Tech Univ Berlin, Inst Chem, Berlin, Germany	CIRAD; Technical University of Berlin	Cociancich, S (corresponding author), Cirad, UMR Biol & Genet Interact Plante Parasite, Montpellier, France.	monique.royer@cirad.fr; suessmuth@chem.tu-berlin.de	; Pesic, Alexander/N-2171-2017; COCIANCICH, Stephane/C-4267-2014	Sussmuth, Roderich/0000-0001-7027-2069; Petras, Daniel/0000-0002-6561-3022; Pesic, Alexander/0000-0002-5348-9810; COCIANCICH, Stephane/0000-0001-8601-3598; Kemper, Sebastian/0000-0003-0192-518X	Deutsche Forschungsgemeinschaft [DFG SU239/11-1, SU 18-1]; Cluster of Excellence 'Unifying Concepts in Catalysis (UniCat)' (DFG); Agence Nationale de la Recherche [ANR-09-BLAN-0413-01]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence 'Unifying Concepts in Catalysis (UniCat)' (DFG)(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG SU239/11-1; SU 18-1), by the Cluster of Excellence 'Unifying Concepts in Catalysis (UniCat)' (DFG) and by a grant from the Agence Nationale de la Recherche (ANR-09-BLAN-0413-01).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Birch R.G., 1985, US patent, Patent No. [4,525,354, 4525354]; BIRCH RG, 1985, J GEN MICROBIOL, V131, P1069; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P199, DOI 10.1016/0885-5765(87)90033-6; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P207, DOI 10.1016/0885-5765(87)90034-8; BIRCH RG, 1983, PHYTOPATHOLOGY, V73, P1368, DOI 10.1094/Phyto-73-1368; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dal-Bianco M, 2012, CURR OPIN BIOTECH, V23, P265, DOI 10.1016/j.copbio.2011.09.002; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Hashimi SM, 2007, ANTIMICROB AGENTS CH, V51, P181, DOI 10.1128/AAC.00918-06; Huang GZ, 2000, GENE, V255, P327, DOI 10.1016/S0378-1119(00)00320-6; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Royer M, 2004, MOL PLANT MICROBE IN, V17, P414, DOI 10.1094/MPMI.2004.17.4.414; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; STACHELHAUS T, 1995, FEMS MICROBIOL LETT, V125, P3, DOI 10.1016/0378-1097(94)00459-5; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Vivien E, 2007, ANTIMICROB AGENTS CH, V51, P1549, DOI 10.1128/AAC.01450-06; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zhang L, 1998, J APPL MICROBIOL, V85, P1023, DOI 10.1111/j.1365-2672.1998.tb05267.x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	26	89	90	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					195	U178		10.1038/nchembio.1734	http://dx.doi.org/10.1038/nchembio.1734			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25599532				2022-12-25	WOS:000349840500008
J	Li, PP; Oh, DY; Bandyopadhyay, G; Lagakos, WS; Talukdar, S; Osborn, O; Johnson, A; Chung, H; Mayoral, R; Maris, M; Ofrecio, JM; Taguchi, S; Lu, M; Olefsky, JM				Li, Pingping; Oh, Da Young; Bandyopadhyay, Gautam; Lagakos, William S.; Talukdar, Saswata; Osborn, Olivia; Johnson, Andrew; Chung, Heekyung; Mayoral, Rafael; Maris, Michael; Ofrecio, Jachelle M.; Taguchi, Sayaka; Lu, Min; Olefsky, Jerrold M.			LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes	NATURE MEDICINE			English	Article							LEUKOTRIENE B-4 RECEPTOR; FATTY LIVER-DISEASE; ADIPOSE-TISSUE INFLAMMATION; ANTAGONIST CP-105,696; METABOLIC SYNDROME; RANDOMIZED-TRIAL; IMMUNE CELLS; T-CELLS; ACTIVATION; CERAMIDE	Insulin resistance results from several pathophysiologic mechanisms, including chronic tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose tissue exhibit higher levels of the chemotactic eicosanoid LTB4 in obese high-fat diet ( HFD)-fed mice. Inhibition of the LTB4 receptor Ltb4r1, through either genetic or pharmacologic loss of function, led to an anti-inflammatory phenotype with protection from insulin resistance and hepatic steatosis. In vitro treatment with LTB4 directly enhanced macrophage chemotaxis, stimulated inflammatory pathways, reduced insulin-stimulated glucose uptake in L6 myocytes, and impaired insulin-mediated suppression of hepatic glucose output in primary mouse hepatocytes. This was accompanied by lower insulin-stimulated Akt phosphorylation and higher Irs-1/2 serine phosphorylation, and all of these events were dependent on G alpha i and Jnk1, two downstream mediators of Ltb4r1 signaling. These observations elucidate a novel role of the LTB4-Ltb4r1 signaling pathway in hepatocyte and myocyte insulin resistance, and they show that in vivo inhibition of Ltb4r1 leads to robust insulin-sensitizing effects.	[Li, Pingping; Oh, Da Young; Bandyopadhyay, Gautam; Lagakos, William S.; Talukdar, Saswata; Osborn, Olivia; Johnson, Andrew; Chung, Heekyung; Mayoral, Rafael; Maris, Michael; Ofrecio, Jachelle M.; Taguchi, Sayaka; Lu, Min; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA	University of California System; University of California San Diego	Li, PP (corresponding author), Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Substance & Funct Nat Med, Beijing 100021, Peoples R China.	lipp@imm.ac.cn; jolefsky@ucsd.edu	osborn, olivia/R-1460-2018; Li, Pingping/F-1109-2019; Mayoral Monibas, Rafael/B-3563-2013	osborn, olivia/0000-0003-0516-7937; Li, Pingping/0000-0003-0679-270X; Mayoral Monibas, Rafael/0000-0002-6645-7172	US National Institute of Diabetes and Digestive and Kidney Diseases [DK033651, DK074868, DK063491, DK09062]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health through a Cooperative Centers Program in Reproduction and Infertility Research; Merck, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009062, P30DK063491, P01DK074868, R37DK033651, R01DK033651, R24DK090962] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health through a Cooperative Centers Program in Reproduction and Infertility Research; Merck, Inc.(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A.D. Luster from Harvard Medical School for providing the Ltb4r1-KO mice. We thank A. Klip at The Hospital for Sick Children in Canada for providing L6 myocytes. This study was funded in part by grants to J.M. Olefsky from the US National Institute of Diabetes and Digestive and Kidney Diseases (DK033651, DK074868, DK063491, DK09062), the Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institutes of Health through a Cooperative Centers Program in Reproduction and Infertility Research (J.M. Olefsky), and a grant to J.M. Olefsky from Merck, Inc.	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Bektas M, 2003, ANAL BIOCHEM, V320, P259, DOI 10.1016/S0003-2697(03)00388-9; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bodennec J, 1997, J LIPID RES, V38, P1702; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Goldfine AB, 2013, DIABETOLOGIA, V56, P714, DOI 10.1007/s00125-012-2819-3; Goldfine AB, 2013, DIABETES CARE, V36, P4132, DOI 10.2337/dc13-0859; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Haffner S, 2003, CIRCULATION, V108, P1541, DOI 10.1161/01.CIR.0000088845.17586.EC; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim ND, 2007, THESCIENTIFICWORLDJO, V7, P1307, DOI 10.1100/tsw.2007.181; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liston TE, 1998, BRIT J CLIN PHARMACO, V45, P115, DOI 10.1046/j.1365-2125.1998.00646.x; Lu M, 2010, MOL ENDOCRINOL, V24, P1413, DOI 10.1210/me.2009-0462; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; OLEFSKY JM, 1988, AM J MED, V85, P86, DOI 10.1016/0002-9343(88)90401-9; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Showell HJ, 1996, BRIT J PHARMACOL, V117, P1127, DOI 10.1111/j.1476-5381.1996.tb16706.x; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YAMAOKA KA, 1989, J IMMUNOL, V143, P1996; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200	67	201	210	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					239	+		10.1038/nm.3800	http://dx.doi.org/10.1038/nm.3800			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25706874	Green Accepted			2022-12-25	WOS:000350362000016
J	Bangs, FK; Schrode, N; Hadjantonakis, AK; Anderson, KV				Bangs, Fiona K.; Schrode, Nadine; Hadjantonakis, Anna-Katerina; Anderson, Kathryn V.			Lineage specificity of primary cilia in the mouse embryo	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; XEN CELLS; INTRAFLAGELLAR TRANSPORT; HEDGEHOG; ENDODERM; MAINTENANCE; DERIVATION; LOCALIZATION; INACTIVATION; CENTROSOME	Primary cilia are required for vertebrate cells to respond to specific intercellular signals. Here we define when and where primary cilia appear in the mouse embryo using a transgenic line that expresses ARL13B-mCherry in cilia and Centrin 2-GFP in centrosomes. Primary cilia first appear on cells of the epiblast at E6.0 and are subsequently present on all derivatives of the epiblast. In contrast, extraembryonic cells of the visceral endoderm and trophectoderm lineages have centrosomes but no cilia. Stem cell lines derived from embryonic lineages recapitulate the in vivo pattern: epiblast stem cells are ciliated, whereas trophoblast stem cells and extraembryonic endoderm (XEN) stem cells lack cilia. Basal bodies in XEN cells are mature and can form cilia when the AURKA-HDAC6 cilium disassembly pathway is inhibited. The lineage-dependent distribution of cilia is stable throughout much of gestation, defining which cells in the placenta and yolk sac are able to respond to Hedgehog ligands.	[Bangs, Fiona K.; Schrode, Nadine; Hadjantonakis, Anna-Katerina; Anderson, Kathryn V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@ski.mskcc.org		Anderson, Kathryn/0000-0003-1657-2161; Schrode, Nadine/0000-0001-5315-6816; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	National Institutes of Health [NS044385, HD035455]; NYSTEM [029568]; MSKCC Cancer Center Support [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455, R37HD035455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD035455] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; MSKCC Cancer Center Support; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Bazzi and S. Goetz for comments on the manuscript and M. Distinti for help with manuscript preparation. We thank the MSKCC Mouse Genetics Facility for help making the transgenic mice, and the Molecular Cytology Facility and the Rockefeller University Bio-Imaging Resource Center for help with imaging. This work was supported by National Institutes of Health grants NS044385 and HD035455 to K.V.A., a NYSTEM postdoctoral fellowship to F.K.B., NYSTEM grant 029568 to A-K.H. and an MSKCC Cancer Center Support Grant (P30 CA008748).	Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chenoweth JG, 2010, METHODS MOL BIOL, V636, P25, DOI 10.1007/978-1-60761-691-7_2; Chuykin I, 2013, J CELL SCI, V126, P128, DOI 10.1242/jcs.110239; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Farrington SM, 1997, MECH DEVELOP, V62, P197, DOI 10.1016/S0925-4773(97)00664-3; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; He Q, 2014, MOL BIOL CELL, V25, P1715, DOI 10.1091/mbc.E13-12-0730; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hunkapiller J, 2011, STEM CELLS DEV, V20, P831, DOI 10.1089/scd.2010.0362; Jiang FL, 2006, HUM MOL GENET, V15, P3293, DOI 10.1093/hmg/ddl405; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Niakan KK, 2013, NAT PROTOC, V8, P1028, DOI 10.1038/nprot.2013.049; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowotschin S, 2013, GENE DEV, V27, P997, DOI 10.1101/gad.215152.113; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wang W, 2014, ELIFE, V3, DOI 10.7554/eLife.03083; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	48	100	102	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					113	+		10.1038/ncb3091	http://dx.doi.org/10.1038/ncb3091			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25599390	Green Accepted			2022-12-25	WOS:000349152400003
J	Fang, S; Suh, JM; Reilly, SM; Yu, E; Osborn, O; Lackey, D; Yoshihara, E; Perino, A; Jacinto, S; Lukasheva, Y; Atkins, AR; Khvat, A; Schnab, B; Yu, RT; Brenner, DA; Coulter, S; Liddle, C; Schoonjans, K; Olefsky, JM; Saltiel, AR; Downes, M; Evans, RM				Fang, Sungsoon; Suh, Jae Myoung; Reilly, Shannon M.; Yu, Elizabeth; Osborn, Olivia; Lackey, Denise; Yoshihara, Eiji; Perino, Alessia; Jacinto, Sandra; Lukasheva, Yelizaveta; Atkins, Annette R.; Khvat, Alexander; Schnab, Bernd; Yu, Ruth T.; Brenner, David A.; Coulter, Sally; Liddle, Christopher; Schoonjans, Kristina; Olefsky, Jerrold M.; Saltiel, Alan R.; Downes, Michael; Evans, Ronald M.			Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance	NATURE MEDICINE			English	Article							FARNESOID-X-RECEPTOR; BILE-ACID RECEPTOR; NUCLEAR RECEPTOR; FEEDBACK-REGULATION; MOUSE-LIVER; IDENTIFICATION; CHOLESTEROL; PGC-1-ALPHA; HOMEOSTASIS; ACTIVATION	The systemic expression of the bile acid (BA) sensor farnesoid X receptor (FXR) has led to promising new therapies targeting cholesterol metabolism, triglyceride production, hepatic steatosis and biliary cholestasis. In contrast to systemic therapy, bile acid release during a meal selectively activates intestinal FXR. By mimicking this tissue-selective effect, the gut-restricted FXR agonist fexaramine (Fex) robustly induces enteric fibroblast growth factor 15 (FGF15), leading to alterations in BA composition, but does so without activating FXR target genes in the liver. However, unlike systemic agonism, we find that Fex reduces diet-induced weight gain, body-wide inflammation and hepatic glucose production, while enhancing thermogenesis and browning of white adipose tissue (WAT). These pronounced metabolic improvements suggest tissue-restricted FXR activation as a new approach in the treatment of obesity and metabolic syndrome.	[Fang, Sungsoon; Suh, Jae Myoung; Yu, Elizabeth; Yoshihara, Eiji; Jacinto, Sandra; Lukasheva, Yelizaveta; Atkins, Annette R.; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Reilly, Shannon M.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Osborn, Olivia; Lackey, Denise; Schnab, Bernd; Brenner, David A.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Perino, Alessia; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Khvat, Alexander] ChemDiv Inc, San Diego, CA USA; [Coulter, Sally; Liddle, Christopher] Univ Sydney, Sydney Med Sch, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW 2006, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Sydney; Westmead Institute for Medical Research; Howard Hughes Medical Institute; Salk Institute	Downes, M (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	osborn, olivia/R-1460-2018; Suh, Jae Myoung/B-3268-2015; Evans, Ronald/AAF-4001-2019; Saltiel, Alan/L-3632-2019; Reilly, Shannon Marie/ABB-6473-2021	osborn, olivia/0000-0003-0516-7937; Suh, Jae Myoung/0000-0001-8097-4662; Evans, Ronald/0000-0002-9986-5965; Reilly, Shannon Marie/0000-0003-0412-2446; Brenner, David/0000-0003-2573-525X; Saltiel, Alan/0000-0002-9726-9828; Yu, Ruth/0000-0002-9527-9627; Schoonjans, Kristina/0000-0003-1247-4265; Atkins, Annette/0000-0003-2558-7058; Yoshihara, Eiji/0000-0001-6324-6495	National Institutes of Health (NIH) [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; California Institute for Regenerative Medicine; Ellison Medical Foundation; National Health and Medical Research Council of Australia Project [512354, 632886, 1043199]; NIH [DK033651, DK074868, T32-DK007494, DK063491, P01-DK054441-14A1, DK60597, DK61618, R24DK090962]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH, Cooperative Centers Program in Reproduction and Infertility Research [U54-HD-012303-25]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060591, P30DK063491, R37DK057978, R24DK090962, R01DK061618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH, Cooperative Centers Program in Reproduction and Infertility Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank H. Juguilon, L. Chong, Y. Yin, J. Alvarez, Y. Dai, S. Kaufman and B. Collins for technical assistance, and L. Ong and C. Brondos for administrative assistance. R.M.E. is an Investigator of the Howard Hughes Medical Institute (HHMI) at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology, and is supported by National Institutes of Health (NIH) grants (DK057978, DK090962, HL088093, HL105278 and ES010337), the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, California Institute for Regenerative Medicine and The Ellison Medical Foundation. CL. and M.D. are funded by grants from the National Health and Medical Research Council of Australia Project Grants 512354, 632886 and 1043199; J.M.O. is supported by NIH grants (DK033651, DK074868, T32-DK007494, DK063491 and P01-DK054441-14A1) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; A.R.S. is supported by NIH grants (DK60597 and DK61618). R.M.E., J.M.O., A.R.S. and D.A.B. are supported by NIH grant R24DK090962.	Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Foster-Schubert KE, 2006, ENDOCR REV, V27, P779, DOI 10.1210/er.2006-0041; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Stanimirov B, 2012, ACTA GASTRO-ENT BELG, V75, P389; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Ullmer C, 2013, BRIT J PHARMACOL, V169, P671, DOI 10.1111/bph.12158; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zollner G, 2003, J HEPATOL, V39, P480, DOI 10.1016/S0168-8278(03)00228-9	45	432	474	12	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					159	165		10.1038/nm.3760	http://dx.doi.org/10.1038/nm.3760			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25559344	Green Accepted			2022-12-25	WOS:000348974800018
J	Kang, S; Tsai, LT; Zhou, YM; Evertts, A; Xu, S; Griffin, MJ; Issner, R; Whitton, HJ; Garcia, BA; Epstein, CB; Mikkelsen, TS; Rosen, ED				Kang, Sona; Tsai, Linus T.; Zhou, Yiming; Evertts, Adam; Xu, Su; Griffin, Michael J.; Issner, Robbyn; Whitton, Holly J.; Garcia, Benjamin A.; Epstein, Charles B.; Mikkelsen, Tarjei S.; Rosen, Evan D.			Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis	NATURE CELL BIOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; VITAMIN-D-RECEPTOR; NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; CHROMATIN-STATE; SKELETAL-MUSCLE; BINDING SITES; CO-REPRESSOR; IKK-BETA	Insulin resistance is a cardinal feature of Type 2 diabetes (T2D) and a frequent complication of multiple clinical conditions, including obesity, ageing and steroid use, among others. How such a panoply of insults can result in a common phenotype is incompletely understood. Furthermore, very little is known about the transcriptional and epigenetic basis of this disorder, despite evidence that such pathways are likely to play a fundamental role. Here, we compare cell autonomous models of insulin resistance induced by the cytokine tumour necrosis factor-alpha or by the steroid dexamethasone to construct detailed transcriptional and epigenomic maps associated with cellular insulin resistance. These data predict that the glucocorticoid receptor and vitamin D receptor are common mediators of insulin resistance, which we validate using gain-and loss-of-function studies. These studies define a common transcriptional and epigenomic signature in cellular insulin resistance enabling the identification of pathogenic mechanisms.	[Kang, Sona; Tsai, Linus T.; Zhou, Yiming; Xu, Su; Griffin, Michael J.; Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Evertts, Adam] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Issner, Robbyn; Whitton, Holly J.; Epstein, Charles B.; Mikkelsen, Tarjei S.; Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA; [Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Rosen, Evan D.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Princeton University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; Harvard University; Harvard Medical School	Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Issner, Robbyn/0000-0003-4132-9219; Epstein, Charles B./0000-0001-8358-8345; Tsai, Linus/0000-0002-0134-6949; Griffin, Michael/0000-0003-4252-2803	NIH [R01 ES017690, R01085171, DP2OD007447]; American Diabetes Association; American Heart Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association)	We would like to thank M. Herman (Beth Israel Deaconess Medical Center, USA) for providing adipose RNA from obese mice. We thank members of the Rosen laboratory for helpful discussions, and E. Merkal for technical assistance. The V729I and D641V GR mutant alleles were from G. Chrousos (Athens University Medical School, Greece), and the N768 allele was a gift from K. Yamamoto (University of California, San Francisco, USA). J-C Wang (University of California, Berkeley , USA) provided the anti-GR antibody used for CHIP-PCR and CHIP-Seq, and he and I. Rogasty were generous with their time and advice. This work was supported by NIH Roadmap grant R01 ES017690, R01085171 and an American Diabetes Association Career Development Award to E.D.R., NIH Innovator grant DP2OD007447 to B.A.C., and by American Heart Association Postdoctoral Awards to S.K. and L.T.T.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Del Aguila LF, 1999, AM J PHYSIOL-ENDOC M, V276, pE849, DOI 10.1152/ajpendo.1999.276.5.E849; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Hernandez R, 2004, DIABETOLOGIA, V47, P1615, DOI 10.1007/s00125-004-1503-7; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Jun LS, 2011, AM J PHYSIOL-ENDOC M, V301, pE825, DOI 10.1152/ajpendo.00147.2011; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; KUSUNOKI M, 1995, DIABETES, V44, P718, DOI 10.2337/diabetes.44.6.718; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039; Masuccio F, 2010, J CHILD NEUROL, V25, P941, DOI 10.1177/0883073809349461; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mezza T, 2012, ANN NUTR METAB, V61, P337, DOI 10.1159/000342771; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nohara A, 2011, J BIOL CHEM, V286, P33457, DOI 10.1074/jbc.M111.231431; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; SUTTERDUB MT, 1986, DIABETES METAB, V12, P329; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Wu Y, 2013, J PROTEOME RES, V12, P316, DOI 10.1021/pr300408v; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	79	48	48	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					44	+		10.1038/ncb3080	http://dx.doi.org/10.1038/ncb3080			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25503565	Green Accepted, Green Submitted			2022-12-25	WOS:000346823900007
J	AlQuraishi, M; Koytiger, G; Jenney, A; MacBeath, G; Sorger, PK				AlQuraishi, Mohammed; Koytiger, Grigoriy; Jenney, Anne; MacBeath, Gavin; Sorger, Peter K.			A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; IDENTIFICATION; PREDICTION; GENE; HGAL; DISCOVERY; PROTEINS; RESOURCE	Functional interpretation of genomic variation is critical to understanding human disease, but it remains difficult to predict the effects of specific mutations on protein interaction networks and the phenotypes they regulate. We describe an analytical framework based on multiscale statistical mechanics that integrates genomic and biophysical data to model the human SH2-phosphoprotein network in normal and cancer cells. We apply our approach to data in The Cancer Genome Atlas (TCGA) and test model predictions experimentally. We find that mutations mapping to phosphoproteins often create new interactions but that mutations altering SH2 domains result almost exclusively in loss of interactions. Some of these mutations eliminate all interactions, but many cause more selective loss, thereby rewiring specific edges in highly connected subnetworks. Moreover, idiosyncratic mutations appear to be as functionally consequential as recurrent mutations. By synthesizing genomic, structural and biochemical data, our framework represents a new approach to the interpretation of genetic variation.	[AlQuraishi, Mohammed; Koytiger, Grigoriy; Jenney, Anne; Sorger, Peter K.] Harvard Univ, Sch Med, Lab Syst Pharmacol, Boston, MA 02138 USA; [AlQuraishi, Mohammed; MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sorger, PK (corresponding author), Harvard Univ, Sch Med, Lab Syst Pharmacol, Boston, MA 02138 USA.	alquraishi@hms.harvard.edu; peter_sorger@hms.harvard.edu		AlQuraishi, Mohammed/0000-0001-6817-1322; Sorger, Peter/0000-0002-3364-1838; MacBeath, Gavin/0000-0003-2585-6772	US National Institutes of Health [GM68762, GM107618, GM072872]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618, R01GM072872, P50GM068762] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants GM68762, GM107618 and GM072872. We used the resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US Department of Energy under contract DE-AC02-05CH11231.	AlQuraishi M, 2011, P NATL ACAD SCI USA, V108, P14819, DOI 10.1073/pnas.1106460108; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freedman LP, 2014, CANCER RES, V74, P4024, DOI 10.1158/0008-5472.CAN-14-0925; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; Haynie DT, 2014, PROTEINS, V82, P1113, DOI 10.1002/prot.24560; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Koytiger G, 2013, MOL CELL PROTEOMICS, V12, P1204, DOI 10.1074/mcp.M112.025858; Kundu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062732; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Liu BA, 2012, PROTEOMICS, V12, P1527, DOI 10.1002/pmic.201100599; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lossos IS, 2003, BLOOD, V101, P433, DOI 10.1182/blood-2002-06-1931; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Natkunam Y, 2007, BLOOD, V109, P298, DOI 10.1182/blood-2006-04-014977; Pan ZG, 2007, BRIT J HAEMATOL, V137, P578, DOI 10.1111/j.1365-2141.2007.06597.x; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Romero-Camarero I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2334; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Wunderlich Z, 2009, NUCLEIC ACIDS RES, V37, P4629, DOI 10.1093/nar/gkp394; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	36	44	44	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1363	1371		10.1038/ng.3138	http://dx.doi.org/10.1038/ng.3138			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362484	Green Accepted, Green Submitted			2022-12-25	WOS:000345547300020
J	Li, N; Fassl, A; Chick, J; Inuzuka, H; Li, XY; Mansour, MR; Liu, LJ; Wang, HZ; King, B; Shaik, S; Gutierrez, A; Ordureau, A; Otto, T; Kreslavsky, T; Baitsch, L; Bury, L; Meyer, CA; Ke, N; Mulry, KA; Kluk, MJ; Roy, M; Kim, S; Zhang, XW; Geng, Y; Zagozdzon, A; Jenkinson, S; Gale, RE; Linch, DC; Zhao, JJ; Mullighan, CG; Harper, JW; Aster, JC; Aifantis, I; von Boehmer, H; Gygi, SP; Wei, WY; Look, AT; Sicinski, P				Li, Na; Fassl, Anne; Chick, Joel; Inuzuka, Hiroyuki; Li, Xiaoyu; Mansour, Marc R.; Liu, Lijun; Wang, Haizhen; King, Bryan; Shaik, Shavali; Gutierrez, Alejandro; Ordureau, Alban; Otto, Tobias; Kreslavsky, Taras; Baitsch, Lukas; Bury, Leah; Meyer, Clifford A.; Ke, Nan; Mulry, Kristin A.; Kluk, Michael J.; Roy, Moni; Kim, Sunkyu; Zhang, Xiaowu; Geng, Yan; Zagozdzon, Agnieszka; Jenkinson, Sarah; Gale, Rosemary E.; Linch, David C.; Zhao, Jean J.; Mullighan, Charles G.; Harper, J. Wade; Aster, Jon C.; Aifantis, Iannis; von Boehmer, Harald; Gygi, Steven P.; Wei, Wenyi; Look, A. Thomas; Sicinski, Piotr			Cyclin C is a haploinsufficient tumour suppressor	NATURE CELL BIOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RNA-POLYMERASE-II; SQUAMOUS-CELL CARCINOMA; IN-SITU HYBRIDIZATION; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVATION; GENE AMPLIFICATION; NOTCH-1 MUTATIONS; DEPENDENT KINASE; ALLELIC LOSS	Cyclin C was cloned as a growth-promoting G(1) cyclin, and was also shown to regulate gene transcription. Here we report that in vivo cyclin C acts as a haploinsufficient tumour suppressor, by controlling Notch1 oncogene levels. Cyclin C activates an 'orphan' CDK19 kinase, as well as CDK8 and CDK3. These cyclin-C-CDK complexes phosphorylate the Notch1 intracellular domain (ICN1) and promote ICN1 degradation. Genetic ablation of cyclin C blocks ICN1 phosphorylation in vivo, thereby elevating ICN1 levels in cyclin-C-knockout mice. Cyclin C ablation or heterozygosity collaborates with other oncogenic lesions and accelerates development of T-cell acute lymphoblastic leukaemia (T-ALL). Furthermore, the cyclin C encoding gene CCNC is heterozygously deleted in a significant fraction of human T-ALLs, and these tumours express reduced cyclin C levels. We also describe point mutations in human T-ALL that render cyclin-C-CDK unable to phosphorylate ICN1. Hence, tumour cells may develop different strategies to evade inhibition by cyclin C.	[Li, Na; Fassl, Anne; Liu, Lijun; Wang, Haizhen; Otto, Tobias; Baitsch, Lukas; Bury, Leah; Ke, Nan; Mulry, Kristin A.; Geng, Yan; Zagozdzon, Agnieszka; Zhao, Jean J.; Sicinski, Piotr] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Li, Na; Fassl, Anne; Liu, Lijun; Wang, Haizhen; Otto, Tobias; Bury, Leah; Ke, Nan; Mulry, Kristin A.; Geng, Yan; Zagozdzon, Agnieszka; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chick, Joel; Ordureau, Alban; Harper, J. Wade; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Inuzuka, Hiroyuki; Shaik, Shavali; Wei, Wenyi] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Li, Xiaoyu; Kreslavsky, Taras; von Boehmer, Harald] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Li, Xiaoyu; Kreslavsky, Taras; von Boehmer, Harald] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Mansour, Marc R.; Gutierrez, Alejandro; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Mansour, Marc R.; Gutierrez, Alejandro; Look, A. Thomas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Mansour, Marc R.; Gutierrez, Alejandro; Look, A. Thomas] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mansour, Marc R.; Jenkinson, Sarah; Gale, Rosemary E.; Linch, David C.] UCL, Dept Haematol, London WC1E 6BT, England; [King, Bryan; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [King, Bryan; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Baitsch, Lukas; Zhao, Jean J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyer, Clifford A.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Meyer, Clifford A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Kluk, Michael J.; Roy, Moni; Aster, Jon C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Sunkyu] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Zhang, Xiaowu] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Mullighan, Charles G.] St Jude Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of London; University College London; Howard Hughes Medical Institute; New York University; New York University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	peter_sicinski@dfci.harvard.edu	Otto, Tobias/AAH-5141-2021; Mullighan, Charles/H-3253-2011; Fassl, Anne/AAA-5249-2022; Ordureau, Alban/C-7558-2012	Otto, Tobias/0000-0001-5594-3055; Mullighan, Charles/0000-0002-1871-1850; Ordureau, Alban/0000-0002-4924-8520; Liu, Lijun/0000-0002-0027-4525; Kreslavsky, Taras/0000-0002-6672-1914; Mansour, Marc/0000-0001-6835-3791; Harper, Jeffrey/0000-0002-6944-7236	American Syrian Lebanese Associated Charities of St. Jude Children's Research Hospital [P01 CA109901, R01 CA083688, GM094777, R01 AG011085]; MRC [G0500389] Funding Source: UKRI; Cancer Research UK [15556] Funding Source: researchfish; Medical Research Council [G0500389] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10144, NF-SI-0507-10370] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA119070, R01CA108950, R01CA133379, R01CA149655, R01CA105129, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218, R01AG011085] Funding Source: NIH RePORTER	American Syrian Lebanese Associated Charities of St. Jude Children's Research Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Blacklow, T. Sanda, T. Roberts, E. Sicinska, I. Kalaszczynska, S. Bukarac and D. Payne-Turner for help at different stages of the project. This work was supported by grants P01 CA109901 (to P.S., H.v.B. and A.T.L.), R01 CA083688 (to P.S.), GM094777 (to W.W.), American Syrian Lebanese Associated Charities of St. Jude Children's Research Hospital (to C.G.M.), and R01 AG011085 (to J.W.H.). C.G.M. is a St. Baldrick's Scholar and Pew Scholar	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; [Anonymous], TE; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Bondi J, 2005, J CLIN PATHOL, V58, P509, DOI 10.1136/jcp.2004.020347; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Furumoto T, 2007, GENES CELLS, V12, P119, DOI 10.1111/j.1365-2443.2007.01036.x; Galamb O, 2007, CYTOM PART B-CLIN CY, V72B, P299, DOI 10.1002/cyto.b.20189; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Husdal A, 2006, CELL ONCOL, V28, P107; Hyytinen ER, 2002, GENE CHROMOSOME CANC, V34, P306, DOI 10.1002/gcc.10065; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson A, 2000, CANCER RES, V60, P2775; Javeed Iqbal, 2007, Indian Journal of Cancer, V44, P72; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LARSON RC, 1994, ONCOGENE, V9, P3675; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Li HM, 1996, GENOMICS, V32, P253, DOI 10.1006/geno.1996.0112; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Liu ZJ, 1998, MOL CELL BIOL, V18, P3445, DOI 10.1128/MCB.18.6.3445; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Makkonen KM, 2009, J MOL BIOL, V393, P261, DOI 10.1016/j.jmb.2009.08.024; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Mansour MR, 2009, J CLIN ONCOL, V27, P4352, DOI 10.1200/JCO.2009.22.0996; Mansour MR, 2006, LEUKEMIA, V20, P537, DOI 10.1038/sj.leu.2404101; MCGUIRE EA, 1992, MOL CELL BIOL, V12, P4186, DOI 10.1128/MCB.12.9.4186; Miyata Y, 2010, STEM CELLS, V28, P308, DOI 10.1002/stem.270; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nature, 2021, NATURE; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Ohata N, 2006, INT J MOL MED, V18, P1153; ORPHANOS V, 1995, BRIT J CANCER, V71, P666, DOI 10.1038/bjc.1995.132; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Rickert P, 1996, ONCOGENE, V12, P2631; Saxena UH, 2009, MOL CELL BIOL, V29, P2335, DOI 10.1128/MCB.00687-08; Sinclair PB, 2004, CANCER RES, V64, P4089, DOI 10.1158/0008-5472.CAN-03-1871; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Utada Y, 2000, JPN J CANCER RES, V91, P293, DOI 10.1111/j.1349-7006.2000.tb00944.x; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Winter SS, 2007, BLOOD, V110, P1429, DOI 10.1182/blood-2006-12-059790; Xu W, 2011, J GENET GENOMICS, V38, P439, DOI 10.1016/j.jgg.2011.09.002; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YM, 2000, GENE CHROMOSOME CANC, V27, P52, DOI 10.1002/(SICI)1098-2264(200001)27:1<52::AID-GCC7>3.0.CO;2-X	71	88	88	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1080	+		10.1038/ncb3046	http://dx.doi.org/10.1038/ncb3046			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25344755	Green Accepted			2022-12-25	WOS:000344744000007
J	Tao, HL; Zhang, Y; Zeng, XG; Shulman, GI; Jin, SK				Tao, Hanlin; Zhang, Yong; Zeng, Xiangang; Shulman, Gerald I.; Jin, Shengkan			Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice	NATURE MEDICINE			English	Article							INDUCED INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; OBESE GENE; LIVER; MECHANISMS; FAT; HYPERGLYCEMIA; EXPRESSION; REVERSAL	Type 2 diabetes (T2D) has reached an epidemic level globally. Most current treatments ameliorate the hyperglycemic symptom of the disease but are not effective in correcting its underlying cause. One important causal factor of T2D is ectopic accumulation of lipids in metabolically sensitive organs such as liver and muscle. Mitochondrial uncoupling, which reduces cellular energy efficiency and increases lipid oxidation, is an appealing therapeutic strategy. The challenge, however, is to discover safe mitochondrial uncouplers for practical use. Niclosamide is an anthelmintic drug approved by the US Food and Drug Administration that uncouples the mitochondria of parasitic worms. Here we show that niclosamide ethanolamine salt (NEN) uncouples mammalian mitochondria at upper nanomolar concentrations. Oral NEN increases energy expenditure and lipid metabolism in mice. It is also efficacious in preventing and treating hepatic steatosis and insulin resistance induced by a high-fat diet. Moreover, it improves glycemic control and delays disease progression in db/db mice. Given the well-documented safety profile of NEN, our study provides a potentially new and practical pharmacological approach for treating T2D.	[Tao, Hanlin; Zhang, Yong; Zeng, Xiangang; Jin, Shengkan] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Zeng, Xiangang] Tsinghua Univ, Yangtze Delta Reg Res Inst, Zhejiang Key Lab Appl Enzymol, Jiaxing, Zhejiang, Peoples R China; [Shulman, Gerald I.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tsinghua University; Howard Hughes Medical Institute; Yale University; Yale University	Jin, SK (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	victor.jin@rutgers.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	US National Institutes of Health [R01AG030081, R01CA116088, R24 DK085638, P30 DK45735, U24 DK059635]; Mito Biopharm, LLC.; Novo Nordisk Foundation for Basic Metabolic Research; NATIONAL CANCER INSTITUTE [R01CA116088, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK092993, R24DK085638, U24DK059635, P30DK034989, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030081] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mito Biopharm, LLC.; Novo Nordisk Foundation for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Kahn at the Yale University School of Medicine for the analysis of hepatocellular DAG and ceramide contents. We thank the US National Mouse Metabolic Phenotyping Centers (MMPC) at various sites for the various metabolic studies: C. Croniger and L. Wang at Case Western Reserve University (U24 DK076174) for the metabolic cage experiments; J. Kim and D.Y. Jung at the University of Massachusetts (U24 DK093000) for the hyperinsulinemic-euglycemic clamp studies and glycogen synthesis rate determination; and S.S. Wirth and J. Graham at University of California, Davis (U24 DK092993) for determination of glycated hemoglobin (HbA1c) in db/db mice. We also thank W. Hu and Y. Zhao at Rutgers University for assistance with the quantitative real-time PCR analyses and R. Patel at the Rutgers Core Facility for technical assistance with electron microscopy studies. H.T., Y.Z., X.Z. and S.J. are supported by the US National Institutes of Health (R01AG030081 and R01CA116088) and Mito Biopharm, LLC. G.I.S. is supported by the US National Institutes of Health (R24 DK085638, P30 DK45735 and U24 DK059635) and the Novo Nordisk Foundation for Basic Metabolic Research.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Frayha GJ, 1997, GEN PHARMACOL-VASC S, V28, P273, DOI 10.1016/S0306-3623(96)00149-8; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; HECHT G., 1962, ZEIT TROPENMED U PARASITOL, V13, P1; HENRY RR, 1986, DIABETES, V35, P990, DOI 10.2337/diabetes.35.9.990; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hollingworth R.M., 2001, HDB PESTICIDE TOXICO, V2, P1225; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Kobayashi K, 2000, METABOLISM, V49, P22, DOI 10.1016/S0026-0495(00)90588-2; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Maragos WF, 2004, J NEUROCHEM, V91, P257, DOI 10.1111/j.1471-4159.2004.02736.x; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PARASCANDOLA J, 1974, MOL CELL BIOCHEM, V5, P69, DOI 10.1007/BF01874175; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sheth U K, 1975, Prog Drug Res, V19, P147; Si Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007000; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Swan GE, 1999, J S AFR VET ASSOC, V70, P61; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; US Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP 20; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	60	180	186	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1263	1269		10.1038/nm.3699	http://dx.doi.org/10.1038/nm.3699			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25282357	Green Accepted			2022-12-25	WOS:000344724300015
J	Farias-Rico, JA; Schmidt, S; Hocker, B				Farias-Rico, Jose Arcadio; Schmidt, Steffen; Hoecker, Birte			Evolutionary relationship of two ancient protein superfolds	NATURE CHEMICAL BIOLOGY			English	Article							(BETA-ALPHA)(8)-BARREL ENZYME; HOMOLOGY; SEQUENCES; DATABASE; DESIGN; ORIGIN; FOLD; FAMILIES; DOMAINS	Proteins are the molecular machines of the cell that fold into specific three-dimensional structures to fulfill their functions. To improve our understanding of how the structure and function of proteins arises, it is crucial to understand how evolution has generated the structural diversity we observe today. Classically, proteins that adopt different folds are considered to be nonhomologous. However, using state-of-the-art tools for homology detection, we found evidence of homology between proteins of two ancient and highly populated protein folds, the (beta alpha)(8)-barrel and the flavodoxin-like fold. We detected a family of sequences that show intermediate features between both folds and determined what is to our knowledge the first representative crystal structure of one of its members, giving new insights into the evolutionary link of two of the earliest folds. Our findings contribute to an emergent vision where protein superfolds share common ancestry and encourage further approaches to complete the mapping of structure space onto sequence space.	[Farias-Rico, Jose Arcadio; Schmidt, Steffen; Hoecker, Birte] Max Planck Inst Dev Biol, Tubingen, Germany	Max Planck Society	Farias-Rico, JA (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	birte.hoecker@tuebingen.mpg.de		Hocker, Birte/0000-0002-8250-9462; Schmidt, Steffen/0000-0001-9077-6010; Farias-Rico, Jose Arcadio/0000-0002-9168-6305	crystallography community at the Max Planck Institute; Deutsche Forschungsgemeinschaft [HO 4022/1-2]	crystallography community at the Max Planck Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. Toledo-Patino, V. Alva and J. Soding for discussions. We are grateful to the crystallography community at the Max Planck Institute for their support. This work was supported by Deutsche Forschungsgemeinschaft grant HO 4022/1-2.	Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Ammelburg M, 2007, STRUCTURE, V15, P1577, DOI 10.1016/j.str.2007.09.027; Bharat TAM, 2008, P NATL ACAD SCI USA, V105, P9942, DOI 10.1073/pnas.0802202105; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Cech TR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006742; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Claren J, 2009, P NATL ACAD SCI USA, V106, P3704, DOI 10.1073/pnas.0810342106; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Eisenbeis S, 2012, J AM CHEM SOC, V134, P4019, DOI 10.1021/ja211657k; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hills RD, 2010, J MOL BIOL, V398, P332, DOI 10.1016/j.jmb.2010.03.001; Hocker B, 2004, P NATL ACAD SCI USA, V101, P16448, DOI 10.1073/pnas.0405832101; Hocker B, 2002, FEBS LETT, V510, P133, DOI 10.1016/S0014-5793(01)03232-X; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Hocker B, 2012, NATURE, V491, P204, DOI 10.1038/491204a; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Lupas AN, 2001, J STRUCT BIOL, V134, P191, DOI 10.1006/jsbi.2001.4393; Ma BG, 2008, BIOCHEM BIOPH RES CO, V366, P607, DOI 10.1016/j.bbrc.2007.12.014; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nelson ED, 2006, J MOL BIOL, V358, P646, DOI 10.1016/j.jmb.2006.02.026; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Richter M, 2010, J MOL BIOL, V398, P763, DOI 10.1016/j.jmb.2010.03.057; Roessler CG, 2008, P NATL ACAD SCI USA, V105, P2343, DOI 10.1073/pnas.0711589105; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964	48	44	45	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					710	715		10.1038/NCHEMBIO.1579	http://dx.doi.org/10.1038/NCHEMBIO.1579			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038785				2022-12-25	WOS:000341126800006
J	Nickless, A; Jackson, E; Marasa, J; Nugent, P; Mercer, RW; Piwnica-Worms, D; You, ZS				Nickless, Andrew; Jackson, Erin; Marasa, Jayne; Nugent, Patrick; Mercer, Robert W.; Piwnica-Worms, David; You, Zhongsheng			Intracellular calcium regulates nonsense-mediated mRNA decay	NATURE MEDICINE			English	Article							GENE-EXPRESSION; BINDING-SITE; INHIBITION; PATHWAY; COMPLEX	The nonsense-mediated mRNA decay (NMD) pathway selectively eliminates aberrant transcripts containing premature translation termination codons and regulates the levels of a number of physiological mRNAs. NMD modulates the clinical outcome of a variety of human diseases, including cancer and many genetic disorders, and may represent a target for therapeutic intervention. Here, we have developed a new multicolored bioluminescence-based reporter system that can specifically and effectively assay NMD in live human cells. Using this reporter system, we conducted a robust high-throughput small-molecule screen in human cells and, unpredictably, identified a group of cardiac glycosides, including ouabain and digoxin, as potent inhibitors of NMD. Cardiac glycoside mediated effects on NMD are dependent on binding and inhibiting the sodium-potassium ATPase on the plasma membrane and subsequent elevation of intracellular calcium levels. Induction of calcium release from the endoplasmic reticulum also leads to inhibition of NMD. Thus, this study reveals intracellular calcium as a key regulator of NMD and has implications for exploiting NMD in the treatment of disease.	[Nickless, Andrew; Nugent, Patrick; Mercer, Robert W.; Piwnica-Worms, David; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Jackson, Erin; Marasa, Jayne; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	You, ZS (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	dpiwnica-worms@mdanderson.org; zyou@wustl.edu		You, Zhongsheng/0000-0002-9719-8791; Nugent, Patrick/0000-0003-2248-087X	Molecular Imaging Center from the US National Institutes of Health; University of Texas MD Anderson Cancer Center [P50 CA94056]; Washington University Molecular Imaging Center; US National Institutes of Health [R01GM098535]; Interdisciplinary Research Initiative from the Children's Discovery Institute of Washington University [MC-II-2012-215]; Siteman Cancer Center (Cancer Center from the US National Cancer Institute) [P30 CA91842]; NATIONAL CANCER INSTITUTE [P50CA094056, T32CA113275, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	Molecular Imaging Center from the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; Washington University Molecular Imaging Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Research Initiative from the Children's Discovery Institute of Washington University; Siteman Cancer Center (Cancer Center from the US National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Wu and X. Chen for their contributions in the early stage of this project. We are grateful to O. Muhlemann (University of Bern) for providing the p beta 510 reporter construct, which we used to obtain the TRB minigene reporter sequence for our reporter construction, and R. Mecham (Washington University School of Medicine) for providing primary mouse skin fibroblasts. This study was supported by a Molecular Imaging Center grant from the US National Institutes of Health to Washington University and The University of Texas MD Anderson Cancer Center (P50 CA94056, D.P.-W), by a Washington University Molecular Imaging Center Pilot Research Project grant (Z.Y.), by a grant from the US National Institutes of Health (R01GM098535, Z.Y.) and by an Interdisciplinary Research Initiative grant from the Children's Discovery Institute of Washington University (MC-II-2012-215, Z.Y. and D.P.-W). The High-Throughput Screening Core at the Washington University School of Medicine is supported in part by the Siteman Cancer Center (Cancer Center Support grant P30 CA91842 from the US National Cancer Institute).	Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Eom T, 2013, ELIFE, V2, DOI 10.7554/eLife.00178; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gudikote JP, 2002, EMBO J, V21, P125, DOI 10.1093/emboj/21.1.125; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hu JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068291; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Johansson MJO, 2010, GENE DEV, V24, P1491, DOI 10.1101/gad.1930710; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Long AA, 2010, J CELL SCI, V123, P3303, DOI 10.1242/jcs.069468; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SMITH TW, 1970, J CLIN INVEST, V49, P2377, DOI 10.1172/JCI106457; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Wang D, 2011, J BIOL CHEM, V286, P40038, DOI 10.1074/jbc.M111.266361; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299	35	48	51	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					961	966		10.1038/nm.3620	http://dx.doi.org/10.1038/nm.3620			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25064126	Green Accepted			2022-12-25	WOS:000340074600030
J	Nolte, WM; Fortin, JP; Stevens, BD; Aspnes, GE; Griffith, DA; Hoth, LR; Ruggeri, RB; Mathiowetz, AM; Limberakis, C; Hepworth, D; Carpino, PA				Nolte, Whitney M.; Fortin, Jean-Philippe; Stevens, Benjamin D.; Aspnes, Gary E.; Griffith, David A.; Hoth, Lise R.; Ruggeri, Roger B.; Mathiowetz, Alan M.; Limberakis, Chris; Hepworth, David; Carpino, Philip A.			A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification	NATURE CHEMICAL BIOLOGY			English	Article							GLUCAGON-LIKE PEPTIDE-1; ALLOSTERIC MODULATION; GLUCOSE-HOMEOSTASIS; RECEPTOR; ACTIVATION; AGONISTS	We report that 4-(3-(benzyloxy)phenyl)-2-ethylsulfinyl-6-(trifluoromethyl) pyrimidine (BETP), which behaves as a positive allosteric modulator at the glucagon-like peptide-1 receptor (GLP-1R), covalently modifies cysteines 347 and 438 in GLP-1R. C347, located in intracellular loop 3 of GLP-1R, is critical to the activity of BETP and a structurally distinct GLP-1R ago-allosteric modulator, N-(tert-butyl)-6,7-dichloro3-(methylsulfonyl)quinoxalin-2-amine. We further show that substitution of cysteine for phenylalanine 345 in the glucagon receptor is sufficient to confer sensitivity to BETP.	[Nolte, Whitney M.; Stevens, Benjamin D.; Griffith, David A.; Ruggeri, Roger B.; Mathiowetz, Alan M.; Hepworth, David; Carpino, Philip A.] Pfizer PharmaTherapeut Res & Dev, Worldwide Med Chem, Cambridge, MA USA; [Fortin, Jean-Philippe] Pfizer PharmaTherapeut Res & Dev, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Aspnes, Gary E.; Limberakis, Chris] Pfizer PharmaTherapeut Res & Dev, Worldwide Med Chem, Groton, CT USA; [Hoth, Lise R.] Pfizer PharmaTherapeut Res & Dev, Struct Biol & Biophys Grp, Ctr Chem Innovat & Excellence, Worldwide Med Chem, Groton, CT USA	Pfizer; Pfizer; Pfizer; Pfizer	Carpino, PA (corresponding author), Pfizer PharmaTherapeut Res & Dev, Worldwide Med Chem, Cambridge, MA USA.	philip.a.carpino@pfizer.com		Nolte, Whitney/0000-0002-0282-0833; Griffith, David/0000-0002-7592-2478				Baggio LL, 2004, BEST PRACT RES CL EN, V18, P531, DOI 10.1016/j.beem.2004.08.001; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; Eng H, 2013, DRUG METAB DISPOS, V41, P1470, DOI 10.1124/dmd.113.052183; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; TAKATA Y, 1991, J BIOL CHEM, V266, P9135; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Underwood CR, 2013, PEPTIDES, V49, P100, DOI 10.1016/j.peptides.2013.09.001; Vazquez P, 2005, J ENDOCRINOL, V185, P35, DOI 10.1677/joe.1.06031; Verges B, 2011, DIABETES METAB, V37, P477, DOI 10.1016/j.diabet.2011.07.001; Willard FS, 2012, MOL PHARMACOL, V82, P1066, DOI 10.1124/mol.112.080432; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/470851; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319	20	60	60	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2014	10	8					629	U162		10.1038/nchembio.1581	http://dx.doi.org/10.1038/nchembio.1581			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8HW	24997604				2022-12-25	WOS:000339380100008
J	Trainor, N; Pietak, A; Smith, T				Trainor, Nuala; Pietak, Alexis; Smith, Tim			Rethinking clinical delivery of adult stem cell therapies	NATURE BIOTECHNOLOGY			English	Article							FDA		[Trainor, Nuala; Pietak, Alexis; Smith, Tim] Octane Biotech Inc, Kingston, ON, Canada		Trainor, N (corresponding author), Octane Biotech Inc, Kingston, ON, Canada.	info@octaneco.com						Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; [Anonymous], 2010, INBOUND LOGISTICS, V30, P75; Atoui R, 2012, STEM CELL TRANSL MED, V1, P200, DOI 10.5966/sctm.2011-0012; Cosh E, 2007, J COMMER BIOTECHNOL, V13, P263, DOI DOI 10.1057/PALGRAVE.JCB.3050062; Denault J., 2008, BIOPROCESS INT, V6, P14; Freeman M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-60; Glotzbach JP, 2011, CURR PROB SURG, V48, P148, DOI 10.1067/j.cpsurg.2010.11.002; Hakimian R, 2004, JAMA-J AM MED ASSOC, V292, P2500, DOI 10.1001/jama.292.20.2500; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002; O'Brien J., 2012, FORTUNE; Porter DL, 2011, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2011.1.292; Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009; Thomas R., 2009, PHARMATECH, V33, P74; US Food and Drug Administration, 2007, GUID IND CELL SEL DE	16	37	41	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					729	735		10.1038/nbt.2970	http://dx.doi.org/10.1038/nbt.2970			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093878				2022-12-25	WOS:000346455900011
J	Das, T; Safferling, K; Rausch, S; Grabe, N; Boehm, H; Spatz, JP				Das, Tamal; Safferling, Kai; Rausch, Sebastian; Grabe, Niels; Boehm, Heike; Spatz, Joachim P.			A molecular mechanotransduction pathway regulates collective migration of epithelial cells	NATURE CELL BIOLOGY			English	Article							NF2 TUMOR-SUPPRESSOR; MERLIN; RAC; ACTIVATION; MOVEMENT; DYNAMICS; COMPLEX; KINASE; CANCER; FORCES	Collective movement of epithelial cells drives essential multicellular organization during various fundamental physiological processes encompassing embryonic morphogenesis, cancer and wound healing. Yet the molecular mechanism that ensures the coordinated movement of many cells remains elusive. Here we show that a tumour suppressor protein, merlin, coordinates collective migration of tens of cells, by acting as a mechanochemical transducer. In a stationary epithelial monolayer and also in three-dimensional human skin, merlin localizes to cortical cell-cell junctions. During migration initiation, a fraction of cortical merlin relocalizes to the cytoplasm. This relocalization is triggered by the intercellular pulling force of the leading cell and depends on the actomyosin-based cell contractility. Then in migrating cells, taking its cue from the intercellular pulling forces, which show long-distance ordering, merlin coordinates polarized Rac1 activation and lamellipodium formation on the multicellular length scale. Together, these results provide a distinct molecular mechanism linking intercellular forces to collective cell movements in migrating epithelia.	[Das, Tamal; Rausch, Sebastian; Boehm, Heike; Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Das, Tamal; Rausch, Sebastian; Boehm, Heike; Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, D-69120 Heidelberg, Germany; [Safferling, Kai; Grabe, Niels] Heidelberg Univ, BIOQUANT, Hamamatsu Tissue Imaging & Anal TIGA Ctr, D-69120 Heidelberg, Germany; [Safferling, Kai; Grabe, Niels] Heidelberg Univ, Dept Med Oncol, NCT Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Das, T (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany.	das@is.mpg.de; spatz@is.mpg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016; Spatz, Joachim P/A-1107-2017; Boehm, Heike/I-8473-2016	Spatz, Joachim P/0000-0003-3419-9807; Boehm, Heike/0000-0002-7124-4913; Grabe, Niels/0000-0003-1732-3706	Max Planck Society; Cell Networks EcTop2; Grassroot Project of the Max Planck Institute for Intelligent Systems; BMBF/MPG network MaxSynBio	Max Planck Society(Max Planck Society); Cell Networks EcTop2; Grassroot Project of the Max Planck Institute for Intelligent Systems; BMBF/MPG network MaxSynBio	We are grateful to B. Geiger and F. Frischknecht for critical review of the manuscript and advice. This work was supported by the Max Planck Society. J.P.S. is the Weston Visiting Professor at the Weizmann Institute of Science and is a member of the Heidelberg Cluster of Excellence Cell Networks. This work was supported by Cell Networks EcTop2 and the Grassroot Project of the Max Planck Institute for Intelligent Systems. Part of this work was supported by the BMBF/MPG network MaxSynBio.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Bernascone I, 2013, TRENDS CELL BIOL, V23, P380, DOI 10.1016/j.tcb.2013.03.007; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Das T, 2011, INTEGR BIOL-UK, V3, P684, DOI 10.1039/c1ib00001b; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Flaiz C, 2007, J NEUROPATH EXP NEUR, V66, P608, DOI 10.1097/nen.0b013e318093e555; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harris AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345102; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huang B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06449; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Rausch S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-32; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; Safferling K, 2013, J CELL BIOL, V203, P691, DOI 10.1083/jcb.201212020; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; Tambe DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055172; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Trepat X, 2011, TRENDS CELL BIOL, V21, P638, DOI 10.1016/j.tcb.2011.06.006; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xu N, 2008, DEV BIOL, V321, P88, DOI 10.1016/j.ydbio.2008.06.007; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017	63	226	228	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					276	+		10.1038/ncb3115	http://dx.doi.org/10.1038/ncb3115			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25706233				2022-12-25	WOS:000350770200012
J	Lewis, HD; Liddle, J; Coote, JE; Atkinson, SJ; Barker, MD; Bax, BD; Bicker, KL; Bingham, RP; Campbell, M; Chen, YH; Chung, CW; Craggs, PD; Davis, RP; Eberhard, D; Joberty, G; Lind, KE; Locke, K; Maller, C; Martinod, K; Patten, C; Polyakova, O; Rise, CE; Rudiger, M; Sheppard, RJ; Slade, DJ; Thomas, P; Thorpe, J; Yao, G; Drewes, G; Wagner, DD; Thompson, PR; Prinjha, RK; Wilson, DM				Lewis, Huw D.; Liddle, John; Coote, Jim E.; Atkinson, Stephen J.; Barker, Michael D.; Bax, Benjamin D.; Bicker, Kevin L.; Bingham, Ryan P.; Campbell, Matthew; Chen, Yu Hua; Chung, Chun-Wa; Craggs, Peter D.; Davis, Rob P.; Eberhard, Dirk; Joberty, Gerard; Lind, Kenneth E.; Locke, Kelly; Maller, Claire; Martinod, Kimberly; Patten, Chris; Polyakova, Oxana; Rise, Cecil E.; Ruediger, Martin; Sheppard, Robert J.; Slade, Daniel J.; Thomas, Pamela; Thorpe, Jim; Yao, Gang; Drewes, Gerard; Wagner, Denisa D.; Thompson, Paul R.; Prinjha, Rab K.; Wilson, David M.			Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation	NATURE CHEMICAL BIOLOGY			English	Article							ARGININE DEIMINASE 4; NEUTROPHIL EXTRACELLULAR TRAPS; TARGET; REFINEMENT; ACTIVATION; SIMILARITY; DESIGN	PAD4 has been strongly implicated in the pathogenesis of autoimmune, cardiovascular and oncological diseases through clinical genetics and gene disruption in mice. New selective PAD4 inhibitors binding a calcium-deficient form of the PAD4 enzyme have validated the critical enzymatic role of human and mouse PAD4 in both histone citrullination and neutrophil extracellular trap formation for, to our knowledge, the first time. The therapeutic potential of PAD4 inhibitors can now be explored.	[Lewis, Huw D.; Liddle, John; Atkinson, Stephen J.; Barker, Michael D.; Campbell, Matthew; Davis, Rob P.; Maller, Claire; Patten, Chris; Sheppard, Robert J.; Prinjha, Rab K.; Wilson, David M.] GlaxoSmithKline, Med Res Ctr, Immunoinflammat Therapy Area, EpiNova DPU, Stevenage, Herts, England; [Coote, Jim E.; Bax, Benjamin D.; Bingham, Ryan P.; Chen, Yu Hua; Chung, Chun-Wa; Craggs, Peter D.; Locke, Kelly; Polyakova, Oxana; Ruediger, Martin; Thomas, Pamela; Thorpe, Jim] GlaxoSmithKline, Med Res Ctr, Stevenage, Herts, England; [Bicker, Kevin L.; Slade, Daniel J.; Thompson, Paul R.] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Eberhard, Dirk; Joberty, Gerard; Drewes, Gerard] A GSK Co, Cellzome GmbH, Heidelberg, Germany; [Lind, Kenneth E.; Rise, Cecil E.; Yao, Gang] GlaxoSmithKline, ELT Boston Platform Technol & Sci, Waltham, MA USA; [Martinod, Kimberly; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Martinod, Kimberly] Harvard Univ, Sch Med, Div Med Sci, Grad Program Immunol, Boston, MA 02115 USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	GlaxoSmithKline; GlaxoSmithKline; Scripps Research Institute; State University System of Florida; University of Florida; GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lewis, HD (corresponding author), GlaxoSmithKline, Med Res Ctr, Immunoinflammat Therapy Area, EpiNova DPU, Stevenage, Herts, England.	huw.d.lewis@gsk.com	Martinod, Kimberly/K-4742-2019; Slade, Daniel/E-1329-2015	Martinod, Kimberly/0000-0002-1026-6107; Slade, Daniel/0000-0001-5634-7220; Drewes, Gerard/0000-0003-0575-6766; Craggs, Pete/0000-0002-9546-6617; Bax, Ben/0000-0003-1940-3785; Sheppard, Robert/0000-0002-5876-5589	US National Institutes of Health [GM079357, R01 HL102101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102101, T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by US National Institutes of Health grants GM079357 (to P. R. T.) and R01 HL102101 (to D. D. W.). We thank the following colleagues for their medicinal and synthetic chemistry contributions to this manuscript: D. Amans, H. Diallo, C. Douault, N. Garton, K. Jones, J. Renaux, T. Shipley, A. Walker, B. Watson and C. Wellaway. We also gratefully acknowledge S. Ready for diligently preparing and quantifying S. aureus for neutrophil studies. For the chemoproteomics data, we would like to thank M. Boesche and Cellzome's tissue culture and target validation teams for technical expertise and M. Bantscheff for stimulating discussion. We thank M. Neu and P. Homes for assistance for structural studies and B. Nolte for advice on crystallography.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Causey CP, 2011, J MED CHEM, V54, P6919, DOI 10.1021/jm2008985; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Jones JE, 2012, ACS CHEM BIOL, V7, P160, DOI 10.1021/cb200258q; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; Lewallen DM, 2014, ACS CHEM BIOL, V9, P913, DOI 10.1021/cb400841k; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Linsky T, 2010, BBA-PROTEINS PROTEOM, V1804, P1943, DOI 10.1016/j.bbapap.2010.07.016; Luo Y, 2006, J AM CHEM SOC, V128, P1092, DOI 10.1021/ja0576233; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohlsson SM, 2014, CLIN EXP IMMUNOL, V176, P363, DOI 10.1111/cei.12301; Slack JL, 2011, BIOCHEMISTRY-US, V50, P3997, DOI 10.1021/bi200309e; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SUGAWARA K, 1981, J BIOCHEM-TOKYO, V89, P771, DOI 10.1093/oxfordjournals.jbchem.a133257; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YJ, 2012, J BIOL CHEM, V287, P25941, DOI 10.1074/jbc.M112.375725; Young RJ, 2011, DRUG DISCOV TODAY, V16, P822, DOI 10.1016/j.drudis.2011.06.001	35	359	374	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					189	+		10.1038/nchembio.1735	http://dx.doi.org/10.1038/nchembio.1735			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25622091	Green Accepted, Green Submitted			2022-12-25	WOS:000349840500006
J	Dang, TTT; Chen, X; Facchini, PJ				Dang, Thu-Thuy T.; Chen, Xue; Facchini, Peter J.			Acetylation serves as a protective group in noscapine biosynthesis in opium poppy	NATURE CHEMICAL BIOLOGY			English	Article							PAPAVER-SOMNIFERUM; MORPHINE BIOSYNTHESIS; ALKALOID NOSCAPINE; LATICIFERS; PLANTS; GENES	We have characterized four sequential enzymes that transform 1-hydroxy-N-methylcanadine to narcotoline hemiacetal, completing our elucidation of noscapine biosynthesis in opium poppy. Two cytochromes P450 catalyze hydroxylations at C13 and C8 on the protoberberine scaffold, the latter step inducing ring opening and the formation of an aldehyde moiety. Acetylation at C13 before C8 hydroxylation introduces a protective group subsequently hydrolyzed by a carboxylesterase, which triggers rearrangement to a cyclic hemiacetal.	[Dang, Thu-Thuy T.; Chen, Xue; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	DANG, THU-THUY/ADM-4345-2022	DANG, THU-THUY/0000-0002-6459-3664; Facchini, Peter/0000-0002-7693-290X	Alberta Innovates Technology Futures; University of Calgary; Genome Canada; Genome Alberta; Government of Alberta [URSI-10-004-SEG]; Canada Foundation for Innovation [CFI-21695]; Natural Sciences and Engineering Research Council of Canada [RGPIN/183573-2009]	Alberta Innovates Technology Futures; University of Calgary; Genome Canada(Genome Canada); Genome Alberta; Government of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank D. Burns and J. Hagel for the NMR and LTQ-Orbitrap analyses, respectively. T.-T.T.D. is the recipient of the Alberta Innovates Technology Futures and University of Calgary Eyes High graduate scholarships. Funding was provided through grants from Genome Canada, Genome Alberta, the Government of Alberta (URSI-10-004-SEG), the Canada Foundation for Innovation (CFI-21695) and the Natural Sciences and Engineering Research Council of Canada (RGPIN/183573-2009) to P.J.F.	BATTERSBY A. R., 1965, TETRAHEDRON LETTERS, V11, P669; Battersby B.A.R., 1975, J CHEM SOC P1, V1975, P1147; Chen X, 2014, PLANT J, V77, P173, DOI 10.1111/tpj.12379; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Dang TTT, 2012, METHOD ENZYMOL, V515, P231, DOI 10.1016/B978-0-12-394290-6.00011-2; Dang TTT, 2014, J BIOL CHEM, V289, P2013, DOI 10.1074/jbc.M113.505099; Dang TTT, 2014, FEBS LETT, V588, P198, DOI 10.1016/j.febslet.2013.11.037; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Fang ZZ, 2012, BRIT J PHARMACOL, V167, P1271, DOI 10.1111/j.1476-5381.2012.02067.x; Gershater MC, 2007, PLANT SCI, V173, P579, DOI 10.1016/j.plantsci.2007.08.008; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; LETTRE H, 1954, Ann N Y Acad Sci, V58, P1264, DOI 10.1111/j.1749-6632.1954.tb45907.x; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Onoyovwe A, 2013, PLANT CELL, V25, P4110, DOI 10.1105/tpc.113.115113; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ruppert M, 2005, PLANTA, V222, P888, DOI 10.1007/s00425-005-0031-0; Shulgin A., 2003, SIMPLE PLANT ISOQUIN; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601	23	53	62	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					104	U122		10.1038/NCHEMBIO.1717	http://dx.doi.org/10.1038/NCHEMBIO.1717			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25485687				2022-12-25	WOS:000348358800006
J	Zetsche, B; Volz, SE; Zhang, F				Zetsche, Bernd; Volz, Sara E.; Zhang, Feng			A split-Cas9 architecture for inducible genome editing and transcription modulation	NATURE BIOTECHNOLOGY			English	Letter							RNA; CRISPR		[Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA USA; [Zetsche, Bernd] Bonn Med Sch, Inst Pathol, Dept Dev Pathol, Bonn, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Bonn	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NIMH NIH HHS [DP1 MH100706] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022	11	445	554	5	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					139	142		10.1038/nbt.3149	http://dx.doi.org/10.1038/nbt.3149			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25643054	Green Accepted, Green Submitted			2022-12-25	WOS:000349198800015
J	Lapique, N; Benenson, Y				Lapique, Nicolas; Benenson, Yaakov			Digital switching in a biosensor circuit via programmable timing of gene availability	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; FEEDFORWARD CIRCUITS; THYMIDINE KINASE; MAMMALIAN-CELLS; EXPRESSION; LOGIC; RECOMBINATION; NETWORK; RNAI; CONSTRUCTION	Transient delivery of gene circuits is required in many potential applications of synthetic biology, yet the pre-steady-state processes that dominate this delivery route pose major challenges for robust circuit deployment. Here we show that site-specific recombinases can rectify undesired effects by programmable timing of gene availability in multigene circuits. We exemplify the concept with a proportional sensor for endogenous microRNA ( miRNA) and show a marked reduction in its ground state leakage due to desynchronization of the circuit's repressor components and their repression target. The new sensors display a dynamic range of up to 1,000-fold compared to 20-fold in the standard configuration. We applied the approach to classify cell types on the basis of miRNA expression profile and measured >200-fold output differential between positively and negatively identified cells. We also showed major improvements in specificity with cytotoxic output. Our study opens new venues in gene circuit design via judicious temporal control of circuits' genetic makeup.	[Lapique, Nicolas; Benenson, Yaakov] Swiss Fed Inst Technol Zurich ETHZ, Dept Biosyst Sci & Engn, Basel, Switzerland		Benenson, Y (corresponding author), Swiss Fed Inst Technol Zurich ETHZ, Dept Biosyst Sci & Engn, Basel, Switzerland.	kobi.benenson@bsse.ethz.ch		Lapique, Nicolas/0000-0003-1217-8597	US National Institutes of Health and National Cancer Institute [5R01CA155320]; NATIONAL CANCER INSTITUTE [R01CA155320] Funding Source: NIH RePORTER	US National Institutes of Health and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded the US National Institutes of Health and National Cancer Institute grant 5R01CA155320 and a European Research Council starting grant CellControl. We wish to thank the M. Fussenegger lab in our department for the ET-ETR inducible system, K. Hoelle and L. Prochazka for plasmids and Benenson lab members for discussions. We thank M. Dessing and V. Jaeggin for assistance with flow cytometry and T. Horn for help with imaging. We thank R. Kellogg from S. Tay's laboratory in our department for help with viability assays.	Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; BACKMAN K, 1984, BIO-TECHNOL, V2, P1045, DOI 10.1038/nbt1284-1045; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; de las Heras A, 2010, FEMS MICROBIOL REV, V34, P842, DOI 10.1111/j.1574-6976.2010.00238.x; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Egbert RG, 2012, P NATL ACAD SCI USA, V109, P16817, DOI 10.1073/pnas.1205693109; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hausser J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.68; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kanegae Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq966; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Liang JC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks636; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mercer KE, 2002, PROTEIN ENG, V15, P903, DOI 10.1093/protein/15.11.903; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Mohr L, 2000, HEPATOLOGY, V31, P606, DOI 10.1002/hep.510310310; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Prochazka L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5729; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Sontag ED, 2010, IET SYST BIOL, V4, P39, DOI 10.1049/iet-syb.2008.0171; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Weber W, 2002, J GENE MED, V4, P676, DOI 10.1002/jgm.314; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, BIOTECHNOL BIOENG, V98, P894, DOI 10.1002/bit.21463; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	48	29	35	3	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1020	+		10.1038/nchembio.1680	http://dx.doi.org/10.1038/nchembio.1680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25306443	Green Accepted			2022-12-25	WOS:000345122300009
J	Baude, A; Lindroth, AM; Plass, C				Baude, Annika; Lindroth, Anders M.; Plass, Christoph			PRC2 loss amplifies Ras signaling in cancer	NATURE GENETICS			English	Editorial Material							TRANSCRIPTIONAL REGULATION; INHIBITION; EZH2; PROTEINS; THERAPY; TARGET	The histone-modifying PRC2 complex has an ambiguous role in cancer, bearing both oncogenic and tumor-suppressive features depending on cell type. Studies of malignant peripheral nerve sheath tumors (MPNSTs) have now identified loss-of-function mutations altering PRC2 subunits, leading to the amplification of Ras-driven transcription and conferring vulnerability to BRD4 inhibitors.	[Baude, Annika; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Lindroth, Anders M.] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang Si, South Korea	Helmholtz Association; German Cancer Research Center (DKFZ); National Cancer Center - Korea (NCC)	Plass, C (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany.	c.plass@dkfz.de	Lindroth, Anders M/C-7744-2015	Lindroth, Anders M/0000-0002-8291-2745				BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; McCabe MT, 2014, EPIGENOMICS-UK, V6, P341, DOI [10.2217/EPI.14.23, 10.2217/epi.14.23]; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116	15	16	17	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1154	1155		10.1038/ng.3124	http://dx.doi.org/10.1038/ng.3124			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25352098				2022-12-25	WOS:000344131900002
J	Lee, W; Teckie, S; Wiesner, T; Ran, LL; Granada, CNP; Lin, MY; Zhu, SN; Cao, Z; Liang, YP; Sboner, A; Tap, WD; Fletcher, JA; Huberman, KH; Qin, LX; Viale, A; Singer, S; Zheng, DY; Berger, MF; Chen, Y; Antonescu, CR; Chi, P				Lee, William; Teckie, Sewit; Wiesner, Thomas; Ran, Leili; Granada, Carlos N. Prieto; Lin, Mingyan; Zhu, Sinan; Cao, Zhen; Liang, Yupu; Sboner, Andrea; Tap, William D.; Fletcher, Jonathan A.; Huberman, Kety H.; Qin, Li-Xuan; Viale, Agnes; Singer, Samuel; Zheng, Deyou; Berger, Michael F.; Chen, Yu; Antonescu, Cristina R.; Chi, Ping			PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors	NATURE GENETICS			English	Article							METHYLTRANSFERASE GENE EZH2; REPRESSIVE COMPLEX 2; HISTONE METHYLTRANSFERASE; SOMATIC MUTATIONS; STEM; PLURIPOTENT; METHYLATION; DELETIONS; CHROMATIN; MAPS	Malignant peripheral nerve sheath tumors (MPNSTs) represent a group of highly aggressive soft-tissue sarcomas that may occur sporadically, in association with neurofibromatosis type I (NF1 associated) or after radiotherapy(1-3). Using comprehensive genomic approaches, we identified loss-of-function somatic alterations of the Polycomb repressive complex 2 (PRC2) components (EED or SUZ12) in 92% of sporadic, 70% of NF1-associated and 90% of radiotherapy-associated MPNSTs. MPNSTs with PRC2 loss showed complete loss of trimethylation at lysine 27 of histone H3 (H3K27me3) and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Introduction of the lost PRC2 component in a PRC2-deficient MPNST cell line restored H3K27me3 levels and decreased cell growth. Additionally, we identified frequent somatic alterations of CDKN2A (81% of all MPNSTs) and NF1 (72% of non-NF1-associated MPNSTs), both of which significantly co-occur with PRC2 alterations. The highly recurrent and specific inactivation of PRC2 components, NF1 and CDKN2A highlights their critical and potentially cooperative roles in MPNST pathogenesis.	[Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Lee, William; Teckie, Sewit] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Teckie, Sewit; Wiesner, Thomas; Ran, Leili; Zhu, Sinan; Cao, Zhen; Liang, Yupu; Berger, Michael F.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Granada, Carlos N. Prieto; Berger, Michael F.; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lin, Mingyan; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Sboner, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Sboner, Andrea] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Sboner, Andrea] Weill Cornell Med Coll, Inst Precis Med, New York, NY USA; [Tap, William D.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Tap, William D.; Chen, Yu; Chi, Ping] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Huberman, Kety H.; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, P (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chip@mskcc.org	Prieto Granada, Carlos N./J-4665-2019; lin, mingyan/HDL-9420-2022	Prieto Granada, Carlos N./0000-0002-5025-7539; Wiesner, Thomas/0000-0001-5877-2992; Singer, Samuel/0000-0001-9713-8230; Zheng, Deyou/0000-0003-4354-5337	US National Institutes of Health (NIH) [NCI U24-CA143840]; Harry J. Lloyd Trust-Translational Research grant; Charles H. Revson Senior Fellowship; Jubilaeumsfonds of the Oesterreichische Nationalbank; US NIH [P50CA140146, DP2CA174499, K08CA151660, K08CA140946]; Sidney Kimmel Foundation; Cycle for Survival Fund; NATIONAL CANCER INSTITUTE [K08CA151660, U24CA143840, P30CA008748, K08CA140946, DP2CA174499, P50CA140146, P50CA127003] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry J. Lloyd Trust-Translational Research grant; Charles H. Revson Senior Fellowship; Jubilaeumsfonds of the Oesterreichische Nationalbank; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Cycle for Survival Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Next-generation sequencing and SNP6.0 analysis were performed at the Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility, Center for Molecular Oncology (CMO). The authors thank members of the cBioPortal team (J. Gao, B. Gross, N. Schultz and C. Sander) for assistance with data analysis and visualization. The authors also thank T. Chan (MSKCC) and HOPP informatics for assistance with data analysis. This work was supported in part by a grant from the US National Institutes of Health (NIH) to W.L. (NCI U24-CA143840), the Harry J. Lloyd Trust-Translational Research grant to T.W., the Charles H. Revson Senior Fellowship to T.W., Jubilaeumsfonds of the Oesterreichische Nationalbank to T.W., grants from the US NIH to P.C. (P50CA140146, Career Development Award and Developmental Research Project.; DP2CA174499; K08CA151660), Y.C. (K08CA140946), L.-X.Q. (P50CA140146), C.R.A. (P50CA140146) and S.S. (P50CA140146), an award from the Sidney Kimmel Foundation to P.C. (Kimmel Scholar Award) and funding from the Cycle for Survival Fund to P.C.	Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Antonescu C.R., 2013, TUMORS PERIPHERAL NE, V553; Brennan M.F., 2013, MANAGEMENT SOFT TISS, P149; Eilber FC, 2004, CANCER-AM CANCER SOC, V101, P2270, DOI 10.1002/cncr.20570; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; LaFemina J, 2013, ANN SURG ONCOL, V20, P66, DOI 10.1245/s10434-012-2573-2; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nielsen GP, 1999, AM J PATHOL, V155, P1879, DOI 10.1016/S0002-9440(10)65507-1; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Perrone F, 2003, CLIN CANCER RES, V9, P4132; Rodriguez FJ, 2012, ACTA NEUROPATHOL, V123, P293, DOI 10.1007/s00401-012-0955-y; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	29	326	332	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1227	1232		10.1038/ng.3095	http://dx.doi.org/10.1038/ng.3095			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240281	Green Accepted			2022-12-25	WOS:000344131900014
J	Lu, HH; Clauser, KR; Tam, WL; Frose, J; Ye, X; Eaton, EN; Reinhardt, F; Donnenberg, VS; Bhargava, R; Carr, SA; Weinberg, RA				Lu, Haihui; Clauser, Karl R.; Tam, Wai Leong; Froese, Julia; Ye, Xin; Eaton, Elinor Ng; Reinhardt, Ferenc; Donnenberg, Vera S.; Bhargava, Rohit; Carr, Steven A.; Weinberg, Robert A.			A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-KINASE-C; EPHA4; EXPRESSION; GROWTH; CD90; GENE; SUBPOPULATIONS; OVEREXPRESSION	The cell-biological program termed the epithelial-mesenchymal transition (EMT) confers on cancer cells mesenchymal traits and an ability to enter the cancer stem cell (CSC) state. However, the interactions between CSCs and their surrounding microenvironment are poorly understood. Here we show that tumour-associated monocytes and macrophages (TAMs) create a CSC niche through juxtacrine signalling with CSCs. We performed quantitative proteomic profiling and found that the EMT program upregulates the expression of CD90, also known as Thy1, and EphA4, which mediate the physical interactions of CSCs with TAMs by directly binding with their respective counter-receptors on these cells. In response, the EphA4 receptor on the carcinoma cells activates Src and NF-kappa B. In turn, NF-kappa B in the CSCs induces the secretion of a variety of cytokines that serve to sustain the stem cell state. Indeed, admixed macrophages enhance the CSC activities of carcinoma cells. These findings underscore the significance of TAMs as important components of the CSC niche.	[Lu, Haihui; Tam, Wai Leong; Froese, Julia; Ye, Xin; Eaton, Elinor Ng; Reinhardt, Ferenc; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lu, Haihui; Tam, Wai Leong; Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Clauser, Karl R.; Carr, Steven A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Tam, Wai Leong] Genome Inst Singapore, Singapore 138672, Singapore; [Froese, Julia] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Froese, Julia] Heidelberg Univ, D-69120 Heidelberg, Germany; [Donnenberg, Vera S.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Donnenberg, Vera S.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA; [Bhargava, Rohit] Univ Pittsburgh, Sch Med, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Carr, Steven A./AAH-8366-2019; Tam, Wai Leong/P-1497-2019	Tam, Wai Leong/0000-0003-2365-5264; Frose, Julia/0000-0002-8179-1777; Clauser, Karl/0000-0002-1052-9456	MIT Ludwig Center for Molecular Oncology; Breast Cancer Research Foundation; National Institutes of Health (NIH) [R01-CA078461, P01-CA080111, U54-CA163109]; Department of Defense [BC032981, BC044784]; NIH [P30CA047904, U24CA160034]; Hillman Foundation; Glimmer of Hope Foundation; Broad Institute of MIT; Broad Institute of Harvard; Cancer Research Institute (NewYork); NATIONAL CANCER INSTITUTE [R01CA078461, U24CA160034, P30CA047904, P30CA014051, P01CA080111, U54CA163109] Funding Source: NIH RePORTER	MIT Ludwig Center for Molecular Oncology; Breast Cancer Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillman Foundation; Glimmer of Hope Foundation; Broad Institute of MIT; Broad Institute of Harvard; Cancer Research Institute (NewYork); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Ma and T. Shibue for critical reviews of the manuscript, R. Bronson for evaluating the histopathology, D. R. Mani and P. Thiru for statistical analyses and C. Baty for assistance in imaging. We also thank A. Oberle, J. Karlsson and E. Procopio for technical assistance. This research was supported by the MIT Ludwig Center for Molecular Oncology and by grants from the Breast Cancer Research Foundation and National Institutes of Health (NIH; R01-CA078461, P01-CA080111 and U54-CA163109) to R.A.W. Additional support comes in part from the Department of Defense (BC032981 and BC044784), NIH (P30CA047904), the Hillman Foundation and the Glimmer of Hope Foundation to V.S.D. This work was also supported in part by the Broad Institute of MIT and Harvard, and by grants from NIH (U24CA160034) to S.A.C. R.A.W. is an American Cancer Society and D. K. Ludwig Foundation Cancer Research Professor. Postdoctoral fellowship support for H.L. was from the Cancer Research Institute (New York) and the MIT Ludwig Center for Molecular Oncology.	[Anonymous], TE; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Ch'ng ES, 2013, VIRCHOWS ARCH, V462, P257, DOI 10.1007/s00428-012-1362-4; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Donnenberg AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052885; Donnenberg VS, 2010, CYTOM PART B-CLIN CY, V78B, P287, DOI 10.1002/cyto.b.20530; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Gisina AM, 2011, B EXP BIOL MED+, V151, P234, DOI 10.1007/s10517-011-1297-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hartman Z. C., 2013, CANC RES; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Li S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-73; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Ohri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021874; Oki M, 2008, WORLD J GASTROENTERO, V14, P5650, DOI 10.3748/wjg.14.5650; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oshima T, 2008, INT J ONCOL, V33, P573, DOI 10.3892/ijo_00000042; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sasaki CY, 2011, J BIOL CHEM, V286, P1093, DOI 10.1074/jbc.M110.119438; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsutsui S, 2005, ONCOL REP, V14, P425; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	68	290	302	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1105	+		10.1038/ncb3041	http://dx.doi.org/10.1038/ncb3041			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25266422	Green Accepted, Green Submitted			2022-12-25	WOS:000344744000009
J	de Vree, PJP; de Wit, E; Yilmaz, M; de Heijning, MV; Klous, P; Verstegen, MJAM; Wan, Y; Teunissen, H; Krijger, PHL; Geeven, G; Eijk, PP; Sie, D; Ylstra, B; Hulsman, LOM; van Dooren, MF; van Zutven, LJCM; van den Ouweland, A; Verbeek, S; van Dijk, KW; Cornelissen, M; Das, AT; Ben Berkhout,; Sikkema-Raddatz, B; van den Berg, E; van der Vlies, P; Weening, D; den Dunnen, JT; Matusiak, M; Lamkanfi, M; Ligtenberg, MJL; ter Brugge, P; Jonkers, J; Foekens, JA; Martens, JW; van der Luijt, R; van Amstel, HKP; van Min, M; Splinter, E; de Laat, W				de Vree, Paula J. P.; de Wit, Elzo; Yilmaz, Mehmet; de Heijning, Monique van; Klous, Petra; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; Eijk, Paul P.; Sie, Daoud; Ylstra, Bauke; Hulsman, Lorette O. M.; van Dooren, Marieke F.; van Zutven, Laura J. C. M.; van den Ouweland, Ans; Verbeek, Sjef; van Dijk, Ko Willems; Cornelissen, Marion; Das, Atze T.; Ben Berkhout; Sikkema-Raddatz, Birgit; van den Berg, Eva; van der Vlies, Pieter; Weening, Desiree; den Dunnen, Johan T.; Matusiak, Magdalena; Lamkanfi, Mohamed; Ligtenberg, Marjolijn J. L.; ter Brugge, Petra; Jonkers, Jos; Foekens, John A.; Martens, John W.; van der Luijt, Rob; van Amstel, Hans Kristian Ploos; van Min, Max; Splinter, Erik; de Laat, Wouter			Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping	NATURE BIOTECHNOLOGY			English	Article							COMPLEX CHROMOSOMAL REARRANGEMENTS; INFLAMMASOME ACTIVATION; GENETIC-VARIATION; 4C TECHNOLOGY; GENOME; DISEASE; TUMORS; CONFORMATION; ENRICHMENT; EXPRESSION	Despite developments in targeted gene sequencing and whole-genome analysis techniques, the robust detection of all genetic variation, including structural variants, in and around genes of interest and in an allele-specific manner remains a challenge. Here we present targeted locus amplification (TLA), a strategy to selectively amplify and sequence entire genes on the basis of the crosslinking of physically proximal sequences. We show that, unlike other targeted re-sequencing methods, TLA works without detailed prior locus information, as one or a few primer pairs are sufficient for sequencing tens to hundreds of kilobases of surrounding DNA. This enables robust detection of single nucleotide variants, structural variants and gene fusions in clinically relevant genes, including BRCA1 and BRCA2, and enables haplotyping. We show that TLA can also be used to uncover insertion sites and sequences of integrated transgenes and viruses. TLA therefore promises to be a useful method in genetic research and diagnostics when comprehensive or allele-specific genetic information is needed.	[de Vree, Paula J. P.; de Wit, Elzo; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; de Laat, Wouter] KNAW, Hubrecht Inst, Utrecht, Netherlands; [de Vree, Paula J. P.; de Wit, Elzo; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; de Laat, Wouter] Univ Med Ctr Utrecht, Utrecht, Netherlands; [de Wit, Elzo; Yilmaz, Mehmet; de Heijning, Monique van; Klous, Petra; van Min, Max; Splinter, Erik; de Laat, Wouter] Cergentis BV, Utrecht, Netherlands; [Eijk, Paul P.; Sie, Daoud; Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Hulsman, Lorette O. M.; van Dooren, Marieke F.; van Zutven, Laura J. C. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Verbeek, Sjef; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Verbeek, Sjef; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Cornelissen, Marion; Das, Atze T.; Ben Berkhout] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Sikkema-Raddatz, Birgit; van den Berg, Eva; van der Vlies, Pieter; Weening, Desiree] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden Genome Technol Ctr, Leiden, Netherlands; [Matusiak, Magdalena; Lamkanfi, Mohamed] VIB, Dept Med Prot Res, Ghent, Belgium; [Matusiak, Magdalena; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [ter Brugge, Petra; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [ter Brugge, Petra; Jonkers, Jos] Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands; [Foekens, John A.; Martens, John W.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [van der Luijt, Rob; van Amstel, Hans Kristian Ploos] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University; Radboud University Nijmegen; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center	Splinter, E (corresponding author), Cergentis BV, Utrecht, Netherlands.	erik.splinter@cergentis.com; w.delaat@hubrecht.eu	van Dijk, Ko Willems/A-1798-2008; Jonkers, Jos/AAG-3246-2019; dunnen, johan den/ABH-4228-2020; van Dijk, Ko Willems/AAT-4681-2021; Ylstra, Bauke/D-2906-2012; Ligtenberg, Marjolijn/N-9666-2013	van Dijk, Ko Willems/0000-0002-2172-7394; Jonkers, Jos/0000-0002-9264-9792; dunnen, johan den/0000-0002-6304-1710; van Dijk, Ko Willems/0000-0002-2172-7394; Ylstra, Bauke/0000-0001-9479-3010; Ligtenberg, Marjolijn/0000-0003-1290-1474; Sie, Daoud/0000-0001-6762-2582; van der Luijt, Rob/0000-0002-0018-1089; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415; Geeven, Geert/0000-0002-5603-0095; Krijger, Peter/0000-0003-1702-348X	Netherlands Genomics Initiative (NGI) [93608003, 93611010]; Cancer Genomics Center (CGC); Dutch Cancer Foundation [2009-4459]	Netherlands Genomics Initiative (NGI); Cancer Genomics Center (CGC); Dutch Cancer Foundation(KWF Kankerbestrijding)	We thank T. P. Driessen for figure graphics. This work was supported by the Netherlands Genomics Initiative (NGI) pre-seed grants 93608003 and 93611010 and a proof of concept grant from the Cancer Genomics Center (CGC) to W.d.L. and an Innovation Credit from NL Agency to Cergentis. P.J.P.d.V. is supported by a Dutch Cancer Foundation grant KWF (2009-4459 to J.A.F., J.W.M. and W.d.L.).	Altmuller J, 2014, BIOL CHEM, V395, P231, DOI 10.1515/hsz-2013-0199; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; de Vree PJP, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-15; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Evers B, 2010, CLIN CANCER RES, V16, P99, DOI 10.1158/1078-0432.CCR-09-2434; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; LANGE B, 1987, BLOOD, V70, P192; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MCKEITHAN TW, 1986, P NATL ACAD SCI USA, V83, P6636, DOI 10.1073/pnas.83.17.6636; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Nagel JHA, 2012, BREAST CANCER RES TR, V132, P439, DOI 10.1007/s10549-011-1588-x; PERSYN JP, 1980, EUR J CANCER, V16, P1513; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; SMITH SD, 1988, BLOOD, V71, P395; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373	39	140	144	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1019	+		10.1038/nbt.2959	http://dx.doi.org/10.1038/nbt.2959			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25129690				2022-12-25	WOS:000343763800019
J	Lopez-Serra, L; Kelly, G; Patel, H; Stewart, A; Uhlmann, F				Lopez-Serra, Lidia; Kelly, Gavin; Patel, Harshil; Stewart, Aengus; Uhlmann, Frank			The Scc2-Scc4 complex acts in sister chromatid cohesion and transcriptional regulation by maintaining nucleosome-free regions	NATURE GENETICS			English	Article							XENOPUS EGG EXTRACTS; REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE; YEAST CHROMOSOMES; NIPPED-B; GENOME; RSC; GENES; IDENTIFICATION; REPLICATION	The cohesin complex is at the heart of many chromosomal activities, including sister chromatid cohesion and transcriptional regulation(1-3). Cohesin loading onto chromosomes depends on the Scc2-Scc4 cohesin loader complex(4-6), but the chromatin features that form cohesin loading sites remain poorly understood. Here we show that the RSC chromatin remodeling complex recruits budding yeast Scc2-Scc4 to broad nucleosome-free regions, which the cohesin loader helps to maintain. Consequently, inactivation of either the cohesin loader or the RSC complex has similar effects on nucleosome positioning, gene expression and sister chromatid cohesion. These results show an intimate link between local chromatin structure and higher-order chromosome architecture. Our findings pertain to the similarities between two severe human disorders, Cornelia de Lange syndrome, which is caused by alterations in the human cohesin loader, and Coffin-Siris syndrome, which results from alterations in human RSC complex components(7-9). Both syndromes can arise from gene misregulation due to related changes in the nucleosome landscape.	[Lopez-Serra, Lidia; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [Kelly, Gavin; Patel, Harshil; Stewart, Aengus] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Kelly, Gavin/ABG-2715-2021	Kelly, Gavin/0000-0001-7219-560X; Uhlmann, Frank/0000-0002-3527-6619; Patel, Harshil/0000-0003-2707-7940	Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain); Marie Curie Intra-European Fellowship; European Research Council; Cancer Research UK [15671] Funding Source: researchfish	Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain); Marie Curie Intra-European Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	We thank P. Chambers at the Cancer Research UK Genome Variation Laboratory at St. James's University Hospital, Leeds, and N. Matthews from the Advanced Sequencing Facility at the Cancer Research UK London Research Institute for high-throughput sequencing. We thank C. Esnault, A. Lengronne and our laboratory members for discussions and comments on the manuscript. This work was supported by a Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain) and a Marie Curie Intra-European Fellowship (L.L.-S.) and the European Research Council (L.L.-S. and F.U.).	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Du J, 1998, GENETICS, V150, P987; Fasulo B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002878; FRYNS JP, 1986, CLIN GENET, V29, P263; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Morohashi N, 2006, EUKARYOT CELL, V5, P1925, DOI 10.1128/EC.00105-06; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Tsurusaki Y, 2014, CLIN GENET, V85, P548, DOI 10.1111/cge.12225; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	37	88	88	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1147	1151		10.1038/ng.3080	http://dx.doi.org/10.1038/ng.3080			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25173104	Green Accepted			2022-12-25	WOS:000342554100021
J	Wei, QY; Yu, DK; Liu, MB; Wang, MY; Zhao, MQ; Liu, M; Jia, WH; Ma, HX; Fang, JG; Xu, W; Chen, KX; Xu, ZG; Wang, JL; Tian, LL; Yuan, H; Chang, J; Hu, ZB; Wei, LX; Huang, Y; Han, YL; Liu, J; Han, DM; Shen, HB; Yang, SM; Zheng, H; Ji, QH; Li, DS; Tan, W; Wu, C; Lin, DX				Wei, Qingyi; Yu, Dianke; Liu, Mingbo; Wang, Mengyun; Zhao, Miaoqing; Liu, Ming; Jia, Weihua; Ma, Hongxia; Fang, Jugao; Xu, Wei; Chen, Kexing; Xu, Zhengang; Wang, Jialing; Tian, Linli; Yuan, Hua; Chang, Jiang; Hu, Zhibin; Wei, Lixun; Huang, Ying; Han, Yaling; Liu, Jie; Han, Demin; Shen, Hongbing; Yang, Shiming; Zheng, Hong; Ji, Qinghai; Li, Duanshu; Tan, Wen; Wu, Chen; Lin, Dongxin			Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population	NATURE GENETICS			English	Article							GENETIC-VARIANTS; COMMON VARIANTS; CIGARETTE-SMOKING; PR INTERVAL; RISK; CANCER; CONTRIBUTE; MUTATIONS	To identify genetic markers for laryngeal squamous cell carcinoma (LSCC), we conducted a genome-wide association study (GWAS) on 993 individuals with LSCC (cases) and 1,995 cancer-free controls from Chinese populations. The most promising variants (association P < 1 x 10(-5)) were then replicated in 3 independent sets including 2,398 cases and 2,804 controls, among which we identified 3 new susceptibility loci at 11q12 (rs174549), 6p21 (rs2857595) and 12q24 (rs10492336). The minor alleles of each of these loci showed protective effects, with odds ratios (95% confidence intervals) of 0.73 (0.68-0.78; P = 1.00 x 10(-20)), 0.78 (0.72-0.84; P = 2.43 x 10(-15)) and 0.71 (0.65-0.77; P = 4.48 x 10(-14)), respectively. None of these variants showed an interaction with smoking or drinking. This is the first GWAS to our knowledge solely on LSCC, and the findings might advance understanding of the etiology of LSCC.	[Wei, Qingyi; Wang, Mengyun] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Wei, Qingyi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wei, Qingyi; Wang, Mengyun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Yu, Dianke; Chang, Jiang; Wei, Lixun; Huang, Ying; Han, Yaling; Tan, Wen; Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Liu, Mingbo; Xu, Zhengang; Chang, Jiang; Wei, Lixun; Huang, Ying; Han, Yaling; Liu, Jie; Tan, Wen; Wu, Chen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Mingbo; Wang, Jialing; Yang, Shiming] Chinese Peoples Liberat Army, Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Zhao, Miaoqing] Shandong Univ, Prov Hosp, Dept Pathol, Jinan 250100, Peoples R China; [Liu, Ming; Tian, Linli] Harbin Med Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Harbin, Peoples R China; [Jia, Weihua] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Hongxia; Yuan, Hua; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Sch Publ Hlth, Dept Epidemiol & Biostat,Jiangsu Key Lab Canc Bio, Nanjing, Jiangsu, Peoples R China; [Fang, Jugao; Han, Demin] Capital Univ Med Sci, Affiliated Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Xu, Wei] Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China; [Chen, Kexing; Zheng, Hong] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Xu, Zhengang; Liu, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Head & Neck Surg Oncol, Beijing 100730, Peoples R China; [Ji, Qinghai; Li, Duanshu] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Dept Head & Neck Surg, Shanghai, Peoples R China	Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese People's Liberation Army General Hospital; Shandong University; Harbin Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Nanjing Medical University; Capital Medical University; Shandong University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Fudan University	Wei, QY (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27708 USA.	qingyi.wei@duke.edu; chenwu@cicams.ac.cn	Wei, Qingyi/T-8315-2019	Wei, Qingyi/0000-0002-3845-9445; Ma, Hongxia/0000-0002-9821-6955; Wu, Chen/0000-0003-4954-1011; Shen, Hongbing/0000-0002-2581-5906; Chen, Kexin/0000-0003-4248-7681; Lin, Dongxin/0000-0002-8723-8868; Liu, Mingbo/0000-0002-0540-2573	Chinese Recruitment Program of Global Experts at Fudan University; National Natural Science Foundation of China [30721001]	Chinese Recruitment Program of Global Experts at Fudan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Chinese Recruitment Program of Global Experts at Fudan University (to Q.W.) and the National Natural Science Foundation of China (30721001 to D. Lin).	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Butler AM, 2012, CIRC-CARDIOVASC GENE, V5, P639, DOI 10.1161/CIRCGENETICS.112.963991; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Ferlay J, 2004, GLOBOCAN 2002 CANCER; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Julia A, 2013, GUT, V62, P1440, DOI 10.1136/gutjnl-2012-302865; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Langevin SM, 2013, CANCER EPIDEM BIOMAR, V22, P1061, DOI 10.1158/1055-9965.EPI-13-0183; Li WQ, 2013, CARCINOGENESIS, V34, P1536, DOI 10.1093/carcin/bgt094; Li XW, 2013, J INFECT DIS, V207, P479, DOI 10.1093/infdis/jis698; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Lubin JH, 2011, CANCER CAUSE CONTROL, V22, P1217, DOI 10.1007/s10552-011-9792-x; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	35	45	50	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1110	1114		10.1038/ng.3090	http://dx.doi.org/10.1038/ng.3090			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25194280				2022-12-25	WOS:000342554100014
J	Araci, IE; Su, BL; Quake, SR; Mandel, Y				Araci, Ismail E.; Su, Baolong; Quake, Stephen R.; Mandel, Yossi			An implantable microfluidic device for self-monitoring of intraocular pressure	NATURE MEDICINE			English	Article							GLAUCOMA WORLDWIDE; LENS; MANAGEMENT; CATARACT; SURGERY; PEOPLE; NUMBER; SENSOR; DAMAGE	Glaucoma is the second most common cause of blindness in the world. It is a multifactorial disease with several risk factors, of which intraocular pressure (IOP) is a primary contributing factor, lop measurements are used for glaucoma diagnosis and patient monitoring. IOP has wide diurnal fluctuation and is dependent on body posture, so the occasional measurements done by the eye care expert in the clinic can be misleading. Here we show that microfluidic principles can be used to develop an implantable sensor that has a limit of detection of 1 mm Hg, high sensitivity and excellent reproducibility. This device has a simple optical interface that enables IOP to be read with a smartphone camera. This sensor, with its ease of fabrication and simple design, as well as its allowance for IOP home monitoring, offers a promising approach for better care of patients with glaucoma.	[Araci, Ismail E.; Su, Baolong; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Araci, Ismail E.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Mandel, Yossi] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA; [Mandel, Yossi] Stanford Univ, Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Mandel, Yossi] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Bar Ilan University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu; yossi.mandel@biu.ac.il						Becker B, 2000, J GLAUCOMA, V9, P487; Blackwell B, 2001, ARCH OPHTHALMOL-CHIC, V119, P1771; BOMER TG, 1995, BRIT J OPHTHALMOL, V79, P809, DOI 10.1136/bjo.79.9.809; Cherrier M, 2010, P SOC PHOTO-OPT INS, V7556, DOI 10.1117/12.843665; Coleman AL, 2012, INVEST OPHTH VIS SCI, V53, P2491, DOI 10.1167/iovs.12-9483l; Doughty MJ, 2007, GRAEF ARCH CLIN EXP, V245, P1603, DOI 10.1007/s00417-007-0601-x; Elman NM, 2010, CURR PHARM BIOTECHNO, V11, P398, DOI 10.2174/138920110791233262; FLOWER RW, 1982, OPHTHALMIC RES, V14, P98, DOI 10.1159/000265179; Fry LL, 1997, ARCH OPHTHALMOL-CHIC, V115, P823, DOI 10.1001/archopht.1997.01100150825033; Gandhi PD, 2001, AM J OPHTHALMOL, V131, P417, DOI 10.1016/S0002-9394(00)00802-3; Harsum S, 2010, EYE, V24, P152, DOI 10.1038/eye.2009.3; Harvey P, 2011, IEEE ENG MED BIO, P3154, DOI 10.1109/IEMBS.2011.6090860; Hughes E, 2003, J GLAUCOMA, V12, P232, DOI 10.1097/00061198-200306000-00009; Hylton C, 2003, AM J OPHTHALMOL, V135, P231, DOI 10.1016/S0002-9394(02)01919-0; Kakaday T, 2009, BRIT J OPHTHALMOL, V93, P992, DOI 10.1136/bjo.2008.144261; Kiuchi T, 2010, J GLAUCOMA, V19, P191, DOI 10.1097/IJG.0b013e3181a98f30; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kwon TH, 2008, J BIOMECH, V41, P1707, DOI 10.1016/j.jbiomech.2008.03.004; Liu JHK, 2011, BRIT J OPHTHALMOL, V95, P599, DOI 10.1136/bjo.2010.199737; Logan AG, 2012, HYPERTENSION, V60, P51, DOI 10.1161/HYPERTENSIONAHA.111.188409; Mansouri K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1534, DOI [10.1001/archophthalmol.2012.2280, 10.1001/jamaophthalmol.2013.1350]; Mansouri K, 2012, EXPERT REV MED DEVIC, V9, P225, DOI [10.1586/ERD.12.14, 10.1586/erd.12.14]; McLaren JW, 1996, INVEST OPHTH VIS SCI, V37, P966; Meyer MA, 1997, OPHTHALMOLOGY, V104, P1221, DOI 10.1016/S0161-6420(97)30154-7; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rizq RN, 2001, BRIT J OPHTHALMOL, V85, P868, DOI 10.1136/bjo.85.7.868; Stangel K, 2001, IEEE J SOLID-ST CIRC, V36, P1094, DOI 10.1109/4.933466; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wagenaar RC, 2011, IEEE ENG MED BIO, P4844, DOI 10.1109/IEMBS.2011.6091200; WOLBARSHT ML, 1980, INT OPHTHALMOL, V3, P11, DOI 10.1007/BF00136208	33	108	117	4	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1074	1078		10.1038/nm.3621	http://dx.doi.org/10.1038/nm.3621			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25150497				2022-12-25	WOS:000341404000022
J	Lawrence, RT; Villen, J				Lawrence, Robert T.; Villen, Judit			Drafts of the human proteome	NATURE BIOTECHNOLOGY			English	Editorial Material								Two studies catalog nearly all human proteins and their abundance throughout the body.	[Lawrence, Robert T.; Villen, Judit] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Lawrence, RT (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jvillen@u.washington.edu		Villen, Judit/0000-0002-1005-1739				Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	9	3	3	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					752	753		10.1038/nbt.2982	http://dx.doi.org/10.1038/nbt.2982			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101745				2022-12-25	WOS:000346455900039
J	Kawagishi, H; Finkel, T				Kawagishi, Hiroyuki; Finkel, Toren			ROS and disease: finding the right balance	NATURE MEDICINE			English	Editorial Material							OXIDATIVE STRESS; REACTIVE OXYGEN; AUTOPHAGY		[Kawagishi, Hiroyuki; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kawagishi, H (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov		Kawagishi, Hiroyuki/0000-0001-7622-341X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Guallar E, 2013, ANN INTERN MED, V159, P850, DOI 10.7326/0003-4819-159-12-201312170-00011; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011	16	100	108	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					711	713		10.1038/nm.3625	http://dx.doi.org/10.1038/nm.3625			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24999942				2022-12-25	WOS:000338689500012
J	Najafabadi, HS; Mnaimneh, S; Schmitges, FW; Garton, M; Lam, KN; Yang, A; Albu, M; Weirauch, MT; Radovani, E; Kim, PM; Greenblatt, J; Frey, BJ; Hughes, TR				Najafabadi, Hamed S.; Mnaimneh, Sanie; Schmitges, Frank W.; Garton, Michael; Lam, Kathy N.; Yang, Ally; Albu, Mihai; Weirauch, Matthew T.; Radovani, Ernest; Kim, Philip M.; Greenblatt, Jack; Frey, Brendan J.; Hughes, Timothy R.			C2H2 zinc finger proteins greatly expand the human regulatory lexicon	NATURE BIOTECHNOLOGY			English	Article							TRANSCRIPTION-FACTOR-BINDING; DNA-BINDING; MOLECULAR-DYNAMICS; SPECIFICITY; RECOGNITION; ELEMENTS; SYSTEM; MODEL; VISUALIZATION; SIMULATION	Cys2-His2 zinc finger (C2H2-ZF) proteins represent the largest class of putative human transcription factors. However, for most C2H2-ZF proteins it is unknown whether they even bind DNA or, if they do, to which sequences. Here, by combining data from a modified bacterial one-hybrid system with protein-binding microarray and chromatin immunoprecipitation analyses, we show that natural C2H2-ZFs encoded in the human genome bind DNA both in vitro and in vivo, and we infer the DNA recognition code using DNA-binding data for thousands of natural C2H2-ZF domains. In vivo binding data are generally consistent with our recognition code and indicate that C2H2-ZF proteins recognize more motifs than all other human transcription factors combined. We provide direct evidence that most KRAB-containing C2H2-ZF proteins bind specific endogenous retroelements (EREs), ranging from currently active to ancient families. The majority of C2H2-ZF proteins, including KRAB proteins, also show widespread binding to regulatory regions, indicating that the human genome contains an extensive and largely unstudied adaptive C2H2-ZF regulatory network that targets a diverse range of genes and pathways.	[Najafabadi, Hamed S.; Mnaimneh, Sanie; Schmitges, Frank W.; Garton, Michael; Yang, Ally; Albu, Mihai; Kim, Philip M.; Greenblatt, Jack; Frey, Brendan J.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Lam, Kathy N.; Radovani, Ernest; Kim, Philip M.; Greenblatt, Jack; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.; Frey, Brendan J.; Hughes, Timothy R.] Canadian Inst Adv Res, Toronto, ON, Canada; [Kim, Philip M.; Frey, Brendan J.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	t.hughes@utoronto.ca	Weirauch, Matthew/M-5459-2019	Najafabadi, Hamed/0000-0003-2735-4231; Lam, Kathy/0000-0003-1543-0161; Yang, Ally/0000-0002-8678-0946	Canadian Institutes of Health Research [MOP-77721, MOP-111007, MOP-272138]; Canadian Institutes for Advanced Research; Canadian Institutes of Health Research Banting Fellowship; European Molecular Biology Organization postdoctoral fellowship; Natural Science and Engineering Research Council CGS-M	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Advanced Research; Canadian Institutes of Health Research Banting Fellowship(Canadian Institutes of Health Research (CIHR)); European Molecular Biology Organization postdoctoral fellowship; Natural Science and Engineering Research Council CGS-M	We are grateful to S. Wolfe for providing B1H reagents and protocols, F. Aidoo, H. Zheng, H. Tang, P. Young, T. Kanagalingam, D. Torti and the Donnelly Sequencing Centre for technical support, and E. Chan, H. van Bakel and X. Chen for computational support and analyses. This work was supported by grants from the Canadian Institutes of Health Research (MOP-77721 and MOP-111007 to T.R.H., MOP-272138 to T.R.H., J.G. and Andrew Emili), and funding from the Canadian Institutes for Advanced Research to T.R.H., B.J.F. and M.T.W.H.S.N. was supported by a Canadian Institutes of Health Research Banting Fellowship, F.W.S. by a European Molecular Biology Organization postdoctoral fellowship, and K.N.L. by a Natural Science and Engineering Research Council CGS-M.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson KA, 2004, J IMMUNOL, V172, P381, DOI 10.4049/jimmunol.172.1.381; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gupta A, 2014, NUCLEIC ACIDS RES, V42, P4800, DOI 10.1093/nar/gku132; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; Klug Aaron, 2010, Annu Rev Biochem, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Umm-e-Kalsoom, 2013, J MED GENET, V50, P47, DOI 10.1136/jmedgenet-2012-101219; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	86	191	192	2	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					555	U181		10.1038/nbt.3128	http://dx.doi.org/10.1038/nbt.3128			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25690854				2022-12-25	WOS:000354314500040
J	Galvagnion, C; Buell, AK; Meisl, G; Michaels, TCT; Vendruscolo, M; Knowles, TPJ; Dobson, CM				Galvagnion, Celine; Buell, Alexander K.; Meisl, Georg; Michaels, Thomas C. T.; Vendruscolo, Michele; Knowles, Tuomas P. J.; Dobson, Christopher M.			Lipid vesicles trigger alpha-synuclein aggregation by stimulating primary nucleation	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE INTERACTIONS; POLYMERIZATION; KINETICS; BINDING; ASSOCIATION; EVOLUTION; PROTEINS; BEHAVIOR; REVEALS; DISEASE	alpha-Synuclein (alpha-syn) is a 140-residue intrinsically disordered protein that is involved in neuronal and synaptic vesicle plasticity, but its aggregation to form amyloid fibrils is the hallmark of Parkinson's disease (PD). The interaction between alpha-syn and lipid surfaces is believed to be a key feature for mediation of its normal function, but under other circumstances it is able to modulate amyloid fibril formation. Using a combination of experimental and theoretical approaches, we identify the mechanism through which facile aggregation of alpha-syn is induced under conditions where it binds a lipid bilayer, and we show that the rate of primary nucleation can be enhanced by three orders of magnitude or more under such conditions. These results reveal the key role that membrane interactions can have in triggering conversion of alpha-syn from its soluble state to the aggregated state that is associated with neurodegeneration and to its associated disease states.	[Galvagnion, Celine; Buell, Alexander K.; Meisl, Georg; Michaels, Thomas C. T.; Vendruscolo, Michele; Knowles, Tuomas P. J.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Galvagnion, C (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk	Galvagnion, Celine/K-7940-2018; Knowles, Tuomas/C-6663-2009; Vendruscolo, Michele/F-5901-2012; Buell, Alexander/B-4155-2013; Meisl, Georg/GLR-2659-2022	Galvagnion, Celine/0000-0001-9753-3310; Knowles, Tuomas/0000-0002-7879-0140; Vendruscolo, Michele/0000-0002-3616-1610; Buell, Alexander/0000-0003-1161-3622; Meisl, Georg/0000-0002-6562-7715; Michaels, Thomas/0000-0001-6931-5041	UK Biotechnology and Biochemical Sciences Research Council [BB/H003843/1]; Wellcome Trust [094425/Z/10/Z]; European Research Council [337969]; Frances and Augustus Newman Foundation; Magdalene College, Cambridge; St John's College, Cambridge; Cambridge Home and EU Scholarship Scheme; Elan Pharmaceuticals; Leverhulme Trust; Biotechnology and Biological Sciences Research Council [BB/J002119/1, BB/H003843/1] Funding Source: researchfish; BBSRC [BB/J002119/1, BB/H003843/1] Funding Source: UKRI	UK Biotechnology and Biochemical Sciences Research Council; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Frances and Augustus Newman Foundation; Magdalene College, Cambridge; St John's College, Cambridge; Cambridge Home and EU Scholarship Scheme; Elan Pharmaceuticals; Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We wish to thank M. Ouberai for her help with the preparation of SUVs and for valuable discussions along with C. Waudby and J. Christodoulou. This work was supported by the UK Biotechnology and Biochemical Sciences Research Council (BB/H003843/1 to C.M.D. and M.V.); the Wellcome Trust (094425/Z/10/Z to C.M.D., T.P.J.K. and M.V.); the European Research Council (337969, T.P.J.K.); the Frances and Augustus Newman Foundation (T.P.J.K.); Magdalene College, Cambridge (A.K.B.); St John's College, Cambridge (T.C.T.M.); the Cambridge Home and EU Scholarship Scheme (G.M.); Elan Pharmaceuticals (C.M.D., T.P.J.K., M.V., C.G. and A.K.B.) and the Leverhulme Trust (A.K.B.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bellucci A, 2012, BRAIN RES, V1476, P183, DOI 10.1016/j.brainres.2012.04.014; Bellucci A, 2012, BRAIN RES, V1432, P95, DOI 10.1016/j.brainres.2011.11.031; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Buell AK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228101; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Giehm L, 2011, METHODS, V53, P295, DOI 10.1016/j.ymeth.2010.12.008; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Gureviciene I, 2007, NEUROBIOL DIS, V28, P83, DOI 10.1016/j.nbd.2007.06.016; Hellstrand E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077235; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oosawa F., 1975, THERMODYNAMICS POLYM; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200; Zhu M., 2003, J BIOL CHEM, V278	57	374	375	2	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					229	U101		10.1038/NCHEMBIO.1750	http://dx.doi.org/10.1038/NCHEMBIO.1750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25643172	Green Accepted			2022-12-25	WOS:000349840500015
J	Goyenvalle, A; Griffith, G; Babbs, A; El Andaloussi, S; Ezzat, K; Avril, A; Dugovic, B; Chaussenot, R; Ferry, A; Voit, T; Amthor, H; Buhr, C; Schurch, S; Wood, MJA; Davies, KE; Vaillend, C; Leumann, C; Garcia, L				Goyenvalle, Aurelie; Griffith, Graziella; Babbs, Arran; El Andaloussi, Samir; Ezzat, Kariem; Avril, Aurelie; Dugovic, Branislav; Chaussenot, Remi; Ferry, Arnaud; Voit, Thomas; Amthor, Helge; Buehr, Claudia; Schuerch, Stefan; Wood, Matthew J. A.; Davies, Kay E.; Vaillend, Cyrille; Leumann, Christian; Garcia, Luis			Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers	NATURE MEDICINE			English	Article							MDX MOUSE; 2'-O-METHYL PHOSPHOROTHIOATE; DEFICIENT MICE; CARDIOMYOPATHY; OLIGONUCLEOTIDES; IMPAIRMENT; EXPRESSION; UTROPHIN; SKELETAL; GENE	Antisense oligonucleotides (AONs) hold promise for therapeutic correction of many genetic diseases via exon skipping, and the first AON-based drugs have entered clinical trials for neuromuscular disorders(1,2). However, despite advances in AON chemistry and design, systemic use of AONs is limited because of poor tissue uptake, and recent clinical reports confirm that sufficient therapeutic efficacy has not yet been achieved. Here we present a new class of AONs made of tricyclo-DNA (tcDNA), which displays unique pharmacological properties and unprecedented uptake by many tissues after systemic administration. We demonstrate these properties in two mouse models of Duchenne muscular dystrophy (DMD), a neurogenetic disease typically caused by frame-shifting deletions or nonsense mutations in the gene encoding dystrophin(3,4) and characterized by progressive muscle weakness, cardiomyopathy, respiratory failure(5) and neurocognitive impairment(6). Although current naked AONs do not enter the heart or cross the blood-brain barrier to any substantial extent, we show that systemic delivery of tcDNA-AONs promotes a high degree of rescue of dystrophin expression in skeletal muscles, the heart and, to a lesser extent, the brain. Our results demonstrate for the first time a physiological improvement of cardio-respiratory functions and a correction of behavioral features in DMD model mice. This makes tcDNA-AON chemistry particularly attractive as a potential future therapy for patients with DMD and other neuromuscular disorders or with other diseases that are eligible for exon-skipping approaches requiring whole-body treatment.	[Goyenvalle, Aurelie; Griffith, Graziella; Avril, Aurelie; Amthor, Helge; Garcia, Luis] Univ Versailles St Quentin, INSERM U1179, LIA BAHN CSM, Montigny Le Bretonneux, France; [Babbs, Arran; Davies, Kay E.] Univ Oxford, MRC Funct Genom Unit, Oxford, England; [El Andaloussi, Samir] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [El Andaloussi, Samir; Ezzat, Kariem; Wood, Matthew J. A.] Univ Oxford, Department Physiol Anat & Genet, Oxford, England; [Dugovic, Branislav] SYNTHENA AG, Bern, Switzerland; [Chaussenot, Remi; Vaillend, Cyrille] Univ Paris 11, Ctr Neurosci Paris Sud, UMR8195, Orsay, France; [Chaussenot, Remi; Vaillend, Cyrille] CNRS, Orsay, France; [Ferry, Arnaud; Voit, Thomas] Univ Paris 06, Inst Myol, INSERM U974, CNRS FRE 3217, Paris, France; [Buehr, Claudia; Schuerch, Stefan; Leumann, Christian] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Karolinska Institutet; University of Oxford; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Bern	Garcia, L (corresponding author), Univ Versailles St Quentin, INSERM U1179, LIA BAHN CSM, Montigny Le Bretonneux, France.	christian.leumann@dcb.unibe.ch; luis.garcia@uvsq.fr	Goyenvalle, Aurelie/G-3402-2016; Wood, Matthew/HDN-1469-2022; Vaillend, Cyrille/K-4626-2012; Schürch, Stefan/ABE-4977-2022; Leumann, Christian/AAB-5923-2019; Ezzat, Kariem/O-6593-2019; Ezzat, Kariem/D-1436-2015; Goyenvalle, Aurélie/GPF-7917-2022; ferry, arnaud/D-2816-2019	Vaillend, Cyrille/0000-0002-8783-8185; Schürch, Stefan/0000-0001-5109-4623; Leumann, Christian/0000-0002-7996-7083; Ezzat, Kariem/0000-0003-4186-0675; Goyenvalle, Aurélie/0000-0003-3938-1165; ferry, arnaud/0000-0002-6050-4556; Wood, Matthew/0000-0002-5436-6011	Agence Nationale de la Recherche (Chair of Excellence HandiMedEx); Association Monegasque Contre les Myopathies; Duchenne Parent Project France; aktion Benni Co.; UK Medical Research Council; MRC [G0900887] Funding Source: UKRI; Medical Research Council [G0900887] Funding Source: researchfish; Rosetrees Trust [M164-F1] Funding Source: researchfish	Agence Nationale de la Recherche (Chair of Excellence HandiMedEx)(French National Research Agency (ANR)); Association Monegasque Contre les Myopathies; Duchenne Parent Project France; aktion Benni Co.; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	We thank P.O. Buclez for technical assistance as well as D. Staunton and the Biophysical Instrumentation Facility at the University of Oxford for help with the SEC-MALS experiment. We also thank S. Vinit, A. Jacquet and N. Mougenot for assistance with the plethysmography and echocardiography experiments, and D. Mornet (INSERM, Montpellier) for the dystrophin-specific primary antibody 5G5. This work was supported by the Agence Nationale de la Recherche (Chair of Excellence HandiMedEx), the Association Monegasque Contre les Myopathies, the Duchenne Parent Project France, the aktion Benni & Co. and the UK Medical Research Council.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BRESOLIN N, 1994, NEUROMUSCULAR DISORD, V4, P359, DOI 10.1016/0960-8966(94)90072-8; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goyenvalle A, 2012, HUM MOL GENET, V21, P2559, DOI 10.1093/hmg/dds082; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Ittig D, 2011, NUCLEIC ACIDS RES, V39, P373, DOI 10.1093/nar/gkq733; Ivanova G, 2007, OLIGONUCLEOTIDES, V17, P54, DOI 10.1089/oli.2006.0046; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; Lu QL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.6; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Malerba A, 2009, HUM GENE THER, V20, P955, DOI 10.1089/hum.2008.157; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Perronnet C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Renneberg D, 2002, NUCLEIC ACIDS RES, V30, P2751, DOI 10.1093/nar/gkf412; Renneberg D, 2002, J AM CHEM SOC, V124, P5993, DOI 10.1021/ja025569+; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Townsend D, 2008, MOL THER, V16, P832, DOI 10.1038/mt.2008.52; Verhaart IEC, 2013, NUCLEIC ACID THER, V23, P228, DOI 10.1089/nat.2012.0398; Wu CCN, 2003, HUM GENE THER, V14, P849, DOI 10.1089/104303403765701141; Yamamoto K, 2010, NEUROMUSCULAR DISORD, V20, P505, DOI 10.1016/j.nmd.2010.05.006	33	204	214	4	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					270	+		10.1038/nm.3765	http://dx.doi.org/10.1038/nm.3765			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25642938				2022-12-25	WOS:000350362000020
J	Matano, M; Date, S; Shimokawa, M; Takano, A; Fujii, M; Ohta, Y; Watanabe, T; Kanai, T; Sato, T				Matano, Mami; Date, Shoichi; Shimokawa, Mariko; Takano, Ai; Fujii, Masayuki; Ohta, Yuki; Watanabe, Toshiaki; Kanai, Takanori; Sato, Toshiro			Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids	NATURE MEDICINE			English	Article							STEM-CELLS; HUMAN COLON; IN-VITRO; TUMORIGENESIS; MOUSE; EXPRESSION; EXPANSION; PATHWAY; GENES; NICHE	Human colorectal tumors bear recurrent mutations in genes encoding proteins operative in the WNT, MAPK, TGF-beta, TP53 and PI3K pathways(1,2). Although these pathways influence intestinal stem cell niche signaling(3-5), the extent to which mutations in these pathways contribute to human colorectal carcinogenesis remains unclear. Here we use the CRISPR-Cas9 genome-editing system(6,7) to introduce multiple such mutations into organoids derived from normal human intestinal epithelium. By modulating the culture conditions to mimic that of the intestinal niche, we selected isogenic organoids harboring mutations in the tumor suppressor genes APC, SMAD4 and TP53, and in the oncogenes KRAS and/or PIK3CA. Organoids engineered to express all five mutations grew independently of niche factors in vitro, and they formed tumors after implantation under the kidney subcapsule in mice. Although they formed micrometastases containing dormant tumor-initiating cells after injection into the spleen of mice, they failed to colonize in the liver. In contrast, engineered organoids derived from chromosome-instable human adenomas formed macrometastatic colonies. These results suggest that 'driver' pathway mutations enable stem cell maintenance in the hostile tumor microenvironment, but that additional molecular lesions are required for invasive behavior.	[Matano, Mami; Date, Shoichi; Shimokawa, Mariko; Takano, Ai; Fujii, Masayuki; Ohta, Yuki; Kanai, Takanori; Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan; [Date, Shoichi] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Shiga, Japan; [Fujii, Masayuki; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan	Keio University; Otsuka Pharmaceutical; University of Tokyo	Sato, T (corresponding author), Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan.	t.sato@a7.keio.jp	Sato, Toshiro/J-3522-2014	Sato, Toshiro/0000-0001-8353-8137; Kanai, Takanori/0000-0002-1466-4532	research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Grant of the Japanese Society of Gastroenterology; Grants-in-Aid for Scientific Research [25670570] Funding Source: KAKEN	research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grant of the Japanese Society of Gastroenterology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), by a Grant-in-Aid for Scientific Research on Innovative Areas 'Stem Cell Aging and Disease', and by Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology of Japan. T.S. received a Research Grant of the Japanese Society of Gastroenterology. T.S. would like to thank H. Clevers (Hubrecht Institute) for providing discussion and comments. We also thank M. Okumura for editorial assistance, Y. Tanada for animal care and the Collaborative Research Resources, School of Medicine, Keio University for technical assistance. The R-spondin-producing cell line was a kind gift from C. Kuo (Stanford University). F. Zhang (Massachusetts Institute of Technology) kindly provided the pX330 vector.	Baba I, 2000, CANCER RES, V60, P6886; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kreso A., 2008, CURR PROTOC STEM CEL, V7, P311; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	35	657	691	16	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					256	+		10.1038/nm.3802	http://dx.doi.org/10.1038/nm.3802			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25706875				2022-12-25	WOS:000350362000018
J	Kim, J; Li, WA; Choi, Y; Lewin, SA; Verbeke, CS; Dranoff, G; Mooney, DJ				Kim, Jaeyun; Li, Weiwei Aileen; Choi, Youngjin; Lewin, Sarah A.; Verbeke, Catia S.; Dranoff, Glenn; Mooney, David J.			Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy	NATURE BIOTECHNOLOGY			English	Article							MESOPOROUS SILICA NANOPARTICLES; DENDRITIC CELLS; NALP3 INFLAMMASOME; DRUG-DELIVERY; T-FH; ANTIGEN; RESPONSES; INNATE; BIOMATERIALS; DEGRADATION	Implanting materials in the body to program host immune cells is a promising alternative to transplantation of cells manipulated ex vivo to direct an immune response, but doing so requires a surgical procedure. Here we demonstrate that high-aspect-ratio, mesoporous silica rods (MSRs) injected with a needle spontaneously assemble in vivo to form macroporous structures that provide a 3D cellular microenvironment for host immune cells. In mice, substantial numbers of dendritic cells are recruited to the pores between the scaffold rods. The recruitment of dendritic cells and their subsequent homing to lymph nodes can be modulated by sustained release of inflammatory signals and adjuvants from the scaffold. Moreover, injection of an MSR-based vaccine formulation enhances systemic helper T cells T(H)1 and T(H)2 serum antibody and cytotoxic T-cell levels compared to bolus controls. These findings suggest that injectable MSRs may serve as a multifunctional vaccine platform to modulate host immune cell function and provoke adaptive immune responses.	[Kim, Jaeyun; Li, Weiwei Aileen; Verbeke, Catia S.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kim, Jaeyun; Li, Weiwei Aileen; Lewin, Sarah A.; Verbeke, Catia S.; Mooney, David J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Kim, Jaeyun; Choi, Youngjin] Sungkyunkwan Univ, Sch Chem Engn, Suwon, South Korea; [Dranoff, Glenn] Dana Farber Canc Inst, Boston, MA 02115 USA; [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard University; Sungkyunkwan University (SKKU); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu	Kim, Jaeyun/E-2915-2015	Kim, Jaeyun/0000-0002-4687-6732; Li, Aileen/0000-0002-1056-5932; Mooney, David/0000-0001-6299-1194	National Institutes of Health (NIH) [1R01EB015498]; National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Research Foundation (NRF) - National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea [2012R1A1A1042735, 2010-0027955]; NIH [UL1 TR001102]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015498] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Research Foundation (NRF) - National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (NIH) (1R01EB015498), the National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP), the Wyss Institute for Biologically Inspired Engineering at Harvard University, and National Research Foundation (NRF) grants (2012R1A1A1042735, 2010-0027955) funded by the National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea. We also thank Dana-Farber/Harvard Cancer Center (DF/HCC) Research Pathology Core and R. Bronson for the examination of the histology slides and J. Weaver from the Wyss Institute of Biologically Inspired Engineering for his help with scanning electron microscopy (SEM). Lastly, we thank R. Betensky from the Department of Biostatistics, Harvard School of Public Health and the Harvard Catalyst for her help with statistical analysis; Harvard Catalyst is supported, in part, by the NIH (UL1 TR001102).	Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Cauda V, 2010, MICROPOR MESOPOR MAT, V132, P60, DOI 10.1016/j.micromeso.2009.11.015; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Faulkner L, 2000, IMMUNOLOGY, V99, P523, DOI 10.1046/j.1365-2567.2000.00018.x; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Garcia-Bennett AE, 2011, NANOMEDICINE-UK, V6, P867, DOI [10.2217/NNM.11.82, 10.2217/nnm.11.82]; He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007; Jahnisch H, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/517493; John ALS, 2012, NAT MATER, V11, P250, DOI [10.1038/NMAT3222, 10.1038/nmat3222]; Kim J, 2008, ANGEW CHEM INT EDIT, V47, P8438, DOI 10.1002/anie.200802469; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lu AH, 2004, CHEM-EUR J, V10, P6085, DOI 10.1002/chem.200400180; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]; Petushkov A, 2010, ADV MOLEC TOXICOL, V4, P223, DOI 10.1016/S1872-0854(10)04007-5; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Russell B., 2010, Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration, Patent No. [EP 2170419 A1, 2170419]; Schmidt-Winkel P, 1999, ADV MATER, V11, P303, DOI 10.1002/(SICI)1521-4095(199903)11:4<303::AID-ADMA303>3.3.CO;2-D; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w; Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107; Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang XQ, 2007, J IMMUNOTHER, V30, P469, DOI 10.1097/CJI.0b013e31802fd8c6; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	326	338	13	326	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					64	U241		10.1038/nbt.3071	http://dx.doi.org/10.1038/nbt.3071			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25485616	Green Accepted, Green Submitted			2022-12-25	WOS:000347714200029
J	Schenck, CA; Chen, SY; Siehl, DL; Maeda, HA				Schenck, Craig A.; Chen, Siyu; Siehl, Daniel L.; Maeda, Hiroshi A.			Non-plastidic, tyrosine-insensitive prephenate dehydrogenases from legumes	NATURE CHEMICAL BIOLOGY			English	Article							SUSPENSION-CULTURED CELLS; AROMATIC-AMINO-ACIDS; AROGENATE DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; PHENYLALANINE BIOSYNTHESIS; ALKALOID BIOSYNTHESIS; FEEDBACK INHIBITION; SHIKIMATE PATHWAY; ESCHERICHIA-COLI	L-Tyrosine (Tyr) and its plant-derived natural products are essential in both plants and humans. In plants, Tyr is generally assumed to be synthesized in the plastids via arogenate dehydrogenase (TyrA(a), also known also ADH), which is strictly inhibited by L-Tyr. Using phylogenetic and expression analyses, together with recombinant enzyme and endogenous activity assays, we identified prephenate dehydrogenases (TyrA(p)s, also known as PDHs) from two legumes, Glycine max (soybean) and Medicago truncatula. The identified PDHs were phylogenetically distinct from canonical plant ADH enzymes, preferred prephenate to arogenate substrate, localized outside of the plastids and were not inhibited by L-Tyr. The results provide molecular evidence for the diversification of primary metabolic Tyr pathway via an alternative cytosolic PDH pathway in plants.	[Schenck, Craig A.; Chen, Siyu; Maeda, Hiroshi A.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Siehl, Daniel L.] DuPont Pioneer, Hayward, CA USA	University of Wisconsin System; University of Wisconsin Madison	Maeda, HA (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	maeda2@wisc.edu		Schenck, Craig/0000-0002-5711-7213; Maeda, Hiroshi/0000-0003-0246-694X	US National Science Foundation [IOS-1354971]; Fritz Went Undergraduate Fellowship; Graduate School, the College of Letters Science; Department of Botany, University of Wisconsin-Madison; Division Of Integrative Organismal Systems [1354971] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Fritz Went Undergraduate Fellowship; Graduate School, the College of Letters Science; Department of Botany, University of Wisconsin-Madison; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Singhal (University of Wisconsin) for help with protoplast isolation; S. Swanson, A. Chanoca and R. Buono (University of Wisconsin) for assistance with confocal imaging and analysis; C. Grau (University of Wisconsin) for soybean Williams82 seeds; J.-M. Ane (University of Wisconsin) for M. truncatula tissues and seeds; and F.R. Marquez (Universidad Andres Bello) for the 35S-pPZP211 vector. The confocal imaging was performed at the Newcomb Imaging Center, Department of Botany, University of Wisconsin-Madison. This work was supported by grant IOS-1354971 from the US National Science Foundation to H.A.M., the Fritz Went Undergraduate Fellowship to S.C. and the start-up funds from the Graduate School, the College of Letters & Science, and the Department of Botany, University of Wisconsin-Madison to H.A.M.	BICKEL H, 1978, PHYTOCHEMISTRY, V17, P119, DOI 10.1016/S0031-9422(00)89691-0; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Bonvin J, 2006, PROTEIN SCI, V15, P1417, DOI 10.1110/ps.051942206; Bramley PM, 2000, J SCI FOOD AGR, V80, P913, DOI [10.1002/(SICI)1097-0010(20000515)80:7<913::AID-JSFA600>3.0.CO;2-3, 10.1002/(SICI)1097-0010(20000515)80:7&lt;913::AID-JSFA600&gt;3.0.CO;2-3]; BYNG G, 1981, PHYTOCHEMISTRY, V20, P1289, DOI 10.1016/0031-9422(81)80023-4; Chiu HJ, 2010, ACTA CRYSTALLOGR F, V66, P1317, DOI 10.1107/S1744309110021688; Christendat D, 1998, BIOCHEMISTRY-US, V37, P15703, DOI 10.1021/bi981412b; Colquhoun TA, 2010, PLANT J, V61, P145, DOI 10.1111/j.1365-313X.2009.04042.x; CONNELLY JA, 1986, Z NATURFORSCH C, V41, P69; Corea ORA, 2012, PHYTOCHEMISTRY, V82, P22, DOI 10.1016/j.phytochem.2012.05.026; Dal Cin V, 2011, PLANT CELL, V23, P2738, DOI 10.1105/tpc.111.086975; DAMATO TA, 1984, PLANTA, V162, P104, DOI 10.1007/BF00410205; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FISCHER R, 1987, METHOD ENZYMOL, V142, P503; GAINES CG, 1982, PLANTA, V156, P233, DOI 10.1007/BF00393730; GILCHRIST DG, 1987, METHOD ENZYMOL, V142, P450; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HIGUCHI T, 1967, PHYTOCHEMISTRY, V6, P875, DOI 10.1016/S0031-9422(00)86035-5; HUDSON GS, 1984, BIOCHEMISTRY-US, V23, P6240, DOI 10.1021/bi00320a054; KANG F, 1994, PLANT J, V6, P795, DOI 10.1046/j.1365-313X.1994.6060795.x; Karunanandaa B, 2005, METAB ENG, V7, P384, DOI 10.1016/j.ymben.2005.05.005; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Legrand P, 2006, STRUCTURE, V14, P767, DOI 10.1016/j.str.2006.01.006; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maeda H, 2011, NAT CHEM BIOL, V7, P19, DOI [10.1038/nchembio.485, 10.1038/NCHEMBIO.485]; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; MILLNER PA, 1984, FEBS LETT, V169, P1, DOI 10.1016/0014-5793(84)80277-X; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Prabhakar V, 2010, PLANT CELL, V22, P2594, DOI 10.1105/tpc.109.073171; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; Rippert P, 2004, PLANT PHYSIOL, V134, P92, DOI 10.1104/pp.103.032441; Rippert P, 2002, PLANT MOL BIOL, V48, P361, DOI 10.1023/A:1014018926676; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; Rosler J, 1997, PLANT PHYSIOL, V113, P175, DOI 10.1104/pp.113.1.175; RUBIN JL, 1979, PLANT PHYSIOL, V64, P727, DOI 10.1104/pp.64.5.727; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHULLER KA, 1990, PLANT PHYSIOL, V93, P1303, DOI 10.1104/pp.93.4.1303; SECOR J, 1994, PLANT PHYSIOL, V106, P1429, DOI 10.1104/pp.106.4.1429; Siehl DL, 1999, BOOK SOIL P, P171; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; Sun W, 2009, J BIOL CHEM, V284, P13223, DOI 10.1074/jbc.M806272200; TURNBULL J, 1991, BIOCHEMISTRY-US, V30, P7783, DOI 10.1021/bi00245a017; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Westfall CS, 2014, J BIOL CHEM, V289, P28619, DOI 10.1074/jbc.M114.591123; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; XIA TH, 1990, J BIOL CHEM, V265, P20033; Xu SF, 2006, PROTEIN EXPRES PURIF, V49, P151, DOI 10.1016/j.pep.2006.05.020; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang CY, 2013, PLANT J, V73, P628, DOI 10.1111/tpj.12067	60	41	42	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					52	+		10.1038/nchembio.1693	http://dx.doi.org/10.1038/nchembio.1693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402771				2022-12-25	WOS:000346448600012
J	Scott, CT; DeFrancesco, L				Scott, Christopher Thomas; DeFrancesco, Laura			Selling long life	NATURE BIOTECHNOLOGY			English	Article							SEARCH											Britt R.R., 2005, INFUSION YOUNG BLOOD; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Garber K, 2008, NAT BIOTECHNOL, V26, P371, DOI 10.1038/nbt0408-371; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168; Steakley L., 2014, EXPT TREATS EACH PER; Stipp D, 2010, YOUTH PILL SCI BRINK	10	14	14	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					31	40		10.1038/nbt.3108	http://dx.doi.org/10.1038/nbt.3108			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574633				2022-12-25	WOS:000347714200021
J	Core, LJ; Martins, AL; Danko, CG; Waters, CT; Siepel, A; Lis, JT				Core, Leighton J.; Martins, Andre L.; Danko, Charles G.; Waters, Colin T.; Siepel, Adam; Lis, John T.			Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers	NATURE GENETICS			English	Article							DIVERGENT TRANSCRIPTION; U1 SNRNP; ACTIVE ENHANCERS; MESSENGER-RNAS; GLOBIN GENE; POLYMERASE; CHROMATIN; RECRUITMENT; EXPRESSION; DISTINCT	Despite the conventional distinction between them, promoters and enhancers share many features in mammals, including divergent transcription and similar modes of transcription factor binding. Here we examine the architecture of transcription initiation through comprehensive mapping of transcription start sites (TSSs) in human lymphoblastoid B cell (GM12878) and chronic myelogenous leukemic (K562) ENCODE Tier 1 cell lines. Using a nuclear run-on protocol called GRO-cap, which captures TSSs for both stable and unstable transcripts, we conduct detailed comparisons of thousands of promoters and enhancers in human cells. These analyses identify a common architecture of initiation, including tightly spaced (110 bp apart) divergent initiation, similar frequencies of core promoter sequence elements, highly positioned flanking nucleosomes and two modes of transcription factor binding. Post-initiation transcript stability provides a more fundamental distinction between promoters and enhancers than patterns of histone modification and association of transcription factors or co-activators. These results support a unified model of transcription initiation at promoters and enhancers.	[Core, Leighton J.; Waters, Colin T.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Martins, Andre L.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	acs4@cornell.edu; jtl10@cornell.edu		Siepel, Adam/0000-0002-3557-7219; Waters, Colin/0000-0002-3096-0833	NIGMS (National Institute of General Medical Sciences); US National Institutes of Health [GM25232, HG0070707]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by NIGMS (National Institute of General Medical Sciences) and NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award numbers GM25232 to J.T.L. and HG0070707 to A.S. and J.T.L., respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R., 2014, BIORXIV         0829, DOI [10.1101/005447, DOI 10.1101/005447]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; MARUYAMA K, 1994, GENE, V138, P171; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Venters BJ, 2014, NATURE, V513, P444, DOI 10.1038/nature13588; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	55	371	376	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1311	1320		10.1038/ng.3142	http://dx.doi.org/10.1038/ng.3142			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383968	Green Accepted			2022-12-25	WOS:000345547300012
J	van Berlo, JH; Molkentin, JD				van Berlo, Jop H.; Molkentin, Jeffery D.			An emerging consensus on cardiac regeneration	NATURE MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOMYOCYTE DNA-SYNTHESIS; HEMATOPOIETIC STEM-CELLS; SIDE POPULATION CELLS; PROGENITOR CELLS; HEART REGENERATION; HUMAN FIBROBLASTS; ADULT HEART; IN-VITRO; MYOCYTES	Cardiac regeneration is a rapidly evolving and controversial field of research. The identification some 12 years ago of progenitor cells that reside within the heart spurred enthusiasm for cell-based regenerative therapies. However, recent evidence has called into question both the presence of a biologically important stem cell population in the heart and the ability of exogenously derived cells to promote regeneration through direct formation of new cardiomyocytes. Here, we discuss recent developments that suggest an emerging consensus on the ability of different cell types to regenerate the adult mammalian heart.	[van Berlo, Jop H.] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	University of Minnesota System; University of Minnesota Twin Cities; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	van Berlo, JH (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	jvanberl@umn.edu; jeff.molkentin@cchmc.org		van Berlo, Jop/0000-0001-9229-4429; Molkentin, Jeffery/0000-0002-3558-6529	US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL112852] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the US National Institutes of Health (to J.H.v.B and J.D.M.). J.D.M. is an investigator of the Howard Hughes Medical Institute.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Ali SR, 2014, P NATL ACAD SCI USA, V111, P8850, DOI 10.1073/pnas.1408233111; Anderson ME, 2014, CIRC RES, V115, P335, DOI 10.1161/CIRCRESAHA.114.304616; Ang KL, 2010, AM J PHYSIOL-CELL PH, V298, pC1603, DOI 10.1152/ajpcell.00435.2009; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Assmus B, 2014, EUR HEART J, V35, P1275, DOI 10.1093/eurheartj/ehu062; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bollini S, 2014, STEM CELLS DEV, V23, P1719, DOI 10.1089/scd.2014.0019; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Fioret BA, 2014, CELL REP, V8, P229, DOI 10.1016/j.celrep.2014.06.004; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Heger K, 2014, EUR J IMMUNOL, V44, P296, DOI 10.1002/eji.201343731; Herget GW, 1997, CARDIOVASC RES, V36, P45, DOI 10.1016/S0008-6363(97)00140-5; Hesse M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2089; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muraoka N, 2014, ANNU REV PHYSIOL, V76, P21, DOI 10.1146/annurev-physiol-021113-170301; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Noseda M, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu098.25; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rumyantsev PP., 1991, GROWTH HYPERPLASIA C; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Senyo SE, 2014, STEM CELL RES, V13, P532, DOI 10.1016/j.scr.2014.09.003; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Simari RD, 2014, CIRC RES, V114, P1564, DOI 10.1161/CIRCRESAHA.114.303720; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, J MOL CELL CARDIOL, V52, P43, DOI 10.1016/j.yjmcc.2011.08.020; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	99	185	192	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1386	1393		10.1038/nm.3764	http://dx.doi.org/10.1038/nm.3764			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25473919	Green Accepted			2022-12-25	WOS:000345817900012
J	Bikard, D; Euler, CW; Jiang, WY; Nussenzweig, PM; Goldberg, GW; Duportet, X; Fischetti, VA; Marraffini, LA				Bikard, David; Euler, Chad W.; Jiang, Wenyan; Nussenzweig, Philip M.; Goldberg, Gregory W.; Duportet, Xavier; Fischetti, Vincent A.; Marraffini, Luciano A.			Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials	NATURE BIOTECHNOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS; GENOME SEQUENCE; RNA; GENE; EXPRESSION; ENCODES	Antibiotics target conserved bacterial cellular pathways or growth functions and therefore cannot selectively kill specific members of a complex microbial population. Here, we develop programmable, sequence-specific antimicrobials using the RNA-guided nuclease Cas9 (refs.1,2) delivered by a bacteriophage. We show that Cas9, reprogrammed to target virulence genes, kills virulent, but not avirulent, Staphylococcus aureus. Reprogramming the nuclease to target antibiotic resistance genes destroys staphylococcal plasmids that harbor antibiotic resistance genes(3,4) and immunizes avirulent staphylococci to prevent the spread of plasmid-borne resistance genes. We also show that CRISPR-Cas9 antimicrobials function in vivo to kill S. aureus in a mouse skin colonization model. This technology creates opportunities to manipulate complex bacterial populations in a sequence-specific manner.	[Bikard, David; Jiang, Wenyan; Nussenzweig, Philip M.; Goldberg, Gregory W.; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10021 USA; [Euler, Chad W.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Duportet, Xavier] INRIA Paris Rocquencourt, Rocquencourt, France; [Duportet, Xavier] MIT, Synthet Biol Ctr, Dept Biol Engn, Cambridge, MA 02139 USA	Rockefeller University; Rockefeller University; Massachusetts Institute of Technology (MIT)	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10021 USA.	david.bikard@pasteur.fr; marraffini@rockefeller.edu	Bikard, David/L-2971-2015; Bikard, David/AAZ-3752-2021	Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211; Goldberg, Gregory/0000-0002-5022-9976	Bettencourt Schuller Foundation; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award [1DP2AI104556-01]; NIH Grant [AI057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556, T32AI070084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Bettencourt Schuller Foundation; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Raz for providing plasmid pCN57 and D. Mucida for assistance with flow cytometry experiments. D.B. is supported by the Bettencourt Schuller Foundation. L.A.M. is supported by the Searle Scholars Program, the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01). VAR is supported by NIH Grant AI057472.	Agarwal R, 2013, THER DELIV, V4, P705, DOI [10.4155/TDE.13.37, 10.4155/tde.13.37]; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Isnard C, 2013, ANTIMICROB AGENTS CH, V57, P4463, DOI 10.1128/AAC.01030-13; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MELNIKOV AA, 1984, GENE, V28, P29, DOI 10.1016/0378-1119(84)90084-2; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; UBUKATA K, 1989, J BACTERIOL, V171, P2882, DOI 10.1128/jb.171.5.2882-2885.1989; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956	26	463	519	12	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1146	1150		10.1038/nbt.3043	http://dx.doi.org/10.1038/nbt.3043			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25282355	Green Accepted			2022-12-25	WOS:000344977000020
J	Sargeant, TJ; Lloyd-Lewis, B; Resemann, HK; Ramos-Montoya, A; Skepper, J; Watson, CJ				Sargeant, Timothy J.; Lloyd-Lewis, Bethan; Resemann, Henrike K.; Ramos-Montoya, Antonio; Skepper, Jeremy; Watson, Christine J.			Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization	NATURE CELL BIOLOGY			English	Article							ACUTE-PHASE RESPONSE; CATHEPSIN-D; APOPTOSIS; AUTOPHAGY; DELETION; EPITHELIUM; VACUOLIZATION; DEGRADATION; EXPRESSION; SECRETION	We have previously demonstrated that Stat3 regulates lysosomal-mediated programmed cell death (LM-PCD) during mouse mammary gland involution in vivo. However, the mechanism that controls the release of lysosomal cathepsins to initiate cell death in this context has not been elucidated. We show here that Stat3 regulates the formation of large lysosomal vacuoles that contain triglyceride. Furthermore, we demonstrate that milk fat globules (MFGs) are toxic to epithelial cells and that, when applied to purified lysosomes, the MFG hydrolysate oleic acid potently induces lysosomal leakiness. Additionally, uptake of secreted MFGs coated in butyrophilin 1A1 is diminished in Stat3-ablated mammary glands and loss of the phagocytosis bridging molecule MFG-E8 results in reduced leakage of cathepsins in vivo. We propose that Stat3 regulates LM-PCD in mouse mammary gland by switching cellular function from secretion to uptake of MFGs. Thereafter, perturbation of lysosomal vesicle membranes by high levels of free fatty acids results in controlled leakage of cathepsins culminating in cell death.	[Sargeant, Timothy J.; Lloyd-Lewis, Bethan; Resemann, Henrike K.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Ramos-Montoya, Antonio] Univ Cambridge, Li Ka Shing Ctr, CRUK Cambridge Inst, Urooncol Res Grp, Cambridge CB2 0RE, England; [Skepper, Jeremy] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QP, England	University of Cambridge; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	cjw53@cam.ac.uk	; Sargeant, Timothy/K-8144-2018	Lloyd-Lewis, Bethan/0000-0001-6511-1818; Sargeant, Timothy/0000-0003-1254-4390	Medical Research Council programme [MR/J001023/1]; Cancer Research UK Cambridge Cancer Centre PhD studentship; Medical Research Council [MR/J001023/1] Funding Source: researchfish; MRC [MR/J001023/1] Funding Source: UKRI	Medical Research Council programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Cambridge Cancer Centre PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Skelton for assistance with histology, A. Gilmore (University of Manchester, UK) for the Bax-GFP construct, I. Mather (University of Maryland, USA) for the anti-BTN antibody and useful advice, and D. Neal, S. Felisbino and S. Hawkins (CRUK Cambridge Institute, University of Cambridge, UK) for providing mouse prostate tissue and advice. We thank also T. Reinheckel for providing the cathepsin L KO mice. In addition, we thank A. Tolkovsky and Z. Zakeri for helpful discussions. This work was supported by a grant from the Medical Research Council programme grant no. MR/J001023/1 (T.J.S. and B.L-L.) and a Cancer Research UK Cambridge Cancer Centre PhD studentship (H.K.R.).	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; [Anonymous], TE; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Becken U, 2010, P NATL ACAD SCI USA, V107, P20726, DOI 10.1073/pnas.1007295107; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; CORNILLON S, 1994, J CELL SCI, V107, P2691; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; Galluzzi L, 2014, NAT CELL BIOL, V16, P728, DOI 10.1038/ncb3005; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; HELMINEN HJ, 1971, EXP CELL RES, V68, P411, DOI 10.1016/0014-4827(71)90167-4; Huai JS, 2013, J CELL SCI, V126, P4015, DOI 10.1242/jcs.129999; Hughes K, 2012, J PATHOL, V227, P106, DOI 10.1002/path.3961; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Jahreiss L, 2009, AUTOPHAGY, V5, P835, DOI 10.4161/auto.9120; Jeong J, 2013, TRAFFIC, V14, P974, DOI 10.1111/tra.12087; Jespersen H, 2012, BIOCHIMIE, V94, P2, DOI 10.1016/j.biochi.2011.07.029; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; KERR JFR, 1973, VIRCHOWS ARCH B, V13, P87; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; LOCKSHIN RICHARD A., 1965, J INSECT PHYSIOL, V11, P831, DOI 10.1016/0022-1910(65)90186-1; Luke CJ, 2011, NAT CELL BIOL, V13, P197, DOI 10.1038/ncb0311-197; Lund LR, 1996, DEVELOPMENT, V122, P181; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Manzoni C, 2013, FASEB J, V27, P3424, DOI 10.1096/fj.12-223842; Margaryan NV, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12534; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Merkel M, 1999, METH MOL B, V109, P95; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; SMITH S, 1968, J LIPID RES, V9, P52; Unger RH, 2013, MOL BIOL CELL, V24, P3011, DOI 10.1091/mbc.E12-10-0774; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zaragoza R, 2009, BIOCHEM J, V419, P279, DOI 10.1042/BJ20081746	61	98	99	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1057	+		10.1038/ncb3043	http://dx.doi.org/10.1038/ncb3043			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25283994	Green Accepted			2022-12-25	WOS:000344744000005
J	Gao, YB; Chen, ZL; Li, JG; Hu, XD; Shi, XJ; Sun, ZM; Zhang, F; Zhao, ZR; Li, ZT; Liu, ZY; Zhao, YD; Sun, J; Zhou, CC; Yao, R; Wang, SY; Wang, P; Sun, N; Zhang, BH; Dong, JS; Yu, Y; Luo, M; Feng, XL; Shi, SS; Zhou, F; Tan, FW; Qiu, B; Li, N; Shao, K; Zhang, LJ; Zhang, LJ; Xue, Q; Gao, SG; He, J				Gao, Yi-Bo; Chen, Zhao-Li; Li, Jia-Gen; Hu, Xue-Da; Shi, Xue-Jiao; Sun, Zeng-Miao; Zhang, Fan; Zhao, Zi-Ran; Li, Zi-Tong; Liu, Zi-Yuan; Zhao, Yu-Da; Sun, Jian; Zhou, Cheng-Cheng; Yao, Ran; Wang, Su-Ya; Wang, Pan; Sun, Nan; Zhang, Bai-Hua; Dong, Jing-Si; Yu, Yue; Luo, Mei; Feng, Xiao-Li; Shi, Su-Sheng; Zhou, Fang; Tan, Feng-Wei; Qiu, Bin; Li, Ning; Shao, Kang; Zhang, Li-Jian; Zhang, Lan-Jun; Xue, Qi; Gao, Shu-Geng; He, Jie			Genetic landscape of esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECURRENT SOMATIC MUTATIONS; SUSCEPTIBILITY LOCI; CANCER GENOME; LUNG-CANCER; GASTRIC ADENOCARCINOMA; FREQUENT MUTATION; LIM PROTEIN; EXOME; FAMILY	Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers'. We performed exome sequencing on 113 tumor-normal pairs, yielding a mean of 82 non-silent mutations per tumor, and 8 cell lines. The mutational profile of ESCC closely resembles those of squamous cell carcinomas of other tissues but differs from that of esophageal adenocarcinoma. Genes involved in cell cycle and apoptosis regulation were mutated in 99% of cases by somatic alterations of TP53 (93%), CCND1 (33%), CDKN2A (20%), NFE2L2 (10%) and RB1 (9%). Histone modifier genes were frequently mutated, including KMT2D (also called MLL2; 19%), KMT2C (MLL3; 6%), KDM6A (7%), EP300 (10%) and CREBBP (6%). EP300 mutations were associated with poor survival. The Hippo and Notch pathways were dysregulated by mutations in FAT1, FAT2, FAT3 or FAT4 (27%) or AJUBA (1UB; 7%) and NOTCH1, NOTCH2 or NOTCH3 (22%) or FBXW7 (5%), respectively. These results define the mutational landscape of ESCC and highlight mutations in epigenetic modulators with prognostic and potentially therapeutic implications.	[Gao, Yi-Bo; Chen, Zhao-Li; Li, Jia-Gen; Hu, Xue-Da; Shi, Xue-Jiao; Sun, Zeng-Miao; Zhang, Fan; Liu, Zi-Yuan; Zhao, Yu-Da; Sun, Jian; Zhou, Cheng-Cheng; Yao, Ran; Wang, Su-Ya; Sun, Nan; Zhang, Bai-Hua; Dong, Jing-Si; Yu, Yue; Luo, Mei; Zhou, Fang; Tan, Feng-Wei; Qiu, Bin; Li, Ning; Shao, Kang; Xue, Qi; Gao, Shu-Geng; He, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [Zhao, Zi-Ran; Li, Zi-Tong; Wang, Pan] Peking Union Med Coll, Dept Clin Med, Beijing 100021, Peoples R China; [Zhao, Zi-Ran; Li, Zi-Tong; Wang, Pan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Feng, Xiao-Li; Shi, Su-Sheng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhang, Li-Jian] Peking Univ, Canc Hosp, Dept Thorac Surg, Beijing 100871, Peoples R China; [Zhang, Lan-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking University; Sun Yat Sen University	He, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China.	prof.hejie@263.net	Gao, Yi-Bo/AAP-4866-2020	Gao, Yi-Bo/0000-0002-0501-9814	National High-Tech Research and Development Program of China [2012AA02A503]; National Natural Science Foundation of China [81172336, 81372219, 81301851, U1302223]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT13006]; Beijing Municipal Natural Science Foundation [7141011]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	We thank M.-H. Xiong and all the staff and assistants in the Lab and Tumor Bank of the Department of Thoracic Surgery for their support in collecting and processing samples. This work was supported by the National High-Tech Research and Development Program of China (2012AA02A503), the National Natural Science Foundation of China (81172336, 81372219, 81301851 and U1302223), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT13006) and the Beijing Municipal Natural Science Foundation (7141011).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hu N, 2002, CLIN CANCER RES, V8, P1121; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li Y, 2011, ANN THORAC SURG, V91, P1531, DOI 10.1016/j.athoracsur.2010.12.012; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; STONER GD, 1991, CANCER RES, V51, P365; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042281; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055834; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	79	456	478	6	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1097	1102		10.1038/ng.3076	http://dx.doi.org/10.1038/ng.3076			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151357				2022-12-25	WOS:000342554100012
J	Tsai, SDQ; Iafrate, AJ; Joung, JK				Tsai, Shengdar Q.; Iafrate, A. John; Joung, J. Keith			Towards a functional understanding of variants for molecular diagnostics using genome editing	NATURE MEDICINE			English	Editorial Material							GENERATION; NUCLEASES		[Tsai, Shengdar Q.; Iafrate, A. John; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tsai, SDQ (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012	Tsai, Shengdar Q./0000-0001-9161-3993				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Dienstmann R, 2014, MOL ONCOL, V8, P859, DOI 10.1016/j.molonc.2014.03.021; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Tang Q, 2014, NAT METHODS, V11, P821, DOI [10.1038/NMETH.3031, 10.1038/nmeth.3031]; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xue W., 2014, NATURE          0806, DOI [10.1038/nature13589, DOI 10.1038/NATURE13589]	13	10	11	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1103	1104		10.1038/nm.3722	http://dx.doi.org/10.1038/nm.3722			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25295940				2022-12-25	WOS:000343194100015
J	Lane, JR; Donthamsetti, P; Shonberg, J; Draper-Joyce, CJ; Dentry, S; Michino, M; Shi, L; Lopez, L; Scammells, PJ; Capuano, B; Sexton, PM; Javitch, JA; Christopoulos, A				Lane, J. Robert; Donthamsetti, Prashant; Shonberg, Jeremy; Draper-Joyce, Christopher J.; Dentry, Samuel; Michino, Mayako; Shi, Lei; Lopez, Laura; Scammells, Peter J.; Capuano, Ben; Sexton, Patrick M.; Javitch, Jonathan A.; Christopoulos, Arthur			A new mechanism of allostery in a G protein-coupled receptor dimer	NATURE CHEMICAL BIOLOGY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; DOPAMINE D3 RECEPTOR; DRUG DISCOVERY; FUNCTIONAL SELECTIVITY; LIGAND-BINDING; PHARMACOLOGY; ANTAGONIST; MODULATION; ACTIVATION; D-3	SB269652 is to our knowledge the first drug-like allosteric modulator of the dopamine D-2 receptor (D2R), but it contains structural features associated with orthosteric D2R antagonists. Using a functional complementation system to control the identity of individual protomers within a dimeric D2R complex, we converted the pharmacology of the interaction between SB269652 and dopamine from allosteric to competitive by impairing ligand binding to one of the protomers, indicating that the allostery requires D2R dimers. Additional experiments identified a 'bitopic' pose for SB269652 extending from the orthosteric site into a secondary pocket at the extracellular end of the transmembrane (TM) domain, involving TM2 and TM7. Engagement of this secondary pocket was a requirement for the allosteric pharmacology of SB269652. This suggests a new mechanism whereby a bitopic ligand binds in an extended pose on one G protein-coupled receptor protomer to allosterically modulate the binding of a ligand to the orthosteric site of a second protomer.	[Lane, J. Robert; Draper-Joyce, Christopher J.; Dentry, Samuel; Lopez, Laura; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic, Australia; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Donthamsetti, Prashant; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Shonberg, Jeremy; Scammells, Peter J.; Capuano, Ben] Monash Univ, Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic, Australia; [Michino, Mayako; Shi, Lei] Cornell Univ, Weill Med Coll, US Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA	Monash University; Columbia University; Columbia University; New York State Psychiatry Institute; Monash University; Cornell University; Cornell University	Lane, JR (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic, Australia.	rob.lane@monash.edu; arthur.christopoulos@monash.edu	Capuano, Ben/AAC-2541-2019; Shi, Lei/AAV-1321-2020; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Shi, Lei/0000-0002-4137-096X; Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Draper-Joyce, Christopher/0000-0003-2055-7706; Scammells, Peter/0000-0003-2930-895X; Javitch, Jonathan/0000-0001-7395-2967; Lane, J. Robert/0000-0002-7361-7875; Shonberg, Jeremy/0000-0003-2178-6412	NHMRC Program [APP1055134, APP1011920, APP1049564]; Australian Research Council Discovery Grant [DP110100687]; Netherlands Organization for Scientific Research (NWO VENT) [863.09.018]; US National Institutes of Health [DA022413, MH54137, DA023694]; Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023694, K05DA022413, K99DA023694] Funding Source: NIH RePORTER	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Grant(Australian Research Council); Netherlands Organization for Scientific Research (NWO VENT)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank TGR BioSciences for generously providing the SureFire ERK1/2 kits. A.C. and P.M.S. are Principal Research Fellows of the National Health and Medical Research Council (NHMRC) of Australia. J.R.L. is a Monash University Larkins Fellow and an R.D. Wright Biomedical Career Development Fellow of the NHMRC. This work was funded in part by NHMRC Program Grant no. APP1055134 (A.C. and P.M.S.), Project Grant no. APP1011920 (J.R.L.), Project Grant APP1049564 (J.R.L. and B.C.) and Australian Research Council Discovery Grant no. DP110100687 (P.J.S. and A.C.). J.R.L. acknowledges the financial support of the Netherlands Organization for Scientific Research (NWO VENT Grant 863.09.018). This work was supported in part by US National Institutes of Health grants DA022413, MH54137 (J.A.J.) and DA023694 (L.S.) and the Lieber Center for Schizophrenia Research and Treatment (J.A.J.). A. Stewart is thanked for technical assistance.	Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Keov P, 2013, MOL PHARMACOL, V84, P425, DOI 10.1124/mol.113.087320; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lane JR, 2013, TRENDS PHARMACOL SCI, V34, P59, DOI 10.1016/j.tips.2012.10.003; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; Michino M, 2013, MOL PHARMACOL, V84, P854, DOI 10.1124/mol.113.087833; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mohr K, 2010, BRIT J PHARMACOL, V159, P997, DOI 10.1111/j.1476-5381.2009.00601.x; Navarro G, 2009, J BIOL CHEM, V284, P28058, DOI 10.1074/jbc.M109.034231; Newman AH, 2012, J MED CHEM, V55, P6689, DOI 10.1021/jm300482h; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Reavill C, 2000, J PHARMACOL EXP THER, V294, P1154; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Silvano E, 2010, MOL PHARMACOL, V78, P925, DOI 10.1124/mol.110.065755; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Stemp G, 2000, J MED CHEM, V43, P1878, DOI 10.1021/jm000090i; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vivo M, 2006, MOL PHARMACOL, V69, P226, DOI 10.1124/mol.105.012443; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang A, 2007, CHEM REV, V107, P274, DOI 10.1021/cr050263h	49	94	94	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					745	752		10.1038/NCHEMBIO.1593	http://dx.doi.org/10.1038/NCHEMBIO.1593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25108820	Green Accepted			2022-12-25	WOS:000341126800011
J	Lannine, BR; Whitby, LR; Dix, MM; Douhan, J; Gilbert, AM; Hett, EC; Johnson, T; Joslynl, C; Kath, JC; Niessen, S; Roberts, LR; Schnute, ME; Wang, C; Hulce, JJ; Wei, BX; Whiteley, LO; Hayward, MM; Cravatt, BF				Lannine, Bryan R.; Whitby, Landon R.; Dix, Melissa M.; Douhan, John; Gilbert, Adam M.; Hett, Erik C.; Johnson, Theodore; Joslynl, Chris; Kath, John C.; Niessen, Sherry; Roberts, Lee R.; Schnute, Mark E.; Wang, Chu; Hulce, Jonathan J.; Wei, Baoxian; Whiteley, Laurence O.; Hayward, Matthew M.; Cravatt, Benjamin F.			A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GROWTH-FACTOR RECEPTOR; IRREVERSIBLE INHIBITORS; TYROSINE KINASES; DRUG-RESISTANCE; EGFR INHIBITOR; IN-VIVO; PCI-32765; TARGET; BINDING	Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active sites have emerged as valuable probes and approved drugs. Many protein classes, however, have functional cysteines, and therefore understanding the proteome-wide selectivity of covalent kinase inhibitors is imperative. Here, we accomplish this objective using activity-based protein profiling coupled with quantitative MS to globally map the targets, both specific and nonspecific, of covalent kinase inhibitors in human cells. Many of the specific off-targets represent nonkinase proteins that, notably, have conserved active site cysteines. We define windows of selectivity for covalent kinase inhibitors and show that, when these windows are exceeded, rampant proteome-wide reactivity and kinase target-independent cell death conjointly occur. Our findings, taken together, provide an experimental road map to illuminate opportunities and surmount challenges for the development of covalent kinase inhibitors.	[Lannine, Bryan R.; Whitby, Landon R.; Dix, Melissa M.; Joslynl, Chris; Wang, Chu; Hulce, Jonathan J.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Lannine, Bryan R.; Whitby, Landon R.; Dix, Melissa M.; Joslynl, Chris; Wang, Chu; Hulce, Jonathan J.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Douhan, John; Hett, Erik C.; Roberts, Lee R.; Schnute, Mark E.] Pfizer Worldwide Res & Dev, Cambridge, MA USA; [Gilbert, Adam M.; Whiteley, Laurence O.; Hayward, Matthew M.] Pfizer Worldwide Res & Dev, Groton, CT USA; [Johnson, Theodore; Kath, John C.; Niessen, Sherry] Pfizer Worldwide Res & Dev, San Diego, CA USA; [Wei, Baoxian] Pfizer Worldwide Res & Dev, Andover, MA USA	Scripps Research Institute; Scripps Research Institute; Pfizer; Pfizer; Pfizer; Pfizer	Lannine, BR (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	matt.m.hayward@pfizer.com; cravatt@scripps.edu	Wang, Chu/AAE-8759-2021; Gilbert, Adam/N-7394-2015; wang, chu/GYJ-2191-2022; Wang, Chu/C-4442-2015	Wang, Chu/0000-0002-6925-1268; Gilbert, Adam/0000-0002-2300-8836; Wang, Chu/0000-0002-6925-1268	National Institutes of Health [CA087660]; Pfizer; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Simon for assistance with proteomic data analysis. This work was supported by the National Institutes of Health (CA087660), Pfizer and the Skaggs Institute for Chemical Biology.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Cameron F, 2014, DRUGS, V74, P263, DOI 10.1007/s40265-014-0178-8; Carmi C, 2012, BIOCHEM PHARMACOL, V84, P1388, DOI 10.1016/j.bcp.2012.07.031; Chang JW, 2013, ACS CHEM BIOL, V8, P1590, DOI 10.1021/cb400261h; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dasmahapatra G, 2013, BRIT J HAEMATOL, V161, P43, DOI 10.1111/bjh.12206; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Krishnamurty R, 2007, COMB CHEM HIGH T SCR, V10, P652, DOI 10.2174/138620707782507368; Leproult E, 2011, J MED CHEM, V54, P1347, DOI 10.1021/jm101396q; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakayama S, 2009, DRUG METAB DISPOS, V37, P1970, DOI 10.1124/dmd.109.027797; Nelson V, 2013, ONCOTARGETS THER, V6, P135, DOI 10.2147/OTT.S23165; Nishino M, 2013, ELIFE, V2, DOI 10.7554/eLife.00712; Pace NJ, 2013, ACS CHEM BIOL, V8, P283, DOI 10.1021/cb3005269; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rosenblum JS, 2013, FEBS LETT, V587, P1870, DOI 10.1016/j.febslet.2013.05.008; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rushworth SA, 2013, CELL SIGNAL, V25, P106, DOI 10.1016/j.cellsig.2012.09.008; Schwartz PA, 2014, P NATL ACAD SCI USA, V111, P173, DOI 10.1073/pnas.1313733111; Shin NY, 2007, CHEM RES TOXICOL, V20, P859, DOI 10.1021/tx700031r; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Smaill JB, 2000, J MED CHEM, V43, P1380, DOI 10.1021/jm990482t; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Tai YT, 2012, BLOOD, V120, P1877, DOI 10.1182/blood-2011-12-396853; Tsou H.R., J MED CHEM, V44, P2719; Tsuboi K, 2011, J AM CHEM SOC, V133, P16605, DOI 10.1021/ja2066972; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Woyach JA, 2014, BLOOD, V123, P1207, DOI 10.1182/blood-2013-07-515361; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f	48	219	226	4	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					760	767		10.1038/NCHEMBIO.1582	http://dx.doi.org/10.1038/NCHEMBIO.1582			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038787	Green Accepted			2022-12-25	WOS:000341126800013
J	Wein, N; Vulin, A; Falzarano, MS; Szigyarto, CA; Maiti, B; Findlay, A; Heller, KN; Uhlen, M; Bakthavachalu, B; Messina, S; Vita, G; Passarelli, C; Gualandi, F; Wilton, SD; Rodino-Klapac, LR; Yang, L; Dunn, DM; Schoenberg, DR; Weiss, RB; Howard, MT; Ferlini, A; Flanigan, KM				Wein, Nicolas; Vulin, Adeline; Falzarano, Maria S.; Szigyarto, Christina Al-Khalili; Maiti, Baijayanta; Findlay, Andrew; Heller, Kristin N.; Uhlen, Mathias; Bakthavachalu, Baskar; Messina, Sonia; Vita, Giuseppe; Passarelli, Chiara; Gualandi, Francesca; Wilton, Steve D.; Rodino-Klapac, Louise R.; Yang, Lin; Dunn, Diane M.; Schoenberg, Daniel R.; Weiss, Robert B.; Howard, Michael T.; Ferlini, Alessandra; Flanigan, Kevin M.			Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice	NATURE MEDICINE			English	Article							BECKER MUSCULAR-DYSTROPHY; RIBOSOME ENTRY SITES; CAP-INDEPENDENT TRANSLATION; ACTIN-BINDING DOMAIN; MESSENGER-RNA; SKELETAL-MUSCLE; CH DOMAINS; PROTEIN; INITIATION; UTROPHIN	Most mutations that truncate the reading frame of the DMD gene cause loss of dystrophin expression and lead to Duchenne muscular dystrophy. However, amelioration of disease severity has been shown to result from alternative, translation initiation beginning in DMD exon 6 that leads to expression of a highly functional N-truncated dystrophin. Here we demonstrate that this isoform results from usage of an internal ribosome entry site (IRES) within exon 5 that is glucocorticoid inducible. We confirmed IRES activity by both peptide sequencing and ribosome profiling in muscle from individuals with minimal symptoms despite the presence of truncating mutations. We generated a truncated reading frame upstream of the IRES by exon skipping, which led to synthesis of a functional N-truncated isoform in both human subject derived cell lines and in a new DMD mouse model, where expression of the truncated isoform protected muscle from contraction-induced injury and corrected muscle force to the same level as that observed in control mice. These results support a potential therapeutic approach for patients with mutations within the 5' exons of DMD.	[Wein, Nicolas; Vulin, Adeline; Findlay, Andrew; Heller, Kristin N.; Rodino-Klapac, Louise R.; Flanigan, Kevin M.] Ohio State Univ, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Falzarano, Maria S.; Gualandi, Francesca; Ferlini, Alessandra] Univ Ferrara, Sect Microbiol & Med Genet, Dept Med Sci, I-44100 Ferrara, Italy; [Szigyarto, Christina Al-Khalili; Uhlen, Mathias] KTH Royal Inst Technol, Sch Biotechnol, Dept Prote & Nanobiotechnol, Stockholm, Sweden; [Maiti, Baijayanta] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bakthavachalu, Baskar; Schoenberg, Daniel R.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Bakthavachalu, Baskar; Schoenberg, Daniel R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Messina, Sonia; Vita, Giuseppe] Univ Messina, Dept Neurosci, Messina, Italy; [Messina, Sonia; Vita, Giuseppe] Ctr Clin Nemo Sud, Messina, Italy; [Passarelli, Chiara] Bambino Gesu Pediat Hosp, Rome, Italy; [Wilton, Steve D.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Rodino-Klapac, Louise R.; Flanigan, Kevin M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yang, Lin] Univ Kentucky, Dept Comp Sci, Div Biomed Informat, Lexington, KY 40506 USA; [Dunn, Diane M.; Weiss, Robert B.; Howard, Michael T.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Flanigan, Kevin M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Ferrara; Royal Institute of Technology; Washington University (WUSTL); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Messina; IRCCS Bambino Gesu; Murdoch University; University System of Ohio; Ohio State University; University of Kentucky; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Flanigan, KM (corresponding author), Ohio State Univ, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43210 USA.	kevin.flanigan@nationwidechildrens.org	Wein, Nicolas/AAE-1476-2020; Uhlen, Mathias/B-3262-2016; Gualandi, Francesca/K-7513-2016; Uhlen, Mathias/AAV-8746-2021; Findlay, Andrew/AAM-1974-2021; Schoenberg, Daniel/J-3423-2019; Rodino-Klapac, Louise/E-3968-2011	Uhlen, Mathias/0000-0002-4858-8056; Gualandi, Francesca/0000-0001-9551-057X; Findlay, Andrew/0000-0002-8728-9833; Schoenberg, Daniel/0000-0003-4570-1946; Neri, Marcella/0000-0001-6133-9831; Wein, Nicolas/0000-0002-5892-3639; Messina, Sonia/0000-0001-7994-3391; Al-Khalili Szigyarto, Cristina/0000-0001-6990-1905; FERLINI, ALESSANDRA/0000-0001-8385-9870; Rodino-Klapac, Louise/0000-0002-8966-5177; Bakthavachalu, Baskar/0000-0002-5114-3429; Wilton, Steve/0000-0002-9400-893X; Vita, Giuseppe/0000-0002-5204-7826; Passarelli, Chiara/0000-0001-7919-4626; Bovolenta, Matteo/0000-0002-9937-009X; Flanigan, Kevin/0000-0001-6440-3376	US National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS043264]; National Institute of General Medical Sciences [R01 GM038277, R01 GM084177]; CureDuchenne; Ohio State University/Nationwide Children's Hospital Muscle Group; Philippe Foundation; EU BIO-NMD project [241665]; Duchenne Parent Project Italy (DMD Diagnostics Project); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084177, R01GM038277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043264] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CureDuchenne; Ohio State University/Nationwide Children's Hospital Muscle Group; Philippe Foundation; EU BIO-NMD project; Duchenne Parent Project Italy (DMD Diagnostics Project); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by the US National Institutes of Health National Institute of Neurological Disorders and Stroke (R01 NS043264 (K.M.F., M.T.H. and R.B.W.)), the National Institute of General Medical Sciences (R01 GM038277 and R01 GM084177 (D.R.S.)), and CureDuchenne (K.M.F.). N.W. has received fellowship support from the Ohio State University/Nationwide Children's Hospital Muscle Group and the Philippe Foundation. We wish to acknowledge the technical assistance of A. Rutherford, Y. Kaminoh and L. Taylor and are grateful for the reagents provided by P. Sarnow (pRDEF; Stanford University) and G. Morris (hybridoma cell lines for antibodies MANEX1A, MANCHO3 and MANDAG2; MDA Monoclonal Antibody Resource at the Wolfson Centre for Inherited Neuromuscular Disease). The EU BIO-NMD project (no. 241665) provided support to A. Ferlini and C.A.-K.S., and the Duchenne Parent Project Italy (DMD Diagnostics Project) provided support to A. Ferlini. Thanks are also due to C. Rodolico, P. Rimessi, M. Fabbri and M. Bovolenta for their technical support. The Clinical Proteomics Mass Spectrometry core facility at Karolinska University Hospital and Science for Life Laboratory provided assistance in mass spectrometry and data analysis.	Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cencig S, 2004, ONCOGENE, V23, P267, DOI 10.1038/sj.onc.1207017; Chaouch S, 2009, HUM GENE THER, V20, P784, DOI 10.1089/hum.2008.163; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Corrado K, 1996, J CELL BIOL, V134, P873, DOI 10.1083/jcb.134.4.873; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Flanigan KM, 2009, NEUROMUSCULAR DISORD, V19, P743, DOI 10.1016/j.nmd.2009.08.010; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, CURR BIOL, V8, pR674; Goss KH, 2002, P NATL ACAD SCI USA, V99, P8161, DOI 10.1073/pnas.112072199; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; HEALD A, 1994, NEUROLOGY, V44, P2388, DOI 10.1212/WNL.44.12.2388; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Henderson DM, 2012, J MOL BIOL, V416, P414, DOI 10.1016/j.jmb.2011.12.040; Hertz MI, 2013, MOL CELL BIOL, V33, P1016, DOI 10.1128/MCB.00879-12; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; KOZAK M, 1978, J BIOL CHEM, V253, P6568; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Lin AY, 2012, J MOL BIOL, V420, P87, DOI 10.1016/j.jmb.2012.04.005; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; MONACO AP, 1989, TRENDS BIOCHEM SCI, V14, P412, DOI 10.1016/0968-0004(89)90290-9; Murray EL, 2007, MOL CELL BIOL, V27, P2791, DOI 10.1128/MCB.01445-06; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Sutherland-Smith AJ, 2003, J MOL BIOL, V329, P15, DOI 10.1016/S0022-2836(03)00422-4; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Vulin A, 2012, MOL THER, V20, P2120, DOI 10.1038/mt.2012.181; White SJ, 2006, HUM MUTAT, V27, P938, DOI 10.1002/humu.20367; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Witting N, 2013, NEUROMUSCULAR DISORD, V23, P25, DOI 10.1016/j.nmd.2012.07.004; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	58	75	80	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					992	1000		10.1038/nm.3628	http://dx.doi.org/10.1038/nm.3628			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25108525	Green Accepted, Green Published			2022-12-25	WOS:000341404000011
J	Gockel, I; Becker, J; Wouters, MM; Niebisch, S; Gockel, HR; Hess, T; Ramonet, D; Zimmermann, J; Vigo, AG; Trynka, G; de Leon, AR; de la Serna, JP; Urcelay, E; Kumar, V; Franke, L; Westra, HJ; Drescher, D; Kneist, W; Marquardt, JU; Galle, PR; Mattheisen, M; Annese, V; Latiano, A; Fumagalli, U; Laghi, L; Cuomo, R; Sarnelli, G; Muller, M; Eckardt, AJ; Tack, J; Hoffmann, P; Herms, S; Mangold, E; Heilmann, S; Kiesslich, R; von Rahden, BHA; Allescher, HD; Schulz, HG; Wijmenga, C; Heneka, MT; Lang, H; Hopfner, KP; Nothen, MM; Boeckxstaens, GE; de Bakker, PIW; Knapp, M; Schumacher, J				Gockel, Ines; Becker, Jessica; Wouters, Mira M.; Niebisch, Stefan; Gockel, Henning R.; Hess, Timo; Ramonet, David; Zimmermann, Julian; Vigo, Ana Gonzalez; Trynka, Gosia; de Leon, Antonio Ruiz; de la Serna, Julio Perez; Urcelay, Elena; Kumar, Vinod; Franke, Lude; Westra, Harm-Jan; Drescher, Daniel; Kneist, Werner; Marquardt, Jens U.; Galle, Peter R.; Mattheisen, Manuel; Annese, Vito; Latiano, Anna; Fumagalli, Uberto; Laghi, Luigi; Cuomo, Rosario; Sarnelli, Giovanni; Mueller, Michaela; Eckardt, Alexander J.; Tack, Jan; Hoffmann, Per; Herms, Stefan; Mangold, Elisabeth; Heilmann, Stefanie; Kiesslich, Ralf; von Rahden, Burkhard H. A.; Allescher, Hans-Dieter; Schulz, Henning G.; Wijmenga, Cisca; Heneka, Michael T.; Lang, Hauke; Hopfner, Karl-Peter; Noethen, Markus M.; Boeckxstaens, Guy E.; de Bakker, Paul I. W.; Knapp, Michael; Schumacher, Johannes			Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia	NATURE GENETICS			English	Article							MHC; ASSOCIATION; INSIGHTS	Idiopathic achalasia is characterized by a failure of the lower esophageal sphincter to relax due to a loss of neurons in the myenteric plexus(1,2). This ultimately leads to massive dilatation and an irreversibly impaired megaesophagus. We performed a genetic association study in 1,068 achalasia cases and 4,242 controls and fine-mapped a strong MHC association signal by imputing classical HLA haplotypes and amino acid polymorphisms. An eight-residue insertion at position 227-234 in the cytoplasmic tail of HLA-DQ beta 1 (encoded by HLA-DQB1*05:03 and HLA-DQB1*06:01) confers the strongest risk for achalasia (P = 1.73 x 10(-19)). In addition, two amino acid substitutions in the. extracellular domain of HLA-DQ alpha 1 at position 41 (lysine encoded by HLA-DQA1*01:03; P = 5.60 x 10(-10)) and of HLA-DQ beta 1 at position 45 (glutamic acid encoded by HLA-DQB1*03:01 and HLA-DQB1*03:04; P = 1.20 x 10(-9)) independently confer achalasia risk. Our study implies that immune-mediated processes are involved in the pathophysiology of achalasia.	[Gockel, Ines; Niebisch, Stefan; Gockel, Henning R.; Drescher, Daniel; Kneist, Werner; Lang, Hauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Gen, Visceral & Transplant Surg, Mainz, Germany; [Becker, Jessica; Hess, Timo; Hoffmann, Per; Herms, Stefan; Mangold, Elisabeth; Heilmann, Stefanie; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Inst Human Genet, Bonn, Germany; [Becker, Jessica; Hess, Timo; Hoffmann, Per; Herms, Stefan; Mangold, Elisabeth; Heilmann, Stefanie; Noethen, Markus M.; Schumacher, Johannes] Univ Bonn, Dept Gen Life & Brain Ctr, Bonn, Germany; [Wouters, Mira M.; Tack, Jan; Boeckxstaens, Guy E.] Catholic Univ Louvain, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Ramonet, David; Zimmermann, Julian; Heneka, Michael T.] Univ Bonn, Dept Neurol, Div Clin Neurosci, Bonn, Germany; [Vigo, Ana Gonzalez; Urcelay, Elena] Hosp Clin San Carlos IDISSC, Inst Invest Sanitaria, Dept Immunol, Madrid, Spain; [Trynka, Gosia; Kumar, Vinod; Franke, Lude; Westra, Harm-Jan; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [de Leon, Antonio Ruiz; de la Serna, Julio Perez] Hosp Clin San Carlos IDISSC, Inst Invest Sanitaria, Dept Gastroenterol, Madrid, Spain; [Marquardt, Jens U.; Galle, Peter R.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, D-55122 Mainz, Germany; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel] Aarhus Univ, Ctr Integrat Sequencing ISEQ, Aarhus, Denmark; [Annese, Vito] Univ Florence, Careggi Hosp, Dept Gastroenterol, Florence, Italy; [Latiano, Anna] Casa Sollievo Sofferenza Hosp, Ist Ric Cura & Carattere Sci, Div Gastroenterol, San Giovanni Rotondo, Italy; [Fumagalli, Uberto] Ist Clin Humanitas, Ist Ric Cura & Carattere Sci, Dept Surg, Milan, Italy; [Laghi, Luigi] Ist Clin Humanitas, Ist Ric Cura & Carattere Sci, Div Gastroenterol, Milan, Italy; [Cuomo, Rosario; Sarnelli, Giovanni] Federico II Univ Hosp, Sch Med, Dept Clin Med & Surg, Div Gastroenterol, Naples, Italy; [Mueller, Michaela; Eckardt, Alexander J.] German Diagnost Clin, Dept Gastroenterol, Wiesbaden, Germany; [Hoffmann, Per; Herms, Stefan] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Hoffmann, Per; Herms, Stefan] Univ Basel, Dept Biomed, Human Genet Res Grp, Basel, Switzerland; [Kiesslich, Ralf] Hosp St Marien, Dept Internal Med, Frankfurt, Germany; [von Rahden, Burkhard H. A.] Univ Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, D-97070 Wurzburg, Germany; [Allescher, Hans-Dieter] Hosp Garmisch Partenkirchen, Ctr Internal Med, Garmisch Partenkirchen, Germany; [Schulz, Henning G.] Protestant Hosp Castrop Rauxel, Dept Gen & Abdominal Surg, Castrop Rauxel, Germany; [Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, Munich, Germany; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	Johannes Gutenberg University of Mainz; University of Bonn; University of Bonn; University of Bonn; Hospital Clinico San Carlos; University of Groningen; Hospital Clinico San Carlos; Johannes Gutenberg University of Mainz; Aarhus University; Aarhus University; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Casa Sollievo Della Sofferenza; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; University of Naples Federico II; University of Basel; University of Basel; St. Marien Hospital; University of Wurzburg; University of Munich; University of Munich; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Bonn	Schumacher, J (corresponding author), Univ Bonn, Inst Human Genet, Bonn, Germany.	johannes.schumacher@uni-bonn.de	Wijmenga, Cisca/D-2173-2009; Herms, Stefan/J-1949-2014; Galle, Peter/ABE-2872-2021; Mattheisen, Manuel/S-3725-2019; Ralf Kiesslich, Dr./AAK-9313-2021; Cuomo, Rosario/C-3446-2011; Annese, Vito/AGW-4200-2022; Mattheisen, Manuel/B-4949-2012; Kneist, Werner/AAP-9266-2020; Hopfner, Karl-Peter/B-6864-2014; Heilmann-Heimbach, Stefanie/H-5942-2018; Franke, Lude/P-7036-2016; Zimmermann, Julian/ABQ-0926-2022; Latiano, Anna/R-1965-2016; Boeckxstaens, Guy/AAP-2502-2020; Laghi, Luigi/GZM-5831-2022; de Bakker, Paul IW/B-8730-2009; Galle, Peter R/T-5292-2018; Kumar, Vinod/ABC-4866-2020; Heneka, Michael/AAE-8011-2019; Sarnelli, Giovanni/AAB-4050-2019; Schumacher, Johannes/F-4970-2015; Wouters, Mira/K-1371-2013; Hoffmann, Per/A-5149-2010; Wijmenga, Cisca/AAE-7719-2019; Heneka, Michael/E-8072-2015	Herms, Stefan/0000-0002-2786-8200; Galle, Peter/0000-0001-8294-0992; Mattheisen, Manuel/0000-0002-8442-493X; Cuomo, Rosario/0000-0003-0768-8381; Annese, Vito/0000-0002-0082-892X; Mattheisen, Manuel/0000-0002-8442-493X; Kneist, Werner/0000-0002-7219-0523; Hopfner, Karl-Peter/0000-0002-4528-8357; Heilmann-Heimbach, Stefanie/0000-0003-1057-465X; Franke, Lude/0000-0002-5159-8802; Zimmermann, Julian/0000-0003-1964-0078; Latiano, Anna/0000-0003-3719-2061; Laghi, Luigi/0000-0003-4187-1059; de Bakker, Paul IW/0000-0001-7735-7858; Galle, Peter R/0000-0001-8294-0992; Kumar, Vinod/0000-0002-2775-6049; Sarnelli, Giovanni/0000-0002-1467-1134; Schumacher, Johannes/0000-0001-9217-6457; Wouters, Mira/0000-0002-3438-1919; Hoffmann, Per/0000-0002-6573-983X; Wijmenga, Cisca/0000-0002-5635-1614; Heneka, Michael/0000-0003-4996-1630; Urcelay, Elena/0000-0001-8470-8396; Ramonet, David/0000-0002-5058-7757; Marquardt, Jens/0000-0002-8314-2682; Nothen, Markus/0000-0002-8770-2464; Tack, Jan/0000-0002-3206-6704; Hess, Timo/0000-0003-2778-4274	Deutsche Forschungsgemeinschaft (DFG) [GO 1795/1-1, KN 378/2-1, SCHU 1596/5-1]; Alfried Krupp von Bohlen und Halbach-Stiftung; Heinz Nixdorf Foundation, Germany; Netherlands Organization for Scientific Research (NWO) [016.126.354]; postdoctoral fellowship of the Fund for Scientific Research (FWO) Flanders, Belgium; Research Foundation-Flanders (FWO) (Odysseus program); DFG [SFB 684]; Center for Integrated Protein Sciences Munich; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alfried Krupp von Bohlen und Halbach-Stiftung; Heinz Nixdorf Foundation, Germany; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); postdoctoral fellowship of the Fund for Scientific Research (FWO) Flanders, Belgium; Research Foundation-Flanders (FWO) (Odysseus program)(FWO); DFG(German Research Foundation (DFG)); Center for Integrated Protein Sciences Munich; DFG(German Research Foundation (DFG))	We thank all subjects for participating to this study. We acknowledge our collaborating clinical partners, all colleagues who contributed to patient recruitment, and our laboratory technicians and colleagues responsible for database management (for a complete list of all individuals, see the Supplementary Note),I.G., M.K. and J.S. received support for this work from the Deutsche Forschungsgemeinschaft (DFG), individual grants GO 1795/1-1, KN 378/2-1 and SCHU 1596/5-1. M.M.N. received support for this work from the Alfried Krupp von Bohlen und Halbach-Stiftung. M.M.N. is a member of the DFG-funded Excellence Cluster ImmunoSensation. The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany. We thank B. Potzsch (University of Bonn) for help with collecting DNA samples from anonymous blood donors. In addition, we thank the Type I Diabetes Genetics Consortium (T1DGC) for data access and J. Sauter (German Bone Marrow Donor Center (DKMS), Tubingen) for help differentiating HLA-DQA1 alleles. P.I.W.d.B. is the recipient of a Vernieuwingsimpuls VIDI Award from the Netherlands Organization for Scientific Research (NWO project 016.126.354). M.M.W. is supported by a postdoctoral fellowship of the Fund for Scientific Research (FWO) Flanders, Belgium. G.E.B. is supported by a grant from the Research Foundation-Flanders (FWO) (Odysseus program). K-P.H. is supported by DFG SFB 684 and the Center for Integrated Protein Sciences Munich.	de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Gockel HR, 2010, HUM GENET, V128, P353, DOI 10.1007/s00439-010-0874-8; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Khalil H, 2003, INT IMMUNOL, V15, P1249, DOI 10.1093/intimm/dxg124; Park W, 2005, AM J GASTROENTEROL, V100, P1404, DOI 10.1111/j.1572-0241.2005.41775.x; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; SENJU S, 1992, IMMUNOGENETICS, V36, P319; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374	11	64	69	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					901	904		10.1038/ng.3029	http://dx.doi.org/10.1038/ng.3029			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24997987				2022-12-25	WOS:000339704400022
J	Li, ML; Zhang, Z; Li, XG; Ye, JY; Wu, XS; Tan, ZJ; Liu, C; Shen, BY; Wang, XA; Wu, WG; Zhou, DZ; Zhang, D; Wang, T; Liu, BY; Qu, K; Ding, QC; Weng, H; Ding, Q; Mu, JS; Shu, YJ; Bao, RF; Cao, Y; Chen, PZ; Liu, TY; Jiang, L; Hu, YP; Dong, P; Gu, J; Lu, W; Shi, WB; Lu, JH; Gong, W; Tang, ZH; Zhang, Y; Wang, XF; Chin, YE; Weng, XL; Zhang, H; Tang, W; Zheng, YL; He, L; Wang, H; Liu, Y; Liu, YB				Li, Maolan; Zhang, Zhou; Li, Xiaoguang; Ye, Junyi; Wu, Xiangsong; Tan, Zhujun; Liu, Chang; Shen, Baiyong; Wang, Xu-An; Wu, Wenguang; Zhou, Daizhan; Zhang, Di; Wang, Ting; Liu, Bingya; Qu, Kai; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Chen, Peizhan; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Chin, Y. Eugene; Weng, Xiaoling; Zhang, Hong; Tang, Wei; Zheng, Yonglan; He, Lin; Wang, Hui; Liu, Yun; Liu, Yingbin			Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway	NATURE GENETICS			English	Article							BILIARY-TRACT; CANCER; MUTAGENESIS; GENOME	Individuals with gallbladder carcinoma (GBC), the most aggressive malignancy of the biliary tract, have a poor prognosis. Here we report the identification of somatic mutations for GBC in 57 tumor-normal pairs through a combination of exome sequencing and ultra-deep sequencing of cancer-related genes. The mutation pattern is defined by a dominant prevalence of C>T mutations at TCN sites. Genes with a significant frequency (false discovery rate (FDR) <0.05) of non-silent mutations include TP53 (47.1%), KRAS (7.8%) and ERBB3 (11.8%). Moreover, ErbB signaling (including EGFR, ERBB2, ERBB3, ERBB4 and their downstream genes) is the most extensively mutated pathway, affecting 36.8% (21/57) of the GBC samples. Multivariate analyses further show that cases with ErbB pathway mutations have a worse outcome (P = 0.001). These findings provide insight into the somatic mutational landscape in GBC and highlight the key role of the ErbB signaling pathway in GBC pathogenesis.	[Li, Maolan; Zhang, Zhou; Wu, Xiangsong; Tan, Zhujun; Wang, Xu-An; Wu, Wenguang; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Liu, Yingbin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Li, Maolan; Zhang, Zhou; Wu, Xiangsong; Tan, Zhujun; Wang, Xu-An; Wu, Wenguang; Ding, Qichen; Weng, Hao; Ding, Qian; Mu, Jiasheng; Shu, Yijun; Bao, Runfa; Cao, Yang; Liu, Tianyu; Jiang, Lin; Hu, Yunping; Dong, Ping; Gu, Jun; Lu, Wei; Shi, Weibin; Lu, Jianhua; Gong, Wei; Tang, Zhaohui; Zhang, Yong; Wang, Xuefeng; Liu, Yingbin] Shanghai Jiao Tong Univ, Sch Med, Inst Biliary Tract Dis, Shanghai, Peoples R China; [Zhang, Zhou; Zhou, Daizhan; Zhang, Di; Wang, Ting; He, Lin] Shanghai Jiao Tong Univ, BioX Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [Li, Xiaoguang; Chen, Peizhan; Wang, Hui] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci,Key Lab Food Safety Res, Shanghai, Peoples R China; [Ye, Junyi; Weng, Xiaoling; Zhang, Hong; He, Lin; Liu, Yun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Chang; Qu, Kai] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Xian, Peoples R China; [Shen, Baiyong; Liu, Bingya] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Chin, Y. Eugene] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Tang, Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, US NIH, Bethesda, MD 20892 USA; [Zheng, Yonglan] Univ Chicago, Dept Med, Chicago, IL USA; [He, Lin] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Xi'an Jiaotong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Zhejiang University	Liu, YB (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China.	huiwang@sibs.ac.cn; superliuyun@fudan.edu.cn; liuybphd@126.com	wang, xuan/GXF-3679-2022; LIU, YING/GZL-7252-2022; Zheng, Yonglan/O-4112-2019; Liu, Yingbin/AAI-1919-2020; Liu, Bingya/GMW-5655-2022	Zheng, Yonglan/0000-0001-6597-7072; Liu, Yingbin/0000-0001-6110-0185; Liu, Bingya/0000-0002-4406-3762; zhou, daizhan/0000-0001-9104-2801; Gong, Wei/0000-0002-9949-6207	National Natural Science Foundation of China [81172026, 81272402, 81301816, 81172029, 81370728, 81125020, 81328022, 81302507]; National High-Technology Research and Development Program (863 Program) [2012AA022606, 2012BAK01B00]; Foundation for Interdisciplinary Research of Shanghai Jiao Tong University [YG2011ZD07]; Shanghai Science and Technology Commission Intergovernmental International Cooperation Project [12410705900]; Shanghai Science and Technology Commission Medical-Guiding Project [12401905800]; China Postdoctoral Science Foundation [2013M541513]; Program for Changjiang Scholars; Leading Talent program of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Foundation for Interdisciplinary Research of Shanghai Jiao Tong University; Shanghai Science and Technology Commission Intergovernmental International Cooperation Project; Shanghai Science and Technology Commission Medical-Guiding Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Leading Talent program of Shanghai	This study was supported by the National Natural Science Foundation of China (81172026, 81272402, 81301816, 81172029, 81370728, 81125020, 81328022 and 81302507), the National High-Technology Research and Development Program (863 Program, 2012AA022606; 2012BAK01B00), the Foundation for Interdisciplinary Research of Shanghai Jiao Tong University (YG2011ZD07), the Shanghai Science and Technology Commission Intergovernmental International Cooperation Project (12410705900), the Shanghai Science and Technology Commission Medical-Guiding Project (12401905800), the China Postdoctoral Science Foundation (2013M541513), the Program for Changjiang Scholars and the Leading Talent program of Shanghai.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Boutros C, 2012, SURG ONCOL, V21, pE183, DOI 10.1016/j.suronc.2012.08.002; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Goldin RD, 2009, HISTOPATHOLOGY, V55, P218, DOI 10.1111/j.1365-2559.2008.03192.x; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kiguchi K, 2001, CANCER RES, V61, P6971; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li M., 2013, CHIN J PRACT SURG, V33, P414; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Maurya SK, 2012, SURG ONCOL, V21, P37, DOI 10.1016/j.suronc.2010.09.003; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sliwkowski MX, 2003, NAT STRUCT BIOL, V10, P158, DOI 10.1038/nsb0303-158; Srivastava K, 2011, MUTAT RES-REV MUTAT, V728, P67, DOI 10.1016/j.mrrev.2011.06.002; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Wolpin BM, 2010, NEW ENGL J MED, V362, P1335, DOI 10.1056/NEJMe1001183; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532	26	273	307	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					872	876		10.1038/ng.3030	http://dx.doi.org/10.1038/ng.3030			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24997986				2022-12-25	WOS:000339704400016
J	Ryoo, J; Choi, J; Oh, C; Kim, S; Seo, M; Kim, SY; Seo, D; Kim, J; White, TE; Brandariz-Nunez, A; Diaz-Griffero, F; Yun, CH; Hollenbaugh, JA; Kim, B; Baek, D; Ahn, K				Ryoo, Jeongmin; Choi, Jongsu; Oh, Changhoon; Kim, Sungchul; Seo, Minji; Kim, Seok-Young; Seo, Daekwan; Kim, Jongkyu; White, Tommy E.; Brandariz-Nunez, Alberto; Diaz-Griffero, Felipe; Yun, Cheol-Heui; Hollenbaugh, Joseph A.; Kim, Baek; Baek, Daehyun; Ahn, Kwangseog			The ribonuclease activity of SAMHD1 is required for HIV-1 restriction	NATURE MEDICINE			English	Article							AICARDI-GOUTIERES SYNDROME; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; CD4(+) T-CELLS; REVERSE-TRANSCRIPTASE; INFECTION; PROTEIN; PHOSPHORYLATION; DGTP; VPX; DEGRADATION	The HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1)(1,2) is proposed to inhibit HIV-1 replication by depleting the intracellular dNTP pool(3-5). However, phosphorylation of SAMHD1 regulates its ability to restrict HIV-1 without decreasing cellular dNTP levels(6-8), which is not consistent with a role for SAMHD1 dNTPase activity in HIV-1 restriction. Here, we show that SAMHD1 possesses RNase activity and that the RNase but not the dNTPase function is essential for HIV-1 restriction. By enzymatically characterizing Aicardi-Goutieres syndrome (AGS)-associated SAMHD1 mutations and mutations in the allosteric dGTP-binding site of SAMHD1 for defects in RNase or dNTPase activity, we identify SAMHD1 point mutants that cause loss of one or both functions. The RNase-positive and dNTPase-negative SAMHD1(D137N) mutant is able to restrict HIV-1 infection, whereas the RNase-negative and dNTPase-positive SAMHD1(Q548A) mutant is defective for HIV-1 restriction. SAMHD1 associates with HIV-1 RNA and degrades it during the early phases of cell infection. SAMHD1 silencing in macrophages and CD4(+) T cells from healthy donors increases HIV-1 RNA stability, rendering the cells permissive for HIV-1 infection. Furthermore, phosphorylation of SAMHD1 at T592 negatively regulates its RNase activity in cells and impedes HIV-1 restriction. Our results reveal that the RNase activity of SAMHD1 is responsible for preventing HIV-1. infection by directly degrading the HIV-1 RNA.	[Ryoo, Jeongmin; Choi, Jongsu; Oh, Changhoon; Kim, Sungchul; Seo, Minji; Kim, Seok-Young; Ahn, Kwangseog] Seoul Natl Univ, Creat Res Initiat Ctr Antigen Presentat, Seoul, South Korea; [Ryoo, Jeongmin; Oh, Changhoon] Seoul Natl Univ, Dept Interdisciplinary Program Genet Engn, Seoul, South Korea; [Choi, Jongsu; Kim, Sungchul; Seo, Minji; Kim, Seok-Young; Seo, Daekwan; Kim, Jongkyu; Baek, Daehyun; Ahn, Kwangseog] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kim, Jongkyu; Baek, Daehyun] Inst for Basic Sci, Ctr RNA Res, Seoul, South Korea; [White, Tommy E.; Brandariz-Nunez, Alberto; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Yun, Cheol-Heui] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Hollenbaugh, Joseph A.; Kim, Baek] Emory Sch Med, Dept Pediat, Ctr Drug Discovery, Atlanta, GA USA; [Kim, Baek] Kyung Hee Univ, Sch Pharm, Seoul, South Korea; [Baek, Daehyun] Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Yeshiva University; Albert Einstein College of Medicine; Seoul National University (SNU); Emory University; Kyung Hee University; Seoul National University (SNU)	Ahn, K (corresponding author), Seoul Natl Univ, Creat Res Initiat Ctr Antigen Presentat, Seoul, South Korea.	ksahn@snu.ac.kr	YUN, Cheol-Heui/AAR-2775-2020; Kim, Sungchul/O-8910-2015; Brandariz, Alberto/S-2630-2016	YUN, Cheol-Heui/0000-0002-0041-2887; Kim, Sungchul/0000-0001-9148-6904; Brandariz, Alberto/0000-0002-0640-1599; Choi, Jongsu/0000-0001-5007-7469; Kim, Seok-Young/0000-0001-8566-839X	US National Institutes of Health [R01 A1087390, R21 AI102824, GM104198, AI049781]; Korean Institute for Basic Science [EM1402]; Korean Basic Science Research Program [2011-0014523]; Korean Creative Research Initiative Program (Research Center for Antigen Presentation) [2006-0050689]; National Research Foundation - Ministry of Education, Science, and Technology of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R01AI087390, R21AI102824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Institute for Basic Science; Korean Basic Science Research Program; Korean Creative Research Initiative Program (Research Center for Antigen Presentation); National Research Foundation - Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the members of our laboratory for discussion and technical help. We thank D. Littman (New York University School of Medicine) for HIV-1-GFP and HCMV-VSV-G, N. Manel (Institut Curie) for pLai Delta envGFP3 and A. Cimarelli (University of Lyon) for pSIV3+ and pSIV3+Delta Vpx. This work was supported by the US National Institutes of Health (R01 A1087390 and R21 AI102824 to F.D.-G. and GM104198 and AI049781 to B.K.), the Korean Institute for Basic Science (EM1402 to D.B.), the Korean Basic Science Research Program (2011-0014523 to D.B.), the Korean Creative Research Initiative Program (Research Center for Antigen Presentation, 2006-0050689 to K.A.) and BK21 plus fellowship to J.C., S.-Y.K. and M.S. from a National Research Foundation grant funded by the Ministry of Education, Science, and Technology of Korea.	Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; MIZRAHI V, 1990, NUCLEIC ACIDS RES, V18, P5359, DOI 10.1093/nar/18.18.5359; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	26	205	212	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					936	941		10.1038/nm.3626	http://dx.doi.org/10.1038/nm.3626			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25038827	Green Accepted			2022-12-25	WOS:000340074600026
J	Chen, YJ; Xiong, M; Zhang, SC				Chen, Yuejun; Xiong, Man; Zhang, Su-Chun			Illuminating Parkinson's therapy with optogenetics	NATURE BIOTECHNOLOGY			English	Editorial Material							PROTEIN-COUPLED RECEPTORS; OPTICAL CONTROL; NEURONS; MICE		[Chen, Yuejun; Xiong, Man; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Chen, YJ (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	chen, yuejun/AAL-4070-2020	Chen, Yuejun/0000-0002-4625-2604	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076352, R24NS086604] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; NIH HHS [P51 OD011106] Funding Source: Medline; NINDS NIH HHS [R01 NS076352, R24 NS086604] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514	10	19	23	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					149	150		10.1038/nbt.3140	http://dx.doi.org/10.1038/nbt.3140			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658280	Green Accepted			2022-12-25	WOS:000349198800017
J	Viotti, M; Nowotschin, S; Hadjantonakis, AK				Viotti, Manuel; Nowotschin, Sonja; Hadjantonakis, Anna-Katerina			SOX17 links gut endoderm morphogenesis and germ layer segregation	NATURE CELL BIOLOGY			English	Article							EMBRYONIC-STEM-CELLS; MOUSE EMBRYO; PRIMITIVE STREAK; DEFINITIVE ENDODERM; CHICK-EMBRYO; EXPRESSION; EOMESODERMIN; GENE; SPECIFICATION; ESTABLISHMENT	Gastrulation leads to three germ layers-ectoderm, mesoderm and endoderm-that are separated by two basement membranes. In the mouse embryo, the emergent gut endoderm results from the widespread intercalation of cells of two distinct origins: pluripotent epiblast-derived definitive endoderm (DE) and extra-embryonic visceral endoderm (VE). Here we image the trajectory of prospective DE cells before intercalating into the VE epithelium. We show that the transcription factor SOX17, which is activated in prospective DE cells before intercalation, is necessary for gut endoderm morphogenesis and the assembly of the basement membrane that separates gut endoderm from mesoderm. Our results mechanistically link gut endoderm morphogenesis and germ layer segregation, two central and conserved features of gastrulation.	[Viotti, Manuel; Nowotschin, Sonja; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Viotti, Manuel] Cornell Univ, Weill Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Hadjantonakis, AK (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	hadj@mskcc.org		Viotti, Manuel/0000-0003-1844-2571; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	NIH [RO1-HD052115, RO1-DK084391]; Frank J. Lappin Horsfall fellowship; Muscular Dystrophy Association Development Grant [186552]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank J. Lappin Horsfall fellowship; Muscular Dystrophy Association Development Grant(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Kwon for implementing and optimizing the embryo electroporation technique and live imaging; M. Pulina for assistance with analysis of FGF signalling mutants; R. Turnbull for assistance with embryo cryosectioning; V. Seshan of the MSKCC Biostatistics Core Facility for advice on fluorescence intensity quantifications; J. Darnell, G. Martin, S. Morrison, C-a. Mao and J. Rossant for mouse lines; K. Anderson, M. Baylies and members of our laboratory for discussions and comments on the manuscript. This work was supported by the NIH (RO1-HD052115 and RO1-DK084391). M.V. was supported by a Frank J. Lappin Horsfall fellowship for part of this work S.N. was supported by a Muscular Dystrophy Association Development Grant (186552).	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AZAR Y, 1983, J EMBRYOL EXP MORPH, V77, P143; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bertocchini F, 2008, GENE EXPR PATTERNS, V8, P477, DOI 10.1016/j.gep.2008.07.001; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; JONES EAV, 2005, IMAGING NEUROSCIENCE; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Khoo P. L., 2007, CSH PROTOC, V2007; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kimura W, 2006, DEV BIOL, V289, P283, DOI 10.1016/j.ydbio.2005.09.009; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Mao CA, 2008, DEVELOPMENT, V135, P271, DOI 10.1242/dev.009688; McKnight KD, 2010, DEV BIOL, V337, P471, DOI 10.1016/j.ydbio.2009.10.040; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nowotschin S, 2013, GENE DEV, V27, P997, DOI 10.1101/gad.215152.113; Nowotschin S, 2010, METHOD ENZYMOL, V476, P351, DOI 10.1016/S0076-6879(10)76020-1; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Nowotschin S, 2009, GENESIS, V47, P330, DOI 10.1002/dvg.20500; Rivera-Perez J. A., 2014, DYNAMICS MORPHOGENES; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; VAKAET L, 1962, J EMBRYOL EXP MORPH, V10, P38; Viotti M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001276; Viotti M, 2011, GENESIS, V49, P124, DOI 10.1002/dvg.20695; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	39	96	101	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1146	U54		10.1038/ncb3070	http://dx.doi.org/10.1038/ncb3070			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25419850	Green Accepted			2022-12-25	WOS:000345777300006
J	Rezania, A; Bruin, JE; Arora, P; Rubin, A; Batushansky, I; Asadi, A; O'Dwyer, S; Quiskamp, N; Mojibian, M; Albrecht, T; Yang, YHC; Johnson, JD; Kieffer, TJ				Rezania, Alireza; Bruin, Jennifer E.; Arora, Payal; Rubin, Allison; Batushansky, Irina; Asadi, Ali; O'Dwyer, Shannon; Quiskamp, Nina; Mojibian, Majid; Albrecht, Tobias; Yang, Yu Hsuan Carol; Johnson, James D.; Kieffer, Timothy J.			Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							PANCREATIC PROGENITOR CELLS; MAFA TRANSCRIPTION FACTOR; AIR-LIQUID INTERFACE; BETA-CELL; ISLET TRANSPLANTATION; DIFFERENTIATION; GLUCOSE; SECRETION; ENDODERM; GENERATION	Transplantation of pancreatic progenitors or insulin-secreting cells derived from human embryonic stem cells (hESCs) has been proposed as a therapy for diabetes. We describe a seven-stage protocol that efficiently converts hESCs into insulin-producing cells. Stage (S) 7 cells expressed key markers of mature pancreatic beta cells, including MAFA, and displayed glucose-stimulated insulin secretion similar to that of human islets during static incubations in vitro. Additional characterization using single-cell imaging and dynamic glucose stimulation assays revealed similarities but also notable differences between S7 insulin-secreting cells and primary human beta cells. Nevertheless, S7 cells rapidly reversed diabetes in mice within 40 days, roughly four times faster than pancreatic progenitors. Therefore, although S7 cells are not funk equivalent to mature beta cells, their capacity for glucose-responsive insulin secretion and rapid reversal of diabetes in vivo makes them a promising alternative to pancreatic progenitor cells or cadaveric islets for the treatment of diabetes.	[Rezania, Alireza; Arora, Payal; Rubin, Allison; Batushansky, Irina] Janssen R&D LLC, BetaL Venture, Raritan, NJ 08869 USA; [Bruin, Jennifer E.; Asadi, Ali; O'Dwyer, Shannon; Quiskamp, Nina; Mojibian, Majid; Albrecht, Tobias; Yang, Yu Hsuan Carol; Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada	Johnson & Johnson; Janssen Pharmaceuticals; University of British Columbia; University of British Columbia	Kieffer, TJ (corresponding author), Janssen R&D LLC, BetaL Venture, Raritan, NJ 08869 USA.	ARezani@its.jnj.com; tim.kieffer@ubc.ca		asadi, ali/0000-0002-6224-9982; Bruin, Jennifer/0000-0003-2326-7819; Yang, Yu Hsuan Carol/0000-0001-6663-0302	JDRF; Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative; Stem Cell Network (SCN); L'Oreal Canada; NSERC Post Graduate Scholarship; Mitacs Elevate Postdoctoral Fellowship; CIHR Transplantation Training Program; Stem Cell Technologies; JDRF postdoctoral fellowship	JDRF(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative(Canadian Institutes of Health Research (CIHR)); Stem Cell Network (SCN); L'Oreal Canada; NSERC Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mitacs Elevate Postdoctoral Fellowship; CIHR Transplantation Training Program(Canadian Institutes of Health Research (CIHR)); Stem Cell Technologies; JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation)	This work was supported in part by funding from the JDRF, the Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative, and the Stem Cell Network (SCN). J.E.B. was funded by a JDRF postdoctoral fellowship and L'Oreal Canada for Women in Science Research Excellence Fellowship. Y.H.C.Y. was the recipient of an NSERC Post Graduate Scholarship and M.M. was the recipient of a Mitacs Elevate Postdoctoral Fellowship. The CIHR Transplantation Training Program provided funding for J.E.B., N.Q. and M.M. We also thank Stem Cell Technologies for their financial support, T. Webber, S. Karuna and B. Hu for their technical assistance, and G. Warnock and Z. Ao from the Irving K. Barber Human Islet Isolation Laboratory (Vancouver, BC) for providing human islets.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Bruin JE, 2013, DIABETOLOGIA, V56, P1987, DOI 10.1007/s00125-013-2955-4; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DAVALLI AM, 1995, TRANSPLANTATION, V59, P817, DOI 10.1097/00007890-199503270-00003; Haase TN, 2013, DIABETOLOGIA, V56, P763, DOI 10.1007/s00125-012-2821-9; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar M, 2003, CURR OPIN GENET DEV, V13, P401, DOI 10.1016/S0959-437X(03)00089-3; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Mahadevan J, 2013, DIABETES, V62, P3582, DOI 10.2337/db13-0357; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Sander M, 2000, DEVELOPMENT, V127, P5533; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; TUCH BE, 1991, TRANSPLANTATION, V51, P557, DOI 10.1097/00007890-199103000-00002; TUCH BE, 1991, TRANSPLANTATION, V51, P1156, DOI 10.1097/00007890-199106000-00003; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	59	902	987	16	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1121	1133		10.1038/nbt.3033	http://dx.doi.org/10.1038/nbt.3033			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25211370				2022-12-25	WOS:000344977000017
J	Lanaya, H; Natarajan, A; Komposch, K; Li, L; Amberg, N; Chen, L; Wculek, SK; Hammer, M; Zenz, R; Peck-Radosavljevic, M; Sieghart, W; Trauner, M; Wang, HY; Sibilia, M				Lanaya, Hanane; Natarajan, Anuradha; Komposch, Karin; Li, Liang; Amberg, Nicole; Chen, Lei; Wculek, Stefanie K.; Hammer, Martina; Zenz, Rainer; Peck-Radosavljevic, Markus; Sieghart, Wolfgang; Trauner, Michael; Wang, Hongyang; Sibilia, Maria			EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; COMPENSATORY PROLIFERATION; CELL-PROLIFERATION; JNK; INFLAMMATION; CANCER; GEFITINIB	Hepatocellular carcinoma (HCC) is a frequent cancer with limited treatment options and poor prognosis. Tumorigenesis has been linked with macrophage-mediated chronic inflammation and diverse signalling pathways, including the epidermal growth factor receptor (EGFR) pathway. The precise role of EGFR in HCC is unknown, and EGFR inhibitors have shown disappointing clinical results. Here we discover that EGFR is expressed in liver macrophages in both human HCC and in a mouse HCC model. Mice lacking EGFR in macrophages show impaired hepatocarcinogenesis, whereas mice lacking EGFR in hepatocytes unexpectedly develop more HCC owing to increased hepatocyte damage and compensatory proliferation. Mechanistically, following interleukin-1 stimulation, EGFR is required in liver macrophages to transcriptionally induce interleukin-6, which triggers hepatocyte proliferation and HCC. Importantly, the presence of EGFR-positive liver macrophages in HCC patients is associated with poor survival. This study demonstrates a tumour-promoting mechanism for EGFR in non-tumour cells, which could lead to more effective precision medicine strategies.	[Lanaya, Hanane; Natarajan, Anuradha; Komposch, Karin; Amberg, Nicole; Wculek, Stefanie K.; Hammer, Martina; Zenz, Rainer; Sibilia, Maria] Med Univ Vienna, Inst Canc Res, Dept Med 1, Ctr Comprehens Canc, A-1090 Vienna, Austria; [Li, Liang; Chen, Lei; Wang, Hongyang] Eastern Hepatobiliary Surg Inst Hosp, Natl Ctr Liver Canc, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Peck-Radosavljevic, Markus; Sieghart, Wolfgang; Trauner, Michael] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, A-1090 Vienna, Austria	Medical University of Vienna; Naval Medical University; Medical University of Vienna	Sibilia, M (corresponding author), Med Univ Vienna, Inst Canc Res, Dept Med 1, Ctr Comprehens Canc, Borschkegasse 8a, A-1090 Vienna, Austria.	maria.sibilia@meduniwien.ac.at	Wculek, Stefanie K/F-9626-2016	Wculek, Stefanie K/0000-0001-5565-8561; Sibilia, Maria/0000-0001-6129-5613; Trauner, Michael/0000-0002-1275-6425	EC [LSHC-CT-2006-037731]; Austrian Science Fund (FWF) [SFB F3518-B20, F3517, FWF-DK W1212, P25925]; Austrian Federal Government's GEN-AU program 'Austromouse' [GZ 200.147/1-VI/1a/2006, 820966]; National Natural Science Foundation of China [30921006]; Austrian Science Fund (FWF) [P 25925] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Government's GEN-AU program 'Austromouse'; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to L. Bakiri, D. P. Barlow, R. Eferl, M. Oft and E. F. Wagner for critical reading of the manuscript. We thank T. Baykuscheva-Gentscheva and S. Bardakji for genotyping and F. Hucke and G. Heinze for statistical support. This work was supported by the EC programme LSHC-CT-2006-037731 (Growthstop), the Austrian Science Fund (FWF) grants SFB F3518-B20 (to MS.), F3517 (to M.T.), FWF-DK W1212 and P25925 and the Austrian Federal Government's GEN-AU program 'Austromouse' (GZ 200.147/1-VI/1a/2006 and 820966). H.W. acknowledges funding by the National Natural Science Foundation of China, 30921006.	Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feitelson MA, 2004, SURG CLIN N AM, V84, P339, DOI 10.1016/S0039-6109(03)00226-3; Finkin S, 2011, CURR TOP MICROBIOL, V349, P185, DOI 10.1007/82_2010_104; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hopfner M, 2004, J HEPATOL, V41, P1008, DOI 10.1016/j.jhep.2004.08.024; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Li HP, 2013, CARCINOGENESIS, V34, P2443, DOI 10.1093/carcin/bgt206; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mallarkey G, 2013, THER ADV MED ONCOL, V5, P5, DOI 10.1177/1758834012467829; McElroy SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038373; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Sell S, 2002, SEMIN CELL DEV BIOL, V13, P419, DOI 10.1016/S1084952102001295; Vainer GW, 2008, CANCER LETT, V267, P182, DOI 10.1016/j.canlet.2008.03.016; Wang K, 2010, HEPATOLOGY, V52, P164, DOI 10.1002/hep.23650; Wang SN, 2012, EUR J CLIN INVEST, V42, P1295, DOI 10.1111/eci.12003; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236	32	164	173	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					972	981		10.1038/ncb3031	http://dx.doi.org/10.1038/ncb3031			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25173978	Green Accepted			2022-12-25	WOS:000342712200007
J	Li, YH; Zhou, GY; Ma, JX; Jiang, WK; Jin, LG; Zhang, ZH; Guo, Y; Zhang, JB; Sui, Y; Zheng, LT; Zhang, SS; Zuo, QY; Shi, XH; Li, YF; Zhang, WK; Hu, YY; Kong, GY; Hong, HL; Tan, B; Song, J; Liu, ZX; Wang, YS; Ruan, H; Yeung, CKL; Liu, J; Wang, HL; Zhang, LJ; Guan, RX; Wang, KJ; Li, WB; Chen, SY; Chang, RZ; Jiang, Z; Jackson, SA; Li, RQ; Qiu, LJ				Li, Ying-hui; Zhou, Guangyu; Ma, Jianxin; Jiang, Wenkai; Jin, Long-guo; Zhang, Zhouhao; Guo, Yong; Zhang, Jinbo; Sui, Yi; Zheng, Liangtao; Zhang, Shan-shan; Zuo, Qiyang; Shi, Xue-hui; Li, Yan-fei; Zhang, Wan-ke; Hu, Yiyao; Kong, Guanyi; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Wang, Yaoshen; Ruan, Hang; Yeung, Carol K. L.; Liu, Jian; Wang, Hailong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Li, Wen-bin; Chen, Shou-yi; Chang, Ru-zhen; Jiang, Zhi; Jackson, Scott A.; Li, Ruiqiang; Qiu, Li-juan			De novo assembly of soybean wild relatives for pan-genome analysis of diversity and agronomic traits	NATURE BIOTECHNOLOGY			English	Article							DISEASE RESISTANCE; GENETIC DIVERSITY; OPEN SOFTWARE; MOSAIC-VIRUS; GLYCINE-SOJA; SEQUENCE; ALIGNMENT; IDENTIFICATION; EXPRESSION; DOMESTICATION	Wild relatives of crops are an important source of genetic diversity for agriculture, but their gene repertoire remains largely unexplored. We report the establishment and analysis of a pan-genome of Glycine soja, the wild relative of cultivated soybean Glycine max, by sequencing and de novo assembly of seven phylogenetically and geographically representative accessions. Intergenomic comparisons identified lineage-specific genes and genes with copy number variation or large-effect mutations, some of which show evidence of positive selection and may contribute to variation of agronomic traits such as biotic resistance, seed composition, flowering and maturity time, organ size and final biomass. Approximately 80% of the pan-genome was present in all seven accessions (core), whereas the rest was dispensable and exhibited greater variation than the core genome, perhaps reflecting a role in adaptation to diverse environments. This work will facilitate the harnessing of untapped genetic diversity from wild soybean for enhancement of elite cultivars.	[Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, MOA, Key Lab Crop Gene Resource & Germplasm Enhancemen, Beijing 100193, Peoples R China; [Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, MOA, Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Zhou, Guangyu; Jiang, Wenkai; Zhang, Zhouhao; Zhang, Jinbo; Zheng, Liangtao; Zuo, Qiyang; Hu, Yiyao; Kong, Guanyi; Wang, Yaoshen; Ruan, Hang; Yeung, Carol K. L.; Liu, Jian; Wang, Hailong; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Zhang, Wan-ke; Chen, Shou-yi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Li, Wen-bin] Northeast Agr Univ, Key Lab Soybean Biol, Chinese Minist Educ, Harbin, Peoples R China; [Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Li, Ruiqiang] Peking Univ, Biodynam Opt Imaging Ctr, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Northeast Agricultural University - China; University System of Georgia; University of Georgia; Peking University; Peking University	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	sjackson@uga.edu; lirq@novogene.cn; qiulijuan@caas.cn	Shanshan, Zhang/AAH-9471-2021; Song, Jian/HGD-2320-2022; zhang, jin/GXV-9154-2022; Ruan, Hang/AAI-7367-2021; Zhang, Li/GWM-7501-2022	Ruan, Hang/0000-0001-7506-3805; jackson, scott/0000-0002-3172-1607; Zheng, Liangtao/0000-0001-9795-3198; Wang, Yaoshen/0000-0003-2034-3855	National Natural Science Foundation of China [31271753]; State Key Basic Research and Development Plan of China (973) [2010CB125903, 2009CB118404]; International Science and Technology Cooperation and Exchanges Projects [2008DFA30550]; Platform of National Crop Germplasm Resources of China [2012-004, 2013-004]; US National Science Foundation [DBI 0822258]; Division Of Integrative Organismal Systems [1229956] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China (973)(National Basic Research Program of China); International Science and Technology Cooperation and Exchanges Projects; Platform of National Crop Germplasm Resources of China; US National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Natural Science Foundation of China (no. 31271753), the State Key Basic Research and Development Plan of China (973) (no. 2010CB125903 and 2009CB118404), the International Science and Technology Cooperation and Exchanges Projects (no. 2008DFA30550), the Platform of National Crop Germplasm Resources of China (nos. 2012-004 and 2013-004) and US National Science Foundation (no. DBI 0822258). We thank R. Stupar for critical reading of this manuscript and valuable suggestions. We also thank H. Zhu, Y. Xin, X. Meng and many additional staff at Novogene Bioinformatics Institute who contributed to this teamwork.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Claros Manuel Gonzalo, 2012, Biology (Basel), V1, P439, DOI 10.3390/biology1020439; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eskandari M, 2013, THEOR APPL GENET, V126, P1839, DOI 10.1007/s00122-013-2096-7; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; FUKUDA YASONA, 1933, JAP JOUR BOT, V6, P489; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Liu B., 2012, ESTIMATION GENOMIC C; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Monteros MJ, 2010, THEOR APPL GENET, V121, P1023, DOI 10.1007/s00122-010-1368-8; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Qi ZM, 2011, EUPHYTICA, V179, P499, DOI 10.1007/s10681-011-0386-1; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shoji T, 2004, PLANT PHYSIOL, V136, P3933, DOI 10.1104/pp.104.051748; Smit A, 1996, REPEATMASKER OPEN 30; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Suh SJ, 2011, PLANT GENOME-US, V4, P55, DOI 10.3835/plantgenome2010.11.0024; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wang D, 2004, THEOR APPL GENET, V108, P458, DOI 10.1007/s00122-003-1449-z; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Wen RH, 2013, MOL PLANT MICROBE IN, V26, P203, DOI 10.1094/MPMI-06-12-0156-R; Xin DW, 2008, EUPHYTICA, V162, P155, DOI 10.1007/s10681-008-9652-2; Xu B., 1993, JINLIN AGR SCI, V2, P1; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yang Y, 2011, PLANT PHYSIOL, V156, P873, DOI 10.1104/pp.111.175950; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JQ, 2013, THEOR APPL GENET, V126, P1555, DOI 10.1007/s00122-013-2073-1	78	351	383	27	199	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1045	+		10.1038/nbt.2979	http://dx.doi.org/10.1038/nbt.2979			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25218520	hybrid			2022-12-25	WOS:000343763800022
J	Bredenkamp, N; Ulyanchenko, S; O'Neill, KE; Manley, NR; Vaidya, HJ; Blackburn, CC				Bredenkamp, Nicholas; Ulyanchenko, Svetlana; O'Neill, Kathy Emma; Manley, Nancy Ruth; Vaidya, Harsh Jayesh; Blackburn, Catherine Clare			An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts	NATURE CELL BIOLOGY			English	Article							T-CELL DEVELOPMENT; EMBRYONIC STEM-CELLS; DELTA-LIKE-1 IN-VITRO; EPITHELIAL-CELLS; LINEAGE COMMITMENT; PROGENITOR CELLS; DIFFERENTIATION; INDUCTION; GROWTH; MICROENVIRONMENT	10.1038/ncb3023	[Bredenkamp, Nicholas; Ulyanchenko, Svetlana; O'Neill, Kathy Emma; Vaidya, Harsh Jayesh; Blackburn, Catherine Clare] Univ Edinburgh, Ctr Regenerat Med, Sch Biol Sci, Inst Stem Cell Res,Med Res Council, Edinburgh EH16 4UU, Midlothian, Scotland; [Manley, Nancy Ruth] Univ Georgia, Dept Genet, Athens, GA 30602 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University System of Georgia; University of Georgia	Blackburn, CC (corresponding author), Univ Edinburgh, Ctr Regenerat Med, Sch Biol Sci, Inst Stem Cell Res,Med Res Council, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009; Vaidya, Harsh/L-4903-2019	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; Ulyanchenko, Svetlana/0000-0003-3124-9178	Leukaemia and Lymphoma Research; Darwin Trust of Edinburgh; School of Biological Sciences, University of Edinburgh; Medical Research Council; European Union [200720, 602587]; NIH/NIAID [R01 AI082127]; BBSRC [BB/H021183/1] Funding Source: UKRI; MRC [MR/L012766/1, G0300058, MR/K017047/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021183/1] Funding Source: researchfish; Medical Research Council [G0300058, MR/L012766/1, MR/K017047/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082127] Funding Source: NIH RePORTER	Leukaemia and Lymphoma Research; Darwin Trust of Edinburgh; School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank O. Rodrigues and C. Cryer for cell sorting, V. Berno for imaging, F. H. Stenhouse and C. D. Peddie for technical assistance and J. Mee for kidney grafting, R. Zamoyska, R. Brown lie and G. Cowan for advice, V. Wilson, K. Kaji, A. G. Smith, I. Chambers and N. Hastie for comments on the manuscript, and the Biological Research Facility staff for animal care. The research leading to these results received funding from Leukaemia and Lymphoma Research (C.C.B. and N.B.), the Darwin Trust of Edinburgh (S.U.), the School of Biological Sciences, University of Edinburgh (H.J.V.), the Medical Research Council (C.C.B.), the European Union Seventh Framework Programme (FP7/2007-2013) collaborative projects EuroSyStem (C.C.B. and N.B.) and ThymiStem (C.C.B., S.U., K.E.O'N) under grant agreement numbers 200720 and 602587, respectively, and NIH/NIAID grant no. R01 AI082127 (N.R.M.).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Dervovic DD, 2013, J IMMUNOL, V191, P1704, DOI 10.4049/jimmunol.1300417; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Inami Y, 2011, IMMUNOL CELL BIOL, V89, P314, DOI 10.1038/icb.2010.96; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lai LJ, 2011, BLOOD, V118, P3410, DOI 10.1182/blood-2011-03-340794; Lai LJ, 2009, STEM CELLS, V27, P3012, DOI 10.1002/stem.238; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Manley NR, 2010, PROG MOL BIOL TRANSL, V92, P103, DOI 10.1016/S1877-1173(10)92005-X; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MILLER JF, 1961, LANCET, V2, P748; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Sheridan JM, 2009, GENESIS, V47, P346, DOI 10.1002/dvg.20505; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024	40	102	108	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					902	908		10.1038/ncb3023	http://dx.doi.org/10.1038/ncb3023			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25150981	Green Accepted			2022-12-25	WOS:000341404400010
J	Gidon, A; Al-Bataineh, MM; Jean-Alphonse, FG; Stevenson, HP; Watanabe, T; Louet, C; Khatri, A; Calero, G; Pastor-Soler, NM; Gardella, TJ; Vilardaga, JP				Gidon, Alexandre; Al-Bataineh, Mohammad M.; Jean-Alphonse, Frederic G.; Stevenson, Hilary P.; Watanabe, Tomoyuki; Louet, Claire; Khatri, Ashok; Calero, Guillermo; Pastor-Soler, Nuria M.; Gardella, Thomas J.; Vilardaga, Jean-Pierre			Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase	NATURE CHEMICAL BIOLOGY			English	Article							PARATHYROID-HORMONE RECEPTOR; HUMAN-FIBROBLASTS; PTH RECEPTOR; ENDOCYTOSIS; ACIDIFICATION; RETROMER; ARRESTIN; PROTEINS; CAMP	The PTH receptor is to our knowledge one of the first G protein-coupled receptor (GPCR) found to sustain cAMP signaling after internalization of the ligand-receptor complex in endosomes. This unexpected model is adding a new dimension on how we think about GPCR signaling, but its mechanism is incompletely understood. We report here that endosomal acidification mediated by the PKA action on the v-ATPase provides a negative feedback mechanism by which endosomal receptor signaling is turned off.	[Gidon, Alexandre; Jean-Alphonse, Frederic G.; Louet, Claire; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA; [Al-Bataineh, Mohammad M.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Stevenson, Hilary P.; Calero, Guillermo] Univ Pittsburgh, Sch Med, Dept Med, Dept Biol Struct, Pittsburgh, PA 15213 USA; [Watanabe, Tomoyuki; Khatri, Ashok; Gardella, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital	Gidon, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA.	jpv@pitt.edu	Gidon, Alexandre/ABC-1477-2020	Vilardaga, Jean-Pierre/0000-0002-1217-1435; Gidon, Alexandre/0000-0001-9722-1253; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH) [R01 DK087688, R01 DK102495, P01 DK11794, R01 DK08184, F32 DK097889]; Cellular Physiology Core of the 'Pittsburgh Kidney Research Center' [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, P30DK079307, R01DK102495, P01DK011794] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH); Cellular Physiology Core of the 'Pittsburgh Kidney Research Center'; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH) under Award numbers R01 DK087688 and R01 DK102495 (to J.-P.V.), P01 DK11794 (project I to T.J.G.), R01 DK08184 (to N.M.P.-S.) and F32 DK097889 (to M.M.A.-B.) as well as the Cellular Physiology Core of the P30 DK079307 'Pittsburgh Kidney Research Center'. The authors thank K.R. Hallows for his suggestions on the v-ATPase phosphorylation assay.	Alzamora R, 2010, J BIOL CHEM, V285, P24676, DOI 10.1074/jbc.M110.106278; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; BROWN MS, 1975, CELL, V6, P307, DOI 10.1016/0092-8674(75)90182-8; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; El Hage T, 2007, FEBS J, V274, P2614, DOI 10.1111/j.1742-4658.2007.05797.x; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; HARFORD J, 1983, J BIOL CHEM, V258, P3191; Krueger KM, 1997, J BIOL CHEM, V272, P5; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pullara F, 2013, PROTEIN EXPRES PURIF, V87, P111, DOI 10.1016/j.pep.2012.10.007; RAO K, 1983, FEBS LETT, V160, P213, DOI 10.1016/0014-5793(83)80969-7; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Vilardaga JP, 2012, TRENDS PHARMACOL SCI, V33, P423, DOI 10.1016/j.tips.2012.05.004; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110	18	52	52	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					707	709		10.1038/NCHEMBIO.1589	http://dx.doi.org/10.1038/NCHEMBIO.1589			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25064832	Green Accepted, Green Submitted			2022-12-25	WOS:000341126800005
J	Liu, YJ; Wilson, TJ; McPhee, SA; Lilley, DMJ				Liu, Yijin; Wilson, Timothy J.; McPhee, Scott A.; Lilley, David M. J.			Crystal structure and mechanistic investigation of the twister ribozyme	NATURE CHEMICAL BIOLOGY			English	Article							ACID-BASE CATALYSIS; DELTA VIRUS RIBOZYME; HAMMERHEAD RIBOZYME; HAIRPIN RIBOZYME; ACTIVE-SITE; GLMS RIBOZYME; SELF-CLEAVAGE; RNA; ACTIVATION; JUNCTION	We present a crystal structure at 2.3-angstrom resolution of the recently described nucleolytic ribozyme twister. The RNA adopts a previously uncharacterized compact fold based on a double-pseudoknot structure, with the active site at its center. Eight highly conserved nucleobases stabilize the core of the ribozyme through the formation of one Watson-Crick and three noncanonical base pairs, and the highly conserved adenine 3' of the scissile phosphate is bound in the major groove of an adjacent pseudoknot. A strongly conserved guanine nucleobase directs its Watson-Crick edge toward the scissile phosphate in the crystal structure, and mechanistic evidence supports a role for this guanine as either a general base or acid in a concerted, general acid-base-catalyzed cleavage reaction.	[Liu, Yijin; Wilson, Timothy J.; McPhee, Scott A.; Lilley, David M. J.] Univ Dundee, Inst Med Sci, Canc Res UK Nucle Add Struct Res Grp, Wellcome Trust Bldg MSI WTB Complex, Dundee, Scotland	University of Dundee	Lilley, DMJ (corresponding author), Univ Dundee, Inst Med Sci, Canc Res UK Nucle Add Struct Res Grp, Wellcome Trust Bldg MSI WTB Complex, Dundee, Scotland.	d.m.j.lilley@dundee.ac.uk			Cancer Research UK [A11722]; Biotechnology and Biological Sciences Research Council [B17092] Funding Source: researchfish; Cancer Research UK [11722] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J017094/1] Funding Source: researchfish; EPSRC [EP/J017094/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are extremely grateful to R. Breaker for early communication of his data on the twister ribozyme and B. Hunter and L. Huang for valuable advice and discussion. The work was funded by Cancer Research UK (program grant A11722).	Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Cochrane JC, 2009, BIOCHEMISTRY-US, V48, P3239, DOI 10.1021/bi802069p; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; Han J, 2005, BIOCHEMISTRY-US, V44, P7864, DOI 10.1021/bi047941z; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; Kath-Schorr S, 2012, J AM CHEM SOC, V134, P16717, DOI 10.1021/ja3067429; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Klein DJ, 2007, J AM CHEM SOC, V129, P14858, DOI 10.1021/ja0768441; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kuzmin YI, 2005, J MOL BIOL, V349, P989, DOI 10.1016/j.jmb.2005.04.005; Lafontaine DA, 2001, J MOL BIOL, V312, P663, DOI 10.1006/jmbi.2001.4996; Lee TS, 2008, J AM CHEM SOC, V130, P3053, DOI 10.1021/ja076529e; Lilley D.M.J., 2011, CHEM ORIGINS LIFE IT, P2851; Lilley David M. J., 2008, P1; Lipfert J, 2008, STRUCTURE, V16, P1357, DOI 10.1016/j.str.2008.07.007; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Murray JB, 1998, CELL, V92, P665, DOI 10.1016/S0092-8674(00)81134-4; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ouellet J, 2010, RNA, V16, P1597, DOI 10.1261/rna.2158410; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Roth A, 2014, NAT CHEM BIOL, V10, P56, DOI [10.1038/nchembio.1386, 10.1038/NCHEMBIO.1386]; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Thomas JM, 2009, J AM CHEM SOC, V131, P1135, DOI 10.1021/ja807790e; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698; Wilson TJ, 2011, RNA, V17, P213, DOI 10.1261/rna.2473711; Wilson TJ, 2010, P NATL ACAD SCI USA, V107, P11751, DOI 10.1073/pnas.1004255107; Wilson TJ, 2009, SCIENCE, V323, P1436, DOI 10.1126/science.1169231; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	41	87	88	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					739	744		10.1038/NCHEMBIO.1587	http://dx.doi.org/10.1038/NCHEMBIO.1587			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038788				2022-12-25	WOS:000341126800010
J	Yu, B; Chang, J; Liu, YS; Li, J; Kevork, K; Al-Hezaimi, K; Graves, DT; Park, NH; Wang, CY				Yu, Bo; Chang, Jia; Liu, Yunsong; Li, Jiong; Kevork, Kareena; Al-Hezaimi, Khalid; Graves, Dana T.; Park, No-Hee; Wang, Cun-Yu			Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-kappa B	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; BONE LOSS; OSTEOCLAST DEVELOPMENT; POSTMENOPAUSAL WOMEN; ESTROGEN DEFICIENCY; BETA-CATENIN; STEM-CELLS; EXPRESSION; OSTEOPOROSIS; MECHANISMS	Aging-related bone loss and osteoporosis affect millions of people worldwide. Chronic inflammation associated with aging promotes bone resorption and impairs bone formation. Here we show that Wnt4 attenuates bone loss in osteoporosis and skeletal aging mouse models by inhibiting nuclear factor-kappa B (NF-kappa B) via noncanonical Wnt signaling. Transgenic mice expressing Wnt4 from osteoblasts were significantly protected from bone loss and chronic inflammation induced by ovariectomy, tumor necrosis factor or natural aging. In addition to promoting bone formation, Wnt4 inhibited osteoclast formation and bone resorption. Mechanistically, Wnt4 inhibited NF-kappa B activation mediated by transforming growth factor-beta-activated kinase-1 (Tak1) in macrophages and osteoclast precursors independently of beta-catenin. Moreover, recombinant Wnt4 alleviated bone loss and inflammation by inhibiting NF-kappa B in vivo in mouse models of bone disease. Given its dual role in promoting bone formation and inhibiting bone resorption, our results suggest that Wnt4 signaling could be an attractive therapeutic target for treating osteoporosis and preventing skeletal aging.	[Yu, Bo; Chang, Jia; Li, Jiong; Kevork, Kareena; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Liu, Yunsong] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Al-Hezaimi, Khalid] King Saud Univ, Div Periodontol, Coll Dent, Engn AB Res Ctr Growth Factors & Bone Regenerat, Riyadh, Saudi Arabia; [Graves, Dana T.] Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA 19104 USA; [Park, No-Hee] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; Peking University; King Saud University; University of Pennsylvania; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90024 USA.	cunywang@ucla.edu			US National Institute of Dental and Craniofacial [DE19412, DE16513]; US National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR63089]; UCLA Broad Stem Cell Research Center Research Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R90DE023057, R01DE016513, R01DE019412] Funding Source: NIH RePORTER	US National Institute of Dental and Craniofacial; US National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UCLA Broad Stem Cell Research Center Research Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Adams for valuable advice. This work was supported by the US National Institute of Dental and Craniofacial Research grants DE19412 and DE16513 (to C.-Y.W.), the US National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR63089 (to C.-Y.W.) and the UCLA Broad Stem Cell Research Center Research Award (to C.-Y.W.).	Almeida M, 2010, MOL ENDOCRINOL, V24, P2030, DOI 10.1210/me.2010-0189; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen Q, 2013, J BONE MINER RES, V28, P1214, DOI 10.1002/jbmr.1851; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Hayward Michael D., 2007, BMC Physiology, V7, P13, DOI 10.1186/1472-6793-7-13; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jimi E, 2005, IMMUNOL REV, V208, P80, DOI 10.1111/j.0105-2896.2005.00329.x; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; KREBSBACH PH, 1993, MOL CELL BIOL, V13, P5168, DOI 10.1128/MCB.13.9.5168; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Pandey AC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt90; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Regard JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007997; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	58	155	171	5	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1009	1017		10.1038/nm.3586	http://dx.doi.org/10.1038/nm.3586			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25108526	Green Accepted, Green Submitted			2022-12-25	WOS:000341404000013
J	Cordeddu, V; Redeker, B; Stellacci, E; Jongejan, A; Fragalet, A; Bradley, TEJ; Anselmi, M; Ciolfi, A; Cecchetti, S; Mutol, V; Bernardini, L; Azage, M; Carvalho, DR; Espay, AJ; Male, A; Molin, AM; Posmyk, R; Battistils, C; Casertano, A; Melis, D; van Kampen, A; Baas, F; Mannensr, MM; Bocchinfuso, G; Stella, L; Tartaglia, M; Hennekam, RC				Cordeddu, Viviana; Redeker, Bert; Stellacci, Emilia; Jongejan, Aldo; Fragalet, Alessandra; Bradley, Ted E. J.; Anselmi, Massimiliano; Ciolfi, Andrea; Cecchetti, Serena; Mutol, Valentina; Bernardini, Laura; Azage, Meron; Carvalho, Daniel R.; Espay, Alberto J.; Male, Alison; Molin, Anna-Maja; Posmyk, Renata; Battistils, Carla; Casertano, Alberto; Melis, Daniela; van Kampen, Antoine; Baas, Frank; Mannensr, Marcel M.; Bocchinfuso, Gianfranco; Stella, Lorenzo; Tartaglia, Marco; Hennekam, Raoul C.			Mutations in ZBTB20 cause Primrose syndrome	NATURE GENETICS			English	Article							FINGER PROTEIN ZBTB20; 3 ZINC FINGERS; DNA-BINDING; TRANSCRIPTION; RECOGNITION; OVERGROWTH; AFFINITY; TFIIIA	Primrose syndrome and 3q13.31 microdeletion syndrome are clinically related disorders characterized by tall stature, macrocephaly, intellectual disability, disturbed behavior and unusual facial features, with diabetes, deafness, progressive muscle wasting and ectopic calcifications specifically occurring in the former. We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome. This finding establishes a genetic link between these disorders and delineates the impact of ZBTB20 dysregulation on development, growth and metabolism.	[Cordeddu, Viviana; Stellacci, Emilia; Ciolfi, Andrea; Mutol, Valentina; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Redeker, Bert; Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Jongejan, Aldo; van Kampen, Antoine] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Fragalet, Alessandra] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie Immuno, I-00161 Rome, Italy; [Bradley, Ted E. J.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [Anselmi, Massimiliano; Bocchinfuso, Gianfranco; Stella, Lorenzo] Univ Roma Tor Vergata, Dipartimento Sci Tecnol Chim, Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Bernardini, Laura] Fdn Casa Sollievo Sofferenza, Lab Mendel, San Giovanni Rotondo, Italy; [Azage, Meron] Childrens Hosp Pittsburgh, Dept Med Genet, Pittsburgh, PA 15213 USA; [Carvalho, Daniel R.] SARAH Network Rehabil Hosp, Med Genet Unit, Brasilia, DF, Brazil; [Espay, Alberto J.] Univ Cincinnati, Gardner Family Ctr Parkinsons Dis & Movement Diso, Dept Neurol, Cincinnati, OH USA; [Male, Alison] Children Natl Hlth Serv NHS Fdn Trust, Great Ormond St Hosp, Clin Genet Dept, London, England; [Molin, Anna-Maja] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Posmyk, Renata] Podlaskie Ctr Clin Genet, Bialystok, Poland; [Battistils, Carla] Univ Siena, Policlin Scotte, Dipartimento Sci Neurol Neurochirurg, I-53100 Siena, Italy; [Melis, Daniela] Univ Naples Federico II, Fac Med & Chirurg, Dipartimento Pediat, Naples, Italy; [Mannensr, Marcel M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	Istituto Superiore di Sanita (ISS); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Istituto Superiore di Sanita (ISS); University of Amsterdam; Academic Medical Center Amsterdam; University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); IRCCS Casa Sollievo Della Sofferenza; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Swedish University of Agricultural Sciences; University of Siena; University of Naples Federico II; University of Amsterdam; Academic Medical Center Amsterdam	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it; r.c.hennekam@amc.uva.nl	Bocchinfuso, Gianfranco/E-9014-2011; cordeddu, viviana/J-2272-2014; Anselmi, Massimiliano/H-9950-2014; Bernardini, Laura/H-5360-2016; Melis, Daniela/AAD-3623-2019; Espay, Alberto J./AAC-4255-2020; stellacci, emilia/J-2747-2014; Stella, Lorenzo/A-7996-2010; Ciolfi, Andrea/J-4954-2018; Baas, Frank/F-9574-2010; Fragale, Alessandra/K-1071-2016; Cecchetti, Serena/N-1061-2015; cordeddu, viviana/A-5612-2016; Tartaglia, Marco/K-2955-2018	Bocchinfuso, Gianfranco/0000-0002-5556-7691; Anselmi, Massimiliano/0000-0001-5711-770X; Bernardini, Laura/0000-0002-3554-2817; Melis, Daniela/0000-0002-9458-3926; Espay, Alberto J./0000-0002-3389-136X; stellacci, emilia/0000-0003-0415-3285; Stella, Lorenzo/0000-0002-5489-7381; Ciolfi, Andrea/0000-0002-6191-0978; Baas, Frank/0000-0003-3912-5428; Fragale, Alessandra/0000-0002-0362-1983; Cecchetti, Serena/0000-0002-3601-176X; cordeddu, viviana/0000-0001-7159-7383; Tartaglia, Marco/0000-0001-7736-9672; Muto, Valentina/0000-0003-1542-5039; Casertano, Alberto/0000-0002-8417-4432	Istituto Superiore di Sanita [RC2013]	Istituto Superiore di Sanita	We are grateful to the patients and their families. We thank M.L. Motta and S Venanzi (Istituto Superiore di Sanita) for technical assistance, the CINECA Consortium for computational resources, and K. Riabowol (University of Calgary), H. Nakabayashi (Hokkaido Information University) and Y. Miura (Graduate School of Medical Science, Nagoya, Japan) for providing the AFP promoter luciferase construct and the HNF1 and ATBF1 expression vectors, respectively. This work was supported by funding from the Istituto Superiore di Sanita (RC2013) to M.T.	CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Dhanasekaran M, 2008, BIOCHEMISTRY-US, V47, P11717, DOI 10.1021/bi801306d; Mathijssen IB, 2006, EUR J MED GENET, V49, P127, DOI 10.1016/j.ejmg.2005.06.001; Mitchelmore C, 2002, J BIOL CHEM, V277, P7598, DOI 10.1074/jbc.M110023200; Molin AM, 2012, J MED GENET, V49, P104, DOI 10.1136/jmedgenet-2011-100534; PRIMROSE DA, 1982, J MENT DEFIC RES, V26, P101; Sabin MA, 2011, BEST PRACT RES CL EN, V25, P207, DOI 10.1016/j.beem.2010.09.010; Shuvarikov A, 2013, HUM MUTAT, V34, P1415, DOI 10.1002/humu.22384; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Zhang WP, 2001, BIOCHEM BIOPH RES CO, V282, P1067, DOI 10.1006/bbrc.2001.4689; Zhang Y, 2012, GASTROENTEROLOGY, V142, P1571, DOI 10.1053/j.gastro.2012.02.043	15	61	62	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					815	817		10.1038/ng.3035	http://dx.doi.org/10.1038/ng.3035			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25017102				2022-12-25	WOS:000339704400008
J	Larsen, DH; Hari, F; Clapperton, JA; Gwerder, M; Gutsche, K; Altmeyer, M; Jungmichel, S; Toleo, LI; Fink, D; Rask, MB; Grofte, M; Lukas, C; Nielsen, ML; Smerdon, SJ; Lukas, J; Stucki, M				Larsen, Dorthe H.; Hari, Flurina; Clapperton, Juliea A.; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toleo, Luis I.; Fink, Daniel; Rask, Maj-Britt; Grofte, Merete; Lukas, Claudia; Nielsen, Michael L.; Smerdon, Stephen J.; Lukas, Jiri; Stucki, Manuel			The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage	NATURE CELL BIOLOGY			English	Article							TREACHER-COLLINS-SYNDROME; GENE-PRODUCT; MDC1; NBS1; ATM; COLLINSSYNDROME,TREACHER; PHOSPHORYLATION; CHECKPOINT; RETENTION; BREAKAGE	Chromosome breakage elicits transient silencing of ribosomal RNA synthesis, but the mechanisms involved remained elusive. Here we discover an in trans signalling mechanism that triggers pan-nuclear silencing of rRNA transcription in response to DNA damage. This is associated with transient recruitment of the Nijmegen breakage syndrome protein 1 (NBS1), a central regulator of DNA damage responses, into the nucleoli. We further identify TCOF1 (also known as Treacle), a nucleolar factor implicated in ribosome biogenesis and mutated in Treacher Collins syndrome, as an interaction partner of NBS1, and demonstrate that NBS1 translocation and accumulation in the nucleoli is Treacle dependent. Finally, we provide evidence that Treacle-mediated NBS1 recruitment into the nucleoli regulates rRNA silencing in trans in the presence of distant chromosome breaks.	[Larsen, Dorthe H.; Gwerder, Myriam; Gutsche, Katrin; Fink, Daniel; Stucki, Manuel] Univ Hosp, Dept Gynaecol, CH-8952 Schlieren, Switzerland; [Larsen, Dorthe H.; Gwerder, Myriam; Gutsche, Katrin; Fink, Daniel; Stucki, Manuel] Univ Zurich, Dept Gynaecol, CH-8952 Schlieren, Switzerland; [Larsen, Dorthe H.; Altmeyer, Matthias; Jungmichel, Stephanie; Toleo, Luis I.; Rask, Maj-Britt; Grofte, Merete; Lukas, Claudia; Nielsen, Michael L.; Lukas, Jiri] Univ Copenhagen, Fac Med & Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Hari, Flurina; Stucki, Manuel] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Clapperton, Juliea A.; Smerdon, Stephen J.] Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England	University of Copenhagen; University of Zurich; MRC National Institute for Medical Research	Lukas, J (corresponding author), Univ Copenhagen, Fac Med & Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk; manuel.stucki@uzh.ch	Altmeyer, Matthias/AAE-8186-2019; Toledo, Luis/M-6685-2019; Stucki, Manuel/H-4739-2017; Toledo, Luis/R-2065-2016; Larsen, Dorthe Helena/E-9771-2010; Larsen, Dorthe Helena/Z-6206-2019	Altmeyer, Matthias/0000-0003-3780-1170; Toledo, Luis/0000-0001-9509-9944; Toledo, Luis/0000-0001-9509-9944; Larsen, Dorthe Helena/0000-0002-8280-1252; Larsen, Dorthe Helena/0000-0002-8280-1252; Gutsche, Katrin/0000-0003-0578-1443; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X; Smerdon, Stephen/0000-0001-5688-8465; Nielsen, Michael/0000-0002-0067-9039	Swiss National Foundation [3100A0-111818, 31003A-144284]; Lundbeckfonden [R93-A8863]; Novo Nordisk Foundation; Medical Research Council UK [U117584228]; Promedica Foundation; MRC [MC_U117584228] Funding Source: UKRI; Medical Research Council [MC_U117584228] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Jiri Lukas, PI Michael Lund Nielsen] Funding Source: researchfish	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Lundbeckfonden(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Promedica Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Foundation Center for Protein Research	We thank S. Jackson (The Gurdon Institute, Cambridge, UK) for reagents, R. Santoro for technical support in relation to rRNA transcription, C. Dinant for critical discussion of the FRAP data and members of the Department of Gynecology, the Novo Nordisk Foundation Center for Protein Research and the National Institute of Medical Research for helpful discussions. This work was supported by grants from the Swiss National Foundation (3100A0-111818 and 31003A-144284), Promedica Foundation, Lundbeckfonden (R93-A8863), Novo Nordisk Foundation and by the Kanton of Z rich. S.J.S. is supported by the Medical Research Council UK (U117584228).	Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Isaac C, 2000, MOL BIOL CELL, V11, P3061, DOI 10.1091/mbc.11.9.3061; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MEIER UT, 1992, CELL, V70, P127; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Sakai D, 2009, INT J BIOCHEM CELL B, V41, P1229, DOI 10.1016/j.biocel.2008.10.026; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wise CA, 1997, P NATL ACAD SCI USA, V94, P3110, DOI 10.1073/pnas.94.7.3110; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105	33	96	98	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					792	U298		10.1038/ncb3007	http://dx.doi.org/10.1038/ncb3007			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	25064736	Green Accepted			2022-12-25	WOS:000339904900011
J	Lim, WK; Ong, CK; Tan, J; Thike, AA; Young Ng, CC; Rajasegaran, V; Myint, SS; Nagarajan, S; Md Nasir, ND; McPherson, JR; Cutcutache, I; Poore, G; Tay, ST; Ooi, WS; Tan, VKM; Hartman, M; Ong, KW; Tan, BKT; Rozen, SG; Tan, PH; Tan, P; Teh, BT				Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Thike, Aye Aye; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Nasir, Nur Diyana Md; McPherson, John R.; Cutcutache, Ioana; Poore, Gregory; Tay, Su Ting; Ooi, Wei Siong; Tan, Veronique Kiak Mien; Hartman, Mikael; Ong, Kong Wee; Tan, Benita K. T.; Rozen, Steven G.; Tan, Puay Hoon; Tan, Patrick; Teh, Bin Tean			Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma	NATURE GENETICS			English	Article							PHYLLODES TUMOR; CANCER; RISK; GENE; LANDSCAPE	Fibroadenomas are the most common breast tumors in women under 30 (refs. 1,2). Exome sequencing of eight fibroadenomas with matching whole-blood samples revealed recurrent somatic mutations solely in MED12, which encodes a Mediator complex subunit. Targeted sequencing of an additional 90 fibroadenomas confirmed highly frequent MED12 exon 2 mutations (58/98, 59%) that are probably somatic, with 71% of mutations occurring in codon 44. Using laser capture microdissection, we show that MED12 fibroadenoma mutations are present in stromal but not epithelial mammary cells. Expression profiling of MED12-mutated and wild-type fibroadenomas revealed that MED12 mutations are associated with dysregulated estrogen signaling and extracellular matrix organization. The fibroadenoma MED12 mutation spectrum is nearly identical to that of previously reported MED12 lesions in uterine leiomyoma but not those of other tumors. Benign tumors of the breast and uterus, both of which are key target tissues of estrogen, may thus share a common genetic basis underpinned by highly frequent and specific MED12 mutations.	[Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Teh, Bin Tean] Natl Canc Ctr, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Tay, Su Ting; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Thike, Aye Aye; Nasir, Nur Diyana Md; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [McPherson, John R.; Cutcutache, Ioana; Rozen, Steven G.] Duke NUS Grad Med Sch, Div Neurosci & Behav Disorders, Singapore, Singapore; [Poore, Gregory] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Ooi, Wei Siong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Tan, Veronique Kiak Mien; Ong, Kong Wee] Natl Canc Ctr, Div Surg Oncol, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Tan, Benita K. T.] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; National University of Singapore; Duke University; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Teh, BT (corresponding author), Natl Canc Ctr, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.	steve.rozen@duke-nus.edu.sg; tan.puay.hoon@sgh.com.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Lim, Weng Khong/Q-8661-2019; Rozen, Steven G./J-5939-2013; Hartman, Mikael/B-4324-2011	Lim, Weng Khong/0000-0003-4391-1130; Teh, Bin Tean/0000-0003-1514-1124; Tan, Jing/0000-0002-4605-4624; Ong, Choon Kiat/0000-0001-6402-4288; Myint, Swe Swe/0000-0002-2430-088X; Rozen, Steven G./0000-0002-4288-0056; Hartman, Mikael/0000-0001-5726-9965	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Tanoto Foundation; Singapore National Cancer Centre Research Fund; Duke-NUS Graduate Medical School; Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Tanoto Foundation; Singapore National Cancer Centre Research Fund; Duke-NUS Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong	This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore Millennium Foundation, the Lee Foundation, the Tanoto Foundation, the Singapore National Cancer Centre Research Fund, the Duke-NUS Graduate Medical School, the Cancer Science Institute, Singapore and the Verdant Foundation, Hong Kong. We thank the Duke-NUS Genome Biology Facility for sequencing services rendered, as well as the Advanced Molecular Pathology Laboratory, Institute of Molecular and Cell Biology, A*STAR, Singapore for providing LCM resources. We also thank the SingHealth Tissue Repository for frozen tissue samples.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardes J R M Jr, 2003, Breast J, V9, P302, DOI 10.1046/j.1524-4741.2003.09410.x; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; Fine RE, 2003, AM J SURG, V186, P362, DOI 10.1016/S0002-9610(03)00263-0; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco N, 2001, CANCER RES, V61, P7955; Harper PS, 2011, HUM GENET, V130, P169, DOI 10.1007/s00439-011-1013-x; Je EM, 2012, INT J CANCER, V131, pE1044, DOI 10.1002/ijc.27610; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krishnamurthy S, 2000, CANCER CYTOPATHOL, V90, P342, DOI 10.1002/1097-0142(20001225)90:6<342::AID-CNCR4>3.3.CO;2-9; Liu XF, 2011, SCAND J SURG, V100, P147, DOI 10.1177/145749691110000302; Makinen N, 2014, INT J CANCER, V134, P1008, DOI 10.1002/ijc.28410; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; MILLIKAN R, 1995, J CLIN ONCOL, V13, P2293, DOI 10.1200/JCO.1995.13.9.2293; Nelson ZC, 2002, AM J EPIDEMIOL, V156, P599, DOI 10.1093/aje/kwf094; NOGUCHI S, 1993, CANCER RES, V53, P4071; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vorkas PA, 2010, J MOL DIAGN, V12, P697, DOI 10.2353/jmoldx.2010.100008; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	27	123	125	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					877	880		10.1038/ng.3037	http://dx.doi.org/10.1038/ng.3037			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038752				2022-12-25	WOS:000339704400017
J	Sinha, G				Sinha, Gunjan			Shire gobbles up Lumena and its fatty liver pills	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P207	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					705	705		10.1038/nbt0814-705	http://dx.doi.org/10.1038/nbt0814-705			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101725	Bronze			2022-12-25	WOS:000346455900031
J	Yamane, D; McGivern, DR; Wauthier, E; Yi, M; Madden, VJ; Welsch, C; Antes, I; Wen, YH; Chugh, PE; McGee, CE; Widmann, DG; Misumi, I; Bandyopadhyay, S; Kim, S; Shimakami, T; Oikawa, T; Whitmire, JK; Heise, MT; Dittmer, DP; Kao, CC; Pitson, SM; Merrill, AH; Reid, LM; Lemon, SM				Yamane, Daisuke; McGivern, David R.; Wauthier, Eliane; Yi, MinKyung; Madden, Victoria J.; Welsch, Christoph; Antes, Iris; Wen, Yahong; Chugh, Pauline E.; McGee, Charles E.; Widmann, Douglas G.; Misumi, Ichiro; Bandyopadhyay, Sibali; Kim, Seungtaek; Shimakami, Tetsuro; Oikawa, Tsunekazu; Whitmire, Jason K.; Heise, Mark T.; Dittmer, Dirk P.; Kao, C. Cheng; Pitson, Stuart M.; Merrill, Alfred H., Jr.; Reid, Lola M.; Lemon, Stanley M.			Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation	NATURE MEDICINE			English	Article							OXIDATIVE STRESS; CULTURE; LIVER; ANTIOXIDANTS; ACTIVATION; EXPRESSION; MEMBRANE; COFACTOR; COMPLEX; KINASE	Oxidative tissue injury often accompanies viral infection, yet there is little understanding of how it influences virus replication. We show that multiple hepatitis C virus (HCV) genotypes are exquisitely sensitive to oxidative membrane damage, a property distinguishing them from other pathogenic RNA viruses. Lipid peroxidation, regulated in part through sphingosine kinase-2, severely restricts HCV replication in Huh-7 cells and primary human hepatoblasts. Endogenous oxidative membrane damage lowers the 50% effective concentration of direct-acting antivirals in vitro, suggesting critical regulation of the conformation of the NS3-4A protease and the NS5B polymerase, membrane-bound HCV replicase components. Resistance to lipid peroxidation maps genetically to transmembrane and membrane-proximal residues within these proteins and is essential for robust replication in cell culture, as exemplified by the atypical JFH1 strain of HCV. Thus, the typical, wild-type HCV replicase is uniquely regulated by lipid peroxidation, providing a mechanism for attenuating replication in stressed tissue and possibly facilitating long-term viral persistence.	[Yamane, Daisuke; McGivern, David R.; Kim, Seungtaek; Shimakami, Tetsuro; Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27514 USA; [Yamane, Daisuke; McGivern, David R.; Wauthier, Eliane; Chugh, Pauline E.; Kim, Seungtaek; Shimakami, Tetsuro; Oikawa, Tsunekazu; Whitmire, Jason K.; Heise, Mark T.; Dittmer, Dirk P.; Reid, Lola M.; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wauthier, Eliane; Oikawa, Tsunekazu; Reid, Lola M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Yi, MinKyung] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Madden, Victoria J.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Welsch, Christoph] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Antes, Iris] Tech Univ Munich, Dept Life Sci, CIPSM, Freising Weihenstephan, Germany; [Wen, Yahong; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Chugh, Pauline E.; Whitmire, Jason K.; Dittmer, Dirk P.; Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [McGee, Charles E.; Misumi, Ichiro; Whitmire, Jason K.; Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Widmann, Douglas G.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Bandyopadhyay, Sibali; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bandyopadhyay, Sibali; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kim, Seungtaek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Pitson, Stuart M.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston; University of North Carolina; University of North Carolina Chapel Hill; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Technical University of Munich; Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Yonsei University; Yonsei University Health System; Centre for Cancer Biology; SA Pathology	Yamane, D (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27514 USA.	yamane@email.unc.edu; smlemon@med.unc.edu	Misumi, Ichiro/H-8573-2019; Mcgivern, David/H-6210-2019; Ariel, Pablo/AGJ-4118-2022; Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022; , PEP-MX Core/AGV-4051-2022; Welsch, Christoph/AAF-6785-2020; Pitson, Stuart/B-9342-2009	Misumi, Ichiro/0000-0003-3892-7605; Mcgivern, David/0000-0003-3497-5087; Dittmer, Dirk/0000-0003-4968-5656; Welsch, Christoph/0000-0002-1823-4863; Pitson, Stuart/0000-0002-9527-2740; Madden, Victoria/0000-0002-7909-7743; Merrill, Alfred/0000-0002-6673-968X; Widman, Douglas/0000-0002-3585-6373; Whitmire, Jason/0000-0003-2578-6073	US National Institutes of Health [RO1-AI095690, RO1-CA164029, U19-AI109965, R21-CA182322, R01-AI075090, RO1-AI073335, RO1-DE018304, F32-AI094941, U54-GM069338]; National Cancer Institute [P30-CA016086]; University of North Carolina Cancer Research Fund; Deutsche Forschungsgemeinschaft [WE 4388/3-1, WE 4388/6-1]; CIPSM Cluster of Excellence; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA164029, P20CA150343, R21CA182322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075090, U19AI109965, R01AI073335, R01AI103083, F32AI094941, P30AI050410, R01AI095690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of North Carolina Cancer Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM Cluster of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L.F. Ping and W. Lovell for expert technical assistance, R. Purcell (US National Institute of Allergy and Infectious Diseases) and J. Bukh (Copenhagen University Hospital, Denmark) for pCV-H77C and pTNcc plasmids, C.M. Rice and M. Saeed (The Rockefeller University) for Huh-7.5 cells and S52/SG-Feo and ED43/SG-Feo plasmids, T. Wakita (National Institute of Infectious Diseases, Japan) for pJFH1 and pJFH-2 plasmids, M.J. Otto (Pharmasset) for PSI-6130, A. Sluder (SCYNEXIS) for SCY-635, R. De Francesco (Istituto Nazionale di Genetica Molecolare, Italy) for compound 23, A.Y. Howe (Merck Research Laboratory) for boceprevir, HCV-796, MK-0608 and MK-7009 and Z. Feng (University of North Carolina) for hepatitis A virus stocks. We also thank S.A. Weinman for critical reading of the manuscript and D.L. Tyrrell, M. Joyce, R.A. Coleman and T. Masaki for helpful discussions. This work was supported by US National Institutes of Health grants RO1-AI095690, RO1-CA164029 and U19-AI109965 (S.M.L.), R21-CA182322 (L.R.), R01-AI075090 (M.Y.), RO1-AI073335 (C.C.K.), RO1-DE018304 (D.P.D.), F32-AI094941 (D.G.W.) and U54-GM069338 (S.B.), a National Cancer Institute Center Core Support Grant to the Lineberger Comprehensive Cancer Center (P30-CA016086) and the University of North Carolina Cancer Research Fund. C.W. was supported by the Deutsche Forschungsgemeinschaft (WE 4388/3-1 and WE 4388/6-1). I.A. was supported by the CIPSM Cluster of Excellence.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andrus L, 2011, HEPATOLOGY, V54, P1901, DOI 10.1002/hep.24557; Beard MR, 1999, HEPATOLOGY, V30, P316, DOI 10.1002/hep.510300137; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Choi J, 2012, FREE RADICAL BIO MED, V52, P1135, DOI 10.1016/j.freeradbiomed.2012.01.008; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang H, 2007, P NATL ACAD SCI USA, V104, P18666, DOI 10.1073/pnas.0708423104; Ibrahim W, 1997, J NUTR, V127, P1401, DOI 10.1093/jn/127.7.1401; Jain SK, 2002, J HEPATOL, V36, P805, DOI 10.1016/S0168-8278(02)00060-0; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kohlway A, 2014, J VIROL, V88, P628, DOI 10.1128/JVI.02052-13; Lackner T, 2005, J VIROL, V79, P9746, DOI 10.1128/JVI.79.15.9746-9755.2005; Li YP, 2012, P NATL ACAD SCI USA, V109, P19757, DOI 10.1073/pnas.1218260109; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	99	101	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					927	935		10.1038/nm.3610	http://dx.doi.org/10.1038/nm.3610			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25064127	Green Accepted, Green Submitted			2022-12-25	WOS:000340074600025
J	Drakeman, DL				Drakeman, Donald L.			Benchmarking biotech and pharmaceutical product development	NATURE BIOTECHNOLOGY			English	Article									[Drakeman, Donald L.] Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Cambridge, England; [Drakeman, Donald L.] Advent Venture Partners, London, England	University of Cambridge	Drakeman, DL (corresponding author), Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Trumpington St, Cambridge, England.	don.drakeman@adventventures.com						[Anonymous], 2008, PHARMALIVE; [Anonymous], 2006, PHARM EXECUTIVE MAGA, P80; [Anonymous], 2005, PHARM EXECUTIVE MAGA, P85; [Anonymous], 2006, PHARMALIVE; [Anonymous], 2007, PHARMALIVE; [Anonymous], 2011, PHARMALIVE; [Anonymous], 2008, PHARM EXECUTIVE MAGA, P75; [Anonymous], 2010, PHARMALIVE; [Anonymous], 2005, PHARMALIVE; [Anonymous], 2007, PHARM EXECUTIVE MAGA, P100; [Anonymous], GUID IND EXP PROGR S; Brichacek A., 2000, PHARM EXECUTIVE MAGA, P63; Cacciotti J., 2011, PHARM EXECUTIVE MAGA, P42; Clinton P., 2010, PHARM EXECUTIVE MAGA, P70; Clinton P., 2012, PHARM EXECUTIVE MAGA, P26; Ernst & Young, 2013, BORD MATT EV; Ernst & Young, 2013, BORD GLOB BIT IND RE; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Noor W., 2013, PHARM EXECUTIVE MAGA, P20; Pharm Exec Staff, 2009, PHARM EXECUTIVE MAGA, P69; Sellers L.J., 2004, PHARM EXECUTIVE MAGA, P61; Sellers L.J., 2003, PHARM EXECUTIVE MAGA, P43; Sellers L. J., 2002, PHARM EXECUTIVE MAGA, P61; Sellers L.J., 1999, PHARM EXECUTIVE MAGA, P63; Trusheim MR, 2010, NBER WORKING PAPERS, V13, P1; US Congressional Budget Office, 2006, RES DEV PHARM IND; US Food and Drug Administration, 2013, RES DEV PHARM IND	28	8	8	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					621	625		10.1038/nbt.2947	http://dx.doi.org/10.1038/nbt.2947			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004226	Bronze			2022-12-25	WOS:000338705900023
J	Crowley, JJ; Zhabotynsky, V; Sun, W; Huang, SP; Pakatci, IK; Kim, Y; Wang, JR; Morgan, AP; Calaway, JD; Aylor, DL; Yun, ZN; Bell, TA; Buus, RJ; Calaway, ME; Didion, JP; Gooch, TJ; Hansen, SD; Robinson, NN; Shaw, GD; Spence, JS; Quackenbush, CR; Barrick, CJ; Nonneman, RJ; Kim, K; Xenakis, J; Xie, YY; Valdar, W; Lenarcic, AB; Wang, W; Welsh, CE; Fu, CP; Zhang, ZJ; Holt, J; Guo, ZS; Threadgill, DW; Tarantino, LM; Miller, DR; Zou, F; McMillan, L; Sullivan, PF; de Villena, FPM				Crowley, James J.; Zhabotynsky, Vasyl; Sun, Wei; Huang, Shunping; Pakatci, Isa Kemal; Kim, Yunjung; Wang, Jeremy R.; Morgan, Andrew P.; Calaway, John D.; Aylor, David L.; Yun, Zaining; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Spence, Jason S.; Quackenbush, Corey R.; Barrick, Cordelia J.; Nonneman, Randal J.; Kim, Kyungsu; Xenakis, James; Xie, Yuying; Valdar, William; Lenarcic, Alan B.; Wang, Wei; Welsh, Catherine E.; Fu, Chen-Ping; Zhang, Zhaojun; Holt, James; Guo, Zhishan; Threadgill, David W.; Tarantino, Lisa M.; Miller, Darla R.; Zou, Fei; McMillan, Leonard; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel			Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance	NATURE GENETICS			English	Article							MAMMALIAN X-CHROMOSOME; DOSAGE COMPENSATION; RNA-SEQ; IMPRINTED GENES; UP-REGULATION; LINKED GENES; HUMAN GENOME; INACTIVATION; EVOLUTION; ORIGIN	Complex human traits are influenced by variation in regulatory DNA through mechanisms that are not fully understood. Because regulatory elements are conserved between humans and mice, a thorough annotation of cis regulatory variants in mice could aid in further characterizing these mechanisms. Here we provide a detailed portrait of mouse gene expression across multiple tissues in a three-way diallel. Greater than 80% of mouse genes have cis regulatory variation. Effects from these variants influence complex traits and usually extend to the human ortholog. Further, we estimate that at least one in every thousand SNPs creates a cis regulatory effect. We also observe two types of parent-of-origin effects, including classical imprinting and a new global allelic imbalance in expression favoring the paternal allele. We conclude that, as with humans, pervasive regulatory variation influences complex genetic traits in mice and provide a new resource toward understanding the genetic control of transcription in mammals.	[Crowley, James J.; Zhabotynsky, Vasyl; Sun, Wei; Kim, Yunjung; Morgan, Andrew P.; Calaway, John D.; Aylor, David L.; Yun, Zaining; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Spence, Jason S.; Quackenbush, Corey R.; Barrick, Cordelia J.; Nonneman, Randal J.; Xie, Yuying; Valdar, William; Lenarcic, Alan B.; Miller, Darla R.; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sun, Wei; Kim, Kyungsu; Xenakis, James] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Huang, Shunping; Pakatci, Isa Kemal; Wang, Jeremy R.; Wang, Wei; Welsh, Catherine E.; Fu, Chen-Ping; Zhang, Zhaojun; Holt, James; Guo, Zhishan; McMillan, Leonard] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Morgan, Andrew P.; Calaway, John D.; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Valdar, William; Miller, Darla R.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Morgan, Andrew P.; Calaway, John D.; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Miller, Darla R.; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Threadgill, David W.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Tarantino, Lisa M.; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	fernando@med.unc.edu	Valdar, William/AAE-4354-2019; Threadgill, David W/N-4425-2013; Wang, Jeremy/L-7971-2019; Guo, Zhishan/AAG-4292-2020	Threadgill, David W/0000-0003-3538-1635; Wang, Jeremy/0000-0002-0673-9418; Guo, Zhishan/0000-0002-5967-1058; Wang, Wei/0000-0002-8180-2886; Kim, Yunjung/0000-0001-9080-4739; Holt, James/0000-0001-6411-9236; Didion, John/0000-0002-8111-6261; Crowley, James/0000-0001-9051-1557; Zhabotynsky, Vasyl/0000-0003-1575-5732	National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grant [P50MH090338, P50HG006582]; National Institute of General Medical Sciences [R01GM074175]; National Institute of Mental Health [K01MH094406]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES021535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105785, R01GM074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094406, P50MH090338, F30MH103925] Funding Source: NIH RePORTER	National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Mieczkowski, A. Brandt, E. Malc, M. Vernon, J. Brennan and M. Calabrese for helpful discussions. Major funding was provided by National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grants (P50MH090338 and P50HG006582, co-principal investigators F.P.-M.d.V. and P.F.S.). This work was also supported by grants R01GM074175 (principal investigator F.Z.) from the National Institute of General Medical Sciences and K01MH094406 (principal investigator J.J.C.) from the National Institute of Mental Health.	Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Calaway JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003853; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CATTANACH BM, 1970, GENET RES, V16, P293, DOI 10.1017/S001667230000255X; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Cui XQ, 2006, GENETICS, V174, P627, DOI 10.1534/genetics.106.060251; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hayden EC, 2012, NATURE, V484, P428, DOI 10.1038/484428a; He XL, 2011, NAT GENET, V43, P1171, DOI 10.1038/ng.1010; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang SP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau057; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Jue NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-150; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kharchenko PV, 2011, NAT GENET, V43, P1167, DOI 10.1038/ng.991; Kim Y, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.96; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Lin FQ, 2012, P NATL ACAD SCI USA, V109, P11752, DOI 10.1073/pnas.1201816109; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Lin H, 2011, NAT GENET, V43, P1169, DOI 10.1038/ng.992; Lopes AM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-82; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; Ohno S., 1967, SEX CHROMOSOMES SEX; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Wang X, 2011, GENETICS, V189, P109, DOI 10.1534/genetics.111.130088; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhang ZJ, 2013, BIOINFORMATICS, V29, P291, DOI 10.1093/bioinformatics/btt216; Zou F, 2014, GENETICS, V197, P389, DOI 10.1534/genetics.113.160119	58	127	130	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					353	U102		10.1038/ng.3222	http://dx.doi.org/10.1038/ng.3222			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730764	Green Accepted, Green Submitted			2022-12-25	WOS:000351922900010
J	Hussin, JG; Hodgkinson, A; Idaghdour, Y; Grenier, JC; Goulet, JP; Gbeha, E; Hip-Ki, E; Awadalla, P				Hussin, Julie G.; Hodgkinson, Alan; Idaghdour, Youssef; Grenier, Jean-Christophe; Goulet, Jean-Philippe; Gbeha, Elias; Hip-Ki, Elodie; Awadalla, Philip			Recombination affects accumulation of damaging and disease-associated mutations in human populations	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; DELETERIOUS MUTATIONS; MOLECULAR EVOLUTION; FINITE POPULATIONS; SEQUENCE VARIATION; MULLERS RATCHET; SELECTION; LINKAGE; VARIANTS; REGIONS	Many decades of theory have demonstrated that, in non-recombining systems, slightly deleterious mutations accumulate non-reversibly(1), potentially driving the extinction of many asexual species. Non-recombining chromosomes in sexual organisms are thought to have degenerated in a similar fashion(2); however, it is not clear the extent to which damaging mutations accumulate along chromosomes with highly variable rates of crossing over. Using high-coverage sequencing data from over 1,400 individuals in the 1000 Genomes and CARTaGENE projects, we show that recombination rate modulates the distribution of putatively deleterious variants across the entire human genome. Exons in regions of low recombination are significantly enriched for deleterious and disease-associated variants, a signature varying in strength across worldwide human populations with different demographic histories. Regions with low recombination rates are enriched for highly conserved genes with essential cellular functions and show an excess of mutations with demonstrated effects on health, a phenomenon likely affecting disease susceptibility in humans.	[Hussin, Julie G.; Hodgkinson, Alan; Idaghdour, Youssef; Grenier, Jean-Christophe; Gbeha, Elias; Hip-Ki, Elodie; Awadalla, Philip] Univ Montreal, Fac Med, Dept Pediat, St Justine Univ Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Hussin, Julie G.; Hodgkinson, Alan; Idaghdour, Youssef; Goulet, Jean-Philippe; Awadalla, Philip] St Justine Univ Hosp, CARTaGENE Project, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Awadalla, P (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	philip.awadalla@umontreal.ca	Awadalla, Philip/AAC-4896-2021	Grenier, Jean-Christophe/0000-0001-7937-5160; Hodgkinson, Alan/0000-0003-1636-491X	Fonds de la Recherche en Sante du Quebec (FRSQ); Genome Quebec; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); Canadian Partnership Against Cancer	Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Genome Quebec; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Canadian Partnership Against Cancer	We thank G. Gibson, E. Hatton, G. McVean, J. Novembre, C. Spencer, E. Stone and the anonymous reviewers for insightful comments on the study, and we thank the CARTaGENE participants and team for data collection. We confirm that informed consent was obtained from all subjects. We acknowledge financial support from Fonds de la Recherche en Sante du Quebec (FRSQ), Genome Quebec, Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) and the Canadian Partnership Against Cancer. J.G.H. is a Human Frontiers Postdoctoral Fellow, A.H. is an FRSQ Research Fellow, and Y.I. is a Banting Postdoctoral Fellow.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Awadalla P, 2013, INT J EPIDEMIOL, V42, P1285, DOI 10.1093/ije/dys160; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bullaughey K, 2008, GENOME RES, V18, P544, DOI 10.1101/gr.071548.107; Campos JL, 2014, MOL BIOL EVOL, V31, P1010, DOI 10.1093/molbev/msu056; Campos JL, 2012, GENOME BIOL EVOL, V4, P278, DOI 10.1093/gbe/evs010; Casals F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003815; Charlesworth B, 1997, GENET RES, V70, P63, DOI 10.1017/S0016672397002899; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 2012, GENETICS, V190, P5, DOI 10.1534/genetics.111.134288; Comeron JM, 2008, HEREDITY, V100, P19, DOI 10.1038/sj.hdy.6801059; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; FELSENSTEIN J, 1974, GENETICS, V78, P737; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gordo I, 2002, GENETICS, V161, P835; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hodgkinson A, 2014, SCIENCE, V344, P413, DOI 10.1126/science.1251110; HUDSON RR, 1995, GENETICS, V141, P1605; Hussin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-65; Kaiser VB, 2009, TRENDS GENET, V25, P9, DOI 10.1016/j.tig.2008.10.009; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; McGaugh SE, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001422; Messer PW, 2013, GENETICS, V194, P1037, DOI 10.1534/genetics.113.152181; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Moreau C, 2011, SCIENCE, V334, P1148, DOI 10.1126/science.1212880; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	46	56	56	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					400	U162		10.1038/ng.3216	http://dx.doi.org/10.1038/ng.3216			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25685891	Green Submitted			2022-12-25	WOS:000351922900018
J	Shoshan, E; Mobley, AK; Braeuer, RR; Kamiya, T; Huang, L; Vasquez, ME; Salameh, A; Lee, HJ; Kim, SJ; Ivan, C; Velazquez-Torres, G; Nip, KM; Zhu, K; Brooks, D; Jones, SJM; Birol, I; Mosqueda, M; Wen, YY; Eterovic, AK; Sood, AK; Hwu, P; Gershenwald, JE; Robertson, AG; Calin, GA; Markel, G; Fidler, IJ; Bar-Eli, M				Shoshan, Einav; Mobley, Aaron K.; Braeuer, Russell R.; Kamiya, Takafumi; Huang, Li; Vasquez, Mayra E.; Salameh, Ahmad; Lee, Ho Jeong; Kim, Sun Jin; Ivan, Cristina; Velazquez-Torres, Guermarie; Nip, Ka Ming; Zhu, Kelsey; Brooks, Denise; Jones, Steven J. M.; Birol, Inanc; Mosqueda, Maribel; Wen, Yu-ye; Eterovic, Agda Karina; Sood, Anil K.; Hwu, Patrick; Gershenwald, Jeffrey E.; Robertson, A. Gordon; Calin, George A.; Markel, Gal; Fidler, Isaiah J.; Bar-Eli, Menashe			Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis	NATURE CELL BIOLOGY			English	Article							ELEMENT-BINDING PROTEIN; SYSTEMATIC IDENTIFICATION; RNA; EXPRESSION; CANCER; POLYADENYLATION; MODULATION; TARGETS; ADAR1; DICER	Although recent studies have shown that adenosine-to-inosine (A-to-I) RNA editing occurs in microRNAs (miRNAs), its effects on tumour growth and metastasis are not well understood. We present evidence of CREB-mediated low expression of ADAR1 in metastatic melanoma cell lines and tumour specimens. Re-expression of ADAR1 resulted in the suppression of melanoma growth and metastasis in vivo. Consequently, we identified three miRNAs undergoing A-to-I editing in the weakly metastatic melanoma but not in strongly metastatic cell lines. One of these miRNAs, miR-455-5p, has two A-to-I RNA-editing sites. The biological function of edited miR-455-5p is different from that of the unedited form, as it recognizes a different set of genes. Indeed, wild-type miR-455-5p promotes melanoma metastasis through inhibition of the tumour suppressor gene CPEB1. Moreover, wild-type miR-455 enhances melanoma growth and metastasis in vivo, whereas the edited form inhibits these features. These results demonstrate a previously unrecognized role for RNA editing in melanoma progression.	[Shoshan, Einav; Mobley, Aaron K.; Braeuer, Russell R.; Kamiya, Takafumi; Huang, Li; Vasquez, Mayra E.; Lee, Ho Jeong; Kim, Sun Jin; Velazquez-Torres, Guermarie; Sood, Anil K.; Fidler, Isaiah J.; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Salameh, Ahmad] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Ivan, Cristina; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Nip, Ka Ming; Zhu, Kelsey; Brooks, Denise; Jones, Steven J. M.; Birol, Inanc; Robertson, A. Gordon] Canadas Michael Smith Canc Agcy, Vancouver, BC V5Z 4S6, Canada; [Mosqueda, Maribel; Wen, Yu-ye; Eterovic, Agda Karina] Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA; [Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Ramat Gan, Israel; [Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Clin Microbiol & Immunol, IL-69978 Ramat Aviv, Israel	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Bar-Eli, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 0173,1515 Holcombe Blvd, Houston, TX 77030 USA.	mbareli@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; Gershenwald, Jeff/AAX-4367-2020; Calin, George/E-9390-2011; Birol, Inanc/G-5440-2011; Jones, Steven J/C-3621-2009	Sood, Anoop Kumar/0000-0001-5702-4108; Gershenwald, Jeff/0000-0003-4519-5369; Birol, Inanc/0000-0003-0950-7839; Jones, Steven J/0000-0003-3394-2208; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615; Ivan, Cristina/0000-0002-4848-0168	SINF; MDACC grant; NIH Skin Cancer SPORE [p50 CA093459]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA093459] Funding Source: NIH RePORTER	SINF; MDACC grant; NIH Skin Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Maas from NIH for providing the ADAR1 A-to-IRNA-editing hairpin loop luciferase reporter plasmid. We thank W.Choi for her help with the miRNA microarray. We thank R. Rajesha for his technical help and support. These studies are supported by SINF, an MDACC grant and NIH Skin Cancer SPORE p50 CA093459.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Caldeira J, 2012, GUT, V61, P1115, DOI 10.1136/gutjnl-2011-300427; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dohroll A. S, 2009, J BIOL CHEM, V284, P26194; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gommans WM, 2010, ANAL BIOCHEM, V399, P230, DOI 10.1016/j.ab.2009.12.037; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jin YF, 2009, IUBMB LIFE, V61, P572, DOI 10.1002/iub.207; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; Melnikova VO, 2008, CANCER BIOL THER, V7, P997, DOI 10.4161/cbt.7.7.6535; Melnikova VO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012452; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mobley AK, 2012, CANCER METAST REV, V31, P621, DOI 10.1007/s10555-012-9358-8; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Sasayama T, 2005, GENES CELLS, V10, P627, DOI 10.1111/j.1365-2443.2005.00870.x; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Wulff BE, 2012, CURR TOP MICROBIOL, V353, P91, DOI 10.1007/82_2011_151; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang JH, 2010, CELL DEATH DIFFER, V17, P1551, DOI 10.1038/cdd.2010.32; Zinshteyn B, 2009, WIRES SYST BIOL MED, V1, P202, DOI 10.1002/wsbm.10	38	155	159	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					311	+		10.1038/ncb3110	http://dx.doi.org/10.1038/ncb3110			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25686251	Green Accepted			2022-12-25	WOS:000350770200015
J	Imig, J; Brunschweiger, A; Brummer, A; Guennewig, B; Mittal, N; Kishore, S; Tsikrika, P; Gerber, AP; Zavolan, M; Hall, J				Imig, Jochen; Brunschweiger, Andreas; Bruemmer, Anneke; Guennewig, Boris; Mittal, Nitish; Kishore, Shivendra; Tsikrika, Panagiota; Gerber, Andre P.; Zavolan, Mihaela; Hall, Jonathan			miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction	NATURE CHEMICAL BIOLOGY			English	Article							ARGONAUTE PROTEIN COMPLEXES; LONG NONCODING RNA; MICRORNA TARGETS; MESSENGER-RNAS; H19 GENE; MUSCLE DIFFERENTIATION; CERNA HYPOTHESIS; IDENTIFICATION; EXPRESSION; SITES	Identifying the interaction partners of noncoding RNAs is essential for elucidating their functions. We have developed an approach, termed microRNA crosslinking and immunoprecipitation (miR-CLIP), using pre-miRNAs modified with psoralen and biotin to capture their targets in cells. Photo-crosslinking and Argonaute 2 immunopurification followed by streptavidin affinity purification of probe-linked RNAs provided selectivity in the capture of targets, which were identified by deep sequencing. miR-CLIP with pre-miR-106a, a miR-17-5p family member, identified hundreds of putative targets in HeLa cells, many carrying conserved sequences complementary to the miRNA seed but also many that were not predicted computationally. miR-106a overexpression experiments confirmed that miR-CLIP captured functional targets, including H19, a long noncoding RNA that is expressed during skeletal muscle cell differentiation. We showed that miR-17-5p family members bind H19 in HeLa cells and myoblasts. During myoblast differentiation, levels of H19, miR-17-5p family members and mRNA targets changed in a manner suggesting that H19 acts as a 'sponge' for these miRNAs.	[Imig, Jochen; Brunschweiger, Andreas; Guennewig, Boris; Tsikrika, Panagiota; Hall, Jonathan] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Bruemmer, Anneke; Mittal, Nitish; Kishore, Shivendra; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland; [Gerber, Andre P.] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Surrey	Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	mihaela.zavolan@unibas.ch; jonathan.hall@pharma.ethz.ch	Zavolan, Mihaela/S-3888-2016; Brunschweiger, Andreas/AAC-9952-2019	Brunschweiger, Andreas/0000-0002-4401-1495; Brummer, Anneke/0000-0002-3576-0750; Imig, Jochen/0000-0003-0385-1081; Zavolan, Mihaela/0000-0002-8832-2041; Guennewig, Boris/0000-0002-6357-818X; Hall, Jonathan/0000-0003-4160-7135	Swiss National Science Foundation [CRSII3_127454];  [CRS205321_124720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 	This work was supported by the Swiss National Science Foundation (in part) with a joint Sinergia grant (CRSII3_127454) to A.P.G., M.Z. and J.H. as well as a grant to J.H. (CRS205321_124720). We thank B. Schoser (Ludwig-Maximilians-Universitat, Munich) for myoblasts, M. Lucic and Y. Wang for help with assays and M. Zimmermann and U. Pradere for synthesis of RNAs. We thank H. Towbin and J.A. Zagalak for helpful discussions and Luca Gebert for graphical layout. We are grateful to Y. Huang (Yale Stem Cell Center) for sharing pH19 expression plasmids.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baigude H, 2012, ANGEW CHEM INT EDIT, V51, P5880, DOI 10.1002/anie.201201512; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Beitzinger M, 2011, METHODS MOL BIOL, V732, P153, DOI 10.1007/978-1-61779-083-6_12; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gibcus JH, 2011, J PATHOL, V225, P609, DOI 10.1002/path.2958; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Guennewig B, 2014, RNA, V20, P61, DOI 10.1261/rna.038968.113; Guo YE, 2014, RNA, V20, P985, DOI 10.1261/rna.045054.114; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Higuchi M, 2009, BIOORGAN MED CHEM, V17, P475, DOI 10.1016/j.bmc.2008.12.001; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jiang YG, 2011, TOXICOL SCI, V119, P50, DOI 10.1093/toxsci/kfq306; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Milligan L, 2000, ONCOGENE, V19, P5810, DOI 10.1038/sj.onc.1203965; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Xia Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00569	57	130	136	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					107	U43		10.1038/NCHEMBIO.1713	http://dx.doi.org/10.1038/NCHEMBIO.1713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25531890				2022-12-25	WOS:000348358800007
J	Rafii, S; Cao, ZW; Lis, R; Siempos, II; Chavez, D; Shido, K; Rabbany, SY; Ding, BS				Rafii, Shahin; Cao, Zhongwei; Lis, Raphael; Siempos, Ilias I.; Chavez, Deebly; Shido, Koji; Rabbany, Sina Y.; Ding, Bi-Sen			Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration	NATURE CELL BIOLOGY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; STEM-CELLS; ANGIOCRINE SIGNALS; PROGENITOR CELLS; STROMAL CELLS; DISEASE; REPAIR; ENDOTHELIUM; GROWTH; MEGAKARYOCYTES	The lung alveoli regenerate after surgical removal of the left lobe by pneumonectomy (PNX). How this alveolar regrowth/regeneration is initiated remains unknown. We found that platelets trigger lung regeneration by supplying stromal-cell-derived factor-1 (SDF-1, also known as CXCL12). After PNX, activated platelets stimulate SDF-1 receptors CXCR4 and CXCR7 on pulmonary capillary endothelial cells (PCECs) to deploy the angiocrine membrane-type metalloproteinase MMP14, stimulating alveolar epithelial cell (AEC) expansion and neo-alveolarization. In mice lacking platelets or platelet Sdf1, PNX-induced alveologenesis was diminished. Reciprocally, infusion of Sdf1(+/+) but not Sdf1-deficient platelets rescued lung regeneration in platelet-depleted mice. Endothelial-specific ablation of Cxcr4 and Cxcr7 in adult mice similarly impeded lung regeneration. Notably, mice with endothelial-specific Mmp14 deletion exhibited impaired expansion of AECs but not PCECs after PNX, which was not rescued by platelet infusion. Therefore, platelets prime PCECs to initiate lung regeneration, extending beyond their haemostatic contribution. Therapeutic targeting of this haemo-vascular niche could enable regenerative therapy for lung diseases.	[Rafii, Shahin; Cao, Zhongwei; Lis, Raphael; Chavez, Deebly; Shido, Koji; Rabbany, Sina Y.; Ding, Bi-Sen] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Rafii, Shahin; Cao, Zhongwei; Lis, Raphael; Siempos, Ilias I.; Chavez, Deebly; Shido, Koji; Rabbany, Sina Y.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Rafii, Shahin; Chavez, Deebly; Ding, Bi-Sen] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Rafii, Shahin; Lis, Raphael] Weill Cornell Med Coll, Dept Reprod Med, New York, NY 10065 USA; [Siempos, Ilias I.] Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care Med & Pulm Serv 1, Athens 10675, Greece; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Cornell University; Cornell University; Cornell University; Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens; Hofstra University	Ding, BS (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA.	bid2004@med.cornell.edu	Siempos, Ilias/GQZ-7330-2022		National Scientist Development Grant from the American Heart Association [12SDG1213004]; New York Stem Cell Foundation; Biotime; Ansary Stem Cell Institute; Empire State Stem Cell Board; New York State Department of Health [C026878, C028117, C029156]; National Heart, Lung, and Blood Institute [R01HL097797, R01HL115128, R01HL119872, R01HL128158]; National Cancer Institute [U54CA163167]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095039]; NATIONAL CANCER INSTITUTE [U54CA163167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115128, R01HL119872, R01HL097797, R01HL128158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	National Scientist Development Grant from the American Heart Association; New York Stem Cell Foundation; Biotime; Ansary Stem Cell Institute; Empire State Stem Cell Board; New York State Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to T. Hla, R. Nachman and A. Choi (Weill Cornell) and S. Albelda and D. Cines (University of Pennsylvania) for critically evaluating our manuscript. Thpo<SUP>-/-</SUP> mice were provided by F. de Sauvage at Genentech. We would also like to thank R. H. Adams, S. J. Weiss and Y-R. Zou for offering inducible EC-specific Cdh5-(PAC)-Cre<SUP>ERT2</SUP> and floxed Mmp14 and Cxcr4 mouse lines. We are indebted to M. E. Penfold at Chemocentryx for his help in providing floxed Cxcr7 mice. B.-S.D. is supported by a National Scientist Development Grant from the American Heart Association (number 12SDG1213004). B-S.D. and Z.C. are both supported by Druckenmiller Fellowships from the New York Stem Cell Foundation. S.Y.R. is supported by Biotime. S.R. and K.S. are supported by Ansary Stem Cell Institute, the Empire State Stem Cell Board and New York State Department of Health grants (C026878, C028117, C029156), and S.R. is supported by the National Heart, Lung, and Blood Institute R01HL097797, R01HL115128, R01HL119872 and R01HL128158, National Cancer Institute U54CA163167 and the National Institute of Diabetes and Digestive and Kidney Diseases R01DK095039.	Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bertozzi CC, 2010, ARTERIOSCL THROM VAS, V30, P2368, DOI 10.1161/ATVBAHA.110.217281; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Ding BS, 2003, CIRCULATION, V108, P2892, DOI 10.1161/01.CIR.0000103685.61137.3D; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fehrenbach H, 2008, EUR RESPIR J, V31, P515, DOI 10.1183/09031936.00109407; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gotts JE, 2013, CHEST, V143, P1525, DOI 10.1378/chest.12-2993; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Martinu T, 2011, AM J RESP CRIT CARE, V183, P968, DOI 10.1164/rccm.201101-0006ED; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Min SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5691; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Sato A, 2007, P NATL ACAD SCI USA, V104, P2361, DOI 10.1073/pnas.0607882104; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stripp BR, 2006, AM J RESP CELL MOL, V34, P517, DOI 10.1165/rcmb.F315; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Thane K, 2014, TRANSL RES, V163, P363, DOI 10.1016/j.trsl.2013.11.010; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	70	95	100	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					123	+		10.1038/ncb3096	http://dx.doi.org/10.1038/ncb3096			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25621952	Green Accepted, Bronze			2022-12-25	WOS:000349152400004
J	Marsh, T; Debnath, J				Marsh, Timothy; Debnath, Jayanta			Ironing out VPS34 inhibition	NATURE CELL BIOLOGY			English	Editorial Material							AUTOPHAGY; MECHANISMS; 3-KINASE; CELLS; HOMEOSTASIS; RECEPTOR; NCOA4		[Marsh, Timothy] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Marsh, T (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW450, San Francisco, CA 94143 USA.	jayanta.debnath@ucsf.edu		Debnath, Jayanta/0000-0002-8745-4069; Marsh, Timothy/0000-0002-8772-7645				Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Boada-Romero E, 2013, EMBO J, V32, P566, DOI 10.1038/emboj.2013.8; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	15	15	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					1	3		10.1038/ncb3089	http://dx.doi.org/10.1038/ncb3089			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25679028	Green Published			2022-12-25	WOS:000346823900001
J	Maury, Y; Come, J; Piskorowski, RA; Salah-Mohellibi, N; Chevaleyre, V; Peschanski, M; Martinat, C; Nedelec, S				Maury, Yves; Come, Julien; Piskorowski, Rebecca A.; Salah-Mohellibi, Nouzha; Chevaleyre, Vivien; Peschanski, Marc; Martinat, Cecile; Nedelec, Stephane			Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes	NATURE BIOTECHNOLOGY			English	Article							HUMAN ES; DOPAMINE NEURONS; MOTOR-NEURONS; SPECIFICATION; DIFFERENTIATION; INHIBITION; GENERATION; HINDBRAIN; REVEAL; MOTONEURONS	Specification of cell identity during development depends on exposure of cells to sequences of extrinsic cues delivered at precise times and concentrations. Identification of combinations of patterning molecules that control cell fate is essential for the effective use of human pluripotent stem cells (hPSCs) for basic and translational studies. Here we describe a scalable, automated approach to systematically test the combinatorial actions of small molecules for the targeted differentiation of hPSCs. Applied to the generation of neuronal subtypes, this analysis revealed an unappreciated role for canonical Wnt signaling in specifying motor neuron diversity from hPSCs and allowed us to define rapid (14 days), efficient procedures to generate spinal and cranial motor neurons as well as spinal interneurons and sensory neurons. Our systematic approach to improving hPSC-targeted differentiation should facilitate disease modeling studies and drug screening assays.	[Maury, Yves; Come, Julien] CECS, I STEM Inst Stem Cell Therapy & Explorat Monogen, AFM, Evry, France; [Piskorowski, Rebecca A.; Chevaleyre, Vivien] Sorbonne Paris Cite, Univ Paris Descartes, CNRS, UMR 8118, Paris, France; [Salah-Mohellibi, Nouzha; Peschanski, Marc; Martinat, Cecile; Nedelec, Stephane] INSERM, UEVE UMR 861, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Nedelec, S (corresponding author), INSERM, UEVE UMR 861, 1-STEM,AFM, Evry, France.	stephane.nedelec@inserm.fr	Peschanski, Marc/N-5769-2017; Piskorowski, Rebecca Ann/G-6610-2017; Nedelec, Stéphane/G-8469-2017; Martinat, Cécile S/F-6777-2010	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Nedelec, Stéphane/0000-0001-8044-2498; Martinat, Cécile S/0000-0002-5234-1064; come, julien/0000-0001-9519-2436; Chevaleyre, Vivien/0000-0002-3679-4856	AFM	AFM(Association Francaise contre les Myopathies)	I-Stem is part of the Biotherapies Institute for Rare Diseases (BIRD) supported by the Association Fran~aise contre les Myopathies (AFM-Tlthon). This project was funded by AFM, INSERM and Laboratoire d'Excellence " Labex Revive" (Investissement d'Avenir; ANR-10-LABX-73). S. N. is currently supported by the " Labex Revive" and was previously supported by a fellowship from the Genopole. N. S.-M. was supported by the program INGESTEM (investissement d'avenir ANR-11-INBS-009-01). R. A. P. and V. C. are supported by ATIP-Avenir, Agence Nationale de la Recherche (ANR-12-BSV4-0021-01, ANR-13-JSV4-0002-01) and the Ville de Paris. We thank C. Varela and N. Lefort (I-STEM) for karyotyping the cell lines and L. Aubry (I-STEM) for providing the IMR90 hiPSC line. We thank H. Wichterle, F. Giudicelli, V. Ribes, E. O. Mazzoni and A. Rebsam for helpful discussion and critical review of the manuscript. We thank J.-F. Brunet for providing the Phox2b antibody, E. R. Lowry and H. Wichterle (Columbia University) for testing the sMN differentiation and for the Hb9oGFP-Neomycin plasmid. We thank D. Furling (Institute of Myology) for providing human primary myoblasts.	Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Bialecka M, 2012, DEV BIOL, V371, P227, DOI 10.1016/j.ydbio.2012.08.018; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marklund U, 2014, STEM CELLS DEV, V23, P5, DOI 10.1089/scd.2013.0309; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Masuda T, 2008, J NEUROSCI, V28, P10380, DOI 10.1523/JNEUROSCI.1926-08.2008; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nedelec S, 2012, J NEUROSCI, V32, P1496, DOI 10.1523/JNEUROSCI.4176-11.2012; Nimchinsky EA, 2000, J COMP NEUROL, V416, P112, DOI 10.1002/(SICI)1096-9861(20000103)416:1<112::AID-CNE9>3.0.CO;2-K; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Sturgeon K, 2011, DEVELOPMENT, V138, P65, DOI 10.1242/dev.058727; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2010, NAT NEUROSCI, V13, P800, DOI 10.1038/nn.2577; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	206	213	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					89	U270		10.1038/nbt.3049	http://dx.doi.org/10.1038/nbt.3049			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25383599				2022-12-25	WOS:000347714200032
J	Noike, M; Matsui, T; Ooya, K; Sasaki, I; Ohtaki, S; Hamano, Y; Maruyama, C; Ishikawa, J; Satoh, Y; Ito, H; Morita, H; Dairi, T				Noike, Motoyoshi; Matsui, Takashi; Ooya, Koichi; Sasaki, Ikuo; Ohtaki, Shouta; Hamano, Yoshimitsu; Maruyama, Chitose; Ishikawa, Jun; Satoh, Yasuharu; Ito, Hajime; Morita, Hiroyuki; Dairi, Tohru			A peptide ligase and the ribosome cooperate to synthesize the peptide pheganomycin	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID LIGASE; GLUTATHIONE SYNTHETASE; BIOSYNTHESIS; ATP; PROTEINS; ENZYME	Peptide antibiotics are typically biosynthesized by one of two distinct machineries in a ribosome-dependent or ribosome-independent manner. Pheganomycin (PGM (1)) and related analogs consist of the nonproteinogenic amino acid (S)-2-(3,5-dihydroxy-4-hydroxymethyl)phenyl-2-guanidinoacetic acid (2) and a proteinogenic core peptide, making their origin uncertain. We report the identification of the biosynthetic gene cluster from Streptomyces cirratus responsible for PGM production. Unexpectedly, the cluster contains a gene encoding multiple precursor peptides along with several genes plausibly encoding enzymes for the synthesis of amino acid 2. We identified PGM1, which has an ATP-grasp domain, as potentially capable of linking the precursor peptides with 2, and validate this hypothesis using deletion mutants and in vitro reconstitution. We document PGM1's substrate permissivity, which could be rationalized by a large binding pocket as confirmed via structural and mutagenesis experiments. This is to our knowledge the first example of cooperative peptide synthesis achieved by ribosomes and peptide ligases using a peptide nucleophile.	[Noike, Motoyoshi; Ooya, Koichi; Sasaki, Ikuo; Satoh, Yasuharu; Ito, Hajime; Dairi, Tohru] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 060, Japan; [Matsui, Takashi; Ohtaki, Shouta; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Toyama 930, Japan; [Hamano, Yoshimitsu; Maruyama, Chitose] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Tokyo, Japan	Hokkaido University; University of Toyama; Fukui Prefectural University; National Institute of Infectious Diseases (NIID)	Morita, H (corresponding author), Toyama Univ, Inst Nat Med, Toyama 930, Japan.	hmortia@inm.u-toyama.ac.jp; dairi@eng.hokudai.ac.jp	Ito, Hajime/D-8337-2012; Satoh, Yasuharu/H-4174-2012	Ito, Hajime/0000-0003-3852-6721; Hamano, Yoshimitsu/0000-0001-5117-5116; Maruyama, Chitose/0000-0001-7354-9342; Dairi, Tohru/0000-0002-3406-7970; Matsui, Takashi/0000-0002-4496-2389	Japan Society for the Promotion of Science [23108101, 25560397, 25108710]; Grants-in-Aid for Scientific Research [26282210] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (23108101 and 25560397 to T.D. and 25108710 to H.M.) from the Japan Society for the Promotion of Science. We thank M. Igarashi from the Institute of Microbial Chemistry and S. Taguchi from Hokkaido University for providing us with S. cirratus and apidaecin, respectively.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ANZAI H, 1988, J ANTIBIOT, V41, P226, DOI 10.7164/antibiotics.41.226; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chan AOY, 2012, J AM CHEM SOC, V134, P2589, DOI 10.1021/ja208009r; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crone WJK, 2012, CHEM SCI, V3, P3516, DOI 10.1039/c2sc21190d; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Giessen TW, 2012, FEBS LETT, V586, P2065, DOI 10.1016/j.febslet.2012.01.017; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOPWOOD DA, 1985, GENE MANIPULATION ST; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Humphries RM, 2013, CLIN MICROBIOL REV, V26, P759, DOI 10.1128/CMR.00030-13; Huo LJ, 2012, CHEM BIOL, V19, P1278, DOI 10.1016/j.chembiol.2012.08.013; Jursic BS, 2000, SYNTHESIS-STUTTGART, P1656; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadi N, 2007, NAT CHEM BIOL, V3, P652, DOI 10.1038/nchembio.2007.23; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kino K, 2010, BIOSCI BIOTECH BIOCH, V74, P129, DOI 10.1271/bbb.90649; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pan YB, 2013, ANGEW CHEM INT EDIT, V52, P9205, DOI 10.1002/anie.201303429; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Sampei G, 2010, J BIOCHEM, V148, P429, DOI 10.1093/jb/mvq088; SUZUKAKETSUCHIYA K, 1988, J ANTIBIOT, V41, P675, DOI 10.7164/antibiotics.41.675; Suzuki M, 2012, ACTA CRYSTALLOGR D, V68, P1535, DOI 10.1107/S0907444912038103; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Taguchi S, 2009, APPL ENVIRON MICROB, V75, P1460, DOI 10.1128/AEM.02096-08; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thoden JB, 2010, BIOCHEMISTRY-US, V49, P752, DOI 10.1021/bi901599u; Thoden JB, 2002, J BIOL CHEM, V277, P23898, DOI 10.1074/jbc.M202251200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Wagner AM, 2011, J AM CHEM SOC, V133, P15139, DOI 10.1021/ja2055098; Wang WR, 1998, BIOCHEMISTRY-US, V37, P15647, DOI 10.1021/bi981405n; YAMAGUCHI H, 1993, J MOL BIOL, V229, P1083, DOI 10.1006/jmbi.1993.1106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	46	32	32	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					71	+		10.1038/nchembio.1697	http://dx.doi.org/10.1038/nchembio.1697			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402768	Green Submitted			2022-12-25	WOS:000346448600015
J	Clatworthy, MR; Aronin, CEP; Mathews, RJ; Morgan, NY; Smith, KGC; Germain, RN				Clatworthy, Menna R.; Aronin, Caren E. Petrie; Mathews, Rebeccah J.; Morgan, Nicole Y.; Smith, Kenneth G. C.; Germain, Ronald N.			Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FC-GAMMA-RIIB; SELECTIVE BLOCKADE; LANGERHANS CELLS; LIPID RAFTS; RECEPTOR; POLYMORPHISM; MATURATION; IGG; METALLOPROTEINASE-9	Antibodies are critical for defense against a variety of microbes, but they may also be pathogenic in some autoimmune diseases. Many effector functions of antibodies are mediated by Fc gamma receptors (Fc gamma Rs), which are found on most immune cells, including dendritic cells (DCs)-important antigen-presenting cells that play a central role in inducing antigen-specific tolerance or immunity(1,2). Following antigen acquisition in peripheral tissues, DCs migrate to draining lymph nodes via the lymphatics to present antigen to T cells. Here we demonstrate that Fc-gamma R engagement by IgG immune complexes (ICs) stimulates DC migration from peripheral tissues to the paracortex of draining lymph nodes. In vitro, IC-stimulated mouse and human DCs showed greater directional migration in a chemokine (C-C) ligand 19 (CCL19) gradient and increased chemokine (C-C) receptor 7 (CCR7) expression. Using intravital two-photon microscopy, we observed that local administration of IC resulted in dermal DC mobilization. We confirmed that dermal DC migration to lymph nodes depended on CCR7 and increased in the absence of the inhibitory receptor Fc gamma RIIB. These observations have relevance to autoimmunity because autoantibody-containing serum from humans with systemic lupus erythematosus (SLE) and from a mouse model of SLE also increased dermal DC migration in vivo, suggesting that this process may occur in lupus, potentially driving the inappropriate localization of autoantigen-bearing DCs.	[Clatworthy, Menna R.; Mathews, Rebeccah J.] Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge CB2 2QQ, England; [Clatworthy, Menna R.; Aronin, Caren E. Petrie; Germain, Ronald N.] NIAID, Lab Syst Biol, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA; [Morgan, Nicole Y.] Natl Inst Biomed Imaging & Bioengn, Microfabricat & Microfluid Unit, NIH, Bethesda, MD USA; [Smith, Kenneth G. C.] Cambridge Inst Med Res, Cambridge, England; [Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); University of Cambridge; University of Cambridge	Clatworthy, MR (corresponding author), Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge CB2 2QQ, England.	mrc38@cam.ac.uk; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Smith, Kenneth/0000-0003-3829-4326; Mathews, Rebeccah/0000-0002-3834-4744	Wellcome Trust [WT081020]; National Institute for Health Research Cambridge Biomedical Research Centre; Intramural Research Program of the US National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000012] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Intramural Research Program of the US National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Wellcome Trust Intermediate Fellowship (WT081020) to M.R.C. and by the National Institute for Health Research Cambridge Biomedical Research Centre and the Intramural Research Program of the US National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health. We thank J. Yoon for technical advice and M. Espeli for helpful discussions.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Crispin JC, 2012, CLIN IMMUNOL, V143, P45, DOI 10.1016/j.clim.2011.12.004; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; Decker P, 2006, RHEUMATOLOGY, V45, P1087, DOI 10.1093/rheumatology/kel061; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Ding DC, 2006, J IMMUNOL, V177, P5878, DOI 10.4049/jimmunol.177.9.5878; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Joller N, 2011, EUR J IMMUNOL, V41, P889, DOI 10.1002/eji.201041340; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kobayashi Y, 1999, J IMMUNOL, V163, P5989; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Krause RM, 1997, J INFECT DIS, V176, P549, DOI 10.1086/514074; Lebre MC, 1999, ARCH DERMATOL RES, V291, P447, DOI 10.1007/s004030050436; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; van Montfoort N, 2012, J IMMUNOL, V189, P92, DOI 10.4049/jimmunol.1103703; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613	37	91	95	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1458	1463		10.1038/nm.3709	http://dx.doi.org/10.1038/nm.3709			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25384086	Green Accepted			2022-12-25	WOS:000345817900022
J	Lee, S; Nam, Y; Koo, JY; Lim, D; Park, J; Ock, J; Kim, J; Suk, K; Park, SB				Lee, Sanghee; Nam, Youngpyo; Koo, Ja Young; Lim, Donghyun; Park, Jongmin; Ock, Jiyeon; Kim, Jaehong; Suk, Kyoungho; Park, Seung Bum			A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation	NATURE CHEMICAL BIOLOGY			English	Article							MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; TARGET IDENTIFICATION; INFLAMMATION; DISCOVERY; TRIGGERS; RELEASE	Because of the critical role of neuroinflammation in various neurological diseases, there are continuous efforts to identify new therapeutic targets as well as new therapeutic agents to treat neuroinflammatory diseases. Here we report the discovery of inflachromene (ICM), a microglial inhibitor with anti-inflammatory effects. Using the convergent strategy of phenotypic screening with early stage target identification, we show that the direct binding target of ICM is the high mobility group box (HMGB) proteins. Mode-of-action studies demonstrate that ICM blocks the sequential processes of cytoplasmic localization and extracellular release of HMGBs by perturbing its post-translational modification. In addition, ICM effectively downregulates proinflammatory functions of HMGB and reduces neuronal damage in vivo. Our study reveals that ICM suppresses microglia-mediated inflammation and exerts a neuroprotective effect, demonstrating the therapeutic potential of ICM in neuroinflammatory diseases.	[Lee, Sanghee; Koo, Ja Young; Park, Jongmin; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Nam, Youngpyo; Ock, Jiyeon; Kim, Jaehong; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Plus KNU Biomed Convergence Program BK21, Dept Pharmacol,Brain Sci & Engn Inst, Taegu, South Korea; [Lim, Donghyun; Park, Seung Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, N Bio Inst, Seoul, South Korea	Seoul National University (SNU); Kyungpook National University; Seoul National University (SNU)	Park, SB (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	ksuk@knu.ac.kr; sbpark@snu.ac.kr	Park, Jongmin/J-1587-2017	Park, Jongmin/0000-0001-8338-9346; Lim, Donghyun/0000-0002-6070-198X	Creative Research Initiative [2014R1A3A2030423]; Bio & Medical Technology Development Program [2012M3A9C4048780]; Basic Research Laboratory-National Research Foundation of Korea (NRF) [2010-0019766]; NRF-Korean government (MSIP) [2008-0062282]; Korea Healthcare Technology R&D Project, Korean Ministry of Health and Welfare [A111345]	Creative Research Initiative; Bio & Medical Technology Development Program; Basic Research Laboratory-National Research Foundation of Korea (NRF); NRF-Korean government (MSIP); Korea Healthcare Technology R&D Project, Korean Ministry of Health and Welfare	This work was supported by a Creative Research Initiative grant (2014R1A3A2030423), the Bio & Medical Technology Development Program (2012M3A9C4048780) and the Basic Research Laboratory (2010-0019766) funded by the National Research Foundation of Korea (NRF). K. S. was supported by a NRF grant funded by the Korean government (MSIP) (2008-0062282) and a grant of the Korea Healthcare Technology R&D Project, Korean Ministry of Health and Welfare (A111345). S.L., Y.N., J.Y.K., D.L., J.P. and J.K. are grateful for a BK21 Scholarship.	Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Kotz J, 2012, SCIBX, V5, P1, DOI DOI 10.1038/SCIBX.2012.380; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Oh S, 2011, CHEM COMMUN, V47, P12754, DOI 10.1039/c1cc14042f; Park J, 2012, ANGEW CHEM INT EDIT, V51, P5447, DOI 10.1002/anie.201200609; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang QC, 2008, BBA-PROTEINS PROTEOM, V1784, P1159, DOI 10.1016/j.bbapap.2008.04.028; Zhu M, 2010, J MED CHEM, V53, P8760, DOI 10.1021/jm1011269	29	77	81	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1055	+		10.1038/nchembio.1669	http://dx.doi.org/10.1038/nchembio.1669			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25306442				2022-12-25	WOS:000345122300014
J	Martin, CA; Ahmad, I; Klingseisen, A; Hussain, MS; Bicknell, LS; Leitch, A; Nurnberg, G; Toliat, MR; Murray, JE; Hunt, D; Khan, F; Ali, Z; Tinschert, S; Ding, J; Keith, C; Harley, ME; Heyn, P; Muller, R; Hoffmann, I; Cormier-Daire, V; Dollfus, H; Dupuis, L; Bashamboo, A; McElreavey, K; Kariminejad, A; Mendoza-Londono, R; Moore, AT; Saggar, A; Schlechter, C; Weleber, R; Thiele, H; Altmuller, J; Hohne, W; Hurles, ME; Noegel, AA; Baig, SM; Nurnberg, P; Jackson, AP				Martin, Carol-Anne; Ahmad, Ilyas; Klingseisen, Anna; Hussain, Muhammad Sajid; Bicknell, Louise S.; Leitch, Andrea; Nuernberg, Gudrun; Toliat, Mohammad Reza; Murray, Jennie E.; Hunt, David; Khan, Fawad; Ali, Zafar; Tinschert, Sigrid; Ding, James; Keith, Charlotte; Harley, Margaret E.; Heyn, Patricia; Mueller, Rolf; Hoffmann, Ingrid; Cormier-Daire, Valerie; Dollfus, Helene; Dupuis, Lucie; Bashamboo, Anu; McElreavey, Kenneth; Kariminejad, Ariana; Mendoza-Londono, Roberto; Moore, Anthony T.; Saggar, Anand; Schlechter, Catie; Weleber, Richard; Thiele, Holger; Altmueller, Janine; Hoehne, Wolfgang; Hurles, Matthew E.; Noegel, Angelika Anna; Baig, Shahid Mahmood; Nuernberg, Peter; Jackson, Andrew P.			Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy	NATURE GENETICS			English	Article							POLO-LIKE KINASE; CHROMOSOMAL INSTABILITY; MOUSE EMBRYO; CENTROSOMAL PROTEIN; HUMAN-CELLS; BRAIN SIZE; DUPLICATION; DISEASE; CEP152; CILIA	Centrioles are essential for ciliogenesis. However, mutations in centriole biogenesis genes have been reported in primary microcephaly and Seckel syndrome, disorders without the hallmark clinical features of ciliopathies. Here we identify mutations in the genes encoding PLK4 kinase, a master regulator of centriole duplication, and its substrate TUBGCP6 in individuals with microcephalic primordial dwarfism and additional congenital anomalies, including retinopathy, thereby extending the human phenotypic spectrum associated with centriole dysfunction. Furthermore, we establish that different levels of impaired PLK4 activity result in growth and cilia phenotypes, providing a mechanism by which microcephaly disorders can occur with or without ciliopathic features.	[Martin, Carol-Anne; Klingseisen, Anna; Bicknell, Louise S.; Leitch, Andrea; Murray, Jennie E.; Hunt, David; Ding, James; Harley, Margaret E.; Heyn, Patricia; Jackson, Andrew P.] Univ Edinburgh, Inst Genet & Mol Med, Med Res Council MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Ahmad, Ilyas; Hussain, Muhammad Sajid; Nuernberg, Gudrun; Toliat, Mohammad Reza; Thiele, Holger; Altmueller, Janine; Hoehne, Wolfgang; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Ahmad, Ilyas; Hussain, Muhammad Sajid; Mueller, Rolf; Noegel, Angelika Anna] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Ahmad, Ilyas; Hussain, Muhammad Sajid; Khan, Fawad; Ali, Zafar; Baig, Shahid Mahmood] NIBGE, Hlth Biotechnol Div, Faisalabad, Pakistan; [Hussain, Muhammad Sajid; Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Tinschert, Sigrid] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-01062 Dresden, Germany; [Keith, Charlotte] Western Gen Hosp, South East Scotland Genet Serv, Cytogenet Lab, Edinburgh EH4 2XU, Midlothian, Scotland; [Hoffmann, Ingrid] German Canc Res Ctr, Heidelberg, Germany; [Cormier-Daire, Valerie] Univ Paris 05, Sorbonne Paris Cite, Hop Necker, AP HP,Dept Genet,INSERM U781, Paris, France; [Dollfus, Helene] Univ Strasbourg, Hop Univ Strasbourg, INSERM U1112, CARGO, Strasbourg, France; [Dollfus, Helene] Univ Strasbourg, Hop Univ Strasbourg, INSERM U1112, IGMA, Strasbourg, France; [Dupuis, Lucie; Mendoza-Londono, Roberto] Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Dupuis, Lucie] Univ Toronto, Toronto, ON, Canada; [Bashamboo, Anu; McElreavey, Kenneth] Inst Pasteur, Unit Human Dev Genet, Paris, France; [Kariminejad, Ariana] Najmabadi Pathol & Genet Ctr, Tehran, Iran; [Moore, Anthony T.] UCL, Inst Ophthalmol, London, England; [Moore, Anthony T.] Moorfields Eye Hosp, London, England; [Saggar, Anand] St Georges Hosp Med Sch, Southwest Thames Reg Genet Serv, London, England; [Schlechter, Catie; Weleber, Richard] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Altmueller, Janine] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge, England; [Noegel, Angelika Anna; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Resp A, D-50931 Cologne, Germany	University of Edinburgh; University of Cologne; University of Cologne; Pakistan Institute of Engineering & Applied Science; University of Cologne; Medical University of Innsbruck; Technische Universitat Dresden; University of Edinburgh; Helmholtz Association; German Cancer Research Center (DKFZ); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; St Georges University London; Oregon Health & Science University; University of Cologne; Wellcome Trust Sanger Institute; University of Cologne	Jackson, AP (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Med Res Council MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	nuernberg@uni-koeln.de; andrew.jackson@igmm.ed.ac.uk	Ali, Zafar/AAE-9281-2021; Ding, James/AAC-6887-2019; Bicknell, Louise/AAL-8003-2020; Baig, Shahid Mahmood/I-7309-2015; BAig, Shahid Mahmood/AAS-8365-2020; Thiele, Holger/ABE-6792-2020; Jackson, Andrew P/D-3442-2009; Ahmad, Ilyas/AAT-6577-2021; Bicknell, Louise/GLR-4215-2022; cormier-daire, valerie/H-6520-2017	Ali, Zafar/0000-0002-2389-3337; Ding, James/0000-0001-7273-9646; Thiele, Holger/0000-0002-0169-998X; Jackson, Andrew P/0000-0002-8739-2646; Ahmad, Ilyas/0000-0003-4845-9227; Bicknell, Louise/0000-0001-6899-9322; Altmuller, Janine/0000-0003-4372-1521; Dollfus, Helene/0000-0002-2249-895X; Hussain, Muhammad Sajid/0000-0002-1353-8809; cormier-daire, valerie/0000-0002-2839-9856; Martin, Carol-Anne/0000-0001-5914-2757; Kariminejad, Ariana/0000-0002-8467-4728	MRC; Lister Institute for Preventative Medicine and the European Research Council (ERG) [281847]; Medical Research Scotland; National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre; Koln Fortune; CMMC; MRC [MC_U127580972, MC_PC_U127580972] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL7-Hunt] Funding Source: researchfish; Medical Research Council [MC_U127580972, MC_PC_U127580972] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute for Preventative Medicine and the European Research Council (ERG); Medical Research Scotland; National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre(National Institute for Health Research (NIHR)); Koln Fortune; CMMC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the families and clinicians for their involvement and participation; P. Mills, T. Hurd, M. Bettencourt-Dias and M. Reijns for commenting on the manuscript; N. Hastie, D. Fitzpatrick and J. Livingston for helpful discussions; C. Janke (Institut Curie) for his kind gift of the GT335 antibody; E. Freyer for assistance with FAGS analysis; P. Gautier for bioinformatics; P. Carroll and A. Vickers for technical assistance; the IGMM core sequencing service; the IGMM imaging facility for assistance with microscopy; E. Patton and the IGMM fish facility for advice and zebrafish technical assistance; E. Liston and the DNA Resource Centre at SickKids for sample processing; A. Pearce and E. Maher (Cytogenetics Laboratory, South East Scotland Genetics Service) for technical advice; G. Hahn (University Hospital Carl Gustav Carus) for her second opinion on the MRI data; and N. Dalibor and E. Kirst (CCG) for their expert technical assistance. This work was supported by funding from the MRC, the Lister Institute for Preventative Medicine and the European Research Council (ERG, 281847) (A.P.J.), Medical Research Scotland (L.S.B.), the National Institute for Health Research Moorfields Eye Hospital Biomedical Research Centre (A.T.M.), Koln Fortune (M.S.H.) and CMMC (P.N. and A.A.N.).	Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; LARISON KD, 1990, DEVELOPMENT, V109, P567; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Slevin LK, 2012, STRUCTURE, V20, P1905, DOI 10.1016/j.str.2012.08.025; SOROKIN SP, 1968, J CELL SCI, V3, P207; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Verloes A., 1993, GENEREVIEWS, P1; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710	42	119	121	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1283	1292		10.1038/ng.3122	http://dx.doi.org/10.1038/ng.3122			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25344692	Green Accepted, Green Submitted			2022-12-25	WOS:000345547300009
J	Peng, X; Alfoldi, J; Gori, K; Eisfeld, AJ; Tyler, SR; Tisoncik-Go, J; Brawand, D; Law, GL; Skunca, N; Hatta, M; Gasper, DJ; Kelly, SM; Chang, J; Thomas, MJ; Johnson, J; Berlin, AM; Lara, M; Russell, P; Swofford, R; Turner-Maier, J; Young, S; Hourlier, T; Aken, B; Searle, S; Sun, XS; Yi, YL; Suresh, M; Tumpey, TM; Siepel, A; Wisely, SM; Dessimoz, C; Kawaoka, Y; Birren, BW; Lindblad-Toh, K; Di Palma, F; Engelhardt, JF; Palermo, RE; Katze, MG				Peng, Xinxia; Alfoeldi, Jessica; Gori, Kevin; Eisfeld, Amie J.; Tyler, Scott R.; Tisoncik-Go, Jennifer; Brawand, David; Law, G. Lynn; Skunca, Nives; Hatta, Masato; Gasper, David J.; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Hourlier, Thibaut; Aken, Bronwen; Searle, Steve; Sun, Xingshen; Yi, Yaling; Suresh, M.; Tumpey, Terrence M.; Siepel, Adam; Wisely, Samantha M.; Dessimoz, Christophe; Kawaoka, Yoshihiro; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica; Engelhardt, John F.; Palermo, Robert E.; Katze, Michael G.			The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease	NATURE BIOTECHNOLOGY			English	Article							CYSTIC-FIBROSIS; INFLUENZA-VIRUS; RNA; EXPRESSION; TRACT; ANNOTATION; PHENOTYPE; INFECTION; IMMUNITY; MODELS	The domestic ferret (Mustela putorius furo) is an important animal model for multiple human respiratory diseases. It is considered the 'gold standard' for modeling human influenza virus infection and transmission(1-)4. Here we describe the 2.41 Gb draft genome assembly of the domestic ferret, constituting 2.28 Gb of sequence plus gaps. We annotated 19,910 protein-coding genes on this assembly using RNA-seq data from 21 ferret tissues. We characterized the ferret host response to two influenza virus infections by RNA-seq analysis of 42 ferret samples from influenza time-course data and showed distinct signatures in ferret trachea and lung tissues specific to 1918 or 2009 human pandemic influenza virus infections. Using microarray data from 16 ferret samples reflecting cystic fibrosis disease progression, we showed that transcriptional changes in the CFTR-knockout ferret lung reflect pathways of early disease that cannot be readily studied in human infants with cystic fibrosis disease.	[Peng, Xinxia; Tisoncik-Go, Jennifer; Law, G. Lynn; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Alfoeldi, Jessica; Brawand, David; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gori, Kevin; Dessimoz, Christophe] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Eisfeld, Amie J.; Hatta, Masato; Gasper, David J.; Suresh, M.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Tyler, Scott R.; Sun, Xingshen; Yi, Yaling; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA; [Tyler, Scott R.] Univ Iowa, Carver Coll Med, Mol & Cellular Biol Program, Iowa City, IA USA; [Skunca, Nives] ETH, Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Skunca, Nives] Swiss Inst Bioinformat, Zurich, Switzerland; [Hourlier, Thibaut; Aken, Bronwen; Searle, Steve] Wellcome Trust Sanger Inst, Cambridge, England; [Tumpey, Terrence M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Wisely, Samantha M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Dessimoz, Christophe] UCL, Dept Genet Evolut & Environm, London, England; [Dessimoz, Christophe] UCL, Dept Comp Sci, London, England; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo, Japan; [Kawaoka, Yoshihiro] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Bioresponses Regulat, Kyoto 606, Japan; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Ctr Gene Therapy, Iowa City, IA USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; University of Iowa; University of Iowa; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Wellcome Trust Sanger Institute; Centers for Disease Control & Prevention - USA; Cornell University; State University System of Florida; University of Florida; University of London; University College London; University of London; University College London; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Kyoto University; Uppsala University; University of Iowa	Katze, MG (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	palermor@uw.edu; honey@uw.edu	Berlin, Aaron M/AFY-6549-2022; Dessimoz, Christophe/D-3678-2011	Berlin, Aaron M/0000-0002-0714-2808; Dessimoz, Christophe/0000-0002-2170-853X; Hourlier, Thibaut/0000-0003-4894-7773; Siepel, Adam/0000-0002-3557-7219; Di-Palma, Federica/0000-0002-4394-0102; Eisfeld, Amie/0000-0003-2231-3107; Aken, Bronwen/0000-0002-3032-4095; Gori, Kevin/0000-0001-7975-4275; Engelhardt, John/0000-0003-2389-9277; Russell, Pamela/0000-0003-2997-6392; Swofford, Ross/0000-0003-3676-8479; Brawand, David/0000-0002-0357-3520; Suresh, Marulasiddappa/0000-0003-1794-3358	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200800060C, HHSN272201400005C, HHSN272200900018C]; Public Health Service Grant [P51OD010425]; NIH Office of the Director [9T32OD010423-06, 5T32RR023916-05]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R37 DK047967, R24 DK096518, P30 DK054759]; National Heart, Lung, and Blood Institute [R01 HL108902]; SNSF [136461]; NIH National Institute of General Medical Sciences [R01 GM102192]; EURYI ERC; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108902, R24HL123482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047967, P30DK054759, R24DK096518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425, T32OD010423] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SNSF(Swiss National Science Foundation (SNSF)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EURYI ERC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract Nos. HHSN272200800060C and HHSN272201400005C and Public Health Service Grant P51OD010425 (M.G.K.). For the Broad Institute of MIT and Harvard, this project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C. D.J.G. also received training grants 9T32OD010423-06 and 5T32RR023916-05 from the NIH Office of the Director. J.F.E., S.R.T., X.S. and Y.Y. (University of Iowa) were supported under the NIH National Institute of Diabetes and Digestive and Kidney Diseases grants R37 DK047967, R24 DK096518 and P30 DK054759, and National Heart, Lung, and Blood Institute grant R01 HL108902. C.D. acknowledges support by SNSF advanced researcher fellowship (#136461). A.S. receives support under NIH National Institute of General Medical Sciences R01 GM102192. For S.S., B.A. and T.H., the Wellcome Trust Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969. K.L.-T. also receives support under EURYI ERC. We thank Marshall Farms, New York, for providing three adult sable female ferrets (M. putorius furo; 421 days old).	Altenhoff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053786; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cavagna P, 2000, MAMM GENOME, V11, P866, DOI 10.1007/s003350010172; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Wisely SM, 2003, ZOO BIOL, V22, P287, DOI 10.1002/zoo.10089; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	42	82	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1250	U114		10.1038/nbt.3079	http://dx.doi.org/10.1038/nbt.3079			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402615	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000346156800027
J	Schubert, D; Bode, C; Kenefeck, R; Hou, TZ; Wing, JB; Kennedy, A; Bulashevska, A; Petersen, BS; Schaffer, AA; Gruning, BA; Unger, S; Frede, N; Baumann, U; Witte, T; Schmidt, RE; Dueckers, G; Niehues, T; Seneviratne, S; Kanariou, M; Speckmann, C; Ehl, S; Rensing-Ehl, A; Warnatz, K; Rakhmanov, M; Thimme, R; Hasselblatt, P; Emmerich, F; Cathomen, T; Backofen, R; Fisch, P; Seidl, M; May, A; Schmitt-Graeff, A; Ikemizu, S; Salzer, U; Franke, A; Sakaguchi, S; Walker, LSK; Sansom, DM; Grimbacher, B				Schubert, Desiree; Bode, Claudia; Kenefeck, Rupert; Hou, Tie Zheng; Wing, James B.; Kennedy, Alan; Bulashevska, Alla; Petersen, Britt-Sabina; Schaeffer, Alejandro A.; Gruening, Bjoern A.; Unger, Susanne; Frede, Natalie; Baumann, Ulrich; Witte, Torsten; Schmidt, Reinhold E.; Dueckers, Gregor; Niehues, Tim; Seneviratne, Suranjith; Kanariou, Maria; Speckmann, Carsten; Ehl, Stephan; Rensing-Ehl, Anne; Warnatz, Klaus; Rakhmanov, Mirzokhid; Thimme, Robert; Hasselblatt, Peter; Emmerich, Florian; Cathomen, Toni; Backofen, Rolf; Fisch, Paul; Seidl, Maximilian; May, Annette; Schmitt-Graeff, Annette; Ikemizu, Shinji; Salzer, Ulrich; Franke, Andre; Sakaguchi, Shimon; Walker, Lucy S. K.; Sansom, David M.; Grimbacher, Bodo			Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; GERMLINE MUTATIONS; CLINICAL-PICTURE; IMMUNODEFICIENCY; MICE; AUTOIMMUNITY; HOMEOSTASIS; ABATACEPT; PATHWAYS; BLOCKADE	The protein cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of immune responses, and its loss causes fatal autoimmunity in mice. We studied a large family in which five individuals presented with a complex, autosomal dominant immune dysregulation syndrome characterized by hypogammaglobulinemia, recurrent infections and multiple autoimmune clinical features. We identified a heterozygous nonsense mutation in exon 1 of CTLA4. Screening of 71 unrelated patients with comparable clinical phenotypes identified five additional families (nine individuals) with previously undescribed splice site and missense mutations in CTLA4. Clinical penetrance was incomplete (eight adults of a total of 19 genetically proven CTLA4 mutation carriers were considered unaffected). However, CTLA-4 protein expression was decreased in regulatory T cells (T-reg cells) in both patients and carriers with CTLA4 mutations. Whereas T-reg cells were generally present at elevated numbers in these individuals, their suppressive function, CTLA-4 ligand binding and transendocytosis of CD80 were impaired. Mutations in CTLA4 were also associated with decreased circulating B cell numbers. Taken together, mutations in CTLA4 resulting in CTLA-4 haploinsufficiency or impaired ligand binding result in disrupted T and B cell homeostasis and a complex immune dysregulation syndrome.	[Schubert, Desiree; Bode, Claudia; Bulashevska, Alla; Unger, Susanne; Frede, Natalie; Speckmann, Carsten; Ehl, Stephan; Rensing-Ehl, Anne; Warnatz, Klaus; Rakhmanov, Mirzokhid; Cathomen, Toni; Salzer, Ulrich; Grimbacher, Bodo] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Schubert, Desiree] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Kenefeck, Rupert; Hou, Tie Zheng; Kennedy, Alan; Seneviratne, Suranjith; Walker, Lucy S. K.; Sansom, David M.; Grimbacher, Bodo] UCL, Inst Immun & Transplantat, London, England; [Wing, James B.; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Petersen, Britt-Sabina; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schaeffer, Alejandro A.] NIH, Natl Lib Med, Bethesda, MD 20892 USA; [Gruening, Bjoern A.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, D-79106 Freiburg, Germany; [Baumann, Ulrich; Witte, Torsten; Schmidt, Reinhold E.] Hannover Med Sch, Dept Pediat Pulmonol Allergy & Neonatol, Hannover, Germany; [Dueckers, Gregor; Niehues, Tim] HELIOS Childrens Hosp, Krefeld, Germany; [Kanariou, Maria] Aghia Sophia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece; [Thimme, Robert; Hasselblatt, Peter] Univ Med Ctr Freiburg, Clin Internal Med 2, Freiburg, Germany; [Emmerich, Florian; Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Fisch, Paul; Seidl, Maximilian; May, Annette; Schmitt-Graeff, Annette] Univ Med Ctr Freiburg, Dept Pathol, Freiburg, Germany; [Ikemizu, Shinji] Kumamoto Univ, Div Struct Biol, Kumamoto, Japan	University of Freiburg; University of Freiburg; University of London; University College London; Osaka University; University of Kiel; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Freiburg; Hannover Medical School; The Aghia Sophia Children's Hospital; University of Freiburg; University of Freiburg; University of Freiburg; Kumamoto University	Grimbacher, B (corresponding author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.	bodo.grimbacher@uniklinik-freiburg.de	Witte, Torsten/B-5783-2016; Seidl, Maxmilian/ABF-3322-2021; Schaffer, Alejandro A/F-2902-2012; HOU, TIEZHENG/B-4848-2015; Franke, Andre/B-2151-2010; Rakhmanov, Mirzokhid/P-8351-2019; Sakaguchi, Shimon/C-9535-2009; Hasselblatt, Peter/AAF-3681-2021; Warnatz, Klaus/AAD-3464-2022; Bulashevska, Alla/C-4910-2019; Cathomen, Toni/ABG-8410-2021; Ehl, Stephan/AAM-6006-2020; Wing, James Badger/H-6256-2019; Schaffer, Alejandro/N-1222-2019; Löscher, Britt-Sabina/I-1671-2012; Rakhmanov, Mirzokhid/GMW-5383-2022; Cathomen, Toni/GZL-2702-2022	Seidl, Maxmilian/0000-0002-5559-4980; Franke, Andre/0000-0003-1530-5811; Cathomen, Toni/0000-0002-7757-4630; Wing, James Badger/0000-0002-3462-1003; Löscher, Britt-Sabina/0000-0001-9022-9017; Cathomen, Toni/0000-0002-7757-4630; Unger, Susanne/0000-0001-6916-7544; Ehl, Stephan/0000-0002-9265-2721; Gruning, Bjorn/0000-0002-3079-6586; Salzer, Ulrich/0000-0002-1769-1157; Walker, Lucy/0000-0001-5986-5015; Kennedy, Alan/0000-0003-0384-3866; Backofen, Rolf/0000-0001-8231-3323; Sansom, David/0000-0001-6506-3115; Speckmann, Carsten/0000-0002-6217-1556	Bundesministerium fur Bildung und Forschung, grant: Integriertes Forschungs und Behandlungszentrum/Center for Chronic Immunodeficiencies [01EO1303]; Bildung und Forschung, grant Systems Biology E:med/SysInflame [012X1306F]; Deutsches Zentrum fur Infelctionsforschung [8000805-3]; Excellence Initiative of the German Research Foundation [GSC-4]; Intramural Research Program of the US National Institutes of Health, National Library of Medicine; DFG [CRC 992]; UK Medical Research Council; Wellcome Trust; Diabetes UK; Japan Society for the Promotion of ScienceYoung Scientist B grant; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Biotechnology and Biological Sciences Research Council [BB/H013598/2, BB/H013598/1] Funding Source: researchfish; Diabetes UK [12/0004477] Funding Source: researchfish; Medical Research Council [G0802382] Funding Source: researchfish; Grants-in-Aid for Scientific Research [25440031] Funding Source: KAKEN; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER; BBSRC [BB/H013598/2, BB/H013598/1] Funding Source: UKRI; MRC [G0802382] Funding Source: UKRI	Bundesministerium fur Bildung und Forschung, grant: Integriertes Forschungs und Behandlungszentrum/Center for Chronic Immunodeficiencies(Federal Ministry of Education & Research (BMBF)); Bildung und Forschung, grant Systems Biology E:med/SysInflame; Deutsches Zentrum fur Infelctionsforschung; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Intramural Research Program of the US National Institutes of Health, National Library of Medicine; DFG(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Diabetes UK(Diabetes UK); Japan Society for the Promotion of ScienceYoung Scientist B grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and their relatives for their participation in this study. We thank F. Atschekzei, S. Kock, A. Gaa, S. Glatzel and M. Stenzel for technical assistance, and D. Comtesse, R. Weinert, R. Wieland, M. Schuler and N. Verma for their excellent and dedicated patient care. This research was funded by the Bundesministerium fur Bildung und Forschung with the following grants: Integriertes Forschungs und Behandlungszentrum/Center for Chronic Immunodeficiencies 01EO1303, Systems Biology E:med/SysInflame: 012X1306F; the Deutsches Zentrum fur Infelctionsforschung #8000805-3 and in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and by the Intramural Research Program of the US National Institutes of Health, National Library of Medicine. We also thank the German Crohn's and Colitis Foundation for support of the exome sequencing and the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at Interfaces' B.A.G. is funded by the DFG CRC 992 Medical Epigenetics, L.S.K.W. by a UK Medical Research Council Senior Fellowship, T.Z.H. by the Wellcome Trust, R.K. by Diabetes UK, J.B.W. by a Japan Society for the Promotion of ScienceYoung Scientist B grant and S.S. by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Atzeni F, 2013, AUTOIMMUN REV, V12, P1115, DOI 10.1016/j.autrev.2013.06.011; Bacchetta R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00077; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jou ST, 2006, INT J IMMUNOGENET, V33, P361, DOI 10.1111/j.1744-313X.2006.00627.x; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Riewaldt J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00141; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Wofsy D, 2012, ARTHRITIS RHEUM-US, V64, P3660, DOI 10.1002/art.34624; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7	45	527	541	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1410	1416		10.1038/nm.3746	http://dx.doi.org/10.1038/nm.3746			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25329329	Green Accepted			2022-12-25	WOS:000345817900016
J	Wang, YH; Bu, F; Royer, C; Serres, S; Larkin, JR; Soto, MS; Sibson, NR; Salter, V; Fritzsche, F; Turnquist, C; Koch, S; Zak, J; Zhong, S; Wu, GB; Liang, AM; Olofsen, PA; Moch, H; Hancock, DC; Downward, J; Goldin, RD; Zhao, J; Tong, X; Guo, YJ; Lu, X				Wang, Yihua; Bu, Fangfang; Royer, Christophe; Serres, Sebastien; Larkin, James R.; Soto, Manuel Sarmiento; Sibson, Nicola R.; Salter, Victoria; Fritzsche, Florian; Turnquist, Casmir; Koch, Sofia; Zak, Jaroslav; Zhong, Shan; Wu, Guobin; Liang, Anmin; Olofsen, Patricia A.; Moch, Holger; Hancock, David C.; Downward, Julian; Goldin, Robert D.; Zhao, Jian; Tong, Xin; Guo, Yajun; Lu, Xin			ASPP2 controls epithelial plasticity and inhibits metastasis through beta-catenin-dependent regulation of ZEB1	NATURE CELL BIOLOGY			English	Article							APOPTOSIS-STIMULATING PROTEIN; TO-MESENCHYMAL-TRANSITION; SQUAMOUS-CELL CARCINOMA; E-CADHERIN; TUMOR-SUPPRESSOR; BASEMENT-MEMBRANE; BREAST-CARCINOMA; P53; CANCER; EXPRESSION	Epithelial to mesenchymal transition (EMT), and the reverse mesenchymal to epithelial transition (MET), are known examples of epithelial plasticity that are important in kidney development and cancer metastasis. Here we identify ASPP2, a haploinsufficient tumour suppressor, p53 activator and PAR3 binding partner, as a molecular switch of MET and EMT. ASPP2 contributes to MET in mouse kidney in vivo. Mechanistically, ASPP2 induces MET through its PAR3-binding amino-terminus, independently of p53 binding. ASPP2 prevents beta-catenin from transactivating ZEB1, directly by forming an ASPP2-beta-catenin-E-cadherin ternary complex and indirectly by inhibiting beta-catenin's N-terminal phosphorylation to stabilize the beta-catenin-E-cadherin complex. ASPP2 limits the pro-invasive property of oncogenic RAS and inhibits tumour metastasis in vivo. Reduced ASPP2 expression results in EMT, and is associated with poor survival in hepatocellular carcinoma and breast cancer patients. Hence, ASPP2 is a key regulator of epithelial plasticity that connects cell polarity to the suppression of WNT signalling, EMT and tumour metastasis.	[Wang, Yihua; Royer, Christophe; Salter, Victoria; Fritzsche, Florian; Turnquist, Casmir; Koch, Sofia; Zak, Jaroslav; Zhong, Shan; Olofsen, Patricia A.; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford OX3 7DQ, England; [Bu, Fangfang; Zhao, Jian; Tong, Xin; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Bu, Fangfang; Zhao, Jian; Tong, Xin; Guo, Yajun] PLA Postgrad Sch Med, PLA Gen Hosp Canc Ctr, Beijing 100853, Peoples R China; [Serres, Sebastien; Larkin, James R.; Soto, Manuel Sarmiento; Sibson, Nicola R.] Univ Oxford, Canc Res UK, Oxford OX3 7LE, England; [Serres, Sebastien; Larkin, James R.; Soto, Manuel Sarmiento; Sibson, Nicola R.] Univ Oxford, Med Res Council Oxford Inst Radiat Oncol, Dept Oncol, Oxford OX3 7LE, England; [Fritzsche, Florian; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Wu, Guobin; Liang, Anmin] Guangxi Med Univ, Guangxi Canc Hosp, Guangxi 530021, Peoples R China; [Hancock, David C.; Downward, Julian] Canc Res UK London Res Inst, London WC2A 3LY, England; [Goldin, Robert D.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Ctr Pathol, London W2 1NY, England	Ludwig Institute for Cancer Research; University of Oxford; Naval Medical University; Cancer Research UK; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Zurich; University Zurich Hospital; Guangxi Medical University; Cancer Research UK; Imperial College London	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; xin.lu@ludwig.ox.ac.uk	Soto, Manuel Sarmiento/L-7417-2016	Goldin, Robert/0000-0001-5184-4519; Lu, Xin/0000-0002-6587-1152; Larkin, James/0000-0002-4169-8447; serres, sebastien/0000-0002-1573-1581; Turnquist, Casmir/0000-0002-5450-7590; SARMIENTO SOTO, MANUEL/0000-0003-0997-0153; Wang, Yihua/0000-0001-5561-0648; Downward, Julian/0000-0002-2331-4729; Royer, Christophe/0000-0002-9882-7676	Ludwig Institute for Cancer Research Ltd; International Cooperation and Exchange Project of the National Natural Science Foundation of China; National Basic Research Program of China (973 Program) [2010CB945600, 2010CB833600]; Medical Research Council [MR/J000930/1]; Cancer Research UK [C5255/A12678]; MRC [MR/J000930/1] Funding Source: UKRI; Cancer Research UK [16945, 15680, 16466] Funding Source: researchfish	Ludwig Institute for Cancer Research Ltd; International Cooperation and Exchange Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported mainly by the Ludwig Institute for Cancer Research Ltd (X.L.), and in part by the International Cooperation and Exchange Project of the National Natural Science Foundation of China (Y.G. and X.L.). Y.G. and J. Zhao are also supported by the National Basic Research Program of China (973 Program: 2010CB945600 and 2010CB833600). Y.W. is supported by the Medical Research Council (MR/J000930/1). S.S., J.R.L., M.S.S. and N.R.S. are funded by Cancer Research UK (grant number C5255/A12678). We thank K. Bryon-Dodd, G. Sutendra, P. Miller, M. White, L. Buti and C. Goding for critical reading of the manuscript. We are grateful to S. Shirasawa for providing HKe3 cells, F. Miller and S. Santner for the 4T1 and MCF10A series of breast cancer cell lines and Y. Fujita for the E-cadherin-Myc construct.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bertocchi Cristina, 2012, J Signal Transduct, V2012, P125295, DOI 10.1155/2012/125295; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liang BB, 2013, CLIN CANCER RES, V19, P2905, DOI 10.1158/1078-0432.CCR-12-1245; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Liu WK, 2010, ONKOLOGIE, V33, P500, DOI 10.1159/000319692; Liu ZJ, 2005, FEBS LETT, V579, P1587, DOI 10.1016/j.febslet.2005.01.069; Llanos S, 2011, J BIOL CHEM, V286, P43039, DOI 10.1074/jbc.M111.270751; Lossos IS, 2002, LEUKEMIA LYMPHOMA, V43, P2309, DOI 10.1080/1042819021000040017; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sadot E, 2002, J CELL SCI, V115, P2771; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Serres S, 2012, P NATL ACAD SCI USA, V109, P6674, DOI 10.1073/pnas.1117412109; Sgroi DC, 1999, CANCER RES, V59, P5656; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Stadler SC, 2012, SEMIN CANCER BIOL, V22, P404, DOI 10.1016/j.semcancer.2012.06.007; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang XD, 2011, CELL DEATH DIFFER, V18, P304, DOI 10.1038/cdd.2010.101; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wang ZP, 2013, P NATL ACAD SCI USA, V110, P312, DOI 10.1073/pnas.1201514110; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yang J, 2005, CANCER GENET CYTOGEN, V158, P180, DOI 10.1016/j.cancergencyto.2004.05.010; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeller E, 2013, ARCH TOXICOL, V87, P611, DOI 10.1007/s00204-013-1035-3; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247	67	103	106	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1092	+		10.1038/ncb3050	http://dx.doi.org/10.1038/ncb3050			53	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25344754				2022-12-25	WOS:000344744000008
J	Cheng, XP; Zhang, XL; Gao, Q; Samie, MA; Azar, M; Tsang, WL; Dong, LB; Sahoo, N; Li, XR; Zhuo, Y; Garrity, AG; Wang, X; Ferrer, M; Dowling, J; Xu, L; Han, RZ; Xu, HX				Cheng, Xiping; Zhang, Xiaoli; Gao, Qiong; Samie, Mohammad Ali; Azar, Marlene; Tsang, Wai Lok; Dong, Libing; Sahoo, Nirakar; Li, Xinran; Zhuo, Yue; Garrity, Abigail G.; Wang, Xiang; Ferrer, Marc; Dowling, James; Xu, Li; Han, Renzhi; Xu, Haoxing			The intracellular Ca2+ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy	NATURE MEDICINE			English	Article							PLASMA-MEMBRANE REPAIR; MOLECULAR-MECHANISMS; GROWTH-FACTOR; TRP CHANNEL; DYSFERLIN; DEFECTS; MG53; IV	The integrity of the plasma membrane is maintained through an active repair process, especially in skeletal and cardiac muscle cells, in which contraction-induced mechanical damage frequently occurs in vivo(1,2). Muscular dystrophies (MDs) are a group of muscle diseases characterized by skeletal muscle wasting and weakness(3,4). An important cause of these group of diseases is defective repair of sarcolemmal injuries, which normally requires Ca2+ sensor proteins5-8 and Ca2+-dependent delivery of intracellular vesicles to the sites of injury(8,9). MCOLN1 (also known as TRPML1, ML1) is an endosomal and lysosomal Ca2+ channel whose human mutations cause mucolipidosis IV (ML4), a neurodegenerative disease with motor disabilities(10,11). Here we report that ML1-null mice develop a primary, early-onset MD independent of neural degeneration. Although the dystrophin-glycoprotein complex and the known membrane repair proteins are expressed normally, membrane resealing was defective in ML1-null muscle fibers and also upon acute and pharmacological inhibition of ML1 channel activity or vesicular Ca2+ release. Injury facilitated the trafficking and exocytosis of vesicles by upmodulating ML1 channel activity. In the dystrophic mdx mouse model, overexpression of ML1 decreased muscle, pathology. Collectively, our data have identified an intracellular Ca2+ channel that regulates membrane repair in skeletal muscle via Ca2+-dependent vesicle exocytosis.	[Cheng, Xiping; Zhang, Xiaoli; Gao, Qiong; Samie, Mohammad Ali; Azar, Marlene; Tsang, Wai Lok; Dong, Libing; Sahoo, Nirakar; Li, Xinran; Zhuo, Yue; Garrity, Abigail G.; Wang, Xiang; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Garrity, Abigail G.; Xu, Haoxing] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Ferrer, Marc] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Dowling, James] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Dowling, James] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Dowling, James] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Dowling, James] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Dowling, James] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Xu, Li; Han, Renzhi] Loyola Univ, Dept Cell & Mol Physiol, Div Hlth Sci, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Loyola University Chicago	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	xpcheng@umich.edu; haoxingx@umich.edu	Zhuo, Yue/Q-5360-2019; Zhuo, Yue/G-2450-2017; xu, hao/GWQ-7394-2022; xu, li/M-1661-2015	Zhuo, Yue/0000-0002-1820-5157; Zhuo, Yue/0000-0002-1820-5157; Gao, Qiong/0000-0002-5281-7392; Han, Renzhi/0000-0002-8202-9186; Sahoo, Nirakar/0000-0003-0669-3840	National Institutes of Health (NIH) [NS062792, MH096595, AR060837, HL116546, AR064241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064241, R01AR060837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH096595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants (NS062792, MH096595 and AR060837 to H.X.; HL116546 and AR064241 to R.H.). We are grateful to S. Slaugenhaupt for the ML1 KO mice, L. Looger for the GCaMP3 construct, R. Edwards for the Vamp7-pHluorin construct, the Center for Live-Cell Imaging at the University of Michigan for the help on TIRE Imaging, and R. Hume and M. Akaaboune for comments on the manuscript. We appreciate the encouragement and helpful comments of other members of the Xu laboratory.	Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; CLARKE MSF, 1993, J CELL SCI, V106, P121; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DEFIGUEIREDO P, 1995, MOL BIOL CELL, V6, P871, DOI 10.1091/mbc.6.7.871; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; McNeil P, 2009, NAT CELL BIOL, V11, P7, DOI 10.1038/ncb0109-7; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; WEITZ R, 1990, BRAIN DEV-JPN, V12, P524, DOI 10.1016/S0387-7604(12)80220-8; ZLOTOGORA J, 1983, NEUROPEDIATRICS, V14, P104, DOI 10.1055/s-2008-1059563	30	87	88	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1187	1192		10.1038/nm.3611	http://dx.doi.org/10.1038/nm.3611			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25216637	Green Accepted			2022-12-25	WOS:000343194100030
J	Herranz, D; Ambesi-Impiombato, A; Palomero, T; Schnell, SA; Belver, L; Wendorff, AA; Xu, LY; Castillo-Martin, M; Llobet-Navas, D; Cordon-Cardo, C; Clappier, E; Soulier, J; Ferrando, AA				Herranz, Daniel; Ambesi-Impiombato, Alberto; Palomero, Teresa; Schnell, Stephanie A.; Belver, Laura; Wendorff, Agnieszka A.; Xu, Luyao; Castillo-Martin, Mireia; Llobet-Navas, David; Cordon-Cardo, Carlos; Clappier, Emmanuelle; Soulier, Jean; Ferrando, Adolfo A.			A NOTCH 1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							C-MYC; APC DEFICIENCY; CANCER; EXPRESSION; MUTATIONS; VARIANT; MICE; SUSCEPTIBILITY; ACTIVATION; MECHANISMS	Efforts to identify and annotate cancer driver genetic lesions have been focused primarily on the analysis of protein-coding genes; however, most genetic abnormalities found in human cancer are located in intergenic regions. Here we identify a new long range acting MYC enhancer controlled by NOTCH1 that is targeted by recurrent chromosomal duplications in human T cell acute lymphoblastic leukemia (T-ALL). This highly conserved regulatory element, hereby named N-Me for NOTCH MYC enhancer, is located within a broad super-enhancer region +1.47 Mb from the MYC transcription initiating site, interacts with the MYC proximal promoter and induces orientation-independent MYC expression in reporter assays. Moreover, analysis of N-Me knockout mice demonstrates a selective and essential role of this regulatory element during thymocyte development and in NOTCH/-induced T-ALL. Together these results identify N-Me as a long-range oncogenic enhancer implicated directly in the pathogenesis of human leukemia and highlight the importance of the NOTCH1-MYC regulatory axis in T cell transformation and as a therapeutic target in T-ALL.	[Herranz, Daniel; Ambesi-Impiombato, Alberto; Palomero, Teresa; Schnell, Stephanie A.; Belver, Laura; Wendorff, Agnieszka A.; Xu, Luyao; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Palomero, Teresa; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Castillo-Martin, Mireia; Llobet-Navas, David; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Clappier, Emmanuelle; Soulier, Jean] Hop St Louis, INSERM, UMR 944, Inst Univ Hematol, Paris, France; [Clappier, Emmanuelle; Soulier, Jean] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	Belver, Laura/AAC-1621-2021; Belver, Laura/AAH-2177-2019; Llobet-Navas, David/AAT-4676-2021; xu, Luyao/F-2381-2015; Herranz, Daniel/L-6986-2017; Llobet-Navas, David/B-5660-2009; Clappier, Emmanuelle/V-2921-2017; Castillo-Martin, Mireia/H-6152-2013	Belver, Laura/0000-0001-7493-7072; Herranz, Daniel/0000-0003-1768-5969; Llobet-Navas, David/0000-0003-1443-7003; 	US National Institutes of Health [CA120196]; Stand Up To Cancer Innovative Research Award; Pershing Square Sohn Foundation Award; Swim Across America Foundation; Canceropole Ile de France; program Cartes d'Identite des Tumeurs from the Ligue Contre le Cancer; European Research Council St. Grant Consolidator [311660]; Saint-Louis Institute program [ANR-10-IBHU-0002]; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA120196, P01CA087497] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer Innovative Research Award; Pershing Square Sohn Foundation Award(Pershing Square Sohn Cancer Research Alliance); Swim Across America Foundation; Canceropole Ile de France(Region Ile-de-France); program Cartes d'Identite des Tumeurs from the Ligue Contre le Cancer; European Research Council St. Grant Consolidator; Saint-Louis Institute program; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health (grant CA120196 to A.A.F.), the Stand Up To Cancer Innovative Research Award (A.A.F.), The Pershing Square Sohn Foundation Award (A.A.F.), the Swim Across America Foundation (A.A.F.), the Canceropole Ile de France (J.S.), the program Cartes d'Identite des Tumeurs from the Ligue Contre le Cancer (J.S.), the European Research Council St. Grant Consolidator 311660 (J.S.) and the Saint-Louis Institute program ANR-10-IBHU-0002 (J.S.). D.H. is a Leukemia and Lymphoma Society postdoctoral fellow. L.B. is a postdoctoral researcher supported by the Lymphoma Research Foundation. We are grateful to P. Sumazin for assistance on the analysis of ChIP-seq data, T. Ludwig (Ohio State University) for the ROSA26<SUP>cre-ERT2/+</SUP> mouse, R. Kopan (Cincinnati Children's Hospital Medical Center, University of Cincinnati) for the Delta E-NOTCH1 construct and R. Baer for helpful discussions and revision of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tzoneva G, 2012, CURR TOP MICROBIOL, V360, P163, DOI 10.1007/82_2012_232; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	42	279	287	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1130	1137		10.1038/nm.3665	http://dx.doi.org/10.1038/nm.3665			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25194570	Green Accepted, Green Submitted			2022-12-25	WOS:000343194100023
J	LeBleu, VS; O'Connell, JT; Herrera, KNG; Wikman, H; Pantel, K; Haigis, MC; de Carvalho, FM; Damascena, A; Chinen, LTD; Rocha, RM; Asara, JM; Kalluri, R				LeBleu, Valerie S.; O'Connell, Joyce T.; Herrera, Karma N. Gonzalez; Wikman, Harriet; Pantel, Klaus; Haigis, Marcia C.; de Carvalho, Fernanda Machado; Damascena, Aline; Domingos Chinen, Ludmilla Thome; Rocha, Rafael M.; Asara, John M.; Kalluri, Raghu			PGC-l alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis	NATURE CELL BIOLOGY			English	Article							ESTROGEN-RELATED RECEPTOR; TRANSCRIPTIONAL COACTIVATORS; MESENCHYMAL TRANSITION; BREAST-CANCER; TUMOR; EXPRESSION; GROWTH; NEURODEGENERATION; PGC1-ALPHA; MECHANISMS	Cancer cells can divert metabolites into anabolic pathways to support their rapid proliferation and to accumulate the cellular building blocks required for tumour growth. However, the specific bioenergetic profile of invasive and metastatic cancer cells is unknown. Here we report that migratory/invasive cancer cells specifically favour mitochondrial respiration and increased ATP production. Invasive cancer cells use the transcription coactivator peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PPARGC1A, also known as PGC-1 alpha) to enhance oxidative phosphorylation, mitochondrial biogenesis and the oxygen consumption rate. Clinical analysis of human invasive breast cancers revealed a strong correlation between PGC-1a, expression in invasive cancer cells and the formation of distant metastases. Silencing of PGC-1 alpha, in cancer cells suspended their invasive potential and attenuated metastasis without affecting proliferation, primary tumour growth or the epithelial-to-mesenchymal program. Inherent genetics of cancer cells can determine the transcriptome framework associated with invasion and metastasis, and mitochondrial biogenesis and respiration induced by PGC-1 alpha are also essential for functional motility of cancer cells and metastasis.	[LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77054 USA; [LeBleu, Valerie S.; O'Connell, Joyce T.; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02115 USA; [Herrera, Karma N. Gonzalez; Haigis, Marcia C.] Harvard Univ, Dept Cell Biol, Paul F Glenn Labs Biol Mech Aging, Sch Med, Boston, MA 02115 USA; [Wikman, Harriet; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, D-20246 Hamburg, Germany; [de Carvalho, Fernanda Machado; Damascena, Aline; Domingos Chinen, Ludmilla Thome; Rocha, Rafael M.] AC Camargo Canc Ctr, Int Res Ctr, BR-01509010 Sao Paulo, Brazil; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; A.C.Camargo Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Thomé Domingos Chinen, Ludmilla/A-9434-2014; LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Thomé Domingos Chinen, Ludmilla/0000-0001-7890-8420; Wikman, Harriet/0000-0001-6862-0888; Kalluri, Raghu/0000-0002-2190-547X	Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center (MDACC); DoD Breast Cancer Research Predoctoral Traineeship Award [W81XWH-09-1-0008]; NIH [CA125550, CA155370, CA151925, DK081576, DK055001];  [CA12096405];  [CA00651646];  [CA16672]; NATIONAL CANCER INSTITUTE [R01CA155370, U01CA151925, P30CA006516, P30CA016672, P01CA120964, R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081576] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center (MDACC); DoD Breast Cancer Research Predoctoral Traineeship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was primarily supported by funds from the Cancer Prevention and Research Institute of Texas and funds from MD Anderson Cancer Center (MDACC). J.T.O'C. was financially supported by the DoD Breast Cancer Research Predoctoral Traineeship Award (W81XWH-09-1-0008). R.K. is supported by NIH Grants CA125550, CA155370, CA151925, DK081576 and DK055001. Mass spectrometry work was partially supported by CA12096405 (J.M.A.) and CA00651646 (J.M.A.). We wish to thank B. Spiegelman and J. Estall (Dana Farber Cancer Institute, Boston, Massachusetts, USA) for providing us with reagents related to PGC-1 alpha. We thank M. Protopopova (MDACC, Houston, Texas) and F. Muller (MDACC, Houston, Texas) for their help with the Seahorse experiments. We thank L. Cantley (BIDMC, Boston, Massachusetts) for his critical reading of the manuscript. We also thank M. Yuan and S. Breitkopf (BIDMC, Boston, Massachusetts) for their help with mass spectrometry experiments, and G. Buruzula and J. LaVecchio at the Joslin Flow Cytometry Core Facility (Joslin Diabetes Center, Boston, Massachusetts) for helping with flow cytometry experiments. For electron microscopy imaging, the High Resolution Electron Microscopy Facility at UTMDACC is supported by the Institutional Core Grant CA16672. We thank R. Langley for help in editing of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIBBINS JR, 1982, CELL MOTIL CYTOSKEL, V2, P25, DOI 10.1002/cm.970020104; Girnun GD, 2012, SEMIN CELL DEV BIOL, V23, P381, DOI 10.1016/j.semcdb.2012.01.007; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Woelfle U, 2003, CANCER RES, V63, P5679; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	32	799	830	8	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					992	1003		10.1038/ncb3039	http://dx.doi.org/10.1038/ncb3039			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25241037	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000342712200009
J	Lyon, RP; Setter, JR; Bovee, TD; Doronina, SO; Hunter, JH; Anderson, ME; Balasubramanian, CL; Duniho, SM; Leiske, CI; Li, F; Senter, PD				Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.			Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates	NATURE BIOTECHNOLOGY			English	Article							ANTITUMOR-ACTIVITY; CANCER-THERAPY; TRASTUZUMAB EMTANSINE; LINKER STABILITY; BREAST-CANCER; IN-VITRO; SITE; POTENT; PIPELINE; CYSTEINE	Many antibody-drug conjugates (ADCs) are unstable in vivo because they are formed from maleimide-containing components conjugated to reactive thiols. These thiosuccinimide linkages undergo two competing reactions in plasma: elimination of the maleimide through a retro-Michael reaction, which results in loss of drug-linker from the ADC, and hydrolysis of the thiosuccinimide ring, which results in a derivative that is resistant to the elimination reaction. In an effort to create linker technologies with improved stability characteristics, we used diaminopropionic acid (DPR) to prepare a drug-linker incorporating a basic amino group adjacent to the maleimide, positioned to provide intramolecular catalysis of thiosuccinimide ring hydrolysis. This basic group induces the thiosuccinimide to undergo rapid hydrolysis at neutral pH and room temperature. Once hydrolyzed, the drug-linker is no longer subject to maleimide elimination reactions, preventing nonspecific deconjugation. In vivo studies demonstrate that the increased stability characteristics can lead to improved ADC antitumor activity and reduced neutropenia.	[Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.] Seattle Genet, Bothell, WA 98021 USA	Seattle Genetics	Lyon, RP (corresponding author), Seattle Genet, Bothell, WA 98021 USA.	rlyon@seagen.com						Agarwal P, 2013, P NATL ACAD SCI USA, V110, P46, DOI 10.1073/pnas.1213186110; Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Badescu G, 2014, BIOCONJUGATE CHEM, V25, P460, DOI 10.1021/bc400245v; Baldwin AD, 2011, BIOCONJUGATE CHEM, V22, P1946, DOI 10.1021/bc200148v; Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628; Chudasama VL, 2012, CLIN PHARMACOL THER, V92, P520, DOI 10.1038/clpt.2012.153; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Kalia J, 2007, BIOORG MED CHEM LETT, V17, P6286, DOI 10.1016/j.bmcl.2007.09.002; KNIGHT P, 1979, BIOCHEM J, V179, P191, DOI 10.1042/bj1790191; Lyon RP, 2012, METHOD ENZYMOL, V502, P123, DOI 10.1016/B978-0-12-416039-2.00006-9; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Okeley NM, 2014, HEMATOL ONCOL CLIN N, V28, P13, DOI 10.1016/j.hoc.2013.10.009; Peddi PF, 2013, FUTURE ONCOL, V9, P319, DOI [10.2217/fon.13.7, 10.2217/FON.13.7]; Ryan CP, 2011, CHEM COMMUN, V47, P5452, DOI 10.1039/c1cc11114k; Sanderson RJ, 2005, CLIN CANCER RES, V11, P843; Sassoon I, 2013, METHODS MOL BIOL, V1045, P1, DOI 10.1007/978-1-62703-541-5_1; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tian F, 2014, P NATL ACAD SCI USA, V111, P1766, DOI 10.1073/pnas.1321237111; Toda N, 2013, ANGEW CHEM INT EDIT, V52, P12592, DOI 10.1002/anie.201306241; Wahl AF, 2002, CANCER RES, V62, P3736; Zolot RS, 2013, NAT REV DRUG DISCOV, V12, P259, DOI 10.1038/nrd3980	30	277	314	13	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1059	+		10.1038/nbt.2968	http://dx.doi.org/10.1038/nbt.2968			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25194818				2022-12-25	WOS:000343763800024
J	Larsen, JB; Jensen, MB; Bhatia, VK; Pedersen, SL; Bjornholm, T; Iversen, L; Uline, MJ; Szleifer, I; Jensen, KJ; Hatzakis, NS; Stamou, D				Larsen, Jannik Bruun; Jensen, Martin Borch; Bhatia, Vikram K.; Pedersen, Soren L.; Bjornholm, Thomas; Iversen, Lars; Uline, Mark J.; Szleifer, Igal; Jensen, Knud J.; Hatzakis, Nikos S.; Stamou, Dimitrios			Membrane curvature enables N-Ras lipid anchor sorting to liquid-ordered membrane phases	NATURE CHEMICAL BIOLOGY			English	Article							AMPHIPATHIC HELICES; DISORDERED PHASES; BILAYER-MEMBRANES; MODEL-MEMBRANE; RAFT DOMAINS; BAR DOMAINS; H-RAS; ASSOCIATION; PROTEINS; MOTIFS	Trafficking and sorting of membrane-anchored Ras GTPases are regulated by partitioning between distinct membrane domains. Here, in vitro experiments and microscopic molecular theory reveal membrane curvature as a new modulator of N-Ras lipid anchor and palmitoyl chain partitioning. Membrane curvature was essential for enrichment in raft-like liquid-ordered phases; enrichment was driven by relief of lateral pressure upon anchor insertion and most likely affects the localization of lipidated proteins in general.	[Larsen, Jannik Bruun; Jensen, Martin Borch; Bhatia, Vikram K.; Bjornholm, Thomas; Iversen, Lars; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Bionanotechnol & Nanomed Lab, DK-1168 Copenhagen, Denmark; [Larsen, Jannik Bruun; Jensen, Martin Borch; Bhatia, Vikram K.; Pedersen, Soren L.; Iversen, Lars; Jensen, Knud J.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-1168 Copenhagen, Denmark; [Larsen, Jannik Bruun; Jensen, Martin Borch; Bhatia, Vikram K.; Pedersen, Soren L.; Iversen, Lars; Jensen, Knud J.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-1168 Copenhagen, Denmark; [Uline, Mark J.] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA; [Szleifer, Igal] Northwestern Univ, Life Proc Inst, Dept Biomed Engn, Dept Chem & Chem, Evanston, IL 60208 USA	University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northwestern University	Larsen, JB (corresponding author), Univ Copenhagen, Nanosci Ctr, Bionanotechnol & Nanomed Lab, DK-1168 Copenhagen, Denmark.	stamou@nano.ku.dk	Uline, Mark Jacob/GZL-2712-2022; Iversen, Lars/C-5298-2011; Larsen, Jannik/M-7950-2015; Jensen, Knud/D-1145-2016; Hatzakis, Nikos/C-2715-2015; Stamou, Dimitrios/D-5042-2016	Iversen, Lars/0000-0002-1314-130X; Larsen, Jannik/0000-0003-4754-2803; Jensen, Knud/0000-0003-3525-5452; Bjornholm, Thomas/0000-0002-2981-8290; Uline, Mark/0000-0002-3533-871X; Hatzakis, Nikos/0000-0003-4202-0328; Szleifer, Igal/0000-0002-8708-0335; Pedersen, Soren Ljungberg/0000-0002-6130-955X; Stamou, Dimitrios/0000-0001-8456-8995	Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; US National Science Foundation [CBET-1403058]; US National Institutes of Health [P20GM103499]; Directorate For Engineering [1403058] Funding Source: National Science Foundation	Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Lundbeck Foundation Center for Biomembranes in Nanomedicine, the Danish Councils for Independent and Strategic Research, and the University of Copenhagen programs of excellence, 'Single-Molecule Nanoscience', 'BioScaRT' and 'UNIK-Synthetic Biology'. I. S. would like to acknowledge support from the US National Science Foundation under grant no. CBET-1403058 and M.J.U. acknowledges support from the US National Institutes of Health under grant no. P20GM103499.	Abreu MSC, 2004, BIOPHYS J, V87, P353, DOI [10.1529/biophysj.104.040576, 10.1529/biophysi.104.040576]; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Chiu VK, 2004, J BIOL CHEM, V279, P7346, DOI 10.1074/jbc.M311602200; Cox Adrienne D, 2010, Small GTPases, V1, P2; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Elizondo E, 2012, J AM CHEM SOC, V134, P1918, DOI 10.1021/ja2086678; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hughes LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087649; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; Larsen J, 2011, J AM CHEM SOC, V133, P10685, DOI 10.1021/ja203984j; Meinhardt S, 2013, P NATL ACAD SCI USA, V110, P4476, DOI 10.1073/pnas.1221075110; Nicolini C, 2006, J AM CHEM SOC, V128, P192, DOI 10.1021/ja055779x; Parthasarathy R, 2006, LANGMUIR, V22, P5095, DOI 10.1021/la060390o; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Silvius JR, 2005, BBA-MOL CELL RES, V1746, P193, DOI 10.1016/j.bbamcr.2005.09.003; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Uline MJ, 2010, BIOPHYS J, V98, P1883, DOI 10.1016/j.bpj.2010.01.036; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Weise K, 2009, J AM CHEM SOC, V131, P1557, DOI 10.1021/ja808691r; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	35	85	85	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2015	11	3					192	U176		10.1038/nchembio.1733	http://dx.doi.org/10.1038/nchembio.1733			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB7WY	25622090				2022-12-25	WOS:000349840500007
J	Adamo, A; Atashpaz, S; Germain, PL; Zanella, M; D'Agostino, G; Albertin, V; Chenoweth, J; Micale, L; Fusco, C; Unger, C; Augello, B; Palumbo, O; Hamilton, B; Carella, M; Donti, E; Pruneri, G; Selicorni, A; Biamino, E; Prontera, P; Mckay, R; Merla, G; Testa, G				Adamo, Antonio; Atashpaz, Sina; Germain, Pierre-Luc; Zanella, Matteo; D'Agostino, Giuseppe; Albertin, Veronica; Chenoweth, Josh; Micale, Lucia; Fusco, Carmela; Unger, Christian; Augello, Bartolomeo; Palumbo, Orazio; Hamilton, Brad; Carella, Massimo; Donti, Emilio; Pruneri, Giancarlo; Selicorni, Angelo; Biamino, Elisa; Prontera, Paolo; Mckay, Ronald; Merla, Giuseppe; Testa, Giuseppe			7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages	NATURE GENETICS			English	Article							WILLIAMS-BEUREN-SYNDROME; DIRECTED DIFFERENTIATION; SYNDROME REGION; CRANIOFACIAL DEVELOPMENT; MENTAL-RETARDATION; DEMETHYLASE JMJD3; HUMAN BRAIN; ABNORMALITIES; DUPLICATION; AUTISM	Cell reprogramming promises to make characterization of the impact of human genetic variation on health and disease experimentally tractable by enabling the bridging of genotypes to phenotypes in developmentally relevant human cell lineages. Here we apply this paradigm to two disorders caused by symmetrical copy number variations of 7q11.23, which display a striking combination of shared and symmetrically opposite phenotypes-Williams-Beuren syndrome and 7q-microduplication syndrome. Through analysis of transgene-free patient-derived induced pluripotent stem cells and their differentiated derivatives, we find that 7q11.23 dosage imbalance disrupts transcriptional circuits in disease-relevant pathways beginning in the pluripotent state. These alterations are then selectively amplified upon differentiation of the pluripotent cells into disease-relevant lineages. A considerable proportion of this transcriptional dysregulation is specifically caused by dosage imbalances in GTF2I, which encodes a key transcription factor at 7q11.23 that is associated with the LSD1 repressive chromatin complex and silences its dosage-sensitive targets.	[Adamo, Antonio; Atashpaz, Sina; Germain, Pierre-Luc; Zanella, Matteo; D'Agostino, Giuseppe; Albertin, Veronica; Pruneri, Giancarlo; Testa, Giuseppe] IRCCS, European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Chenoweth, Josh; Mckay, Ronald] Lieber Inst Brain Dev, Baltimore, MD USA; [Micale, Lucia; Augello, Bartolomeo; Palumbo, Orazio; Carella, Massimo; Merla, Giuseppe] IRCCS, Casa Sollievo Sofferenza Hosp, Med Genet Unit, San Giovanni Rotondo, Italy; [Unger, Christian] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Hamilton, Brad] Stemgent, Cambridge, MA USA; [Donti, Emilio; Prontera, Paolo] Univ Perugia, Hosp Santa Maria Misericordia, Med Genet Unit, I-06100 Perugia, Italy; [Selicorni, Angelo] Azienda Osped San Gerardo, Fdn MBBM, Genet Clin Pediatr, UOS, Monza, Italy; [Biamino, Elisa] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Testa, Giuseppe] Univ Milan, Dept Hlth Sci, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Casa Sollievo Della Sofferenza; University of Sheffield; Hospital Santa Maria della Misericordia; University of Perugia; University of Turin; University of Milan	Testa, G (corresponding author), IRCCS, European Inst Oncol, Dept Expt Oncol, Milan, Italy.	giuseppe.testa@ieo.eu	merla, giuseppe/K-4627-2012; Pruneri, Giancarlo/AAC-7767-2022; Prontera, Paolo/AAC-3911-2022; Augello, Bartolomeo/B-1927-2017; PALUMBO, ORAZIO/C-1133-2014; Micale, Lucia/K-3909-2016; Fusco, Carmela/H-2964-2016; Germain, Pierre-Luc/K-9326-2016; Carella, Massimo/A-2804-2014	merla, giuseppe/0000-0001-5078-928X; Pruneri, Giancarlo/0000-0002-7963-7172; Augello, Bartolomeo/0000-0001-7475-6976; PALUMBO, ORAZIO/0000-0001-6583-3482; Fusco, Carmela/0000-0001-7794-6046; Germain, Pierre-Luc/0000-0003-3418-4218; Unger, Christian/0000-0002-4216-3575; Zanella, Matteo/0000-0002-1614-4370; Atashpaz, Sina/0000-0003-0566-5629; Adamo, Antonio/0000-0003-1080-3547; Testa, Giuseppe/0000-0002-9104-0918; D'Agostino, Giuseppe Alessandro/0000-0001-8315-7406; Micale, Lucia/0000-0003-3604-194X; Prontera, Paolo/0000-0003-4960-9223; Carella, Massimo/0000-0002-6830-6829	Telethon Network of Genetic Biobanks [GTB12001G, GTB12001A]; European Research Council [616441-DISEASEAVATARS]; Italian Ministry of Health; EPIGEN Flagship Project of the Italian National Research Council; Jerome-Lejeune Foundation; ERA-NET Neuron Program; Umberto Veronesi Foundation; Federation of European Biochemical Societies (FEBS); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon Network of Genetic Biobanks(Fondazione Telethon); European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy); EPIGEN Flagship Project of the Italian National Research Council; Jerome-Lejeune Foundation; ERA-NET Neuron Program; Umberto Veronesi Foundation(Fondazione Umberto Veronesi); Federation of European Biochemical Societies (FEBS); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank the AFSW (Associazione Famiglie Sindrome di Williams) and AISW (Associazione Italiana Sindrome di Williams) for agreeing to participate and making this study possible and the Genomic and Genetic Disorder Biobank, Galliera Genetic Bank and members of the Telethon Network of Genetic Biobanks (project numbers GTB12001G and GTB12001A), along with the EuroBioBank network, for providing us with specimens. We also thank scientists at the Drug Discovery Unit, Drug Development Program (DDU-DDP) of the European Institute of Oncology (IEO) for sharing with us the two LSD1 inhibitors used in this study; A. Bachi, A. Cattaneo and P. Soffiantini from the Mass Spectrometry service of the FIRC (Fondazione Italians per la Ricerca sul Cancro) Institute of Molecular Oncology (IFOM); F. Pisati for processing of the teratomas; P. Andrews (University of Sheffield) for sharing two control iPSC lines (CTL2-C1 and CTL2-C2; reprogrammed from CRL-2429 fibroblasts); G. Mostoslavsky and the Center for Regenerative Medicine of Boston University for sharing the BU1Cr3-1 line; G. Barbagiovanni for help with FACS profiling and analysis; and L. Marelli along with all other members of the Testa laboratory for discussion. This work was funded by the European Research Council (consolidator grant number 616441-DISEASEAVATARS to G.T.), the Italian Ministry of Health (Ricerca Corrente to G.T. and G.M. and Bando Giovani Ricercatori 2008 and 2009 to G.T.), the EPIGEN Flagship Project of the Italian National Research Council (G.T.), the Jerome-Lejeune Foundation (G.T. and G.M.), the ERA-NET Neuron Program (G.T.), the Umberto Veronesi Foundation (S.A. and G.D.) and the Federation of European Biochemical Societies (FEBS; fellowship awarded to A.A. to work in the laboratory of G.T.).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Antonell A, 2010, HUM GENET, V128, P27, DOI 10.1007/s00439-010-0817-4; Barnett C, 2012, MECH DEVELOP, V129, P324, DOI 10.1016/j.mod.2012.06.001; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Campuzano V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002458; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Cobourne MT, 2009, DEV BIOL, V331, P38, DOI 10.1016/j.ydbio.2009.04.021; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Fan AX, 2014, NUCLEIC ACIDS RES, V42, P7625, DOI 10.1093/nar/gku467; Ferrero GB, 2010, EUR J HUM GENET, V18, P33, DOI 10.1038/ejhg.2009.108; Fusco C, 2014, EUR J HUM GENET, V22, P64, DOI 10.1038/ejhg.2013.101; Ge X, 2012, CIRCULATION, V126, P1695, DOI 10.1161/CIRCULATIONAHA.112.116996; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gothelf D, 2006, NEUROLOGY, V66, P390, DOI 10.1212/01.wnl.0000196643.35395.5f; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; KRUSE K, 1992, J PEDIATR-US, V121, P902, DOI 10.1016/S0022-3476(05)80336-1; Kurosaka H, 2014, J CLIN INVEST, V124, P1660, DOI 10.1172/JCI72688; Lazebnik MB, 2009, J BIOL CHEM, V284, P36234, DOI 10.1074/jbc.C109.063115; Letra A, 2010, AM J MED GENET A, V152A, P1701, DOI 10.1002/ajmg.a.33482; Leung A, 2013, STEM CELL REP, V1, P451, DOI 10.1016/j.stemcr.2013.10.003; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Makeyev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044443; Makeyev AV, 2011, CLEFT PALATE-CRAN J, V48, P109, DOI 10.1597/09-093; Malenfant P, 2012, J AUTISM DEV DISORD, V42, P1459, DOI 10.1007/s10803-011-1389-4; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Mervis CB, 2012, AM J HUM GENET, V90, P1064, DOI 10.1016/j.ajhg.2012.04.012; Metzis V, 2013, HUM MOL GENET, V22, P5026, DOI 10.1093/hmg/ddt353; Ming GL, 2011, J NEUROSCI, V31, P16070, DOI 10.1523/JNEUROSCI.4218-11.2011; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; O'Leary J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023868; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Osborne LR, 2010, AM J MED GENET C, V154C, P209, DOI 10.1002/ajmg.c.30257; Pankau R, 1996, AM J MED GENET, V63, P301, DOI 10.1002/(SICI)1096-8628(19960503)63:1<301::AID-AJMG49>3.0.CO;2-P; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Phillips HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037685; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Prontera P, 2014, J AUTISM DEV DISORD, V44, P2608, DOI 10.1007/s10803-014-2117-7; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Sabaratnam M, 2000, EUR CHILD ADOLES PSY, V9, P307, DOI 10.1007/s007870070035; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Singh S, 2007, BIRTH DEFECTS RES A, V79, P35, DOI 10.1002/bdra.20320; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Wang KS, 2012, J PSYCHIATR NEUROSCI, V37, P46, DOI 10.1503/jpn.100173; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Zhao XY, 2014, CYTOKINE GROWTH F R, V25, P35, DOI 10.1016/j.cytogfr.2013.12.010	65	84	89	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					132	141		10.1038/ng.3169	http://dx.doi.org/10.1038/ng.3169			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CA1TQ	25501393				2022-12-25	WOS:000348694700008
J	Nishii, W; Kukimoto-Niino, M; Terada, T; Shirouzu, M; Muramatsu, T; Kojima, M; Kihara, H; Yokoyama, S				Nishii, Wataru; Kukimoto-Niino, Mutsuko; Terada, Takaho; Shirouzu, Mikako; Muramatsu, Tomonari; Kojima, Masaki; Kihara, Hiroshi; Yokoyama, Shigeyuki			A redox switch shapes the Lon protease exit pore to facultatively regulate proteolysis	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-PRODUCT; CATALYTIC DOMAIN; ATP HYDROLYSIS; DEGRADATION; LA; OXYR; PEPTIDES; FEATURES	The Lon AAA+ protease degrades damaged or misfolded proteins in its intramolecular chamber. Its activity must be precisely controlled, but the mechanism by which Lon is regulated in response to different environments is not known. Facultative anaerobes in the Enterobacteriaceae family, mostly symbionts and pathogens, encounter both anaerobic and aerobic environments inside and outside the host's body, respectively. The bacteria characteristically have two cysteine residues on the Lon protease (P) domain surface that unusually form a disulfide bond. Here we show that the cysteine residues act as a redox switch of Lon. Upon disulfide bond reduction, the exit pore of the P-domain ring narrows by similar to 30%, thus interrupting product passage and decreasing activity by 80%; disulfide bonding by oxidation restores the pore size and activity. The redox switch (E-o' = -227 mV) is appropriately tuned to respond to variation between anaerobic and aerobic conditions, thus optimizing the cellular proteolysis level for each environment.	[Nishii, Wataru; Kukimoto-Niino, Mutsuko; Terada, Takaho; Shirouzu, Mikako; Muramatsu, Tomonari; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Nishii, Wataru; Terada, Takaho; Muramatsu, Tomonari; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Yokohama, Kanagawa, Japan; [Kukimoto-Niino, Mutsuko; Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Kojima, Masaki] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Kihara, Hiroshi] Himeji Hinomoto Coll, Himeji, Hyogo, Japan	RIKEN; RIKEN; RIKEN; Tokyo University of Pharmacy & Life Sciences	Nishii, W (corresponding author), RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan.	wataru.nishii@riken.jp; yokoyama@riken.jp	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Kukimoto-Niino, Mutsuko/C-6704-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17770116]; Targeted Proteins Research Program (TPRP); Platform for Drug Discovery, Informatics, and Structural Life Science, both from MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science, both from MEXT	We thank T. Nishii for assistance with the enzyme preparation and F. Amano (Osaka University of Pharmaceutical Science) for providing the E. coli AB1157 and JK405 strains. We would like to thank the beamline staff at BL26B1 and BL26B2 of SPring-8 for assistance during data collection. We wish to thank T. Nakagawa (UNISOKU, Co., Ltd.) for assistance with stopped-flow experiments. We thank A. Ishii, K. Ake, T. Imada and T. Nakayama for assistance with manuscript preparation. This work was supported in part by a Grant-in-Aid for Scientific Research (17770116) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to W.N.). This work was also supported in part by the Targeted Proteins Research Program (TPRP) and the Platform for Drug Discovery, Informatics, and Structural Life Science, both from MEXT (to S.Y.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Botos I, 2004, J STRUCT BIOL, V146, P113, DOI 10.1016/j.jsb.2003.09.003; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISCHER H, 1993, J BIOL CHEM, V268, P22502; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GOFF SA, 1987, J BIOL CHEM, V262, P4508; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; GOLDBERG AL, 1985, J BIOL CHEM, V260, P2029; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; KROH HE, 1991, J BACTERIOL, V173, P2691, DOI 10.1128/jb.173.8.2691-2695.1991; Lee I, 2006, MOL BIOSYST, V2, P477, DOI 10.1039/b609936j; Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805; MAURIZI MR, 1987, J BIOL CHEM, V262, P2696; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nishii W, 2005, FEBS LETT, V579, P6846, DOI 10.1016/j.febslet.2005.11.026; Nishii W, 2002, EUR J BIOCHEM, V269, P451, DOI 10.1046/j.0014-2956.2001.02668.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Thomas-Wohlever J, 2002, BIOCHEMISTRY-US, V41, P9418, DOI 10.1021/bi0255470; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; WAXMAN L, 1985, J BIOL CHEM, V260, P2022; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wilson M., 2008, BACTERIOLOGY HUMANS; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	49	22	23	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					46	+		10.1038/nchembio.1688	http://dx.doi.org/10.1038/nchembio.1688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25383757				2022-12-25	WOS:000346448600011
J	Thorne, CA; Wichaidit, C; Coster, AD; Posner, BA; Wu, LF; Altschuler, SJ				Thorne, Curtis A.; Wichaidit, Chonlarat; Coster, Adam D.; Posner, Bruce A.; Wu, Lani F.; Altschuler, Steven J.			GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GSK-3-BETA-MEDIATED PHOSPHORYLATION; BETA-CATENIN; MTOR; POLO; INACTIVATION; ACTIVATION; SUBSTRATE; PEPTIDE; AKT	A fundamental challenge in treating disease is identifying molecular states that affect cellular responses to drugs. Here, we focus on glycogen synthase kinase 3 (GSK-3), a key regulator for many of the hallmark behaviors of cancer cells. We alter GSK-3 activity in colon epithelial cells to test its role in modulating drug response. We find that GSK-3 activity broadly affects the cellular sensitivities to a panel of oncology drugs and kinase inhibitors. Specifically, inhibition of GSK-3 activity can strongly desensitize or sensitize cells to kinase inhibitors (for example, mTOR or PLK1 inhibitors, respectively). Additionally, colorectal cancer cell lines, in which GSK-3 function is commonly suppressed, are resistant to mTOR inhibitors and yet highly sensitive to PLK1 inhibitors, and this is further exacerbated by additional GSK-3 inhibition. Finally, by conducting a kinome-wide RNAi screen, we find that GSK-3 modulates the cell proliferative phenotype of a large fraction (similar to 35%) of the kinome, which includes similar to 50% of current, clinically relevant kinase-targeted drugs. Our results highlight an underappreciated interplay of GSK-3 with therapeutically important kinases and suggest strategies for identifying disease-specific molecular profiles that can guide optimal selection of drug treatment.	[Thorne, Curtis A.; Wichaidit, Chonlarat; Coster, Adam D.; Wu, Lani F.; Altschuler, Steven J.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Posner, Bruce A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wu, Lani F.; Altschuler, Steven J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Wu, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dallas, TX 75390 USA.	lani.wu@ucsf.edu; steven.altschuler@ucsf.edu			Cancer Biology Training Grant [T32 CA124334]; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health [K99 DK103126-01, CA133253, CA184984, R01 GM081549, CPRIT RP10900]; Welch Foundation [I-1619, I-1644]; NATIONAL CANCER INSTITUTE [R01CA133253, R01CA184984, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK103126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081549] Funding Source: NIH RePORTER	Cancer Biology Training Grant; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cobb and members of the Altschuler and Wu laboratories for critical reading of the manuscript; J. Shay (University of Texas Southwestern) for providing the HCEC cell line and guidance on culture techniques, M. Ramirez for experimental support and J. Life for help with high-throughput screening experiments. This research was supported by a Cancer Biology Training Grant T32 CA124334 (C.A.T.), an American Cancer Society-Lakeshore Division Postdoctoral Fellowship (C.A.T.), the National Institute of Health grants K99 DK103126-01 (C.A.T.), CA133253 (S.J.A.), CA184984 (L.F.W.), R01 GM081549 (L.F.W.), CPRIT RP10900 (L.F.W.), and the Welch Foundation I-1619 (S.J.A.) and I-1644 (L.F.W.).	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Coster AD, 2014, NAT METHODS, V11, P602, DOI 10.1038/nmeth.2971; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Leis H, 2002, MOL CARCINOGEN, V35, P180, DOI 10.1002/mc.10087; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Roig A.I., 2010, GASTROENTEROLOGY, V138; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Simpson GL, 2009, CURR OPIN DRUG DISC, V12, P585; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; US National Cancer Institutes-National Institutes of Health, 2014, SYNTH PUR NAT PROD D; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zheng HC, 2007, ANTICANCER RES, V27, P3561; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	40	23	25	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					58	+		10.1038/nchembio.1690	http://dx.doi.org/10.1038/nchembio.1690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25402767	Green Accepted, Green Submitted			2022-12-25	WOS:000346448600013
J	Hong-Hermesdorf, A; Miethke, M; Gallaher, SD; Kropat, J; Dodani, SC; Chan, J; Barupala, D; Domaille, DW; Shirasaki, DI; Loo, JA; Weber, PK; Pett-Ridge, J; Stemmler, TL; Chang, CJ; Merchant, SS				Hong-Hermesdorf, Anne; Miethke, Marcus; Gallaher, Sean D.; Kropat, Janette; Dodani, Sheel C.; Chan, Jefferson; Barupala, Dulmini; Domaille, Dylan W.; Shirasaki, Dyna I.; Loo, Joseph A.; Weber, Peter K.; Pett-Ridge, Jennifer; Stemmler, Timothy L.; Chang, Christopher J.; Merchant, Sabeeha S.			Subcellular metal imaging identifies dynamic sites of Cu accumulation in Chlamydomonas	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; ZINC STORAGE; COPPER SENSOR; REINHARDTII; CELLS; ACIDOCALCISOMES; METALLOPROTEINS; TRANSPORTERS; PLASTOCYANIN; ASSIMILATION	We identified a Cu-accumulating structure with a dynamic role in intracellular Cu homeostasis. During Zn limitation, Chlamydomonas reinhardtii hyperaccumulates Cu, a process dependent on the nutritional Cu sensor CRR1, but it is functionally Cu deficient. Visualization of intracellular Cu revealed major Cu accumulation sites coincident with electron-dense structures that stained positive for low pH and polyphosphate, suggesting that they are lysosome-related organelles. Nano-secondary ion MS showed colocalization of Ca and Cu, and X-ray absorption spectroscopy was consistent with Cu+ accumulation in an ordered structure. Zn resupply restored Cu homeostasis concomitant with reduced abundance of these structures. Cu isotope labeling demonstrated that sequestered Cu+ became bioavailable for the synthesis of plastocyanin, and transcriptome profiling indicated that mobilized Cu became visible to CRR1. Cu trafficking to intracellular accumulation sites may be a strategy for preventing protein mismetallation during Zn deficiency and enabling efficient cuproprotein metallation or remetallation upon Zn resupply.	[Hong-Hermesdorf, Anne; Miethke, Marcus; Gallaher, Sean D.; Kropat, Janette; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Dodani, Sheel C.; Chan, Jefferson; Domaille, Dylan W.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dodani, Sheel C.; Chan, Jefferson; Domaille, Dylan W.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Barupala, Dulmini; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI USA; [Shirasaki, Dyna I.; Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Loo, Joseph A.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA; [Weber, Peter K.; Pett-Ridge, Jennifer] Lawrence Livermore Natl Lab, Div Chem Sci, Livermore, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Wayne State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	merchant@chem.ucla.edu	Weber, Peter Kilian/AAP-9517-2020; , Jennifer Pett RIdge/AFF-7780-2022; , Jennifer Pett RIdge/AAE-9934-2022	Weber, Peter Kilian/0000-0001-6022-6050; Pett-Ridge, Jennifer/0000-0002-4439-2398; Gallaher, Sean/0000-0002-9773-6051; Stemmler, Timothy/0000-0002-6298-088X; Domaille, Dylan Wythe/0000-0003-0127-7485	US National Institutes of Health (NIH) [GM42143, GM092473, GM079465]; United States Department of Energy Cooperative Agreement [DE-FC0202ER63421]; German Academic Exchange Service DAAD [D0847579, D1242134]; US Department of Energy at LLNL [DE-AC52-07NA27344]; US Department of Energy Genomic Science Program [SCW1039]; Department of Energy-Office of Biological and Environmental Research; NIH-National Center for Research Resources Biomedical Technology Program; NIH [T32HL120822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092473, R01GM079465, R37GM042143, R01GM042143, R29GM042143] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Cooperative Agreement; German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); US Department of Energy at LLNL; US Department of Energy Genomic Science Program; Department of Energy-Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH-National Center for Research Resources Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in part, by grants from the US National Institutes of Health (NIH; GM42143 and GM092473 to S.S.M., DK068139 to T.L.S.and GM079465 to C.J.C.), the United States Department of Energy Cooperative Agreement (DE-FC0202ER63421 to D. Eisenberg for support of J.A.L.) and the German Academic Exchange Service DAAD (D0847579 to A.H.-H. and D1242134 to M.M.). Work at Lawrence Livermore National Laboratory (LLNL) was performed under the auspices of the US Department of Energy at LLNL under contract DE-AC52-07NA27344, with funding provided by the US Department of Energy Genomic Science Program under contract SCW1039. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). SSRL is a national user facility operated by Stanford University, and the SSRL Structural Molecular Biology Program is supported by the Department of Energy-Office of Biological and Environmental Research and by the NIH-National Center for Research Resources Biomedical Technology Program. D.B. is supported by the NIH (T32HL120822), and C.J.C. is an investigator with the Howard Hughes Medical Institute. Electron microscopy was performed at the Electron Microscopy Services Center of the University of California-Los Angeles Brain Research Institute. We thank A. Aron and K.M. Ramos-Torres for their help with resynthesis and optical spectroscopy of fresh CS3 and Ctrl-CS3 for control experiments.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Bickmeyer U, 2008, BIOCHEM BIOPH RES CO, V373, P419, DOI 10.1016/j.bbrc.2008.06.056; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chandra S., 2010, ENCY MASS SPECTROMET, P469; Chauhan S, 2014, BIOCHEMISTRY-US, V53, P1069, DOI 10.1021/bi4015264; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; CZUPRYN M, 1993, BIOCHEMISTRY-US, V32, P1204, DOI 10.1021/bi00056a002; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Foster AW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-25; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Gudipaty SA, 2012, FEMS MICROBIOL LETT, V330, P30, DOI 10.1111/j.1574-6968.2012.02529.x; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; LI HH, 1995, J BIOL CHEM, V270, P23504, DOI 10.1074/jbc.270.40.23504; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Malasarn D, 2013, J BIOL CHEM, V288, P10672, DOI 10.1074/jbc.M113.455105; MERCHANT S, 1987, EMBO J, V6, P2531, DOI 10.1002/j.1460-2075.1987.tb02540.x; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Miyabe S, 2001, BIOCHEM BIOPH RES CO, V282, P79, DOI 10.1006/bbrc.2001.4522; Miyayama T, 2009, TOXICOL APPL PHARM, V237, P205, DOI 10.1016/j.taap.2009.03.024; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Remacle C, 2010, PLANT MOL BIOL, V74, P223, DOI 10.1007/s11103-010-9668-6; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Slaveykova VI, 2009, ANAL BIOANAL CHEM, V393, P583, DOI 10.1007/s00216-008-2486-x; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Yagisawa F, 2009, PLANT J, V60, P882, DOI 10.1111/j.1365-313X.2009.04008.x	55	99	101	3	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1034	+		10.1038/nchembio.1662	http://dx.doi.org/10.1038/nchembio.1662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25344811	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000345122300011
J	Kikuchi, R; Nakamura, K; MacLauchlan, S; Ngo, DTM; Shimizu, I; Fuster, JJ; Katanasaka, Y; Yoshida, S; Qiu, Y; Yamaguchi, TP; Matsushita, T; Murohara, T; Gokce, N; Bates, DO; Hamburg, NM; Walsh, K				Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Doan Thi-Minh Ngo; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Qiu, Yan; Yamaguchi, Terry P.; Matsushita, Tadashi; Murohara, Toyoaki; Gokce, Noyan; Bates, David O.; Hamburg, Naomi M.; Walsh, Kenneth			An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERMITTENT CLAUDICATION; SKELETAL-MUSCLE; SPLICE VARIANT; ANGIOGENESIS; INFLAMMATION; MECHANISMS; VEGF(165)B; PATHWAY; BINDING	Peripheral artery disease (PAD) generates tissue ischemia through arterial occlusions and insufficient collateral vessel formation. Vascular insufficiency in PAD occurs despite higher circulating levels of vascular endothelial growth factor A (VEGF-A)1,2, a key regulator of angiogenesis. Here we show that clinical PAD is associated with elevated levels of an antiangiogenic VEGF-A splice isoform (VEGF-A(165)b) and a corresponding reduction in levels of the proangiogenic VEGF-A(165)a splice isoform. In mice, VEGF-A(165)b expression was upregulated by conditions associated with impaired limb revascularization, including leptin deficiency, diet-induced obesity, genetic ablation of the secreted frizzled-related protein 5 (Sfrp5) adipokine and transgenic overexpression of Wnt5a in myeloid cells. In a mouse model of PAD, delivery of VEGF-A(165)b inhibited revascularization of ischemic hind limbs, Whereas treatment with an isoform-specific neutralizing antibody reversed impaired revascularization caused by metabolic dysfunction or perturbations in the Wnt5a-Sfrp5 regulatory system. These results indicate that inflammation-driven expression of the antiangiogenic VEGF-A isoform can contribute to impaired collateralization in ischemic cardiovascular disease.	[Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Hamburg, Naomi M.; Walsh, Kenneth] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Doan Thi-Minh Ngo; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Gokce, Noyan; Hamburg, Naomi M.; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Kikuchi, Ryosuke] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Doan Thi-Minh Ngo; Gokce, Noyan] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Qiu, Yan; Bates, David O.] Univ Bristol, Sch Physiol & Pharmacol, Microvasc Res Labs, Bristol, Avon, England; [Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21701 USA; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Bates, David O.] Univ Nottingham, Sch Med, Queens Med Ctr, Div Canc & Stem Cells, Nottingham, England; [Hamburg, Naomi M.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Boston University; Boston University; Nagoya University; Boston University; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nagoya University; Nagoya University; University of Nottingham; Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	kxwalsh@bu.edu	Matsushita, Tadadshi/I-7349-2014; Hamburg, Naomi/AAY-6685-2020; Kikuchi, Ryosuke/AAX-4971-2021; Fuster, José J/D-3685-2011; Murohara, Toyoaki/M-4958-2014	Fuster, José J/0000-0002-5970-629X; Shimizu, Ippei/0000-0003-3333-8131; Hamburg, Naomi/0000-0001-5504-5589; Bates, David/0000-0003-4850-2360; MacLauchlan, Susan/0000-0001-9689-0826	US National Institutes of Health (NIH) [HL102874, AG34972, HL68758, HL126141]; Uehara Memorial Foundation; NIH [HL102299, HL109790, HL081587, HL1145675]; British Heart Foundation [PG/13/47130337, PG/08/054/25272]; Wellcome Trust; Cancer Research UK; Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R21HL109790, R01HL114675, R01HL115391, T32HL007224, R01HL102299, R01HL126141, R21HL102874, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER; British Heart Foundation [PG/13/47/30337] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	This work was supported by US National Institutes of Health (NIH) grants HL102874, AG34972, HL68758 and HL126141 to K.W. R.K. is supported by the Uehara Memorial Foundation and the Grant-in-Aid for Young Scientists B. N.M.H. is supported by NIH grants HL102299 and HL109790, and N.G. is supported by NIH grants HL081587 and HL1145675. D.O.B. is supported by the British Heart Foundation PG/13/47130337 and PG/08/054/25272, the Wellcome Trust, Cancer Research UK and the Medical Research Council. We are grateful to S.M. Eswarappa and P.L. Fox, Department of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, for providing Ax-specific antibody and recombinant VEGF-Ax protein.	Anderson PL, 2004, J VASC SURG, V39, P1200, DOI 10.1016/j.jvs.2004.02.039; Bates DO, 2012, CLIN CANCER RES, V18, P6384, DOI 10.1158/1078-0432.CCR-12-2223; Bates DO, 2002, CANCER RES, V62, P4123; Blann AD, 2002, CLIN SCI, V102, P187, DOI 10.1042/CS20010178; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Dokun AO, 2011, CIRC RES, V109, P246, DOI 10.1161/CIRCRESAHA.111.249953; Duscha BD, 2011, ARTERIOSCL THROM VAS, V31, P2742, DOI 10.1161/ATVBAHA.111.230441; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamburg NM, 2011, CIRCULATION, V123, P87, DOI 10.1161/CIRCULATIONAHA.109.881888; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Jones WS, 2012, VASC MED, V17, P94, DOI 10.1177/1358863X11436334; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; McDermott MM, 2007, J AM COLL CARDIOL, V50, P897, DOI 10.1016/j.jacc.2007.05.017; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Vidula H, 2008, ANN INTERN MED, V148, P85, DOI 10.7326/0003-4819-148-2-200801150-00003	29	133	136	1	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1464	1471		10.1038/nm.3703	http://dx.doi.org/10.1038/nm.3703			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25362254	Green Accepted			2022-12-25	WOS:000345817900023
J	London, N; Miller, RM; Krishnan, S; Uchida, K; Irwin, JJ; Eidam, O; Gibold, L; Cimermancic, P; Bonnet, R; Shoichet, BK; Taunton, J				London, Nir; Miller, Rand M.; Krishnan, Shyam; Uchida, Kenji; Irwin, John J.; Eidam, Oliv; Gibold, Lucie; Cimermancic, Peter; Bonnet, Richard; Shoichet, Brian K.; Taunton, Jack			Covalent docking of large libraries for the discovery of chemical probes	NATURE CHEMICAL BIOLOGY			English	Article							INHIBITORS; PREDICTION; REACTIVITY; DESIGN; OPTIMIZATION; GENERATION; COORDINATE; CYSTEINES; LIGANDS; PLACEBO	Chemical probes that form a covalent bond with a protein target often show enhanced selectivity, potency and utility for biological studies. Despite these advantages, protein-reactive compounds are usually avoided in high-throughput screening campaigns. Here we describe a general method (DOCKovalent) for screening large virtual libraries of electrophilic small molecules. We apply this method prospectively to discover reversible covalent fragments that target distinct protein nucleophiles, including the catalytic serine of AmpC beta- lactamase and noncatalytic cysteines in RSK2, MSK1 and JAK3 kinases. We identify submicromolar to low-nanomolar hits with high ligand efficiency, cellular activity and selectivity, including what are to our knowledge the first reported reversible covalent inhibitors of JAK3. Crystal structures of inhibitor complexes with AmpC and RSK2 confirm the docking predictions and guide further optimization. As covalent virtual screening may have broad utility for the rapid discovery of chemical probes, we have made the method freely available through an automated web server (http://covalent.docking.org/).	[London, Nir; Irwin, John J.; Eidam, Oliv; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Miller, Rand M.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA; [Krishnan, Shyam; Uchida, Kenji; Cimermancic, Peter; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Krishnan, Shyam; Uchida, Kenji; Taunton, Jack] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Irwin, John J.; Gibold, Lucie; Shoichet, Brian K.] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Irwin, John J.; Gibold, Lucie; Shoichet, Brian K.] Univ Toronto, Ontario Inst Canc Res, Toronto, ON, Canada; [Gibold, Lucie; Bonnet, Richard] Univ Clermont Ferrand 2, INSERM, UMR 1071, Univ Auvergne, Clermont Ferrand, France; [Bonnet, Richard] INRA, USC 2018, Clermont Ferrand, France; [Bonnet, Richard] Ctr Hosp Univ, Serv Bacteriol, Clermont Ferrand, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bshoichet@gmail.com; jack.taunton@ucsf.edu	Bonnet, Richard/C-8544-2015	Irwin, John/0000-0002-1195-6417; London, Nir/0000-0003-2687-0699	US National Institutes of Health (NIH) [GM59957, GM71896]; Ministsre de la Recherche et de la Technologie; Institut national de la sante et de la recherche medicale [U1071]; Institut National de la Recherche Agronomique [USC-2018]; Centre Hospitalier Regional Universitaire de Clermont-Ferrand, France; EMBO long-term fellowship [ALTF 1121-2011]; Sandler Foundation; California Tobacco-Related Disease Research Program [19FT-0091]; Howard Hughes Medical Institute Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059957, T32GM064337, T32GM067547, R01GM071896] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministsre de la Recherche et de la Technologie; Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Centre Hospitalier Regional Universitaire de Clermont-Ferrand, France; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Sandler Foundation; California Tobacco-Related Disease Research Program(University of California System); Howard Hughes Medical Institute Predoctoral Fellowship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational methods supported by US National Institutes of Health (NIH) grant GM59957, and the web portal was supported by NIH GM71896. This work was also supported by the Ministsre de la Recherche et de la Technologie, the Institut national de la sante et de la recherche medicale (UMR Inserm U1071), the Institut National de la Recherche Agronomique (USC-2018) and the Centre Hospitalier Regional Universitaire de Clermont-Ferrand, France (to R. B.). We thank M. Fischer and D. Shaya for help with X-ray data collection, A. O'Donoghue (UCSF) for protease substrates, P. Coffino and S. Menant (UCSF) for the proteasome and the PA26 complex sample, X. Ouyang (Nanyang Technological University) for the r.m.s. calculation software used for the beta-lactam benchmark, and S. Barelier for reading of this manuscript. N. L. was supported by an EMBO long-term fellowship (ALTF 1121-2011) and the University of California-San Francisco Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation. S. K. was supported by a fellowship from the California Tobacco-Related Disease Research Program (no. 19FT-0091). P. C. was supported by Howard Hughes Medical Institute Predoctoral Fellowship.	ADAMS J, 2008, Patent No. 2008063300; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Chang JW, 2011, CHEM BIOL, V18, P476, DOI 10.1016/j.chembiol.2011.02.008; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; De Cesco S, 2012, J MED CHEM, V55, P6306, DOI 10.1021/jm3002839; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Eidam O, 2012, P NATL ACAD SCI USA, V109, P17448, DOI 10.1073/pnas.1208337109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer M, 2014, NAT CHEM, V6, P575, DOI [10.1038/NCHEM.1954, 10.1038/nchem.1954]; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Glick M, 2011, CURR OPIN CHEM BIOL, V15, P540, DOI 10.1016/j.cbpa.2011.02.021; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jiang JK, 2008, J MED CHEM, V51, P8012, DOI 10.1021/jm801142b; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kathman SG, 2014, J MED CHEM, V57, P4969, DOI 10.1021/jm500345q; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Li JB, 1999, THEOR CHEM ACC, V103, P9, DOI 10.1007/s002140050513; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P1825, DOI 10.1093/jac/dkt118; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Le NT, 2013, CIRCULATION, V127, P486, DOI 10.1161/CIRCULATIONAHA.112.116988; Ouyang XC, 2013, J COMPUT CHEM, V34, P326, DOI 10.1002/jcc.23136; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Pouvreau L, 1998, FEBS LETT, V423, P167, DOI 10.1016/S0014-5793(98)00062-3; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Rodriguez-Martinez JA, 2009, BIOTECHNOL LETT, V31, P883, DOI 10.1007/s10529-009-9947-y; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schroder J, 2013, J MED CHEM, V56, P1478, DOI 10.1021/jm3013932; Schwobel JAH, 2010, CHEM RES TOXICOL, V23, P1576, DOI 10.1021/tx100172x; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wikler MA, 2010, PERFORMANCE STANDA S; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	60	174	178	5	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1066	+		10.1038/nchembio.1666	http://dx.doi.org/10.1038/nchembio.1666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25344815	Green Accepted, Green Submitted			2022-12-25	WOS:000345122300016
J	Schubert, J; Siekierska, A; Langlois, M; May, P; Huneau, C; Becker, F; Muhle, H; Suls, A; Lemke, JR; de Kovel, CGF; Thiele, H; Konrad, K; Kawalia, A; Toliat, MR; Sander, T; Ruschendorf, F; Caliebe, A; Nagel, I; Kohl, B; Kecskes, A; Jacmin, M; Hardies, K; Weckhuysen, S; Riesch, E; Dorn, T; Brilstra, EH; Baulac, S; Moller, RS; Hjalgrim, H; Koeleman, BPC; Jurkat-Rott, K; Lehman-Horn, F; Roach, JC; Glusman, G; Hood, L; Galas, DJ; Martin, B; de Witte, PAM; Biskup, S; De Jonghe, P; Helbig, I; Balling, R; Nurnberg, P; Crawford, AD; Esguerra, CV; Weber, YG; Lerche, H				Schubert, Julian; Siekierska, Aleksandra; Langlois, Melanie; May, Patrick; Huneau, Clement; Becker, Felicitas; Muhle, Hiltrud; Suls, Arvid; Lemke, Johannes R.; de Kovel, Carolien G. F.; Thiele, Holger; Konrad, Kathryn; Kawalia, Amit; Toliat, Mohammad R.; Sander, Thomas; Rueschendorf, Franz; Caliebe, Almuth; Nagel, Inga; Kohl, Bernard; Kecskes, Angela; Jacmin, Maxime; Hardies, Katia; Weckhuysen, Sarah; Riesch, Erik; Dorn, Thomas; Brilstra, Eva H.; Baulac, Stephanie; Moller, Rikke S.; Hjalgrim, Helle; Koeleman, Bobby P. C.; Jurkat-Rott, Karin; Lehman-Horn, Frank; Roach, Jared C.; Glusman, Gustavo; Hood, Leroy; Galas, David J.; Martin, Benoit; de Witte, Peter A. M.; Biskup, Saskia; De Jonghe, Peter; Helbig, Ingo; Balling, Rudi; Nuernberg, Peter; Crawford, Alexander D.; Esguerra, Camila V.; Weber, Yvonne G.; Lerche, Holger		EuroEPINOMICS RES Consortium	Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes	NATURE GENETICS			English	Article							PAROXYSMAL KINESIGENIC DYSKINESIA; SYNAPTIC VESICLE FUSION; DE-NOVO MUTATIONS; FEBRILE SEIZURES; INFANTILE CONVULSIONS; GENERALIZED EPILEPSY; PRRT2 MUTATIONS; GENERATION; DISORDERS; ZEBRAFISH	Febrile seizures affect 2-4% of all children(1) and have a strong genetic component(2). Recurrent mutations in three main genes (SCN1A, SCN1B and GABRG2)(3-5) have been identified that cause febrile seizures with or without epilepsy. Here we report the identification of mutations in STX1B, encoding syntaxin-1B(6), that are associated with both febrile seizures and epilepsy. Whole-exome sequencing in independent large pedigrees(7,8) identified cosegregating STX1B mutations predicted to cause an early truncation or an in-frame insertion or deletion. Three additional nonsense or missense mutations and a de novo microdeletion encompassing STX1B were then identified in 449 familial or sporadic cases. Video and local field potential analyses of zebrafish larvae with antisense knockdown of stx1b showed seizure-like behavior and epileptiform discharges that were highly sensitive to increased temperature. Wild-type human syntaxin-1B but not a mutated protein rescued the effects of stx1b knockdown in zebrafish. Our results thus implicate STX1B and the presynaptic release machinery in fever-associated epilepsy syndromes.	[Schubert, Julian; Becker, Felicitas; Weber, Yvonne G.; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Siekierska, Aleksandra; Kecskes, Angela; de Witte, Peter A. M.; Crawford, Alexander D.; Esguerra, Camila V.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Leuven, Belgium; [Langlois, Melanie; May, Patrick; Jacmin, Maxime; Galas, David J.; Balling, Rudi; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [May, Patrick; Roach, Jared C.; Glusman, Gustavo; Hood, Leroy; Galas, David J.] Inst Syst Biol, Seattle, WA USA; [Huneau, Clement; Martin, Benoit] INSERM, U1099, Rennes, France; [Huneau, Clement; Martin, Benoit] Univ Rennes 1, LTSI, Rennes, France; [Muhle, Hiltrud; Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Suls, Arvid; Hardies, Katia; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Suls, Arvid; Hardies, Katia; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2020 Antwerp, Belgium; [Lemke, Johannes R.] Inselspital Bern, Univ Childrens Hosp, Div Human Genet, CH-3010 Bern, Switzerland; [Lemke, Johannes R.] Univ Hosp Leipzig, Inst Human Genet, Leipzig, Germany; [de Kovel, Carolien G. F.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Sect Complex Genet, Utrecht, Netherlands; [Thiele, Holger; Konrad, Kathryn; Kawalia, Amit; Toliat, Mohammad R.; Sander, Thomas] Univ Cologne, CCG, D-50931 Cologne, Germany; [Rueschendorf, Franz] Max Delbruck Ctr Mol Med, Berlin, Germany; [Caliebe, Almuth; Nagel, Inga] Univ Kiel, Inst Human Genet, Kiel, Germany; [Caliebe, Almuth; Nagel, Inga] Univ Hosp Schleswig Holstein, Kiel, Germany; [Kohl, Bernard] Kinderkrankenhaus Wilhelmstift, Rahlstedt, Germany; [Riesch, Erik; Biskup, Saskia] CeGaT, Tubingen, Germany; [Riesch, Erik; Biskup, Saskia] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Dorn, Thomas] Swiss Epilepsy Ctr, Zurich, Switzerland; [Baulac, Stephanie] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7225,UMRS 1127,INSERM U1127, Paris, France; [Baulac, Stephanie] Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Moller, Rikke S.; Hjalgrim, Helle] Danish Epilepsy Ctr, Dianalund, Denmark; [Moller, Rikke S.; Hjalgrim, Helle] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Jurkat-Rott, Karin; Lehman-Horn, Frank] Univ Ulm, Div Neurophysiol, D-89069 Ulm, Germany; [Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; KU Leuven; University of Luxembourg; Institute for Systems Biology (ISB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Kiel; Schleswig Holstein University Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Bern; University Hospital of Bern; Leipzig University; Utrecht University; Utrecht University Medical Center; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; CeGaT; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark; Ulm University; Pacific Northwest Diabetes Research Institute (PNDRI); University of Cologne; University of Cologne	Lerche, H (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.	c.v.esguerra@biotek.uio.no; holger.lerche@uni-tuebingen.de	Thiele, Holger/ABE-6792-2020; May, Patrick/N-1019-2019; de Kovel, Carolien/AAI-3531-2021; Baulac, Stéphanie/O-2099-2016; Caliebe, Almuth/G-1248-2018; Helbig, Ingo/G-8467-2018; Weckhuysen, Sarah/HGB-9957-2022; Esguerra, Camila/N-6159-2015; Suls, Arvid/M-2694-2013; Brilstra, Eva/AAT-3092-2021; Muhle, Hiltrud/F-5715-2010; May, Patrick/B-1238-2010	Thiele, Holger/0000-0002-0169-998X; May, Patrick/0000-0001-8698-3770; de Kovel, Carolien/0000-0002-7818-1396; Baulac, Stéphanie/0000-0001-6430-4693; Caliebe, Almuth/0000-0003-2157-425X; Helbig, Ingo/0000-0001-8486-0558; Weckhuysen, Sarah/0000-0003-2878-1147; Esguerra, Camila/0000-0002-2271-8094; Suls, Arvid/0000-0003-0328-198X; May, Patrick/0000-0001-8698-3770; Siekierska, Aleksandra/0000-0003-4907-605X; Glusman, Gustavo/0000-0001-8060-5955; Balling, Rudi/0000-0003-2902-5650; Moller, Rikke S./0000-0002-9664-1448; de Witte, Peter/0000-0002-9989-9567	Federal Ministry for Education and Research (BMBF; NGENplus/EMINet) [01GS08123, 01G508120, 01GM1105]; European Science Foundation from the German Research Foundation (DFG) [Le1030/11-1, He5415/3-1, Sa43415-1, Nu50/8-1]; Swiss National Fund [32EP30_136042/1]; Fund for Scientific Research Flanders [GA13611N]; German Research Foundation (DFG) [WE4896/3-1, HE5415/6-1]; University of Tubingen [AKF 297-0-0]; German Society for Epileptology (DGfE); foundation no-epilep; University of Kiel; Institute of Clinical Molecular Biology in Kiel; BMBF [01EY1103]; Center for Systems Biology P50 grant (US National Institutes of Health) [GM076547]; DEG; University of Luxembourg-Institute for Systems Biology Program; 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB); University of Luxembourg; Agency for Innovation by Science and Technology (IWT, Flanders); LCSB KT program; Hertie Foundation; program 'Investissements d'Avenir' [ANR-10-IAIHU-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	Federal Ministry for Education and Research (BMBF; NGENplus/EMINet); European Science Foundation from the German Research Foundation (DFG); Swiss National Fund(Swiss National Science Foundation (SNSF)); Fund for Scientific Research Flanders(FWO); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Tubingen; German Society for Epileptology (DGfE); foundation no-epilep; University of Kiel; Institute of Clinical Molecular Biology in Kiel; BMBF(Federal Ministry of Education & Research (BMBF)); Center for Systems Biology P50 grant (US National Institutes of Health); DEG; University of Luxembourg-Institute for Systems Biology Program; 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB); University of Luxembourg; Agency for Innovation by Science and Technology (IWT, Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); LCSB KT program; Hertie Foundation; program 'Investissements d'Avenir'(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the families and their relatives for their cooperation. We thank P. Verstreken (VIB, KU Leuven) for providing access to the electrophysiology equipment. This study was supported by the Federal Ministry for Education and Research (BMBF; NGENplus/EMINet to H.L., RN. and T.S., 01GS08123 and 01G508120; lonNeurONet to H.L., K.J.-R., EL-H. and S. Biskup, 01GM1105), funding to the EuroEPINOMICS Consortium coordinated by the European Science Foundation from the German Research Foundation (DFG; Le1030/11-1 to H.L., He5415/3-1 to I.H., Sa43415-1 to T.S. and Nu50/8-1 to RN.), the Swiss National Fund (32EP30_136042/1 to J.R.L.) and the Fund for Scientific Research Flanders (GA13611N to P.D.J.). Y.G.W. and I.H. were funded by the German Research Foundation (DFG: WE4896/3-1 and HE5415/6-1). Y.G.W. and S. Biskup received intramural funding from the University of Tubingen (AKF 297-0-0). The German Society for Epileptology (DGfE) gave funding to H.L., Y.G.W., I.H. and H.M., and the foundation no-epilep gave funding to H.L. I.H. and H.M. received further support through intramural grants from the University of Kiel and infrastructural support from the Institute of Clinical Molecular Biology in Kiel, supported in part by the popgen 2.0 network (P2N) through a grant from the BMBF (01EY1103) and Cluster of Excellence 'Inflammation at Interfaces' and 'Future Ocean' programs funded by the DEG. The study was further supported by a Center for Systems Biology P50 grant (GM076547, US National Institutes of Health) to L.H. and by the University of Luxembourg-Institute for Systems Biology Program (P.M., J.C.R., G.G., L.H. and D.J.G.). M. Brunkow provided project management for the whole-genome sequencing. P.M. was supported by 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg. A. Kecskes and K.H. are recipients of a PhD fellowship from the Agency for Innovation by Science and Technology (IWT, Flanders). A. Suls is a postdoctoral fellow of the Research Foundation-Flanders (FWO Vlaanderen). M.L. and M.J. were supported by the LCSB KT program. EL-H. and K.J.-R. are supported by the Hertie Foundation. S. Baulac received financial support from the program 'Investissements d'Avenir' (ANR-10-IAIHU-06).	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Becker F, 2013, J NEUROL, V260, P1234, DOI 10.1007/s00415-012-6777-y; Berg AT, 2013, HAND CLINIC, V111, P391, DOI 10.1016/B978-0-444-52891-9.00043-9; Bragina L, 2010, NEUROSCIENCE, V165, P934, DOI 10.1016/j.neuroscience.2009.11.009; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Eckhaus J, 2013, EPILEPSY RES, V105, P103, DOI 10.1016/j.eplepsyres.2013.02.011; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lerche H, 2001, NEUROLOGY, V57, P1191, DOI 10.1212/WNL.57.7.1191; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Schubert J, 2012, HUM MUTAT, V33, P1439, DOI 10.1002/humu.22126; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Weber YG, 2008, EPILEPSIA, V49, P1959, DOI 10.1111/j.1528-1167.2008.01646.x; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307	25	133	140	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1327	1332		10.1038/ng.3130	http://dx.doi.org/10.1038/ng.3130			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362483				2022-12-25	WOS:000345547300014
J	Zheng, ZL; Liebers, M; Zhelyazkova, B; Cao, Y; Panditi, D; Lynch, KD; Chen, JX; Robinson, HE; Shim, HS; Chmielecki, J; Pao, W; Engelman, JA; Iafrate, AJ; Le, LP				Zheng, Zongli; Liebers, Matthew; Zhelyazkova, Boryana; Cao, Yi; Panditi, Divya; Lynch, Kerry D.; Chen, Juxiang; Robinson, Hayley E.; Shim, Hyo Sup; Chmielecki, Juliann; Pao, William; Engelman, Jeffrey A.; Iafrate, A. John; Le, Long Phi			Anchored multiplex FOR for targeted next-generation sequencing	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; PCR; GENOMES; DNA; ENRICHMENT; DISCOVERY; VARIANTS; FUSIONS; TUMORS; ROS1	We describe a rapid target enrichment method for next-generation sequencing, termed anchored multiplex PCR (AMP), that is compatible with low nucleic acid input from formalin-fixed paraffin-embedded (FFPE) specimens. AMP is effective in detecting gene rearrangements (without prior knowledge of the fusion partners), single nucleotide variants, insertions, deletions and copy number changes. Validation of a gene rearrangement panel using 319 FFPE samples showed 100% sensitivity (95% confidence limit: 96.5-100%) and 100% specificity (95% confidence limit: 99.3-100%) compared with reference assays. On the basis of our experience with performing AMP on 986 clinical FFPE samples, we show its potential as both a robust clinical assay and a powerful discovery tool, which we used to identify new therapeutically important gene fusions: ARHGEF2-NTRK1 and CHTOP-NTRK1 in glioblastoma, MSN-ROS1, TRIM4-BRAF, VAMP2-NRG1, TPM3-NTRK1 and RUFY2-RET in lung cancer, FGFR2-CREB5 in cholangiocarcinoma and PPL-NTRK1 in thyroid carcinoma. AMP is a scalable and efficient next-generation sequencing target enrichment method for research and clinical applications.	[Zheng, Zongli; Liebers, Matthew; Zhelyazkova, Boryana; Cao, Yi; Panditi, Divya; Lynch, Kerry D.; Chen, Juxiang; Robinson, Hayley E.; Shim, Hyo Sup; Iafrate, A. John; Le, Long Phi] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zheng, Zongli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Juxiang] Shanghai Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Shim, Hyo Sup] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Chmielecki, Juliann; Pao, William] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Engelman, Jeffrey A.; Iafrate, A. John; Le, Long Phi] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts General Hospital; Karolinska Institutet; Naval Medical University; Yonsei University; Yonsei University Health System; Vanderbilt University; Harvard University; Massachusetts General Hospital	Iafrate, AJ (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	aiafrate@partners.org; lple@partners.org	Shim, Hyo Sup/ABI-6190-2020; zheng, zongli/C-7309-2008; zheng, zongli/B-2917-2011	zheng, zongli/0000-0003-4849-4903; Shim, Hyo Sup/0000-0002-5718-3624	US National Institutes of Health [R21CA161590]; Swedish Research Council [350-2012-368]; NATIONAL CANCER INSTITUTE [R21CA161590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a US National Institutes of Health grant (R21CA161590) to A.J.I. and a postdoctoral fellowship from the Swedish Research Council (350-2012-368) to Z.Z.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Chmielecki J, 2010, NUCLEIC ACIDS RES, V38, P6985, DOI 10.1093/nar/gkq579; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Crystal AS, 2012, CLIN CANCER RES, V18, P4479, DOI 10.1158/1078-0432.CCR-12-1952; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Johansson H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1005; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neiman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048616; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Wang T, 2009, EXPERT OPIN THER PAT, V19, P305, DOI 10.1517/13543770902721261; Yousem SA, 2013, CHEST, V143, P1679, DOI 10.1378/chest.12-1917; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	26	541	584	9	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1479	1484		10.1038/nm.3729	http://dx.doi.org/10.1038/nm.3729			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25384085				2022-12-25	WOS:000345817900025
J	Cavallari, M; Stallforth, P; Kalinichenko, A; Rathwell, DCK; Gronewold, TMA; Adibekian, A; Mori, L; Landmann, R; Seeberger, PH; De Libero, G				Cavallari, Marco; Stallforth, Pierre; Kalinichenko, Artem; Rathwell, Dominea C. K.; Gronewold, Thomas M. A.; Adibekian, Alexander; Mori, Lucia; Landmann, Regine; Seeberger, Peter H.; De Libero, Gennaro			A semisynthetic carbohydrate-lipid vaccine that protects against S-pneumoniae in mice	NATURE CHEMICAL BIOLOGY			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; KILLER T-CELLS; NKT CELLS; CAPSULAR POLYSACCHARIDE; SEROTYPE REPLACEMENT; CUTTING EDGE; B-CELLS; ACTIVATION; RESPONSES; 7-VALENT	Severe forms of pneumococcal meningitis, bacteraemia and pneumonia result in more than 1 million deaths each year despite the widespread introduction of carbohydrate-protein conjugate vaccines against Streptococcus pneumoniae. Here we describe a new and highly efficient antipneumococcal vaccine design based on synthetic conjugation of S. pneumoniae capsule polysaccharides to the potent lipid antigen alpha-galactosylceramide, which stimulates invariant natural killer T (iNKT) cells when presented by the nonpolymorphic antigen-presenting molecule CD1d. Mice injected with the new lipid-carbohydrate conjugate vaccine produced high-affinity IgG antibodies specific for pneumococcal polysaccharides. Vaccination stimulated germinal center formation; accumulation of iNKT cells with a T follicular helper cell phenotype; and increased frequency of carbohydrate-specific, long-lived memory B cells and plasmablasts. This new lipid-carbohydrate vaccination strategy induced potent antipolysaccharide immunity that protected against pneumococcal disease in mice and may also prove effective for the design of carbohydrate-based vaccines against other major bacterial pathogens.	[Cavallari, Marco; Kalinichenko, Artem; Mori, Lucia; Landmann, Regine; De Libero, Gennaro] Univ Basel, Dept Biomed, Basel, Switzerland; [Cavallari, Marco; Kalinichenko, Artem; Mori, Lucia; Landmann, Regine; De Libero, Gennaro] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Stallforth, Pierre; Rathwell, Dominea C. K.; Adibekian, Alexander; Seeberger, Peter H.] Max Planck Inst Colloids & Interfaces, Biomol Syst, Potsdam, Germany; [Gronewold, Thomas M. A.] SAW Instruments, Bonn, Germany; [Mori, Lucia; De Libero, Gennaro] A STAR Agcy Sci Technol & Res Biopolis, SIgN Singapore Immunol Network, Singapore, Singapore	University of Basel; University of Basel; Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Cavallari, M (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	peter.seeberger@mpikg.mpg.de; gennaro_delibero@immunol.a-star.edu.sg	De Libero, Gennaro/P-2694-2017	De Libero, Gennaro/0000-0003-0853-7868; Kalinichenko, Artem/0000-0002-7020-7256; Stallforth, Pierre/0000-0001-7260-9921	European Union Framework Programme 7 grant [CAREPNEUMO 223111]; Swiss National Science Foundation (Sinergia) [310030_149571, CRS133-124819]; Scholarship of the Studienstiftung des deutschen Volkes; Alexander von Humboldt Foundation; Peter and Traudl Engerlhorn-Stiftung; Max Planck Society; US National Institutes of Health Tetramer Core Facility [HHSN272201300006C]	European Union Framework Programme 7 grant; Swiss National Science Foundation (Sinergia)(Swiss National Science Foundation (SNSF)); Scholarship of the Studienstiftung des deutschen Volkes; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Peter and Traudl Engerlhorn-Stiftung; Max Planck Society(Max Planck Society); US National Institutes of Health Tetramer Core Facility	We thank A.G. Rolink and D. Finke for materials and helpful discussions, R. Lange and S. Hammerschmidt for S. pneumoniae strains and C. Gartner for help in preparing the tissue sections. We acknowledge the US National Institutes of Health Tetramer Core Facility (contract HHSN272201300006C) for provision of CD1d tetramers. This study was supported by European Union Framework Programme 7 grant CAREPNEUMO 223111 (to R.L. and G.D.L.), the Swiss National Science Foundation (310030_149571 and Sinergia CRS133-124819 to G.D.L.), a Scholarship of the Studienstiftung des deutschen Volkes (to P.S.), the Alexander von Humboldt Foundation for a postdoctoral research fellowship (to D.C.K.R.), Peter and Traudl Engerlhorn-Stiftung (to A.K.) and funding of the Max Planck Society (P.H.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors wish to thank L. Robinson and N. McCarthy of Insight Editing London for critical review and manuscript editing and A. K. for the artwork.	Alexandre C, 2010, ACTA PAEDIATR, V99, P1686, DOI 10.1111/j.1651-2227.2010.01914.x; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Bai L, 2013, P NATL ACAD SCI USA, V110, P16097, DOI 10.1073/pnas.1303218110; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brandau DT, 2003, J PHARM SCI-US, V92, P218, DOI 10.1002/jps.10296; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chang Q, 2002, INFECT IMMUN, V70, P4977, DOI 10.1128/IAI.70.9.4977-4986.2002; Colino J, 2009, J IMMUNOL, V183, P1551, DOI 10.4049/jimmunol.0900238; Coughlin RT, 1998, VACCINE, V16, P1761, DOI 10.1016/S0264-410X(98)00139-X; Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I; Dellabona P, 2014, EUR J IMMUNOL, V44, P2230, DOI 10.1002/eji.201344399; Fattom A, 1999, VACCINE, V17, P126, DOI 10.1016/S0264-410X(98)00162-5; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Goldblatt D, 1998, J MED MICROBIOL, V47, P563, DOI 10.1099/00222615-47-7-563; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Hecht ML, 2009, CURR OPIN CHEM BIOL, V13, P354, DOI 10.1016/j.cbpa.2009.05.127; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Johnson DR, 2012, VACCINE, V30, P2206, DOI 10.1016/j.vaccine.2011.12.119; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; KOHN J, 1982, ENZYME MICROB TECH, V4, P161, DOI 10.1016/0141-0229(82)90109-0; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nagato K, 2012, J CLIN IMMUNOL, V32, P1071, DOI 10.1007/s10875-012-9697-9; Phalipon A, 2009, J IMMUNOL, V182, P2241, DOI 10.4049/jimmunol.0803141; Reilly EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037991; Richter J, 2013, BLOOD, V121, P423, DOI 10.1182/blood-2012-06-435503; Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10; Saeland E, 2003, J IMMUNOL, V170, P6158, DOI 10.4049/jimmunol.170.12.6158; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tonti E, 2012, J IMMUNOL, V188, P3217, DOI 10.4049/jimmunol.1103501; Tyo KR, 2011, VACCINE, V29, P6686, DOI 10.1016/j.vaccine.2011.06.091; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Vliegenthart JFG, 2006, FEBS LETT, V580, P2945, DOI 10.1016/j.febslet.2006.03.053; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yamashita Y, 1998, EUR J IMMUNOL, V28, P2981, DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D; Yarema KJ, 1998, CURR OPIN CHEM BIOL, V2, P49, DOI 10.1016/S1367-5931(98)80035-5; Zhou XT, 2002, ORG LETT, V4, P1267, DOI 10.1021/ol025565+	45	69	71	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					950	956		10.1038/NCHEMBIO.1650	http://dx.doi.org/10.1038/NCHEMBIO.1650			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25282505				2022-12-25	WOS:000343621500018
J	Price, FD; von Maltzahn, J; Bentzinger, CF; Dumont, NA; Yin, H; Chang, NC; Wilson, DH; Frenette, J; Rudnicki, MA				Price, Feodor D.; von Maltzahn, Julia; Bentzinger, C. Florian; Dumont, Nicolas A.; Yin, Hang; Chang, Natasha C.; Wilson, David H.; Frenette, Jerome; Rudnicki, Michael A.			Inhibition of JAK-STAT signaling stimulates adult satellite cell function	NATURE MEDICINE			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; AGED MUSCLE; GROWTH; REGENERATION; ACTIVATION; EXPRESSION; POLARITY; REJUVENATION	Diminished regenerative capacity of skeletal muscle occurs during adulthood. We identified a reduction in the intrinsic capacity of mouse adult satellite cells to contribute to muscle regeneration and repopulation of the niche. Gene expression analysis identified higher expression of JAK-STAT signaling targets in 18-month-old relative to 3-week-old mice. Knockdown of Jak2 or Stat3 significantly stimulated symmetric satellite stem cell divisions on cultured myofibers. Genetic knockdown of Jak2 or Stat3 expression in prospectively isolated satellite cells markedly enhanced their ability to repopulate the satellite cell niche after transplantation into regenerating tibialis anterior muscle. Pharmacological inhibition of Jak2 and Stat3 activity similarly stimulated symmetric expansion of satellite cells in vitro and their engraftment in vivo. Intramuscular injection of these drugs resulted in a marked enhancement of muscle repair and force generation after cardiotoxin injury. Together these results reveal age-related intrinsic properties that functionally distinguish satellite cells and suggest a promising therapeutic avenue for the treatment of muscle-wasting diseases.	[Price, Feodor D.; von Maltzahn, Julia; Bentzinger, C. Florian; Dumont, Nicolas A.; Yin, Hang; Chang, Natasha C.; Wilson, David H.; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada; [Price, Feodor D.; von Maltzahn, Julia; Bentzinger, C. Florian; Dumont, Nicolas A.; Yin, Hang; Chang, Natasha C.; Rudnicki, Michael A.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Frenette, Jerome] Univ Laval, Dept Readaptat, Programme Physiotherapie, Quebec City, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Laval University	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada.	mrudnicki@ohri.ca	Yin, Hang/J-3613-2019; von Maltzahn, Julia/AFP-2284-2022; Bentzinger, C. Florian/A-1151-2015; von Maltzahn, Julia/A-6689-2017	Yin, Hang/0000-0002-9621-0138; von Maltzahn, Julia/0000-0001-7674-1487; Bentzinger, C. Florian/0000-0003-0422-9622; von Maltzahn, Julia/0000-0001-7674-1487; Wilson, David/0000-0001-8322-0380; Frenette, Jerome/0000-0002-4308-9418; Rudnicki, Michael/0000-0002-3866-5249; Chang, Natasha C./0000-0003-0589-9660	Canadian Stem Cell Network; Canadian Institutes of Health Research; German Research Foundation [MA-3975/2-1]; Swiss National Science Foundation; US National Institutes of Health [R01AR044031]; Canadian Institutes for Health Research [MOP-81288]; Stem Cell Network; Ontario Ministry of Economic Development and Innovation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Canadian Stem Cell Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; Ontario Ministry of Economic Development and Innovation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Oleynik for conducting cell sorting and providing guidance regarding FACS isolation and analysis. We thank J. Ritchie for mouse husbandry, A. Grayston for his help with myofibers counts and G. Palidwor for RMA normalization of microarray data sets and constructive discussions. We thank V. Soleimani for constructive discussions and access to unpublished microarray data. We thank M. Kyba, University of Minnesota, for the Pax7-ZsGreen mice. F.D.P. was supported by the Canadian Stem Cell Network and a Doctoral Research Award from the Canadian Institutes of Health Research. J.v.M. was supported by a grant from the German Research Foundation (MA-3975/2-1). C.F.B. was supported by the Swiss National Science Foundation. M.A.R. holds the Canada Research Chair in Molecular Genetics. These studies were carried out with support of grants to M.A.R. from the US National Institutes of Health (R01AR044031), the Canadian Institutes for Health Research (MOP-81288), the Stem Cell Network and the Ontario Ministry of Economic Development and Innovation.	ALLBROOK DB, 1971, PATHOLOGY, V3, P233; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bentzinger CF, 2014, NAT MED, V20, P234, DOI 10.1038/nm.3499; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cooper RN, 1999, J CELL SCI, V112, P2895; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Eriksen KW, 2001, LEUKEMIA, V15, P787, DOI 10.1038/sj.leu.2402093; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Launay T, 2006, AM J PHYSIOL-REG I, V290, pR1508, DOI 10.1152/ajpregu.00486.2005; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McKay BR, 2013, AM J PHYSIOL-CELL PH, V304, pC717, DOI 10.1152/ajpcell.00305.2012; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23, DOI 10.1177/002215549904700104; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	44	240	246	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1174	1181		10.1038/nm.3655	http://dx.doi.org/10.1038/nm.3655			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25194569	Green Accepted			2022-12-25	WOS:000343194100028
J	Fledrich, R; Stassart, RM; Klink, A; Rasch, LM; Prukop, T; Haag, L; Czesnik, D; Kungl, T; Abdelaal, TAM; Keric, N; Stadelmann, C; Bruck, W; Nave, KA; Sereda, MW				Fledrich, Robert; Stassart, Ruth M.; Klink, Axel; Rasch, Lennart M.; Prukop, Thomas; Haag, Lauren; Czesnik, Dirk; Kungl, Theresa; Abdelaal, Tamer A. M.; Keric, Naureen; Stadelmann, Christine; Brueck, Wolfgang; Nave, Klaus-Armin; Sereda, Michael W.			Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A	NATURE MEDICINE			English	Article							SCHWANN-CELL DIFFERENTIATION; ERK-SIGNALING PATHWAY; RAT MODEL; NEUROPATHY; MICE; DUPLICATION; EXPRESSION; CHILDREN; REPAIR; CMT1A	Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22) underlies the most common inherited neuropathy, Charcot-Marie-Tooth 1A (CMT1A)(1-3), a disease without a known cure(4-6). Although demyelination represents a characteristic feature, the clinical phenotype of CMT1A is determined by the degree of axonal loss, and patients suffer from progressive muscle weakness and impaired sensation(4,7). CMT1A disease manifests within the first two decades of life(8,9), and walking disabilities, foot deformities and electrophysiological abnormalities are already present in childhood(7-11). Here, we show in Pmp22-transgenic rodent models of CMT1A that Schwann cells acquire a persistent differentiation defect during early postnatal development, caused by imbalanced activity of the PI3K-Akt and the Mek-Erk signaling pathways. We demonstrate that enhanced PI3K-Akt signaling by axonally overexpressed neuregulin-1 (NRG1) type I drives diseased Schwann cells toward differentiation and preserves peripheral nerve axons. Notably, in a preclinical experimental therapy using a CMT1A rat model, when treatment is restricted to early postnatal development, soluble NRG1 effectively overcomes impaired peripheral nerve development and restores axon survival into adulthood. Our findings suggest a model in which Schwann cell differentiation within a limited time window is crucial for the long-term maintenance of axonal support.	[Fledrich, Robert; Stassart, Ruth M.; Klink, Axel; Rasch, Lennart M.; Prukop, Thomas; Kungl, Theresa; Abdelaal, Tamer A. M.; Keric, Naureen; Nave, Klaus-Armin; Sereda, Michael W.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Stassart, Ruth M.; Stadelmann, Christine; Brueck, Wolfgang] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany; [Prukop, Thomas] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany; [Haag, Lauren; Czesnik, Dirk; Sereda, Michael W.] Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Keric, Naureen] Johannes Gutenberg Univ Mainz, Dept Neurosurg, Univ Med Ctr, D-55122 Mainz, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; Johannes Gutenberg University of Mainz	Stassart, RM (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	stassart@em.mpg.de; nave@em.mpg.de; sereda@em.mpg.de	Fledrich, Robert/AAF-1590-2020; Fledrich, Robert/M-1911-2019; Stassart, Ruth M/T-7093-2019	Stadelmann, Christine/0000-0003-1766-5458; Abdelaal, Tamer/0000-0003-4693-7379	German Research Foundation (DFG) Research Center Molecular Physiology of the Brain; European Commission [FP7-201535]; German Ministry of Education and Research (BMBF) [FKZ 01ES0812]; Association Francaise contre les Myopathies [NR 15037]; DFG [GZ: SE 1944/1-1]; European Research Council	German Research Foundation (DFG) Research Center Molecular Physiology of the Brain(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank U. Suter (Eidgenossische Technische Hochschule Zurich) for providing Pmp22-deficient mice and C. Huxley (Imperial College School of Medicine, London) for providing Pmp22-transgenic mice. We are grateful to T. Durkaya, C. Maack, A. Fahrenholz, T. Freerck, M. Wehe and A. Wohltmann for technical support. We thank W Mobius and T. Ruhwedel for help with electron microscopy. This work was supported by grants of the German Research Foundation (DFG) Research Center Molecular Physiology of the Brain, European Commission FP7-201535 (Neuron-Glia Interactions in Nerve Development and Disease) to K.-A.N. M.W.S. and R.F. were supported by the German Ministry of Education and Research (BMBF, FKZ 01ES0812 to M.W.S.). M.W.S. was also supported by the Association Francaise contre les Myopathies (NR 15037) and holds a Heisenberg Professorship granted by the DFG (GZ: SE 1944/1-1). K.-A.N. holds a European Research Council Advanced Investigator Grant.	ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Berciano J, 2000, NEUROMUSCULAR DISORD, V10, P419, DOI 10.1016/S0960-8966(99)00114-5; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Burns J, 2009, MUSCLE NERVE, V39, P158, DOI 10.1002/mus.21140; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Fischer S, 2008, GLIA, V56, P836, DOI 10.1002/glia.20657; Fledrich R, 2012, BRIT MED BULL, V102, P89, DOI 10.1093/bmb/lds010; Fledrich R, 2012, BRAIN, V135, P72, DOI 10.1093/brain/awr322; GABREELSFESTEN AAWM, 1995, ACTA NEUROPATHOL, V90, P645, DOI 10.1007/BF00318579; Hanemann CO, 1997, ACTA NEUROPATHOL, V94, P310, DOI 10.1007/s004010050712; Hanemann CO, 1996, BRAIN, V119, P1461, DOI 10.1093/brain/119.5.1461; Haney C, 1996, J NEUROPATH EXP NEUR, V55, P290, DOI 10.1097/00005072-199603000-00004; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; Huxley C, 1998, HUM MOL GENET, V7, P449, DOI 10.1093/hmg/7.3.449; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Kobsar I, 2005, J NEUROSCI RES, V81, P857, DOI 10.1002/jnr.20601; Kohl B, 2010, AM J PATHOL, V176, P1390, DOI 10.2353/ajpath.2010.090694; Koike H, 2007, J NEUROPATH EXP NEUR, V66, P1027, DOI 10.1097/NEN.0b013e3181598294; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Martini R, 2013, AM J PATHOL, V183, P655, DOI 10.1016/j.ajpath.2013.06.002; Mendes-Ferreira P, 2013, DRUG DISCOV TODAY, V18, P836, DOI 10.1016/j.drudis.2013.01.010; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nobbio L, 2004, NEUROBIOL DIS, V16, P263, DOI 10.1016/j.nbd.2004.02.007; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; Patzko A, 2012, BRAIN, V135, P3551, DOI 10.1093/brain/aws299; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465; Yiu EM, 2008, J PERIPHER NERV SYST, V13, P236, DOI 10.1111/j.1529-8027.2008.00182.x	40	115	119	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2014	20	9					1055	1061		10.1038/nm.3664	http://dx.doi.org/10.1038/nm.3664			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AO5RW	25150498				2022-12-25	WOS:000341404000019
J	Hardwicke, MA; Rendina, AR; Williams, SP; Moore, ML; Wang, LP; Krueger, JA; Plant, RN; Totoritis, RD; Zhang, GF; Briand, J; Burkhart, WA; Brown, KK; Parrish, CA				Hardwicke, Mary Ann; Rendina, Alan R.; Williams, Shawn P.; Moore, Michael L.; Wang, Liping; Krueger, Julie A.; Plant, Ramona N.; Totoritis, Rachel D.; Zhang, Guofeng; Briand, Jacques; Burkhart, William A.; Brown, Kristin K.; Parrish, Cynthia A.			A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site	NATURE CHEMICAL BIOLOGY			English	Article							CANCER; TARGET; LIVER; SYNTHETASE; DISCOVERY; PATHWAY; ENZYME	Human fatty acid synthase (hFAS) is a complex, multifunctional enzyme that is solely responsible for the de novo synthesis of long chain fatty acids. hFAS is highly expressed in a number of cancers, with low expression observed in most normal tissues. Although normal tissues tend to obtain fatty acids from the diet, tumor tissues rely on de novo fatty acid synthesis, making hFAS an attractive metabolic target for the treatment of cancer. We describe here the identification of GSK2194069, a potent and specific inhibitor of the beta-ketoacyl reductase (KR) activity of hFAS; the characterization of its enzymatic and cellular mechanism of action; and its inhibition of human tumor cell growth. We also present the design of a new protein construct suitable for crystallography, which resulted in what is to our knowledge the first co-crystal structure of the human KR domain and includes a bound inhibitor.	[Hardwicke, Mary Ann; Moore, Michael L.; Krueger, Julie A.; Plant, Ramona N.; Parrish, Cynthia A.] GlaxoSmithKline, Oncol Res & Dev, Collegeville, PA 19426 USA; [Rendina, Alan R.; Totoritis, Rachel D.; Zhang, Guofeng; Briand, Jacques; Brown, Kristin K.] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA; [Williams, Shawn P.; Wang, Liping; Burkhart, William A.] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Hardwicke, MA (corresponding author), GlaxoSmithKline, Oncol Res & Dev, Collegeville, PA 19426 USA.	cynthia.a.parrish@gsk.com		Williams, Shawn/0000-0001-8311-2638	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	We are grateful to C. Aquino for designing and first preparing GSK2194069 and to A. Chaudhari, J. Mack and K. Erhard for preparing additional quantities. We thank Y. Shen for construct engineering, J. Christie for virus generation and G. Barrett for large-scale cell culture. We thank B. Rodriguez, M. Jesus Vazquez and R. Liu for the high-throughput screening data; K. McKenzie and J. Gross for the initial FAS inhibition data for GSK2194069; and G. Waitt for the LC/MS/MS analyses in the M-CoA experiments. We also thank G. Graczyk-Millbrandt and M. Wang for final structure confirmation by NMR. Support of this program by R. Wooster is gratefully acknowledged. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant no. 085P1000817).	Adams N., 2012, [No title captured], Patent No. [WO 2012/096928, 2012096928]; Adams N.D., 2012, World Intellectual Property Organization, Patent No. [WO2012037299, 2012037299]; Adams N. D., 2011, [No title captured], Patent No. [WO 2011/103546, 2011103546, WO 2011103546 Al]; ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2088, DOI 10.1021/bi00304a033; Aquino C. J., 2012, [No title captured], Patent No. [WO 2012/037298, 2012037298]; Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carlisle-Moore L, 2005, J BIOL CHEM, V280, P42612, DOI 10.1074/jbc.M507082200; Chaudhari A. M., 2011, [No title captured], Patent No. [WO 2011/066211, 2011066211]; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; CLELAND WW, 1973, J BIOL CHEM, V248, P8353; Cook P. F., 2007, ENZYME KINETICS MECH; Denney J.W., 1980, European Patent Office, Patent No. [EP0009222, 0009222]; DODDS PF, 1981, J BIOL CHEM, V256, P6282; DUTLER H, 1971, EUR J BIOCHEM, V22, P213, DOI 10.1111/j.1432-1033.1971.tb01534.x; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Hallman J, 2011, World Intellectual Property Organization, Patent No. [WO2011056635, 2011056635, WO 2011/056635]; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; KATIYAR SS, 1975, J BIOL CHEM, V250, P2709; Kley JT, 2011, BIOORG MED CHEM LETT, V21, P5924, DOI 10.1016/j.bmcl.2011.07.083; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Meanwell NA, 2011, CHEM RES TOXICOL, V24, P1420, DOI 10.1021/tx200211v; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Pizer ES, 1996, CANCER RES, V56, P745; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; Vazquez MJ, 2008, FEBS J, V275, P1556, DOI 10.1111/j.1742-4658.2008.06314.x; Wang Y, 2001, CLIN CHIM ACTA, V304, P107, DOI 10.1016/S0009-8981(00)00404-6; WEISS L, 1986, BIOL CHEM H-S, V367, P905, DOI 10.1515/bchm3.1986.367.2.905; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	40	66	71	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					774	779		10.1038/NCHEMBIO.1603	http://dx.doi.org/10.1038/NCHEMBIO.1603			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25086508				2022-12-25	WOS:000341126800015
J	Lorenzo, FR; Huff, C; Myllymaki, M; Olenchock, B; Swierczek, S; Tashi, T; Gordeuk, V; Wuren, T; Ri-Li, G; McClain, DA; Khan, TM; Koul, PA; Guchhait, P; Salama, ME; Xing, JC; Semenza, GL; Liberzon, E; Wilson, A; Simonson, TS; Jorde, LB; Kaelin, WG; Koivunen, P; Prchal, JT				Lorenzo, Felipe R.; Huff, Chad; Myllymaki, Mikko; Olenchock, Benjamin; Swierczek, Sabina; Tashi, Tsewang; Gordeuk, Victor; Wuren, Tana; Ri-Li, Ge; McClain, Donald A.; Khan, Tahsin M.; Koul, Parvaiz A.; Guchhait, Prasenjit; Salama, Mohamed E.; Xing, Jinchuan; Semenza, Gregg L.; Liberzon, Ella; Wilson, Andrew; Simonson, Tatum S.; Jorde, Lynn B.; Kaelin, William G., Jr.; Koivunen, Peppi; Prchal, Josef T.			A genetic mechanism for Tibetan high-altitude adaptation	NATURE GENETICS			English	Article							HYPOXIA-INDUCIBLE FACTOR; HYDROXYLASE DOMAIN PROTEIN-2; OXYGEN SENSING PATHWAY; FACTOR-I; PROLYL 4-HYDROXYLASES; ERYTHROCYTOSIS; IDENTIFICATION; POLYCYTHEMIA; HOMEOSTASIS; MUTATION	Tibetans do not exhibit increased hemoglobin concentration at high altitude. We describe a high-frequency missense mutation in the EGLN1 gene, which encodes prolyl hydroxylase 2 (PHD2), that contributes to this adaptive response. We show that a variant in EGLN1, c.[12C>G; 380G>C], contributes functionally to the Tibetan high-altitude phenotype. PHD2 triggers the degradation of hypoxia-inducible factors (HIFs), which mediate many physiological responses to hypoxia, including erythropoiesis. The PHD2 p.[Asp4Glu; Cys127Ser] variant exhibits a lower Km value for oxygen, suggesting that it promotes increased HIF degradation under hypoxic conditions. Whereas hypoxia stimulates the proliferation of wild-type erythroid progenitors, the proliferation of progenitors with the c.[12C>G; 380G>C] mutation in EGLN1 is significantly impaired under hypoxic culture conditions. We show that the c.[12C>G; 380G>C] mutation originated similar to 8,000 years ago on the same haplotype previously associated with adaptation to high altitude. The c.[12C>G; 380G>C] mutation abrogates hypoxia-induced and HIF-mediated augmentation of erythropoiesis, which provides a molecular mechanism for the observed protection of Tibetans from polycythemia at high altitude.	[Lorenzo, Felipe R.; Swierczek, Sabina; Tashi, Tsewang; McClain, Donald A.; Prchal, Josef T.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Swierczek, Sabina; Tashi, Tsewang; McClain, Donald A.; Prchal, Josef T.] Geoger E Wahlin Vet Adm Med Ctr, Salt Lake City, UT USA; [Huff, Chad; Xing, Jinchuan; Simonson, Tatum S.; Jorde, Lynn B.; Prchal, Josef T.] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT USA; [Huff, Chad] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Myllymaki, Mikko; Koivunen, Peppi] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland; [Olenchock, Benjamin] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA USA; [Gordeuk, Victor] Univ Illinois, Sickle Cell Ctr, Chicago, IL USA; [Wuren, Tana; Ri-Li, Ge] Qinghai Univ, Res Ctr High Altitude Med, Xining, Peoples R China; [Khan, Tahsin M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Koul, Parvaiz A.] Sherikashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India; [Guchhait, Prasenjit] Reg Ctr Biotechnol, Gurgaon, India; [Salama, Mohamed E.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Salama, Mohamed E.] ARUP Labs, Salt Lake City, UT USA; [Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vascr Program, Baltimore, MD USA; [Liberzon, Ella; Kaelin, William G., Jr.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liberzon, Ella] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wilson, Andrew] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84112 USA; [Simonson, Tatum S.] Univ Calif San Diego, Sch Med, Div Physiol, La Jolla, CA 92093 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Oulu; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Qinghai University; Icahn School of Medicine at Mount Sinai; Sher-i-Kashmir Institute of Medical Sciences; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Rutgers State University New Brunswick; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Prchal, JT (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA.	josef.prchal@hsc.utah.edu	Koul, Parvaiz/AFK-7442-2022; Koul, Parvaiz/B-1666-2017; Gordeuk, Victor/AAG-6577-2019; Koul, Parvaiz/AAS-8828-2021	Koul, Parvaiz/0000-0002-1700-9285; Koul, Parvaiz/0000-0002-1700-9285; Koul, Parvaiz/0000-0002-1700-9285; McClain, Don/0000-0002-3310-2359; Wilson, Andrew/0000-0003-3679-9232; Myllymaki, Mikko/0000-0002-8194-7356	Academy of Finland [120156, 140765, 218129]; S. Juselius Foundation; Finnish Cultural Foundation; Finnish Cancer Organizations; US National Institutes of Health (NIH) [HL119355-01, P01CA108671, HL098062]; National Human Genome Research Institute [HG005846]; National Basic Research Program of China [2012CB518200]; Program of International Science and Technology Cooperation of China [2011DFA32720]; University of Utah; Johns Hopkins Institute for Cell Engineering; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL118215, K08HL119355, T32HL098062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG005846, K99HG005846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001140] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); S. Juselius Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Cancer Organizations; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Basic Research Program of China(National Basic Research Program of China); Program of International Science and Technology Cooperation of China; University of Utah; Johns Hopkins Institute for Cell Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Veterans Affairs(US Department of Veterans Affairs)	P.K. is supported by Academy of Finland grants 120156, 140765 and 218129, the S. Juselius Foundation, the Finnish Cultural Foundation and the Finnish Cancer Organizations. B.O. is supported by US National Institutes of Health (NIH) Mentored Career Development Award HL119355-01. J.X. is supported by the National Human Genome Research Institute (HG005846). G.R.-L. is supported by the National Basic Research Program of China (grant 2012CB518200) and by the Program of International Science and Technology Cooperation of China (grant 2011DFA32720). S.S. is supported by US NIH grant P01CA108671. T.S.S. is supported by the US NIH T32 Postdoctoral Fellowship HL098062. L.B.J. is supported by the University of Utah Seed Grant Program for studies of hypoxic adaptation. G.L.S. is supported by the Johns Hopkins Institute for Cell Engineering. J.T.P. is supported by US NIH grant P01CA108671, a Veterans Affairs Merit Review Award and the University of Utah Seed Grant Program for studies of hypoxic adaptation.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Albiero E, 2012, HAEMATOL-HEMATOL J, V97, P123, DOI 10.3324/haematol.2010.039545; Albiero E, 2011, BRIT J HAEMATOL, V153, P405, DOI 10.1111/j.1365-2141.2010.08551.x; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Ang SO, 2002, BLOOD CELL MOL DIS, V28, P57, DOI 10.1006/bcmd.2002.0488; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham Abigail W., 2009, Human Genomics, V4, P79; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cipolleschi MG, 1997, EXP HEMATOL, V25, P1187; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; Goldstein D. B., 1999, MICROSATELLITES EVOL, V368; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Ladroue C, 2012, HAEMATOL-HEMATOL J, V97, P9, DOI 10.3324/haematol.2011.044644; LOEFFLER M, 1984, BLUT, V49, P427, DOI 10.1007/BF00320485; Lorenzo F.R., 2010, ASH 52 ANN M; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy Melanie J, 2008, Ulster Med J, V77, P86; Percy MJ, 2012, AM J HEMATOL, V87, P439, DOI 10.1002/ajh.23123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Prchal J.T., 2010, SECONDARY POLYCYTHEM, P823; Prchal J.T., 2010, PRODUCTION ERYTHROCY; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Swierczek SI, 2012, BLOOD, V119, pE100, DOI 10.1182/blood-2011-11-390351; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011	42	255	275	3	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					951	+		10.1038/ng.3067	http://dx.doi.org/10.1038/ng.3067			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129147	Green Accepted			2022-12-25	WOS:000341579400008
J	Bailey, AM; Mendicino, M; Au, P				Bailey, Alexander M.; Mendicino, Michael; Au, Patrick			An FDA perspective on preclinical development of cell-based regenerative medicine products	NATURE BIOTECHNOLOGY			English	Letter									[Bailey, Alexander M.; Mendicino, Michael; Au, Patrick] US FDA, Ctr Biol Evaluat & Res, Off Cellular Tissue & Gene Therapies, Silver Spring, MD 20993 USA; [Mendicino, Michael] US FDA, Off Commissioner, Off Chief Scientist, Off Regulatory Sci & Innovat, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Bailey, AM (corresponding author), US FDA, Ctr Biol Evaluat & Res, Off Cellular Tissue & Gene Therapies, Silver Spring, MD 20993 USA.	alexander.bailey@fda.hhs.gov; m.mendicino.phd@gmail.com; pakwai.au@fda.hhs.gov						Anatol R, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1781, DOI 10.1016/B978-0-12-398358-9.00086-0; Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Robinson R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003394	4	47	50	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					721	723		10.1038/nbt.2971	http://dx.doi.org/10.1038/nbt.2971			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093890				2022-12-25	WOS:000346455900008
J	Ng, A; Tan, S; Singh, G; Rizk, P; Swathi, Y; Tan, TZ; Huang, RYJ; Leushacke, M; Barker, N				Ng, Annie; Tan, Shawna; Singh, Gurmit; Rizk, Pamela; Swathi, Yada; Tan, Tuan Zea; Huang, Ruby Yun-Ju; Leushacke, Marc; Barker, Nick			Lgr5 marks stem/progenitor cells in ovary and tubal epithelia	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; SURFACE EPITHELIUM; CANCER; OVULATION; CONTAINS; STOMACH; ORIGIN; MICE	The ovary surface epithelium (OSE) undergoes ovulatory tear and remodelling throughout life. Resident stem cells drive such tissue homeostasis in many adult epithelia, but their existence in the ovary has not been definitively proven. Lgr5 marks stem cells in multiple epithelia. Here we use reporter mice and single-molecule fluorescent in situ hybridization to document candidate Lgr5(+) stem cells in the mouse ovary and associated structures. Lgr5 is broadly expressed during ovary organogenesis, but becomes limited to the OSE in neonate life. In adults, Lgr5 expression is predominantly restricted to proliferative regions of the OSE and mesovarian-fimbria junctional epithelia. Using in vivo lineage tracing, we identify embryonic and neonate Lgr5(+) populations as stem/progenitor cells contributing to the development of the OSE cell lineage, as well as epithelia of the mesovarian ligament and oviduct/fimbria. Adult Lgr5(+) populations maintain OSE homeostasis and ovulatory regenerative repair in vivo. Thus, Lgr5 marks stem/progenitor cells of the ovary and tubal epithelia.	[Ng, Annie; Tan, Shawna; Singh, Gurmit; Rizk, Pamela; Swathi, Yada; Leushacke, Marc; Barker, Nick] A STAR Inst Med Biol, Singapore 138648, Singapore; [Tan, Tuan Zea; Huang, Ruby Yun-Ju] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Huang, Ruby Yun-Ju] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Barker, Nick] Univ Edinburgh, Ctr Regenerat Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Barker, Nick] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; University of Edinburgh; National University of Singapore	Barker, N (corresponding author), A STAR Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	nicholas.barker@imb.a-star.edu.sg	Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Huang, Ruby Yun-Ju/AAE-8854-2019; Tan, Tuan Zea/I-9227-2019	Barker, Nick/0000-0003-3566-4475; Huang, Ruby Yun-Ju/0000-0001-6376-3185; Tan, Tuan Zea/0000-0001-6624-1593	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We thank A. Ong, A. Wong and A. Tan for technical assistance, G. Wright and J. Lim for imaging assistance, S. Mustafah for FACS experiments, and D. Tan for technical expertise and manuscript proofreading. We also thank M. Choolani and B. Pang for providing human material and critical discussions before publication. N.B. is supported by the Agency for Science, Technology and Research (A*STAR), Singapore.	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg Nelly, 2013, Front Biosci (Schol Ed), V5, P709; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Burdette JE, 2006, ENDOCRINOLOGY, V147, P2338, DOI 10.1210/en.2005-1629; Carlson JW, 2008, J CLIN ONCOL, V26, P4160, DOI 10.1200/JCO.2008.16.4814; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Gamwell LF, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100347; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Paik DY, 2012, STEM CELLS, V30, P2487, DOI 10.1002/stem.1207; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Tan OL, 2004, BIOL REPROD, V71, P1501, DOI 10.1095/biolreprod.104.030460; Usongo M, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-17; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040691	26	144	147	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2014	16	8					745	U342		10.1038/ncb3000	http://dx.doi.org/10.1038/ncb3000			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AM5MW	24997521				2022-12-25	WOS:000339904900007
J	Sheridan, C				Sheridan, Cormac			Cancer centers zero in on exceptional responders	NATURE BIOTECHNOLOGY			English	News Item							EVEROLIMUS											2014, CANCER DISCOV, V4, P546; 2014, ONCOTARGET, V5, P95; 2014, NATURE, V505, P495; 2014, NAT BIOTECHNOL, V32, P3; 2012, SCIENCE, V338, P221; 2014, NAT BIOTECHNOL, V32, P506	6	5	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					703	704		10.1038/nbt0814-703	http://dx.doi.org/10.1038/nbt0814-703			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101721				2022-12-25	WOS:000346455900030
J	Canales, A; Jia, XT; Froriep, UP; Koppes, RA; Tringides, CM; Selvidge, J; Lu, C; Hou, C; Wei, L; Fink, Y; Anikeeva, P				Canales, Andres; Jia, Xiaoting; Froriep, Ulrich P.; Koppes, Ryan A.; Tringides, Christina M.; Selvidge, Jennifer; Lu, Chi; Hou, Chong; Wei, Lei; Fink, Yoel; Anikeeva, Polina			Multifunctional fibers for simultaneous optical, electrical and chemical interrogation of neural circuits in vivo	NATURE BIOTECHNOLOGY			English	Article							TISSUE; BRAIN; ELECTRODE; NEURONS; DESIGN; PROBE; CHANNELRHODOPSIN-2; RECORDINGS; SYSTEMS; SURFACE	Brain function depends on simultaneous electrical, chemical and mechanical signaling at the cellular level. This multiplicity has confounded efforts to simultaneously measure or modulate these diverse signals in vivo. Here we present fiber probes that allow for simultaneous optical stimulation, neural recording and drug delivery in behaving mice with high resolution. These fibers are fabricated from polymers by means of a thermal drawing process that allows for the integration of multiple materials and interrogation modalities into neural probes. Mechanical, electrical, optical and microfluidic measurements revealed high flexibility and functionality of the probes under bending deformation. Long-term in vivo recordings, optogenetic stimulation, drug perturbation and analysis of tissue response confirmed that our probes can form stable brain-machine interfaces for at least 2 months. We expect that our multifunctional fibers will permit more detailed manipulation and analysis of neural circuits deep in the brain of behaving animals than achievable before.	[Canales, Andres; Tringides, Christina M.; Selvidge, Jennifer; Lu, Chi; Hou, Chong; Fink, Yoel; Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Jia, Xiaoting; Froriep, Ulrich P.; Koppes, Ryan A.; Wei, Lei; Fink, Yoel; Anikeeva, Polina] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Froriep, Ulrich P.] MIT, Simons Ctr Social Brain, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	anikeeva@mit.edu	Wei, Lei/F-1596-2010; Koppes, Ryan/AAK-3044-2020; Jia, Xiaoting/E-2669-2015; Hou, Chong/E-7433-2015	Jia, Xiaoting/0000-0003-4890-6103; Hou, Chong/0000-0002-1975-0747; Wei, Lei/0000-0003-0819-8325	National Science Foundation under a CAREER award [CBET-1253890]; Center for Materials Science and Engineering [DMR-0819762]; Center for Sensorimotor Neural Engineering [EEC-1028725]; McGovern Institute for Brain Research; US Army Research Laboratory; US Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-13-D-0001]; Simons Foundation	National Science Foundation under a CAREER award; Center for Materials Science and Engineering; Center for Sensorimotor Neural Engineering(National Science Foundation (NSF)); McGovern Institute for Brain Research; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office through the Institute for Soldier Nanotechnologies; Simons Foundation	This work was supported in part by the National Science Foundation under a CAREER award to P.A. (CBET-1253890), the Center for Materials Science and Engineering (DMR-0819762), the Center for Sensorimotor Neural Engineering (EEC-1028725), the McGovern Institute for Brain Research, the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies under contract number W911NF-13-D-0001, and a grant from the Simons Foundation to the Simons Center for the Social Brain at MIT. The authors are grateful to G. Feng for the generous donation of Thy1-ChR2-YFP mice, W. Jia and J. LaVine for initial help with microfluidic characterization and C. Moritz and L.H. Tsai for assistance with equipment.	Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889; Aden M, 2010, J POLYM SCI POL PHYS, V48, P451, DOI 10.1002/polb.21906; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ferguson JE, 2009, SENSOR ACTUAT A-PHYS, V156, P388, DOI 10.1016/j.sna.2009.10.001; GOFF D, 2002, FIBER OPTIC REFERENC; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8; Khanarian G, 2001, OPT ENG, V40, P1024, DOI 10.1117/1.1369411; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kuo JTW, 2013, LAB CHIP, V13, P554, DOI 10.1039/c2lc40935f; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Merolli A, 1999, J MATER SCI-MATER M, V10, P265, DOI 10.1023/A:1008949311714; Minev IR, 2013, ACTA BIOMATER, V9, P6936, DOI 10.1016/j.actbio.2013.02.048; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Rubehn B, 2013, LAB CHIP, V13, P579, DOI 10.1039/c2lc40874k; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Steenland HW, 2008, J NEUROSCI, V28, P6826, DOI 10.1523/JNEUROSCI.1019-08.2008; Takeuchi S, 2004, J MICROMECH MICROENG, V14, P104, DOI 10.1088/0960-1317/14/1/014; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007; YALON M, 1988, J CATARACT REFR SURG, V14, P393, DOI 10.1016/S0886-3350(88)80145-7; Yaman M, 2011, NAT MATER, V10, P494, DOI [10.1038/NMAT3038, 10.1038/nmat3038]; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	383	390	22	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					277	+		10.1038/nbt.3093	http://dx.doi.org/10.1038/nbt.3093			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25599177				2022-12-25	WOS:000350766900024
J	Merker, M; Blin, C; Mona, S; Duforet-Frebourg, N; Lecher, S; Willery, E; Blum, MGB; Ruch-Gerdes, S; Mokrousov, I; Aleksic, E; Allix-Beguec, C; Antierens, A; Augustynowicz-Kopec, E; Banff', M; Barletta, F; Beckr, HP; Barry, CE; Bonnet, M; Borroni, E; Campos-Herrero, I; Cirillo, D; Cox, H; Crowe, S; Crudu, V; Die, R; Drobniewski, F; Fauville-Dufaux, M; Gagneuxr, S; Ghebremichael, S; Hanekom, M; Hoffner, S; Jiao, WW; Kalon, S; Kohl, TA; Kontsevaya, I; Lillebaek, T; Maeda, S; Nikolayevskyy, V; Rasmussen, M; Rastogi, N; Samper, S; Sanchez-Padilla, E; Savic, B; Shamputa, IC; Shen, A; Sng, LH; Stakenas, P; Toit, K; Varaine, F; Vukovic, D; Wahl, C; Warren, R; Supply, P; Niemann, S; Wirth, T				Merker, Matthias; Blin, Camille; Mona, Stefano; Duforet-Frebourg, Nicolas; Lecher, Sophie; Willery, Eve; Blum, Michael G. B.; Ruech-Gerdes, Sabine; Mokrousov, Igor; Aleksic, Eman; Allix-Beguec, Caroline; Antierens, Annick; Augustynowicz-Kopec, Ewa; Banff', Marie; Barletta, Francesca; Beckr, Hans Peter; Barry, Clifton E., III; Bonnet, Maryline; Borroni, Emanuele; Campos-Herrero, Isolina; Cirillo, Daniela; Cox, Helen; Crowe, Suzanne; Crudu, Valeriu; Die, Roland; Drobniewski, Francis; Fauville-Dufaux, Maryse; Gagneuxr, Sebastien; Ghebremichael, Solomon; Hanekom, Madeleine; Hoffner, Sven; Jiao, Wei-wei; Kalon, Stobdan; Kohl, Thomas A.; Kontsevaya, Irina; Lillebaek, Troels; Maeda, Shinji; Nikolayevskyy, Vladyslav; Rasmussen, Michael; Rastogi, Nalin; Samper, Sofia; Sanchez-Padilla, Elisabeth; Savic, Branislava; Shamputa, Isdore Chola; Shen, Adong; Sng, Li-Hwei; Stakenas, Petras; Toit, Kadri; Varaine, Francis; Vukovic, Dragana; Wahl, Celine; Warren, Robin; Supply, Philip; Niemann, Stefan; Wirth, Thierrv			Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage	NATURE GENETICS			English	Article							DRUG-RESISTANT TUBERCULOSIS; NEW-YORK-CITY; MUTATION-RATE; MAXIMUM-LIKELIHOOD; SOUTH-AFRICA; MCE OPERONS; STRAINS; POPULATION; EMERGENCE; TRANSMISSION	Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here we reconstructed the biogeographical structure and evolutionary history of this lineage by genetic analysis of 4,987 isolates from 99 countries and whole-genome sequencing of 110 representative isolates. We show that this lineage initially originated in the Far East, from where it radiated worldwide in several waves. We detected successive increases in population size for this pathogen over the last 200 years, practically coinciding with the Industrial Revolution, the First World War and HIV epidemics. Two MDR clones of this lineage started to spread throughout central Asia and Russia concomitantly with the collapse of the public health system in the former Soviet Union. Mutations identified in genes putatively under positive selection and associated with virulence might have favored the expansion of the most successful branches of the lineage.	[Merker, Matthias; Kohl, Thomas A.] Mol Mycobacteriol Res Ctr Borstel, Borstel, Germany; [Blin, Camille; Mona, Stefano] Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France; [Blin, Camille; Mona, Stefano; Wirth, Thierrv] Univ Paris 06, Sorbonne Univ, Ecole Prat Hautes Etud,UMR CNRS 7205, Inst Systemat Evolut Biodivers,Museum Natl Hist N, Paris, France; [Duforet-Frebourg, Nicolas; Blum, Michael G. B.] Univ Grenoble 1, CNRS, Lab Techn Ingn Med Complexite Informat Math & App, Grenoble, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Ctr Infect & Immun Lille, INSERM, U1019, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] CNRS, UMR 8204, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Univ Lille Nord, Ctr Infect & Immun Lille, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Mokrousov, Igor] St Petersburg Pasteur Inst, Lab Mol Microbiol, St Petersburg, Russia; [Aleksic, Eman] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Allix-Beguec, Caroline; Wahl, Celine; Supply, Philip] Genoscreen, Lille, France; [Antierens, Annick] Med Sans Frontieres Switzerland, Dept Med, Geneva, Switzerland; [Augustynowicz-Kopec, Ewa] Natl TB & Lung Dis Res Inst, Dept Microbiol, Warsaw, Poland; [Banff', Marie] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Barletta, Francesca] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Lima, Peru; [Beckr, Hans Peter; Gagneuxr, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Barry, Clifton E., III; Shamputa, Isdore Chola] NIAID, TB Res Sect, US NIH, Bethesda, MD 20892 USA; [Bonnet, Maryline; Sanchez-Padilla, Elisabeth] Epictr, Clin Res Dept, Paris, France; [Borroni, Emanuele; Cirillo, Daniela] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Campos-Herrero, Isolina] Hosp Univ Gran Canaria Dr Negrin, Dept Microbiol, Las Palmas Gran Canaria, Spain; [Cox, Helen] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Crowe, Suzanne] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Crowe, Suzanne] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Crudu, Valeriu] Phthysiopneumol Inst, Natl TB Reference Lab, Kishinev, Moldova; [Die, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference, London, England; Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference &, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Human Immunodeficiency Virus Grp, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Fauville-Dufaux, Maryse] TB & Mycobacteria Sci Inst Publ Hlth, Brussels, Belgium; [Ghebremichael, Solomon] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden; [Hanekom, Madeleine; Warren, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr TB Res,Div Mol Biol & Human Genet, Ctr Excellence Biomed TB Res,MRC,Natl Res Fdn,Dep, Cape Town, South Africa; [Hoffner, Sven] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Kalon, Stobdan] US Agcy Int Dev Qual Hlth Care Project, Bishkek, Kyrgyzstan; [Kontsevaya, Irina] Sarnara Oblast TB Serv, Samara, Russia; [Lillebaek, Troels; Rasmussen, Michael] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Maeda, Shinji] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan; [Rastogi, Nalin] WHO, Inst Paslieur Guadeloupe, Supranat TB Reference Lab, Abymes, France; [Samper, Sofia] Hosp Univ Miguel Servet, Inst Invest Sanit Aragon, Zaragoza, Spain; [Savic, Branislava; Vukovic, Dragana] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Sng, Li-Hwei] Singapore Gen Hosp, Dept Pathol, Cent TB Lab, Singapore, Singapore; [Stakenas, Petras] Vilnius Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania; [Toit, Kadri] Tartu Univ Hosp, United Labs, Tartu, Estonia; [Varaine, Francis] Med Sans Frontieres, Dept Med, Paris, France; [Niemann, Stefan] German Ctr Infect Res, Borstel Site, Borstel, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Forschungszentrum Borstel; Saint-Petersburg Pasteur Institute; Burnet Institute; Doctors Without Borders; University of Bern; Universidad Peruana Cayetano Heredia; University of Basel; Swiss Tropical & Public Health Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cape Town; Florey Institute of Neuroscience & Mental Health; Monash University; University of Kiel; Schleswig Holstein University Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Public Health Agency of Sweden; National Research Foundation - South Africa; Stellenbosch University; Swedish Institute for Infectious Disease Control; Capital Medical University; Capital Medical University; Statens Serum Institut; World Health Organization; Miguel Servet University Hospital; University of Belgrade; Singapore General Hospital; Vilnius University; Doctors Without Borders; Sanofi-Aventis; Sanofi France; German Center for Infection Research	Wirth, T (corresponding author), Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France.	philip.supply@ibl.cnrs.fr; sniemann@fz-borstel.de; wirth@rnram.fr	Kontsevaya, Irina/AAJ-8173-2020; RASTOGI, NALIN/AAP-1958-2020; Augustynowicz-Kopeć, Ewa/AAL-1757-2020; Kohl, Thomas Andreas/AAB-9782-2020; Shamputa, Isdore Chola/AAR-3252-2020; Mokrousov, Igor/Q-5941-2019; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Wirth, Thierry/B-4915-2008; Nikolayevskyy, Vladyslav/HFZ-7738-2022; Mokrousov, Igor/J-3640-2014; Allix-Béguec, Caroline/AAI-4645-2021; Shamputa, Isdore Chola/AAR-7683-2020; Mona, Stefano/AAF-5061-2019; Cirillo, Daniela Maria/AAB-3646-2019; Gagneux, Sebastien/ABE-7909-2020; Blum, Michael/F-9978-2010; Merker, Matthias/P-7399-2015; Niemann, Stefan/C-9327-2011; Supply, Philip/A-9580-2019; Borroni, Emanuele/K-5179-2016	RASTOGI, NALIN/0000-0002-7199-7747; Augustynowicz-Kopeć, Ewa/0000-0001-6162-8748; Kohl, Thomas Andreas/0000-0002-1126-6803; Shamputa, Isdore Chola/0000-0003-1888-8936; Mokrousov, Igor/0000-0001-5924-0576; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Wirth, Thierry/0000-0002-7371-0172; Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Mokrousov, Igor/0000-0001-5924-0576; Allix-Béguec, Caroline/0000-0001-7642-4844; Shamputa, Isdore Chola/0000-0003-1888-8936; Cirillo, Daniela Maria/0000-0001-6415-1535; Blum, Michael/0000-0003-4174-7373; Merker, Matthias/0000-0003-1386-2331; Supply, Philip/0000-0003-3690-3853; Niemann, Stefan/0000-0002-6604-0684; Lillebaek, Troels/0000-0002-2601-2718; Beck, Hans-Peter/0000-0001-8326-4834; Cox, Helen/0000-0002-6538-7192; Gagneux, Sebastien/0000-0001-7783-9048; Vukovic, Dragana/0000-0002-4028-308X; Mona, Stefano/0000-0001-9087-0656; Borroni, Emanuele/0000-0001-6780-5119; Klaos, Kadri/0000-0002-0055-755X; Kontsevaya, Irina/0000-0003-3421-7550; Warren, Robin/0000-0001-5741-7358; Samper, Sofia/0000-0002-3011-2519	European Community [278864]; European Union [223681]; Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes; Acteurs Cles dans les Ecosystemes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	European Community(European Commission); European Union(European Commission); Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes; Acteurs Cles dans les Ecosystemes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge L. Cowan and J. Posey (US Centers for Disease Control and Prevention) for pros ding us with significant amounts of genot)iping data for M. tuberculosis Beijing isolates. We thank T. Ubben, I. Radzio, F Struwe-Sonnenschein and). Zallet (Research Center Borstel) for excellent technical assistance. We acknowledge J. Peh for her assistance and support in the study and I. Comas for statistical advice. Parts of this work have been supported by grants from the European Community's Seventh ilramework Programme (FP7120072013) under grant agreement 278864 in the framework ot. the European Union PathoNGenTrace project and grant agreement 223681 in the framework of the TB-PAN-NET project. We also thank Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes, Acteurs Cles dans les Ecosystemes' for financial support. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Ahmad S, 2004, SCAND J IMMUNOL, V60, P382, DOI 10.1111/j.0300-9475.2004.01490.x; Beaumont MA, 1999, GENETICS, V153, P2013; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DROLET GJ, 1945, AM J PUBLIC HEALTH, V35, P689, DOI 10.2105/AJPH.35.7.689; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duforet-Frebourg N, 2014, MOL BIOL EVOL, V31, P2483, DOI 10.1093/molbev/msu182; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fang J., 2013, ATLAS SUSTAINABILITY; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Holden C, 1999, SCIENCE, V286, P1670, DOI 10.1126/science.286.5445.1670; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Laruelle M., 2009, CHINA EURASIA FORUM, V7, P93; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Meikle V, 2009, CLIN VACCINE IMMUNOL, V16, P1352, DOI 10.1128/CVI.00211-09; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Munsiff SS, 2003, J INFECT DIS, V188, P356, DOI 10.1086/376837; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Nieselt-Struwe K, 2001, MOL BIOL EVOL, V18, P1204, DOI 10.1093/oxfordjournals.molbev.a003907; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Osorio NS, 2013, MOL BIOL EVOL, V30, P1326, DOI 10.1093/molbev/mst038; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ragheb MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-145; Reyes JF, 2010, INFECT GENET EVOL, V10, P1046, DOI 10.1016/j.meegid.2010.06.016; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sirakova TD, 2002, J BACTERIOL, V184, P6796, DOI 10.1128/JB.184.24.6796-6802.2002; Stavrum R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026295; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Supply P, 2011, INFECT GENET EVOL, V11, P251, DOI 10.1016/j.meegid.2010.12.009; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wilson IJ, 1998, GENETICS, V150, P499; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2019, 10 HLTH ISS WHO WILL, DOI DOI 10.1016/S2213-2600(19)30418-7; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	78	324	344	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					242	249		10.1038/ng.3195	http://dx.doi.org/10.1038/ng.3195			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25599400				2022-12-25	WOS:000350327900014
J	Pertea, M; Pertea, GM; Antonescu, CM; Chang, TC; Mendell, JT; Salzberg, SL				Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Chang, Tsung-Cheng; Mendell, Joshua T.; Salzberg, Steven L.			StringTie enables improved reconstruction of a transcriptome from RNA-seq reads	NATURE BIOTECHNOLOGY			English	Article							ABUNDANCE ESTIMATION; ISOFORM DISCOVERY; REFERENCE GENOME; NONCODING RNAS; QUANTIFICATION; EXPRESSION; REVEALS; ANNOTATION	Methods used to sequence the transcriptome often produce more than 200 million short sequences. We introduce StringTie, a computational method that applies a network flow algorithm originally developed in optimization theory, together with optional de novo assembly, to assemble these complex data sets into transcripts. When used to analyze both simulated and real data sets, StringTie produces more complete and accurate reconstructions of genes and better estimates of expression levels, compared with other leading transcript assembly programs including Cufflinks, IsoLasso, Scripture and Traph. For example, on 90 million reads from human blood, StringTie correctly assembled 10,990 transcripts, whereas the next best assembly was of 7,187 transcripts by Cufflinks, which is a 53% increase in transcripts assembled. On a simulated data set, StringTie correctly assembled 7,559 transcripts, which is 20% more than the 6,310 assembled by Cufflinks. As well as producing a more complete transcriptome assembly, StringTie runs faster on all data sets tested to date compared with other assembly software, including Cufflinks.	[Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Salzberg, Steven L.] Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA; [Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Salzberg, Steven L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Chang, Tsung-Cheng; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Dept Med Biol, Dallas, TX 75390 USA; [Chang, Tsung-Cheng; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins University	Salzberg, SL (corresponding author), Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA.	salzberg@jhu.edu	Pertea, Mihaela/AAT-2705-2021; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432	US National Institutes of Health [R01-HG006677, R01-HG006102, R01-GM105705, R01-CA120185, P01-CA134292]; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE [R01CA120185, P01CA134292] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported in part by US National Institutes of Health grants R01-HG006677 (S.L.S.), R01-HG006102 (S.L.S.), R01-GM105705 (G.M.P.), R01-CA120185 (J.T.M.), P01-CA134292 (J.T.M.), and the Cancer Prevention and Research Institute of Texas (J.T.M.).	Behr J, 2013, BIOINFORMATICS, V29, P2529, DOI 10.1093/bioinformatics/btt442; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Dantzig G. B., 1962, LINEAR PROGRAMMING E; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2011, J COMPUT BIOL, V18, P305, DOI 10.1089/cmb.2010.0243; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ford L. R. J., 1962, FLOWS NETWORKS; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; GOLDBERG AV, 1991, MATH OPER RES, V16, P351, DOI 10.1287/moor.16.2.351; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Li W, 2011, J COMPUT BIOL, V18, P1693, DOI 10.1089/cmb.2011.0171; Mezlini AM, 2013, GENOME RES, V23, P519, DOI 10.1101/gr.142232.112; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rehrauer H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-370; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tomescu AI, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S15; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	34	4190	4299	72	519	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					290	+		10.1038/nbt.3122	http://dx.doi.org/10.1038/nbt.3122			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25690850	Green Accepted			2022-12-25	WOS:000350766900026
J	Peralta, D; Bronowska, AK; Morgan, B; Doka, E; Van Laer, K; Nagy, P; Grater, F; Dick, TP				Peralta, David; Bronowska, Agnieszka K.; Morgan, Bruce; Doka, Eva; Van Laer, Koen; Nagy, Peter; Graeter, Frauke; Dick, Tobias P.			A proton relay enhances H2O2 sensitivity of GAPDH to facilitate metabolic adaptation	NATURE CHEMICAL BIOLOGY			English	Article							PARTICLE MESH EWALD; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HYDROGEN-PEROXIDE; MOLECULAR-DYNAMICS; SUBSTRATE-BINDING; PROTEIN; CHEMISTRY; MECHANISM; BIOLOGY	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is sensitive to reversible oxidative inactivation by hydrogen peroxide (H2O2). Here we show that H2O2 reactivity of the active site thiolate (C152) is catalyzed by a previously unrecognized mechanism based on a dedicated proton relay promoting leaving group departure. Disruption of the peroxidatic reaction mechanism does not affect the glycolytic activity of GAPDH. Therefore, specific and separate mechanisms mediate the reactivity of the same thiolate nucleophile toward H2O2 and glyceraldehyde 3-phosphate, respectively. The generation of mutants in which the glycolytic and peroxidatic activities of GAPDH are comprehensively uncoupled allowed for a direct assessment of the physiological relevance of GAPDH H2O2 sensitivity. Using yeast strains in which wild-type GAPDH was replaced with H2O2-insensitive mutants retaining full glycolytic activity, we demonstrate that H2O2 sensitivity of GAPDH is a key component of the cellular adaptive response to increased H2O2 levels.	[Peralta, David; Morgan, Bruce; Van Laer, Koen; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany; [Bronowska, Agnieszka K.; Graeter, Frauke] Heidelberg Inst Theoret Studies, Heidelberg, Germany; [Bronowska, Agnieszka K.] Heidelberg Univ, Fac Chem, Heidelberg, Germany; [Doka, Eva; Nagy, Peter] Natl Inst Oncol, Dept Mol Immunol & Toxicol, Budapest, Hungary; [Doka, Eva] Univ Debrecen, Dept Inorgan & Analyt Chem, H-4012 Debrecen, Hungary	Helmholtz Association; German Cancer Research Center (DKFZ); Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; National Institute of Oncology Hungary; University of Debrecen	Dick, TP (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany.	t.dick@dkfz.de	Gräter, Frauke/D-3450-2009; Nagy, Peter/C-6768-2008	Gräter, Frauke/0000-0003-2891-3381; Nagy, Peter/0000-0003-3393-235X; Morgan, Bruce/0000-0001-9393-1071; Peralta, David/0000-0002-8172-6377	German Research Foundation [SFB 1036, SPP 1710]; Klaus Tschira Foundation; Helmholtz International Graduate School for Cancer Research; Heidelberg University BIOMS program; FP7 PEOPLE RG (Marie Curie International Reintegration Grant) [PIRG08-GA-2010-277006]; Hungarian National Science Foundation (OTKA) [K 109843]; EurocanPlatform project	German Research Foundation(German Research Foundation (DFG)); Klaus Tschira Foundation; Helmholtz International Graduate School for Cancer Research; Heidelberg University BIOMS program; FP7 PEOPLE RG (Marie Curie International Reintegration Grant); Hungarian National Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EurocanPlatform project	T.P.D. is supported by the German Research Foundation (SFB 1036, SPP 1710). F.G. is supported by the Klaus Tschira Foundation. D.P. was supported by a PhD scholarship from the Helmholtz International Graduate School for Cancer Research. A.K.B. was supported by the Heidelberg University BIOMS program. P.N. is grateful for financial support from FP7 PEOPLE 2010 RG (Marie Curie International Reintegration Grant; grant no. PIRG08-GA-2010-277006), the Hungarian National Science Foundation (OTKA; grant no.: K 109843) and the EurocanPlatform project. T. Ruppert (DKFZ-ZMBH Alliance) is acknowledged for performing MS analysis. K. Ballago and G. Kuntz are acknowledged for their technical assistance.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beutler E., 1984, GLUTATHIONE RED CELL; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D.A., 2022, AMBER 2020; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; LAMBRAKOS SG, 1989, J COMPUT PHYS, V85, P473, DOI 10.1016/0021-9991(89)90160-5; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Mukherjee S, 2010, J MOL BIOL, V401, P949, DOI 10.1016/j.jmb.2010.07.002; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Reis M, 2013, PHYS CHEM CHEM PHYS, V15, P3772, DOI 10.1039/c3cp43968b; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHUPPEKOISTINEN I, 1994, EUR J BIOCHEM, V221, P1033, DOI 10.1111/j.1432-1033.1994.tb18821.x; Seidler NW, 2013, ADV EXP MED BIOL, V985, P1, DOI 10.1007/978-94-007-4716-6; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Stewart J. J. P., 2012, MOPAC 2012; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yun M, 2000, BIOCHEMISTRY-US, V39, P10702, DOI 10.1021/bi9927080	47	129	133	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					156	U105		10.1038/NCHEMBIO.1720	http://dx.doi.org/10.1038/NCHEMBIO.1720			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25580853				2022-12-25	WOS:000348358800014
J	Davies, MR; Holden, MT; Coupland, P; Chen, JHK; Venturini, C; Barnett, TC; Ben Zakour, NL; Tse, H; Dougan, G; Yuen, KY; Walker, MJ				Davies, Mark R.; Holden, Matthew T.; Coupland, Paul; Chen, Jonathan H. K.; Venturini, Carola; Barnett, Timothy C.; Ben Zakour, Nouri L.; Tse, Herman; Dougan, Gordon; Yuen, Kwok-Yung; Walker, Mark J.			Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance	NATURE GENETICS			English	Article							GROUP-A STREPTOCOCCUS; PYOGENES; OUTBREAK; CHINA; EVOLUTION; INFECTIONS; EPIDEMICS; SPREAD; TOOL	A scarlet fever outbreak began in mainland China and Hong Kong in 2011 (refs. 1-6). Macrolide-and tetracycline-resistant Streptococcus pyogenes emm12 isolates represent the majority of clinical cases. Recently, we identified two mobile genetic elements that were closely associated with emm12 outbreak isolates: the integrative and conjugative element ICE-emm12, encoding genes for tetracycline and macrolide resistance, and prophage phi HKU. vir, encoding the superantigens SSA and SpeC, as well as the DNase Spd1 (ref. 4). Here we sequenced the genomes of 141 emm12 isolates, including 132 isolated in Hong Kong between 2005 and 2011. We found that the introduction of several ICE-emm12 variants, phi HKU. vir and a new prophage, phi HKU. ssa, occurred in three distinct emm12 lineages late in the twentieth century. Acquisition of ssa and transposable elements encoding multidrug resistance genes triggered the expansion of scarlet fever-associated emm12 lineages in Hong Kong. The occurrence of multidrug-resistant ssa-harboring scarlet fever strains should prompt heightened surveillance within China and abroad for the dissemination of these mobile genetic elements.	[Davies, Mark R.; Venturini, Carola; Barnett, Timothy C.; Ben Zakour, Nouri L.; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Davies, Mark R.; Holden, Matthew T.; Coupland, Paul; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Chen, Jonathan H. K.; Tse, Herman; Yuen, Kwok-Yung] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Yuen, Kwok-Yung] State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Queensland; Wellcome Trust Sanger Institute; University of Hong Kong; University of Hong Kong	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.	mark.walker@uq.edu.au	Venturini, Carola/G-6642-2018; Barnett, Timothy/G-2155-2011; Holden, Matthew TG/K-6449-2014; Davies, Mark R/J-2128-2014; ZAKOUR, Nouri L BEN/B-9338-2011	Venturini, Carola/0000-0003-2370-8661; Barnett, Timothy/0000-0002-3346-5117; Holden, Matthew TG/0000-0002-4958-2166; Davies, Mark R/0000-0001-6141-5179; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Walker, Mark/0000-0001-7423-2769; Chen, Jonathan Hon Kwan/0000-0002-7510-1696; Coupland, Paul/0000-0002-2871-3374	National Health and Medical Research Council of Australia (NHMRC) [565526]; Australian Research Council [DP140102881]; Research Fund for the Control of Infectious Diseases Commissioned Grant from the Hong Kong government; Wellcome Trust [098051]; NHMRC [635250, 631386]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Research Fund for the Control of Infectious Diseases Commissioned Grant from the Hong Kong government; Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank the core sequencing and pathogen informatics teams at the Sanger Institute for their assistance. This work was supported by National Health and Medical Research Council of Australia (NHMRC) program grant 565526, Australian Research Council grant DP140102881, a Research Fund for the Control of Infectious Diseases Commissioned Grant from the Hong Kong government and Wellcome Trust grant 098051. M.R.D. is supported by an NHMRC postdoctoral training fellowship (635250). M.J.W. is supported by an NHMRC principal research fellowship (631386).	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen ML, 2012, PEDIATR INFECT DIS J, V31, pE158, DOI 10.1097/INF.0b013e31825874f3; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duncan SR, 2000, EUR J EPIDEMIOL, V16, P619, DOI 10.1023/A:1007645110006; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Hsieh YC, 2011, J MICROBIOL IMMUNOL, V44, P409, DOI 10.1016/j.jmii.2011.07.003; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jing HB, 2006, J MED MICROBIOL, V55, P1101, DOI 10.1099/jmm.0.46243-0; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; Lau EHY, 2012, EMERG INFECT DIS, V18, P1700, DOI 10.3201/eid1810.120062; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liang YM, 2012, J MED MICROBIOL, V61, P975, DOI 10.1099/jmm.0.042309-0; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Silva-Costa C, 2014, PEDIATR INFECT DIS J, V33, P306, DOI 10.1097/INF.0000000000000088; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su YF, 2009, J CLIN MICROBIOL, V47, P2658, DOI 10.1128/JCM.01078-09; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Wong SSY, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.9; Wong SSY, 1999, CLIN INFECT DIS, V29, P760, DOI 10.1086/520429; Yang P, 2013, EMERG INFECT DIS, V19, P909, DOI 10.3201/eid1906.121020; You YH, 2012, J BACTERIOL, V194, P5983, DOI 10.1128/JB.01474-12; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	34	99	103	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					84	+		10.1038/ng.3147	http://dx.doi.org/10.1038/ng.3147			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25401300				2022-12-25	WOS:000346990400016
J	Ma, B; Chen, Y; Chen, L; Cheng, HC; Mu, CL; Li, J; Gao, RZ; Zhou, CQ; Cao, L; Liu, JH; Zhu, YS; Chen, Q; Wu, S				Ma, Biao; Chen, Yan; Chen, Ling; Cheng, Hongcheng; Mu, Chenglong; Li, Jie; Gao, Ruize; Zhou, Changqian; Cao, Lei; Liu, Jinhua; Zhu, Yushan; Chen, Quan; Wu, Shian			Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; CELL-PROLIFERATION; GROWTH-CONTROL; BREAST-CANCER; SIZE-CONTROL; PATHWAY; DROSOPHILA; GENE; HOMOLOG	The Hippo signalling pathway plays important roles in animal development, physiology and tumorigenesis(1-3). Understanding how the activity of this pathway is regulated by the cellular microenvironment remains a major challenge. Here we elucidate a molecular mechanism by which hypoxia deactivates Hippo signalling. We demonstrate that the E3 ubiquitin ligase SIAH2 stimulates YAP by destabilizing LATS2, a critical component of the Hippo pathway, in response to hypoxia. Loss of SIAH2 suppresses tumorigenesis in a LATS2-dependent manner in a xenograft mouse model. We further show that YAP complexes with HIF1 alpha and is essential for HIF1 alpha stability and function in tumours in vivo. LATS2 is downregulated in human breast tumours and negatively correlates with SIAH2 expression levels, indicating that the SIAH2-LATS2 pathway may have a role in human cancer. Our data uncover oxygen availability as a microenvironment signal for the Hippo pathway and have implications for understanding the regulation of Hippo signalling in tumorigenesis.	[Ma, Biao; Chen, Yan; Chen, Ling; Cheng, Hongcheng; Mu, Chenglong; Li, Jie; Gao, Ruize; Zhou, Changqian; Cao, Lei; Liu, Jinhua; Zhu, Yushan; Chen, Quan; Wu, Shian] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhu, YS (corresponding author), Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	zhuys@nankai.edu.cn; chenq@ioz.ac.cn; wusa@nankai.edu.cn	CHEN, YAN/N-4135-2018; Gao, Ruize/HHS-4967-2022	Gao, Ruize/0000-0002-3582-4726; CHEN, YAN/0000-0003-3516-9546; Chen, Quan/0000-0001-7539-8728; Wu, Shian/0000-0003-4990-6594	National Basic Research Program of China [2010CB912204, 2011CB9109903, 2011CB943903, 2013CB531200]; National Natural Sciences Foundation of China [31471319, 81130045, 31171411]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	We thank H. Deng from Tsinghua University for Mass spectrometry analysis, Y. (YZ) Luo from Tsinghua University for providing the HRE-luciferase reporter plasmid and Y. (YG) Chen from Tsinghua University for providing the HA-VHL plasmid. We are deeply grateful to D. (DJ) Pan from Johns Hopkins University for his suggestions during the manuscript revision. This work was supported by the National Basic Research Program of China (2010CB912204, 2011CB9109903, 2011CB943903 and 2013CB531200) and the National Natural Sciences Foundation of China (31471319, 81130045 and 31171411).	Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Bendinelli P, 2013, EUR J CANCER, V49, P2608, DOI 10.1016/j.ejca.2013.03.002; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Christian PA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-57; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Ishizaki K, 2002, INT J ONCOL, V21, P1053; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Matteucci E, 2013, EUR J CANCER, V49, P231, DOI 10.1016/j.ejca.2012.05.006; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powzaniuk M, 2004, MOL ENDOCRINOL, V18, P2011, DOI 10.1210/me.2004-0065; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	37	159	170	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					95	+		10.1038/ncb3073	http://dx.doi.org/10.1038/ncb3073			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25438054				2022-12-25	WOS:000346823900011
J	Kupecz, A				Kupecz, Andra			Who owns CRISPR-Cas9 in Europe?	NATURE BIOTECHNOLOGY			English	Editorial Material									Kupecz Intellectual Property, Amsterdam, Netherlands		Kupecz, A (corresponding author), Kupecz Intellectual Property, Amsterdam, Netherlands.	andras@kupecz-ip.com						Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Letter of the applicant (the Broad Institute and MIT), 2014, [No title captured], Patent No. 2764103; Sheridan C, 2014, NAT BIOTECHNOL, V32, P599, DOI 10.1038/nbt0714-599; Zhang F., 2014, US Patent, Patent No. [8,697,359, 8697359]	5	7	7	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1194	1196		10.1038/nbt.3086	http://dx.doi.org/10.1038/nbt.3086			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489834				2022-12-25	WOS:000346156800018
J	Smanski, MJ; Bhatia, S; Zhao, DH; Park, Y; Woodruff, LBA; Giannoukos, G; Ciulla, D; Busby, M; Calderon, J; Nicol, R; Gordon, DB; Densmore, D; Voigt, CA				Smanski, Michael J.; Bhatia, Swapnil; Zhao, Dehua; Park, YongJin; Woodruff, Lauren B. A.; Giannoukos, Georgia; Ciulla, Dawn; Busby, Michele; Calderon, Johnathan; Nicol, Robert; Gordon, D. Benjamin; Densmore, Douglas; Voigt, Christopher A.			Functional optimization of gene clusters by combinatorial design and assembly	NATURE BIOTECHNOLOGY			English	Article							NITROGEN-FIXATION GENES; KLEBSIELLA-PNEUMONIAE; EXPRESSION; CONSTRUCTION; PROMOTERS; PROSPECTS; AMMONIUM; KINETICS; SEQUENCE; SITES	Large microbial gene clusters encode useful functions, including energy utilization and natural product biosynthesis, but genetic manipulation of such systems is slow, difficult and complicated by complex regulation. We exploit the modularity of a refactored Klebsiella oxytoca nitrogen fixation (nif) gene cluster (16 genes, 103 parts) to build genetic permutations that could not be achieved by starting from the wild-type cluster. Constraint-based combinatorial design and DNA assembly are used to build libraries of radically different cluster architectures by varying part choice, gene order, gene orientation and operon occupancy. We construct 84 variants of the nifUSVWZM operon, 145 variants of the nifHDKY operon, 155 variants of the nifHDKYENJ operon and 122 variants of the complete 16-gene pathway. The performance and behavior of these variants are characterized by nitrogenase assay and strand-specific RNA sequencing (RNA-seq), and the results are incorporated into subsequent design cycles. We have produced a fully synthetic cluster that recovers 57% of wild-type activity. Our approach allows the performance of genetic parts to be quantified simultaneously in hundreds of genetic contexts. This parallelized design-build-test-learn cycle, which can access previously unattainable regions of genetic space, should provide a useful, fast tool for genetic optimization and hypothesis testing.	[Smanski, Michael J.; Zhao, Dehua; Park, YongJin; Woodruff, Lauren B. A.; Calderon, Johnathan; Gordon, D. Benjamin; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Bhatia, Swapnil; Densmore, Douglas] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Woodruff, Lauren B. A.; Giannoukos, Georgia; Ciulla, Dawn; Busby, Michele; Nicol, Robert; Gordon, D. Benjamin; Voigt, Christopher A.] Broad Inst MIT & Harvard, Broad Technol Labs, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com	Densmore, Douglas/AAC-7059-2020	Nicol, Robert/0000-0003-1932-1392; Bhatia, Swapnil/0000-0003-1079-7570; Andrews, Lauren/0000-0003-1627-1430	US Defense Advanced Research Projects Agency (DARPA) [HR0011-12-C-0067]; US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; Institute for Collaborative Biotechnologies through from the US Army Research Office [W911NF-09-0001]; DARPA Living Foundries [HR0011-12-C-0067]; Samsung Scholarship	US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC); Institute for Collaborative Biotechnologies through from the US Army Research Office; DARPA Living Foundries; Samsung Scholarship(Samsung)	M.J.S., D.Z.,J.C., R.N., D.B.G. and C.A.V. are supported by the US Defense Advanced Research Projects Agency (DARPA) Living Foundries grant HR0011-12-C-0067 and the US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) through grant SA5284-11210 and are also supported by the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the US Army Research Office. The content of the information does not necessarily reflect the position or the policy of the US government, and no official endorsement should be inferred. S.B. and D.D. are supported by DARPA Living Foundries grant HR0011-12-C-0067. M.J.S. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation, DRG-2129-12. Y.P. is supported by the Samsung Scholarship.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; ARNOLD W, 1988, J MOL BIOL, V203, P715, DOI 10.1016/0022-2836(88)90205-7; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; BEYNON J, 1983, CELL, V34, P665, DOI 10.1016/0092-8674(83)90399-9; Bilitchenko L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018882; CANNON FC, 1976, J GEN MICROBIOL, V93, P111, DOI 10.1099/00221287-93-1-111; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Crook NC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr346; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Densmore D., 2010, P 2010 IEEE ISCAS, DOI [10.1109/ISCAS.2010.5537540, DOI 10.1109/ISCAS.2010.5537540]; Dixon R, 1997, PLANT SOIL, V194, P193, DOI 10.1023/A:1004296703638; DIXON R, 1976, NATURE, V260, P268, DOI 10.1038/260268a0; DIXON RA, 1972, NATURE, V237, P102, DOI 10.1038/237102a0; Dukes P., 2008, BANFF INT RES STAT M; EADY RR, 1978, J GEN MICROBIOL, V104, P277, DOI 10.1099/00221287-104-2-277; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Fischbach M, 2010, BIOTECHNOL J, V5, P1277, DOI 10.1002/biot.201000181; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gorochowski TE, 2014, ACS SYNTH BIOL, V3, P129, DOI 10.1021/sb4001245; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; JENG ST, 1990, J BIOL CHEM, V265, P3823; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang LW, 2013, GENETICS, V193, P453, DOI 10.1534/genetics.112.147199; Lim HN, 2011, P NATL ACAD SCI USA, V108, P10626, DOI 10.1073/pnas.1105692108; LOWE DJ, 1984, BIOCHEM J, V224, P877, DOI 10.1042/bj2240877; May O., 2002, ENZYME CATALYSIS ORG; MCALLISTER WT, 1981, J MOL BIOL, V153, P527, DOI 10.1016/0022-2836(81)90406-X; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Stacy G.S., 1992, BIOL NITROGEN FIXATI; STEWART WDP, 1967, SCIENCE, V158, P536, DOI 10.1126/science.158.3800.536; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Suh MH, 2002, BIOCHEM BIOPH RES CO, V299, P233, DOI 10.1016/S0006-291X(02)02620-7; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068677; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]	50	233	249	5	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1241	U104		10.1038/nbt.3063	http://dx.doi.org/10.1038/nbt.3063			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419741				2022-12-25	WOS:000346156800026
J	Tsvetanova, NG; von Zastrow, M				Tsvetanova, Nikoleta G.; von Zastrow, Mark			Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis	NATURE CHEMICAL BIOLOGY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; ADENYLYL-CYCLASE; MEMBRANE; TRAFFICKING; ACTIVATION; ENDOSOMES; KINASE; CAMP; EFFICACY; DYNAMICS	G protein-coupled receptors (GPCRs) are well known to signal via cyclic AMP (cAMP) production at the plasma membrane, but it is now clear that various GPCRs also signal after internalization. Apart from its temporal impact through prolonging the cellular response, we wondered whether the endosome-initiated signal encodes any discrete spatial information. Using the beta 2-adrenoceptor (beta 2-AR) as a model, we show that endocytosis is required for the full repertoire of downstream cAMP-dependent trans-criptional control. Next, we describe an orthogonal optogenetic approach to definitively establish that the location of cAMP production is indeed the critical variable determining the transcriptional response. Finally, our results suggest that this spatial encoding scheme helps cells functionally discriminate chemically distinct beta 2-AR ligands according to differences in their ability to promote receptor endocytosis. These findings reveal a discrete principle for achieving cellular signaling specificity based on endosome-mediated spatial encoding of intracellular second messenger production and 'location-aware' downstream transcriptional control.	[Tsvetanova, Nikoleta G.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			National Institute on Drug Abuse of the US National Institutes of Health [DA010711, DA012864]; American Heart Association; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012864, R37DA010711, P01DA010154, R29DA010711, R01DA010711] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the US National Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Brown for generously providing access to microarray facilities; P. Hegemann, H. Stenmark and T. Meyer for plasmids; D. Udwari and T. Oertner for initially suggesting the use of bPAC; and H. Bourne, B. Cheyette, R. Irannejad, B. Lobingier, A. Marley and D. Riordan for valuable discussion. These studies were supported by the National Institute on Drug Abuse of the US National Institutes of Health (DA010711 and DA012864 to M.v.Z.). N.G.T. is supported by the American Heart Association.	Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kholodenko BN, 2008, CELL, V133, P566, DOI 10.1016/j.cell.2008.04.033; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; OBrien RM, 1995, BBA-GENE STRUCT EXPR, V1264, P284, DOI 10.1016/0167-4781(95)00194-8; Ostrom RS, 2012, N-S ARCH PHARMACOL, V385, P5, DOI 10.1007/s00210-011-0696-9; Perino A, 2012, CIRC RES, V111, P482, DOI 10.1161/CIRCRESAHA.111.262899; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	41	162	164	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1061	+		10.1038/nchembio.1665	http://dx.doi.org/10.1038/nchembio.1665			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25362359	Green Accepted, Green Submitted			2022-12-25	WOS:000345122300015
J	Xie, MC; Lu, C; Wang, JY; McLellan, MD; Johnson, KJ; Wendl, MC; McMichael, JF; Schmidt, HK; Yellapantula, V; Miller, CA; Ozenberger, BA; Welch, JS; Link, DC; Walter, MJ; Mardis, ER; Dipersio, JF; Chen, F; Wilson, RK; Ley, TJ; Ding, L				Xie, Mingchao; Lu, Charles; Wang, Jiayin; McLellan, Michael D.; Johnson, Kimberly J.; Wendl, Michael C.; McMichael, Joshua F.; Schmidt, Heather K.; Yellapantula, Venkata; Miller, Christopher A.; Ozenberger, Bradley A.; Welch, John S.; Link, Daniel C.; Walter, Matthew J.; Mardis, Elaine R.; Dipersio, John F.; Chen, Feng; Wilson, Richard K.; Ley, Timothy J.; Ding, Li			Age-related mutations associated with clonal hematopoietic expansion and malignancies	NATURE MEDICINE			English	Article							MCCUNE-ALBRIGHT-SYNDROME; GS-ALPHA MUTATIONS; CANCER; CELLS; VALIDATION; MOSAICISM; EVOLUTION; DEFECTS; GENOME; GENES	Several genetic alterations characteristic of leukemia and lymphoma have been detected in the blood of individuals without apparent hematological malignancies. The Cancer Genome Atlas (TCGA) provides a unique resource for comprehensive discovery of mutations and genes in blood that may contribute to the clonal expansion of hematopoietic stem/progenitor cells. Here, we analyzed blood-derived sequence data from 2,728 individuals from TCGA and discovered 77 blood-specific mutations in cancer-associated genes, the majority being associated with advanced age. Remarkably, 83% of these mutations were from 19 leukemia and/or lymphoma-associated genes, and nine were recurrently mutated (DNMT3A, TET2, JAK2, ASXL1, TP53, GNAS, PPM1D, BCORL1 and SF3B1). We identified 14 additional mutations in a very small fraction of blood cells, possibly representing the earliest stages of clonal expansion in hematopoietic stem cells. Comparison of these findings to mutations in hematological malignancies identified several recurrently mutated genes that may be disease initiators. Our analyses show that the blood cells of more than 2% of individuals (5-6% of people older than 70 years) contain mutations that may represent premalignant events that cause clonal hematopoietic expansion.	[Xie, Mingchao; Lu, Charles; Wang, Jiayin; McLellan, Michael D.; Wendl, Michael C.; McMichael, Joshua F.; Schmidt, Heather K.; Yellapantula, Venkata; Miller, Christopher A.; Ozenberger, Bradley A.; Mardis, Elaine R.; Wilson, Richard K.; Ley, Timothy J.; Ding, Li] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Xie, Mingchao; Wang, Jiayin; Yellapantula, Venkata; Ozenberger, Bradley A.; Welch, John S.; Link, Daniel C.; Walter, Matthew J.; Mardis, Elaine R.; Dipersio, John F.; Chen, Feng; Wilson, Richard K.; Ley, Timothy J.; Ding, Li] Washington Univ, Dept Med, St Louis, MO USA; [Johnson, Kimberly J.] Washington Univ, Brown Sch Master Publ Hlth Program, St Louis, MO USA; [Wendl, Michael C.; Mardis, Elaine R.; Wilson, Richard K.; Ley, Timothy J.; Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63130 USA; [Welch, John S.; Link, Daniel C.; Walter, Matthew J.; Mardis, Elaine R.; Dipersio, John F.; Chen, Feng; Wilson, Richard K.; Ley, Timothy J.; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Ding, L (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63130 USA.	lding@genome.wustl.edu	Wang, Jiayin/C-5047-2015; Yellapantula, Venkata/AAM-3996-2021; Wilson, Richard K./AAF-4139-2019; Walter, Matthew J/S-7758-2018; Mardis, Elaine/W-2202-2019	Wang, Jiayin/0000-0002-3862-6557; Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher/0000-0003-4266-6700; Yellapantula, Venkata/0000-0001-9848-3263; MCLELLAN, MICHAEL/0000-0002-2703-8784	US National Cancer Institute [R01CA180006, PO1CA101937]; US National Human Genome Research Institute [U54HG003079, U01HG006517]; Leukemia and Lymphoma Society Scholar Award [1230-14];  [R00HL103975]; NATIONAL CANCER INSTITUTE [P01CA101937, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517, U54HG003079] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by US National Cancer Institute grants R01CA180006 to L.D. and PO1CA101937 to T.J.L. and US National Human Genome Research Institute grants U54HG003079 to R.K.W. and U01HG006517 to L.D. M.J.W. is supported by a Leukemia and Lymphoma Society Scholar Award (1230-14), and J.S.W. is supported by R00HL103975. We thank M. Wyczalkowski for suggestions on figures and C. Kandoth on somatic mutation analysis. We also acknowledge The Cancer Genome Atlas as the source of primary data.	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; BIERNAUX C, 1995, BLOOD, V86, P3118; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li M, 2011, BLOOD, V118, P5914, DOI 10.1182/blood-2011-05-356204; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lumbroso S, 2004, J CLIN ENDOCR METAB, V89, P2107, DOI 10.1210/jc.2003-031225; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Ringel MD, 1996, MEDICINE, V75, P171, DOI 10.1097/00005792-199607000-00001; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Weinstein LS, 2006, J BONE MINER RES, V21, pP120, DOI 10.1359/JBMR.06S223; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	37	1121	1147	4	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1472	1478		10.1038/nm.3733	http://dx.doi.org/10.1038/nm.3733			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25326804	Green Accepted			2022-12-25	WOS:000345817900024
J	Freiburger, L; Miletti, T; Zhu, SQ; Baettig, O; Berghuis, A; Auclair, K; Mittermaier, A				Freiburger, Lee; Miletti, Teresa; Zhu, Siqi; Baettig, Oliver; Berghuis, Albert; Auclair, Karine; Mittermaier, Anthony			Substrate-dependent switching of the allosteric binding mechanism of a dimeric enzyme	NATURE CHEMICAL BIOLOGY			English	Article							SOLVENT REARRANGEMENT; HUMAN-HEMOGLOBIN; PLAUSIBLE MODEL; PROTEINS; AAC(6')-II; ENSEMBLE; NONPOLAR; SURFACE; WATER	Enzyme activity is commonly controlled by allostery, where ligand binding at one site alters the activities of distant sites. Classical explanations for multisubunit proteins involve conformational transitions that are fundamentally deterministic. For example, in the Monod-Wyman-Changeaux (MWC) paradigm, conformational transitions occur simultaneously in all subunits. In the Koshland-Nemethy-Filmer (KNF) paradigm, conformational transitions only occur in ligand-bound subunits. In contrast, recent models predict conformational changes that are governed by probabilities rather than absolute rules. To better understand allostery at the molecular level, we applied a recently developed spectroscopic and calorimetric method to the interactions of a dimeric enzyme with two different ligands. We found that conformational transitions appear MWC-like for a ligand that binds at the dimer interface and KNF-like for a distal ligand. These results provide strong experimental support for probabilistic allosteric theory predictions that an enzyme can exhibit a mixture of MWC and KNF character, with the balance partly governed by subunit interface energies.	[Freiburger, Lee; Miletti, Teresa; Zhu, Siqi; Auclair, Karine; Mittermaier, Anthony] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Baettig, Oliver; Berghuis, Albert] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University	Freiburger, L (corresponding author), McGill Univ, Dept Chem, Montreal, PQ, Canada.	anthony.mittermaier@mcgill.ca	Berghuis, Albert M/A-6495-2008; Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research (CIHR) [MOP-89784]; CIHR training grant; McGill University; GRASP; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR training grant(Canadian Institutes of Health Research (CIHR)); McGill University; GRASP; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	The authors would like to thank G.D. Wright (McMaster University) for providing the AAC(6')-Ii expression construct. This research was funded by operating grants from the Canadian Institutes of Health Research (CIHR MOP-89784) to K.A. and A.M. L.F. was supported through a CIHR training grant. A.B. holds a Canada Research Chair in Structural Biology. A.B. and A.M. are members of Groupe de Recherche Axe sur la Structure des Proteines (GRASP), which funds the NMR centre where the experiments were performed. NMR experiments were recorded at the Quebec-Eastern Canada High Field NMR Facility, supported by McGill University and GRASP.	Adler A J, 1973, Methods Enzymol, V27, P675; Burk DL, 2005, ACTA CRYSTALLOGR D, V61, P1273, DOI 10.1107/S0907444905021487; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DAUGHERTY MA, 1991, P NATL ACAD SCI USA, V88, P1110, DOI 10.1073/pnas.88.4.1110; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Freiburger LA, 2012, THERMOCHIM ACTA, V527, P148, DOI 10.1016/j.tca.2011.10.018; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Gao F, 2005, ANGEW CHEM INT EDIT, V44, P6859, DOI 10.1002/anie.200501399; GILL SJ, 1986, BIOPHYS J, V50, P747, DOI 10.1016/S0006-3495(86)83514-7; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Norris AL, 2011, BIOCHEMISTRY-US, V50, P9309, DOI 10.1021/bi2011916; Ozen C, 2008, BIOCHEMISTRY-US, V47, P40, DOI 10.1021/bi701711j; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wright GD, 1997, ANTIMICROB AGENTS CH, V41, P956, DOI 10.1128/AAC.41.5.956; Wybenga-Groot LE, 1999, STRUCTURE, V7, P497, DOI 10.1016/S0969-2126(99)80066-5; WYMAN J, 1972, CURRENT TOPICS CELLU, V6, P209; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	33	18	18	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					937	942		10.1038/NCHEMBIO.1626	http://dx.doi.org/10.1038/NCHEMBIO.1626			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25218742				2022-12-25	WOS:000343621500016
J	Rosser, EC; Oleinika, K; Tonon, S; Doyle, R; Bosma, A; Carter, NA; Harris, KA; Jones, SA; Klein, N; Mauri, C				Rosser, Elizabeth C.; Oleinika, Kristine; Tonon, Silvia; Doyle, Ronan; Bosma, Anneleen; Carter, Natalie A.; Harris, Kathryn A.; Jones, Simon A.; Klein, Nigel; Mauri, Claudia			Regulatory B cells are induced by gut microbiota-driven interleukin-1 beta and interleukin-6 production	NATURE MEDICINE			English	Article							IL-10; AUTOIMMUNITY; ACTIVATION; RESPONSES	Regulatory B cells (B-reg cells) differentiate in response to inflammation and subsequently restrain excessive immune responses via the release of interleukin-10 (IL-10)(1). However, the precise inflammatory signals governing their differentiation remain to be elucidated. Here we show that the gut microbiota promotes the differentiation of B-reg cells in the spleen as well as in the mesenteric lymph nodes. Perturbation of the gut microbiome imposed either by antibiotic treatment or by changes in the sterility of housing conditions reduces the number and function of B-reg cells. Following the induction of arthritis, IL-1 beta and IL-6 are produced only in conventionally housed mice and both cytokines directly promote B-reg cell differentiation and IL-10 production. Mice lacking IL-6 receptor (IL-6R) or IL-1 receptor 1 (IL-1R1) specifically on B cells have a reduced number of IL-10-producing B cells and develop exacerbated arthritis compared to control animals. Thus, in response to inflammatory signals induced by both the gut flora and arthritis, B-reg cells increase in number and restrain excessive inflammation.	[Rosser, Elizabeth C.; Oleinika, Kristine; Bosma, Anneleen; Carter, Natalie A.; Mauri, Claudia] UCL, Div Med, Ctr Rheumatol, London, England; [Tonon, Silvia] Univ Udine, Dipartimento Med & Sci Biol, Udine, Italy; [Doyle, Ronan; Klein, Nigel] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Harris, Kathryn A.] Natl Hlth Serv Fdn Trust, Great Ormond St Hosp, Dept Microbiol Virol & Infect Control, London, England; [Jones, Simon A.] Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Cardiff, Wales	University of London; University College London; University of Udine; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University	Mauri, C (corresponding author), UCL, Div Med, Ctr Rheumatol, London, England.	c.mauri@ucl.ac.uk	Tonon, Silvia/GNP-1542-2022; Mauri, Chiara/GXN-0766-2022; Doyle, Ronan/L-8091-2019; Jones, Simon Arnett/Q-7017-2018	Tonon, Silvia/0000-0002-3361-2906; Doyle, Ronan/0000-0001-5001-1945; Mauri, Claudia/0000-0001-9761-2625; Klein, Nigel/0000-0003-3925-9258; Harris, Kathryn/0000-0003-3807-9749; Rosser, Elizabeth/0000-0003-4800-4695; Jones, Simon Arnett/0000-0001-7297-9711; Oleinika, Kristine/0000-0002-2021-2938	Arthritis Research United Kingdom programme [MP/17707]; Arthritis Research United Kingdom PhD studentship [MP/19314]; Food and Nutritional Technical Assistance III project (FANTA III); Erasmus Placement programme (Consorzio KTEU EP6); Versus Arthritis [17707, 19314] Funding Source: researchfish	Arthritis Research United Kingdom programme(Versus Arthritis); Arthritis Research United Kingdom PhD studentship(Versus Arthritis); Food and Nutritional Technical Assistance III project (FANTA III); Erasmus Placement programme (Consorzio KTEU EP6); Versus Arthritis(Versus Arthritis)	This work is funded by an Arthritis Research United Kingdom programme grant (MP/17707) awarded to C.M. E.C.R. is funded by an Arthritis Research United Kingdom PhD studentship (MP/19314) also awarded to C.M. R.D. is funded by a Food and Nutritional Technical Assistance III project (FANTA III). S.T. is funded by an Erasmus Placement programme (Consorzio KTEU EP6). We would like to thank the University College London Biological Service Unit staff for all their help controlling animal husbandry, J. Evans for cell sorting, K. Nistala for comments and P. Blair for critically reviewing the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Vasconcellos R, 2011, J IMMUNOL, V187, P3402, DOI 10.4049/jimmunol.1100224; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	22	275	285	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1334	1339		10.1038/nm.3680	http://dx.doi.org/10.1038/nm.3680			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326801				2022-12-25	WOS:000344724300024
J	Savage, PB				Savage, Paul B.			VACCINE DEVELOPMENT NKT-cell adjuvants in conjugate	NATURE CHEMICAL BIOLOGY			English	News Item									Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Savage, PB (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	paul_savage@byu.edu	Savage, Paul B/HGB-3414-2022; Savage, Paul B/E-1448-2011	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109				Anderson RJ, 2014, NAT CHEM BIOL, V10, P943, DOI [10.1038/NCHEMBIO.1640, 10.1038/nchembio.1640]; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Carreiio L.J., IMMUNOTHERAPY; Cavallari M, 2014, NAT CHEM BIOL, V10, P950, DOI [10.1038/NCHEMBIO.1650, 10.1038/nchembio.1650]; Enomoto N, 2012, J IMMUNOL, V188, P1734, DOI 10.4049/jimmunol.1102699; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Tonti E, 2012, J IMMUNOL, V188, P3217, DOI 10.4049/jimmunol.1103501	9	6	7	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					882	883		10.1038/nchembio.1667	http://dx.doi.org/10.1038/nchembio.1667			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25325698	Bronze			2022-12-25	WOS:000343621500007
J	Mayo, L; Trauger, SA; Blain, M; Nadeau, M; Patel, B; Alvarez, JI; Mascanfroni, ID; Yeste, A; Kivisakk, P; Kallas, K; Ellezam, B; Bakshi, R; Prat, A; Antel, JP; Weiner, HL; Quintana, FJ				Mayo, Lior; Trauger, Sunia A.; Blain, Manon; Nadeau, Meghan; Patel, Bonny; Alvarez, Jorge I.; Mascanfroni, Ivan D.; Yeste, Ada; Kivisaekk, Pia; Kallas, Keith; Ellezam, Benjamin; Bakshi, Rohit; Prat, Alexandre; Antel, Jack P.; Weiner, Howard L.; Quintana, Francisco J.			Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REACTIVE ASTROCYTES; LACTOSYLCERAMIDE SYNTHASE; T-CELLS; EXPRESSION; MONOCYTES; MICE; INFILTRATION; ADHESION; DISTINCT	Astrocytes have complex roles in health and disease, thus it is important to study the pathways that regulate their function. Here we report that lactosylceramide (LacCer) synthesized by beta-1,4-galactosyltransferase 6 (B4GALT6) is upregulated in the central nervous system (CNS) of mice during chronic experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS). LacCer acts in an autocrine manner to control astrocyte transcriptional programs that promote neurodegeneration. In addition, LacCer in astrocytes controls the recruitment and activation of microglia and CNS-infiltrating monocytes in a non cell autonomous manner by regulating production of the chemokine CCL2 and granulocyte-macrophage colony stimulating factor (GM-CSF), respectively. We also detected high B4GALT6 gene expression and LacCer concentrations in CNS MS lesions. Inhibition of LacCer synthesis in mice suppressed local CNS innate immunity and neurodegeneration in EAE and interfered with the activation of human astrocytes in vitro. Thus, B4GALT6 regulates astrocyte activation and is a potential therapeutic target for MS and other neuroinflammatory disorders.	[Mayo, Lior; Nadeau, Meghan; Patel, Bonny; Mascanfroni, Ivan D.; Yeste, Ada; Kivisaekk, Pia; Kallas, Keith; Bakshi, Rohit; Weiner, Howard L.; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Trauger, Sunia A.] Harvard Univ, FAS Ctr Syst Biol, Boston, MA 02115 USA; [Blain, Manon; Antel, Jack P.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada; [Alvarez, Jorge I.; Prat, Alexandre] Univ Montreal, Dept Neurosci, Ctr Excellence Neur, Neuroimmunol Res Lab, Montreal, PQ, Canada; [Ellezam, Benjamin] Univ Montreal, Dept Pathol, Montreal, PQ H3C 3J7, Canada; [Ellezam, Benjamin] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	m, Lior/AGK-3671-2022; Quintana, Francisco Javier/AAB-6915-2020	m, Lior/0000-0002-1296-6692; Trauger, Sunia/0000-0002-1678-8715; antel, jack/0000-0002-5148-0636	US National Institutes of Health [AI075285, AI093903]; National Multiple Sclerosis Society [RG4111A1, JF2161-A-5, FG1941A1/2]; International Progressive MS Alliance [PA0069]; US National Institutes Transformative Grant [AG-043975]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, R00AI075285, R01AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043975] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Progressive MS Alliance; US National Institutes Transformative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank G. Losyev and D. Kozoriz for cell sorting, E Kirchhoff (University of Saarland) for providing us with GFAP transgenic mice and G.-X. Zhang (Thomas Jefferson University) for the pLenti-GFAP-EGFP-mir30-shAct1 vector. This work was supported by grants AI075285 and AI093903 from the US National Institutes of Health, RG4111A1 and JF2161-A-5 from the National Multiple Sclerosis Society and PA0069 from the International Progressive MS Alliance (F.J.Q.) and US National Institutes Transformative Grant AG-043975 (H.W.L.); L.M. is supported by a postdoctoral fellowship (FG1941A1/2) from National Multiple Sclerosis Society.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Chatterjee S, 2012, ADV EXP MED BIOL, V749, P153, DOI 10.1007/978-1-4614-3381-1_11; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Ho PP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003831; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee JK, 2011, KOREAN J PHYSIOL PHA, V15, P251, DOI 10.4196/kjpp.2011.15.5.251; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nakamura H, 2013, J BIOL CHEM, V288, P23264, DOI 10.1074/jbc.M113.491431; Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Quintana FJ, 2012, J NEUROIMMUNOL, V248, P53, DOI 10.1016/j.jneuroim.2012.01.002; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Toft-Hansen H, 2011, GLIA, V59, P166, DOI 10.1002/glia.21088; Tokuda N, 2013, GLYCOBIOLOGY, V23, P1175, DOI 10.1093/glycob/cwt054; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12	40	273	277	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1147	1156		10.1038/nm.3681	http://dx.doi.org/10.1038/nm.3681			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25216636	Green Accepted			2022-12-25	WOS:000343194100025
J	Tierney, MT; Aydogdu, T; Sala, D; Malecova, B; Gatto, S; Puri, PL; Latella, L; Sacco, A				Tierney, Matthew Timothy; Aydogdu, Tufan; Sala, David; Malecova, Barbora; Gatto, Sole; Puri, Pier Lorenzo; Latella, Lucia; Sacco, Alessandra			STAT3 signaling controls satellite cell expansion and skeletal muscle repair	NATURE MEDICINE			English	Article							SELF-RENEWAL; STEM-CELLS; ACTIVATION; INTERLEUKIN-6; PROLIFERATION; INFLAMMATION; EXPRESSION; PATHWAY; INJURY; ROLES	The progressive loss of muscle regenerative capacity with age or disease results in part from a decline in the number and function of satellite cells, the direct cellular contributors to muscle repair(1-11). However, little is known about the molecular effectors underlying satellite cell impairment and depletion. Elevated levels of inflammatory cytokines, including interleukin-6 (IL-6), are associated with both age-related and muscle-wasting conditions(12-15). The levels of STAT3, a downstream effector of IL-6, are also elevated with muscle wasting(16,17), and STAT3 has been implicated in the regulation of self-renewal and stem cell fate in several tissues18-21. Here we show that IL-6-activated Stat3 signaling regulates satellite cell behavior, promoting myogenic lineage progression through myogenic differentiation 1 (Myod1) regulation. Conditional ablation of Stat3 in Pax7-expressing satellite cells resulted in their increased expansion during regeneration, but compromised myogenic differentiation prevented the contribution of these cells to regenerating myofibers. In contrast, transient Stat3 inhibition promoted satellite cell expansion and enhanced tissue repair in both aged and dystrophic muscle. The effects of STAT3 inhibition on cell fate and proliferation were conserved in human myoblasts. The results of this study indicate that pharmacological manipulation of STAT3 activity can be used to counteract the functional exhaustion of satellite cells in pathological conditions, thereby maintaining the endogenous regenerative response and ameliorating muscle-wasting diseases.	[Tierney, Matthew Timothy] Sanford Burnham Med Res Inst, Grad Sch Biomed Sci, La Jolla, CA USA; [Aydogdu, Tufan; Sala, David; Malecova, Barbora; Gatto, Sole; Puri, Pier Lorenzo; Sacco, Alessandra] Sanford Burnham Med Res Inst, Dev Aging & Regenerat Program DARe, La Jolla, CA 92037 USA; [Aydogdu, Tufan] Thermo Fisher Sci, Life Sci Solut, Carlsbad, CA USA; [Puri, Pier Lorenzo; Latella, Lucia] Fdn Santa Lucia, IRCCS, Rome, Italy; [Latella, Lucia] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Thermo Fisher Scientific; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Sacco, A (corresponding author), Sanford Burnham Med Res Inst, Dev Aging & Regenerat Program DARe, La Jolla, CA 92037 USA.	asacco@sanfordburnham.org	Latella, Lucia/K-7834-2016	Malecova, Barbora/0000-0001-5334-3195; LATELLA, LUCIA/0000-0003-1317-9233	US National Institutes of Health (NIH) [P30 AR061303, R03 AR063328]; Sanford-Burnham Center; California Institute for Regenerative Medicine (CIRM) Training grant [TG2 001162]; Italian Foreign Ministry (MAE); NIH [P30 AR061303, R01AR056712, R01AR052779]; Fondazione Telethon Funding Source: Custom; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063328, P30AR061303, F31AR065923, R01AR056712, R01AR052779, R01AR064873] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford-Burnham Center; California Institute for Regenerative Medicine (CIRM) Training grant; Italian Foreign Ministry (MAE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Cortez, J. Morales and B. Charbono for technical support. We thank the following Stanford-Burnham Medical Research Institute Core Facilities for technical support: Vivarium, Flow Cytometry, Viral Core and Cell Imaging. We thank S. Akira (Osaka University) and S. Schenk (University of California, San Diego) for providing the Stat3<SUP>flox/flox</SUP> mice, C. Keller (Oregon Health and Science University) and H. Makarenkova (The Scripps Research Institute) for providing the Pax7-CreER mice and H.M. Blau (Stanford University) for providing the mdx/mTR<SUP>G2</SUP> mice. We thank M. Karin (University of California, San Diego) for providing the shSTAT3 construct. We thank EuroBioBank and the Telethon Network of Genetic Biobanks (GTB12001F) for providing the human biological samples. This work was supported by US National Institutes of Health (NIH) grants P30 AR061303 and R03 AR063328 and the Sanford-Burnham Center to A.S., California Institute for Regenerative Medicine (CIRM) Training grant TG2 001162 to T.A., an Italian Foreign Ministry (MAE) grant to L.L. and NIH grants R01AR056712, R01AR052779 and P30 AR061303 to P.L.P.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; Gorissen M, 2011, J ENDOCRINOL, V209, P175, DOI 10.1530/JOE-11-0033; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Oh IH, 2002, ONCOGENE, V21, P4778, DOI 10.1038/sj.onc.1205592; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	42	231	238	1	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1182	1186		10.1038/nm.3656	http://dx.doi.org/10.1038/nm.3656			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25194572	Green Accepted			2022-12-25	WOS:000343194100029
J	Andrews, PW; Cavagnaro, J; Deans, R; Feigal, E; Horowitz, E; Keating, A; Rao, M; Turner, M; Wilmut, I; Yamanaka, S				Andrews, Peter W.; Cavagnaro, Joy; Deans, Robert; Feigal, Ellen; Horowitz, Ed; Keating, Armand; Rao, Mahendra; Turner, Marc; Wilmut, Ian; Yamanaka, Shinya			Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Letter							CELLULAR THERAPY; INFORMED-CONSENT		[Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Andrews, Peter W.] Int Stem Cell Initiat, Harbor, ME USA; [Cavagnaro, Joy] Access BIO, Boyce, VA USA; [Deans, Robert] Alliance Regenerat Med Athersys, Cleveland, OH USA; [Feigal, Ellen] Calif Inst Regenerat Med, San Francisco, CA USA; [Horowitz, Ed] Int Soc Cell Therapy, Vancouver, BC, Canada; [Keating, Armand] Univ Toronto, Amer Soc Hematol, Toronto, ON, Canada; [Keating, Armand] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Turner, Marc] Scottish Natl Blood Transfus Serv Headquarters, Edinburgh, Midlothian, Scotland; [Wilmut, Ian] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh BioQuarter, Edinburgh, Midlothian, Scotland; [Yamanaka, Shinya] Kyoto Univ, Kyoto Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto, Japan; [Yamanaka, Shinya] Int Soc Stem Cell Res, Northbrook, IL USA	University of Sheffield; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; National Institutes of Health (NIH) - USA; University of Edinburgh; Kyoto University	Andrews, PW (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	mrao@nyscf.org		Andrews, Peter/0000-0001-7215-4410				Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Allison M, 2012, NAT BIOTECHNOL, V30, P304, DOI 10.1038/nbt0412-304; Bravery CA, 2013, CYTOTHERAPY, V15, P9, DOI 10.1016/j.jcyt.2012.10.008; Carpenter MK, 2010, REGEN MED, V5, P569, DOI [10.2217/rme.10.55, 10.2217/RME.10.55]; Clarke D, 2012, CYTOTHERAPY, V14, P1032, DOI 10.3109/14653249.2012.706709; Georgieva BP, 2010, REGEN MED, V5, P581, DOI 10.2217/RME.10.43; Lomax GP, 2013, STEM CELL TRANSL MED, V2, P727, DOI 10.5966/sctm.2013-0099; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Magnus D, 2010, J LAW MED ETHICS, V38, P267, DOI 10.1111/j.1748-720X.2010.00487.x; Obasogie Osagie K., 2012, STANFORD TECHNOLOGY, V16, P51; Rao MS, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-98, 10.1186/scrt309]; Rao MM, 2012, ELECTROCHEM COMMUN, V17, P1, DOI 10.1016/j.elecom.2011.12.022; Rawley J., 2012, BIOPROCESS INT, V10, P16; Sipp D, 2012, SCIENCE, V338, P1296, DOI 10.1126/science.1229918; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	16	46	47	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					724	726		10.1038/nbt.2973	http://dx.doi.org/10.1038/nbt.2973			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093882				2022-12-25	WOS:000346455900009
J	Elvidge, S				Elvidge, Suzanne			Anti-CGRP antibodies for migraine turn industry heads	NATURE BIOTECHNOLOGY			English	News Item																			0	7	12	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					707	707		10.1038/nbt0814-707a	http://dx.doi.org/10.1038/nbt0814-707a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101728				2022-12-25	WOS:000346455900033
J	Rodriguez-Fraticelli, AE; Bagwell, J; Bosch-Fortea, M; Boncompain, G; Reglero-Real, N; Garcia-Leon, MJ; Andres, G; Toribio, ML; Alonso, MA; Millan, J; Perez, F; Bagnat, M; Martin-Belmonte, F				Rodriguez-Fraticelli, Alejo E.; Bagwell, Jennifer; Bosch-Fortea, Minerva; Boncompain, Gaelle; Reglero-Real, Natalia; Garcia-Leon, Maria J.; Andres, German; Toribio, Maria L.; Alonso, Miguel A.; Millan, Jaime; Perez, Franck; Bagnat, Michel; Martin-Belmonte, Fernando			Developmental regulation of apical endocytosis controls epithelial patterning in vertebrate tubular organs	NATURE CELL BIOLOGY			English	Article							NOTCH SIGNALING CONTROLS; MEMBRANE DOMAIN; LUMEN FORMATION; ZEBRAFISH; DROSOPHILA; PROTEINS; EPSINR; CELLS; DIFFERENTIATION; PROLIFERATION	Epithelial organs develop through tightly coordinated events of cell proliferation and differentiation in which endocytosis plays a major role. Despite recent advances, how endocytosis regulates the development of vertebrate organs is still unknown. Here we describe a mechanism that facilitates the apical availability of endosomal SNARE receptors for epithelial morphogenesis through the developmental upregulation of plasmolipin (pllp) in a highly endocytic segment of the zebrafish posterior midgut. The protein PLLP (Pllp in fish) recruits the clathrin adaptor EpsinR to sort the SNARE machinery of the endolysosomal pathway into the subapical compartment, which is a switch for polarized endocytosis. Furthermore, PLLP expression induces apical Crumbs internalization and the activation of the Notch signalling pathway, both crucial steps in the acquisition of cell polarity and differentiation of epithelial cells. We thus postulate that differential apical endosomal SNARE sorting is a mechanism that regulates epithelial patterning.	[Rodriguez-Fraticelli, Alejo E.; Bosch-Fortea, Minerva; Martin-Belmonte, Fernando] CSIC, UAM, Ctr Biol Mol Severo Ochoa, Dept Dev & Differentiat, E-28049 Madrid, Spain; [Bagwell, Jennifer; Bagnat, Michel] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Boncompain, Gaelle; Perez, Franck] Inst Curie, UMR144, Dept Subcellular Struct & Cellular Dynam, F-75005 Paris, France; [Reglero-Real, Natalia; Garcia-Leon, Maria J.; Toribio, Maria L.; Alonso, Miguel A.; Millan, Jaime] CSIC, UAM, Ctr Biol Mol Severo Ochoa, Dept Immunol & Cell Biol, E-28049 Madrid, Spain; [Andres, German] CSIC, Ctr Biol Mol Severo Ochoa, Electron Microscopy Core, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Bagnat, M (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	m.bagnat@cellbio.duke.edu; fmartin@cbm.csic.es	Alonso, Miguel A/J-3945-2016; Andres, German/E-2632-2016; Boncompain, Gaelle/AAX-8374-2021; Rodriguez-Fraticelli, Alejo/AAG-7462-2020; Perez, Franck/A-1558-2014; Martin-Belmonte, Fernando/J-8029-2014; Bosch-Fortea, Minerva/W-7118-2019; Reglero, Natalia/AAU-2845-2021; Toribio, Maria L/C-2039-2017	Alonso, Miguel A/0000-0002-7001-8826; Andres, German/0000-0003-0265-5409; Boncompain, Gaelle/0000-0003-4274-035X; Rodriguez-Fraticelli, Alejo/0000-0002-4017-8714; Perez, Franck/0000-0002-9129-9401; Bosch-Fortea, Minerva/0000-0003-2831-2818; Bagnat, Michel/0000-0002-3829-0168; Millan, Jaime/0000-0003-3107-147X; Martin-Belmonte, Fernando/0000-0002-2564-4430; Reglero Real, Natalia/0000-0002-3916-119X; Toribio, Maria L/0000-0002-8637-0373; Garcia-Leon, Maria Jesus/0000-0001-9790-808X	MINECO [BFU2011-22622]; CONSOLIDER [CSD2009-00016]; NIH [SAF2013-44857-R, 1DP2OD006486, AGL2013-48998-C2-2]; CSIC JAE PhD fellowship; Fundacion Obra Social 'La Caixa' PhD fellowship; Amarouto Program tor senior researchers from the Comunidad Autonoma de Madrid; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1108132] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006486] Funding Source: NIH RePORTER	MINECO(Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIC JAE PhD fellowship; Fundacion Obra Social 'La Caixa' PhD fellowship; Amarouto Program tor senior researchers from the Comunidad Autonoma de Madrid; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. M. Ruiz-barabo for her ecnninents on the manuscr p the Martin-Bel montc laboratory and Bagnat lahoratorics for helpful ii SC us n We thank A. Alvers (Duke Univer sity, North Carolina, USA) far helping in the isolation at gut cells, J. Cocchiaro and L. Mrajoram (Duke University, North Carolina, USA) foI help in gavaging experiments, B. Margolis (University of)slichigan, Michigan, USA for the Crb3/panCrb) antibody, R. Jahn (Max Planck Institute for Biophysical Chemistry, Germany) for Stx7 plasmids, M. Robinson (University at Cambridge, UK) for BpsR plasmids, and R. Kopan and J. L. de la IN (CMG, Spain) (Cl Notch plasmids and mib1<SUP>ta52b</SUP> embryos. We also thank M. Guerra at the EM Unit tor skillful technical assistance. This work was supported by grunts from the MINECO (BFU2011-22622) and CONSOLIDER (CSD2009-00016) to F.M-R, by grant SAF2013-44857-R to M.L.T by NIH innovator grant 1DP2OD006486 to and by grant AGL2013-48998-C2-2 R to GA. A.E.R-F was supported by a CSIC JAE PhD fellowship. M.R-F. is a recipient of a Fundacion Obra Social 'La Caixa' PhD fellowship. G.A. was supported by the Amarouto Program tor senior researchers from the Comunidad Autonoma de Madrid.	Alvers AL, 2014, DEVELOPMENT, V141, P1110, DOI 10.1242/dev.100313; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bokel C., 2014, COLD SPRING HARB PER, V6; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Bosse F, 2003, J NEUROCHEM, V86, P508, DOI 10.1046/j.1471-4159.2003.01870.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Cocchiaro JL, 2013, JOVE-J VIS EXP, DOI 10.3791/4434; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Eaton S., 2014, COLD SPRING HARB PER, V6; Fabrowski P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3244; Fre S, 2011, EXP CELL RES, V317, P2740, DOI 10.1016/j.yexcr.2011.06.012; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Harder JL, 2012, TRAFFIC, V13, P1170, DOI 10.1111/j.1600-0854.2012.01376.x; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Leventis PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025466; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Navis A, 2013, DEVELOPMENT, V140, P1703, DOI 10.1242/dev.091819; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Schier AF, 1996, DEVELOPMENT, V123, P165; Thompson BJ, 2013, NAT REV MOL CELL BIO, V14, P307, DOI 10.1038/nrm3568; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wibowo I, 2011, DEVELOPMENT, V138, P1143, DOI 10.1242/dev.060566; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011	42	47	47	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					241	+		10.1038/ncb3106	http://dx.doi.org/10.1038/ncb3106			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25706235	Green Accepted, Green Published			2022-12-25	WOS:000350770200009
J	Crane, JD; Palanivel, R; Mottillo, EP; Bujak, AL; Wang, HQ; Ford, RJ; Collins, A; Blumer, RM; Fullerton, MD; Yabut, JM; Kim, JJ; Ghia, JE; Hamza, SM; Morrison, KM; Schertzer, JD; Dyck, JRB; Khan, WI; Steinberg, GR				Crane, Justin D.; Palanivel, Rengasamy; Mottillo, Emilio P.; Bujak, Adam L.; Wang, Huaqing; Ford, Rebecca J.; Collins, Andrew; Bluemer, Regje M.; Fullerton, Morgan D.; Yabut, Julian M.; Kim, Janice J.; Ghia, Jean-Eric; Hamza, Shereen M.; Morrison, Katherine M.; Schertzer, Jonathan D.; Dyck, Jason R. B.; Khan, Waliul I.; Steinberg, Gregory R.			Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis	NATURE MEDICINE			English	Article							FAT; TRYPTOPHAN; MICE; ACTIVATION; EXPRESSION; ABLATION; UCP1; SEX	Mitochondrial uncoupling protein 1 (UCP1) is enriched within interscapular brown adipose tissue (iBAT) and beige (also known as brite) adipose tissue(1,2), but its thermogenic potential is reduced with obesity and type 2 diabetes(3-5) for reasons that are not understood. Serotonin (5-hydroxytryptamine, 5-HT) is a highly conserved biogenic amine that resides in non-neuronal and neuronal tissues that are specifically regulated via tryptophan hydroxylase 1 (Tph1) and Tph2, respectively(6-8). Recent findings suggest that increased peripheral serotonin(9) and polymorphisms in TPH1 are associated with obesity(10); however, whether this is directly related to reduced BAT thermogenesis and obesity is not known. We find that Tph1-deficient mice fed a high-fat diet (HFD) are protected from obesity, insulin resistance and nonalcoholic fatty liver disease (NAFLD) while exhibiting greater energy expenditure by BAT. Small-molecule chemical inhibition of Tph1 in HFD-fed mice mimics the benefits ascribed to Tph1 genetic deletion, effects that depend on UCP1-mediated thermogenesis. The inhibitory effects of serotonin on energy expenditure are cell autonomous, as serotonin blunts beta-adrenergic induction of the thermogenic program in brown and beige adipocytes in vitro. As obesity increases peripheral serotonin, the inhibition of serotonin signaling or its synthesis in adipose tissue may be an effective treatment for obesity and its comorbidities.	[Crane, Justin D.; Palanivel, Rengasamy; Mottillo, Emilio P.; Bujak, Adam L.; Ford, Rebecca J.; Collins, Andrew; Bluemer, Regje M.; Fullerton, Morgan D.; Yabut, Julian M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada; [Crane, Justin D.; Morrison, Katherine M.; Schertzer, Jonathan D.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Palanivel, Rengasamy; Wang, Huaqing; Kim, Janice J.; Ghia, Jean-Eric; Khan, Waliul I.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Palanivel, Rengasamy; Wang, Huaqing; Kim, Janice J.; Khan, Waliul I.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Hamza, Shereen M.; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Fac Med & Dent, Cardiovasc Res Ctr,Alberta Diabet Inst, Edmonton, AB, Canada; [Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University; McMaster University; University of Alberta; McMaster University	Khan, WI (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	khanwal@mcmaster.ca; gsteinberg@mcmaster.ca	RENGASAMY, PALANIVEL/GMW-4099-2022; Morrison, Katherine/AAO-8046-2021; Schertzer, Jonathan/P-3395-2017	Morrison, Katherine/0000-0002-1737-256X; Crane, Justin/0000-0002-5380-5676; Dyck, Jason/0000-0002-7045-2884; Schertzer, Jonathan/0000-0002-1547-5856; Steinberg, Gregory/0000-0001-5425-8275; Ghia, Jean-Eric/0000-0002-3018-9719; Kim, Janice/0000-0001-5096-4068	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR); Crohn's and Colitis Canada; Natural Sciences and Engineering Research Council of Canada; Faculty of Health Sciences at McMaster University	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculty of Health Sciences at McMaster University	These studies were supported by grants from the Canadian Diabetes Association (CDA) (J.R.B.D., G.R.S.) the Canadian Institutes of Health Research (CIHR) (J.R.B.D., W.I.K., G.R.S.), Crohn's and Colitis Canada (W.I.K.), the Natural Sciences and Engineering Research Council of Canada (G.R.S.) and the Faculty of Health Sciences at McMaster University to the MAC-Obesity Research Program (G.R.S., K.M.M.). E.P.M. is a CDA Postdoctoral Fellow, M.D.F. is a CIHR Banting Postdoctoral Fellow, A.C. was a Canadian Liver Foundation Summer Student, S.M.H. is a Heart & Stroke Foundation of Canada and Alberta Innovates Health Solutions Postdoctoral Fellow, J.D.S. is a CDA Scholar and W.I.K. is a CIHR New Investigator. G.R.S. is a Canada Research Chair in Metabolism and Obesity and the J. Bruce Duncan Chair in Metabolic Diseases.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Asghari R, 2011, NEUROSCIENCE, V199, P429, DOI 10.1016/j.neuroscience.2011.10.036; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bertrand RL, 2011, ENDOCRINOLOGY, V152, P36, DOI 10.1210/en.2010-0377; Breum L, 2003, AM J CLIN NUTR, V77, P1112, DOI 10.1093/ajcn/77.5.1112; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Khan WI, 2010, CLIN EXP IMMUNOL, V161, P19, DOI 10.1111/j.1365-2249.2010.04150.x; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kwak SH, 2012, OBESITY, V20, P233, DOI 10.1038/oby.2011.253; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; SERRA F, 1992, BRAIN RES, V578, P327, DOI 10.1016/0006-8993(92)90265-B; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stunes AK, 2011, DIABETES OBES METAB, V13, P551, DOI 10.1111/j.1463-1326.2011.01378.x; Sullo A, 2011, MLTJ-MUSCLE LIGAMENT, V1, P48; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098	40	291	300	6	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					166	172		10.1038/nm.3766	http://dx.doi.org/10.1038/nm.3766			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25485911	Green Accepted			2022-12-25	WOS:000348974800019
J	Gaali, S; Kirschner, A; Cuboni, S; Hartmann, J; Kozany, C; Balsevich, G; Namendorf, C; Fernandez-Vizarra, P; Sippel, C; Zannas, AS; Draenert, R; Binder, EB; Almeida, OFX; Ruhter, G; Uhr, M; Schmidt, MV; Touma, C; Bracher, A; Hausch, F				Gaali, Steffen; Kirschner, Alexander; Cuboni, Serena; Hartmann, Jakob; Kozany, Christian; Balsevich, Georgia; Namendorf, Christian; Fernandez-Vizarra, Paula; Sippel, Claudia; Zannas, Anthony S.; Draenert, Rika; Binder, Elisabeth B.; Almeida, Osborne F. X.; Ruehter, Gerd; Uhr, Manfred; Schmidt, Mathias V.; Touma, Chadi; Bracher, Andreas; Hausch, Felix			Selective inhibitors of the FK506-binding protein 51 by induced fit	NATURE CHEMICAL BIOLOGY			English	Article							TREATMENT RESPONSE; FKBP52; STRESS; IMMUNOPHILIN; COCHAPERONE; INVOLVEMENT; DEPRESSION; REACTIVITY; BEHAVIOR; LIGANDS	The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the structurally similar but functional opposing homolog FKBP52, and all known FKBP ligands are unselective. Here, we report the discovery of the potent and highly selective inhibitors of FKBP51, SAFit1 and SAFit2. This new class of ligands achieves selectivity for FKBP51 by an induced-fit mechanism that is much less favorable for FKBP52. By using these ligands, we demonstrate that selective inhibition of FKBP51 enhances neurite elongation in neuronal cultures and improves neuroendocrine feedback and stress-coping behavior in mice. Our findings provide the structural and functional basis for the development of mechanistically new antidepressants.	[Gaali, Steffen; Kirschner, Alexander; Cuboni, Serena; Kozany, Christian; Namendorf, Christian; Sippel, Claudia; Zannas, Anthony S.; Binder, Elisabeth B.; Uhr, Manfred; Hausch, Felix] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Hartmann, Jakob; Balsevich, Georgia; Fernandez-Vizarra, Paula; Almeida, Osborne F. X.; Schmidt, Mathias V.; Touma, Chadi] Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, D-80804 Munich, Germany; [Zannas, Anthony S.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Draenert, Rika] Hosp Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Binder, Elisabeth B.] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA USA; [Ruehter, Gerd] Lead Discovery Ctr GmbH, Dortmund, Germany; [Bracher, Andreas] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society; Duke University; University of Munich; Emory University; Lead Discovery Center GmbH (LDC); Max Planck Society	Hausch, F (corresponding author), Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany.	hausch@mpipsykl.mpg.de	Hartmann, Jakob/GPF-5919-2022; Touma, Chadi/G-4677-2011; Almeida, Osborne F.X. F/E-8402-2010; Fernandez-Vizarra, Paula/H-5588-2012	Hartmann, Jakob/0000-0002-1960-8177; Almeida, Osborne F.X. F/0000-0001-7331-6928; Fernandez-Vizarra, Paula/0000-0002-0322-6844; Balsevich, Georgia/0000-0002-7839-018X; Schmidt, Mathias/0000-0002-3788-2268	Bayrisches Staatsministerium fur Wirtschaft, Infrastruktur Verkehr und Technologie [M4]	Bayrisches Staatsministerium fur Wirtschaft, Infrastruktur Verkehr und Technologie	This work was supported by the M4 Award 2011 from the Bayrisches Staatsministerium fur Wirtschaft, Infrastruktur Verkehr und Technologie (to F.H.). We thank A. Vogel, S. Giusti, D. Refojo (Max Planck Institute of Psychiatry) and M. Baumann (Lead Discovery Center) for experimental advice and L. Tietze, T. Gerlach and B. Hoogeland for technical support. We are indebted to E. Weyher (Max Planck Institute of Biochemistry) and to C. Dubler (Ludwig-Maximilians-University Munich) for high-resolution MS and NMR measurements. We thank S. Ley for a sample of antascomycin B (University of Cambridge, UK); the Joint Structural Biology Group staff at the European Synchrotron Radiation Facility in Grenoble, France; the staff at beamline X10SA of the Swiss Synchrotron Light Source (SLS) in Villigen, Switzerland; and F. Holsboer for continuous support.	Albu S, 2014, J SLEEP RES, V23, P176, DOI 10.1111/jsr.12112; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Babine RE, 2005, EXPERT OPIN THER PAT, V15, P555, DOI 10.1517/13543776.15.5.555; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beurel E, 2013, BIOL PSYCHIAT, V73, P622, DOI 10.1016/j.biopsych.2012.09.021; Blackburn EA, 2011, CURR OPIN PHARMACOL, V11, P365, DOI 10.1016/j.coph.2011.04.007; Bracher A, 2013, J MOL BIOL, V425, P4134, DOI 10.1016/j.jmb.2013.07.041; Bracher A, 2011, ACTA CRYSTALLOGR D, V67, P549, DOI 10.1107/S0907444911013862; Brittain DEA, 2005, ANGEW CHEM INT EDIT, V44, P2732, DOI 10.1002/anie.200500174; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cioffi DL, 2011, CURR OPIN PHARMACOL, V11, P308, DOI 10.1016/j.coph.2011.03.013; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS DA, 1984, J AM CHEM SOC, V106, P1154, DOI 10.1021/ja00316a077; Evans P., 1997, SCALA JOINT CCP4 ESF, V33, P22; Fabian AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057508; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gaali S, 2011, CURR MED CHEM, V18, P5355, DOI 10.2174/092986711798194342; Gerard M, 2011, MOL NEUROBIOL, V44, P13, DOI 10.1007/s12035-011-8184-2; Gold BG, 1999, J PHARMACOL EXP THER, V289, P1202; Gopalakrishnan R, 2012, J MED CHEM, V55, P4123, DOI 10.1021/jm201747c; Gopalakrishnan R, 2012, J MED CHEM, V55, P4114, DOI 10.1021/jm201746x; Hartmann J, 2012, PSYCHONEUROENDOCRINO, V37, P2009, DOI 10.1016/j.psyneuen.2012.04.017; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Hausch F, 2013, CELL CYCLE, V12, P2366, DOI 10.4161/cc.25508; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kozany C, 2009, CHEMBIOCHEM, V10, P1402, DOI 10.1002/cbic.200800806; Marz AM, 2013, MOL CELL BIOL, V33, P1357, DOI 10.1128/MCB.00678-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers AG, 1997, J AM CHEM SOC, V119, P6496, DOI 10.1021/ja970402f; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Price RD, 2005, EUR J PHARMACOL, V509, P11, DOI 10.1016/j.ejphar.2004.12.023; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Revill WP, 2002, J PHARMACOL EXP THER, V302, P1278, DOI 10.1124/jpet.102.034264; Sanchez ER, 2012, BBA-MOL CELL RES, V1823, P722, DOI 10.1016/j.bbamcr.2011.11.006; Schmidt MV, 2012, CHEMMEDCHEM, V7, P1351, DOI 10.1002/cmdc.201200137; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Sugimoto Y, 2011, EUR J PHARMACOL, V672, P121, DOI 10.1016/j.ejphar.2011.10.002; Touma C, 2011, PHARMACOPSYCHIATRY, V44, pS15, DOI 10.1055/s-0031-1271702; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wang YS, 2013, J MED CHEM, V56, P3922, DOI 10.1021/jm400087k; Weiwad M, 2006, BIOCHEMISTRY-US, V45, P15776, DOI 10.1021/bi061616p; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zou YF, 2010, NEUROSCI LETT, V484, P56, DOI 10.1016/j.neulet.2010.08.019	57	133	135	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2015	11	1					33	+		10.1038/nchembio.1699	http://dx.doi.org/10.1038/nchembio.1699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW7MR	25436518				2022-12-25	WOS:000346448600009
J	Gu, L; Frommel, SC; Oakes, CC; Simon, R; Grupp, K; Gerig, CY; Bar, D; Robinson, MD; Baer, C; Weiss, M; Gu, ZG; Schapira, M; Kuner, R; Sultmann, H; Provenzano, M; Yaspo, ML; Brors, B; Korbel, J; Schlomm, T; Sauter, G; Eils, R; Plass, C; Santoro, R				Gu, Lei; Frommel, Sandra C.; Oakes, Christopher C.; Simon, Ronald; Grupp, Katharina; Gerig, Cristina Y.; Baer, Dominik; Robinson, Mark D.; Baer, Constance; Weiss, Melanie; Gu, Zuguang; Schapira, Matthieu; Kuner, Ruprecht; Sueltmann, Holger; Provenzano, Maurizio; Yaspo, Marie-Laure; Brors, Benedikt; Korbel, Jan; Schlomm, Thorsten; Sauter, Guido; Eils, Roland; Plass, Christoph; Santoro, Raffaella		ICGC Project Early Onset Prostate	BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence	NATURE GENETICS			English	Article							RNA-POLYMERASE-I; GROUP PROTEIN EZH2; ANDROGEN RECEPTOR; HETEROCHROMATIN FORMATION; DNA METHYLATION; POLYCOMB; EXPRESSION; PROLIFERATION; CHROMATIN; COMPLEX	Prostate cancer is driven by a combination of genetic and/or epigenetic alterations. Epigenetic alterations are frequently observed in all human cancers, yet how aberrant epigenetic signatures are established is poorly understood. Here we show that the gene encoding BAZ2A (TIP5), a factor previously implicated in epigenetic rRNA gene silencing, is overexpressed in prostate cancer and is paradoxically involved in maintaining prostate cancer cell growth, a feature specific to cancer cells. BAZ2A regulates numerous protein-coding genes and directly interacts with EZH2 to maintain epigenetic silencing at genes repressed in metastasis. BAZ2A overexpression is tightly associated with a molecular subtype displaying a CpG island methylator phenotype (CIMP). Finally, high BAZ2A levels serve as an independent predictor of biochemical recurrence in a cohort of 7,682 individuals with prostate cancer. This work identifies a new aberrant role for the epigenetic regulator BAZ2A, which can also serve as a useful marker for metastatic potential in prostate cancer.	[Gu, Lei; Gu, Zuguang; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Gu, Lei; Oakes, Christopher C.; Baer, Constance; Weiss, Melanie; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Frommel, Sandra C.; Gerig, Cristina Y.; Baer, Dominik; Santoro, Raffaella] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland; [Frommel, Sandra C.] Univ Zurich, Life Sci Zurich Grad Sch, Mol Life Sci Program, Zurich, Switzerland; [Simon, Ronald; Grupp, Katharina; Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Robinson, Mark D.] Univ Zurich, SIB, Zurich, Switzerland; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Kuner, Ruprecht; Sueltmann, Holger] German Canc Res Ctr, Unit Canc Genome Res, Heidelberg, Germany; [Kuner, Ruprecht; Sueltmann, Holger] Natl Ctr Tumour Dis, Heidelberg, Germany; [Provenzano, Maurizio] Univ Zurich Hosp, Div Urol, Oncol Res Unit, CH-8091 Zurich, Switzerland; [Yaspo, Marie-Laure] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Korbel, Jan] EMBL, Genome Biol Unit, Heidelberg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol IPMB & BioQuant, Dept Bioinformat & Funct Genom, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University of Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Santoro, R (corresponding author), Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland.	g.sauter@uke.de; r.eils@dkfz-heidelberg.de; c.plass@dkfz-heidelberg.de; raffaella.santoro@vetbio.uzh.ch	Eils, Roland/B-6121-2009; Gu, Zuguang/C-5914-2009; Brors, Benedikt/E-5620-2013; Santoro, Raffaella/L-2637-2013; Robinson, Mark D./O-2254-2019; Gu, Lei/GWQ-6785-2022; Oakes, Christopher C/H-7288-2014; Sultmann, Holger/E-4534-2013	Eils, Roland/0000-0002-0034-4036; Brors, Benedikt/0000-0001-5940-3101; Robinson, Mark D./0000-0002-3048-5518; Oakes, Christopher C/0000-0001-8000-9694; Schlomm, Thorsten/0000-0001-9557-4653; Sultmann, Holger/0000-0002-5257-8600; Gu, Zuguang/0000-0002-7395-8709	German Federal Ministry of Education and Science in the Program for Medical Genome Research [01KU1001A, 01KU1001B, 01KU1001C, 01KU1001D, 01GS0890]; Krebsforschung Schweiz (KFS) [02732-02-2011]; Swiss National Science Foundation (SNF) [310003A-135801, 31003A-152854]; Swiss Life; Muller Molecular Life Science fellowship; Maxi Stiftung	German Federal Ministry of Education and Science in the Program for Medical Genome Research; Krebsforschung Schweiz (KFS); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Life; Muller Molecular Life Science fellowship; Maxi Stiftung	We acknowledge the entire team of the German ICGC Project on Early Onset Prostate Cancer. We thank M. Lupien, C. Schmidt, D. Wuttig, O. Bogatyrova, A. Postepska-Igielska and N. Schmitt for assistance with experiments and data. This project was supported by the German Federal Ministry of Education and Science in the Program for Medical Genome Research including the EOPC project within ICGC (FKZ; 01KU1001A, 01KU1001B, 01KU1001C, 01KU1001D and 01GS0890), by Krebsforschung Schweiz (KFS; 02732-02-2011), by the Swiss National Science Foundation (SNF; 310003A-135801 and 31003A-152854), by Swiss Life, by a Muller Molecular Life Science fellowship and by Maxi Stiftung. We acknowledge assistance provided by the Genomics and Proteomics Core Facility at the German Cancer Research Center. In particular, we acknowledge the excellent technical support of M. Schick.	Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cheng XF, 2008, TOHOKU J EXP MED, V216, P35, DOI 10.1620/tjem.216.35; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Doherty RE, 2011, BIOCHEM BIOPH RES CO, V414, P801, DOI 10.1016/j.bbrc.2011.10.010; Dong YJ, 2012, GASTROENTEROLOGY, V142, pS185; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grupp K, 2013, MODERN PATHOL, V26, P733, DOI 10.1038/modpathol.2012.206; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Hinz S, 2008, J CANCER RES CLIN, V134, P331, DOI 10.1007/s00432-007-0288-8; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Kashat M, 2012, AM J TRANSL RES, V4, P432; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kron K, 2013, CLIN CANCER RES, V19, P3450, DOI 10.1158/1078-0432.CCR-12-3139; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Mirlacher M, 2010, METHODS MOL BIOL, V664, P37, DOI 10.1007/978-1-60761-806-5_4; Mori Y, 2011, ENDOCR-RELAT CANCER, V18, P465, DOI 10.1530/ERC-11-0083; Muller J, 2013, INT J CANCER, V132, P1333, DOI 10.1002/ijc.27768; Nguyen AHT, 2013, HUM MOL GENET, V22, P2400, DOI 10.1093/hmg/ddt088; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2014, METHODS MOL BIOL, V1094, P319, DOI 10.1007/978-1-62703-706-8_25; Santoro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006653; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Sheng X, 2013, ONCOL LETT, V5, P787, DOI 10.3892/ol.2012.1090; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Uchida Y, 2013, UROL ONCOL-SEMIN ORI, V31, P115, DOI 10.1016/j.urolonc.2010.09.017; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang N, 2012, ANAT REC, V295, P748, DOI 10.1002/ar.22441; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang JS, 2007, ONCOGENE, V26, P111, DOI 10.1038/sj.onc.1209769; Zhang KX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-319; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	69	102	104	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					22	+		10.1038/ng.3165	http://dx.doi.org/10.1038/ng.3165			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25485837	Green Published			2022-12-25	WOS:000346990400007
J	Madsen, CD; Hooper, S; Tozluoglu, M; Bruckbauer, A; Fletcher, G; Erler, JT; Bates, PA; Thompson, B; Sahai, E				Madsen, Chris D.; Hooper, Steven; Tozluoglu, Melda; Bruckbauer, Andreas; Fletcher, Georgina; Erler, Janine T.; Bates, Paul A.; Thompson, Barry; Sahai, Erik			STRIPAK components determine mode of cancer cell migration and metastasis	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; MYOSIN PHOSPHATASE; MICROARRAY DATA; ACTIVATION; INVASION; SUBUNIT; COMPLEX; KINASE; FAMILY; PP2A	The contractile actomyosin cytoskeleton and its connection to the plasma membrane are critical for control of cell shape and migration. We identify three STRIPAK complex components, FAM40A, FAM40B and STRN3, as regulators of the actomyosin cortex. We show that FAM40A negatively regulates the MST3 and MST4 kinases, which promote the co-localization of the contractile actomyosin machinery with the Ezrin/Radixin/Moesin family proteins by phosphorylating the inhibitors of PPP1CB, PPP1R14A-D. Using computational modelling, in vitro cell migration assays and in vivo breast cancer metastasis assays we demonstrate that co-localization of contractile activity and actin-plasma membrane linkage reduces cell speed on planar surfaces, but favours migration in confined environments similar to those observed in vivo. We further show that FAM40B mutations found in human tumours uncouple it from PP2A and enable it to drive a contractile phenotype, which may underlie its role in human cancer.	[Madsen, Chris D.; Hooper, Steven; Sahai, Erik] Canc Res UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3LY, England; [Madsen, Chris D.; Erler, Janine T.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Tozluoglu, Melda; Bates, Paul A.] Canc Res UK London Res Inst, Biomol Modelling Lab, London WC2A 3LY, England; [Bruckbauer, Andreas] Canc Res UK London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Fletcher, Georgina; Thompson, Barry] Canc Res UK London Res Inst, Epithelial Biol Lab, London WC2A 3LY, England	Cancer Research UK; University of Copenhagen; Cancer Research UK; Cancer Research UK; Cancer Research UK	Sahai, E (corresponding author), Canc Res UK London Res Inst, Tumour Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	erik.sahai@cancer.org.uk		Sahai, Erik/0000-0002-3932-5086; Madsen, Chris D/0000-0001-6838-2103; Thompson, Barry/0000-0002-0103-040X; Erler, Janine/0000-0001-8675-6527; Bates, Paul/0000-0003-0621-0925	Cancer Research UK; FEBS; Cancer Research UK [15154, 10748] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish; The Francis Crick Institute [10144, 10180] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); FEBS; Cancer Research UK(Cancer Research UK); Novo Nordisk Fonden(Novo Nordisk Foundation); The Francis Crick Institute	C.D.M., S.H., M.T., A.B., G.F., P.A.B., B.T. and E.S. are financially supported by Cancer Research UK. C.D.M. was further supported by a FEBS long-term fellowship. We thank laboratory members for help and advice through out this work. We thank N. O' Reilly and S. Kjaer for help with peptide synthesis and protein purification, and members of the BRU for help with metastasis assays.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Basu S, 2011, CURR PROTEIN PEPT SC, V12, P3, DOI 10.2174/138920311795659443; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chen HW, 2002, MOL CELL BIOL, V22, P1792, DOI 10.1128/MCB.22.6.1792-1803.2002; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fidalgo M, 2012, J BIOL CHEM, V287, P11556, DOI 10.1074/jbc.M111.320259; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	63	112	116	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					68	+		10.1038/ncb3083	http://dx.doi.org/10.1038/ncb3083			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25531779	Green Accepted			2022-12-25	WOS:000346823900009
J	Borcherds, W; Theillet, FX; Katzer, A; Finzel, A; Mishall, KM; Powell, AT; Wu, HW; Manieri, W; Dieterich, C; Selenko, P; Loewer, A; Daughdrill, GW				Borcherds, Wade; Theillet, Francois-Xavier; Katzer, Andrea; Finzel, Ana; Mishall, Katie M.; Powell, Anne T.; Wu, Hongwei; Manieri, Wanda; Dieterich, Christoph; Selenko, Philipp; Loewer, Alexander; Daughdrill, Gary W.			Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells	NATURE CHEMICAL BIOLOGY			English	Article							TUMOR-SUPPRESSOR P53; TRANSACTIVATION DOMAIN; ACTIVATION; DYNAMICS; PROTEIN; MDM2; EXPRESSION; LANDSCAPE; SYSTEM; PULSES	Levels of residual structure in disordered interaction domains determine in vitro binding affinities, but whether they exert similar roles in cells is not known. Here, we show that increasing residual p53 helicity results in stronger Mdm2 binding, altered p53 dynamics, impaired target gene expression and failure to induce cell cycle arrest upon DNA damage. These results establish that residual structure is an important determinant of signaling fidelity in cells.	[Borcherds, Wade; Mishall, Katie M.; Powell, Anne T.; Wu, Hongwei; Daughdrill, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Borcherds, Wade; Mishall, Katie M.; Powell, Anne T.; Wu, Hongwei; Daughdrill, Gary W.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA; [Theillet, Francois-Xavier; Selenko, Philipp] Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Berlin, Germany; [Katzer, Andrea; Finzel, Ana; Loewer, Alexander] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Berlin, Germany; [Manieri, Wanda] Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, Tampa, FL 33682 USA; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Cologne, Germany	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Max Planck Society	Selenko, P (corresponding author), Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Berlin, Germany.	selenko@fmp-berlin.de; alexander.loewer@mdc-berlin.de; gdaughdrill@usf.edu	Theillet, François-Xavier/AAZ-9137-2021; Dieterich, Christoph/ABF-8459-2021; Loewer, Alexander/AAL-6943-2021	Theillet, François-Xavier/0000-0002-3264-210X; Loewer, Alexander/0000-0002-8819-3040	Deutsche Forschungsgemeinschaft [PS1794/1-1]; Association pour la Recherche contre le Cancer; European Union FP7; American Cancer Society [RSG-07-289-01-GMC]; National Science Foundation [MCB-0939014]; Center for Drug Discovery and Innovation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); European Union FP7(European Commission); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Center for Drug Discovery and Innovation	We thank P. Schmieder and M. Beerbaum for excellent NMR infrastructure maintenance (FMP Berlin) and W. Chen for Illumina sequencing (Max Delbrueck Center). This research was supported by the Deutsche Forschungsgemeinschaft (Emmy Noether grant PS1794/1-1 to P.S.), the Association pour la Recherche contre le Cancer (postdoctoral fellowship to F.-X.T.), the European Union FP7 (Marie Curie CIG to A.L.), the American Cancer Society (RSG-07-289-01-GMC to G.W.D.) and the National Science Foundation (MCB-0939014 to G.W.D.). Protein NMR resources at the University of South Florida were provided by the Center for Drug Discovery and Innovation.	Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Mittal J, 2013, J PHYS CHEM B, V117, P118, DOI 10.1021/jp308984e; MIYASHITA T, 1995, CELL, V80, P293; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Theillet FX, 2013, NAT PROTOC, V8, P1416, DOI 10.1038/nprot.2013.083; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	31	120	121	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2014	10	12					1000	+		10.1038/nchembio.1668	http://dx.doi.org/10.1038/nchembio.1668			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AT7MT	25362358	Green Accepted			2022-12-25	WOS:000345122300005
J	Mishra, D; Rivera, PM; Lin, A; Del Vecchio, D; Weiss, R				Mishra, Deepak; Rivera, Phillip M.; Lin, Allen; Del Vecchio, Domitilla; Weiss, Ron			A load driver device for engineering modularity in biological networks	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ESCHERICHIA-COLI; COVALENT MODIFICATION; SIGNALING PATHWAYS; SYNTHETIC BIOLOGY; TOGGLE SWITCH; CELL BIOLOGY; YEAST; SYSTEMS	The behavior of gene modules in complex synthetic circuits is often unpredictable(1-4). After joining modules to create a circuit, downstream elements (such as binding sites for a regulatory protein) apply a load to upstream modules that can negatively affect circuit function(1,5). Here we devised a genetic device named a load driver that mitigates the impact of load on circuit function, and we demonstrate its behavior in Saccharomyces cerevisiae. The load driver implements the design principle of timescale separation: inclusion of the load driver's fast phosphotransfer processes restores the capability of a slower transcriptional circuit to respond to time-varying input signals even in the presence of substantial load. Without the load driver, we observed circuit behavior that suffered from a 76% delay in response time and a 25% decrease in system bandwidth due to load. With the addition of a load driver, circuit performance was almost completely restored. Load drivers will serve as fundamental building blocks in the creation of complex, higher-level genetic circuits.	[Mishra, Deepak; Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mishra, Deepak; Rivera, Phillip M.; Lin, Allen; Del Vecchio, Domitilla; Weiss, Ron] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Rivera, Phillip M.; Del Vecchio, Domitilla] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lin, Allen; Weiss, Ron] MIT, Dept Elect Engn Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weiss, R (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ddv@mit.edu; rweiss@mit.edu			Eni-MIT Energy Research Fellowship; National Science Foundation (NSF) [DGE-1122374]; NSF [CCF-1058127]; NSF SynBERC [SA5284-11210]; USAFOSR [FA9550-12-1-0129]; USARO ICB [W911NF-09-D-0001]; US National Institutes of Health [P50 GM098792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330914] Funding Source: National Science Foundation; Direct For Computer & Info Scie & Enginr [0964646] Funding Source: National Science Foundation	Eni-MIT Energy Research Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF SynBERC(National Science Foundation (NSF)); USAFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); USARO ICB; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank members of the labs of R. W. and D. D. V. for discussions, M.-T. Chen (Department of Electrical Engineering, Princeton University) for plasmids containing both STAT5-HKRR and JAK2, and the Synthetic Biology Center at Massachusetts Institute of Technology's cytometry facility. D.M. was supported by the Eni-MIT Energy Research Fellowship, and both D.M. and P.M.R. were supported by the National Science Foundation (NSF) Graduate Research Fellowship Plan under grant DGE-1122374. This research was supported by the NSF (CCF-1058127), NSF SynBERC (SA5284-11210), USAFOSR (FA9550-12-1-0129), USARO ICB (W911NF-09-D-0001) and the US National Institutes of Health (P50 GM098792).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alon U., 2013, INTRO SYSTEMS BIOL D; Ansaldi M, 2001, J BACTERIOL, V183, P2691, DOI 10.1128/JB.183.8.2691-2695.2001; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bashor CJ, 2012, NAT BIOTECHNOL, V30, P1061, DOI 10.1038/nbt.2411; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Del Vecchio D., 2014, BIOMOLECULAR FEEDBAC; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Franklin G.F., 2010, FEEDBACK CONTROL DYN, V6th ed.; FUTCHER AB, 1984, J BACTERIOL, V157, P283, DOI 10.1128/JB.157.1.283-290.1984; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Gyorgy A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003486; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jayanthi S, 2013, ACS SYNTH BIOL, V2, P431, DOI 10.1021/sb300098w; Jayanthi S, 2011, IEEE T AUTOMAT CONTR, V56, P748, DOI 10.1109/TAC.2010.2069631; Jiang P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002152; Kim Y, 2011, DEV CELL, V20, P880, DOI 10.1016/j.devcel.2011.05.009; Kim Y, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.121; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Millman J., 1987, MICROELECTRONICS; Nilgiriwala K. S., 2014, ACS SYNTH BIOL, DOI [10.1021/sb5002533, DOI 10.1021/SB5002533]; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x	54	98	104	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1268	U141		10.1038/nbt.3044	http://dx.doi.org/10.1038/nbt.3044			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419739	Green Accepted, Green Submitted			2022-12-25	WOS:000346156800030
J	Wu, H; Wu, XJ; Shen, L; Zhang, Y				Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi			Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ANALYSIS; CELL SELF-RENEWAL; TET PROTEINS; 5-METHYLCYTOSINE OXIDATION; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; 5-CARBOXYLCYTOSINE; REVEALS; SEQ; PLURIPOTENT	Active DNA demethylation in mammals involves TET-mediated iterative oxidation of 5-methylcytosine (5mC)/5-hydroxymethylcytosine (5hmC) and subsequent excision repair of highly oxidized cytosine bases 5-formylcytosine (5fC)/5-carboxylcytosine (5caC) by thymine DNA glycosylase (TDG). However, quantitative and high-resolution analysis of active DNA demethylation activity remains challenging. Here, we describe M. SssI methylase-assisted bisulfite sequencing (MAB-seq), a method that directly maps 5fC/5caC at single-base resolution. Genome-wide MAB-seq allows systematic identification of 5fC/5caC in Tdg-depleted embryonic stem cells, thereby generating a base-resolution map of active DNA demethylome. A comparison of 5fC/5caC and 5hmC distribution maps indicates that catalytic processivity of TET enzymes correlates with local chromatin accessibility. MAB-seq also reveals strong strand asymmetry of active demethylation within palindromic CpGs. Integrating MAB-seq with other base-resolution mapping methods enables quantitative measurement of cytosine modification states at key transitioning steps of the active DNA demethylation cascade and reveals a regulatory role of 5fC/5caC excision repair in this step-wise process.	[Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Howard Hughes Med Inst, Boston, MA 02115 USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Harvard Stem Cell Inst, Boston, MA USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	haowu7@gmail.com; yzhang@genetics.med.harvard.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354; Wu, Hao/0000-0003-4395-6929	National Institutes of Health [U01DK089565]; Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute [K99HG007982]; China Scholarship Council; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG007982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); China Scholarship Council(China Scholarship Council); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Yamaguchi and F. Lu for generating and characterizing Tet mutant mouse ESCs. We also thank L.M. Tuesta and S. Yamaguchi for critical reading of the manuscript. This project is supported by National Institutes of Health grant U01DK089565. H.W. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research and is currently supported by the National Human Genome Research Institute (K99HG007982). X.W. was supported by the China Scholarship Council. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booth MJ, 2014, NAT CHEM, V6, P435, DOI [10.1038/NCHEM.1893, 10.1038/nchem.1893]; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Lu XY, 2013, J AM CHEM SOC, V135, P9315, DOI 10.1021/ja4044856; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	47	96	102	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1231	U92		10.1038/nbt.3073	http://dx.doi.org/10.1038/nbt.3073			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25362244	Green Submitted, Green Accepted			2022-12-25	WOS:000346156800025
J	Wang, C; Gong, BS; Bushel, PR; Thierry-Mieg, J; Thierry-Mieg, D; Xu, JS; Fang, H; Hong, HX; Shen, J; Su, ZQ; Meehan, J; Li, XJ; Yang, L; Li, HQ; Labaj, PP; Kreil, DP; Megherbi, D; Gaj, S; Caiment, F; van Delft, J; Kleinjans, J; Scherer, A; Devanarayan, V; Wang, J; Yang, Y; Qian, HR; Lancashire, LJ; Bessarabova, M; Nikolsky, Y; Furlanello, C; Chierici, M; Albanese, D; Jurman, G; Riccadonna, S; Filosi, M; Visintainer, R; Zhang, KK; Li, JY; Hsieh, JH; Svoboda, DL; Fuscoe, JC; Deng, YD; Shi, LM; Paules, RS; Auerbach, SS; Tong, WD				Wang, Charles; Gong, Binsheng; Bushel, Pierre R.; Thierry-Mieg, Jean; Thierry-Mieg, Danielle; Xu, Joshua; Fang, Hong; Hong, Huixiao; Shen, Jie; Su, Zhenqiang; Meehan, Joe; Li, Xiaojin; Yang, Lu; Li, Haiqing; Labaj, Pawel P.; Kreil, David P.; Megherbi, Dalila; Gaj, Stan; Caiment, Florian; van Delft, Joost; Kleinjans, Jos; Scherer, Andreas; Devanarayan, Viswanath; Wang, Jian; Yang, Yong; Qian, Hui-Rong; Lancashire, Lee J.; Bessarabova, Marina; Nikolsky, Yuri; Furlanello, Cesare; Chierici, Marco; Albanese, Davide; Jurman, Giuseppe; Riccadonna, Samantha; Filosi, Michele; Visintainer, Roberto; Zhang, Ke K.; Li, Jainying; Hsieh, Jui-Hua; Svoboda, Daniel L.; Fuscoe, James C.; Deng, Youping; Shi, Leming; Paules, Richard S.; Auerbach, Scott S.; Tong, Weida			The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; REPRODUCIBILITY; CONSISTENCY; ARRAYS	The concordance of RNA-sequencing (RNA-seq) with microarrays for genome-wide analysis of differential gene expression has not been rigorously assessed using a range of chemical treatment conditions. Here we use a comprehensive study design to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples of rats exposed in triplicate to varying degrees of perturbation by 27 chemicals representing multiple modes of action (MOAs). The cross-platform concordance in terms of differentially expressed genes (DEGs) or enriched pathways is linearly correlated with treatment effect size (R-2 approximate to 0.8). Furthermore, the concordance is also affected by transcript abundance and biological complexity of the MOA. RNA-seq outperforms microarray (93% versus 75%) in DEG verification as assessed by quantitative PCR, with the gain mainly due to its improved accuracy for low-abundance transcripts. Nonetheless, classifiers to predict MOAs perform similarly when developed using data from either platform. Therefore, the endpoint studied and its biological complexity, transcript abundance and the genomic application are important factors in transcriptomic research and for clinical and regulatory decision making.	[Wang, Charles] Loma Linda Univ, Sch Med, Ctr Genom, Loma Linda, CA USA; [Wang, Charles] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA USA; [Gong, Binsheng; Xu, Joshua; Hong, Huixiao; Shen, Jie; Su, Zhenqiang; Meehan, Joe; Shi, Leming; Tong, Weida] US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Bushel, Pierre R.; Li, Jainying] NIEHS, Microarray & Genome Informat Grp, Res Triangle Pk, NC 27709 USA; [Bushel, Pierre R.] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Thierry-Mieg, Jean; Thierry-Mieg, Danielle] Natl Lib Med, Nat Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Fang, Hong] US FDA, Off Sci Coordinat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Li, Xiaojin; Yang, Lu; Li, Haiqing] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Funct Genom Core, Duarte, CA USA; [Labaj, Pawel P.; Kreil, David P.] Boku Univ Vienna, Chair Bioinformat Res Grp, Vienna, Austria; [Kreil, David P.] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Megherbi, Dalila] Univ Massachusetts, Dept Elect & Comp Engn, Francis Coll Engn, CMINDS Res Ctr, Lowell, MA USA; [Gaj, Stan; Caiment, Florian; van Delft, Joost; Kleinjans, Jos] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands; [Scherer, Andreas] Australian Genome Res Facil Ltd, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Devanarayan, Viswanath] AbbVie Inc, N Chicago, IL USA; [Wang, Jian; Yang, Yong; Qian, Hui-Rong] Eli Lilly & Co, Lilly Corp Ctr, Res Informat & Stat, Indianapolis, IN 46285 USA; [Lancashire, Lee J.; Bessarabova, Marina] Thomson Reuters, IP & Sci, Carlsbad, CA USA; [Nikolsky, Yuri] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Furlanello, Cesare; Chierici, Marco; Albanese, Davide; Jurman, Giuseppe; Riccadonna, Samantha; Filosi, Michele; Visintainer, Roberto] Fdn Bruno Kessler, Trento, Italy; [Albanese, Davide; Riccadonna, Samantha] Fdn Edmund Mach, Computat Biol Dept, Res & Innovat Ctr, San Michele All Adige, Italy; [Zhang, Ke K.] Univ N Dakota, Dept Pathol, Bioinformat CORE, Grand Forks, ND 58201 USA; [Li, Jainying] Kelly Govt Solut Inc, Durham, NC USA; [Hsieh, Jui-Hua; Auerbach, Scott S.] NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Svoboda, Daniel L.] SRA Int, Durham, NC USA; [Fuscoe, James C.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Deng, Youping] Rush Univ, Med Ctr, Dept Internal Med & Biochem, Chicago, IL 60612 USA; [Shi, Leming] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Pharm, Shanghai 200433, Peoples R China; [Paules, Richard S.] NIEHS, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA	Loma Linda University; Loma Linda University; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA); City of Hope; Beckman Research Institute of City of Hope; University of Natural Resources & Life Sciences, Vienna; University of Warwick; University of Massachusetts System; University of Massachusetts Lowell; Maastricht University; AbbVie; Eli Lilly; Clarivate; Russian Academy of Sciences; Vavilov Institute of General Genetics; Fondazione Bruno Kessler; Fondazione Edmund Mach; University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRA International; US Food & Drug Administration (FDA); Rush University; Fudan University; Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Tong, WD (corresponding author), US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	bushel@niehs.nih.gov; AuerbachS@niehs.nih.gov; weida.tong@fda.hhs.gov	Gong, Binsheng/E-2306-2015; Jurman, Giuseppe/GRS-8221-2022; Scherer, Andreas/ABD-8660-2020; Kleinjans, Jos C.S./E-7241-2015; Kreil, D/O-1783-2013; Riccadonna, Samantha/H-7247-2019; Albanese, Davide/AAA-7295-2021; caiment, florian/N-7623-2015; Łabaj, Paweł/N-5425-2014; THIERRY-MIEG, Jean/F-1975-2017; yang, lu/D-5099-2015; Shi, Leming/B-3150-2010; Chierici, Marco/P-9949-2019	Gong, Binsheng/0000-0002-8724-5435; Kreil, D/0000-0001-7538-2056; Riccadonna, Samantha/0000-0002-9737-8274; Albanese, Davide/0000-0002-9493-3850; THIERRY-MIEG, Jean/0000-0002-0396-6789; Shi, Leming/0000-0002-7143-2033; Chierici, Marco/0000-0001-9791-9301; Jurman, Giuseppe/0000-0002-2705-5728; Scherer, Andreas/0000-0002-4254-7122; Deng, Youping/0000-0002-5951-8213; Filosi, Michele/0000-0002-3872-347X; Thierry-Mieg, Danielle/0000-0001-9568-4211; Meehan, Joe/0000-0001-9602-3394; Lancashire, Lee/0000-0003-4835-4847; Hong, Huixiao/0000-0001-8087-3968; Labaj, Pawel/0000-0002-4994-0234; Caiment, Florian/0000-0002-3325-0466; Paules, Richard S/0000-0001-9106-7486; Visintainer, Roberto/0000-0003-1289-6871	National Institutes of Health (NIH); National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) [ES102345-04, ES023026]; National Library of Medicine; Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf; Austrian Centre of Biopharmaceutical Technology (ACBT); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf(Australian Research Council); Austrian Centre of Biopharmaceutical Technology (ACBT); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Arana and D. Mendrick for their critical review of the manuscript. This research was supported, in part, by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ES102345-04 and ES023026) and National Library of Medicine. P.P.L. and D.P.K. acknowledge support by the Vienna Scientific Cluster (VSC), the Vienna Science and Technology Fund (WWTF), Baxter AG, Austrian Research Centres (ARC) Seibersdorf and the Austrian Centre of Biopharmaceutical Technology (ACBT).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Fan X, 2010, PHARMACOGENOMICS J, V10, P247, DOI 10.1038/tpj.2010.34; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hamburg MA, 2011, SCIENCE, V331, P987, DOI 10.1126/science.1204432; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu J, 2013, GENE, V527, P616, DOI 10.1016/j.gene.2013.06.052; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S11; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Subramaniam S, 2012, NAT IMMUNOL, V13, P199, DOI 10.1038/ni.2244; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108	37	295	305	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					926	932		10.1038/nbt.3001	http://dx.doi.org/10.1038/nbt.3001			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150839	Green Accepted			2022-12-25	WOS:000342600300032
J	Li, JH; Jia, HJ; Cai, XH; Zhong, HZ; Feng, Q; Sunagawa, S; Arumugam, M; Kultima, JR; Prifti, E; Nielsen, T; Juncker, AS; Manichanh, C; Chen, B; Zhang, WW; Levenez, F; Wang, J; Xu, X; Xiao, L; Liang, SS; Zhang, DY; Zhang, ZX; Chen, WN; Zhao, HL; Al-Aama, JY; Edris, S; Yang, HM; Wang, J; Hansen, T; Nielsen, HB; Brunak, S; Kristiansen, K; Guarner, F; Pedersen, O; Dore, J; Ehrlich, SD; Bork, P; Wang, J				Li, Junhua; Jia, Huijue; Cai, Xianghang; Zhong, Huanzi; Feng, Qiang; Sunagawa, Shinichi; Arumugam, Manimozhiyan; Kultima, Jens Roat; Prifti, Edi; Nielsen, Trine; Juncker, Agnieszka Sierakowska; Manichanh, Chaysavanh; Chen, Bing; Zhang, Wenwei; Levenez, Florence; Wang, Juan; Xu, Xun; Xiao, Liang; Liang, Suisha; Zhang, Dongya; Zhang, Zhaoxi; Chen, Weineng; Zhao, Hailong; Al-Aama, Jumana Yousuf; Edris, Sherif; Yang, Huanming; Wang, Jian; Hansen, Torben; Nielsen, Henrik Bjorn; Brunak, Soren; Kristiansen, Karsten; Guarner, Francisco; Pedersen, Oluf; Dore, Joel; Ehrlich, S. Dusko; Bork, Peer; Wang, Jun		MetaHIT Consortium	An integrated catalog of reference genes in the human gut microbiome	NATURE BIOTECHNOLOGY			English	Article							EUKARYOTIC DIVERSITY; FECAL MICROBIOTA; POPULATION-SIZE; METAGENOME; GENOMES; IMPACT; SETS	Many analyses of the human gut microbiome depend on a catalog of reference genes. Existing catalogs for the human gut microbiome are based on samples from single cohorts or on reference genomes or protein sequences, which limits coverage of global microbiome diversity. Here we combined 249 newly sequenced samples of the Metagenomics of the Human Intestinal Tract (MetaHit) project with 1,018 previously sequenced samples to create a cohort from three continents that is at least threefold larger than cohorts used for previous gene catalogs. From this we established the integrated gene catalog (IGC) comprising 9,879,896 genes. The catalog includes close-to-complete sets of genes for most gut microbes, which are also of considerably higher quality than in previous catalogs. Analyses of a group of samples from Chinese and Danish individuals using the catalog revealed country-specific gut microbial signatures. This expanded catalog should facilitate quantitative characterization of metagenomic, metatranscriptomic and metaproteomic data from the gut microbiome to understand its variation across populations in human health and disease.	[Li, Junhua; Jia, Huijue; Cai, Xianghang; Zhong, Huanzi; Feng, Qiang; Arumugam, Manimozhiyan; Chen, Bing; Zhang, Wenwei; Wang, Juan; Xu, Xun; Xiao, Liang; Liang, Suisha; Zhang, Dongya; Zhang, Zhaoxi; Chen, Weineng; Zhao, Hailong; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Junhua] BGI Hong Kong Res Inst, Hong Kong, Hong Kong, Peoples R China; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Feng, Qiang; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Sunagawa, Shinichi; Arumugam, Manimozhiyan; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Arumugam, Manimozhiyan; Nielsen, Trine; Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Prifti, Edi; Levenez, Florence; Dore, Joel; Ehrlich, S. Dusko] INRA, Metagenopolis, Jouy En Josas, France; [Juncker, Agnieszka Sierakowska; Nielsen, Henrik Bjorn; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Manichanh, Chaysavanh] Univ Hosp Vall dHebron, Digest Syst Res Unit, Barcelona, Spain; [Al-Aama, Jumana Yousuf] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21413, Saudi Arabia; [Al-Aama, Jumana Yousuf; Edris, Sherif; Yang, Huanming; Wang, Jun] KAU, Fac Med, Princess Al Jawhara AlBrahim Ctr Excellence Res H, Jeddah, Saudi Arabia; [Edris, Sherif] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Dore, Joel] INRA, Unite Mixte Rech 14121, Microbiol Alimentat Serv Sante, Jouy En Josas, France; [Ehrlich, S. Dusko] Kings Coll London, Guys Hosp, Inst Dent, Cent Off,Ctr Host Microbiome Interact, London, England; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wang, Jun] Macau Univ Sci & Technol, Macau, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); South China University of Technology; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation; University of Copenhagen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Denmark; Hospital Universitari Vall d'Hebron; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Macau University of Science & Technology	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	bork@embl.de; wangj@genomics.org.cn	Kristiansen, Karsten/J-5148-2014; Knol, Jan/A-2178-2010; Rescigno, Maria/J-9704-2012; Pedersen, Oluf/AAG-8015-2020; GUEDON, Eric/N-8624-2019; Prifti, Edi/F-3967-2019; Nielsen, Henrik/B-8961-2019; Veiga, Patrick/A-9862-2011; Ho, Igor Osorio/AAG-8616-2020; Guedon, Eric/S-5635-2016; Arumugam, Manimozhiyan/E-1211-2011; Guarner, Francisco/ABF-1192-2020; Li, Junhua/AAG-3919-2019; Jia, Huijue/M-3991-2015; Xu, Xun/AAI-6763-2020; Pedersen, Oluf/Z-1731-2019; Bork, Peer/F-1813-2013; Ehrlich, S./Y-2423-2019; Dore, Joel/ABA-8921-2020; Sunagawa, Shinichi/Q-5950-2019; van Hylckama Vlieg, Johan/F-7887-2014; Edris, Sherif/I-8070-2012; Knol, Jan/AAL-6487-2020; Edris, Sherif/GXZ-9995-2022; Tap, Julien/E-5760-2010; BLOTTIERE, Hervé M/C-6120-2011; Borruel, Natalia/AFO-6891-2022; Arumugam, Manimozhiyan/AAJ-2394-2020; Al-aama, Jumana/AAA-8653-2021; Xiao, Liang/L-5614-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Brunak, Soren/O-6621-2016	Kristiansen, Karsten/0000-0002-6024-0917; Knol, Jan/0000-0002-2103-5961; Rescigno, Maria/0000-0002-6464-509X; GUEDON, Eric/0000-0002-0901-4447; Prifti, Edi/0000-0001-8861-1305; Nielsen, Henrik/0000-0003-2281-5713; Veiga, Patrick/0000-0001-6318-8547; Guedon, Eric/0000-0002-0901-4447; Arumugam, Manimozhiyan/0000-0002-0886-9101; Guarner, Francisco/0000-0002-4051-0836; Li, Junhua/0000-0001-6784-1873; Jia, Huijue/0000-0002-3592-126X; Xu, Xun/0000-0002-5338-5173; Pedersen, Oluf/0000-0002-3321-3972; Bork, Peer/0000-0002-2627-833X; Ehrlich, S./0000-0002-7563-4046; Sunagawa, Shinichi/0000-0003-3065-0314; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Edris, Sherif/0000-0002-2810-3736; Knol, Jan/0000-0002-2103-5961; Edris, Sherif/0000-0002-2810-3736; Tap, Julien/0000-0001-8998-5413; BLOTTIERE, Hervé M/0000-0002-8390-0607; Borruel, Natalia/0000-0002-4449-2292; Arumugam, Manimozhiyan/0000-0002-0886-9101; Xiao, Liang/0000-0003-0836-4397; Kennedy, Sean/0000-0002-3932-8922; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Pelletier, Eric/0000-0003-4228-1712; Brunak, Soren/0000-0003-0316-5866; Chaysavanh, Manichanh/0000-0002-2287-4003; Liang, Suisha/0000-0003-0426-9827; TORREJON, ANTONIO/0000-0002-3126-1532; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235; Hansen, Torben/0000-0001-8748-3831; Nielsen, Trine/0000-0002-2066-7895; Varela Castro, Encarna/0000-0001-6334-9320; Delorme, Christine/0000-0002-5208-7238	European Commission [HEALTH-F4-2007-201052, HEALTH-F4-2010-261376]; Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; European Research Council CancerBiome [268985]; METACARDIS project [FP7-HEALTH-2012-INNOVATION-I-305312]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care; Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk Foundation; Metagenopolis grant [ANR-11-DPBS-0001]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; European Research Council CancerBiome; METACARDIS project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care; Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Metagenopolis grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	This research was supported by the European Commission FP7 grant HEALTH-F4-2007-201052 and HEALTH-F4-2010-261376, Natural Science Foundation of China (30890032, 30725008, 30811130531 and 31161130357), the Shenzhen Municipal Government of China (ZYC200903240080A, BGI20100001, CXB201108250096A and CXB201108250098A), European Research Council CancerBiome grant (project reference 268985), METACARDIS project (FP7-HEALTH-2012-INNOVATION-I-305312), the Danish Strategic Research Council grant (2106-07-0021), the Ole Romer grant from Danish Natural Science Research Council and the Solexa project (272-07-0196). Additional funding came from the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (http://www.lucamp.org/), the Novo Nordisk Foundation Center for Basic Metabolic Research (an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation; http://www.metabol.ku.dk) and the Metagenopolis grant ANR-11-DPBS-0001. We are indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this work.	Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li J., 2014, GIGASCIENCE DATABASE, DOI [10.5524/100064, DOI 10.5524/100064]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; World Health Organization, 2000, ASIA PACIFIC PERSPEC; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	53	1038	1108	21	330	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					834	841		10.1038/nbt.2942	http://dx.doi.org/10.1038/nbt.2942			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24997786				2022-12-25	WOS:000346455900045
J	Fu, NY; Rios, AC; Pal, B; Soetanto, R; Lun, ATL; Liu, K; Beck, T; Best, SA; Vaillant, F; Bouillet, P; Strasser, A; Preiss, T; Smyth, GK; Lindeman, RJ; Visvader, JE				Fu, Nai Yang; Rios, Anne C.; Pal, Bhupinder; Soetanto, Rina; Lun, Aaron T. L.; Liu, Kevin; Beck, Tamara; Best, Sarah A.; Vaillant, Francois; Bouillet, Philippe; Strasser, Andreas; Preiss, Thomas; Smyth, Gordon K.; Lindeman, Rey J.; Visvader, Jane E.			EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival	NATURE CELL BIOLOGY			English	Article							MAMMARY-GLAND DEVELOPMENT; INDUCED APOPTOSIS; KEY STAGES; GENE; GROWTH; CANCER; ROLES; EXPRESSION; DELETION; DIFFERENTIATION	Expansion and remodelling of the mammary epithelium requires a tight balance between cellular proliferation, differentiation and death. To explore cell survival versus cell death decisions in this organ, we deleted the pro-survival gene Mcl-1 in the mammary epithelium. Mcl-1 was found to be essential at multiple developmental stages including morphogenesis in puberty and alveologenesis in pregnancy. Moreover, Mcl-1-deficient basal cells were virtually devoid of repopulating activity, suggesting that this gene is required for stem cell function. Profound upregulation of the Mcl-1 protein was evident in alveolar cells at the switch to lactation, and Mcl-1 deficiency impaired lactation. Interestingly, EGF was identified as one of the most highly upregulated genes on lactogenesis and inhibition of EGF or mTOR signalling markedly impaired lactation, with concomitant decreases in Mcl-1 and phosphorylated ribosomal protein S6. These data demonstrate that Mcl-1 is essential for mammopoiesis and identify EGF as a critical trigger of Mcl-1 translation to ensure survival of milk-producing alveolar cells.	[Fu, Nai Yang; Rios, Anne C.; Pal, Bhupinder; Liu, Kevin; Beck, Tamara; Best, Sarah A.; Vaillant, Francois; Lindeman, Rey J.; Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Fu, Nai Yang; Rios, Anne C.; Pal, Bhupinder; Lun, Aaron T. L.; Liu, Kevin; Beck, Tamara; Best, Sarah A.; Vaillant, Francois; Bouillet, Philippe; Strasser, Andreas; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Soetanto, Rina; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genome Biol Dept, Canberra, ACT 0200, Australia; [Lun, Aaron T. L.; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Bouillet, Philippe; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Lindeman, Rey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3010, Australia; [Lindeman, Rey J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Australian National University; John Curtin School of Medical Research; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Victor Chang Cardiac Research Institute; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia.	visvader@wehi.edu.au	Bouillet, Philippe/E-1241-2013; Preiss, Thomas/F-7355-2010; Smyth, Gordon/B-5276-2008; Pal, Bhupinder/AAF-4011-2020; Lun, Aaron T. L./J-3807-2019; Strasser, Andreas/C-7581-2013	Bouillet, Philippe/0000-0002-9012-6058; Preiss, Thomas/0000-0001-6273-784X; Smyth, Gordon/0000-0001-9221-2892; Lun, Aaron T. L./0000-0002-3564-4813; Strasser, Andreas/0000-0002-5020-4891; Beck, Tamara/0000-0002-1125-1871; Rios, Anne/0000-0002-9082-8068; Best, Sarah/0000-0002-4232-9432; Lindeman, Geoffrey/0000-0001-9386-2416; FU, Naiyang/0000-0001-5457-4323; Pal, Bhupinder/0000-0002-3684-4331	Australian National Illealth and Medical Research Council (INHIMRC) [1016701]	Australian National Illealth and Medical Research Council (INHIMRC)	We are grateful to J. Takeda and M. Takaishi for the gift of K5-cre transgenic mice and S. Glaser for provision of an We thank D. Huang for advice. We also thank J. L. Clancy, S. K. Archer and G. III./irtan for assistance with the polysome experiments, Py Helbert for genotyping, and the Ai iii FACS, Imaging and HistirTogy Hcilities il TI HI This work was supported by the Australian National Illealth and Medical Research Council (INHIMRC) grants no. 1016701, no. 1024852, no. 1086727; NHMRC RI S the VDtorian State Government through RICA Minding of the Victorian Breast Cancer Reseamh Consortium and Operational infrastructure Support; and the Australian Cancer Research Foundation. N.Y.F. and. are supported by a National Breast Cancer Foundation (NB( F)/Cure Cancer Australia FellowshM; AT.L.L. by an Elizabeth and Vernon Puzey Scholarship from the University of Metbaurne; S. IF. by a N IV R 1 ystgraduate ScholarshM to 1017256; P.B., G.K.S. and G.I.L by NITAIRC Fell ships no. 1042629, no. 1058892, no. 637307; and J.E. V. by an Australia Fellowship.	Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Malone CD, 2012, MOL CELL NEUROSCI, V49, P439, DOI 10.1016/j.mcn.2012.02.003; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Okamoto T, 2014, P NATL ACAD SCI USA, V111, P261, DOI 10.1073/pnas.1321259110; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pal B, 2013, CELL REP, V3, P411, DOI 10.1016/j.celrep.2012.12.020; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Preuss E, 2013, J BIOL CHEM, V288, P35287, DOI 10.1074/jbc.M113.495986; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Stoelzle T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-63; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Walton KD, 2001, MECH DEVELOP, V109, P281, DOI 10.1016/S0925-4773(01)00549-4; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Wintermantel TM, 2002, GENESIS, V33, P125, DOI 10.1002/gene.10097; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	60	48	48	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					365	+		10.1038/ncb3117	http://dx.doi.org/10.1038/ncb3117			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CE6BJ	25730472				2022-12-25	WOS:000351920500007
J	Bulik-Sullivan, BK; Loh, PR; Finucane, HK; Ripke, S; Yang, J; Patterson, N; Daly, MJ; Price, AL; Neale, BM				Bulik-Sullivan, Brendan K.; Loh, Po-Ru; Finucane, Hilary K.; Ripke, Stephan; Yang, Jian; Patterson, Nick; Daly, Mark J.; Price, Alkes L.; Neale, Benjamin M.		Schizophrenia Working Grp	LD Score regression distinguishes confounding from polygenicity in genome-wide association studies	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; IDENTIFIES 13; METAANALYSIS; LOCI; LINKAGE; TRAITS; MODELS; REGIONS; RISK	Both polygenicity (many small genetic effects) and confounding biases, such as cryptic relatedness and population stratification, can yield an inflated distribution of test statistics in genome-wide association studies (GWAS). However, current methods cannot distinguish between inflation from a true polygenic signal and bias. We have developed an approach, LD Score regression, that quantifies the contribution of each by examining the relationship between test statistics and linkage disequilibrium (LD). The LD Score regression intercept can be used to estimate a more powerful and accurate correction factor than genomic control. We find strong evidence that polygenicity accounts for the majority of the inflation in test statistics in many GWAS of large sample size.	[Bulik-Sullivan, Brendan K.; Loh, Po-Ru; Patterson, Nick; Daly, Mark J.; Price, Alkes L.; Neale, Benjamin M.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Bulik-Sullivan, Brendan K.; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Bulik-Sullivan, Brendan K.; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Harvard Univ, Sch Med, Boston, MA USA; [Bulik-Sullivan, Brendan K.; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Loh, Po-Ru; Finucane, Hilary K.; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); University of Queensland; Harvard University; Harvard T.H. Chan School of Public Health	Neale, BM (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.	bneale@broadinstitute.org	Zimprich, Fritz/W-1738-2017; Yang, Jian/A-5852-2010; Agerbo, Esben/A-2645-2012; Liu, Jianjun/AAK-4989-2020; KUČINSKAS, Vaidutis/A-4798-2013; Andreassen, Ole A./AAY-7531-2020; Lee, Jimmy/ABB-2919-2020; Ruderfer, Douglas M/M-5795-2016; Reichenberg, Abraham/GQB-1227-2022; Mortensen, Preben B/D-2358-2015; SCHALL, ULRICH ANDREAS/G-7452-2013; van Os, Jim/C-2113-2014; Slominsky, Petr/AAO-1852-2020; Roffman, Joshua/G-8228-2012; Ripke, Stephan/AAK-5486-2021; Visscher, Peter/ABB-6151-2020; Melle, Ingrid S/B-4858-2011; Collier, David A/D-1649-2011; Domenici, Enrico/K-8194-2016; Zimprich, Fritz/O-1406-2019; So, Hon-Cheong/I-1100-2016; McQuillin, Andrew/C-1623-2008; Bramon, Elvira/HHC-3809-2022; Hansen, Thomas Folkmann/O-5965-2014; Lee, Sang Hong/A-2569-2011; O'Neill, Francis A/C-5582-2008; Stroup, Thomas/AAB-7780-2019; Mattheisen, Manuel/B-4949-2012; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Bergen, Sarah/I-8313-2012; Konte, Bettina/AAT-1142-2021; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Slominsky, Petr A/B-4640-2016; Daly, Mark J/B-2453-2017; Myin-Germeys, Inez/L-5106-2014; Milani, Lili/N-1097-2019; Webb, Bradley T/B-1459-2009; Catts, Stanley V/G-6917-2013; McIntosh, Andrew M/B-9379-2008; Hartmann, Annette/AAS-6331-2021; Wu, Jingqin/V-9319-2019; Hammer, Christian/C-5827-2014; O'Donovan, Michael C/P-7005-2018; Zai, Clement C/G-7379-2015; Pantelis, Christos/H-7722-2014; Mattingsdal, Morten/Q-9367-2016; Golimbet, V/E-2328-2016; Mattheisen, Manuel/S-3725-2019; Meier, Sandra/AAB-1242-2021; murray, robin/F-8658-2012; Ptackova, Hana/M-9763-2017; Kelly, Brian/G-7755-2013; Mowry, Bryan/G-5046-2010; Sigurdsson, Engilbert/D-2486-2014; Scott, Rodney/B-2827-2013	Zimprich, Fritz/0000-0002-6998-5480; Yang, Jian/0000-0003-2001-2474; Agerbo, Esben/0000-0002-2849-524X; Liu, Jianjun/0000-0002-3255-3019; Lee, Jimmy/0000-0002-7724-7445; Ruderfer, Douglas M/0000-0002-2365-386X; Mortensen, Preben B/0000-0002-5230-9865; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Slominsky, Petr/0000-0003-3530-0655; Roffman, Joshua/0000-0003-4073-532X; Visscher, Peter/0000-0002-2143-8760; Melle, Ingrid S/0000-0002-9783-548X; Collier, David A/0000-0003-4087-1559; Domenici, Enrico/0000-0001-7436-6919; Zimprich, Fritz/0000-0002-6998-5480; McQuillin, Andrew/0000-0003-1567-2240; Bramon, Elvira/0000-0003-1369-5983; Hansen, Thomas Folkmann/0000-0001-6703-7762; Lee, Sang Hong/0000-0001-9701-2718; O'Neill, Francis A/0000-0002-7531-7657; Stroup, Thomas/0000-0002-3123-0672; Mattheisen, Manuel/0000-0002-8442-493X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Bergen, Sarah/0000-0002-5888-0034; Konte, Bettina/0000-0001-5287-308X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Slominsky, Petr A/0000-0003-3530-0655; Daly, Mark J/0000-0002-0949-8752; Milani, Lili/0000-0002-5323-3102; Webb, Bradley T/0000-0002-0576-5366; McIntosh, Andrew M/0000-0002-0198-4588; Wu, Jingqin/0000-0002-2052-3875; Hammer, Christian/0000-0003-4548-7548; O'Donovan, Michael C/0000-0001-7073-2379; Pantelis, Christos/0000-0002-9565-0238; Mattingsdal, Morten/0000-0003-4440-0324; Golimbet, V/0000-0002-9960-7114; Mattheisen, Manuel/0000-0002-8442-493X; Klovins, Janis/0000-0001-8362-5505; murray, robin/0000-0003-0829-0519; Curtis, David/0000-0002-4089-9183; Ptackova, Hana/0000-0002-5694-3695; Legge, Sophie/0000-0001-6617-0289; Chen, Eric/0000-0002-5247-3593; Joa, Inge/0000-0002-5516-2336; /0000-0002-8114-7615; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Black, Donald/0000-0001-8038-1971; Julia Cano, Antonio/0000-0001-6064-3620; Nothen, Markus/0000-0002-8770-2464; Mors, Ole/0000-0002-5660-0393; Tooney, Paul/0000-0003-3745-4367; Giusti-Rodriguez, Paola/0000-0002-1921-1305; Pers, Tune/0000-0003-0207-4831; Suvisaari, Jaana/0000-0001-7167-0990; IWATA, Nakao/0000-0003-3189-6076; Zai, Clement C/0000-0003-0496-7262; Bruggeman, Richard/0000-0002-3238-8471; Moran, Jennifer/0000-0002-5664-4716; TOSATO, Sarah/0000-0002-9665-7538; Toncheva, Draga/0000-0002-7451-6363; ripke, stephan/0000-0003-3622-835X; Lubinski, Jan/0000-0003-2931-3003; Donohoe, Gary/0000-0003-3037-7426; Murphy, Kieran/0000-0003-2930-4465; Cairns, Murray/0000-0003-2490-2538; Freedman, Robert/0000-0002-2181-2898; Quested, Digby/0000-0001-6155-3336; Stefansson, Hreinn/0000-0002-9331-6666; Walters, James/0000-0002-6980-4053; Demontis, Ditte/0000-0001-9124-2766; Kirov, George/0000-0002-3427-3950; Milovancevic, Milos/0000-0002-7891-1010; So, Hon-Cheong/0000-0002-7102-833X; Buxbaum, Joseph/0000-0001-8898-8313; Stogmann, Elisabeth/0000-0003-4688-8482; Kelly, Brian/0000-0003-4460-1134; Petryshen, Tracey/0000-0002-7972-4612; Buccola, Nancy/0000-0003-1378-4636; Papiol, Sergi/0000-0001-9366-8728; Myin-Germeys, Inez/0000-0002-3731-4930; Knight, Joanne/0000-0002-7148-1660; Mowry, Bryan/0000-0002-4115-5645; Djurovic, Srdjan/0000-0002-8140-8061; Sigurdsson, Engilbert/0000-0001-9404-7982; Scott, Rodney/0000-0001-7724-3404; Posthuma, Danielle/0000-0001-7582-2365; Agartz, Ingrid/0000-0002-9839-5391; Ehrenreich, Hannelore/0000-0001-8371-5711; Jonsson, Erik/0000-0001-8368-6332; Pocklington, Andrew/0000-0002-2137-0452; Crowley, James/0000-0001-9051-1557; Esko, Tonu/0000-0003-1982-6569; marsal, sara/0000-0001-5515-3854; Escott-Price, Valentina/0000-0003-1784-5483; Sim, Kang/0000-0003-3209-9626; Bacanu, Silviu-Alin/0000-0002-4364-1583; Corvin, Aiden/0000-0001-6717-4089; Adolfsson, Rolf/0000-0001-9785-8473; Dinan, Timothy/0000-0002-2316-7220; Borglum, Anders/0000-0001-8627-7219; Golimbet, Vera/0000-0002-0114-4300	US National Institutes of Health [F32 HG007805, R01 HG006399, R03 CA173785, R01 MH094421]; Fannie and John Hertz Foundation; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0801418, MR/L010305/1, MR/L023784/2, G0801418B] Funding Source: researchfish; MRC [MR/L023784/2, G0801418] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R03CA173785] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG007805, R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH094432, U01MH094421, R01MH101244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank P. Sullivan for helpful discussion. This work was supported by US National Institutes of Health grants F32 HG007805 (P.-R.L.), R01 HG006399 (A.L.P.), R03 CA173785 (H.K.F.) and R01 MH094421 (PGC) and by the Fannie and John Hertz Foundation (H.K.F.). Data on coronary artery disease and myocardial infarction were contributed by CARDIoGRAMplusC4D investigators and were downloaded from Psychiatric Genomics Consortium.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yin P, 2001, J EXP EDUC, V69, P203, DOI 10.1080/00220970109600656	43	1842	1851	10	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					291	+		10.1038/ng.3211	http://dx.doi.org/10.1038/ng.3211			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25642630	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000350327900023
J	Kressmann, S; Compos, C; Castanon, I; Furthauer, M; Gonzalez-Gaitan, M				Kressmann, Sabine; Compos, Claudia; Castanon, Irinka; Fuerthauer, Maximilian; Gonzalez-Gaitan, Marcos			Directional Notch trafficking in Sara endosomes during asymmetric cell division in the spinal cord	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; STEM-CELLS; DELTA; LOCALIZATION; ACTIVATION	Asymmetric division of neural precursor cells contributes to the generation of a variety of neuronal types. Asymmetric division is mediated by the asymmetric inheritance of fate determinants by the two daughter cells(1,2). In vertebrates, asymmetric fate determinants, such as Par3 and Mib, are only now starting to be identified(3,4). Here we show that, during mitosis of neural precursors in zebrafish, directional trafficking of Sara endosomes to one of the daughters can function as such a determinant. In asymmetric lineages, where one daughter cell becomes a neuron (n cell) whereas the other divides again to give rise to two neurons (p cell), we found that the daughter that inherits most of the Sara endosomes acquires the p fate. Sara endosomes carry an endocytosed pool of the Notch ligand DeltaD, which is thereby itself distributed asymmetrically. Sara and Notch are both essential for cell fate assignation within asymmetric lineages. Therefore, the Sara endosome system determines the fate decision between neuronal differentiation and mitosis in asymmetric lineages and thereby contributes to controlling the number of neural precursors and differentiated neurons during neurogenesis in a vertebrate.	[Kressmann, Sabine; Compos, Claudia; Castanon, Irinka; Gonzalez-Gaitan, Marcos] Univ Geneva, Dept Biochem, Sci 2, CH-1211 Geneva 4, Switzerland; [Fuerthauer, Maximilian] Univ Nice Sophia Antipolis, INSERM 1091, CNRS UMR7277, Inst Biol Valrose, F-6108 Nice, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Castanon, I (corresponding author), Univ Geneva, Dept Biochem, Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Irinka.Castanon@unige.ch; Marcos.Gonzalez@unige.ch	FÃrthauer, Maximilian/AAY-4516-2020	FÃrthauer, Maximilian/0000-0001-6344-6585; Campos, Claudia/0000-0003-1809-8272; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321	Fundacao para a Ciencia e Tecnologia [SFRH/BD/15210/2004]; ONCASYM; PGDB PhD programme; HFSP; CNRS; INSERM; Departement de l'Instruction Publique of the Canton of Geneva; SNSF; SystemsX epiPhysX grant; ERC advanced grants; NCCR Frontiers in Genetics and Chemical Biology programs; Polish-Swiss research program	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ONCASYM; PGDB PhD programme; HFSP(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Departement de l'Instruction Publique of the Canton of Geneva; SNSF(Swiss National Science Foundation (SNSF)); SystemsX epiPhysX grant; ERC advanced grants; NCCR Frontiers in Genetics and Chemical Biology programs; Polish-Swiss research program	We are very grateful to O. Schaad, C. Seum, C. Alliod, E. Derivery and F. Schutz for technical help, A. Reugels and M. Brand for the Par3-GFP and Palmitoylated-RFP constructs, respectively, and A. Oates, C. Gonzalez and J. Bertrand for critical reading of the manuscript. We also thank R. Finazzi, S. Borgers and O. Seum for fish care. C.C. was supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/15210/2004) and ONCASYM and the PGDB PhD programme. M.F. was supported by HFSP, CNRS and INSERM. This work was supported by the Departement de l'Instruction Publique of the Canton of Geneva, SNSF, the SystemsX epiPhysX grant, ERC advanced grants (Sara and Morphogen), the NCCR Frontiers in Genetics and Chemical Biology programs and the Polish-Swiss research program to M.G-G.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Haddon C, 1998, DEVELOPMENT, V125, P359; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawaguchi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2895; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Montagne C, 2014, DEVELOPMENT, V141, P2014, DOI 10.1242/dev.104240; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 2002, MECH DEVELOP, V112, P9, DOI 10.1016/S0925-4773(01)00621-9; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	29	46	46	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					333	+		10.1038/ncb3119	http://dx.doi.org/10.1038/ncb3119			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25706234				2022-12-25	WOS:000350770200017
J	Liu, MD; Maurano, MT; Wang, H; Qi, HY; Song, CZ; Navas, PA; Emery, DW; Stamatoyannopoulos, JA; Stamatoyannopoulos, G				Liu, Mingdong; Maurano, Matthew T.; Wang, Hao; Qi, Heyuan; Song, Chao-Zhong; Navas, Patrick A.; Emery, David W.; Stamatoyannopoulos, John A.; Stamatoyannopoulos, George			Genomic discovery of potent chromatin insulators for human gene therapy	NATURE BIOTECHNOLOGY			English	Article							PROTEIN CTCF; REGULATORY ELEMENTS; VECTOR INTEGRATION; LENTIVIRAL VECTORS; ERYTHROID-CELLS; CHS4 INSULATOR; SCID-X1; BINDING; GENOTOXICITY; ACTIVATION	Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic malignancy, represent major barriers to realizing the promise of gene therapy. Although insulator sequences that block transcriptional enhancers could mitigate or eliminate these risks, so far no human insulators with high functional potency have been identified: Here we describe a genomic approach for the identification of compact sequence elements that function as insulators. These elements are highly occupied by the insulator protein CTCF, are DNase I hypersensitive and represent only a small minority of the CTCF recognition sequences in the human genome. We show that the elements identified acted as potent enhancer blockers and substantially decreased the risk of tumor formation in a cancer-prone animal model. The elements are small, can be efficiently accommodated by viral vectors and have no detrimental effects on viral titers. The insulators we describe here are expected to increase the safety of gene therapy for genetic diseases.	[Liu, Mingdong; Qi, Heyuan; Song, Chao-Zhong; Navas, Patrick A.; Emery, David W.; Stamatoyannopoulos, George] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Maurano, Matthew T.; Wang, Hao; Stamatoyannopoulos, John A.; Stamatoyannopoulos, George] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qi, Heyuan] Chinese Acad Sci, Beijing Inst Gen, Beijing, Peoples R China; [Song, Chao-Zhong; Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, G (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	gstam@uw.edu			US National Institutes of Health (NIH) [PO1 HL53750, R90 HG004152];  [U54 HG007010];  [UO1 ES017156];  [F31 MH 094073]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, R90HG004152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health (NIH) grants PO1 HL53750 and R90 HG004152 to G.S., grants U54 HG007010 and UO1 ES017156 to J.A.S., and fellowship F31 MH 094073 to M.T.M.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Baum C, 2011, MOL THER, V19, P2103, DOI 10.1038/mt.2011.252; Baum C, 2011, STEM CELLS, V29, P1479, DOI 10.1002/stem.716; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunbar CE, 2010, NAT MED, V16, P163, DOI 10.1038/nm0210-163; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Evans-Galea MV, 2007, MOL THER, V15, P801, DOI 10.1038/sj.mt.6300103; Galy A, 2011, CURR OPIN ALLERGY CL, V11, P545, DOI 10.1097/ACI.0b013e32834c230c; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Giles KE, 2010, COLD SH Q B, V75, P79, DOI 10.1101/sqb.2010.75.006; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Ryu BY, 2007, BLOOD CELL MOL DIS, V39, P221, DOI 10.1016/j.bcmd.2007.05.003; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	45	67	71	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					198	203		10.1038/nbt.3062	http://dx.doi.org/10.1038/nbt.3062			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25580597				2022-12-25	WOS:000349198800026
J	Xue, L; Rovira, X; Scholler, P; Zhao, H; Liu, JF; Pin, JP; Rondard, P				Xue, Li; Rovira, Xavier; Scholler, Pauline; Zhao, Han; Liu, Jianfeng; Pin, Jean-Philippe; Rondard, Philippe			Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer	NATURE CHEMICAL BIOLOGY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; TIME-RESOLVED FRET; CRYSTAL-STRUCTURE; ALLOSTERIC PROPERTIES; ACTIVATION MECHANISM; TRANSMEMBRANE DOMAIN; STRUCTURAL BASIS; CLASS-A; REVEALS	G protein-coupled receptors (GPCRs) are major players in cell communication. Although they form functional monomers, increasing evidence indicates that GPCR dimerization has a critical role in cooperative phenomena that are important for cell signal integration. However, the structural bases of these phenomena remain elusive. Here, using well-characterized receptor dimers, the metabotropic glutamate receptors (mGluRs), we show that structural changes at the dimer interface are linked to receptor activation. We demonstrate that the main dimer interface is formed by transmembrane a helix 4 (TM4) and TM5 in the inactive state and by TM6 in the active state. This major change in the dimer interface is required for receptor activity because locking the TM4-TM5 interface prevents activation by agonist, whereas locking the TM6 interface leads to a constitutively active receptor. These data provide important information on the activation mechanism of mGluRs and improve our understanding of the structural basis of the negative cooperativity observed in these GPCR dimers.	[Xue, Li; Zhao, Han; Liu, Jianfeng] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Cellular Signaling Lab,Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Xue, Li; Rovira, Xavier; Scholler, Pauline; Pin, Jean-Philippe; Rondard, Philippe] CNRS, UMR5203, Inst Genom Fonct, Montpellier, France; [Xue, Li; Rovira, Xavier; Scholler, Pauline; Pin, Jean-Philippe; Rondard, Philippe] INSERM, U661, Montpellier, France; [Xue, Li; Rovira, Xavier; Scholler, Pauline; Pin, Jean-Philippe; Rondard, Philippe] Univ Montpellier 1 & 2, Montpellier, France	Huazhong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Cellular Signaling Lab,Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	jfliu@mail.hust.edu.cn; jean-philippe.pin@igf.cnrs.fr	Rondard, Philippe/N-9720-2018; Pin, Jean-Philippe/Y-6668-2019; Algans, Xavier Rovira/M-4669-2015; Liu, Jianfeng/E-2786-2012	Pin, Jean-Philippe/0000-0002-1423-345X; Algans, Xavier Rovira/0000-0002-9764-9927; RONDARD, Philippe/0000-0003-1134-2738; XUE, Li/0000-0003-0650-2194	National Natural Science Foundation of China [31130028, 31225011]; Ministry of Science and Technology [2012CB518000]; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]; Merieux Research Grants Program of the Institut Merieux; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-09-PIRI-0011]; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20130326522]; Fondation Bettencourt Schueller; French Embassy in China; FEBS long-term fellowship; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) BP post-doctoral fellowship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for Introducing Talents of Discipline to the Universities of the Ministry of Education; Merieux Research Grants Program of the Institut Merieux; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt Schueller; French Embassy in China; FEBS long-term fellowship; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) BP post-doctoral fellowship	We thank the Cisbio Company for their support in providing reagents. The intracellular calcium release and FRET experiments were performed at the ARPEGE (Pharmacology Screening-Interactome) facility, Institut de Genomique Fonctionnelle (Montpellier, France). J.L. was supported by the National Natural Science Foundation of China (grant numbers 31130028 and 31225011), the Ministry of Science and Technology (grant number 2012CB518000), the Program for Introducing Talents of Discipline to the Universities of the Ministry of Education (grant number B08029) and the Merieux Research Grants Program of the Institut Merieux. P.R. and J.-P.P. are supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale and by grants from the Agence Nationale de la Recherche (ANR-09-PIRI-0011), the Fondation pour la Recherche Medicale (Equipe FRM DEQ20130326522) and the Fondation Bettencourt Schueller. L.X. was supported by a doctoral fellowship from the French Embassy in China and X.R. by a FEBS long-term fellowship and by a Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) BP post-doctoral fellowship.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondard P, 2011, NEUROPHARMACOLOGY, V60, P82, DOI 10.1016/j.neuropharm.2010.08.009; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	55	135	137	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					134	U76		10.1038/NCHEMBIO.1711	http://dx.doi.org/10.1038/NCHEMBIO.1711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ6WN	25503927				2022-12-25	WOS:000348358800011
J	Linnemann, C; van Buuren, MM; Bies, L; Verdegaal, EME; Schotte, R; Calis, JJA; Behjati, S; Velds, A; Hilkmann, H; el Atmioui, D; Visser, M; Stratton, MR; Haanen, JBAG; Spits, H; van der Burg, SH; Schumacher, TNM				Linnemann, Carsten; van Buuren, Marit M.; Bies, Laura; Verdegaal, Els M. E.; Schotte, Remko; Calis, Jorg J. A.; Behjati, Sam; Velds, Arno; Hilkmann, Henk; el Atmioui, Dris; Visser, Marten; Stratton, Michael R.; Haanen, John B. A. G.; Spits, Hergen; van der Burg, Sjoerd H.; Schumacher, Ton N. M.			High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma	NATURE MEDICINE			English	Article							CD4+T CELLS; B-CELLS; TUMOR; PATIENT; IDENTIFICATION; REACTIVITY; GENES	Tumor-specific neo-antigens that arise as a consequence of mutations(1,2) are thought to be important for the therapeutic efficacy of cancer immunotherapies(3-5). Accumulating evidence suggests that neo-antigens may be commonly recognized by intratumoral CD8(+) T cells(3-7), but it is unclear whether neoantigen-specific CD4(+) T cells also frequently reside within human tumors. In view of the accepted role of tumor-specific CD4(+) T-cell responses in tumor control(8-10), we addressed whether neo-antigen-specific CD4(+) T-cell reactivity is a common property in human melanoma.	[Linnemann, Carsten; van Buuren, Marit M.; Bies, Laura; Calis, Jorg J. A.; Haanen, John B. A. G.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Verdegaal, Els M. E.; Visser, Marten; van der Burg, Sjoerd H.] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Schotte, Remko; Spits, Hergen] AIMM Therapeut BV, Amsterdam, Netherlands; [Behjati, Sam; Stratton, Michael R.] Wellcome Trust Res Labs, Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Velds, Arno] Netherlands Canc Inst, Cent Genom Facil, Amsterdam, Netherlands; [Hilkmann, Henk; el Atmioui, Dris] Netherlands Canc Inst, Peptide Synth Facil, Amsterdam, Netherlands; [Haanen, John B. A. G.] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wellcome Trust Sanger Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	c.linnemann@nki.nl; t.schumacher@nki.nl	Haanen, John/AAD-8534-2022; Haanen, John/AAD-8578-2022; van der Burg, Sjoerd H/T-1875-2017; Schumacher, Ton/Y-2432-2019; Verdegaal, Elizabeth/Y-2597-2018; Spits, Hergen/N-2581-2019	Haanen, John/0000-0001-5884-7704; van der Burg, Sjoerd H/0000-0002-6556-0354; Schumacher, Ton/0000-0003-0517-8804; Verdegaal, Elizabeth/0000-0002-4449-8707; Spits, Hergen/0000-0003-3269-8338; Velds, Arno/0000-0003-4333-8872	Worldwide Cancer Research [14-0321]; PhD Fellowship Program of Boehringer Ingelheim Fonds-Foundation; Dutch Cancer Society [UVA 2010-4822, NKI 2012-5463, UL 2012-5544]; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust [WT098051]; Anticancer Fund; K.G. Jebsen Foundation; EU; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant	Worldwide Cancer Research; PhD Fellowship Program of Boehringer Ingelheim Fonds-Foundation(Boehringer Ingelheim); Dutch Cancer Society(KWF Kankerbestrijding); Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust(Wellcome TrustEuropean Commission); Anticancer Fund; K.G. Jebsen Foundation; EU(European Commission); Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant	We are grateful to A. Pfauth, F. van Diepen and C. Bachas for flow cytometric support; W van de Kasteele and T. de Jong for technical assistance; N. van Root) and B. Heemskerk for handling of patient material; and R. Kluin, M. Nieuwland and R. van Kerkhoven for support with next generation sequencing. We thank G. Bendle and P. Kvistborg for critical reading of the manuscript, and members from the Schumacher and Haanen laboratories for useful discussions. This work was supported by Worldwide Cancer Research grant 14-0321 (to C.L. and T.N.M.S.), the PhD Fellowship Program of Boehringer Ingelheim Fonds-Foundation for Basic Research in Biomedicine (to C.L.), Dutch Cancer Society grants: UVA 2010-4822 (to H.S.), NKI 2012-5463 (to J.B.A.G.H., S.H.v.d.B. and T.N.M.S.) and UL 2012-5544 (to E.M.E.V.), The Wellcome Trust Research Training Fellowship for Clinicians (to S.B.), The Wellcome Trust Grant WT098051 (to MRS.), the Anticancer Fund (to E.M.E.V., M.V.) the K.G. Jebsen Foundation (to T.N.M.S.), EU FP7 SUPERSIST, and the Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant (to T.N.M.S.). SU2C is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Britten CM, 2013, NAT BIOTECHNOL, V31, P880, DOI 10.1038/nbt.2708; Champiat S, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27817; Deffrennes V, 2001, J IMMUNOL, V167, P98, DOI 10.4049/jimmunol.167.1.98; Friedman KM, 2012, J IMMUNOTHER, V35, P400, DOI 10.1097/CJI.0b013e31825898c5; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jandus C, 2009, CANCER RES, V69, P8085, DOI 10.1158/0008-5472.CAN-09-2226; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kitano S, 2013, CANCER IMMUNOL RES, V1, P235, DOI 10.1158/2326-6066.CIR-13-0068; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Kwakkenbos MJ, 2014, METHODS, V65, P38, DOI 10.1016/j.ymeth.2013.07.002; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mautner J, 2005, INT J CANCER, V115, P752, DOI 10.1002/ijc.20927; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Overwijk WW, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-11; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2011, CANCER IMMUNOL IMMUN, V60, P953, DOI 10.1007/s00262-011-1004-8; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wick DA, 2014, CLIN CANCER RES, V20, P1125, DOI 10.1158/1078-0432.CCR-13-2147	28	472	500	5	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					81	85		10.1038/nm.3773	http://dx.doi.org/10.1038/nm.3773			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25531942				2022-12-25	WOS:000348408000017
J	Bansal, M; Yang, JC; Karan, C; Menden, MP; Costello, JC; Tang, H; Xiao, GH; Li, YJ; Allen, J; Zhong, R; Chen, BB; Kim, MS; Wang, T; Heiser, LM; Realubit, R; Mattioli, M; Alvarez, MJ; Shen, Y; Gallahan, D; Singer, D; Saez-Rodriguez, J; Xie, Y; Stolovitzky, G; Califano, A; Abbuehl, JP; Altman, RB; Balcome, S; Bell, A; Bender, A; Berger, B; Bernard, J; Bieberich, AA; Borboudakis, G; Chan, C; Chen, TH; Choi, J; Coelho, LP; Creighton, CJ; Dampier, W; Davisson, VJ; Deshpande, R; Diao, LX; Di Camillo, B; Dundar, M; Ertel, A; Goswami, CP; Gottlieb, A; Gould, MN; Goya, J; Grau, M; Gray, JW; Hejase, HA; Hoffmann, MF; Homicsko, K; Homilius, M; Hwang, W; Ijzerman, AP; Kallioniemi, O; Karacali, B; Kaski, S; Kim, J; Krishnan, A; Lee, J; Lee, YS; Lenselink, EB; Lenz, P; Li, L; Li, J; Liang, H; Mpindi, JP; Myers, CL; Newton, MA; Overington, JP; Parkkinen, J; Prill, RJ; Peng, J; Pestell, R; Qiu, P; Rajwa, B; Sadanandam, A; Sambo, F; Sridhar, A; Sun, W; Toffolo, GM; Tozeren, A; Troyanskaya, OG; Tsamardinos, I; van Vlijmen, HWT; Wang, W; Wegner, JK; Wennerberg, K; van Westen, GJP; Xia, T; Yang, Y; Yao, V; Yuan, Y; Zeng, HY; Zhang, SH; Zhao, JF; Zhou, J				Bansal, Mukesh; Yang, Jichen; Karan, Charles; Menden, Michael P.; Costello, James C.; Tang, Hao; Xiao, Guanghua; Li, Yajuan; Allen, Jeffrey; Zhong, Rui; Chen, Beibei; Kim, Minsoo; Wang, Tao; Heiser, Laura M.; Realubit, Ronald; Mattioli, Michela; Alvarez, Mariano J.; Shen, Yao; Gallahan, Daniel; Singer, Dinah; Saez-Rodriguez, Julio; Xie, Yang; Stolovitzky, Gustavo; Califano, Andrea; Abbuehl, Jean-Paul; Altman, Russ B.; Balcome, Shawn; Bell, Ana; Bender, Andreas; Berger, Bonnie; Bernard, Jonathan; Bieberich, Andrew A.; Borboudakis, Giorgos; Chan, Christina; Chen, Ting-Huei; Choi, Jaejoon; Coelho, Luis Pedro; Creighton, Chad J.; Dampier, Will; Davisson, V. Jo; Deshpande, Raamesh; Diao, Lixia; Di Camillo, Barbara; Dundar, Murat; Ertel, Adam; Goswami, Chirayu P.; Gottlieb, Assaf; Gould, Michael N.; Goya, Jonathan; Grau, Michael; Gray, Joe W.; Hejase, Hussein A.; Hoffmann, Michael F.; Homicsko, Krisztian; Homilius, Max; Hwang, Woochang; Ijzerman, Adriaan P.; Kallioniemi, Olli; Karacali, Bilge; Kaski, Samuel; Kim, Junho; Krishnan, Arjun; Lee, Junehawk; Lee, Young-Suk; Lenselink, Eelke B.; Lenz, Peter; Li, Lang; Li, Jun; Liang, Han; Mpindi, John-Patrick; Myers, Chad L.; Newton, Michael A.; Overington, John P.; Parkkinen, Juuso; Prill, Robert J.; Peng, Jian; Pestell, Richard; Qiu, Peng; Rajwa, Bartek; Sadanandam, Anguraj; Sambo, Francesco; Sridhar, Arvind; Sun, Wei; Toffolo, Gianna M.; Tozeren, Aydin; Troyanskaya, Olga G.; Tsamardinos, Ioannis; van Vlijmen, Herman W. T.; Wang, Wen; Wegner, Joerg K.; Wennerberg, Krister; van Westen, Gerard J. P.; Xia, Tian; Yang, Yang; Yao, Victoria; Yuan, Yuan; Zeng, Haoyang; Zhang, Shihua; Zhao, Junfei; Zhou, Jian		Cellworks Group; NCI-DREAM Community	A community computational challenge to predict the activity of pairs of compounds	NATURE BIOTECHNOLOGY			English	Article							DRUG-COMBINATIONS; SYSTEMS BIOLOGY; CANCER; THERAPY; NETWORK; CHEMOTHERAPY; MODELS; INHIBITION; EXPRESSION; RESISTANCE	Recent therapeutic successes have renewed interest in drug combinations, but experimental screening approaches are costly and often identify only small numbers of synergistic combinations. The DREAM consortium launched an open challenge to foster the development of in silico methods to computationally rank 91 compound pairs, from the most synergistic to the most antagonistic, based on gene-expression profiles of human B cells treated with individual compounds at multiple time points and concentrations. Using scoring metrics based on experimental dose-response curves, we assessed 32 methods (31 community-generated approaches and SynGen), four of which performed significantly better than random guessing. We highlight similarities between the methods. Although the accuracy of predictions was not optimal, we find that computational prediction of compound-pair activity is possible, and that community challenges can be useful to advance the field of in silico compound-synergy prediction.	[Bansal, Mukesh; Alvarez, Mariano J.; Shen, Yao; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY USA; [Bansal, Mukesh; Alvarez, Mariano J.; Shen, Yao; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Yang, Jichen; Tang, Hao; Xiao, Guanghua; Allen, Jeffrey; Zhong, Rui; Chen, Beibei; Kim, Minsoo; Wang, Tao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Karan, Charles; Realubit, Ronald] Columbia Univ, Columbia Genome Ctr, High Throughput Screening Facil, New York, NY USA; [Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Costello, James C.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Costello, James C.] Boston Univ, Howard Hughes Med Inst, Ctr Synthet Biol, Boston, MA 02215 USA; [Li, Yajuan] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kim, Minsoo; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX USA; [Heiser, Laura M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Mattioli, Michela] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy; [Gallahan, Daniel; Singer, Dinah] NCI, Div Canc Biol, Bethesda, MD 20892 USA; [Stolovitzky, Gustavo] IBM Corp, Thomas J Watson Res Ctr, IBM Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Abbuehl, Jean-Paul; Bernard, Jonathan] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Altman, Russ B.; Gottlieb, Assaf] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Balcome, Shawn; Deshpande, Raamesh; Myers, Chad L.; Wang, Wen; Xia, Tian] Univ Minnesota, Minneapolis, MN USA; [Bell, Ana; Homilius, Max; Lee, Young-Suk; Troyanskaya, Olga G.; Yao, Victoria] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Bell, Ana; Goya, Jonathan; Homilius, Max; Krishnan, Arjun; Lee, Young-Suk; Troyanskaya, Olga G.; Yao, Victoria; Zhou, Jian] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Bender, Andreas] Univ Cambridge, Unilever Ctr, Cambridge, England; [Berger, Bonnie; Peng, Jian; Zeng, Haoyang] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bieberich, Andrew A.; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Borboudakis, Giorgos; Tsamardinos, Ioannis] Univ Crete, Dept Comp Sci, Iraklion, NE, Greece; [Borboudakis, Giorgos; Tsamardinos, Ioannis] FORTH, Inst Comp Sci, Iraklion, NE, Greece; [Chan, Christina; Hejase, Hussein A.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chen, Ting-Huei; Sun, Wei] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Choi, Jaejoon; Hwang, Woochang; Kim, Junho; Lee, Junehawk] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [Coelho, Luis Pedro] Univ Lisbon, Inst Med Mol, Fac Med, Lisbon, Portugal; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Dan L Duncan Ctr Div Biostat, Houston, TX 77030 USA; [Dampier, Will; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA; [Diao, Lixia; Li, Jun; Liang, Han; Qiu, Peng; Yang, Yang; Yuan, Yuan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Di Camillo, Barbara; Sambo, Francesco; Toffolo, Gianna M.] Univ Padua, Dept Informat Engn, Padua, Italy; [Dundar, Murat] IUPUI, Dept Comp & Informat Sci, Indianapolis, IN USA; [Ertel, Adam; Pestell, Richard] Jefferson Kimmel Canc Ctr, Philadelphia, PA USA; [Cellworks Group] Cellworks Grp Inc, San Jose, CA USA; [Goswami, Chirayu P.; Li, Lang] IU Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Gould, Michael N.; Hoffmann, Michael F.] Univ Wisconsin, Dept Oncol & Carbone Canc Ctr, Madison, WI USA; [Grau, Michael; Lenz, Peter] Univ Marburg, Dept Phys, Marburg, Germany; [Ijzerman, Adriaan P.; Lenselink, Eelke B.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Kallioniemi, Olli; Mpindi, John-Patrick; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Karacali, Bilge] Izmir Inst Technol, Izmir, Turkey; [Kaski, Samuel; Parkkinen, Juuso] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Kaski, Samuel] Univ Helsinki, Inst Informat Technol HIIT, Dept Comp Sci, Helsinki, Finland; [Lee, Junehawk] Korea Inst Sci & Technol Informat, Daejeon, South Korea; [Li, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Liang, Han; Yuan, Yuan] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Overington, John P.; van Westen, Gerard J. P.] Wellcome Trust Genome Campus, European Bioinformat Inst EMBL EBI, Cambridge, England; [Prill, Robert J.] IBM Almaden Res Ctr, San Jose, CA USA; [Rajwa, Bartek] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Sridhar, Arvind] Swiss Fed Inst Technol Lausanne EPFL, Inst Elect Engn, Embedded Syst Lab ESL, Lausanne, Switzerland; [Sun, Wei] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [van Vlijmen, Herman W. T.; Wegner, Joerg K.] Janssen Pharmaceut, Beerse, Belgium; [Yang, Yang] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Zhang, Shihua; Zhao, Junfei] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Qiu, Peng] Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus, Aurora, CO USA; [Qiu, Peng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA USA; [Qiu, Peng] Emory Univ, Atlanta, GA 30322 USA	Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; European Molecular Biology Laboratory (EMBL); Boston University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; Istituto Italiano di Tecnologia - IIT; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Business Machines (IBM); Columbia University; Columbia University; Columbia University; Columbia University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Princeton University; Princeton University; University of Cambridge; Massachusetts Institute of Technology (MIT); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Crete; Foundation for Research & Technology - Hellas (FORTH); Michigan State University; Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; Korea Advanced Institute of Science & Technology (KAIST); Universidade de Lisboa; Baylor College of Medicine; Drexel University; University of Texas System; UTMD Anderson Cancer Center; University of Padua; Indiana University System; Indiana University-Purdue University Indianapolis; Jefferson University; Indiana University System; Indiana University Bloomington; University of Wisconsin System; University of Wisconsin Madison; Philipps University Marburg; Leiden University; Leiden University - Excl LUMC; University of Helsinki; Izmir Institute of Technology; Aalto University; University of Helsinki; University of Helsinki; Korea Institute of Science & Technology Information (KISTI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; International Business Machines (IBM); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of North Carolina; University of North Carolina Chapel Hill; Johnson & Johnson; Janssen Pharmaceuticals; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; Emory University	Stolovitzky, G (corresponding author), IBM Corp, Thomas J Watson Res Ctr, IBM Computat Biol Ctr, Yorktown Hts, NY 10598 USA.	Yang.Xie@UTSouthwestern.edu; gustavo@us.ibm.com; califano@c2b2.columbia.edu	IJzerman, Ad/ABG-1353-2020; Rajwa, Bartek/B-3169-2009; Wennerberg, Krister/AFM-0539-2022; Dundar, M. Murat/C-3846-2011; Gray, Joe/AAX-9549-2020; Dundar, Murat/U-1837-2019; Bender, Andreas/C-6942-2009; Zhao, Junfei/J-1425-2018; Overington, John P/G-8607-2015; Saez-Rodriguez, Julio/H-7114-2019; Wang, Wen/E-6320-2012; Wang, Tao/K-3518-2016; Hwang, Woochang/AAU-8398-2020; Mattioli, Michela/K-3951-2013; Yao, Vicky/AAC-6183-2020; Homilius, Max/AAW-1251-2021; Di Camillo, Barbara/L-3202-2013; yang, jichen/HDL-9203-2022; He, Liye/C-8843-2015; Kallioniemi, Olli P/H-5111-2011; Coelho, Luis Pedro/D-1260-2009; van Westen, Gerard/HHZ-3762-2022; Yuan, Yuan/H-4007-2013; van Westen, Gerard JP/D-7432-2011; Kaski, Samuel/B-6684-2008; Wennerberg, Krister/AAH-2919-2022; Li, Jun/AAE-4393-2022	IJzerman, Ad/0000-0002-1182-2259; Rajwa, Bartek/0000-0001-7540-8236; Wennerberg, Krister/0000-0002-1352-4220; Bender, Andreas/0000-0002-6683-7546; Overington, John P/0000-0002-5859-1064; Saez-Rodriguez, Julio/0000-0002-8552-8976; Wang, Wen/0000-0002-5812-6744; Hwang, Woochang/0000-0003-0876-7305; Mattioli, Michela/0000-0002-1692-9178; Yao, Vicky/0000-0002-3201-9983; Homilius, Max/0000-0001-7240-0028; Di Camillo, Barbara/0000-0001-8415-4688; He, Liye/0000-0002-6632-2112; Kallioniemi, Olli P/0000-0002-3231-0332; Coelho, Luis Pedro/0000-0002-9280-7885; Yuan, Yuan/0000-0003-4706-7897; van Westen, Gerard JP/0000-0003-0717-1817; Kaski, Samuel/0000-0003-1925-9154; Wennerberg, Krister/0000-0002-1352-4220; Li, Jun/0000-0002-1171-7141; Dundar, Murat/0000-0001-5752-468X; Bansal, Mukesh/0000-0003-1481-6767; Borboudakis, Giorgos/0000-0001-7355-8871; Peng, Jian/0000-0002-1736-2978; Lee, Junehawk/0000-0001-8908-0884; Califano, Andrea/0000-0003-4742-3679; Lenz, Peter/0000-0001-7705-3950; Homicsko, Krisztian/0000-0003-0912-6198; Zeng, Haoyang/0000-0003-1057-2865; Sadanandam, Anguraj/0000-0001-8485-5150; Grau, Michael/0000-0003-1909-0133; Abbuehl, Jean-Paul/0000-0003-3135-6969; Wegner, Jorg Kurt/0000-0002-1852-9434; Altman, Russ/0000-0003-3859-2905; Troyanskaya, Olga/0000-0002-5676-5737; Costello, James/0000-0003-3158-9682	Multiscale Analysis of Genomic and Cellular Networks (MAGNet) [5U54CA121852-08]; Library of Integrated Network-based Cellular Signatures Program (LINCS) [1U01CA164184-02, 3U01HL111566-02]; National Institutes of Health (NIH) [5R01CA152301]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP101251]; NIH, NCI [U54 CA112970]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA058207, U01CA168426, P50CA098258, R01CA152301, U01CA164184, U54CA121852, U54CA112970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111566] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071966, R01GM081871] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1252648] Funding Source: National Science Foundation	Multiscale Analysis of Genomic and Cellular Networks (MAGNet); Library of Integrated Network-based Cellular Signatures Program (LINCS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The data for this challenge were kindly provided prepublication by A. Califano's laboratory. The general idea of the challenge was conceived in a workshop co-organized by National Cancer Institute (NCI) and Dialogue for Reverse Engineering Assessments and Methods (DREAM) on April 23, 2012. We acknowledge the contributions of all the participants in that summit, whose list of attendees can be accessed by the following link http://tinyurl.com/n3zp443. We would like to thank L. Pasqualucci and A. Holmes for processing the genetic profile of the OCI-LY3 cell line; W.K. Lim for normalizing GEPs; S. Dhindaw for proofreading the manuscript; F.M. Giorgi for helping with the figures of the manuscript; H. Li for tissue culture; P. Guarnieri, A. Ambesi, S. Anand, P. Subramaniam and S. Irshad for their valuable comments and feedback during the preparation of this manuscript. GeneTitan hybridizations were run at Rutgers University facility (Bionomics Research and Technology Center -BRTC). This work is supported in part by the Multiscale Analysis of Genomic and Cellular Networks (MAGNet) grant (5U54CA121852-08) and Library of Integrated Network-based Cellular Signatures Program (LINCS) grants (1U01CA164184-02 and 3U01HL111566-02) to A.C.; National Institutes of Health (NIH) grant (5R01CA152301) and Cancer Prevention and Research Institute of Texas (CPRIT) grant (RP101251) to Y.X. and NIH, NCI grant (U54 CA112970) to J.W.G.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Alexe G, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P322, DOI 10.1109/CSB.2005.7; Araujo RP, 2005, BIOSYSTEMS, V80, P57, DOI 10.1016/j.biosystems.2004.10.002; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen J. C., CELL IN PRESS; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032391; FERNANDES DJ, 1980, P NATL ACAD SCI-BIOL, V77, P5663, DOI 10.1073/pnas.77.10.5663; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helguera AM, 2013, EUR J MED CHEM, V59, P75, DOI 10.1016/j.ejmech.2012.10.035; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Nelson HS, 2001, J ALLERGY CLIN IMMUN, V107, P397, DOI 10.1067/mai.2001.112939; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Puri Neelu, 2008, J Carcinog, V7, P9; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Rawlinson R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-483; Recht A, 1996, NEW ENGL J MED, V334, P1356, DOI 10.1056/NEJM199605233342102; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Shah MA, 2001, CLIN CANCER RES, V7, P2168; STEIN GE, 1984, CLIN PHARMACY, V3, P591; van Westen GJP, 2013, NAT METHODS, V10, P116, DOI 10.1038/nmeth.2339; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	49	175	177	3	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1213	+		10.1038/nbt.3052	http://dx.doi.org/10.1038/nbt.3052			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419740	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000346156800023
J	Li, WD; Cavelti-Weder, C; Zhang, YY; Clement, K; Donovan, S; Gonzalez, G; Zhu, J; Stemann, M; Xu, K; Hashimoto, T; Yamada, T; Nakanishi, M; Zhang, YM; Zeng, S; Gifford, D; Meissner, A; Weir, G; Zhou, Q				Li, Weida; Cavelti-Weder, Claudia; Zhang, Yinying; Clement, Kendell; Donovan, Scott; Gonzalez, Gabriel; Zhu, Jiang; Stemann, Marianne; Xu, Ke; Hashimoto, Tatsu; Yamada, Takatsugu; Nakanishi, Mio; Zhang, Yuemei; Zeng, Samuel; Gifford, David; Meissner, Alexander; Weir, Gordon; Zhou, Qiao			Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; DEFINED FACTORS; FUNCTIONAL-NEURONS; INSULIN-SECRETION; EXOCRINE CELLS; ISLETS; FIBROBLASTS; GROWTH; CARDIOMYOCYTES; MICE	Direct lineage conversion is a promising approach to generate therapeutically important cell types for disease modeling and tissue repair. However, the survival and function of lineage-reprogrammed cells in vivo over the long term has not been examined. Here, using an improved method for in vivo conversion of adult mouse pancreatic acinar cells toward beta cells, we show that induced beta cells persist for up to 13 months (the length of the experiment), form pancreatic islet-like structures and support normoglycemia in diabetic mice. Detailed molecular analyses of induced beta cells over 7 months reveal that global DNA methylation changes occur within 10 d, whereas the transcriptional network evolves over 2 months to resemble that of endogenous beta cells and remains stable thereafter. Progressive gain of beta-cell function occurs over 7 months, as measured by glucose-regulated insulin release and suppression of hyperglycemia. These studies demonstrate that lineage-reprogrammed cells persist for > 1 year and undergo epigenetic, transcriptional, anatomical and functional development toward a beta-cell phenotype.	[Li, Weida; Zhang, Yinying; Clement, Kendell; Donovan, Scott; Gonzalez, Gabriel; Xu, Ke; Nakanishi, Mio; Zhang, Yuemei; Zeng, Samuel; Meissner, Alexander; Zhou, Qiao] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cavelti-Weder, Claudia; Stemann, Marianne; Yamada, Takatsugu; Weir, Gordon] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Zhang, Yinying; Clement, Kendell; Donovan, Scott; Zhu, Jiang; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA; [Clement, Kendell] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gonzalez, Gabriel] Harvard Univ, Sch Med, West Roxbury, MA USA; [Zhu, Jiang] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Hashimoto, Tatsu; Gifford, David] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Zhou, Q (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	qiao_zhou@harvard.edu	Clement, Kendell/AAZ-6854-2021; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zhou, Qiao/0000-0002-0099-3909; Cavelti-Weder, Claudia/0000-0002-0650-6091; Zhang, Yuemei/0000-0003-3555-4524; Li, Weida/0000-0001-6578-6321; Gonzalez, Gabriel/0000-0003-1842-3119	US National Institutes of Health; Juvenile Diabetes Research Foundation; Swiss Science Foundation; Swiss Foundation for Grants in Biology and Medicine	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Biology and Medicine	We thank M. Shear, J. Brown, J. Hollister-Lock, and R. Zhao for technical assistance; H.-H. Chen for assistance with gene profiling; D. Yu and T. Fabbro for statistical analysis; Boston Children's Hospital core facility for an Illumina array; Joslin Specialized Assay Core for insulin measurement; members of the Zhou laboratory for advice and feedback; and D. Melton and D. Breault for discussion and reading of the manuscript. Q.Z. was supported by awards from the US National Institutes of Health. W.L. is supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. C.C.-W. is supported by postdoctoral fellowships from the Swiss Science Foundation and the Swiss Foundation for Grants in Biology and Medicine.	Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cavelti-Weder C, 2014, METHODS MOL BIOL, V1150, P247, DOI 10.1007/978-1-4939-0512-6_17; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen YJ, 2014, CELL REP, V6, P1046, DOI 10.1016/j.celrep.2014.02.013; Dahl U, 1996, DEVELOPMENT, V122, P2895; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; HOPCROFT DW, 1985, ENDOCRINOLOGY, V117, P2073, DOI 10.1210/endo-117-5-2073; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; JUANG JH, 1994, DIABETES, V43, P1334, DOI 10.2337/diabetes.43.11.1334; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Li WD, 2014, ELIFE, V3, DOI 10.7554/eLife.01846; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; MONTANA E, 1994, J CLIN INVEST, V93, P1577, DOI 10.1172/JCI117137; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	34	67	70	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1223	U79		10.1038/nbt.3082	http://dx.doi.org/10.1038/nbt.3082			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402613				2022-12-25	WOS:000346156800024
J	Weisenfeld, NI; Yin, SY; Sharpe, T; Lau, B; Hegarty, R; Holmes, L; Sogoloff, B; Tabbaa, D; Williams, L; Russ, C; Nusbaum, C; Lander, ES; MacCallum, L; Jaffe, DB				Weisenfeld, Neil I.; Yin, Shuangye; Sharpe, Ted; Lau, Bayo; Hegarty, Ryan; Holmes, Laurie; Sogoloff, Brian; Tabbaa, Diana; Williams, Louise; Russ, Carsten; Nusbaum, Chad; Lander, Eric S.; MacCallum, Lain; Jaffe, David B.			Comprehensive variation discovery in single human genomes	NATURE GENETICS			English	Article							DNA-SEQUENCING DATA; IDENTIFICATION; FRAMEWORK; COMMON	Complete knowledge of the genetic variation in individual human genomes is a crucial foundation for understanding the etiology of disease. Genetic variation is typically characterized by sequencing individual genomes and comparing reads to a reference. Existing methods do an excellent job of detecting variants in approximately 90% of the human genome; however, calling variants in the remaining 10% of the genome (largely low-complexity sequence and segmental duplications) is challenging. To improve variant calling, we developed a new algorithm, DISCOVAR, and examined its performance on improved, low-cost sequence data. Using a newly created reference set of variants from the finished sequence of 103 randomly chosen fosmids, we find that some standard variant call sets miss up to 25% of variants. We show that the combination of new methods and improved data increases sensitivity by several fold, with the greatest impact in challenging regions of the human genome.	[Weisenfeld, Neil I.; Yin, Shuangye; Sharpe, Ted; Lau, Bayo; Hegarty, Ryan; Holmes, Laurie; Sogoloff, Brian; Tabbaa, Diana; Williams, Louise; Russ, Carsten; Nusbaum, Chad; Lander, Eric S.; MacCallum, Lain; Jaffe, David B.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jaffe, DB (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jaffe@broadinstitute.org	Yin, Shuangye/C-3707-2009	Yin, Shuangye/0000-0002-2779-2584; Lau, Bayo/0000-0001-7243-9221	National Human Genome Research Institute; US National Institutes of Health; US Department of Health and Human Services [R01HG003474, U54HG003067]; National Institute of Allergy and Infectious Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG003474] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Broad Institute Genomics Platform for generating data for this project and J. Bochicchio for project management. We thank the 1000 Genomes Project for early access to 250-base reads from the Centre d'Etude du Polymorphisme Humain (CEPH) trio. We thank Illumina for the use of sequence data from the 17-member CEPH pedigree and M. Eberle for detailed information on these data. We thank Z. lqbal for detailed advice regarding running Cortex on 250-base reads and M. Carneiro and E. Banks for detailed advice regarding running GATK on the same data. We thank H. Li for early access to bwa-mem and for his extensive examination of our manuscript. We thank S. Fisher for help preparing the data cost estimate. We thank M. Daly, M. DePristo, S. Gabriel, Z. Iqbal, D. MacArthur, D. Neafsey and M. Zody for helpful comments. This project has been funded in part with federal funds from the National Human Genome Research Institute, US National Institutes of Health, US Department of Health and Human Services, under grants R01HG003474 and U54HG003067, and in part with federal funds from the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services, under contract HHSN272200900018C.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Labeit S, 2011, FASEB J, V25, P822, DOI 10.1096/fj.10-157412; Li BS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002944; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112	21	125	131	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1350	1355		10.1038/ng.3121	http://dx.doi.org/10.1038/ng.3121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25326702	Green Accepted, Green Submitted			2022-12-25	WOS:000345547300018
J	Zhao, M; Perry, JM; Marshall, H; Venkatraman, A; Qian, PX; He, XC; Ahamed, J; Li, LH				Zhao, Meng; Perry, John M.; Marshall, Heather; Venkatraman, Aparna; Qian, Pengxu; He, Xi C.; Ahamed, Jasimuddin; Li, Linheng			Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells	NATURE MEDICINE			English	Article							PROGENITOR CELLS; TGF-BETA; NICHE; IDENTIFICATION; GENERATION; EXPANSION	Multiple bone marrow stromal cell types have been identified as hematopoietic stem cell (HSC)-regulating niche cells(1-7). However, whether HSC progeny can serve directly as HSC niche cells has not previously been shown. Here we report a dichotomous role of megakaryocytes (MKs) in both maintaining HSC quiescence during homeostasis and promoting HSC regeneration after chemotherapeutic stress. We show that MKs are physically associated with HSCs in the bone marrow of mice and that MK ablation led to activation of quiescent HSCs and increased HSC proliferation. RNA sequencing (RNA-seq) analysis revealed that transforming growth factor beta 1 (encoded by Tgfb1) is expressed at higher levels in MKs as compared to other stromal niche cells. MK ablation led to reduced levels of biologically active TGF-beta 1 protein in the bone marrow and nuclear-localized phosphorylated SMAD2/3 (pSMAD2/3) in HSCs, suggesting that MKs maintain HSC quiescence through TGF-beta-SMAD signaling(8,9). Indeed, TGF-beta 1 injection into mice in which MKs had been ablated restored HSC quiescence, and conditional deletion of Tgfb1 in MKs increased HSC activation and proliferation. These data demonstrate that TGF-beta 1 is a dominant signal emanating from MKs that maintains HSC quiescence. However, under conditions of chemotherapeutic challenge, MK ablation resulted in a severe defect in HSC expansion. In response to stress, fibroblast growth factor 1 (FGF1) signaling from MKs transiently dominates over TGF-beta inhibitory signaling to stimulate HSC expansion(10,11). Overall, these observations demonstrate that MKs serve as HSC-derived niche cells to dynamically regulate HSC function.	[Zhao, Meng; Perry, John M.; Marshall, Heather; Venkatraman, Aparna; Qian, Pengxu; He, Xi C.; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Venkatraman, Aparna] Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Ahamed, Jasimuddin] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; Rockefeller University; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers.org	Qian, Pengxu/B-9376-2016	Qian, Pengxu/0000-0001-5636-6704; Zhao, Meng/0000-0001-7909-7594; Li, Linheng/0000-0001-9963-430X	Stowers Institute for Medical Research	Stowers Institute for Medical Research	We are grateful to members of the Li lab for scientific discussion and manuscript critical reading, M. Hembree, K. Zapien, D. Dukes and B. Lewis for technical support and K. Tannen for manuscript editing and proofreading. We thank H. Lin (Massachusetts General Hospital), who generously provided the CAGA-luc plasmid. We thank C. Deng (US National Institutes of Health) for providing Fgfr 1<SUP>flox/flox</SUP> mice. This work was funded by the Stowers Institute for Medical Research.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Brenet F, 2013, J EXP MED, V210, P623, DOI 10.1084/jem.20121610; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Heazlewood SY, 2013, STEM CELL RES, V11, P782, DOI 10.1016/j.scr.2013.05.007; Itkin T, 2012, BLOOD, V120, P1843, DOI 10.1182/blood-2011-11-394692; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kunisaki Y., 2013, NATURE, V23, P3865; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao M, 2012, BLOOD, V120, P1831, DOI 10.1182/blood-2011-11-393991	35	361	379	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2014	20	11					1321	1326		10.1038/nm.3706	http://dx.doi.org/10.1038/nm.3706			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AT1XM	25326798				2022-12-25	WOS:000344724300022
J	Kutys, ML; Yamada, KM				Kutys, Matthew L.; Yamada, Kenneth M.			An extracellular-matrix-specific GEE GAP interaction regulates Rho GTPase crosstalk for 3D collagen migration	NATURE CELL BIOLOGY			English	Article							BETA-PIX; SIGNAL-TRANSDUCTION; CELL-MIGRATION; FAMILY GTPASES; LEADING-EDGE; ACTIVATION; ADHESION; CDC42; COORDINATION; REVEALS	Rho-family GTPases govern distinct types of cell migration on different extracellular matrix proteins in tissue culture or three-dimensional (3D) matrices1-3. We searched for mechanisms selectively regulating 3D cell migration in different matrix environments4'5 and discovered a form of Cdc42-RhoA crosstalk governing cell migration through a specific pair of GTPase activator and inhibitor molecules. We first identified pPix, a guanine nucleotide exchange factor (GEF), as a specific regulator of migration in 3D collagen using an affinity-precipitation-based GEF screen. Knockdown of PPix specifically blocks cell migration in fibrillar collagen microenvironments, leading to hyperactive cellular protrusion accompanied by increased collagen matrix contraction. Live FRET imaging and RNAi knockdown linked this I3Pix knockdown phenotype to loss of polarized Cdc42 but not Racl activity, accompanied by enhanced, de-localized RhoA activity. Mechanistically, collagen phospho-regulates pPix, leading to its association with srGAP1, a GTPase-activating protein (GAP), needed to suppress RhoA activity. Our results reveal a matrix-specific pathway controlling migration involving a GEF-GAP interaction of f3Pix with srGAP1 that is critical for maintaining suppressive crosstalk between Cdc42 and RhoA during 3D collagen migration.	[Kutys, Matthew L.; Yamada, Kenneth M.] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kutys, ML (corresponding author), Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.	kutysml@mail.nih.gov; kyamada@mail.nih.gov		Kutys, Matthew/0000-0002-0752-649X	National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000718] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank W Daley, R. Petrie and D. Tran for critical reading of the manuscript. This study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH.	Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Coutinho-Budd J, 2012, J CELL SCI, V125, P3390, DOI 10.1242/jcs.098962; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Koh CG, 2001, J CELL SCI, V114, P4239; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mayhew MW, 2007, J CELL SCI, V120, P3911, DOI 10.1242/jcs.008177; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	38	58	60	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					909	917		10.1038/ncb3026	http://dx.doi.org/10.1038/ncb3026			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25150978	Green Accepted			2022-12-25	WOS:000341404400011
J	Shimoda, M; Principe, S; Jackson, HW; Luga, V; Fang, H; Molyneux, SD; Shao, YW; Aiken, A; Waterhouse, PD; Karamboulas, C; Hess, FM; Ohtsuka, T; Okada, Y; Ailles, L; Ludwig, A; Wrana, JL; Kislinger, T; Khokha, R				Shimoda, Masayuki; Principe, Simona; Jackson, Hartland W.; Luga, Valbona; Fang, Hui; Molyneux, Sam D.; Shao, Yang W.; Aiken, Alison; Waterhouse, Paul D.; Karamboulas, Christina; Hess, Franz M.; Ohtsuka, Takashi; Okada, Yasunori; Ailles, Laurie; Ludwig, Andreas; Wrana, Jeffrey L.; Kislinger, Thomas; Khokha, Rama			Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state	NATURE CELL BIOLOGY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; STROMAL FIBROBLASTS; BREAST-CANCER; TUMOR-CELLS; MEMBRANE-VESICLES; STEM-CELLS; TGF-BETA; EXOSOMES; METALLOPROTEINASES; METASTASIS	Cancer-associated fibroblasts (CAFs) drive tumour progression, but the emergence of this cell state is poorly understood. A broad spectrum of metalloproteinases, controlled by the Timp gene family, influence the tumour microenvironment in human cancers. Here, we generate quadruple TIMP knockout (TIMPless) fibroblasts to unleash metalloproteinase activity within the tumour-stromal compartment and show that complete Timp loss is sufficient for the acquisition of hallmark CAF functions. Exosomes produced by TIMPless fibroblasts induce cancer cell motility and cancer stem cell markers. The proteome of these exosomes is enriched in extracellular matrix proteins and the metalloproteinase ADAM10. Exosomal ADAM10 increases aldehyde dehydrogenase expression in breast cancer cells through Notch receptor activation and enhances motility through the GTPase RhoA. Moreover, ADAM 10 knockdown in TIMPless fibroblasts abrogates their CAF function. Importantly, human CAFs secrete ADAM 10-rich exosomes that promote cell motility and activate RhoA and Notch signalling in cancer cells. Thus, limps suppress cancer stroma where activated-fibroblast-secreted exosomes impact tumour progression.	[Shimoda, Masayuki; Principe, Simona; Jackson, Hartland W.; Fang, Hui; Molyneux, Sam D.; Shao, Yang W.; Aiken, Alison; Waterhouse, Paul D.; Karamboulas, Christina; Ailles, Laurie; Kislinger, Thomas; Khokha, Rama] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Luga, Valbona; Wrana, Jeffrey L.] Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Hess, Franz M.; Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany; [Ohtsuka, Takashi; Okada, Yasunori] Keio Univ, Sch Med, Tokyo 1608582, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; RWTH Aachen University; Keio University	Khokha, R (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Ludwig, Andreas/I-5685-2012; Kislinger, Thomas/A-5934-2008; Jackson, Hartland/AAL-7751-2020; Okada, Yasunori/B-5550-2014; Wrana, Jeffrey/F-8857-2013; OHTSUKA, TAKASHI/I-3988-2019	Ludwig, Andreas/0000-0001-8536-4986; Jackson, Hartland/0000-0001-6423-2415; Okada, Yasunori/0000-0001-9208-4755; OHTSUKA, TAKASHI/0000-0002-8039-9159; Waterhouse, Paul/0000-0001-8745-5224; Khokha, Rama/0000-0002-6028-1524; Kislinger, Thomas/0000-0003-3525-5540	JSPS; Canadian Institutes of Health Research; Ontario Institute of Cancer Research	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute of Cancer Research	The authors thank M. A. Di Grappa and S. R. Narala for technical assistance. M. Shimoda is supported by a JSPS postdoctoral fellowship for research abroad, and this work is supported by funding from the Canadian Institutes of Health Research and Ontario Institute of Cancer Research to the R.K. laboratory.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Casey TM, 2008, BREAST CANCER RES TR, V110, P39, DOI 10.1007/s10549-007-9684-7; Cruz-Munoz W, 2008, CRIT REV CL LAB SCI, V45, P291, DOI 10.1080/10408360801973244 ; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Giannoni E, 2013, J MOL MED, V91, P103, DOI 10.1007/s00109-012-0941-9; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nagumo H, 2000, AM J PHYSIOL-CELL PH, V278, pC57, DOI 10.1152/ajpcell.2000.278.1.C57; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shannon BA, 2009, HUM PATHOL, V40, P425, DOI 10.1016/j.humpath.2008.05.021; Shimoda M, 2013, PROTEOMICS, V13, P1624, DOI 10.1002/pmic.201200458; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trimis G, 2008, HUM MOL GENET, V17, P3596, DOI 10.1093/hmg/ddn252; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849	47	148	154	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2014	16	9					889	901		10.1038/ncb3021	http://dx.doi.org/10.1038/ncb3021			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AO5SA	25150980				2022-12-25	WOS:000341404400009
J	Riebold, M; Kozany, C; Freiburger, L; Sattler, M; Buchfelder, M; Hausch, F; Stalla, GK; Paez-Pereda, M				Riebold, Mathias; Kozany, Christian; Freiburger, Lee; Sattler, Michael; Buchfelder, Michael; Hausch, Felix; Stalla, Guenter K.; Paez-Pereda, Marcelo			A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease	NATURE MEDICINE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONES; RECEPTOR FUNCTION; BINDING DOMAIN; ATP-BINDING; NOVOBIOCIN; HSP70; GELDANAMYCIN; MODULATION; SILYMARIN	One function of the glucocorticoid receptor (GR) in corticotroph cells is to suppress the transcription of the gene encoding proopiomelanocortin (POMC), the precursor of the stress hormone adrenocorticotropin (ACTH)(1). Cushing disease is a neuroendocrine condition caused by partially glucocorticoid-resistant corticotroph adenomas that excessively secrete ACTH, which leads to hypercortisolism(2-4). Mutations that impair GR function explain glucocorticoid resistance only in sporadic cases(5,6). However, the proper folding of GR depends on direct interactions with the chaperone heat shock protein 90 (HSP90, refs. 7,8). We show here that corticotroph adenomas overexpress HSP90 compared to the normal pituitary. N- and C-terminal HSP90 inhibitors act at different steps of the HSP90 catalytic cycle to regulate corticotroph cell proliferation and GR transcriptional activity. C-terminal inhibitors cause the release of mature GR from HSP90, which promotes its exit from the chaperone cycle and potentiates its transcriptional activity in a corticotroph cell line and in primary cultures of human corticotroph adenomas. In an allograft mouse model, the C-terminal HSP90 inhibitor silibinin showed anti-tumorigenic effects, partially reverted hormonal alterations, and alleviated symptoms of Cushing disease. These results suggest that the pathogenesis of Cushing disease caused by overexpression of heat shock proteins and consequently misregulated GR sensitivity may be overcome pharmacologically with an appropriate HSP90 inhibitor.	[Riebold, Mathias; Stalla, Guenter K.; Paez-Pereda, Marcelo] Max Planck Inst Psychiat, Munich, Germany; [Kozany, Christian; Hausch, Felix] Max Planck Inst Psychiat, Dept Translat Res Psychiat, D-80804 Munich, Germany; [Freiburger, Lee; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci, D-80290 Munich, Germany; [Freiburger, Lee; Sattler, Michael] Helmholtz Zentrum, Inst Biol Struct, Munich, Germany; [Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany	Max Planck Society; Max Planck Society; Technical University of Munich; University of Munich; Helmholtz Association; University of Erlangen Nuremberg	Paez-Pereda, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	paezpereda@psych.mpg.de	Sattler, Michael/A-2407-2012	Sattler, Michael/0000-0002-1594-0527; Paez-Pereda, Marcelo/0000-0001-6029-0706	German Research Foundation [SFB1035]; Bayerisches Staatsministerium fur Wirtschaft, Infrastruktur, Verkehr und Technologie (m4 Award); Federal Ministry of Education and Research (BMBF; PersoMed); European Commission [FP7-PEOPLE-20112011-IIF 301193, Hsp90NMR]; European Molecular Biology Organization [EMBO ALTF 1255-2011]	German Research Foundation(German Research Foundation (DFG)); Bayerisches Staatsministerium fur Wirtschaft, Infrastruktur, Verkehr und Technologie (m4 Award); Federal Ministry of Education and Research (BMBF; PersoMed)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was partly supported by a grant from the German Research Foundation (SFB1035 to M.S.), the Bayerisches Staatsministerium fur Wirtschaft, Infrastruktur, Verkehr und Technologie (m4 Award to F.H. and M.P.-P.), Federal Ministry of Education and Research (BMBF; PersoMed to M.P.-P. and F.H.); and postdoctoral fellowships to L.F. from the European Commission (FP7-PEOPLE-20112011-IIF 301193, Hsp90NMR) and the European Molecular Biology Organization (EMBO ALTF 1255-2011). The expression plasmids for the HSP90-alpha CTD and GR were gifts from U. Hartl (Max Planck Institute of Biochemistry) and S. Simons Jr. (US National Institutes of Health), respectively. We thank J. Stalla and T. Kloss for technical assistance. We thank M. Theodoropoulou and K. Lucia for valuable comments on the manuscript.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Dahia PLM, 1999, ENDOCR REV, V20, P136, DOI 10.1210/er.20.2.136; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Kanelakis KC, 2002, J BIOL CHEM, V277, P33698, DOI 10.1074/jbc.M204164200; Kang KI, 1999, P NATL ACAD SCI USA, V96, P1439, DOI 10.1073/pnas.96.4.1439; Karl M, 1996, P ASSOC AM PHYSICIAN, V108, P296; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lamberts SWJ, 2002, MOL CELL ENDOCRINOL, V197, P69, DOI 10.1016/S0303-7207(02)00280-0; LEUNG CKH, 1982, VIRCHOWS ARCH A, V396, P303, DOI 10.1007/BF00431389; LIU B, 1992, MOL CELL BIOL, V12, P3978, DOI 10.1128/MCB.12.9.3978; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tritos NA, 2011, NAT REV ENDOCRINOL, V7, P279, DOI 10.1038/nrendo.2011.12; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhao HP, 2011, BIOORG MED CHEM LETT, V21, P2659, DOI 10.1016/j.bmcl.2010.12.088	41	69	70	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					276	+		10.1038/nm.3776	http://dx.doi.org/10.1038/nm.3776			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25665180				2022-12-25	WOS:000350362000021
J	Roccuzzo, M; Visintin, C; Tili, F; Visintin, R				Roccuzzo, Michela; Visintin, Clara; Tili, Federico; Visintin, Rosella			FEAR-mediated activation of Cdc14 is the limiting step for spindle elongation and anaphase progression	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE CHECKPOINT; POLO KINASE CDC5; SISTER-CHROMATID SEPARATION; COHESIN SUBUNIT SCC1; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; MICROTUBULE DYNAMICS; ASSEMBLY CHECKPOINT	Cleavage of cohesins and cyclin-dependent kinase (CDK) inhibition are thought to be sufficient for triggering chromosome segregation. Here we identify an essential requirement for anaphase chromosome movement. We show that, at anaphase onset, the phosphatase Cdc14 and the polo-like kinase Cdc5 are redundantly required to drive spindle elongation. This role of Cdc14 is mediated by the FEAR network, a group of proteins that activates Cdc14 at anaphase onset, and we suggest that Cdc5 facilitates both Cdc14 activation and CDK inhibition. We further identify the kinesin-5 motor protein Cin8 as a key target of Cdc14. Indeed, Cin8 mutants lacking critical CDK phosphorylation sites suppress the requirement for Cdc14 and Cdc5 in anaphase spindle elongation. Our results indicate that cohesin dissolution and CDK inhibition per se are not sufficient to drive sister chromatid segregation but that the motor protein Cin8 must be activated to elongate the spindle.	[Roccuzzo, Michela; Visintin, Clara; Tili, Federico; Visintin, Rosella] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Visintin, R (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.	rosella.visintin@ieo.eu	Visintin, Clara/AAR-8630-2020	Visintin, Rosella/0000-0001-6758-9946; Roccuzzo, Michela/0000-0002-0799-9369	International Early Career Scientist grant from the Howard Hughes Medical Institute; Associazione Italiana Ricerca sul Cancro [AIRC-IG-12878]; 'Armanda e Enrico Mirto' FIRC Fellowship	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); 'Armanda e Enrico Mirto' FIRC Fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank F. Uhlmann (LRI, UK), L. Ghebcr (Ben Gurion University, Israel), U. Surana), (IMCB, Singapore), A. Amon(MIT, USA), S. Gasser (FMI, Switzerland), A. Ruiner (Ottawa Institute of Systems Biology, Canada), E. Schiebel (ZMBH, Germany) and A. Marston (Wellcome Trust Centre tor Cell Biology, UK) for strains and reagents; L. fornasari for helping with statistical analyses; S. Piatti for critical discussion and A. Amon, R De Wulf, M. Foiani, A. Rudner and members ot our laboratory for critical reading of the manuscript. Work in the R.V. laboratory was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute, by a grant from the Associazione Italiana Ricerca sul Cancro (AIRC-IG-12878) to R.V. and by an 'Armanda e Enrico Mirto' FIRC Fellowship to F.T.	Agarwal R, 2003, J BIOL CHEM, V278, P45027, DOI 10.1074/jbc.M306783200; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Amon A, 2002, METHOD ENZYMOL, V351, P457; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Amon A, 2013, J CELL BIOL, V201, P843; Avunie-Masala R, 2011, J CELL SCI, V124, P873, DOI 10.1242/jcs.077396; Bouchoux C, 2011, CELL, V147, P803, DOI 10.1016/j.cell.2011.09.047; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hotz M, 2012, CELL CYCLE, V11, P3109, DOI 10.4161/cc.21504; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Liang FS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003319; Liang FS, 2009, MOL BIOL CELL, V20, P3671, DOI 10.1091/mbc.E08-10-1049; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Park CJ, 2008, EUKARYOT CELL, V7, P444, DOI 10.1128/EC.00283-07; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Rahal R, 2008, GENE DEV, V22, P1534, DOI 10.1101/gad.1638308; Rock JM, 2009, CURR BIOL, V19, pR1063, DOI 10.1016/j.cub.2009.10.002; Rozelle DK, 2011, J CELL BIOL, V193, P285, DOI 10.1083/jcb.201011002; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Toone WM, 1997, ANNU REV MICROBIOL, V51, P125, DOI 10.1146/annurev.micro.51.1.125; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Woodbury EL, 2007, J BIOL CHEM, V282, P32138, DOI 10.1074/jbc.M705344200; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X	59	26	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					251	+		10.1038/ncb3105	http://dx.doi.org/10.1038/ncb3105			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25706236				2022-12-25	WOS:000350770200010
J	Finan, B; Yang, B; Ottaway, N; Smiley, DL; Ma, T; Clemmensen, C; Chabenne, J; Zhang, L; Habegger, KM; Fischer, K; Campbell, JE; Sandoval, DL; Seeley, RJ; Bleicher, K; Uhles, S; Riboulet, W; Funk, J; Hertel, C; Belli, S; Sebokova, E; Conde-Knape, K; Konkar, A; Drucker, DJ; Gelfanov, V; Pfluger, PT; Muller, TD; Perez-Tilve, D; DiMarchi, RD; Tschop, MH				Finan, Brian; Yang, Bin; Ottaway, Nickki; Smiley, David L.; Ma, Tao; Clemmensen, Christoffer; Chabenne, Joe; Zhang, Lianshan; Habegger, Kirk M.; Fischer, Katrin; Campbell, Jonathan E.; Sandoval, Dar Leen; Seeley, Randy J.; Bleicher, Konrad; Uhles, Sabine; Riboulet, William; Funk, Jurgen; Hertel, Cornelia; Belli, Sara; Sebokova, Elena; Conde-Knape, Karin; Konkar, Anish; Drucker, Daniel J.; Gelfanov, Vasily; Pfluger, Paul T.; Muller, Timo D.; Perez-Tilve, Diego; DiMarchi, Richard D.; Tschop, Matthias H.			A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents	NATURE MEDICINE			English	Article							CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; GLP-1 RECEPTOR ACTIVATION; TRIPLE-ACTING AGONIST; GLUCAGON RECEPTORS; LEPTIN RESPONSIVENESS; METABOLIC BENEFITS; HYBRID PEPTIDE; WEIGHT; GLUCOSE; FAT	We report the discovery of a new monomeric peptide that reduces body weight and diabetic complications in rodent models of obesity by acting as an agonist at three key metabolically-related peptide hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. This triple agonist demonstrates supraphysiological potency and equally aligned constituent activities at each receptor, all without cross-reactivity at other related receptors. Such balanced unimolecular triple agonism proved superior to any existing dual coagonists and best-in-class monoagonists to reduce body weight, enhance glycemic control and reverse hepatic steatosis in relevant rodent models. Various loss-of-function models, including genetic knockout, pharmacological blockade and selective chemical knockout, confirmed contributions of each constituent activity in vivo. We demonstrate that these individual constituent activities harmonize to govern the overall metabolic efficacy, which predominantly results from synergistic glucagon action to increase energy expenditure, GLP-1 action to reduce caloric intake and improve glucose control, and GIP action to potentiate the incretin effect and buffer against the diabetogenic effect of inherent glucagon activity; These preclinical studies suggest that, so far, this unimolecular, polypharmaceutical strategy has potential to be the most effective pharmacological approach to reversing obesity and related metabolic disorders.	[Finan, Brian; Clemmensen, Christoffer; Fischer, Katrin; Pfluger, Paul T.; Muller, Timo D.; Tschop, Matthias H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Diabetes & Obes, Neuherberg, Germany; [Clemmensen, Christoffer; Fischer, Katrin; Pfluger, Paul T.; Muller, Timo D.; Tschop, Matthias H.] Tech Univ Munich, Div Metab, Dept Med, D-80290 Munich, Germany; [Finan, Brian; Yang, Bin; Smiley, David L.; Ma, Tao; Chabenne, Joe; Gelfanov, Vasily; DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Yang, Bin; Zhang, Lianshan] Marcadia Biotech, Carmel, IN USA; [Ottaway, Nickki; Sandoval, Dar Leen; Seeley, Randy J.; Perez-Tilve, Diego] Univ Cincinnati, Coll Med, Dept Internal Med, Metabol Dis Inst,Div Endocrinol, Cincinnati, OH USA; [Ma, Tao] Beijing Hanmi Pharm, Res Ctr, Beijing, Peoples R China; [Chabenne, Joe] AIT Labs, Indianapolis, IN USA; [Habegger, Kirk M.] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, Comprehens Diabet Ctr, Birmingham, AL USA; [Campbell, Jonathan E.; Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Bleicher, Konrad; Uhles, Sabine; Riboulet, William; Funk, Jurgen; Hertel, Cornelia; Belli, Sara; Sebokova, Elena; Conde-Knape, Karin; Konkar, Anish] HoffmannLa Roche Ltd, Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Roche Holding	Finan, B (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Diabetes & Obes, Neuherberg, Germany.	brian.finan@helmholtz-muenchen.de; rdimarch@indiana.edu; tschoep@helmholtz-muenchen.de	Drucker, Daniel J/A-4092-2010; Yang, Bin/J-4044-2015; Pfluger, Paul T/A-3770-2019; Müller, Timo D./AAZ-4445-2020; Clemmensen, Christoffer/N-4680-2017; Clemmensen, Christoffer/AAM-3347-2020; Funk, Juergen/AGD-6896-2022; Yang, Bin/W-7014-2019	Yang, Bin/0000-0003-4110-1513; Pfluger, Paul T/0000-0002-8118-7588; Clemmensen, Christoffer/0000-0003-2456-9667; Clemmensen, Christoffer/0000-0003-2456-9667; Yang, Bin/0000-0003-1180-6184; Seeley, Randy/0000-0002-3721-5625; Tschoep, Matthias/0000-0002-4744-371X; MA, TAO/0000-0001-9856-2631; Habegger, Kirk/0000-0002-0342-5480; Uhles, Sabine/0000-0002-2836-8726; Campbell, Jonathan/0000-0001-8223-1600; Muller, Timo/0000-0002-0624-9339; Gelfanov, Vasily/0000-0001-5216-5227; Perez-Tilve, Diego/0000-0002-0351-4133; Fischer, Katrin/0000-0001-5278-3949	Marcadia Biotech; F.Hoffmann-La Roche Ltd.; Deutsche Forschungsgesellschaft (DFG) [TS226/1-1]; Deutsches Zentrum fur Diabetesforschung (DZD); EurOCHIP [FP-7-HEALTH-2009-241592]	Marcadia Biotech; F.Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Deutsches Zentrum fur Diabetesforschung (DZD); EurOCHIP	ACKNOWLEDGMENTS We thank J. Levy for technical and chemical support of peptide synthesis. We thank J. Ford for cell culture maintenance. We thank J. Patterson, J. Day, B. Ward and C. Ouyang for discussions on chemical structure-activity relationships and seminal work in mixed agonist peptides. We thank J. Holland, J. Hembree, C. Raver, S. Amburgy, J. Pressler, J. Sorrell, D. Kuchler and L. Sehrer for assistance during in vivo pharmacological studies. At F. Hoffmann-La Roche Ltd., we thank A. Roeckel, A. Vandjour and E. Hainaut for assistance during in vivo pharmacological studies; M. Brecheisen, C. Richardson, G. Branellec and V. Ott for necropsy and immunohistological procedures; C. Apfel, C. Wohlgesinger and V. Griesser for bioanalytics; and M. Kapps, C. Flament, P. Schrag, C. Rapp, M.S. Gruyer, V. Dall'Asen, F. Schuler and M. Otteneder for assistance in pharmacokinetic studies. We thank M. Charron (Albert Einstein College of Medicine) for providing Gcgr<SUP>-I-</SUP> mice and Y. Seino (Kansai Electric Power Hospital) for providing Gipri- mice. Partial research funding was provided by Marcadia Biotech, which has been acquired by F.Hoffmann-La Roche Ltd., and by grants from the Deutsche Forschungsgesellschaft (DFG; TS226/1-1), Deutsches Zentrum fur Diabetesforschung (DZD), EurOCHIP (FP-7-HEALTH-2009-241592), Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases (through the Initiative and Networking Fund of the Helmholtz Association) and the Canadian Institutes of Health Research (93749).	Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Bhat VK, 2013, DIABETOLOGIA, V56, P1417, DOI 10.1007/s00125-013-2892-2; Bhat VK, 2013, BIOCHEM PHARMACOL, V85, P1655, DOI 10.1016/j.bcp.2013.03.009; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chabenne Joseph R, 2010, J Diabetes Sci Technol, V4, P1322; Clemmensen C, 2014, DIABETES, V63, P1422, DOI 10.2337/db13-1609; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Di Dalmazi G, 2013, ENDOCRINE, V44, P598, DOI 10.1007/s12020-013-9983-1; European Medicines Agency, 2009, EMEA3791722009; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Fosgerau K, 2013, DIABETES OBES METAB, V15, P62, DOI 10.1111/j.1463-1326.2012.01676.x; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Gault VA, 2013, J BIOL CHEM, V288, P35581, DOI 10.1074/jbc.M113.512046; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Ionut V, 2013, OBESITY, V21, P1093, DOI 10.1002/oby.20364; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Mukharji A, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.112; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Scrocchi LA, 1998, ENDOCRINOLOGY, V139, P3127, DOI 10.1210/en.139.7.3127; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Ward BP, 2013, MOL METAB, V2, P468, DOI 10.1016/j.molmet.2013.08.008; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004	34	367	394	6	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					27	36		10.1038/nm.3761	http://dx.doi.org/10.1038/nm.3761			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25485909				2022-12-25	WOS:000348408000010
J	Marvig, RL; Sommer, LM; Molin, S; Johansen, HK				Marvig, Rasmus Lykke; Sommer, Lea Mette; Molin, Soren; Johansen, Helle Krogh			Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis	NATURE GENETICS			English	Article							REGULATES BIOFILM FORMATION; DI-GMP PHOSPHODIESTERASE; RESISTANCE MECHANISMS; CARBAPENEM RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; EFFLUX PUMP; EPIDEMIOLOGY; POPULATIONS; MUTATIONS	Little is known about how within-host evolution compares between genotypically different strains of the same pathogenic species. We sequenced the whole genomes of 474 longitudinally collected clinical isolates of Pseudomonas aeruginosa sampled from 34 children and young individuals with cystic fibrosis. Our analysis of 36 P. aeruginosa lineages identified convergent molecular evolution in 52 genes. This list of genes suggests a role in host adaptation for remodeling of regulatory networks and central metabolism, acquisition of antibiotic resistance and loss of extracellular virulence factors. Furthermore, we find an ordered succession of mutations in key regulatory networks. Accordingly, mutations in downstream transcriptional regulators were contingent upon mutations in upstream regulators, suggesting that remodeling of regulatory networks might be important in adaptation. The characterization of genes involved in host adaptation may help in predicting bacterial evolution in patients with cystic fibrosis and in the design of future intervention strategies.	[Marvig, Rasmus Lykke; Johansen, Helle Krogh] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Marvig, Rasmus Lykke; Sommer, Lea Mette; Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Sommer, Lea Mette; Molin, Soren; Johansen, Helle Krogh] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	Rigshospitalet; University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Marvig, RL (corresponding author), Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.	rmarvig@gmail.com		Madsen Sommer, Lea Mette/0000-0002-1622-6691; Molin, Soren/0000-0002-7973-2639; Marvig, Rasmus L./0000-0002-5267-3173	Lundbeck Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R167-2013-15229] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015920, NNF10CC1016517] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank U.R. Johansen, P. Poss, H. Nordbjerg, N. Kirkby, K. Bloksted and B.H. Erichsen for excellent technical assistance and T. Pressler and M. Skov for information about the patients' visits to the hospital. This work was supported by the Lundbeck Foundation, and H.K.J. was supported by a clinical research stipend from the Novo Nordisk Foundation.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Ballestero S, 1996, J ANTIMICROB CHEMOTH, V38, P39, DOI 10.1093/jac/38.1.39; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Damkiaer S, 2013, P NATL ACAD SCI USA, V110, P7766, DOI 10.1073/pnas.1221466110; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grad YH, 2014, LANCET INFECT DIS, V14, P220, DOI 10.1016/S1473-3099(13)70693-5; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Heeb S, 2006, J MOL BIOL, V355, P1026, DOI 10.1016/j.jmb.2005.11.045; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoiby N., 2000, CYSTIC FIBROSIS, V2nd, P83; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Huse HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082621; Islam S, 2004, CLIN MICROBIOL INFEC, V10, P877, DOI 10.1111/j.1469-0691.2004.00991.x; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Johansen HK, 2008, J CYST FIBROS, V7, P391, DOI 10.1016/j.jcf.2008.02.003; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; LUZAR MA, 1985, INFECT IMMUN, V50, P572, DOI 10.1128/IAI.50.2.572-576.1985; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Pasca MR, 2012, MICROB DRUG RESIST, V18, P23, DOI 10.1089/mdr.2011.0019; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Waine DJ, 2008, J CLIN MICROBIOL, V46, P3491, DOI 10.1128/JCM.00357-08; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; YU H, 1995, J BACTERIOL, V177, P3259, DOI 10.1128/jb.177.11.3259-3268.1995; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZIMAKOFF J, 1983, J HOSP INFECT, V4, P31, DOI 10.1016/0195-6701(83)90062-2	64	333	333	3	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					57	+		10.1038/ng.3148	http://dx.doi.org/10.1038/ng.3148			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25401299				2022-12-25	WOS:000346990400012
J	Chanut-Delalande, H; Hashimoto, Y; Pelissier-Monier, A; Spokony, R; Dib, A; Kondo, T; Bohere, J; Niimi, K; Latapie, Y; Inagaki, S; Dubois, L; Valenti, P; Polesello, C; Kobayashi, S; Moussian, B; White, KP; Plaza, S; Kageyama, Y; Payre, F				Chanut-Delalande, Helene; Hashimoto, Yoshiko; Pelissier-Monier, Anne; Spokony, Rebecca; Dib, Azza; Kondo, Takefumi; Bohere, Jerome; Niimi, Kaori; Latapie, Yvan; Inagaki, Sachi; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Kobayashi, Satoru; Moussian, Bernard; White, Kevin P.; Plaza, Serge; Kageyama, Yuji; Payre, Francois			Pri peptides are mediators of ecdysone for the temporal control of development	NATURE CELL BIOLOGY			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; DROSOPHILA-MELANOGASTER; EPIDERMIS DIFFERENTIATION; ECDYSTEROID BIOSYNTHESIS; MORPHOLOGICAL EVOLUTION; TRANSCRIPTION FACTOR; CELL MORPHOGENESIS; P450 ENZYME; ECR GENE	Animal development fundamentally relies on the precise control, in space and time, of genome expression. Whereas we have a wealth of information about spatial patterning, the mechanisms underlying temporal control remain poorly understood. Here we show that Pri peptides, encoded by small open reading frames, are direct mediators of the steroid hormone ecdysone for the timing of developmental programs in Drosophila. We identify a previously uncharacterized enzyme of ecdysone biosynthesis, GstE14, and find that ecdysone triggers pri expression to define the onset of epidermal trichome development, through post-translational control of the Shavenbaby transcription factor. We show that manipulating pri expression is sufficient to either put on hold or induce premature differentiation of trichomes. Furthermore, we find that ecdysone-dependent regulation of pri is not restricted to epidermis and occurs over various tissues and times. Together, these findings provide a molecular framework to explain how systemic hormonal control coordinates specific programs of differentiation with developmental timing.	[Chanut-Delalande, Helene; Pelissier-Monier, Anne; Dib, Azza; Bohere, Jerome; Latapie, Yvan; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Plaza, Serge; Payre, Francois] Univ Toulouse, UPS, Ctr Biol Dev, F-31062 Toulouse 9, France; [Chanut-Delalande, Helene; Pelissier-Monier, Anne; Dib, Azza; Bohere, Jerome; Latapie, Yvan; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Plaza, Serge; Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, F-31062 Toulouse 9, France; [Hashimoto, Yoshiko; Kondo, Takefumi; Kobayashi, Satoru] Natl Inst Nat Sci Okazaki, Okazaki Inst Integrat Biosci, Aichi 4448787, Japan; [Spokony, Rebecca; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Spokony, Rebecca; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Niimi, Kaori; Inagaki, Sachi; Kageyama, Yuji] Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Genom, Kobe, Hyogo 657850, Japan; [Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Kageyama, Yuji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657850, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Chicago; University of Chicago; Kobe University; Eberhard Karls University of Tubingen; Kobe University	Kageyama, Y (corresponding author), Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Genom, Kobe, Hyogo 657850, Japan.	kageyama@ruby.kobe-u.ac.jp; francois.payre@univ-tlse3.fr	Spokony, Rebecca/AAD-3014-2020; plaza, serge/F-5290-2015; Inagaki, Sachi/P-8036-2019; Cédric, POLESELLO/ABC-3406-2021	Inagaki, Sachi/0000-0002-2365-9938; Moussian, Bernard/0000-0002-2854-9500; CHANUT-DELALANDE, Helene/0000-0002-1720-2069; Kondo, Takefumi/0000-0001-8127-1141; PAYRE, Francois/0000-0002-8144-6711; Bohere, Jerome/0000-0001-8305-129X	ANR (smORFpeptides and Chrononet); Association pour la Recherche sur le Cancer [12011669]; Azm & Saade Association; JST PRESTO program; MEXT KAKENHI [21115007]; Fondation RITC; Grants-in-Aid for Scientific Research [25114002] Funding Source: KAKEN	ANR (smORFpeptides and Chrononet)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Azm & Saade Association; JST PRESTO program; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fondation RITC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to FlyBase and the Bloomington,Vienna and Kyoto stock centres, as well as R. Niwa, M. Kamimura and J. Colombani for providing flies, and H. Bellen for bacterial artificial chromosome constructs. We thank B. Ronsin (Toulouse RIO Imaging) for help with microscopy and O. Bohner for technical assistance. We also thank A. Khila, A. Vincent, P. Leopold and E. France for critical reading of the manuscript, and are indebted to R. Niwa for sharing unpublished results. This work was supported by ANR (smORFpeptides and Chrononet), Association pour la Recherche sur le Cancer (12011669), Azm & Saade Association, JST PRESTO program, MEXT KAKENHI (21115007) and Fondation RITC.	Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Andrew DJ, 2008, DEV DYNAM, V237, P1198, DOI 10.1002/dvdy.21512; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Carney GE, 2000, GENETICS, V154, P1203; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Chanut-Delalande H, 2012, SEMIN CELL DEV BIOL, V23, P341, DOI 10.1016/j.semcdb.2012.03.002; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chavoshi TM, 2010, MECH DEVELOP, V127, P308, DOI 10.1016/j.mod.2010.01.003; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Dunne JC, 2002, DEV BIOL, V245, P172, DOI 10.1006/dbio.2002.0632; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Fluegel ML, 2006, GENETICS, V172, P185, DOI 10.1534/genetics.105.046565; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Hanada K, 2013, P NATL ACAD SCI USA, V110, P2395, DOI 10.1073/pnas.1213958110; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kamimura M, 2012, J BIOL CHEM, V287, P16488, DOI 10.1074/jbc.M112.341180; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McLean PF, 2013, SCIENCE, V340, P1445, DOI 10.1126/science.1234887; Menoret D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r86; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pi HW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-42; POODRY CA, 1970, ROUX ARCH DEV BIOL, V166, P1, DOI 10.1007/BF00576805; Pueyo JI, 2011, DEV BIOL, V355, P183, DOI 10.1016/j.ydbio.2011.03.033; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Riddiford Lynn M., 1993, P899; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Talamillo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003473; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	66	55	61	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1035	+		10.1038/ncb3052	http://dx.doi.org/10.1038/ncb3052			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AT2EF	25344753				2022-12-25	WOS:000344744000003
J	Julien, O; Kampmann, M; Bassik, MC; Zorn, JA; Venditto, VJ; Shimbo', K; Agard, NJ; Shimada, K; Rheingold, AL; Stockwell, BR; Weissman, JS; Wells, JA				Julien, Olivier; Kampmann, Martin; Bassik, Michael C.; Zorn, Julie A.; Venditto, Vincent J.; Shimbo', Kazutaka; Agard, Nicholas J.; Shimada, Kenichi; Rheingold, Arnold L.; Stockwell, Brent R.; Weissman, Jonathan S.; Wells, James A.			Unraveling the mechanism of cell death induced by chemical fibrils	NATURE CHEMICAL BIOLOGY			English	Article							GENETIC INTERACTION MAPS; RAB GTPASES; PROPAGATION; PROTEIN; PROCASPASE-3; MATURATION; INHIBITORS; APOPTOSIS; PLATFORM; DISEASES	We previously discovered a small-molecule inducer of cell death, named 1541, that noncovalently self-assembles into chemical fibrils ('chemi-fibrils') and activates procaspase-3 in vitro. We report here that 1541-induced cell death is caused by the fibrillar rather than the soluble form of the drug. A short hairpin RNA screen reveals that knockdown of genes involved in endocytosis, vesicle trafficking and lysosomal acidification causes partial 1541 resistance. We confirm the role of these pathways using pharmacological inhibitors. Microscopy shows that the fluorescent chemi-fibrils accumulate in punctae inside cells that partially colocalize with lysosomes. Notably, the chemi-fibrils bind and induce liposome leakage in vitro, suggesting they may do the same in cells. The chemi-fibrils induce extensive proteolysis including caspase substrates, yet modulatory profiling reveals that chemi-fibrils form a distinct class from existing inducers of cell death. The chemi-fibrils share similarities with proteinaceous fibrils and may provide insight into their mechanism of cellular toxicity.	[Julien, Olivier; Zorn, Julie A.; Shimbo', Kazutaka; Agard, Nicholas J.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Kampmann, Martin; Bassik, Michael C.; Weissman, Jonathan S.; Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Venditto, Vincent J.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Shimada, Kenichi; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Rheingold, Arnold L.] Univ Calif San Diego, Dept Chem, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	jim.wells@ucsf.edu	Julien, Olivier/A-1594-2013; Julien, Olivier/N-9198-2019; Rheingold, Arnold/U-4735-2019; Stockwell, Brent R/AAE-7200-2019; Shimada, Kenichi/AAD-7996-2021; Wells, Jim A/O-9854-2016; Agard, Nicholas/AAU-6495-2020	Julien, Olivier/0000-0001-7068-7299; Rheingold, Arnold/0000-0003-4472-8127; Stockwell, Brent R/0000-0002-3532-3868; Shimada, Kenichi/0000-0001-8540-9785; Kampmann, Martin/0000-0002-3819-7019; Agard, Nicholas/0000-0003-4916-2484; Weissman, Jonathan/0000-0003-2445-670X	US National Institutes of Health [R01 CA136779, R01 CA097061, F32AI095062]; Howard Hughes Medical Institute; Achievement Rewards for College Scientists Foundation Award; Schleroderma Research Foundation Evnin-Wright Fellowship; Jane Coffin Childs Memorial Fund; Canadian Institutes of Health Research; Government of Canada; University of California-San Francisco Program for Breakthrough Biomedical Research; Sandler Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA136779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI095062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081051, P41GM103481, T32GM064337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Achievement Rewards for College Scientists Foundation Award; Schleroderma Research Foundation Evnin-Wright Fellowship; Jane Coffin Childs Memorial Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Canada(CGIAR); University of California-San Francisco Program for Breakthrough Biomedical Research; Sandler Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank F. Brodsky, B. Shoichet, W Degrado, M. Zhuang, A. Wilts, Z. Hill, J.T. Koerber, N. Thomsen, J. Watts, S.-A. Mok and J. Rettenmaier for insightful discussions and/or critical reading of the manuscript. A special thanks to Y. Chen (cell culture and laboratory practices expertise), Y. Cheng and M. Braunfield (EM), A. Doak (DLS), H. Tran (yeast expertise), D. Larsen (live cell imaging), J. Lund (deep sequencing), M. Hornsby and K. Verbs (fluorescence) and T. Matsuguchi (qPCR) for technical help. This work was supported, in whole or in part, by US National Institutes of Health grant R01 CA136779 (to J.A.W.), R01 CA097061 (to B.R.S.) and F32AI095062 (to V.J.V.) and by the Howard Hughes Medical Institute (to B.R.S. and J.S.W.). J.A.Z. received an Achievement Rewards for College Scientists Foundation Award and a Schleroderma Research Foundation Evnin-Wright Fellowship. M.K. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund. O.J. is the recipient of a Banting Postdoctoral Fellowship funded by the Canadian Institutes of Health Research and the Government of Canada. O.J. and M.K. both received a fellowship from the University of California-San Francisco Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation.	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Huff ME, 2003, CURR OPIN STRUC BIOL, V13, P674, DOI 10.1016/j.sbi.2003.10.010; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Owen SC, 2014, ACS CHEM BIOL, V9, P777, DOI 10.1021/cb4007584; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shimbo K, 2012, P NATL ACAD SCI USA, V109, P12432, DOI 10.1073/pnas.1208616109; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wiita AP, 2014, METHOD ENZYMOL, V544, P327, DOI 10.1016/B978-0-12-417158-9.00013-3; Wiita AP, 2013, ELIFE, V2, DOI 10.7554/eLife.01236; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; Zorn JA, 2012, J BIOL CHEM, V287, P33781, DOI 10.1074/jbc.M112.386128; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	33	38	38	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					969	976		10.1038/NCHEMBIO.1639	http://dx.doi.org/10.1038/NCHEMBIO.1639			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25262416	Green Submitted, Green Accepted			2022-12-25	WOS:000343621500021
J	Raina, K; Noblin, DJ; Serebrenik, YV; Adams, A; Zhao, C; Crews, CM				Raina, Kanak; Noblin, Devin J.; Serebrenik, Yevgeniy V.; Adams, Alison; Zhao, Connie; Crews, Craig M.			Targeted protein destabilization reveals an estrogen-mediated ER stress response	NATURE CHEMICAL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; RECEPTOR-ALPHA; INDEPENDENT ACTIVATION; MAMMALIAN-CELLS; GENE-EXPRESSION; FUSION PROTEINS; DEGRADATION; IRE1; PATHWAY; ATF6	Accumulation of unfolded proteins within the endoplasmic reticulum (ER) of eukaryotic cells leads to an unfolded protein response (UPR) that either restores homeostasis or commits the cells to apoptosis. Tools traditionally used to study the UPR are proapoptotic and thus confound analysis of long-term cellular responses to ER stress. Here, we describe an ER-localized Halo Tag (ERHT) protein that can be conditionally destabilized using a small-molecule hydrophobic tag (HyT36). Treatment of ERHT-expressing cells with HyT36 induces acute, resolvable ER stress that results in transient UPR activation without induction of apoptosis. Transcriptome analysis of late-stage responses to this UPR stimulus reveals a link between UPR activity and estrogen signaling.	[Raina, Kanak; Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Noblin, Devin J.; Serebrenik, Yevgeniy V.; Adams, Alison; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Zhao, Connie] Yale Univ, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Crews, CM (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	craig.crews@yale.edu	Crews, Craig M./ABH-9346-2020	Crews, Craig M./0000-0002-8456-2005; Zhao, Connie/0000-0002-8275-8688; Serebrenik, Yevgeniy/0000-0002-9247-5243	US National Institutes of Health [R01AI084140, R01CA083049, T32GM067543]; Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067543, T32GM007324] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to acknowledge financial support from the US National Institutes of Health (R01AI084140, R01CA083049 and T32GM067543) and the Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program.	Bernasconi R, 2013, MOL CELL, V52, P783, DOI 10.1016/j.molcel.2013.10.016; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carlberg M, 1996, CARCINOGENESIS, V17, P2589, DOI 10.1093/carcin/17.12.2589; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han XX, 2013, J NEUROSCI, V33, P2671, DOI 10.1523/JNEUROSCI.4937-12.2013; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Kang BH, 2010, CLIN CANCER RES, V16, P4779, DOI 10.1158/1078-0432.CCR-10-1818; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Li QX, 2001, ENDOCRINOLOGY, V142, P2390, DOI 10.1210/en.142.6.2390; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mercier I, 2009, AM J PATHOL, V174, P1172, DOI 10.2353/ajpath.2009.080882; Mori A, 2011, NEUROCHEM INT, V58, P344, DOI 10.1016/j.neuint.2010.12.010; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Neklesa TK, 2013, ACS CHEM BIOL, V8, P2293, DOI 10.1021/cb400569k; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tae HS, 2012, CHEMBIOCHEM, V13, P538, DOI 10.1002/cbic.201100793; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Thompson CJ, 2002, ENDOCRINOLOGY, V143, P2093, DOI 10.1210/en.143.6.2093; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Y, 2000, J BIOL CHEM, V275, P27013	48	52	53	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					957	962		10.1038/NCHEMBIO.1638	http://dx.doi.org/10.1038/NCHEMBIO.1638			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25242550	Green Accepted			2022-12-25	WOS:000343621500019
J	van der Hoff, H				van der Hoff, Hilary			Antibody claims granted by the European Patent Office	NATURE BIOTECHNOLOGY			English	Editorial Material									Mewburn Ellis LLP, Cambridge, England		van der Hoff, H (corresponding author), Mewburn Ellis LLP, Cambridge, England.	hilary.vanderhoff@mewburn.com						Di Padova F, 2011, IL-17 antagonistic antibodies, Patent No. [EP 1776142, 1776142]; Fukuzawa H., 2010, Polypeptide having a delta 5 fatty acid unsaturating activity, poly-. nucleotide coding for the polypeptide and use thereof, Patent No. [EP1780275, 1780275]; Funaro A., 2011, Antibodies against human cytomegalovirus (HCMV), Patent No. [EP2126049, 2126049]; Gelber C., 2011, Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof, Patent No. [EP1204683, 1204683]; Heinegard D., 2011, Method for determining a tissue degradation process by detection of COMP neoepitopes, Patent No. [EP1766411, 1766411]; Jacquemin M., 2011, Human inhibitory anti-factor VIII antibodies binding to the A2 domain, Patent No. [EP1910420, 1910420]; Klemt V., 2011, Method of detecting ProBNP with a monoclonal antibody binding to the amino acids 42-46, Patent No. [EP 1625164, 1625164]; Matsuo M., 2011, Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody, Patent No. [EP1832654, 1832654]; Ohashi T., 2010, Hybridoma capable of producing a monoclonal antibody specific to tartrate-resistant acid phosphatase 5b (TRACP 5b), Patent No. [EP 1359161, 1359161]; Pilkington G., 2011, OVR110 antibody compositions and methods of use, Patent No. [EP1633784, 1633784]; Rinderknecht E., 2011, Linear VH-CH1-VH-CH1 heavy chain antibody fragment, Patent No. [EP1752465, 1752465]; Roschke V., 2011, Human G-protein chemokine receptor (CCR5) HDGNR10, Patent No. [EP 1366058, 1366058]; Salamone S., 2010, Doxorubicin immunoassay, Patent No. [EP 1864129, 1864129]; Shiver J., 2011, Human antibodies interacting with HIV gp41, Patent No. [EP1765398, 1765398]; Throsby M., 2011, Binding molecules capable of neutralizing West Nile virus and uses thereof, Patent No. [EP1828247, 1828247]; Wang X., 2010, Gene engineering recombinant anti-CEA. Anti-CD3 and anti-CD28 single-chain tri-specific antibody, Patent No. [EP1736484, 1736484]	16	1	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1094	1099	10.1038/nbt.3054	10.1038/nbt.3054	http://dx.doi.org/10.1038/nbt.3054			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380442				2022-12-25	WOS:000344977000011
J	Xu, C; Wang, X; Liu, K; Roundtree, IA; Tempel, W; Li, YJ; Lu, ZK; He, C; Min, JR				Xu, Chao; Wang, Xiao; Liu, Ke; Roundtree, Ian A.; Tempel, Wolfram; Li, Yanjun; Lu, Zhike; He, Chuan; Min, Jinrong			Structural basis for selective binding of m(6)A RNA by the YTHDC1 YTH domain	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR-RNA; PROTEIN; N6-METHYLADENOSINE; REVEALS; SITES	N-6-methyladenosine (m(6)A) is the most abundant internal modification of nearly all eukaryotic mRNAs and has recently been reported to be recognized by the YTH domain family proteins. Here we present the crystal structures of the YTH domain of YTHDC1, a member of the YTH domain family, and its complex with an m(6)A-containing RNA. Our structural studies, together with transcriptome-wide identification of YTHDC1-binding sites and biochemical experiments, not only reveal the specific mode of m(6)A-YTH binding but also explain the preferential recognition of the GG(m(6)A)C sequences by YTHDC1.	[Xu, Chao; Liu, Ke; Tempel, Wolfram; Li, Yanjun; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Wang, Xiao; Lu, Zhike; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Wang, Xiao; Li, Yanjun; Lu, Zhike] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wang, Xiao; Roundtree, Ian A.; Lu, Zhike; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Roundtree, Ian A.] Univ Chicago, Med Scientist Training Program, Chicago, IL 60637 USA; [Roundtree, Ian A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Toronto	Xu, C (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	chao.xu@utoronto.ca; chuanhe@uchicago.edu; jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; , KE/0000-0002-7082-262X; Wang, Xiao/0000-0002-3090-9894	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Howard Hughes Medical Institute; National Science Foundation [CHE-1048528]	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	We would like to thank J. Walker for assistance in structure determination. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute (OGI-055), GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z to J.M.). C.H. is supported by the Howard Hughes Medical Institute as an investigator. The Mass Spectrometry Facility of the University of Chicago is funded by the National Science Foundation (CHE-1048528).	Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hirschfeld M, 2014, MOL CARCINOGEN, V53, P883, DOI 10.1002/mc.22045; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Zhang B, 2010, INT J GYNECOL CANCER, V20, P492, DOI 10.1111/IGC.0b013e3181d66ffe; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	23	390	409	12	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					927	929		10.1038/NCHEMBIO.1654	http://dx.doi.org/10.1038/NCHEMBIO.1654			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25242552				2022-12-25	WOS:000343621500014
J	Chua, CW; Shibata, M; Lei, M; Toivanen, R; Barlow, LJ; Bergren, SK; Badani, KK; Mc Kiernan, JM; Benson, MC; Hibshoosh, H; Shen, MM				Chua, Chee Wai; Shibata, Maho; Lei, Ming; Toivanen, Roxanne; Barlow, LaMont J.; Bergren, Sarah K.; Badani, Ketan K.; Mc Kiernan, James M.; Benson, Mitchell C.; Hibshoosh, Hanina; Shen, Michael M.			Single luminal epithelial progenitors can generate prostate organoids in culture	NATURE CELL BIOLOGY			English	Article							IN-VITRO EXPANSION; STEM-CELLS; SELF-RENEWAL; MOUSE MODEL; CANCER; BASAL; ANDROGEN; DIFFERENTIATION; ADENOCARCINOMA; NKX3.1	The intrinsic ability to exhibit self-organizing morphogenetic properties in ex vivo culture may represent a general property of tissue stem cells. Here we show that single luminal stem/progenitor cells can generate prostate organoids in a three-dimensional culture system in the absence of stroma. Organoids generated from CARNs (castration-resistant Nkx3.1-expressing cells) or normal prostate epithelia exhibit tissue architecture containing luminal and basal cells, undergo long-term expansion in culture and exhibit functional androgen receptor signalling. Lineage-tracing demonstrates that luminal cells are favoured for organoid formation and generate basal cells in culture. Furthermore, tumour organoids can initiate from CARNs after oncogenic transformation and from mouse models of prostate cancer, and can facilitate analyses of drug response. Finally, we provide evidence supporting the feasibility of organoid studies of human prostate tissue. Our studies underscore the progenitor properties of luminal cells, and identify in vitro approaches for studying prostate biology.	[Chua, Chee Wai; Shibata, Maho; Lei, Ming; Toivanen, Roxanne; Bergren, Sarah K.; Shen, Michael M.] Columbia Univ, Dept Med, Herbert Irving Comprehens Canc Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Chua, Chee Wai; Shibata, Maho; Lei, Ming; Toivanen, Roxanne; Bergren, Sarah K.; Shen, Michael M.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Chua, Chee Wai; Shibata, Maho; Lei, Ming; Toivanen, Roxanne; Bergren, Sarah K.; Shen, Michael M.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol, New York, NY 10032 USA; [Chua, Chee Wai; Shibata, Maho; Lei, Ming; Toivanen, Roxanne; Barlow, LaMont J.; Bergren, Sarah K.; Badani, Ketan K.; Mc Kiernan, James M.; Benson, Mitchell C.; Shen, Michael M.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10032 USA; [Hibshoosh, Hanina] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Shen, MM (corresponding author), Columbia Univ, Dept Med, Herbert Irving Comprehens Canc Ctr, Coll Phys & Surg, New York, NY 10032 USA.	mshen@columbia.edu	Chua, Chee Wai/G-4135-2014; Shibata, Maho/A-3912-2015; Shen, Michael M/C-7546-2009; Shibata, Maho/I-6782-2019	Shibata, Maho/0000-0002-7056-3939; Shen, Michael M/0000-0002-4042-1657; Shibata, Maho/0000-0002-7056-3939; Shen, Mouquan/0000-0001-6448-4866; Chua, Chee Wai/0000-0002-9634-7265	DOD; Urology Care Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA154293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076602] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Urology Care Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kruithof-de Julio, M. Hanoun and P. Frenette for initial discussions about organoid culture, C. Sawyers and C. Abate-Shen for providing pathway inhibitors, C. Liu and the HICCC Flow Cytometry Shared Resource for flow-sorting, D. Sun for assistance with specimen acquisition, the HICCC Molecular Pathology Shared Resource for organoid sectioning and H&E staining, F. Tales for helpful comments on the culture protocol, D-E Parfitt for assistance with cell-picking, and C. Abate-Shen and F. Tabs for insightful discussions and comments on the manuscript. This work was supported by postdoctoral fellowships from the DOD Prostate Cancer Research Program (C.W.C., M.S. and R.T.), by a Residency Research Award from the Urology Care Foundation (L.J.B.), and by grants from the National Institutes of Health (M.M.S.).	Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Cano P, 2007, CANCER RES, V67, P511, DOI 10.1158/0008-5472.CAN-06-1478; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Floc'h N, 2012, CANCER RES, V72, P4483, DOI 10.1158/0008-5472.CAN-12-0283; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Guo Changyong, 2012, Methods Mol Biol, V879, P315, DOI 10.1007/978-1-61779-815-3_18; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kim MJ, 2002, CANCER RES, V62, P2999; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Korenchuk S, 2001, IN VIVO, V15, P163; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lang SH, 2006, IN VITRO CELL DEV-AN, V42, P273; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Masumori N, 2001, CANCER RES, V61, P2239; MCKEEHAN WL, 1984, CANCER RES, V44, P1998; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Ranga A, 2014, ADV DRUG DELIVER REV, V69, P19, DOI 10.1016/j.addr.2014.02.006; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi XD, 2007, DEV BIOL, V312, P396, DOI 10.1016/j.ydbio.2007.09.042; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Toivanen R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005688; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018271	65	214	222	6	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					951	961		10.1038/ncb3047	http://dx.doi.org/10.1038/ncb3047			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25241035	Green Accepted			2022-12-25	WOS:000342712200005
J	Prater, MD; Petit, V; Russell, IA; Giraddi, RR; Shehata, M; Menon, S; Schulte, R; Kalajzic, I; Rath, N; Olson, MF; Metzger, D; Faraldo, MM; Deugnier, MA; Glukhova, MA; Stingl, J				Prater, Michael D.; Petit, Valerie; Russell, I. Alasdair; Giraddi, Rajshekhar R.; Shehata, Mona; Menon, Suraj; Schulte, Reiner; Kalajzic, Ivo; Rath, Nicola; Olson, Michael F.; Metzger, Daniel; Faraldo, Marisa M.; Deugnier, Marie-Ange; Glukhova, Marina A.; Stingl, John			Mammary stem cells have myoepithelial cell properties	NATURE CELL BIOLOGY			English	Article							DISSOCIATION; POPULATIONS; EXPRESSION; CONTRIBUTE; PROTEINS; BINDING; GLAND	Contractile myoepithelial cells dominate the basal layer of the mammary epithelium and are considered to be differentiated cells. However, we observe that up to 54% of single basal cells can form colonies when seeded into adherent culture in the presence of agents that disrupt actin-myosin interactions, and on average, 65% of the single-cell-derived basal colonies can repopulate a mammary gland when transplanted in vivo. This indicates that a high proportion of basal myoepithelial cells can give rise to a mammary repopulating unit (MRU). We demonstrate that myoepithelial cells, flow-sorted using two independent myoepithelial-specific reporter strategies, have MRU capacity. Using an inducible lineage-tracing approach we follow the progeny of myoepithelial cells that express a-smooth muscle actin and show that they function as long-lived lineage-restricted stem cells in the virgin state and during pregnancy.	[Prater, Michael D.; Russell, I. Alasdair; Giraddi, Rajshekhar R.; Shehata, Mona; Menon, Suraj; Schulte, Reiner; Stingl, John] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Petit, Valerie; Faraldo, Marisa M.; Deugnier, Marie-Ange; Glukhova, Marina A.] Inst Curie, Ctr Rech, F-75248 Paris, France; [Petit, Valerie; Faraldo, Marisa M.; Deugnier, Marie-Ange; Glukhova, Marina A.] CNRS, UMR144, F-75248 Paris, France; [Kalajzic, Ivo] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Rath, Nicola; Olson, Michael F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Metzger, Daniel] Univ Strasbourg, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS,INSERM, F-67404 Illkirch Graffenstaden, France	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Connecticut; Beatson Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Glukhova, MA (corresponding author), Inst Curie, Ctr Rech, F-75248 Paris, France.	marina.glukhova@curie.fr; john.stingl@cruk.cam.ac.uk	Olson, Michael/ABA-4240-2021; Martin-Faraldo, Maria-Luisa/M-5811-2018; Deugnier, Marie-Ange/AAF-5877-2021; Rath, Nicola/M-6766-2015; Deugnier, Marie-Ange/M-7556-2018	Olson, Michael/0000-0003-3428-3507; Deugnier, Marie-Ange/0000-0002-2199-1099; Rath, Nicola/0000-0002-2342-6843; Faraldo, Marisa/0000-0001-9497-1171; Schulte, Reiner/0000-0003-4928-2857; PETIT, Valerie/0000-0003-1645-9396; Metzger, Daniel/0000-0002-5555-046X; Giraddi, Rajshekhar/0000-0001-9728-7674	Cancer Research UK; Breast Cancer Campaign; University of Cambridge; Hutchison Whampoa Limited; La Ligue Nationale Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche [ANR-08-BLAN-0078-01, ANR-13-BSV2-0001]; Cancer Research UK [10208, 18276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; La Ligue Nationale Contre le Cancer (Equipe Labelisee); Agence Nationale de la Recherche(French National Research Agency (ANR)); Cancer Research UK(Cancer Research UK)	We thank A. Saadi for contributing to data interpretation and A. Chiche, G. Carita, T. Makdessi and A. Di-Cicco for help with lineage-tracing experiments. We are grateful to P. Chambon and P. Soriano for providing mice. We thank M. Leeson and L. Tauzin for assistance with cell sorting; J. Atkinson and J. Miller for sectioning and immunohistochemistry; M. Osborne for conducting the microarrays; J. Gray for help with western blotting; S. Fre and V. Rodilla for advice on the cell sorting of R26<SUP>mTmG</SUP> mouse mammary cells. We thank F. Watt and S. Broad for useful discussions and providing FAD media. We thank S. Nourshargh, M. Finsterbusch and J. Brown for access to mammary tissue from transgenic mice. This work was funded by Cancer Research UK, Breast Cancer Campaign, the University of Cambridge, Hutchison Whampoa Limited, La Ligue Nationale Contre le Cancer (Equipe Labelisee 2013) and grants from Agence Nationale de la Recherche ANR-08-BLAN-0078-01 and ANR-13-BSV2-0001 to M.A.G.	BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chepko G, 2005, TISSUE CELL, V37, P393, DOI 10.1016/j.tice.2005.06.005; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; FRANKE WW, 1980, J CELL BIOL, V84, P633, DOI 10.1083/jcb.84.3.633; GOTTLIEB C, 1990, MODERN PATHOL, V3, P135; Haaksma CJ, 2011, BIOL REPROD, V85, P13, DOI 10.1095/biolreprod.110.090639; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; SMITH GH, 1988, J CELL SCI, V90, P173; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5	26	145	148	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					942	950		10.1038/ncb3025	http://dx.doi.org/10.1038/ncb3025			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25173976	Green Accepted			2022-12-25	WOS:000342712200004
J	Rampias, T; Vgenopoulou, P; Avgeris, M; Polyzos, A; Stravodimos, K; Valavanis, C; Scorilas, A; Klinakis, A				Rampias, Theodoros; Vgenopoulou, Paraskevi; Avgeris, Margaritis; Polyzos, Alexander; Stravodimos, Konstantinos; Valavanis, Christos; Scorilas, Andreas; Klinakis, Apostolos			A new tumor suppressor role for the Notch pathway in bladder cancer	NATURE MEDICINE			English	Article							CELL CARCINOMA; WHOLE-GENOME; STEM-CELLS; MUTATIONS; REVEALS; GROWTH; LUNG; INHIBITION; EXPRESSION; INITIATION	The Notch signaling pathway controls cell fates through interactions between neighboring cells by positively or negatively affecting the processes of proliferation, differentiation and apoptosis in a context-dependent manner(1). This pathway has been implicated in human cancer as both an oncogene and a tumor suppressor(2). Here we report new inactivating mutations in Notch pathway components in over 40% of human bladder cancers examined. Bladder cancer is the fourth most commonly diagnosed malignancy in the male population of the United States(3). Thus far, driver mutations in fibroblast growth factor receptor 3 (FGFR3) and, less commonly, in RAS proteins have been identified(4,5). We show that Notch activation in bladder cancer cells suppresses proliferation both in vitro and in vivo by directly upregulating dual-specificity phosphatases (DUSPs), thus reducing the phosphorylation of ERK1 and ERK2 (ERK1/2). In mouse models, genetic inactivation of Notch signaling leads to Erk1/2 phosphorylation, resulting in tumorigenesis in the urinary tract. Collectively our findings show that loss of Notch activity is a driving event in urothelial cancer.	[Rampias, Theodoros; Vgenopoulou, Paraskevi; Polyzos, Alexander; Klinakis, Apostolos] Acad Athens, Biomed Res Fdn, Athens, Greece; [Avgeris, Margaritis; Scorilas, Andreas] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens, Greece; [Stravodimos, Konstantinos] Univ Athens, Sch Med, Dept Urol 1, Laiko Gen Hosp, GR-11527 Athens, Greece; [Valavanis, Christos] Metaxa Canc Hosp, Dept Pathol, Mol Pathol Unit, Piraeus, Greece	Academy of Athens; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens	Klinakis, A (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	aklinakis@bioacademy.gr	Rampias, Theodoros/AAX-7941-2020; Avgeris, Margaritis/AAG-1818-2020	Rampias, Theodoros/0000-0002-5460-5334; Avgeris, Margaritis/0000-0002-2135-9886; Scorilas, Andreas/0000-0003-2427-4949; STRAVODIMOS, KONSTANTINOS/0000-0003-4030-4546	Marie Curie Reintegration grant [224821]; Greek General Secretariat for Research and Technology 'Excellence' grant [UTN_1466]; Fondation Sante Grant in Biomedical Sciences	Marie Curie Reintegration grant(European Commission); Greek General Secretariat for Research and Technology 'Excellence' grant; Fondation Sante Grant in Biomedical Sciences	We thank J. Kitajewski (Columbia University), P. Dotto (University of Lausanne), M. Post (Maastricht University), D. Stravopodis (University f Athens) and K. Zoi (Biomedical Research Foundation Academy of Athens) for donating reagents, S. Artavanis-Tsakonas (Harvard Medical School) for donating mice, Z. Kanaki for pronuclear injections for the generation of the UpkII-Cre-eGFP line, M. Roubelaki for help with the cell cycle analysis and A. Efstratiadis for critically reading the manuscript. This work was supported by a Marie Curie Reintegration grant (224821), a Greek General Secretariat for Research and Technology 'Excellence' grant (UTN_1466) and a Fondation Sante Grant in Biomedical Sciences to A.K.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Funahashi Y, 2008, CANCER RES, V68, P4727, DOI 10.1158/0008-5472.CAN-07-6499; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Kimura F, 2001, BRIT J CANCER, V85, P1887, DOI 10.1054/bjoc.2001.2154; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Zhou HP, 2012, CARCINOGENESIS, V33, P770, DOI 10.1093/carcin/bgs025	34	131	134	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1199	1205		10.1038/nm.3678	http://dx.doi.org/10.1038/nm.3678			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25194568				2022-12-25	WOS:000343194100032
J	Seano, G; Chiaverina, G; Gagliardi, PA; Blasio, L; Puliafito, A; Bouvard, C; Sessa, R; Tarone, G; Sorokin, L; Helley, D; Jain, RK; Serini, G; Bussolino, F; Primo, L				Seano, Giorgio; Chiaverina, Giulia; Gagliardi, Paolo Armando; di Blasio, Laura; Puliafito, Alberto; Bouvard, Claire; Sessa, Roberto; Tarone, Guido; Sorokin, Lydia; Helley, Dominique; Jain, Rakesh K.; Serini, Guido; Bussolino, Federico; Primo, Luca			Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; CELLS; INTEGRIN; MEMBRANE; INVADOPODIA; EXPRESSION; CANCER; MICE; METASTASIS	The mechanism by which angiogenic endothelial cells break the physical barrier of the vascular basement membrane and consequently sprout to form new vessels in mature tissues is unclear. Here, we show that the angiogenic endothelium is characterized by the presence of functional podosome rosettes. These extracellular-matrix-degrading and adhesive structures are precursors of de novo branching points and represent a key feature in the formation of new blood vessels. VEGF-A stimulation induces the formation of endothelial podosome rosettes by upregulating integrin alpha(6)beta(1). In contrast, the binding of alpha(6)beta(1) integrin to the laminin of the vascular basement membrane impairs the formation of podosome rosettes by restricting alpha(6)beta(1) integrin to focal adhesions and hampering its translocation to podosomes. Using an ex vivo sprouting angiogenesis assay, transgenic and knockout mouse models and human tumour sample analysis, we provide evidence that endothelial podosome rosettes control blood vessel branching and are critical regulators of pathological angiogenesis.	[Seano, Giorgio; Chiaverina, Giulia; Gagliardi, Paolo Armando; di Blasio, Laura; Puliafito, Alberto; Sessa, Roberto; Serini, Guido; Bussolino, Federico; Primo, Luca] Univ Turin, Dept Oncol, I-10100 Turin, Italy; [Seano, Giorgio; Chiaverina, Giulia; Gagliardi, Paolo Armando; di Blasio, Laura; Puliafito, Alberto; Sessa, Roberto; Serini, Guido; Bussolino, Federico; Primo, Luca] IRCCS, Candiolo Canc Inst FPO, I-10060 Candiolo, Italy; [Seano, Giorgio; Jain, Rakesh K.] Harvard Univ, Massachusetts Gen Hosp, Edwin L Steele Lab Tumor Biol, Sch Med, Boston, MA 02114 USA; [Bouvard, Claire] Univ Paris 05, UMR S 765, Sorbonne Paris Cite, F-75006 Paris, France; [Tarone, Guido] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10124 Turin, Italy; [Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Helley, Dominique] Univ Paris 05, UMR S 970, Sorbonne Paris Cite, F-75006 Paris, France	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Harvard University; Harvard Medical School; Massachusetts General Hospital; UDICE-French Research Universities; Universite Paris Cite; University of Turin; University of Munster; UDICE-French Research Universities; Universite Paris Cite	Seano, G (corresponding author), Univ Turin, Dept Oncol, I-10100 Turin, Italy.	seano@steele.mgh.harvard.edu; luca.primo@ircc.it	Bussolino, Federico/AES-3951-2022; Serini, Guido/AAF-2873-2021; Gagliardi, Paolo Armando/D-1836-2018; Puliafito, Alberto/K-2462-2018; di Blasio, Laura/J-7352-2018; Jain, Rakesh K/I-1384-2017; Seano, Giorgio/R-6611-2016; bouvard, claire/AAA-4638-2019; CHIAVERINA, GIULIA/AAB-8089-2020; Bussolino, Federico/K-2500-2016	Serini, Guido/0000-0002-3502-8367; Gagliardi, Paolo Armando/0000-0002-4818-035X; di Blasio, Laura/0000-0002-1337-7654; Jain, Rakesh K/0000-0001-7571-3548; Seano, Giorgio/0000-0002-7294-302X; bouvard, claire/0000-0001-5252-754X; PRIMO, Luca/0000-0002-1294-0441; Sorokin, Lydia/0000-0001-7704-7921; Bussolino, Federico/0000-0002-5348-1341; CHIAVERINA, GIULIA/0000-0002-7170-2953; Puliafito, Alberto/0000-0002-0096-1536	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10133, 14635, 13016, 13604, 15026]; AIRC 5x1000 [12182]; Converging Technologies Program, grant: 'Photonic Biosensors for Early Cancer Diagnostics'; Technological Platforms for Biotechnology: grant DRUIDI; Fondazione Cassa di Risparmio Torino (CRT); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS; Fondo Investimenti per la Ricerca di Base [RBAP11BYNP]; University of Torino-Compagnia di San Paolo: RETHE grant; GeneRNet grant; NIH HHS/United States [P01 CA080124/CA/NCI]; Fondazione T. & L. de Beaumont Bonelli; Girardi Family; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA126642, R01CA163815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015903] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC 5x1000(Fondazione AIRC per la ricerca sul cancro); Converging Technologies Program, grant: 'Photonic Biosensors for Early Cancer Diagnostics'; Technological Platforms for Biotechnology: grant DRUIDI; Fondazione Cassa di Risparmio Torino (CRT); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS; Fondo Investimenti per la Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); University of Torino-Compagnia di San Paolo: RETHE grant; GeneRNet grant; NIH HHS/United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione T. & L. de Beaumont Bonelli; Girardi Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	A special thank you to E. Georges-Labouesse (CNRS/INSERM/ULP, Illkirch, France), who recently passed away, for kindly providing Tie2-dependent integrin alpha<INF>6</INF> KO mice. We thank P. C. Marchisio (San Raffaele Scientific Institute, Milano, Italy) for discussion and insightful suggestions on the manuscript; D. R. Sherwood (Duke University Medical Center, Durham, USA) for critical reading of the manuscript; K. Tryggvason (Karolinska Institutet, Stockholm, Sweden) for providing laminin alpha<INF>4</INF> null mice; R. Wedlich-Soldner (Max-Planck Institute of Biochemistry, Martinsried, Germany) and L. M. Machesky (Beatson Institute for Cancer Research, Glasgow, UK) for providing breeding pairs for the LifeAct-EGFP mouse colony and reagents; R. Falcioni (National Cancer Institute 'Regina Elena', Rome, Italy) for critical reading and reagents; E. De Luca and M. Gai (MBC, Torino, Italy) for their assistance in multiphoton microscopy; Y. Boucher and C. Smith (HMS, Boston, USA) for assistance in immunohistochemistry on human tissues; and E. Giraudo and F. Maione (IRCC, Candiolo, Italy) for their help in the treatment of RipTag2 mice. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) investigator grants IG (10133, F.B.; 14635, L.P.; 13016 G. Serini) and fellowships (13604 G. Seano; 15026 P.A.G.); AIRC 5x1000 (12182); Converging Technologies Program, grant: 'Photonic Biosensors for Early Cancer Diagnostics'; Technological Platforms for Biotechnology: grant DRUIDI; Fondazione Cassa di Risparmio Torino (CRT); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS (Intramural Grant 5x1000 2008) (L.P.); Fondo Investimenti per la Ricerca di Base RBAP11BYNP (Newton) (F.B. and L.P.); University of Torino-Compagnia di San Paolo: RETHE grant (F.B.); GeneRNet grant (L.P.); P01 CA080124/CA/NCI NIH HHS/United States (R.K.J.); The 'Fondazione T. & L. de Beaumont Bonelli' and the Girardi Family (G. Seano).	Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Bouvard C, 2012, CARDIOVASC RES, V95, P39, DOI 10.1093/cvr/cvs153; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Couffinhal T, 1998, AM J PATHOL, V152, P1667; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Eble JA, 2009, CURR PHARM DESIGN, V15, P1385, DOI 10.2174/138161209787846757; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Lee TH, 2006, J BIOL CHEM, V281, P40450, DOI 10.1074/jbc.M607525200; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; livanainen A., 1997, J BIOL CHEM, V272, P27862; Magnussen A, 2005, CANCER RES, V65, P2712, DOI 10.1158/0008-5472.CAN-04-2691; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Mizutani K, 2002, CANCER RES, V62, P669; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Pan YR, 2011, J CELL BIOL, V195, P113, DOI 10.1083/jcb.201103016; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Prewett M, 1999, CANCER RES, V59, P5209; Primo L, 2010, CANCER RES, V70, P5759, DOI 10.1158/0008-5472.CAN-10-0507; Rattlers P., 2009, J CELL SCI, V122, P4311; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Seano G, 2013, BLOOD, V121, pE129, DOI 10.1182/blood-2012-08-452292; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zhou ZJ, 2004, CANCER RES, V64, P4059, DOI 10.1158/0008-5472.CAN-04-0291	45	84	86	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					931	941		10.1038/ncb3036	http://dx.doi.org/10.1038/ncb3036			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25218639	Green Accepted			2022-12-25	WOS:000342712200003
J	Gao, A; Serganov, A				Gao, Ang; Serganov, Alexander			Structural insights into recognition of c-di-AMP by the ydaO riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA ELEMENT; LIGAND RECOGNITION; SENSING RIBOSWITCH; BACTERIAL 2ND-MESSENGER; TERTIARY INTERACTIONS; GLYCINE RIBOSWITCH; LYSINE RIBOSWITCH; BACILLUS-SUBTILIS; EUBACTERIA SENSE; GENE-REGULATION	Bacterial second messenger cyclic di-AMP (c-di-AMP) is implicated in signaling DNA damage and cell wall stress through interactions with several protein receptors and a widespread ydaO-type riboswitch. We report the crystal structures of c-di-AMP riboswitches from Thermoanaerobacter pseudethanolicus and Thermovirga lienii determined at similar to 3.0-angstrom resolution. In both species, the RNA adopts an unforeseen 'square'-shaped pseudosymmetrical architecture that features two three-way junctions, a turn and a pseudoknot, positioned in the square corners. Uncharacteristically for riboswitches, the structure is stapled by two ligand molecules that span the interior of the structure and employ similar noncanonical interactions for RNA recognition. Mutations in either ligand-binding site negatively affect c-di-AMP binding, suggesting that the riboswitch-triggered genetic response requires contribution of both ligands. Our data provide what are to our knowledge the first insights into specific sensing of c-di-AMP and a molecular mechanism underlying the common c-di-AMP-dependent control of essential cellular processes in bacteria.	[Gao, Ang; Serganov, Alexander] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA	New York University	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	alexander.serganov@nyumc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; New York University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103403] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); New York University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamlines X25 at the Brookhaven National Laboratory and 24-ID at the Argonne National Laboratory funded by the US Department of Energy. We thank O. Ouerfelli for the synthesis of iridium hexamine and L. Jaeger for discussions. A.S. was supported by funds from the New York University School of Medicine.	Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Hainzl T, 2002, NATURE, V417, P767, DOI 10.1038/nature00768; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lee JC, 2006, J MOL BIOL, V360, P978, DOI 10.1016/j.jmb.2006.05.066; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Liberman JA, 2013, NAT CHEM BIOL, V9, P353, DOI 10.1038/nchembio.1231; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Peselis A, 2014, BBA-GENE REGUL MECH, V1839, P908, DOI 10.1016/j.bbagrm.2014.02.012; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Smith KD, 2011, P NATL ACAD SCI USA, V108, P7757, DOI 10.1073/pnas.1018857108; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Wadley LM, 2004, NUCLEIC ACIDS RES, V32, P6650, DOI 10.1093/nar/gkh1002; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	47	73	77	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					787	792		10.1038/NCHEMBIO.1607	http://dx.doi.org/10.1038/NCHEMBIO.1607			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25086507	Green Accepted			2022-12-25	WOS:000341126800017
J	Hansen, KB; Travnelis, SF				Hansen, Kasper B.; Travnelis, Stephen F.			GLUTAMATE RECEPTORS Mechanistic twists and turns	NATURE CHEMICAL BIOLOGY			English	News Item								Ionotropic glutamate receptors are ligand-gated ion channels that mediate excitatory neurotransmission, which is crucial for memory and learning. New cryo-electron microscopy structures of these receptors trapped in distinct functional states provide remarkable insight into conformational changes triggered by agonist binding.	[Hansen, Kasper B.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Travnelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	University of Montana System; University of Montana; Emory University	Hansen, KB (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	strayne@emory.edu	Hansen, Kasper B/C-4062-2008	Hansen, Kasper B/0000-0002-3303-4819				Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Hansen KB, 2011, J NEUROSCI, V31, P3650, DOI 10.1523/JNEUROSCI.5565-10.2011; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Meyerson J.R., 2014, NATURE          0803, DOI [10.1038/nature13603, DOI 10.1038/NATURE13603]; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451	10	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					698	699		10.1038/nchembio.1614	http://dx.doi.org/10.1038/nchembio.1614			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25271345				2022-12-25	WOS:000341126800003
J	Herzog, VA; Lempradl, A; Trupke, J; Okulski, H; Altmutter, C; Ruge, F; Boidol, B; Kubicek, S; Schmauss, G; Aumayr, K; Ruf, M; Pospisilik, A; Dimond, A; Senergin, HB; Vargas, ML; Simon, JA; Ringrose, L				Herzog, Veronika A.; Lempradl, Adelheid; Trupke, Johanna; Okulski, Helena; Altmutter, Christina; Ruge, Frank; Boidol, Bernd; Kubicek, Stefan; Schmauss, Gerald; Aumayr, Karin; Ruf, Marius; Pospisilik, Andrew; Dimond, Andrew; Senergin, Hasene Basak; Vargas, Marcus L.; Simon, Jeffrey A.; Ringrose, Leonie			A strand-specific switch in noncoding transcription switches the function of a Polycomb/Trithorax response element	NATURE GENETICS			English	Article							POLYCOMB GROUP PROTEINS; EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; VESTIGIAL GENE; WING FORMATION; HOX LOCI; DROSOPHILA; RNAS; CHROMATIN	Polycomb/Trithorax response elements (PRE/TREs) can switch their function reversibly between silencing and activation by mechanisms that are poorly understood. Here we show that a switch in forward and reverse noncoding transcription from the Drosophila melanogaster vestigial (vg) PRE/TRE switches the status of the element between silencing (induced by the forward strand) and activation (induced by the reverse strand). In vitro, both noncoding RNAs inhibit PRC2 histone methyltransferase activity, but, in vivo, only the reverse strand binds PRC2. Overexpression of the reverse strand evicts PRC2 from chromatin and inhibits its enzymatic activity. We propose that the interaction of RNAs with PRC2 is differentially regulated in vivo, allowing regulated inhibition of local PRC2 activity. Genome-wide analysis shows that strand switching of noncoding RNAs occurs at several hundred Polycomb-binding sites in fly and vertebrate genomes. This work identifies a previously unreported and potentially widespread class of PRE/TREs that switch function by switching the direction of noncoding RNA transcription.	[Herzog, Veronika A.; Lempradl, Adelheid; Trupke, Johanna; Okulski, Helena; Altmutter, Christina; Ruge, Frank; Dimond, Andrew; Senergin, Hasene Basak; Ringrose, Leonie] IMBA Inst Mol Biotechnol, Vienna, Austria; [Lempradl, Adelheid; Ruf, Marius; Pospisilik, Andrew] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Boidol, Bernd; Kubicek, Stefan] CeMM Res Ctr Mol Med, Vienna, Austria; [Schmauss, Gerald; Aumayr, Karin] IMP, Vienna, Austria; [Dimond, Andrew] Babraham Inst, Cambridge, England; [Vargas, Marcus L.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Max Planck Society; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Minnesota System; University of Minnesota Twin Cities	Ringrose, L (corresponding author), IMBA Inst Mol Biotechnol, Vienna, Austria.	leonie.ringrose@imba.oeaw.ac.at	Ringrose, Leonie/AAV-4734-2021; Lempradl, Adelheid/AAJ-2529-2021; Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Okulski, Helena/0000-0002-2254-4282; Dimond, Andrew/0000-0002-2996-2479; Trupke, Johanna/0000-0003-3144-5267	Austrian Academy of Sciences; European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome'; European Union Framework Programme 7 Network of Excellence 'Epigenesys'; FWF Austrian Science Fund [P21525-B20]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850] Funding Source: NIH RePORTER	Austrian Academy of Sciences; European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome'; European Union Framework Programme 7 Network of Excellence 'Epigenesys'; FWF Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gasser for discussions and for critical reading of the manuscript. We thank M. Rehmsmeier and members of our laboratories for discussions, P. Pasierbek for advice and training on imaging, P.A. Steffen (IMBA) for the GFP and E(z) :: GFP constructs, C. Ehrhardt and E. Dworschak for technical assistance, B. Dickson (Janelia Farm) for the enGAL4 driver line, J.M. Dura (Institute of Human Genetics, Montpelier, France) for the daGAL4 driver line, I. Tamir (CSF Vienna) for the bioinformatics analysis of ChIP-seq data and sharing the 'Fuge' algorithm, F. Bantignies (Institute of Human Genetics, Montpelier, France) for advice on three-dimensional DNA FISH, R. Jones (Dedman College, Southern Methodist University) for providing antibody to E(Z) and the Vienna Campus Support Facility (CSF) for library preparation, deep sequencing and the purification of Drosophila PRC2. This work was funded by the Austrian Academy of Sciences, by European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome' (to L.R.) and the European Union Framework Programme 7 Network of Excellence 'Epigenesys' (to L.R.), and by an FWF Austrian Science Fund grant (P21525-B20 to L.R.).	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aszodi A, 2012, BIOINFORMATICS, V28, P3318, DOI 10.1093/bioinformatics/bts607; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; BATE M, 1990, DEVELOPMENT, V110, P791; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; COHEN B, 1993, DEVELOPMENT, V117, P597; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Gemkow M. J., 1996, Bioimaging, V4, P107, DOI 10.1002/1361-6374(199606)4:2<107::AID-BIO8>3.3.CO;2-H; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; Guss KA, 2008, DEV DYNAM, V237, P2483, DOI 10.1002/dvdy.21664; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Katayama S, 2004, BRIEF BIOINFORM, V5, P249, DOI 10.1093/bib/5.3.249; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Okulski H, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-4; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Perez L, 2011, DEVELOPMENT, V138, P3125, DOI 10.1242/dev.065599; Rai AN, 2013, MOL CELL BIOL, V33, P4844, DOI 10.1128/MCB.00307-13; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Steffen PA, 2013, NUCLEIC ACIDS RES, V41, P5235, DOI 10.1093/nar/gkt217; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042102; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	54	79	81	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					973	+		10.1038/ng.3058	http://dx.doi.org/10.1038/ng.3058			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108384	Green Accepted			2022-12-25	WOS:000341579400011
J	Fernandez-Nogales, M; Cabrera, JR; Santos-Galindo, M; Hoozemans, JJM; Ferrer, I; Rozemuller, AJM; Hernandez, F; Avila, J; Lucas, JJ				Fernandez-Nogales, Marta; Cabrera, Jorge R.; Santos-Galindo, Maria; Hoozemans, Jeroen J. M.; Ferrer, Isidro; Rozemuller, Annemieke J. M.; Hernandez, Felix; Avila, Jesus; Lucas, Jose J.			Huntington's disease is a four-repeat tauopathy with tau nuclear rods	NATURE MEDICINE			English	Article							PROTEIN; INCLUSIONS; EXPRESSION; MUTATIONS; FTDP-17; CHOREA	An imbalance of tau isoforms containing either three or four microtubule-binding repeats causes frontotemporal dementia with parkinsonism linked to-chromosome 17 (FTDP-17) in families with intronic mutations in the MAPT gene. Here we report equivalent imbalances at the mRNA and protein levels and increased total tau levels in the brains of subjects with Huntington's disease (HD) together with rod-like tau deposits along neuronal nuclei. These tau nuclear rods show an ordered filamentous ultrastructure and can be found filling the neuronal nuclear indentations previously reported in HD brains. Finally, alterations in serine/arginine-rich splicing factor-6 coincide with tau missplicing, and a role of tau in HD pathogenesis is evidenced by the attenuation of motor abnormalities of mutant HTT transgenic mice in tau knockout backgrounds.	[Fernandez-Nogales, Marta; Cabrera, Jorge R.; Santos-Galindo, Maria; Hernandez, Felix; Avila, Jesus; Lucas, Jose J.] CSIC, CBMSO, Madrid, Spain; [Fernandez-Nogales, Marta; Cabrera, Jorge R.; Santos-Galindo, Maria; Hernandez, Felix; Avila, Jesus; Lucas, Jose J.] UAM, CSIC, Madrid, Spain; [Fernandez-Nogales, Marta; Cabrera, Jorge R.; Santos-Galindo, Maria; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus; Lucas, Jose J.] Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIBERNED, Madrid, Spain; [Hoozemans, Jeroen J. M.; Rozemuller, Annemieke J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Ferrer, Isidro] Univ Barcelona, Univ Hosp Bellvitge, Inst Neuropathol, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBERNED; Instituto de Salud Carlos III; Vrije Universiteit Amsterdam; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Lucas, JJ (corresponding author), CSIC, CBMSO, Madrid, Spain.	jjlucas@cbm.csic.es	Rozemuller, Annemieke/C-2084-2008; Hernandez, Felix/L-2114-2015; Lucas, Jose J./U-6543-2019; Nogales, Marta Fernandez/AAG-9229-2019; Santos-Galindo, María/H-7627-2015; Avila, Jesus/I-2610-2015; Cabrera, Jorge Rubén/H-6310-2015	Hernandez, Felix/0000-0001-8753-8249; Nogales, Marta Fernandez/0000-0001-7151-4808; Avila, Jesus/0000-0002-6288-0571; Cabrera, Jorge Rubén/0000-0003-4481-0198; Santos-Galindo, Maria/0000-0003-2725-6228; Lucas, Jose J./0000-0003-1597-3916; Hoozemans, Jeroen/0000-0002-2888-8967	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (MICINN); Ministerio de Economia y Competitividad (MINECO); Comunidad Autonoma de Madrid; Fundacion Ramon Areces; European Commission [278486]; CSIC	Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; European Commission(European CommissionEuropean Commission Joint Research Centre); CSIC	We thank P. Gomez-Ramos for helpful suggestions on electron microscopy experiments and A. Rabano and E. Gelpi for advice on human sample analysis. We also thank A. Tomico, M. Lucas and the team at the CBMSO Genomics Facility for their excellent technical assistance, as well as members of the Lucas lab for helpful advice and critical reading of the manuscript. P. Davies (Albert Einstein University) provided the PHF-1 antibody to phosphorylated tau; M. Novak (Slovak Academy of Sciences) and C.M. Wischik (University of Aberdeen) provided the 7.51 antibody to total tau; R. Kayed (University of Texas) provided the T22 antibody to oligomeric tau; S. Finkbeiner (Gladstone Institute) provided Htt constructs comprising the N-terminal fragment of Htt with 17 or 72 CAG repeats fused to the EGFP; and A.R. Krainer (Cold Spring Harbor Laboratory) provided SRSF6 expression vector. This work was supported by Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CiberNed-Instituto de Salud Carlos III) and by grants from Ministerio de Ciencia e Innovacion (MICINN), Ministerio de Economia y Competitividad (MINECO), Comunidad Autonoma de Madrid, Fundacion Ramon Areces and the Seventh Framework Programme of the European Commission (grant agreement 278486, project DEVELAGE). M.F.-N. was the recipient of a CSIC JAE-Pre research contract.	BOTS GTAM, 1981, ACTA NEUROPATHOL, V55, P21, DOI 10.1007/BF00691525; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Diaz-Hernandez M., 2003, J NEUROSCI, V23, P11653; Evert BO, 1999, HUM MOL GENET, V8, P1169, DOI 10.1093/hmg/8.7.1169; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Rodriguez-Martin T, 2009, HUM MOL GENET, V18, P3266, DOI 10.1093/hmg/ddp264; ROOS RAC, 1983, J NEUROL SCI, V61, P37, DOI 10.1016/0022-510X(83)90053-9; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Takahashi H, 2001, BRAIN RES, V919, P12, DOI 10.1016/S0006-8993(01)02986-9; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Zander C, 2001, HUM MOL GENET, V10, P2569, DOI 10.1093/hmg/10.22.2569	20	145	150	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					881	885		10.1038/nm.3617	http://dx.doi.org/10.1038/nm.3617			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25038828	Green Published			2022-12-25	WOS:000340074600019
J	Gracz, AD; Williamson, IA; Roche, KC; Johnston, MJ; Wang, FC; Wang, YL; Attayek, PJ; Balowski, J; Liu, XF; Laurenza, RJ; Gaynor, LT; Sims, CE; Galanko, JA; Li, LH; Allbritton, NL; Magness, ST				Gracz, Adam D.; Williamson, Ian A.; Roche, Kyle C.; Johnston, Michael J.; Wang, Fengchao; Wang, Yuli; Attayek, Peter J.; Balowski, Josep; Liu, Xiao Fu; Laurenza, Ryan J.; Gaynor, Liam T.; Sims, Christopher E.; Galanko, Joseph A.; Li, Linheng; Allbritton, Nancy L.; Magness, Scott T.			A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis	NATURE CELL BIOLOGY			English	Article							SMALL-INTESTINE; MOUSE; POPULATIONS; ORGANOIDS; MARKER; COLON	Stem cells reside in 'niches', where support cells provide critical signalling for tissue renewal. Culture methods mimic niche conditions and support the growth of stem cells in vitro. However, current functional assays preclude statistically meaningful studies of clonal stem cells, stem cell-niche interactions, and genetic analysis of single cells and their organoid progeny. Here, we describe a 'microraft array' (MRA) that facilitates high-throughput clonogenic culture and computational identification of single intestinal stem cells (ISCs) and niche cells. We use MRAs to demonstrate that Paneth cells, a known ISC niche component, enhance organoid formation in a contact-dependent manner. MRAs facilitate retrieval of early enteroids for quantitative PCR to correlate functional properties, such as enteroid morphology, with differences in gene expression. MRAs have broad applicability to assaying stem cell-niche interactions and organoid development, and serve as a high-throughput culture platform to interrogate gene expression at early stages of stem cell fate choices.	[Gracz, Adam D.; Roche, Kyle C.; Magness, Scott T.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Gracz, Adam D.; Williamson, Ian A.; Johnston, Michael J.; Liu, Xiao Fu; Laurenza, Ryan J.; Gaynor, Liam T.; Galanko, Joseph A.; Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Wang, Fengchao; Li, Linheng] Univ Kansas, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Wang, Yuli; Balowski, Josep; Sims, Christopher E.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Attayek, Peter J.; Allbritton, Nancy L.; Magness, Scott T.] Univ N Carolina, NC State Biomed Engn, Chapel Hill, NC 27599 USA; [Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kansas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stowers Institute for Medical Research	Magness, ST (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	magness@med.unc.edu	Wang, Yuli/C-6297-2011; , UNC Flow Cytometry Core/AGU-9839-2022; , Advanced Analytics Core/AAE-5263-2022	Magness, Scott/0000-0002-2746-1224; Williamson, Ian/0000-0003-2795-6099; Attayek, Peter/0000-0001-7572-6381; Johnston, Michael/0000-0001-6769-6311; Gracz, Adam/0000-0003-1298-568X; Li, Linheng/0000-0001-9963-430X	National Institutes of Health [R01 DK091427, R03 EB013803, R01EB012549]; Small Business Innovation Research [R43 GM106421]; University Cancer Research Fund of the University of North Carolina; Center for Gastrointestinal Biology and Disease [P30 DK034987]; NIDDK; NIAID; UNC Graduate School Dissertation Completion Fellowship;  [U01 DK085541];  [U01 DK085507-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB013803, R01EB012549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091427, T32DK007737, U01DK085507, U01DK085547, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM106421, R42GM106421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Small Business Innovation Research(United States Department of Agriculture (USDA)); University Cancer Research Fund of the University of North Carolina; Center for Gastrointestinal Biology and Disease; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC Graduate School Dissertation Completion Fellowship; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the UNC flow cytometry facility (P30CA06086), especially B. Udis and N.Fisher; C. D. Collins for help with quantification of survival; D. DeBree for data verification; A. Ahmad and P.Shah for useful discussions regarding array fabrication and analysis; D.Trotier for technical assistance with enteroid retrieval and graphics support; P.K. Lund, S. Henning (SJH) and C. Dekaney for useful discussions and critical review of the manuscript. A.D.G. received partial salary support from U01 DK085541 (SJH). This work was financially supported by the National Institutes of Health R01 DK091427 (S.T.M.), R03 EB013803 (Y.W./S.T.M.), R01EB012549 (N.L.A.), Small Business Innovation Research R43 GM106421 (S.T.M./Y.W.), U01 DK085507-01 (L.L.), University Cancer Research Fund of the University of North Carolina (S.T.M./N.L.A.), and the Center for Gastrointestinal Biology and Disease P30 DK034987 (S.T.M., Y.W., J.A.G.). L.L. is a member of the Intestinal Stem Cell Consortium, supported by NIDDK and NIAID. A.D.G. was supported by a UNC Graduate School Dissertation Completion Fellowship.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Burdick JA, 2011, NAT METHODS, V8, P915, DOI 10.1038/nmeth.1745; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Pai JH, 2007, ANAL CHEM, V79, P8774, DOI 10.1021/ac071528q; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Roccio M, 2012, INTEGR BIOL-UK, V4, P391, DOI 10.1039/c2ib00070a; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shah PK, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/10/107002; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Wang YL, 2010, LAB CHIP, V10, P2917, DOI [10.1039/c0lc00186d, 10.1039/c01c00186d]; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	43	98	104	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					340	+		10.1038/ncb3104	http://dx.doi.org/10.1038/ncb3104			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25664616	Green Submitted, Green Accepted			2022-12-25	WOS:000350770200018
J	Murrow, L; Malhotra, R; Debnath, J				Murrow, Lyndsay; Malhotra, Ritu; Debnath, Jayanta			ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function	NATURE CELL BIOLOGY			English	Article							MULTIVESICULAR BODIES; ESCRT MACHINERY; PROTEIN ALIX; CONJUGATION; MATURATION; FUSION; BIOGENESIS; HOMOLOG; ENZYME; ROLES	The ubiquitin-like molecule ATG12 is required for the early steps of autophagy. Recently, we identified ATG3, the E2-like enzyme required for LC3 lipidation during autophagy, as an ATG12 conjugation target. Here, we demonstrate that cells lacking ATG12-ATG3 have impaired basal autophagic flux, accumulation of perinuclear late endosomes, and impaired endolysosomal trafficking. Furthermore, we identify an interaction between ATG12-ATG3 and the ESCRT-associated protein Alix (also known as PDCD6IP) and demonstrate that ATG12-ATG3 controls multiple Alix-dependent processes including late endosome distribution, exosome biogenesis and viral budding. Similar to ATG12-ATG3, Alix is functionally required for efficient basal, but not starvation-induced, autophagy. Overall, these results identify a link between the core autophagy and ESCRT machineries and uncover a role for ATG12-ATG3 in late endosome function that is distinct from the canonical role of either ATG in autophagosome formation.	[Murrow, Lyndsay; Malhotra, Ritu; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Murrow, Lyndsay; Malhotra, Ritu; Debnath, Jayanta] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Murrow, Lyndsay; Debnath, Jayanta] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Debnath, J (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	Jayanta.Debnath@ucsf.edu		Murrow, Lyndsay/0000-0002-5935-8977; Debnath, Jayanta/0000-0002-8745-4069	NIH [CA126792, CA188404]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; National Science Foundation Graduate Research Fellowship [DGE-1144247]; NATIONAL CANCER INSTITUTE [R01CA126792, R01CA188404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Confocal microscopy was performed in the Biological Imaging Development Center at UCSF. Grant support to J.D. includes the NIH (CA126792, CA188404) and a Howard Hughes Medical Institute Physician-Scientist Early Career Award. This material is based on work supported by the National Science Foundation Graduate Research Fellowship to L.M. under grant DGE-1144247.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Cheung ZH, 2011, J NEUROCHEM, V118, P317, DOI 10.1111/j.1471-4159.2011.07314.x; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lu Y, 2013, MOL CELL, V52, P264, DOI 10.1016/j.molcel.2013.08.041; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pan S, 2006, J BIOL CHEM, V281, P34640, DOI 10.1074/jbc.M602263200; Petiot A, 2008, BIOCHEM BIOPH RES CO, V375, P63, DOI 10.1016/j.bbrc.2008.07.136; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Zhou X, 2008, BIOCHEM J, V414, P215, DOI 10.1042/BJ20080642	52	175	181	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					300	+		10.1038/ncb3112	http://dx.doi.org/10.1038/ncb3112			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25686249	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000350770200014
J	Chan, SM; Thomas, D; Corces-Zimmerman, MR; Xavy, S; Rastogi, S; Hong, WJ; Zhao, FF; Medeiros, BC; Tyvoll, DA; Majeti, R				Chan, Steven M.; Thomas, Daniel; Corces-Zimmerman, M. Ryan; Xavy, Seethu; Rastogi, Suchita; Hong, Wan-Jen; Zhao, Feifei; Medeiros, Bruno C.; Tyvoll, David A.; Majeti, Ravindra			Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia	NATURE MEDICINE			English	Article							CYTOCHROME-C-OXIDASE; STEM-CELLS; D-2-HYDROXYGLUTARIC ACID; FAMILY-MEMBERS; IDH2 MUTATIONS; GLIOMA-CELLS; INHIBITION; 2-HYDROXYGLUTARATE; GROWTH; DEATH	Mutant isocitrate dehydrogenase (IDH) 1 and 2 proteins alter the epigenetic landscape in acute myeloid leukemia (AML) cells through production of the oncometabolite (R)-2-hydroxyglutarate (2-HG). Here we performed a large-scale RNA interference (RNAi) screen to identify genes that are synthetic lethal to the IDH1(R132H) mutation in AML and identified the anti-apoptotic gene BCL-2. IDH1- and IDH2-mutant primary human AML cells were more sensitive than IDH1/2 wildtype cells to ABT-199, a highly specific BCL-2 inhibitor that is currently in clinical trials for hematologic malignancies, both ex vivo and in xenotransplant models. This sensitization effect was induced by (R)-2-HG-mediated inhibition of the activity of cytochrome c oxidase (COX) in the mitochondrial electron transport chain (ETC); suppression of COX activity lowered the mitochondrial threshold to trigger apoptosis upon BCL-2 inhibition. Our findings indicate that IDH1/2 mutation status may identify patients that are likely to respond to pharmacologic BCL-2 inhibition and form the rational basis for combining agents that disrupt ETC activity with ABT-199 in future clinical studies.	[Chan, Steven M.; Hong, Wan-Jen; Medeiros, Bruno C.; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Chan, Steven M.; Thomas, Daniel; Corces-Zimmerman, M. Ryan; Xavy, Seethu; Rastogi, Suchita; Hong, Wan-Jen; Zhao, Feifei; Majeti, Ravindra] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Tyvoll, David A.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Corces, M. Ryan/ABG-6947-2020	Corces, M. Ryan/0000-0001-7465-7652; Medeiros, Bruno/0000-0001-6972-8137; Rastogi, Suchita/0000-0001-7808-1777; Majeti, Ravindra/0000-0002-5814-0984	Stanford University School of Medicine Dean's Postdoctoral Fellowship; American Society of Hematology Scholar Award; Burroughs Wellcome Fund; New York Stem Cell Foundation; National Institutes of Health [R01CA188055]; NATIONAL CANCER INSTITUTE [R01CA188055] Funding Source: NIH RePORTER	Stanford University School of Medicine Dean's Postdoctoral Fellowship; American Society of Hematology Scholar Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); New York Stem Cell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the Hematology Division Tissue Bank and the patients for donating their samples. We acknowledge A. Giaccia for providing access to the Seahorse extracellular flux analyzer. S.M.C. is supported by a Stanford University School of Medicine Dean's Postdoctoral Fellowship and an American Society of Hematology Scholar Award. R.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is a New York Stem Cell Foundation Robertson Investigator. This research was supported by the Burroughs Wellcome Fund, the New York Stem Cell Foundation, and a National Institutes of Health grant (R01CA188055) to R.M.	[Anonymous], 2014, Cancer Discov, V4, pOF5, DOI 10.1158/2159-8290.CD-NB2013-178; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Chan SM, 2013, INT J HEMATOL, V98, P648, DOI 10.1007/s12185-013-1407-8; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chou WC, 2010, BLOOD, V115, P2749, DOI 10.1182/blood-2009-11-253070; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Craddock C, 2013, LEUKEMIA, V27, P1028, DOI 10.1038/leu.2012.312; da Silva CG, 2002, BBA-MOL BASIS DIS, V1586, P81, DOI 10.1016/S0925-4439(01)00088-6; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hetschko H, 2008, NEOPLASIA, V10, P873, DOI 10.1593/neo.07842; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Mohrenz IV, 2013, APOPTOSIS, V18, P1416, DOI 10.1007/s10495-013-0877-8; NICHOLLS P, 1978, BIOCHEM J, V173, P65, DOI 10.1042/bj1730065; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rohlena J, 2013, CURR PHARM BIOTECHNO, V14, P377, DOI 10.2174/1389201011314030011; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; SHERMAN D, 1991, P NATL ACAD SCI USA, V88, P4265, DOI 10.1073/pnas.88.10.4265; Shi JL, 2014, NEUROL SCI, V35, P839, DOI 10.1007/s10072-013-1607-2; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shroff EH, 2007, CELL CYCLE, V6, P807, DOI 10.4161/cc.6.7.4044; Silkjaer T, 2013, EUR J HAEMATOL, V90, P385, DOI 10.1111/ejh.12090; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Wajner M, 2002, J INHERIT METAB DIS, V25, P28, DOI 10.1023/A:1015165212965; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WAY JL, 1984, ANNU REV PHARMACOL, V24, P451, DOI 10.1146/annurev.pa.24.040184.002315; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; YOSHIKAWA S, 1995, J BIOL CHEM, V270, P4270, DOI 10.1074/jbc.270.9.4270	60	350	362	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					178	184		10.1038/nm.3788	http://dx.doi.org/10.1038/nm.3788			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25599133	Green Accepted			2022-12-25	WOS:000348974800021
J	Zhang, MY; Churpek, JE; Keel, SB; Walsh, T; Lee, MK; Loeb, KR; Gulsuner, S; Pritchard, CC; Sanchez-Bonilla, M; Delrow, JJ; Basom, RS; Forouhar, M; Gyurkocza, B; Schwartz, BS; Neistadt, B; Marquez, R; Mariani, CJ; Coats, SA; Hofmann, I; Lindsley, RC; Williams, DA; Abkowitz, JL; Horwitz, MS; King, MC; Godley, LA; Shimamura, A				Zhang, Michael Y.; Churpek, Jane E.; Keel, Sioban B.; Walsh, Tom; Lee, Ming K.; Loeb, Keith R.; Gulsuner, Suleyman; Pritchard, Colin C.; Sanchez-Bonilla, Marilyn; Delrow, Jeffrey J.; Basom, Ryan S.; Forouhar, Melissa; Gyurkocza, Boglarka; Schwartz, Bradford S.; Neistadt, Barbara; Marquez, Rafael; Mariani, Christopher J.; Coats, Scott A.; Hofmann, Inga; Lindsley, R. Coleman; Williams, David A.; Abkowitz, Janis L.; Horwitz, Marshall S.; King, Mary-Claire; Godley, Lucy A.; Shimamura, Akiko			Germ line ETV6 mutations in familial thrombocytopenia and hematologic malignancy	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; INHERITED THROMBOCYTOPENIA; GENOMIC LANDSCAPE; GATA2 MUTATIONS; DNA-BINDING; TEL; GENE; PROTEIN	We report germline missense mutations in ETV6 segregating with the dominant transmission of thrombocytopenia and hematologic malignancy in three unrelated kindreds, defining a new hereditary syndrome featuring thrombocytopenia with susceptibility to diverse hematologic neoplasms. Two variants, p.Arg369Gln and p.Arg399Cys, reside in the highly conserved ETS DNA-binding domain. The third variant, p.Pro214Leu, lies within the internal linker domain, which regulates DNA binding. These three amino acid sites correspond to hotspots for recurrent somatic mutation in malignancies. Functional studies show that the mutations abrogate DNA binding, alter subcellular localization, decrease transcriptional repression in a dominant-negative fashion and impair hematopoiesis. These familial genetic studies identify a central role for ETV6 in hematopoiesis and malignant transformation. The identification of germline predisposition to cytopenias and cancer informs the diagnosis and medical management of at-risk individuals.	[Zhang, Michael Y.; Loeb, Keith R.; Sanchez-Bonilla, Marilyn; Gyurkocza, Boglarka; Coats, Scott A.; Shimamura, Akiko] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Churpek, Jane E.; Neistadt, Barbara; Marquez, Rafael; Mariani, Christopher J.; Godley, Lucy A.] Univ Chicago, Ctr Clin Canc Genet, Sect Hematol Oncol, Chicago, IL 60637 USA; [Churpek, Jane E.; Neistadt, Barbara; Marquez, Rafael; Mariani, Christopher J.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Keel, Sioban B.; Abkowitz, Janis L.] Univ Washington, Div Hematol, Dept Med, Seattle, WA 98195 USA; [Walsh, Tom; Lee, Ming K.; Gulsuner, Suleyman; King, Mary-Claire] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Walsh, Tom; Lee, Ming K.; Gulsuner, Suleyman; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Loeb, Keith R.; Horwitz, Marshall S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Pritchard, Colin C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Delrow, Jeffrey J.; Basom, Ryan S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Forouhar, Melissa] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Schwartz, Bradford S.] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA; [Schwartz, Bradford S.] Univ Wisconsin, Dept Med, Madison, WI USA; [Schwartz, Bradford S.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Hofmann, Inga; Williams, David A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Hofmann, Inga; Williams, David A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hofmann, Inga; Williams, David A.] Harvard Stem Cell Inst, Boston, MA USA; [Lindsley, R. Coleman] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Lindsley, R. Coleman] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shimamura, Akiko] Seattle Childrens Hosp, Seattle, WA USA; [Shimamura, Akiko] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Madigan Army Medical Center; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Shimamura, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	ashimamu@fhcrc.org	Lindsley, Coleman/AAA-3040-2021; Gulsuner, Suleyman/AAF-2098-2020	Gulsuner, Suleyman/0000-0002-3897-1238; King, Mary-Claire/0000-0001-9426-1743; Zhang, Michael/0000-0003-4036-117X; Horwitz, Marshall/0000-0002-1683-1680; Walsh, Tom/0000-0002-8875-0310	US National Institutes of Health [R24DK093425, R24DK099808-01, K12CA139160]; Ghiglione Aplastic Anemia Fund; Julian's Dinosaur Guild from Seattle Children's Hospital; Medical Scientist Training Program [T32GM007266]; Genetic Approaches to Aging Training grant [T32AG000057]; Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009172, R35CA197458, K12CA139160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099808, R24DK093425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ghiglione Aplastic Anemia Fund; Julian's Dinosaur Guild from Seattle Children's Hospital; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Approaches to Aging Training grant; Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all patients and their families for participation in this research study. We thank M. Chin (University of Washington), B. Turok-Storb (Fred Hutchinson Cancer Research Center) and S. Tapscott (Fred Hutchinson Cancer Research Center) for luciferase plasmids and reagents. We thank H. Hock, B. Stoddard, S. Meshinchi, G. Smith, A. Kumar, C. Toledo, S. Yu, A. Fong and K. MacQuarrie for helpful discussions. We thank S. Castro for clinical sample processing. This work was supported by US National Institutes of Health grants R24DK093425 and R24DK099808-01 to A.S., M.-C.K. and J.L.A.; by the Ghiglione Aplastic Anemia Fund and Julian's Dinosaur Guild from Seattle Children's Hospital to A.S.; by Medical Scientist Training Program Training grant T32GM007266 and Genetic Approaches to Aging Training grant T32AG000057 to M.Y.Z.; and by grants from the US National Institutes of Health (K12CA139160) and the Cancer Research Foundation to J.E.C. M.-C.K. is an American Cancer Society professor.	Auer F, 2014, LEUKEMIA, V28, P1136, DOI 10.1038/leu.2013.363; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bluteau D, 2014, J CLIN INVEST, V124, P580, DOI 10.1172/JCI71861; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Coyne HJ, 2012, J MOL BIOL, V421, P67, DOI 10.1016/j.jmb.2012.05.010; Del S, 2014, J MOL BIOL, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Fenrick R, 1999, MOL CELL BIOL, V19, P6566; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Griesinger F, 2002, BRIT J HAEMATOL, V119, P454, DOI 10.1046/j.1365-2141.2002.03850.x; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kirwan M, 2012, AM J HUM GENET, V90, P888, DOI 10.1016/j.ajhg.2012.03.020; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Marquez R, 2014, LEUKEMIA LYMPHOMA, V55, P2945, DOI 10.3109/10428194.2014.903476; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Padron E, 2014, BLOOD, V123, P3675, DOI 10.1182/blood-2014-03-562637; Park H, 2006, CANCER GENET CYTOGEN, V167, P117, DOI 10.1016/j.cancergencyto.2006.01.006; Pippucci T, 2011, AM J HUM GENET, V88, P115, DOI 10.1016/j.ajhg.2010.12.006; Powell BC, 2013, PEDIATR BLOOD CANCER, V60, pE1, DOI 10.1002/pbc.24417; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Wang QR, 2014, HAEMATOLOGICA, V99, pE176, DOI 10.3324/haematol.2014.104406; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xu L, 2014, P NATL ACAD SCI USA, V111, P8589, DOI 10.1073/pnas.1407688111; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zhang MY, 2015, HAEMATOLOGICA, V100, P42, DOI 10.3324/haematol.2014.113456	45	219	224	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					180	185		10.1038/ng.3177	http://dx.doi.org/10.1038/ng.3177			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25581430	Green Accepted			2022-12-25	WOS:000348694700014
J	Doench, JG; Hartenian, E; Graham, DB; Tothova, Z; Hegde, M; Smith, I; Sullender, M; Ebert, BL; Xavier, RJ; Root, DE				Doench, John G.; Hartenian, Ella; Graham, Daniel B.; Tothova, Zuzana; Hegde, Mudra; Smith, Ian; Sullender, Meagan; Ebert, Benjamin L.; Xavier, Ramnik J.; Root, David E.			Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; CAS9; ENDONUCLEASE; SYSTEM; DNA; IDENTIFICATION; SPECIFICITY; NUCLEASES; IMMUNITY; CANCER	Components of the prokaryotic clustered, regularly interspaced, short palindromic repeats (CRISPR) loci have recently been repurposed for use in mammalian cells(1-6). The CRISPR-associated (Cas) 9 can be programmed with a single guide RNA (sgRNA) to generate site-specific DNA breaks, but there are few known rules governing on-target efficacy of this system(7,8). We created a pool of sgRNAs, tiling across all possible target sites of a panel of six endogenous mouse and three endogenous human genes and quantitatively assessed their ability to produce null alleles of their target gene by antibody staining and flow cytometry. We discovered sequence features that improved activity, including a further optimization of the protospacer-adjacent motif (PAM) of Streptococcus pyogenes Cas9. The results from 1,841 sgRNAs were used to construct a predictive model of sgRNA activity to improve sgRNA design for gene editing and genetic screens. We provide an online tool for the design of highly active sgRNAs for any gene of interest.	[Doench, John G.; Hartenian, Ella; Graham, Daniel B.; Tothova, Zuzana; Hegde, Mudra; Smith, Ian; Sullender, Meagan; Ebert, Benjamin L.; Xavier, Ramnik J.; Root, David E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tothova, Zuzana; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Doench, JG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jdoench@broadinstitute.org; droot@broadinstitute.org	Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Hegde, Mudra/0000-0003-4530-4633; Sullender, Meagan/0000-0001-6666-8650	US National Institutes of Health [5T32CA009172-39]; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	E.H., D B G., Z T. and J.G.D. designed experiments; E.H., M.S., D.B.G. and Z.T. ran experiments; E.H. and J.G.D. analyzed experimental results; M.H. and J.G.D. analyzed sequencing data and developed analysis tools; I. S. developed the sgRNA scoring model; E.H., D.E.R. and J.G.D. wrote the manuscript with help from other authors; B.L.E., R.J.X. and D.E.R. supervised the research. J.G.D. is a Merkin Institute Fellow. Z.T. is supported by US National Institutes of Health 5T32CA009172-39.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	25	1044	1168	14	316	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1262	U130		10.1038/nbt.3026	http://dx.doi.org/10.1038/nbt.3026			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25184501	Green Accepted			2022-12-25	WOS:000346156800029
J	Nijenhuis, W; Vallardi, G; Teixeira, A; Kops, GJPL; Saurin, AT				Nijenhuis, Wilco; Vallardi, Giulia; Teixeira, Antoinette; Kops, Geert J. P. L.; Saurin, Adrian T.			Negative feedback at kinetochores underlies a responsive spindle checkpoint signal	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 1; AURORA B KINASE; ASSEMBLY CHECKPOINT; CHROMOSOME SEGREGATION; B56-PP2A PHOSPHATASE; MITOTIC CHECKPOINT; MELT REPEATS; MPS1; KNL1; MITOSIS	Kinetochores are specialized multi-protein complexes that play a crucial role in maintaining genome stability(1). They bridge attachments between chromosomes and microtubules during mitosis and they activate the spindle assembly checkpoint (SAC) to arrest division until all chromosomes are attached(2). Kinetochores are able to efficiently integrate these two processes because they can rapidly respond to changes in microtubule occupancy by switching localized SAC signalling ON or OFF2-4. We show that this responsiveness arises because the SAC primes kinetochore phosphatases to induce negative feedback and silence its own signal. Active SAC signalling recruits PP2A-B56 to kinetochores where it antagonizes Aurora B to promote PP1 recruitment. PP1 in turn silences the SAC and delocalizes PP2A-B56. Preventing or bypassing key regulatory steps demonstrates that this spatiotemporal control of phosphatase feedback underlies rapid signal switching at the kinetochore by: allowing the SAC to quickly transition to the ON state in the absence of antagonizing phosphatase activity; and ensuring phosphatases are then primed to rapidly switch the SAC signal OFF when kinetochore kinase activities are diminished by force-producing microtubule attachments.	[Nijenhuis, Wilco; Teixeira, Antoinette; Kops, Geert J. P. L.] UMC Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Nijenhuis, Wilco; Teixeira, Antoinette; Kops, Geert J. P. L.] UMC Utrecht, NL-3584 CG Utrecht, Netherlands; [Nijenhuis, Wilco; Teixeira, Antoinette; Kops, Geert J. P. L.] UMC Utrecht, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands; [Vallardi, Giulia; Saurin, Adrian T.] Univ Dundee, Ninewells Hosp, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, Dundee DD1 9SY, Scotland; [Vallardi, Giulia; Saurin, Adrian T.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Kops, Geert J. P. L.] UMC Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Dundee; University of Dundee; Utrecht University; Utrecht University Medical Center	Kops, GJPL (corresponding author), UMC Utrecht, Dept Med Oncol, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl; a.saurin@dundee.ac.uk		Vallardi, Giulia/0000-0001-5902-1445; Saurin, Adrian/0000-0001-9317-2255; Kops, Geert/0000-0003-3555-5295	European Research Council (ERC-StG KINSIGN); Netherlands Organisation for Scientific Research [NWO-Vici 865.12.004]; KWF Kankerbestrijding [UU-2012-5427]; TiPharma [T3-503]; Ninewells Cancer Campaign; Leng Charitable Trust; Tenovus Scotland Tayside	European Research Council (ERC-StG KINSIGN)(European Research Council (ERC)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); KWF Kankerbestrijding(KWF Kankerbestrijding); TiPharma; Ninewells Cancer Campaign; Leng Charitable Trust; Tenovus Scotland Tayside	We thank M. Vleugel and M. Omerzu for help with the pMELT-KNL1 antibody, and I. Cheeseman (Whitehead Institute, USA), A. Musacchio (MPI-Dortmund, Germany), A. de Antoni (IFOM, Italy), P. Parker (CRUK London Research Institute, UK) and S. Taylor (University of Manschester, UK) for reagents. We thank the Kops, Lens, Saurin, Swedlow and Griffis laboratories for discussions. This work is supported by the European Research Council (ERC-StG KINSIGN to G.J.P.L.K.), by the Netherlands Organisation for Scientific Research (NWO-Vici 865.12.004 to G.J.P.L.K.), by the KWF Kankerbestrijding (UU-2012-5427 to G.J.P.L.K.), by TiPharma (T3-503 to G.J.P.L.K.) and by financial support to A.T.S. (from the Ninewells Cancer Campaign, Leng Charitable Trust and Tenovus Scotland Tayside).	Akopyan K, 2014, MOL CELL, V53, P843, DOI 10.1016/j.molcel.2014.01.031; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Espert A, 2014, J CELL BIOL, V206, P833, DOI 10.1083/jcb.201406109; Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Funabiki H, 2013, CHROMOSOMA, V122, P135, DOI 10.1007/s00412-013-0401-5; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Gutierrez-Caballero C, 2012, TRENDS GENET, V28, P351, DOI 10.1016/j.tig.2012.03.003; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Krenn V, 2014, CURR BIOL, V24, P29, DOI 10.1016/j.cub.2013.11.046; Kruse T, 2013, J CELL SCI, V126, P1086, DOI 10.1242/jcs.122481; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Morin V, 2012, CURR BIOL, V22, P289, DOI 10.1016/j.cub.2011.12.048; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Vazquez-Novelle MD, 2014, CURR BIOL, V24, P638, DOI 10.1016/j.cub.2014.01.034; Vleugel M, 2013, J CELL BIOL, V203, P943, DOI 10.1083/jcb.201307016; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Xu P., 2014, J CELL SCI; Xu P, 2013, BIOL OPEN, V2, P479, DOI 10.1242/bio.20134051; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Zhang G, 2014, J CELL SCI, V127, P871, DOI 10.1242/jcs.139725	42	126	126	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1257	U269		10.1038/ncb3065	http://dx.doi.org/10.1038/ncb3065			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25402682	Green Accepted, Green Submitted			2022-12-25	WOS:000345777300016
J	Burikhanov, R; Sviripa, VM; Hebbar, N; Zhang, W; Layton, WJ; Hamza, A; Zhan, CG; Watt, DS; Liu, C; Rangnekar, VM				Burikhanov, Ravshan; Sviripa, Vitaliy M.; Hebbar, Nikhil; Zhang, Wen; Layton, W. John; Hamza, Adel; Zhan, Chang-Guo; Watt, David S.; Liu, Chunming; Rangnekar, Vivek M.			Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis	NATURE CHEMICAL BIOLOGY			English	Article							SUPPRESSOR PAR-4; BREAST-CANCER; PATHWAY; P53	The tumor suppressor protein prostate apoptosis response-4 (Par-4), which is secreted by normal cells, selectively induces apoptosis in cancer cells. We identified a 3-arylquinoline derivative, designated Arylquin 1, as a potent Par-4 secretagogue in cell cultures and mice. Mechanistically, Arylquin 1 binds vimentin, displaces Par-4 from vimentin for secretion and triggers the efficient paracrine apoptosis of diverse cancer cells. Thus, targeting vimentin with Par-4 secretagogues efficiently induces paracrine apoptosis of tumor cells.	[Burikhanov, Ravshan; Rangnekar, Vivek M.] Univ Kentucky, Coll Med, Dept Radiat Med, Lexington, KY 40508 USA; [Sviripa, Vitaliy M.; Zhang, Wen; Watt, David S.; Liu, Chunming] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Sviripa, Vitaliy M.; Zhan, Chang-Guo; Watt, David S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY USA; [Hebbar, Nikhil; Rangnekar, Vivek M.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA; [Zhang, Wen; Watt, David S.; Liu, Chunming; Rangnekar, Vivek M.] Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY USA; [Layton, W. John; Watt, David S.] Univ Kentucky, Coll Arts & Sci, Dept Chem, Lexington, KY USA; [Hamza, Adel; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Mol Modeling & Biopharmaceut Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Rangnekar, VM (corresponding author), Univ Kentucky, Coll Med, Dept Radiat Med, Lexington, KY 40508 USA.	vmrang01@email.uky.edu	Burikhanov, Ravshan/AAF-4895-2021	Sviripa, Vitaliy/0000-0002-7272-373X	National Center for Research Resources through 'COBRE Center for Biomedical Research Excellence' [P20 RR020171]; NIH-National Cancer Institute [R01 CA60872, R21 CA179283]; University of Kentucky Center for Clinical and Translational Science Drug Discovery Pilot grant; NATIONAL CANCER INSTITUTE [R21CA179283, R01CA060872, R01CA172379, P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER	National Center for Research Resources through 'COBRE Center for Biomedical Research Excellence'; NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Kentucky Center for Clinical and Translational Science Drug Discovery Pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Center for Research Resources through 'COBRE Center for Biomedical Research Excellence' grant P20 RR020171 (to L. Hersh, who is the principal investigator of the study on which D.S.W. is core director), NIH-National Cancer Institute grants R01 CA60872 and R21 CA179283 (to V.M.R.) and University of Kentucky Center for Clinical and Translational Science Drug Discovery Pilot grant (to V.M.R., D.S.W. and CL.).	Alvarez JV, 2013, CANCER CELL, V24, P30, DOI 10.1016/j.ccr.2013.05.007; Burikhanov R, 2014, CELL REP, V6, P271, DOI 10.1016/j.celrep.2013.12.020; Burikhanov R, 2013, CANCER RES, V73, P1011, DOI 10.1158/0008-5472.CAN-12-3212; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Eckes B, 2000, J CELL SCI, V113, P2455; Gillard BK, 1996, GLYCOBIOLOGY, V6, P33, DOI 10.1093/glycob/6.1.33; Hebbar N, 2012, J CELL PHYSIOL, V227, P3715, DOI 10.1002/jcp.24098; Luo Susan Y, 2013, Transl Respir Med, V1, P6, DOI 10.1186/2213-0802-1-6; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shrestha-Bhattarai T, 2013, CANCER CELL, V24, P3, DOI 10.1016/j.ccr.2013.06.010; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; VIALLET J, 1990, AM J RESP CELL MOL, V2, P225, DOI 10.1165/ajrcmb/2.3.225	14	41	46	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					924	926		10.1038/NCHEMBIO.1631	http://dx.doi.org/10.1038/NCHEMBIO.1631			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR5JP	25218743	Green Accepted			2022-12-25	WOS:000343621500013
J	Xu, P; Zhang, XF; Wang, XM; Li, JT; Liu, GM; Kuang, YY; Xu, J; Zheng, XH; Ren, LF; Wang, GL; Zhang, Y; Huo, LH; Zhao, ZX; Cao, DC; Lu, CY; Li, C; Zhou, Y; Liu, ZJ; Fan, ZH; Shan, GL; Li, XG; Wu, SX; Song, LP; Hou, GY; Jiang, YL; Jeney, Z; Yu, D; Wang, L; Shao, CJ; Song, L; Sun, J; Ji, PF; Wang, J; Li, Q; Xu, LM; Sun, FY; Feng, JX; Wang, CH; Wang, SL; Wang, BS; Li, Y; Zhu, YP; Xue, W; Zhao, L; Wang, JT; Gu, Y; Lv, WH; Wu, KJ; Xiao, JF; Wu, JY; Zhang, Z; Yu, J; Sun, XW				Xu, Peng; Zhang, Xiaofeng; Wang, Xumin; Li, Jiongtang; Liu, Guiming; Kuang, Youyi; Xu, Jian; Zheng, Xianhu; Ren, Lufeng; Wang, Guoliang; Zhang, Yan; Huo, Linhe; Zhao, Zixia; Cao, Dingchen; Lu, Cuiyun; Li, Chao; Zhou, Yi; Liu, Zhanjiang; Fan, Zhonghua; Shan, Guangle; Li, Xingang; Wu, Shuangxiu; Song, Lipu; Hou, Guangyuan; Jiang, Yanliang; Jeney, Zsigmond; Yu, Dan; Wang, Li; Shao, Changjun; Song, Lai; Sun, Jing; Ji, Peifeng; Wang, Jian; Li, Qiang; Xu, Liming; Sun, Fanyue; Feng, Jianxin; Wang, Chenghui; Wang, Shaolin; Wang, Baosen; Li, Yan; Zhu, Yaping; Xue, Wei; Zhao, Lan; Wang, Jintu; Gu, Ying; Lv, Weihua; Wu, Kejing; Xiao, Jingfa; Wu, Jiayan; Zhang, Zhang; Yu, Jun; Sun, Xiaowen			Genome sequence and genetic diversity of the common carp, Cyprinus carpio	NATURE GENETICS			English	Article							LINKAGE MAP; MICROSATELLITE LOCI; TELEOST FISH; HOX CLUSTERS; EVOLUTION; DUPLICATION; L.; DIVERSIFICATION; PIGMENTATION; ANNOTATION	The common carp, Cyprinus carpio, is one of the most important cyprinid species and globally accounts for 10% of freshwater aquaculture production. Here we present a draft genome of domesticated C. carpio (strain Songpu), whose current assembly contains 52,610 protein-coding genes and approximately 92.3% coverage of its paleotetraploidized genome (2n = 100). The latest round of whole-genome duplication has been estimated to have occurred approximately 8.2 million years ago. Genome resequencing of 33 representative individuals from worldwide populations demonstrates a single origin for C. carpio in 2 subspecies (C. carpio Haematopterus and C. carpio carpio). Integrative genomic and transcriptomic analyses were used to identify loci potentially associated with traits including scaling patterns and skin color. In combination with the high-resolution genetic map, the draft genome paves the way for better molecular studies and improved genome-assisted breeding of C. carpio and other closely related species.	[Xu, Peng; Li, Jiongtang; Xu, Jian; Zhang, Yan; Zhao, Zixia; Liu, Zhanjiang; Hou, Guangyuan; Jiang, Yanliang; Ji, Peifeng; Wang, Jian; Li, Qiang; Xu, Liming; Wang, Baosen; Li, Yan; Zhu, Yaping; Xue, Wei; Zhao, Lan; Wang, Jintu; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Zhang, Xiaofeng; Kuang, Youyi; Zheng, Xianhu; Cao, Dingchen; Lu, Cuiyun; Li, Chao; Gu, Ying; Lv, Weihua; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China; [Wang, Xumin; Liu, Guiming; Ren, Lufeng; Wang, Guoliang; Huo, Linhe; Fan, Zhonghua; Shan, Guangle; Li, Xingang; Wu, Shuangxiu; Song, Lipu; Yu, Dan; Wang, Li; Shao, Changjun; Song, Lai; Sun, Jing; Wu, Kejing; Xiao, Jingfa; Wu, Jiayan; Zhang, Zhang; Yu, Jun] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhou, Yi] Harvard Univ, Sch Med, Stem Cell Program, Div Hematol & Oncol,Boston Childrens Hosp, Boston, MA USA; [Zhou, Yi] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Liu, Zhanjiang; Sun, Fanyue] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Jeney, Zsigmond] Res Inst Fisheries Aquaculture & Irrigat, Szarvas, Hungary; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Peoples R China; [Wang, Chenghui] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Wang, Shaolin] Univ Virginia, Dept Psychiat & Neurobiol Sci, Charlottesville, VA USA	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Auburn University System; Auburn University; Shanghai Ocean University; University of Virginia	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	junyu@big.ac.cn; sunxw@cafs.ac.cn	Zhao, Zi-Xia/AAM-8065-2021; wang, xumin/HII-8627-2022; Xu, Peng/J-4018-2012; Wang, Shaolin/FDL-8163-2022; Kuang, Youyi/AFO-8327-2022; Wu, Ke/HCQ-3503-2022; Wang, Jian/M-4594-2018; Xu, Jian/H-5349-2019; Wang, Shaolin/M-2282-2013; Liu, Zhanjiang/R-9633-2019	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Peng/0000-0002-1531-5078; Wang, Shaolin/0000-0003-0866-4584; Kuang, Youyi/0000-0003-4053-9353; Xu, Jian/0000-0003-0274-4268; Wang, Shaolin/0000-0003-0866-4584; Zhao, Lan/0000-0003-2681-7695; wu, jia yan/0000-0001-6048-405X; Li, Xingang/0000-0003-0252-154X	National High-Technology Research and Development Program of China (863 program) [2011AA100401, 2011AA100402, 2009AA10Z105]; National Department Public Benefit Research Foundation of China [200903045]; National Basic Research Program of China (973 Program) [2010CB126305]; National Natural Science Foundation of China [31302174, 31101893]; Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences [2009B002, 2011C016]	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Department Public Benefit Research Foundation of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences	We acknowledge Z. Zhu, N. Li, J. Gui, Z. Bao, G. Zhang, X.L. Zhang, J. Li, Y. Liu, Q. Liu and S. Chen for their support on the common carp genome project. We thank H. Hu, G.Z. Liu, J.H. Yu and C.J. Li for their assistance in sample collection and Y. Wan, T. Sun, W. Liu, L. Jiang, Shu Wang, Y. Zhu, X. Xing, P. Zhou and R. Cut for genotyping and sequencing. We thank J. Postlethwait, G. Hulata, L. David, L. Orban and F. Zhao for their helpful discussions. We acknowledge grant support from the National High-Technology Research and Development Program of China (863 program; 2011AA100401,2011AA100402 and 2009AA10Z105), the National Department Public Benefit Research Foundation of China (200903045), the National Basic Research Program of China (973 Program; 2010CB126305), the National Natural Science Foundation of China (31302174 and 31101893) and Special Scientific Research Funds for Central Non-Profit Institutes of the Chinese Academy of Fishery Sciences (2009B002 and 2011C016).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; *FAO FISH AQ DEP, 2007, STAT WORLD FISH AQ 2; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; OHNO S, 1967, CHROMOSOMA, V23, P1, DOI 10.1007/BF00293307; Ojima Y., 1990, Kromosomo (Tokyo), V57, P1871; Pritchard JK, 2000, GENETICS, V155, P945; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x	43	414	473	16	213	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1212	1219		10.1038/ng.3098	http://dx.doi.org/10.1038/ng.3098			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240282	hybrid			2022-12-25	WOS:000344131900012
J	Kang, JH; Super, M; Yung, CW; Cooper, RM; Domansky, K; Graveline, AR; Mammoto, T; Berthet, JB; Tobin, H; Cartwright, MJ; Watters, AL; Rottman, M; Waterhouse, A; Mammoto, A; Gamini, N; Rodas, MJ; Kole, A; Jiang, A; Valentin, TM; Diaz, A; Takahashi, K; Ingber, DE				Kang, Joo H.; Super, Michael; Yung, Chong Wing; Cooper, Ryan M.; Domansky, Karel; Graveline, Amanda R.; Mammoto, Tadanori; Berthet, Julia B.; Tobin, Heather; Cartwright, Mark J.; Watters, Alexander L.; Rottman, Martin; Waterhouse, Anna; Mammoto, Akiko; Gamini, Nazita; Rodas, Melissa J.; Kole, Anxhela; Jiang, Amanda; Valentin, Thomas M.; Diaz, Alexander; Takahashi, Kazue; Ingber, Donald E.			An extracorporeal blood-cleansing device for sepsis therapy	NATURE MEDICINE			English	Article							MANNOSE-BINDING LECTIN; RECOGNITION; SURVEILLANCE; RESISTANCE; MORTALITY; CELLS	Here we describe a blood-cleansing device for sepsis therapy inspired by the spleen, which can continuously remove pathogens and toxins from blood without first identifying the infectious agent. Blood flowing from an infected individual is mixed with magnetic nanobeads coated with an engineered human opsonin mannose-binding lectin (MBL) that captures a broad range of pathogens and toxins without activating complement factors or coagulation. Magnets pull the opsonin-bound pathogens and toxins from the blood; the cleansed blood is then returned back to the individual. The biospleen efficiently removes multiple Gram-negative and Gram-positive bacteria, fungi and endotoxins from whole human blood flowing through a single biospleen unit at up to 1.25 liters per h in vitro. In rats infected with Staphylococcus aureus or Escherichia coli, the biospleen cleared >90% of bacteria from blood, reduced pathogen and immune cell infiltration in multiple organs and decreased inflammatory cytokine levels. In a model of endotoxemic shock, the biospleen increased survival rates after a 5-h treatment.	[Kang, Joo H.; Super, Michael; Yung, Chong Wing; Cooper, Ryan M.; Domansky, Karel; Graveline, Amanda R.; Berthet, Julia B.; Cartwright, Mark J.; Watters, Alexander L.; Rottman, Martin; Waterhouse, Anna; Gamini, Nazita; Rodas, Melissa J.; Kole, Anxhela; Valentin, Thomas M.; Diaz, Alexander; Ingber, Donald E.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Kang, Joo H.; Yung, Chong Wing; Cooper, Ryan M.; Mammoto, Tadanori; Tobin, Heather; Mammoto, Akiko; Jiang, Amanda; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Kang, Joo H.; Yung, Chong Wing; Cooper, Ryan M.; Mammoto, Tadanori; Tobin, Heather; Mammoto, Akiko; Jiang, Amanda; Takahashi, Kazue; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Kang, Joo H.; Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Cooper, Ryan M.] Harvard MIT Hlth Sci & Technol Grad Program, Cambridge, MA USA; [Takahashi, Kazue] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital	Ingber, DE (corresponding author), Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Kang, Joo H./D-5436-2017; Super, Michael/AAW-7952-2021; Waterhouse, Anna/E-2464-2011; Domansky, Karel/AAD-3195-2020; Rottman, Martin/I-3005-2012; Rottman, Martin/AAD-9075-2021; Waterhouse, Anna/M-1681-2018; Ingber, Donald E/AAC-5894-2019	Kang, Joo H./0000-0001-9636-3209; Waterhouse, Anna/0000-0003-1498-9393; Rottman, Martin/0000-0001-5953-3344; Hicks-Berthet, Julia/0000-0002-6549-8116; Graveline, Amanda/0000-0002-2626-4093	Defense Advanced Research Projects Agency [N66001-11-1-4180, HR0011-13-C-0025]; Department of Defense/Center for Integration of Medicine and Innovative Technology; Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship from the Wyss Institute; Harvard University; National Science Foundation [ECS-0335765]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Defense/Center for Integration of Medicine and Innovative Technology(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship from the Wyss Institute; Harvard University; National Science Foundation(National Science Foundation (NSF))	This work was supported by Defense Advanced Research Projects Agency grant N66001-11-1-4180 and contract HR0011-13-C-0025, Department of Defense/Center for Integration of Medicine and Innovative Technology and the Wyss Institute for Biologically Inspired Engineering at Harvard University. We thank M. Montoya-Zavala and D. Breslau for micromachining,of the blood-cleansing microdevice and technical support; P. Snell and J. Tomolonis for microbiology assistance; A. Schulte for assistance in biospleen experiments; J. Weaver for help with scanning electron microscopy; R. Betensky for statistical analysis assistance; and A. Onderdonk, M. Puder, A. Nedder and their teams for assistance in developing the rat cecal contents sepsis model. We thank J. Fiering and his team for helpful discussions during the early phase of this project. J.H.K. is a recipient of a Wyss Technology Development Fellowship from the Wyss Institute and a professional development postdoctoral award from Harvard University. Scanning electron microscopy images were obtained at the Center for Nanoscale Systems at Harvard University; supported by the National Science Foundation under award no. ECS-0335765.	Angus DC, 2012, CRIT CARE, V16, DOI 10.1186/cc11152; [Anonymous], 2012, Nat Med, V18, P997, DOI 10.1038/nm0712-997; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P833, DOI 10.1128/AAC.01896-13; Chuang YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014133; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Garnacho-Montero J, 2006, CRIT CARE, V10, DOI 10.1186/cc4995; Gijs MAM, 2004, MICROFLUID NANOFLUID, V1, P22, DOI 10.1007/s10404-004-0010-y; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54; Jayakumar JS, 2010, COMPUT CHEM ENG, V34, P430, DOI 10.1016/j.compchemeng.2009.11.008; Kang JH, 2008, J AM CHEM SOC, V130, P396, DOI 10.1021/ja0770678; Kang JH, 2012, LAB CHIP, V12, P2175, DOI 10.1039/c2lc40072c; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Lo KM, 1998, PROTEIN ENG, V11, P495, DOI 10.1093/protein/11.6.495; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meijer HEH, 2012, PROG POLYM SCI, V37, P1333, DOI 10.1016/j.progpolymsci.2011.12.004; Morrow BJ, 2013, DIAGN MICR INFEC DIS, V75, P412, DOI 10.1016/j.diagmicrobio.2012.12.012; Neff LP, 2013, J TRAUMA ACUTE CARE, V75, pS120, DOI 10.1097/TA.0b013e318299d0cb; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; OBRIEN TF, 1992, NEW ENGL J MED, V326, P339, DOI 10.1056/NEJM199201303260510; Orsini Jose, 2012, J Clin Med Res, V4, P371, DOI 10.4021/jocmr1099w; PASS LJ, 1984, AM J PHYSIOL, V246, pH344, DOI 10.1152/ajpheart.1984.246.3.H344; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Townsend R, 2001, CLIN EXP IMMUNOL, V124, P223, DOI 10.1046/j.1365-2249.2001.01549.x; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Yung CW, 2009, LAB CHIP, V9, P1171, DOI 10.1039/b816986a	36	196	204	5	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1211	1216		10.1038/nm.3640	http://dx.doi.org/10.1038/nm.3640			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25216635				2022-12-25	WOS:000343194100034
J	Rudalska, R; Dauch, D; Longerich, T; McJunkin, K; Wuestefeld, T; Kang, TW; Hohmeyer, A; Pesic, M; Leibold, J; von Thun, A; Schirmacher, P; Zuber, J; Weiss, KH; Powers, S; Malek, NP; Eilers, M; Sipos, B; Lowe, SW; Geffers, R; Laufer, S; Zender, L				Rudalska, Ramona; Dauch, Daniel; Longerich, Thomas; McJunkin, Katherine; Wuestefeld, Torsten; Kang, Tae-Won; Hohmeyer, Anja; Pesic, Marina; Leibold, Josef; von Thun, Anne; Schirmacher, Peter; Zuber, Johannes; Weiss, Karl-Heinz; Powers, Scott; Malek, Nisar P.; Eilers, Martin; Sipos, Bence; Lowe, Scott W.; Geffers, Robert; Laufer, Stefan; Zender, Lars			In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer	NATURE MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; KINASE INHIBITORS; MAP KINASES; PATHWAYS; SENSITIVITY; INTEGRATION; STRATEGIES; JAK/STAT; GENES	In solid tumors, resistance to therapy inevitably develops upon treatment with cytotoxic drugs or molecularly targeted therapies. Here, we describe a system that enables pooled shRNA screening directly in mouse hepatocellular carcinomas (HCC) in vivo to identify genes likely to be involved in therapy resistance. Using a focused shRNA library targeting genes located within focal genomic amplifications of human HCC, we screened for genes whose inhibition increased the therapeutic efficacy of the multikinase inhibitor sorafenib. Both shRNA-mediated and pharmacological silencing of Mapk14 (p38 alpha) were found to sensitize mouse HCC to sorafenib therapy and prolong survival by abrogating Mapk14-dependent activation of Mek-Erk and Atf2 signaling. Elevated Mapk14-Atf2 signaling predicted poor response to sorafenib therapy in human HCC, and sorafenib resistance of p-Mapk14-expressing HCC cells could be reverted by silencing Mapk14. Our results suggest that a combination of sorafenib and Mapk14 blockade is a promising approach to overcoming therapy resistance of human HCC.	[Rudalska, Ramona; Dauch, Daniel; Wuestefeld, Torsten; Kang, Tae-Won; Hohmeyer, Anja; Pesic, Marina; Leibold, Josef; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany; [Longerich, Thomas; Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [McJunkin, Katherine] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Kang, Tae-Won; Hohmeyer, Anja; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany; [von Thun, Anne; Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [von Thun, Anne; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97070 Wurzburg, Germany; [Zuber, Johannes] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Weiss, Karl-Heinz] Univ Heidelberg Hosp, Dept Gastroenterol, Heidelberg, Germany; [Powers, Scott] Cold Spring Harbor Lab, Canc Genome Ctr, Cold Spring Harbor, NY 11724 USA; [Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany; [Sipos, Bence] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA; [Geffers, Robert] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Laufer, Stefan] Univ Tubingen, Dept Pharmaceut & Med Chem, Tubingen, Germany	Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Cold Spring Harbor Laboratory; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; University of Wurzburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Ruprecht Karls University Heidelberg; Cold Spring Harbor Laboratory; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen	Zender, L (corresponding author), Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.	lars.zender@med.uni-tuebingen.de	Weiss, Karl Heinz/AAA-9117-2022; Zuber, Johannes/E-7517-2011; Kang, Tae Won/S-4864-2019	Zuber, Johannes/0000-0001-8810-6835; Kang, Tae Won/0000-0003-1497-8926; Eilers, Martin/0000-0002-0376-6533; Powers, Scott/0000-0003-2769-1932; Leibold, Josef/0000-0003-2336-1987; Laufer, Stefan/0000-0001-6952-1486; McJunkin, Katherine/0000-0001-9730-442X	German Research Foundation, DFG [ZE 545/2-1, SFB/TRR77, SFB685]; Helmholtz Association of German Research Centers [VH-NG-424]; European Commission; Wilhelm Sander Stiftung; NATIONAL CANCER INSTITUTE [P01CA013106, U01CA168409, P30CA008748] Funding Source: NIH RePORTER	German Research Foundation, DFG(German Research Foundation (DFG)); Helmholtz Association of German Research Centers(Helmholtz Association); European Commission(European CommissionEuropean Commission Joint Research Centre); Wilhelm Sander Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Rinkel, N. Struever, C. Hermann, V. Geissler, U. Koppenhoefer, H. Riedesel, M. Jarek, M. Scharfe and the HZI Genome Analytics Group team for technical assistance. We thank the tissue bank of the National Center for Tumor Diseases Heidelberg for providing human HCC tissues. This work was supported by the German Research Foundation, DFG (Emmy Noether Programme ZE 545/2-1 to L.Z., the "Rebirth" Cluster of Excellence, project "Liver regeneration", SFB/TRR77 and SFB685), the Helmholtz Association of German Research Centers (VH-NG-424 to L.Z.), the European Commission (project 'Heptromic') and the Wilhelm Sander Stiftung.	Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421; Fischer S, 2013, J MED CHEM, V56, P241, DOI 10.1021/jm301539x; Giroux V, 2006, FASEB J, V20, P1982, DOI 10.1096/fj.06-6239com; Goldstein DM, 2010, J MED CHEM, V53, P2345, DOI [10.1021/jm9012906, 10.1021/acs.jmedchem.8b00124]; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hartsough E, 2014, J INVEST DERMATOL, V134, P319, DOI 10.1038/jid.2013.358; Hindley A, 2002, J CELL SCI, V115, P1575; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hope HR, 2009, J PHARMACOL EXP THER, V331, P882, DOI 10.1124/jpet.109.158329; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x; MacNee W, 2013, THORAX, V68, P738, DOI 10.1136/thoraxjnl-2012-202744; Margutti S, 2007, CHEMMEDCHEM, V2, P1116, DOI 10.1002/cmdc.200600271; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yau T, 2008, WORLD J GASTROENTERO, V14, P6437, DOI 10.3748/wjg.14.6437; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008	33	203	210	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2014	20	10					1138	1146		10.1038/nm.3679	http://dx.doi.org/10.1038/nm.3679			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AQ9RV	25216638	Green Accepted			2022-12-25	WOS:000343194100024
J	Van Batavia, J; Yamany, T; Molotkov, A; Dan, HB; Mansukhani, M; Batourina, E; Schneider, K; Oyon, D; Dunlop, M; Wu, XR; Cordon-Cardo, C; Mendelsohn, C				Van Batavia, Jason; Yamany, Tammer; Molotkov, Andrei; Dan, Hanbin; Mansukhani, Mahesh; Batourina, Ekaterina; Schneider, Kerry; Oyon, Daniel; Dunlop, Mark; Wu, Xue-Ru; Cordon-Cardo, Carlos; Mendelsohn, Cathy			Bladder cancers arise from distinct urothelial sub-populations	NATURE CELL BIOLOGY			English	Article							TRANSITIONAL-CELL CARCINOMA; URINARY-BLADDER; MOLECULAR PATHWAYS; STEM-CELLS; IN-SITU; N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE; PROLIFERATION; MICE; CARCINOGENESIS; IDENTIFICATION	Bladder cancer is the sixth most common cancer in humans. This heterogeneous set of lesions including urothelial carcinoma (Uca) and squamous cell carcinoma (SCC) arise from the urothelium, a stratified epithelium composed of K5-expressing basal cells, intermediate cells and umbrella cells. Superficial Uca lesions are morphologically distinct and exhibit different clinical behaviours: carcinoma in situ (CIS) is a flat aggressive lesion, whereas papillary carcinomas are generally low-grade and non-invasive. Whether these distinct characteristics reflect different cell types of origin is unknown. Here we show using lineage tracing in a murine model of carcinogenesis that intermediate cells give rise primarily to papillary lesions, whereas K5-basal cells are likely progenitors of CIS, muscle-invasive lesions and SCC depending on the genetic background. Our results provide a cellular and genetic basis for the diversity in bladder cancer lesions and provide a possible explanation for their clinical and morphological differences.	[Van Batavia, Jason; Yamany, Tammer; Molotkov, Andrei; Dan, Hanbin; Batourina, Ekaterina; Schneider, Kerry; Oyon, Daniel; Dunlop, Mark; Mendelsohn, Cathy] Columbia Univ, Dept Urol, New York, NY 10032 USA; [Van Batavia, Jason; Yamany, Tammer; Molotkov, Andrei; Dan, Hanbin; Batourina, Ekaterina; Schneider, Kerry; Oyon, Daniel; Dunlop, Mark; Mendelsohn, Cathy] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Mansukhani, Mahesh] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbour Healthcare Syst, New York, NY 10010 USA; [Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; New York University; New York University; Icahn School of Medicine at Mount Sinai	Mendelsohn, C (corresponding author), Columbia Univ, Dept Urol, New York, NY 10032 USA.	clm20@cumc.columbia.edu	Mendelsohn, Cathy/H-4280-2016	Mendelsohn, Cathy/0000-0002-4026-4073; Wu, Xue-Ru/0000-0001-6058-6291	TJ Martell Foundation; Columbia University; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	TJ Martell Foundation; Columbia University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Finstad for help with data collection, D. Metzger and P. Chambon for the Krt5CreERT2 line, F. H. Li for technical assistance, the Herbert Irving Comprehensive Cancer Center Histology Core facility for paraffin embedding and the Herbert Irving Comprehensive Cancer Center Microscopy Core for help with confocal microscopy. We thank C. Abate-Shen for critical reading of the manuscript and M. Benson, T. Owczarek and J. Mckiernan for helpful discussions. This work was funded by The TJ Martell Foundation (C.M.) and a Dean's Research Fellowship from Columbia University (T.Y.).	Bamgbola O. F., 2014, PEDIAT NEPHROL; BERTRAM JS, 1972, EUR J CANCER, V8, P587, DOI 10.1016/0014-2964(72)90137-5; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chan KS, 2010, CURR OPIN UROL, V20, P393, DOI 10.1097/MOU.0b013e32833cc9df; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheng L, 1999, CANCER, V86, P2098, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2098::AID-CNCR30>3.3.CO;2-0; Cheng L, 2000, CANCER, V88, P625, DOI 10.1002/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.3.CO;2-1; Cheville JC, 2000, CANCER, V88, P632, DOI 10.1002/(SICI)1097-0142(20000201)88:3<632::AID-CNCR21>3.0.CO;2-F; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Dahm P, 2003, EUR UROL, V44, P672, DOI 10.1016/S0302-2838(03)00416-0; DALBAGNI G, 1993, LANCET, V342, P469, DOI 10.1016/0140-6736(93)91595-D; Dancik GM, 2014, STEM CELLS, V32, P974, DOI 10.1002/stem.1625; Delnay KM, 1999, J UROLOGY, V161, P1106, DOI 10.1016/S0022-5347(01)61601-X; Edgecombe A, 2012, APPL IMMUNOHISTO M M, V20, P264, DOI 10.1097/PAI.0b013e3182351ed3; FARSUND T, 1978, VIRCHOWS ARCH B, V26, P215; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammes JS, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.05.037; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; Herr HW, 2000, J UROLOGY, V163, P60, DOI 10.1016/S0022-5347(05)67972-4; Hsu JW, 2013, AM J PATHOL, V182, P1811, DOI 10.1016/j.ajpath.2013.01.018; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JOST SP, 1989, VIRCHOWS ARCH B, V57, P27, DOI 10.1007/BF02899062; JOST SP, 1986, VIRCHOWS ARCH B, V51, P65, DOI 10.1007/BF02899016; JOST SP, 1989, J ANAT, V167, P103; JOST SP, 1986, CELL TISSUE KINET, V19, P155, DOI 10.1111/j.1365-2184.1986.tb00725.x; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Knowles MA, 2008, SCAND J UROL NEPHROL, V42, P116, DOI 10.1080/03008880802284605; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; LOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9; Madeb R, 2004, UROL ONCOL-SEMIN ORI, V22, P86, DOI 10.1016/S1078-1439(03)00139-X; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Montironi R, 2008, J CLIN PATHOL, V61, P3, DOI 10.1136/jcp.2007.049312; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; Morrison CD, 2014, P NATL ACAD SCI USA, V111, pE672, DOI 10.1073/pnas.1313580111; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Ogawa K, 1999, TOXICOL PATHOL, V27, P645, DOI 10.1177/019262339902700606; Ozaki K, 1998, CANCER RES, V58, P3806; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Ray D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001912; Shariat SF, 2000, UROLOGY, V56, P735, DOI 10.1016/S0090-4295(00)00756-1; Shen T. H., 2012, PLOS ONE, V7; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRUCK CH, 1994, CANCER RES, V54, P784; Sun TT, 1999, ADV EXP MED BIOL, V462, P7; Vasconcelos-Nobrega C, 2012, IN VIVO, V26, P727; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamany T., 2014, CURR OPIN ORGAN TRAN; Yin H, 2006, APPL IMMUNOHISTO M M, V14, P260, DOI 10.1097/00129039-200609000-00002; Zupancic D., 2011, VIRCHOWS ARCH	64	141	143	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2014	16	10					982	991		10.1038/ncb3038	http://dx.doi.org/10.1038/ncb3038			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ3RW	25218638				2022-12-25	WOS:000342712200008
J	Wu, C; Wang, ZM; Song, X; Feng, XS; Abnet, CC; He, J; Hu, N; Zuo, XB; Tan, W; Zhan, QM; Hu, ZB; He, ZH; Jia, WH; Zhou, YF; Yu, K; Shu, XO; Yuan, JM; Zheng, W; Zhao, XK; Gao, SG; Yuan, ZQ; Zhou, FY; Fan, ZM; Cui, JL; Lin, HL; Han, XN; Li, B; Chen, X; Dawsey, SM; Liao, LD; Lee, MP; Ding, T; Qiao, YL; Liu, ZH; Liu, Y; Yu, DK; Chang, J; Wei, LX; Gao, YT; Koh, WP; Xiang, YB; Tang, ZZ; Fan, JH; Han, JJ; Zhou, SL; Zhang, P; Zhang, DY; Yuan, Y; Huang, Y; Liu, CL; Zhai, K; Qiao, Y; Jin, GF; Guo, CH; Fu, JH; Miao, XP; Lu, CD; Yang, HJ; Wang, CY; Wheeler, WA; Gail, M; Yeager, M; Yuenger, J; Guo, ET; Li, AL; Zhang, W; Li, XM; Sun, LD; Ma, BG; Li, Y; Tang, S; Peng, XQ; Liu, J; Hutchinson, A; Jacobs, K; Giffen, C; Burdette, L; Fraumeni, JF; Shen, HB; Ke, Y; Zeng, YX; Wu, TC; Kraft, P; Chung, CC; Tucker, MA; Hou, ZC; Liu, YL; Hu, YL; Liu, Y; Wang, L; Yuan, G; Chen, LS; Liu, X; Ma, T; Meng, H; Sun, L; Li, XM; Li, XM; Ku, JW; Zhou, YF; Yang, LQ; Wang, Z; Li, Y; Qige, QRW; Yang, WJ; Lei, GY; Chen, LQ; Li, EM; Yuan, L; Yue, WB; Wang, R; Wang, LW; Fan, XP; Zhu, FH; Zhao, WX; Mao, YM; Zhang, M; Xing, GL; Li, JL; Han, M; Ren, JL; Liu, B; Ren, SW; Kong, QP; Kong, QP; Sheyhidin, I; Wei, W; Zhang, YR; Feng, CW; Wang, J; Yang, YH; Hao, HZ; Bao, QD; Liu, BC; Wu, AQ; Xie, D; Yang, WC; Wang, L; Zhao, XH; Chen, SQ; Hong, JY; Zhang, XJ; Freedman, ND; Goldstein, AM; Lin, DX; Taylor, PR; Wang, LD; Chanock, SJ				Wu, Chen; Wang, Zhaoming; Song, Xin; Feng, Xiao-Shan; Abnet, Christian C.; He, Jie; Hu, Nan; Zuo, Xian-Bo; Tan, Wen; Zhan, Qimin; Hu, Zhibin; He, Zhonghu; Jia, Weihua; Zhou, Yifeng; Yu, Kai; Shu, Xiao-Ou; Yuan, Jian-Min; Zheng, Wei; Zhao, Xue-Ke; Gao, She-Gan; Yuan, Zhi-Qing; Zhou, Fu-You; Fan, Zong-Min; Cui, Ji-Li; Lin, Hong-Li; Han, Xue-Na; Li, Bei; Chen, Xi; Dawsey, Sanford M.; Liao, Linda; Lee, Maxwell P.; Ding, Ti; Qiao, You-Lin; Liu, Zhihua; Liu, Yu; Yu, Dianke; Chang, Jiang; Wei, Lixuan; Gao, Yu-Tang; Koh, Woon-Puay; Xiang, Yong-Bing; Tang, Ze-Zhong; Fan, Jin-Hu; Han, Jing-Jing; Zhou, Sheng-Li; Zhang, Peng; Zhang, Dong-Yun; Yuan, Yuan; Huang, Ying; Liu, Chunling; Zhai, Kan; Qiao, Yan; Jin, Guangfu; Guo, Chuanhai; Fu, Jianhua; Miao, Xiaoping; Lu, Changdong; Yang, Haijun; Wang, Chaoyu; Wheeler, William A.; Gail, Mitchell; Yeager, Meredith; Yuenger, Jeff; Guo, Er-Tao; Li, Ai-Li; Zhang, Wei; Li, Xue-Min; Sun, Liang-Dan; Ma, Bao-Gen; Li, Yan; Tang, Sa; Peng, Xiu-Qing; Liu, Jing; Hutchinson, Amy; Jacobs, Kevin; Giffen, Carol; Burdette, Laurie; Fraumeni, Joseph F., Jr.; Shen, Hongbing; Ke, Yang; Zeng, Yixin; Wu, Tangchun; Kraft, Peter; Chung, Charles C.; Tucker, Margaret A.; Hou, Zhi-Chao; Liu, Ya-Li; Hu, Yan-Long; Liu, Yu; Wang, Li; Yuan, Guo; Chen, Li-Sha; Liu, Xiao; Ma, Teng; Meng, Hui; Sun, Li; Li, Xin-Min; Li, Xiu-Min; Ku, Jian-Wei; Zhou, Ying-Fa; Yang, Liu-Qin; Wang, Zhou; Li, Yin; Qige, Qirenwang; Yang, Wen-Jun; Lei, Guang-Yan; Chen, Long-Qi; Li, En-Min; Yuan, Ling; Yue, Wen-Bin; Wang, Ran; Wang, Lu-Wen; Fan, Xue-Ping; Zhu, Fang-Heng; Zhao, Wei-Xing; Mao, Yi-Min; Zhang, Mei; Xing, Guo-Lan; Li, Ji-Lin; Han, Min; Ren, Jing-Li; Liu, Bin; Ren, Shu-Wei; Kong, Qing-Peng; Li, Feng; Sheyhidin, Ilyar; Wei, Wu; Zhang, Yan-Rui; Feng, Chang-Wei; Wang, Jin; Yang, Yu-Hua; Hao, Hong-Zhang; Bao, Qi-De; Liu, Bao-Chi; Wu, Ai-Qun; Xie, Dong; Yang, Wan-Cai; Wang, Liang; Zhao, Xiao-Hang; Chen, Shu-Qing; Hong, Jun-Yan; Zhang, Xue-Jun; Freedman, Neal D.; Goldstein, Alisa M.; Lin, Dongxin; Taylor, Philip R.; Wang, Li-Dong; Chanock, Stephen J.			Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; RISK; VARIANTS; CANCER; NASOPHARYNGEAL; METAANALYSIS; LEUKEMIA; GLIOMA; COHORT; PLCE1	We conducted a joint (pooled) analysis of three genome-wide association studies (GWAS)(1-3) of esophageal squamous cell carcinoma (ESCC) in individuals of Chinese ancestry (5,337 ESCC cases and 5,787 controls) with 9,654 ESCC cases and 10,058 controls for follow-up. In a logistic regression model adjusted for age, sex, study and two eigenvectors, two new loci achieved genome-wide significance, marked by rs7447927 at 5q31.2 (per-allele odds ratio (OR) = 0.85, 95% confidence interval (CI) = 0.82-0.88; P = 7.72 x 10(-20)) and rs1642764 at 17p13.1 (per-allele OR = 0.88, 95% CI = 0.85-0.91; P = 3.10 x 10(-13)). rs7447927 is a synonymous SNP in TMEM173, and rs1642764 is an intronic SNP in ATP1B2, near TP53. Furthermore, a locus in the HLA class II region at 6p21.32 (rs35597309) achieved genome-wide significance in the two populations at highest risk for ESSC (OR = 1.33, 95% CI = 1.22-1.46; P = 1.99 x 10(-10)). Our joint analysis identifies new ESCC susceptibility loci overall as well as a new locus unique to the population in the Taihang Mountain region at high risk of ESCC.	[Wu, Chen; Tan, Wen; Zhan, Qimin; Liu, Zhihua; Liu, Yu; Yu, Dianke; Chang, Jiang; Wei, Lixuan; Huang, Ying; Liu, Chunling; Zhai, Kan; Qiao, Yan; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Tan, Wen; Zhan, Qimin; Liu, Zhihua; Liu, Yu; Yu, Dianke; Chang, Jiang; Wei, Lixuan; Huang, Ying; Liu, Chunling; Zhai, Kan; Qiao, Yan; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Zhaoming; Abnet, Christian C.; Hu, Nan; Dawsey, Sanford M.; Liao, Linda; Gail, Mitchell; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin; Burdette, Laurie; Fraumeni, Joseph F., Jr.; Chung, Charles C.; Tucker, Margaret A.; Freedman, Neal D.; Goldstein, Alisa M.; Taylor, Philip R.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Wang, Zhaoming; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin; Burdette, Laurie; Chung, Charles C.] SAIC Frederick Inc, NCI Frederick, Adv Technol Program, Div Canc Epidemiol & Genet,Canc Genome Res Lab, Frederick, MD USA; [Song, Xin; Yuan, Zhi-Qing; Cui, Ji-Li; Lin, Hong-Li; Liu, Ya-Li; Hu, Yan-Long; Wang, Li; Yuan, Guo; Chen, Li-Sha; Li, Xiu-Min; Zhao, Wei-Xing; Yang, Wan-Cai; Wang, Liang; Wang, Li-Dong] Xinxiang Med Univ, Basic Med Coll, Canc Res Ctr, Dept Pathol, Xinxiang, Peoples R China; [Song, Xin; Zhao, Xue-Ke; Fan, Zong-Min; Cui, Ji-Li; Lin, Hong-Li; Han, Xue-Na; Li, Bei; Chen, Xi; Han, Jing-Jing; Zhou, Sheng-Li; Zhang, Peng; Zhang, Dong-Yun; Yuan, Yuan; Guo, Er-Tao; Li, Ai-Li; Zhang, Wei; Li, Yan; Tang, Sa; Peng, Xiu-Qing; Liu, Jing; Hou, Zhi-Chao; Liu, Ya-Li; Hu, Yan-Long; Liu, Yu; Yuan, Guo; Chen, Li-Sha; Liu, Xiao; Ma, Teng; Meng, Hui; Sun, Li; Li, Xin-Min; Ku, Jian-Wei; Zhou, Ying-Fa; Yue, Wen-Bin; Wang, Ran; Wang, Lu-Wen; Fan, Xue-Ping; Zhang, Mei; Xing, Guo-Lan; Wang, Jin; Wang, Li-Dong] Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou, Peoples R China; [Feng, Xiao-Shan; Gao, She-Gan; Peng, Xiu-Qing; Mao, Yi-Min] Henan Univ Sci & Technol, Affiliated Hosp 1, Clin Lab & Resp Med, Dept Oncol, Luoyang, Peoples R China; [He, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [He, Jie] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zuo, Xian-Bo; Sun, Liang-Dan; Zhang, Xue-Jun] Anhui Med Univ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Jin, Guangfu; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [He, Zhonghu; Guo, Chuanhai; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Sch Oncol, Beijing 100871, Peoples R China; [Jia, Weihua; Fu, Jianhua; Zeng, Yixin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weihua; Fu, Jianhua; Zeng, Yixin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Peoples R China; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Zhou, Fu-You; Lu, Changdong; Yang, Haijun] Anyang Tumor Hosp, Anyang, Peoples R China; [Chen, Xi; Han, Jing-Jing] Zhengzhou Univ, Coll Med, Dept Basic Oncol & Pathol, Zhengzhou 450052, Peoples R China; [Lee, Maxwell P.] NCI, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Epidemiol, Beijing 100730, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing; Wang, Chaoyu] Shanghai Canc Inst, Shanghai, Peoples R China; [Koh, Woon-Puay] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Wheeler, William A.; Giffen, Carol] Informat Management Serv Inc, Silver Spring, MD USA; [Li, Ai-Li] Tumor Hosp Linzhou, Dept Med Oncol, Linzhou, Peoples R China; [Li, Xue-Min] Cixian Hosp, Ctr Hlth Screening & Endoscopy, Dept Pathol & Thorac Surg, Cixian, Peoples R China; [Ma, Bao-Gen; Zhang, Yan-Rui] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Peoples R China; [Ma, Bao-Gen; Zhang, Yan-Rui] Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China; [Ma, Bao-Gen; Zhang, Yan-Rui] Henan Prov Peoples Hosp, Cent Lab, Zhengzhou, Peoples R China; [Kraft, Peter; Zhou, Ying-Fa] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Li; Ren, Jing-Li; Feng, Chang-Wei] Zhengzhou Univ, Affiliated Hosp 2, Dept Basic Oncol Pathol & Gastroenterol, Zhengzhou 450052, Peoples R China; [Ku, Jian-Wei] Nanyang Med Coll, Affiliated Hosp 2, Dept Oncol, Nanyang, Peoples R China; [Yang, Liu-Qin; Zhu, Fang-Heng] Cent Hosp Xinxiang, Dept Radiotherapy Pathol & Pediat, Xinxiang, Peoples R China; [Wang, Zhou] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China; [Li, Yin; Yuan, Ling] Canc Hosp Henan Prov, Dept Thorac Surg & Radiotherapy, Zhengzhou, Peoples R China; [Qige, Qirenwang] Inner Mongolia Med Coll, Affiliated Hosp, Dept Internal Mongolia Med, Hohhot, Peoples R China; [Yang, Wen-Jun] Ningxia Med Univ, Dept Biotechnol, Yinchuan, Peoples R China; [Lei, Guang-Yan] Tumor Hosp Shaanxi Prov, Dept Thorac Surg, Xian, Peoples R China; [Chen, Long-Qi] Sichuan Univ, West China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610064, Peoples R China; [Li, En-Min] Shantou Univ, Coll Med, Dept Oncol Pathol, Shantou, Peoples R China; [Li, En-Min] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Peoples R China; [Yue, Wen-Bin] Puyang City Oil Field Gen Hosp, Dept Oncol, Puyang, Peoples R China; [Li, Ji-Lin] Linzhou Esophageal Canc Hosp, Dept Pathol & Thorac Surg, Linzhou, Peoples R China; [Han, Min] First Peoples Hosp Shangqiu, Dept Gastroenterol & Thorac Surg, Shangqiu, Peoples R China; [Liu, Bin] Capital Med Univ, Beijing Tongren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Ren, Shu-Wei] Xinyang Cent Hosp, Dept Oncol, Xinyang, Peoples R China; [Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resource & Evolut, Kunming, Peoples R China; [Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Peoples R China; [Sheyhidin, Ilyar] Xinjiang Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Urumqi, Peoples R China; [Sheyhidin, Ilyar] Xinjiang Med Univ, Affiliated Hosp 1, Med Res Ctr, Urumqi, Peoples R China; [Wei, Wu] Changzhi Med Univ, Inst Hematol Dis, Changzhi, Peoples R China; [Wei, Wu] Changzhi Med Univ, Dept Pathol, Changzhi, Peoples R China; [Yang, Yu-Hua] Hebi Dahejian Hosp, Dept Surg, Hebi, Peoples R China; [Hao, Hong-Zhang; Bao, Qi-De] Anyang Dist Hosp, Anyang, Peoples R China; [Liu, Bao-Chi] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Surg Dept, Shanghai 200433, Peoples R China; [Wu, Ai-Qun] Second Mil Med Univ Chinese Peoples Liberat Army, Dept Anat, Shanghai, Peoples R China; [Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Liang] Med Coll Wisconsin, Canc Res Ctr, Milwaukee, WI 53226 USA; [Zhao, Xiao-Hang] Chinese Acad Med Sci, Canc Inst & Hosp, Natl Lab Mol Oncol, Beijing 100730, Peoples R China; [Chen, Shu-Qing; Hong, Jun-Yan] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hong, Jun-Yan] Univ Med & Dent New Jersey, Dept Environm & Occupat Hlth, Newark, NJ 07103 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Xinxiang Medical University; Zhengzhou University; Henan University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Anhui Medical University; Nanjing Medical University; Peking University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Soochow University - China; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhengzhou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; National University of Singapore; Huazhong University of Science & Technology; Information Management Services, Inc.; Zhengzhou University; Zhengzhou University; Zhengzhou University; Harvard University; Harvard T.H. Chan School of Public Health; Zhengzhou University; Nanyang Medical College; Shandong University; Inner Mongolia Medical University; Ningxia Medical University; Sichuan University; Shantou University; Shantou University; Capital Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Shihezi University; Xinjiang Medical University; Xinjiang Medical University; Changzhi Medical College; Changzhi Medical College; Fudan University; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Medical College of Wisconsin; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Zhejiang University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Taylor, PR (corresponding author), NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA.	ptaylor@mail.nih.gov; lindx72@cicams.ac.cn	zhang, weihua/GXV-1334-2022; miao, xiaoping/C-4336-2011; Chang, Jiang/AAP-6156-2020; Gao, Yu/HGE-1937-2022; Zheng, Wei/O-3351-2013; Yeager, Meredith/AAA-5322-2020; li, xiu/GXV-1745-2022; Yang, Wancai/O-7655-2019; Freedman, Neal David/B-9741-2015; Liao, Linda M/B-3960-2011; Gao, Y./GWZ-3665-2022; Abnet, Christian C/C-4111-2015; Tucker, Margaret A/B-4297-2015; zhou, sheng/GYJ-6012-2022; Wang, Zhaoming/R-5527-2018; Qiao, You-Lin/B-4139-2012; gao, yi/HCI-8298-2022	miao, xiaoping/0000-0002-6818-9722; Zheng, Wei/0000-0003-1226-070X; Yang, Wancai/0000-0001-7437-9197; Freedman, Neal David/0000-0003-0074-1098; Liao, Linda M/0000-0002-1923-5294; Abnet, Christian C/0000-0002-3008-7843; Wang, Zhaoming/0000-0001-7556-3869; Qiao, You-Lin/0000-0001-6380-0871; Wu, Chen/0000-0003-4954-1011; Yang, Wenjun/0000-0001-5671-1344; Lin, Dongxin/0000-0002-8723-8868; fan, jinhu/0000-0003-3159-7893; Shen, Hongbing/0000-0002-2581-5906; Yuan, Jian-Min/0000-0002-4620-3108; Jin, Guangfu/0000-0003-0249-5337; ren, jingli/0000-0001-9891-0579; wei, lixuan/0000-0001-7465-7513; Kraft, Peter/0000-0002-4472-8103; Chen, Shuqing/0000-0002-0792-3735; Xie, Dong/0000-0002-1150-8657	National High-Tech Research and Development Program of China [2009AA022706]; National Basic Research Program of China [2011CB504303]; National Natural Science Foundation of China [30721001, 81071783]; Invitation Team of the Ministry of Education [2008IRTSTHN010]; 863 High-Tech Key Projects [2012AA02A209, 2012AA02A503, 2012AA02A201]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [3047]; Key Disciplines Revitalization Plan of Zhengzhou University [20132016]; Collaborative Innovation Center for Esophageal Cancer Research of Henan Province [20132016]; NCI [R01 CA82729, R37 CA70837, NO2-CP-11010, NO2-SC-66211, NO1-SC-91030, HHSN261200477001C]; Vanderbilt University; Shanxi Cancer Hospital and Institute; Cancer Institute and Hospital of the Chinese Academy of Medical Sciences; intramural research program of the US NIH/NCI; Division of Cancer Epidemiology and Genetics; Center for Cancer Research; US NIH/NCI [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [R03CA070837, UM1CA173640, ZIACP000112, R01CA082729, UM1CA182876, R01CA080205, UM1CA182910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Invitation Team of the Ministry of Education; 863 High-Tech Key Projects(National High Technology Research and Development Program of China); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Key Disciplines Revitalization Plan of Zhengzhou University; Collaborative Innovation Center for Esophageal Cancer Research of Henan Province; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt University; Shanxi Cancer Hospital and Institute; Cancer Institute and Hospital of the Chinese Academy of Medical Sciences; intramural research program of the US NIH/NCI; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National High-Tech Research and Development Program of China (2009AA022706 to D.L.), the National Basic Research Program of China (2011CB504303 to D.L. and W.T.) and the National Natural Science Foundation of China (30721001 to D.L., Q.Z. and Z.L.).; This work was supported by the Invitation Team of the Ministry of Education (2008IRTSTHN010), the National Natural Science Foundation of China (81071783), 863 High-Tech Key Projects (2012AA02A209, 2012AA02A503 and 2012AA02A201), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (3047), the Key Disciplines Revitalization Plan of Zhengzhou University (20132016) and the Collaborative Innovation Center for Esophageal Cancer Research of Henan Province (20132016).; The Shanghai Men's Health Study (SMHS) was supported by NCI extramural research grant R01 CA82729. The Shanghai Women's Health Study (SWHS) was supported by NCI extramural research grant R37 CA70837 and, in part, for biological sample collection, by NCI intramural research program contract NO2-CP-11010 with Vanderbilt University. The studies would not be possible without continuing support and devotion from the study participants and the staff of SMHS and SWHS.; The Shanxi Upper Gastrointestinal Cancer Genetics Project was supported by NCI intramural research program contract NO2-SC-66211 with the Shanxi Cancer Hospital and Institute.; The Nutrition Intervention Trials (NIT) was supported by NCI intramural research program contracts NO1-SC-91030 and HHSN261200477001C with the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences.; This research was supported in part by the intramural research program of the US NIH/NCI, the Division of Cancer Epidemiology and Genetics, and the Center for Cancer Research.; This project was funded in part with federal funds from the US NIH/NCI under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Eck P, 2007, GENES NUTR, V2, P143, DOI 10.1007/s12263-007-0040-7; Enciso-Mora V, 2013, BRIT J CANCER, V108, P2178, DOI 10.1038/bjc.2013.155; Freedman ND, 2010, CANCER-AM CANCER SOC, V116, P1572, DOI 10.1002/cncr.24880; Gu F, 2013, BRIT J CANCER, V108, P1378, DOI 10.1038/bjc.2013.7; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hu N, 2001, CLIN CANCER RES, V7, P883; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Su Z, 2012, NAT GENET, V44, P1131, DOI 10.1038/ng.2408; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang QM, 2011, MED ONCOL, V28, P188, DOI 10.1007/s12032-010-9457-8; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; YANG CS, 1980, CANCER RES, V40, P2633	32	116	124	7	163	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1001	+		10.1038/ng.3064	http://dx.doi.org/10.1038/ng.3064			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129146	Green Submitted, Green Accepted			2022-12-25	WOS:000341579400015
J	Kottyan, LC; Davis, BP; Sherrill, JD; Liu, K; Rochman, M; Kaufman, K; Weirauch, MT; Vaughn, S; Lazaro, S; Rupert, AM; Kohram, M; Stucke, EM; Kemme, KA; Magnusen, A; He, H; Dexheimer, P; Chehade, M; Wood, RA; Pesek, RD; Vickery, BP; Fleischer, DM; Lindbad, R; Sampson, HA; Mukkada, VA; Putnam, PE; Abonia, JP; Martin, LJ; Harley, JB; Rothenberg, ME				Kottyan, Leah C.; Davis, Benjamin P.; Sherrill, Joseph D.; Liu, Kan; Rochman, Mark; Kaufman, Kenneth; Weirauch, Matthew T.; Vaughn, Samuel; Lazaro, Sara; Rupert, Andrew M.; Kohram, Mojtaba; Stucke, Emily M.; Kemme, Katherine A.; Magnusen, Albert; He, Hua; Dexheimer, Phillip; Chehade, Mirna; Wood, Robert A.; Pesek, Robbie D.; Vickery, Brian P.; Fleischer, David M.; Lindbad, Robert; Sampson, Hugh A.; Mukkada, Vincent A.; Putnam, Phil E.; Abonia, J. Pablo; Martin, Lisa J.; Harley, John B.; Rothenberg, Marc E.			Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease	NATURE GENETICS			English	Article							INTERLEUKIN-4 RECEPTOR-ALPHA; GENE-EXPRESSION; SUSCEPTIBILITY LOCI; CHROMOSOME 11Q13.5; ATOPIC-DERMATITIS; DIETARY THERAPY; METAANALYSIS; VARIANTS; COMMON; DIFFERENTIATION	Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder associated with allergic hypersensitivity to food. We interrogated >1.5 million genetic variants in EoE cases of European ancestry and subsequently in a multi-site cohort with local and out-of-study control subjects. In addition to replicating association of the 5q22 locus (meta-analysis P = 1.9 x 10(-16)), we identified an association at 2p23 spanning CAPN14 (P = 2.5 x 10(-10)). CAPN14 was specifically expressed in the esophagus, was dynamically upregulated as a function of disease activity and genetic haplotype and after exposure of epithelial cells to interleukin (IL)-13, and was located in an epigenetic hotspot modified by IL-13. Genes neighboring the top 208 EoE-associated sequence variants were enriched for esophageal expression, and multiple loci for allergic sensitization were associated with EoE susceptibility (4.8 x 10(-2) < P < 5.1 x 10(-11)). We propose a model to explain the tissue-specific nature of EoE that involves the interplay of allergic sensitization with an EoE-specific, IL-13-inducible esophageal response involving CAPN14.	[Kottyan, Leah C.; Kaufman, Kenneth; Weirauch, Matthew T.; Vaughn, Samuel; Lazaro, Sara; Magnusen, Albert; Harley, John B.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Ctr Autoimmune Genom & Etiol,Div Rheumatol, Cincinnati, OH USA; [Kottyan, Leah C.; Kaufman, Kenneth; Lazaro, Sara; Magnusen, Albert; Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA; [Kottyan, Leah C.; Davis, Benjamin P.; Sherrill, Joseph D.; Liu, Kan; Rochman, Mark; Stucke, Emily M.; Kemme, Katherine A.; Abonia, J. Pablo; Rothenberg, Marc E.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45220 USA; [Weirauch, Matthew T.; Kohram, Mojtaba; Dexheimer, Phillip] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [He, Hua; Martin, Lisa J.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH USA; [Chehade, Mirna; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Pesek, Robbie D.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72205 USA; [Vickery, Brian P.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Fleischer, David M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Lindbad, Robert] EMMES Corp, Rockville, MD USA; [Mukkada, Vincent A.; Putnam, Phil E.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill; National Jewish Health; Emmes Corporation; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45220 USA.	rothenberg@cchmc.org	Mukkada, Vincent/AAF-6995-2019; Kottyan, Leah C./H-3050-2019; Martin, Lisa/E-2425-2016; Weirauch, Matthew/M-5459-2019	Mukkada, Vincent/0000-0003-4225-5506; Kottyan, Leah C./0000-0003-3979-2220; Martin, Lisa/0000-0001-8702-9946; Liu, Kan/0000-0001-5625-8180; Dexheimer, Phillip/0000-0003-3965-6894; Vickery, Brian/0000-0002-7243-5543; Vaughn, Samuel/0000-0001-9280-1953; davis, benjamin/0000-0003-2108-8059; Abonia, Juan/0000-0003-3788-6485; Rochman, Mark/0000-0002-0818-927X	US NIH, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI) [U19 AI066738, U01 HG006828, U01 HG006828-S1, U01 HG006828-S2, U01 AI066560, R37 AI024717, P01 AI083194, T32 HL7752-19, K23 AI099083, P01 AR049084]; US NIH from NIAID and NIDDK [U19 AI066738]; National Center for Research Resources (NCRR), a component of the US NIH [UL1 TR001082, UL1 TR-000067, UL1 TR-000039, UL1 TR-000083, UL1 TR-000424]; US Department of Veteran Affairs [IMMA 9]; US Department of Defense [PR094002]; Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort; Campaign Urging Research for Eosinophilic Diseases (CURED); Buckeye Foundation; Food Allergy Research Education (FARE) Foundation; Foundation of the American College of Allergy, Asthma and Immunology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000424, UL1TR000083, UL1TR001082, UL1TR000067, UL1TR000039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007752] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066738, T32AI060515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER	US NIH, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US NIH from NIAID and NIDDK; National Center for Research Resources (NCRR), a component of the US NIH; US Department of Veteran Affairs(US Department of Veterans Affairs); US Department of Defense(United States Department of Defense); Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort; Campaign Urging Research for Eosinophilic Diseases (CURED); Buckeye Foundation; Food Allergy Research Education (FARE) Foundation; Foundation of the American College of Allergy, Asthma and Immunology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Funding for this project was provided by the US NIH, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart, Lung, and Blood Institute (NHLBI) and National Human Genome Research Institute (NHGRI) (U19 AI066738, U01 HG006828, U01 HG006828-S1, U01 HG006828-S2, U01 AI066560, R37 AI024717, P01 AI083194, T32 HL7752-19, K23 AI099083 and P01 AR049084). The CoFAR arm of the study was supported by US NIH grant U19 AI066738 from NIAID and NIDDK. The project was also supported by several grants from the National Center for Research Resources (NCRR), a component of the US NIH: UL1 TR001082 (National Jewish), UL1 TR-000067 (Mount Sinai), UL1 TR-000039 (Arkansas), UL1 TR-000083 (University of North Carolina) and UL1 TR-000424 (Johns Hopkins). Support was also received from the US Department of Veteran Affairs (IMMA 9) and the US Department of Defense (PR094002). This research was supported in part by the Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort. Other support was derived from the Campaign Urging Research for Eosinophilic Diseases (CURED), the Buckeye Foundation, the Food Allergy Research Education (FARE) Foundation and the Foundation of the American College of Allergy, Asthma and Immunology.	Abonia JP, 2012, ANNU REV MED, V63, P421, DOI 10.1146/annurev-med-041610-134138; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amato AA, 2008, NEUROLOGY, V70, P730, DOI 10.1212/01.wnl.0000287138.89373.6b; Arnandis T, 2014, BIOCHEM J, V459, P355, DOI 10.1042/BJ20130847; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bartoli M, 2012, CLIN GENET, V81, P99, DOI 10.1111/j.1399-0004.2011.01708.x; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Brown RH, 2006, ANN NEUROL, V59, P875, DOI 10.1002/ana.20900; Collins MH, 2008, CLIN GASTROENTEROL H, V6, P621, DOI 10.1016/j.cgh.2008.01.004; Davis BP, 2013, EXPERT REV CLIN IMMU, V9, P285, DOI [10.1586/eci.13.15, 10.1586/ECI.13.15]; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; Fuentebella J, 2010, J PEDIATR GASTR NUTR, V51, P283, DOI 10.1097/MPG.0b013e3181e0817b; Greisenegger EK, 2013, EUR J DERMATOL, V23, P142, DOI 10.1684/ejd.2013.1955; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Krahn M, 2011, CLIN GENET, V80, P398, DOI 10.1111/j.1399-0004.2010.01620.x; Krahn M, 2006, ANN NEUROL, V59, P905, DOI 10.1002/ana.20833; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lupp C, 2012, NATURE, V489, P219, DOI [10.1038/489219a, 10.1038/489045a]; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Oflazer PS, 2009, NEUROMUSCULAR DISORD, V19, P261, DOI 10.1016/j.nmd.2009.01.010; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Putnam Philip E, 2009, Curr Gastroenterol Rep, V11, P220, DOI 10.1007/s11894-009-0034-2; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rothenberg ME, 2012, J ALLERGY CLIN IMMUN, V130, P617, DOI 10.1016/j.jaci.2012.06.051; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rothenberg ME, 2009, GASTROENTEROLOGY, V137, P1238, DOI 10.1053/j.gastro.2009.07.007; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Shin HD, 2003, HUM MOL GENET, V12, P1279, DOI 10.1093/hmg/ddg142; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Stuck MC, 2011, ALLERGY, V66, P705, DOI 10.1111/j.1398-9995.2010.02525.x; Tang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035334; Tantibhaedhyangkul U, 2009, ANN CLIN LAB SCI, V39, P99; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Ueta M, 2011, JPN J OPHTHALMOL, V55, P405, DOI 10.1007/s10384-011-0030-6; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1239, DOI 10.1136/bjo.2009.173419; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhu X, 2009, AM J PHYSIOL-GASTR L, V297, pG550, DOI 10.1152/ajpgi.00148.2009; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	53	179	188	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					895	900		10.1038/ng.3033	http://dx.doi.org/10.1038/ng.3033			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25017104	Green Accepted, Green Submitted			2022-12-25	WOS:000339704400021
J	Dey, SS; Kester, L; Spanjaard, B; Bienko, M; van Oudenaarden, A				Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander			Integrated genome and transcriptome sequencing of the same cell	NATURE BIOTECHNOLOGY			English	Article							COPY NUMBER VARIATION; SINGLE-CELL; RNA-SEQ; GENE-EXPRESSION; CONSEQUENCES; NUCLEOTIDE; PHENOTYPES; WIDE	Single-cell genomics and single-cell transcriptomics have emerged as powerful tools to study the biology of single cells at a genome-wide scale. However, a major challenge is to sequence both genomic DNA and mRNA from the same cell, which would allow direct comparison of genomic variation and transcriptome heterogeneity. We describe a quasilinear amplification strategy to quantify genomic DNA and mRNA from the same cell without physically separating the nucleic acids before amplification. We show that the efficiency of our integrated approach is similar to existing methods for single-cell sequencing of either genomic DNA or mRNA. Further, we find that genes with high cell-to-cell variability in transcript numbers generally have lower genomic copy numbers, and vice versa, suggesting that copy number variations may drive variability in gene expression among individual cells. Applications of our integrated sequencing approach could range from gaining insights into cancer evolution and heterogeneity to understanding the transcriptional consequences of copy number variations in healthy and diseased tissues.	[Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	Bienko, Magda/AAM-8867-2020; van Oudenaarden, Alexander/AAA-1705-2019	Bienko, Magda/0000-0002-6499-9082; Dey, Siddharth S./0000-0002-1161-1654; Kester, Lennart/0000-0002-8259-9971; Spanjaard, Bastiaan/0000-0003-1309-8839	European Research Council Advanced grant (ERC-AdG) [294325-GeneNoiseControl]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award; Human Frontier Science Program	European Research Council Advanced grant (ERC-AdG)(European Research Council (ERC)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award; Human Frontier Science Program(Human Frontier Science Program)	We would like to thank C. Zong (Harvard University) for sharing details of MALBAC and D. Grun (Hubrecht Institute) for assistance in data analysis. We would also like to thank N. Crosetto (Hubrecht Institute) for assistance in preparing DNA FISH probes. This work was supported by the European Research Council Advanced grant (ERC-AdG 294325-GeneNoiseControl), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award and by the Human Frontier Science Program (to M.B.).	Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bienko M, 2013, NAT METHODS, V10, P122, DOI [10.1038/nmeth.2306, 10.1038/NMETH.2306]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054236; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	27	291	350	8	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					285	+		10.1038/nbt.3129	http://dx.doi.org/10.1038/nbt.3129			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25599178	Green Accepted			2022-12-25	WOS:000350766900025
J	Nishikawa, K; Iwamoto, Y; Kobayashi, Y; Katsuoka, F; Kawaguchi, S; Tsujita, T; Nakamura, T; Kato, S; Yamamoto, M; Takayanagi, H; Ishii, M				Nishikawa, Keizo; Iwamoto, Yoriko; Kobayashi, Yasuhiro; Katsuoka, Fumiki; Kawaguchi, Shin-ichi; Tsujita, Tadayuki; Nakamura, Takashi; Kato, Shigeaki; Yamamoto, Masayuki; Takayanagi, Hiroshi; Ishii, Masaru			DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway	NATURE MEDICINE			English	Article							BONE LOSS; METHYLATION; DNMT3A; GENES; CELLS; EFFICIENT; BISPHOSPHONATES; OSTEOIMMUNOLOGY; PRECURSORS; EXPRESSION	Metabolic reprogramming occurs in response to the cellular environment to mediate differentiation(1-3), but the fundamental mechanisms linking metabolic processes to differentiation programs remain to be elucidated. During osteoclast differentiation, a shift toward more oxidative metabolic processes occurs(3). In this study we identified the de novo DNA methyltransferase 3a (Dnmt3a) as a transcription factor that couples these metabolic changes to osteoclast differentiation. We also found that receptor activator of nuclear factor-kappa B ligand (RANKL), an essential cytokine for osteoclastogenesis(4-7), induces this metabolic shift towards oxidative metabolism, which is accompanied by an increase in S-adenosylmethionine (SAM) production. We found that SAM-mediated DNA methylation by Dnmt3a regulates osteoclastogenesis via epigenetic repression of anti-osteoclastogenic genes. The importance of Dnmt3a in bone homeostasis was underscored by the observations that Dnmt3a-deficient osteoclast precursor cells do not differentiate efficiently into osteoclasts and that mice with an osteoclast-specific deficiency in Dnmt3a have elevated bone mass due to a smaller number of osteoclasts. Furthermore, inhibition of DNA methylation by theaflavin-3,3'-digallate abrogated bone loss in models of osteoporosis. Thus, this study reveals the role of epigenetic processes in the regulation of cellular metabolism and differentiation, which may provide the molecular basis for a new therapeutic strategy for a variety of bone disorders.	[Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan; [Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, WPI, Osaka, Japan; [Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] CREST, Japan Sci & Technol Agcy, Tokyo, Japan; [Iwamoto, Yoriko] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Kobayashi, Yasuhiro] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Katsuoka, Fumiki] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Gen, Sendai, Miyagi 980, Japan; [Katsuoka, Fumiki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Kawaguchi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Nakamura, Takashi] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Kato, Shigeaki] Soma Cent Hosp, Fukushima, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Takayanagi, Hiroshi] ERATO, Japan Sci & Technol Agcy, Takayanagi Osteonetwork Project, Tokyo, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Matsumoto Dental University; Tohoku University; Tohoku University; Tohoku University; Keio University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Nishikawa, K (corresponding author), Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan.	nishi@ifrec.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Yamamoto, Masayuki/A-4873-2010; Kawaguchi, Shin-ichi/U-7798-2019; KOBAYASHI, YASUHIRO/AAU-4931-2021; Tsujita, Tadayuki/AAH-2347-2019; Kawaguchi, Shin-ichi/D-1182-2012	Yamamoto, Masayuki/0000-0002-9073-9436; Tsujita, Tadayuki/0000-0002-7189-0376; Katsuoka, Fumiki/0000-0003-0939-7887; Kobayashi, Yasuhiro/0000-0002-0903-3226; Kawaguchi, Shin-ichi/0000-0002-4140-9959; Nakamura, Takashi/0000-0002-6124-061X	Japan Society for the Promotion of Science (JSPS) [26116719]; JSPS [26713010, 25253070]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT, Japan; Astellas Foundation for Research on Metabolic Disorders; Ichiro Kanehara Foundation; Shimadzu Science Foundation; Takeda Science Foundation; International Human Frontier Science Program [RGY0077/2011]; Grants-in-Aid for Scientific Research [25670792, 25750357, 22113007, 26111002] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT, Japan; Astellas Foundation for Research on Metabolic Disorders; Ichiro Kanehara Foundation; Shimadzu Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); International Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kaseda, M. Shirazaki, and Y. Maijima for technical assistance and J. Kikuta, S. Fujimori, and S. Simmons for helpful discussions. We also thank M. Okano, S. Takeda, and G. Karsenty; H. Wu, M. Takami, and K. Ozato for the gifts of Dnmt3a-deficient ESCs, Col1a1-Cre transgenic mice, the Dnmt3a expression vector, and Irf8<SUP>-/-</SUP> mice, respectively. This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas from the Japan Society for the Promotion of Science (JSPS) (26116719; K.N.); Grants-in-Aid for Creative Scientific Research and Young Scientists (A) from the JSPS (26713010; K.N.); Grants-in-Aid for Scientific Research (A) from the JSPS (25253070; M.I.); the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT; M.I.); the Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT, Japan (T.T., S. Kawaguchi and M.Y.); and grants from the Astellas Foundation for Research on Metabolic Disorders (K.N.), the Ichiro Kanehara Foundation (K.N.), the Shimadzu Science Foundation (K.N.), the Takeda Science Foundation (K.N. and M.I.), and the International Human Frontier Science Program (RGY0077/2011 to M.I.).	Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Goldring SR, 2004, ARTHRITIS RHEUM-US, V50, P2044, DOI 10.1002/art.20383; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hikiji H, 2014, FASEB J, V28, P871, DOI 10.1096/fj.13-233106; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mund C, 2006, EPIGENETICS-US, V1, P7; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Nishikawa K, 2014, J BONE MINER METAB, V32, P331, DOI 10.1007/s00774-013-0547-5; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Rajavelu A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-16; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Teo BHD, 2012, BIOCHEM J, V447, P229, DOI 10.1042/BJ20120888; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yasui T, 2011, ANN NY ACAD SCI, V1240, P7, DOI 10.1111/j.1749-6632.2011.06245.x; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	44	142	150	4	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					281	+		10.1038/nm.3774	http://dx.doi.org/10.1038/nm.3774			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25706873				2022-12-25	WOS:000350362000022
J	Rui, YN; Xu, Z; Patel, B; Chen, ZH; Chen, DS; Tito, A; David, G; Sun, YM; Stimming, EF; Bellen, HJ; Cuervo, AM; Zhang, S				Rui, Yan-Ning; Xu, Zhen; Patel, Bindi; Chen, Zhihua; Chen, Dongsheng; Tito, Antonio; David, Gabriela; Sun, Yamin; Stimming, Erin F.; Bellen, Hugo J.; Cuervo, Ana Maria; Zhang, Sheng			Huntingtin functions as a scaffold for selective macroautophagy	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER; AUTOPHAGIC DEGRADATION; EMBRYONIC LETHALITY; AGGREGATE FORMATION; MUTANT HUNTINGTIN; CASPASE CLEAVAGE; DISEASE; ULK1; GENE; NEURODEGENERATION	Selective macroautophagy is an important protective mechanism against diverse cellular stresses. In contrast to the well-characterized starvation-induced autophagy, the regulation of selective autophagy is largely unknown. Here, we demonstrate that Huntingtin, the Huntington disease gene product, functions as a scaffold protein for selective macroautophagy but it is dispensable for non-selective macroautophagy. In Drosophila, Huntingtin genetically interacts with autophagy pathway components. In mammalian cells, Huntingtin physically interacts with the autophagy cargo receptor p62 to facilitate its association with the integral autophagosome component LC3 and with Lys-63-linked ubiquitin-modified substrates. Maximal activation of selective autophagy during stress is attained by the ability of Huntingtin to bind ULK1, a kinase that initiates autophagy, which releases ULK1 from negative regulation by mTOR. Our data uncover an important physiological function of Huntingtin and provide a missing link in the activation of selective macroautophagy in metazoans.	[Rui, Yan-Ning; Xu, Zhen; Chen, Zhihua; Chen, Dongsheng; Tito, Antonio; Sun, Yamin; Zhang, Sheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Univ Texas Med Sch Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Patel, Bindi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Tito, Antonio; Zhang, Sheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Univ Texas Grad Sch Biomed Sci, Program Human & Mol Genet, Houston, TX 77030 USA; [Tito, Antonio; Zhang, Sheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Univ Texas Grad Sch Biomed Sci, Program Neurosci, Houston, TX 77030 USA; [David, Gabriela] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Program Dev Biol, Houston, TX 77030 USA; [Stimming, Erin F.] Univ Texas Hlth Sci Ctr Houston UTHlth, Univ Texas Med Sch Houston, Dept Neurol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Neurosci, Houston, TX 77030 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Zhang, Sheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu; sheng.zhang@uth.tmc.edu		Cuervo, Ana Maria/0000-0002-0771-700X; Bellen, Hugo/0000-0001-5992-5989; Rui, Yanning/0000-0002-4482-5579	R&R Belfer foundation; Hufftington foundation; T32 developmental biology training grant from the NICHD; NIH [R01-NS069880, P01-AG031782, AG038072]; RR Belfer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK098408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, P01AG031782] Funding Source: NIH RePORTER	R&R Belfer foundation; Hufftington foundation; T32 developmental biology training grant from the NICHD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RR Belfer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to T. Neufeld and U. Pandey for their fly lines; P. B. Dennis for the pRK5-GST-BHMT plasmid; D. Contamine for anti-Ref(2)P antibody; I. Bezprozvanny for MEF-Htt-WT and MEF-Htt-KO lines; M. Kundu for MEF-ULK1-KO and MEF-ULK1-WT lines ; J. Botas for UAS-hHtt DNA and fly lines. We also thank Z. Mao for technical assistance in confocal microscopy, and Z. Sun and N. Perrimon for critically reading the manuscript. H.J.B. is an investigator of the HHMI and supported by the R&R Belfer and Hufftington foundations. G.D. was supported by a T32 developmental biology training grant from the NICHD. This work was supported by NIH grants R01-NS069880 (to S.Z.) and P01-AG031782 and AG038072 (to A.M.C.) and the generous support of R&R Belfer (to A.M.C.).	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Carre-Mouka A, 2007, GENETICS, V176, P409, DOI 10.1534/genetics.106.063826; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Cheong H, 2014, AUTOPHAGY, V10, P45, DOI 10.4161/auto.26505; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cumming RC, 2008, METHOD ENZYMOL, V451, P639, DOI 10.1016/S0076-6879(08)03235-7; Dennis PB, 2009, METHOD ENZYMOL, V452, P97, DOI 10.1016/S0076-6879(08)03607-0; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Li Z, 1999, HUM MOL GENET, V8, P1807, DOI 10.1093/hmg/8.9.1807; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Martin DDO, 2014, HUM MOL GENET, V23, P3166, DOI 10.1093/hmg/ddu027; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Reiner A, 2003, MOL NEUROBIOL, V28, P259, DOI 10.1385/MN:28:3:259; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sullivan W., 2000, DROSOPHILA PROTOCOLS, P240; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838	83	262	267	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2015	17	3					262	+		10.1038/ncb3101	http://dx.doi.org/10.1038/ncb3101			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD0NE	25686248	Green Accepted			2022-12-25	WOS:000350770200011
J	Do, R; Balick, D; Li, H; Adzhubei, I; Sunyaev, S; Reich, D				Do, Ron; Balick, Daniel; Li, Heng; Adzhubei, Ivan; Sunyaev, Shamil; Reich, David			No evidence that selection has been less effective at removing deleterious mutations in Europeans than in Africans	NATURE GENETICS			English	Article							GENOME SEQUENCE; INFERENCE; EVOLUTION; HISTORY; IMPACT	Non-African populations have experienced size reductions in the time since their split from West Africans, leading to the hypothesis that natural selection to remove weakly deleterious Mutations has been less effective in the history of non-Africans. To test this hypothesis, we measured the per-genome accumulation of nonsynonymous substitutions across diverse pairs of populations. We find no evidence for a higher load of deleterious mutations in non-Africans. However, we detect significant differences among more divergent populations, as archaic Denisovans have accumulated nonsynonymous mutations faster than either modern humans or Neanderthals. To reconcile these findings with patterns that have been interpreted as evidence of the less effective removal of deleterious mutations in non-Africans than in West Africans, we Use simulations to show that the observed patterns are not likely to reflect changes in the effectiveness of selection after the populations split but are instead likely to be driven by other population genetic factors.	[Do, Ron; Balick, Daniel; Li, Heng; Sunyaev, Shamil; Reich, David] Broad Inst MIT & Harvard, Broad Inst, Cambridge, MA 02138 USA; [Do, Ron; Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Balick, Daniel; Adzhubei, Ivan; Sunyaev, Shamil] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sunyaev, S (corresponding author), Broad Inst MIT & Harvard, Broad Inst, Cambridge, MA 02138 USA.	ssunyaev@rics.bwh.harvard.edu; reich@genetics.med.harvard.edu	Li, Heng/D-9344-2011	Li, Heng/0000-0003-4874-2874; Adzhubey, Ivan/0000-0002-1483-9259	Canadian Institutes of Health Research; US National Institutes of Health [R01GM078598, R01MH101244, GM100233, HG006399]; US National Science Foundation [1032255]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857, R01GM100233, R01GM078598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Akey, D. Altshuler, C. Bustamante, S. Castellano, C. de Filippo, A. Keinan, A. Kondrashov, E. Lander, K. Lohmueller, S. Mallick, S. Paabo, N. Patterson, J. Pritchard, M. Przeworski, J. Schaiber, G. Sella and M. Slatkin for valuable discussions. R.D. was supported by a Banting fellowship from the Canadian Institutes of Health Research. S.S. was supported by US National Institutes of Health grants R01GM078598 and R01MH101244. D.R. was supported by US National Institutes of Health grants GM100233 and HG006399 and US National Science Foundation grant 1032255 and is an investigator of the Howard Hughes Medical Institute.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Balick D.J., 2014, BIORXIV, DOI [10.1101/003491, DOI 10.1101/003491]; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Carmi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5835; Casals F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003815; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gazave E, 2013, GENETICS, V195, P969, DOI 10.1534/genetics.113.153973; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Lohmueller K.E., 2014, BIORXIV, DOI [10.1101/005330, DOI 10.1101/005330]; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240	26	108	108	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					126	131		10.1038/ng.3186	http://dx.doi.org/10.1038/ng.3186			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25581429	Green Submitted, Green Accepted			2022-12-25	WOS:000348694700007
J	Goyette, P; Boucher, G; Mallon, D; Ellinghaust, E; Jostins, L; Huang, HL; Ripke, S; Gusareva, ES; Annese, V; Hauser, SL; Oksenberg, JR; Thomsent, I; Leslie, S; Daly, MJ; Van Steen, K; Duerr, RH; Barrett, JC; McGovern, DPB; Schumm, LP; Traherne, JA; Carrington, MN; Kosmoliaptsis, V; Karsen, TH; Franke, A; Rioux, JD				Goyette, Philippe; Boucher, Gabrielle; Mallon, Dermot; Ellinghaust, Eva; Jostins, Luke; Huang, Hailiang; Ripke, Stephan; Gusareva, Elena S.; Annese, Vito; Hauser, Stephen L.; Oksenberg, Jorge R.; Thomsent, Ingo; Leslie, Stephen; Daly, Mark J.; Van Steen, Kristel; Duerr, Richard H.; Barrett, Jeffrey C.; McGovern, Dermot P. B.; Schumm, L. Philip; Traherne, James A.; Carrington, Mary N.; Kosmoliaptsis, Vasilis; Karsen, Tom H.; Franke, Andre; Rioux, John D.		Int Inflammatory Bowel Dis Genetic	High-density mapping of the MHC identifies a shared role for HLA-DRB1(star)01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis	NATURE GENETICS			English	Article							PRIMARY SCLEROSING CHOLANGITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN STRUCTURES; HLA-DR; SUSCEPTIBILITY; HAPLOTYPE; GENOTYPE; ALLELES; ASSOCIATION; VARIANTS	Genome-wide association studies of the related chronic inflammatory bowel diseases (IBD) known as Crohn's disease and ulcerative colitis have shown strong evidence of association to the major histocompatibility complex (MHC). This region encodes a large number of immunological candidates, including the antigen-presenting classical human leukocyte antigen (HLA) molecules(1). Studies in IBD have indicated that multiple independent associations exist at HLA and non-HLA genes, but they have lacked the statistical power to define the architecture of association and causal alleles2,3. To address this, we performed high-density SNP typing of the MHC in >32,000 individuals with IBD, implicating multiple HLA alleles, with a primary role for HLA-DRB1*01:03 in both Crohn's disease and ulcerative colitis. Noteworthy differences were observed between these diseases, including a predominant role for class II HLA variants and heterozygous advantage observed in ulcerative colitis, suggesting an important role of the adaptive immune response in the colonic environment in the pathogenesis of IBD.	[Goyette, Philippe; Boucher, Gabrielle; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Mallon, Dermot; Kosmoliaptsis, Vasilis] Univ Cambridge, Dept Surg, Cambridge, England; [Mallon, Dermot; Kosmoliaptsis, Vasilis] Cambridge Biomed Res Ctr, NIHR, Cambridge, England; [Ellinghaust, Eva; Thomsent, Ingo; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Huang, Hailiang; Ripke, Stephan; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Analyt & Translat Genet Unit, Boston, MA 02115 USA; [Huang, Hailiang; Ripke, Stephan; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gusareva, Elena S.; Van Steen, Kristel] Univ Liege, Inst Montefiore, Syst & Modeling Unit, B-4000 Liege, Belgium; [Gusareva, Elena S.; Van Steen, Kristel] Univ Liege, GIGA R Grp Interdisciplinaire Genoproteom Appl Re, Liege, Belgium; [Annese, Vito] IRCCS CSS Hosp, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Annese, Vito] Azienda Osped Univ AOU Careggi, Strut Org Dipartimentali, Unit Gastroenterol SOD2, Florence, Italy; [Hauser, Stephen L.; Oksenberg, Jorge R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Thomsent, Ingo; Leslie, Stephen] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Schumm, L. Philip] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Traherne, James A.] Cambridge Inst Med Res, Cambridge, England; [Traherne, James A.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Carrington, Mary N.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD USA; [Carrington, Mary N.] Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA USA; [Karsen, Tom H.] Oslo Univ Hosp, Rikshosp, Res Inst Internal Med, Dept Transplantat Med,Div Canc Surg & Transplanta, N-0450 Oslo, Norway; [Karsen, Tom H.] Oslo Univ Hosp, Rikshosp, Norwegian Primary Sclerosing Cholangitis Res Ctr, Dept Transplantat Med,Div Canc Surg & Transplanta, N-0450 Oslo, Norway; [Karsen, Tom H.] Univ Oslo, Inst Clin Med, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Rioux, John D.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Cambridge; University of Cambridge; University of Kiel; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Liege; University of Liege; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of California System; University of California San Francisco; Murdoch Children's Research Institute; University of Melbourne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; University of Chicago; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Universite de Montreal	Rioux, JD (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	john.david.rioux@umontreal.ca	Ellinghaus, Eva/E-6490-2012; Kennedy, Nicholas Alexander/AET-5648-2022; Radford-Smith, Graham L/G-5749-2017; Whiteman, David C/P-2728-2014; Palmieri, Orazio/J-7697-2012; Franke, Andre/B-2151-2010; Duerr, Richard H/B-4188-2009; Ng, Siew Chien/N-4733-2015; Ripke, Stephan/AAK-5486-2021; Daly, Mark J/B-2453-2017; Andersen, Vibeke/I-7932-2012; Gearry, Richard B/H-3959-2019; Van Limbergen, Johan/L-1855-2019; Barclay, Murray Lindsay/D-9000-2012; Rioux, John D/A-9599-2015; D'Amato, Mauro/B-5050-2019; Zeissig, Sebastian/B-6297-2012; Prescott, Natalie J/F-6490-2011; Annese, Vito/AGW-4200-2022; Mallon, Dermot/GQO-7563-2022; Mallon, Dermot/AAK-7356-2021; van der Meulen, Andrea/AAU-9430-2020; Silverberg, Mark/B-4183-2008; D'Amato, Mauro/F-2450-2010; hayward, nicholas/C-1367-2015; Latiano, Anna/R-1965-2016	Ellinghaus, Eva/0000-0003-2914-3382; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Radford-Smith, Graham L/0000-0002-2047-6239; Whiteman, David C/0000-0003-2563-9559; Palmieri, Orazio/0000-0002-0019-7929; Franke, Andre/0000-0003-1530-5811; Duerr, Richard H/0000-0001-6586-3905; Ng, Siew Chien/0000-0002-6850-4454; Daly, Mark J/0000-0002-0949-8752; Andersen, Vibeke/0000-0002-0127-2863; Gearry, Richard B/0000-0002-2298-5141; Van Limbergen, Johan/0000-0001-5822-4371; Barclay, Murray Lindsay/0000-0003-2944-8338; Rioux, John D/0000-0001-7560-8326; D'Amato, Mauro/0000-0003-2743-5197; Zeissig, Sebastian/0000-0001-5124-0897; Prescott, Natalie J/0000-0002-5901-7371; Annese, Vito/0000-0002-0082-892X; Mallon, Dermot/0000-0001-7434-1201; Mallon, Dermot/0000-0001-7434-1201; van der Meulen, Andrea/0000-0001-9353-5431; D'Amato, Mauro/0000-0003-2743-5197; Parkes, Miles/0000-0002-6467-0631; Schumm, Phil/0000-0002-3050-2429; ripke, stephan/0000-0003-3622-835X; Stronati, Laura/0000-0001-5222-9497; Nothen, Markus/0000-0002-8770-2464; Potocnik, Uros/0000-0003-1624-9428; Seielstad, Mark/0000-0001-5783-1401; Winkelmann, Juliane/0000-0003-2667-9691; Harrison, Pille/0000-0003-4117-6910; Ellinghaus, David/0000-0002-4332-6110; hayward, nicholas/0000-0003-4760-1033; Wei, Zhi/0000-0001-6059-4267; Anderson, Carl/0000-0003-1719-7009; Huang, Hailiang/0000-0003-1461-5762; Newman, William/0000-0002-6382-4678; Laukens, Debby/0000-0002-1984-5850; Henderson, Paul/0000-0003-3634-6428; Massey, Dunecan/0000-0002-7144-4579; Lee, James/0000-0001-5711-9385; Kosmoliaptsis, Vasilis/0000-0001-7298-1387; ZHANG, HU/0000-0002-3281-4661; Barrett, Jeffrey/0000-0002-1152-370X; Simmons, Alison/0000-0003-3454-0710; Simms, Lisa/0000-0002-5387-7397; Vermeire, Severine/0000-0001-9942-3019; Van Steen, Kristel/0000-0001-9868-5033; Georges, Michel/0000-0003-4124-2375; Latiano, Anna/0000-0003-3719-2061; Gusareva, Elena/0000-0001-9019-8097; Lees, Charlie/0000-0002-0732-8215; Danese, Silvio/0000-0001-7341-1351; Gieger, Christian/0000-0001-6986-9554	Canada Research Chair; US National Institute of Diabetes and Digestive and Kidney Diseases grant (NIDDK) [R01 DK064869, U01 DK062432]; German Ministry of Education and Research (BMBF) grant programe: Med (sysINFLAME); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces'; Foundation for Experimental Biomedicine (Zurich, Switzerland); European Union Seventh Framework Programme (FP7) [262055]; Intramural Research Program of the US National Institutes of Health (NIH); Frederick National Laboratory; Center for Cancer Research; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Wellcome Trust [WT098051]; NIHR Cambridge Biomedical Research Centre; NIDDK [U01 DK062429-14, U01 DK062413, P01 DK046763-19, U54 DE023789-01, U01 DK062420]; UK Medical Research Council; Leona M. and Harry B. Helmsley Charitable Trust; European Union [305479]; National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI067068]; Agency for Healthcare Research and Quality (AHRQ) [HS021747]; Inflammatory Bowel Disease Genetic Research endowed chair at the University of Pittsburgh; US National Cancer Institute grant [CA141743]; US NIH [R01 NSO49477, 1U19 A1067152]; National Multiple Sclerosis Society [RG 2899-D11]; Australian National Health and Medical Research Council (R.D. Wright Career Development Fellowship) [APP1053756]; Academy of Medical Sciences (AMS) [AMS-SGCL11-Kosmoliaptsis] Funding Source: researchfish; Medical Research Council [G0800675, G0600329, MC_UU_12010/7, 1202121] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; National Institute for Health Research [CL-2011-14-001, NIHR-RP-R3-12-026] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Chief Scientist Office [ETM/137, ETM/75, CZB/4/540] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021747] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA141743, ZIABC010791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067068, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062431, R01DK064869, P01DK046763, P30DK043351, U01DK062423, U01DK062420, U01DK062429, U01DK062432, U01DK062413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER; MRC [MC_UU_12010/7, G0800675, G0600329] Funding Source: UKRI	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); US National Institute of Diabetes and Digestive and Kidney Diseases grant (NIDDK); German Ministry of Education and Research (BMBF) grant programe: Med (sysINFLAME)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); Foundation for Experimental Biomedicine (Zurich, Switzerland); European Union Seventh Framework Programme (FP7); Intramural Research Program of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leona M. and Harry B. Helmsley Charitable Trust; European Union(European Commission); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Inflammatory Bowel Disease Genetic Research endowed chair at the University of Pittsburgh; US National Cancer Institute grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Australian National Health and Medical Research Council (R.D. Wright Career Development Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Crohn&quot;s and Colitis UK; Chief Scientist Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the International PSC study group (http://www.ipscsg.org/) for sharing data. We are grateful to B.A. Lie and K. Holm for helpful discussions. J.D.R. holds a Canada Research Chair, and this work was supported by a US National Institute of Diabetes and Digestive and Kidney Diseases grant (NIDDK; R01 DK064869 and U01 DK062432). The laboratory of A.F. is supported by the German Ministry of Education and Research (BMBF) grant programe: Med (sysINFLAME). A.F. receives infrastructure support from the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' and holds an endowment professorship (Peter Hans Hofschneider Professorship) of the Foundation for Experimental Biomedicine (Zurich, Switzerland). Grant support for T.H.K. and A.F. was received from the European Union Seventh Framework Programme (FP7/2007-2013, grant number 262055, ESGI). M.N.C. is supported by the Intramural Research Program of the US National Institutes of Health (NIH), Frederick National Laboratory, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government. J.C.B. was supported by a Wellcome Trust grant (WT098051). D.M. and V.K. are supported by the NIHR Cambridge Biomedical Research Centre. L.P.S. is supported by an NIDDK grant (U01 DK062429-14). J.A.T. is supported by the UK Medical Research Council. D.P.B.M. is supported by the Leona M. and Harry B. Helmsley Charitable Trust, the European Union (305479) and by grants from the NIDDK (U01 DK062413, P01 DK046763-19, U54 DE023789-01), the National Institute of Allergy and Infectious Diseases (NIAID; U01 AI067068) and the Agency for Healthcare Research and Quality (AHRQ; HS021747). R.H.D. holds the Inflammatory Bowel Disease Genetic Research endowed chair at the University of Pittsburgh and was supported by an NIDDK grant (U01 DK062420) and a US National Cancer Institute grant (CA141743). S.L.H. and J.R.O. would like to also acknowledge the support of the US NIH (R01 NSO49477 and 1U19 A1067152) and the National Multiple Sclerosis Society (RG 2899-D11). S.L. wishes to acknowledge support from the Australian National Health and Medical Research Council (R.D. Wright Career Development Fellowship, APP1053756).	Achkar JP, 2012, GENES IMMUN, V13, P245, DOI 10.1038/gene.2011.79; ALPER CA, 1987, J CLIN INVEST, V79, P251, DOI 10.1172/JCI112791; Aly TA, 2006, DIABETES, V55, P1265, DOI 10.2337/db05-1276; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donaldson PT, 2002, AUTOIMMUNITY, V35, P555, DOI 10.1080/0891693021000054093; ESWAR N, 2007, CURR PROTOC PROT; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jones DC, 2006, GENES IMMUN, V7, P576, DOI 10.1038/sj.gene.6364333; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lipsitch Marc, 2003, BMC Med Genet, V4, P2, DOI 10.1186/1471-2350-4-2; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Veall M.R., 1996, J ECON SURV, V10, P241, DOI [10.1111/j.1467-6419.1996.tb00013.x, DOI 10.1111/J.1467-6419.1996.TB00013.X]; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wiencke K, 2001, HEPATOLOGY, V34, P625, DOI 10.1053/jhep.2001.27543	38	176	180	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					172	179		10.1038/ng.3176	http://dx.doi.org/10.1038/ng.3176			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25559196	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000348694700013
J	Palumbo-Zerr, K; Zerr, P; Distler, A; Fliehr, J; Mancuso, R; Huang, JG; Mielenz, D; Tomcik, M; Furnrohr, BG; Scholtysek, C; Dees, C; Beyer, C; Kronke, G; Metzger, D; Distler, O; Schettl, G; Distler, JHW				Palumbo-Zerr, Katrin; Zerr, Pawel; Distler, Alfiya; Fliehr, Judith; Mancuso, Rossella; Huang, Jingang; Mielenz, Dirk; Tomcik, Michal; Fuernrohr, Barbara G.; Scholtysek, Carina; Dees, Clara; Beyer, Christian; Kroenke, Gerhard; Metzger, Daniel; Distler, Oliver; Schettl, Georg; Distler, Joerg H. W.			Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis	NATURE MEDICINE			English	Article							MECHANISMS; KINASE; DIFFERENTIATION; ACTIVATION; EXPRESSION; RESPONSES; MURINE; REPAIR; CELLS; MODEL	Mesenchymal responses are an essential aspect of tissue repair. Failure to terminate this repair process correctly, however, results in fibrosis and organ dysfunction. Therapies that block fibrosis and restore tissue homeostasis are not yet available for clinical use. Here we characterize the nuclear receptor NR4A1 as an endogenous inhibitor of transforming growth factor-beta (TGF-beta) signaling and as a potential target for anti-fibrotic therapies. NR4A1 recruits a repressor complex comprising SP1, SIN3A, CoREST, LSD1, and HDAC1 to TGF-beta target genes, thereby limiting pro-fibrotic TGF-beta effects. Even though temporary upregulation of TGF-beta in physiologic wound healing induces NR4A1 expression and thereby creates a negative feedback loop, the persistent activation of TGF-beta signaling in fibrotic diseases uses AKT- and HDAC-dependent mechanisms to inhibit NR4A1 expression and activation. Small-molecule NR4A1 agonists can overcome this lack of active NR4A1 and inhibit experimentally-induced skin, lung, liver, and kidney fibrosis in mice. Our data demonstrate a regulatory role of NR4A1 in TGF-beta signaling and fibrosis, providing the first proof of concept for targeting NR4A1 in fibrotic diseases.	[Palumbo-Zerr, Katrin; Zerr, Pawel; Distler, Alfiya; Fliehr, Judith; Mancuso, Rossella; Huang, Jingang; Tomcik, Michal; Scholtysek, Carina; Dees, Clara; Beyer, Christian; Kroenke, Gerhard; Schettl, Georg; Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Mielenz, Dirk; Fuernrohr, Barbara G.] Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, D-91054 Erlangen, Germany; [Tomcik, Michal] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Tomcik, Michal] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Fuernrohr, Barbara G.] Med Univ Innsbruck, Div Biol Chem, A-6020 Innsbruck, Austria; [Metzger, Daniel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, CNRS UMR7104,U964, Illkirch Graffenstaden, France; [Distler, Oliver] Univ Zurich Hosp, Ctr Res Syst Autoimmune Dis, CH-8091 Zurich, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Charles University Prague; Institute of Rheumatology; Charles University Prague; Medical University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Zurich; University Zurich Hospital	Distler, JHW (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany.	joerg.distler@uk-erlangen.de	Krönke, Gerhard/C-6615-2014; Distler, Oliver/AAE-6225-2019; Tomcik, Michal/P-1510-2017	Krönke, Gerhard/0000-0002-7566-4325; Distler, Oliver/0000-0002-0546-8310; Tomcik, Michal/0000-0002-8616-7850; Metzger, Daniel/0000-0002-5555-046X	Interdisciplinary Center for Clinical Research (IZKF) in Erlangen [A40, A57, 120, J29]; German Research Foundation [DI 1537/4-1, DI 1537/5-1, DI 1537/8-1, DI 1537/9-1, BE 5191/1-1, AK 144/1-1, SCHE 1583/7-1, SPP1468-IMMUNOBONE]; IMI-funded project BTCURE; Metarthros project of the German Ministry of Education and Sciences; Ministry of Health of the Czech Republic [00023728]	Interdisciplinary Center for Clinical Research (IZKF) in Erlangen; German Research Foundation(German Research Foundation (DFG)); IMI-funded project BTCURE; Metarthros project of the German Ministry of Education and Sciences; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	We thank D. Metzger and H. Ichinose for kindly providing us with Nr4a1<SUP>fl/fl</SUP> and alpha Sma-Cre-ER mice. We thank M. Pascual Mate, R. Kleinlein, K. Dreissigacker and S. Fritz for excellent technical support. We also thank T. Kireva and E. Gianchecchi for their support in the study. We thank S. Wirtz and A. Weidemann for the expertise in experimental hepatic and kidney fibrosis. All figure drawings were adapted from Servier Medical Art. This study was supported by grants A40, A57,120 and J29 of the Interdisciplinary Center for Clinical Research (IZKF) in Erlangen, individual grants from the German Research Foundation (Grants DI 1537/4-1, DI 1537/5-1, DI 1537/8-1, DI 1537/9-1 (Heisenberg Professorship), BE 5191/1-1, AK 144/1-1 and SCHE 1583/7-1), the SPP1468-IMMUNOBONE program of the German Research Foundation, the IMI-funded project BTCURE, the Metarthros project of the German Ministry of Education and Sciences and the project 00023728 from the Ministry of Health of the Czech Republic for conceptual development and SVV260031.	Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Beyer C, 2013, BBA-MOL BASIS DIS, V1832, P897, DOI 10.1016/j.bbadis.2012.06.008; Beyer C, 2013, ANN RHEUM DIS, V72, P621, DOI 10.1136/annrheumdis-2012-202476; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zerr P, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204378; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388	35	210	218	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2015	21	2					150	158		10.1038/nm.3777	http://dx.doi.org/10.1038/nm.3777			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CA5VB	25581517				2022-12-25	WOS:000348974800017
J	Zhou, WC; Ke, SQ; Huang, Z; Flavahan, W; Fang, XG; Paul, J; Wu, L; Sloan, AE; McLendon, RE; Li, XX; Rich, JN; Bao, SD				Zhou, Wenchao; Ke, Susan Q.; Huang, Zhi; Flavahan, William; Fang, Xiaoguang; Paul, Jeremy; Wu, Ling; Sloan, Andrew E.; McLendon, Roger E.; Li, Xiaoxia; Rich, Jeremy N.; Bao, Shideng			Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth	NATURE CELL BIOLOGY			English	Article							HUMAN GLIOMAS; TYROSINE KINASE; SELF-RENEWAL; CANCER-CELLS; EXPRESSION; MICROENVIRONMENT; RECEPTOR; ANGIOGENESIS; METASTASIS; MICROGLIA	Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin alpha(v)beta(3) as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.	[Zhou, Wenchao; Ke, Susan Q.; Huang, Zhi; Flavahan, William; Fang, Xiaoguang; Paul, Jeremy; Rich, Jeremy N.; Bao, Shideng] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Wu, Ling; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Univ Hosp,Case Med Ctr, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Univ Hosp,Case Med Ctr, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Duke University	Bao, SD (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA.	baos@ccf.org	Rich, Jeremy/AAM-1445-2021; Zhou, Wenchao/ABE-9015-2020; Sloan, Andrew/AAE-9842-2020		Cleveland Clinic Foundation; NIH R01 [NS070315]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996, R01NS070315] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Brain Tumor and Neuro-Oncology Centers at Cleveland Clinic and University Hospitals Case Medical Center for providing GBM surgical specimens for this study. We are grateful to members in J.N.R.'s laboratory for their assistance and scientific discussion. We also thank C. Shermo and S.O'Bryant of the Flow Cytometry Core, J. Drazba and L. Vargo of the Imaging Core at Cleveland Clinic Lerner Research Institute, and D. Schumick of the Center for Medical Art and Photography for their assistance. This work was supported by the Cleveland Clinic Foundation and an NIH R01 grant (NS070315) to S.B.	Abou-Ghazal M, 2008, CLIN CANCER RES, V14, P8228, DOI 10.1158/1078-0432.CCR-08-1329; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Auffinger B, 2014, CELL DEATH DIFFER, V21, P1119, DOI 10.1038/cdd.2014.31; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deininger MH, 2001, J NEURO-ONCOL, V55, P141, DOI 10.1023/A:1013805915224; Deininger MH, 2000, ACTA NEUROPATHOL, V100, P673, DOI 10.1007/s004010000233; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fang XG, 2014, STEM CELLS, V32, P2033, DOI 10.1002/stem.1730; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Gillan L, 2002, CANCER RES, V62, P5358; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Graf MR, 2002, CANCER IMMUNOL IMMUN, V51, P179, DOI 10.1007/s00262-002-0269-3; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Guvenc H, 2013, CLIN CANCER RES, V19, P631, DOI 10.1158/1078-0432.CCR-12-0647; Hao CH, 2002, ACTA NEUROPATHOL, V103, P171; Hirano H, 2001, J NEUROSURG, V95, P89, DOI 10.3171/jns.2001.95.1.0089; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kanamori M, 2006, J BIOL CHEM, V281, P37256, DOI 10.1074/jbc.M605344200; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Koronyo-Hamaoui M, 2009, J NEUROCHEM, V111, P1409, DOI 10.1111/j.1471-4159.2009.06402.x; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Ludwig HC, 2000, ANTICANCER RES, V20, P299; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Mineharu Y, 2011, CLIN CANCER RES, V17, P4705, DOI 10.1158/1078-0432.CCR-11-0915; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Morford LA, 1999, J NEUROSURG, V91, P935, DOI 10.3171/jns.1999.91.6.0935; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Pyonteck SM, 2012, ONCOGENE, V31, P1459, DOI 10.1038/onc.2011.337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Samaras V, 2007, MOL CELL BIOCHEM, V304, P343, DOI 10.1007/s11010-007-9517-3; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spear P, 2012, J IMMUNOL, V188, P6389, DOI 10.4049/jimmunol.1103019; Staudt ND, 2013, CANCER RES, V73, P3902, DOI 10.1158/0008-5472.CAN-12-4233; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Tran CT, 1998, NEUROPATH APPL NEURO, V24, P293, DOI 10.1046/j.1365-2990.1998.00120.x; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Yang I, 2011, J NEUROSURG, V115, P505, DOI 10.3171/2011.4.JNS101172; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573	67	506	520	13	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2015	17	2					170	+		10.1038/ncb3090	http://dx.doi.org/10.1038/ncb3090			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CA8FI	25580734	Green Accepted			2022-12-25	WOS:000349152400008
J	Chakradhar, S				Chakradhar, Shraddha			Biting back: Vaccine efforts redoubled as rabies deadline looms	NATURE MEDICINE			English	News Item							MONOCLONAL-ANTIBODY; SAFETY; VIRUS											Bakker ABH, 2008, VACCINE, V26, P5922, DOI 10.1016/j.vaccine.2008.08.050; Gogtay N, 2012, VACCINE, V30, P7315, DOI 10.1016/j.vaccine.2012.09.027; Johnson N, 2008, EMERG INFECT DIS, V14, P1950, DOI 10.3201/eid1412.080944; Shantavasinkul P, 2010, CLIN INFECT DIS, V50, P56, DOI 10.1086/649211; Sudarshan MK, 2012, HUM VACC IMMUNOTHER, V8, P1077, DOI 10.4161/hv.20471	5	4	4	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					8	10		10.1038/nm0115-8	http://dx.doi.org/10.1038/nm0115-8			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569542				2022-12-25	WOS:000348408000004
J	Davis, H; Irshad, S; Bansal, M; Rafferty, H; Boitsova, T; Bardella, C; Jaeger, E; Lewis, A; Freeman-Mills, L; Giner, FC; Rodenas-Cuadrado, P; Mallappa, S; Clark, S; Thomas, H; Jeffery, R; Poulsom, R; Rodriguez-Justo, M; Novelli, M; Chetty, R; Silver, A; Sansom, OJ; Greten, FR; Wang, LM; East, JE; Tomlinson, I; Leedham, SJ				Davis, Hayley; Irshad, Shazia; Bansal, Mukesh; Rafferty, Hannah; Boitsova, Tatjana; Bardella, Chiara; Jaeger, Emma; Lewis, Annabelle; Freeman-Mills, Luke; Giner, Francesc C.; Rodenas-Cuadrado, Pedro; Mallappa, Sreelakshmi; Clark, Susan; Thomas, Huw; Jeffery, Rosemary; Poulsom, Richard; Rodriguez-Justo, Manuel; Novelli, Marco; Chetty, Runjan; Silver, Andrew; Sansom, Owen J.; Greten, Florian R.; Wang, Lai Mun; East, James E.; Tomlinson, Ian; Leedham, Simon J.			Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche	NATURE MEDICINE			English	Article							MIXED POLYPOSIS SYNDROME; COLORECTAL-CANCER; ADENOMA; LGR5; INTESTINE; EXPANSION; ORIGIN; MOUSE; RISK	Hereditary mixed polyposis syndrome (HMPS) is characterized by the development of mixed-morphology colorectal tumors and is caused by a 40-kb genetic duplication that results in aberrant epithelial expression of the gene encoding mesenchymal bone morphogenetic protein antagonist, GREM1. Here we use HMPS tissue and a mouse model of the disease to show that epithelial GREM1 disrupts homeostatic intestinal morphogen gradients, altering cell fate that is normally determined by position along the vertical epithelial axis. This promotes the persistence and/or reacquisition of stem cell properties in Lgr5-negative progenitor cells that have exited the stem cell niche. These cells form ectopic crypts, proliferate, accumulate somatic mutations and can initiate intestinal neoplasia, indicating that the crypt base stem cell is not the sole cell of origin of colorectal cancer. Furthermore, we show that epithelial expression of GREM1 also occurs in traditional serrated adenomas, sporadic premalignant lesions with a hitherto unknown pathogenesis, and these lesions can be considered the sporadic equivalents of HMPS polyps.	[Davis, Hayley; Irshad, Shazia; Rafferty, Hannah; Boitsova, Tatjana; Rodenas-Cuadrado, Pedro; Leedham, Simon J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Gastrointestinal Stem Cell Biol Lab, Oxford, England; [Bansal, Mukesh] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Boitsova, Tatjana; Jeffery, Rosemary; Poulsom, Richard; Silver, Andrew] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Digest Dis, London, England; [Bardella, Chiara; Jaeger, Emma; Lewis, Annabelle; Freeman-Mills, Luke; Giner, Francesc C.; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Mallappa, Sreelakshmi; Clark, Susan; Thomas, Huw] St Marks Hosp, Polyposis Registry, Harrow, Middx, England; [Rodriguez-Justo, Manuel; Novelli, Marco] Univ Coll London Hosp, Dept Histopathol, London, England; [Chetty, Runjan] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Chetty, Runjan] Univ Toronto, Toronto, ON, Canada; [Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Greten, Florian R.] Georg Speyer Haus Inst Tumor Biol & Expt Therapy, Frankfurt, Germany; [Wang, Lai Mun] John Radcliffe Hosp, Oxford OX3 9DU, England; [East, James E.; Leedham, Simon J.] John Radcliffe Hosp, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford Natl Inst Hlth Res Comprehens Biomed Res C, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; Columbia University; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Beatson Institute; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Tomlinson, I (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	ian.tomlinson@well.ox.ac.uk; simon.leedham@well.ox.ac.uk	Castro-Giner, Francesc/D-7992-2014; bardella, chiara/AAG-6272-2021; Greten, Florian R/AAF-5196-2020; Rodriguez-Justo, Manuel/C-6204-2009	Castro-Giner, Francesc/0000-0001-6111-0754; Greten, Florian R/0000-0002-3928-6080; Rodriguez-Justo, Manuel/0000-0001-5007-1761; Sansom, Owen J./0000-0001-9540-3010; Bansal, Mukesh/0000-0003-1481-6767; Rafferty, Hannah/0000-0002-0398-1567; Lewis, Annabelle/0000-0003-1876-1927; Bardella, Chiara/0000-0002-7780-2541	Cancer Research UK Clinician Scientist Fellowship [A16581, A16459]; Wellcome Trust [090532/Z/09/Z]; Cancer Research UK [16459, 16581] Funding Source: researchfish; Medical Research Council [1243081] Funding Source: researchfish; Versus Arthritis [21139] Funding Source: researchfish	Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was funded by Cancer Research UK Clinician Scientist Fellowship A16581 to S.J.L. and Programme grant A16459 to I.T. Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). We thank the transgenics core and the staff of the Functional Genomics Facility at the Wellcome Trust Centre for Human Genetics. Villin-MES-SV40polyA plasmid was a kind gift from S. Robine (Institut Curie, Paris, France).	[Anonymous], 2012, QIAG BIOSC; [Anonymous], 2012, QIAG BIOSC; [Anonymous], 2012, QIAG BIOSC; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Lewis A, 2014, CELL REP, V8, P983, DOI 10.1016/j.celrep.2014.07.020; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Potti TA, 2011, HUM MUTAT, V32, P877, DOI 10.1002/humu.21515; Preston SL, 2003, CANCER RES, V63, P3819; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlinson I, 2013, NAT GENET, V45, P2, DOI 10.1038/ng.2475; Torlakovic EE, 2008, AM J SURG PATHOL, V32, P21, DOI 10.1097/PAS.0b013e318157f002; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286	36	155	157	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					62	70		10.1038/nm.3750	http://dx.doi.org/10.1038/nm.3750			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25419707	Green Submitted, Green Accepted			2022-12-25	WOS:000348408000014
J	Angeli, JPF; Schneider, M; Proneth, B; Tyurina, YY; Tyurin, VA; Hammond, VJ; Herbach, N; Aichler, M; Walch, A; Eggenhofer, E; Basavarajappa, D; Radmark, O; Kobayashi, S; Seibt, T; Beck, H; Neff, F; Esposito, I; Wanke, R; Forster, H; Yefremova, O; Heinrichmeyer, M; Bornkamm, GW; Geissler, EK; Thomas, SB; Stockwell, BR; O'Donnell, VB; Kagan, VE; Schick, JA; Conrad, M				Angeli, Jose Pedro Friedmann; Schneider, Manuela; Proneth, Bettina; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Hammond, Victoria J.; Herbach, Nadja; Aichler, Michaela; Walch, Axel; Eggenhofer, Elke; Basavarajappa, Devaraj; Radmark, Olof; Kobayashi, Sho; Seibt, Tobias; Beck, Heike; Neff, Frauke; Esposito, Irene; Wanke, Ruediger; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Bornkamm, Georg W.; Geissler, Edward K.; Thomas, Stephen B.; Stockwell, Brent R.; O'Donnell, Valerie B.; Kagan, Valerian E.; Schick, Joel A.; Conrad, Marcus			Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice	NATURE CELL BIOLOGY			English	Article							CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; GLUTATHIONE; IRON; 5-LIPOXYGENASE; PHOSPHOLIPIDS; INFLAMMATION; CARDIOLIPIN; DISRUPTION	Ferroptosis is a non-apoptotic form of cell death induced by small molecules in specific tumour types, and in engineered cells overexpressing oncogenic RAS. Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic. Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathologically relevant form of ferroptosis. Using inducible Gpx4(-/-) mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidation-induced acute renal failure and associated death. We furthermore systematically evaluated a library of small molecules for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine derivative called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4(-/-) mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage. In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.	[Angeli, Jose Pedro Friedmann; Proneth, Bettina; Kobayashi, Sho; Seibt, Tobias; Foerster, Heidi; Yefremova, Olena; Heinrichmeyer, Marc; Schick, Joel A.; Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Schneider, Manuela] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Tyurina, Yulia Y.; Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Hammond, Victoria J.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, D-80539 Munich, Germany; [Aichler, Michaela; Walch, Axel; Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany; [Eggenhofer, Elke; Geissler, Edward K.] Univ Med Ctr Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Basavarajappa, Devaraj; Radmark, Olof] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Kobayashi, Sho] Yamagata Univ, Dept Food & Appl Life Sci, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Beck, Heike] Univ Munich, Walter Brendel Ctr Expt Med, Munich Heart Alliance, D-81377 Munich, Germany; [Esposito, Irene] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Bornkamm, Georg W.] Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, D-81377 Neuherberg, Germany; [Thomas, Stephen B.; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Thomas, Stephen B.; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Chem, New York, NY 10027 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cardiff University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Karolinska Institutet; Yamagata University; Munich Heart Alliance; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Conrad, M (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Angeli, J Pedro Friedmann/ABG-6270-2020; Proneth, Bettina/AGZ-9097-2022; Aichler, Michaela/B-5356-2014; Conrad, Marcus/E-8792-2015; Eggenhofer, PD Dr. Elke/E-2400-2016; Friedmann Angeli, Jose/C-9038-2014; Geissler, Edward/R-4131-2016; Schick, Joel/ABA-3728-2021; Stockwell, Brent R/AAE-7200-2019; Walch, Axel/B-4554-2012	Angeli, J Pedro Friedmann/0000-0001-7706-1379; Conrad, Marcus/0000-0003-1140-5612; Schick, Joel/0000-0002-8623-4910; Stockwell, Brent R/0000-0002-3532-3868; Walch, Axel/0000-0001-5578-4023; Kagan, Valerian E./0000-0002-7245-1885; /0000-0003-4089-8460; Tyurin, Vladimir/0000-0002-3474-1697; Basavarajappa, Devaraj/0000-0003-0997-0196; Herbach, Nadja/0000-0001-5893-0356; Wanke, Rudiger/0000-0002-0153-224X; Tyurina, Yulia/0000-0003-0287-2091	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3]; Alexander von Humboldt-Stiftung; Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP) [RGP0013]; m4 Award (Bavarian Ministry of Economic Affairs); NIH [HL114453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114453] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); m4 Award (Bavarian Ministry of Economic Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to D. Green for his valuable comments and critical reading of the manuscript. We would also like to thank A. Berns, The Netherlands Cancer Institute, Amsterdam, for providing the ROSA26-CreER<SUP>T2</SUP> mouse line, J. Silke (The Walter and Eliza Hall Institute, Melbourne, Australia) for the Rip1-knockout cells and M. P. Murphy (Medical Research Council, London, UK) for provision of MitoQ and Mito-BODIPY. We are most grateful to L. Pichl for excellent technical assistance. This work was in part supported by the Deutsche Forschungsgemeinschaft (DFG) CO 291/2-3 to M.C., a fellowship from Alexander von Humboldt-Stiftung to J.P.F.A., a fellowship from the Japan Society for the Promotion of Science (JSPS) to S.K., the Human Frontier Science Program (HFSP) RGP0013 to M.C. and V.E.K., HL114453 (NIH) to V.E.K., and by the m4 Award (Bavarian Ministry of Economic Affairs) to M.C. and J.A.S.	Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Eggenhofer E, 2013, J IMMUNOL, V191, P480, DOI 10.4049/jimmunol.1202975; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim J, 2011, J LIPID RES, V52, P389, DOI 10.1194/jlr.D010587; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Kriska T, 2010, J LIPID RES, V51, P3174, DOI 10.1194/jlr.M008342; Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Mannes AM, 2011, FASEB J, V25, P2135, DOI 10.1096/fj.10-177147; McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tanaka R, 2006, FISHERIES SCI, V72, P665, DOI 10.1111/j.1444-2906.2006.01197.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tyurina YY, 2008, FREE RADICAL BIO MED, V44, P299, DOI 10.1016/j.freeradbiomed.2007.08.021; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867	44	1379	1397	81	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2014	16	12					1180	U120		10.1038/ncb3064	http://dx.doi.org/10.1038/ncb3064			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AU7JR	25402683	Green Accepted			2022-12-25	WOS:000345777300009
J	Giannakis, M; Hodis, E; Mu, XJ; Yamauchi, M; Rosenbluh, J; Cibulskis, K; Saksena, G; Lawrence, MS; Qian, ZR; Nishihara, R; Van Allen, EM; Hahn, WC; Gabriel, SB; Lander, ES; Getz, G; Ogino, S; Fuchs, CS; Garraway, LA				Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.			RNF43 is frequently mutated in colorectal and endometrial cancers	NATURE GENETICS			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; GASTRIC ADENOCARCINOMA; DRIVER MUTATIONS; CARCINOMA; LANDSCAPE; COLON	We report somatic mutations of RNF43 in over 18% of colorectal adenocarcinomas and endometrial carcinomas. RNF43 encodes an E3 ubiquitin ligase that negatively regulates Wnt signaling. Truncating mutations of RNF43 are more prevalent in microsatellite-unstable tumors and show mutual exclusivity with inactivating APC mutations in colorectal adenocarcinomas. These results indicate that RNF43 is one of the most commonly mutated genes in colorectal and endometrial cancers.	[Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hodis, Eran] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Hodis, Eran] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Nishihara, Reiko; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Getz, Gad] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Fuchs, Charles S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Charming Div Network Med,Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Cibulskis, Kristian/AAC-7380-2019; Mu, Xinmeng/P-2562-2016; Lawrence, Michael/AAC-8202-2020; Giannakis, Marios/Z-4908-2019	Mu, Xinmeng/0000-0002-8079-0828; Ogino, Shuji/0000-0002-3909-2323; Cibulskis, Kristian/0000-0003-1343-1582; Rosenbluh, Joseph/0000-0001-9815-8049	Dana-Farber Cancer Institute Leadership Council; Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research [14-40-40-GIAN]; Perry S. Levy Endowed Fellowship; National Institute of General Medical Sciences [T32GM007753]; Herchel Smith Fellowship; Agrusa Fund for Colorectal Cancer Research; National Human Genome Research Institute [U54HG003067]; National Cancer Institute [K07CA190673, P01CA87969, UM1CA167552, R01CA151993, R01CA118553, R01CA168141, P50CA127003]; NATIONAL CANCER INSTITUTE [P01CA087969, U01CA176058, K07CA190673, R01CA118553, P50CA127003, UM1CA167552, R01CA151993] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Leadership Council; Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research; Perry S. Levy Endowed Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Herchel Smith Fellowship; Agrusa Fund for Colorectal Cancer Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bahl, E. Nickerson and S. Chauvin for project management and A. Regev for help with computing resources, as well as A. Sivachenko, F. Huang and P. Tamayo for helpful discussions. This work was supported by the Dana-Farber Cancer Institute Leadership Council, the 2014 Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research, grant 14-40-40-GIAN, the Perry S. Levy Endowed Fellowship (M.G.), award T32GM007753 from the National Institute of General Medical Sciences, the Herchel Smith Fellowship (E.H.) and the Agrusa Fund for Colorectal Cancer Research (C.S.F.), as well as National Human Genome Research Institute grant U54HG003067 (E.S.L. and S.B.G.) and National Cancer Institute grants, K07CA190673 (R.N.), P01CA87969, UM1CA167552 and R01CA151993 (S.O.), R01CA118553 and R01CA168141 (C.S.F.) and P50CA127003 (M.G., W.C.H., L.A.G. and C.S.F.).	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	16	294	303	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1264	1266		10.1038/ng.3127	http://dx.doi.org/10.1038/ng.3127			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25344691	Green Accepted, Green Published			2022-12-25	WOS:000345547300006
J	Zaitlen, N; Pasaniuc, B; Sankararaman, S; Bhatia, G; Zhang, JQ; Gusev, A; Young, T; Tandon, A; Pollack, S; Vilhjalmsson, BJ; Assimes, TL; Berndt, SI; Blot, WJ; Chanock, S; Franceschini, N; Goodman, PG; He, J; Hennis, AJM; Hsing, A; Ingles, SA; Isaacs, W; Kittles, RA; Klein, EA; Lange, LA; Nemesure, B; Patterson, N; Reich, D; Rybicki, BA; Stanford, JL; Stevens, VL; Strom, SS; Whitse, EA; Witte, JS; Xu, JF; Haiman, C; Wilson, JG; Kooperberg, C; Stram, D; Reiner, AP; Tang, H; Price, AL				Zaitlen, Noah; Pasaniuc, Bogdan; Sankararaman, Sriram; Bhatia, Gaurav; Zhang, Jianqi; Gusev, Alexander; Young, Taylor; Tandon, Arti; Pollack, Samuela; Vilhjalmsson, Bjarni J.; Assimes, Themistocles L.; Berndt, Sonja I.; Blot, William J.; Chanock, Stephen; Franceschini, Nora; Goodman, Phyllis G.; He, Jing; Hennis, Anselm J. M.; Hsing, Ann; Ingles, Sue A.; Isaacs, William; Kittles, Rick A.; Klein, Eric A.; Lange, Leslie A.; Nemesure, Barbara; Patterson, Nick; Reich, David; Rybicki, Benjamin A.; Stanford, Janet L.; Stevens, Victoria L.; Strom, Sara S.; Whitse, Eric A.; Witte, John S.; Xu, Jianfeng; Haiman, Christopher; Wilson, James G.; Kooperberg, Charles; Stram, Daniel; Reiner, Alex P.; Tang, Hua; Price, Alkes L.			Leveraging population admixture to characterize the heritability of complex traits	NATURE GENETICS			English	Article							MISSING HERITABILITY; GENETIC-VARIATION; GENOME; ANCESTRY; PROPORTION; PITFALLS; LINKAGE; HEIGHT; LOCI	Despite recent progress on estimating the heritability explained by genotyped SNPs (h(g)())(2), a large gap between h(g)(2) estimates of total narrow-sense heritability (h(2)) remains. Explanations for this gap include rare variants or upward bias in family-based estimates of h(2) due to shared environment or epistasis. We estimate h(2) from unrelated individuals in admixed populations by first estimating the heritability explained by local ancestry (h(gamma)(2)). We show that h(gamma)(2) = 2F(STC)theta(1 - theta)h(2), where F-STC measures frequency differences between populations at causal loci and theta is the genome-wide ancestry proportion. Our approach is not susceptible to biases caused by epistasis or shared environment. We applied this approach to the analysis of 13 phenotypes in 21,497 African-American individuals from 3 cohorts. For height and body mass index (BMI), we obtained h(2) estimates of 0.55 +/- 0.09 and 0.23 +/- 0.06, respectively, which are larger than estimates of h(g)(2) these and other data but smaller than family-based estimates of h(2).	[Zaitlen, Noah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Pasaniuc, Bogdan] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA; [Sankararaman, Sriram; Bhatia, Gaurav; Gusev, Alexander; Young, Taylor; Tandon, Arti; Pollack, Samuela; Vilhjalmsson, Bjarni J.; Patterson, Nick; Reich, David; Price, Alkes L.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Sankararaman, Sriram; Tandon, Arti; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Bhatia, Gaurav; Gusev, Alexander; Pollack, Samuela; Vilhjalmsson, Bjarni J.; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Bhatia, Gaurav; Gusev, Alexander; Pollack, Samuela; Vilhjalmsson, Bjarni J.; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zhang, Jianqi; He, Jing; Ingles, Sue A.; Haiman, Christopher; Stram, Daniel] Univ Calif San Francisco, Dept Prevent Med, San Francisco, CA 94143 USA; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Berndt, Sonja I.; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Blot, William J.] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Blot, William J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Franceschini, Nora; Whitse, Eric A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Goodman, Phyllis G.] SWOG Stat Ctr, Seattle, WA USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Hennis, Anselm J. M.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; Univ W Indies, Fac Med Sci, Bridgetown, Barbados; [Hennis, Anselm J. M.] Minist Hlth, Bridgetown, Barbados; [Hsing, Ann] Canc Prevent Inst Calif, Fremont, CA USA; [Hsing, Ann] Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA; [Isaacs, William] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol, Baltimore, MD USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Stanford, Janet L.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stevens, Victoria L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Haiman, Christopher] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Reiner, Alex P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Tang, Hua] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Southwest Oncology Group; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University West Indies Mona Jamaica; University of the West Indies Open Campus; University West Indies Mona Jamaica; University of the West Indies Open Campus; Cancer Prevention Institute of California; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Henry Ford Health System; Henry Ford Hospital; Fred Hutchinson Cancer Center; American Cancer Society; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center; University of Southern California; University of Mississippi; University of Mississippi Medical Center; University of Washington; University of Washington Seattle; Stanford University	Zaitlen, N (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	noah.zaitlen@ucsf.edu; huatang@stanford.edu; aprice@hsph.harvard.edu	Rybicki, Benjamin/L-4614-2019; Assimes, Themistocles Leonard/D-9696-2015; Vilhjálmsson, Bjarni/ABC-1369-2020; Vilhjalmsson, Bjarni/K-3971-2014; Berndt, Sonja I/J-8423-2016	Rybicki, Benjamin/0000-0003-3190-3467; Assimes, Themistocles Leonard/0000-0003-2349-0009; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Pasaniuc, Bogdan/0000-0002-0227-2056; Zhang, Jianqi/0000-0002-4399-459X	US National Institutes of Health [R01 HG006399, R01 GM073059, 1K25HL121295-01A1, R21 ES020754]; National Heart, Lung, and Blood Institute; US National Institutes of Health; US Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [P30CA015704, UG1CA189974, U10CA037429, UM1CA182883, R01CA092447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123677, K25HL121295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142, R01ES011126, R21ES020754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106584, R01GM100233, R01GM073059] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by US National Institutes of Health grants R01 HG006399, R01 GM073059, 1K25HL121295-01A1 and R21 ES020754. The WHI program is funded by the National Heart, Lung, and Blood Institute, US National Institutes of Health, US Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C.	Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fox ER, 2008, AM J CARDIOL, V102, P835, DOI 10.1016/j.amjcard.2008.05.049; Freedman BI, 2005, DIABETOLOGIA, V48, P661, DOI 10.1007/s00125-005-1679-5; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Golan D., 2013, NARROWING GAP HERITA; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lynch M., 1998, GENETICS ANAL QUANTI; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Pasaniuc B, 2013, BIOINFORMATICS, V29, P1407, DOI 10.1093/bioinformatics/btt166; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wilson JG, 2005, ETHNIC DIS, V15, pS30; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	44	44	44	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1356	1362		10.1038/ng.3139	http://dx.doi.org/10.1038/ng.3139			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383972	Green Submitted, Green Accepted			2022-12-25	WOS:000345547300019
J	Lee, CS; Bhaduri, A; Mah, A; Johnson, WL; Ungewickell, A; Aros, CJ; Nguyen, CB; Rios, EJ; Siprashvili, Z; Straight, A; Kim, J; Aasi, SZ; Khavari, PA				Lee, Carolyn S.; Bhaduri, Aparna; Mah, Angela; Johnson, Whitney L.; Ungewickell, Alexander; Aros, Cody J.; Nguyen, Christie B.; Rios, Eon J.; Siprashvili, Zurab; Straight, Aaron; Kim, Jinah; Aasi, Sumaira Z.; Khavari, Paul A.			Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma	NATURE GENETICS			English	Article							CANCER GENOME; SKIN-CANCER; ANEUPLOIDY; PATTERNS; P53	Here we report the discovery of recurrent mutations concentrated at an ultraviolet signature hotspot in KNSTRN, which encodes a kinetochore protein, in 19% of cutaneous squamous cell carcinomas (SCCs). Cancer-associated KNSTRN mutations, most notably those encoding p.Ser24Phe, disrupt chromatid cohesion in normal cells, occur in SCC precursors, correlate with increased aneuploidy in primary tumors and enhance tumorigenesis in vivo. These findings suggest a role for KNSTRN mutagenesis in SCC development.	[Lee, Carolyn S.; Bhaduri, Aparna; Mah, Angela; Ungewickell, Alexander; Aros, Cody J.; Nguyen, Christie B.; Rios, Eon J.; Siprashvili, Zurab; Kim, Jinah; Aasi, Sumaira Z.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Johnson, Whitney L.; Straight, Aaron] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Lee, Carolyn/0000-0002-6511-3757; Straight, Aaron/0000-0001-5885-7881	US Veterans Affairs Office of Research and Development; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR43799]; NIH/NIAMS [K08 AR064732]; NIH/National Institute of General Medical Science (NIGMS) [GM074728]; American Cancer Society [120161-RSG]; National Science Foundation (NSF) [DGE-114747]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043799, K08AR064732, R29AR043799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Institute of General Medical Science (NIGMS); American Cancer Society(American Cancer Society); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.G. Rheinwald (Dana-Farber/Harvard Cancer Center) for his generous gift of SCC cell lines. We thank A.E. Oro, H.Y. Chang, M. Diehn, M.P. Scott, S.E. Artandi, G.R. Crabtree and T. Waldman as well as A. Zehnder, X. Bao, B.K. Sun, R.J. Flockhart and V. Lopez-Pajares for presubmission review and helpful comments. This work was supported by the US Veterans Affairs Office of Research and Development and by US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) grant AR43799 to P.A.K. C.S.L. is the recipient of career award K08 AR064732 from the NIH/NIAMS. A.S. is supported by NIH/National Institute of General Medical Science (NIGMS) grant GM074728 and American Cancer Society grant 120161-RSG. W.L.J. is the recipient of National Science Foundation (NSF) graduate research fellowship grant DGE-114747.	BIESTERFELD S, 1995, BRIT J DERMATOL, V133, P557, DOI 10.1111/j.1365-2133.1995.tb02704.x; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	10	87	89	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1060	1062		10.1038/ng.3091	http://dx.doi.org/10.1038/ng.3091			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25194279	Green Accepted			2022-12-25	WOS:000342554100007
J	Witty, AD; Mihic, A; Tam, RY; Fisher, SA; Mikryukov, A; Shoichet, MS; Li, RK; Kattman, SJ; Keller, G				Witty, Alec D.; Mihic, Anton; Tam, Roger Y.; Fisher, Stephanie A.; Mikryukov, Alexander; Shoichet, Molly S.; Li, Ren-Ke; Kattman, Steven J.; Keller, Gordon			Generation of the epicardial lineage from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							TO-MESENCHYMAL TRANSITION; SMOOTH-MUSCLE-CELLS; RETINOIC ACID SYNTHESIS; WNT/BETA-CATENIN; MOUSE EMBRYOS; DIFFERENTIATION; HEART; SPECIFICATION; BMP; EXPRESSION	The epicardium supports cardiomyocyte proliferation early in development and provides fibroblasts and vascular smooth muscle cells to the developing heart. The epicardium has been shown to play an important role during tissue remodeling after cardiac injury, making access to this cell lineage necessary for the study of regenerative medicine. Here we describe the generation of epicardial lineage cells from human pluripotent stem cells by stage-specific activation of the BMP and WNT signaling pathways. These cells display morphological characteristics and express markers of the epicardial lineage, including the transcription factors WT1 and TBX18 and the retinoic acid-producing enzyme ALDH1A2. When induced to undergo epithelial-to-mesenchymal transition, the cells give rise to populations that display characteristics of the fibroblast and vascular smooth muscle lineages. These findings identify BMP and WNT as key regulators of the epicardial lineage in vitro and provide a model for investigating epicardial function in human development and disease.	[Witty, Alec D.; Mihic, Anton; Mikryukov, Alexander; Shoichet, Molly S.; Li, Ren-Ke; Kattman, Steven J.; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Witty, Alec D.; Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Toronto Gen Res Inst, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada; [Keller, Gordon] Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca		Keller, Gordon/0000-0001-9309-9297; Li, Ren-Ke/0000-0002-2584-060X; Mikryukov, Alexander/0000-0002-7632-9529; Tam, Roger/0000-0002-8441-6681	Canadian Institute of Health Research [MOP-84524, MOP-119507, MOP-106538, CPG-127793]; Natural Sciences and Engineering Research Council of Canada [CHRPJ 446379-13]; US National Institutes of Health [5U01 HL100405]; VistaGen Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VistaGen Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Araki and B. Neel (Ontario Cancer Institute, Toronto) for providing the Sendai hiPSC line, O. El-Mounayri and M. Husain for their advice on epithelial-to-mesenchymal transition, Mark Gagliardi for his assistance in the culture of hESC-derived epicardial cells and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. We thank members of the Keller laboratory for their advice on the studies and comments on the manuscript. This work was supported by the Canadian Institute of Health Research (MOP-84524; MOP-119507; MOP-106538; CPG-127793), the Natural Sciences and Engineering Research Council of Canada (CHRPJ 446379-13) and the US National Institutes of Health (5U01 HL100405). This work was funded in part by VistaGen Therapeutics, Inc.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bochmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011429; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Casanova JC, 2013, GENESIS, V51, P32, DOI 10.1002/dvg.22353; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; de la Cuesta F, 2013, J PROTEOMICS, V82, P155, DOI 10.1016/j.jprot.2013.01.032; DERUITER MC, 1992, ANAT EMBRYOL, V185, P461; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; El-Mounayri O, 2013, CARDIOVASC RES, V98, P125, DOI 10.1093/cvr/cvs357; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lie-Venema H, 2007, THESCIENTIFICWORLDJO, V7, P1777, DOI 10.1100/tsw.2007.294; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; MacNeill C, 2000, DEV BIOL, V217, P62, DOI 10.1006/dbio.1999.9539; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Moore AW, 1999, DEVELOPMENT, V126, P1845; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Phillips MD, 2011, INT J CARDIOL, V150, P186, DOI 10.1016/j.ijcard.2010.04.007; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	49	115	121	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1026	+		10.1038/nbt.3002	http://dx.doi.org/10.1038/nbt.3002			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25240927	Green Accepted			2022-12-25	WOS:000343763800020
J	Nguyen, GKT; Wang, SJ; Qiu, YB; Hemu, X; Lian, YL; Tam, JP				Nguyen, Giang K. T.; Wang, Shujing; Qiu, Yibo; Hemu, Xinya; Lian, Yilong; Tam, James P.			Butelase 1 is an Asx-specific ligase enabling peptide macrocyclization and synthesis	NATURE CHEMICAL BIOLOGY			English	Article							ASPARAGINYL ENDOPEPTIDASE; CIRCULAR PROTEINS; STRUCTURAL MOTIF; NATURAL-PRODUCTS; KALATA B1; CYCLIZATION; BIOSYNTHESIS; PURIFICATION; LIGATION; PROTEASE	Proteases are ubiquitous in nature, whereas naturally occurring peptide ligases, enzymes catalyzing the reverse reactions of proteases, are rare occurrences. Here we describe the discovery of butelase 1, to our knowledge the first asparagine/aspartate (Asx) peptide ligase to be reported. This highly efficient enzyme was isolated from Clitoria ternatea, a cyclic peptide-producing medicinal plant. Butelase 1 shares 71% sequence identity and the same catalytic triad with legumain proteases but does not hydrolyze the protease substrate of legumain. Instead, butelase 1 cyclizes various peptides of plant and animal origin with yields greater than 95%. With K-cat values of up to 17 s(-1) and catalytic efficiencies as high as 542,000 M-1 s(-1) butelase 1 is the fastest peptide ligase known. Notably, butelase 1 also displays broad specificity for the N-terminal amino acids of the peptide substrate, thus providing a new tool for C terminus-specific intermolecular peptide ligations.	[Nguyen, Giang K. T.; Wang, Shujing; Qiu, Yibo; Hemu, Xinya; Lian, Yilong; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nguyen, GKT (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Lian, Yilong/0000-0003-0139-1245	Singapore National Research Foundation [NRF-CRP8-2011-05]	Singapore National Research Foundation(National Research Foundation, Singapore)	We thank M. Bogyo at Stanford University for providing the legumain-specific probe LP-1 and R. Wang at Nanyang Technological University for helpful comments on this manuscript. This work was supported in part by the Singapore National Research Foundation grant NRF-CRP8-2011-05.	ABE Y, 1993, J BIOL CHEM, V268, P3525; Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Austin J, 2010, AMINO ACIDS, V38, P1313, DOI 10.1007/s00726-009-0338-4; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Barber CJS, 2013, J BIOL CHEM, V288, P12500, DOI 10.1074/jbc.M112.437947; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Conlan BF, 2012, J BIOL CHEM, V287, P28037, DOI 10.1074/jbc.M112.347823; Craik DJ, 2012, TOXINS, V4, P139, DOI 10.3390/toxins4020139; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gould A, 2012, MOL BIOSYST, V8, P1359, DOI 10.1039/c2mb05451e; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Haase J, 1997, J BACTERIOL, V179, P5728, DOI 10.1128/jb.179.18.5728-5735.1997; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jia XY, 2014, J BIOL CHEM, V289, P6627, DOI 10.1074/jbc.M113.539262; KEMBHAVI AA, 1993, ARCH BIOCHEM BIOPHYS, V303, P208, DOI 10.1006/abbi.1993.1274; Kimura RH, 2006, ANGEW CHEM INT EDIT, V45, P973, DOI 10.1002/anie.200503882; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Kohli RM, 2001, BIOCHEMISTRY-US, V40, P7099, DOI 10.1021/bi010036j; Lee J, 2009, J AM CHEM SOC, V131, P2122, DOI 10.1021/ja8092168; Lee J, 2010, ACS CHEM BIOL, V5, P233, DOI 10.1021/cb900232a; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Sieber SA, 2003, J BACTERIOL, V185, P7036, DOI 10.1128/JB.185.24.7036-7043.2003; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Tam JP, 2012, J BIOL CHEM, V287, P27020, DOI 10.1074/jbc.R111.323568; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Xu MQ, 2001, METHODS, V24, P257, DOI 10.1006/meth.2001.1187; Young TS, 2011, P NATL ACAD SCI USA, V108, P11052, DOI 10.1073/pnas.1108045108	47	272	287	11	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					732	738		10.1038/NCHEMBIO.1586	http://dx.doi.org/10.1038/NCHEMBIO.1586			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25038786	Green Accepted			2022-12-25	WOS:000341126800009
J	Daetwyler, HD; Capitan, A; Pausch, H; Stothard, P; Van Binsbergen, R; Brondum, RF; Liao, XP; Djari, A; Rodriguez, SC; Grohs, C; Esquerre, D; Bouchez, O; Rossignol, MN; Klopp, C; Rocha, D; Fritz, S; Eggen, A; Bowman, PJ; Coote, D; Chamberlain, AJ; Anderson, C; VanTassell, CP; Hulsegge, I; Goddard, ME; Guldbrandtsen, B; Lund, MS; Veerkamp, RF; Boichard, DA; Fries, R; Hayes, BJ				Daetwyler, Hans D.; Capitan, Aurelien; Pausch, Hubert; Stothard, Paul; Van Binsbergen, Rianne; Brondum, Rasmus F.; Liao, Xiaoping; Djari, Anis; Rodriguez, Sabrina C.; Grohs, Cecile; Esquerre, Diane; Bouchez, Olivier; Rossignol, Marie-Noelle; Klopp, Christophe; Rocha, Dominique; Fritz, Sebastien; Eggen, Andre; Bowman, Phil J.; Coote, David; Chamberlain, Amanda J.; Anderson, Charlotte; VanTassell, Curt P.; Hulsegge, Ina; Goddard, Mike E.; Guldbrandtsen, Bernt; Lund, Mogens S.; Veerkamp, Roel F.; Boichard, Didier A.; Fries, Ruedi; Hayes, Ben J.			Whole-genome sequencing of 234 bulls facilitates mapping of monogenic and complex traits in cattle	NATURE GENETICS			English	Article							BOOPHILUS-MICROPLUS RESISTANCE; GENOTYPE IMPUTATION; MILK-YIELD; CONDENSIN; GENE; MUTATIONS; HYPOCHONDROGENESIS; IDENTIFICATION; SUBSTITUTION; POLYMORPHISM	The 1000 bull genomes project supports the goal of accelerating the rates of genetic gain in domestic cattle while at the same time considering animal health and welfare by providing the annotated sequence variants and genotypes of key ancestor bulls. In the first phase of the 1000 bull genomes project, we sequenced the whole genomes of 234 cattle to an average of 8.3-fold coverage. This sequencing includes data for 129 individuals from the global Holstein-Friesian population, 43 individuals from the Fleckvieh breed and 15 individuals from the Jersey breed. We identified a total of 28.3 million variants, with an average of 1.44 heterozygous sites per kilobase for each individual. We demonstrate the use of this database in identifying a recessive mutation underlying embryonic death and a dominant mutation underlying lethal chrondrodysplasia. We also performed genome-wide association studies for milk production and curly coat, using imputed sequence variants, and identified variants associated with these traits in cattle.	[Daetwyler, Hans D.; Bowman, Phil J.; Coote, David; Chamberlain, Amanda J.; Anderson, Charlotte; Goddard, Mike E.; Hayes, Ben J.] Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia; [Daetwyler, Hans D.; Hayes, Ben J.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Daetwyler, Hans D.; Bowman, Phil J.; Coote, David; Chamberlain, Amanda J.; Goddard, Mike E.; Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic, Australia; [Capitan, Aurelien; Rodriguez, Sabrina C.; Grohs, Cecile; Rocha, Dominique; Eggen, Andre; Boichard, Didier A.] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Capitan, Aurelien; Fritz, Sebastien] Union Natl Cooperat Elevage & Inseminat Anim, Paris, France; [Pausch, Hubert; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Stothard, Paul; Liao, Xiaoping] Univ Alberta, Dept Agr, Food & Nutr Sci, Edmonton, AB, Canada; [Van Binsbergen, Rianne; Hulsegge, Ina; Veerkamp, Roel F.] Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Brondum, Rasmus F.; Guldbrandtsen, Bernt; Lund, Mogens S.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Djari, Anis; Klopp, Christophe] INRA, Sigenae Bioinformat Grp, UR875, Castres, France; [Esquerre, Diane; Bouchez, Olivier] INRA, Lab Genet Cellulaire, UMR 444, Castres, France; [Rossignol, Marie-Noelle] LABOGENA, Jouy En Josas, France; [VanTassell, Curt P.] USDA ARS, Anim & Nat Resources Inst, Bovine Funct Genom Lab BARC East, Beltsville, MD USA; [Goddard, Mike E.] Univ Melbourne, Fac Land & Food Resources, Parkville, Vic 3052, Australia	La Trobe University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich; University of Alberta; Wageningen University & Research; Aarhus University; INRAE; INRAE; United States Department of Agriculture (USDA); University of Melbourne	Hayes, BJ (corresponding author), Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia.	ben.hayes@depi.vic.gov.au	Klopp, Christophe/J-3164-2019; Veerkamp, Roel/ABC-9073-2020; Rocha, Dominique/R-5546-2019; Capitan, Aurélien/M-3732-2015; Pausch, Hubert/B-7637-2018; Pausch, Hubert/U-5934-2019; van Binsbergen, Rianne/B-5315-2013; Boichard, Didier/AAD-8675-2020; Daetwyler, Hans D/H-9775-2019; Van Tassell, Curtis P./O-4247-2019; Hayes, Ben J/L-3308-2016; veerkamp, roel/D-9313-2012; Lund, Mogens S/I-4321-2016	Klopp, Christophe/0000-0001-7126-5477; Veerkamp, Roel/0000-0002-5240-6534; Rocha, Dominique/0000-0003-4998-9641; Pausch, Hubert/0000-0002-0501-6760; Boichard, Didier/0000-0003-0361-2961; Van Tassell, Curtis P./0000-0002-8416-2087; Hayes, Ben J/0000-0002-5606-3970; Daetwyler, Hans D/0000-0002-3018-3640; Brondum, Rasmus/0000-0001-5537-6767; van Binsbergen, Rianne/0000-0002-4645-0221; ROSSIGNOL, Marie-Noelle/0000-0003-1673-5258; Goddard, Michael/0000-0001-9917-7946; Fries, Ruedi/0000-0002-4657-1787; FRITZ, Sebastien/0000-0002-3378-1048	German Federal Ministry of Education and Research (BMBF) [0315527B]; Genome Canada project entitled 'Whole-Genome Sequence Selection Through Genome-Wide Imputation in Beef Cattle'; Agence Nationale de la Recherche; Apisgene [ANR-10-GENM-0018]; Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries [3405-10-0137]; Milk Levy Fund; Strategic Research Council and Viking Genetics [12-132452 (GenSAP)]; USDA-ARS [1245-31000-104-00D]; USDA-National Institute of Food and Agriculture (NIFA) competitive grant from the Animal Genome Program [2009-65205-05635]; Dairy Futures Cooperative Research Centre, Dairy Australia; Cooperative Research Centre for Beef Genetic Technologies	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Genome Canada project entitled 'Whole-Genome Sequence Selection Through Genome-Wide Imputation in Beef Cattle'; Agence Nationale de la Recherche(French National Research Agency (ANR)); Apisgene; Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries; Milk Levy Fund; Strategic Research Council and Viking Genetics; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Institute of Food and Agriculture (NIFA) competitive grant from the Animal Genome Program; Dairy Futures Cooperative Research Centre, Dairy Australia; Cooperative Research Centre for Beef Genetic Technologies(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	H.P. and R.F. acknowledge funding from the German Federal Ministry of Education and Research (BMBF) within the AgroClustEr-Synbreed Synergistic Plant and Animal Breeding' (grant 0315527B). We acknowledge the Bavarian State Research Center and Vereinigte Informationssysteme Tierhaltung (VIT) Verden for providing phenotype data. Swissgenetics is acknowledged for providing the DNA material for a Swiss Simmental bull. P.S. and X.L. acknowledge funding from the Genome Canada project entitled 'Whole-Genome Sequence Selection Through Genome-Wide Imputation in Beef Cattle' and acknowledge WestGrid and Compute/Calcul Canada for providing computing resources. D.A.B., A.C., S.F. and D.R. acknowledge the Agence Nationale de la Recherche and Apisgene for funding the Cartoseq project (ANR-10-GENM-0018). T. Simon (EVOLUTION), S. Legrain and P. Laurent (INRA) are acknowledged for providing samples from bulldog calves and information. J.-M. Vacelet (GEN'IAtest), G. Fayolle (UMOTEST) and D. Peinturier (Jura Mail) are acknowledged for providing samples and phenotypic information for curly coat in Montbeliarde cattle A. Baur (UNCEIA) and A. Barbat (INRA) are acknowledged for providing haplotype and fertility information for the HH3 study. We would like to thank E. Mullaart (CRV) for providing sequences for ten of the bulls used in this project. B.G., R.F.B. and M.S.L. acknowledge support from grant 3405-10-0137 from the Green Development and Demonstration Programme of the Danish Ministry of Food, Agriculture and Fisheries, the Milk Levy Fund, grant 12-132452 (GenSAP) from the Strategic Research Council and Viking Genetics. C.P.V. acknowledges funding from USDA-ARS project 1245-31000-104-00D and USDA-National Institute of Food and Agriculture (NIFA) competitive grant 2009-65205-05635 from the Animal Genome Program. B.J.H., H.D.D., A.J.C., P.J.B. and M.E.G. acknowledge funding from the Dairy Futures Cooperative Research Centre, Dairy Australia and the Cooperative Research Centre for Beef Genetic Technologies.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agerholm JS, 2004, J VET DIAGN INVEST, V16, P293, DOI 10.1177/104063870401600406; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Boichard D, 2012, ANIMAL, V6, P544, DOI 10.1017/S1751731112000018; BONAVENTURE J, 1995, BIOCHEM J, V307, P823, DOI 10.1042/bj3070823; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Dalton R, 2009, NATURE, V457, P369, DOI 10.1038/457369a; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gasparin G, 2007, ANIM GENET, V38, P453, DOI 10.1111/j.1365-2052.2007.01634.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GODFREY M, 1988, AM J HUM GENET, V43, P894; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Hegarty RS, 2010, ANIM PROD SCI, V50, P1026, DOI 10.1071/AN10104; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Korkko J, 2000, AM J MED GENET, V92, P95, DOI 10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; MacLeod IM, 2009, GENET RES, V91, P413, DOI 10.1017/S0016672309990358; Martinez ML, 2006, GENET MOL RES, V5, P513; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Mortier G.R., 1995, RADIOGRAPHIC MORPHOL; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Porter RM, 2004, BRIT J DERMATOL, V150, P195, DOI 10.1111/j.1365-2133.2004.05720.x; Runkel F, 2006, MAMM GENOME, V17, P1172, DOI 10.1007/s00335-006-0084-9; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; Siddiqui NU, 2003, DEVELOPMENT, V130, P3283, DOI 10.1242/dev.00542; Stray JE, 2005, J BIOL CHEM, V280, P34723, DOI 10.1074/jbc.M506589200; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Tanaka S, 2007, GENOMICS, V90, P703, DOI 10.1016/j.ygeno.2007.07.013; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VISSING H, 1989, J BIOL CHEM, V264, P18265; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	51	522	548	8	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					858	865		10.1038/ng.3034	http://dx.doi.org/10.1038/ng.3034			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25017103				2022-12-25	WOS:000339704400014
J	Ristow, M				Ristow, Michael			Mitohormesis explains ROS-induced health benefits	NATURE MEDICINE			English	Editorial Material							EXTENDS LIFE-SPAN; SUPPLEMENTATION; EXERCISE		Swiss Fed Inst Technol, Energy Metab Lab, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ristow, M (corresponding author), Swiss Fed Inst Technol, Energy Metab Lab, Schwerzenbach, Switzerland.	michael-ristow@ethz.ch	Ristow, Michael/O-9858-2014	Ristow, Michael/0000-0003-2109-2453				Bjelakovic G, 2014, CURR OPIN CLIN NUTR, V17, P40, DOI 10.1097/MCO.0000000000000009; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Grodstein F, 2013, ANN INTERN MED, V159, P806, DOI 10.7326/0003-4819-159-12-201312170-00006; Lin JS, 2013, ANN INTERN MED, V159, P601, DOI 10.7326/0003-4819-159-9-201311050-00730; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Powers SK, 1999, MED SCI SPORT EXER, V31, P987, DOI 10.1097/00005768-199907000-00011; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Ro SH, 2014, P NATL ACAD SCI USA, V111, P7849, DOI 10.1073/pnas.1401787111; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	20	291	292	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2014	20	7					709	711		10.1038/nm.3624	http://dx.doi.org/10.1038/nm.3624			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AK8PF	24999941				2022-12-25	WOS:000338689500011
J	Liang, C; Guo, BS; Wu, H; Shao, NS; Li, DF; Liu, J; Dang, L; Wang, C; Li, H; Li, SH; Lau, WK; Cao, Y; Yang, ZJ; Lu, C; He, XJ; Au, DWT; Pan, XH; Zhang, BT; Lu, CW; Zhang, HQ; Yue, KM; Qian, AR; Shang, P; Xu, JK; Xiao, LB; Bian, ZX; Tan, WH; Liang, ZC; He, FC; Zhang, LQ; Lu, AP; Zhang, G				Liang, Chao; Guo, Baosheng; Wu, Heng; Shao, Ningsheng; Li, Defang; Liu, Jin; Dang, Lei; Wang, Cheng; Li, Hui; Li, Shaohua; Lau, Wing Ki; Cao, Yu; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Au, D. W. T.; Pan, Xiaohua; Zhang, Bao-Ting; Lu, Changwei; Zhang, Hongqi; Yue, Kinman; Qian, Airong; Shang, Peng; Xu, Jiake; Xiao, Lianbo; Bian, Zhaoxiang; Tan, Weihong; Liang, Zicai; He, Fuchu; Zhang, Lingqiang; Lu, Aiping; Zhang, Ge			Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy	NATURE MEDICINE			English	Article							OSTEOCLAST-ASSOCIATED RECEPTOR; SIRNA; PHARMACOKINETICS; DELIVERY; PHASE	Currently, major concerns about the safety and efficacy of RNA interference (RNAi)-based bone anabolic strategies still exist because of the lack of direct osteoblast-specific delivery systems for osteogenic siRNAs. Here we screened the aptamer CH6 by cell-SELEX, specifically targeting both rat and human osteoblasts, and then we developed CH6 aptamer-functionalized lipid nanoparticles (LNPs) encapsulating osteogenic pleckstrin homology domain-containing family O member 1 (Plekho1) siRNA (CH6-LNPs-siRNA). Our results showed that CH6 facilitated in vitro osteoblast-selective uptake of Plekho1 siRNA, mainly via macropinocytosis, and boosted in vivo osteoblast-specific Plekho1 gene silencing, which promoted bone formation, improved bone microarchitecture, increased bone mass and enhanced mechanical properties in both osteopenic and healthy rodents. These results indicate that osteoblast-specific aptamer-functionalized LNPs could act as a new RNAi-based bone anabolic strategy, advancing the targeted delivery selectivity of osteogenic siRNAs from the tissue level to the cellular level.	[Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Wang, Cheng; Lau, Wing Ki; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Pan, Xiaohua; Lu, Changwei; Zhang, Hongqi; Yue, Kinman; Xiao, Lianbo; Bian, Zhaoxiang; Tan, Weihong; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Liang, Chao; Guo, Baosheng; Lu, Cheng; He, Xiaojuan; Lu, Aiping; Zhang, Ge] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Cao, Yu; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Bian, Zhaoxiang; Liang, Zicai; Lu, Aiping; Zhang, Ge] Kunshan Ind Technol Res Inst, Kunshan RNAi Inst, Kunshan, Jiangsu, Peoples R China; [Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Shenzhen Res Inst & Continuing Educ, Inst Integrated Bioinfomed & Translat Sci, Shenzhen, Peoples R China; [Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Shenzhen Res Inst & Continuing Educ, Shum Yiu Foon Shum Bik Chuen Mem Ctr Canc & Infla, Shenzhen, Peoples R China; [Liang, Chao; Guo, Baosheng; Wu, Heng; Li, Defang; Liu, Jin; Dang, Lei; Yang, Zhijun; Lu, Cheng; He, Xiaojuan; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Hunan Univ, Hong Kong Baptist Univ, State Key Lab Chemo Biosensing & Chemometr, Hong Kong, Hong Kong, Peoples R China; [Liang, Chao; Guo, Baosheng; Li, Defang; Liu, Jin; Dang, Lei; Lu, Cheng; Qian, Airong; Shang, Peng; Lu, Aiping; Zhang, Ge] Northwestern Polytech Univ, Hong Kong Baptist Univ, Joint Res Ctr Translat Med Musculoskeletal Hlth S, Shenzhen, Peoples R China; [Shao, Ningsheng; Li, Hui; Li, Shaohua] Beijing Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Wang, Cheng] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao, Peoples R China; [Au, D. W. T.] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; [Zhang, Bao-Ting] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Qian, Airong; Shang, Peng; Zhang, Ge] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Mol Lab, Nedlands, WA 6009, Australia; [Xiao, Lianbo; Zhang, Ge] Shanghai Acad Chinese Med Sci, Inst Arthrit Res, Shanghai, Peoples R China; [Tan, Weihong] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Mol Sci & Biomed Lab, Changsha, Hunan, Peoples R China; [Tan, Weihong] Hunan Univ, Coll Biol, Changsha, Hunan, Peoples R China; [Tan, Weihong] Hunan Univ, Collaborat Res Ctr Mol Engn Theranost, Changsha, Hunan, Peoples R China; [Tan, Weihong] Univ Florida, Dept Chem, Gainesville, FL USA; [Tan, Weihong] Univ Florida, Dept Physiol & Funct Gen, Gainesville, FL USA; [Tan, Weihong] Univ Florida, Shands Canc Ctr, Ctr Res Bio Nano Interface, Gainesville, FL USA	Hong Kong Baptist University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Academy of Military Medical Sciences - China; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University; Hunan University; Hong Kong Baptist University; Northwestern Polytechnical University; Academy of Military Medical Sciences - China; Ocean University of China; City University of Hong Kong; Chinese University of Hong Kong; Northwestern Polytechnical University; University of Western Australia; Hunan University; Hunan University; Hunan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhang, G (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China.	zhanglq@nic.bmi.ac.cn; aipinglu@hkbu.edu.hk; zhangge@hkbu.edu.hk	Zhang, Ge/K-9118-2019; LI, SHAOHUA/E-2733-2015; Guo, Baosheng/ABD-4800-2021; Liang, Chao/AAF-7703-2019; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; GUO, Baosheng/M-6023-2013; Zhang, Baoting/B-6273-2015	Zhang, Ge/0000-0002-7807-7695; Guo, Baosheng/0000-0002-4510-5418; Tan, Weihong/0000-0002-8066-1524; Li, Defang/0000-0003-4151-9151; Zhang, Lingqiang/0000-0002-9795-2141; Xu, Jiake/0000-0003-2021-8309; Yang, Zhijun/0000-0002-6094-0438; AU, Wai Ting Doris/0000-0003-4490-5971; Zhang, Hong Qi/0000-0003-4316-9378; Yue, Kevin/0000-0002-9250-2416; Zhang, Bao-Ting/0000-0003-1421-0212	Ministry of Science and Technology of China [2013ZX09301307]; Hong Kong General Research Fund [HKBU479111, HKBU478312, HKBU12102914, HKBU261113]; Natural Science Foundation Council of China [81272045, 81228013, 21221003]; Research Grants Council & Natural Science Foundation Council of China [N_HKBU435/12]; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University [RC-IRMS/12-13/02, RC-IRMS/13-14/02]; Hong Kong Baptist University Strategic Development Fund (SDF) [SDF13-1209-P01]; Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) [489213]; Faculty Research Grant of Hong Kong Baptist University [FRG1/13-14/024, FRG2/12-13/027]; China Academy of Chinese Medical Sciences [Z0252, Z0293]; Chinese National High-Tech Research and Development Programme [2012AA022501]; National Key Technologies R&D Programs for New Drugs of China [2012ZX09301003-001-001, 2014ZX09J14106-04C]; Collaborative Research Programme (CRP)-International Centre for Genetic Engineering and Biotechnology (ICGEB) grant [CRP/CHN13-02]; Chinese National Natural Science Foundation Project [81261160503]; National Key Scientific Program of China [2011CB911000]; National Institutes of Health [GM079359]; Beijing Natural Science Foundation [7131012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hong Kong General Research Fund; Natural Science Foundation Council of China(National Natural Science Foundation of China (NSFC)); Research Grants Council & Natural Science Foundation Council of China; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University; Hong Kong Baptist University Strategic Development Fund (SDF); Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS); Faculty Research Grant of Hong Kong Baptist University; China Academy of Chinese Medical Sciences(Chinese Academy of Sciences); Chinese National High-Tech Research and Development Programme(National High Technology Research and Development Program of China); National Key Technologies R&D Programs for New Drugs of China; Collaborative Research Programme (CRP)-International Centre for Genetic Engineering and Biotechnology (ICGEB) grant; Chinese National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); National Key Scientific Program of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the academic staff (L. Qin) from the Chinese University of Hong Kong and H.Y.S. Cheung from the Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University for providing critical comments and technical support. This study was supported by the Ministry of Science and Technology of China (2013ZX09301307 to A.L.), the Hong Kong General Research Fund (HKBU479111 to G.Z., HKBU478312 to G.Z., HKBU12102914 to G.Z. and HKBU261113 to A.L.), the Natural Science Foundation Council of China (81272045 to G.Z., 81228013 to J.X. and 21221003 to W.T.), the Research Grants Council & Natural Science Foundation Council of China (N_HKBU435/12 to G.Z.), the Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University (RC-IRMS/12-13/02 to A.L. and RC-IRMS/13-14/02 to G.Z.), the Hong Kong Baptist University Strategic Development Fund (SDF) (SDF13-1209-P01 to A.L.), the Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) (489213 to B.-T.Z.), the Faculty Research Grant of Hong Kong Baptist University (FRG1/13-14/024 and FRG2/12-13/027 to G.Z.), the China Academy of Chinese Medical Sciences (Z0252 and Z0293 to A.L.), the Chinese National High-Tech Research and Development Programme (2012AA022501 to N.S.), the National Key Technologies R&D Programs for New Drugs of China (2012ZX09301003-001-001 and 2014ZX09J14106-04C to L.Z.), the Collaborative Research Programme (CRP)-International Centre for Genetic Engineering and Biotechnology (ICGEB) grant (CRP/CHN13-02 to L.Z.), the Chinese National Natural Science Foundation Project (81261160503 to L.Z.), the National Key Scientific Program of China (2011CB911000 to W.T.), the National Institutes of Health (GM079359 to W.T.) and the Beijing Natural Science Foundation (7131012 to L.Z.). The statistical analysis was performed by a contract service from Bioinformedicine (http://www.bioinformedicine.com/index.php).	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Auguste DT, 2008, J CONTROL RELEASE, V130, P266, DOI 10.1016/j.jconrel.2008.06.004; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Fukushima N, 2010, BIOCHEM BIOPH RES CO, V400, P157, DOI 10.1016/j.bbrc.2010.08.036; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Guo BS, 2014, BONE, V59, P76, DOI 10.1016/j.bone.2013.11.007; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Herman S, 2008, ARTHRITIS RHEUM-US, V58, P3041, DOI 10.1002/art.23943; Ishikawa S, 2004, INT IMMUNOL, V16, P1019, DOI 10.1093/intimm/dxh103; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kishimoto Y, 2004, RHEUMATOLOGY, V43, P1496, DOI 10.1093/rheumatology/keh395; Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lopez-Fraga M, 2009, BIODRUGS, V23, P305, DOI 10.2165/11318190-000000000-00000; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Mui BL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.66; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Sanguineti R, 2008, ANN NY ACAD SCI, V1126, P166, DOI 10.1196/annals.1433.044; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Tam Yuen Yi C, 2013, Pharmaceutics, V5, P498, DOI 10.3390/pharmaceutics5030498; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; Wang GL, 2010, J DRUG TARGET, V18, P611, DOI 10.3109/10611861003622560; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wang YW, 2012, ADV DRUG DELIVER REV, V64, P1341, DOI 10.1016/j.addr.2011.09.002; Wu H., 2014, PROTOCOL EXCHANGE, DOI [10.1038/protex.2014.053, DOI 10.1038/PROTEX.2014.053]; Yang ML, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-5; Ye M, 2012, INT J MOL SCI, V13, P3341, DOI 10.3390/ijms13033341; Zamboni WC, 2005, CLIN CANCER RES, V11, P8230, DOI 10.1158/1078-0432.CCR-05-1895; ZERNIK J, 1990, DIFFERENTIATION, V44, P207, DOI 10.1111/j.1432-0436.1990.tb00619.x; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617	35	197	210	13	330	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					288	+		10.1038/nm.3791	http://dx.doi.org/10.1038/nm.3791			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	25665179	Green Accepted			2022-12-25	WOS:000350362000023
J	Sottoriva, A; Kang, H; Ma, ZC; Graham, TA; Salomon, MP; Zhao, JS; Marjoram, P; Siegmund, K; Press, MF; Shibata, D; Curtis, C				Sottoriva, Andrea; Kang, Haeyoun; Ma, Zhicheng; Graham, Trevor A.; Salomon, Matthew P.; Zhao, Junsong; Marjoram, Paul; Siegmund, Kimberly; Press, Michael F.; Shibata, Darryl; Curtis, Christina			A Big Bang model of human colorectal tumor growth	NATURE GENETICS			English	Article							STEM-CELLS; INTRATUMOR HETEROGENEITY; GENETIC INSTABILITY; PASSENGER MUTATIONS; CLONAL EXPANSION; COPY NUMBER; CANCER; EVOLUTION; PROGRESSION; REVEALS	What happens in early, still undetectable human malignancies is unknown because direct observations are impractical. Here we present and validate a 'Big Bang' model, whereby tumors grow predominantly as a single expansion producing numerous intermixed subclones that are not subject to stringent selection and where both public (clonal) and most detectable private (subclonal) alterations arise early during growth. Genomic profiling of 349 individual glands from 15 colorectal tumors showed an absence of selective sweeps, uniformly high intratumoral heterogeneity (ITH) and subclone mixing in distant regions, as postulated by our model. We also verified the prediction that most detectable ITH originates from early private alterations and not from later clonal expansions, thus exposing the profile of the primordial tumor. Moreover, some tumors appear 'born to be bad', with subclone mixing indicative of early malignant potential. This new model provides a quantitative framework to interpret tumor growth dynamics and the origins of ITH, with important clinical implications.	[Sottoriva, Andrea; Ma, Zhicheng; Salomon, Matthew P.; Zhao, Junsong; Marjoram, Paul; Siegmund, Kimberly; Curtis, Christina] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Kang, Haeyoun; Press, Michael F.; Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Kang, Haeyoun] CHA Univ, Dept Pathol, Songnam, South Korea; [Graham, Trevor A.] Univ Calif San Francisco, Ctr Evolut & Canc, San Francisco, CA 94143 USA; [Graham, Trevor A.] Queen Mary Univ London, Barts Canc Inst, Tumor Biol Ctr, London, England	University of Southern California; University of Southern California; Pochon Cha University; University of California System; University of California San Francisco; University of London; Queen Mary University London	Shibata, D (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	dshibata@usc.edu; cncurtis@stanford.edu		Graham, Trevor/0000-0001-9582-1597; Curtis, Christina/0000-0003-0166-3802; Sottoriva, Andrea/0000-0001-6709-9533	V Foundation for Cancer Research; National Cancer Institute [P30CA014089, R21CA149990, R21CA151139]; California Institute for Regenerative Medicine (CIRM); NATIONAL CANCER INSTITUTE [R21CA149990, R21CA151139, P30CA014089, R21CA185016] Funding Source: NIH RePORTER	V Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge the technical assistance of R. Guzman. This project was supported in part by an award to C.C. from the V Foundation for Cancer Research and by award numbers P30CA014089, R21CA149990 and R21CA151139 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the US National Institutes of Health. M.F.P. was supported by a grant from the California Institute for Regenerative Medicine (CIRM).	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basanta D, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0020; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Datta RS, 2013, EVOL APPL, V6, P20, DOI 10.1111/eva.12024; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Garcia SB, 1999, J PATHOL, V187, P61, DOI 10.1002/(SICI)1096-9896(199901)187:1<61::AID-PATH247>3.0.CO;2-I; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Humphries A, 2013, P NATL ACAD SCI USA, V110, pE2490, DOI 10.1073/pnas.1220353110; Korolev KS, 2010, REV MOD PHYS, V82, P1691, DOI 10.1103/RevModPhys.82.1691; Korolev KS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026008; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Marjoram P, 2006, NAT REV GENET, V7, P759, DOI 10.1038/nrg1961; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Schwarz RF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003535; Siegmund KD, 2009, CELL CYCLE, V8, P2187, DOI 10.4161/cc.8.14.9151; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sottoriva A, 2013, CANCER RES, V73, P41, DOI 10.1158/0008-5472.CAN-12-2273; Sottoriva A, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P57, DOI 10.1007/978-3-7908-2604-3_5; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wright NA, 2002, GUT, V51, P306, DOI 10.1136/gut.51.3.306; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	55	620	631	1	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					209	+		10.1038/ng.3214	http://dx.doi.org/10.1038/ng.3214			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665006	Green Accepted			2022-12-25	WOS:000350327900010
J	Moisan, A; Lee, YK; Zhang, JD; Hudak, CS; Meyer, CA; Prummer, M; Zoffmann, S; Truong, HH; Ebeling, M; Kiialainen, A; Gerard, R; Xia, F; Schinzel, RT; Amrein, KE; Cowan, CA				Moisan, Annie; Lee, Youn-Kyoung; Zhang, Jitao David; Hudak, Carolyn S.; Meyer, Claas A.; Prummer, Michael; Zoffmann, Sannah; Truong, Hoa Hue; Ebeling, Martin; Kiialainen, Anna; Gerard, Regine; Xia, Fang; Schinzel, Robert T.; Amrein, Kurt E.; Cowan, Chad A.			White-to-brown metabolic conversion of human adipocytes by JAK inhibition	NATURE CELL BIOLOGY			English	Article							UNCOUPLING PROTEIN GENE; ADIPOSE-TISSUE; THYROID-HORMONE; CELLULAR PLASTICITY; TYROSINE KINASE; FAT; ACTIVATION; DISCOVERY; OBESITY; MOUSE	The rising incidence of obesity and related disorders such as diabetes and heart disease has focused considerable attention on the discovery of new therapeutics. One promising approach has been to increase the number or activity of brown-like adipocytes in white adipose depots, as this has been shown to prevent diet-induced obesity and reduce the incidence and severity of type 2 diabetes. Thus, the conversion of fat-storing cells into metabolically active thermogenic cells has become an appealing therapeutic strategy to combat obesity. Here, we report a screening platform for the identification of small molecules capable of promoting a white-to-brown metabolic conversion in human adipocytes. We identified two inhibitors of Janus kinase (JAK) activity with no precedent in adipose tissue biology that stably confer brown-like metabolic activity to white adipocytes. Importantly, these metabolically converted adipocytes exhibit elevated UCP1 expression and increased mitochondrial activity. We further found that repression of interferon signalling and activation of hedgehog signalling in JAK-inactivated adipocytes contributes to the metabolic conversion observed in these cells. Our findings highlight a previously unknown role for the JAK-STAT pathway in the control of adipocyte function and establish a platform to identify compounds for the treatment of obesity.	[Moisan, Annie; Zhang, Jitao David; Meyer, Claas A.; Prummer, Michael; Zoffmann, Sannah; Truong, Hoa Hue; Ebeling, Martin; Kiialainen, Anna; Gerard, Regine; Amrein, Kurt E.] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Lee, Youn-Kyoung; Hudak, Carolyn S.; Xia, Fang; Schinzel, Robert T.; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lee, Youn-Kyoung; Hudak, Carolyn S.; Xia, Fang; Schinzel, Robert T.; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lee, Youn-Kyoung; Hudak, Carolyn S.; Xia, Fang; Schinzel, Robert T.; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Roche Holding; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Moisan, A (corresponding author), Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, 124 Grenzacherstr, CH-4070 Basel, Switzerland.	annie.moisan@roche.com; chad_cowan@harvard.edu	Prummer, Michael/G-6464-2011	Prummer, Michael/0000-0001-9896-3929; Moisan, Annie/0000-0002-4944-4548	Roche Postdoctoral Fellowship (RPF) program; F.Hoffmann-La Roche; United States Institutes of Health (NIH) [R01DK095384, R01DK097768]; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095384, R01DK097768] Funding Source: NIH RePORTER	Roche Postdoctoral Fellowship (RPF) program; F.Hoffmann-La Roche(Hoffmann-La Roche); United States Institutes of Health (NIH); Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank I. Clausen, M. Kapps, R. Schmucki and A. Schuler for technical support, K. Christensen and M. Graf for stem cell support, L. Badi for preliminary data analysis, C. Solier, A. Schell-Steven and T. Bergauer for experimental planning and M. Pawlak (Natural and Medical Sciences Institute at the University of Tubingen) for RPPA analyses. A.M. was supported by the Roche Postdoctoral Fellowship (RPF) program (2011-2013). This research was supported in part by F.Hoffmann-La Roche; grant R01DK095384 (C.A.C. and Y.K.L.) and R01DK097768 (C.A.C.) from the United States Institutes of Health (NIH); and Harvard University.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bray MA, 2004, ASSAY GUIDANCE MANUA; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Koh YJ, 2009, EXP MOL MED, V41, P880, DOI 10.3858/emm.2009.41.12.094; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Prummer M, 2012, J BIOMOL SCREEN, V17, P519, DOI 10.1177/1087057111431278; RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3267, DOI 10.1210/en.136.8.3267; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3277, DOI 10.1210/en.136.8.3277; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	35	122	134	6	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					57	+		10.1038/ncb3075	http://dx.doi.org/10.1038/ncb3075			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AX3ET	25487280	Green Accepted, Green Submitted			2022-12-25	WOS:000346823900008
J	Overwijk, WW				Overwijk, Willem W.			Human CD4(+) T cells spontaneously detect somatic mutations in cancer cells	NATURE MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Overwijk, WW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.	woverwijk@mdanderson.org			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cobbold M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006061; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Hunuel N.N., 2000, NEW ENGL J MED, V558, P2698; Kim HJ, 2014, CANCER IMMUNOL RES, V2, P91, DOI 10.1158/2326-6066.CIR-13-0216; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2014, NAT REV CLIN ONCOL, V11, P630, DOI 10.1038/nrclinonc.2014.174; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102	9	9	11	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					12	14		10.1038/nm.3783	http://dx.doi.org/10.1038/nm.3783			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25569544	Green Accepted			2022-12-25	WOS:000348408000006
J	Stanley, SA; Sauer, J; Kane, RS; Dordick, JS; Friedman, JM				Stanley, Sarah A.; Sauer, Jeremy; Kane, Ravi S.; Dordick, Jonathan S.; Friedman, Jeffrey M.			Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles	NATURE MEDICINE			English	Article							ISOFLURANE ANESTHESIA; MAMMALIAN-CELLS; LIVING CELLS; TETRACYCLINES; ACTIVATION; EMBRYOS; SYSTEM	Means for temporally regulating gene expression and cellular activity are invaluable for elucidating underlying physiological processes and would have therapeutic implications. Here we report the development of a genetically encoded system for remote regulation of gene expression by low-frequency radio waves (RFs) or a magnetic field. Iron oxide nanoparticles are synthesized intracellularly as a GFP-tagged ferritin heavy and light chain fusion. The ferritin nanoparticles associate with a camelid anti-GFP-transient receptor potential vanilloid 1 fusion protein, alpha GFP-TRPV1, and can transduce noninvasive RE or magnetic fields into channel activation, also showing that TRPV1 can transduce a mechanical stimulus. This, in turn, initiates calcium-dependent transgene expression. In mice with stem cell or viral expression of these genetically encoded components, remote stimulation of insulin transgene expression with RE or a magnet lowers blood glucose. This robust, repeatable method for remote regulation in vivo may ultimately have applications in basic science, technology and therapeutics.	[Stanley, Sarah A.; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; [Sauer, Jeremy; Kane, Ravi S.; Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Friedman, Jeffrey M.] Howard Hughes Med Inst, New York, NY USA	Rockefeller University; Rensselaer Polytechnic Institute; Howard Hughes Medical Institute	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	dordick@rpl.edu; friedj@mail.rockefeller.edu			Howard Hughes Medical Institute; JPB Foundation; US National Institutes of Health [GM095654]; Rensselaer Fellowship under US National Institutes of Health predoctoral training grant [GM067545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654, T32GM067545] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rensselaer Fellowship under US National Institutes of Health predoctoral training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Friedman laboratory members for helpful discussions and S. Korres for assistance with preparation and submission of the manuscript. This work was funded by the Howard Hughes Medical Institute, the JPB Foundation, the US National Institutes of Health (GM095654) and a Rensselaer Fellowship (to J.S.) under a US National Institutes of Health predoctoral training grant (GM067545).	Aleman A, 2013, CLIN PSYCHOPHARM NEU, V11, P53, DOI 10.9758/cpn.2013.11.2.53; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; BEYER BK, 1989, TOXICOL APPL PHARM, V98, P113, DOI 10.1016/0041-008X(89)90139-7; BOCKER R, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2116; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Durand JL, 2009, HORM METAB RES, V41, P339, DOI 10.1055/s-0028-1112114; Fortin JP, 2008, EUR BIOPHYS J BIOPHY, V37, P223, DOI 10.1007/s00249-007-0197-4; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; Gilles C, 2002, J MAGN MAGN MATER, V241, P430, DOI 10.1016/S0304-8853(01)00461-9; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hong L, 2006, CELLS TISSUES ORGANS, V183, P133, DOI 10.1159/000095987; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; Iordanova B, 2010, J BIOL INORG CHEM, V15, P957, DOI 10.1007/s00775-010-0657-7; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kawano T, 2012, ANESTH ANALG, V115, P62, DOI 10.1213/ANE.0b013e318253cbf0; Kim T, 2012, J BIOTECHNOL, V162, P237, DOI 10.1016/j.jbiotec.2012.09.019; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Knight L. C., 2010, J MOL BIOMARK DIAGN, V1; Lauwers M, 2013, CURR BIOL, V23, P924, DOI 10.1016/j.cub.2013.04.025; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; PETERS RW, 1978, ANN INTERN MED, V88, P17, DOI 10.7326/0003-4819-88-1-17; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; SAXEN L, 1966, SCIENCE, V153, P1384, DOI 10.1126/science.153.3742.1384-a; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Vore SJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE93, DOI 10.1152/ajpendo.2001.281.1.E93; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]	32	143	154	5	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2015	21	1					92	98		10.1038/nm.3730	http://dx.doi.org/10.1038/nm.3730			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AZ7OM	25501906	Green Accepted			2022-12-25	WOS:000348408000019
J	Hashizume, R; Andor, N; Ihara, Y; Lerner, R; Gan, HY; Chen, XY; Fang, D; Huang, X; Tom, MW; Ngo, V; Solomon, D; Mueller, S; Paris, PL; Zhang, ZG; Petritsch, C; Gupta, N; Waldman, TA; James, CD				Hashizume, Rintaro; Andor, Noemi; Ihara, Yuichiro; Lerner, Robin; Gan, Haiyun; Chen, Xiaoyue; Fang, Dong; Huang, Xi; Tom, Maxwell W.; Ngo, Vy; Solomon, David; Mueller, Sabine; Paris, Pamela L.; Zhang, Zhiguo; Petritsch, Claudia; Gupta, Nalin; Waldman, Todd A.; James, C. David			Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma	NATURE MEDICINE			English	Article							HIGH-GRADE GLIOMAS; GENE-EXPRESSION; GLIOBLASTOMA; METHYLATION; MUTATIONS; H3K27ME3; EZH2	Pediatric brainstem gliomas often harbor oncogenic K27M mutation of histone H3.3. Here we show that GSKJ4 pharmacologic inhibition of K27 demethylase JMJD3 increases cellular H3K27 methylation in K27M tumor cells and demonstrate potent antitumor activity both in vitro against K27M cells and in vivo against K27M xenografts. Our results demonstrate that increasing H3K27 methylation by inhibiting K27 demethylase is a valid therapeutic strategy for treating K27M-expressing brainstem glioma.	[Hashizume, Rintaro; James, C. David] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Andor, Noemi; Ihara, Yuichiro; Lerner, Robin; Tom, Maxwell W.; Mueller, Sabine; Petritsch, Claudia; Gupta, Nalin] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Gan, Haiyun; Chen, Xiaoyue; Fang, Dong; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Huang, Xi] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Ngo, Vy; Paris, Pamela L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Solomon, David] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Solomon, David; Waldman, Todd A.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Mueller, Sabine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mueller, Sabine] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Georgetown University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hashizume, R (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	rintaro.hashizume@northwestern.edu	Petritsch, Claudia/AAP-9597-2021; Huang, Xi/C-2409-2017	Huang, Xi/0000-0002-7177-7525	US National Institutes of Health (NIH) Brain Tumor SPORE grant [CA97257]; Pediatric Brain Tumor Foundation; Matthew Larson Foundation; Bear Necessities Pediatric Cancer Foundation; Rally Foundation; American Cancer Society [IRG-97-150-13]; NIH [CA157489, CA164746]; Childhood Brain Tumor Foundation; Voices Against Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA159467, R01CA164746, P50CA097257, R01CA157489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080619] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Brain Tumor SPORE grant; Pediatric Brain Tumor Foundation; Matthew Larson Foundation; Bear Necessities Pediatric Cancer Foundation; Rally Foundation; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Childhood Brain Tumor Foundation; Voices Against Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by US National Institutes of Health (NIH) Brain Tumor SPORE grant CA97257 (R.H., C.D.J.), the Pediatric Brain Tumor Foundation (R.H., N.G., C.D.J.), the Matthew Larson Foundation (R.H.), the Bear Necessities Pediatric Cancer Foundation (R.H.) and Rally Foundation (R.H.), American Cancer Society IRG-97-150-13 (R.H.), NIH CA157489 (Z.Z.), the Childhood Brain Tumor Foundation (C.P.), the Voices Against Brain Tumor Foundation (C.P.) and NIH CA164746 (C.P.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Aoki Y, 2012, J NEURO-ONCOL, V108, P29, DOI 10.1007/s11060-011-0796-x; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Grimm SA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0346-3; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mueller S, 2014, NEURO-ONCOLOGY, V16, P352, DOI 10.1093/neuonc/not220; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	15	313	329	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1394	1396		10.1038/nm.3716	http://dx.doi.org/10.1038/nm.3716			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	25401693	Green Accepted, Green Submitted			2022-12-25	WOS:000345817900013
J	Gatza, ML; Silva, GO; Parker, JS; Fan, C; Perou, CM				Gatza, Michael L.; Silva, Grace O.; Parker, Joel S.; Fan, Cheng; Perou, Charles M.			An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer	NATURE GENETICS			English	Article							GENE-EXPRESSION SIGNATURE; BASAL-LIKE; GROWTH-FACTOR; TUMOR-SUPPRESSOR; PATHWAY; PROGNOSIS; PROFILES; SURVIVAL; CLASSIFICATION; ACTIVATION	Elucidating the molecular drivers of human breast cancers requires a strategy that is capable of integrating multiple forms of data and an ability to interpret the functional consequences of a given genetic aberration. Here we present an integrated genomic strategy based on the use of gene expression signatures of oncogenic pathway activity (n = 52) as a framework to analyze DNA copy number alterations in combination with data from a genome-wide RNA-mediated interference screen. We identify specific DNA amplifications and essential genes within these amplicons representing key genetic drivers, including known and new regulators of oncogenesis. The genes identified include eight that are essential for cell proliferation (FGD5, METTL6, CPT1A, DTX3, MRPS23, EIF2S2, EIF6 and SLC2A10) and are uniquely amplified in patients with highly proliferative luminal breast tumors, a clinical subset of patients for which few therapeutic options are effective. This general strategy has the potential to identify therapeutic targets within amplicons through an integrated use of genomic data sets. is of	[Gatza, Michael L.; Silva, Grace O.; Parker, Joel S.; Fan, Cheng; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gatza, Michael L.; Silva, Grace O.; Parker, Joel S.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Silva, Grace O.; Perou, Charles M.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Perou, Charles M/H-9934-2014; Parker, Joel/AAG-1108-2019	Perou, Charles M/0000-0001-9827-2247; Gatza, Michael/0000-0001-6796-7791	National Cancer Institute of the US National Institutes of Health [K99-CA166228-01A1]; National Cancer Institute of the US National Institutes of Health Breast SPORE program [P50-CA58223-09A1, RO1-CA148761-04]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R00CA166228, P50CA058223, P30CA016086, K99CA166228, R01CA148761] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute of the US National Institutes of Health Breast SPORE program; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of our laboratory for helpful discussion and suggestions. Research reported in this publication was supported by the National Cancer Institute of the US National Institutes of Health under award number K99-CA166228-01A1 to M.L.G. Additional funding for research reported in this study was provided by the National Cancer Institute of the US National Institutes of Health Breast SPORE program grant P50-CA58223-09A1 and RO1-CA148761-04, as well as grants from the Susan G. Komen for the Cure and the Breast Cancer Research Foundation to C.M.P.	Benelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032047; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2344; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Harrell JC, 2014, CLIN EXP METASTAS, V31, P33, DOI 10.1007/s10585-013-9607-4; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Hutti JE, 2012, CANCER RES, V72, P3260, DOI 10.1158/0008-5472.CAN-11-4141; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kishi N, 2001, INT J DEV NEUROSCI, V19, P21, DOI 10.1016/S0736-5748(00)00071-X; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-154; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miluzio A, 2011, CANCER CELL, V19, P765, DOI 10.1016/j.ccr.2011.04.018; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Thorner AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013073; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	55	165	171	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1051	1059		10.1038/ng.3073	http://dx.doi.org/10.1038/ng.3073			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25151356	Green Accepted, Green Submitted			2022-12-25	WOS:000342554100006
J	Pollen, AA; Nowakowski, TJ; Shuga, J; Wang, XH; Leyrat, AA; Lui, JH; Li, NZ; Szpankowski, L; Fowler, B; Chen, PL; Ramalingam, N; Sun, G; Thu, M; Norris, M; Lebofsky, R; Toppani, D; Kemp, DW; Wong, M; Clerkson, B; Jones, BN; Wu, SQ; Knutsson, L; Alvarado, B; Wang, J; Weaver, LS; May, AP; Jones, RC; Unger, MA; Kriegstein, AR; West, JAA				Pollen, Alex A.; Nowakowski, Tomasz J.; Shuga, Joe; Wang, Xiaohui; Leyrat, Anne A.; Lui, Jan H.; Li, Nianzhen; Szpankowski, Lukasz; Fowler, Brian; Chen, Peilin; Ramalingam, Naveen; Sun, Gang; Thu, Myo; Norris, Michael; Lebofsky, Ronald; Toppani, Dominique; Kemp, Darnell W., II; Wong, Michael; Clerkson, Barry; Jones, Brittnee N.; Wu, Shiquan; Knutsson, Lawrence; Alvarado, Beatriz; Wang, Jing; Weaver, Lesley S.; May, Andrew P.; Jones, Robert C.; Unger, Marc A.; Kriegstein, Arnold R.; West, Jay A. A.			Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL LANDSCAPE; SEQ EXPERIMENTS; HUMAN BRAIN; MIGRATION; GENOME; EGR1	Large-scale surveys of single-cell gene expression have the potential to reveal rare cell populations and lineage relationships but require efficient methods for cell capture and mRNA sequencing(1-4). Although cellular barcoding strategies allow parallel sequencing of single cells at ultra-low depths(5), the limitations of shallow sequencing have not been investigated directly. By capturing 301 single cells from 11 populations using microfluidics and analyzing single-cell transcriptomes across downsampled sequencing depths, we demonstrate that shallow single-cell mRNA sequencing (similar to 50,000 reads per cell) is sufficient for unbiased cell-type classification and biomarker identification. In the developing cortex, we identify diverse cell types, including multiple progenitor and neuronal subtypes, and we identify EGR1 and FOS as previously unreported candidate targets of Notch signaling in human but not mouse radial glia. Our strategy establishes an efficient method for unbiased analysis and comparison of cell populations from heterogeneous tissue by microfluidic single-cell capture and low-coverage sequencing of many cells.	[Pollen, Alex A.; Nowakowski, Tomasz J.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Pollen, Alex A.; Nowakowski, Tomasz J.; Leyrat, Anne A.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shuga, Joe; Wang, Xiaohui; Leyrat, Anne A.; Li, Nianzhen; Szpankowski, Lukasz; Fowler, Brian; Chen, Peilin; Ramalingam, Naveen; Sun, Gang; Thu, Myo; Norris, Michael; Lebofsky, Ronald; Toppani, Dominique; Kemp, Darnell W., II; Wong, Michael; Clerkson, Barry; Jones, Brittnee N.; Wu, Shiquan; Knutsson, Lawrence; Alvarado, Beatriz; Wang, Jing; Weaver, Lesley S.; May, Andrew P.; Jones, Robert C.; Unger, Marc A.; West, Jay A. A.] Fluidigm Corp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollen, AA (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	alex.pollen@gmail.com; kriegsteina@stemcell.ucsf.edu	Nowakowski, Tomasz/P-7731-2014	Nowakowski, Tomasz/0000-0003-2345-4964; Ramalingam, Naveen/0000-0003-2584-8094; Jones, Robert C/0000-0001-7235-9854	California Institute for Regenerative Medicine Tools and Technologies II [RT2-02052]; Damon Runyon Cancer Research Foundation postdoctoral fellowship [DRG-2166-13]; National Institute of Neurological Disorders and Stroke [R01NS075998, R01NS072630]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998, R01NS072630] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine Tools and Technologies II; Damon Runyon Cancer Research Foundation postdoctoral fellowship; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Bershteyn (University of California, San Francisco (UCSF)), E. Di Lullo (UCSF), C. Gertz (UCSF), C. McLean (23andMe), F. Ng (Fluidigm Corporation), J. Liu (UCSF), C. Lowe (Stanford University), M. Oldham (UCSF), A. Diaz (UCSF) and H. Retallack (UCSF) for reading the manuscript and for useful suggestions, S. Wang and Y. Wang for technical assistance, K. Davies (University of Oxford) for providing the antibody to syncoilin, A. Simeone (Institute of Genetics and Biophysics, Adriano Buzzati-Traverso) for providing the Emx2 probe, S. Yao and S. Ku (Allen Institute for Brain Research) for assistance in the neural progenitor induction protocol, G. Wang (Stanford University) for providing human induced pluripotent stem cells (hiPSCs) and the staff at the San Francisco General Hospital for providing access to donated fetal tissue. L.S., N.L. and M.A.U. are partially supported by California Institute for Regenerative Medicine Tools and Technologies II grant RT2-02052 to M.A.U., and the generation and maintenance of the hiPSCs and neural progenitor cells was also supported by RT2-02052 to M.A.U. A.A.P. is supported by a Damon Runyon Cancer Research Foundation postdoctoral fellowship (DRG-2166-13). This research was also supported by National Institute of Neurological Disorders and Stroke awards R01NS075998 and R01NS072630 to A.R.K.	Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Fan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030794; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	38	548	562	23	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1053	+		10.1038/nbt.2967	http://dx.doi.org/10.1038/nbt.2967			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25086649	Green Accepted, Green Submitted			2022-12-25	WOS:000343763800023
J	Zhang, M; Meng, XY; Cu, M; Pascal, JM; Logothetis, DE; Zhang, JF				Zhang, Miao; Meng, Xuan-Yu; Cu, Meng; Pascal, John M.; Logothetis, Diomedes E.; Zhang, Ji-Fang			Selective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complex	NATURE CHEMICAL BIOLOGY			English	Article							CA2+-ACTIVATED K+-CHANNEL; ACTIVATED POTASSIUM CHANNELS; LONG-TERM POTENTIATION; SMALL-CONDUCTANCE; STRUCTURAL BASIS; KCNQ CHANNELS; MEMORY; INHIBITION; RECEPTORS; IDENTIFICATION	Phosphatidylinositol bisphosphate (PIP2) regulates the activities of many membrane proteins, including ion channels, through direct interactions. However, the affinity of PIP2 is so high for some channel proteins that its physiological role as a modulator has been questioned. Here we show that PIP2 is a key cofactor for activation of small conductance Ca2+-activated potassium channels (SKs) by Ca2+-bound calmodulin (CaM). Removal of the endogenous PIP2 inhibits SKs. The PIP2-binding site resides at the interface of CaM and the SK C terminus. We further demonstrate that the affinity of PIP, for its target proteins can be regulated by cellular signaling. Phosphorylation of CaM T79, located adjacent to the PIP2-binding site, by casein kinase 2 reduces the affinity of PIP2 for the CaM-SK channel complex by altering the dynamic interactions among amino acid residues surrounding the PIP2-binding site. This effect of CaM phosphorylation promotes greater channel inhibition by G protein-mediated hydrolysis of PIP2.	[Zhang, Miao; Zhang, Ji-Fang] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Zhang, Miao; Meng, Xuan-Yu; Cu, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA USA; [Zhang, Ji-Fang] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Zhang, Ji-Fang] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Zhang, Ji-Fang] Thomas Jefferson Univ, Grad Program Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Virginia Commonwealth University; Jefferson University; Jefferson University; Jefferson University	Zhang, M (corresponding author), Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA.	delogothetis@vcu.edu; ji-fang.zhang@jefferson.edu		Zhang, Miao/0000-0002-3099-155X	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; American Heart Association [13SDG16150007]; US National Institutes of Health (NIH) [S10RR027411]; NIH [HL059949, HL090882, R01MH073060, R01NS39355]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090882, R01HL059949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039355] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); American Heart Association(American Heart Association); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Adelman, R. Horn, I. Levitan and S. Siegelbaum for their helpful discussions and comments on this work. We thank M. Eto for advice on the in vitro phosphorylation assay. We thank J.P. Bennett Jr. and L. O'Brien for sharing their mammalian cell patch clamp setup. We are grateful to H. Vaananen for technical assistance. We thank I.S. Ramsey for the HEK-293 stably transfected cell line with the muscarinic M1 receptor, the structural facility of the Kimmel Cancer Center of Thomas Jefferson University for access of equipment in initial protein crystal screening and initial in-house X-ray diffraction; staff at the Beamline facility (X6A) of the Brookhaven National labs for assistance with collection of X-ray diffraction data. The use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-98CH10886. This work was partly supported by grants 13SDG16150007 from the American Heart Association to M.Z., S10RR027411 from the US National Institutes of Health (NIH) to M.C., HL059949 and HL090882 from NIH to D.E.L. and R01MH073060 and R01NS39355 from NIH to J.F.Z.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2007, CLIN EXP PHARMACOL P, V34, P1077, DOI 10.1111/j.1440-1681.2007.04725.x; Garland CJ, 2010, BRIT J PHARMACOL, V160, P833, DOI 10.1111/j.1476-5381.2010.00692.x; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Horn Richard, 2005, Sci STKE, V2005, ppe50, DOI 10.1126/stke.3072005pe50; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2010, PFLUG ARCH EUR J PHY, V460, P343, DOI 10.1007/s00424-009-0768-6; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Maingret F, 2008, NEURON, V59, P439, DOI 10.1016/j.neuron.2008.05.026; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; McKay BM, 2013, J NEUROSCI, V33, P5499, DOI 10.1523/JNEUROSCI.4068-12.2013; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Mpari B, 2010, HIPPOCAMPUS, V20, P352, DOI 10.1002/hipo.20622; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tucker SJ, 2008, J GEN PHYSIOL, V131, P431, DOI 10.1085/jgp.200709936; Wagner EJ, 2001, J PHARMACOL EXP THER, V299, P21; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; Zhang M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2017; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019	49	48	48	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2014	10	9					753	759		10.1038/NCHEMBIO.1592	http://dx.doi.org/10.1038/NCHEMBIO.1592			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO2DX	25108821	Green Accepted, Green Submitted			2022-12-25	WOS:000341126800012
J	Garber, K				Garber, Ken			Between disease and a dish	NATURE BIOTECHNOLOGY			English	News Item							ALZHEIMERS-DISEASE; NEURONS; CELLS											Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duan LS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-3; Griswold-Prenner I., 2013, ANN M SOC NEUR SAN D; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Qiang L, 2014, CELL, V157, P514, DOI 10.1016/j.cell.2014.03.002; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	13	4	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					712	715		10.1038/nbt.2977	http://dx.doi.org/10.1038/nbt.2977			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093880				2022-12-25	WOS:000346455900006
J	Gibbs, J; Ince, L; Matthews, L; Mei, JJ; Bell, T; Yang, N; Saer, B; Begley, N; Poolman, T; Pariollaud, M; Farrow, S; DeMayo, F; Hussell, T; Worthen, GS; Ray, D; Loudon, A				Gibbs, Julie; Ince, Louise; Matthews, Laura; Mei, Junjie; Bell, Thomas; Yang, Nan; Saer, Ben; Begley, Nicola; Poolman, Toryn; Pariollaud, Marie; Farrow, Stuart; DeMayo, Francesco; Hussell, Tracy; Worthen, G. Scott; Ray, David; Loudon, Andrew			An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action	NATURE MEDICINE			English	Article							NEUTROPHIL HOMEOSTASIS; GENE-EXPRESSION; IMMUNE-RESPONSE; RECEPTOR; LUNG; MICE; INFECTION; CHEMOKINE; INNATE; CXCL5	The circadian system is an important regulator of immune function. Human inflammatory lung diseases frequently show time-of-day variation in symptom severity and lung function, but the mechanisms and cell types underlying these effects remain unclear. We show that pulmonary antibacterial responses are modulated by a circadian clock within epithelial club (Clara) cells. These drive circadian neutrophil recruitment to the lung via the chemokine CXCL5. Genetic ablation of the clock gene Bmal1 (also called Amt1 or MOP3) in bronchiolar cells disrupts rhythmic Cxcl5 expression, resulting in exaggerated inflammatory responses to lipopolysaccharide and an impaired host response to Streptococcus pneumoniae infection. Adrenalectomy blocks rhythmic inflammatory responses and the circadian regulation of CXCL5, suggesting a key role for the adrenal axis in driving CXCL5 expression and pulmonary neutrophil recruitment. Glucocorticoid receptor occupancy at the Cxcl5 locus shows circadian oscillations, but this is disrupted in mice with bronchiole-specific ablation of Bmal1, leading to enhanced CXCL5 expression despite normal corticosteroid secretion. The therapeutic effects of the synthetic glucocorticoid dexamethasone depend on intact clock function in the airway. We now define a regulatory mechanism that links the circadian clock and glucocorticoid hormones to control both time-of-day variation and the magnitude of pulmonary inflammation and responses to bacterial infection.	[Gibbs, Julie; Matthews, Laura; Yang, Nan; Poolman, Toryn; Pariollaud, Marie; Farrow, Stuart; Ray, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England; [Ince, Louise; Saer, Ben; Begley, Nicola; Loudon, Andrew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Mei, Junjie; Worthen, G. Scott] Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Bell, Thomas; Hussell, Tracy] Univ Manchester, Core Technol Facil, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England; [Farrow, Stuart] GlaxoSmithKline, Resp Therapy Area, Stevenage, Herts, England; [DeMayo, Francesco] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	University of Manchester; University of Manchester; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Manchester; GlaxoSmithKline; Baylor College of Medicine	Ray, D (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England.	david.w.ray@manchester.ac.uk; andrew.loudon@manchester.ac.uk	Ince, Louise/K-6149-2019; Hussell, Tracy/O-4630-2014; DeMayo, Francesco/C-6255-2019	Ince, Louise/0000-0002-2093-0876; Hussell, Tracy/0000-0001-7186-6141; Loudon, Andrew/0000-0003-3648-445X; Gibbs, Julie/0000-0002-4248-2947; DeMayo, Francesco/0000-0002-9480-7336; Pariollaud, Marie/0000-0003-2325-6394; Yang, Nan/0000-0002-1610-5240; Ray, David/0000-0002-4739-6773; Poolman, Toryn/0000-0002-7427-6603	GlaxoSmithKline; Biotechnology and Biological Sciences Research Council, UK [BB/D004357/1, BB/K003119/1, BB/K003097/1]; Wellcome Trust; UK National Institute for Health Research Musculoskeletal Biomedical Research Unit Manchester; US National Institute of Diabetes and Digestive and Kidney Diseases [P01 DK59820]; US National Institutes of Health [1RO1HL105834, 1RO1AI099479]; BBSRC [BB/K003097/1, BB/K003119/1, BB/L000954/1, BB/D004357/1] Funding Source: UKRI; EPSRC [EP/I037253/1] Funding Source: UKRI; MRC [G0802752, MR/L010240/1, MR/L00254X/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1237048, BB/L000954/1, 1065772, BB/K003119/1, BB/D004357/1, BB/K003097/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I037253/1] Funding Source: researchfish; Medical Research Council [MR/L00254X/1, MR/L010240/1, G0802752] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research Musculoskeletal Biomedical Research Unit Manchester; US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J.S. Takahashi, Southwestern University, for the gift of the Per2-luc mice, F. Scott and A. Hughes for help with imaging lung tissue slices and J. Woodburn for technical help. We thank M.H. Hastings for comments on the manuscript. The work was supported by research grants to A.L. from GlaxoSmithKline and the Biotechnology and Biological Sciences Research Council, UK (BB/D004357/1, BB/K003119/1 and BB/K003097/1), to D.R. from the Wellcome Trust and the UK National Institute for Health Research Musculoskeletal Biomedical Research Unit Manchester, as well as the US National Institute of Diabetes and Digestive and Kidney Diseases grant P01 DK59820 to F.D. and US National Institutes of Health grants 1RO1HL105834 and 1RO1AI099479 to G.S.W.	Aschoff, 1965, CIRCADIAN CLOCKS, P95; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Elizur A, 2007, AM J PHYSIOL-LUNG C, V293, pL383, DOI 10.1152/ajplung.00024.2007; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guilding C, 2013, J PHYSIOL-LONDON, V591, P1063, DOI 10.1113/jphysiol.2012.242198; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Han DH, 2014, MOL CELL ENDOCRINOL, V383, P170, DOI 10.1016/j.mce.2013.12.013; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakagome K, 2012, INT ARCH ALLERGY IMM, V158, P96, DOI 10.1159/000337801; Ota T, 2012, MOL CELL ENDOCRINOL, V349, P30, DOI 10.1016/j.mce.2011.08.010; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; SHACKELFORD PG, 1973, SCIENCE, V182, P285, DOI 10.1126/science.182.4109.285; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; SMITH JB, 1995, J BIOL CHEM, V270, P16756, DOI 10.1074/jbc.270.28.16756; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Tuller T, 2013, GENES IMMUN, V14, P67, DOI 10.1038/gene.2012.55; Vasu VT, 2009, INTEGR CANCER THER, V8, P321, DOI 10.1177/1534735409352027; Vyas S, 2013, MOL CELL, V49, P1, DOI 10.1016/j.molcel.2012.12.017; Wang XJ, 2011, BRAIN BEHAV IMMUN, V25, P127, DOI 10.1016/j.bbi.2010.09.007; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	45	269	274	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2014	20	8					919	926		10.1038/nm.3599	http://dx.doi.org/10.1038/nm.3599			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AM7UQ	25064128	Green Accepted			2022-12-25	WOS:000340074600024
